PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kim, JK; Jang, HA; Kim, MS; Cho, JH; Lee, J; Di Lorenzo, F; Sturiale, L; Silipo, A; Molinaro, A; Lee, BL				Kim, Jiyeun Kate; Jang, Ho Am; Kim, Min Seon; Cho, Jae Hyun; Lee, Junbeom; Di Lorenzo, Flaviana; Sturiale, Luisa; Silipo, Alba; Molinaro, Antonio; Lee, Bok Luel			The lipopolysaccharide core oligosaccharide of Burkholderia plays a critical role in maintaining a proper gut symbiosis with the bean bug Riptortus pedestris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosynthesis; insect; lipopolysaccharide (LPS); oligosaccharide; symbiosis	ESCHERICHIA-COLI; INNATE IMMUNITY; BACTERIAL LIPOPOLYSACCHARIDES; ANTIMICROBIAL PEPTIDES; INSECT GUT; O-ANTIGEN; BIOSYNTHESIS; ASSOCIATION; STINKBUG; COLONIZATION	Lipopolysaccharide, the outer cell-wall component of Gram-negative bacteria, has been shown to be important for symbiotic associations. We recently reported that the lipopolysaccharide O-antigen of Burkholderia enhances the initial colonization of the midgut of the bean bug, Riptortus pedestris. However, the midgut-colonizing Burkholderia symbionts lack the O-antigen but display the core oligosaccharide on the cell surface. In this study, we investigated the role of the core oligosaccharide, which directly interacts with the host midgut, in the Riptortus-Burkholderia symbiosis. To this end, we generated the core oligosaccharide mutant strains, wabS, wabO, waaF, and waaC, and determined the chemical structures of their oligosaccharides, which exhibited different compositions. The symbiotic properties of these mutant strains were compared with those of the wild-type and O-antigen-deficient wbiG strains. Upon introduction into Riptortus via the oral route, the core oligosaccharide mutant strains exhibited different rates of colonization of the insect midgut. The symbiont titers in fifth-instar insects revealed significantly reduced population sizes of the inner core oligosaccharide mutant strains waaF and waaC. These two strains also negatively affected host growth rate and fitness. Furthermore, R. pedestris individuals colonized with the waaF and waaC strains were vulnerable to septic bacterial challenge, similar to insects without a Burkholderia symbiont. Taken together, these results suggest that the core oligosaccharide from Burkholderia symbionts plays a critical role in maintaining a proper symbiont population and in supporting the beneficial effects of the symbiont on its host in the Riptortus-Burkholderia symbiosis.	[Kim, Jiyeun Kate] Kosin Univ, Dept Microbiol, Coll Med, Busan 49267, South Korea; [Jang, Ho Am; Kim, Min Seon; Cho, Jae Hyun; Lee, Junbeom; Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Global Res Lab, Busan 46241, South Korea; [Di Lorenzo, Flaviana; Silipo, Alba; Molinaro, Antonio] Univ Napoli Federico II, Complesso Univ Monte S Angelo, Dipartimento Sci Chim, Via Cintia 4, I-80126 Naples, Italy; [Sturiale, Luisa] CNR, IPCB, Via P Gaifami 18, I-95126 Catania, Italy	Pusan National University; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Polimeri, Compositi e Biomateriali (IPCB-CNR)	Lee, BL (corresponding author), Pusan Natl Univ, Coll Pharm, Global Res Lab, Busan 46241, South Korea.	brlee@pusan.ac.kr	Silipo, Alba/L-5929-2014	Di Lorenzo, Flaviana/0000-0003-4821-0114	Ministry of Agriculture, Food and Rural Affairs [916009-02-1-SB020]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning [NRF-2017R1A2B1002706]	Ministry of Agriculture, Food and Rural Affairs; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning	This work was supported by Ministry of Agriculture, Food and Rural Affairs Grant 916009-02-1-SB020 and Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Science, ICT, and Future Planning Grant NRF-2017R1A2B1002706. The authors declare that they have no conflicts of interest with the contents of this article.	Bennett HPJ, 2005, J BACTERIOL, V187, P77, DOI 10.1128/JB.187.1.77-84.2005; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Caroff M, 2003, CARBOHYD RES, V338, P2431, DOI 10.1016/j.carres.2003.07.010; De Castro C, 2010, METHOD ENZYMOL, V480, P89, DOI 10.1016/S0076-6879(10)80005-9; De Soyza A, 2008, INNATE IMMUN-LONDON, V14, P127, DOI 10.1177/1753425908093984; Di Lorenzo F, 2013, CHEMBIOCHEM, V14, P1105, DOI 10.1002/cbic.201300062; Dohi H, 2008, CHEM-EUR J, V14, P9530, DOI 10.1002/chem.200801279; Durka M, 2011, CHEM-EUR J, V17, P11305, DOI 10.1002/chem.201100396; Hassan AA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01027; Kikuchi Y, 2005, APPL ENVIRON MICROB, V71, P4035, DOI 10.1128/AEM.71.7.4035-4043.2005; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kikuchi Y, 2014, MOL ECOL, V23, P1445, DOI 10.1111/mec.12479; Kikuchi Y, 2013, APPL ENVIRON MICROB, V79, P2088, DOI 10.1128/AEM.03299-12; Kikuchi Y, 2011, APPL ENVIRON MICROB, V77, P4075, DOI 10.1128/AEM.00358-11; Kikuchi Y, 2011, ISME J, V5, P446, DOI 10.1038/ismej.2010.150; Kim Jiyeun Kate, 2016, Developmental & Comparative Immunology, V64, P75, DOI 10.1016/j.dci.2016.01.005; Kim JK, 2016, DEV COMP IMMUNOL, V60, P202, DOI 10.1016/j.dci.2016.02.009; Kim JK, 2015, J BIOL CHEM, V290, P21042, DOI 10.1074/jbc.M115.651158; Kim JK, 2015, DEV COMP IMMUNOL, V53, P265, DOI 10.1016/j.dci.2015.07.006; Kim JK, 2015, ARCH INSECT BIOCHEM, V88, P4, DOI 10.1002/arch.21218; Kim JK, 2014, ISME J, V8, P552, DOI 10.1038/ismej.2013.168; Kim JK, 2013, APPL ENVIRON MICROB, V79, P4879, DOI 10.1128/AEM.01269-13; Kim JK, 2013, P NATL ACAD SCI USA, V110, pE2381, DOI 10.1073/pnas.1303228110; Lee DJ, 2017, DEV COMP IMMUNOL, V67, P427, DOI 10.1016/j.dci.2016.08.009; Lee JB, 2015, FEBS LETT, V589, P2784, DOI 10.1016/j.febslet.2015.08.022; LEONTEIN K, 1978, CARBOHYD RES, V62, P359, DOI 10.1016/S0008-6215(00)80882-4; Loutet SA, 2006, J BACTERIOL, V188, P2073, DOI 10.1128/JB.188.6.2073-2080.2006; Molinaro A, 2015, CHEM-EUR J, V21, P500, DOI 10.1002/chem.201403923; Moreau F, 2008, BIOORG MED CHEM LETT, V18, P4022, DOI 10.1016/j.bmcl.2008.05.117; Ohbayashi T, 2015, P NATL ACAD SCI USA, V112, pE5179, DOI 10.1073/pnas.1511454112; Ortega X, 2009, J BIOL CHEM, V284, P21738, DOI 10.1074/jbc.M109.008532; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; Post DMB, 2012, J BIOL CHEM, V287, P8515, DOI 10.1074/jbc.M111.324012; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Ruby EG, 2008, NAT REV MICROBIOL, V6, P752, DOI 10.1038/nrmicro1958; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAFER A, 1994, J BACTERIOL, V176, P7309; Shibata TF, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00441-13; Silipo A, 2004, EUR J ORG CHEM, V2004, P2263, DOI 10.1002/ejoc.200400048; Silipo A, 2006, EUR J ORG CHEM, V2006, P4874, DOI 10.1002/ejoc.200600520; Stabb EV, 2002, METHOD ENZYMOL, V358, P413; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; Sturiale L, 2011, J MASS SPECTROM, V46, P1135, DOI 10.1002/jms.2000; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030	46	17	17	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19226	19237		10.1074/jbc.M117.813832	http://dx.doi.org/10.1074/jbc.M117.813832			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972189	Green Published, hybrid			2022-12-26	WOS:000416226700007
J	Pierman, B; Toussaint, F; Bertin, A; Levy, D; Smargiasso, N; De Pauw, E; Boutry, M				Pierman, Baptiste; Toussaint, Frederic; Bertin, Aurelie; Levy, Daniel; Smargiasso, Nicolas; De Pauw, Edwin; Boutry, Marc			Activity of the purified plant ABC transporter NtPDR1 is stimulated by diterpenes and sesquiterpenes involved in constitutive and induced defenses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; glycosylation; liposome; membrane reconstitution; plant defense; protein purification; single particle analysis; BY-2 cells; Nicotiana tabacum; terpenes	ATP-BINDING CASSETTE; DRUG-RESISTANCE TRANSPORTER; LIPID TRANSFER PROTEIN; NICOTIANA-TABACUM; H+-ATPASE; TOBACCO; EXPRESSION; SECRETION; MULTIDRUG; RECONSTITUTION	Within the plant ATP-binding cassette transporter family, pleiotropic drug resistance (PDR) transporters play essential functions, such as in hormone transport or defense against biotic and abiotic stresses. NtPDR1 from Nicotiana tabacum has been shown to be involved in the constitutive defense against pathogens through the secretion of toxic cyclic diterpenes, such as the antimicrobial substrates cembrene and sclareol from the leaf hairs (trichomes). However, direct evidence of an interaction between NtPDR1 and terpenes is lacking. Here, we stably expressed NtPDR1 in N. tabacum BY-2 suspension cells. NtPDR1 was purified as an active monomer glycosylated at a single site in the third external loop. NtPDR1 reconstitution in proteoliposomes stimulated its basal ATPase activity from 21 to 38 nmol of P(i<bold>)mg(</bold>-1<bold>)min(</bold>-1), and ATPase activity was further stimulated by the NtPDR1 substrates cembrene and sclareol, providing direct evidence of an interaction between NtPDR1 and its two substrates. Interestingly, NtPDR1 was also stimulated by capsidiol, a sesquiterpene produced by N. tabacum upon pathogen attack. We also monitored the transcriptional activity from the NtPDR1 promoter in situ with a reporter gene and found that, although NtPDR1 expression was limited to trichomes under normal conditions, addition of methyl jasmonate, a biotic stress hormone, induced expression in all leaf tissues. This finding indicated that NtPDR1 is involved not only in constitutive but also in induced plant defenses. In conclusion, we provide direct evidence of an interaction between the NtPDR1 transporter and its substrates and that NtPDR1 transports compounds involved in both constitutive (diterpenes) and induced (sesquiterpenes) plant defenses.	[Pierman, Baptiste; Toussaint, Frederic; Boutry, Marc] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain La Neuve, Belgium; [Bertin, Aurelie; Levy, Daniel] Univ Pierre & Marie Curie Paris 06, Lab Phys Chim Curie, Inst Curie, Paris Sci & Lettres Res Univ,CNRS,UMR168, F-75005 Paris, France; [Bertin, Aurelie; Levy, Daniel] Univ Pierre & Marie Curie Paris 06, Sorbonne Univ, F-75005 Paris, France; [Smargiasso, Nicolas; De Pauw, Edwin] Univ Liege, Mol Syst Res Unit, Mass Spectrometry Lab, B-4000 Liege, Belgium	Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; Sorbonne Universite; University of Liege	Boutry, M (corresponding author), Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain La Neuve, Belgium.	marc.boutry@uclouvain.be		Bertin, Aurelie/0000-0002-3400-6887; levy, daniel/0000-0002-8949-4072; Toussaint, Frederic/0000-0002-4869-4350	French National Research Agency through the "Investments for the Future" [ANR-10-INSB-04]; Plateforme d'Imagerie Cellulaire et Tissulaire - Infrastructures Biologie Sante et Agronomie (PICT-IBiSA) (Institut Curie, Paris, France); Belgian Fund for Scientific Research; Interuniversity Poles of Attraction Program (Belgian State, Scientific, Technical and Cultural Services)	French National Research Agency through the "Investments for the Future"(French National Research Agency (ANR)); Plateforme d'Imagerie Cellulaire et Tissulaire - Infrastructures Biologie Sante et Agronomie (PICT-IBiSA) (Institut Curie, Paris, France); Belgian Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Interuniversity Poles of Attraction Program (Belgian State, Scientific, Technical and Cultural Services)	This work was supported by grants from the French National Research Agency through the "Investments for the Future" (France-BioImaging, Grant ANR-10-INSB-04), the Plateforme d'Imagerie Cellulaire et Tissulaire - Infrastructures Biologie Sante et Agronomie (PICT-IBiSA) (Institut Curie, Paris, France), the Belgian Fund for Scientific Research, and the Interuniversity Poles of Attraction Program (Belgian State, Scientific, Technical and Cultural Services). The authors declare that they have no conflicts of interest with the contents of this article.	Adebesin F, 2017, SCIENCE, V356, P1386, DOI 10.1126/science.aan0826; Banasiak J, 2013, J EXP BOT, V64, P1005, DOI 10.1093/jxb/ers380; Bessire M, 2011, PLANT CELL, V23, P1958, DOI 10.1105/tpc.111.083121; Biala W, 2017, J EXP BOT, V68, P3231, DOI 10.1093/jxb/erx059; Bienert MD, 2012, PLANT J, V72, P745, DOI 10.1111/j.1365-313X.2012.05108.x; Bouige P, 2002, CURR PROTEIN PEPT SC, V3, P541, DOI 10.2174/1389203023380486; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURDEN RS, 1975, PHYTOCHEMISTRY, V14, P221, DOI 10.1016/0031-9422(75)85043-6; Cacas JL, 2016, PLANT PHYSIOL, V170, P367, DOI 10.1104/pp.15.00564; Champagne A, 2016, BBA-PROTEINS PROTEOM, V1864, P1039, DOI 10.1016/j.bbapap.2016.02.010; Cho M, 2007, PLANT CELL, V19, P3930, DOI 10.1105/tpc.107.054288; Choi YE, 2012, PLANT J, V70, P480, DOI 10.1111/j.1365-313X.2011.04886.x; Crouzet J, 2006, FEBS LETT, V580, P1123, DOI 10.1016/j.febslet.2005.12.043; Crouzet J, 2013, PLANT MOL BIOL, V82, P181, DOI 10.1007/s11103-013-0053-0; De Muynck B, 2009, TRANSGENIC RES, V18, P467, DOI 10.1007/s11248-008-9240-1; Demessie Z, 2017, PHYTOCHEMISTRY, V140, P118, DOI 10.1016/j.phytochem.2017.04.019; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fu XQ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00723; Furt F, 2011, PLANT CELL MONOGR, V19, P3, DOI 10.1007/978-3-642-13431-9_1; Galian C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019677; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Goderis IJWM, 2002, PLANT MOL BIOL, V50, P17, DOI 10.1023/A:1016052416053; Hammerschmidt R, 1999, ANNU REV PHYTOPATHOL, V37, P285, DOI 10.1146/annurev.phyto.37.1.285; Herget M, 2009, J BIOL CHEM, V284, P33740, DOI 10.1074/jbc.M109.047779; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Holland IB, 2011, ESSAYS BIOCHEM, V50, P1, DOI [10.1042/BSE0500001, 10.1042/bse0500001]; Hwang JU, 2016, MOL PLANT, V9, P338, DOI 10.1016/j.molp.2016.02.003; Ito H, 2006, PLANT PHYSIOL, V142, P63, DOI 10.1104/pp.106.084533; Jasinski M, 2001, PLANT CELL, V13, P1095, DOI 10.1105/tpc.13.5.1095; Jeter CR, 2004, PLANT CELL, V16, P2652, DOI 10.1105/tpc.104.023945; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Kim DY, 2007, PLANT J, V50, P207, DOI 10.1111/j.1365-313X.2007.03044.x; Klappe K, 2009, CHEM PHYS LIPIDS, V161, P57, DOI 10.1016/j.chemphyslip.2009.07.004; Kretzschmar T, 2012, NATURE, V483, P341, DOI 10.1038/nature10873; Kretzschmar T, 2011, ESSAYS BIOCHEM, V50, P145, DOI [10.1042/BSE0500145, 10.1042/bse0500145]; Kubes M, 2012, PLANT J, V69, P640, DOI 10.1111/j.1365-313X.2011.04818.x; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Lee JY, 2016, NATURE, V533, P561, DOI 10.1038/nature17666; Lee M, 2005, PLANT PHYSIOL, V138, P827, DOI 10.1104/pp.104.058107; Lefevre F, 2015, BIOCHEM SOC T, V43, P931, DOI 10.1042/BST20150108; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maldonado-Bonilla LD, 2008, EUR J PLANT PATHOL, V121, P439, DOI 10.1007/s10658-007-9262-1; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Miah MF, 2016, BIOCHEM BIOPH RES CO, V469, P954, DOI 10.1016/j.bbrc.2015.12.095; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Moriau L, 1999, PLANT J, V19, P31, DOI 10.1046/j.1365-313X.1999.00495.x; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Navarre C, 2017, TRANSGENIC RES, V26, P375, DOI 10.1007/s11248-017-0013-6; Nocarova E, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-44; Pernstich C, 2014, PROTEIN EXPRES PURIF, V101, P68, DOI 10.1016/j.pep.2014.05.011; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Ruzicka K, 2010, P NATL ACAD SCI USA, V107, P10749, DOI 10.1073/pnas.1005878107; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Sasabe M, 2002, FEBS LETT, V518, P164, DOI 10.1016/S0014-5793(02)02697-2; Sasse J, 2016, PLANT CELL ENVIRON, V39, P2725, DOI 10.1111/pce.12828; Shibata Y, 2016, PLANT CELL, V28, P1163, DOI 10.1105/tpc.15.00721; Shoji T, 2014, INT REV CEL MOL BIO, V309, P303, DOI 10.1016/B978-0-12-800255-1.00006-5; Strader LC, 2009, PLANT CELL, V21, P1992, DOI 10.1105/tpc.109.065821; Strasser R, 2016, GLYCOBIOLOGY, V26, P926, DOI 10.1093/glycob/cww023; Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006; Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI [10.1016/S0005-2736(00)00132-2, 10.1199/tab.0153]; Toussaint F, 2017, BIOCHEM J, V474, P1689, DOI 10.1042/BCJ20170108; van der Fits L, 2000, PLANT MOL BIOL, V43, P495, DOI 10.1023/A:1006440221718; Vasiliou Vasilis, 2009, Human Genomics, V3, P281; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; WAGNER GJ, 1991, PLANT PHYSIOL, V96, P675, DOI 10.1104/pp.96.3.675; Wagner GJ, 2004, ANN BOT-LONDON, V93, P3, DOI 10.1093/aob/mch011; Wang B, 2016, METAB ENG, V38, P159, DOI 10.1016/j.ymben.2016.07.004; Yazaki K, 2009, INT REV CEL MOL BIO, V276, P263, DOI 10.1016/S1937-6448(09)76006-X; Yu F, 2013, P NATL ACAD SCI USA, V110, P15830, DOI 10.1073/pnas.1307504110	75	27	29	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19491	19502		10.1074/jbc.M117.811935	http://dx.doi.org/10.1074/jbc.M117.811935			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972149	hybrid, Green Published			2022-12-26	WOS:000416226700028
J	Tunduguru, R; Zhang, J; Aslamy, A; Salunkhe, VA; Brozinick, JT; Elmendorf, JS; Thurmond, DC				Tunduguru, Ragadeepthi; Zhang, Jing; Aslamy, Arianne; Salunkhe, Vishal A.; Brozinick, Joseph T.; Elmendorf, Jeffrey S.; Thurmond, Debbie C.			The actin-related p41ARC subunit contributes to p21-activated kinase-1 (PAK1)-mediated glucose uptake into skeletal muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; glucose transporter type 4 (GLUT4); insulin resistance; serine; threonine protein kinase PAK 1 (PAK1); skeletal muscle; insulin signaling	GLUT4 TRANSLOCATION; N-WASP; ARP2/3 COMPLEX; INSULIN SENSITIVITY; PHOSPHATIDYLINOSITOL 3-KINASE; SYNTAXIN 4; TRANSPORT; KINASE; PAK1; ACTIVATION	Defects in translocation of the glucose transporter GLUT4 are associated with peripheral insulin resistance, preclinical diabetes, and progression to type 2 diabetes. GLUT4 recruitment to the plasma membrane of skeletal muscle cells requires F-actin remodeling. Insulin signaling in muscle requires p21-activated kinase-1 (PAK1), whose downstream signaling triggers actin remodeling, which promotes GLUT4 vesicle translocation and glucose uptake into skeletal muscle cells. Actin remodeling is a cyclic process, and although PAK1 is known to initiate changes to the cortical actin-binding protein cofilin to stimulate the depolymerizing arm of the cycle, how PAK1 might trigger the polymerizing arm of the cycle remains unresolved. Toward this, we investigated whether PAK1 contributes to the mechanisms involving the actin-binding and -polymerizing proteins neural Wiskott-Aldrich syndrome protein (N-WASP), cortactin, and ARP2/3 subunits. We found that the actin-polymerizing ARP2/3 subunit p41ARC is a PAK1 substrate in skeletal muscle cells. Moreover, co-immunoprecipitation experiments revealed that insulin stimulates p41ARC phosphorylation and increases its association with N-WASP coordinately with the associations of N-WASP with cortactin and actin. Importantly, all of these associations were ablated by the PAK inhibitor IPA3, suggesting that PAK1 activation lies upstream of these actin-polymerizing complexes. Using the N-WASP inhibitor wiskostatin, we further demonstrated that N-WASP is required for localized F-actin polymerization, GLUT4 vesicle translocation, and glucose uptake. These results expand the model of insulin-stimulated glucose uptake in skeletal muscle cells by implicating p41ARC as a new component of the insulin-signaling cascade and connecting PAK1 signaling to N-WASP-cortactin-mediated actin polymerization and GLUT4 vesicle translocation.	[Tunduguru, Ragadeepthi; Elmendorf, Jeffrey S.; Thurmond, Debbie C.] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Aslamy, Arianne; Elmendorf, Jeffrey S.; Thurmond, Debbie C.] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Tunduguru, Ragadeepthi; Zhang, Jing; Aslamy, Arianne; Salunkhe, Vishal A.; Thurmond, Debbie C.] City Hope Natl Med Ctr, Diabet & Metab Res Inst, Dept Mol & Cellular Endocrinol, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Tunduguru, Ragadeepthi; Zhang, Jing; Aslamy, Arianne; Salunkhe, Vishal A.; Thurmond, Debbie C.] City Hope Natl Med Ctr, Beckman Res Inst, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Brozinick, Joseph T.] Eli Lilly & Co, Indianapolis, IN 46285 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; City of Hope; City of Hope; Beckman Research Institute of City of Hope; Eli Lilly	Thurmond, DC (corresponding author), City Hope Natl Med Ctr, Diabet & Metab Res Inst, Dept Mol & Cellular Endocrinol, 1500 E Duarte Rd, Duarte, CA 91010 USA.; Thurmond, DC (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, 1500 E Duarte Rd, Duarte, CA 91010 USA.	dthurmond@coh.org	Tunduguru, Ragadeepthi/AAU-6056-2020; Zhang, Jing/E-4844-2013	Zhang, Jing/0000-0003-0391-7298; Tunduguru, Ragadeepthi/0000-0001-7075-5511	NCI, National Institutes of Health [P30CA33572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097512, R01DK067912, R01DK102233] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Susan Gunst and Dr. Simon Atkinson (Indiana University) for the N-WASP plasmid and sage advice and feedback on this project emanating from the doctoral dissertation of R. T. We also thank Lixuan Tackett, Erika Olson, and Rajakrishnan Veluthakal for technical assistance. The research reported in this publication also includes work performed in the Light Microscopy Core, supported by the NCI, National Institutes of Health under Award P30CA33572.	Abella JVG, 2016, NAT CELL BIOL, V18, P76, DOI 10.1038/ncb3286; Band AM, 2002, FEBS LETT, V531, P513, DOI 10.1016/S0014-5793(02)03605-0; Carlier MF, 2015, CELL MOL LIFE SCI, V72, P3051, DOI 10.1007/s00018-015-1914-2; Cheatham B, 1996, P NATL ACAD SCI USA, V93, P15169, DOI 10.1073/pnas.93.26.15169; Chen SA, 2011, CELL METAB, V13, P68, DOI 10.1016/j.cmet.2010.12.005; Chiu TT, 2010, MOL BIOL CELL, V21, P3529, DOI 10.1091/mbc.E10-04-0316; De Meyts P., 2016, ENDOTEXT; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; FERRANNINI E, 1985, J CLIN INVEST, V76, P357, DOI 10.1172/JCI111969; Foley K, 2011, BIOCHEMISTRY-US, V50, P3048, DOI 10.1021/bi2000356; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Grassart A, 2010, TRAFFIC, V11, P1079, DOI 10.1111/j.1600-0854.2010.01075.x; Gruenbaum-Cohen Y, 2012, P NATL ACAD SCI USA, V109, P11211, DOI 10.1073/pnas.1116065109; Guerriero CJ, 2007, AM J PHYSIOL-CELL PH, V292, pC1562, DOI 10.1152/ajpcell.00426.2006; Habegger KM, 2012, DIABETOLOGIA, V55, P457, DOI 10.1007/s00125-011-2334-y; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Ho H, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12058; Ishikura S, 2008, AM J PHYSIOL-CELL PH, V295, pC1016, DOI 10.1152/ajpcell.00277.2008; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Jiang ZY, 2002, J BIOL CHEM, V277, P509, DOI 10.1074/jbc.M108280200; KANAI F, 1993, J BIOL CHEM, V268, P14523; Khayat ZA, 2000, J CELL SCI, V113, P279; Kim YB, 2015, J BIOL CHEM, V290, P21076, DOI 10.1074/jbc.M115.675124; Klip A, 2014, AM J PHYSIOL-CELL PH, V306, pC879, DOI 10.1152/ajpcell.00069.2014; Kramer HF, 2006, J BIOL CHEM, V281, P31478, DOI 10.1074/jbc.M605461200; Langlais P, 2012, J BIOL CHEM, V287, P39245, DOI 10.1074/jbc.M112.394148; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Lim CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6951; Lopez JP, 2010, AM J PHYSIOL-ENDOC M, V299, pE772, DOI 10.1152/ajpendo.00199.2010; McCarthy AM, 2006, AM J PHYSIOL-CELL PH, V291, pC860, DOI 10.1152/ajpcell.00107.2006; Nazari H, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1262, DOI 10.1134/S0006297911110083; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Peterson JR, 2004, NAT STRUCT MOL BIOL, V11, P747, DOI 10.1038/nsmb796; Ramalingam L, 2014, DIABETOLOGIA, V57, P1476, DOI 10.1007/s00125-014-3227-7; Ramalingam L, 2013, CELL MOL LIFE SCI, V70, P2815, DOI 10.1007/s00018-012-1176-1; Randhawa VK, 2008, J BIOL CHEM, V283, P27208, DOI 10.1074/jbc.M804282200; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sun Y, 2010, P NATL ACAD SCI USA, V107, P19909, DOI 10.1073/pnas.1009523107; Sylow L, 2013, DIABETES, V62, P1865, DOI 10.2337/db12-1148; THIEBAUD D, 1982, DIABETES, V31, P957, DOI 10.2337/diacare.31.11.957; Tomasevic N, 2007, BIOCHEMISTRY-US, V46, P3494, DOI 10.1021/bi062152y; Tsakiridis T, 1996, J BIOL CHEM, V271, P19664, DOI 10.1074/jbc.271.33.19664; Tunduguru R, 2014, BIOCHEM PHARMACOL, V92, P380, DOI 10.1016/j.bcp.2014.08.033; Ueyama A, 1999, AM J PHYSIOL-ENDOC M, V277, pE572, DOI 10.1152/ajpendo.1999.277.3.E572; Vadlamudi RK, 2004, EMBO REP, V5, P154, DOI 10.1038/sj.embor.7400079; Volchuk A, 1996, MOL BIOL CELL, V7, P1075, DOI 10.1091/mbc.7.7.1075; Vu V, 2013, J MOL ENDOCRINOL, V51, P155, DOI 10.1530/JME-13-0059; WALKER PS, 1990, J BIOL CHEM, V265, P1516; Wang RA, 2006, ONCOGENE, V25, P2931, DOI 10.1038/sj.onc.1209309; Wang ZX, 2011, J BIOL CHEM, V286, P41359, DOI 10.1074/jbc.M111.291500; Webb BA, 2006, ARCH BIOCHEM BIOPHYS, V456, P183, DOI 10.1016/j.abb.2006.06.011; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Zhang WW, 2005, AM J PHYSIOL-CELL PH, V288, pC1145, DOI 10.1152/ajpcell.00387.2004	55	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19034	19043		10.1074/jbc.M117.801340	http://dx.doi.org/10.1074/jbc.M117.801340			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972183	Green Published, hybrid			2022-12-26	WOS:000415848000026
J	Khanal, MK; Dhungana, RR; Bhandari, P; Gurung, Y; Paudel, KN				Khanal, Mahesh Kumar; Dhungana, Raja Ram; Bhandari, Pratiksha; Gurung, Yadav; Paudel, K. N.			Prevalence, associated factors, awareness, treatment, and control of hypertension: Findings from a cross sectional study conducted as a part of a community based intervention trial in Surkhet, Mid-western region of Nepal	PLOS ONE			English	Article							BLOOD-PRESSURE; RISK-FACTOR; ALCOHOL-CONSUMPTION; GLOBAL BURDEN; POPULATION; COUNTRIES; SMOKING; DISEASE; SODIUM; WOMEN	Background Hypertension is one of the leading public health problems globally. About half of the deaths from cardiovascular diseases were attributed to hypertension in 2008. Reduction of blood pressure to normal range is one of the major challenges in preventing complications and future burden of cardiovascular diseases. Therefore, this study aims to determine prevalence, awareness, treatment and control of hypertension and its associated factors in Nepal. Methods This was a community based cross-sectional study conducted as a part of a community based intervention trial in Birendranagar Municipality of Surkhet district located at the Midwestern region of Nepal. We enrolled 1159 subjects aged 30 years and above. Out of 12 wards (administrative unit), four wards were selected randomly. Three hundred participants were recruited from each selected ward. Trained enumerator collected socio-demographic, anthropometric, and clinical data using standard STEPS questionnaires. Results Out of all participants, women were 71% and mean age was 47 +/- 12.6 years. The overall prevalence of hypertension was 38.9% (95% CI: 36 +/- 41.7) while age and sex adjusted prevalence was 40.6%. The hypertension was present in 48.1% (95% CI: 45.2 +/- 50.9) of men and 35.2% (95% CI: 32.4 +/- 37.9)] of women. Male gender (OR = 1.49), older age (OR = 1.04 per year), Dalit caste (OR = 1.71), past history of cigarettes smoking (OR = 2.78), current alcohol consumption (OR = 1.75), and raised body mass index (OR = 1.17 per unit) were identified as significant factors associated with hypertension. Of total hypertensive respondents, 53.4% (95% CI: 48.7-58) were aware, 29% (95% CI: 24.8-33.1) were receiving treatment for high blood pressure, and 8.2% (95% CI: 5.6-10.7) had controlled blood pressure. The awareness, treatment, and control status were worse in younger participants. Conclusions The study revealed high prevalence with low awareness, treatment, and control of hypertension in Nepal. Gender, age, ethnicity, smoking, drinking alcohol, and body mass index were associated with hypertension. Immediate public health and individual measures are warranted to reduce future burden of cardiovascular diseases.	[Khanal, Mahesh Kumar] Bheri Zonal Ayurveda Hosp, Minist Hlth, Surkhet, Nepal; [Dhungana, Raja Ram] Nepal Publ Hlth Fdn, Kathmandu, Nepal; [Bhandari, Pratiksha; Paudel, K. N.] Mid Western Reg Hosp, Minist Hlth, Surkhet, Nepal; [Gurung, Yadav] Populat Serv Int Nepal, Lalitpur, Nepal		Khanal, MK (corresponding author), Bheri Zonal Ayurveda Hosp, Minist Hlth, Surkhet, Nepal.	drmkkhanal@gmail.com	Dhungana, Raja Ram/B-3673-2016	Dhungana, Raja Ram/0000-0002-9610-6306; Gurung, Yadav/0000-0002-0397-0489; Khanal, Dr. Mahesh Kumar/0000-0001-5324-2802	Nepal Family Development Foundation, Kathmandu, Nepal	Nepal Family Development Foundation, Kathmandu, Nepal	The study was supported by a fund from Nepal Family Development Foundation, Kathmandu, Nepal. YG received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, WHO FOR TECHN M PAR; Aryal KN S, 2014, NONCOMMUNICABLE DIS; Aryal KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134834; Beilin LJ, 2006, HYPERTENSION, V47, P1035, DOI 10.1161/01.HYP.0000218586.21932.3c; Bowman TS, 2007, J AM COLL CARDIOL, V50, P2085, DOI 10.1016/j.jacc.2007.08.017; CBC, 2014, POPULATION MONOGRAPH; CBS. , 2014, NAT POP HOUS CENS 20; Central Bureau of Statistics and World Bank, 2012, POV NEP 2010 11; Chataut J, 2015, Kathmandu Univ Med J (KUMJ), V13, P346; Chataut J, 2011, Kathmandu Univ Med J (KUMJ), V9, P13; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Cooper R, 1984, J Hypertens, V2, P361; Devkota S, 2016, FRONT CARDIOVASC MED, V3, DOI 10.3389/fcvm.2016.00026; Dhungana RR, 2016, INT J HYPERTENS, V2016, P1, DOI 10.1155/2016/1656938; Dhungana RR, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-92; Di Cesare M, 2013, INT J EPIDEMIOL, V42, P838, DOI 10.1093/ije/dyt063; GREEN MS, 1986, AM HEART J, V111, P932, DOI 10.1016/0002-8703(86)90645-9; Janus ED, 2008, INTERN MED J, V38, P879, DOI 10.1111/j.1445-5994.2007.01583.x; Kannel WB, 1996, CLIN CHIM ACTA, V246, P59; KAPLAN NM, 1995, LANCET, V345, P1588, DOI 10.1016/S0140-6736(95)90110-8; Karmacharya BM, 2017, HEART ASIA, V9, P1, DOI 10.1136/heartasia-2016-010766; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Klungel OH, 1997, J HYPERTENS, V15, P591, DOI 10.1097/00004872-199715060-00004; Kowalski K, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-148; Law MR, 2009, BMJ, V338; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Manandhar K, 2012, Kathmandu Univ Med J (KUMJ), V10, P35; McLean RM, 2014, NUTRIENTS, V6, P4651, DOI 10.3390/nu6114651; Meshram II, 2012, J POSTGRAD MED, V58, P255, DOI 10.4103/0022-3859.105444; NELSON L, 1986, LANCET, V2, P473, DOI 10.1016/S0140-6736(86)90354-5; Neupane D, 2017, AM J HYPERTENS; ROCCHINI AP, 1989, NEW ENGL J MED, V321, P580, DOI 10.1056/NEJM198908313210905; Roerecke M, LANCET PUBLIC HLTH, V2, pe108; Sacco RL, 1999, JAMA-J AM MED ASSOC, V281, P53, DOI 10.1001/jama.281.1.53; Sankoh O, 2014, GLOBAL HLTH ACTION, V7; Sesso HD, 2008, HYPERTENSION, V51, P1080, DOI 10.1161/HYPERTENSIONAHA.107.104968; Sharma Deewakar, 2006, Indian Heart J, V58, P34; Sharma SK, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/821971; WEBER MA, 1989, AM J CARDIOL, V63, pH25; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2013, GLOB BRIEF HYP; WHO, 1997, PREV MAN GLOB EP OB; World Health Organization, 2005, WHO STEPS SURV MAN W; World Health Organization, 2008, WAIST CIRCUMFERENCE; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424	48	22	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185806	10.1371/journal.pone.0185806	http://dx.doi.org/10.1371/journal.pone.0185806			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982159	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300069
J	Perrotti, PP; Aterido, A; Fernandez-Nebro, A; Canete, JD; Ferrandiz, C; Tomero, J; Gisbert, JP; Domenech, E; Fernandez-Gutierrez, B; Gomollon, F; Garcia-Planella, E; Fernandez, E; Sanmarti, R; Gratacos, J; Martinez-Taboada, VM; Rodriguez-Rodriguez, L; Palau, N; Tortosa, R; Corbeto, ML; Lasanta, ML; Marsal, S; Julia, A				Perrotti, Pedro P.; Aterido, Adria; Fernandez-Nebro, Antonio; Canete, Juan D.; Ferrandiz, Carlos; Tomero, Jesus; Gisbert, Javier P.; Domenech, Eugeni; Fernandez-Gutierrez, Benjamin; Gomollon, Fernando; Garcia-Planella, Esther; Fernandez, Emilia; Sanmarti, Raimon; Gratacos, Jordi; Manuel Martinez-Taboada, Victor; Rodriguez-Rodriguez, Luis; Palau, Nuria; Tortosa, Raul; Corbeto, Mireia L.; Lasanta, Maria L.; Marsal, Sara; Julia, Antonio		IMID Consortium	Genetic variation associated with cardiovascular risk in autoimmune diseases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; IMMUNE-SYSTEM; LOCUS; SUSCEPTIBILITY; METAANALYSIS; MECHANISMS; PATHWAYS	Autoimmune diseases have a higher prevalence of cardiovascular events compared to the general population. The objective of this study was to investigate the genetic basis of cardiovascular disease (CVD) risk in autoimmunity. We analyzed genome-wide genotyping data from 6,485 patients from six autoimmune diseases that are associated with a high socioeconomic impact. First, for each disease, we tested the association of established CVD risk loci. Second, we analyzed the association of autoimmune disease susceptibility loci with CVD. Finally, to identify genetic patterns associated with CVD risk, we applied the cross-phenotype meta-analysis approach (CPMA) on the genome-wide data. A total of 17 established CVD risk loci were significantly associated with CVD in the autoimmune patient cohorts. From these, four loci were found to have significantly different genetic effects across autoimmune diseases. Six autoimmune susceptibility loci were also found to be associated with CVD risk. Genome-wide CPMA analysis identified 10 genetic clusters strongly associated with CVD risk across all autoimmune diseases. Two of these clusters are highly enriched in pathways previously associated with autoimmune disease etiology (TNF alpha and IFN gamma cytokine pathways). The results of this study support the presence of specific genetic variation associated with the increase of CVD risk observed in autoimmunity.	[Perrotti, Pedro P.; Aterido, Adria; Palau, Nuria; Tortosa, Raul; Corbeto, Mireia L.; Lasanta, Maria L.; Marsal, Sara; Julia, Antonio] Vail dHebron Res Inst, Rheumatol Res Grp, Barcelona, Spain; [Perrotti, Pedro P.] Univ Barcelona, Dept Med, Barcelona, Spain; [Aterido, Adria] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain; [Fernandez-Nebro, Antonio] Univ Malaga, Hosp Reg Univ Malaga, Inst Invest Biomed IBIMA, UGC Reumatol, Malaga, Spain; [Canete, Juan D.; Fernandez, Emilia; Sanmarti, Raimon] Hosp Clin Barcelona, Barcelona, Spain; [Canete, Juan D.; Fernandez, Emilia; Sanmarti, Raimon] IDIBAPS, Barcelona, Spain; [Ferrandiz, Carlos; Tomero, Jesus; Domenech, Eugeni] Hosp Badalona Germans Trias & Pujol, Badalona, Spain; [Tomero, Jesus] Hosp Univ Guadalajara, Guadalajara, Spain; [Gisbert, Javier P.; Domenech, Eugeni] CIBERehd, Madrid, Spain; [Gisbert, Javier P.] Hosp Univ Princesa, Madrid, Spain; [Gisbert, Javier P.] IIS IP, Madrid, Spain; [Fernandez-Gutierrez, Benjamin; Rodriguez-Rodriguez, Luis] Hosp Clin San Carlos, IDISSC, Madrid, Spain; [Gomollon, Fernando] Hosp Clin Univ, Zaragoza, Spain; [Garcia-Planella, Esther] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Gratacos, Jordi] Hosp Parc Tauli, Sabadell, Spain; [Manuel Martinez-Taboada, Victor] Hosp Univ Marques de Valdecilla, Santander, Spain	University of Barcelona; Pompeu Fabra University; Universidad de Malaga; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital Germans Trias i Pujol; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital de La Princesa; Hospital Clinico San Carlos; Universidad de la Laguna; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Hospital Universitario Marques de Valdecilla (HUMV)	Marsal, S; Julia, A (corresponding author), Vail dHebron Res Inst, Rheumatol Res Grp, Barcelona, Spain.	sara.marsal@vhir.org; toni.julia@vhir.org	gratacos, jordi/AHC-4573-2022; Fernandez-Nebro, Antonio/K-7628-2012; Fernandez-Gutierrez, Benjamin/AAM-9063-2020; Gisbert, Javier P/ABB-7531-2021; Cañete, Juan D/AAV-8910-2021; Gisbert, Javier P/GRY-2719-2022; Sanmarti, Raimon/M-4434-2017	Fernandez-Nebro, Antonio/0000-0002-2962-9844; Gisbert, Javier P/0000-0003-2090-3445; Cañete, Juan D/0000-0003-2606-0573; Julia Cano, Antonio/0000-0001-6064-3620; Sanmarti, Raimon/0000-0002-8864-3806; marsal, sara/0000-0001-5515-3854; Gratacos, Jordi/0000-0003-4007-4103	Spanish Ministry of Economy and Competitiveness [PSE-010000-2006-6, IPT-010000-2010-36]; "Agenda de Gestio d'Ajuts Universitaris i de Recerca" (AGAUR, Generalitat de Catalunya, FI-DGR) [00587]	Spanish Ministry of Economy and Competitiveness(Spanish Government); "Agenda de Gestio d'Ajuts Universitaris i de Recerca" (AGAUR, Generalitat de Catalunya, FI-DGR)	This study was funded by the Spanish Ministry of Economy and Competitiveness (grant numbers: PSE-010000-2006-6 and IPT-010000-2010-36) and by the "Agenda de Gestio d'Ajuts Universitaris i de Recerca" (AGAUR, Generalitat de Catalunya, FI-DGR 2016, grant number: 00587). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aterido A, 2016, J INVEST DERMATOL, V136, P593, DOI 10.1016/j.jid.2015.11.026; Bentham J, 2015, NAT GENET, V47, P1457, DOI 10.1038/ng.3434; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Bowes J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7046; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Cutolo M, 2005, LUPUS, V14, P675, DOI 10.1191/0961203305lu2198oa; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; El-Gabalawy H, 2010, J RHEUMATOL, V37, P2, DOI 10.3899/jrheum.091461; Gutierrez-Arcelus M, 2016, NAT REV GENET, V17, P160, DOI 10.1038/nrg.2015.33; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Jacobsson LTH, 2005, J RHEUMATOL, V32, P1213; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Julia A, 2016, ARTHRITIS RHEUMATOL, V68, P1384, DOI 10.1002/art.39591; Julia A, 2015, ANN RHEUM DIS, V74, P1875, DOI 10.1136/annrheumdis-2014-207190; Julia A, 2014, HUM MOL GENET, V23, P6927, DOI 10.1093/hmg/ddu398; Julia A, 2013, GUT, V62, P1440, DOI 10.1136/gutjnl-2012-302865; Kahlenberg JM, 2013, ANNU REV MED, V64, P249, DOI 10.1146/annurev-med-060911-090007; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht367; Kochi Y, 2016, INT IMMUNOL, V28, P155, DOI 10.1093/intimm/dxw002; Kuek A, 2007, POSTGRAD MED J, V83, P251, DOI 10.1136/pgmj.2006.052688; Lara-Pezzi E, 2012, DIS MODEL MECH, V5, P434, DOI 10.1242/dmm.009787; Lin EA, 2010, PROTEIN CELL, V1, P33, DOI 10.1007/s13238-010-0002-5; Mankad R, 2015, CURR ATHEROSCLER REP, V17, DOI 10.1007/s11883-015-0497-6; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marson A, 2015, J CLIN INVEST, V125, P2234, DOI 10.1172/JCI78086; Mason JC, 2015, EUR HEART J, V36, P482, DOI 10.1093/eurheartj/ehu403; Matsukura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139262; Nielsen CM, 2004, LAB INVEST, V84, P1631, DOI 10.1038/labinvest.3700197; Nurmohamed MT, 2015, NAT REV RHEUMATOL, V11, P693, DOI 10.1038/nrrheum.2015.112; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Ortona Elena, 2016, Ann Ist Super Sanita, V52, P205, DOI 10.4415/ANN_16_02_12; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Paulis L, 2015, SCI REP-UK, V5, DOI 10.1038/srep07983; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ramos PS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002406; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Talmud PJ, 2009, AM J HUM GENET, V85, P628, DOI 10.1016/j.ajhg.2009.10.014; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X	45	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185889	10.1371/journal.pone.0185889	http://dx.doi.org/10.1371/journal.pone.0185889			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982122	Green Submitted, Green Published, gold			2022-12-26	WOS:000412360300081
J	Gnan, S; Marsh, T; Kover, PX				Gnan, Sebastian; Marsh, Tom; Kover, Paula X.			Inflorescence photosynthetic contribution to fitness releases Arabidopsis thaliana plants from trade-off constraints on early flowering	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; CLIMATE-CHANGE; GROWTH; TIME; SELECTION; REPRODUCTION; PHENOLOGY; SHAPE; SIZE; ADAPTATION	Leaves are thought to be the primary carbon source for reproduction in plants, so a positive relationship between vegetative size and reproductive output is expected, establishing a trade-off between time to reproduction and reproductive output. A common response to higher temperatures due to climate changes is the induction of earlier transition into reproduction. Thus, in annual plants, earlier transition into flowering can potentially constrain plant size and reduce seed production. However, trade-offs between early reproduction and fitness are not always observed, suggesting mechanisms to escape the constraints of early flowering do exist. Here, we test whether inflorescence photosynthesis contribution to the reproductive output of Arabidopsis thaliana can offset the cost of early reproduction. We followed the development, growth rate and fitness of 15 accessions, and removed all rosette leaves at flowering (prior to the completion of inflorescence development or any fruit production) in half of the plants to determine the ability of inflorescences to maintain fitness in the absence of leaves. Although leaf removal significantly reduced fruit number, seed weight and plant height, even the most severely impacted accessions maintained 35% of their fitness with the inflorescence as the sole photosynthetic organ; and some accessions experienced no reduction in fitness. Differences between accessions in their ability to maintain fitness after leaf removal is best explained by earlier flowering time and the ability to maintain as many or more branches after leaf removal as in the control treatment. Although earlier flowering does constrain plant vegetative size, we found that inflorescence photosynthesis can significantly contribute to seed production, explaining why early flowering plants can maintain high fitness despite a reduction in vegetative size. Thus, plants can be released from the usually assumed trade-offs associated with earlier reproduction, and selection on inflorescence traits can mediate the impact of climate change on phenology.	[Gnan, Sebastian; Marsh, Tom; Kover, Paula X.] Univ Bath, Milner Ctr Evolut, Dept Biol & Biochem, Claverton Down, Bath, Avon, England	University of Bath	Kover, PX (corresponding author), Univ Bath, Milner Ctr Evolut, Dept Biol & Biochem, Claverton Down, Bath, Avon, England.	p.x.kover@bath.ac.uk						Akiyama R, 2012, PLOS ONE, V7; Anderson JT, 2011, EVOLUTION, V65, P771, DOI 10.1111/j.1558-5646.2010.01175.x; Anwar MR, 2015, AGR SYST, V132, P133, DOI 10.1016/j.agsy.2014.09.010; Araujo R, 2015, J PHYCOL, V51, P808, DOI 10.1111/jpy.12321; Aschan G, 2003, FLORA, V198, P81, DOI 10.1078/0367-2530-00080; Austen EJ, 2015, EVOLUTION, V69, P2018, DOI 10.1111/evo.12709; Banta JA, 2012, ECOL LETT, V15, P769, DOI 10.1111/j.1461-0248.2012.01796.x; BAZZAZ FA, 1979, NATURE, V279, P554, DOI 10.1038/279554a0; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; CLAUSS MJ, 1994, J ECOL, V82, P447, DOI 10.2307/2261254; Colautti RI, 2013, SCIENCE, V342, P364, DOI 10.1126/science.1242121; Craufurd PQ, 2009, J EXP BOT, V60, P2529, DOI 10.1093/jxb/erp196; Debieu M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061075, 10.1371/journal.pone.0082943]; Earley EJ, 2009, AM J BOT, V96, P786, DOI 10.3732/ajb.0800149; Franco M, 1996, PHILOS T R SOC B, V351, P1341, DOI 10.1098/rstb.1996.0117; GALEN C, 1993, EVOLUTION, V47, P1073, DOI 10.1111/j.1558-5646.1993.tb02136.x; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Gauslaa Y, 2006, BASIC APPL ECOL, V7, P455, DOI 10.1016/j.baae.2005.12.007; Haro RJ, 2015, FIELD CROP RES, V174, P12, DOI 10.1016/j.fcr.2015.01.005; Haselhorst MSH, 2011, MOL ECOL, V20, P4042, DOI 10.1111/j.1365-294X.2011.05227.x; Johansson J, 2013, GLOBAL CHANGE BIOL, V19, P197, DOI 10.1111/gcb.12006; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Kover PX, 2009, NEW PHYTOL, V183, P816, DOI 10.1111/j.1469-8137.2009.02943.x; Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551; Laporte MM, 1996, OECOLOGIA, V106, P63, DOI 10.1007/BF00334408; Leonardos ED, 2014, ENVIRON EXP BOT, V107, P84, DOI 10.1016/j.envexpbot.2014.05.007; MitchellOlds T, 1996, EVOLUTION, V50, P140, DOI [10.2307/2410788, 10.1111/j.1558-5646.1996.tb04480.x]; Montesinos-Navarro A, 2011, NEW PHYTOL, V189, P282, DOI 10.1111/j.1469-8137.2010.03479.x; Neytcheva MS, 2008, OIKOS, V117, P1298, DOI 10.1111/j.0030-1299.2008.16695.x; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Reekie Edward G., 2005, P185; Remington DL, 2013, GENETICS, V195, P1087, DOI 10.1534/genetics.113.151803; Roff DA, 2007, J EVOLUTION BIOL, V20, P433, DOI 10.1111/j.1420-9101.2006.01255.x; Roff DA, 2000, J EVOLUTION BIOL, V13, P434, DOI 10.1046/j.1420-9101.2000.00186.x; SILVERTOWN J, 1989, TRENDS ECOL EVOL, V4, P24, DOI 10.1016/0169-5347(89)90013-X; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Stinchcombe JR, 2010, EVOLUTION, V64, P2887, DOI 10.1111/j.1558-5646.2010.01060.x; Thiele J, 2009, BASIC APPL ECOL, V10, P340, DOI 10.1016/j.baae.2008.04.002; Tucker C, 2010, OECOLOGIA, V164, P1005, DOI 10.1007/s00442-010-1738-6; Vermeulen PJ, 2015, NEW PHYTOL, V205, P429, DOI 10.1111/nph.12984; WATSON MA, 1984, ANNU REV ECOL SYST, V15, P233, DOI 10.1146/annurev.es.15.110184.001313; Weigel D, 2012, PLANT PHYSL; Weinig C, 2003, EVOLUTION, V57, P1270, DOI 10.1111/j.0014-3820.2003.tb00335.x; Weis AE, 2014, EVOL ECOL, V28, P885, DOI 10.1007/s10682-014-9719-6; Zeeman SC, 2002, PLANT PHYSIOL, V129, P516, DOI 10.1104/pp.003756; Zhang X, 2012, G3-GENES GENOM GENET, V2, P29, DOI 10.1534/g3.111.001487	46	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185835	10.1371/journal.pone.0185835	http://dx.doi.org/10.1371/journal.pone.0185835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973036	Green Published, gold, Green Submitted			2022-12-26	WOS:000412131900058
J	Stuart, RM; Kerr, CC; Haghparast-Bidgoli, H; Estill, J; Grobicki, L; Baranczuk, Z; Prieto, L; Montanez, V; Reporter, L; Gray, RT; Skordis-Worrall, J; Keiser, O; Cheikhll, N; Boonto, K; Osornprasop, S; Lavadenz, F; Benedikt, CJ; Martin-Hughes, R; Hussain, SA; Kelly, SL; Kedziora, J; Wilson, DP				Stuart, Robyn M.; Kerr, Cliff C.; Haghparast-Bidgoli, Hassan; Estill, Janne; Grobicki, Laura; Baranczuk, Zofia; Prieto, Lorena; Montanez, Vilma; Reporter, Lyanoosh; Gray, Richard T.; Skordis-Worrall, Jolene; Keiser, Olivia; Cheikhll, Nejma; Boonto, Krittayawan; Osornprasop, Sutayut; Lavadenz, Fernando; Benedikt, Clemens J.; Martin-Hughes, Rowan; Hussain, S. Azfar; Kelly, Sherrie L.; Kedziora, J.; Wilson, David P.			Getting it right when budgets are tight: Using optimal expansion pathways to prioritize responses to concentrated and mixed HIV epidemics	PLOS ONE			English	Article							PREVENTION; RISK; INTERVENTIONS; PROGRAMS; SCALE	Background Prioritizing investments across health interventions is complicated by the nonlinear relationship between intervention coverage and epidemiological outcomes. It can be difficult for countries to know which interventions to prioritize for greatest epidemiological impact, particularly when budgets are uncertain. Methods We examined four case studies of HIV epidemics in diverse settings, each with different characteristics. These case studies were based on public data available for Belarus, Peru, Togo, and Myanmar. The Optima HIV model and software package was used to estimate the optimal distribution of resources across interventions associated with a range of budget envelopes. We constructed "investment staircases", a useful tool for understanding investment priorities. These were used to estimate the best attainable cost-effectiveness of the response at each investment level. Findings We find that when budgets are very limited, the optimal HIV response consists of a smaller number of 'core' interventions. As budgets increase, those core interventions should first be scaled up, and then new interventions introduced. We estimate that the cost-effectiveness of HIV programming decreases as investment levels increase, but that the overall cost-effectiveness remains below GDP per capita. Significance It is important for HIV programming to respond effectively to the overall level of funding availability. The analytic tools presented here can help to guide program planners understand the most cost-effective HIV responses and plan for an uncertain future.	[Stuart, Robyn M.; Kerr, Cliff C.; Reporter, Lyanoosh; Martin-Hughes, Rowan; Hussain, S. Azfar; Kelly, Sherrie L.; Kedziora, J.; Wilson, David P.] Burnet Inst, Melbourne, Vic, Australia; [Stuart, Robyn M.] Univ Copenhagen, Dept Math Sci, Copenhagen, Denmark; [Kerr, Cliff C.] Univ Sydney, Sch Phys, Sydney, NSW, Australia; [Haghparast-Bidgoli, Hassan] UCL, Inst Global Hlth, London, England; [Estill, Janne; Baranczuk, Zofia; Keiser, Olivia] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Estill, Janne; Baranczuk, Zofia; Keiser, Olivia] Univ Geneva, Inst Global Hlth, Geneva, Switzerland; [Estill, Janne] Univ Bern, Inst Math Stat & Actuarial Sci, Bern, Switzerland; [Baranczuk, Zofia] Univ Zurich, Inst Math, Zurich, Switzerland; [Prieto, Lorena; Montanez, Vilma] Univ Pacifico, Lima, Peru; [Gray, Richard T.] UNSW Sydney, Kirby Inst, Sydney, NSW, Australia; [Cheikhll, Nejma; Osornprasop, Sutayut; Lavadenz, Fernando; Benedikt, Clemens J.] World Bank Grp, Washington, DC USA; [Boonto, Krittayawan] UNAIDS Myanmar, Yangon, Myanmar	Burnet Institute; University of Copenhagen; University of Sydney; University of London; University College London; University of Bern; University of Geneva; University of Bern; University of Zurich; Universidad del Pacifico Peru; University of New South Wales Sydney; Kirby Institute; The World Bank	Stuart, RM (corresponding author), Burnet Inst, Melbourne, Vic, Australia.; Stuart, RM (corresponding author), Univ Copenhagen, Dept Math Sci, Copenhagen, Denmark.	robyn@optimamodel.com	Bidgoli, Hassan Haghparast/C-1601-2018; Prieto, Ana Lorena/AAD-6328-2021	Bidgoli, Hassan Haghparast/0000-0001-6365-2944; Prieto, Ana Lorena/0000-0002-6134-0987; Gray, Richard/0000-0002-2885-0483; Kedziora, David/0000-0002-0673-182X; Skordis, Jolene/0000-0002-8633-0208	Australian National Health and Medical Research Council; World Bank; World Bank's allocative efficiency program	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); World Bank(The World Bank India); World Bank's allocative efficiency program	Funding for this study was provided by the Australian National Health and Medical Research Council (https.//www.nhmrc.gov.au/) and the World Bank (http://www.worldbank.org/).; The authors are grateful for the collaborative efforts of the teams who worked on the allocative efficiency studies conducted in Myanmar, Peru, Togo, and Belarus as part of the country-led studies funded by the World Bank's allocative efficiency program for country planning. Those activities were conducted separately to this research project but discussions in the country planning activities were valuable in highlighting distinct principles of relevance to other settings globally which created some motivation for this research study. We value the leadership of our country partners in ongoing relationships and Optima modeling activities to guide HIV response planning and decision making in each country. We also acknowledge Emiko Masaki, Marelize Gorgens and David Wilson (World Bank), who provided useful guidance on this study.	Alistar SS, 2012, MED DECIS MAKING, V32, P105, DOI 10.1177/0272989X10391808; [Anonymous], 2017, GDP PER CAP CURR US; [Anonymous], 2017, UNIT COST REPOSITORY; [Anonymous], 2017, AIDSINFO; Bautista-Arredondo S, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327625.69974.08; Brandeau ML, 2009, HEALTH CARE MANAG SC, V12, P27, DOI 10.1007/s10729-008-9074-7; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Guinness Lorna, 2007, Cost Eff Resour Alloc, V5, P13, DOI 10.1186/1478-7547-5-13; Henry J, 2016, FINANCING RESPONSE H; Howard AA, 2016, GLOBAL HLTH ACTION, P9; Kelly SL, 2017, POTENTIAL GLOBAL GAI; Kerr CC, 2017, OPTIMIZATION ADAPTIV; Kerr CC, 2015, JAIDS-J ACQ IMM DEF, V69, P365, DOI 10.1097/QAI.0000000000000605; Kumaranayake L, 2008, AIDS, V22, pS23, DOI 10.1097/01.aids.0000327620.47103.1d; Marjoram P, 2003, P NATL ACAD SCI USA, V100, P15324, DOI 10.1073/pnas.0306899100; Ministry of Health P, 2014, PLAN ESTR MULT PREV; Myanmar Ministry of Health NAP, 2015, HIV SENT SER SURV SU; Programme National de Lutte contre le Sida et les IST, 2011, PROGRAMME NATL LUTTE; Pham QD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133171; Resch S, 2015, LANCET GLOB HEALTH, V3, pE52, DOI 10.1016/S2214-109X(14)70342-0; Schroeder SA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-19; Scott N, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2019-1; Soto RJ, 2007, JAIDS-J ACQ IMM DEF, V46, P101; Stuart RM, 2017, SHOULD HIV RESOURCES; The Optima Consortium for Decision Science, 2017, OPT HIV US GUID, VVI; The World Bank, 2017, OPT INV TOG HIV RESP; The World Bank, 2017, IMPR ALL TECHN EFF M; The World Bank, 2017, ALL HIV FUND EFF MYA; Togo Ministry of Health, 2014, MSM BBS SURV 2015; Togo Ministry of Health, 2014, FSW BBS SURV 2015; UNAIDS, 2010, COMB HIV PREV TAIL C; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; Vassall A, 2014, LANCET GLOB HEALTH, V2, pE531, DOI 10.1016/S2214-109X(14)70277-3; Walker PGT, 2016, LANCET GLOB HEALTH, V4, pE474, DOI 10.1016/S2214-109X(16)30073-0; World Bank, 2015, OPT INV BEL NAT HIV; World Bank, 2017, OPT INV RESP HIV PER; Youngkong S, 2009, TROP MED INT HEALTH, V14, P930, DOI 10.1111/j.1365-3156.2009.02311.x	37	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185077	10.1371/journal.pone.0185077	http://dx.doi.org/10.1371/journal.pone.0185077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972975	Green Published, gold			2022-12-26	WOS:000412131900011
J	Aukes, K; Forsman, C; Brady, NJ; Astleford, K; Blixt, N; Sachdev, D; Jensen, ED; Mansky, KC; Schwertfeger, KL				Aukes, Kelly; Forsman, Cynthia; Brady, Nicholas J.; Astleford, Kristina; Blixt, Nicholas; Sachdev, Deepali; Jensen, Eric D.; Mansky, Kim C.; Schwertfeger, Kathryn L.			Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions	PLOS ONE			English	Article							KAPPA-B PATHWAYS; BONE-RESORPTION; TARGETING FGFR; MAP KINASE; DIFFERENTIATION; SURVIVAL; OSTEOBLAST; CHONDROCYTE; ACTIVATION; REGULATOR	Fibroblast growth factors (FGFs) and their receptors (FGFRs) have been implicated in promoting breast cancer growth and progression. While the autocrine effects of FGFR activation in tumor cells have been extensively studied, little is known about the effects of tumor cell-derived FGFs on cells in the microenvironment. Because FGF signaling has been implicated in the regulation of bone formation and osteoclast differentiation, we hypothesized that tumor cell-derived FGFs are capable of modulating osteoclast function and contributing to growth of metastatic lesions in the bone. Initial studies examining FGFR expression during osteoclast differentiation revealed increased expression of FGFR1 in osteoclasts during differentiation. Therefore, studies were performed to determine whether tumor cell-derived FGFs are capable of promoting osteoclast differentiation and activity. Using both non-transformed and transformed cell lines, we demonstrate that breast cancer cells express a number of FGF ligands that are known to activate FGFR1. Furthermore our results demonstrate that inhibition of FGFR activity using the clinically relevant inhibitor BGJ398 leads to reduced osteoclast differentiation and activity in vitro. Treatment of mice injected with tumor cells into the femurs with BGJ398 leads to reduced osteoclast activity and bone destruction. Together, these studies demonstrate that tumor cell-derived FGFs enhance osteoclast function and contribute to the formation of metastatic lesions in breast cancer.	[Aukes, Kelly; Forsman, Cynthia; Schwertfeger, Kathryn L.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Brady, Nicholas J.] Univ Minnesota, Microbiol Canc Biol & Immunol Grad Program, Minneapolis, MN USA; [Astleford, Kristina; Mansky, Kim C.] Univ Minnesota, Sch Dent, Dev & Surg Sci, Minneapolis, MN 55455 USA; [Blixt, Nicholas] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Sachdev, Deepali; Mansky, Kim C.; Schwertfeger, Kathryn L.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Sachdev, Deepali] Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA; [Jensen, Eric D.] Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA; [Schwertfeger, Kathryn L.] Univ Minnesota, Ctr Immunol, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Schwertfeger, KL (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.; Mansky, KC (corresponding author), Univ Minnesota, Sch Dent, Dev & Surg Sci, Minneapolis, MN 55455 USA.; Mansky, KC; Schwertfeger, KL (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.; Schwertfeger, KL (corresponding author), Univ Minnesota, Ctr Immunol, Minneapolis, MN USA.	kmansky@umn.edu; schwe251@umn.edu	Brady, Nicholas/AAB-2888-2019	Brady, Nicholas/0000-0002-2928-0232; Mansky, Kim/0000-0002-2826-5030	National Institute of Arthritis and Musculoskeletal and Skin Diseases [5T32AR050938]; University of Minnesota Academic Health Center; National Cancer Institute [R01CA132827, R01CA215052]; NATIONAL CANCER INSTITUTE [R01CA132827, R01CA215052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR050938] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Minnesota Academic Health Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding for this work was provided by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (5T32AR050938), the University of Minnesota Academic Health Center and the National Cancer Institute including R01CA132827 and R01CA215052 to KLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS, 2014, BREAST CANC FACTS FI; Andre F, 2013, CLIN CANCER RES, V19, P3693, DOI 10.1158/1078-0432.CCR-13-0190; Babina IS, 2017, NAT REV CANCER, V17, P318, DOI 10.1038/nrc.2017.8; Bosetti M, 2010, J CELL PHYSIOL, V225, P466, DOI 10.1002/jcp.22225; Bradley EW, 2008, J CELL BIOCHEM, V104, P1439, DOI 10.1002/jcb.21719; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Broege A, 2013, J BIOL CHEM, V288, P37230, DOI 10.1074/jbc.M113.496950; Cenni E, 2007, ANTICANCER RES, V27, P315; Chikazu D, 2000, J BIOL CHEM, V275, P31444, DOI 10.1074/jbc.M910132199; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Dieci MV, 2013, CANCER DISCOV, V3, P264, DOI 10.1158/2159-8290.CD-12-0362; Du X, 2012, J CELL PHYSL, V227, P3731, DOI DOI 10.1002/JCP.24083; Duchesne L, 2006, J BIOL CHEM, V281, P27178, DOI 10.1074/jbc.M601248200; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Guagnano V, 2012, CANCER DISCOV, V2, P1118, DOI 10.1158/2159-8290.CD-12-0210; He YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024780; Hung IH, 2007, DEV BIOL, V307, P300, DOI 10.1016/j.ydbio.2007.04.048; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; Linares GR, 2012, J BONE MINER RES, V27, P1553, DOI 10.1002/jbmr.1600; Lu XM, 2009, BIOCHEM BIOPH RES CO, V390, P494, DOI 10.1016/j.bbrc.2009.09.123; Matsumoto T, 2013, J BONE MINER RES, V28, P1191, DOI 10.1002/jbmr.1844; Mellis DJ, 2011, J ENDOCRINOL, V211, P131, DOI 10.1530/JOE-11-0212; Meng X, 2016, ONCOGENE, V35, P2370, DOI 10.1038/onc.2015.297; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Ornitz DM, 2015, GENE DEV, V29, P1463, DOI 10.1101/gad.266551.115; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Rissanen JP, 2008, CALCIFIED TISSUE INT, V82, P108, DOI 10.1007/s00223-007-9091-4; Sharpe R, 2011, CLIN CANCER RES, V17, P5275, DOI 10.1158/1078-0432.CCR-10-2727; Shimoaka T, 2002, J BIOL CHEM, V277, P7493, DOI 10.1074/jbc.M108653200; Su N, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.3; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Thudium CS, 2014, CALCIFIED TISSUE INT, V95, P83, DOI 10.1007/s00223-014-9865-4; Valta MP, 2008, INT J CANCER, V123, P22, DOI 10.1002/ijc.23422; Wan XH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009332; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Xian W, 2005, J CELL BIOL, V171, P663, DOI 10.1083/jcb.200505098; Yoon WJ, 2014, J BIOL CHEM, V289, P8828, DOI 10.1074/jbc.M113.516237	43	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185736	10.1371/journal.pone.0185736	http://dx.doi.org/10.1371/journal.pone.0185736			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968431	Green Published, Green Submitted, gold			2022-12-26	WOS:000412029600040
J	Rutledge, RG; Stewart, D; Overton, C; Klimaszewska, K				Rutledge, R. G.; Stewart, D.; Overton, C.; Klimaszewska, K.			Gene expression analysis of primordial shoot explants collected from mature white spruce (Picea glauca) trees that differ in their responsiveness to somatic embryogenesis induction	PLOS ONE			English	Article							ASCORBATE PEROXIDASE; NORWAY SPRUCE; GENOME; PROPAGATION; ANNOTATION; BLAST2GO; CULTURES; PCR	Within a plantation of clonal somatic embryo-derived white spruce trees that belonged to four genotypes, one genotype (G6) has consistently responded for the last 16 years, to the induction of somatic embryogenesis within primordial shoot explants. Analysis of fourteen individuals within this genotype subsequently revealed a group of clonal trees that were non-responsive. This in turn provided a unique opportunity to conduct differential gene expression analysis in the absence of genotype-specific factors. Absolute qPCR was first used to expand the analysis of several genes previously identified via microarray analysis to be differentially expressed during SE induction, along with the inclusion of two nonresponsive genotypes. While this demonstrated a high level of repeatability within, and between, responsive and nonresponsive genotypes, it did not support our previous contention that an adaptive stress response plays a role in SE induction responsiveness, at least with respect to the candidate genes we analyzed. RNAseq analysis was then used to compare responsive and nonresponsive G6 primordial shoots during the somatic embryogenesis induction treatment. Although not analyzed in this study, this included samples of callus and embryonal masses previously generated from G6 explants. In addition to revealing a large number of differentially expressed genes, de novo assembly of unmapped reads was used to generate over 25,000 contigs that potentially represent previously unidentified transcripts. This included a MADS-domain gene that was found to be the most highly differentially expressed gene within responsive shoot explants during the first seven days of the induction treatment.	[Rutledge, R. G.; Stewart, D.; Overton, C.; Klimaszewska, K.] Nat Resources Canada, Laurentian Forestry Ctr, Canadian Forest Serv, 1055 PEPS, Stn St Foy, PQ, Canada	Natural Resources Canada; Canadian Forest Service	Klimaszewska, K (corresponding author), Nat Resources Canada, Laurentian Forestry Ctr, Canadian Forest Serv, 1055 PEPS, Stn St Foy, PQ, Canada.	Krystyna.Klimaszewska@canada.ca			Natural Resources Canada, Canadian Forest Service	Natural Resources Canada, Canadian Forest Service(Natural Resources CanadaCanadian Forest Service)	This work was financially supported by Natural Resources Canada, Canadian Forest Service. The funders had no role in study design,	Adams G., 2016, VEGETATIVE PROPAGATI, P323; Birol I, 2013, BIOINFORMATICS, V29, P1492, DOI 10.1093/bioinformatics/btt178; Bonga JM, 2010, PLANT CELL TISS ORG, V100, P241, DOI 10.1007/s11240-009-9647-2; Chalupa V., 1985, Communicationes Instituti Forestalis Cechosloveniae, V14, P57; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Devonshire AS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-118; Elhiti M, 2013, IN VITRO CELL DEV-PL, V49, P631, DOI 10.1007/s11627-013-9547-3; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Garcia-Mendiguren O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128679; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gramzow L, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-214; HAKMAN I, 1985, PLANT SCI, V38, P53, DOI 10.1016/0168-9452(85)90079-2; Harvengt L, 2001, PLANTA, V213, P828, DOI 10.1007/s004250100628; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ishikawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P1143, DOI 10.1271/bbb.80062; Klimaszewska K., 2016, VEGETATIVE PROPAGATI, P195; Klimaszewska K, 2011, PLANTA, V233, P635, DOI 10.1007/s00425-010-1325-4; Koussevitzky S, 2008, J BIOL CHEM, V283, P34197, DOI 10.1074/jbc.M806337200; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Panchuk II, 2002, PLANT PHYSIOL, V129, P838, DOI 10.1104/pp.001362; Park SY, 2010, TREE PHYSIOL, V30, P1469, DOI 10.1093/treephys/tpq081; Park Y., 2016, VEGETATIVE PROPAGATI, P302; Rigault P, 2011, PLANT PHYSIOL, V157, P14, DOI 10.1104/pp.111.179663; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Rutledge RG, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-116; Rutledge RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017636; Rutledge RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009731; Rutledge RG, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-96; Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47; Sutton B, 2002, ANN FOR SCI, V59, P657, DOI 10.1051/forest:2002052; Trontin JF, 2016, VEGETATIVE PROPAGATI, P211; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesompele Jo, 2009, P47; Vermeulen J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp721; Yakovlev IA, 2008, PLANTA, V228, P459, DOI 10.1007/s00425-008-0750-0	36	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185015	10.1371/journal.pone.0185015	http://dx.doi.org/10.1371/journal.pone.0185015			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968421	Green Published, Green Submitted, gold			2022-12-26	WOS:000412029600011
J	Loutfy, M; de Pokomandy, A; Kennedy, VL; Carter, A; O'Brien, N; Proulx-Boucher, K; Ding, E; Lewis, J; Nicholson, V; Beaver, K; Greene, S; Tharao, W; Benoit, A; Dubuc, D; Thomas-Pavanel, J; Sereda, P; Jabbari, S; Shurgold, JH; Colley, G; Hogg, RS; Kaida, A				Loutfy, Mona; de Pokomandy, Alexandra; Kennedy, V. Logan; Carter, Allison; O'Brien, Nadia; Proulx-Boucher, Karene; Ding, Erin; Lewis, Johanna; Nicholson, Valerie; Beaver, Kerrigan; Greene, Saara; Tharao, Wangari; Benoit, Anita; Dubuc, Daniele; Thomas-Pavanel, Jamie; Sereda, Paul; Jabbari, Shahab; Shurgold, Jayson H.; Colley, Guillaume; Hogg, Robert S.; Kaida, Angela		CHIWOS Res Team	Cohort profile: The Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS)	PLOS ONE			English	Article							COMMUNITY-BASED RESEARCH; GENDER-DIFFERENCES; INTERSECTIONALITY; REFLECTIONS; QUALITY	Globally, women are at increased vulnerability to HIV due to biological, social, structural, and political reasons. Women living with HIV also experience unique issues related to their medical and social healthcare, which makes a clinical care model specific to their needs worthy of exploration. Furthermore, there is a dearth of research specific to women living with HIV. Research for this population has often been narrowly focused on pregnancy-related issues without considering their complex structural inequalities, social roles, and healthcare and biological needs. For these reasons, we have come together, as researchers, clinicians and community members in Canada, to develop the Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS) to investigate the concept of women-centred HIV care (WCHC) and its impact on the overall, HIV, women's, mental, sexual, and reproductive health outcomes of women living with HIV. Here, we present the CHIWOS cohort profile, which describes the cohort and presents preliminary findings related to perceived WCHC. CHIWOS is a prospective, observational cohort study of women living with HIV in British Columbia (BC), Ontario, and Quebec. Two additional Canadian provinces, Saskatchewan and Manitoba, will join the cohort in 2018. Using community-based research principles, CHIWOS engages women living with HIV throughout the entire research process meeting the requirements of the 'Greater Involvement of People living with HIV/AIDS'. Study data are collected through an interviewer-administered questionnaire that uses a web-based platform. From August 2013 to May 2015, a total of 1422 women living with HIV in BC, Ontario, and Quebec were enrolled and completed the baseline visit.Follow-up interviews are being conducted at 18-month intervals. Of the 1422 participants at baseline, 356 were from BC (25%), 713 from Ontario (50%), 353 from Quebec (25%). The median age of the participants at baseline was 43 years (range, 16-74). 22% identified as Indigenous, 30% as African, Caribbean or Black, 41% as Caucasian/White, and 7% as other ethnicities. Overall, 83% of women were taking antiretroviral therapy at the time of the baseline interview and of them, 87% reported an undetectable viral load. Of the 1326 women who received HIV medical care in the previous year and responded to corresponding questions, 57% (95% CI: 54%-60%) perceived that the care they received from their primary HIV doctor had been women-centred. There were provincial and age differences among women who indicated that they received WCHC versus not; women from BC or Ontario were more likely to report WCHC compared to participants in Quebec. They were also more likely to be younger. CHIWOS will be an important tool to develop care models specific for women living with HIV. Moreover, CHIWOS is collecting extensive information on socio-demographics, social determinants of health, psychological factors, and sexual and reproductive health and offers an important platform to answer many relevant research questions for and with women living with HIV. Information on the cohort can be found on the study website(http://www.chiwos.ca).	[Loutfy, Mona; Kennedy, V. Logan; Lewis, Johanna; Beaver, Kerrigan; Benoit, Anita; Thomas-Pavanel, Jamie] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Loutfy, Mona; Thomas-Pavanel, Jamie] Univ Toronto, Fac Med, Toronto, ON, Canada; [Loutfy, Mona; Benoit, Anita] Univ Toronto, Dalla Sch Publ Hlth, Toronto, ON, Canada; [de Pokomandy, Alexandra; O'Brien, Nadia] McGill Univ, Dept Family Med, Montreal, PQ, Canada; [de Pokomandy, Alexandra; Proulx-Boucher, Karene; Dubuc, Daniele] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Carter, Allison; Nicholson, Valerie; Shurgold, Jayson H.; Hogg, Robert S.; Kaida, Angela] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Carter, Allison; Ding, Erin; Sereda, Paul; Jabbari, Shahab; Colley, Guillaume; Hogg, Robert S.] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Lewis, Johanna] York Univ, Dept Environm Sci, Toronto, ON, Canada; [Greene, Saara] McMaster Univ, Sch Social Work, Hamilton, ON, Canada; [Tharao, Wangari] Womens Hlth Womens Hands Community Hlth Ctr, Toronto, ON, Canada; [Shurgold, Jayson H.] Contag Consulting Grp, Vancouver, BC, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; McGill University; McGill University; Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; York University - Canada; McMaster University	Loutfy, M (corresponding author), Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada.; Loutfy, M (corresponding author), Univ Toronto, Fac Med, Toronto, ON, Canada.; Loutfy, M (corresponding author), Univ Toronto, Dalla Sch Publ Hlth, Toronto, ON, Canada.	mona.loutfy@wchospital.ca		Carter, Allison/0000-0003-2151-2622; Sereda, Paul/0000-0002-6411-8089	Canadian Institutes of Health Research (CIHR) Operating Grant [MOP -111041]; CIHR Canadian HIV Trials Network [CTN 262]; Ontario HIV Treatment Network; Academic Health Science Centres (AHSC) Alternative Funding Plans (AFP) Innovation Fund; CHIWOS Indigenous Advisory Board; CHIWOS African, Caribbean and Black Advisory Board; provincial Community Advisory Boards	Canadian Institutes of Health Research (CIHR) Operating Grant(Canadian Institutes of Health Research (CIHR)); CIHR Canadian HIV Trials Network(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network; Academic Health Science Centres (AHSC) Alternative Funding Plans (AFP) Innovation Fund; CHIWOS Indigenous Advisory Board; CHIWOS African, Caribbean and Black Advisory Board; provincial Community Advisory Boards	This work was funded by a Canadian Institutes of Health Research (CIHR) Operating Grant (grant# MOP -111041), the CIHR Canadian HIV Trials Network (CTN 262), the Ontario HIV Treatment Network, and the Academic Health Science Centres (AHSC) Alternative Funding Plans (AFP) Innovation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS) Research Team would like to especially thank all of the women living with HIV who participate in the research and entrust CHIWOS with their experiences of HIV treatment, care, and support. We also thank the entire national team of Co-Investigators, Collaborators, and Peer Research Associates. We would like to acknowledge the three provincial Community Advisory Boards, and the national CHIWOS Indigenous Advisory Board, CHIWOS African, Caribbean and Black Advisory Board, and our partnering organizations for supporting the study. We also acknowledge the BC Centre for Excellence in HIV/AIDS for in kind data management and analytic support.	Abelsohn K, 2015, PROG COMM HLTH PARTN, V9, P561, DOI 10.1353/cpr.2015.0079; [Anonymous], 2013, GLOB AIDS RESP PROGR; BC Centre for Disease Control, 2011, DAT REQ FEM TEST NEW; Bowleg L, 2008, SEX ROLES, V59, P312, DOI 10.1007/s11199-008-9400-z; Bredstrom A, 2006, EUR J WOMENS STUD, V13, P229, DOI 10.1177/1350506806065754; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Carter A, 2017, BMC RES NOTES; Carter A, 2015, HEALTH CARE WOMEN IN, V36, P936, DOI 10.1080/07399332.2014.954703; Carter A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092334; CHIWOS, 2014, CHIWOS PAP QUEST; CHIWOS, 2013, CAN HIV WOM SEX REPR; Cornell M, 2012, PLOS ONE; DeReus L, 2005, MULTICULTURAL CRITIC; Druyts E, 2013, AIDS, V27, P417, DOI 10.1097/QAD.0b013e328359b89b; Dworkin SL, 2007, AM J PUBLIC HEALTH, V97, P13, DOI 10.2105/AJPH.2005.074591; Gray K, 2012, CONDUCTING RES HARD; Hankivsky O, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-5; Hirschhorn LR, 2006, WOMEN HEALTH ISS, V16, P104, DOI 10.1016/j.whi.2006.02.004; Institut national de sante A publique Que A bec, 2012, SURV INF TRANSM SEX; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; Loutfy M, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0190-7; Mills EJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-52; Monforte AD, 2010, AIDS, V24, P1091, DOI 10.1097/QAD.0b013e3283390db3; Mrus JM, 2005, QUAL LIFE RES, V14, P479, DOI 10.1007/s11136-004-4693-z; OBrien N, 6 INT WORKSH HIV WOM; Oguntibeju OO, 2012, HIV AIDS-RES PALLIAT, V4, P117, DOI 10.2147/HIV.S32321; Ontario HIV Treatment Network, 2014, ONT HIV TREATM NETW; Ontario HIV Treatment Network, 2013, INT HIV OTH HLTH REL; Palmer AK, 2011, INT J EPIDEMIOL, V40, P25, DOI 10.1093/ije/dyp393; Patterson S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0969-x; Public Health Agency of Canada, 2015, SUMM EST HIV INC PRE; Raikhel E., 2009, EPISTEMOLOGICAL FRAM; Remis RS, 2013, REPORT HIV AIDS ONTA; UNAIDS, 2011, GREAT INV PEOPL LIV; Walmsley SL, 2010, HIV POSITIVE WOMEN C, P197; Wingood GM, 2003, J URBAN HEALTH, V80, P67; World Health Organization, 2017, CONS GUID SEX REPR H	37	50	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184708	10.1371/journal.pone.0184708	http://dx.doi.org/10.1371/journal.pone.0184708			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957412	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200017
J	Zhao, X; Li, P; An, K; Jia, XH; Cheng, YT; Jia, TJ				Zhao, Xia; Li, Ping; An, Kang; Jia, Xiaohui; Cheng, Yongting; Jia, Tianjun			Chlamydia pneumoniae inclusion membrane protein Cpn0147 interacts with host protein CREB3	PLOS ONE			English	Article							TRANSCRIPTION; STRESS; LUMAN	Chlamydiae are Gram-negative obligate intracellular bacteria that cause diseases with significant medical and economic impacts. Like other chlamydial species, Chlamydia pneumoniae possesses a unique developmental cycle, the infectious elementary body gains access to the susceptible host cell, where it transforms into the replicative reticulate body. The cytoplasmic vacuole where Chlamydia pneumoniae replicates is called an inclusion, which is extensively modified by the insertion of chlamydial effectors known as inclusion membrane proteins (Incs). The C. pneumoniae-specific inclusion membrane protein (Inc) Cpn0147 contains domains that are predicted to be exposed to the host cytoplasm. To map host cell binding partners of Cpn0147, a yeast two-hybrid system was used to screen Cpn0147 against a HeLa cell cDNA library, which led to the finding that Cpn0147 interacted with the host cell protein cyclic adenosine monophosphate (cAMP)-responsive element (CRE)-binding protein (CREB3). The interaction was validated by co-immunoprecipitation of Cpn0147 with CREB3 from HeLa cells ectopically expressing both. Furthermore, Cpn0147 and CREB3 were co-localised in HeLa cells under confocal fluorescence microscopy. The above observations suggest that CREB3 may directly bind to the cytoplasmic domain of Cpn0147 to mediate the interactions of chlamydial inclusions with host cell endoplasmic reticulum.	[Zhao, Xia; Li, Ping; An, Kang; Jia, Xiaohui; Cheng, Yongting; Jia, Tianjun] Hebei North Univ, Lab Med Coll, Zhang Jiakou, Hebei, Peoples R China	Hebei North University	Jia, TJ (corresponding author), Hebei North Univ, Lab Med Coll, Zhang Jiakou, Hebei, Peoples R China.	tjjia1968@163.com			Hebei Natural Science Foundation [C2014405041]	Hebei Natural Science Foundation(Natural Science Foundation of Hebei Province)	This study was supported by the Hebei Natural Science Foundation (http://www.hensf.gov.cn/), grant no. C2014405041 to TJ. The funder had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grant of Hebei Natural Science Foundation (grant numbers: C2014405041).	Agaisse H, 2014, INFECT IMMUN, V82, P2037, DOI 10.1128/IAI.01530-14; Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; Blot G, 2006, J MOL BIOL, V364, P1034, DOI 10.1016/j.jmb.2006.09.080; Cortes C, 2007, INFECT IMMUN, V75, P5586, DOI 10.1128/IAI.01020-07; Delevoye C, 2004, J BIOL CHEM, V279, P46896, DOI 10.1074/jbc.M407227200; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Dumoux M, 2012, TRAFFIC, V13, P1612, DOI 10.1111/tra.12002; Flores R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127909; Grieshaber S, 2002, CELL MICROBIOL, V4, P273, DOI 10.1046/j.1462-5822.2002.00191.x; Hackstadt T, 1997, TRENDS MICROBIOL, V5, P288, DOI 10.1016/S0966-842X(97)01061-5; Liang GQ, 2006, MOL CELL BIOL, V26, P7999, DOI 10.1128/MCB.01046-06; Lu R, 2000, J VIROL, V74, P934, DOI 10.1128/JVI.74.2.934-943.2000; Luo JH, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-38; Mirabelli C, 2016, J GEN VIROL, V97, P2194, DOI 10.1099/jgv.0.000544; Reiling JH, 2013, NAT CELL BIOL, V15, P1473, DOI 10.1038/ncb2865; Shima K, 2015, CELL MICROBIOL, V17, P923, DOI 10.1111/cmi.12416; Tatu U, 1997, J CELL BIOL, V136, P555, DOI 10.1083/jcb.136.3.555	17	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185593	10.1371/journal.pone.0185593	http://dx.doi.org/10.1371/journal.pone.0185593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957394	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200090
J	Li, M; Hong, WX; Hao, CZ; Li, LY; Wu, DM; Shen, AG; Lu, J; Zheng, YL; Li, P; Xu, Y				Li, Min; Hong, Wenxuan; Hao, Chenzhi; Li, Luyang; Wu, Dongmei; Shen, Aiguo; Lu, Jun; Zheng, Yuanlin; Li, Ping; Xu, Yong			SIRT1 antagonizes liver fibrosis by blocking hepatic stellate cell activation in mice	FASEB JOURNAL			English	Article						transcriptional regulation; epigenetics; myofibroblast	TO-MESENCHYMAL TRANSITION; TISSUE GROWTH-FACTOR; NONALCOHOLIC STEATOHEPATITIS; TRANSCRIPTIONAL REPRESSION; ENERGY-EXPENDITURE; CANCER METASTASIS; GENE-EXPRESSION; FIBROTIC LIVER; FATTY LIVER; MOUSE MODEL	Hepatic stellate cells (HSCs) are a major source of fibrogenesis in the liver, contributing to cirrhosis. When activated, HSCs transdifferentiate into myofibroblasts and undergo profound functional alterations paralleling an overhaul of the transcriptome, the mechanism of which remains largely undefined. We investigated the involvement of the class III deacetylase sirtuin [silent information regulator 1 (SIRT1)] in HSC activation and liver fibrosis. SIRT1 levels were down-regulated in the livers inmouse models of liver fibrosis, in patients with cirrhosis, and in activated HSCs as opposed to quiescent HSCs. SIRT1 activation halted, whereas SIRT1 inhibition promoted, HSC transdifferentiation into myofibroblasts. Liver fibrosis was exacerbated in mice with HSC-specific deletion of SIRT1 [conditional knockout (cKO)], receiving CCl4 (1 mg/kg) injection or subjected to bile duct ligation, compared to wild-type littermates. SIRT1 regulated peroxisome proliferator activated receptor gamma (PPAR gamma) transcription by deacetylating enhancer of zeste homolog 2 (EZH2) in quiescentHSCs. Finally, EZH2 inhibition or PPARg activation ameliorated fibrogenesis in cKO mice. In summary, our data suggest that SIRT1 plays an essential role guiding the transition of HSC phenotypes.	[Li, Min; Hong, Wenxuan; Hao, Chenzhi; Li, Luyang; Li, Ping; Xu, Yong] Nanjing Med Univ, Dept Pathophysiol, Key Lab Targeted Intervent Cardiovasc Dis, Nanjing, Jiangsu, Peoples R China; [Li, Min; Hong, Wenxuan; Hao, Chenzhi; Li, Luyang; Li, Ping; Xu, Yong] Nanjing Med Univ, Innovat Collaborat Ctr Cardiovasc Translat Med, Nanjing, Jiangsu, Peoples R China; [Wu, Dongmei; Lu, Jun; Zheng, Yuanlin] Jiangsu Normal Univ, Sch Life Sci, Key Lab Biotechnol Med Plants Jiangsu Prov, Xuzhou, Peoples R China; [Shen, Aiguo] Nantong Univ, Coll Med, Key Lab Inflammat & Mol Targets, Nantong, Peoples R China	Nanjing Medical University; Nanjing Medical University; Jiangsu Normal University; Nantong University	Lu, J (corresponding author), Jiangsu Normal Univ, 101 Shanghai Rd, Xuzhou 221116, Jiangsu, Peoples R China.; Xu, Y (corresponding author), Nanjing Med Univ, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China.	lu-jun75@163.com; yjxu@njmu.edu.cn	Lu, Jun/N-6109-2019	Lu, Jun/0000-0002-2801-5330	Jiangsu Province [2016 333]; Qinglan Project of the Young and Middle-Aged Academic Leader of Jiangsu College and University; Natural Science Foundation of China [81670223, 81500426, 81570420, 81571055, 81400902, 81271225, 31201039, 81171012, 30950031]; Major Fundamental Research Program of the Natural Science Foundation of the Jiangsu Higher Education Institutions of China [13KJA180001]; Cultivate National Science Fund for Distinguished Young Scholars of Jiangsu Normal University; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Jiangsu Province; Qinglan Project of the Young and Middle-Aged Academic Leader of Jiangsu College and University; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Fundamental Research Program of the Natural Science Foundation of the Jiangsu Higher Education Institutions of China; Cultivate National Science Fund for Distinguished Young Scholars of Jiangsu Normal University; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported, in part, by grants from the 2016 333 Project Award of Jiangsu Province, the 2013 Qinglan Project of the Young and Middle-Aged Academic Leader of Jiangsu College and University, the Natural Science Foundation of China (81670223, 81500426, 81570420, 81571055, 81400902, 81271225, 31201039, 81171012, and 30950031), the Major Fundamental Research Program of the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (13KJA180001), the Cultivate National Science Fund for Distinguished Young Scholars of Jiangsu Normal University, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). Y.X. is a fellow at the Collaborative Innovative Center for Cardiovascular Translational Medicine. The authors declare no conflicts of interest.	Chavez E, 2008, J APPL TOXICOL, V28, P35, DOI 10.1002/jat.1249; Chen Y, 2012, MOL CELL PROTEOMICS, V11, P1048, DOI 10.1074/mcp.M112.019547; Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802; Fan ZW, 2017, HEPATOLOGY, V65, P1904, DOI 10.1002/hep.29127; Fan ZW, 2015, BBA-GENE REGUL MECH, V1849, P1219, DOI 10.1016/j.bbagrm.2015.07.013; Fang F, 2013, CIRC RES, V113, P986, DOI 10.1161/CIRCRESAHA.113.301296; Fang F, 2011, CIRC RES, V108, P797, DOI 10.1161/CIRCRESAHA.111.240655; Fang MM, 2016, BBA-GENE REGUL MECH, V1859, P294, DOI 10.1016/j.bbagrm.2015.11.010; Fang MM, 2015, J BIOMED RES, V29, P308, DOI 10.7555/JBR.29.20150055; Gariani K, 2017, J HEPATOL, V66, P132, DOI 10.1016/j.jhep.2016.08.024; Iwaisako K, 2014, P NATL ACAD SCI USA, V111, pE3297, DOI 10.1073/pnas.1400062111; Kanzler S, 1999, AM J PHYSIOL-GASTR L, V276, pG1059, DOI 10.1152/ajpgi.1999.276.4.G1059; Kessoku T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22251; Kisseleva T, 2017, HEPATOLOGY, V65, P1039, DOI 10.1002/hep.28948; Kitao A, 2009, AM J PATHOL, V175, P616, DOI 10.2353/ajpath.2009.081061; Kong XC, 2009, J MOL CELL CARDIOL, V46, P748, DOI 10.1016/j.yjmcc.2009.01.011; Li P, 2012, NUCLEIC ACIDS RES, V40, P1609, DOI 10.1093/nar/gkr984; Lu Lu, 2011, Chinese Medical Sciences Journal, V26, P77; Maizel J, 2014, AM J PHYSIOL-HEART C, V307, pH1691, DOI 10.1152/ajpheart.00281.2014; Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Moran-Salvador E, 2013, J HEPATOL, V59, P1045, DOI 10.1016/j.jhep.2013.06.023; Mukhopadhyay P, 2017, J HEPATOL, V66, P589, DOI 10.1016/j.jhep.2016.10.023; Popov Y, 2009, HEPATOLOGY, V50, P1294, DOI 10.1002/hep.23123; Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035; Purushotham A, 2012, MOL CELL BIOL, V32, P1226, DOI 10.1128/MCB.05988-11; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Ramirez T, 2017, J HEPATOL, V66, P601, DOI 10.1016/j.jhep.2016.11.004; Robertson H, 2007, HEPATOLOGY, V45, P977, DOI 10.1002/hep.21624; Sakai K, 2014, AM J PATHOL, V184, P2611, DOI 10.1016/j.ajpath.2014.06.009; Schnabl B, 2001, HEPATOLOGY, V34, P89, DOI 10.1053/jhep.2001.25349; Simic P, 2013, CELL REP, V3, P1175, DOI 10.1016/j.celrep.2013.03.019; Sun LN, 2013, J CELL SCI, V126, P3939, DOI 10.1242/jcs.127381; Sun LN, 2013, JNCI-J NATL CANCER I, V105, P887, DOI 10.1093/jnci/djt118; Tian WF, 2016, INT J BIOCHEM CELL B, V71, P35, DOI 10.1016/j.biocel.2015.12.005; Tian WF, 2013, HEPATOLOGY, V58, P576, DOI 10.1002/hep.26207; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Weng HL, 2007, HEPATOLOGY, V46, P1257, DOI 10.1002/hep.21806; Wu XY, 2011, NUCLEIC ACIDS RES, V39, P9549, DOI 10.1093/nar/gkr651; Wu YT, 2015, TUMOR BIOL, V36, P4063, DOI 10.1007/s13277-015-3488-x; Yang G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14941; Yang L, 2013, GASTROENTEROLOGY, V144, P1042, DOI 10.1053/j.gastro.2013.01.056; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yin HQ, 2014, GASTROENTEROLOGY, V146, P801, DOI 10.1053/j.gastro.2013.11.008; Zhou YQ, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/506390	45	48	52	1	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					500	511		10.1096/fj.201700612R	http://dx.doi.org/10.1096/fj.201700612R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28970250				2022-12-26	WOS:000419172700044
J	Idica, A; Sevrioukov, EA; Zisoulis, DG; Hamdorf, M; Daugaard, I; Kadandale, P; Pedersen, IM				Idica, Adam; Sevrioukov, Evgueni A.; Zisoulis, Dimitrios G.; Hamdorf, Matthias; Daugaard, Iben; Kadandale, Pavan; Pedersen, Irene M.			MicroRNA miR-128 represses LINE-1 (L1) retrotransposition by down-regulating the nuclear import factor TNPO1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						genomic instability; inhibitor; microRNA (miRNA); microRNA mechanism; nuclear transport; LINE-1 (L1); miR-128; nuclear import; mobile elements; miR; restriction; TNPO1; retrotransposition	ANTISENSE PROMOTER; KARYOPHERIN-BETA; GENOME EVOLUTION; SOMATIC-CELLS; PROTEIN; RNA; TRANSPORTIN; MECHANISM; ELEMENTS; PATHWAY	Repetitive elements, including LINE-1 (L1), comprise approximately half of the human genome. These elements can potentially destabilize the genome by initiating their own replication and reintegration into new sites (retrotransposition). In somatic cells, transcription of L1 elements is repressed by distinct molecular mechanisms, including DNA methylation and histone modifications, to repress transcription. Under conditions of hypomethylation (e.g. in tumor cells), a window of opportunity for L1 derepression arises, and additional restriction mechanisms become crucial. We recently demonstrated that the microRNA miR-128 represses L1 activity by directly binding to L1 ORF2 RNA. In this study, we tested whether miR-128 can also control L1 activity by repressing cellular proteins important for L1 retrotransposition. We found that miR-128 targets the 3 UTR of nuclear import factor transportin 1 (TNPO1) mRNA. Manipulation of miR-128 and TNPO1 levels demonstrated that induction or depletion of TNPO1 affects L1 retrotransposition and nuclear import of an L1-ribonucleoprotein complex (using L1-encoded ORF1p as a proxy for L1-ribonucleoprotein complexes). Moreover, TNPO1 overexpression partially reversed the repressive effect of miR-128 on L1 retrotransposition. Our study represents the first description of a protein factor involved in nuclear import of the L1 element and demonstrates that miR-128 controls L1 activity in somatic cells through two independent mechanisms: direct binding to L1 RNA and regulation of a cellular factor necessary for L1 nuclear import and retrotransposition.	[Idica, Adam; Sevrioukov, Evgueni A.; Zisoulis, Dimitrios G.; Hamdorf, Matthias; Daugaard, Iben; Kadandale, Pavan; Pedersen, Irene M.] Univ Calif Irvine, Dept Mol Biol & Biochem, Francisco J Ayala Sch Biol Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine	Pedersen, IM (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, 3244 McGaugh Hall,503 Phys Sci Rd, Irvine, CA 92697 USA.	imp@uci.edu	Daugaard, Iben/J-5699-2017	Daugaard, Iben/0000-0002-1766-0705	University of California Cancer Research Coordinating Committee [55205]; American Cancer Society Institutional Research Grant [98-279-08]; University of California Irvine Institute for Memory Impairments and Neurological Disorders grant; California Institute of Regenerative Medicine Grant [TG2-01152]	University of California Cancer Research Coordinating Committee(University of California System); American Cancer Society Institutional Research Grant(American Cancer Society); University of California Irvine Institute for Memory Impairments and Neurological Disorders grant; California Institute of Regenerative Medicine Grant	This work was supported by University of California Cancer Research Coordinating Committee 55205 (to I. M. P.), American Cancer Society Institutional Research Grant 98-279-08 (to I. M. P.), a University of California Irvine Institute for Memory Impairments and Neurological Disorders grant (to I. M. P.), and California Institute of Regenerative Medicine Grant TG2-01152 (to A. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Bogerd HP, 2007, VIROLOGY, V364, P486, DOI 10.1016/j.virol.2007.03.019; Bonifaci N, 1997, P NATL ACAD SCI USA, V94, P5055, DOI 10.1073/pnas.94.10.5055; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; De Iaco A, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-20; De Iaco A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-98; Erwin JA, 2014, NAT REV NEUROSCI, V15, P497, DOI 10.1038/nrn3730; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Fridell RA, 1997, J CELL SCI, V110, P1325; Goodier JL, 2007, MOL CELL BIOL, V27, P6469, DOI 10.1128/MCB.00332-07; Goodier JL, 2013, NUCLEIC ACIDS RES, V41, P7401, DOI 10.1093/nar/gkt512; Guttinger S, 2004, P NATL ACAD SCI USA, V101, P2918, DOI 10.1073/pnas.0400342101; Hamdorf M, 2015, NAT STRUCT MOL BIOL, V22, P824, DOI 10.1038/nsmb.3090; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Heras SR, 2013, NAT STRUCT MOL BIOL, V20, P1173, DOI 10.1038/nsmb.2658; Hogan DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100951; Hunter SE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003353; Jin M, 2014, CANCER RES, V74, P4183, DOI 10.1158/0008-5472.CAN-14-0404; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kent OA, 2013, ONCOGENE, V32, P2576, DOI 10.1038/onc.2012.266; Kimura M, 2013, MOL CELL PROTEOMICS, V12, P145, DOI 10.1074/mcp.M112.019414; KLECKNER N, 1990, ANNU REV CELL BIOL, V6, P297, DOI 10.1146/annurev.cb.06.110190.001501; Koito Atsushi, 2011, Mob Genet Elements, V1, P197; Kolosha VO, 1997, P NATL ACAD SCI USA, V94, P10155, DOI 10.1073/pnas.94.19.10155; Krishnan L, 2010, J VIROL, V84, P397, DOI 10.1128/JVI.01899-09; Kubo S, 2006, P NATL ACAD SCI USA, V103, P8036, DOI 10.1073/pnas.0601954103; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Lin CW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2876; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Macia A, 2017, GENOME RES, V27, P335, DOI 10.1101/gr.206805.116; Maertens GN, 2014, P NATL ACAD SCI USA, V111, P2728, DOI 10.1073/pnas.1320755111; Masri S, 2010, BREAST CANCER RES TR, V124, P89, DOI 10.1007/s10549-009-0716-3; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2007, NATURE, V446, P208, DOI 10.1038/nature05560; Nakielny S, 1996, EXP CELL RES, V229, P261, DOI 10.1006/excr.1996.0369; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Nigumann P, 2002, GENOMICS, V79, P628, DOI 10.1006/geno.2002.6758; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Qian PX, 2012, CANCER RES, V72, P6036, DOI 10.1158/0008-5472.CAN-12-1507; Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304; SCOTT A F, 1987, Genomics, V1, P113, DOI 10.1016/0888-7543(87)90003-6; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shi X, 2007, MOL CELL BIOL, V27, P1264, DOI 10.1128/MCB.01888-06; Shi Z, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/J0URNAL.P0NE.0032709; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; Singer T, 2010, TRENDS NEUROSCI, V33, P345, DOI 10.1016/j.tins.2010.04.001; Siomi MC, 1997, J CELL BIOL, V138, P1181, DOI 10.1083/jcb.138.6.1181; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Tsutsumi Y, 2000, JPN J CLIN ONCOL, V30, P289, DOI 10.1093/jjco/30.7.289; Twyffels L, 2014, FEBS LETT, V588, P1857, DOI 10.1016/j.febslet.2014.04.023; Valle-Casuso JC, 2012, J VIROL, V86, P5931, DOI 10.1128/JVI.00451-12; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Wissing S, 2012, HUM MOL GENET, V21, P208, DOI 10.1093/hmg/ddr455; Xie Y, 2013, MOBILE DNA-UK, V4, DOI 10.1186/1759-8753-4-10; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Zhang Y, 2009, J MOL MED, V87, P43, DOI 10.1007/s00109-008-0403-6	80	14	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20494	20508		10.1074/jbc.M117.807677	http://dx.doi.org/10.1074/jbc.M117.807677			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	28974576	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000418267000013
J	Boselli, M; Lee, BH; Robert, J; Prado, MA; Min, SW; Cheng, CL; Silva, MC; Seong, C; Elsasser, S; Hatle, KM; Gahman, TC; Gygi, SP; Haggarty, SJ; Gan, L; King, RW; Finley, D				Boselli, Monica; Lee, Byung-Hoon; Robert, Jessica; Prado, Miguel A.; Min, Sang-Won; Cheng, Chialin; Silva, M. Catarina; Seong, Changhyun; Elsasser, Suzanne; Hatle, Ketki M.; Gahman, Timothy C.; Gygi, Steven P.; Haggarty, Stephen J.; Gan, Li; King, Randall W.; Finley, Daniel			An inhibitor of the proteasomal deubiquitinating enzyme USP14 induces tau elimination in cultured neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurodegenerative disease; proteasome; small molecule; tauopathy; ubiquitin; IU1; IU1-47	UBIQUITIN-SPECIFIC PROTEASE; SMALL-MOLECULE INHIBITOR; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; 26S PROTEASOME; MEDIATED NEURODEGENERATION; TRANSGENIC MICE; ATAXIA MICE; DEGRADATION; AUTOPHAGY	The ubiquitin-proteasome system (UPS) is responsible for most selective protein degradation in eukaryotes and regulates numerous cellular processes, including cell cycle control and protein quality control. A component of this system, the deubiquitinating enzyme USP14, associates with the proteasome where it can rescue substrates from degradation by removal of the ubiquitin tag. We previously found that a small-molecule inhibitor of USP14, known as IU1, can increase the rate of degradation of a subset of proteasome substrates. We report here the synthesis and characterization of 87 variants of IU1, which resulted in the identification of a 10-fold more potent USP14 inhibitor that retains specificity for USP14. The capacity of this compound, IU1-47, to enhance protein degradation in cells was tested using as a reporter the microtubule-associated protein tau, which has been implicated in many neurodegenerative diseases. Using primary neuronal cultures, IU1-47 was found to accelerate the rate of degradation of wild-type tau, the pathological tau mutants P301L and P301S, and the A152T tau variant. We also report that a specific residue in tau, lysine 174, is critical for the IU1-47-mediated tau degradation by the proteasome. Finally, we show that IU1-47 stimulates autophagic flux in primary neurons. In summary, these findings provide a powerful research tool for investigating the complex biology of USP14.	[Boselli, Monica; Lee, Byung-Hoon; Robert, Jessica; Prado, Miguel A.; Seong, Changhyun; Elsasser, Suzanne; Hatle, Ketki M.; Gygi, Steven P.; King, Randall W.; Finley, Daniel] Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA; [Lee, Byung-Hoon] Daegu Gyeongbuk Inst Sci & Technol, Dept New Biol, Daegu 42988, South Korea; [Min, Sang-Won; Gan, Li] Univ Calif San Francisco, Gladstone Inst Neurol Dis, Dept Neurol, San Francisco, CA 94158 USA; [Cheng, Chialin; Silva, M. Catarina; Haggarty, Stephen J.] Harvard Med Sch, Massachusetts Gen Hosp, Chem Neurobiol Lab, Ctr Genom Med,Dept Neurol, Boston, MA 02114 USA; [Seong, Changhyun] Regeneron Pharmaceut, Tarrytown, NY 10591 USA; [Gahman, Timothy C.] Ludwig Inst Canc Res, Small Mol Discovery Program, La Jolla, CA 92093 USA	Harvard University; Harvard Medical School; Daegu Gyeongbuk Institute of Science & Technology (DGIST); University of California System; University of California San Francisco; The J David Gladstone Institutes; Harvard University; Harvard Medical School; Massachusetts General Hospital; Regeneron; Ludwig Institute for Cancer Research	King, RW; Finley, D (corresponding author), Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	randy_king@hms.harvard.edu; daniel_finley@hms.harvard.edu	Prado, Miguel A/P-3922-2017	Prado, Miguel A/0000-0002-4914-1619; Lee, Byung-Hoon/0000-0002-7101-0471; Gan, Li/0000-0003-4600-275X	Tau Consortium; National Institutes of Health [R01 GM095526, GM043601, R01 GM66492, R01 AG054214]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science and Information Communication and Technology (ICT) [2017R1A2B4006671]; Daegu Gyeongbuk Institute of Science and Technology start-up fund; High Risk High Return, Ministry of Science, ICT, and Future Planning [2017010074, 2017010133]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095526, R01GM043601, R37GM043601, R01GM067945, R01GM066492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG054214] Funding Source: NIH RePORTER	Tau Consortium; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science and Information Communication and Technology (ICT); Daegu Gyeongbuk Institute of Science and Technology start-up fund; High Risk High Return, Ministry of Science, ICT, and Future Planning; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the Tau Consortium (to D. F. and S. J. H.); by National Institutes of Health Grants R01 GM095526 and GM043601 (to D. F.), R01 GM66492 (to R. W. K.), and R01 AG054214 (to L. G.); and by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Science and Information Communication and Technology (ICT) Grant 2017R1A2B4006671, a Daegu Gyeongbuk Institute of Science and Technology start-up fund, and High Risk High Return, Ministry of Science, ICT, and Future Planning Grants 2017010074 and 2017010133 (to B.-H. L.). Patents 8933087 and 9201073 are held on IU1, IU1-47, and USP14 inhibition. A patent application on this work has been filed by Harvard University on behalf of the authors. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali A, 2017, BIOCHEM J, V474, P1653, DOI 10.1042/BCJ20160304; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Bashore C, 2015, NAT STRUCT MOL BIOL, V22, P712, DOI 10.1038/nsmb.3075; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Budenholzer L, 2017, J MOL BIOL, V429, P3500, DOI 10.1016/j.jmb.2017.05.027; Bugiani O, 1999, J NEUROPATH EXP NEUR, V58, P667, DOI 10.1097/00005072-199906000-00011; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Chen MX, 2016, MOL CELL, V64, P105, DOI 10.1016/j.molcel.2016.08.025; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; Coppola G, 2012, HUM MOL GENET, V21, P3500, DOI 10.1093/hmg/dds161; Crimmins S, 2006, J NEUROSCI, V26, P11423, DOI 10.1523/JNEUROSCI.3600-06.2006; Damme M, 2015, ACTA NEUROPATHOL, V129, P337, DOI 10.1007/s00401-014-1361-4; Doeppner TR, 2013, ACTA NEUROPATHOL, V126, P251, DOI 10.1007/s00401-013-1142-5; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; Eletr ZM, 2014, BBA-MOL CELL RES, V1843, P114, DOI 10.1016/j.bbamcr.2013.06.027; Fan YH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.400; Ferreira A, 2011, MOL MED, V17, P676, DOI 10.2119/molmed.2010.00220; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gendron TF, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-13; Gotz J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00072; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; GOTZ J, 1995, EMBO J, V14, P1304, DOI 10.1002/j.1460-2075.1995.tb07116.x; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Harrill JA, 2015, IN VITRO CELL DEV-AN, V51, P612, DOI 10.1007/s11626-015-9873-3; Hjerpe R, 2016, CELL, V166, P935, DOI 10.1016/j.cell.2016.07.001; Homma T, 2015, SCI REP-UK, V5, DOI 10.1038/srep11028; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Hua YN, 2015, BBA-MOL BASIS DIS, V1852, P195, DOI 10.1016/j.bbadis.2014.04.032; Inobe T, 2014, CURR OPIN STRUC BIOL, V24, P156, DOI 10.1016/j.sbi.2014.02.002; Irwin DJ, 2013, AM J PATHOL, V183, P344, DOI 10.1016/j.ajpath.2013.04.025; Jung H, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.28; Kabashi E, 2006, BBA-MOL BASIS DIS, V1762, P1038, DOI 10.1016/j.bbadis.2006.06.006; KHATOON S, 1992, J NEUROCHEM, V59, P750, DOI 10.1111/j.1471-4159.1992.tb09432.x; Kim HT, 2017, J BIOL CHEM, V292, P9830, DOI 10.1074/jbc.M116.763128; King RW, 2014, NAT CHEM BIOL, V10, P870, DOI 10.1038/nchembio.1671; Kiprowska MJ, 2017, BBA-MOL BASIS DIS, V1863, P1157, DOI 10.1016/j.bbadis.2017.03.017; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lee BH, 2016, NATURE, V532, P398, DOI 10.1038/nature17433; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Liao YN, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.477; Lim KH, 2013, CURR PHARM DESIGN, V19, P4039, DOI 10.2174/1381612811319220013; Lokireddy S, 2015, P NATL ACAD SCI USA, V112, pE7176, DOI 10.1073/pnas.1522332112; Lopez A, 2017, BRAIN, V140, P1128, DOI 10.1093/brain/awx005; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Marshall AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084042; Matyskiela ME, 2013, J MOL BIOL, V425, P199, DOI 10.1016/j.jmb.2012.11.001; McKinnon C, 2016, ACTA NEUROPATHOL, V131, P411, DOI 10.1007/s00401-015-1508-y; Min JW, 2017, J NEUROCHEM, V140, P826, DOI 10.1111/jnc.13941; Min SW, 2015, NAT MED, V21, P1154, DOI 10.1038/nm.3951; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Mirra SS, 1999, J NEUROPATH EXP NEUR, V58, P335, DOI 10.1097/00005072-199904000-00004; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Myeku N, 2016, NAT MED, V22, P46, DOI 10.1038/nm.4011; Nag DK, 2012, VIRUS RES, V165, P103, DOI 10.1016/j.virusres.2012.01.009; Nakashima A, 2016, BIOCHEM BIOPH RES CO, V472, P598, DOI 10.1016/j.bbrc.2016.03.022; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Pir GJ, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0096-1; Ponnappan S, 2013, MECH AGEING DEV, V134, P53, DOI 10.1016/j.mad.2012.12.007; Rademakers R, 2004, HUM MUTAT, V24, P277, DOI 10.1002/humu.20086; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sareen-Khanna K, 2016, AM J PHYSIOL-RENAL, V311, pF1035, DOI 10.1152/ajprenal.00252.2016; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Silva MC, 2016, STEM CELL REP, V7, P325, DOI 10.1016/j.stemcr.2016.08.001; Son JH, 2012, EXP MOL MED, V44, P89, DOI 10.3858/emm.2012.44.2.031; Sorimachi H, 2012, CARDIOVASC RES, V96, P11, DOI 10.1093/cvr/cvs157; Sperfeld AD, 1999, ANN NEUROL, V46, P708, DOI 10.1002/1531-8249(199911)46:5<708::AID-ANA5>3.0.CO;2-K; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Vaden JH, 2015, MOL NEURODEGENER, V10, DOI 10.1186/1750-1326-10-3; Vale C, 2010, CELL MOL NEUROBIOL, V30, P577, DOI 10.1007/s10571-009-9482-3; Walters BJ, 2014, J PHYSIOL-LONDON, V592, P571, DOI 10.1113/jphysiol.2013.266015; Weathington NM, 2014, J CLIN INVEST, V124, P6, DOI 10.1172/JCI71602; Wiesner DA, 1996, J NEUROCHEM, V66, P1418; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Xu DC, 2016, GENE DEV, V30, P1718, DOI 10.1101/gad.285122.116; YANG LS, 1995, EUR J BIOCHEM, V233, P9, DOI 10.1111/j.1432-1033.1995.009_1.x; Young ZT, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a024612; Zhang YN, 2013, NAT CHEM BIOL, V9, P51, DOI [10.1038/NCHEMBIO.1134, 10.1038/nchembio.1134]; Zhao WN, 2012, J BIOMOL SCREEN, V17, P1252, DOI 10.1177/1087057112456876; Zhu Y, 2017, ONCOTARGET, V8, P48725, DOI 10.18632/oncotarget.10706	89	77	78	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19209	19225		10.1074/jbc.M117.815126	http://dx.doi.org/10.1074/jbc.M117.815126			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972160	hybrid, Green Published			2022-12-26	WOS:000416226700006
J	Thom, SR; Bhopale, VM; Yu, K; Huang, WL; Kane, MA; Margolis, DJ				Thom, Stephen R.; Bhopale, Veena M.; Yu, Kevin; Huang, Weiliang; Kane, Maureen A.; Margolis, David J.			Neutrophil microparticle production and inflammasome activation by hyperglycemia due to cytoskeletal instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; inflammasome; interleukin 1 (IL-1); nitric oxide; nitrosylation; NLRP3	NITRIC-OXIDE SYNTHASE; TYPE-2 DIABETES-MELLITUS; FOCAL ADHESION KINASE; BETA(2) INTEGRIN INHIBITION; ACTIN S-NITROSYLATION; OXIDATIVE STRESS; NLRP3 INFLAMMASOME; VASCULAR INJURIES; ENDOTHELIAL-CELLS; SIGNALING PATHWAY	Microparticles are lipid bilayer-enclosed vesicles produced by cells under oxidative stress. MP production is elevated in patients with diabetes, but the underlying cellular mechanisms are poorly understood. We hypothesized that raising glucose above the physiological level of 5.5 mm would stimulate leukocytes to produce MPs and activate the nucleotide-binding domain, leucine-rich repeat pyrin domain-containing 3 (NLRP3) inflammasome. We found that when incubated in buffer with up to 20 mm glucose, human and murine neutrophils, but not monocytes, generate progressively more MPs with high interleukin (IL)-1 content. Enhanced MP production required generation of reactive chemical species by mitochondria, NADPH oxidase, and type 2 nitric-oxide synthase (NOS-2) and resulted in S-nitrosylation of actin. Depleting cells of capon (C-terminal PDZ ligand of neuronal nitric-oxide synthase protein), apoptosis-associated speck-like protein containing C-terminal caspase recruitment domain (ASC), or pro-IL-1 prevented the hyperglycemia-induced enhancement of reactive species production, MP generation, and IL-1 synthesis. Additional components required for these responses included inositol 1,3,5-triphosphate receptors, PKC, and enhancement of filamentous-actin turnover. Numerous proteins become localized to short filamentous actin in response to S-nitrosylation, including vasodilator-stimulated phosphoprotein, focal adhesion kinase, the membrane phospholipid translocation enzymes flippase and floppase, capon, NLRP3, and ASC. We conclude that an interdependent oxidative stress response to hyperglycemia perturbs neutrophil cytoskeletal stability leading to MP production and IL-1 synthesis.	[Thom, Stephen R.; Bhopale, Veena M.; Yu, Kevin] Univ Maryland, Sch Med, Dept Emergency Med, 655 W Baltimore St,Bressler Res Bldg,Rm 4-013, Baltimore, MD 21201 USA; [Huang, Weiliang; Kane, Maureen A.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Margolis, David J.] Univ Penn, Dept Dermatol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Margolis, David J.] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Thom, SR (corresponding author), Univ Maryland, Sch Med, Dept Emergency Med, 655 W Baltimore St,Bressler Res Bldg,Rm 4-013, Baltimore, MD 21201 USA.	sthom@em.umaryland.edu			National Institutes of Health from NIDDK [R01-DK094260]; Office of Naval Research [N00014-16-1-2868]; University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center [SOP1841-IQB2014]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094260] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Office of Naval Research(Office of Naval Research); University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01-DK094260 from NIDDK (to S. R. T. and D. J. M.), Office of Naval Research Grant N00014-16-1-2868 (to S. R. T.), and University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center Grant SOP1841-IQB2014 (to W. H. and M. A. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abderrazak A, 2015, REDOX BIOL, V4, P296, DOI 10.1016/j.redox.2015.01.008; Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Alexandru N, 2016, BIOCHEM BIOPH RES CO, V472, P1, DOI 10.1016/j.bbrc.2016.02.038; Andreasen CH, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-118; Armstrong DG, 2013, DIABETES CARE, V36, P1815, DOI 10.2337/dc12-2285; Bansaghi S, 2014, J BIOL CHEM, V289, P8170, DOI 10.1074/jbc.M113.504159; Bearer EL, 2000, CELL MOTIL CYTOSKEL, V47, P351, DOI 10.1002/1097-0169(200012)47:4<351::AID-CM8>3.0.CO;2-8; Becker ML, 2008, PHARMACOGENET GENOM, V18, P591, DOI 10.1097/FPC.0b013e328300e8c5; Bei JJ, 2016, THROMB HAEMOSTASIS, V115, P632, DOI 10.1160/TH15-04-0322; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; Bhopale VM, 2015, J BIOL CHEM, V290, P17474, DOI 10.1074/jbc.M115.651620; Bhullar J, 2016, FREE RADICAL BIO MED, V101, P154, DOI 10.1016/j.freeradbiomed.2016.10.010; Bianco F, 2005, J IMMUNOL, V174, P7268, DOI 10.4049/jimmunol.174.11.7268; Bonini MG, 2006, FREE RADICAL BIO MED, V40, P968, DOI 10.1016/j.freeradbiomed.2005.10.042; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Butin-Israeli V, 2016, FASEB J, V30, P4007, DOI 10.1096/fj.201600734R; Buzzo CD, 2017, SCI REP-UK, V7, DOI 10.1038/srep41686; Campello E, 2018, CYTOM PART B-CLIN CY, V94, P334, DOI 10.1002/cyto.b.21507; Carrel D, 2015, BIOL PSYCHIAT, V77, P969, DOI 10.1016/j.biopsych.2014.10.016; Chen ML, 2008, J MOL NEUROSCI, V34, P89, DOI 10.1007/s12031-007-9005-y; Chen W, 2017, INFLAMM RES, V66, P157, DOI 10.1007/s00011-016-1002-6; Chen Y, 2016, J MOL MED, V94, P1335, DOI 10.1007/s00109-016-1481-5; Chiva-Blanch G, 2017, INT J CARDIOL, V227, P876, DOI 10.1016/j.ijcard.2016.11.302; Chu AY, 2010, DIABETOLOGIA, V53, P510, DOI 10.1007/s00125-009-1608-0; Clattenburg L, 2015, MOL CELL BIOL, V35, P2265, DOI 10.1128/MCB.00062-15; Courtney MJ, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00252; Deretic V, 2012, TRENDS CELL BIOL, V22, P397, DOI 10.1016/j.tcb.2012.04.008; Diamant M, 2002, CIRCULATION, V106, P2442, DOI 10.1161/01.CIR.0000036596.59665.C6; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; El Jamali A, 2010, FREE RADICAL BIO MED, V48, P798, DOI 10.1016/j.freeradbiomed.2009.12.018; Elliott EI, 2016, IMMUNITY, V44, P713, DOI 10.1016/j.immuni.2016.03.015; Eng JK, 2008, J PROTEOME RES, V7, P4598, DOI 10.1021/pr800420s; Enjeti AK, 2007, SEMIN THROMB HEMOST, V33, P771, DOI 10.1055/s-2007-1000369; Giardina TM, 2008, BBA-BIOENERGETICS, V1777, P118, DOI 10.1016/j.bbabio.2007.11.006; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Heijnen HFG, 2006, FREE RADICAL BIO MED, V40, P1903, DOI 10.1016/j.freeradbiomed.2005.09.006; Hewinson J, 2008, J IMMUNOL, V180, P8410, DOI 10.4049/jimmunol.180.12.8410; Hu C, 2010, DIABETOLOGIA, V53, P290, DOI 10.1007/s00125-009-1594-2; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; Joosten LAB, 2013, SEMIN IMMUNOL, V25, P416, DOI 10.1016/j.smim.2013.10.018; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kasorn A, 2009, J IMMUNOL, V183, P1032, DOI 10.4049/jimmunol.0802984; Koga H, 2005, J AM COLL CARDIOL, V45, P1622, DOI 10.1016/j.jacc.2005.02.047; LAL AA, 1984, J BIOL CHEM, V259, P8794; Li SY, 2016, CELL PHYSIOL BIOCHEM, V39, P2439, DOI 10.1159/000452512; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Margolis DJ, 2017, WOUND REPAIR REGEN, V25, P733, DOI 10.1111/wrr.12564; Margolis DJ, 2013, WOUND REPAIR REGEN, V21, P17, DOI 10.1111/j.1524-475X.2012.00866.x; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Niu CG, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004099; Ogata N, 2006, DIABETES RES CLIN PR, V73, P241, DOI 10.1016/j.diabres.2006.01.014; Paes AMD, 2011, J LEUKOCYTE BIOL, V90, P799, DOI 10.1189/jlb.0610324; Pitanga TN, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-21; Pizzirani C, 2007, BLOOD, V109, P3856, DOI 10.1182/blood-2005-06-031377; Puren AJ, 1999, P NATL ACAD SCI USA, V96, P2256, DOI 10.1073/pnas.96.5.2256; Qiao C, 2015, J CELL PHYSIOL, V230, P1054, DOI 10.1002/jcp.24833; Qin W, 2010, ACTA PHARMACOL SIN, V31, P450, DOI 10.1038/aps.2010.25; Qiu YY, 2016, PHARMACOL RES, V114, P251, DOI 10.1016/j.phrs.2016.11.004; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Schlegel N, 2009, J CELL PHYSIOL, V220, P357, DOI 10.1002/jcp.21772; Schlegel N, 2009, AM J PHYSIOL-CELL PH, V296, pC453, DOI 10.1152/ajpcell.00360.2008; Schmidt RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045186; Slater TW, 2017, J IMMUNOL, V198, P2886, DOI 10.4049/jimmunol.1601810; Sokolovska A, 2013, NAT IMMUNOL, V14, P543, DOI 10.1038/ni.2595; Sugiyama K, 2016, INT HEART J, V57, P341, DOI 10.1536/ihj.15-471; Tan KT, 2005, DIABETIC MED, V22, P1657, DOI 10.1111/j.1464-5491.2005.01707.x; Thom SR, 2008, J BIOL CHEM, V283, P10822, DOI 10.1074/jbc.M709200200; Thom SR, 2017, FREE RADICAL BIO MED, V106, P406, DOI 10.1016/j.freeradbiomed.2017.03.005; Thom SR, 2014, J BIOL CHEM, V289, P18831, DOI 10.1074/jbc.M113.543702; Thom SR, 2013, J BIOL CHEM, V288, P4810, DOI 10.1074/jbc.M112.426353; Thom SR, 2012, J BIOL CHEM, V287, P30346, DOI 10.1074/jbc.M112.355875; Thom SR, 2012, J APPL PHYSIOL, V112, P1268, DOI 10.1152/japplphysiol.01305.2011; Thom SR, 2011, J BIOL CHEM, V286, P32854, DOI 10.1074/jbc.M111.255778; Thom SR, 2011, J APPL PHYSIOL, V110, P340, DOI 10.1152/japplphysiol.00811.2010; Waldeck-Weiermair M, 2010, CELL CALCIUM, V47, P433, DOI 10.1016/j.ceca.2010.03.004; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Wang J, 2016, BRAIN RES BULL, V125, P99, DOI 10.1016/j.brainresbull.2016.05.014; Wang T, 2014, PHARMACOTHERAPY, V34, P131, DOI 10.1002/phar.1379; Wehman AM, 2011, CURR BIOL, V21, P1951, DOI 10.1016/j.cub.2011.10.040; Williamson JC, 2016, PROTEOMICS, V16, P907, DOI 10.1002/pmic.201400545; Yang M, 2012, J APPL PHYSIOL, V112, P204, DOI 10.1152/japplphysiol.00953.2011; Zhang Y, 2011, AM J RHINOL ALLERGY, V25, pE49, DOI 10.2500/ajra.2011.25.3588; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028	84	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18312	18324		10.1074/jbc.M117.802629	http://dx.doi.org/10.1074/jbc.M117.802629			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28972154	hybrid, Green Published			2022-12-26	WOS:000414458200028
J	Ohno, M; Nishida, A; Sugitani, Y; Nishino, K; Inatomi, O; Sugimoto, M; Kawahara, M; Andoh, A				Ohno, Masashi; Nishida, Atsushi; Sugitani, Yoshihiko; Nishino, Kyohei; Inatomi, Osamu; Sugimoto, Mitsushige; Kawahara, Masahiro; Andoh, Akira			Nanoparticle curcumin ameliorates experimental colitis via modulation of gut microbiota and induction of regulatory T cells	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; ULCERATIVE-COLITIS; CONTROLLED-TRIAL; CLINICAL-TRIALS; HUMAN FECES; BIOAVAILABILITY; CANCER; MICE	Background and Aims Curcumin is a hydrophobic polyphenol derived from turmeric, a traditional Indian spice. Curcumin exhibits various biological functions, but its clinical application is limited due to its poor absorbability after oral administration. A newly developed nanoparticle curcumin shows improved absorbability in vivo. In this study, we examined the effects of nanoparticle curcumin (named Theracurmin) on experimental colitis in mice. Methods BALB/c mice were fed with 3% dextran sulfate sodium (DSS) in water. Mucosal cytokine expression and lymphocyte subpopulation were analyzed by real-time PCR and flow cytometry, respectively. The profile of the gut microbiota was analyzed by real-time PCR. Results Treatment with nanoparticle curcumin significantly attenuated body weight loss, disease activity index, histological colitis score and significantly improved mucosal permeability. Immunoblot analysis showed that NF-kappa B activation in colonic epithelial cells was significantly suppressed by treatment with nanoparticle curcumin. Mucosal mRNA expression of inflammatory mediators was significantly suppressed by treatment with nanoparticle curcumin. Treatment with nanoparticle curcumin increased the abundance of butyrate-producing bacteria and fecal butyrate level. This was accompanied by increased expansion of CD4(+) Foxp3(+) regulatory T cells and CD103(+) CD8 alpha(-) regulatory dendritic cells in the colonic mucosa. Conclusions Treatment with nanoparticle curcumin suppressed the development of DSS-induced colitis potentially via modulation of gut microbial structure. These responses were associated with induction of mucosal immune cells with regulatory properties. Nanoparticle curcumin is one of the promising candidates as a therapeutic option for the treatment of IBD.	[Ohno, Masashi; Nishida, Atsushi; Sugitani, Yoshihiko; Nishino, Kyohei; Inatomi, Osamu; Sugimoto, Mitsushige; Kawahara, Masahiro; Andoh, Akira] Shiga Univ Med Sci, Dept Med, Otsu, Shiga, Japan	Shiga University of Medical Science	Nishida, A (corresponding author), Shiga Univ Med Sci, Dept Med, Otsu, Shiga, Japan.	atsuda@belle.shiga-med.ac.jp	Andoh, Akira/AAB-9303-2022	Inatomi, Osamu/0000-0002-5837-6575; Kawahara, Masahiro/0000-0002-2721-7571	Ministry of Education, Culture, Sports, Science and Technology of Japan [15K08967, 15K19322]; Ministry of Health, Labor and Welfare of Japan [067]; Japan Agency for Medical Research and Development, AMED [15AeK0109047h0002]; Smoking Research Foundation [1848]; Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan [067]; Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development, AMED [15AeK0109047h0002]; Grants-in-Aid for Scientific Research [16K09846, 15K08948] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Smoking Research Foundation; Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan; Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (15K08967, 15K19322), a grant for the Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan (067), a grant from the Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development, AMED (15AeK0109047h0002), and a grant from the Smoking Research Foundation (1848).; This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; https://www.jsps.go.jp/english/e-grants/index.html, 15K08967 to A.A and 15K19322 to A.N., the Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan http://www.nanbyou.or.jp/english/index.htm, 067 to A.A., the Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development, AMED http://www.amed.go.jp/en/program/list/01/05/016.html, 15AeK0109047h0002 to A.A., and the Smoking Research Foundation; http://www.srf.or.jp/english/index.html, 1848 to A.A.	Ali T, 2012, DIGESTION, V85, P249, DOI 10.1159/000336720; Andoh A, 2011, J GASTROENTEROL, V46, P479, DOI 10.1007/s00535-010-0368-4; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Berberat PO, 2005, INFLAMM BOWEL DIS, V11, P350, DOI 10.1097/01.MIB.0000164017.06538.8a; Cardona F, 2013, J NUTR BIOCHEM, V24, P1415, DOI 10.1016/j.jnutbio.2013.05.001; Espin JC, 2017, BIOCHEM PHARMACOL, V139, P82, DOI 10.1016/j.bcp.2017.04.033; Cheifetz AS, 2016, GASTROENTEROLOGY; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Epstein J, 2010, BRIT J NUTR, V103, P1545, DOI 10.1017/S0007114509993667; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Hanai H, 2006, CLIN GASTROENTEROL H, V4, P1502, DOI 10.1016/j.cgh.2006.08.008; Huang Y.-L., 2015, NAT COMMUN, V6; Kanai M, 2014, WORLD J GASTROENTERO, V20, P9384, DOI 10.3748/wjg.v20.i28.9384; Kunnumakkara A. B., 2016, BRIT J PHARM; Lang A, 2015, CLIN GASTROENTEROL H, V13, P1444, DOI 10.1016/j.cgh.2015.02.019; Langhorst J, 2015, J CROHNS COLITIS, V9, P86, DOI 10.1093/ecco-jcc/jju007; Law IKM, 2015, GUT, V64, P1095, DOI 10.1136/gutjnl-2014-307329; Milano F, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00137; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Narushima S, 2014, GUT MICROBES, V5, P333, DOI 10.4161/gmic.28572; Nishida A, 2012, GASTROENTEROLOGY, V142, P865, DOI 10.1053/j.gastro.2011.12.036; Obermeier F, 1999, CLIN EXP IMMUNOL, V116, P238; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Sasaki H, 2011, BIOL PHARM BULL, V34, P660, DOI 10.1248/bpb.34.660; Sheehan D, 2015, J GASTROENTEROL, V50, P495, DOI 10.1007/s00535-015-1064-1; Shehzad A, 2010, ARCH PHARM, V343, P489, DOI 10.1002/ardp.200900319; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Strojny B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164637; Sun M, 2016, J GASTROENTEROL; Sunagawa Y, 2012, BIOL PHARM BULL, V35, P139, DOI 10.1248/bpb.35.139; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Torii T, 2010, ANN CLIN BIOCHEM, V47, P447, DOI 10.1258/acb.2010.010047; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Yoshikawa K, 2017, J GASTROENTEROL, V52, P61, DOI 10.1007/s00535-016-1205-1	38	98	102	8	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0185999	10.1371/journal.pone.0185999	http://dx.doi.org/10.1371/journal.pone.0185999			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ1QR	28985227	Green Submitted, Green Published, gold			2022-12-26	WOS:000412493000013
J	Castillo, DS; Serantes, DAR; Melli, LJ; Ciocchini, AE; Ugalde, JE; Comerci, DJ; Cassola, A				Castillo, Daniela S.; Rey Serantes, Diego A.; Melli, Luciano J.; Ciocchini, Andres E.; Ugalde, Juan E.; Comerci, Diego J.; Cassola, Alejandro			A recombinant O-polysaccharide-protein conjugate approach to develop highly specific monoclonal antibodies to Shiga toxin-producing Escherichia coli O157 and O145 serogroups	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; N-LINKED GLYCOSYLATION; TERM-FOLLOW-UP; BRUCELLA-ABORTUS; FLOW-CYTOMETRY; CAMPYLOBACTER-JEJUNI; BOVINE BRUCELLOSIS; RAPID DETECTION; GROUND-BEEF; LYMPH-NODE	Shiga toxin-producing Escherichia coli (STEC) is the major etiologic agent of hemolytic-uremic syndrome (HUS). The high rate of HUS emphasizes the urgency for the implementation of primary prevention strategies to reduce its public health impact. Argentina shows the highest rate of HUS worldwide, being E. coli O157 the predominant STEC-associated HUS serogroup (>70%), followed by E. coli O145 (>9%). To specifically detect these serogroups we aimed at developing highly specific monoclonal antibodies (mAbs) against the O-polysaccharide (O-PS) section of the lipopolysaccharide (LPS) of the dominant STEC-associated HUS serogroups in Argentina. The development of hybridomas secreting mAbs against O157 or O145 was carried out through a combined immunization strategy, involving adjuvated-bacterial immunizations followed by immunizations with recombinant O-PS-protein conjugates. We selected hybridoma clones that specifically recognized the engineered O-PS-protein conjugates of O157 or O145 serogroups. Indirect ELISA of heat-killed bacteria showed specific binding to O157 or O145 serogroups, respectively, while no cross-reactivity with other epidemiological important STEC strains, Brucella abortus, Salmonella group N or Yersinia enterocolitica O9 was observed. Western blot analysis showed specific recognition of the sought O-PS section of the LPS by all mAbs. Finally, the ability of the developed mAbs to bind the surface of whole bacteria cells was confirmed by flow cytometry, confocal microscopy and agglutination assays, indicating that these mAbs present an exceptional degree of specificity and relative affinity in the detection and identification of E. coli O157 and O145 serogroups. These mAbs may be of significant value for clinical diagnosis and food quality control applications. Thus, engineered O-PS specific moieties contained in the recombinant glycoconjugates used for combined immunization and hybridoma selection are an invaluable resource for the development of highly specific mAbs.	[Castillo, Daniela S.; Rey Serantes, Diego A.; Melli, Luciano J.; Ciocchini, Andres E.; Ugalde, Juan E.; Comerci, Diego J.; Cassola, Alejandro] Univ Nacl San Martin UNSAM, CONICET, Consejo Nacl Invest Cient & Tecn, Inst Invest Biotecnol,Inst Tecnol Chascomus IIB I, San Martin, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Cassola, A (corresponding author), Univ Nacl San Martin UNSAM, CONICET, Consejo Nacl Invest Cient & Tecn, Inst Invest Biotecnol,Inst Tecnol Chascomus IIB I, San Martin, Buenos Aires, Argentina.	acassola@iibintech.com.ar		Cassola, Alejandro/0000-0001-7366-5327; Comerci, Diego J./0000-0003-1949-4226	FITS Salud Diarreas Bacterianas Fondo Nacional Sectorial -Agencia Nacional de Promocion Cientifica y Tecnologica (AEC JEU DJC) [0002/2011]; PICT Fondo para la Investigacion Cientifica y Tecnologica - Agencia Nacional de Promocion Cientifica y Tecnologica [1707]	FITS Salud Diarreas Bacterianas Fondo Nacional Sectorial -Agencia Nacional de Promocion Cientifica y Tecnologica (AEC JEU DJC); PICT Fondo para la Investigacion Cientifica y Tecnologica - Agencia Nacional de Promocion Cientifica y Tecnologica	This work was supported by FITS Salud Diarreas Bacterianas 0002/2011 Fondo Nacional Sectorial -Agencia Nacional de Promocion Cientifica y Tecnologica (AEC JEU DJC); PICT 2013-1707 Fondo para la Investigacion Cientifica y Tecnologica - Agencia Nacional de Promocion Cientifica y Tecnologica (AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Rivero MA, 2010, J MED MICROBIOL, V59, P345, DOI 10.1099/jmm.0.015560-0; Baker M, 2015, NATURE, V521, P274, DOI 10.1038/521274a; Basalp A, 2003, HYBRIDOMA HYBRIDOM, V22, P329, DOI 10.1089/153685903322538863; BITZAN M, 1991, J PEDIATR-US, V119, P380, DOI 10.1016/S0022-3476(05)82049-9; Bitzan M, 2009, KIDNEY INT, V75, pS62, DOI 10.1038/ki.2008.624; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; BUNDLE DR, 1984, INFECT IMMUN, V46, P389, DOI 10.1128/IAI.46.2.389-393.1984; CAROFF M, 1984, INFECT IMMUN, V46, P384, DOI 10.1128/IAI.46.2.384-388.1984; CAROFF M, 1984, EUR J BIOCHEM, V139, P195, DOI 10.1111/j.1432-1033.1984.tb07994.x; Chain PSG, 2005, INFECT IMMUN, V73, P8353, DOI 10.1128/IAI.73.12.8353-8361.2005; Chinen I, 2001, J FOOD PROTECT, V64, P1346, DOI 10.4315/0362-028X-64.9.1346; Ciocchini AE, 2014, VET MICROBIOL, V172, P455, DOI 10.1016/j.vetmic.2014.04.014; Ciocchini AE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002048; Cobenas CJ, 2007, PEDIATR NEPHROL, V22, P1343, DOI 10.1007/s00467-007-0522-2; CORBEL MJ, 1984, DEV BIOLOGICALS, V56, P341; Cortina ME, 2016, J CLIN MICROBIOL, V54, P1448, DOI 10.1128/JCM.00151-16; Exeni RA, 2001, ARCH LATINOAMERICANO, P35; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Feng L, 2005, J BACTERIOL, V187, P758, DOI 10.1128/JB.187.2.758-764.2005; FENG P, 1995, EMERG INFECT DIS, V1, P47, DOI 10.3201/eid0102.950202; GIANANTONIO CA, 1964, J PEDIATR-US, V64, P478, DOI 10.1016/S0022-3476(64)80337-1; Goding J.W., 1996, MONOCLONAL ANTIBODIE; Gomez D., 2002, Revista Argentina de Microbiologia, V34, P66; GREATOREX JS, 1994, J CLIN MICROBIOL, V32, P1172, DOI 10.1128/JCM.32.5.1172-1178.1994; Guttikonda S, 2007, J IMMUNOL METHODS, V327, P1, DOI 10.1016/j.jim.2007.06.010; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Hegde NV, 2012, J CLIN MICROBIOL, V50, P2137, DOI 10.1128/JCM.00137-12; Iwashkiw JA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-13; Johnson KE, 2006, CLIN INFECT DIS, V43, P1587, DOI 10.1086/509573; Johnson RP, 2014, APPL ENVIRON MICROB, V80, P2166, DOI 10.1128/AEM.03391-13; Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011; Keir LS, 2015, HEMATOL ONCOL CLIN N, V29, P525, DOI 10.1016/j.hoc.2015.01.007; Kelly J, 2006, J BACTERIOL, V188, P2427, DOI 10.1128/JB.188.7.2427-2434.2006; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Lopez EL, 2000, INFECT DIS CLIN N AM, V14, P41, DOI 10.1016/S0891-5520(05)70217-8; Mathusa EC, 2010, J FOOD PROTECT, V73, P1721, DOI 10.4315/0362-028X-73.9.1721; Melli LJ, 2015, J CLIN MICROBIOL, V53, P528, DOI 10.1128/JCM.02262-14; MIRZA IH, 1987, J IMMUNOL METHODS, V105, P235, DOI 10.1016/0022-1759(87)90271-7; Navarro A, 2007, J MED MICROBIOL, V56, P1447, DOI 10.1099/jmm.0.47201-0; NIELSEN KH, 1995, VET IMMUNOL IMMUNOP, V46, P285, DOI 10.1016/0165-2427(94)05361-U; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Oteiza JM, 2006, FOOD MICROBIOL, V23, P283, DOI 10.1016/j.fm.2005.04.003; PADHYE NV, 1991, J CLIN MICROBIOL, V29, P99, DOI 10.1128/JCM.29.1.99-103.1991; Palermo MS, 2009, EXPERT REV ANTI-INFE, V7, P697, DOI [10.1586/eri.09.49, 10.1586/ERI.09.49]; Patra KP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002926; PERRY MB, 1986, BIOCHEM CELL BIOL, V64, P21, DOI 10.1139/o86-004; PERRY MB, 1986, CARBOHYD RES, V156, P107, DOI 10.1016/S0008-6215(00)90103-4; Raybourne RB, 2001, CURRENT PROTOCOLS CY; Reilly A, 1998, B WORLD HEALTH ORGAN, V76, P245; Repetto HA, 2005, KIDNEY INT, V68, pS102, DOI 10.1111/j.1523-1755.2005.09717.x; Rivas M, 2006, FOODBORNE PATHOG DIS, V3, P88, DOI 10.1089/fpd.2006.3.88; Rivas M, 2003, EMERG INFECT DIS, V9, P1184; Rivas M, 2006, MEDICINA-BUENOS AIRE, V66, P27; Ruiz-Ranwez V, 2013, INFECT IMMUN, V81, P996, DOI 10.1128/IAI.01241-12; SHIMADA T, 1992, CURR MICROBIOL, V25, P215, DOI 10.1007/BF01570721; Spizzirri FD, 1997, PEDIATR NEPHROL, V11, P156, DOI 10.1007/s004670050248; STUART FA, 1982, VET REC, V110, P202, DOI 10.1136/vr.110.9.202-a; Szijarto V, 2014, CLIN VACCINE IMMUNOL, V21, P930, DOI 10.1128/CVI.00685-13; Tanaka Y, 2000, J APPL MICROBIOL, V88, P228, DOI 10.1046/j.1365-2672.2000.00960.x; Uhlen M, 2016, NAT METHODS, V13, P823, DOI [10.1038/nmeth.3995, 10.1038/NMETH.3995]; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Westerman RB, 1997, J CLIN MICROBIOL, V35, P679, DOI 10.1128/JCM.35.3.679-684.1997; Yamaguchi N, 2003, CYTOM PART A, V54A, P27, DOI 10.1002/cyto.a.10045	64	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0182452	10.1371/journal.pone.0182452	http://dx.doi.org/10.1371/journal.pone.0182452			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981517	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300002
J	Coloigner, J; Kim, Y; Bush, A; Choi, S; Balderrama, MC; Coates, TD; O'Neil, SH; Lepore, N; Wood, JC				Coloigner, Julie; Kim, Yeun; Bush, Adam; Choi, Soyoung; Balderrama, Melissa C.; Coates, Thomas D.; O'Neil, Sharon H.; Lepore, Natasha; Wood, John C.			Contrasting resting-state fMRI abnormalities from sickle and non-sickle anemia	PLOS ONE			English	Article							SILENT CEREBRAL INFARCTS; WHITE-MATTER LESIONS; CELL-DISEASE; FUNCTIONAL CONNECTIVITY; BRAIN ACTIVITY; BLOOD-FLOW; CHILDREN; BOLD; PERFUSION; MRI	Sickle cell disease (SCD) is a chronic blood disorder that is often associated with acute and chronic cerebrovascular complications, including strokes and impaired cognition. Using functional resting state magnetic resonance images, we performed whole-brain analysis of the amplitude of low frequency fluctuations (ALFF), to detect areas of spontaneous blood oxygenation level dependent signal across brain regions. We compared the ALFF of 20 SCD patients to that observed in 19 healthy, age and ethnicity-matched, control subjects. Significant differences were found in several brain regions, including the insula, precuneus, anterior cingulate cortex and medial superior frontal gyrus. To identify the ALFF differences resulting from anemia alone, we also compared the ALFF of SCD patients to that observed in 12 patients having comparable hemoglobin levels but lacking sickle hemoglobin. Increased ALFF in the orbitofrontal cortex and the anterior and posterior cingulate cortex and decreased ALFF in the frontal pole, cerebellum and medial superior frontal gyrus persisted after accounting for the effect of anemia. The presence of white matter hyperintensities was associated with depressed frontal and medial superior frontal gyri activity in the SCD subjects. Decreased ALFF in the frontal lobe was correlated with decreased verbal fluency and cognitive flexibility. These findings may lead to a better understanding of the pathophysiology of SCD.	[Coloigner, Julie; Kim, Yeun; Lepore, Natasha] Childrens Hosp, Div Radiol, CIBORG Lab, Los Angeles, CA 90027 USA; [Bush, Adam] Univ Southern Calif, Dept Biomed Engn, Los Angeles, CA USA; [Choi, Soyoung] Univ Southern Calif, Neurosci Grad Program, Los Angeles, CA USA; [Balderrama, Melissa C.; Coates, Thomas D.] Childrens Hosp, Div Hematol Oncol & Blood & Marrow Transplantat, Los Angeles, CA 90027 USA; [Balderrama, Melissa C.; Coates, Thomas D.; O'Neil, Sharon H.; Wood, John C.] Univ Southern Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA USA; [O'Neil, Sharon H.] Childrens Hosp, Div Neurol, Los Angeles, CA 90027 USA; [O'Neil, Sharon H.] Childrens Hosp, Saban Res Inst, Los Angeles, CA 90027 USA; [Wood, John C.] Childrens Hosp, Div Cardiol, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles; University of Southern California; University of Southern California; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; Children's Hospital Los Angeles; Children's Hospital Los Angeles	Coloigner, J (corresponding author), Childrens Hosp, Div Radiol, CIBORG Lab, Los Angeles, CA 90027 USA.	julie.coloigner@gmail.com	Coloigner, Julie/ABB-8849-2021; Coates, Thomas/AAN-3556-2020	Coates, Thomas/0000-0001-9878-6029; Coloigner, Julie/0000-0001-7774-8015; Choi, So Young/0000-0001-7165-4691	National Heart Lung and Blood Institute [U01 HL117718]; Clinical Translational Science Institute at Children's Hospital Los Angeles [UL1 TR001855-02]	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Clinical Translational Science Institute at Children's Hospital Los Angeles	This work was supported by the National Heart Lung and Blood Institute U01 HL117718 and the Clinical Translational Science Institute at Children's Hospital Los Angeles (UL1 TR001855-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Heart Lung and Blood Institute U01 HL117718 and the Clinical Translational Science Institute at Children's Hospital Los Angeles (UL1 TR001855-02).	Balci A, 2012, AM J ROENTGENOL, V198, P1167, DOI 10.2214/AJR.11.7404; Baliki MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106133; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Beissner F, 2013, J NEUROSCI, V33, P10503, DOI 10.1523/JNEUROSCI.1103-13.2013; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernaudin F, 2015, BLOOD, V125, P1653, DOI 10.1182/blood-2014-09-599852; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Borzage MT, 2016, PREDICTOR CEREBRAL B; Brousseau DC, 2010, AM J HEMATOL, V85, P77, DOI 10.1002/ajh.21570; Brown GG, 2003, J CEREBR BLOOD F MET, V23, P829, DOI 10.1097/01.WCB.0000071887.63724.B2; BROWN RT, 1993, J LEARN DISABIL-US, V26, P33, DOI 10.1177/002221949302600104; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; Bush AM, 2016, AM J HEMATOL, V91, P912, DOI 10.1002/ajh.24441; Cha J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/907464; Chalacheva P, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12463; Chen R, 2015, AM J NEURORADIOL, V36, P403, DOI 10.3174/ajnr.A4101; Choi S, 2017, NEUROIMAGE CLIN; Choi S-Y, 2015, DIFFUSE T1 HRI WHITE; Colombatti R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157090; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Darbari DS, 2015, J PAIN, V16, P1077, DOI 10.1016/j.jpain.2015.07.005; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; DeBaun MR, 2011, HEMATOL-AM SOC HEMAT, P427, DOI 10.1182/asheducation-2011.1.427; DeBaun MR, 2012, BLOOD, V119, P4587, DOI 10.1182/blood-2011-02-272682; DeBaun MR, 2012, BLOOD, V119, P3684, DOI 10.1182/blood-2011-05-349621; Delis DC, 2001, DELIS KAPLAN EXECUTI; Delis DC, 2000, MANUAL CALIFORNIA VE; FOWLER MG, 1988, J DEV BEHAV PEDIATR, V9, P213; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Hampson M, 2010, MAGN RESON IMAGING, V28, P1051, DOI 10.1016/j.mri.2010.03.021; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Helton KJ, 2009, PEDIATR BLOOD CANCER, V52, P85, DOI 10.1002/pbc.21745; HEROLD S, 1986, STROKE, V17, P692, DOI 10.1161/01.STR.17.4.692; Inamo J, 2009, AM J HEMATOL, V84, P311, DOI 10.1002/ajh.21377; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kassim AA, 2016, BLOOD, V127, P2038, DOI 10.1182/blood-2016-01-694562; Kawadler JM, 2016, DEV MED CHILD NEUROL; KIM SG, 1994, NMR BIOMED, V7, P69, DOI 10.1002/nbm.1940070111; Kirk GR, 2009, CEREB CORTEX, V19, P1549, DOI 10.1093/cercor/bhn193; Kong X, 2014, HEAD MOTION CHILDREN; Kosinski PD, 2016, BRIT J HAEMATOLOGY; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044556; Liu CH, 2015, BEHAV BRAIN RES, V281, P339, DOI 10.1016/j.bbr.2014.11.047; Liu YJ, 2007, AM J NEURORADIOL, V28, P1009, DOI 10.3174/ajnr.A0535; Ma XF, 2015, CLIN NEUROPHYSIOL, V126, P1190, DOI 10.1016/j.clinph.2014.10.004; Mennes M, 2011, NEUROIMAGE, V54, P2950, DOI 10.1016/j.neuroimage.2010.10.046; Mestre JCR, 1997, CLIN AUTON RES, V7, P121, DOI 10.1007/BF02308838; Meyers JM, 1995, REY COMPLEX XFIGURE; Moser FG, 1996, AM J NEURORADIOL, V17, P965; Musallam KM, 2012, THROMB RES, V130, P695, DOI 10.1016/j.thromres.2012.07.013; Neema M, 2009, AM J NEURORADIOL, V30, P911, DOI 10.3174/ajnr.A1514; Nelson MD, 2000, PEDIATR RADIOL, V30, P705, DOI 10.1007/s002470000290; Noll RB, 2001, J PEDIATR PSYCHOL, V26, P69, DOI 10.1093/jpepsy/26.2.69; Ohene-Frempong K, 1998, BLOOD, V91, P288; Pearson SR, 2005, CLIN AUTON RES, V15, P400, DOI 10.1007/s10286-005-0300-9; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Posner MI, 2007, COGN AFFECT BEHAV NE, V7, P391, DOI 10.3758/CABN.7.4.391; Postma IR, 2016, J CLIN EXP NEUROPSYC, V38, P585, DOI 10.1080/13803395.2016.1143453; Prohovnik I, 2009, J CEREBR BLOOD F MET, V29, P803, DOI 10.1038/jcbfm.2009.6; Qi RF, 2012, RADIOLOGY, V264, P187, DOI 10.1148/radiol.12111429; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Ren WC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/129180; Reynolds CR., 2004, BEHAV ASSESSMENT SYS; RODGERS GP, 1990, AM J PHYSIOL, V258, pH113, DOI 10.1152/ajpheart.1990.258.1.H113; RODGERS GP, 1984, NEW ENGL J MED, V311, P1534, DOI 10.1056/NEJM198412133112403; Sangkatumvong S, 2010, 32 ANN INT C ENG MED; Sangkatumvong S, 2008, 30 ANN INT C ENG MED; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Steen RG, 2005, J CHILD NEUROL, V20, P102, DOI 10.1177/08830738050200020301; Steen RG, 2005, AM J NEURORADIOL, V26, P455; Taher AT, 2010, J THROMB HAEMOST, V8, P54, DOI 10.1111/j.1538-7836.2009.03651.x; Tak S, 2015, BRAIN CONNECT, V5, P137, DOI 10.1089/brain.2014.0299; Tak S, 2014, NEUROIMAGE, V84, P672, DOI 10.1016/j.neuroimage.2013.09.057; Tsai YH, 2014, PLOS ONE, V9; van der Land V, 2016, BRIT J HAEMATOL, V172, P274, DOI 10.1111/bjh.13819; Vigneau-Roy N, 2014, HUM BRAIN MAPP, V35, P1906, DOI 10.1002/hbm.22301; Wang LJ, 2014, J INT MED RES, V42, P966, DOI 10.1177/0300060514533524; Wang W, 2001, J PEDIATR-US, V139, P391, DOI 10.1067/mpd.2001.116935; WASSERMAN AL, 1991, AM J PEDIAT HEMATOL, V13, P14; Wechsler D., 1999, ADM SCORING MANUAL; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 2003, WISC 4 WECHSLER INTE, V4th ed.; Woolrich Mark W, 2009, Neuroimage, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yang Z, 2014, FRONTIERS NEUROSCIEN, V8; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zou P, 2011, BRAIN IMAGING BEHAV, V5, P295, DOI 10.1007/s11682-011-9133-4; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	91	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184860	10.1371/journal.pone.0184860	http://dx.doi.org/10.1371/journal.pone.0184860			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981541	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300022
J	Cui, H; Wang, CL; Qin, TF; Xu, FF; Tang, YC; Gao, Y; Zhao, KJ				Cui, Hua; Wang, Chunlian; Qin, Tengfei; Xu, Feifei; Tang, Yongchao; Gao, Ying; Zhao, Kaijun			Promoter variants of Xa23 alleles affect bacterial blight resistance and evolutionary pattern	PLOS ONE			English	Article							ORYZAE PV. ORYZAE; DISEASE-RESISTANCE; XANTHOMONAS-ORYZAE; ARABIDOPSIS-THALIANA; GENETIC-VARIATION; TAL-EFFECTOR; NATURAL VARIATION; DNA POLYMORPHISM; PLANT-PATHOGENS; WILD RELATIVES	Bacterial blight, caused by Xanthomonas oryzae pv. oryzae (Xoo), is the most important bacterial disease in rice (Oryza sativa L.). Our previous studies have revealed that the bacterial blight resistance gene Xa23 from wild rice O. rufipogon Griff. confers the broadest-spectrum resistance against all the naturally occurring Xoo races. As a novel executor R gene, Xa23 is transcriptionally activated by the bacterial avirulence (Avr) protein AvrXa23 via binding to a 28-bp DNA element (EBEAvrXa23) in the promoter region. So far, the evolutionary mechanism of Xa23 remains to be illustrated. Here, a rice germplasm collection of 97 accessions, including 29 rice cultivars (indica and japonica) and 68 wild relatives, was used to analyze the evolution, phylogeographic relationship and association of Xa23 alleles with bacterial blight resistance. All the similar to 473 bp DNA fragments consisting of promoter and coding regions of Xa23 alleles in the germplasm accessions were PCR-amplified and sequenced, and nine single nucleotide polymorphisms (SNPs) were detected in the promoter regions (similar to 131 bp sequence upstream from the start codon ATG) of Xa23/xa23 alleles while only two SNPs were found in the coding regions. The SNPs in the promoter regions formed 5 haplotypes (Pro-A, B, C, D, E) which showed no significant difference in geographic distribution among these 97 rice accessions. However, haplotype association analysis indicated that Pro-A is the most favored haplotype for bacterial blight resistance. Moreover, SNP changes among the 5 haplotypes mostly located in the EBE/ebe regions (EBEAvrXa23 and corresponding ebes located in promoters of xa23 alleles), confirming that the EBE region is the key factor to confer bacterial blight resistance by altering gene expression. Polymorphism analysis and neutral test implied that Xa23 had undergone a bottleneck effect, and selection process of Xa23 was not detected in cultivated rice. In addition, the Xa23 coding region was found highly conserved in the Oryza genus but absent in other plant species by searching the plant database, suggesting that Xa23 originated along with the diversification of the Oryza genus from the grass family during evolution. This research offers a potential for flexible use of novel Xa23 alleles in rice breeding programs and provide a model for evolution analysis of other executor R genes.	[Cui, Hua; Wang, Chunlian; Qin, Tengfei; Xu, Feifei; Tang, Yongchao; Gao, Ying; Zhao, Kaijun] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhao, KJ (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China.	zhaokaijun@caas.cn			Major Science and Technology Project [2014ZX0801001B, 2016ZX08001002-009]; Chinese Academy of Agricultural Sciences	Major Science and Technology Project; Chinese Academy of Agricultural Sciences	This work was supported by grants from the Major Science and Technology Project to Create New Crop Cultivars using Gene Transfer Technology (2014ZX0801001B, 2016ZX08001002-009) and the Innovation Program of Chinese Academy of Agricultural Sciences.	Alexandrov N, 2015, NUCLEIC ACIDS RES, V43, pD1023, DOI 10.1093/nar/gku1039; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bergelson J, 2001, SCIENCE, V292, P2281, DOI 10.1126/science.1061337; Bimolata W, 2013, PLANTA, V238, P293, DOI 10.1007/s00425-013-1891-3; Buckler ES, 2001, GENET RES, V77, P213, DOI 10.1017/S0016672301005158; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Ding J, 2007, MOL GENET GENOMICS, V277, P619, DOI 10.1007/s00438-007-0213-5; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Ellur RK, 2016, PLANT SCI, V242, P330, DOI 10.1016/j.plantsci.2015.08.020; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; FU YX, 1993, GENETICS, V133, P693; Greenberg JT, 2003, CURR OPIN MICROBIOL, V6, P20, DOI 10.1016/S1369-5274(02)00004-8; Gu K, 2004, THEOR APPL GENET, V108, P800, DOI 10.1007/s00122-003-1491-x; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; Hall T., 2011, GERF B BIOSCI, V2, P60; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hofberger JA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-966; HOPKINS CM, 1992, MOL PLANT MICROBE IN, V5, P451, DOI 10.1094/MPMI-5-451; Huang B, 2012, EUPHYTICA, V187, P449, DOI 10.1007/s10681-012-0758-1; Hummel AW, 2012, NEW PHYTOL, V195, P883, DOI 10.1111/j.1469-8137.2012.04216.x; Jia YL, 2003, PHYTOPATHOLOGY, V93, P1452, DOI 10.1094/PHYTO.2003.93.11.1452; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Kover PX, 2002, P NATL ACAD SCI USA, V99, P11270, DOI 10.1073/pnas.102288999; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li J, 2010, MOL GENET GENOMICS, V283, P427, DOI 10.1007/s00438-010-0527-6; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; May R.M., 1983, P186; McDowell JM, 2003, TRENDS BIOTECHNOL, V21, P178, DOI 10.1016/S0167-7799(03)00053-2; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Noir S, 2001, MOL GENET GENOMICS, V265, P654, DOI 10.1007/s004380100459; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Romer P, 2009, P NATL ACAD SCI USA, V106, P20526, DOI 10.1073/pnas.0908812106; Rose LE, 2007, GENETICS, V175, P1307, DOI 10.1534/genetics.106.063602; Rose LE, 2004, GENETICS, V166, P1517, DOI 10.1534/genetics.166.3.1517; Shen JD, 2006, GENETICS, V172, P1243, DOI 10.1534/genetics.105.047290; Small RL, 2000, GENETICS, V155, P1913; Strauss T, 2012, P NATL ACAD SCI USA, V109, P19480, DOI 10.1073/pnas.1212415109; TAJIMA F, 1989, GENETICS, V123, P585; Tian Dacheng, UNBALANCED GENE COPY; Tian DS, 2014, PLANT CELL, V26, P497, DOI 10.1105/tpc.113.119255; Tiffin P, 2006, TRENDS GENET, V22, P662, DOI 10.1016/j.tig.2006.09.011; Wang CL, 2014, MOL PLANT PATHOL, V15, P333, DOI 10.1111/mpp.12092; Wang CL, 2015, MOL PLANT, V8, P290, DOI 10.1016/j.molp.2014.10.010; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wu LF, 2008, PLANT PHYSIOL, V148, P1497, DOI 10.1104/pp.108.123356; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Yang SH, 2008, THEOR APPL GENET, V116, P165, DOI 10.1007/s00122-007-0656-4; Yang SH, 2006, PLANT MOL BIOL, V62, P181, DOI 10.1007/s11103-006-9012-3; YOSHIMURA A, 1983, PHYTOPATHOLOGY, V73, P1409, DOI 10.1094/Phyto-73-1409; Yu JY, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-3, 10.1186/1471-2199-15-20]; Zhang Q., 2001, RICE GENET NEWSL, V18, P71; Zhang XP, 2013, CROP J, V1, P143, DOI 10.1016/j.cj.2013.07.009; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z; Zhou YL, 2009, MOL BREEDING, V23, P279, DOI 10.1007/s11032-008-9232-0; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	57	6	7	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185925	10.1371/journal.pone.0185925	http://dx.doi.org/10.1371/journal.pone.0185925			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982185	gold, Green Submitted, Green Published			2022-12-26	WOS:000412360300089
J	Holm, MB; Bastani, NE; Holme, AM; Zucknick, M; Jansson, T; Refsum, H; Morkrid, L; Blomhoff, R; Henriksen, T; Michelsen, TM				Holm, Maia Blomhoff; Bastani, Nasser Ezzatkhah; Holme, Ane Moe; Zucknick, Manuela; Jansson, Thomas; Refsum, Helga; Morkrid, Lars; Blomhoff, Rune; Henriksen, Tore; Michelsen, Trond Melbye			Uptake and release of amino acids in the fetal-placental unit in human pregnancies	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; HUMAN-FETUS; TRANSPORT; PLASMA; LEUCINE; METABOLISM; GLYCINE; APPROPRIATE; NUTRITION; MOTHER	Objectives The current concepts of human fetal-placental amino acid exchange and metabolism are mainly based on animal-, in vitro-and ex vivo models. We aimed to determine and assess the paired relationships between concentrations and arteriovenous differences of 19 amino acids on the maternal and fetal sides of the human placenta in a large study sample. Methods This cross-sectional in vivo study included 179 healthy women with uncomplicated term pregnancies. During planned cesarean section, we sampled blood from incoming and outgoing vessels on the maternal (radial artery and uterine vein) and fetal (umbilical vein and artery) sides of the placenta. Amino acid concentrations were measured by liquid chromatography-tandem mass spectrometry. We calculated paired arteriovenous differences and performed Wilcoxon signed-rank tests and Spearman's correlations. Results In the umbilical circulation, we observed a positive venoarterial difference (fetal uptake) for 14 amino acids and a negative venoarterial difference (fetal release) for glutamic acid (p<0.001). In the maternal circulation, we observed a positive arteriovenous difference (uteroplacental uptake) for leucine (p = 0.005), isoleucine (p = 0.01), glutamic acid (p<0.001) and arginine (p = 0.04) and a negative arteriovenous difference (uteroplacental release) for tyrosine (p = 0.002), glycine (p = 0.01) and glutamine (p = 0.02). The concentrations in the maternal artery and umbilical vein were correlated for all amino acids except tryptophan, but we observed no correlations between the uteroplacental uptake and the fetal uptake or the umbilical vein concentration. Two amino acids showed a correlation between the maternal artery concentration and the fetal uptake. Conclusions Our human in vivo study expands the current insight into fetal-placental amino acid exchange, and discloses some differences from what has been previously described in animals. Our findings are consistent with the concept that the fetal supply of amino acids in the human is the result of a dynamic interplay between fetal and placental amino acid metabolism and interconversions.	[Holm, Maia Blomhoff; Holme, Ane Moe; Henriksen, Tore; Michelsen, Trond Melbye] Oslo Univ Hosp, Dept Obstet, Div Obstet & Gynecol, Oslo, Norway; [Holm, Maia Blomhoff; Holme, Ane Moe; Henriksen, Tore] Univ Oslo, Inst Clin Med, Oslo, Norway; [Bastani, Nasser Ezzatkhah; Refsum, Helga; Blomhoff, Rune] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Zucknick, Manuela] Univ Oslo, Inst Basic Med Sci, Oslo Ctr Biostat & Epidemiol, Dept Biostat, Oslo, Norway; [Jansson, Thomas] Univ Colorado, Dept OB GYN, Div Reprod Sci, Anschutz Med Campus, Aurora, CO USA; [Morkrid, Lars] Oslo Univ Hosp, Dept Med Biochem, Analyt Unit Metab Dis, Oslo, Norway; [Blomhoff, Rune] Oslo Univ Hosp, Dept Clin Serv, Div Canc Med, Oslo, Norway; [Michelsen, Trond Melbye] Oslo Univ Hosp, Norwegian Advisory Unit Womens Hlth, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Oslo; University of Oslo; University of Oslo	Holm, MB (corresponding author), Oslo Univ Hosp, Dept Obstet, Div Obstet & Gynecol, Oslo, Norway.; Holm, MB (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	maia.blomhoff.holm@outlook.com	Refsum, Helga/A-4073-2010	Zucknick, Manuela/0000-0003-1317-7422	South-Eastern Norway Regional Health Authority [2016066, 2013043]; Department of Obstetrics, Oslo University Hospital, Oslo, Norway; Throne Holst Foundation; Norwegian National Advisory Unit on Womens Health, Oslo University Hospital, Oslo, Norway; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	South-Eastern Norway Regional Health Authority; Department of Obstetrics, Oslo University Hospital, Oslo, Norway; Throne Holst Foundation; Norwegian National Advisory Unit on Womens Health, Oslo University Hospital, Oslo, Norway; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	MBH received a PhD grant from South-Eastern Norway Regional Health Authority, grant number 2016066 (http://www.helse-sorost.no/omoss_/english_/) and was partly funded by Department of Obstetrics, Oslo University Hospital, Oslo, Norway (http://www.oslo-universitetssykehus.no/omoss_/avdelinger_/fodeavdelingen_). NEB was supported by grants from the Throne Holst Foundation (http://www.throneholst.org/). AMH received a PhD grant from South-Eastern Norway Regional Health Authority, grant number 2013043 (http://www.helse-sorost.no/omoss_/english_/) and was partly funded by the Norwegian National Advisory Unit on Womens Health, Oslo University Hospital, Oslo, Norway (http://ous-research.no/nrcwh/). TMM was funded by the Norwegian National Advisory Unit on Womens Health, Oslo University Hospital, Oslo, Norway (http://ous-research.no/nrcwh/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alterman MA, 2011, AMINO ACID ANAL METH; Barker DJP, 2013, CLIN OBSTET GYNECOL, V56, P511, DOI 10.1097/GRF.0b013e31829cb9ca; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Battaglia FC, 2001, PLACENTA, V22, P145, DOI 10.1053/plac.2000.0612; Benirschke K, 2012, PATHOLOGY HUMAN PLAC; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CETIN I, 1995, PEDIATR RES, V37, P571, DOI 10.1203/00006450-199505000-00002; CETIN I, 1988, AM J OBSTET GYNECOL, V158, P120, DOI 10.1016/0002-9378(88)90792-2; Cetin I, 2005, AM J OBSTET GYNECOL, V192, P610, DOI 10.1016/j.ajog.2004.08.011; Cetin I, 2003, EUR J OBSTET GYN R B, V110, pS50, DOI 10.1016/S0301-2115(03)00172-6; Cetin I, 1996, AM J OBSTET GYNECOL, V174, P1575, DOI 10.1016/S0002-9378(96)70609-9; CETIN I, 1991, BIOL NEONATE, V60, P83; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; Chung M, 1998, AM J PHYSIOL-ENDOC M, V274, pE13, DOI 10.1152/ajpendo.1998.274.1.E13; Cleal JK, 2008, J NEUROENDOCRINOL, V20, P419, DOI 10.1111/j.1365-2826.2008.01662.x; Day PEL, 2013, PLACENTA, V34, P1223, DOI 10.1016/j.placenta.2013.10.003; ECONOMIDES DL, 1989, AM J OBSTET GYNECOL, V161, P1219, DOI 10.1016/0002-9378(89)90670-4; Elshorbagy AK, 2010, NUTRITION, V26, P1201, DOI 10.1016/j.nut.2009.09.017; Galan HL, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.06.054; Geddie G, 1996, PLACENTA, V17, P619, DOI 10.1016/S0143-4004(96)80080-4; Grillo MA, 2008, AMINO ACIDS, V34, P517, DOI 10.1007/s00726-007-0006-5; HAYASHI S, 1978, BIOL NEONATE, V34, P11; Holme AM, 2017, JOVE-J VIS EXP, DOI 10.3791/55847; Holme AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117084; HOLZMAN I R, 1979, Journal of Developmental Physiology (Eynsham), V1, P137; Jozwik M, 1999, AM J OBSTET GYNECOL, V180, P447, DOI 10.1016/S0002-9378(99)70230-9; Jozwik M, 2004, AM J PHYSIOL-ENDOC M, V286, pE376, DOI 10.1152/ajpendo.00428.2003; Lager S, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/179827; Paolini CL, 2001, J CLIN ENDOCR METAB, V86, P5427, DOI 10.1210/jc.86.11.5427; PHILIPPS AF, 1978, AM J OBSTET GYNECOL, V131, P881, DOI 10.1016/S0002-9378(16)33136-2; Prenton M A, 1969, J Obstet Gynaecol Br Commonw, V76, P404; Regnault TRH, 2002, ENDOCRINE, V19, P23, DOI 10.1385/ENDO:19:1:23; Ronzoni S, 1999, AM J OBSTET GYNECOL, V181, P477, DOI 10.1016/S0002-9378(99)70581-8; Schaefer A, PLACENTA, V14, P103; SOLTESZ G, 1985, PEDIATR RES, V19, P91, DOI 10.1203/00006450-198501000-00024; STEINGRIMSDOTTIR T, 1993, EUR J OBSTET GYN R B, V50, P197, DOI 10.1016/0028-2243(93)90201-M; Tsuchiya H, 2009, ARCH DIS CHILD-FETAL, V94, pF155, DOI 10.1136/adc.2008.147256; van den Akker CHP, 2011, PEDIATR RES, V70, P566, DOI 10.1203/PDR.0b013e31823214d1; VELAZQUEZ A, 1976, BIOL NEONATE, V29, P28	39	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185760	10.1371/journal.pone.0185760	http://dx.doi.org/10.1371/journal.pone.0185760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982184	Green Submitted, Green Published, gold			2022-12-26	WOS:000412360300067
J	Jonczyk, J; Malawska, B; Bajda, M				Jonczyk, Jakub; Malawska, Barbara; Bajda, Marek			Hybrid approach to structure modeling of the histamine H3 receptor: Multi-level assessment as a tool for model verification	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; 2ND EXTRACELLULAR LOOP; H-3 RECEPTOR; LIGAND-BINDING; ACTIVATION; DOCKING; POTENT; MUTAGENESIS; RECOGNITION; ANTAGONISTS	The crucial role of G-protein coupled receptors and the significant achievements associated with a better understanding of the spatial structure of known receptors in this family encouraged us to undertake a study on the histamine H3 receptor, whose crystal structure is still unresolved. The latest literature data and availability of different software enabled us to build homology models of higher accuracy than previously published ones. The new models are expected to be closer to crystal structures; and therefore, they are much more helpful in the design of potential ligands. In this article, we describe the generation of homology models with the use of diverse tools and a hybrid assessment. Our study incorporates a hybrid assessment connecting knowledge-based scoring algorithms with a two-step ligand-based docking procedure. Knowledge-based scoring employs probability theory for global energy minimum determination based on information about native amino acid conformation from a dataset of experimentally determined protein structures. For a two-step docking procedure two programs were applied: GOLD was used in the first step and Glide in the second. Hybrid approaches offer advantages by combining various theoretical methods in one modeling algorithm. The biggest advantage of hybrid methods is their intrinsic ability to self-update and self-refine when additional structural data are acquired. Moreover, the diversity of computational methods and structural data used in hybrid approaches for structure prediction limit inaccuracies resulting from theoretical approximations or fuzziness of experimental data. The results of docking to the new H3 receptor model allowed us to analyze ligand-receptor interactions for reference compounds.	[Jonczyk, Jakub; Malawska, Barbara; Bajda, Marek] Jagiellonian Univ, Med Coll, Fac Pharm, Dept Physicochem Drug Anal, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University	Bajda, M (corresponding author), Jagiellonian Univ, Med Coll, Fac Pharm, Dept Physicochem Drug Anal, Krakow, Poland.	marek.bajda@uj.edu.pl	Jonczyk, Jakub/AAN-1701-2020; Bajda, Marek/L-5585-2015	Jonczyk, Jakub/0000-0002-9731-908X; Bajda, Marek/0000-0001-6032-0354	National Science Center in Poland [UMO-2014/15/N/NZ7/02965]	National Science Center in Poland(National Science Centre, Poland)	A research grant no. UMO-2014/15/N/NZ7/02965 for PhD students was obtained from the National Science Center in Poland (www.ncn.gov.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PYMOL; [Anonymous], 2016, MAESTR; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ARRANG JM, 1983, NATURE, V302, P832, DOI 10.1038/302832a0; ARRANG JM, 1987, NATURE, V327, P117, DOI 10.1038/327117a0; Axe FU, 2006, J MOL GRAPH MODEL, V24, P456, DOI 10.1016/j.jmgm.2005.10.005; Ballesteros J, 2001, Curr Opin Drug Discov Devel, V4, P561; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Benkert P, QMEAN SERVER; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1145/1656274.1656280; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bitner RS, 2011, NEUROPHARMACOLOGY, V60, P460, DOI 10.1016/j.neuropharm.2010.10.026; Bongers G, 2007, J NEUROCHEM, V103, P248, DOI 10.1111/j.1471-4159.2007.04752.x; Bongers G, 2007, BIOCHEM PHARMACOL, V73, P1195, DOI 10.1016/j.bcp.2007.01.008; Brunskole I, 2011, N-S ARCH PHARMACOL, V384, P301, DOI 10.1007/s00210-011-0673-3; BURGAUD JL, 1993, BRIT J PHARMACOL, V109, P960, DOI 10.1111/j.1476-5381.1993.tb13714.x; Bywater RP, 2005, J MOL RECOGNIT, V18, P60, DOI 10.1002/jmr.685; Deane CM, 2012, PLOS ONE, V7; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; Esbenshade TA, 2004, BIOCHEM PHARMACOL, V68, P933, DOI 10.1016/j.bcp.2004.05.048; Fox GB, 2005, J PHARMACOL EXP THER, V313, P176, DOI 10.1124/jpet.104.078402; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gabilondo AM, 1996, EUR J PHARMACOL, V307, P243, DOI 10.1016/0014-2999(96)00247-6; Galici R, 2011, PSYCHOPHARMACOLOGY, V214, P829, DOI 10.1007/s00213-010-2092-4; Gatica EA, 2012, J CHEM INF MODEL, V52, P1, DOI 10.1021/ci200412p; Godyn J, 2016, PHARMACOL REP, V68, P127, DOI 10.1016/j.pharep.2015.07.006; Gondard E, 2013, NEUROPSYCHOPHARMACOL, V38, P1015, DOI 10.1038/npp.2012.266; Gonzalez-Dominguez J, 2016, BIOINFORMATICS, V32, P3826, DOI 10.1093/bioinformatics/btw558; Greasley PJ, 2002, MOL PHARMACOL, V61, P1025, DOI 10.1124/mol.61.5.1025; Grove RA, 2014, CURR ALZHEIMER RES, V11, P47, DOI 10.2174/1567205010666131212110148; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Hancock Arthur A, 2003, Curr Opin Investig Drugs, V4, P1190; Harusawa S, 2013, BIOORG MED CHEM LETT, V23, P6415, DOI 10.1016/j.bmcl.2013.09.052; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; Huang YJP, 2014, PROTEINS, V82, P43, DOI 10.1002/prot.24488; Istyastono EP, 2011, J MED CHEM, V54, P8136, DOI 10.1021/jm201042n; Jacobsen ML., 2003, 32 ANN M EUR HIST RE; Jongejan A, 2005, ARCH PHARM, V338, P248, DOI 10.1002/ardp.200400998; Kim SK, 2011, J CHEM INF MODEL, V51, P3262, DOI 10.1021/ci200435b; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Kollb-Sielecka M, 2017, SLEEP MED, V33, P125, DOI 10.1016/j.sleep.2017.01.002; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Latacz D., BIOORG MED CHEM; Latek D, 2016, J CHEM INF MODEL, V56, P630, DOI 10.1021/acs.jcim.5b00451; Lazewska D, 2014, EXPERT OPIN THER PAT, V24, P89, DOI 10.1517/13543776.2014.848197; Levoin N, 2008, ARCH PHARM, V341, P610, DOI 10.1002/ardp.200800042; Levoin N, 2013, BIOORGAN MED CHEM, V21, P4526, DOI 10.1016/j.bmc.2013.05.035; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lovenberg TW, 1999, MOL PHARMACOL, V55, P1101, DOI 10.1124/mol.55.6.1101; Modi V, 2016, PROTEINS, V84, P200, DOI 10.1002/prot.25049; MORALESFIGUEROA GE, 2014, AM CHEM SOC, V5, P637, DOI DOI 10.1021/CN500001M; Morisset S, 2000, NATURE, V408, P860, DOI 10.1038/35048583; Morrey C, 2008, J PHARMACOL EXP THER, V326, P871, DOI 10.1124/jpet.108.137919; Munk C, 2016, BRIT J PHARMACOL, V173, P2195, DOI 10.1111/bph.13509; Nakamura T, 2014, BRIT J PHARMACOL, V171, P171, DOI 10.1111/bph.12429; Neudert G, 2011, J CHEM INF MODEL, V51, P2731, DOI 10.1021/ci200274q; Passani MB, 2000, NEUROSCI BIOBEHAV R, V24, P107, DOI 10.1016/S0149-7634(99)00053-6; Passani MB, 2004, TRENDS PHARMACOL SCI, V25, P618, DOI 10.1016/j.tips.2004.10.003; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Rai BK, 2010, PROTEINS, V78, P457, DOI 10.1002/prot.22571; Rang H., 2011, RANG DALES PHARM; Ratnala VRP, 2007, J AM CHEM SOC, V129, P867, DOI 10.1021/ja0652262; SADOWSKI J, 1994, J CHEM INF COMP SCI, V34, P1000, DOI 10.1021/ci00020a039; Sander K, 2008, BIOL PHARM BULL, V31, P2163, DOI 10.1248/bpb.31.2163; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Schultes S, 2013, MEDCHEMCOMM, V4, P193, DOI 10.1039/c2md20212c; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Trenite DKN, 2013, EPILEPSY BEHAV, V28, P66, DOI 10.1016/j.yebeh.2013.03.018; Trzaskowski B, 2012, CURR MED CHEM, V19, P1090, DOI 10.2174/092986712799320556; Uveges AJ, 2002, J PHARMACOL EXP THER, V301, P451, DOI 10.1124/jpet.301.2.451; VANDERGOOT H, 1992, EUR J MED CHEM, V27, P511, DOI 10.1016/0223-5234(92)90185-4; Venkatakrishnan AJ, 2016, NATURE, V536, P484, DOI 10.1038/nature19107; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wifling D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117185; Xiang Z., 2007, COMPUTATIONAL METHOD, P319; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang R, 2002, PHARMACOLOGY, V66, P128, DOI 10.1159/000063794; Yao BB, 2003, NEUROPHARMACOLOGY, V44, P773, DOI 10.1016/S0028-3908(03)00056-X; Zamponi GW, 2013, BBA-BIOMEMBRANES, V1828, P1629, DOI 10.1016/j.bbamem.2012.10.004	85	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186108	10.1371/journal.pone.0186108	http://dx.doi.org/10.1371/journal.pone.0186108			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982153	Green Submitted, Green Published, gold			2022-12-26	WOS:000412360300125
J	Pineda, C; Aguilera-Tejero, E; Morales, MC; Belinchon-Lorenzo, S; Gomez-Nieto, LC; Garcia, P; Martinez-Moreno, JM; Rodriguez-Ortiz, ME; Lopez, I				Pineda, Carmen; Aguilera-Tejero, Escolastico; Morales, Maria C.; Belinchon-Lorenzo, Silvia; Gomez-Nieto, Luis C.; Garcia, Pablo; Martinez-Moreno, Julio M.; Rodriguez-Ortiz, Maria E.; Lopez, Ignacio			Treatment of canine leishmaniasis with marbofloxacin in dogs with renal disease	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; PARASITOLOGICAL FOLLOW-UP; TIME PCR ASSAY; VISCERAL LEISHMANIASIS; MEGLUMINE ANTIMONIATE; SYSTEMIC HYPERTENSION; CYSTATIN C; INFANTUM; ALLOPURINOL; PROTEINURIA	Treatment of canine leishmaniasis (CanL) represents a challenge. Due to the high prevalence of renal disease associated to CanL, it is important to find an effective drug that does not damage the kidneys. Marbofloxacin has been shown to be effective and well tolerated in non-azotemic dogs with leishmaniasis. To evaluate the safety and efficacy of marbofloxacin in dogs with leishmaniasis and decreased renal function, 28 dogs suffering from leishmaniasis and chronic kidney disease (CKD) were treated with oral marbofloxacin at 2 mg/Kg/day for 28 days. During treatment dogs were assessed by performing weekly physical exams, measuring blood pressure and evaluating blood and urine parameters. Lymph node aspirations were also obtained at days 0 and 28. The global clinical score decreased significantly, from 6.2 +/- 3.4 to 4.7 +/- 3.1 (p = 0.0001), after treatment. Marbofloxacin also decreased parasitic load in 72% of the dogs. No significant differences in plasma creatinine, urine specific gravity, urinary concentrations of cystatin C, ferritin and urinary protein loss were detected during treatment. A transient but significant decrease in blood pressure was detected up to day 14 (from 180.1 +/- 36.6 to 166.0 +/- 32.7 mmHg; p = 0.016). Moreover, dogs showed a significant increase in plasma albumin concentration (from 15.0 +/- 5.2 to 16.6 +/- 3.9 g/L; p = 0.014) and a significant decrease in globulin concentration (from 59.0 +/- 18.1 to 54.1 +/- 18.0 g/L; p = 0.005). The results demonstrate that, in addition to being effective for treatment of CanL, marbofloxacin is a very safe drug in dogs with CKD and leishmaniasis.	[Pineda, Carmen; Aguilera-Tejero, Escolastico; Morales, Maria C.; Garcia, Pablo; Lopez, Ignacio] Univ Cordoba, Dept Med & Cirugia Anim, Cordoba, Spain; [Pineda, Carmen; Aguilera-Tejero, Escolastico; Martinez-Moreno, Julio M.; Lopez, Ignacio] Univ Cordoba, Reina Sofia Univ Hosp, Maimonides Biomed Res Inst Cordoba IMIBIC, Cordoba, Spain; [Belinchon-Lorenzo, Silvia; Gomez-Nieto, Luis C.] Univ Extremadura, Parasitol Unit, LeishmanCeres Lab, Caceres, Spain; [Rodriguez-Ortiz, Maria E.] Fdn Jimenez Diaz, Inst Invest Sanitaria, Nephrol Lab, Madrid, Spain	Universidad de Cordoba; Universidad de Cordoba; Universidad de Extremadura; Fundacion Jimenez Diaz	Lopez, I (corresponding author), Univ Cordoba, Dept Med & Cirugia Anim, Cordoba, Spain.; Lopez, I (corresponding author), Univ Cordoba, Reina Sofia Univ Hosp, Maimonides Biomed Res Inst Cordoba IMIBIC, Cordoba, Spain.	ignacio.lopez@uco.es	Belinchón-Lorenzo, Silvia/AAS-2719-2021; Martínez, Julio Manuel/AAA-6724-2020; Pineda, Carmen/AAF-4385-2020	Belinchón-Lorenzo, Silvia/0000-0003-2248-853X; Martínez, Julio Manuel/0000-0002-1945-5078; Lopez Villalba, Ignacio/0000-0002-4936-6121; Pineda Martos, Carmen Maria/0000-0002-3664-8699	Vetoquinol, Spain; Vetoquinol (Spain)	Vetoquinol, Spain; Vetoquinol (Spain)	This study was funded by Vetoquinol, Spain. Marbofloxacin was also supplied by Vetoquinol, Spain. Although the study was funded by Vetoquinol (Spain) and marbofloxacin was also supplied by them, the funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alvar J, 2004, ADV PARASIT, V57, P1, DOI 10.1016/S0065-308X(04)57001-X; Bianciardi P, 2009, TOXICOL PATHOL, V37, P770, DOI 10.1177/0192623309344088; Braga ET, 2015, REV BRAS PARASITOL V, V24, P45, DOI 10.1590/S1984-29612015007; Carcelen J, 2009, VACCINE, V27, P5964, DOI 10.1016/j.vaccine.2009.07.069; Clementi A, 2011, CLIN KIDNEY J, V4, P147, DOI 10.1093/ndtplus/sfr008; Cortadellas O, 2003, J VET INTERN MED, V17, P808, DOI 10.1892/0891-6640(2003)017&lt;0808:IALEOA&gt;2.3.CO;2; Cortadellas O, 2006, J VET INTERN MED, V20, P941, DOI 10.1892/0891-6640(2006)20[941:SHIDWL]2.0.CO;2; Costa FAL, 2003, VET PATHOL, V40, P677, DOI 10.1354/vp.40-6-677; Dujardin JC, 2008, EMERG INFECT DIS, V14, P1013, DOI 10.3201/eid1407.071589; Finco DR, 2004, J VET INTERN MED, V18, P289, DOI 10.1892/0891-6640(2004)18&lt;289:AOSHWR&gt;2.0.CO;2; Francino O, 2006, VET PARASITOL, V137, P214, DOI 10.1016/j.vetpar.2006.01.011; Garcia-Martinez JD, 2015, RES VET SCI, V99, P204, DOI 10.1016/j.rvsc.2015.01.002; Goldstein RE, 2013, J VET INTERN MED, V27, pS60, DOI 10.1111/jvim.12232; Grauer GF, 2005, J SMALL ANIM PRACT, V46, P469, DOI 10.1111/j.1748-5827.2005.tb00275.x; Ikeda-Garcia FA, 2007, VET PARASITOL, V143, P254, DOI 10.1016/j.vetpar.2006.08.019; KarginKiral F, 2004, REV MED VET, V155, P226; Koutinas AF, 2001, VET PARASITOL, V98, P247, DOI 10.1016/S0304-4017(01)00399-5; Manna L, 2004, VET PARASITOL, V125, P251, DOI 10.1016/j.vetpar.2004.07.019; Manna L, 2008, VET J, V177, P279, DOI 10.1016/j.tvjl.2007.04.013; Manna L, 2009, VET J, V182, P441, DOI 10.1016/j.tvjl.2008.08.009; Manna L, 2009, RES VET SCI, V87, P76, DOI 10.1016/j.rvsc.2008.12.009; Mateo M, 2009, PARASITOL RES, V105, P155, DOI 10.1007/s00436-009-1375-3; Mettler M, 2005, BERL MUNCH TIERARZTL, V118, P37; Miro G, 2009, VET DERMATOL, V20, P397, DOI 10.1111/j.1365-3164.2009.00824.x; Mitchell HC, 1997, AM J KIDNEY DIS, V29, P897, DOI 10.1016/S0272-6386(97)90464-9; Monti P, 2012, J SMALL ANIM PRACT, V53, P254, DOI 10.1111/j.1748-5827.2012.01198.x; Pennisi MG, 2005, VET REC, V156, P346, DOI 10.1136/vr.156.11.346; Petanides TA, 2008, J VET INTERN MED, V22, P866, DOI 10.1111/j.1939-1676.2008.0129.x; Pierantozzi M, 2013, J AM ANIM HOSP ASSOC, V49, P231, DOI 10.5326/JAAHA-MS-5840; Plevraki K, 2006, J VET INTERN MED, V20, P228, DOI 10.1892/0891-6640(2006)20[228:EOATOT]2.0.CO;2; Poot J, 2005, VET PARASITOL, V130, P41, DOI 10.1016/j.vetpar.2005.03.002; Quinnell RJ, 2003, VET IMMUNOL IMMUNOP, V91, P161, DOI 10.1016/S0165-2427(02)00311-2; Riera C, 1999, VET PARASITOL, V84, P33, DOI 10.1016/S0304-4017(99)00084-9; Rodrigues M. L. O., 1999, Revista do Instituto de Medicina Tropical de Sao Paulo, V41, P33, DOI 10.1590/S0036-46651999000100007; Rougier S, 2008, VET PARASITOL, V153, P244, DOI 10.1016/j.vetpar.2008.01.041; Rougier S, 2012, VET PARASITOL, V186, P245, DOI 10.1016/j.vetpar.2011.11.016; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Sasaki A, 2014, J COMP PATHOL, V151, P264, DOI 10.1016/j.jcpa.2014.06.001; Solano-Gallego L, 2009, VET PARASITOL, V165, P1, DOI 10.1016/j.vetpar.2009.05.022; Solano-Gallego L, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1519-0; Solano-Gallego L, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-86; Vouldoukis I, 2006, VET PARASITOL, V135, P137, DOI 10.1016/j.vetpar.2005.09.003; Wehner A, 2008, VET REC, V162, P141, DOI 10.1136/vr.162.5.141; Woerly V, 2009, PARASITOL RES, V105, P463, DOI 10.1007/s00436-009-1404-2	44	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185981	10.1371/journal.pone.0185981	http://dx.doi.org/10.1371/journal.pone.0185981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982165	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300101
J	Sun, RY; Tian, J; Zhang, J; Wang, LP; Guo, J; Liu, YN				Sun, Ruiying; Tian, Jie; Zhang, Jun; Wang, Liping; Guo, Jing; Liu, Yani			Monitoring inflammation injuries in the progression of atherosclerosis with contrast enhanced ultrasound molecular imaging	PLOS ONE			English	Article							CELL-ADHESION MOLECULE-1; DISEASE; PLAQUES; MICROBUBBLES; INHIBITION; MECHANISMS; SELECTIN; LESIONS; VCAM-1	Purpose The upregulation of vascular cell adhesion molecule-1 (VCAM-1) on vascular endothelium plays a great role in the progression of atherosclerosis (AS). In this study, ultrasound molecular imaging was performed to monitor the inflammation injuries in the onset and progression of atherosclerosis with microbubbles targeted to VCAM-1. Methods Mice deficient for the apolipoprotein E (ApoE(-/-)mice) with high-cholesterol diet were studied as an age-dependent model of atherosclerosis. At 8, 16, 24, and 32 weeks of age, contrast enhanced ultrasound (CEU) molecular imaging of proximal ascending aorta was performed with microbubbles targeted to VCAM-1. Plaque size, monocytes infiltration and the expression of VCAM-1 in the proximal ascending aorta were assessed by histology and western blot analysis, separately. Results In ApoE(-/-) mice, molecular imaging for VCAM-1 detected selective signal enhancement (P<0.01 versus non-targeted microbubbles) at all ages of ApoE(-/-) mice. Moreover, signals from targeted microbubbles increased from 8wks to 32wks age (P<0.05 for trend) in ApoE(-/-) mice, indicating the upregulation of VCAM-1 with the progression of atherosclerosis. Consistent with CEU imaging results, both western blot analysis and immunohistochemistry revealed the expression of VCAM-1 and monocytes infiltration were age-dependent in ApoE(-/-) mice. Conclusions CEU molecular imaging can be used to noninvasively detect the VCAM-1 expression on the endothelium in the progression of atherosclerosis. By investigating specific molecular biomarkers, it could help to monitor the inflammation and the progression of AS, which may in some extent contribute to the prediction of vulnerable plaque.	[Sun, Ruiying; Tian, Jie; Zhang, Jun; Wang, Liping; Guo, Jing; Liu, Yani] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Med Ultrasound, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Liu, YN (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Med Ultrasound, Wuhan, Hubei, Peoples R China.	yani.liu@aliyun.com		Liu, Yani/0000-0001-5706-0811	National Science Foundation of China [81371581, 81101053]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	YNL is supported by a grant (81371581, 81101053) from the National Science Foundation of China (http://www.nsfc.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721; Boekholdt SM, 2008, CIRCULATION, V118, P1120, DOI 10.1161/CIRCULATIONAHA.108.795195; Bruckman MA, 2014, NANO LETT, V14, P1551, DOI 10.1021/nl404816m; Brunetti ND, 2014, ATHEROSCLEROSIS, V236, P456, DOI 10.1016/j.atherosclerosis.2014.07.037; Davidson BP, 2014, J AM SOC ECHOCARDIOG, V27, P786, DOI 10.1016/j.echo.2014.03.013; Deshpande N, 2012, RADIOLOGY, V262, P172, DOI 10.1148/radiol.11110323; Huo YQ, 2000, CIRC RES, V87, P153, DOI 10.1161/01.RES.87.2.153; Joseph P, 2017, EUR J NUCL MED MOL I, V44, P141, DOI 10.1007/s00259-016-3524-0; Kaufmann BA, 2007, CIRCULATION, V116, P276, DOI 10.1161/CIRCULATIONAHA.106.684738; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; Lindner JR, 2001, CIRCULATION, V104, P2107, DOI 10.1161/hc4201.097061; Liu YN, 2013, CIRC-CARDIOVASC IMAG, V6, P74, DOI 10.1161/CIRCIMAGING.112.975193; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; Narula J, 2013, J AM COLL CARDIOL, V61, P1041, DOI 10.1016/j.jacc.2012.10.054; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Silvola JMU, 2016, SCI REP-UK, V6, DOI 10.1038/srep35089; Singh P, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004195; Soeki T, 2016, INT HEART J, V57, P134, DOI 10.1536/ihj.15-346; Steinl DC, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.004720; Veseli B. Emini, 2017, EUR J PHARM; Wu ZJ, 2013, CIRC-CARDIOVASC IMAG, V6, P974, DOI 10.1161/CIRCIMAGING.113.000805; Zhang MD, 2015, CARDIOVASC THER, V33, P118, DOI 10.1111/1755-5922.12119	23	9	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186155	10.1371/journal.pone.0186155	http://dx.doi.org/10.1371/journal.pone.0186155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982198	Green Submitted, Green Published, gold			2022-12-26	WOS:000412360300130
J	Huang, XW; Zhang, YL; Meng, L; Abbott, D; Qian, M; Wong, KKL; Zheng, RQ; Zheng, HR; Niu, LL				Huang, Xiaowei; Zhang, Yanling; Meng, Long; Abbott, Derek; Qian, Ming; Wong, Kelvin K. L.; Zheng, Rongqing; Zheng, Hairong; Niu, Lili			Evaluation of carotid plaque echogenicity based on the integral of the cumulative probability distribution using gray-scale ultrasound images	PLOS ONE			English	Article							B-MODE IMAGES; CARDIOVASCULAR EVENTS; CORONARY EVENTS; ISCHEMIC-STROKE; HIGH-RISK; ECHOLUCENT; TEXTURE; CLASSIFICATION; PREDICTION; STENOSIS	Objective Carotid plaque echogenicity is associated with the risk of cardiovascular events. Gray-scale median (GSM) of the ultrasound image of carotid plaques has been widely used as an objective method for evaluation of plaque echogenicity in patients with atherosclerosis. We proposed a computer-aided method to evaluate plaque echogenicity and compared its efficiency with GSM. Methods One hundred and twenty-five carotid plaques (43 echo-rich, 35 intermediate, 47 echolucent) were collected from 72 patients in this study. The cumulative probability distribution curves were obtained based on statistics of the pixels in the gray-level images of plaques. The area under the cumulative probability distribution curve (AUCPDC) was calculated as its integral value to evaluate plaque echogenicity. Results The classification accuracy for three types of plaques is 78.4% (kappa value, kappa = 0.673), when the AUCPDC is used for classifier training, whereas GSM is 64.8% (kappa = 0.460). The receiver operating characteristic curves were produced to test the effectiveness of AUCPDC and GSM for the identification of echolucent plaques. The area under the curve (AUC) was 0.817 when AUCPDC was used for training the classifier, which is higher than that achieved using GSM (AUC = 0.746). Compared with GSM, the AUCPDC showed a borderline association with coronary heart disease (Spearman r = 0.234, p = 0.050). Conclusions Our experimental results suggest that AUCPDC analysis is a promising method for evaluation of plaque echogenicity and predicting cardiovascular events in patients with plaques.	[Huang, Xiaowei; Meng, Long; Qian, Ming; Zheng, Hairong; Niu, Lili] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China; [Huang, Xiaowei] Univ Chinese Acad Sci, Shenzhen Coll Adv Technol, Shenzhen, Peoples R China; [Zhang, Yanling; Zheng, Rongqing] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Ultrasound, Guangzhou, Guangdong, Peoples R China; [Abbott, Derek] Univ Adelaide, Ctr Biomed Engn, Adelaide, SA, Australia; [Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia; [Wong, Kelvin K. L.] Western Sydney Univ, Sch Med, Campbelltown, NSW, Australia	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Sun Yat Sen University; University of Adelaide; University of Adelaide; University of Sydney; Western Sydney University	Niu, LL (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China.	ll.niu@siat.ac.cn	Abbott, Derek/E-8352-2011; Wong, Kelvin Kian Loong/ABA-3915-2021; Wong, Kelvin/AAL-8636-2021	Abbott, Derek/0000-0002-0945-2674; Wong, Kelvin Kian Loong/0000-0002-8600-1105; 	National Key R&D Program of China [2016YFC0104700]; National Science Foundation Grants (NSFC) [11574341, 11674347, 81527901, 11325420, 11574342]; Shenzhen Basic Science Research [JCYJ20160429190550139, JCYJ20160429184552717]; Natural Science Foundation of Guangdong Province [2016TQ03X716, 2016TQ03R472]	National Key R&D Program of China; National Science Foundation Grants (NSFC); Shenzhen Basic Science Research; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	The work was supported by National Key R&D Program of China (2016YFC0104700), National Science Foundation Grants (NSFC Grant Nos. 11574341, 11674347, 81527901,11325420, 11574342), Shenzhen Basic Science Research (JCYJ20160429190550139, JCYJ20160429184552717), and Natural Science Foundation of Guangdong Province (2016TQ03X716, 2016TQ03R472). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2012, ULTRASOUND MED BIOL, V38, P899, DOI 10.1016/j.ultrasmedbio.2012.01.015; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Christodoulou CI, 2003, IEEE T MED IMAGING, V22, P902, DOI 10.1109/TMI.2003.815066; Doonan RJ, 2013, EUR J VASC ENDOVASC, V46, P299, DOI 10.1016/j.ejvs.2013.05.024; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; European Carotid Plaque Study Group, 2011, Eur J Vasc Endovasc Surg, V42 Suppl 1, pS32, DOI 10.1016/j.ejvs.2011.06.022; Expert Committee, 2003, DIABETES CARE S1, V26, pS5, DOI DOI 10.2337/DIACARE.26.2007.S5; GEROULAKOS G, 1993, BRIT J SURG, V80, P1274, DOI 10.1002/bjs.1800801016; Giede-Jeppe A, 2016, STROKE, V47, P1239, DOI 10.1161/STROKEAHA.116.013003; Goldenberg R, 2013, CAN J DIABETES, V37, pS8, DOI 10.1016/j.jcjd.2013.01.011; Gronholdt MLM, 2001, CIRCULATION, V104, P68, DOI 10.1161/hc2601.091704; Gronholdt MLM, 1997, EUR J VASC ENDOVASC, V14, P439, DOI 10.1016/S1078-5884(97)80121-9; Heider P, 2010, EUR J VASC ENDOVASC, V39, P668, DOI 10.1016/j.ejvs.2010.03.012; Hirano M, 2010, ATHEROSCLEROSIS, V211, P451, DOI 10.1016/j.atherosclerosis.2010.03.003; Honda O, 2004, J AM COLL CARDIOL, V43, P1177, DOI 10.1016/j.jacc.2003.09.063; Huang XW, 2016, J ULTRAS MED, V35, P2253, DOI 10.7863/ultra.15.09002; Irie Y, 2013, ATHEROSCLEROSIS, V230, P399, DOI 10.1016/j.atherosclerosis.2013.08.015; Mathiesen EB, 2001, CIRCULATION, V103, P2171; Mayor I, 2003, ULTRASOUND MED BIOL, V29, P961, DOI 10.1016/S0301-5629(03)00905-0; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nakamura T, 2013, INT J CARDIOL, V167, P555, DOI 10.1016/j.ijcard.2012.01.064; Nordestgaard BG, 2003, CURR OPIN LIPIDOL, V14, P505, DOI 10.1097/00041433-200310000-00012; Prahl U, 2010, ULTRASOUND MED BIOL, V36, P218, DOI 10.1016/j.ultrasmedbio.2009.10.002; Reiter M, 2008, RADIOLOGY, V248, P1050, DOI 10.1148/radiol.2483071817; Roy J, 2016, EUR J VASC ENDOVASC, V51, P622, DOI 10.1016/j.ejvs.2016.01.002; Ruiz-Ares G, 2014, ULTRASOUND MED BIOL, V40, P1958, DOI 10.1016/j.ultrasmedbio.2014.04.015; Sabetai MM, 2000, STROKE, V31, P2189, DOI 10.1161/01.STR.31.9.2189; Salem MK, 2014, EUR J VASC ENDOVASC, V48, P118, DOI 10.1016/j.ejvs.2014.05.015; Shankar PM, 2003, ULTRASOUND MED BIOL, V29, P1305, DOI 10.1016/S0301-5629(03)00983-9; Tsiaparas NN, 2011, IEEE T INF TECHNOL B, V15, P130, DOI 10.1109/TITB.2010.2091511; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	33	7	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185261	10.1371/journal.pone.0185261	http://dx.doi.org/10.1371/journal.pone.0185261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977008	Green Published, gold			2022-12-26	WOS:000412163100019
J	Sprokholt, JK; Heineke, MH; Kaptein, TM; van Hamme, JL; Geijtenbeek, TBH				Sprokholt, Joris K.; Heineke, Marieke H.; Kaptein, Tanja M.; van Hamme, John L.; Geijtenbeek, Teunis B. H.			DCs facilitate B cell responses against microbial DNA via DC-SIGN	PLOS ONE			English	Article							DENDRITIC CELLS; EXTRACELLULAR DNA; LECTIN RECEPTORS; MANNOSE RECEPTOR; IDENTIFICATION; RESISTANCE; LANGERIN; BIOFILMS; IMMUNITY; ANTIGEN	Microbial DNA is highly immunostimulatory and is sensed by endosomal pattern recognition receptors after release from internalized microbes. It is unclear how extracellular DNA released from dead microbes is delivered to endosomal PRRs to induce immune responses. Here we have investigated the ability of DCs to bind and internalize extracellular E.coli DNA as well as synthetic DNA. DCs internalized E.coli and synthetic DNA, which was dependent on the C-type lectin receptor DC-SIGN. Notably, endosomal uptake of DNA by DCs enhanced TLR9-dependent responses of B cells against DNA. Hence, we have identified DC-SIGN as a cell surface receptor for DNA that facilitates immune responses directed against DNA.	[Sprokholt, Joris K.; Heineke, Marieke H.; Kaptein, Tanja M.; van Hamme, John L.; Geijtenbeek, Teunis B. H.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands; [Sprokholt, Joris K.; Heineke, Marieke H.; Kaptein, Tanja M.; van Hamme, John L.; Geijtenbeek, Teunis B. H.] Amsterdam Infect & Immun Inst, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Geijtenbeek, TBH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands.; Geijtenbeek, TBH (corresponding author), Amsterdam Infect & Immun Inst, Amsterdam, Netherlands.	t.b.geijtenbeek@amc.uva.nl		Sprokholt, Joris/0000-0001-8104-0028	Netherlands Organization for Scientific Research; TBHG [NGI 40-41009-98-8057, NWOVICI918.10.619, 670424]; European Research Council	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); TBHG; European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Netherlands Organization for Scientific Research (http://www.nwo.nl/) TBHG, grants NGI 40-41009-98-8057 and NWOVICI918.10.619 and the European Research Council (https://erc.europa.eu/) TBHG, Advanced grant 670424. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ana M. A, 2009, J IMMUNOL, V76, P211; Bode C, 2012, CPG DNA VACCINE ADJU, V10, P499; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Ewald SE, 2011, CURR OPIN IMMUNOL, V23, P3, DOI 10.1016/j.coi.2010.11.006; Frison N, 2003, J BIOL CHEM, V278, P23922, DOI 10.1074/jbc.M302483200; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Geijtenbeek TBH, 2002, J BIOL CHEM, V277, P11314, DOI 10.1074/jbc.M111532200; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2016, NAT REV IMMUNOL, V16, P433, DOI 10.1038/nri.2016.55; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Goodman SD, 2011, MUCOSAL IMMUNOL, V4, P625, DOI 10.1038/mi.2011.27; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hovius JWR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040031; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kerkmann M, 2005, J BIOL CHEM, V280, P8086, DOI 10.1074/jbc.M410868200; Kostakioti M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010306; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Lahoud MH, 2012, DEC 205 IS CELL SURF, DOI [10.1073/pnas.1208796109/-/DCSupplemental, DOI 10.1073/PNAS.1208796109/-/DCSUPPLEMENTAL]; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Liu HH, 2008, CURR MICROBIOL, V57, P139, DOI 10.1007/s00284-008-9166-0; McHutchison JG, 2007, HEPATOLOGY, V46, P1341, DOI 10.1002/hep.21773; Moseman AP, 2013, J IMMUNOL, V191, P5615, DOI 10.4049/jimmunol.1301438; Ohba Y., 2005, NATURE, V2, P1; Pasare C, 2003, CURR OPIN IMMUNOL, V15, P677, DOI 10.1016/j.coi.2003.09.002; Pisetsky DS, 2012, CLIN IMMUNOL, V144, P32, DOI 10.1016/j.clim.2012.04.006; Sandgren S, 2004, J BIOL CHEM, V279, P17951, DOI 10.1074/jbc.M311440200; Takahara K, 2004, INT IMMUNOL, V16, P819, DOI 10.1093/intimm/dxh084; van Liempt E, 2006, FEBS LETT, V580, P6123, DOI 10.1016/j.febslet.2006.10.009; Verthelyi D, 2003, J IMMUNOL, V170, P4717, DOI 10.4049/jimmunol.170.9.4717; Wang BX, 2012, TRENDS IMMUNOL, V33, P190, DOI 10.1016/j.it.2012.01.004; Wykes M, 1998, J IMMUNOL, V161, P1313	39	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185580	10.1371/journal.pone.0185580	http://dx.doi.org/10.1371/journal.pone.0185580			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976999	Green Submitted, Green Published, gold			2022-12-26	WOS:000412163100031
J	Mei, LL; Wang, WJ; Qiu, YT; Xie, XF; Bai, J; Shi, ZZ				Mei, Li-Li; Wang, Wen-Jun; Qiu, Yun-Tan; Xie, Xiu-Feng; Bai, Jie; Shi, Zhi-Zhou			miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma	PLOS ONE			English	Article							BREAST-CANCER; MESENCHYMAL TRANSITION; DOWN-REGULATION; PROGNOSIS; INVASION; MICRORNA; METASTASIS; EXPRESSION; RESISTANCE; MIGRATION	MicroRNAs (miRNAs) play important roles in the progression of human cancer including esophageal squamous cell carcinoma (ESCC). Although previous reports showed that miR-125b-5p was down-regulated in ESCC, the roles and mechanisms of loss of function of miR-125b-5p in ESCC were still unknown. Using microRNA microarray and GEO datasets, we found and confirmed that miR-125b-5p was down-regulated in ESCC tissues. In-vitro assays showed that ectopic miR-125b-5p expression repressed cell proliferation, migration and invasion, and induced cell senescence. We also found that miR-125b-5p reduced the expressions of cell cycle regulatory genes including CCNA2, CCND1 and CCNE1, and regulated the markers of epithelial to mesenchymal transition (EMT) including E-cadherin, N-cadherin and EMT associated transcription factor Slug, and also decreased the MMPs including MMP2, MMP7 and MMP13. Furthermore, the candidate target gene HMGA2 was negatively regulated by miR-125b-5p both in mRNA and protein levels. Importantly, knockdown of HMGA2 partially phenocopied the effects of miR-125b-5p overexpression on cell cycle regulators and EMT markers. In conclusion, our results suggested that overexpression of miR-125b-5p inhibited cell proliferation, migration and invasion partially by down-regulating HMGA2 in ESCC.	[Mei, Li-Li; Wang, Wen-Jun; Qiu, Yun-Tan; Xie, Xiu-Feng; Bai, Jie; Shi, Zhi-Zhou] Kunming Univ Sci & Technol, Med Sch, Kunming, Yunnan, Peoples R China; [Shi, Zhi-Zhou] CAMS, Canc Hosp, State Key Lab Mol Oncol, Beijing, Peoples R China	Kunming University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College	Bai, J; Shi, ZZ (corresponding author), Kunming Univ Sci & Technol, Med Sch, Kunming, Yunnan, Peoples R China.; Shi, ZZ (corresponding author), CAMS, Canc Hosp, State Key Lab Mol Oncol, Beijing, Peoples R China.	jiebai662001@126.com; zhizhoushi@kmust.edu.cn		Qiu, Yuntan/0000-0001-5653-7956; Mei, LiLi/0000-0003-2100-736X	National Natural Science Foundation of China [81460425, 81760526]; Open Project Program of State Key Laboratory of Molecular Oncology [SKL-KF-2017-11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Project Program of State Key Laboratory of Molecular Oncology	The National Natural Science Foundation of China (No.81460425 and No. 81760526) and the Open Project Program of State Key Laboratory of Molecular Oncology (SKL-KF-2017-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bu QG, 2017, BIOMED PHARMACOTHER, V88, P443, DOI 10.1016/j.biopha.2016.11.090; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cisneros-Soberanis F, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2475-z; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Deakin NE, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00070; Dong JQ, 2017, CLIN CANCER RES, V23, P3461, DOI 10.1158/1078-0432.CCR-16-2180; Fassan M, 2013, HUM PATHOL, V44, P1804, DOI 10.1016/j.humpath.2013.01.023; Foda HD, 2001, DRUG DISCOV TODAY, V6, P478, DOI 10.1016/S1359-6446(01)01752-4; Fujino Y, 2017, CANCER SCI, V108, P390, DOI 10.1111/cas.13152; Gu J, 2013, CURR PHARM DESIGN, V19, P1292; Hong LQ, 2016, ONCOTARGETS THER, V9, P2639, DOI 10.2147/OTT.S102713; Hsieh YS, 2017, J CELL BIOCH; Jin Liyan, 2016, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V32, P1238; Liu BQ, 2017, HUM PATHOL, V64, P44, DOI 10.1016/j.humpath.2017.03.016; Liu Q, 2012, MOL BIOL REP, V39, P1239, DOI 10.1007/s11033-011-0854-7; Luo YW, 2017, ONCOL LETT, V13, P867, DOI 10.3892/ol.2016.5482; Mittal R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091885; Nakanishi H, 2014, ONCOGENE, V33, P702, DOI 10.1038/onc.2013.13; Palumbo A, 2016, ONCOTARGET, V7, P25872, DOI 10.18632/oncotarget.8288; Palumbo A, 2016, CELL CYCLE, V15, P2410, DOI 10.1080/15384101.2016.1215388; Pei GS, 2017, ONCOTARGET, V8, P13898, DOI 10.18632/oncotarget.14687; Shi Z, 2016, J BIOSCIENCES, V41, P229, DOI 10.1007/s12038-016-9603-3; Sun JY, 2017, AM J CANCER RES, V7, P260; Sun M, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0445-8; Wei RN, 2016, J CANCER RES THER, V12, P1291, DOI 10.4103/0973-1482.180616; Wu SQ, 2015, J ELECTR COMPUT ENG, V2015, DOI 10.1155/2015/835357; Yang D, 2017, SCI REP-UK, V7, DOI 10.1038/srep43109; Yang LL, 2017, ONCOTARGET, V8, P59867, DOI 10.18632/oncotarget.16729; Yu XF, 2017, SCI REP-UK, V7, DOI 10.1038/srep42226; Yuan TZ, 2017, MOL MED REP, V15, P2223, DOI 10.3892/mmr.2017.6233; Zang B, 2015, INT J CLIN EXP PATHO, V8, P13687; Zhang MY, 2016, MINERVA CHIR, V71, P239; Zhang X, 2017, ONCOTARGET; Zuberi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153902	35	50	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185636	10.1371/journal.pone.0185636	http://dx.doi.org/10.1371/journal.pone.0185636			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968424	gold, Green Published, Green Submitted			2022-12-26	WOS:000412029600033
J	Shao, XX; Sheng, XC; Wu, M; Wu, H; Ning, X				Shao, Xuexin; Sheng, Xuancai; Wu, Ming; Wu, Hao; Ning, Xiao			Methane production potential and emission at different water levels in the restored reed wetland of Hangzhou Bay	PLOS ONE			English	Article							NATURAL WETLANDS; DIURNAL-VARIATIONS; TABLE; CHINA; METHANOGENESIS; EXCHANGE; PEATLAND; IMPACT; MARSH; RATES	Changes in the hydrological conditions of coastal wetlands may potentially affect the role of wetlands in the methane (CH4) cycle. In this study, the CH4 production potential and emissions from restored coastal reed wetlands at different water levels were examined in eastern China at a field scale in two phenological seasons. Results showed that the total CH4 flux from reeds at various water levels were positive, indicating that they were "sources" of CH4. During the peak growing season, CH4 flux from reeds was greater than that during the spring thaw. CH4 flux from reeds in inundated conditions was greater than that in non-inundated conditions. The CH4 production potential during the peak growing season was far greater than that during the spring thaw. However, the effect of water level on wetland CH4 production potential differed among seasons. The correlations among CH4 production potential, soil properties and CH4 flux change at different water level. These results demonstrate that water level was related to CH4 production and CH4 flux. The growing season also plays a role in CH4 fluxes. Controlling the hydrological environment in restored wetlands has important implications for the maintenance of their function as carbon sinks.	[Shao, Xuexin; Wu, Ming; Wu, Hao; Ning, Xiao] Chinese Acad Forestry, Res Inst Subtrop Forestry, Wetland Ecosyst Res Stn Hangzhou Bay, Hangzhou, Zhejiang, Peoples R China; [Sheng, Xuancai] State Forestry Adm, East China Forest Inventory & Planning Inst, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Wu, M (corresponding author), Chinese Acad Forestry, Res Inst Subtrop Forestry, Wetland Ecosyst Res Stn Hangzhou Bay, Hangzhou, Zhejiang, Peoples R China.	hangzhoubay@126.com			Special Fund for Forest Scientific Research in the Public Welfare [201404210]; Fundamental Research Funds for the Central Non-profit Research Institution [CAFYBB2014MA002]; Fund for Cooperation of Zhejiang Province; Chinese Academy of Forestry [2015SY01]	Special Fund for Forest Scientific Research in the Public Welfare; Fundamental Research Funds for the Central Non-profit Research Institution; Fund for Cooperation of Zhejiang Province; Chinese Academy of Forestry	This study was supported by the Special Fund for Forest Scientific Research in the Public Welfare (201404210), the Fundamental Research Funds for the Central Non-profit Research Institution (CAFYBB2014MA002) and the Fund for Cooperation of Zhejiang Province and Chinese Academy of Forestry (2015SY01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery GB, 2003, BIOGEOCHEMISTRY, V62, P19, DOI 10.1023/A:1021128400602; Berglund O, 2011, SOIL BIOL BIOCHEM, V43, P923, DOI 10.1016/j.soilbio.2011.01.002; Brix H, 2001, AQUAT BOT, V69, P313, DOI 10.1016/S0304-3770(01)00145-0; Buckley DH, 2008, ENVIRON MICROBIOL, V10, P967, DOI 10.1111/j.1462-2920.2007.01517.x; Chang YiLu, 1999, Mangroves and Salt Marshes, V3, P41; Chasar LS, 2000, ANN BOT-LONDON, V86, P655, DOI 10.1006/anbo.2000.1172; Chen H, 2013, GLOBAL CHANGE BIOL, V19, P19, DOI 10.1111/gcb.12034; Dasselaar PV, 1999, SOIL BIOL BIOCHEM, V31, P877; Ding WX, 2007, PEDOSPHERE, V17, P475, DOI 10.1016/S1002-0160(07)60057-5; Ding WX, 2010, ATMOS ENVIRON, V44, P3894, DOI 10.1016/j.atmosenv.2010.07.025; Ding WX, 2004, ATMOS ENVIRON, V38, P751, DOI 10.1016/j.atmosenv.2003.10.016; Duan XN, 2005, ATMOS ENVIRON, V39, P4479, DOI 10.1016/j.atmosenv.2005.03.045; Faubert P, 2010, ATMOS ENVIRON, V44, P4432, DOI 10.1016/j.atmosenv.2010.07.039; [冯利华 FENG Lihua], 2006, [海洋科学, Marine Sciences], V30, P88; Grunfeld S, 1999, AQUAT BOT, V64, P63, DOI 10.1016/S0304-3770(99)00010-8; Herbst M, 2011, AGR FOREST METEOROL, V151, P841, DOI 10.1016/j.agrformet.2011.02.002; Hu QF, 2009, WATER SCI ENG, V2, P1, DOI 10.3882/j.issn.1674-2370.2009.01.001; Huang Pu-yi, 2011, Yingyong Shengtai Xuebao, V22, P1219; Joabsson A, 1999, TRENDS ECOL EVOL, V14, P385, DOI 10.1016/S0169-5347(99)01649-3; Joosten H, 2002, WISE USE MIRES PEATL; Juutinen S, 2003, BIOL FERT SOILS, V38, P10, DOI 10.1007/s00374-003-0618-1; Kettunen A, 1999, SOIL BIOL BIOCHEM, V31, P1741, DOI 10.1016/S0038-0717(99)00093-0; Knorr KH, 2008, SOIL BIOL BIOCHEM, V40, P1781, DOI 10.1016/j.soilbio.2008.03.019; Kohl JG, 2000, AQUAT BOT, V54, P199; Liu DY, 2014, APPL MICROBIOL BIOT, V98, P4711, DOI 10.1007/s00253-014-5571-4; [刘小燕 Liu Xiaoyan], 2006, [生态环境, Ecology and Environment], V15, P265; Lu L. K, 1999, SOIL AGRO CHEM ANALY; Luo G, 2013, BIOGEOSCI DISCUSS, V10, P927, DOI DOI 10.5194/bgd-10-927-2013; Ma ZJ, 2014, SCIENCE, V346, P912, DOI 10.1126/science.1257258; Macdonald JA, 1998, ATMOS ENVIRON, V32, P3219, DOI 10.1016/S1352-2310(97)00464-0; Purvaja R, 2004, GLOBAL CHANGE BIOL, V10, P1825, DOI 10.1111/j.1365-2486.2004.00834.x; 王明星, 1993, Advances in Atmospheric Sciences, V10, P307; Shang QY, 2011, GLOBAL CHANGE BIOL, V17, P2196, DOI 10.1111/j.1365-2486.2010.02374.x; Shao X, ENV PROGR SUSTAINABL; Shao XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142677; Singh S.N., 2000, CHEMOSPHERE GLOB CHA, V2, DOI [10.1016/S1465- 9972(99)00046-X, DOI 10.1016/S1465-9972(99)00046-X]; Sun L, 2013, ATMOS ENVIRON, V81, P356, DOI 10.1016/j.atmosenv.2013.09.033; Tiiva P, 2009, ATMOS ENVIRON, V43, P5469, DOI 10.1016/j.atmosenv.2009.07.026; Tong C, 2013, ESTUAR COAST, V36, P633, DOI 10.1007/s12237-013-9596-1; Villa Jorge A., 2014, Ecohydrology & Hydrobiology, V14, P253, DOI 10.1016/j.ecohyd.2014.07.005; [万忠梅 Wan Zhongmei], 2013, [生态环境学报, Ecology and Environmental Sciences], V22, P465; WANG ZP, 1993, SOIL SCI SOC AM J, V57, P382, DOI 10.2136/sssaj1993.03615995005700020016x; Whalen SC, 2005, ENVIRON ENG SCI, V22, P73, DOI 10.1089/ees.2005.22.73; Yang JS, 2013, SOIL BIOL BIOCHEM, V61, P52, DOI 10.1016/j.soilbio.2013.02.009; Yuan JJ, 2014, APPL MICROBIOL BIOT, V98, P1817, DOI 10.1007/s00253-013-5104-6	45	11	13	8	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185709	10.1371/journal.pone.0185709	http://dx.doi.org/10.1371/journal.pone.0185709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968419	Green Published, gold, Green Submitted			2022-12-26	WOS:000412029600037
J	McClellan, SA; Jerome, A; Suvas, S; Hazlett, LD				McClellan, Sharon A.; Jerome, Andrew; Suvas, Susmit; Hazlett, Linda D.			NLRC4 regulates caspase-1 and IL-1beta production in a CD11b(low) Ly6G(low) population of cells required for resistance to Pseudomonas aeruginosa keratitis	PLOS ONE			English	Article							CORNEAL INFECTION; SUPPRESSOR-CELLS; OCULAR INFECTION; GAMMA PRODUCTION; DENDRITIC CELLS; RISK-FACTORS; SOUTH-INDIA; MICE; INFLAMMASOMES; ACTIVATION	Psbetaeudomonas (P.) aeruginosa infection of the cornea in BALB/c mice does not result in perforation and the mice have been classified as resistant. However, regulation of this response via inflammasome activation remained untested. Therefore, BALB/c mice were infected with P. aeruginosa ATCC strain 19660 and NLRP3 and NLRC4 protein tested by ELISA. Since NLRC4 vs NLRP3 protein levels were significantly higher in the corneas of BALB/c at 1 and 5 days postinfection we used silencing to knockdown NLRC4. Silencing NLRC4 vs scrambled siRNA treatment exacerbated disease in BALB/c mice, reduced myeloperoxidase levels and elevated bacterial plate counts at 5 days postinfection. It also increased pro IL-1beta, but reduced total protein for IL-1beta and IL-18 at 5 days postinfection. Flow cytometry to identify cells affected by silencing, showed reduced caspase-1 levels in a CD11b(low) Ly6G(low) population of cells, (but not PMN or macrophages) from the infected cornea of siNLRC4 treated mice that produced less mature IL-1beta. These data provide evidence that the NLRC4 inflammasome contributes to resistance through regulation of caspase-1, IL-1beta and IL-18 in a CD11b(low) Ly6G(low) population of cells.	[McClellan, Sharon A.; Jerome, Andrew; Suvas, Susmit; Hazlett, Linda D.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Suvas, Susmit; Hazlett, Linda D.] Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI 48202 USA	Wayne State University; Wayne State University	Hazlett, LD (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.; Hazlett, LD (corresponding author), Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI 48202 USA.	lhaziett@med.wayne.edu		Jerome, Andrew/0000-0002-6748-8114	National Eye Institute, National Institutes of Health [R01EY016058, R01EY022417, P30EY004068]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY022417] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants R01EY016058 (LDH), R01EY022417 (SS) and P30EY004068 (LDH) from the National Eye Institute, National Institutes of Health and by a Research to Prevent Blindness unrestricted grant to the Department of Ophthalmology/Kresge Eye Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauernfeind F, 2011, CELL MOL LIFE SCI, V68, P765, DOI 10.1007/s00018-010-0567-4; Bharathi MJ, 2007, OPHTHAL EPIDEMIOL, V14, P61, DOI 10.1080/09286580601001347; Bharathi MJ, 2009, INDIAN J MED RES, V130, P749; Brissette-Storkus CS, 2002, INVEST OPHTH VIS SCI, V43, P2264; Carvalho FA, 2012, MUCOSAL IMMUNOL, V5, P288, DOI 10.1038/mi.2012.8; Chen KWW, 2014, CELL REP, V8, P569, DOI 10.1016/j.celrep.2014.06.028; Chen KWW, 2013, CURR OPIN MICROBIOL, V16, P311, DOI 10.1016/j.mib.2013.02.004; Cohen TS, 2013, J CLIN INVEST, V123, P1630, DOI 10.1172/JCI66142; Franchi L, 2012, NAT IMMUNOL, V13, P449, DOI 10.1038/ni.2263; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Gorham JD, 1996, P NATL ACAD SCI USA, V93, P12467, DOI 10.1073/pnas.93.22.12467; Hamrah P, 2003, INVEST OPHTH VIS SCI, V44, P581, DOI 10.1167/iovs.02-0838; Hazlett LD, 2004, PROG RETIN EYE RES, V23, P1, DOI 10.1016/j.preteyeres.2003.10.002; Hazlett LD, 2000, INVEST OPHTH VIS SCI, V41, P805; HAZLETT LD, 1987, INVEST OPHTH VIS SCI, V28, P1978; Huang X, 2005, INVEST OPHTH VIS SCI, V46, P4209, DOI 10.1167/iovs.05-0185; Huang X, 2003, INVEST OPHTH VIS SCI, V44, P3409, DOI 10.1167/iovs.03-0162; Huang X, 2002, J IMMUNOL, V168, P5756, DOI 10.4049/jimmunol.168.11.5756; Karmakar M, 2012, J IMMUNOL, V189, P4231, DOI 10.4049/jimmunol.1201447; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Kwon B, 1997, J IMMUNOL, V159, P6283; Lighvani S, 2005, EUR J IMMUNOL, V35, P1567, DOI 10.1002/eji.200425902; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Rudner XL, 2000, J IMMUNOL, V164, P6576, DOI 10.4049/jimmunol.164.12.6576; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Singh PK, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.34; Singh PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119541; Tolle L, 2015, J INNATE IMMUN, V7, P177, DOI 10.1159/000367790; West TE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003178; WILHELMUS K R, 1987, CLAO Journal, V13, P211; WILLIAMS RN, 1982, CURR EYE RES, V2, P465, DOI 10.3109/02713688208996350; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895	36	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185718	10.1371/journal.pone.0185718	http://dx.doi.org/10.1371/journal.pone.0185718			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961278	Green Published, Green Submitted, gold			2022-12-26	WOS:000412027700035
J	Quides, KW; Stomackin, GM; Lee, HH; Chang, JH; Sachs, JL				Quides, Kenjiro W.; Stomackin, Glenna M.; Lee, Hsu-Han; Chang, Jeff H.; Sachs, Joel L.			Lotus japonicus alters in planta fitness of Mesorhizobium loti dependent on symbiotic nitrogen fixation	PLOS ONE			English	Article							LEGUMINOSARUM BV TRIFOLII; PARTNER CHOICE; INEFFECTIVE NODULATION; MUTUALISM STABILITY; RHIZOBIUM-TRIFOLII; HOST SANCTIONS; MUTANT; DIVERSITY; INFECTION; GENOTYPE	Rhizobial bacteria are known for their capacity to fix nitrogen for legume hosts. However ineffective rhizobial genotypes exist and can trigger the formation of nodules but fix little if any nitrogen for hosts. Legumes must employ mechanisms to minimize exploitation by the ineffective rhizobial genotypes to limit fitness costs and stabilize the symbiosis. Here we address two key questions about these host mechanisms. What stages of the interaction are controlled by the host, and can hosts detect subtle differences in nitrogen fixation? We provide the first explicit evidence for adaptive host control in the interaction between Lotus japonicus and Mesorhizobium loti. In both single inoculation and co-inoculation experiments, less effective rhizobial strains exhibited reduced in planta fitness relative to the wildtype M. loti. We uncovered evidence of host control during nodule formation and during post-infection proliferation of symbionts within nodules. We found a linear relationship between rhizobial fitness and symbiotic effectiveness. Our results suggest that L. japonicus can adaptively modulate the fitness of symbionts as a continuous response to symbiotic nitrogen fixation.	[Quides, Kenjiro W.; Stomackin, Glenna M.; Lee, Hsu-Han; Sachs, Joel L.] Univ Calif Riverside, Dept Evolut Ecol & Organismal Biol, Riverside, CA 92521 USA; [Chang, Jeff H.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Sachs, Joel L.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Sachs, Joel L.] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside; Oregon State University; University of California System; University of California Riverside; University of California System; University of California Riverside	Sachs, JL (corresponding author), Univ Calif Riverside, Dept Evolut Ecol & Organismal Biol, Riverside, CA 92521 USA.; Sachs, JL (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.; Sachs, JL (corresponding author), Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	joels@ucr.edu	Sachs, Joel/AAB-9348-2019	Sachs, Joel/0000-0002-0221-9247	University of California, Riverside Department of Biology; National Science Foundation, Division of Environmental Biology [1150278]; U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) [2014-51181-22384]; Division Of Environmental Biology [1150278] Funding Source: National Science Foundation	University of California, Riverside Department of Biology; National Science Foundation, Division of Environmental Biology(National Science Foundation (NSF)); U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	KWQ was supported by a grant through the University of California, Riverside Department of Biology (http://www.biology.ucr.edu1). JLS was supported by the National Science Foundation, Division of Environmental Biology #1150278 (https://www.nsf.goy/by/index.jsp?div=DEB). JHC is supported in part by the U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) grant 2014-51181-22384 (https://nifa.usda.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARGER N, 1981, SOIL BIOL BIOCHEM, V13, P481, DOI 10.1016/0038-0717(81)90038-9; AMARGER N, 1981, SOIL BIOL BIOCHEM, V13, P475, DOI 10.1016/0038-0717(81)90037-7; BEATTIE GA, 1989, APPL ENVIRON MICROB, V55, P2755, DOI 10.1128/AEM.55.11.2755-2761.1989; Berrabah F, 2015, J EXP BOT, V66, P1977, DOI 10.1093/jxb/eru545; Bromfield ESP, 2010, MICROBIOL-SGM, V156, P505, DOI 10.1099/mic.0.034058-0; Burdon JJ, 1999, J APPL ECOL, V36, P398, DOI 10.1046/j.1365-2664.1999.00409.x; CHAMPION RA, 1992, CROP SCI, V32, P457, DOI 10.2135/cropsci1992.0011183X003200020034x; Checcucci A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00835; Chen LS, 2002, BIOL FERT SOILS, V35, P448, DOI 10.1007/s00374-002-0493-1; Chungopast S, 2014, J PLANT PHYSIOL, V171, P104, DOI 10.1016/j.jplph.2013.10.015; Collins MT, 2002, AUST J SOIL RES, V40, P1319, DOI 10.1071/SR01052; Cooper JE, 2007, J APPL MICROBIOL, V103, P1355, DOI 10.1111/j.1365-2672.2007.03366.x; Crespo-Rivas JC, 2016, ENVIRON MICROBIOL, V18, P2392, DOI 10.1111/1462-2920.13101; DEBOER MH, 1995, PROTOPLASMA, V185, P58, DOI 10.1007/BF01272754; Denison RF, 2000, AM NAT, V156, P567, DOI 10.1086/316994; Denton MD, 2000, AUST J EXP AGR, V40, P25, DOI 10.1071/EA99035; Devine TE, 1996, PLANT SOIL, V186, P173, DOI 10.1007/BF00035072; DEVINE TE, 1990, THEOR APPL GENET, V80, P33, DOI 10.1007/BF00224012; DJORDJEVIC SP, 1988, J BACTERIOL, V170, P1848, DOI 10.1128/jb.170.4.1848-1857.1988; Ehinger M, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-8; Fening JO, 2002, APPL SOIL ECOL, V21, P23, DOI 10.1016/S0929-1393(02)00042-2; Friesen ML, 2013, NEW PHYTOL, V198, P7, DOI 10.1111/nph.12173; Friesen ML, 2012, NEW PHYTOL, V194, P1096, DOI 10.1111/j.1469-8137.2012.04099.x; Gano-Cohen KA, 2016, APPL ENVIRON MICROB, V82, P5259, DOI 10.1128/AEM.01116-16; GAUR YD, 1980, NEW ZEAL J AGR RES, V23, P529; GIBSON AH, 1975, SOIL BIOL BIOCHEM, V7, P95, DOI 10.1016/0038-0717(75)90005-X; Gubry-Rangin C, 2010, P ROY SOC B-BIOL SCI, V277, P1947, DOI 10.1098/rspb.2009.2072; HAHN M, 1986, FEMS MICROBIOL LETT, V33, P143; HANDBERG K, 1992, PLANT J, V2, P487, DOI 10.1111/j.1365-313X.1992.00487.x; Heath KD, 2009, EVOLUTION, V63, P652, DOI 10.1111/j.1558-5646.2008.00582.x; Ivanova KA, 2015, PROTOPLASMA, V252, P1505, DOI 10.1007/s00709-015-0780-y; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; Kawaguchi M, 2002, MOL PLANT MICROBE IN, V15, P17, DOI 10.1094/MPMI.2002.15.1.17; Kiers ET, 2006, EVOL ECOL RES, V8, P1077; Kiers ET, 2013, NEW PHYTOL, V198, P4, DOI 10.1111/nph.12015; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; KOSCH K, 1994, Z NATURFORSCH C, V49, P727; KUYKENDALL LD, 1976, APPL ENVIRON MICROB, V32, P511, DOI 10.1128/AEM.32.4.511-519.1976; Limpens E, 2015, ANN REV PHYTOPATHOL; Ling J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070138; Lotocka B, 2000, ACTA BIOL CRACOV BOT, V42, P87; Marco DE, 2009, J THEOR BIOL, V259, P423, DOI 10.1016/j.jtbi.2009.03.033; Moawad H, 1998, PLANT SOIL, V204, P95, DOI 10.1023/A:1004335112402; NOEL KD, 1986, J BACTERIOL, V168, P1392, DOI 10.1128/jb.168.3.1392-1401.1986; Oono R, 2011, P ROY SOC B-BIOL SCI, V278, P2698, DOI 10.1098/rspb.2010.2193; Oono R, 2010, NEW PHYTOL, V187, P508, DOI 10.1111/j.1469-8137.2010.03261.x; PARNISKE M, 1990, BOT ACTA, V103, P143, DOI 10.1111/j.1438-8677.1990.tb00140.x; PARNISKE M, 1994, MOL PLANT MICROBE IN, V7, P631, DOI 10.1094/MPMI-7-0631; Porter SS, 2014, ECOL LETT, V17, P1121, DOI 10.1111/ele.12318; Puppo A, 2005, NEW PHYTOL, V165, P683, DOI 10.1111/j.1469-8137.2004.01285.x; Quigley PE, 1997, AUST J EXP AGR, V37, P623, DOI 10.1071/EA96089; Rangin C, 2008, APPL ENVIRON MICROB, V74, P5653, DOI 10.1128/AEM.01107-08; Ratcliff WC, 2009, ISME J, V3, P870, DOI 10.1038/ismej.2009.38; Regus JU, 2015, J EVOLUTION BIOL, V28, P447, DOI 10.1111/jeb.12579; Regus JU, 2017, AM J BOT, V104, P1299, DOI 10.3732/ajb.1700165; Regus JU, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2587; Roth V., 2006, DOUBLING TIME COMPUT; Sachs JL, 2010, J EVOLUTION BIOL, V23, P1919, DOI 10.1111/j.1420-9101.2010.02056.x; Sachs JL, 2010, J EVOLUTION BIOL, V23, P1075, DOI 10.1111/j.1420-9101.2010.01980.x; Sachs JL, 2009, APPL ENVIRON MICROB, V75, P4727, DOI 10.1128/AEM.00667-09; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Shimoda Y, 2008, DNA RES, V15, P297, DOI 10.1093/dnares/dsn017; Simms EL, 2006, P ROY SOC B-BIOL SCI, V273, P77, DOI 10.1098/rspb.2005.3292; Simms EL, 2002, INTEGR COMP BIOL, V42, P369, DOI 10.1093/icb/42.2.369; SINGLETON PW, 1983, CROP SCI, V23, P69, DOI 10.2135/cropsci1983.0011183X002300010019x; Somasegaran P., 1994, HDB RHIZOBIA, DOI [10.1007/978-1-4613-8375-8, DOI 10.1007/978-1-4613-8375-8]; SPRENT JI, 1987, PHILOS T R SOC B, V317, P111, DOI 10.1098/rstb.1987.0051; Trainer MA, 2006, APPL MICROBIOL BIOT, V71, P377, DOI 10.1007/s00253-006-0354-1; VASSE J, 1993, PLANT J, V4, P555, DOI 10.1046/j.1365-313X.1993.04030555.x; West SA, 2002, J EVOLUTION BIOL, V15, P830, DOI 10.1046/j.1420-9101.2002.00441.x; West SA, 2002, P ROY SOC B-BIOL SCI, V269, P685, DOI 10.1098/rspb.2001.1878; Westhoek A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01634-2; Yasuda M, 2016, PLANT CELL PHYSIOL, V57, P1791, DOI 10.1093/pcp/pcw104; Zgadzaj R, 2016, P NATL ACAD SCI USA	74	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185568	10.1371/journal.pone.0185568	http://dx.doi.org/10.1371/journal.pone.0185568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957401	Green Published, gold			2022-12-26	WOS:000411985200087
J	Stein, K; Pearson, RM; Stein, A; Fazel, M				Stein, Kate; Pearson, Rebecca. M.; Stein, Alan; Fazel, Mina			The predictive value of childhood recurrent abdominal pain for adult emotional disorders, and the influence of negative cognitive style. Findings from a cohort study	PLOS ONE			English	Article							FUNCTIONAL SOMATIC SYMPTOMS; DIFFICULTIES QUESTIONNAIRE; COMMUNITY SAMPLE; POPULATION; DEPRESSION; CHILDREN; ANXIETY; EPIDEMIOLOGY; INFORMATION; COMPLAINTS	Background Recurrent abdominal pain (RAP) in childhood is common, with no explanatory pathology identified in the majority of cases. Previous studies have consistently demonstrated an association between childhood RAP and later emotional distress disorders. The aim of this study was to replicate this finding through the analysis of a large dataset, and explore how a negative style of thinking could potentially influence this relationship. Methods The Avon Longitudinal Study of Parents and Children (ALSPAC) is a population cohort of children born in the Avon area of the UK, between 1991-1992. Data on childhood RAP was collected via maternal reports at 3, 4, 7 and 9 years. Mood, anxiety and cognitive style were measured at age 18. We controlled for various confounding factors, including maternal anxiety and the child's pre-existing psychopathology. Logistic regression models were used to examine associations, and moderation effects of cognitive style were analysed using likelihood ratios. Results Experiencing RAP at any one time-point is associated with an increased odds of depression and/or anxiety disorder at 18 (OR = 1.41, 95% CI 1.09-1.83). We found a dose-response relationship and each additional marker of RAP was associated with a 26% (CI: 7% to 47%) increase in risk of having a mood and/or anxiety disorder. Individuals who attribute adversity to global, stable or personal factors were at amplified risk. Conclusions Childhood RAP predicts depression and anxiety disorders at 18 and should be targeted for early intervention. Individuals with a negative cognitive style may be particularly vulnerable, suggesting that cognitive interpretations of physical symptoms could play an important role in long-term health outcomes.	[Stein, Kate; Stein, Alan; Fazel, Mina] Univ Oxford, Dept Psychiat, Oxford, England; [Pearson, Rebecca. M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Oxford; University of Bristol	Stein, K (corresponding author), Univ Oxford, Dept Psychiat, Oxford, England.	kate.stein@psych.ox.ac.uk		Pearson, Rebecca/0000-0001-8527-3400; STEIN, KATE/0000-0001-8788-984X; Fazel, Mina/0000-0001-9342-2365; Stein, Alan/0000-0001-8207-2822	NIHR; Wellcome Trust [092731]; Oxford University Clinical Academic Graduate Scheme (OUCAGS); Medical Research Council [G9815508, MC_PC_15018] Funding Source: researchfish; National Institute for Health Research [ACF-2014-13-013] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Oxford University Clinical Academic Graduate Scheme (OUCAGS); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Dr Kate Stein is an NIHR funded Academic Clinical Fellow and Dr Mina Fazel is an NIHR funded post-doctoral research fellow. The UK Medical Research Council and the Wellcome Trust (Grant ref: 092731) and the University of Bristol provide core support for ALSPAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. The UK Medical Research Council and the Wellcome Trust (Grant ref: 092731) and the University of Bristol provide core support for ALSPAC. Ethical approval for this study was obtained from the ALSPAC Law and Ethics Committee.; This publication is the work of the authors and Kate Stein and Mina Fazel will serve as guarantors for the contents of this paper. Dr Kate Stein is an NIHR funded Academic Clinical Fellow and Dr Mina Fazel is an NIHR funded post-doctoral research fellow. We are also grateful to Oxford University Clinical Academic Graduate Scheme (OUCAGS) for their support.	ALLOY LB, 1988, BRIT J CLIN PSYCHOL, V27, P5, DOI 10.1111/j.2044-8260.1988.tb00749.x; APLEY J, 1958, ARCH DIS CHILD, V33, P165, DOI 10.1136/adc.33.168.165; Barrett PM, 1996, J ABNORM CHILD PSYCH, V24, P187, DOI 10.1007/BF01441484; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Campo JV, 2012, J CHILD PSYCHOL PSYC, V53, P575, DOI 10.1111/j.1469-7610.2012.02535.x; Chitkara DK, 2005, AM J GASTROENTEROL, V100, P1868, DOI 10.1111/j.1572-0241.2005.41893.x; Clark DM, 1997, J CONSULT CLIN PSYCH, V65, P203, DOI 10.1037/0022-006X.65.2.203; Creswell C, 2011, BEHAV COGN PSYCHOTH, V39, P191, DOI 10.1017/S1352465810000494; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Goubert L, 2008, J PAIN, V9, P272, DOI 10.1016/j.jpain.2007.11.006; Goubert L, 2006, PAIN, V123, P254, DOI 10.1016/j.pain.2006.02.035; Hewitt CE, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13360; Hotopf M, 1998, BRIT MED J, V316, P1196, DOI 10.1136/bmj.316.7139.1196; Hyde JS, 2008, PSYCHOL REV, V115, P291, DOI 10.1037/0033-295X.115.2.291; Janssens KAM, 2010, J CHILD PSYCHOL PSYC, V51, P304, DOI 10.1111/j.1469-7610.2009.02174.x; Kolk AM, 2003, SOC SCI MED, V57, P2343, DOI 10.1016/S0277-9536(02)00451-3; Langer SL, 2009, CHILD HEALTH CARE, V38, P169, DOI 10.1080/02739610903038750; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Mars B, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5954; Pearson RM, 2015, J AFFECT DISORDERS, V171, P60, DOI 10.1016/j.jad.2014.08.057; Pearson RM, 2013, JAMA PSYCHIAT, V70, P1312, DOI 10.1001/jamapsychiatry.2013.2163; Ramchandani PG, 2005, PEDIATRICS, V116, P46, DOI 10.1542/peds.2004-1854; Saps M, 2009, J PEDIATR-US, V154, P322, DOI 10.1016/j.jpeds.2008.09.047; Scharff L, 1997, CLIN PSYCHOL REV, V17, P145, DOI 10.1016/S0272-7358(96)00001-3; Schoth DE, 2016, HEALTH PSYCHOL, V35, P944, DOI 10.1037/hea0000342; Shanahan L, 2015, PSYCHOL MED, V45, P1721, DOI 10.1017/S0033291714002840; SRINATH S, 1993, J AM ACAD CHILD PSY, V32, P822, DOI 10.1097/00004583-199307000-00017; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Williams N, 1999, BRIT MED J, V318, P1455, DOI 10.1136/bmj.318.7196.1455	31	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185643	10.1371/journal.pone.0185643	http://dx.doi.org/10.1371/journal.pone.0185643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957435	Green Published, gold			2022-12-26	WOS:000411985200100
J	Lee, EJ; Jan, AT; Baig, MH; Ahmad, K; Malik, A; Rabbani, G; Kim, T; Lee, IK; Lee, YH; Park, SY; Choi, I				Lee, Eun Ju; Jan, Arif Tasleem; Baig, Mohammad Hassan; Ahmad, Khurshid; Malik, Adeel; Rabbani, Gulam; Kim, Taeyeon; Lee, In-Kyu; Lee, Yong Ho; Park, So-Young; Choi, Inho			Fibromodulin and regulation of the intricate balance between myoblast differentiation to myocytes or adipocyte-like cells	FASEB JOURNAL			English	Article						extracellular matrix; adipogenesis; myogenesis; muscle disease	MATRIX GLA PROTEIN; SKELETAL-MUSCLE REGENERATION; SATELLITE CELLS; STEM-CELLS; MEMBRANE-PROTEIN; SELF-RENEWAL; MYOSTATIN; EXPRESSION; CLUSTERIN; NETWORKS	Interactions between myoblasts and the surrounding microenvironment led us to explore the role of fibromodulin (FMOD), an extracellular matrix protein, in the maintenance of myoblast stemness and function. Microarray analysis of FMODkd myoblasts and in silico studies were used to identify the top most differentially expressed genes in FMODkd, and helped establish that FMOD-based regulations of integral membrane protein 2a and clusterin are essential components of the myogenic program. Studies in knockout, obese, and diabetic mouse models helped characterize the operation of a novel FMOD-based regulatory circuit that controls myoblast switching from a myogenic to a lipid accumulation fate. FMOD regulation of myoblasts is an essential part of the myogenic program, and it offers opportunities for the development of therapeutics for the treatment of different muscle diseases.	[Lee, Eun Ju; Jan, Arif Tasleem; Baig, Mohammad Hassan; Ahmad, Khurshid; Rabbani, Gulam; Kim, Taeyeon; Choi, Inho] Yeungnam Univ, Dept Med Biotechnol, 280 Daehak Ro, Gyongsan 38541, South Korea; [Malik, Adeel] Chungnam Natl Univ, Dept Microbiol & Mol Biol, Daejeon, South Korea; [Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Lee, Yong Ho] Catholic Univ Daegu, Dept Biomed Sci, Gyongsan, South Korea; [Park, So-Young] Yeungnam Univ, Coll Med, Dept Physiol, Daegu, South Korea	Yeungnam University; Chungnam National University; Kyungpook National University; Catholic University of Daegu; Yeungnam University	Choi, I (corresponding author), Yeungnam Univ, Dept Med Biotechnol, 280 Daehak Ro, Gyongsan 38541, South Korea.	inhochoi@ynu.ac.kr	Lee, In-Kyu/AAR-6374-2021; Ahmad, Khurshid/M-4676-2014; Rabbani, Gulam/AAE-5629-2022; Park, So-Young/AAC-5528-2022; Malik, Adeel/ABD-4831-2020; Jan, Arif Tasleem/AAX-6531-2020	Ahmad, Khurshid/0000-0002-1095-8445; Rabbani, Gulam/0000-0002-5293-8231; Park, So-Young/0000-0002-6018-0440; Malik, Adeel/0000-0002-3453-6001; Jan, Arif Tasleem/0000-0002-3607-543X; Baig, Mohd Hassan/0000-0001-8227-4838	National Research Foundation (NRF) of Korea - Ministry of Education [2016R1C1B1011478]; Gyeongsangbuk-Do and Gyeongbuk Science & Technology Promotion Center of Korea [SF316001A]	National Research Foundation (NRF) of Korea - Ministry of Education; Gyeongsangbuk-Do and Gyeongbuk Science & Technology Promotion Center of Korea	This work was supported, in part, by the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education (2016R1C1B1011478), and by the Creative Economy Leading Technology Development Program through the Gyeongsangbuk-Do and Gyeongbuk Science & Technology Promotion Center of Korea (SF316001A). The authors declare no conflicts of interest.	Afanasyeva MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098349; Ahmad S, 2017, LIFE SCI, V172, P55, DOI 10.1016/j.lfs.2016.12.011; Baig MH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06067-5; Bentzinger CF, 2013, EMBO REP, V14, P1062, DOI 10.1038/embor.2013.182; Bi PP, 2016, ELIFE, V5, DOI 10.7554/eLife.17355; Chang NC, 2014, CURR TOP DEV BIOL, V107, P161, DOI 10.1016/B978-0-12-416022-4.00006-8; Corda D, 2009, J BIOL CHEM, V284, P24848, DOI 10.1074/jbc.M109.035444; Deleersnijder W, 1996, J BIOL CHEM, V271, P19475, DOI 10.1074/jbc.271.32.19475; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Dumon NA, 2015, DEVELOPMENT, V142, P1572, DOI 10.1242/dev.114223; Gonzalez-Freire M, 2017, J CACHEXIA SARCOPENI, V8, P5, DOI 10.1002/jcsm.12121; Hsueh W, 2007, CIRC RES, V100, P1415, DOI 10.1161/01.RES.0000266449.37396.1f; Jan AT, 2016, INT J BIOCHEM CELL B, V80, P66, DOI 10.1016/j.biocel.2016.09.023; Kalamajski S, 2007, J BIOL CHEM, V282, P26740, DOI 10.1074/jbc.M704026200; Kalamajski S, 2016, J BIOL CHEM, V291, P7951, DOI 10.1074/jbc.M115.693408; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kim DS, 2015, BIOCHEM BIOPH RES CO, V459, P534, DOI 10.1016/j.bbrc.2015.02.144; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Le Grand F, 2007, DEVELOPMENT, V134, P3953, DOI 10.1242/dev.005934; Lee EJ, 2016, FASEB J, V30, P2708, DOI 10.1096/fj.201500133R; Lee EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079780; Lee EJ, 2012, GENES GENOM, V34, P133, DOI 10.1007/s13258-011-0096-z; Matukumalli SR, 2017, SCI REP-UK, V7, DOI 10.1038/srep41235; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Namkoong S, 2015, AUTOPHAGY, V11, P756, DOI 10.1080/15548627.2015.1034412; Pasut A, 2016, CELL REP, V16, P333, DOI 10.1016/j.celrep.2016.06.001; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Rudnicki MA, 2008, COLD SH Q B, V73, P323, DOI 10.1101/sqb.2008.73.064; Scime A, 2010, MECH AGEING DEV, V131, P9, DOI 10.1016/j.mad.2009.11.001; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Su G, 2010, BIOINFORMATICS, V26, P3135, DOI 10.1093/bioinformatics/btq596; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Wallin R, 2000, THROMB HAEMOSTASIS, V84, P1039; Wang YX, 2014, J CELL SCI, V127, P4543, DOI 10.1242/jcs.151209; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wilson MR, 2017, EXPERT OPIN THER TAR, V21, P201, DOI 10.1080/14728222.2017.1267142; Yanaka N, 2003, J BIOL CHEM, V278, P43595, DOI 10.1074/jbc.M302867200; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200; Zhang F, 2015, BIOCHEM BIOPH RES CO, V458, P375, DOI 10.1016/j.bbrc.2015.01.120; Zheng Z, 2015, J AM COLL SURGEONS, V221, pE35, DOI 10.1016/j.jamcollsurg.2015.08.391; Zheng Z, 2016, AM J PATHOL, V186, P2824, DOI 10.1016/j.ajpath.2016.07.023; Zheng Z, 2012, BIOMATERIALS, V33, P5821, DOI 10.1016/j.biomaterials.2012.04.049	47	30	30	3	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					768	781		10.1096/fj.201700665R	http://dx.doi.org/10.1096/fj.201700665R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28974563	Green Submitted			2022-12-26	WOS:000425146900020
J	Esteso, G; Guerra, S; Vales-Gomez, M; Reyburn, HT				Esteso, Gloria; Guerra, Susana; Vales-Gomez, Mar; Reyburn, Hugh T.			Innate immune recognition of double-stranded RNA triggers increased expression of NKG2D ligands after virus infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellular immune response; double-stranded RNA (dsRNA); natural killer cells (NK cells); pattern recognition receptor (PRR); virus; NKG2D; NKG2D ligands; dsRNA; self; non-self-discrimination; virus infection	NATURAL CYTOTOXICITY RECEPTORS; PARAMYXOVIRUS V-PROTEINS; RIG-I; HUMAN CYTOMEGALOVIRUS; HUMAN FIBROBLASTS; HELICASE LGP2; CELLS; VIRULENCE; PATHWAYS; TARGETS	Self/non-self-discrimination by the innate immune system relies on germline-encoded, non-rearranging receptors expressed by innate immune cells recognizing conserved pathogen-associated molecular patterns. The natural killer group 2D (NKG2D) receptor is a potent immune-activating receptor that binds human genome-encoded ligands, whose expression is negligible in normal tissues, but increased in stress and disease conditions for reasons that are incompletely understood. Here it is not clear how the immune system reconciles receptor binding of self-proteins with self/non-self-discrimination to avoid autoreactivity. We now report that increased expression of NKG2D ligands after virus infection depends on interferon response factors activated by the detection of viral double-stranded RNA by pattern-recognition receptors (RIG-I/MDA-5) and that NKG2D ligand up-regulation can be blocked by the expression of viral dsRNA-binding proteins. Thus, innate immunity-mediated recognition of viral nucleic acids triggers the infected cell to release interferon for NK cell recruitment and to express NKG2D ligands to become more visible to the immune system. Finally, the observation that NKG2D-ligand induction is a consequence of signaling by pattern-recognition receptors that have been selected over evolutionary time to be highly pathogen-specific explains how the risks of autoreactivity in this system are minimized.	[Esteso, Gloria; Vales-Gomez, Mar; Reyburn, Hugh T.] CSIC, Dept Immunol & Oncol, CNB, Madrid 28049, Spain; [Guerra, Susana] Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, Madrid 28029, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Autonomous University of Madrid	Reyburn, HT (corresponding author), CSIC, Dept Immunol & Oncol, CNB, Madrid 28049, Spain.	htreyburn@cnb.csic.es	Valés-Gómez, Mar/F-5351-2012; Vales-Gomez, Mar/ABG-7808-2020	Valés-Gómez, Mar/0000-0001-7424-3206; Vales-Gomez, Mar/0000-0001-7424-3206; Esteso Tornero, Gloria/0000-0001-6162-013X	Fondo de Investigacion Sanitaria (FIS) [PI11/00298, PS09/00181]; Ministerio de Economia y Competividad (MINECO) [SAF2012-32293, SAF2014-54623, SAF2014-58752-R, SAF2015-69169-R]; Comunidad de Madrid [S2010/BMD-2326]	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Ministerio de Economia y Competividad (MINECO); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by Fondo de Investigacion Sanitaria (FIS) Grants PI11/00298 and PS09/00181, Ministerio de Economia y Competividad (MINECO) Grants SAF2012-32293, SAF2014-54623, SAF2014-58752-R, and SAF2015-69169-R, and Comunidad de Madrid Grant S2010/BMD-2326. The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez-Breckenridge CA, 2012, NAT MED, V18, P1827, DOI 10.1038/nm.3013; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Bahar MW, 2011, J STRUCT BIOL, V175, P127, DOI 10.1016/j.jsb.2011.03.010; Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; BOONE RF, 1979, J VIROL, V30, P365, DOI 10.1128/JVI.30.1.365-374.1979; Cham CM, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/780436; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; Childs K, 2007, VIROLOGY, V359, P190, DOI 10.1016/j.virol.2006.09.023; Childs K, 2012, J VIROL, V86, P3411, DOI 10.1128/JVI.06405-11; Chisholm SE, 2006, J VIROL, V80, P2225, DOI 10.1128/JVI.80.5.2225-2233.2006; Chisholm SE, 2007, J INFECT DIS, V195, P1160, DOI 10.1086/512862; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; Esteso G, 2014, J IMMUNOL, V193, P1344, DOI 10.4049/jimmunol.1303441; Everett RD, 2008, J VIROL, V82, P8871, DOI 10.1128/JVI.00613-08; Ferguson BJ, 2013, J GEN VIROL, V94, P2070, DOI 10.1099/vir.0.054114-0; Fernandez-Messina L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00299; Gowen BG, 2015, ELIFE, V4, DOI 10.7554/eLife.08474; Greene TT, 2016, ELIFE, V5, DOI 10.7554/eLife.14749; Guerra S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028677; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jarahian M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002195; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Lam AR, 2014, CANCER RES, V74, P2193, DOI 10.1158/0008-5472.CAN-13-1703; Liu RK, 2016, J VIROL, V90, P7864, DOI 10.1128/JVI.00869-16; Lopez-Pelaez M, 2014, P NATL ACAD SCI USA, V111, P17432, DOI 10.1073/pnas.1418399111; Lopez-Soto A, 2009, ONCOGENE, V28, P2370, DOI 10.1038/onc.2009.117; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McSharry BP, 2001, J GEN VIROL, V82, P855, DOI 10.1099/0022-1317-82-4-855; Nachmani D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5186; Nanbakhsh A, 2014, BLOOD, V123, P3585, DOI 10.1182/blood-2013-11-536219; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Ribaudo Randall, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1011s04; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Uccellini L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-170; Unterholzner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002247; Vales-Gomez M, 2006, CELL MICROBIOL, V8, P581, DOI 10.1111/j.1462-5822.2005.00645.x; Van Belle TL, 2009, MOL IMMUNOL, V47, P8, DOI 10.1016/j.molimm.2009.02.023; Wen F, 2011, AUTOIMMUNITY, V44, P82, DOI 10.3109/08916934.2010.491842	47	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20472	20480		10.1074/jbc.M117.818393	http://dx.doi.org/10.1074/jbc.M117.818393			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	28986447	hybrid, Green Published			2022-12-26	WOS:000418267000011
J	Lee, YK; Lim, JJ; Jeoun, UW; Min, S; Lee, EB; Kwon, SM; Lee, C; Yoon, G				Lee, Young-Kyoung; Lim, Jin J.; Jeoun, Un-woo; Min, Seongki; Lee, Eun-beom; Kwon, So Mee; Lee, Changhan; Yoon, Gyesoon			Lactate-mediated mitoribosomal defects impair mitochondrial oxidative phosphorylation and promote hepatoma cell invasiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell invasion; hepatocellular carcinoma; mitochondrial metabolism; mitochondrial respiratory chain complex; ribosome	HUMAN BREAST-CANCER; TUMOR MICROENVIRONMENT; LARGE SUBUNIT; EXPRESSION; GENE; DNA; DYSFUNCTION; METABOLISM; RIBOSOME; DEHYDROGENASE	Impaired mitochondrial oxidative phosphorylation (OXPHOS) capacity, accompanied by enhanced glycolysis, is a key metabolic feature of cancer cells, but its underlying mechanism remains unclear. Previously, we reported that human hepatoma cells that harbor OXPHOS defects exhibit high tumor cell invasiveness via elevated claudin-1 (CLN1). In the present study, we show that OXPHOS-defective hepatoma cells (SNU354 and SNU423 cell lines) exhibit reduced expression of mitochondrial ribosomal protein L13 (MRPL13), a mitochondrial ribosome (mitoribosome) subunit, suggesting a ribosomal defect. Specific inhibition of mitoribosomal translation by doxycycline, chloramphenicol, or siRNA-mediated MRPL13 knockdown decreased mitochondrial protein expression, reduced oxygen consumption rate, and increased CLN1-mediated tumor cell invasiveness in SNU387 cells, which have active mitochondria. Interestingly, we also found that exogenous lactate treatment suppressed MRPL13 expression and oxygen consumption rate and induced CLN1 expression. A bioinformatic analysis of the open RNA-Seq database from The Cancer Genome Atlas (TCGA) liver hepatocellular carcinoma (LIHC) cohort revealed a significant negative correlation between MRPL13 and CLN1 expression. Moreover, in patients with low MRPL13 expression, two oxidative metabolic indicators, pyruvate dehydrogenase B expression and the ratio of lactate dehydrogenase type B to type A, significantly and negatively correlated with CLN1 expression, indicating that the combination of elevated glycolysis and deficient MRPL13 activity was closely linked to CLN1-mediated tumor activity in LIHC. These results suggest that OXPHOS defects may be initiated and propagated by lactate-mediated mitoribosomal deficiencies and that these deficiencies are critically involved in LIHC development.	[Lee, Young-Kyoung; Lim, Jin J.; Jeoun, Un-woo; Min, Seongki; Lee, Eun-beom; Kwon, So Mee; Yoon, Gyesoon] Ajou Univ, Sch Med, Dept Biochem, Suwon 16499, South Korea; [Jeoun, Un-woo; Min, Seongki; Lee, Eun-beom; Yoon, Gyesoon] Ajou Univ, Sch Med, Dept Biomed Sci, Suwon 16499, South Korea; [Lee, Changhan] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA 90089 USA	Ajou University; Ajou University; University of Southern California	Yoon, G (corresponding author), Ajou Univ, Sch Med, Dept Biochem, Suwon 16499, South Korea.	ypeace@ajou.ac.kr		LIM, Jin J./0000-0003-0616-5183	National Research Foundation of Korea from the Korean Ministry of Science, ICT and Future Planning [2015R1A2A1A10055038]; NATIONAL INSTITUTE ON AGING [R01AG052558] Funding Source: NIH RePORTER	National Research Foundation of Korea from the Korean Ministry of Science, ICT and Future Planning; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Research Foundation of Korea Grant 2015R1A2A1A10055038 from the Korean Ministry of Science, ICT and Future Planning. The authors declare that they have no conflicts of interest with the contents of this article.	ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Baracca A, 2010, BBA-BIOENERGETICS, V1797, P314, DOI 10.1016/j.bbabio.2009.11.006; Byun HO, 2012, EXP CELL RES, V318, P1808, DOI 10.1016/j.yexcr.2012.04.012; Chandra D, 2011, BBA-BIOENERGETICS, V1807, P620, DOI 10.1016/j.bbabio.2010.10.023; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; D'Andrea A, 2016, ONCOTARGET, V7, P72415, DOI 10.18632/oncotarget.11719; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Drent M, 1996, EUR RESPIR J, V9, P1736, DOI 10.1183/09031936.96.09081736; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatza ML, 2014, NAT GENET, V46, P1051, DOI 10.1038/ng.3073; Gopisetty G, 2016, GENE, V589, P27, DOI 10.1016/j.gene.2016.05.008; Greber BJ, 2016, ANNU REV BIOCHEM, V85, P103, DOI 10.1146/annurev-biochem-060815-014343; Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872; Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895; GROHMANN L, 1994, CURR GENET, V26, P8, DOI 10.1007/BF00326298; Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402; He XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061677; Hung WY, 2012, BBA-GEN SUBJECTS, V1820, P1102, DOI 10.1016/j.bbagen.2012.04.016; Kim JH, 2011, AUTOPHAGY, V7, P1187, DOI 10.4161/auto.7.10.16643; Kim JH, 2011, EXP CELL RES, V317, P1108, DOI 10.1016/j.yexcr.2011.02.011; KOIKE K, 1990, P NATL ACAD SCI USA, V87, P5594, DOI 10.1073/pnas.87.15.5594; Lee C, 2016, FREE RADICAL BIO MED, V100, P182, DOI 10.1016/j.freeradbiomed.2016.05.015; Lee J, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000380; Lee YK, 2015, HEPATOLOGY, V62, P1174, DOI 10.1002/hep.27976; Lee YK, 2013, MOL CELLS, V35, P489, DOI 10.1007/s10059-013-2343-4; Li XN, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/863564; Ma JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064912; Modica-Napolitano JS, 2004, MITOCHONDRION, V4, P755, DOI 10.1016/j.mito.2004.07.027; Nishikawa M, 2001, CANCER RES, V61, P1843; Peng SH, 2011, BREAST CANCER RES TR, V127, P309, DOI 10.1007/s10549-011-1459-5; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; PIETROMONACO SF, 1991, BIOCHIMIE, V73, P827, DOI 10.1016/0300-9084(91)90062-6; Rattigan YL, 2012, EXP CELL RES, V318, P326, DOI 10.1016/j.yexcr.2011.11.014; Rudrabhatla SR, 2006, J INVEST DERMATOL, V126, P1378, DOI 10.1038/sj.jid.5700255; Singh AK, 2014, MITOCHONDR DNA, V25, P329, DOI 10.3109/19401736.2013.796520; Sotgia F, 2012, CELL CYCLE, V11, P4390, DOI 10.4161/cc.22777; Tang XH, 2012, CANCER RES, V72, P491, DOI 10.1158/0008-5472.CAN-11-2076; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Wazir U, 2012, ANTICANCER RES, V32, P671; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753	41	34	35	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20208	20217		10.1074/jbc.M117.809012	http://dx.doi.org/10.1074/jbc.M117.809012			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	28978646	Green Published, hybrid			2022-12-26	WOS:000417696400025
J	Ahn, DH; Lee, KY; Lee, SJ; Park, SJ; Yoon, HJ; Kim, SJ; Lee, BJ				Ahn, Do-Hwan; Lee, Ki-Young; Lee, Sang Jae; Park, Sung Jean; Yoon, Hye-Jin; Kim, Soon-Jong; Lee, Bong-Jin			Structural analyses of the MazEF4 toxin-antitoxin pair in Mycobacterium tuberculosis provide evidence for a unique extracellular death factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; nuclear magnetic resonance (NMR); protein structure; quorum sensing; X-ray crystallography; MazEF system; extracellular death factor; toxin-antitoxin system	MEDIATED CELL-DEATH; MESSENGER-RNA INTERFERASES; ESCHERICHIA-COLI; PROTEIN; SYSTEMS; MAZF; FEATURES; VISUALIZATION; ENDONUCLEASE; CONSERVATION	The bacterial toxin-antitoxin MazEF system in the tuberculosis (TB)-causing bacterium Mycobacterium tuberculosis is activated under unfavorable conditions, including starvation, antibiotic exposure, and oxidative stress. This system contains the ribonucleolytic enzyme MazF and has emerged as a promising drug target for TB treatments targeting the latent stage of M. tuberculosis infection and reportedly mediates a cell death process via a peptide called extracellular death factor (EDF). Although it is well established that the increase in EDF-mediated toxicity of MazF drives a cell-killing phenomenon, the molecular details are poorly understood. Moreover, the divergence in sequences among reported EDFs suggests that each bacterial species has a unique EDF. To address these open questions, we report here the structures of MazF4 and MazEF4 complexes from M. tuberculosis, representing the first MazEF structures from this organism. We found that MazF4 possesses a negatively charged MazE4-binding pocket in contrast to the positively charged MazE-binding pockets in homologous MazEF complex structures from other bacteria. Moreover, using NMR spectroscopy and biochemical assays, we unraveled the molecular interactions of MazF4 with its RNA substrate and with a new EDF homolog originating from M. tuberculosis. The EDF homolog discovered here possesses a positively charged residue at the C terminus, making this EDF distinct from previously reported EDFs. Overall, our results suggest that M. tuberculosis evolved a unique MazF and EDF and that the distinctive EDF sequence could serve as a starting point for designing new anti-tuberculosis drugs. We therefore conclude that this study might contribute to the development of a new line of anti-tuberculosis agents.	[Ahn, Do-Hwan; Lee, Ki-Young; Lee, Sang Jae; Lee, Bong-Jin] Seoul Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, Seoul 151742, South Korea; [Park, Sung Jean] Gachon Univ, Coll Pharm, 534-2 Yeonsu Dong, Incheon, South Korea; [Yoon, Hye-Jin] Seoul Natl Univ, Coll Nat Sci, Dept Biophys & Chem Biol, Seoul 151742, South Korea; [Kim, Soon-Jong] Mokpo Natl Univ, Dept Chem, Chungnam 534729, South Korea	Seoul National University (SNU); Gachon University; Seoul National University (SNU); Mokpo National University	Lee, BJ (corresponding author), Seoul Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, Seoul 151742, South Korea.	lbj@nmr.snu.ac.kr	Lee, Sang Jae/AAX-7611-2021; Lee, Bong-Jin/AAQ-1609-2020	Lee, Sang Jae/0000-0002-5366-2900; Lee, Bong-Jin/0000-0001-7896-2961	National Research Foundation of Korea grants - Korean government [2015R1A2A1A05001894, 2014K1A3A1A19067618]; Korea Healthcare Technology R&D Project, Ministry for Health & Welfare, Republic of Korea [A092006]; BK21plus Project for Medicine, Dentistry and Pharmacy	National Research Foundation of Korea grants - Korean government; Korea Healthcare Technology R&D Project, Ministry for Health & Welfare, Republic of Korea; BK21plus Project for Medicine, Dentistry and Pharmacy	This work was supported by National Research Foundation of Korea grants funded by the Korean government 2015R1A2A1A05001894 and 2014K1A3A1A19067618, Korea Healthcare Technology R&D Project, Ministry for Health & Welfare, Republic of Korea Grant A092006, and 2016 BK21plus Project for Medicine, Dentistry and Pharmacy. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Belitsky M, 2011, MOL CELL, V41, P625, DOI 10.1016/j.molcel.2011.02.023; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chen R, 2017, BIOCHEM BIOPH RES CO, V486, P804, DOI 10.1016/j.bbrc.2017.03.132; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diago-Navarro E, 2010, FEBS J, V277, P3097, DOI 10.1111/j.1742-4658.2010.07722.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Harding S. E., 1992, ANAL ULTRACENTRIFUGA; Hargreaves D, 2002, STRUCTURE, V10, P1425, DOI 10.1016/S0969-2126(02)00856-0; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Hazan R, 2004, MOL GENET GENOMICS, V272, P227, DOI 10.1007/s00438-004-1048-y; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Hoffer ED, 2017, J BIOL CHEM, V292, P7718, DOI 10.1074/jbc.M117.779306; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kolodkin-Gal A, 2008, J BACTERIOL, V190, P3169, DOI 10.1128/JB.01918-07; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar S, 2016, MBIO, V7, DOI 10.1128/mBio.02034-15; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sala A, 2014, TOXINS, V6, P1002, DOI 10.3390/toxins6031002; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; Schluger NW, 2013, SEMIN RESP CRIT CARE, V34, P60, DOI 10.1055/s-0032-1333545; Schuster CF, 2013, FEMS MICROBIOL LETT, V340, P73, DOI 10.1111/1574-6968.12074; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Simanshu DK, 2013, MOL CELL, V52, P447, DOI 10.1016/j.molcel.2013.09.006; Singh KK, 2005, INFECT IMMUN, V73, P5004, DOI 10.1128/IAI.73.8.5004-5014.2005; Suzuki M, 2005, MOL CELL, V18, P253, DOI 10.1016/j.molcel.2005.03.011; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Verma S, 2015, J BIOMOL STRUCT DYN, V33, P606, DOI 10.1080/07391102.2014.899924; Wang NR, 2007, ANAL BIOCHEM, V371, P173, DOI 10.1016/j.ab.2007.07.017; WL D, 2002, PYMOL MOL GRAPHICS S; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Zhu L, 2008, MOL MICROBIOL, V69, P559, DOI 10.1111/j.1365-2958.2008.06284.x; Zhu L, 2006, J BIOL CHEM, V281, P18638, DOI 10.1074/jbc.M512693200; Zorzini V, 2016, J BIOL CHEM, V291, P10950, DOI 10.1074/jbc.M116.715912; Zorzini V, 2014, NUCLEIC ACIDS RES, V42, P6709, DOI 10.1093/nar/gku266	53	18	18	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18832	18847		10.1074/jbc.M117.807974	http://dx.doi.org/10.1074/jbc.M117.807974			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972145	Green Published, hybrid			2022-12-26	WOS:000415848000010
J	Inomata, T; Mashaghi, A; Hong, JX; Nakao, T; Dana, R				Inomata, Takenori; Mashaghi, Alireza; Hong, Jiaxu; Nakao, Takeshi; Dana, Reza			Scaling and maintenance of corneal thickness during aging	PLOS ONE			English	Article							DRY EYE DISEASE; ULTRASOUND PACHYMETRY; BODY-SIZE; ORGAN SIZE; PREVALENCE; ANATOMY; PROFILE; MICE	Corneal thickness is tightly regulated by its boundary endothelial and epithelial layers. The regulated set-point of corneal thickness likely shows inter-individual variations, changes by age, and response to stress. Using anterior segment-optical coherence tomography, we measure murine central corneal thickness and report on body size scaling of murine central corneal thickness during aging. For aged-matched mice, we find that corneal thickness depends on sex and strain. To shed mechanistic insights into these anatomical changes, we measure epithelial layer integrity and endothelial cell density during the life span of the mice using corneal fluorescein staining and in vivo confocal microscopy, respectively and compare their trends with that of the corneal thickness. Cornea thickness increases initially (1 month: 114.7 +/- 3.0 mu m, 6 months: 126.3 +/- 1.6 mu m), reaches a maximum (9 months: 129.3 +/- 4.4 mu m) and then reduces (12 months: 127 +/- 2.9 mu m, 13 months: 119.5 +/- 7.6 mu m, 14 months: 110.6 +/- 10.6 mu m), while the body size (weight) increases with age. We find that endothelial cell density reduces from 2 months old to 8 months old as the mice age and epithelial layer accumulates damages within this time frame. Finally, we compare murine corneal thickness with those of several other mammals including humans and show that corneal thickness has an allometric scaling with body size. Our results have relevance for organ size regulation, translational pharmacology, and veterinary medicine.	[Inomata, Takenori; Mashaghi, Alireza; Hong, Jiaxu; Nakao, Takeshi; Dana, Reza] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02115 USA; [Inomata, Takenori] Juntendo Univ, Fac Med, Dept Ophthalmol, Tokyo, Japan; [Mashaghi, Alireza] Leiden Univ, Fac Math & Nat Sci, Leiden Acad Ctr Drug Res, Leiden, Netherlands	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Juntendo University; Leiden University; Leiden University - Excl LUMC	Dana, R (corresponding author), Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02115 USA.	Reza_Dana@meei.harvard.edu	Inomata, Takenori/L-8210-2019; Mashaghi, Alireza/Q-8218-2017	Inomata, Takenori/0000-0003-3435-1055; Mashaghi, Alireza/0000-0002-2157-1211	National Institutes of Health [EY20889, EY12963]; NATIONAL EYE INSTITUTE [R01EY012963, R01EY020889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Institutes of Health grant EY20889 (RD) and National Institutes of Health grant EY12963 (RD).	Alario AF, 2014, VET OPHTHALMOL, V17, P207, DOI 10.1111/vop.12074; Bapodra P, 2010, J ZOO WILDLIFE MED, V41, P409, DOI 10.1638/2009-0018.1; Bekerman I, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/503645; Chen SH, 2012, ACTA OPHTHALMOL, V90, P449, DOI 10.1111/j.1755-3768.2010.01947.x; Chen Y, 2014, MUCOSAL IMMUNOL, V7, P38, DOI 10.1038/mi.2013.20; Chou TH, 2011, INVEST OPHTH VIS SCI, V52, P3604, DOI 10.1167/iovs.10-6340; Darveau CA, 2002, NATURE, V417, P166, DOI 10.1038/417166a; Das A, 2015, J ANIM PHYSIOL AN N, V99, P367, DOI 10.1111/jpn.12200; Den S, 2006, CORNEA, V25, P651, DOI 10.1097/01.ico.0000227889.11500.6f; Detweiler KB, 2017, J NUTR SCI, V6, DOI 10.1017/jns.2017.19; Doughty MJ, 1995, CAN J ZOOL, V73, P2159, DOI 10.1139/z95-253; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Faber C, 2008, SCAND J LAB ANIM SCI, V35, P39; GILGER BC, 1993, AM J VET RES, V54, P228; Giuseppe Longo MM, 2014, SCALING SCALE SYMMET, P23; Gomer RH, 2001, NAT REV MOL CELL BIO, V2, P48, DOI 10.1038/35048058; Han SB, 2013, INVEST OPHTH VIS SCI, V54, P6179, DOI 10.1167/iovs.13-12089; Haskell JP, 2002, NATURE, V418, P527, DOI 10.1038/nature00840; Howland HC, 2004, VISION RES, V44, P2043, DOI 10.1016/j.visres.2004.03.023; HYKIN PG, 1992, CORNEA, V11, P334, DOI 10.1097/00003226-199207000-00012; Launer KJ, 1996, AGE AGEING, V25, P300, DOI 10.1093/ageing/25.4.300; Lemp Michael A., 1995, CLAO Journal, V21, P221; Leung DYL, 2006, CLIN EXP OPHTHALMOL, V34, P751, DOI 10.1111/j.1442-9071.2006.01343.x; Li LY, 2006, J R SOC INTERFACE, V3, P303, DOI 10.1098/rsif.2005.0085; Lively GD, 2010, INVEST OPHTH VIS SCI, V51, P160, DOI 10.1167/iovs.09-3429; Nemesure B, 2003, ARCH OPHTHALMOL-CHIC, V121, P240; Puk O, 2013, MAMM GENOME, V24, P295, DOI 10.1007/s00335-013-9470-2; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Schaumberg DA, 2009, ARCH OPHTHALMOL-CHIC, V127, P763, DOI 10.1001/archophthalmol.2009.103; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; Shingleton AW., 2010, NAT ED KNOWL, V3, P2; Siemann E, 1996, NATURE, V380, P704, DOI 10.1038/380704a0; Song Ha Tae, 2007, Korean J Ophthalmol, V21, P163, DOI 10.3341/kjo.2007.21.3.163; Song J, 2003, INVEST OPHTH VIS SCI, V44, P548, DOI 10.1167/iovs.02-0592; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Stevens CF, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0123-7; Ueno Y, 2015, OPHTHALMOLOGY, V122, P1072, DOI 10.1016/j.ophtha.2015.01.021; Vaughan D, 2004, VAUGHAN ASBURYS GEN, pv; Wang XG, 2013, VET OPHTHALMOL, V16, P130, DOI 10.1111/j.1463-5224.2012.01041.x; West GB, 2003, NATURE, V421, P713, DOI 10.1038/421713a; Zheng YF, 2008, CORNEA, V27, P776, DOI 10.1097/ICO.0b013e31816f62d3	41	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0185694	10.1371/journal.pone.0185694	http://dx.doi.org/10.1371/journal.pone.0185694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ1QR	28985226	Green Published, gold, Green Submitted			2022-12-26	WOS:000412493000009
J	Bordas-Le Floch, V; Le Mignon, M; Bussieres, L; Jain, K; Martelet, A; Baron-Bodo, V; Nony, E; Mascarell, L; Moingeon, P				Bordas-Le Floch, Veronique; Le Mignon, Maxime; Bussieres, Laetitia; Jain, Karine; Martelet, Armelle; Baron-Bodo, Veronique; Nony, Emmanuel; Mascarell, Laurent; Moingeon, Philippe			A combined transcriptome and proteome analysis extends the allergome of house dust mite Dermatophagoides species	PLOS ONE			English	Article							GRASS-POLLEN; IDENTIFICATION; PTERONYSSINUS; RECONSTRUCTION; EXTRACTS; RHINITIS; GENOME; ASTHMA	Background House dust mites (HDMs) such as Dermatophagoides farinae and D. pteronyssinus represent major causes of perennial allergy. HDM proteomes are currently poorly characterized, with information mostly restricted to allergens. As of today, 33 distinct allergen groups have been identified for these 2 mite species, with groups 1 and 2 established as major allergens. Given the multiplicity of IgE-reactive mite proteins, potential additional allergens have likely been overlooked. Objective To perform a comprehensive characterization of the transcriptomes, proteomes and allergomes of D. farinae and D. pteronyssinus in order to identify novel allergens. Methods Transcriptomes were analyzed by RNA sequencing and de novo assembly. Comprehensive mass spectrometry-based analyses proteomes were combined with two-dimensional IgE reactivity profiling. Results Transcripts from D. farinae and D. pteronyssinus were assembled, translated into protein sequences and used to populate derived sequence databases in order to inform immunoproteomic analyses. A total of 527 and 157 proteins were identified by bottom-up MS analyses in aqueous extracts from purified HDM bodies and fecal pellets, respectively. Based on high sequence similarities (>71% identity), we also identified 2 partial and 11 complete putative sequences of currently undisclosed D. pteronyssinus counterparts of D. farinae registered allergens. Immunoprofiling on 2D-gels revealed the presence of unknown 23 kDa IgE reactive proteins in both species. Following expression of non-glycosylated recombinant forms of these molecules, we confirm that these new allergens react with serum IgEs from 42% (8/19) of HDM-allergic individuals. Conclusions Using combined transcriptome and immunoproteome approaches, we provide a comprehensive characterization of D. farinae and D. pteronyssinus allergomes. We expanded the known allergen repertoire for D. pteronyssinus and identified two novel HDM allergens, now officially referred by the International Union of Immunological Societies (IUIS) Nomenclature Subcommittee as Der f 36 and Der p 36.	[Bordas-Le Floch, Veronique; Le Mignon, Maxime; Bussieres, Laetitia; Jain, Karine; Martelet, Armelle; Baron-Bodo, Veronique; Nony, Emmanuel; Mascarell, Laurent; Moingeon, Philippe] Stallergenes Greer, Antony, France	Stallergenes Greer	Bordas-Le Floch, V (corresponding author), Stallergenes Greer, Antony, France.	veronique.bordas@stallergenesgreer.com		Martelet, Armelle/0000-0002-2348-4648; Nony, Emmanuel/0000-0003-1820-8881	Stallergenes Greer	Stallergenes Greer	This study was supported by Stallergenes Greer which provided support in the form of salaries for authors [VBLF, MLM, LB, KJ, AM, VBB, EN, LM, PM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other specific funding was received for this work. The specific roles of these authors are articulated in the 'author contributions' section.	An S, 2013, MOL CELL PROTEOMICS, V12, P1818, DOI 10.1074/mcp.M112.027136; Angus Aaron Chen, 2004, Am J Pharmacogenomics, V4, P357, DOI 10.2165/00129785-200404060-00003; Batard T, 2016, ALLERGY, V71, P220, DOI 10.1111/all.12796; Batard T, 2006, INT ARCH ALLERGY IMM, V140, P295, DOI 10.1159/000093707; Bessot J C, 2011, Eur Ann Allergy Clin Immunol, V43, P141; Bi XZ, 2004, MOL CELL PROTEOMICS, V3, pS203; Bordas-Le Floch V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136258; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Campbell BC, 2015, J ALLERGY CLIN IMMUN, V135, P133, DOI 10.1016/j.jaci.2014.06.034; Carnes J, 2017, ANN ALLERG ASTHMA IM, V118, P249, DOI 10.1016/j.anai.2016.08.018; Chan TF, 2015, J ALLERGY CLIN IMMUN, V135, P539, DOI 10.1016/j.jaci.2014.09.031; Choopong J, 2016, J PROTEOME RES, V15, P422, DOI 10.1021/acs.jproteome.5b00663; Cui Y, 2016, ALLERGY, V71, P1635, DOI 10.1111/all.12999; ElRamlawy KG, 2016, J BIOL CHEM, V291, P21607, DOI 10.1074/jbc.M116.728006; Erban T, 2014, EXP APPL ACAROL, V65, P73; Evans VC, 2012, NAT METHODS, V9, P1207, DOI [10.1038/nmeth.2227, 10.1038/NMETH.2227]; Fernandez-Caldas E, 2006, CURR ALLERGY ASTHM R, V6, P413, DOI 10.1007/s11882-996-0015-6; Fernandez-Caldas Enrique, 2008, Clin Allergy Immunol, V21, P161; Fujimura T, 2017, ALLERGY; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Kidon MI, 2011, PEDIAT ALLERG IMM-UK, V22, P202, DOI 10.1111/j.1399-3038.2010.01094.x; Matricardi PM, 2016, PEDIAT ALLERG IMM-UK, V27, P1, DOI 10.1111/pai.12563; Moingeon P, 2014, EXPERT REV VACCINES, V13, P1463, DOI 10.1586/14760584.2014.948861; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mueller GA, 2016, CLIN EXP ALLERGY, V46, P365, DOI 10.1111/cea.12680; Pittner G, 2004, CLIN EXP ALLERGY, V34, P597, DOI 10.1111/j.1365-2222.2004.1930.x; Pomes A, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0622-9; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Resch Y, 2015, J ALLERGY CLIN IMMUN, V136, P1083, DOI 10.1016/j.jaci.2015.03.024; Rider SD, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1198-2; Schulten V, 2013, P NATL ACAD SCI USA, V110, P3459, DOI 10.1073/pnas.1300512110; Spiric J, 2017, CLIN EXP ALLERGY, V47, P604, DOI 10.1111/cea.12931; Thomas WR, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0649-y; Thomas WR, 2015, ALLERGOL INT, V64, P304, DOI 10.1016/j.alit.2015.05.004; Thomas WR, 2010, ASIAN PAC J ALLERGY, V28, P211; Thomas WR, 2002, INT ARCH ALLERGY IMM, V129, P1, DOI 10.1159/000065179; Trombone APF, 2002, CLIN EXP ALLERGY, V32, P1323, DOI 10.1046/j.1365-2745.2002.01455.x; Weghofer M, 2008, EUR J CLIN INVEST, V38, P959, DOI 10.1111/j.1365-2362.2008.02048.x; Weghofer M, 2005, CLIN EXP ALLERGY, V35, P1384, DOI 10.1111/j.1365-2222.2005.02345.x; Weghofer M, 2013, J IMMUNOL, V190, P3059, DOI 10.4049/jimmunol.1202288	41	20	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185830	10.1371/journal.pone.0185830	http://dx.doi.org/10.1371/journal.pone.0185830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982170	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300073
J	Engelen, T; Watson, R; Pavani, F; de Gelder, B				Engelen, Tahnee; Watson, Rebecca; Pavani, Francesco; de Gelder, Beatrice			Affective vocalizations influence body ownership as measured in the rubber hand illusion	PLOS ONE			English	Article							EMOTION; EXCITABILITY; STIMULI; CAPTURE; THREAT; TOUCH	Emotional signals, like threatening sounds, automatically ready the perceiver to prepare an appropriate defense behavior. Conjecturing that this would manifest itself in extending the safety zone around the body we used the rubber hand illusion (RHI) to test this prediction. The RHI is a perceptual illusion in which body ownership is manipulated by synchronously stroking a rubber hand and real hand occluded from view. Many factors, both internal and external, have been shown to influence the strength of the illusion, yet the effect of emotion perception on body ownership remains unexplored. We predicted that listening to affective vocalizations would influence how strongly participants experience the RHI. In the first experiment four groups were tested that listened either to affective sounds (angry or happy vocalizations), non-vocal sounds or no sound while undergoing synchronous or asynchronous stroking of the real and rubber hand. In a second experiment three groups were tested comparing angry or neutral vocalizations and no sound condition. There was a significantly larger drift towards the rubber hand in the emotion versus the no emotion conditions. We interpret these results in the framework that the spatial increase in the RHI indicates that under threat the body has the capacity to extend its safety zone.	[Engelen, Tahnee; Watson, Rebecca; de Gelder, Beatrice] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Pavani, Francesco] Univ Trento, Dept Psychol & Cognit Sci, Trento, Italy	Maastricht University; University of Trento	de Gelder, B (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.	b.degelder@maastrichtuniversity.nl	Engelen, Tahnée/Q-3615-2019	Engelen, Tahnée/0000-0001-9285-8968	European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC Grant [295673]; Teaching Staff Mobility fellowship - LPP/Erasmus program [2013-1-IT2-ERA02-53126]	European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC Grant(European Research Council (ERC)); Teaching Staff Mobility fellowship - LPP/Erasmus program	TE, RW and BdG are supported by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement number 295673. FP was supported by a Teaching Staff Mobility fellowship funded by the LPP/Erasmus program (2013-1-IT2-ERA02-53126).	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Banissy MJ, 2010, J NEUROSCI, V30, P13552, DOI 10.1523/JNEUROSCI.0786-10.2010; Belin P, 2008, BEHAV RES METHODS, V40, P531, DOI 10.3758/BRM.40.2.531; Borgomaneri S, 2015, CORTEX, V65, P232, DOI 10.1016/j.cortex.2015.01.014; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; de Vignemont F, 2017, SUBJECTS MATTER BODI; Engelen T, 2015, CORTEX, V73, P195, DOI 10.1016/j.cortex.2015.08.013; Flogel M, 2016, PSYCHOL RES-PSYCH FO, V80, P298, DOI 10.1007/s00426-015-0650-4; Gonzalez-Franco M, 2014, EXP BRAIN RES, V232, P875, DOI 10.1007/s00221-013-3800-1; Haans A, 2008, BODY IMAGE, V5, P389, DOI 10.1016/j.bodyim.2008.04.003; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P91, DOI 10.1111/j.1469-8986.2006.00487.x; IJsselsteijn WA, 2006, PRESENCE-TELEOP VIRT, V15, P455, DOI 10.1162/pres.15.4.455; in 't Veld EMJH, 2014, SOC NEUROSCI-UK, V9, P249, DOI 10.1080/17470919.2014.890668; Keil A, 2007, COGN AFFECT BEHAV NE, V7, P18, DOI 10.3758/CABN.7.1.18; Komeilipoor N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063060; Morgan HL, 2011, BIOL PSYCHIAT, V69, P35, DOI 10.1016/j.biopsych.2010.07.032; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Pavani F, 2007, PERCEPTION, V36, P1547, DOI 10.1068/p5853; Roelofs K, 2010, PSYCHOL SCI, V21, P1575, DOI 10.1177/0956797610384746; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Schutter DJLG, 2008, PSYCHOPHYSIOLOGY, V45, P345, DOI 10.1111/j.1469-8986.2007.00635.x; Seth AK, 2013, TRENDS COGN SCI, V17, P565, DOI 10.1016/j.tics.2013.09.007; Sforza A, 2010, SOC NEUROSCI-UK, V5, P148, DOI 10.1080/17470910903205503; Tieri G, 2015, SCI REP-UK, V5, DOI 10.1038/srep17139; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2011, P ROY SOC B-BIOL SCI, V278, P2470, DOI 10.1098/rspb.2010.2547; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; van Loon AM, 2010, COGN AFFECT BEHAV NE, V10, P174, DOI 10.3758/CABN.10.2.174; Warren JE, 2006, J NEUROSCI, V26, P13067, DOI 10.1523/JNEUROSCI.3907-06.2006	31	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186009	10.1371/journal.pone.0186009	http://dx.doi.org/10.1371/journal.pone.0186009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28982176	Green Submitted, Green Published, gold			2022-12-26	WOS:000412360300106
J	Ingerslev, AK; Mutt, SJ; Laerke, HN; Hedemann, MS; Theil, PK; Nielsen, KL; Jorgensen, H; Herzig, KH; Knudsen, KEB				Ingerslev, Anne Krog; Mutt, Shivaprakash Jagalur; Laerke, Helle Nygaard; Hedemann, Mette Skou; Theil, Peter Kappel; Nielsen, Kirstine Lykke; Jorgensen, Henry; Herzig, Karl-Heinz; Knudsen, Knud Erik Bach			Postprandial PYY increase by resistant starch supplementation is independent of net portal appearance of short-chain fatty acids in pigs	PLOS ONE			English	Article							WHOLE-WHEAT GRAIN; PEPTIDE-YY; SMALL-INTESTINE; NEURAL REGULATION; RYE INGREDIENTS; DIETARY FIBER; GUT HORMONES; RELEASE; GLUCOSE; FERMENTATION	Increased dietary fiber (DF) fermentation and short-chain fatty acid (SCFA) production may stimulate peptide tyrosine-tyrosine (PYY) secretion. In this study, the effects of hindgut SCFA production on postprandial PYY plasma levels were assessed using different experimental diets in a porto-arterial catheterized pig model. The pigs were fed experimental diets varying in source and levels of DF for one week in 3x3 Latin square designs. The DF sources were whole-wheat grain, wheat aleurone, rye aleurone-rich flour, rye flakes, and resistant starch. Postprandial blood samples were collected from the catheters and analyzed for PYY levels and net portal appearance (NPA) of PYY was correlated to NPA of SCFA. No significant effects of diets on NPA of PYY were observed (P > 0.05), however, resistant starch supplementation increased postprandial NPA of PYY levels by 37 to 54% compared with rye-based and Western-style control diets (P = 0.19). This increase was caused by higher mesenteric artery and portal vein PYY plasma levels (P < 0.001) and was independent of SCFA absorption (P > 0.05). The PYY levels were higher in response to the second daily meal compared with the first daily meal (P < 0.001), but similar among diets (P > 0.10). In conclusion, the increased postprandial PYY responses in pigs fed with different levels and sources of DF are not caused by an increased SCFA absorption and suggest that other mechanisms such as neural reflexes and possibly an increased flow of digesta in the small intestine may be involved. The content of DF and SCFA production did not affect PYY levels.	[Ingerslev, Anne Krog; Laerke, Helle Nygaard; Hedemann, Mette Skou; Theil, Peter Kappel; Nielsen, Kirstine Lykke; Jorgensen, Henry; Knudsen, Knud Erik Bach] Aarhus Univ, Dept Anim Sci, Tjele, Denmark; [Mutt, Shivaprakash Jagalur; Herzig, Karl-Heinz] Univ Oulu, Dept Physiol, Res Unit Biomed, Oulu, Finland; [Mutt, Shivaprakash Jagalur; Herzig, Karl-Heinz] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Herzig, Karl-Heinz] Poznan Univ Med Sci, Dept Gastroenterol & Metab, Poznan, Poland; [Herzig, Karl-Heinz] Med Res Ctr, Oulu, Finland; [Herzig, Karl-Heinz] Univ Hosp, Oulu, Finland; [Nielsen, Kirstine Lykke] Aarhus Univ, Dept Forens Med, Forens Chem, Aarhus N, Denmark	Aarhus University; University of Oulu; University of Oulu; Poznan University of Medical Sciences; Aarhus University	Knudsen, KEB (corresponding author), Aarhus Univ, Dept Anim Sci, Tjele, Denmark.	KnudErik.Bach.Knudsen@anis.au.dk	Nielsen, Kirstine/ABE-4989-2020; Mutt, Shivaprakash Jagalur/AAC-9768-2019; Lærke, Helle Nygaard/D-9882-2011	Nielsen, Kirstine/0000-0002-5955-6156; Mutt, Shivaprakash Jagalur/0000-0001-8285-551X; Lærke, Helle Nygaard/0000-0002-0303-0745; Hedemann, Mette Skou/0000-0002-1164-4405; Ingerslev, Anne Krog/0000-0001-5151-9548	Danish Strategic Research Council [10-093526]; European Commission in the Communities Sixth Framework Programme, Project HEALTHGRAIN [FOOD-CT-2005-514008]	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); European Commission in the Communities Sixth Framework Programme, Project HEALTHGRAIN	The present research projects were financially supported by The Danish Strategic Research Council, project "Concepts for enhanced butyrate production to improve colonic health and insulin sensitivity ButColns" (Project No. 10-093526), and by the European Commission in the Communities Sixth Framework Programme, Project HEALTHGRAIN (FOOD-CT-2005-514008) to KEBK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam CL, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-36; ADRIAN TE, 1985, GASTROENTEROLOGY, V89, P1070, DOI 10.1016/0016-5085(85)90211-2; BECKH K, 1992, REGUL PEPTIDES, V37, P205, DOI 10.1016/0167-0115(92)90615-2; Boey D, 2007, PEPTIDES, V28, P390, DOI 10.1016/j.peptides.2006.07.031; Brouns F, 2002, TRENDS FOOD SCI TECH, V13, P251, DOI 10.1016/S0924-2244(02)00131-0; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cani PD, 2007, BRIT J NUTR, V98, P32, DOI 10.1017/S0007114507691648; Cherbut C, 1998, AM J PHYSIOL-GASTR L, V275, pG1415, DOI 10.1152/ajpgi.1998.275.6.G1415; Cho HJ, 2015, CELL TISSUE RES, V359, P693, DOI 10.1007/s00441-014-2033-3; Cuche G, 2000, AM J PHYSIOL-GASTR L, V279, pG925, DOI 10.1152/ajpgi.2000.279.5.G925; da Silva CS, 2014, ANIMAL, V8, P1402, DOI 10.1017/S1751731114001116; Freeland KR, 2010, BRIT J NUTR, V103, P460, DOI 10.1017/S0007114509991863; Gemen R, 2011, NUTR REV, V69, P22, DOI 10.1111/j.1753-4887.2010.00357.x; Habib AM, 2012, ENDOCRINOLOGY, V153, P3054, DOI 10.1210/en.2011-2170; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hooda S, 2010, J NUTR, V140, P1564, DOI 10.3945/jn.110.122721; Ingerslev AK, 2014, BRIT J NUTR, V111, P1564, DOI 10.1017/S0007114513004066; Juvonen KR, 2011, NUTR METAB CARDIOVAS, V21, P748, DOI 10.1016/j.numecd.2010.02.002; Juvonen KR, 2009, J NUTR, V139, P461, DOI 10.3945/jn.108.099945; Kaji I, 2011, J MOL HISTOL, V42, P27, DOI 10.1007/s10735-010-9304-4; Karhunen LJ, 2008, REGUL PEPTIDES, V149, P70, DOI 10.1016/j.regpep.2007.10.008; Karhunen LJ, 2010, J NUTR, V140, P737, DOI 10.3945/jn.109.115436; Keenan MJ, 2006, OBESITY, V14, P1523, DOI 10.1038/oby.2006.176; Keenan MJ, 2012, J NUTRIGENET NUTRIGE, V5, P26, DOI 10.1159/000335319; Le Gall M, 2009, BRIT J NUTR, V102, P1590, DOI 10.1017/S0007114509990924; Leonel AJ, 2012, CURR OPIN CLIN NUTR, V15, P474, DOI 10.1097/MCO.0b013e32835665fa; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Mortensen K, 2003, REGUL PEPTIDES, V114, P189, DOI 10.1016/S0167-0115(03)00125-3; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Nielsen TS, 2014, BRIT J NUTR, V112, P1837, DOI 10.1017/S000711451400302X; Nielsen TS, 2015, J AGR FOOD CHEM; Nilsson AC, 2015, BR J NUTR, P1; Psichas A, 2015, INT J OBESITY, V39, P424, DOI 10.1038/ijo.2014.153; Regmi PR, 2011, J NUTR, V141, P398, DOI 10.3945/jn.110.132449; Reimer RA, 2012, J PROTEOME RES, V11, P4065, DOI 10.1021/pr300487s; RERAT AA, 1984, BRIT J NUTR, V51, P517, DOI 10.1079/BJN19840057; Sandberg JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151985; SHEIKH SP, 1989, REGUL PEPTIDES, V26, P253, DOI 10.1016/0167-0115(89)90193-6; Slavin J, 2007, NUTR BULL, V32, P32, DOI 10.1111/j.1467-3010.2007.00603.x; Smith CE, 2011, NUTR RES REV, V24, P118, DOI 10.1017/S0954422411000023; Svendsen B, 2015, ENDOCRINOLOGY, V156, P847, DOI 10.1210/en.2014-1710; Theil PK, 2011, BRIT J NUTR, V105, P373, DOI 10.1017/S0007114510003715; van der Wielen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107531; Voortman T, 2012, J AGR FOOD CHEM, V60, P9035, DOI 10.1021/jf2045697; Wewer Albrechtsen Nicolai J, 2016, BMC Res Notes, V9, P60, DOI 10.1186/s13104-016-1872-2; ZHANG T, 1993, REGUL PEPTIDES, V48, P321, DOI 10.1016/0167-0115(93)90160-A; Zhou J, 2006, OBESITY, V14, P683, DOI 10.1038/oby.2006.77; Zhou J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1160, DOI 10.1152/ajpendo.90637.2008	48	14	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185927	10.1371/journal.pone.0185927	http://dx.doi.org/10.1371/journal.pone.0185927			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982156	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300090
J	Jia, LQ; Tu, TY; Huai, QQ; Sun, JW; Chen, SS; Li, X; Shi, ZP; Ding, J				Jia, Luqiang; Tu, Tingyong; Huai, Qiangqiang; Sun, Jiaowen; Chen, Shanshan; Li, Xin; Shi, Zhongping; Ding, Jian			Enhancing monellin production by Pichia pastoris at low cell induction concentration via effectively regulating methanol metabolism patterns and energy utilization efficiency	PLOS ONE			English	Article							HETEROLOGOUS PROTEIN EXPRESSION; PORCINE INTERFERON; SWEET; DEHYDROGENASE; FERMENTATION; PURIFICATION; PROMOTER; STRATEGY	In heterologous protein productions by P. pastoris, methanol induction is generally initiated when cell concentration reaches very high density. The alternative strategy by initiating methanol induction at lower cells concentration was also reported to be effective in easing DO control, reducing toxic by-metabolites accumulation and increasing targeted proteins titers. However, the methanol/energy regulation mechanisms are seldom reported. We theoretically analyzed the methanol/energy metabolisms in protein expression process with the strategies of initiating induction at higher or lower cells concentrations, using monellin production as a prototype. When initiating induction at lower cells concentration and controlling induction temperature at 30 degrees C, monellin concentration reached the highest levels of 2.62 similar to 2.71 g/L, which was 2.5 similar to 4.9 fold of those obtained with the strategy of initiating induction at higher cells concentration. With the desired induction strategy, 1) carbon metabolism ratio directing into the precursors synthesis route for monellin production reached the highest level of 65%, carbon metabolism ratios towards to precursors synthesis and ATP regeneration routes were regulated at relatively balanced levels; 2) monellin synthesis was completely cell growth associated, with the largest associated coefficient and higher specific growth rate; 3) theoretical NADH (energy) utilization efficiency. was the highest, and. stayed high levels (>= 0.8) during most period (89%) within induction phase to supply sufficient energy in supporting monellin synthesis.	[Jia, Luqiang; Tu, Tingyong; Huai, Qiangqiang; Sun, Jiaowen; Chen, Shanshan; Shi, Zhongping; Ding, Jian] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China; [Li, Xin] Wuhan Polytech Univ, Sch Biol & Pharmaceut Engn, Wuhan, Hubei, Peoples R China	Jiangnan University; Wuhan Polytechnic University	Shi, ZP; Ding, J (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China.	zpshi@jiangnan.edu.cn; dingjian@jiangnan.edu.cn	Shi, Zhongping/K-9884-2019	Jia, Luqiang/0000-0001-5738-2423	Natural Science Foundation of China [21606106]; Natural Science Foundation of Jiangsu Province [BK20150127, BK20160162]; 111 Project of China [111-2-06]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); 111 Project of China(Ministry of Education, China - 111 Project)	This work was supported by Natural Science Foundation of China (#21606106), Natural Science Foundation of Jiangsu Province (#BK20150127, #BK20160162) and the 111 Project (#111-2-06) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the financial supports by Natural Science Foundation of China (#21606106), Natural Science Foundation of Jiangsu Province (#BK20150127, #BK20160162) and the 111 Project (#111-2-06) of China.	Celik E, 2010, BIOTECHNOL BIOENG, V105, P317, DOI 10.1002/bit.22543; Cereghino GPL, 2002, CURR OPIN BIOTECH, V13, P329, DOI 10.1016/S0958-1669(02)00330-0; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Charoenrat T, 2005, BIOPROC BIOSYST ENG, V27, P399, DOI 10.1007/s00449-005-0005-4; Chen ZJ, 2007, APPL MICROBIOL BIOT, V73, P1377, DOI 10.1007/s00253-006-0609-x; Ding J, 2014, J CHEM TECHNOL BIOT, V89, P1948, DOI 10.1002/jctb.4281; Ding J, 2014, CHEM IND CHEM ENG Q, V20, P29, DOI 10.2298/CICEQ120704097D; Gao MJ, 2011, KOREAN J CHEM ENG, V28, P1412, DOI 10.1007/s11814-010-0527-6; Gunes H, 2016, J CHEM TECHNOL BIOT, V91, P664, DOI 10.1002/jctb.4619; Guo YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089264; Hong F, 2002, BIOTECHNOL BIOENG, V79, P438, DOI 10.1002/bit.10297; Jahic M, 2003, MICROB CELL FACT, V2, DOI 10.1186/1475-2859-2-6; Jia DX, 2013, BIOPROC BIOSYST ENG, V36, P1095, DOI 10.1007/s00449-012-0863-5; Jin H, 2011, APPL BIOCHEM BIOTECH, V165, P559, DOI 10.1007/s12010-011-9275-2; Jin H, 2010, BIOCHEM ENG J, V52, P91, DOI 10.1016/j.bej.2010.07.009; Jin S, 1995, J FERMENT BIOENG, V80, P541, DOI 10.1016/0922-338X(96)87729-4; Jungo C, 2007, J BIOTECHNOL, V131, P57, DOI 10.1016/j.jbiotec.2007.05.019; Lee CY, 2003, PROCESS BIOCHEM, V38, P1147, DOI 10.1016/S0032-9592(02)00280-7; Leone S, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0299-0; Liu J, 2014, J SCI FOOD AGR, V95, P2646; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Masuda T, 2006, J BIOSCI BIOENG, V102, P375, DOI 10.1263/jbb.102.375; MORRIS JA, 1972, BIOCHIM BIOPHYS ACTA, V261, P114, DOI 10.1016/0304-4165(72)90320-0; SCHUTTE H, 1976, EUR J BIOCHEM, V62, P151, DOI 10.1111/j.1432-1033.1976.tb10108.x; SUYE S, 1990, AGR BIOL CHEM TOKYO, V54, P1297, DOI 10.1080/00021369.1990.10870130; Temussi PA, 2002, FEBS LETT, V526, P1, DOI 10.1016/S0014-5793(02)03155-1; Wang F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120458; Wang HL, 2012, BIORESOURCE TECHNOL, V124, P338, DOI 10.1016/j.biortech.2012.08.027; Xu AC, 2011, CHINA BREWING, V2, P117	29	6	7	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184602	10.1371/journal.pone.0184602	http://dx.doi.org/10.1371/journal.pone.0184602			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981536	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300015
J	Mouthier, TMB; Kilic, B; Vervoort, P; Gruppen, H; Kabel, MA				Mouthier, Thibaut M. B.; Kilic, Baris; Vervoort, Pieter; Gruppen, Harry; Kabel, Mirjam A.			Potential of a gypsum-free composting process of wheat straw for mushroom production	PLOS ONE			English	Article							AQUEOUS-AMMONIA; ENZYMATIC-HYDROLYSIS; AGARICUS-BISPORUS; PRETREATMENT; LIGNIN; FERMENTATION; CONVERSION; PYROLYSIS; GROWTH; SUGARS	Wheat straw based composting generates a selective substrate for mushroom production. The first phase of this process requires 5 days, and a reduction in time is wished. Here, we aim at understanding the effect of gypsum on the duration of the first phase and the mechanism behind it. Hereto, the regular process with gypsum addition and the same process without gypsum were studied during a 5-day period. The compost quality was evaluated based on compost lignin composition analysed by py-GC/MS and its degradability by a commercial (hemi-) cellulolytic enzyme cocktail. The composting phase lead to the decrease of the pyrolysis products 4-vinylphenol and 4-vinylguaiacol that can be associated with p-coumarates and ferulates linking xylan and lignin. In the regular compost, the enzymatic conversion reached 32 and 39% for cellulose, and 23 and 32% for xylan after 3 and 5 days, respectively. In absence of gypsum similar values were reached after 2 and 4 days, respectively. Thus, our data show that in absence of gypsum the desired compost quality was reached 20% earlier compared to the control process.	[Mouthier, Thibaut M. B.; Kilic, Baris; Gruppen, Harry; Kabel, Mirjam A.] Wageningen Univ & Res, Lab Food Chem, Wageningen, Netherlands; [Vervoort, Pieter] CNC Grondstoffen BV, Milsbeek, Netherlands	Wageningen University & Research	Kabel, MA (corresponding author), Wageningen Univ & Res, Lab Food Chem, Wageningen, Netherlands.	mirjam.kabel@wur.nl	Kabel, Mirjam/M-1051-2016	Kabel, Mirjam/0000-0002-2787-7852	Netherlands Organisation for Scientific Research (NWO) [05324104]; Netherlands Organisation for Scientific Research (NWO)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The work described in this manuscript was performed at the Laboratory of Food Chemistry, Wageningen University, The Netherlands. TM, BK, GH and MK were financially supported by the Netherlands Organisation for Scientific Research (NWO) (grant number 05324104), C4C Holding BV (the Netherlands), Royal DSM and CNC holding, and DSM (The Netherlands). PV (C4C) helped in sample collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by The Netherlands Organisation for Scientific Research (NWO), Royal DSM and CNC holding.	Camarero S, 2001, J ANAL APPL PYROL, P58; Collins SRA, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0121-y; de Wild PJ, 2012, J ANAL APPL PYROL, V93, P95, DOI 10.1016/j.jaap.2011.10.002; del Rio JC, 2007, J ANAL APPL PYROL, V79, P39, DOI 10.1016/j.jaap.2006.09.003; del Rio JC, 2012, J AGR FOOD CHEM, V60, P5922, DOI 10.1021/jf301002n; ENGLYST HN, 1984, ANALYST, V109, P937, DOI 10.1039/an9840900937; Fincher GB, 2009, PLANT PHYSIOL, V149, P27, DOI 10.1104/pp.108.130096; Gerrits J. P. G., 1988, NUTR COMPOST CULTIVA, P206; Huyen TLN, 2010, BIORESOURCE TECHNOL, V101, P8224, DOI 10.1016/j.biortech.2010.05.087; IIYAMA K, 1994, APPL ENVIRON MICROB, V60, P1538, DOI 10.1128/AEM.60.5.1538-1546.1994; JONES D. B., 1931, U.S. Dept. Agric., Circular; Jurak E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138909; Jurak E, 2014, CARBOHYD POLYM, V101, P281, DOI 10.1016/j.carbpol.2013.09.050; Kim TH, 2005, APPL BIOCHEM BIOTECH, V121, P1119; Kjeldahl Johan Z., 1883, ANAL CHEM, V22, P366, DOI DOI 10.1007/BF01338151; KORMELINK FJM, 1993, CARBOHYD RES, V249, P355, DOI 10.1016/0008-6215(93)84100-K; Li XA, 2011, BIORESOURCE TECHNOL, V102, P4779, DOI 10.1016/j.biortech.2011.01.008; Liu ZG, 2013, BIORESOURCE TECHNOL, V135, P23, DOI 10.1016/j.biortech.2012.10.133; Maheshwari R, 2000, MICROBIOL MOL BIOL R, V64, P461, DOI 10.1128/MMBR.64.3.461-488.2000; Martinez AT, 2001, J ANAL APPL PYROL, V58, P401, DOI 10.1016/S0165-2370(00)00116-9; Martinez PM, 2016, BIORESOURCE TECHNOL, V216, P44, DOI 10.1016/j.biortech.2016.05.040; MILLER FC, 1991, AUST J EXP AGR, V31, P415, DOI 10.1071/EA9910415; Moretti MMS, 2012, BRAZ J MICROBIOL, V43, P1062, DOI [10.1590/S1517-83822012000300032, 10.1590/S1517-838220120003000032]; Pandey MP, 2011, CHEM ENG TECHNOL, V34, P29, DOI 10.1002/ceat.201000270; Prasad S, 2007, RESOUR CONSERV RECY, V50, P1, DOI 10.1016/j.resconrec.2006.05.007; RALPH J, 1991, J AGR FOOD CHEM, V39, P1426, DOI 10.1021/jf00008a014; Remond C, 2010, BIORESOURCE TECHNOL, V101, P6712, DOI 10.1016/j.biortech.2010.03.115; Sutton M.A, 2011, EUROPEAN NITROGEN AS, DOI DOI 10.1017/CBO9780511976988; Talebnia F, 2010, BIORESOURCE TECHNOL, V101, P4744, DOI 10.1016/j.biortech.2009.11.080; THIBAULT JF, 1979, LEBENSM WISS TECHNOL, V12, P247; Yang Q, 2010, J ANAL APPL PYROL, V87, P65, DOI 10.1016/j.jaap.2009.10.006; Yang Z, 2014, BIORESOURCE TECHNOL, V173, P198, DOI 10.1016/j.biortech.2014.09.109	32	7	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185901	10.1371/journal.pone.0185901	http://dx.doi.org/10.1371/journal.pone.0185901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982119	Green Submitted, gold, Green Published			2022-12-26	WOS:000412360300082
J	Romaszko, E; Marzec-Wroblewska, U; Badura, A; Bucinski, A				Romaszko, Ewa; Marzec-Wroblewska, Urszula; Badura, Anna; Bucinski, Adam			Does consumption of red grapefruit juice alter naringenin concentrations in milk produced by breastfeeding mothers?	PLOS ONE			English	Article							ORANGE JUICE; FOOD SOURCES; FLAVANONES; HESPERETIN; HUMANS; BIOAVAILABILITY; FLAVONOLS; EXCRETION; EXPOSURE	The content of certain ingredients of human milk, such as flavonoids, depend on the types and amounts of plant products consumed and may vary from woman to woman. The aim of the study was to determine to what extent consumption of an average amount of grapefruit juice (250 ml) affected naringenin content in human milk. A total of 14 breastfeeding mothers were included in the study. The subjects remained on a diet with restricted intake of naringenin for a total of five days except on the third day, when they drank a single serving of 250 ml of grapefruit juice. A considerable subject-to-subject variability in naringenin content was observed in both initial and subsequent determinations. Baseline concentration values, which may reflect naringenin content in the milk produced by the breastfeeding mother who eat an everyday (unmodified) diet, ranged from 420.86 nmol/l to 1568.89 nmol/l, with a mean of 823.24 nmol/l. Switching to the modified diet resulted in a decrease in naringenin concentrations to the mean value of 673.89 nmol/l measured 48 hours after the switch. The highest mean values were observed four and 12 hours after consumption of the juice, equalling l908.25 nmol/l (SD +/- 676.84 nmol/l) and 868.96 nmol/l (SD +/- 665.54 nmol/l), respectively. Naringenin is commonly found in human milk in quantities expressed in nmol/l, and its concentrations vary from woman to woman. Consumption of 250 ml of red grapefruit juice by breastfeeding mothers does not significantly alter naringenin concentrations in their milk.	[Romaszko, Ewa] Univ Warmia & Mazury, Family Med Unit, Olsztyn, Poland; [Marzec-Wroblewska, Urszula; Badura, Anna; Bucinski, Adam] Nicolaus Copernicus Univ Torun, Collegium Med Bydgoszcz, Fac Farmacy, Chair & Dept Biopharm, Bydgoszcz, Poland	University of Warmia & Mazury; Nicolaus Copernicus University	Bucinski, A (corresponding author), Nicolaus Copernicus Univ Torun, Collegium Med Bydgoszcz, Fac Farmacy, Chair & Dept Biopharm, Bydgoszcz, Poland.	kizbiofarmacji@cm.umk.pl	Marzec-Wróblewska, Urszula/D-4724-2014; Badura, Anna/G-9306-2014	Marzec-Wróblewska, Urszula/0000-0002-4189-6451; Badura, Anna/0000-0002-6560-8231; Bucinski, Adam/0000-0002-0558-9139	University of Warmia and Mazury in Olsztyn, Poland	University of Warmia and Mazury in Olsztyn, Poland	This study was financially supported by University of Warmia and Mazury in Olsztyn, Poland (purchase of reagents only). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MA, 2014, ADV NUTR, V5, P404, DOI 10.3945/an.113.005603; ALLEN JC, 1991, AM J CLIN NUTR, V54, P69, DOI 10.1093/ajcn/54.1.69; Bolca S, 2010, MOL NUTR FOOD RES, V54, pS284, DOI 10.1002/mnfr.200900519; Bolca S, 2010, AM J CLIN NUTR, V91, P976, DOI 10.3945/ajcn.2009.28854; Bredsdorff L, 2010, BRIT J NUTR, V103, P1602, DOI 10.1017/S0007114509993679; Chun OK, 2007, J NUTR, V137, P1244, DOI 10.1093/jn/137.5.1244; DALY SEJ, 1993, EXP PHYSIOL, V78, P209, DOI 10.1113/expphysiol.1993.sp003681; Erlund I, 2001, J NUTR, V131, P235, DOI 10.1093/jn/131.2.235; Felgines C, 2000, AM J PHYSIOL-GASTR L, V279, pG1148, DOI 10.1152/ajpgi.2000.279.6.G1148; Franke AA, 1996, CLIN CHEM, V42, P955; Franke AA, 1998, AM J CLIN NUTR, V68, p1466S, DOI 10.1093/ajcn/68.6.1466S; Fujioka K, 2006, J MED FOOD, V9, P49, DOI 10.1089/jmf.2006.9.49; Hanley MJ, 2011, EXPERT OPIN DRUG MET, V7, P267, DOI 10.1517/17425255.2011.553189; Justesen U, 1998, J CHROMATOGR A, V799, P101, DOI 10.1016/S0021-9673(97)01061-3; Kanaze FI, 2007, EUR J CLIN NUTR, V61, P472, DOI 10.1038/sj.ejcn.1602543; Liu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061420; Lorber M, 2002, ENVIRON HEALTH PERSP, V110, pA325, DOI 10.1289/ehp.021100325; Lown KS, 1997, J CLIN INVEST, V99, P2545, DOI 10.1172/JCI119439; Lu WJ, 2011, CHIRALITY, V23, P891, DOI 10.1002/chir.21005; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mullen W, 2007, J AGR FOOD CHEM, V55, P3148, DOI 10.1021/jf062970x; Nielsen ILF, 2006, J NUTR, V136, P404, DOI 10.1093/jn/136.2.404; Perrin MT, 2016, MATERN CHILD NUTR; Romaszko E, 2014, MOL NUTR FOOD RES, V58, P221, DOI 10.1002/mnfr.201200773; Rowe H, 2013, PEDIATR CLIN N AM, V60, P275, DOI 10.1016/j.pcl.2012.10.009; Shirasaka Y, 2013, J PHARM SCI-US, V102, P280, DOI [10.1002/jps.23653, 10.1002/jps.23357]; Song BJ, 2013, NUTRITION, V29, P195, DOI 10.1016/j.nut.2012.07.015; Zamora-Ros R, 2011, BRIT J NUTR, V106, P1915, DOI 10.1017/S000711451100239X	28	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185954	10.1371/journal.pone.0185954	http://dx.doi.org/10.1371/journal.pone.0185954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982188	Green Submitted, Green Published, gold			2022-12-26	WOS:000412360300096
J	Tiwari, P; Kutum, R; Sethi, T; Shrivastava, A; Girase, B; Aggarwal, S; Patil, R; Agarwal, D; Gautam, P; Agrawal, A; Dash, D; Ghosh, S; Juvekar, S; Mukerji, M; Prasher, B				Tiwari, Pradeep; Kutum, Rintu; Sethi, Tavpritesh; Shrivastava, Ankita; Girase, Bhushan; Aggarwal, Shilpi; Patil, Rutuja; Agarwal, Dhiraj; Gautam, Pramod; Agrawal, Anurag; Dash, Debasis; Ghosh, Saurabh; Juvekar, Sanjay; Mukerji, Mitali; Prasher, Bhavana			Recapitulation of Ayurveda constitution types by machine learning of phenotypic traits	PLOS ONE			English	Article							REGRESSION; REGULARIZATION; SELECTION; MEDICINE; MODELS; AREA	In Ayurveda system of medicine individuals are classified into seven constitution types, "Prakriti", for assessing disease susceptibility and drug responsiveness. Prakriti evaluation involves clinical examination including questions about physiological and behavioural traits. A need was felt to develop models for accurately predicting Prakriti classes that have been shown to exhibit molecular differences. The present study was carried out on data of phenotypic attributes in 147 healthy individuals of three extreme Prakriti types, from a genetically homogeneous population of Western India. Unsupervised and supervised machine learning approaches were used to infer inherent structure of the data, and for feature selection and building classification models for Prakriti respectively. These models were validated in a North Indian population. Unsupervised clustering led to emergence of three natural clusters corresponding to three extreme Prakriti classes. The supervised modelling approaches could classify individuals, with distinct Prakriti types, in the training and validation sets. This study is the first to demonstrate that Prakriti types are distinct verifiable clusters within a multidimensional space of multiple interrelated phenotypic traits. It also provides a computational framework for predicting Prakriti classes from phenotypic attributes. This approach may be useful in precision medicine for stratification of endophenotypes in healthy and diseased populations.	[Tiwari, Pradeep; Sethi, Tavpritesh; Aggarwal, Shilpi; Gautam, Pramod; Agrawal, Anurag; Mukerji, Mitali; Prasher, Bhavana] CSIR, Genom & Mol Med, Inst Genom & Integrat Biol, New Delhi, India; [Tiwari, Pradeep; Kutum, Rintu; Mukerji, Mitali; Prasher, Bhavana] CSIR, TRISUTRA Translat Res & Innovat Sci Ayurgen, Ayurgen Unit, Inst Genom & Integrat Biol, New Delhi, India; [Tiwari, Pradeep; Kutum, Rintu; Agrawal, Anurag; Dash, Debasis; Mukerji, Mitali; Prasher, Bhavana] CSIR, Acad Sci & Innovat Res AcSIR, IGIB, Delhi, India; [Kutum, Rintu; Dash, Debasis] CSIR, GN Ramachandran Knowledge Ctr Genome Informat, Inst Genom & Integrat Biol, New Delhi, India; [Shrivastava, Ankita; Girase, Bhushan; Patil, Rutuja; Agarwal, Dhiraj; Juvekar, Sanjay] KEM Hosp Res Ctr, Vadu Rural Hlth Program, Pune, Maharashtra, India; [Ghosh, Saurabh] Indian Stat Inst, Human Genet Unit, Kolkata, India; [Sethi, Tavpritesh] Indraprastha Inst Informat Technol, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Indian Statistical Institute; Indian Statistical Institute Kolkata; Indraprastha Institute of Information Technology Delhi	Mukerji, M; Prasher, B (corresponding author), CSIR, Genom & Mol Med, Inst Genom & Integrat Biol, New Delhi, India.; Mukerji, M; Prasher, B (corresponding author), CSIR, TRISUTRA Translat Res & Innovat Sci Ayurgen, Ayurgen Unit, Inst Genom & Integrat Biol, New Delhi, India.; Mukerji, M; Prasher, B (corresponding author), CSIR, Acad Sci & Innovat Res AcSIR, IGIB, Delhi, India.; Juvekar, S (corresponding author), KEM Hosp Res Ctr, Vadu Rural Hlth Program, Pune, Maharashtra, India.	sanjay.juvekar@gmail.com; mitali@igib.res.in; Bhavana.p@igib.res.in	Agrawal, Anurag/GZL-5821-2022; Patil, Rutuja/O-9996-2018; Tiwari, Dr. Pradeep/V-8314-2018; Dash, Debasis/F-3137-2012	Patil, Rutuja/0000-0001-6390-4363; Mukerji, Mitali/0000-0003-0697-5055; Agrawal, Anurag/0000-0002-0340-5252; Sethi, Tavpritesh/0000-0002-4776-7941; Tiwari, Dr. Pradeep/0000-0003-0387-9236; Girase, Bhushan/0000-0001-7105-3730; Kutum, Rintu/0000-0001-8667-6199; Dash, Debasis/0000-0002-5647-3785	CSIR [MLP901]; DBT-BINC fellowship; Council of Scientific & Industrial Research [MLP901]	CSIR(Council of Scientific & Industrial Research (CSIR) - India); DBT-BINC fellowship; Council of Scientific & Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	Funding from CSIR (MLP901) and DBT-BINC fellowship to PT are acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors acknowledge all field staffs and study population from KEMHRC-VADU. Authors also acknowledge Binuja Varma, Amruta Vasudevan for help in genotyping experiments and Ankita Narang in genotype analysis. Indian Genome Variation Consortium (IGVC) is also acknowledged for genotype data for diverse Indian population. Project funding MLP901 from Council of Scientific & Industrial Research (http://www.csir.res.in and DBT-BINC fellowship to PT are acknowledged. CSIR-IGIB is acknowledged for infrastructure support including the data centre.	Aggarwal S, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0542-9; Aggarwal S, 2010, P NATL ACAD SCI USA, V107, P18961, DOI 10.1073/pnas.1006108107; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Brahmachari SK, 2005, HUM GENET, V118, P1, DOI 10.1007/s00439-005-0009-9; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Dance A, 2016, NATURE, V537, pS52, DOI 10.1038/537S52a; FARRAR DE, 1967, REV ECON STAT, V49, P92, DOI 10.2307/1937887; Flores M, 2013, PERS MED, V10, P565, DOI 10.2217/pme.13.57; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Govindaraj P, 2015, SCI REP-UK, V5, DOI 10.1038/srep15786; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hastie T., 2009, UNSUPERVISED LEARNIN, P485; Hood L, 2011, NAT REV CLIN ONCOL, V8, P184, DOI 10.1038/nrclinonc.2010.227; Hornik M, 2012, R PACKAGE VERSION 1; Juyal RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045752; Katzenberg D, 1998, SLEEP, V21, P569, DOI 10.1093/sleep/21.6.569; Kaufman L., 1990, FINDING GROUPS DATA, P68, DOI [10.1002/9780470316801.ch2, DOI 10.1002/9780470316801.CH2]; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Leboyer M, 1998, TRENDS NEUROSCI, V21, P102, DOI 10.1016/S0166-2236(97)01187-9; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Prasher B, 2016, J ETHNOPHARMACOL; Prasher B, 2016, J GENET, V95, P209, DOI 10.1007/s12041-015-0607-9; Prasher B, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-48; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; R Core Team, 2021, R LANGUAGE ENV STAT; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Rotti H, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0506-0; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Sethi TP, 2011, ACS CHEM BIOL, V6, P875, DOI 10.1021/cb2003016; Sharma P, 1999, SUSRUTA SAMHITA ENGL; Shi T, 2005, MODERN PATHOL, V18, P547, DOI 10.1038/modpathol.3800322; SLINKER BK, 1985, AM J PHYSIOL, V249, pR1, DOI 10.1152/ajpregu.1985.249.1.R1; Tian Q, 2012, J INTERN MED, V271, P111, DOI 10.1111/j.1365-2796.2011.02498.x; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Van der Laan MJ, 2003, J STAT COMPUT SIM, V73, P575, DOI 10.1080/0094965031000136012; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	40	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185380	10.1371/journal.pone.0185380	http://dx.doi.org/10.1371/journal.pone.0185380			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981546	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300037
J	Tyler, AD; Randell, E; Baikie, M; Antonation, K; Janella, D; Christianson, S; Tyrrell, GJ; Graham, M; Van Domselaar, G; Sharma, MK				Tyler, Andrea D.; Randell, Elaine; Baikie, Maureen; Antonation, Kym; Janella, Debra; Christianson, Sara; Tyrrell, Gregory J.; Graham, Morag; Van Domselaar, Gary; Sharma, Meenu K.			Application of whole genome sequence analysis to the study of Mycobacterium tuberculosis in Nunavut, Canada	PLOS ONE			English	Article							MIRU-VNTRPLUS; INFECTION; MICE; TOOL; VISUALIZATION; TRANSMISSION; POLYMORPHISM; ALGORITHMS; RESISTANCE; DISCOVERY	Canada has one of the lowest rates of tuberculosis (TB) in the world, however, among certain sub-populations, disease incidence rates approach those observed in sub-Saharan Africa, and other high incidence regions. In this study, we applied mycobacterial interspersed repetitive unit (MIRU) variable number of tandem repeat (VNTR) and whole genome sequencing (WGS) to the analysis of Mycobacterium tuberculosis isolates obtained from Northern communities in the territory of Nunavut. WGS was carried out using the Illumina MiSeq, with identified variants used to infer phylogenetic relationships and annotated to infer functional implications. Additionally, the sequencing data from these isolates were augmented with publically available WGS to evaluate data from the Nunavut outbreak in the broader Canadian context. In this study, isolates could be classified into four major clusters by MIRU-VNTR analysis. These could be further resolved into sub-clusters using WGS. No evidence for antimicrobial resistance, either genetic or phenotypic, was observed in this cohort. Among most subjects with multiple samples, reactivation/incomplete treatment likely contributed to recurrence. However, isolates from two subjects appeared more likely to have occurred via reinfection, based on the large number of genomic single nucleotide variants detected. Finally, although quite distinct from previously reported Canadian MTB strains, isolates obtained from Nunavut clustered most closely with a cohort of samples originating in the Nunavik region of Northern Quebec. This study demonstrates the benefit of using WGS for discriminatory analysis of MTB in Canada, especially in high incidence regions. It further emphasizes the importance of focusing epidemiological intervention efforts on interrupting transmission chains of endemic TB throughout Northern communities, rather than relying on strategies applied in regions where the majority of TB cases result from importation of foreign strains.	[Tyler, Andrea D.; Antonation, Kym; Janella, Debra; Christianson, Sara; Graham, Morag; Van Domselaar, Gary; Sharma, Meenu K.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Randell, Elaine; Baikie, Maureen] Govt Nunavut, Iqaluit, NU, Canada; [Tyrrell, Gregory J.] Univ Alberta, Div Diagnost & Appl Microbiol, Edmonton, AB, Canada; [Tyrrell, Gregory J.] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Tyrrell, Gregory J.] Prov Lab Publ Hlth Microbiol, Edmonton, AB, Canada; [Graham, Morag; Van Domselaar, Gary; Sharma, Meenu K.] Univ Manitoba, Max Rady Coll Med, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada; [Van Domselaar, Gary] Univ Manitoba, Dept Comp Sci, Winnipeg, MB, Canada	Public Health Agency of Canada; University of Alberta; University of Alberta; University of Manitoba; University of Manitoba	Sharma, MK (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.; Sharma, MK (corresponding author), Univ Manitoba, Max Rady Coll Med, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada.	meenu.sharma@canada.ca	Sharma, Meenu/GWM-5030-2022; Tyrrell, Gregory/ABA-7203-2021; Sharma, Meenu/AAE-2536-2022	Sharma, Meenu/0000-0002-6020-9995	Canadian federal Genomics Research and Development Initiative (GRDI) from the Government of Canada; Public Health Agency of Canada	Canadian federal Genomics Research and Development Initiative (GRDI) from the Government of Canada; Public Health Agency of Canada	This study was funded through an intramural grant to Meenu K Sharma from the Canadian federal Genomics Research and Development Initiative (GRDI) from the Government of Canada and the Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar P, 2006, MICROBES INFECT, V8, P2855, DOI 10.1016/j.micinf.2006.09.004; Al-Hajoj SAM, 2010, J CLIN MICROBIOL, V48, P3813, DOI 10.1128/JCM.00556-10; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Bjorn-Mortensen K, 2016, SCI REP-UK, V6, DOI 10.1038/srep33180; Blackwood KS, 2004, J CLIN MICROBIOL, V42, P5001, DOI 10.1128/JCM.42.11.5001-5006.2004; Bradley P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10063; Christianson S, 2010, TUBERCULOSIS, V90, P31, DOI 10.1016/j.tube.2009.12.003; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Coll F, 2012, BIOINFORMATICS, V28, P2991, DOI 10.1093/bioinformatics/bts544; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012; de Beer JL, 2014, J CLIN MICROBIOL, V52, P1338, DOI 10.1128/JCM.03436-13; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Dhillon BK, 2015, NUCLEIC ACIDS RES, V43, pW104, DOI 10.1093/nar/gkv401; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Garrison E, 2012, HAPLOTYPE BASED VARI; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hatherell HA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0566-x; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Khan K, 2011, EMERG INFECT DIS, V17, P357, DOI 10.3201/eid1703.100833; Lee RS, 2015, P NATL ACAD SCI USA, V112, P13609, DOI 10.1073/pnas.1507071112; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lillebaek T, 2016, INT J MED MICROBIOL, V306, P580, DOI 10.1016/j.ijmm.2016.05.017; MacDonald N, 2011, CAN MED ASSOC J, V183, P741, DOI 10.1503/cmaj.110160; Caceres SM, 2011, PEPTIDES, V32, P1, DOI 10.1016/j.peptides.2010.09.017; Mehaffy C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112928; Minion J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053466; Niemann S, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TBTB2-0022-2016; Orr P, 2013, CAN MED ASSOC J, V185, P287, DOI 10.1503/cmaj.121536; Pandey R, 2012, INFECT IMMUN, V80, P3650, DOI 10.1128/IAI.00229-12; Pankhurst LJ, 2016, LANCET RESP MED, V4, P49, DOI 10.1016/S2213-2600(15)00466-X; Pepperell CS, 2011, P NATL ACAD SCI USA, V108, P6526, DOI 10.1073/pnas.1016708108; Petkau A, 2016, 092940 BIRXIV; Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-317; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Revell LJ, 2012, EVOLUTION, V66, P2697, DOI 10.1111/j.1558-5646.2012.01645.x; Ribeiro-Goncalves B, 2016, NUCLEIC ACIDS RES, V44, pW246, DOI 10.1093/nar/gkw359; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Shamputa IC, 2004, J CLIN MICROBIOL, V42, P5528, DOI 10.1128/JCM.42.12.5528-5536.2004; Shamputa IC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-99; Sreevatsan S, 1997, ANTIMICROB AGENTS CH, V41, P1677, DOI 10.1128/AAC.41.8.1677; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Stucki D, 2016, J CLIN MICROBIOL, V54, P1862, DOI 10.1128/JCM.00126-16; Tischler AD, 2013, INFECT IMMUN, V81, P317, DOI 10.1128/IAI.01136-12; Tuite AR, 2013, INT J TUBERC LUNG D, V17, P1322, DOI 10.5588/ijtld.13.0145; Tyler AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148676; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vitol I, 2006, INFECT GENET EVOL, V6, P491, DOI 10.1016/j.meegid.2006.03.003; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Walker TM, 2016, CLIN MICROBIOL INFEC; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2016, TB EL LOW INC COUNTR; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	58	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185656	10.1371/journal.pone.0185656	http://dx.doi.org/10.1371/journal.pone.0185656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982116	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300053
J	Rawal, LB; Biswas, TI; Khandker, NN; Saha, SR; Chowdhury, MMB; Khan, ANS; Chowdhury, EH; Renzaho, A				Rawal, Lal B.; Biswas, Tuh In; Khandker, Nusrat Nausheen; Saha, Shekhar Ranjan; Chowdhury, Mohammed Mahiul Bidet; Khan, Abdullah Nurus Salem; Chowdhury, Enamul Hasib; Renzaho, Andre			Non-communicable disease (NCD) risk factors and diabetes among adults living in slum areas of Dhaka, Bangladesh	PLOS ONE			English	Article							HEALTH	Background Despite one-third of the urban population in Bangladesh living in urban slums and at increased risk of non-communicable diseases (NCDs), little is known about the NCD risk profile of this at-risk population. The aim of the study was to identify the prevalence of the NCD risk factors and the association of NCD risk factors with socio-demographic factors among the adults of urban slums in Dhaka, Bangladesh. Method A cross-sectional study was conducted among adult slum dwellers (aged 25 and above) residing in three purposively selected urban slums of Dhaka for at least six months preceding the survey. The risk factors assessed were-currently smoking, fruit and vegetable intake, physical activity, hypertension and body mass index (BMI). Information on selfreported diabetes was also taken. A total of 507 participants (252 females; 49.7%) were interviewed and their physical measures were taken using the WHO NCD STEPS instrument. Result The overall prevalence of NCD risk factors was: 36.0% (95% CI: 31.82-40.41) for smoking; 95.60% (95% CI: 93.60-97.40) for insufficient fruit and vegetable intake; 15.30% (95% CI: 12.12-18.71) for low physical activity; 13.70% (95% CI: 10.71-16.92) for hypertension; 22.70% (95% CI: 19.31-26.02) for overweight or obesity; and 5.00% (95%: 3.20-7.00) for self-reported diabetes. In the logistic regression model, the clustering of three or more NCD risk factors was positively associated with younger age groups (p = 0.02), no formal education (p < 0.001) and primary education level (p = 0.01), but did not differ by sex of the participants, monthly income and occupation. Conclusion All NCD risk factors are markedly high among the urban slum adults. These findings are important to support the formulation and implementation of NCD-related polices and plan of actions that recognize urban slum populations in Bangladesh as a priority sub-population.	[Rawal, Lal B.; Biswas, Tuh In; Khan, Abdullah Nurus Salem] Int Ctr Diarrhoeal Dis Res, 68 Shaheed Tajuddin Ahmed Sharani, Dhaka, Bangladesh; [Rawal, Lal B.; Khandker, Nusrat Nausheen; Saha, Shekhar Ranjan; Chowdhury, Mohammed Mahiul Bidet; Chowdhury, Enamul Hasib] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Biswas, Tuh In] Univ Queensland, Long Pocket Precinct, Indooroopilly, Qld, Australia; [Renzaho, Andre] Western Sydney Univ, Locked Bag 1797, Penrith, NSW, Australia	International Centre for Diarrhoeal Disease Research (ICDDR); Bangladesh Rural Advancement Committee BRAC; BRAC University; University of Queensland; Western Sydney University	Rawal, LB (corresponding author), Int Ctr Diarrhoeal Dis Res, 68 Shaheed Tajuddin Ahmed Sharani, Dhaka, Bangladesh.; Rawal, LB (corresponding author), BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh.	drlalrawal@gmail.com	Khan, Abdullah Nurus Salam/J-1661-2018; Renzaho, Andre M.N./AAH-7679-2021	Khan, Abdullah Nurus Salam/0000-0002-8694-4349; Biswas, Tuhin/0000-0002-7837-0306; Rawal, Lal/0000-0003-1106-0108; RENZAHO, ANDRE/0000-0002-6844-0833	Australian Research Council [FT110100345]	Australian Research Council(Australian Research Council)	AR is supported by an Australian Research Council Future Fellowship FT110100345. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SM, 2009, GLOBAL HEALTH ACTION, V2, P68, DOI 10.3402/gha.v2i0.1986; Akter S, 2014, B WORLD HEALTH ORGAN, V92, P204, DOI 10.2471/BLT.13.128371; Alam Dewan S, 2016, BMC Obes, V3, P19, DOI 10.1186/s40608-016-0099-z; Allender S, 2010, B WORLD HEALTH ORGAN, V88, P297, DOI 10.2471/BLT.09.065847; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Aryal KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134834; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Burkart K, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-32; Burkart K, 2011, ENVIRON POLLUT, V159, P2035, DOI 10.1016/j.envpol.2011.02.005; Cancer IAfRo, 2007, REV RISK ATT QUITT S; Chowdhury MAB, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0197-3; ElSaharty S, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9920-0; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Federation I, 2013, INT DIAB FED IDF DIA; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Goli S, 2011, CITIES, V28, P461, DOI 10.1016/j.cities.2011.05.006; Hahn EJ, 2010, AM J PREV MED, V39, pS66, DOI 10.1016/j.amepre.2010.08.013; Heilig G.K., 2014, WORLD URBANIZATION P; Islam SMS, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0081-9; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Ministry of Health Myanmar World Health Organization, 2014, WORLD DIAB FDN REP N; Mirelman AJ, 2016, RELATIONSHIP NONCOMM; National Institute of Population Research and Training (NIPORT), 2014, MEASRE EV ICDDRB BAN; Organization. GWH. WHO, 2014, STEPS MAN; Razzaque A, 2011, ASIA-PAC J PUBLIC HE, V23, P183, DOI 10.1177/1010539510392743; Scollo M, 2008, TOBACCO AUSTR FACTS, P49; Streatfield PK, 2008, J HEALTH POPUL NUTR, V26, P261; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2011, NONC DIS RISK FACT S; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2005, WHO STEPS SURV MAN W; World Health Organization, 2011, GLOB STAT REP ALC HL; World Health Organization, 2015, STEPWISE APPR NONC D; World Health Organization, 2013, STEPS MAN; World Health Organization, 2014, NONC DIS COUNTR PROF; World Health Organization (WHO), 2015, PHYS ACTIVITY; Zaman MM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1938-4; Zaman MM, 2015, BMC PUBLIC HEALTH, V15, P1	38	23	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0184967	10.1371/journal.pone.0184967	http://dx.doi.org/10.1371/journal.pone.0184967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972972	gold, Green Published, Green Submitted			2022-12-26	WOS:000412131900009
J	Aveni, E; Bauer, B; Ramelet, AS; Decosterd, I; Ballabeni, P; Bonvin, E; Rodondi, PY				Aveni, Eleonore; Bauer, Brent; Ramelet, Anne-Sylvie; Decosterd, Isabelle; Ballabeni, Pierluigi; Bonvin, Eric; Rodondi, Pierre-Yves			Healthcare professionals' sources of knowledge of complementary medicine in an academic center	PLOS ONE			English	Article							THEORY-PRACTICE GAP; ALTERNATIVE MEDICINE; INTERPROFESSIONAL EDUCATION; PHYSICIANS ATTITUDES; THERAPIES; NURSES; COMMUNICATION; PAIN	Background Complementary medicine ( CM) is utilized in a growing number of academic centers despite the debate concerning its value, risks and benefits. Healthcare professionals often feel uncomfortable discussing CM with patients, and little is known about their sources of knowledge in the field of CM. Objective To assess healthcare professionals' sources of knowledge and attitude toward CM in an academic hospital. Design and participants The cross-sectional web-based survey took place from October to December 2013. A total of 4,925 healthcare professionals working at Lausanne University Hospital, Switzerland, were invited to answer the questionnaire. Main measures Factors influencing healthcare professionals' opinion toward CM, knowledge and communication about CM. Key results The questionnaire was answered by 1,247 healthcare professionals. The three key factors influencing professionals' opinion toward CM were personal experience, clinical experience and evidence demonstrating the physiological mechanism of CM. Personal experience was more associated with nurses' and midwives' opinion compared to physicians' (80.8% vs 57.1%, OR = 3.08, [95% CI: 2.35-4.05], P<0.001 and 85.3% vs 57.1%, OR = 3.83, [95% CI: 1.95-7.53], P<0.001, respectively) as well as with professionals trained in CM compared tonon-trained professionals (86.0% vs 73.2%, OR = 2.60, [95% CI: 1.92-3.53], P<0.001). Physicians relied more on randomized controlled clinical trials compared to nurses (81.3% vs 62.9%, OR = 0.43, [95% CI: 0.33-0.57], P<0.001). A majority of the respondents (82.5%) agreed that they lacked knowledge about CM and 65.0% noted that it was the patient who initially started the discussion about CM. Conclusions Different professionals used different strategies to forge opinions regarding CM: physicians relied more on scientific evidence, while nurses and midwives were more influenced by personal experience. Regardless of preferred information source, most respondents did not feel prepared to address patient questions regarding CM. Enhancing interprofessional education opportunities is an important strategy to help providers become empowered to discuss CM with patients. This in turn will help patients making informed decisions in their healthcare.	[Aveni, Eleonore; Ballabeni, Pierluigi; Rodondi, Pierre-Yves] Lausanne Univ Hosp, Inst Social & Prevent Med, Lausanne, Switzerland; [Bauer, Brent] Mayo Clin, Div Gen Internal Med, Rochester, MN USA; [Ramelet, Anne-Sylvie] Lausanne Univ, IUFRS, Inst Higher Educ & Res Healthcare, Lausanne, Switzerland; [Decosterd, Isabelle] Lausanne Univ Hosp, Dept Anesthesiol, Pain Ctr, Lausanne, Switzerland; [Bonvin, Eric] Lausanne Univ Hosp, Dept Psychiat, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Mayo Clinic; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Aveni, E (corresponding author), Lausanne Univ Hosp, Inst Social & Prevent Med, Lausanne, Switzerland.	eleonore.aveni@chuv.ch	Ramelet, Anne-Sylvie/G-8451-2013; Rodondi, Pierre-Yves/AAU-3708-2020	Ramelet, Anne-Sylvie/0000-0001-8809-2920; Ballabeni, Pierluigi/0000-0002-1572-7179; Rodondi, Pierre-Yves/0000-0003-2007-2995; Bonvin, Eric/0000-0001-7995-2490	Lebherz-Cornelius Celsius Foundation	Lebherz-Cornelius Celsius Foundation	This study was supported by a grant from the Lebherz-Cornelius Celsius Foundation. The authors who received the funding: PYR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association of American Medical Colleges (AAMS), 1998, LEARN OBJ MED STUD E; Aveni E, 2016, EXPLORE-NY, V12, P341, DOI 10.1016/j.explore.2016.06.001; Blue AV, 2010, J INTERPROF CARE, V24, P204, DOI 10.3109/13561820903442887; Brock D, 2013, POSTGRAD MED J, V89, P642, DOI [10.1136/postgradmedj-2012-000952rep, 10.1136/bmjqs-2012-000952]; Brooke Joanne, 2015, Nurse Educ Today, V35, pe6, DOI 10.1016/j.nedt.2015.02.026; Chen L, 2010, PAIN MED, V11, P530, DOI 10.1111/j.1526-4637.2010.00815.x; Chen XW, 2011, CURR MED CHEM, V18, P4836, DOI 10.2174/092986711797535317; Clarke TC, 2015, NATL HLTH STAT REPOR, P1; Condon C, 2016, PHYSIOTHERAPY, V102, P10, DOI 10.1016/j.physio.2015.06.003; Coulter ID, 2008, HOSP BASED INTEGRATI; Coulter ID, 2004, MAINSTREAMING COMPLE, P103; Cowen VS, 2015, AM J PREV MED, V49, pS257, DOI 10.1016/j.amepre.2015.07.035; Dawes Martin, 2005, BMC Med Educ, V5, P1; Estabrooks CA, 2005, QUAL HEALTH RES, V15, P460, DOI 10.1177/1049732304273702; Forsman H, 2012, INT J NURS STUD, V49, P1155, DOI 10.1016/j.ijnurstu.2012.04.002; Geisler C, 2015, J AM ASSOC NURSE PRA, V27, P380, DOI 10.1002/2327-6924.12190; Hall Amanda, 2004, Health Info Libr J, V21, P102, DOI 10.1111/j.1471-1842.2004.00506.x; Hall H, 2017, INT J NURS STUD, V69, P47, DOI 10.1016/j.ijnurstu.2017.01.008; Hatlevik IK, 2012, J ADV NURS, V68, P868; Hollenberg DB, 2011, J COMPLEMENT INTEGR; HUMPHREYS BL, 1994, B MED LIBR ASSOC, V82, P18; Institute of Medicine (US), 2005, COMM US COMPL ALT ME; Interprofessional Education Collaborative Expert Panel, 2011, COR COMP INT COLL PR; Jong MC, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-4; Jung B, 2016, EXPLORE; Kadar GE, 2015, J INTERPROF CARE, V29, P377, DOI 10.3109/13561820.2014.967337; Klein SD, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0141985, 10.1371/journal.pone.0144676]; Labriola D, 1999, ONCOLOGY-NY, V13, P1003; Lin V, 2015, HEALTH EXPECT, V18, P2651, DOI 10.1111/hex.12239; Nematollahi R, 2012, INT NURS REV, V59, P194, DOI 10.1111/j.1466-7657.2011.00949.x; Ott M, 2015, TRACE ELEM ELECTROLY, V32, P74; Patterson C, 2008, INTEGR MED INSIGHTS, V3; Reeves S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002213.pub3; Robinson A, 2004, COMPLEMENT THER MED, V12, P90, DOI 10.1016/j.ctim.2004.09.006; Scully NJ, 2011, COLLEGIAN, V18, P93, DOI 10.1016/j.colegn.2010.04.002; Silverman J, 2012, SKILLS COMMUNICATING; Straus SE, 2009, CAN MED ASSOC J, V181, P165, DOI 10.1503/cmaj.081229; SUDMAN S, 1985, EVALUATION REV, V9, P349, DOI 10.1177/0193841X8500900306; Templeman K, 2011, COMPLEMENT THER MED, V19, P84, DOI 10.1016/j.ctim.2011.02.003; Thompson Carl, 2004, Evid Based Nurs, V7, P68; Trimborn A, 2013, ANN ONCOL, V24, P2641, DOI 10.1093/annonc/mdt299; VanGeest JB, 2007, EVAL HEALTH PROF, V30, P303, DOI 10.1177/0163278707307899; Vaucher C, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0120-5; Verloo H, 2017, J EVAL CLIN PRACT, V23, P139, DOI 10.1111/jep.12653; Wahner-Roedler DL, 2006, EVID-BASED COMPL ALT, V3, P495, DOI 10.1093/ecam/nel036; Wahner-Roedler DL, 2014, COMPLEMENT THER CLIN, V20, P54, DOI 10.1016/j.ctcp.2013.09.003; Widmer M, 2006, FORSCH KOMP KLAS NAT, V13, P356, DOI 10.1159/000097254; Winslow LC, 2002, ARCH INTERN MED, V162, P1176; World Health Organization, TRADITIONAL MED; Youngblut J M, 2001, AACN Clin Issues, V12, P468, DOI 10.1097/00044067-200111000-00003	50	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0184979	10.1371/journal.pone.0184979	http://dx.doi.org/10.1371/journal.pone.0184979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MG	28961256	gold, Green Published, Green Submitted			2022-12-26	WOS:000412027700013
J	Kennedy, AE; Kandalam, S; Olivares-Navarrete, R; Dickinson, AJG				Kennedy, Allyson E.; Kandalam, Suraj; Olivares-Navarrete, Rene; Dickinson, Amanda J. G.			E-cigarette aerosol exposure can cause craniofacial defects in Xenopus laevis embryos and mammalian neural crest cells	PLOS ONE			English	Article							PROPYLENE-GLYCOL; OROFACIAL DEVELOPMENT; MATERNAL SMOKING; CLEFT-LIP; NICOTINE; BUTTER; MODEL; MALFORMATIONS; METABOLISM; DIACETYL	Since electronic cigarette (ECIG) introduction to American markets in 2007, vaping has surged in popularity. Many, including women of reproductive age, also believe that ECIG use is safer than traditional tobacco cigarettes and is not hazardous when pregnant. However, there are few studies investigating the effects of ECIG exposure on the developing embryo and nothing is known about potential effects on craniofacial development. Therefore, we have tested the effects of several aerosolized e-cigarette liquids (e-cigAM) in an in vivo craniofacial model, Xenopus laevis, as well as a mammalian neural crest cell line. Results demonstrate that e-cigAM exposure during embryonic development induces a variety of defects, including median facial clefts and midface hypoplasia in two of e-cigAMs tested e-cigAMs. Detailed quantitative analyses of the facial morphology revealed that nicotine is not the main factor in inducing craniofacial defects, but can exacerbate the effects of the other e-liquid components. Additionally, while two different e-cigAMs can have very similar consequences on facial appearances, there are subtle differences that could be due to the differences in e-cigAM components. Further assessment of embryos exposed to these particular e-cigAMs revealed cranial cartilage and muscle defects and a reduction in the blood supply to the face. Finally, the expression of markers for vascular and cartilage differentiation was reduced in a mammalian neural crest cell line corroborating the in vivo effects. Our work is the first to show that ECIG use could pose a potential hazard to the developing embryo and cause craniofacial birth defects. This emphasizes the need for more testing and regulation of this new popular product.	[Kennedy, Allyson E.; Dickinson, Amanda J. G.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA; [Kandalam, Suraj; Olivares-Navarrete, Rene] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University	Dickinson, AJG (corresponding author), Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA.	ajdickinson@vou.edu		Dickinson, Amanda/0000-0002-1427-9140	NIDCR [5R56DE026024-02]; NIH National Institute of Dental and Craniofacial Research [5R56DE026024-02]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R56DE026024] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by NIDCR 5R56DE026024-02 to Olivares-Navarrete and Dickinson co-PIs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by a Grant awarded by the NIH National Institute of Dental and Craniofacial Research (Grant number: 5R56DE026024-02) to Rene Olivares-Navarrete and Amanda Dickinson. The authors would also like to acknowledge Chesapeake Tschaenn and Deborah Howton for specimen collection and frog husbandry (Dickinson lab). Finally we would like to especially thank Alison Breland and Tom Eissenberg for their insight into the human use of ECIGs and the needs for testing these products in embryos.	Adams DS, 2016, J PHYSIOL-LONDON, V594, P3245, DOI 10.1113/JP271930; Ashford K, 2016, NURS RES, V65, P408, DOI 10.1097/NNR.0000000000000176; Bahl V, 2012, REPROD TOXICOL, V34, P529, DOI 10.1016/j.reprotox.2012.08.001; Bailey RL, 2015, AM J IND MED, V58, P1235, DOI 10.1002/ajim.22533; Martelli DRB, 2015, BRAZ J OTORHINOLAR, V81, P514, DOI 10.1016/j.bjorl.2015.07.011; Bnait KS, 1995, EXP TOXICOL PATHOL, V47, P453, DOI 10.1016/S0940-2993(11)80327-1; Brass DM, 2017, AM J RESP CELL MOL B; Breland A, 2017, ANN NY ACAD SCI, V1394, P5, DOI 10.1111/nyas.12977; Breland AB, 2014, J ADDICT MED, V8, P223, DOI 10.1097/ADM.0000000000000049; Bruin JE, 2010, TOXICOL SCI, V116, P364, DOI 10.1093/toxsci/kfq103; Burstyn I, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-18; Cavalcanti ZD, 2012, J BRAS PNEUMOL, V38, P395, DOI 10.1590/S1806-37132012000300016; Conlon F, 2011, BENZIDINE PEROXIDASE; Curwin BD, 2015, J EXPO SCI ENV EPID, V25, P324, DOI 10.1038/jes.2014.52; DARLINGTON RB, 1973, REV EDUC RES, V43, P433, DOI 10.3102/00346543043004433; Deniz E, 2017, SCI REP-UK, V7, DOI 10.1038/srep42506; Devotta A, 2016, DEV BIOL, V415, P371, DOI 10.1016/j.ydbio.2016.02.010; Dickinson AJG, 2016, SEMIN CELL DEV BIOL, V51, P53, DOI 10.1016/j.semcdb.2016.03.005; Dickinson AJG, 2016, SEMIN CELL DEV BIOL, V51, P54, DOI 10.1016/j.semcdb.2016.01.016; Dubey A, 2017, CURR PATHOBIOL REP, V5, P79, DOI 10.1007/s40139-017-0128-8; FDA, 2017, VAP E CIG OTH EL NIC; Fowles JR, 2013, CRIT REV TOXICOL, V43, P363, DOI 10.3109/10408444.2013.792328; Gouignard N, 2016, DIS MODEL MECH, V9, P607, DOI 10.1242/dmm.024661; Griffin JN, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005018; Gunnerbeck A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084715; Hanken J, 2005, J ANAT, V207, P437, DOI 10.1111/j.1469-7580.2005.00481.x; HEMMATIBRIVANLOU A, 1995, DEV GENET, V17, P78, DOI 10.1002/dvg.1020170109; Holden VK, 2016, CURR OPIN PULM MED, V22, P158, DOI 10.1097/MCP.0000000000000250; Honein MA, 2014, BIRTH DEFECTS RES A, V100, P822, DOI 10.1002/bdra.23274; Huerta TR, 2017, AM J PREV MED, V52, P339, DOI 10.1016/j.amepre.2016.10.017; Jensen RP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42549; JOSCHKO MA, 1991, NEUROTOXICOL TERATOL, V13, P307, DOI 10.1016/0892-0362(91)90076-9; Kang P, 2003, Orthod Craniofac Res, V6, P129, DOI 10.1034/j.1600-0544.2003.02236.x; Kennedy AE, 2014, JOVE-J VIS EXP, DOI 10.3791/52062; Kennedy AE, 2014, ANAT REC, V297, P834, DOI 10.1002/ar.22864; Kienhuis AS, 2015, TOB INDUC DIS, V13, DOI 10.1186/s12971-015-0038-7; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kreiss K, 2002, NEW ENGL J MED, V347, P330, DOI 10.1056/NEJMoa020300; Lauterstein DE, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040417; Levine AJ, 2003, DEV BIOL, V254, P50, DOI 10.1016/S0012-1606(02)00029-5; Mark KS, 2015, J ADDICT MED, V9, P266, DOI 10.1097/ADM.0000000000000128; Massarsky A, 2017, ZEBRAFISH, V14, P216, DOI 10.1089/zeb.2016.1400; MCCARTHY M, 2014, BMJ-BRIT MED J, V349, DOI DOI 10.1136/BMJ.G5154; McMillen RC, 2015, NICOTINE TOB RES, V17, P1195, DOI 10.1093/ntr/ntu213; Oncken C, 2017, NICOTINE TOB RES, V19, P585, DOI 10.1093/ntr/ntw225; Palpant NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126259; Pankow JF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173055; Peace MR, 2016, J ANAL TOXICOL, V40, P403, DOI 10.1093/jat/bkw037; Pu J, 2017, PERSPECT PUBLIC HEAL; Rigler MW, 2010, INT J OCCUP ENV HEAL, V16, P291; Rinon A, 2007, DEVELOPMENT, V134, P3065, DOI 10.1242/dev.002501; Rom O, 2015, ANN NY ACAD SCI, V1340, P65, DOI 10.1111/nyas.12609; Rowell TR, 2017, AM J PHYSIOL-LUNG C, V313, pL52, DOI 10.1152/ajplung.00392.2016; Schmidt J, 2013, J ANAT, V222, P134, DOI 10.1111/j.1469-7580.2012.01541.x; [Services DoHaH Administration FaD], 2016, RESTR SAL DISTR TOB; Shen X, 2004, INT J PHARMACEUT, V275, P249, DOI 10.1016/j.ijpharm.2004.02.005; Shi M, 2007, AM J HUM GENET, V80, P76, DOI 10.1086/510518; Singh T, 2016, TOBACCO USE AMONOG M; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Spindle TR, 2015, NICOTINE TOB RES, V17, P142, DOI 10.1093/ntr/ntu186; Tahir R, 2014, MECH DEVELOP, V133, P91, DOI 10.1016/j.mod.2014.05.004; TAYLOR DJ, 1985, BIOCHEM J, V225, P315, DOI 10.1042/bj2250315; Tierney PA, 2016, TOB CONTROL, V25, pE10, DOI 10.1136/tobaccocontrol-2014-052175; van Rooij IALM, 2001, EPIDEMIOLOGY, V12, P502, DOI 10.1097/00001648-200109000-00007; Wagner NJ, 2017, MATERN CHILD HLTH J, V21, P1655, DOI 10.1007/s10995-016-2257-9; Wahl SE, 2015, DEV BIOL, V405, P108, DOI 10.1016/j.ydbio.2015.07.001; Warkman AS, 2007, SEMIN CELL DEV BIOL, V18, P46, DOI 10.1016/j.semcdb.2006.11.010; Werley MS, 2011, TOXICOLOGY, V287, P76, DOI 10.1016/j.tox.2011.05.015; Wheeler GN, 2012, GENESIS, V50, P207, DOI 10.1002/dvg.22009; Wickstrom R, 2007, CURR NEUROPHARMACOL, V5, P213, DOI 10.2174/157015907781695955; Wyszynski DF, 1997, CLEFT PALATE-CRAN J, V34, P206, DOI 10.1597/1545-1569(1997)034<0206:MCSAOC>2.3.CO;2; Xu YQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147184; Yildirim M, 2012, J DENT RES, V91, P556, DOI 10.1177/0022034512444928; Yingst JM, 2017, NICOTINE TOB RES; Zaccone EJ, 2015, TOXICOL APPL PHARM, V289, P542, DOI 10.1016/j.taap.2015.10.004; Zhao ZY, 2005, BIRTH DEFECTS RES B, V74, P383, DOI 10.1002/bdrb.20052; Zhu SH, 2014, TOB CONTROL, V23, P3, DOI 10.1136/tobaccocontrol-2014-051670; Ziermann JM, 2014, J EXP ZOOL PART B, V322, P586, DOI 10.1002/jez.b.22566	78	29	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185729	10.1371/journal.pone.0185729	http://dx.doi.org/10.1371/journal.pone.0185729			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957438	Green Submitted, Green Published, gold			2022-12-26	WOS:000411985200111
J	Meliambro, K; Wong, JS; Ray, J; Calizo, RC; Towne, S; Cole, B; El Salem, F; Gordon, RE; Kaufman, L; He, JC; Azeloglu, EU; Campbell, KN				Meliambro, Kristin; Wong, Jenny S.; Ray, Justina; Calizo, Rhodora C.; Towne, Sara; Cole, Beatriz; El Salem, Fadi; Gordon, Ronald E.; Kaufman, Lewis; He, John C.; Azeloglu, Evren U.; Campbell, Kirk N.			The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-CONTROL; WW DOMAIN; PROTEIN; NEPHRIN; EXPRESSION; APOPTOSIS; CANCER; MORPHOLOGY; FAILURE; DISEASE	Kidney podocytes represent a key constituent of the glomerular filtration barrier. Identifying the molecular mechanisms of podocyte injury and survival is important for better understanding and management of kidney diseases. KIBRA (kidney brain protein), an upstream regulator of the Hippo signaling pathway encoded by the Wwc1 gene, shares the pro-injury properties of its putative binding partner dendrin and antagonizes the pro-survival signaling of the downstream Hippo pathway effector YAP (Yes-associated protein) in Drosophila and MCF10A cells. We recently identified YAP as an essential component of the glomerular filtration barrier that promotes podocyte survival by inhibiting dendrin pro-apoptotic function. Despite these recent advances, the signaling pathways that mediate podocyte injury remain poorly understood. Here we tested the hypothesis that, similar to its role in other model systems, KIBRA promotes podocyte injury. We found increased expression of KIBRA and phosphorylated YAP protein in glomeruli of patients with biopsy-proven focal segmental glomerulosclerosis (FSGS). KIBRA/WWc1 overexpression in murine podocytes promoted LATS kinase phosphorylation, leading to subsequent YAP Ser-127 phosphorylation, YAP cytoplasmic sequestration, and reduction in YAP target gene expression. Functionally, KIBRA overexpression induced significant morphological changes in podocytes, including disruption of the actin cytoskeletal architecture and reduction of focal adhesion size and number, all of which were rescued by subsequent YAP overexpression. Conversely, constitutive KIBRA knockout mice displayed reduced phosphorylated YAP and increased YAP expression at baseline. These mice were protected from acute podocyte foot process effacement following protamine sulfate perfusion. KIBRA knockdown podocytes were also protected against protamine-induced injury. These findings suggest an important role for KIBRA in the pathogenesis of podocyte injury and the progression of proteinuric kidney disease.	[Meliambro, Kristin; Wong, Jenny S.; Ray, Justina; Cole, Beatriz; Kaufman, Lewis; He, John C.; Campbell, Kirk N.] Icahn Sch Med Mt Sinai, Div Nephrol, Box 1243,One Gustave L Levy Pl, New York, NY 10029 USA; [Calizo, Rhodora C.; Towne, Sara; He, John C.; Azeloglu, Evren U.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA; [El Salem, Fadi; Gordon, Ronald E.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Campbell, KN (corresponding author), Icahn Sch Med Mt Sinai, Div Nephrol, Box 1243,One Gustave L Levy Pl, New York, NY 10029 USA.	kirk.campbell@mssm.edu	Salem, Fadi/AAP-9399-2020	Salem, Fadi/0000-0002-2603-2778; Azeloglu, Evren/0000-0001-6137-109X	National Institutes of Health [R01 DK103022]; American Society of Nephrology Nephcure Kidney International-ASN Foundation for Kidney Research Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Nephrology Nephcure Kidney International-ASN Foundation for Kidney Research Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01 DK103022 (to K. N. C.) and an American Society of Nephrology Nephcure Kidney International-ASN Foundation for Kidney Research Career Development Award (to E. U. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Asanuma K, 2007, P NATL ACAD SCI USA, V104, P10134, DOI 10.1073/pnas.0700917104; Azeloglu EU, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004621; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; Campbell KN, 2013, J BIOL CHEM, V288, P17057, DOI 10.1074/jbc.C113.457390; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Diepenbruck M, 2014, J CELL SCI, V127, P1523, DOI 10.1242/jcs.139865; Duning K, 2008, J AM SOC NEPHROL, V19, P1891, DOI 10.1681/ASN.2007080916; George B, 2014, KIDNEY INT, V85, P1382, DOI 10.1038/ki.2013.556; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Griffin SV, 2006, J BIOL CHEM, V281, P28048, DOI 10.1074/jbc.M513336200; Griffin SV, 2004, AM J PATHOL, V165, P1175, DOI 10.1016/S0002-9440(10)63378-0; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kanwar YS, 2015, AM J PHYSIOL-RENAL, V308, pF420, DOI 10.1152/ajprenal.00640.2014; Katschnig AM, 2017, ONCOGENE, V36, P5995, DOI 10.1038/onc.2017.202; Kitiyakara C, 2004, AM J KIDNEY DIS, V44, P815, DOI 10.1016/S0272-6386(04)01081-9; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; KURIHARA H, 1992, AM J PATHOL, V141, P805; Leeuwis JW, 2010, ADV DRUG DELIVER REV, V62, P1325, DOI 10.1016/j.addr.2010.08.012; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Low BC, 2014, FEBS LETT, V588, P2663, DOI 10.1016/j.febslet.2014.04.012; Makuch L, 2011, NEURON, V71, P1022, DOI 10.1016/j.neuron.2011.08.017; Marshall CB, 2007, NEPHRON EXP NEPHROL, V106, pE51, DOI 10.1159/000101793; Mohammadhoseiniakbari H, 2009, MED SCI MONITOR, V15, pPH109; Moleirinho S, 2013, ONCOGENE, V32, P1821, DOI 10.1038/onc.2012.196; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Polito MG, 2010, NEPHROL DIAL TRANSPL, V25, P490, DOI 10.1093/ndt/gfp355; Reiser J, 2010, KIDNEY INT, V77, P662, DOI 10.1038/ki.2009.559; Saleem MA, 2002, AM J PATHOL, V161, P1459, DOI 10.1016/S0002-9440(10)64421-5; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Saleem MA, 2008, AM J PHYSIOL-RENAL, V295, pF959, DOI 10.1152/ajprenal.00559.2007; Schaldecker T, 2013, J CLIN INVEST, V123, P5298, DOI 10.1172/JCI71165; Schiwek D, 2004, KIDNEY INT, V66, P91, DOI 10.1111/j.1523-1755.2004.00711.x; Schwartzman M, 2016, J AM SOC NEPHROL, V27, P216, DOI 10.1681/ASN.2014090916; Stanger BZ, 2012, GENE DEV, V26, P1263, DOI 10.1101/gad.196501.112; Sudol M, 2012, SEMIN CELL DEV BIOL, V23, P827, DOI 10.1016/j.semcdb.2012.05.002; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Wada T, 2005, KIDNEY INT, V68, P1618, DOI 10.1111/j.1523-1755.2005.00574.x; Wagrowska-Danilewicz M, 2007, NEFROLOGIA, V27, P710; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Weins A, 2015, AM J PATHOL, V185, P2143, DOI 10.1016/j.ajpath.2015.04.011; Wennmann DO, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.476; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	48	23	24	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21137	21148		10.1074/jbc.M117.819029	http://dx.doi.org/10.1074/jbc.M117.819029			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	28982981	hybrid, Green Published			2022-12-26	WOS:000418453400028
J	Heron, PW; Sygusch, J				Heron, Paul W.; Sygusch, Jurgen			Isomer activation controls stereospecificity of class I fructose-1,6-bisphosphate aldolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme catalysis; enzyme mechanism; glycolysis; stereoselectivity	TRIOSE PHOSPHATE ISOMERASE; SCHIFF-BASE FORMATION; FRUCTOSE-BISPHOSPHATE ALDOLASE; DIHYDROXYACETONE PHOSPHATE; MUSCLE ALDOLASE; GLYCERALDEHYDE 3-PHOSPHATE; SUBSTRATE-SPECIFICITY; PROTON-TRANSFER; ACTIVE-SITE; STEREOCHEMISTRY	Fructose-1,6-bisphosphate (FBP) aldolase, a glycolytic enzyme, catalyzes the reversible and stereospecific aldol addition of dihydroxyacetone phosphate (DHAP) and d-glyceraldehyde 3-phosphate (d-G3P) by an unresolved mechanism. To afford insight into the molecular determinants of FBP aldolase stereospecificity during aldol addition, a key ternary complex formed by DHAP and d-G3P, comprising 2% of the equilibrium population at physiological pH, was cryotrapped in the active site of Toxoplasma gondii aldolase crystals to high resolution. The growth of T. gondii aldolase crystals in acidic conditions enabled trapping of the ternary complex as a dominant population. The obligate 3(S)-4(R) stereochemistry at the nascent C3-C4 bond of FBP requires a si-face attack by the covalent DHAP nucleophile on the d-G3P aldehyde si-face in the active site. The cis-isomer of the d-G3P aldehyde, representing the dominant population trapped in the ternary complex, would lead to re-face attack on the aldehyde and yield tagatose 1,6-bisphosphate, a competitive inhibitor of the enzyme. We propose that unhindered rotational isomerization by the d-G3P aldehyde moiety in the ternary complex generates the active trans-isomer competent for carbonyl bond activation by active-site residues, thereby enabling si-face attack by the DHAP enamine. C-C bond formation by the cis-isomer is suppressed by hydrogen bonding of the cis-aldehyde carbonyl with the DHAP enamine phosphate dianion through a tetrahedrally coordinated water molecule. The active site geometry further suppresses C-C bond formation with the l-G3P enantiomer of d-G3P. Understanding C-C formation is of fundamental importance in biological reactions and has considerable relevance to biosynthetic reactions in organic chemistry.	[Heron, Paul W.; Sygusch, Jurgen] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Sygusch, J (corresponding author), Stn Ctr Ville, CP 6128, Montreal, PQ H3C 3J7, Canada.	jurgen.sygusch@umontreal.ca		Sygusch, Jurgen/0000-0002-6629-2128	DOE Office of Science by Brookhaven National Laboratory [DE-AC02-98CH10886]	DOE Office of Science by Brookhaven National Laboratory(United States Department of Energy (DOE))	We are grateful to Dr. David Sibley and Bang Shen (University of Washington, St. Louis) for providing T. gondii aldolase expression vector. This research used resources of beamlines X25 and X29A of the National Synchrotron Light Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Brookhaven National Laboratory under contract DE-AC02-98CH10886.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2015, ACTA CRYSTALLOGR D, V71, P646, DOI 10.1107/S1399004714028132; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; BEDNARSKI MD, 1989, J AM CHEM SOC, V111, P627, DOI 10.1021/ja00184a034; BISSETT DL, 1980, J BIOL CHEM, V255, P8745; Boucher LE, 2014, ACTA CRYSTALLOGR F, V70, P1186, DOI 10.1107/S2053230X14017087; BURGI HB, 1974, TETRAHEDRON, V30, P1563, DOI 10.1016/S0040-4020(01)90678-7; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CONNETT RJ, 1985, J BIOL CHEM, V260, P3314; CORDES EH, 1962, J AM CHEM SOC, V84, P832, DOI 10.1021/ja00864a031; DeLano WL, 2014, PYMOL MOL GRAPH SYST; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; DUAN XF, 1992, J AM CHEM SOC, V114, P5849, DOI 10.1021/ja00040a055; DUBOIS JE, 1972, TETRAHEDRON, V28, P1653, DOI 10.1016/0040-4020(72)88047-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espelt L, 2005, CHEM-EUR J, V11, P1392, DOI 10.1002/chem.200400648; Fleming I., 2011, MOL ORBITALS ORGANIC; Gefflaut T, 1995, PROG BIOPHYS MOL BIO, V63, P301, DOI 10.1016/0079-6107(95)00008-9; Gorbitz C. H., 1992, J CHEM SOC P2, V1, P131; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; GRAZI E, 1962, BIOCHEM BIOPH RES CO, V9, P38, DOI 10.1016/0006-291X(62)90083-9; GRAZI E, 1974, BIOCHEM BIOPH RES CO, V56, P106, DOI 10.1016/S0006-291X(74)80321-9; GRAZI E, 1973, BIOCHEMISTRY-US, V12, P2583, DOI 10.1021/bi00738a006; HARTMAN FC, 1965, BIOCHEMISTRY-US, V4, P1068, DOI 10.1021/bi00882a014; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KOBES RD, 1969, J BIOL CHEM, V244, P1919; KUO DJ, 1985, BIOCHEMISTRY-US, V24, P3947, DOI 10.1021/bi00336a022; LAI CY, 1968, BIOCHEM BIOPH RES CO, V30, P665, DOI 10.1016/0006-291X(68)90564-0; Light SH, 2014, ACTA CRYSTALLOGR D, V70, P544, DOI 10.1107/S1399004713030666; LowKam C, 2010, J BIOL CHEM, V285, P21143, DOI 10.1074/jbc.M109.080358; Maurady A, 2002, J BIOL CHEM, V277, P9474, DOI 10.1074/jbc.M107600200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MELOCHE HP, 1973, J BIOL CHEM, V248, P6333; Azofra LM, 2015, CHEMPHYSCHEM, V16, P2226, DOI 10.1002/cphc.201500139; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Myers J, 2006, PROTEINS, V63, P928, DOI 10.1002/prot.20922; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PECZON BD, 1972, BIOCHEMISTRY-US, V11, P2209, DOI 10.1021/bi00762a001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RACKER E, 1947, J BIOL CHEM, V167, P843; REYNOLDS SJ, 1971, BIOCHEM J, V122, P285, DOI 10.1042/bj1220285; RICHARDS OC, 1961, J BIOL CHEM, V236, P3185; ROSE IA, 1977, J BIOL CHEM, V252, P479; ROSE IA, 1969, J BIOL CHEM, V244, P126; ROSE IA, 1985, BIOCHEMISTRY-US, V24, P3952, DOI 10.1021/bi00336a023; ROSE IA, 1987, J BIOL CHEM, V262, P692; ROSE IA, 1969, J BIOL CHEM, V244, P6548; SAYER JM, 1974, J AM CHEM SOC, V96, P7998, DOI 10.1021/ja00833a027; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; St-Jean M, 2005, J BIOL CHEM, V280, P27262, DOI 10.1074/jbc.M502413200; St-Jean M, 2007, J BIOL CHEM, V282, P31028, DOI 10.1074/jbc.M704968200; St-Jean M, 2009, BIOCHEMISTRY-US, V48, P4528, DOI 10.1021/bi8021558; Terwilliger TC, 2007, ACTA CRYSTALLOGR D, V63, P597, DOI 10.1107/S0907444907009791; TRENTHAM DR, 1969, BIOCHEM J, V114, P19, DOI 10.1042/bj1140019; TUNG TC, 1954, BIOCHIM BIOPHYS ACTA, V14, P488, DOI 10.1016/0006-3002(54)90228-0; VEECH RL, 1969, BIOCHEM J, V115, P837, DOI 10.1042/bj1150837; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; ZIMMERMAN HE, 1957, J AM CHEM SOC, V79, P1920, DOI 10.1021/ja01565a041	67	4	4	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19849	19860		10.1074/jbc.M117.811034	http://dx.doi.org/10.1074/jbc.M117.811034			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972169	Green Published, hybrid			2022-12-26	WOS:000416911300028
J	Richard, AJ; Hang, H; Stephens, JM				Richard, Allison J.; Hang, Hardy; Stephens, Jacqueline M.			Pyruvate dehydrogenase complex (PDC) subunits moonlight as interaction partners of phosphorylated STAT5 in adipocytes and adipose tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); adipocyte; growth hormone; pyruvate dehydrogenase complex (PDC); signal transducers and activators of transcription 1 (STAT1)	ELECTRON-TRANSPORT CHAIN; HISTONE ACETYLATION; MITOCHONDRIAL STAT3; SIGNAL TRANSDUCER; TRANSCRIPTION; METABOLISM; EXPRESSION; ACTIVATOR; PROTEIN; TRANSLOCATION	STAT5 proteins play a role in adipocyte development and function, but their specific functions are largely unknown. To this end, we used an unbiased MS-based approach to identify novel STAT5-interacting proteins. We observed that STAT5A bound the E1 and E2 subunits of the pyruvate dehydrogenase complex (PDC). Whereas STAT5A typically localizes to the cytosol or nucleus, PDC normally resides within the mitochondrial matrix where it converts pyruvate to acetyl-CoA. We employed affinity purification and immunoblotting to validate the interaction between STAT5A and PDC subunits in murine and human cultured adipocytes, as well as in adipose tissue. We found that multiple PDC subunits interact with hormone-activated STAT5A in a dose- and time-dependent manner that coincides with tyrosine phosphorylation of STAT5. Using subcellular fractionation and immunofluorescence microscopy, we observed that PDC-E2 is present within the adipocyte nucleus where it associates with STAT5A. Because STAT5A is a transcription factor, we used chromatin immunoprecipitation (ChIP) to assess PDC's ability to interact with STAT5 DNA-binding sites. These analyses revealed that PDC-E2 is bound to a STAT5-binding site in the promoter of the STAT5 target gene cytokine-inducible SH2-containing protein (cish). We have demonstrated a compelling interaction between STAT5A and PDC subunits in adipocytes under physiological conditions. There is previous evidence that PDC localizes to cancer cell nuclei where it plays a role in histone acetylation. On the basis of our ChIP data and these previous findings, we hypothesize that PDC may modulate STAT5's ability to regulate gene expression by controlling histone or STAT5 acetylation.	[Richard, Allison J.; Hang, Hardy; Stephens, Jacqueline M.] Pennington Biomed Res Ctr, Adipocyte Biol Lab, Baton Rouge, LA 70808 USA; [Stephens, Jacqueline M.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University	Stephens, JM (corresponding author), Louisiana State Univ, Pennington Biomed Res Ctr, Adipocyte Biol Lab, Baton Rouge, LA 70808 USA.	jsteph1@lsu.edu	Stephens, Jacqueline M/R-5217-2018	Hang, Hardy/0000-0003-0794-3514	COBRE from the National Institutes of Health [NIH8 1P30GM118430-01]; NORC center from the National Institutes of Health [NIH 1P30-DK072476]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052968, P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM118430] Funding Source: NIH RePORTER	COBRE from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NORC center from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Anik Boudreau for technical support and manuscript editing. We are also grateful to Drs. Randy Mynatt, David Burk, and Rob Noland for sharing resources and equipment and for providing technical advice that helped us assess the association of PDC with STAT5A in vitro and in vivo. This project used Genomics and Cell Biology and Bioimaging core facilities that are supported in part by COBRE (NIH8 1P30GM118430-01) and NORC (NIH 1P30-DK072476) center grants from the National Institutes of Health.	Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Carrer A, 2017, J BIOL CHEM, V292, P3312, DOI 10.1074/jbc.M116.750620; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Chueh FY, 2011, CELL SIGNAL, V23, P1170, DOI 10.1016/j.cellsig.2011.03.004; Chueh FY, 2010, BIOCHEM BIOPH RES CO, V402, P778, DOI 10.1016/j.bbrc.2010.10.112; Davey HW, 1999, MOL CELL ENDOCRINOL, V158, P111, DOI 10.1016/S0303-7207(99)00175-6; Fuller S, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/862575; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Hiromasa Y, 2004, J BIOL CHEM, V279, P6921, DOI 10.1074/jbc.M308172200; Hogan JC, 2005, DIABETES, V54, P1968, DOI 10.2337/diabetes.54.7.1968; Khan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055426; Kheterpal I, 2010, PHYTOTHER RES, V24, P1278, DOI 10.1002/ptr.3093; Ling C, 2001, ENDOCRINOLOGY, V142, P4880, DOI 10.1210/en.142.11.4880; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Monaghan RM, 2015, TRENDS BIOCHEM SCI, V40, P728, DOI 10.1016/j.tibs.2015.10.003; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Richard AJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/549750; Richard AJ, 2012, BBA-MOL BASIS DIS, V1822, P557, DOI 10.1016/j.bbadis.2011.12.005; Richard AJ, 2011, TRENDS ENDOCRIN MET, V22, P325, DOI 10.1016/j.tem.2011.03.007; Stewart WC, 2011, OBESITY, V19, P1731, DOI 10.1038/oby.2011.66; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046; Szczepanek K, 2012, MITOCHONDRION, V12, P180, DOI 10.1016/j.mito.2011.08.011; Szczepanek K, 2011, J BIOL CHEM, V286, P29610, DOI 10.1074/jbc.M111.226209; Tammineni P, 2013, J BIOL CHEM, V288, P4723, DOI 10.1074/jbc.M112.378984; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; White UA, 2016, AM J PHYSIOL-ENDOC M, V310, pE129, DOI 10.1152/ajpendo.00068.2015; Xu YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep39517; Zhou ZH, 2001, J BIOL CHEM, V276, P21704, DOI 10.1074/jbc.M101765200	31	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19733	19742		10.1074/jbc.M117.811794	http://dx.doi.org/10.1074/jbc.M117.811794			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28982698	Green Published, hybrid			2022-12-26	WOS:000416911300018
J	Kanai, SM; Edwards, AJ; Rurik, JG; Osei-Owusu, P; Blumer, KJ				Kanai, Stanley M.; Edwards, Alethia J.; Rurik, Joel G.; Osei-Owusu, Patrick; Blumer, Kendall J.			Proteolytic degradation of regulator of G protein signaling 2 facilitates temporal regulation of G(q/11) signaling and vascular contraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; G protein; proteasome; regulator of G protein signaling (RGS); ubiquitylation; ubiquitination; ubiquitin; vascular biology; vascular smooth muscle cells	BLOOD MONONUCLEAR-CELLS; SMOOTH-MUSCLE-CELLS; END RULE PATHWAY; ANGIOTENSIN-II; MESSENGER-RNA; UP-REGULATION; RGS PROTEINS; HYPERTENSIVE PATIENTS; PRESSURE; IDENTIFICATION	Regulator of G protein signaling 2 (RGS2) controls signaling by receptors coupled to the G(q/11) class heterotrimeric G proteins. RGS2 deficiency causes several phenotypes in mice and occurs in several diseases, including hypertension in which a proteolytically unstable RGS2 mutant has been reported. However, the mechanisms and functions of RGS2 proteolysis remain poorly understood. Here we addressed these questions by identifying degradation signals in RGS2, and studying dynamic regulation of G(q/11)-evoked Ca2+ signaling and vascular contraction. We identified a novel bipartite degradation signal in the N-terminal domain of RGS2. Mutations disrupting this signal blunted proteolytic degradation downstream of E3 ubiquitin ligase binding to RGS2. Analysis of RGS2 mutants proteolyzed at various rates and the effects of proteasome inhibition indicated that proteolytic degradation controls agonist efficacy by setting RGS2 protein expression levels, and affecting the rate at which cells regain agonist responsiveness as synthesis of RGS2 stops. Analyzing contraction of mesenteric resistance arteries supported the biological relevance of this mechanism. Because RGS2 mRNA expression often is strikingly and transiently up-regulated and then down-regulated upon cell stimulation, our findings indicate that proteolytic degradation tightly couples RGS2 transcription, protein levels, and function. Together these mechanisms provide tight temporal control of G(q/11)-coupled receptor signaling in the cardiovascular, immune, and nervous systems.	[Kanai, Stanley M.; Rurik, Joel G.; Blumer, Kendall J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Edwards, Alethia J.; Osei-Owusu, Patrick] Drexel Univ, Dept Physiol & Pharmacol, Coll Med, Philadelphia, PA 19102 USA	Washington University (WUSTL); Drexel University	Blumer, KJ (corresponding author), Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	kblumer@wustl.edu	Rurik, Joel/ABD-6427-2021; Osei-Owusu, Patrick/AAH-9063-2019	Kanai, Stanley/0000-0001-9074-0624; Dixon, Alethia/0000-0002-4374-0688; Rurik, Joel/0000-0002-7156-4626	National Institutes of Health [GM044592, HL075632]; American Heart Association [16SDG27260276]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS086741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were supported by National Institutes of Health Grants GM044592 and HL075632 (to K.J.B.) and American Heart Association Grant 16SDG27260276 (to P. O.-O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; de Queiroz DB, 2015, BRIT J PHARMACOL, V172, P4699, DOI 10.1111/bph.13244; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Grant SL, 2000, MOL PHARMACOL, V57, P460, DOI 10.1124/mol.57.3.460; Gu S, 2008, MOL PHARMACOL, V73, P1, DOI 10.1124/mol.107.036285; Guharoy M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10239; Gurley SB, 2010, J AM SOC NEPHROL, V21, P1847, DOI 10.1681/ASN.2009121306; Hahntow IN, 2009, AM J HYPERTENS, V22, P80, DOI 10.1038/ajh.2008.310; Han S, 2007, J BIOL CHEM, V282, P26140, DOI 10.1074/jbc.M701969200; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Heximer SP, 2001, J BIOL CHEM, V276, P14195, DOI 10.1074/jbc.M009942200; Heximer SP, 2003, J CLIN INVEST, V111, P445, DOI 10.1172/JC1200315598; Heximer SP, 1997, DNA CELL BIOL, V16, P589, DOI 10.1089/dna.1997.16.589; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Hurst JH, 2009, BIOCHEM PHARMACOL, V78, P1289, DOI 10.1016/j.bcp.2009.06.028; Ingi T, 1998, J NEUROSCI, V18, P7178; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Jong YJI, 2005, J BIOL CHEM, V280, P30469, DOI 10.1074/jbc.M501775200; Kach J, 2012, AM J PHYSIOL-HEART C, V303, pH19, DOI 10.1152/ajpheart.00764.2011; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kimple AJ, 2009, J BIOL CHEM, V284, P19402, DOI 10.1074/jbc.M109.024711; Ko JK, 2001, BIOCHEM BIOPH RES CO, V287, P1025, DOI 10.1006/bbrc.2001.5692; Lu C, 2010, EUR J PHARMACOL, V634, P107, DOI 10.1016/j.ejphar.2010.02.006; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Neubig RR, 2015, PROG MOL BIOL TRANSL, V133, P13, DOI 10.1016/bs.pmbts.2015.04.010; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; Noe L, 2010, J THROMB HAEMOST, V8, P1594, DOI 10.1111/j.1538-7836.2010.03885.x; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Osei-Owusu P, 2007, J BIOL CHEM, V282, P31656, DOI 10.1074/jbc.M706360200; Osei-Owusu P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132594; Osei-Owusu P, 2014, AM J PHYSIOL-HEART C, V306, pH654, DOI 10.1152/ajpheart.00601.2013; Osei-Owusu P, 2012, J BIOL CHEM, V287, P12541, DOI 10.1074/jbc.M111.332130; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Park-Windhol C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040048; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Raveh A, 2014, MOL PHARMACOL, V86, P406, DOI 10.1124/mol.114.092403; Riddle EL, 2006, HYPERTENSION, V47, P415, DOI 10.1161/01.HYP.0000200714.81990.61; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Roy AA, 2006, J BIOL CHEM, V281, P32684, DOI 10.1074/jbc.M604416200; Sadowski M, 2010, MOL CELL BIOL, V30, P2316, DOI 10.1128/MCB.01094-09; Salim S, 2003, J BIOL CHEM, V278, P15842, DOI 10.1074/jbc.M210663200; Sastre E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126017; Semplicini A, 2006, J HYPERTENS, V24, P1115, DOI 10.1097/01.hjh.0000226202.80689.8f; Sethakorn N, 2010, CELL SIGNAL, V22, P1274, DOI 10.1016/j.cellsig.2010.03.016; SIDEROVSKI DP, 1994, DNA CELL BIOL, V13, P125, DOI 10.1089/dna.1994.13.125; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; Sjogren B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123581; Sjogren B, 2012, MOL PHARMACOL, V82, P500, DOI 10.1124/mol.112.079293; Sjogren B, 2016, J PHARMACOL EXP THER, V357, P311, DOI 10.1124/jpet.115.231571; Sun XG, 2005, MOL PHARMACOL, V67, P631, DOI 10.1124/mol.104.007724; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Thestrup T, 2014, NAT METHODS, V11, P175, DOI [10.1038/NMETH.2773, 10.1038/nmeth.2773]; Xie ZW, 2011, J BIOL CHEM, V286, P44646, DOI 10.1074/jbc.M111.265462; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Yang J, 2005, J HYPERTENS, V23, P1497, DOI 10.1097/01.hjh.0000174606.41651.ae; Zhang W, 2006, J BIOL CHEM, V281, P5811, DOI 10.1074/jbc.M507871200; Zou MX, 2006, CELL SIGNAL, V18, P1655, DOI 10.1016/j.cellsig.2006.01.012	60	7	7	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19266	19278		10.1074/jbc.M117.797134	http://dx.doi.org/10.1074/jbc.M117.797134			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28974581	Green Published, hybrid			2022-12-26	WOS:000416226700010
J	Lamontagne, J; Al-Mass, A; Nolan, CJ; Corkey, BE; Madiraju, SRM; Joly, E; Prentki, M				Lamontagne, Julien; Al-Mass, Anfal; Nolan, Christopher J.; Corkey, Barbara E.; Madiraju, S. R. Murthy; Joly, Erik; Prentki, Marc			Identification of the signals for glucose-induced insulin secretion in INS1 (832/13) -cells using metformin-induced metabolic deceleration as a model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (B-cell); glucose metabolism; insulin secretion; metformin; mitochondrial metabolism; metabolic coupling factors; metabolic deceleration	PANCREATIC BETA-CELLS; ACTIVATED PROTEIN-KINASE; CHRONIC EXPOSURE; MOUSE ISLETS; MALONYL-COA; CHAIN; FUEL; MITOCHONDRIA; PATHWAYS; POTENTIATION	Metabolic deceleration in pancreatic -cells is associated with inhibition of glucose-induced insulin secretion (GIIS), but only in the presence of intermediate/submaximal glucose concentrations. Here, we used acute metformin treatment as a tool to induce metabolic deceleration in INS1 (832/13) -cells, with the goal of identifying key pathways and metabolites involved in GIIS. Metabolites and pathways previously implicated as signals for GIIS were measured in the cells at 2-25 mm glucose, with or without 5 mm metformin. We defined three criteria to identify candidate signals: 1) glucose-responsiveness, 2) sensitivity to metformin-induced inhibition of the glucose effect at intermediate glucose concentrations, and 3) alleviation of metformin inhibition by elevated glucose concentrations. Despite the lack of recovery from metformin-induced impairment of mitochondrial energy metabolism (glucose oxidation, O-2 consumption, and ATP production), insulin secretion was almost completely restored at elevated glucose concentrations. Meeting the criteria for candidates involved in promoting GIIS were the following metabolic indicators and metabolites: cytosolic NAD(+)/NADH ratio (inferred from the dihydroxyacetone phosphate:glycerol-3-phosphate ratio), mitochondrial membrane potential, ADP, Ca2+, 1-monoacylglycerol, diacylglycerol, malonyl-CoA, and HMG-CoA. On the contrary, most of the purine and nicotinamide nucleotides, acetoacetyl-CoA, H2O2, reduced glutathione, and 2-monoacylglycerol were not glucose-responsive. Overall these results underscore the significance of mitochondrial energy metabolism-independent signals in GIIS regulation; in particular, the candidate lipid signaling molecules 1-monoacylglycerol, diacylglycerol, and malonyl-CoA; the predominance of K-ATP/Ca2+ signaling control by low ADPMg(2+) rather than by high ATP levels; and a role for a more oxidized state (NAD(+)/NADH) in the cytosol during GIIS that favors high glycolysis rates.	[Lamontagne, Julien; Al-Mass, Anfal; Madiraju, S. R. Murthy; Joly, Erik; Prentki, Marc] CRCHUM, Mol Nutr Unit, Montreal, PQ H2X 0A9, Canada; [Lamontagne, Julien; Al-Mass, Anfal; Madiraju, S. R. Murthy; Joly, Erik; Prentki, Marc] CRCHUM, Montreal Diabet Res Ctr, 900 St Denis,Rm R08-412, Montreal, PQ H2X 0A9, Canada; [Prentki, Marc] Univ Montreal, Dept Nutr, Montreal, PQ H3T 1J4, Canada; [Prentki, Marc] Univ Montreal, Dept Biochem, Montreal, PQ H3T 1J4, Canada; [Al-Mass, Anfal] McGill Univ, Dept Med, Montreal, PQ H4A 3J1, Canada; [Nolan, Christopher J.] Australian Natl Univ, Canberra Hosp, Dept Endocrinol, Canberra, ACT 2605, Australia; [Nolan, Christopher J.] Australian Natl Univ, Sch Med, Canberra, ACT 2605, Australia; [Corkey, Barbara E.] Boston Univ, Dept Med, Obes Res Ctr, Sch Med, Boston, MA 02118 USA	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University; Australian National University; Canberra Hospital; Australian National University; Boston University	Prentki, M (corresponding author), CRCHUM, Montreal Diabet Res Ctr, 900 St Denis,Rm R08-412, Montreal, PQ H2X 0A9, Canada.	marc.prentki@umontreal.ca	Nolan, Christopher J/B-2026-2008	Nolan, Christopher J/0000-0002-6964-3819	Canadian Institutes of Health Research; Kuwait University	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kuwait University	This work was supported by grants from Canadian Institutes of Health Research (to M. P. and S. R. M. M.) and a scholarship from Kuwait University (to A. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Andrikopoulos S, 2010, MOL CELL ENDOCRINOL, V316, P140, DOI 10.1016/j.mce.2009.09.031; Attane C, 2016, DIABETOLOGIA, V59, P2654, DOI 10.1007/s00125-016-4105-2; BRADLEY DC, 1989, ANAL BIOCHEM, V180, P11, DOI 10.1016/0003-2697(89)90081-X; Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Corkey BE, 2012, TRENDS ENDOCRIN MET, V23, P594, DOI 10.1016/j.tem.2012.07.006; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; El-Azzouny M, 2014, J BIOL CHEM, V289, P13575, DOI 10.1074/jbc.M113.531970; Erion KA, 2015, J BIOL CHEM, V290, P16191, DOI 10.1074/jbc.M114.620351; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Ferdaoussi M, 2012, DIABETOLOGIA, V55, P2682, DOI 10.1007/s00125-012-2650-x; Ferdaoussi M, 2017, TRENDS CELL BIOL, V27, P163, DOI 10.1016/j.tcb.2016.10.003; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Fu A, 2015, DIABETOLOGIA, V58, P1513, DOI 10.1007/s00125-015-3579-7; Guay C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077097; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Hinke SA, 2007, BRIT J PHARMACOL, V150, P1031, DOI 10.1038/sj.bjp.0707189; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Kefas BA, 2004, BIOCHEM PHARMACOL, V68, P409, DOI 10.1016/j.bcp.2004.04.003; Lamontagne J, 2013, DIABETES, V62, P2122, DOI 10.2337/db12-0428; Lamontagne J, 2009, ENDOCRINOLOGY, V150, P3465, DOI 10.1210/en.2008-1557; Leclerc I, 2004, AM J PHYSIOL-ENDOC M, V286, pE1023, DOI 10.1152/ajpendo.00532.2003; Lorenz MA, 2013, J BIOL CHEM, V288, P10923, DOI 10.1074/jbc.M112.414961; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Masini M, 2014, DIABETES RES CLIN PR, V104, P163, DOI 10.1016/j.diabres.2013.12.031; MATSCHINSKY FM, 1986, J BIOL CHEM, V261, P14057; Mugabo Y, 2017, J BIOL CHEM, V292, P7407, DOI 10.1074/jbc.M116.763060; Mugabo Y, 2016, P NATL ACAD SCI USA, V113, pE430, DOI 10.1073/pnas.1514375113; Mulder H, 2016, DIABETOLOGIA, V59, P2510, DOI 10.1007/s00125-016-4111-4; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nicholls DG, 2016, PHYSIOL REV, V96, P1385, DOI 10.1152/physrev.00009.2016; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Panten U, 2013, METABOLISM, V62, P1375, DOI 10.1016/j.metabol.2013.05.006; Pearson GL, 2016, MOL METAB, V5, P404, DOI 10.1016/j.molmet.2016.04.003; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Prentki M, 2012, MOL CELL ENDOCRINOL, V353, P88, DOI 10.1016/j.mce.2011.11.004; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Rutter GA, 2015, BIOCHEM J, V466, P203, DOI 10.1042/BJ20141384; Salani B, 2014, ENDOCR-RELAT CANCER, V21, pR461, DOI 10.1530/ERC-14-0284; Schmitz-Peiffer C, 2008, DIABETES, V57, P1774, DOI 10.2337/db07-1769; Sheu L, 2003, J BIOL CHEM, V278, P27556, DOI 10.1074/jbc.M303203200; Spegel P, 2015, ENDOCRINOLOGY, V156, P1995, DOI 10.1210/en.2014-1391; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Swisa A, 2015, J BIOL CHEM, V290, P20934, DOI 10.1074/jbc.M115.639237; Templeman NM, 2017, J ENDOCRINOL, V232, pR173, DOI [10.1530/JOE-16-0449, 10.1530/joe-16-0449]; Thorens B, 2014, DIABETES OBES METAB, V16, P87, DOI 10.1111/dom.12346; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914; Zhao S, 2015, MOL METAB, V4, P940, DOI 10.1016/j.molmet.2015.09.012; Zhao SG, 2014, CELL METAB, V19, P993, DOI 10.1016/j.cmet.2014.04.003	59	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19458	19468		10.1074/jbc.M117.808105	http://dx.doi.org/10.1074/jbc.M117.808105			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972173	Green Published, hybrid			2022-12-26	WOS:000416226700025
J	Inghels, M; Niangoran, S; Minga, A; Yoboue, JM; Dohoun, L; Yao, A; Eholie, S; Anglaret, X; Danel, C				Inghels, Maxime; Niangoran, Serge; Minga, Albert; Yoboue, Jean Michel; Dohoun, Lambert; Yao, Abo; Eholie, Serge; Anglaret, Xavier; Danel, Christine			Missed opportunities for HIV testing among newly diagnosed HIV-infected adults in Abidjan, Cote d'Ivoire	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CARE SETTINGS; AFRICA	Background HIV testing is crucial for starting ART earlier in HIV-infected people. We describe Missed Opportunities (MO) for HIV testing among adults newly diagnosed with HIV in Abidjan, Cote d'Ivoire. Methods Between april, 2nd 2013 and april 1st 2014, a cross-sectional study was conducted among all adults newly diagnosed (< 1year) for HIV at the Blood Donors Medical Center of Abidjan with face to face questionnaire. An MO for HIV testing was defined as a medical consultation for a clinical indicator (e.g. symptoms, hospitalization, and pregnancy) or a non-clinical indicator (e.g. high-risk sexual behavior, HIV-infected partner) potentially related to an HIV infection but did not lead to HIV test proposal by a health care professional. Results Of the 341 patients who attended the center suring this period, 273 (157 women and 116 men) were included in this analysis. 130 (47.6%) reported at least one medical consultation for an indicator relevant for a test proposal between 1 month and five years prior to their diagnosis. Among them, 92 (77.3%) experienced at least one MO for testing. The 273 included patients reported a total of 216 indicators; 146 (67.6%) were reported without test proposal and thus were MO. Hospitalization, extreme lose of weight, chronic or repeat fever and herpes zoster were the indicators with the largest number of MO. While 66 (24.2%) patients experienced non-clinical indicators relevant to risk of HIV infection, only 11 (4.0%) mentioned it to a health professional. Conclusion MO for HIV testing are frequent, even in situations for which testing is clearly recommended. Better train healthcare professionals and creating new opportunities of testing inside and, outside of medical settings are crucial to improve HIV control.	[Inghels, Maxime] Paris Descartes Inst Rech & Dev IRD, UMR 196, Ctr Populat & Dev CEPED, Paris, France; [Niangoran, Serge; Minga, Albert; Yoboue, Jean Michel; Dohoun, Lambert; Yao, Abo; Eholie, Serge; Anglaret, Xavier; Danel, Christine] CHU Treichville, Programme PAC CI ANRS Res Site, Abidjan, Cote Ivoire; [Minga, Albert; Yoboue, Jean Michel; Dohoun, Lambert; Yao, Abo] CNTS, Ctr Med Suivi Donneurs Sang, CMSDS, Abidjan, Cote Ivoire; [Eholie, Serge] Treichville Hosp, Dept Infect Dis, Abidjan, Cote Ivoire; [Anglaret, Xavier; Danel, Christine] Bordeaux Univ, Ctr Inserm 1219, Bordeaux, France	UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm)	Inghels, M (corresponding author), Paris Descartes Inst Rech & Dev IRD, UMR 196, Ctr Populat & Dev CEPED, Paris, France.	maxime.inghels@gmail.com	Inghels, Maxime/AAY-1967-2020; Anglaret, Xavier/F-7333-2013; Anglaret, Xavier/T-2757-2019; Eholie, Serge/T-6008-2019	Inghels, Maxime/0000-0002-9340-2054; NIANGORAN, Serge/0000-0003-1747-1995; Anglaret, Xavier/0000-0003-3319-8423	France Recherche Nord AMP; Sud Sida-hiv Hepatites; SIDACTION	France Recherche Nord AMP; Sud Sida-hiv Hepatites; SIDACTION	The study was funded by the France Recherche Nord & Sud Sida-hiv Hepatites (http:// www.anrs.fr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank Alvine Gomene, Benjamin Osher and Justine Althea Scott for the translation and editing of the manuscript. We also thank SIDACTION for the financial support to Maxime Inghels.	Burns FM, 2008, AIDS, V22, P115, DOI 10.1097/QAD.0b013e3282f1d4b6; Champenois K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-200; Chin T, 2013, AIDS PATIENT CARE ST, V27, P392, DOI 10.1089/apc.2013.0099; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Duffus WA, 2012, J WOMENS HEALTH, V21, P170, DOI 10.1089/jwh.2010.2655; Ekouevi DK, 2010, TROP MED INT HEALTH, V15, P34, DOI 10.1111/j.1365-3156.2010.02505.x; Ellis S, 2012, CLIN MED, V12, P430, DOI 10.7861/clinmedicine.12-5-430; Jenkins TC, 2006, SEX TRANSM DIS, V33, P329, DOI 10.1097/01.olq.0000194617.91454.3f; Klein D, 2003, JAIDS-J ACQ IMM DEF, V32, P143, DOI 10.1097/00126334-200302010-00005; Liddicoat RV, 2004, J GEN INTERN MED, V19, P349, DOI 10.1111/j.1525-1497.2004.21251.x; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Manga NM, 2009, MED MALADIES INFECT, V39, P95, DOI 10.1016/j.medmal.2008.09.021; Ministere de la Sante A et de la Lutte contre le Sida [Co A te d'Ivoire] & Institut National de la Statistique (INS) MEASURE DHS, 2013, ENQ DEM SANT IND MUL; Moore RD, 1998, J ACQ IMMUN DEF SYND, V19, P29, DOI 10.1097/00042560-199809010-00004; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; UNAIDS, 2013, RAPP EP MOND SID 201; van der Loeff MFS, 2006, INT J EPIDEMIOL, V35, P1322, DOI 10.1093/ije/dyl037; Wanyenze RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021794; Wohlgemut J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-72; World Health Organization, 2015, GUID START ANT THER; World Health Organization, WORLD HLTH STAT 2015	24	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185117	10.1371/journal.pone.0185117	http://dx.doi.org/10.1371/journal.pone.0185117			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977006	Green Published, gold, Green Submitted			2022-12-26	WOS:000412163100016
J	Lombardi, MS; Gillieron, C; Berkelaar, M; Gabay, C				Lombardi, Maria Stella; Gillieron, Corine; Berkelaar, Majoska; Gabay, Cem			Salt-inducible kinases (SIK) inhibition reduces RANKL-induced osteoclastogenesis	PLOS ONE			English	Article							NF-KAPPA-B; RECEPTOR ACTIVATOR; PROTEIN-KINASE; BONE-RESORPTION; C-FOS; DIFFERENTIATION; EXPRESSION; PATHWAYS; LIGAND; TLR	Osteoclasts are large multinucleated cells responsible for bone resorption. Excessive inflammatory activation of osteoclasts leads to bony erosions, which are the hallmark of several diseases such as rheumatoid arthritis (RA). Salt-inducible kinases (SIK) constitute a subfamily of kinases comprising three members (SIK1,-2, and -3). Inhibition of SIK kinase activity induces an anti-inflammatory phenotype in macrophages. Since osteoclasts originate from precursors of macrophage origin, we hypothesized a role of SIK in osteoclastogenesis. We analyzed SIK1,-2 and -3 expression and function in osteoclast differentiation using the mouse macrophage cell line RAW264.7 and bone marrow-derived macrophages (BMM). We show that all three SIK are expressed in fully differentiated osteoclasts and that in BMM-derived osteoclasts there is an increased expression of SIK1 and SIK3 proteins. Interestingly, the pan-SIK inhibitor HG-9-91-01 significantly inhibited osteoclastogenesis by dose dependently reducing osteoclast differentiation markers (i. e. CathepsinK, MMP-9 and TRAP) and bone resorbing activity. Analysis of the signaling pathways activated by RANKL in RAW cells showed that SIK inhibitors did not affect RANKL-induced ERK1/2, JNK, p38 or NF-.B activation, but induced a significant downregulation in c-Fos and NFATc1 protein levels, the two main transcription factors involved in the regulation of osteoclast-specific genes. Moreover, SIK inhibition partially increased the proteasome-mediated degradation of c-Fos. SIK2 and SIK3 knockout RAW cells were generated by the CRISPR/Cas9 approach. SIK2 KO and, to a lesser extent, SIK3 KO recapitulated the effect of SIK small molecule inhibitor, thus confirming the specificity of the effect of SIK inhibition on the reduction of osteoclastogenesis. Overall, our results support the notion that the SIK signaling pathway plays a significant role among the check-points controlling osteoclastogenesis. SIK kinase inhibitors could thus represent a potential novel therapy to prevent bone erosions.	[Lombardi, Maria Stella; Gillieron, Corine; Berkelaar, Majoska; Gabay, Cem] Univ Hosp Geneva, Div Rheumatol, Dept Internal Med Specialties, Geneva, Switzerland; [Lombardi, Maria Stella; Gillieron, Corine; Berkelaar, Majoska; Gabay, Cem] Univ Geneva, Dept Pathol & Immunol, Sch Med, Geneva, Switzerland; [Lombardi, Maria Stella] GSK Consumer Healthcare, Dept Preclin Dev, Nyon, Switzerland	University of Geneva; University of Geneva	Lombardi, MS; Gabay, C (corresponding author), Univ Hosp Geneva, Div Rheumatol, Dept Internal Med Specialties, Geneva, Switzerland.; Lombardi, MS; Gabay, C (corresponding author), Univ Geneva, Dept Pathol & Immunol, Sch Med, Geneva, Switzerland.; Lombardi, MS (corresponding author), GSK Consumer Healthcare, Dept Preclin Dev, Nyon, Switzerland.	maria-stella.x.lombardi@gsk.com; cem.gabay@houge.ch			Rheumasearch Foundation; Institute of Arthritis Research (iAR); Swiss National Science Foundation (SNF) [310030_172674]	Rheumasearch Foundation; Institute of Arthritis Research (iAR); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	This work was supported by the Rheumasearch Foundation (grant to M.S. Lombardi) and by the Institute of Arthritis Research (iAR) and the Swiss National Science Foundation (SNF grant number 310030_172674) to C. Gabay.	Adamopoulos IE, 2015, NAT REV RHEUMATOL, V11, P189, DOI 10.1038/nrrheum.2014.198; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bagnis Claude, 2009, V515, P151, DOI 10.1007/978-1-59745-559-6_10; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; BURGER EH, 1982, J EXP MED, V156, P1604, DOI 10.1084/jem.156.6.1604; Clark K, 2014, BIOCHEM SOC T, V42, P11, DOI 10.1042/BST20130124; Clark K, 2012, P NATL ACAD SCI USA, V109, P16986, DOI 10.1073/pnas.1215450109; Darling NJ, 2017, BIOCHEM J, V474, P521, DOI 10.1042/BCJ20160646; Fu Q, 2002, J BIOL CHEM, V277, P48868, DOI 10.1074/jbc.M208494200; Granholm S, 2007, J ENDOCRINOL, V195, P415, DOI 10.1677/JOE-07-0338; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Han KY, 2007, BIOCHEM PHARMACOL, V74, P911, DOI 10.1016/j.bcp.2007.06.044; Ito Y, 2005, BONE, V37, P842, DOI 10.1016/j.bone.2005.04.030; Katoh Y, 2004, MOL CELL ENDOCRINOL, V217, P109, DOI 10.1016/j.mce.2003.10.016; Kim JH, 2010, J BIOL CHEM, V285, P5224, DOI 10.1074/jbc.M109.042812; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Li X, 2015, SHOCK VIB, V2015, DOI 10.1155/2015/431476; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lombardi MS, 2016, J LEUKOCYTE BIOL, V99, P711, DOI 10.1189/jlb.2A0715-307R; Lubberts E, 2002, ARTHRITIS RHEUM, V46, P3055, DOI 10.1002/art.10607; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Ozanne J, 2015, BIOCHEM J, V465, P271, DOI 10.1042/BJ20141165; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phan TCA, 2004, HISTOL HISTOPATHOL, V19, P1325, DOI 10.14670/HH-19.1325; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sasagawa S, 2012, DEVELOPMENT, V139, P1153, DOI 10.1242/dev.072652; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Wei S, 2001, ENDOCRINOLOGY, V142, P1290, DOI 10.1210/en.142.3.1290; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200	36	16	17	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185426	10.1371/journal.pone.0185426	http://dx.doi.org/10.1371/journal.pone.0185426			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973003	Green Published, Green Submitted, gold			2022-12-26	WOS:000412131900017
J	Sesti-Costa, R; Francozo, MCS; Silva, GK; Proenca-Modena, JL; Silva, JS				Sesti-Costa, Renata; Santiago Francozo, Marcela Cristina; Silva, Grace Kelly; Proenca-Modena, Jose Luiz; Silva, Joao Santana			TLR3 is required for survival following Coxsackievirus B3 infection by driving T lymphocyte activation and polarization: The role of dendritic cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; B3-INDUCED MYOCARDITIS; SIGNALING PATHWAYS; VIRAL MYOCARDITIS; INTERFERON-GAMMA; CUTTING EDGE; TH17 CELLS; RECOGNITION; MACROPHAGE; IMMUNITY	Type B coxsackievirus (CVB) is a common cause of acute and chronic myocarditis, meningitis and pancreatitis, often leading to heart failure and pancreatic deficiency. The polarization of CD4(+) T lymphocytes and their cytokine milieu are key factors in the outcome of CVB-induced diseases. Thus, sensing the virus and driving the adaptive immune response are essential for the establishment of a protective immune response. TLR3 is a crucial virus recognition receptor that confers the host with resistance to CVB infection. In the current study, we found that TLR3 expression in dendritic cells plays a role in their activation upon CVB3 infection in vitro, as TLR3-deficient dendritic cells up-regulate CD80 and CD86 to a less degree than WT cells. Instead, they up-regulated the inhibitory molecule PD-L1 and secreted considerably lower levels of TNF-alpha and IL-10 and a higher level of IL-23. T lymphocyte proliferation in co-culture with CVB3-infected dendritic cells was increased by TLR3-expressing DCs and other cells. Furthermore, in the absence of TLR3, the T lymphocyte response was shifted toward a Th17 profile, which was previously reported to be deleterious for the host. TLR3-deficient mice were very susceptible to CVB3 infection, with increased pancreatic injury and extensive inflammatory infiltrate in the heart that was associated with uncontrolled viral replication. Adoptive transfer of TLR3(+) dendritic cells slightly improved the survival of TLR-deficient mice following CVB3 infection. Therefore, our findings highlight the importance of TLR3 signaling in DCs and in other cells to induce activation and polarization of the CD4(+) T lymphocyte response toward a Th1 profile and consequently for a better outcome of CVB3 infection. These data provide new insight into the immune-mediated mechanisms by which CVBs are recognized and cleared in order to prevent the development of myocarditis and pancreatitis and may contribute to the design of therapies for enteroviral infections.	[Sesti-Costa, Renata; Santiago Francozo, Marcela Cristina; Silva, Grace Kelly; Silva, Joao Santana] Univ Sao Paulo, Dept Biochem & Immunol, Sch Med Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Santiago Francozo, Marcela Cristina] Ctr Expt & Clin Infect Res GmbH, TWINCORE, Inst Infect Immunol, Hannover, Germany; [Proenca-Modena, Jose Luiz] Univ Campinas UNICAMP, Dept Genet Evolut & Bioagents, Inst Biol, Campinas, SP, Brazil	Universidade de Sao Paulo; Helmholtz Association; Helmholtz-Center for Infection Research; Universidade de Sao Paulo; Universidade Estadual de Campinas	Silva, JS (corresponding author), Univ Sao Paulo, Dept Biochem & Immunol, Sch Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.	jsdsilva@fmrp.usp.br	Sesti-Costa, Renata/H-9115-2012; Silva, Joao/A-4484-2008; Proenca-Modena, Jose Luiz/C-8231-2014	Sesti-Costa, Renata/0000-0002-7098-2850; Silva, Joao/0000-0002-3410-3927; Proenca-Modena, Jose Luiz/0000-0002-4996-3153	Sao Paulo Research Foundation (FAPESP) [2012/20786-6, 2013/08216-2]; University of Sao Paulo NAP-DIN [11.1.21625.01.0]; CNPq [445271/2014-0]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); University of Sao Paulo NAP-DIN; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The research leading to these results received funding from the Sao Paulo Research Foundation (FAPESP) under grants agreements no. 2012/20786-6 and no. 2013/08216-2 (Center for Research in Inflammatory Disease), and from the University of Sao Paulo NAP-DIN under grant agreement no. 11.1.21625.01.0, http://www.fapesp.br/en/. This study was also funded by CNPq, process number 445271/2014-0. http://www.cnpq.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Cristiane M. Milanezi and Wander C. R. da Silva for technical support. The research leading to these results received funding from the Sao Paulo Research Foundation (FAPESP) under grants agreements no 2012/20786-6 and no. 2013/08216-2 (Center for Research in Inflammatory Disease), from the University of Sao Paulo NAP-DIN under grant agreement no. 11.1.21625.01.0. http://www.fapesp.br/en/. This study was also funded by CNPq, process number 445271/2014-0. http://www.cnpq.br.	Abston ED, 2013, AM J PHYSIOL-REG I, V304, pR267, DOI 10.1152/ajpregu.00516.2011; Abston ED, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/129486; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Chen P, 2009, INT IMMUNOPHARMACOL, V9, P1304, DOI 10.1016/j.intimp.2009.07.014; Cihakova D, 2008, AM J PATHOL, V172, P1195, DOI 10.2353/ajpath.2008.070207; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Fairweather D, 2005, J IMMUNOL, V174, P261, DOI 10.4049/jimmunol.174.1.261; Fairweather D, 2004, AM J PATHOL, V165, P1883, DOI 10.1016/S0002-9440(10)63241-5; Fan YH, 2011, VIROL J, V8, DOI [10.1186/1743-422X-8-492, 10.1186/1743-422X-8-17]; Frisancho-Kiss S, 2009, BRAIN BEHAV IMMUN, V23, P649, DOI 10.1016/j.bbi.2008.12.002; Fuse K, 2005, CIRCULATION, V112, P2276, DOI 10.1161/CIRCULATIONAHA.105.536433; Gauntt C, 2003, FRONT BIOSCI-LANDMRK, V8, pE23, DOI 10.2741/928; Gorbea C, 2010, J BIOL CHEM, V285, P23206, DOI 10.1074/jbc.M109.047464; Gupta S, 2008, NAT CLIN PRACT CARD, V5, P693, DOI 10.1038/ncpcardio1331; Hardarson HS, 2007, AM J PHYSIOL-HEART C, V292, pH251, DOI 10.1152/ajpheart.00398.2006; Huber S, 2004, VIRAL IMMUNOL, V17, P358, DOI 10.1089/vim.2004.17.358; Huber SA, 2005, J VIROL, V79, P2659, DOI 10.1128/JVI.79.5.2659-2665.2005; Huber SA, 2006, CIRC RES, V99, P1109, DOI 10.1161/01.RES.0000249405.13536.49; Kandolf R, 1999, VIRUS RES, V62, P149, DOI 10.1016/S0168-1702(99)00041-6; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kaya Z, 2002, J IMMUNOL, V168, P1552, DOI 10.4049/jimmunol.168.4.1552; Kemball CC, 2012, VIROLOGY, V429, P74, DOI 10.1016/j.virol.2012.04.005; Kemball CC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000618; Klingel K, 2003, AM J PATHOL, V162, P1709, DOI 10.1016/S0002-9440(10)64305-2; KLINGEL K, 1992, P NATL ACAD SCI USA, V89, P314, DOI 10.1073/pnas.89.1.314; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Lee HK, 2007, SEMIN IMMUNOL, V19, P48, DOI 10.1016/j.smim.2006.12.001; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004937; Leonard EG, 2004, PEDIATR INFECT DIS J, V23, P665, DOI 10.1097/01.inf.0000132280.36984.a9; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; McCall KD, 2015, ENDOCRINOLOGY, V156, P453, DOI 10.1210/en.2013-2006; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Menager P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000315; Negishi H, 2008, P NATL ACAD SCI USA, V105, P20446, DOI 10.1073/pnas.0810372105; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Oshiumi H, 2011, J IMMUNOL, V187, P5320, DOI 10.4049/jimmunol.1101503; Pankuweit S, 2013, HEART FAIL REV, V18, P683, DOI 10.1007/s10741-012-9357-4; Proietto AI, 2004, IMMUNOBIOLOGY, V209, P163, DOI 10.1016/j.imbio.2004.03.002; Rahnefeld A, 2011, EUR J IMMUNOL, V41, P2774, DOI 10.1002/eji.201041039; Riad A, 2011, J IMMUNOL, V186, P2561, DOI 10.4049/jimmunol.1002029; Richer MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004127; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Sesti-Costa R, 2013, J IMMUNOL, V191, P283, DOI 10.4049/jimmunol.1202806; Shi Y, 2010, CIRCULATION, V121, P2624, DOI 10.1161/CIRCULATIONAHA.109.893248; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Szeles L, 2015, J IMMUNOL, V195, P1025, DOI 10.4049/jimmunol.1402033; Tracy S, 2000, J MED VIROL, V62, P70, DOI 10.1002/1096-9071(200009)62:1<70::AID-JMV11>3.0.CO;2-R; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Weinzierl AO, 2008, J VIROL, V82, P8149, DOI 10.1128/JVI.00047-08; Whitton JL, 2005, NAT REV MICROBIOL, V3, P765, DOI 10.1038/nrmicro1284; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Xie YQ, 2011, VIROLOGY, V421, P78, DOI 10.1016/j.virol.2011.09.006; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yanagawa B, 2004, J INFECT DIS, V189, P1431, DOI 10.1086/382598; Yuan J, 2010, J IMMUNOL, V185, P4004, DOI 10.4049/jimmunol.1001718; Yuan J, 2010, J CLIN IMMUNOL, V30, P226, DOI 10.1007/s10875-009-9355-z	61	12	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185819	10.1371/journal.pone.0185819	http://dx.doi.org/10.1371/journal.pone.0185819			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973047	Green Published, gold, Green Submitted			2022-12-26	WOS:000412131900057
J	Brauswetter, D; Gurbi, B; Varga, A; Varkondi, E; Schwab, R; Banhegyi, G; Fabian, O; Keri, G; Valyi-Nagy, I; Petak, I				Brauswetter, Diana; Gurbi, Bianka; Varga, Attila; Varkondi, Edit; Schwab, Richard; Banhegyi, Gabor; Fabian, Orsolya; Keri, Gyorgy; Valyi-Nagy, Istvan; Petak, Istvan			Molecular subtype specific efficacy of MEK inhibitors in pancreatic cancers	PLOS ONE			English	Article							LUNG-CANCER; KRAS; ADENOCARCINOMA; COMBINATION; TRAMETINIB; EXPRESSION; LANDSCAPE; FEEDBACK; GROWTH; MODEL	Pancreatic cancer is an increasing cause of cancer related death worldwide. KRAS is the dominant oncogene in this cancer type and molecular rationale would indicate, that inhibitors of the downstream target MEK could be appropriate targeted agents, but clinical trials have failed so far to achieve statistically significant benefit in unselected patients. We aimed to identify predictive molecular biomarkers that can help to define subgroups where MEK inhibitors might be beneficial alone or in combination. Next-generation sequencing data of 50 genes in three pancreatic cancer cell lines (MiaPaCa2, BxPC3 and Panc1) were analyzed and compared to the molecular profile of 138 clinical pancreatic cancer samples to identify the molecular subtypes of pancreatic cancer these cell lines represent. Luminescent cell viability assay was used to determine the sensitivity of cell lines to kinase inhibitors. Western blot was used to analyze the pathway activity of the examined cell lines. According to our cell viability and pathway activity data on these model cell lines only cells harboring the rare G12C KRAS mutation and low EGFR expression are sensitive to single MEK inhibitor (trametinib) treatment. The common G12D KRAS mutation leads to elevated baseline Akt activity, thus treatment with single MEK inhibitors fails. However, combination of MEK and Akt inhibitors are synergistic in this case. In case of wild-type KRAS and high EGFR expression MEK inhibitor induced Akt phosphorylation leads to trametinib resistance which necessitates for MEK and EGFR or Akt inhibitor combination treatment. In all we provide strong preclinical rational and possible molecular mechanism to revisit MEK inhibitor therapy in pancreatic cancer in both monotherapy and combination, based on molecular profile analysis of pancreatic cancer samples and cell lines. According to our most remarkable finding, a small subgroup of patients with G12C KRAS mutation may still benefit from MEK inhibitor monotherapy.	[Brauswetter, Diana; Gurbi, Bianka; Varga, Attila; Banhegyi, Gabor; Keri, Gyorgy; Petak, Istvan] MTA SE Pathobiochem Res Grp, Budapest, Hungary; [Varkondi, Edit; Schwab, Richard; Fabian, Orsolya; Petak, Istvan] Oncompass Med Ltd, Budapest, Hungary; [Banhegyi, Gabor] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, Budapest, Hungary; [Valyi-Nagy, Istvan] St Istvan & St Laszlo Hosp, Budapest, Hungary	Semmelweis University; Semmelweis University	Brauswetter, D (corresponding author), MTA SE Pathobiochem Res Grp, Budapest, Hungary.	brauswetter.diana@med.semmelweis-univ.hu	Petak, Istvan/X-3656-2019; Gurbi, Bianka/F-4220-2017; Schwab, Richard/AAX-9262-2020	Gurbi, Bianka/0000-0002-5635-6255; Valyi-Nagy, Istvan/0000-0003-3581-113X	(National Oncogenomical and Precision Oncotherapy Program) by NFKI Fund of National Research, Development and Innovation Office [NVKP_16-1-2016-0005]	(National Oncogenomical and Precision Oncotherapy Program) by NFKI Fund of National Research, Development and Innovation Office	This study was supported by the grant NVKP_16-1-2016-0005 (National Oncogenomical and Precision Oncotherapy Program) by NFKI Fund of National Research, Development and Innovation Office.	Bedard PL, 2015, CLIN CANCER RES, V21, P730, DOI 10.1158/1078-0432.CCR-14-1814; Bloomston M, 2006, DIGEST SURG, V23, P74, DOI 10.1159/000093497; Bodoky G, 2012, INVEST NEW DRUG, V30, P1216, DOI 10.1007/s10637-011-9687-4; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Collisson EA, 2012, CANCER DISCOV, V2, P685, DOI 10.1158/2159-8290.CD-11-0347; Dumble M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100880; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Glubb DM, 2011, CLIN CANCER RES, V17, P5257, DOI 10.1158/1078-0432.CCR-11-0379; Heestand GM, 2015, ONCOTARGET, V6, P4553, DOI 10.18632/oncotarget.2972; Ihle NT, 2012, JNCI-J NATL CANCER I, V104, P228, DOI 10.1093/jnci/djr523; Infante JR, 2014, EUR J CANCER, V50, P2072, DOI 10.1016/j.ejca.2014.04.024; Janne PA, 2015, BRIT J CANCER, V113, P199, DOI 10.1038/bjc.2015.215; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Makohon-Moore A, 2016, NAT REV CANCER, V16, P553, DOI 10.1038/nrc.2016.66; Manchado E, 2016, NATURE, V534, P647, DOI 10.1038/nature18600; Mirzoeva OK, 2013, MOL CANCER THER, V12, P2213, DOI 10.1158/1535-7163.MCT-13-0104; Modest DP, 2013, J CANCER RES CLIN, V139, P953, DOI 10.1007/s00432-013-1401-9; Mullendore ME, 2009, CLIN CANCER RES, V15, P2291, DOI 10.1158/1078-0432.CCR-08-2004; Nadal E, 2015, J THORAC ONCOL, V10, pE9, DOI 10.1097/JTO.0000000000000438; Pettazzoni P, 2015, CANCER RES, V75, P1091, DOI 10.1158/0008-5472.CAN-14-1854; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Silva IP, 2016, CLIN CANCER RES, V22, P2377, DOI 10.1158/1078-0432.CCR-15-1811; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Walters DM, 2013, NEOPLASIA, V15, P143, DOI 10.1593/neo.121712; Wolfgang CL, 2013, CA-CANCER J CLIN, V63, P318, DOI 10.3322/caac.21190; Zhang NN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153546; Zhou L, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0745-9	30	15	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185687	10.1371/journal.pone.0185687	http://dx.doi.org/10.1371/journal.pone.0185687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957417	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000411985200106
J	Hossein, F; Ghosh, P; Khan, MAA; Duthie, MS; Vallur, AC; Picone, A; Howard, RF; Reed, SG; Mondai, D				Hossein, Faria; Ghosh, Prakash; Khan, Md. Anik Ashfaq; Duthie, Malcolm S.; Vallur, Aarthy C.; Picone, Alessandro; Howard, Randall F.; Reed, Steven G.; Mondai, Dinesh			Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatment	PLOS ONE			English	Article							AZAR DERMAL LEISHMANIASIS; POLYMERASE-CHAIN-REACTION; PERIPHERAL-BLOOD; CLINICAL MANAGEMENT; INFANTUM DNA; ENDEMIC AREA; ASSAY; QUANTIFICATION; SAMPLES; TOOLS	Sustained elimination of Visceral Leishmaniasis (VL) requires the reduction and control of parasite reservoirs to minimize the transmission of Leishmania donovani infection. A simple, reproducible and definitive diagnostic procedure is therefore indispensable for the early and accurate detection of parasites in VL, Relapsed VL (RVL) and Post Kala-azar Dermal Leishmaniasis (PKDL) patients, all of whom are potential reservoirs of Leishmania parasites. To overcome the limitations of current diagnostic approaches, a novel quantitative real-time polymerase chain reaction (qPCR) method based on Taqman chemistry was devised for the detection and quantification of L. donovani in blood and skin. The diagnostic efficacy was evaluated using archived peripheral blood buffy coat DNA from 40 VL, 40 PKDL, 10 RVL, 20 cured VL, and 40 cured PKDL along with 10 tuberculosis (TB) cases and 80 healthy endemic controls. Results were compared to those obtained using a Leishmania-specific nested PCR (Ln-PCR). The real time PCR assay was 100% (95% CI, 91.19-100%) sensitive in detecting parasite genomes in VL and RVL samples and 85.0% (95% CI, 70.16-94.29%) sensitive for PKDL samples. In contrast, the sensitivity of Ln-PCR was 77.5% (95% CI, 61.55-89.16%) for VL samples, 100% (95% CI, 69.15-100%) for RVL samples, and 52.5% (95% CI, 36.13-68.49%) for PKDL samples. There was significant discordance between the two methods with the overall sensitivity of the qPCR assay being considerably higher than Ln-PCR. None of the assay detected L. donovani DNA in buffy coats from cured VL cases, and reduced infectious burdens were demonstrated in cured PKDL cases who remained positive in 7.5% (3/40) and 2.5% (1/40) cases by real-time PCR and Ln-PCR, respectively. Both assays were 100% (95% CI, 95.98-100) specific with no positive signals in either endemic healthy control or TB samples. The real time PCR assay we developed offers a molecular tool for accurate detection of circulating L. donovani parasites in VL, PKDL and RVL patients, as well as being capable of assessing response to treatment. As such, this real time PCR assay represents an important contribution in efforts to eliminate VL.	[Hossein, Faria; Ghosh, Prakash; Khan, Md. Anik Ashfaq; Mondai, Dinesh] Int Ctr Diarrhoea Dis Res, Nutr & Clin Sci Div, Lab Emerging Infect & Parasitol, Dhaka, Bangladesh; [Duthie, Malcolm S.; Picone, Alessandro; Howard, Randall F.; Reed, Steven G.] Infect Dis Res Inst, Seattle, WA USA; [Vallur, Aarthy C.] InBios Int Inc, Seattle, WA USA	International Centre for Diarrhoeal Disease Research (ICDDR)	Mondai, D (corresponding author), Int Ctr Diarrhoea Dis Res, Nutr & Clin Sci Div, Lab Emerging Infect & Parasitol, Dhaka, Bangladesh.	din63d@icddrb.org	Khan, Md Anik Ashfaq/ABA-7789-2021; Ghosh, Prakash/ABS-4307-2022	Khan, Md Anik Ashfaq/0000-0003-2963-7649; Ghosh, Prakash/0000-0002-4300-8761; Duthie, Malcolm/0000-0002-8515-5516	Bill and Melinda Gates Foundation [OPP49932, OPP1084251]; NIAID of the National Institutes of Health [R01A1025038]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIAID of the National Institutes of Health	This research was supported with funding from the Bill and Melinda Gates Foundation, under grants OPP49932 and OPP1084251 and by Grant No. R01A1025038 from NIAID of the National Institutes of Health to Dr. Steven G Reed. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Bill and Melinda Gates Foundation or the National Institutes of Health. The funder provided support in the form of salaries for authors [DM, PG, FH, MAAK,], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section". One of the authors is working in InBios International Inc who voluntarily worked in developing the manuscript. Therefore, InBios International Inc has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeijon C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002161; Adams ER, 2013, J TROP MED-US, V2013, DOI 10.1155/2013/150746; Antinori S, 2007, CLIN INFECT DIS, V44, P1602, DOI 10.1086/518167; Antinori S, 2009, AM J TROP MED HYG, V81, P46, DOI 10.4269/ajtmh.2009.81.46; Bossolasco S, 2003, J CLIN MICROBIOL, V41, P5080, DOI 10.1128/JCM.41.11.5080-5084.2003; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Cruz I, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS185, DOI 10.1016/S0035-9203(02)90074-X; Cruz I, 2006, J CLIN MICROBIOL, V44, P2343, DOI 10.1128/JCM.02297-05; Freitas-Junior LH, 2012, INT J PARASITOL-DRUG, V2, P11, DOI 10.1016/j.ijpddr.2012.01.003; Ghasemian Mehrdad, 2016, J Parasit Dis, V40, P81, DOI 10.1007/s12639-014-0452-4; Ghosh P, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1667-2; Hasnain MG, 2016, AM J TROP MED HYG, V94, P99, DOI 10.4269/ajtmh.15-0136; Islam S, 2013, AM J TROP MED HYG, V89, P345, DOI 10.4269/ajtmh.12-0711; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Lima Junior M. S. da C., 2013, Asian Pacific Journal of Tropical Disease, V3, P10; Marking U, 2014, PLOS NEGLECT TROP D, V8, P6; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; Mary C, 2006, AM J TROP MED HYG, V75, P858, DOI 10.4269/ajtmh.2006.75.858; Matlashewski G, 2011, LANCET INFECT DIS, V11, P322, DOI 10.1016/S1473-3099(10)70320-0; Mondal D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000355; Mukhopadhyay D, 2014, TRENDS PARASITOL, V30, P65, DOI 10.1016/j.pt.2013.12.004; Nasreen SA, 2012, JPN J INFECT DIS, V65, P315, DOI 10.7883/yoken.65.315; Pereira MR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/639310; Pita-Pereira D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-15; Ruiter CM, 2014, J CLIN MICROBIOL, V52; Salam MA, 2010, ACTA TROP, V113, P52, DOI 10.1016/j.actatropica.2009.09.005; Salotra P, 2006, INDIAN J MED RES, V123, P295; Sharma Umakant, 2008, Journal of Vector Borne Diseases, V45, P255; Sreenivas G, 2004, J CLIN MICROBIOL, V42, P1777, DOI 10.1128/JCM.42.4.1777-1778.2004; Srivastava P, 2011, T ROY SOC TROP MED H, V105, P1, DOI 10.1016/j.trstmh.2010.09.006; Srividya G, 2012, PARASITOL RES, V110, P1065, DOI 10.1007/s00436-011-2680-1; Sudarshan M, 2015, J CLIN MICROBIOL, V53, P3905, DOI 10.1128/JCM.01465-15; Sudarshan M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003366; Sudarshan M, 2011, J ANTIMICROB CHEMOTH, V66, P1751, DOI 10.1093/jac/dkr185; Tiwary P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061370; Topno RK, 2010, AM J TROP MED HYG, V83, P502, DOI 10.4269/ajtmh.2010.09-0345; Tsokana CN, 2014, LEISHMANIASIS - TRENDS IN EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT, P161, DOI 10.5772/57448; Vallur AC, 2014, CLIN MICROBIOL INFEC, V20, pO374, DOI 10.1111/1469-0691.12421; Verma N, 2013, J CLIN MICROBIOL, V51, P4217, DOI 10.1128/JCM.01482-13; Verma S, 2010, PLOS ONE, V5; Verma S, 2013, TROP MED INT HEALTH, V18, P268, DOI 10.1111/tmi.12047; Weirather JL, 2011, J CLIN MICROBIOL, V49, P3892, DOI 10.1128/JCM.r00764-11; World Health Organization, 2015, KAL AZ EL PROGR; Wortmann G, 2005, AM J TROP MED HYG, V73, P999, DOI 10.4269/ajtmh.2005.73.999; Zijlstra EE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1721-0	45	46	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185606	10.1371/journal.pone.0185606	http://dx.doi.org/10.1371/journal.pone.0185606			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957391	gold, Green Published, Green Submitted			2022-12-26	WOS:000411985200093
J	Smith, CEL; Alexandraki, A; Cordery, SF; Parmar, R; Bonthron, DT; Valleley, EMA				Smith, Claire E. L.; Alexandraki, Alexia; Cordery, Sarah F.; Parmar, Rekha; Bonthron, David T.; Valleley, Elizabeth M. A.			A tissue-specific promoter derived from a SINE retrotransposon drives biallelic expression of PLAGL1 in human lymphocytes	PLOS ONE			English	Review							T-CELLS; GENE; ZAC/PLAGL1	The imprinted gene PLAGL1 is an important regulator of apoptosis and cell cycle arrest. Loss of its expression has been implicated in tumorigenesis in a range of different cancers, and overexpression during fetal development causes transient neonatal diabetes mellitus (TNDM). PLAGL1 lies within an imprinted region of chromosome 6q24, and monoallelic expression from the major, differentially methylated promoter (P1) occurs in most human tissues. However, in peripheral blood leukocytes, the active promoter (P2) is non-imprinted and drives biallelic transcription. We report here a novel PLAGL1 promoter (P5) derived from the insertion of a primate-specific, MIR3 SINE retrotransposon. P5 is highly utilized in lymphocytes, particularly in T cells, and like P2, directs biallelic transcription. Our results show that it is important to consider P5 in relation to PLAGL1 function in T cells when investigating the dysregulation of this gene.	[Smith, Claire E. L.; Alexandraki, Alexia; Cordery, Sarah F.; Parmar, Rekha; Bonthron, David T.; Valleley, Elizabeth M. A.] Univ Leeds, St Jamess Univ Hosp, Sch Med, Leeds, W Yorkshire, England; [Cordery, Sarah F.] Univ Bath, Dept Pharm & Pharmacol, Bath, Avon, England	Saint James's University Hospital; University of Leeds; University of Bath	Valleley, EMA (corresponding author), Univ Leeds, St Jamess Univ Hosp, Sch Med, Leeds, W Yorkshire, England.	E.M.A.Valleley@leeds.ac.uk		Smith, Claire/0000-0001-8320-5105	Yorkshire Cancer Research Pump-Priming awards; Pilot grant award from Breast Cancer Campaign; Yorkshire Cancer Research project grant [L330]; University of Leeds 110 Anniversary Postgraduate Research Scholarship; Medical Research Council [MR/M009084/1] Funding Source: researchfish; MRC [MR/M009084/1] Funding Source: UKRI	Yorkshire Cancer Research Pump-Priming awards; Pilot grant award from Breast Cancer Campaign; Yorkshire Cancer Research project grant; University of Leeds 110 Anniversary Postgraduate Research Scholarship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CELS, SFC and RP were supported by two Yorkshire Cancer Research Pump-Priming awards and a Pilot grant award from Breast Cancer Campaign. Funding is also acknowledged from a Yorkshire Cancer Research project grant (L330) to EMAV and DTB. AA is supported by a University of Leeds 110 Anniversary Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2007, J CELL PHYSIOL, V210, P16, DOI 10.1002/jcp.20835; Berg JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026410; Bilanges B, 2001, ONCOGENE, V20, P1246, DOI 10.1038/sj.onc.1204237; Carr IM, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm330; Cheong CY, 2015, GENOME RES, V25, P611, DOI 10.1101/gr.183301.114; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Estecio MRH, 2012, MOL CANCER RES, V10, P1332, DOI 10.1158/1541-7786.MCR-12-0351; Frost JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013556; Fu WX, 2012, NAT IMMUNOL, V13, P972, DOI 10.1038/ni.2420; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Hide T, 2009, CANCER RES, V69, P7953, DOI 10.1158/0008-5472.CAN-09-2006; Hubley R., 2013, REPEATMASKER OPEN 40; Iglesias-Platas I, 2013, NUCLEIC ACIDS RES, V41, P2171, DOI 10.1093/nar/gks1355; Jjingo D, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-14; Kamiya M, 2000, HUM MOL GENET, V9, P453, DOI 10.1093/hmg/9.3.453; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Lin L, 2009, HUM MOL GENET, V18, P2204, DOI 10.1093/hmg/ddp152; Macaulay EC, 2011, MAMM GENOME, V22, P722, DOI 10.1007/s00335-011-9355-1; Miyagawa Y, 2009, IMMUNOLOGY, V128, P405, DOI 10.1111/j.1365-2567.2009.03122.x; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; SMIT AFA, 1995, NUCLEIC ACIDS RES, V23, P98, DOI 10.1093/nar/23.1.98; Valleley EM, 2007, HUM MOL GENET, V16, P972, DOI 10.1093/hmg/ddm041; Valleley EMA, 2010, GENE CHROMOSOME CANC, V49, P480, DOI 10.1002/gcc.20758; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Vega-Benedetti AF, 2017, J APPL GENET, V58, P71, DOI 10.1007/s13353-016-0355-4; Wang J, 2015, P NATL ACAD SCI USA, V112, pE4428, DOI 10.1073/pnas.1507253112	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185678	10.1371/journal.pone.0185678	http://dx.doi.org/10.1371/journal.pone.0185678			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957425	Green Published, gold			2022-12-26	WOS:000411985200105
J	Inata, Y; Kikuchi, S; Samraj, RS; Hake, PW; O'Connor, M; Ledford, JR; O'Connor, J; Lahni, P; Wolfe, V; Piraino, G; Zingarelli, B				Inata, Yu; Kikuchi, Satoshi; Samraj, Ravi S.; Hake, Paul W.; O'Connor, Michael; Ledford, John R.; O'Connor, James; Lahni, Patrick; Wolfe, Vivian; Piraino, Giovanna; Zingarelli, Basilia			Autophagy and mitochondrial biogenesis impairment contribute to age-dependent liver injury in experimental sepsis: dysregulation of AMP-activated protein kinase pathway	FASEB JOURNAL			English	Article						AICAR; cecal ligation and puncture; MODS; PGC-1 alpha	PHOSPHORYLATION; INHIBITION; KNOCKOUT	Age is an independent risk factor of multiple organ failure in patients with sepsis. However, the age-related mechanisms of injury are not known. AMPK is a crucial regulator of energy homeostasis, which controls mitochondrial biogenesis by activation of peroxisome proliferator-activated receptor-gamma coactivator-alpha (PGC-1 alpha) and disposal of defective organelles by autophagy. We investigated whether AMPK dysregulation might contribute to age-dependent liver injury in young (2-3 mo) and mature male mice (11-13 mo) subjected to sepsis. Liver damage was higher in mature mice than in young mice and was associated with impairment of hepatocyte mitochondrial function, structure, and biogenesis and reduced autophagy. At molecular analysis, there was a time-dependent nuclear translocation of the active phosphorylated catalytic subunits AMPK alpha 1/alpha 2 and PGC-1 alpha in young, but not in mature, mice after sepsis. Treatment with the AMPK activator 5-amino-4-imidazolecarboxamide riboside-1-beta-D-ribofuranoside (AICAR) improved liver mitochondrial structure in both age groups compared with vehicle. In loss-of-function studies, young knockout mice with systemic deficiency of AMPK alpha 1 exhibited greater liver injury than did wild-type mice after sepsis. Our study suggests that AMPK is important for liver metabolic recovery during sepsis. Although its function may diminish with age, pharmacological activation of AMPK may be of therapeutic benefit.	[Inata, Yu; Kikuchi, Satoshi; Samraj, Ravi S.; Hake, Paul W.; O'Connor, Michael; Ledford, John R.; O'Connor, James; Lahni, Patrick; Wolfe, Vivian; Piraino, Giovanna; Zingarelli, Basilia] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr,Div Crit Care M, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Zingarelli, B (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	basilia.zingarelli@cchmc.org	, Basilia/AAV-7582-2021; Inata, Yu/H-7572-2019	Inata, Yu/0000-0002-2180-9517	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [R01 GM-067202]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK-078392]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067202] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Benoit Viollet (INSERM and Cochin Institute, University Paris Descartes, Paris, France) for providing AMPK-alpha 1 WT and KO mice. This work was supported by the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grant R01 GM-067202 (to B.Z.) and, in part, by NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant P30 DK-078392 to the Digestive Research Core Center (Integrative Morphology Core). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Angele MK, 2014, VIRULENCE, V5, P12, DOI 10.4161/viru.26982; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; Botez G, 2015, INNATE IMMUN-LONDON, V21, P609, DOI 10.1177/1753425915569367; Botros Mona, 2013, Clin Biochem Rev, V34, P117; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Chien WS, 2011, SHOCK, V35, P506, DOI 10.1097/SHK.0b013e31820b2f05; Collier J, 2002, CLIN MED, V2, P406, DOI 10.7861/clinmedicine.2-5-406; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Donnino MW, 2011, CRIT CARE, V15, DOI 10.1186/cc10343; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Gustafsson AB, 2008, J MOL CELL CARDIOL, V44, P654, DOI 10.1016/j.yjmcc.2008.01.010; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kale S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013852; Kramer KA, 2005, CLIN CHEM, V51, P2110, DOI 10.1373/clinchem.2005.050146; Liu AD, 2013, LIVER TRANSPLANT, V19, P762, DOI 10.1002/lt.23666; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Milbrandt EB, 2010, AM J RESP CRIT CARE, V182, P995, DOI 10.1164/rccm.200904-0630CP; MULLANE KM, 1985, J PHARMACOL METHOD, V14, P157, DOI 10.1016/0160-5402(85)90029-4; Mulligan JD, 2005, J GERONTOL A-BIOL, V60, P21, DOI 10.1093/gerona/60.1.21; Nguyen-Lefebvre Anh Thu, 2015, J Enzymol Metab, V1; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Parajuli N, 2013, AM J PHYSIOL-RENAL, V304, pF257, DOI 10.1152/ajprenal.00435.2012; Protzer U, 2012, NAT REV IMMUNOL, V12, P201, DOI 10.1038/nri3169; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Rohas LM, 2007, P NATL ACAD SCI USA, V104, P7933, DOI 10.1073/pnas.0702683104; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Stapleton D, 1997, FEBS LETT, V409, P452, DOI 10.1016/S0014-5793(97)00569-3; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Sun K, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-26; Vincent JL, 2011, CRIT CARE MED, V39, P1050, DOI 10.1097/CCM.0b013e31820eda29; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Watanabe E, 2009, LAB INVEST, V89, P549, DOI 10.1038/labinvest.2009.8	42	35	38	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					728	741		10.1096/fj.201700576R	http://dx.doi.org/10.1096/fj.201700576R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28974562	Green Published, Bronze			2022-12-26	WOS:000425146900017
J	Rebholz, SL; Melchior, JT; Davidson, WS; Jones, HN; Welge, JA; Prentice, AM; Moore, SE; Woollett, LA				Rebholz, Sandra L.; Melchior, John T.; Davidson, W. Sean; Jones, Helen N.; Welge, Jeffrey A.; Prentice, Andrew M.; Moore, Sophie E.; Woollett, Laura A.			Studies in genetically modified mice implicate maternal HDL as a mediator of fetal growth	FASEB JOURNAL			English	Article						apolipoprotein A-I; cholesterol; placenta; pregnancy; fetus	LOW-BIRTH-WEIGHT; PLACENTAL NUTRIENT TRANSPORT; ADVERSE PREGNANCY OUTCOMES; HIGH-DENSITY-LIPOPROTEINS; LIPID-METABOLISM; SERUM-LIPIDS; CHOLESTEROL; RISK; RESTRICTION; CHILDHOOD	Studies in humans have shown a direct association between maternal plasma cholesterol concentrations and infant birthweight. Similarly, previous studies in our laboratory have shown that chow-fed mice lacking apolipoprotein (apo) A-I, the major protein in HDL, have low HDL-cholesterol (HDL-C) concentrations and smaller fetuses in midgestation. In the current study, we measured fetal weights in mice with varying levels of apoA-I gene dose (knockout, wild-type, and transgenic) and examined metabolic pathways known to affect fetal growth. As expected, we found the differences in apoA-I expression led to changes in HDL particle size and protein cargo as well as plasma cholesterol concentrations. Fetal masses correlated directly with maternal plasma cholesterol and apoA-I concentrations, but placental masses and histology did not differ between groups of mice. There was no significant difference in glucose or amino acid transport to the fetus or in expression levels of the glucose (glucose transporter 1 and 2) or amino acid (sodium-coupled neutral amino acid transporter 1 and 2) transporters in whole placentas, although there was a trend for greater uptake of both nutrients in the whole fetal unit (fetus + placenta) of mice with greater apoA-I levels; significant differences in transport rates occurred when mice without apoA-I (knockout) vs. mice with apoA-I (wild-type and transgenic) were compared. Glucose tolerance tests were improved in the mice with the highest level of apoA-I, suggesting increased insulin-induced uptake of glucose by tissues of apoA-I transgenic mice. Thus, maternal HDL is associated with fetal growth, an effect that is likely mediated by plasma cholesterol or other HDL-cargo, including apolipoproteins or complement system proteins. A direct role of enhanced glucose and/or amino acid transport cannot be excluded.	[Rebholz, Sandra L.; Melchior, John T.; Davidson, W. Sean; Woollett, Laura A.] Univ Cincinnati, Sch Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; [Welge, Jeffrey A.] Univ Cincinnati, Sch Med, Dept Psychiat & Behav Neurosci, Cincinnati, OH 45267 USA; [Jones, Helen N.] Cincinnati Childrens Hosp Med Ctr, Div Gen & Thorac Surg & Reprod Sci, Cincinnati, OH 45229 USA; [Prentice, Andrew M.; Moore, Sophie E.] Med Res Council MRC Unit, Serekunda, Gambia; [Prentice, Andrew M.] LSHTM, MCR Int Nutr Grp, London, England; [Moore, Sophie E.] Kings Coll London, Div Womens Hlth, London, England	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London	Woollett, LA (corresponding author), Univ Cincinnati, 2180 East Galbreith Rd,Reading Campus, Cincinnati, OH 45267 USA.	laura.woollett@uc.edu	Prentice, Andrew/AAG-1961-2019	Davidson, William/0000-0003-2756-2989; Moore, Sophie/0000-0003-1650-3238	Bill and Melinda Gates Foundation [OPP1110668]; Medical Research Council [MC_UU_00026/3, MC_U123292701, MC_UP_1005/1, MR/P012019/1] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK059630] Funding Source: NIH RePORTER; MRC [MC_UU_00026/3, MC_UP_1005/1, MR/P012019/1, MC_U123292701] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Dr. Debi Swertfeger (Cincinnati Children's Hospital Medical Center) and Dr. Philip Howells (University of Cincinnati) for critical review of the manuscript, and Kathryn Owens (Cincinnati Children's Hospital Medical Center) for technical assistance. This work was supported by the Bill and Melinda Gates Foundation (OPP1110668 to L.A.W.). The University of Cincinnati Mouse Metabolic Phenotype Center measured the fatty acid composition of the samples (U2C DK059630). The authors declare no conflicts of interest.	Baardman ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.003; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; Barker DJP, 2013, ACTA PAEDIATR, V102, P732, DOI 10.1111/apa.12257; Barker DJP, 2005, HORM RES, V64, P2, DOI 10.1159/000089311; BOERSMA ER, 1980, ACTA PAEDIATR SCAND, V69, P747, DOI 10.1111/j.1651-2227.1980.tb07144.x; Brett KE, 2014, INT J MOL SCI, V15, P16153, DOI 10.3390/ijms150916153; Burillo E, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-116; CHAMBAZ J, 1985, BIOL NEONATE, V47, P136, DOI 10.1159/000242104; Clausen T, 2005, EUR J ENDOCRINOL, V153, P887, DOI 10.1530/eje.1.02034; Crume TL, 2015, J CLIN ENDOCR METAB, V100, P1672, DOI 10.1210/jc.2014-2949; de Bernabe JV, 2004, EUR J OBSTET GYN R B, V116, P3, DOI 10.1016/j.ejogrb.2004.03.007; Edison RJ, 2007, PEDIATRICS, V120, P723, DOI 10.1542/peds.2006-1939; Fernandez-Nino SMG, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00044; Fielding CJ, 2004, BIOCHEM SOC T, V32, P65, DOI 10.1042/BST0320065; Friis CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057467; Gordon SM, 2011, TRENDS ENDOCRIN MET, V22, P9, DOI 10.1016/j.tem.2010.10.001; Gordon SM, 2010, J PROTEOME RES, V9, P5239, DOI 10.1021/pr100520x; Haghiac M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137309; He S, 2016, J MATERN-FETAL NEO M, V29, P1999, DOI 10.3109/14767058.2015.1072159; Heinecke JW, 2010, J CLIN LIPIDOL, V4, P371, DOI 10.1016/j.jacl.2010.08.005; Herrera E, 2014, CURR PHARM BIOTECHNO, V15, P24, DOI 10.2174/1389201015666140330192345; Hviid A, 2007, AM J EPIDEMIOL, V165, P756, DOI 10.1093/aje/kwk064; Jansson T, 2012, PLACENTA, V33, pE23, DOI 10.1016/j.placenta.2012.05.010; Jones HN, 2007, PLACENTA, V28, P763, DOI 10.1016/j.placenta.2007.05.002; Jones HN, 2009, FASEB J, V23, P271, DOI 10.1096/fj.08-116889; Knopp R H, 1985, Diabetes, V34 Suppl 2, P71; Kohler Iliana V., 2012, Genus, V68, P1; Kontush A., 2012, HIGH DENSITY LIPOPRO; Kramer MS, 2013, J PEDIATR-US, V163, P983, DOI 10.1016/j.jpeds.2013.05.014; Kramer MS, 2003, J NUTR, V133, p1592S, DOI 10.1093/jn/133.5.1592S; Kulkarni SR, 2013, DIABETES CARE, V36, P2706, DOI 10.2337/dc12-2445; Lager S, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/179827; Mark PJ, 2006, PLACENTA, V27, P208, DOI 10.1016/j.placenta.2005.01.004; Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1; McConihay JA, 2000, J LIPID RES, V41, P424; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; McNamara RK, 2009, LIPIDS, V44, P1, DOI 10.1007/s11745-008-3244-8; Melchior JT, 2017, J LIPID RES, V58, P1374, DOI 10.1194/jlr.M075382; Misra VK, 2011, OBESITY, V19, P1476, DOI 10.1038/oby.2011.43; Mitra Subarna, 2012, Indian J Endocrinol Metab, V16, P754, DOI 10.4103/2230-8210.100669; Moore SE, 2001, DIABETIC MED, V18, P646, DOI 10.1046/j.1464-5491.2001.00565.x; Morgan TK, 2016, AM J PERINAT, V33, P258, DOI 10.1055/s-0035-1570379; Mudd LM, 2015, ACTA OBSTET GYN SCAN, V94, P852, DOI 10.1111/aogs.12665; Naksen W, 2015, ENVIRON RES, V142, P288, DOI 10.1016/j.envres.2015.06.035; Napoli C, 1997, J CLIN INVEST, V100, P2680, DOI 10.1172/JCI119813; Pecks U, 2012, J PERINAT MED, V40, P287, DOI [10.1515/jpm.2011.135, 10.1515/JPM.2011.135]; Prentice AM, 2005, ARCH DIS CHILD, V90, P429, DOI 10.1136/adc.2004.059030; Raqib R, 2007, AM J CLIN NUTR, V85, P845, DOI 10.1093/ajcn/85.3.845; Regal JF, 2015, MOL IMMUNOL, V67, P56, DOI 10.1016/j.molimm.2015.02.030; Retnakaran R, 2012, CAN MED ASSOC J, V184, P1353, DOI 10.1503/cmaj.111154; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Sattar N, 1999, J CLIN ENDOCR METAB, V84, P128, DOI 10.1210/jc.84.1.128; Shah AS, 2013, J LIPID RES, V54, P2575, DOI 10.1194/jlr.R035725; Stein REK, 2006, PEDIATRICS, V118, P217, DOI 10.1542/peds.2005-2836; Tofail F, 2012, EUR J CLIN NUTR, V66, P237, DOI 10.1038/ejcn.2011.165; Udoh A. E., 1994, Acta Medica Hungarica, V50, P75; Wadsack C, 2007, AM J PHYSIOL-ENDOC M, V292, pE476, DOI 10.1152/ajpendo.00547.2005; WARNICK GR, 1978, J LIPID RES, V19, P65; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; WHO, 2014, GLOBAL NUTRITION TAR; Woollett LA, 2008, ANNU REV NUTR, V28, P97, DOI 10.1146/annurev.nutr.26.061505.111311; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417	63	4	4	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					717	727		10.1096/fj.201700528R	http://dx.doi.org/10.1096/fj.201700528R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28982731	Bronze, Green Published			2022-12-26	WOS:000425146900016
J	Guo, P; Ma, X; Zhao, W; Huai, W; Li, T; Qiu, Y; Zhang, Y; Han, L				Guo, P.; Ma, X.; Zhao, W.; Huai, W.; Li, T.; Qiu, Y.; Zhang, Y.; Han, L.			TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex	ONCOGENE			English	Article							TUMOR-SUPPRESSOR; NLRP3 INFLAMMASOME; DOWN-REGULATION; LIVER-CANCER; PROTEIN; LIGASE; CELLS; TSC1; DEGRADATION; CONTRIBUTES	Tripartite motif (TRIM) 31 is a member of the tripartite motif-containing protein family, and TRIM family proteins are involved in a broad range of biological and pathological processes. However, the role of TRIM31 in hepatocellular carcinoma (HCC) progression is not known. Here we demonstrated that TRIM31 expression was significantly upregulated in liver cancer tissues compared with paired distal non-cancerous liver tissues from HCC patients, and its overexpression was significantly correlated with advanced disease status. Both gain and loss of function assay verified that TRIM31 promoted the malignant behaviors of HCC cells through overactivation of mammalian target of rapamycin complex1 (mTORC1) pathway. We further demonstrated that TRIM31 exerted its oncogenic effect by directly interacting with the tuberous sclerosis complex (TSC) 1 and TSC2 complex, the upstream suppressor of mTORC1 pathway, and promoting the E3 ligase-mediated K48-linked ubiquitination and degradation of this complex. In conclusion, this study demonstrated TRIM31 could promote HCC progression by targeting TSC1-TSC2 complex for degradation and further overactivating mTORC1 pathway. Thus, it revealed a novel molecular mechanism of HCC progression and indicated a potential therapeutic strategy against HCC by targeting TRIM31.	[Guo, P.; Ma, X.; Zhao, W.; Huai, W.; Qiu, Y.; Zhang, Y.; Han, L.] Shandong Univ, Sch Basic Med Sci, Dept Immunol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Li, T.] Shandong Univ, Prov Hosp, Dept Gastroenterol, Jinan 250021, Shandong, Peoples R China	Shandong University; Shandong University	Han, L (corresponding author), Shandong Univ, Sch Basic Med Sci, Dept Immunol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	hanlihui@sdu.edu.cn		Zhao, Wei/0000-0001-8440-2274; Han, Lihui/0000-0003-1030-2232	National Natural Science Foundation of China [81472269, 81672391]; Science and Technology Development Project of Shandong Province [2015GSF118047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Project of Shandong Province	We thank Dr Brendan D Manning (Harvard University) and Dr Cheryl Lyn Walker (Texas A&M University) for providing the TSC1 and TSC2 plasmids. This study was supported by the National Natural Science Foundation of China (No. 81472269 and No. 81672391) and the Science and Technology Development Project of Shandong Province (No. 2015GSF118047).	Argyriou P, 2011, ANN HEMATOL, V90, P315, DOI 10.1007/s00277-010-1070-6; Bhat M, 2013, HEPATOLOGY, V58, P810, DOI 10.1002/hep.26323; Chano T, 2006, INT J MOL MED, V18, P425; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; Ding QS, 2015, TUMOR BIOL, V36, P8761, DOI 10.1007/s13277-015-3572-2; Dodd KM, 2015, ONCOGENE, V34, P2239, DOI 10.1038/onc.2014.164; El-Naggar AM, 2015, CANCER CELL, V27, P682, DOI 10.1016/j.ccell.2015.04.003; Feng M, 2013, PROTEIN CELL, V4, P142, DOI 10.1007/s13238-012-2088-4; Han S, 2008, CELL SIGNAL, V20, P1084, DOI 10.1016/j.cellsig.2008.01.020; Herquel B, 2011, P NATL ACAD SCI USA, V108, P8212, DOI 10.1073/pnas.1101544108; Hu J, 2008, GENE DEV, V22, P866, DOI 10.1101/gad.1624008; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Huynh H, 2015, MOL CANCER THER, V14, P1224, DOI 10.1158/1535-7163.MCT-14-0768; Iwai K, 2010, SUBCELL BIOCHEM, V54, P100, DOI 10.1007/978-1-4419-6676-6_8; Kang YJ, 2011, CELL DEATH DIFFER, V18, P133, DOI 10.1038/cdd.2010.82; Kim YH, 2016, BRIT J NEUROSURG, V2016, P1, DOI DOI 10.1155/2016/1489692; Kozakova L, 2015, CELL CYCLE, V14, P920, DOI 10.1080/15384101.2014.1000112; Li H, 2014, TUMOR BIOL, V35, P5747, DOI 10.1007/s13277-014-1763-x; Ma XM, 2016, ONCOTARGET, V7, P36185, DOI 10.18632/oncotarget.9154; Menon S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002739; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Njei B, 2015, HEPATOLOGY, V61, P191, DOI 10.1002/hep.27388; Ra EA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11726; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Shen WC, 2015, AUTOPHAGY, V11, P685, DOI 10.4161/auto.36098; Song H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13727; Sugiura T, 2011, CELL BIOL INT, V35, P657, DOI 10.1042/CBI20100772; Sugiura T, 2008, J CELL BIOCHEM, V105, P1081, DOI 10.1002/jcb.21908; Sun XF, 2013, HEPATOLOGY, V57, P205, DOI 10.1002/hep.25989; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Wang Y, 2015, BIOCHEM BIOPH RES CO, V463, P458, DOI 10.1016/j.bbrc.2015.05.117; Watanabe M, 2017, J BIOCHEM, V161, P135, DOI 10.1093/jb/mvw087; Wei Q, 2015, LAB INVEST, V95, P804, DOI 10.1038/labinvest.2015.63; Wei Q, 2014, LAB INVEST, V94, P52, DOI 10.1038/labinvest.2013.126; Wei Q, 2013, PURINERG SIGNAL, V9, P585, DOI 10.1007/s11302-013-9369-0; Yamada D, 2014, J BIOCHEM, V155, P227, DOI 10.1093/jb/mvt112; Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6; Zhang L, 2014, INT J CLIN EXP PATHO, V7, P3887; Zhang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06248; Zhao X, 2014, CANCER RES, V74, P2455, DOI 10.1158/0008-5472.CAN-13-3009	40	58	62	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 25	2018	37	4					478	488		10.1038/onc.2017.349	http://dx.doi.org/10.1038/onc.2017.349			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT7KP	28967907				2022-12-26	WOS:000423331600006
J	Horvath, TD; Dagan, S; Lorenzi, PL; Hawke, DH; Scaraffia, PY				Horvath, Thomas D.; Dagan, Shai; Lorenzi, Philip L.; Hawke, David H.; Scaraffia, Patricia Y.			Positional stable isotope tracer analysis reveals carbon routes during ammonia metabolism of Aedes aegypti mosquitoes	FASEB JOURNAL			English	Article						mass spectrometry; nitrogen waste; metabolomics	PROTEIN CATABOLISM; ISOBUTYL ESTER; MEAL PROTEIN; AMINO-ACIDS; SERINE; FRAGMENTATION; PATHWAY; FATE	In Aedes aegypti females, the ammonia released during blood meal digestion is partiallymetabolized to facilitate the disposal of excess nitrogen. In this study, we used low- and high-resolution liquid chromatography-mass spectrometry (LC/MS) techniques to investigate the role of glucose during ammonia detoxification. Mosquitoes were fed a blood meal supplemented with [1,2-C-13(2)] glucose, and downstream metabolites were measured for 24 h. Quantification of [C-13] amino acids in the entire mosquito body was conducted without sample derivatization using selected reaction monitoring of mass transitions that are indicative of the structural position of [C-13] atomincorporation. Identification of unlabeled and [C-13] isotopologs of 43 compounds, including amino acids, amino acid derivatives, and organic acids, was performed by high-resolution LC/MS techniques. Blood-fed mosquitoes synthesized [C-13] metabolites in mainly 2 carbon positions from [1,2-C-13(2)] glucose. [C-13(2)] Ala and [C-13(2)] Pro were themost abundant andrapidly labeledamino acids synthesized. Additional [C-13] amino acids, [C-13] amino acid derivatives, and [C-13] organic acids in 1 or 2 carbon positionswere also identified. Two kinetic routeswere proposed based on the incorporation of a [C-13] atom at position 1 in specific amino acids. Our findings provide evidence that glucose is used for ammonia detoxification and [C-13] uric acid synthesis through multiple metabolic pathways, uncovering a metabolic link at the carbon atomic level in ammonia metabolism of A. aegypti.	[Horvath, Thomas D.; Lorenzi, Philip L.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Hawke, David H.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol Prote & Metabol Core Facil, Houston, TX 77030 USA; [Dagan, Shai] Israel Inst Biol Res, Ness Ziona, Israel; [Scaraffia, Patricia Y.] Tulane Univ, Sch Publ Hlth & Trop Med, Vector Borne Infect Dis Res Ctr, Dept Trop Med, New Orleans, LA 70118 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tulane University	Scaraffia, PY (corresponding author), Tulane Univ, Dept Trop Med, Vector Borne Infect Dis Res Ctr, 1430 Tulane Ave,SL 17,J Bennett Johnston Bldg, New Orleans, LA 70112 USA.	pscaraff@tulane.edu	Horvath, Thomas Donald/AAI-2216-2019	Horvath, Thomas Donald/0000-0001-9761-3484	Corine Adams Baines Professorship Award; U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases [R01AI088092]; NIH [1S10OD012304-01]; Cancer Prevention Research Institute of Texas (CPRIT) [RP130397]; University of Texas M.D. Anderson National Cancer Institute Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088092] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012304] Funding Source: NIH RePORTER	Corine Adams Baines Professorship Award; U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas (CPRIT); University of Texas M.D. Anderson National Cancer Institute Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Dr. Lin Tan and Dr. Di Du (Proteomics and Metabolomics Core Facility, University of Texas MD Anderson Cancer Center) for technical assistance. The authors also thank Dr. Robert Swaim, Ken Miller, and Jamie Humphries (Thermo Fisher Scientific, Waltham, MA, USA) for assistance with training and use of TraceFinder software. This work was supported financially by the Corine Adams Baines Professorship Award, the U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (Grant R01AI088092 to P.Y.S.), NIH 1S10OD012304-01, Cancer Prevention Research Institute of Texas (CPRIT; Grant RP130397), and The University of Texas M.D. Anderson National Cancer Institute Cancer Center (Grant CA016672). The authors declare no conflicts of interest.	Alabaster A, 2011, INSECT BIOCHEM MOLEC, V41, P946, DOI 10.1016/j.ibmb.2011.09.004; Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135; Armstrong Najealicka, 2017, World J Virol, V6, P1, DOI 10.5501/wjv.v6.i1.1; Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28; Belloni V, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-373; Briegel H, 2002, J INSECT PHYSIOL, V48, P547, DOI 10.1016/S0022-1910(02)00072-0; BRIEGEL H, 1985, J INSECT PHYSIOL, V31, P15, DOI 10.1016/0022-1910(85)90036-8; Bush DR, 2012, J MASS SPECTROM, V47, P1364, DOI 10.1002/jms.3063; Chang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep37350; Soares JBRC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120600; Dong W, 2017, METAB ENG, V43, P113, DOI 10.1016/j.ymben.2017.02.002; FELL DA, 1988, BIOCHEM J, V256, P97, DOI 10.1042/bj2560097; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; Goldstrohm DA, 2003, J INSECT PHYSIOL, V49, P629, DOI 10.1016/S0022-1910(03)00072-6; Hou Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005309; Isoe J, 2017, FASEB J, V31, P2276, DOI 10.1096/fj.201601185R; Isoe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065393; Li SZ, 2007, MAGN RESON MED, V57, P265, DOI 10.1002/mrm.21148; Ma X, 2013, J AM SOC MASS SPECTR, V24, P622, DOI 10.1007/s13361-012-0574-9; Martin CA, 2014, NEUROCHEM INT, V73, P71, DOI 10.1016/j.neuint.2014.03.015; Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020; Mazzalupo S, 2016, FASEB J, V30, P111, DOI 10.1096/fj.15-277087; Pacold ME, 2016, NAT CHEM BIOL, V12, P452, DOI [10.1038/NCHEMBIO.2070, 10.1038/nchembio.2070]; Scaraffia PY, 2008, P NATL ACAD SCI USA, V105, P518, DOI 10.1073/pnas.0708098105; Scaraffia PY, 2006, INSECT BIOCHEM MOLEC, V36, P614, DOI 10.1016/j.ibmb.2006.05.003; Scaraffia PY, 2010, J INSECT PHYSIOL, V56, P1040, DOI 10.1016/j.jinsphys.2010.02.016; Scaraffia PY, 2005, INSECT BIOCHEM MOLEC, V35, P491, DOI 10.1016/j.ibmb.2005.01.012; Scaraffia PY, 2003, J INSECT PHYSIOL, V49, P591, DOI 10.1016/S0022-1910(03)00031-3; von Dungern P, 2001, J INSECT PHYSIOL, V47, P73, DOI 10.1016/S0022-1910(00)00095-0; von Dungern P, 2001, J INSECT PHYSIOL, V47, P131, DOI 10.1016/S0022-1910(00)00096-2; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Zhang QF, 2005, J AM SOC MASS SPECTR, V16, P1192, DOI 10.1016/j.jasms.2005.03.052; Zhou GL, 2004, INSECT BIOCHEM MOLEC, V34, P919, DOI 10.1016/j.ibmb.2004.05.009; Zhou GL, 2004, J INSECT PHYSIOL, V50, P337, DOI 10.1016/j.jinsphys.2004.02.003	34	8	8	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					466	477		10.1096/fj.201700657R	http://dx.doi.org/10.1096/fj.201700657R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28970248	Green Published			2022-12-26	WOS:000419172700041
J	Li, YY; Wang, R; Qiao, N; Peng, GD; Zhang, K; Tang, K; Han, JDJ; Jing, NH				Li, Yuanyuan; Wang, Ran; Qiao, Nan; Peng, Guangdun; Zhang, Ke; Tang, Ke; Han, Jing-Dong J.; Jing, Naihe			Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell; human; neurodevelopment; neurodifferentiation; transcriptomics	CEREBRAL-CORTEX DEVELOPMENT; SEPTO-OPTIC DYSPLASIA; MOUSE EMBRYO; NEURAL-STEM; HUMAN NEUROECTODERM; HESX1 MUTATIONS; HUMAN BRAIN; DIRECTED DIFFERENTIATION; CLINICAL SPECTRUM; GENE-FUNCTION	Proper neural commitment is essential for ensuring the appropriate development of the human brain and for preventing neurodevelopmental diseases such as autism spectrum disorders, schizophrenia, and intellectual disorders. However, the molecular mechanisms underlying the neural commitment in humans remain elusive. Here, we report the establishment of a neural differentiation system based on human embryonic stem cells (hESCs) and on comprehensive RNA sequencing analysis of transcriptome dynamics during early hESC differentiation. Using weighted gene co-expression network analysis, we reveal that the hESC neurodevelopmental trajectory has five stages: pluripotency (day 0); differentiation initiation (days 2, 4, and 6); neural commitment (days 8-10); neural progenitor cell proliferation (days 12, 14, and 16); and neuronal differentiation (days 18, 20, and 22). These stages were characterized by unique module genes, which may recapitulate the early human cortical development. Moreover, a comparison of our RNA-sequencing data with several other transcriptome profiling datasets from mice and humans indicated that Module 3 associated with the day 8-10 stage is a critical window of fate switch from the pluripotency to the neural lineage. Interestingly, at this stage, no key extrinsic signals were activated. In contrast, using CRISPR/Cas9-mediated gene knockouts, we also found that intrinsic hub transcription factors, including the schizophrenia-associated SIX3 gene and septo-optic dysplasia-related HESX1 gene, are required to program hESC neural determination. Our results improve the understanding of the mechanism of neural commitment in the human brain and may help elucidate the etiology of human mental disorders and advance therapies for managing these conditions.	[Li, Yuanyuan; Wang, Ran; Peng, Guangdun; Zhang, Ke; Jing, Naihe] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China; [Qiao, Nan; Han, Jing-Dong J.] Chinese Acad Sci, Shanghai Inst Biol Sci, Chinese Acad Sci Key Lab Computat Biol, Chinese Acad Sci Max Planck Partner Inst Computat, 320 Yue Yang Rd, Shanghai 200031, Peoples R China; [Tang, Ke] Nanchang Univ, Inst Life Sci, Nanchang 330031, Jiangxi, Peoples R China; [Jing, Naihe] ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Nanchang University; ShanghaiTech University	Jing, NH (corresponding author), Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.; Jing, NH (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China.	njing@sibcb.ac.cn	Peng, Guangdun/AAH-9044-2019	Peng, Guangdun/0000-0002-8586-0637	"Strategic Priority Research Program" of the Chinese Academy of Sciences Grant [XDA01010201]; National Key Basic Research and Development Program of China [2014CB964804, 2015CB964500]; National Natural Science Foundation of China [31430058, 31571513, 31630043, 91519314, 31661143042]	"Strategic Priority Research Program" of the Chinese Academy of Sciences Grant; National Key Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the "Strategic Priority Research Program" of the Chinese Academy of Sciences Grant XDA01010201, National Key Basic Research and Development Program of China Grants 2014CB964804 and 2015CB964500, and National Natural Science Foundation of China Grants 31430058, 31571513, 31630043, 91519314, and 31661143042. The authors declare that they have no conflicts of interest with the contents of this article.	Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Bass JIF, 2013, NAT METHODS, V10, P1169, DOI [10.1038/NMETH.2728, 10.1038/nmeth.2728]; Bhinge A, 2014, EMBO J, V33, P1271, DOI 10.1002/embj.201387215; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bissonnette CJ, 2011, STEM CELLS, V29, P802, DOI 10.1002/stem.626; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189; Cajal M, 2012, DEVELOPMENT, V139, P423, DOI 10.1242/dev.075499; Carlin D, 2012, DEVELOPMENT, V139, P2614, DOI 10.1242/dev.076018; Carvalho LR, 2003, J CLIN INVEST, V112, P1192, DOI 10.1172/JCI200318589; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen J, 2017, NAT PROTOC, V12, P566, DOI 10.1038/nprot.2017.003; Cho MS, 2008, NAT PROTOC, V3, P1888, DOI 10.1038/nprot.2008.188; Chovsepian A, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00036; Cohen RN, 2003, J CLIN ENDOCR METAB, V88, P4832, DOI 10.1210/jc.2002-021868; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; Di-Gregorio A, 2007, DEVELOPMENT, V134, P3359, DOI 10.1242/dev.005967; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Hehr U, 2010, HUM GENET, V127, P555, DOI 10.1007/s00439-010-0797-4; Hu BY, 2010, METHODS MOL BIOL, V636, P123, DOI 10.1007/978-1-60761-691-7_8; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; Huang CTL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32600; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim JE, 2011, P NATL ACAD SCI USA, V108, P3005, DOI 10.1073/pnas.1007753108; Kostovic I, 2006, DEV MED CHILD NEUROL, V48, P388, DOI 10.1017/S0012162206000831; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Lacbawan F, 2009, J MED GENET, V46, P389, DOI 10.1136/jmg.2008.063818; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li LY, 2013, DEVELOPMENT, V140, P4533, DOI 10.1242/dev.092866; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Linker C, 2004, DEVELOPMENT, V131, P5671, DOI 10.1242/dev.01445; Lippmann ES, 2015, STEM CELL REP, V4, P632, DOI 10.1016/j.stemcr.2015.02.018; Liu W, 2010, J CLIN INVEST, V120, P3568, DOI 10.1172/JCI43219; Lu CC, 2001, CURR OPIN GENET DEV, V11, P384, DOI 10.1016/S0959-437X(00)00208-2; Luo YP, 2015, CELL, V161, P1175, DOI 10.1016/j.cell.2015.04.001; Mcnay DEG, 2007, J CLIN ENDOCR METAB, V92, P691, DOI 10.1210/jc.2006-1609; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Ozair MZ, 2013, WIRES DEV BIOL, V2, P479, DOI 10.1002/wdev.90; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Parish EV, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0311-6; Pasquier L, 2000, EUR J HUM GENET, V8, P797, DOI 10.1038/sj.ejhg.5200540; Peng GD, 2016, DEV CELL, V36, P681, DOI 10.1016/j.devcel.2016.02.020; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Preuss TM, 2004, NAT REV GENET, V5, P850, DOI 10.1038/nrg1469; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Ribeiro LA, 2006, AM J MED GENET A, V140A, P2577, DOI 10.1002/ajmg.a.31377; Sansom S. N., 2009, COLD SPRING HARB PER, V1; Sheng NY, 2010, P NATL ACAD SCI USA, V107, P18886, DOI 10.1073/pnas.1009244107; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Sobrier ML, 2006, J CLIN ENDOCR METAB, V91, P4528, DOI 10.1210/jc.2006-0426; Solomon BD, 2009, AM J MED GENET A, V149A, P919, DOI 10.1002/ajmg.a.32813; Strangward P, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006267; Tajima T, 2003, J CLIN ENDOCR METAB, V88, P45, DOI 10.1210/jc.2002-020818; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Thomas PQ, 2001, HUM MOL GENET, V10, P39, DOI 10.1093/hmg/10.1.39; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; van de Leemput J, 2014, NEURON, V83, P51, DOI 10.1016/j.neuron.2014.05.013; Walker MG, 1999, GENOME RES, V9, P1198, DOI 10.1101/gr.9.12.1198; Wallis DE, 1999, NAT GENET, V22, P196, DOI 10.1038/9718; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Weinstein DC, 1997, CURR OPIN NEUROBIOL, V7, P7, DOI 10.1016/S0959-4388(97)80114-6; Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yao ZZ, 2017, CELL STEM CELL, V20, P120, DOI 10.1016/j.stem.2016.09.011; Yeung J, 2016, J NEUROSCI, V36, P9057, DOI 10.1523/JNEUROSCI.4385-15.2016; Yoo YD, 2011, STEM CELLS, V29, P1975, DOI 10.1002/stem.758; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zhu QQ, 2014, ELIFE, V3, DOI 10.7554/eLife.02224	76	17	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19590	19604		10.1074/jbc.M117.796383	http://dx.doi.org/10.1074/jbc.M117.796383			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972157	hybrid, Green Published			2022-12-26	WOS:000416911300005
J	Gordiienko, I; Shlapatska, L; Kholodniuk, V; Sklyarenko, L; Gluzman, DF; Clark, EA; Sidorenko, SP				Gordiienko, Inna; Shlapatska, Larysa; Kholodniuk, Valeriia; Sklyarenko, Lilia; Gluzman, Daniel F.; Clark, Edward A.; Sidorenko, Svetlana P.			The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; MONOCLONAL-ANTIBODIES; INOSITOL PHOSPHATASE; SURFACE PHENOTYPE; PLASMA-CELLS; T-CELL; SLAM; ACTIVATION; ANTIGENS; CLL	Cell surface expression of CD150 and CD180 receptors in chronic lymphocytic leukemia (CLL) associates with mutational IGHV status and favourable prognosis. Here we show a direct correlation between cell surface expression and colocalization of these receptors on CLL B cells. In the absence of CD150 and CD180 on the cell surface both receptors were expressed in the cytoplasm. The CD150 receptor was colocalized with markers of the endoplasmic reticulum, the Golgi apparatus and early endosomes. In contrast, CD180 was detected preferentially in early endosomes. Analysis of CD150 isoforms differential expression revealed that regardless of CD150 cell surface expression the mCD150 isoform with two ITSM signaling motifs was a predominant CD150 isoform in CLL B cells. The majority of CLL cases had significantly elevated expression level of the soluble sCD150, moreover CLL B cells secrete this isoform. CD150 or CD180 crosslinking on CLL B cells alone led to activation of Akt, mTORC1, ERK1/2, p38MAPK and JNK1/2 networks. Both CD150 and CD180 target the translation machinery through mTOR independent as well as mTOR dependent pathways. Moreover, both these receptors transmit pro-survival signals via Akt-mediated inhibition of GSK3 beta and FOXO1/FOXO3a. Unexpectedly, coligation CD150 and CD180 receptors on CLL B cells led to mutual inhibition of the Akt and MAPK pathways. While CD150 and CD180 coligation resulted in reduced phosphorylation of Akt, ERK1/2, c-Jun, RSK, p70S6K, S6RP, and 4E-BP; it led to complete blocking of mTOR and p38MAPK phosphorylation. At the same time coligation of CD150 and CD40 receptors did not result in Akt and MAPK inhibition. This suggests that combination of signals via CD150 and CD180 leads to blocking of pro-survival pathways that may be a restraining factor for neoplastic CLL B cells propagation in more than 50% of CLL cases where these receptors are coexpressed.	[Gordiienko, Inna; Shlapatska, Larysa; Kholodniuk, Valeriia; Sidorenko, Svetlana P.] Natl Acad Sci Ukraine, RE Kavetsky Inst Expt Pathol Oncol & Radiobiol, Dept Mol & Cellular Pathobiol, Kiev, Ukraine; [Sklyarenko, Lilia; Gluzman, Daniel F.] Natl Acad Sci Ukraine, RE Kavetsky Inst Expt Pathol Oncol & Radiobiol, Dept Oncohematol, Kiev, Ukraine; [Clark, Edward A.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	National Academy of Sciences Ukraine; Kavetsky Institute of Experimental Pathology, Oncology & Radiobiology of NASU; National Academy of Sciences Ukraine; Kavetsky Institute of Experimental Pathology, Oncology & Radiobiology of NASU; University of Washington; University of Washington Seattle	Sidorenko, SP (corresponding author), Natl Acad Sci Ukraine, RE Kavetsky Inst Expt Pathol Oncol & Radiobiol, Dept Mol & Cellular Pathobiol, Kiev, Ukraine.	svitasyd@yahoo.com		Sidorenko, Svetlana/0000-0001-8281-8006; Gordiienko, Inna/0000-0003-3759-6138; Gluzman, Daniel/0000-0001-8335-6827; Shcherbina, Valeriia/0000-0001-6077-4786	National Academy of Sciences of Ukraine [01150002970, 01160007817]; National Institutes of Health [AI52203]	National Academy of Sciences of Ukraine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by grants from National Academy of Sciences of Ukraine 01150002970 and 01160007817 (SPS) http://www.nas.gov.ua/EN/Pages/default.aspx, National Institutes of Health grant AI52203 (EAC), https://www.niaid.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger SB, 2010, NAT IMMUNOL, V11, P920, DOI 10.1038/ni.1931; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bologna C, 2016, J CLIN INVEST, V126, P181, DOI 10.1172/JCI83013; Chaplin JW, 2013, J EXP MED, V210, P2135, DOI 10.1084/jem.20130188; Chaplin JW, 2011, J IMMUNOL, V187, P4199, DOI 10.4049/jimmunol.1100198; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; De Salort J, 2011, IMMUNOL LETT, V134, P129, DOI 10.1016/j.imlet.2010.09.021; Fabbri G, 2016, NAT REV CANCER, V16, P145, DOI 10.1038/nrc.2016.8; Fanoni D, 2011, IMMUNOL LETT, V134, P157, DOI 10.1016/j.imlet.2010.09.022; Goncalves-Carneiro D, 2017, J VIROL, V91, DOI 10.1128/JVI.02255-16; Gordiienko I. M., 2016, Experimental Oncology, V38, P101; Guarini A, 2008, BLOOD, V112, P782, DOI 10.1182/blood-2007-12-127688; Guieze R, 2015, BLOOD, V126, P445, DOI 10.1182/blood-2015-02-585042; Huang PY, 2014, LEUKEMIA LYMPHOMA, V55, P2085, DOI 10.3109/10428194.2013.867486; Ingley E, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-21; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Mavaddat N, 2000, J BIOL CHEM, V275, P28100; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Mikhalap SV, 2004, BLOOD, V104, P4063, DOI 10.1182/blood-2004-04-1273; Mikhalap SV, 1999, J IMMUNOL, V162, P5719; Muccio VE, 2016, CYTOM PART B-CLIN CY, V90, P81, DOI 10.1002/cyto.b.21279; Neufeld TP, 2010, CURR OPIN CELL BIOL, V22, P157, DOI 10.1016/j.ceb.2009.11.005; Oakes CC, 2016, NAT GENET, V48, P253, DOI 10.1038/ng.3488; Packham G, 2014, HAEMATOLOGICA, V99, P1138, DOI 10.3324/haematol.2013.098384; Porakishvili N, 2005, BRIT J HAEMATOL, V131, P313, DOI 10.1111/j.1365-2141.2005.05775.x; Porakishvili N, 2015, MOL MED, V21, DOI 10.2119/molmed.2014.00265; Punnonen J, 1997, J EXP MED, V185, P993, DOI 10.1084/jem.185.6.993; Rodriguez-Bayona B, 2011, IMMUNOL LETT, V134, P122, DOI 10.1016/j.imlet.2010.09.015; Romanets-Korbut O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118302; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Schultz TE, 2017, J LEUKOCYTE BIOL, V101, P183, DOI 10.1189/jlb.2VMR1215-582R; Schweighofer CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028277; Shlapatska L. M., 2014, Experimental Oncology, V36, P2; Shlapatska LM, 2001, J IMMUNOL, V166, P5480, DOI 10.4049/jimmunol.166.9.5480; Sidorenko SP, 2003, NAT IMMUNOL, V4, P19, DOI 10.1038/ni0103-19; SIDORENKO SP, 1992, NEOPLASMA, V39, P3; SIDORENKO SP, 1993, J IMMUNOL, V151, P4614; Sintes J, 2011, IMMUNOL CELL BIOL, V89, P161, DOI 10.1038/icb.2010.145; Somani AK, 2001, J BIOL CHEM, V276, P1938, DOI 10.1074/jbc.M006820200; ten Hacken E, 2016, J IMMUNOL, V197, P2522, DOI 10.4049/jimmunol.1600915; Wiestner A, 2015, HAEMATOLOGICA, V100, P1495, DOI 10.3324/haematol.2014.119123; Woyach JA, 2015, BLOOD, V126, P471, DOI 10.1182/blood-2015-03-585075; Wu N, 2016, CURR OPIN IMMUNOL, V38, P45, DOI 10.1016/j.coi.2015.11.003; Yurchenko M., 2011, Experimental Oncology, V33, P9; Yurchenko MY, 2010, IMMUNOL CELL BIOL, V88, P565, DOI 10.1038/icb.2010.14; Yurchenko OV, 2003, EXP ONCOL, V25, P186; Zhang SP, 2014, ANNU REV PATHOL-MECH, V9, P103, DOI 10.1146/annurev-pathol-020712-163955; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zucchetto A, 2011, IMMUNOL LETT, V134, P137, DOI 10.1016/j.imlet.2010.09.017	51	8	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185940	10.1371/journal.pone.0185940	http://dx.doi.org/10.1371/journal.pone.0185940			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982149	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300093
J	Khan, S; Simpson, J; Lynch, JC; Turay, D; Mirshahidi, S; Gonda, A; Sanchez, TW; Casiano, CA; Wall, NR				Khan, Salma; Simpson, Jennifer; Lynch, James C.; Turay, David; Mirshahidi, Saied; Gonda, Amber; Sanchez, Tino W.; Casiano, Carlos A.; Wall, Nathan R.			Racial differences in the expression of inhibitors of apoptosis (IAP) proteins in extracellular vesicles (EV) from prostate cancer patients	PLOS ONE			English	Article							AFRICAN-AMERICAN; HEALTH DISPARITIES; UP-REGULATION; EXOSOMES; SURVIVIN; PROGNOSIS; PATHWAY	African-American men with prostate cancer typically develop more aggressive tumors than men from other racial/ethnic groups, resulting in a disproportionately high mortality from this malignancy. This study evaluated differences in the expression of inhibitors of apoptosis proteins (IAPs), a known family of oncoproteins, in blood-derived exosomal vesicles (EV) between African-American and European-American men with prostate cancer. The Exo-Quick (TM) method was used to isolate EV from both plasma and sera of African-American (n = 41) and European-American (n = 31) men with prostate cancer, as well as from controls with no cancer diagnosis (n = 10). EV preparations were quantified by acetylcholinesterase activity assays, and assessed for their IAP content by Western blotting and densitometric analysis. Circulating levels of the IAP Survivin were evaluated by ELISA. We detected a significant increase in the levels of circulating Survivin in prostate cancer patients compared to controls (P<0.01), with the highest levels in African-American patients (P<0.01). African-American patients with prostate cancer also contained significantly higher amounts of EVs in their plasma (P<0.01) and sera (P<0.05) than European-American patients. In addition, EVs from African-American patients with prostate cancer contained significantly higher amounts of the IAPs Survivin (P<0.05), XIAP (P<0.001), and cIAP-2 (P<0.01) than EVs from European-American patients. There was no significant correlation between expression of IAPs and clinicopathological parameters in the two patient groups. Increased expression of IAPs in EVs from African-American patients with prostate cancer may influence tumor aggressiveness and contribute to the mortality disparity observed in this patient population. EVs could serve as reservoirs of novel biomarkers and therapeutic targets that may have clinical utility in reducing prostate cancer health disparities.	[Khan, Salma; Simpson, Jennifer; Lynch, James C.; Turay, David; Gonda, Amber; Sanchez, Tino W.; Casiano, Carlos A.; Wall, Nathan R.] Loma Linda Univ, Sch Med, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA; [Khan, Salma; Simpson, Jennifer; Lynch, James C.; Turay, David; Mirshahidi, Saied; Gonda, Amber; Sanchez, Tino W.; Casiano, Carlos A.; Wall, Nathan R.] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA 92350 USA; [Mirshahidi, Saied] Loma Linda Univ, Sch Med, Canc Ctr, Loma Linda, CA USA; [Mirshahidi, Saied] Loma Linda Univ, Sch Med, Biospecimen Lab, Loma Linda, CA USA	Loma Linda University; Loma Linda University; Loma Linda University; Loma Linda University	Wall, NR (corresponding author), Loma Linda Univ, Sch Med, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA.; Wall, NR (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA 92350 USA.	nwall@llu.edu	Wall, Nathan R./H-7368-2015	Wall, Nathan R./0000-0002-3235-4386; Sanchez, Tino/0000-0002-2901-2211	National Institutes of Health (NIH)-National Institute of Minority Health and Health Disparities [P20MD0016321, P20MD006988]; Loma Linda University School of Medicine; Center for Health Disparities and Molecular Medicine	National Institutes of Health (NIH)-National Institute of Minority Health and Health Disparities; Loma Linda University School of Medicine; Center for Health Disparities and Molecular Medicine	Research reported in this publication was supported by the National Institutes of Health (NIH)-National Institute of Minority Health and Health Disparities under award numbers P20MD0016321 and P20MD006988. The authors thank Loma Linda University School of Medicine and the Center for Health Disparities and Molecular Medicine for supporting this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Altieri DC, 2015, SEMIN CELL DEV BIOL, V39, P91, DOI 10.1016/j.semcdb.2014.12.007; Basu A, 2011, PROSTATE, V71, P755, DOI 10.1002/pros.21292; Caradec J, 2014, CLIN BIOCHEM, V47, P1286, DOI 10.1016/j.clinbiochem.2014.06.011; Chaudhary AK, 2016, BRIT J CANCER, V114, P1090, DOI 10.1038/bjc.2016.88; Chornokur G, 2011, PROSTATE, V71, P985, DOI 10.1002/pros.21314; Clayton A, 2004, FASEB J, V18, P977, DOI 10.1096/fj.03-1094fje; Danilewicz M, 2015, POL J PATHOL, V66, P44, DOI 10.5114/PJP.2015.51152; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P290, DOI 10.3322/caac.21340; Djeu JY, 2009, ADV CANCER RES, V105, P77, DOI 10.1016/S0065-230X(09)05005-2; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Farrell J, 2013, INT J MOL SCI, V14, P15510, DOI 10.3390/ijms140815510; Ghosh JC, 2008, J BIOL CHEM, V283, P5188, DOI 10.1074/jbc.M705904200; Grasso L, 2015, ANAL BIOANAL CHEM, V407, P5425, DOI 10.1007/s00216-015-8711-5; Guo L, 2015, CRIT REV ONCOL HEMAT, V95, P346, DOI 10.1016/j.critrevonc.2015.04.002; Hardiman G, 2016, PHARMACOGENOMICS, V17, P1129, DOI 10.2217/pgs-2016-0025; Khan S, 2009, BRIT J CANCER, V100, P1073, DOI 10.1038/sj.bjc.6604978; Khan S, 2015, BIOL-TARGETS THER, V9, P57, DOI 10.2147/BTT.S83864; Khan S, 2015, HISTOL HISTOPATHOL, V30, P43, DOI 10.14670/HH-30.43; Khan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046737; Khan S, 2011, APOPTOSIS, V16, P1, DOI 10.1007/s10495-010-0534-4; Martin DN, 2013, CURR OPIN ONCOL, V25, P235, DOI 10.1097/CCO.0b013e32835eb5d1; McGinley KF, 2016, NAT REV UROL, V13, P99, DOI 10.1038/nrurol.2015.298; Mediavilla-Varela M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-68; Minciacchi V. R., 2017, PROSTATE CANC PROSTA; Myers JS, 2016, J CANCER, V7, P1452, DOI 10.7150/jca.15860; Powell IJ, 2014, CANCER EPIDEM BIOMAR, V23, P1505, DOI 10.1158/1055-9965.EPI-13-1328; Powell IJ, 2013, MOL ENDOCRINOL, V27, P879, DOI 10.1210/me.2013-1039; Powell IJ, 2010, J UROLOGY, V183, P1792, DOI 10.1016/j.juro.2010.01.015; Rodriguez-Berriguete G, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-18; Saleem M, 2013, CHEM BIOL DRUG DES, V82, P243, DOI 10.1111/cbdd.12176; Savina A, 2002, J CELL SCI, V115, P2505; Schlette EJ, 2004, J CLIN ONCOL, V22, P1682, DOI 10.1200/JCO.2004.10.172; Seisen T, 2016, CANCER TREAT REV, V48, P25, DOI 10.1016/j.ctrv.2016.06.005; Shi R, 2015, ONCOTARGET, V6, P26971, DOI 10.18632/oncotarget.4699; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Singh N, 2015, DRUG DISCOV TODAY, V20, P578, DOI 10.1016/j.drudis.2014.11.013; Turay D, 2016, CANCER INVEST, V34, P1, DOI 10.3109/07357907.2015.1081921; Turner DP, 2015, CANCER RES, V75, P1925, DOI 10.1158/0008-5472.CAN-15-0169; Urbanelli Lorena, 2015, Recent Pat CNS Drug Discov, V10, P10; Valenzuela MMA, 2015, CANCER MICROENVIRON, V8, P65, DOI 10.1007/s12307-015-0167-9; Xiao M, 2015, ASD; Yamamoto Tetsuhisa, 2001, Medical Electron Microscopy, V34, P207, DOI 10.1007/s007950100017; Yu SR, 2015, ONCOTARGET, V6, P37151, DOI 10.18632/oncotarget.6022; Zhang L, 2016, CANCER RES, V76, P6290, DOI 10.1158/0008-5472.CAN-16-0087	44	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0183122	10.1371/journal.pone.0183122	http://dx.doi.org/10.1371/journal.pone.0183122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981528	gold, Green Submitted, Green Published			2022-12-26	WOS:000412360300003
J	Wang, XH; Zheng, YC; Gan, L; Wang, X; Sang, XT; Kong, XF; Zhao, J				Wang, Xuehu; Zheng, Yongchang; Gan, Lan; Wang, Xuan; Sang, Xinting; Kong, Xiangfeng; Zhao, Jie			Liver segmentation from CT images using a sparse priori statistical shape model (SP-SSM)	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; CLASSIFICATION; ALGORITHM	This study proposes a new liver segmentation method based on a sparse a priori statistical shape model (SP-SSM). First, mark points are selected in the liver a priori model and the original image. Then, the a priori shape and its mark points are used to obtain a dictionary for the liver boundary information. Second, the sparse coefficient is calculated based on the correspondence between mark points in the original image and those in the a priori model, and then the sparse statistical model is established by combining the sparse coefficients and the dictionary. Finally, the intensity energy and boundary energy models are built based on the intensity information and the specific boundary information of the original image. Then, the sparse matching constraint model is established based on the sparse coding theory. These models jointly drive the iterative deformation of the sparse statistical model to approximate and accurately extract the liver boundaries. This method can solve the problems of deformation model initialization and a priori method accuracy using the sparse dictionary. The SP-SSM can achieve a mean overlap error of 4.8% and a mean volume difference of 1.8%, whereas the average symmetric surface distance and the root mean square symmetric surface distance can reach 0.8 mm and 1.4 mm, respectively.	[Wang, Xuehu; Zhao, Jie] Hebei Univ, Sch Elect & Informat Engn, Baoding, Peoples R China; [Wang, Xuehu; Zhao, Jie] Key Lab Digital Med Engn Hebei Prov, Baoding, Peoples R China; [Zheng, Yongchang; Wang, Xuan; Sang, Xinting; Kong, Xiangfeng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Liver Surg, Beijing, Peoples R China; [Zheng, Yongchang; Wang, Xuan; Sang, Xinting; Kong, Xiangfeng] Peking Union Med Coll, Beijing, Peoples R China; [Gan, Lan] East China Jiaotong Univ, Sch Informat Engn, Nanchang, Jiangxi, Peoples R China	Hebei University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; East China Jiaotong University	Zheng, YC (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Liver Surg, Beijing, Peoples R China.; Zheng, YC (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	wangxuehu_tougao@163.com			Natural Science Foundation of China [61401308, 61572063]; Natural Science Foundation of Hebei Province [F2016201142, F2016201187]; Natural Social Foundation of Hebei Province [HB15TQ015]; Science research project of Hebei Province [QN2016085, ZC2016040]; Science and technology support project of Hebei Province [15210409]; Natural Science Foundation of Hebei University [2014303]; Hebei university improve comprehensive strength special funds in the Midwest	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Natural Social Foundation of Hebei Province; Science research project of Hebei Province; Science and technology support project of Hebei Province; Natural Science Foundation of Hebei University(Natural Science Foundation of Hebei Province); Hebei university improve comprehensive strength special funds in the Midwest	This work was supported in part by Natural Science Foundation of China under grant 61401308 and 61572063, Natural Science Foundation of Hebei Province under grant F2016201142 and F2016201187, Natural Social Foundation of Hebei Province under grant HB15TQ015, Science research project of Hebei Province under grant QN2016085 and ZC2016040, Science and technology support project of Hebei Province under grant 15210409, Natural Science Foundation of Hebei University under grant 2014303; Hebei university improve comprehensive strength special funds in the Midwest.	Afzali M, 2016, COMPUT BIOL MED, V73, P56, DOI 10.1016/j.compbiomed.2016.03.022; Al-Shaikhli SDS, 2016, BIOMED ENG-BIOMED TE, V61, P413, DOI 10.1515/bmt-2015-0071; Anas Emran Mohammad Abu, 2016, IEEE Trans Med Imaging, V35, P1789, DOI 10.1109/TMI.2016.2529500; Aslan MS, 2014, IET COMPUT VIS, V8, P182, DOI 10.1049/iet-cvi.2012.0226; Aslan MS, 2013, I S BIOMED IMAGING, P840; Cao SY, 2012, IEEE ENG MED BIO, P4942, DOI 10.1109/EMBC.2012.6347101; Faghih DV, 2016, APPL BIONICS BIOMECH, V2016; Farag AA, 2006, IEEE T IMAGE PROCESS, V15, P952, DOI 10.1109/TIP.2005.863949; Franceschini A, 2016, BIOINFORMATICS, V32, P1085, DOI 10.1093/bioinformatics/btv696; Guo YR, 2014, MED PHYS, V41, DOI 10.1118/1.4884224; Haddad AE, 2015, INT C IEEE ENG MED B; Heimann T, 2009, IEEE T MED IMAGING, V28, P1251, DOI 10.1109/TMI.2009.2013851; Hiwatashi A, 2016, J NEURORADIOLOGY, V43, P266, DOI 10.1016/j.neurad.2016.01.147; Kato T, 2015, NEURAL NETWORKS, V66, P64, DOI 10.1016/j.neunet.2015.02.009; Khormuji MK, 2016, MED BIOL ENG COMPUT, V54, P869, DOI 10.1007/s11517-015-1382-8; Liao S, 2012, LECT NOTES COMPUT SC, V7512, P385, DOI 10.1007/978-3-642-33454-2_48; Liu HB, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0221-y; Nawano S, 2016, INT J COMPUTER ASSIS, V12, P1; Oliveira DAB, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-30; Palomba D, 2012, MOLECULES, V17, P14937, DOI 10.3390/molecules171214937; Pontier DB, 2009, CURR BIOL, V19, P1384, DOI 10.1016/j.cub.2009.06.045; Ptucha R, 2014, IEEE T IMAGE PROCESS, V23, P1737, DOI 10.1109/TIP.2014.2303648; Rikxoort EMV, 2007, AUTOMATIC SEGMENTATI; Saddi Kinda A, 2007, GLOBAL TO LOCAL SHAP; Seghers D, 2007, LANDMARK BASED LIVER; Soliman A, 2017, IEEE T MED IMAGING, VPP, P1; Tong T, 2013, NEUROIMAGE, V76, P11, DOI 10.1016/j.neuroimage.2013.02.069; Wang XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118064; Ying C, 2008, DISCUSSION EVALUATIO	29	10	10	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185249	10.1371/journal.pone.0185249	http://dx.doi.org/10.1371/journal.pone.0185249			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981530	gold, Green Published, Green Submitted			2022-12-26	WOS:000412360300030
J	Bonyah, E; Khan, MA; Okosun, KO; Islam, S				Bonyah, Ebenezer; Khan, Muhammad Altaf; Okosun, K. O.; Islam, Saeed			A theoretical model for Zika virus transmission	PLOS ONE			English	Article							BRUCELLOSIS MODEL; INFECTION; DYNAMICS; OUTBREAK	In this paper, we present and analyze an SEIR Zika epidemic model. Firstly, we investigate the model with constant controls. The steady states of the model is found to be locally and globally asymptotically stable. Thereafter, we incorporate time dependent controls into the model in order to investigate the optimal effects of bednets, treatments of infective and spray of insecticides on the disease spread. Furthermore, we used Pontryagin's Maximum Principle to determine the necessary conditions for effective control of the disease. Also, the numerical results were presented.	[Bonyah, Ebenezer] Kumasi Tech Univ, Dept Math & Stat, Kumasi, Ghana; [Khan, Muhammad Altaf] City Univ Sci & Informat Technol, Dept Math, Peshawar 25000, KP, Pakistan; [Bonyah, Ebenezer; Okosun, K. O.] Vaal Univ Technol, Dept Math, Vanderbijlpark, South Africa; [Islam, Saeed] Univ Mardan, Dept Math Abdul Wali Khan, KP, Pakistan	Vaal University of Technology (VUT)	Bonyah, E (corresponding author), Kumasi Tech Univ, Dept Math & Stat, Kumasi, Ghana.; Bonyah, E (corresponding author), Vaal Univ Technol, Dept Math, Vanderbijlpark, South Africa.	ebbonya@yahoo.com	Saeed, Islam/AAD-6067-2020; Khan, Muhammad Altaf/K-2201-2013; Bonyah, Ebenezer/ABE-2160-2020	Saeed, Islam/0000-0001-5263-4871; Khan, Muhammad Altaf/0000-0002-4483-7879; 				Allenl LJS, 2007, INTRO MATH BIOL; [Anonymous], 2015, ADV STUD BIOL; Birkhoff G., 1982, ORDINARY DIFFERENTIA; Bonyah E, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/576039; Castillo-Chavez C, 2004, MATH BIOSCI ENG, V1, P361, DOI 10.3934/mbe.2004.1.361; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Fleming W.H., 2012, DETERMINISTIC STOCHA; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070; Gui HL, 2017, PLOS ONE, V12; Guo H, P AM MATH SOC, V136, P2793; Javidi M, 2014, WOR J MOD SIMUL, V10, P163; Khan M.A., 2015, IJAMM, V2, P1; KHAN MM, 2017, SCI REP UK, V7; LaSalle J.P., 1976, SOC IND APPL MATH; Lee Eva K, 2016, AMIA Annu Symp Proc, V2016, P743; Li L, 2016, J BIOL SYST, V24, P519, DOI 10.1142/S0218339016500261; Li MT, 2014, APPL MATH COMPUT, V237, P582, DOI 10.1016/j.amc.2014.03.094; Mingai L., 2016, J INTELL FUZZY SYST, P1; Mojumder MS, B WHO IN PRESS; Musso D, 2014, CLIN MICR INFECT, V20, P59; Musso D, 2014, EURO SURVEILL, V19; Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017; Okosun KO, 2014, MATH BIOSCI, V258, P19, DOI 10.1016/j.mbs.2014.09.008; Okosun KO, 2013, BIOSYSTEMS, V111, P83, DOI 10.1016/j.biosystems.2012.09.008; Peng M, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/842614; Piqueira JRC, 2008, COMPUT SECUR, V27, P355, DOI 10.1016/j.cose.2008.07.006; Pontryagin LS, 1962, MATH THEORY OPTIMAL; Shi XY, 2011, TURK J MATH, V35, P649, DOI 10.3906/mat-1006-333; Simpson D, 1964, T ROY SOC TROP MED H, V58, P33; Sun GQ, 2016, TRANSMISSION DYNAMIC; Sun GQ, 2017, COMMUN NONLINEAR SCI, V45, P235, DOI 10.1016/j.cnsns.2016.10.007; Sun GQ, 2014, APPL MATH COMPUT, V246, P336, DOI 10.1016/j.amc.2014.08.028; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Wan H, 2013, J APPL MATH, V2013, P1; Xing Y, 2017, APPL MATH COMPUT, V309, P192, DOI 10.1016/j.amc.2017.04.007; Yu P, 2016, J BIOL DYNAM, V10, P263, DOI 10.1080/17513758.2016.1166270; Zhang Jinhong, 2014, ScientificWorldJournal, V2014, P910421, DOI 10.1155/2014/910421	39	51	51	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185540	10.1371/journal.pone.0185540	http://dx.doi.org/10.1371/journal.pone.0185540			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977007	Green Published, gold, Green Submitted			2022-12-26	WOS:000412163100026
J	Yang, JH; Zhang, XW; Zhang, WW; Sun, JY; Xie, YW; Zhang, YM; Burton, GA; Yu, HX				Yang, Jianghua; Zhang, Xiaowei; Zhang, Wanwan; Sun, Jingying; Xie, Yuwei; Zhang, Yimin; Burton, G. Allen; Yu, Hongxia			Indigenous species barcode database improves the identification of zooplankton	PLOS ONE			English	Article							OPEN SOFTWARE; GENE FLOW; DNA; DIVERSITY; SPECIATION; ROTIFERA; COLONIZATION; SEQUENCES; PATTERNS; ECOLOGY	Incompleteness and inaccuracy of DNA barcode databases is considered an important hindrance to the use of metabarcoding in biodiversity analysis of zooplankton at the specieslevel. Species barcoding by Sanger sequencing is inefficient for organisms with small body sizes, such as zooplankton. Here mitochondrial cytochrome c oxidase I (COI) fragment barcodes from 910 freshwater zooplankton specimens (87 morphospecies) were recovered by a high-throughput sequencing platform, Ion Torrent PGM. Intraspecific divergence of most zooplanktons was < 5%, except Branchionus leydign (Rotifer, 14.3%), Trichocerca elongate (Rotifer, 11.5%), Lecane bulla (Rotifer, 15.9%), Synchaeta oblonga (Rotifer, 5.95%) and Schmackeria forbesi (Copepod, 6.5%). Metabarcoding data of 28 environmental samples from Lake Tai were annotated by both an indigenous database and NCBI Genbank database. The indigenous database improved the taxonomic assignment of metabarcoding of zooplankton. Most zooplankton (81%) with barcode sequences in the indigenous database were identified by metabarcoding monitoring. Furthermore, the frequency and distribution of zooplankton were also consistent between metabarcoding and morphology identification. Overall, the indigenous database improved the taxonomic assignment of zooplankton.	[Yang, Jianghua; Zhang, Xiaowei; Zhang, Wanwan; Sun, Jingying; Xie, Yuwei; Yu, Hongxia] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing, Jiangsu, Peoples R China; [Zhang, Yimin] Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China; [Burton, G. Allen] Univ Michigan, Sch Environm & Sustainabil, Ann Arbor, MI 48109 USA	Nanjing University; University of Michigan System; University of Michigan	Zhang, XW (corresponding author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing, Jiangsu, Peoples R China.	howard50003250@yahoo.com	Zhang, Xiaowei/I-2259-2012; Xie, Yuwei/CAI-7227-2022	Zhang, Xiaowei/0000-0001-8974-9963; Xie, Yuwei/0000-0001-5652-6413	Science Foundation of Jiangsu Province [BK20130015]; China Major Science and Technology Program for Water Pollution Control and Treatment [2012ZX07506-003, 2012ZX07101-007]; Fundamental Research Funds for the Central Universities; Collaborative Innovation Center for Regional Environmental Quality	Science Foundation of Jiangsu Province; China Major Science and Technology Program for Water Pollution Control and Treatment; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Collaborative Innovation Center for Regional Environmental Quality	For support, we thank Science Foundation of Jiangsu Province (BK20130015) and China Major Science and Technology Program for Water Pollution Control and Treatment (Grant #2012ZX07506-003 and 2012ZX07101-007). X.Z. was supported by the Fundamental Research Funds for the Central Universities. The research was also supported by the Collaborative Innovation Center for Regional Environmental Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; For support, we thank Science Foundation of Jiangsu Province (BK20130015) and China Major Science and Technology Program for Water Pollution Control and Treatment (Grant #2012ZX07506-003 and 2012ZX07101-007). X.Z. was supported by the Fundamental Research Funds for the Central Universities. The research was also supported by the Collaborative Innovation Center for Regional Environmental Quality.	Blancobercial L, 2014, DNA BARCODING MARINE, V6, pS122; Bourlat SJ, 2013, MAR POLLUT BULL, V74, P19, DOI 10.1016/j.marpolbul.2013.05.042; Bucklin A, 2016, J PLANKTON RES, V38, P393, DOI 10.1093/plankt/fbw023; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chiang Sieh-chih, 1979, FAUNA SINICA CRUSTAC; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; Cox AJ, 2001, MOL ECOL, V10, P371, DOI 10.1046/j.1365-294x.2001.01188.x; Cristescu ME, 2012, MOL ECOL, V21, P1411, DOI 10.1111/j.1365-294X.2011.05465.x; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elias-Gutierrez M, 2008, ZOOTAXA, P1; Esling P, 2015, NUCLEIC ACIDS RES, V43, P2513, DOI 10.1093/nar/gkv107; Field D, 2006, NAT BIOTECHNOL, V24, P801, DOI 10.1038/nbt0706-801; Frolov S, 2013, HARMFUL ALGAE, V21-22, P1, DOI 10.1016/j.hal.2012.11.001; Garcia-Morales AE, 2013, MOL ECOL RESOUR, V13, P1097, DOI 10.1111/1755-0998.12080; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilbert JJ, 2005, HYDROBIOLOGIA, V546, P257, DOI 10.1007/s10750-005-4205-3; Gomez A, 2002, EVOLUTION, V56, P1431; Gomez A, 2002, J EVOLUTION BIOL, V15, P158, DOI 10.1046/j.1420-9101.2002.00368.x; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lee CL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037897, 10.1371/journal.pone.0030077]; Leray M, 2012, CORAL REEFS, V31, P383, DOI 10.1007/s00338-011-0845-0; Leray M, 2015, P NATL ACAD SCI USA, V112, P2076, DOI 10.1073/pnas.1424997112; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Lindeque PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081327; Machida RJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-438; Montero-Pau J, 2008, LIMNOL OCEANOGR-METH, V6, P218, DOI 10.4319/lom.2008.6.218; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Papakostas S, 2016, SYST BIOL, V65, P508, DOI 10.1093/sysbio/syw016; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Segers H, 2008, BIODIVERS CONSERV, V17, P303, DOI 10.1007/s10531-007-9262-7; Segers H, 2008, HYDROBIOLOGIA, V595, P49, DOI 10.1007/s10750-007-9003-7; Shen Chia-jui, 1979, FAUNA SINICA CRUSTAC; Shokralla S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09687; Shokralla S, 2014, MOL ECOL RESOUR, V14, P892, DOI 10.1111/1755-0998.12236; Smith ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043319; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Steinberg DK, 2008, LIMNOL OCEANOGR, V53, P1327, DOI 10.4319/lo.2008.53.4.1327; Suatoni E, 2006, MOL PHYLOGENET EVOL, V41, P86, DOI 10.1016/j.ympev.2006.04.025; Sun CS, 2015, AQUAT BIOL, V24, P9, DOI 10.3354/ab00629; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Visco JA, 2015, ENVIRON SCI TECHNOL, V49, P7597, DOI 10.1021/es506158m; Wallace RL, 2002, INTEGR COMP BIOL, V42, P660, DOI 10.1093/icb/42.3.660; Wares JP, 2001, EVOLUTION, V55, P2455; Wiwatanaratanabutr I, 2016, J INVERTEBR PATHOL, V141, P18, DOI 10.1016/j.jip.2016.10.003; Wiwatanaratanabutr I, 2013, J INVERTEBR PATHOL, V114, P341, DOI 10.1016/j.jip.2013.04.014; Xiang XL, 2011, MOL PHYLOGENET EVOL, V59, P386, DOI 10.1016/j.ympev.2011.02.011; Zannatul Ferdous, 2009, American Journal of Applied Sciences, V6, P1815, DOI 10.3844/ajassp.2009.1815.1819	53	15	19	5	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185697	10.1371/journal.pone.0185697	http://dx.doi.org/10.1371/journal.pone.0185697			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977035	Green Published, Green Submitted, gold			2022-12-26	WOS:000412163100038
J	Bilinski, A; Birru, E; Peckarsky, M; Herce, M; Kalanga, N; Neumann, C; Bronson, G; Po-Chedley, S; Kachimanga, C; McBain, R; Keck, J				Bilinski, Alyssa; Birru, Ermyas; Peckarsky, Matthew; Herce, Michael; Kalanga, Noel; Neumann, Christian; Bronson, Gay; Po-Chedley, Stephen; Kachimanga, Chembe; McBain, Ryan; Keck, James			Distance to care, enrollment and loss to follow-up of HIV patients during decentralization of antiretroviral therapy in Neno District, Malawi: A retrospective cohort study	PLOS ONE			English	Article							SCALE-UP	HIV/AIDS remains the second most common cause of death in low and middle-income countries (LMICs), and only 34% of eligible patients in Africa received antiretroviral therapy (ART) in 2013. This study investigated the impact of ART decentralization on patient enrollment and retention in rural Malawi. We reviewed electronic medical records of patients registered in the Neno District ART program from August 1, 2006, when ART first became available, through December 31, 2013. We used GPS data to calculate patient-level distance to care, and examined number of annual ART visits and one-year lost to follow-up (LTFU) in HIV care. The number of ART patients in Neno increased from 48 to 3,949 over the decentralization period. Mean travel distance decreased from 7.3 km when ART was only available at the district hospital to 4.7 km when ART was decentralized to 12 primary health facilities. For patients who transferred from centralized care to nearer health facilities, mean travel distance decreased from 9.5 km to 4.7 km. Following a transfer, the proportion of patients achieving the clinic's recommended >= 4 annual visits increased from 89% to 99%. In Cox proportional hazards regression, patients living >= 8 km from a health facility had a greater hazard of being LTFU compared to patients < 8 km from a facility (adjusted HR: 1.7; 95% CI: 1.5-1.9). ART decentralization in Neno District was associated with increased ART enrollment, decreased travel distance, and increased retention in care. Increasing access to ART by reducing travel distance is one strategy to achieve the ART coverage and viral suppression objectives of the 90-90-90 UNAIDS targets in rural impoverished areas.	[Bilinski, Alyssa; Birru, Ermyas; Peckarsky, Matthew; Herce, Michael; Kalanga, Noel; Neumann, Christian; Bronson, Gay; Po-Chedley, Stephen; Kachimanga, Chembe; McBain, Ryan; Keck, James] Malawi & Partners In Hlth, Abwenzi Pa Za Umoyo, Boston, MA 02199 USA; [Bilinski, Alyssa] Harvard Grad Sch Arts & Sci, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA; [Herce, Michael] Univ N Carolina, Sch Med, Dept Med, Div Infect Dis, Chapel Hill, NC USA	Harvard University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Bilinski, A (corresponding author), Malawi & Partners In Hlth, Abwenzi Pa Za Umoyo, Boston, MA 02199 USA.; Bilinski, A (corresponding author), Harvard Grad Sch Arts & Sci, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA.	abilinski@g.harvard.edu	Po-Chedley, Stephen/O-3450-2019; kachimanga, chiyembekezo/W-9967-2019; Po-Chedley, Stephen/E-9706-2013	kachimanga, chiyembekezo/0000-0003-3507-9591; Po-Chedley, Stephen/0000-0002-0390-238X; Keck, James/0000-0001-7193-065X	Partners In Health/Abwenzi Pa Za Umoyo; National Institutes of Health [1K01TW010272-01]; Agency for Healthcare Research and Quality [T32HS000055]	Partners In Health/Abwenzi Pa Za Umoyo; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Partners In Health/Abwenzi Pa Za Umoyo (http://www.pih.org/) supported the work through routine salary/program expenses (all authors). This work was funded in part by National Institutes of Health (https://grants.nil.gov/grants/oer.htm) grant 1K01TW010272-01 (MH). This project was also supported by grant number T32HS000055 from the Agency for Healthcare Research and Quality (https://www.ahrq.gov/funding/index.html) (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, 1 ED MAL GUID CLIN M; [Anonymous], 2013, GLOB REP UNAIDS REP; [Anonymous], 2013, INT HIV PROGR REP OC; [Anonymous], 2013, ACC ANT THER AFR STA; Bastard M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049091; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Boyer S, 2010, AIDS; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Buyse M, 1996, STAT MED, V15, P2797, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2797::AID-SIM290>3.0.CO;2-V; Carlucci JG, 2008, J ACQ IMMUN DEF SYND, V47, P615; Chan AK, 2010, TROP MED INT HEALTH, V15, P90, DOI 10.1111/j.1365-3156.2010.02503.x; Chi BH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001111; Franke MF, 2013, CLIN INFECT DIS, V56, P1319, DOI 10.1093/cid/cis1193; Herce ME, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19929; Houben RMGJ, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-49; Kredo T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009987.pub2; Long L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001055; McGuire M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038044; *MIN HLTH, 2006, TREATM AIDS GUID US; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Neno District Executive Committee, 2013, NEN DISTR SOC PROF 2; Suthar AB, 2014, AIDS, V28, pS175, DOI 10.1097/QAD.0000000000000259; Therneau T, 2016, SURVIV VIGNETTES; UNAIDS, 2014, CAM DEV SUBN EST HIV, P19; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369; WHO, 2013, GLOB UPD HIV TREATM; Wilson DP, 2005, PLOS MED, V2, P132, DOI 10.1371/journal.pmed.0020050; World Health Organization, 2014, GLOB HLTH OBS GHO HI	28	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185699	10.1371/journal.pone.0185699	http://dx.doi.org/10.1371/journal.pone.0185699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973035	Green Published, gold, Green Submitted			2022-12-26	WOS:000412131900037
J	Carrasco, JM; Garcia, M; Navas, A; Olza, I; Gomez-Baceiredo, B; Pujol, F; Garralda, E; Centeno, C				Miguel Carrasco, Jose; Garcia, Miriam; Navas, Alejandro; Olza, Ines; Gomez-Baceiredo, Beatriz; Pujol, Francesc; Garralda, Eduardo; Centeno, Carlos			What does the media say about palliative care? A descriptive study of news coverage in written media in Spain	PLOS ONE			English	Article							COMMUNICATION; PERSPECTIVE; COUNTRIES; BARRIERS; EUROPE	Introduction The goal of palliative care (PC) is to improve the quality of life of terminal stage patients and their families. The subject frequently appears in the mass-media and this helps create a socially accepted identity. The aim of this study is to describe and analyse PC related news items appeared in the Spanish written media. Methodology A descriptive cross-sectional study was designed. Considering diffusion, scope and the range in editorial policy criteria, four printed newspapers (PN) were selected, together with four exclusively digital media sources (DM). Through Mynews, a newspaper content depository, and the search tool for each DM website, articles published between 2009 and 2014 which included the terms "palliative care" and "palliative medicine" were sought. A questionnaire was created to characterise each article identified and a descriptive analysis was undertaken. Results A total of 627 articles were identified, of which 359 (57%) were published in PN (42% in the printed editions -PE- 16% in their online editions -OE-) and 268 (43%) in DM. In general, they appeared mainly in sections concerning Health (23%), Culture and Society (18%) and General/Home News (15%). In PE, just 2% were found in the Health section and nearly 70% in Culture and Society and General/Home News. Most of the articles were informative in nature and contained socio-political messages (90%). Statements by PC professionals were found in 35% of the articles and by politicians in 32%. The most frequent content was related to facing end of life (74%) and patient quality of life (70%). Conclusions The Spanish written media reflects the socio-political interest aroused by PC. Nevertheless, messages circulating about PC do not describe professional practice, or the contribution of the same for patients. Content more in line with the clinical practice might help contribute to the development of this new area of medicine.	[Miguel Carrasco, Jose; Garralda, Eduardo; Centeno, Carlos] Univ Navarra, Inst Culture & Soc, ATLANTES Res Program, Pamplona, Spain; [Miguel Carrasco, Jose; Garralda, Eduardo; Centeno, Carlos] Navarra Inst Hlth Res IdiSNA, Pamplona, Spain; [Garcia, Miriam] Errea Comunicac, Pamplona, Spain; [Navas, Alejandro] Univ Navarra, Sch Commun, Publ Commun Dept, Pamplona, Spain; [Olza, Ines] Univ Navarra, Inst Culture & Soc, GRADUN, Pamplona, Spain; [Gomez-Baceiredo, Beatriz] Univ Navarra, Sch Commun, Journalism Projects Dept, Pamplona, Spain; [Pujol, Francesc] Univ Navarra, Sch Econ & Business Adm, Dept Econ, Pamplona, Spain	University of Navarra; University of Navarra; University of Navarra; University of Navarra; University of Navarra	Carrasco, JM (corresponding author), Univ Navarra, Inst Culture & Soc, ATLANTES Res Program, Pamplona, Spain.; Carrasco, JM (corresponding author), Navarra Inst Hlth Res IdiSNA, Pamplona, Spain.	jmcarrascog@unay.es	Centeno, Carlos/H-3430-2013; Gomez, Beatriz/AAF-1391-2021; Pujol, Francesc/Z-4767-2019; Carrasco, Jose Miguel/I-3482-2015	Centeno, Carlos/0000-0003-3395-7039; Gomez, Beatriz/0000-0001-5332-0698; Pujol, Francesc/0000-0002-0368-0529; Carrasco, Jose Miguel/0000-0002-3847-8312	Institute for Culture and Society (ICS) of the University Navarra	Institute for Culture and Society (ICS) of the University Navarra	Support for this work was received from the Institute for Culture and Society (ICS) of the University Navarra. One of the authors [MG] is employed by a commercial company [Errea Comunicacion], but the company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aguiar F, 2013, ADV APPL SOCIOLOGY, V3, P124; Akintola O, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0051-6; Akiyama M, 2016, SUPPORT CARE CANCER, V24, P347, DOI 10.1007/s00520-015-2788-4; [Anonymous], 2011, ASOCIACION INVESTIGA; Centeno C, 2015, PALLIATIVE MED, P31; Conde F, 2009, ANALISIS SOCIOLOGICO; Daw JR, 2013, HEALTH POLICY, V110, P67, DOI 10.1016/j.healthpol.2013.01.006; De Leon E, 2014, J MED INTERNET RES, V16, P119, DOI 10.2196/jmir.2837; Duran M.A., 2004, REV ESP INVESTIG SOC, V106, P9; Gempeler F. E., 2015, REV COLOMB ANESTESIO, V43, P142; Habermas J, 1981, HIST CRITICA OPINION; Husemann S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1742-1; Khaw KT, 1999, BRIT MED J, V319, P1350, DOI 10.1136/bmj.319.7221.1350; Lynch T, 2010, PALLIATIVE MED, V24, P812, DOI 10.1177/0269216310368578; Lynch T, 2009, J PAIN SYMPTOM MANAG, V37, P305, DOI 10.1016/j.jpainsymman.2008.03.011; McIlfatrick S, 2014, PALLIATIVE MED, V28, P273, DOI 10.1177/0269216313502372; McIlfatrick S, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-34; Muszbek K, 2007, J PAIN SYMPTOM MANAG, V33, P605, DOI 10.1016/j.jpainsymman.2007.02.027; Naugle DA, 2014, J HEALTH COMMUN, V19, P190, DOI 10.1080/10810730.2014.918217; Norton SA, 2013, RES NURS HEALTH, V36, P582, DOI 10.1002/nur.21563; Oliver D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4846; Parry R, 2014, BMJ SUPPORT PALLIAT, V4, P331, DOI 10.1136/bmjspcare-2014-000649; Pastrana T, 2015, J PALLIAT MED, V18, P429, DOI 10.1089/jpm.2014.0120; Rodriguez Diaz R, 2004, OBSERVATORIO EUROPEO; StataCorp, 2011, STAT STAT SOFTW REL; Taiwo R., 2007, PERSPECTIVES MEDIA D; Van den Berg R, 2011, EUR J GEN PRACT, V17, P14, DOI 10.3109/13814788.2010.549224; Vega T, 2011, GAC SANIT, V25, P205, DOI 10.1016/j.gaceta.2011.02.005; World Health Organization, 2013, EUR HLTH REP 2012 CH; World Health Organization-WHO, 2014, DEF PALL CAR; World Palliative Care Alliance World Health Organization, 2014, GLOBAL ATLAS PALLIAT; Wurz A, 2013, J HEALTH COMMUN, V18, P1566, DOI 10.1080/10810730.2013.840698; 2013, WORLD HLTH REP 2013, P1	34	13	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0184806	10.1371/journal.pone.0184806	http://dx.doi.org/10.1371/journal.pone.0184806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968433	Green Published, gold, Green Submitted			2022-12-26	WOS:000412029600010
J	Guo, YY; We, HY; Li, X; Li, Q; Zhao, XY; Duan, XQ; An, YR; Lv, W; An, HL				Guo, Yuyu; We, Hongyu; Li, Xiang; Li, Qi; Zhao, Xinyan; Duan, Xueqing; An, Yanrong; Lv, Wei; An, Hailong			Identification and expression of GRAS family genes in maize (Zea mays L.)	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; GIBBERELLIN SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTOR; MOLECULAR ANALYSIS; SCARECROW GENE; ARABIDOPSIS; PROTEINS; PHYTOCHROME; REGULATOR; RICE	GRAS transcriptional factors have diverse functions in plant growth and development, and are named after the first three transcription factors, namely, GAI (GIBBERELLIC ACID INSENSITIVE), RGA (REPRESSOR OF GAI) and SCR (SCARECROW) identified in this family. Knowledge of the GRAS gene family in maize remains was largely unknown, and their characterization is necessary to understand their importance in the maize life cycle. This study identified 86 GRAS genes in maize, and further characterized with phylogenetics, gene structural analysis, genomic loci, and expression patterns. The 86 GRAS genes were divided into 8 groups (SCL3, HAM, LS, SCR, DELLA, SHR, PAT1 and LISCL) by phylogenetic analysis. Most of the maize GRAS genes contain one exon (80.23%) and closely related members in the phylogenetic tree had similar structure and motif composition. Different motifs especially in the N-terminus might be the sources of their functional divergence. Segmental-and tandem-duplication occurred in this family leading to expansion of maize GRAS genes and the expression patterns of the duplicated genes in the heat map according to the published microarray data were very similar. Quantitative RT-PCR (qRT-PCR) results demonstrated that the expression level of genes in different tissues were different, suggesting their differential roles in plant growth and development. The data set expands our knowledge to understanding the function of GRAS genes in maize, an important crop plant in the world.	[Guo, Yuyu; We, Hongyu; Li, Xiang; Li, Qi; Zhao, Xinyan; Duan, Xueqing; An, Yanrong; Lv, Wei; An, Hailong] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Lv, W; An, HL (corresponding author), Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	lvwei_star@163.com; hlan@sdau.edu.cn	Li, Qi/AHD-9922-2022	Li, Qi/0000-0002-7736-764X; An, Hailong/0000-0002-5169-0246	Ministry of Agriculture of China [2016ZX08009002]; foundation of the Ministry of Education Key Laboratory of Cell Activities and Stress Adaptations [lzujbky-2016-bt05]; National Natural Science Foundation of China [31301080]; Funds of Shandong "Double Tops" Program	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); foundation of the Ministry of Education Key Laboratory of Cell Activities and Stress Adaptations; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funds of Shandong "Double Tops" Program	This work was supported by the Ministry of Agriculture of China (grant number 2016ZX08009002), the foundation of the Ministry of Education Key Laboratory of Cell Activities and Stress Adaptations (grant number lzujbky-2016-bt05), the National Natural Science Foundation of China (grant number 31301080) and Funds of Shandong "Double Tops" Program.	Abarca D, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0354-8; Andersen JR, 2005, THEOR APPL GENET, V111, P206, DOI 10.1007/s00122-005-1996-6; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bolle C, 2000, GENE DEV, V14, P1269; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chandler PM, 2002, PLANT PHYSIOL, V129, P181, DOI 10.1104/pp.010917; Claeys H, 2014, TRENDS PLANT SCI, V19, P231, DOI 10.1016/j.tplants.2013.10.001; Curaba J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-6; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Dill A, 2001, GENETICS, V159, P777; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Fuxreiter M, 2011, TRENDS BIOCHEM SCI, V36, P415, DOI 10.1016/j.tibs.2011.04.006; Gallagher KL, 2009, PLANT J, V57, P785, DOI 10.1111/j.1365-313X.2008.03735.x; Greb T, 2003, GENE DEV, V17, P1175, DOI 10.1101/gad.260703; Gubler F, 2002, PLANT PHYSIOL, V129, P191, DOI 10.1104/pp.010918; GUILTINAN MJ, 1994, PLANT MOL BIOL, V26, P1041, DOI 10.1007/BF00040687; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Heo JO, 2011, P NATL ACAD SCI USA, V108, P2166, DOI 10.1073/pnas.1012215108; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Huang W, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0590-6; Ikeda A, 2002, PLANT CELL PHYSIOL, V43, P974, DOI 10.1093/pcp/pcf115; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawit SJ, 2010, PLANT CELL PHYSIOL, V51, P1854, DOI 10.1093/pcp/pcq153; Lee H, 2008, PLANT MOL BIOL, V67, P659, DOI 10.1007/s11103-008-9345-1; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Lim J, 2000, PLANT CELL, V12, P1307, DOI 10.1105/tpc.12.8.1307; Liu XY, 2014, PLANT MOL BIOL REP, V32, P1129, DOI 10.1007/s11105-014-0721-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Lu JX, 2015, MOL GENET GENOMICS, V290, P303, DOI 10.1007/s00438-014-0918-1; Ma ZX, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004519; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; PATTHY L, 1987, FEBS LETT, V214, P1, DOI 10.1016/0014-5793(87)80002-9; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Revell LJ, 2014, METHODS ECOL EVOL, V5, P976, DOI 10.1111/2041-210X.12233; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schulze S, 2010, PLANT J, V64, P668, DOI 10.1111/j.1365-313X.2010.04359.x; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Shimada MK, 2017, MOL PHYLOGENET EVOL, V109, P409, DOI 10.1016/j.ympev.2017.02.012; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Slewinski TL, 2012, PLANT CELL PHYSIOL, V53, P2030, DOI 10.1093/pcp/pcs147; Song LL, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2393-x; Song XM, 2014, GENOMICS, V103, P135, DOI 10.1016/j.ygeno.2013.12.004; Stuurman J, 2002, GENE DEV, V16, P2213, DOI 10.1101/gad.230702; Sun XL, 2012, BIOCHEM J, V442, P1, DOI 10.1042/BJ20111766; Sun XL, 2011, PLANT MOL BIOL, V77, P205, DOI 10.1007/s11103-011-9803-z; Sun X, 2016, FUNCT INTEGR GENOMIC, V16, P347, DOI 10.1007/s10142-016-0479-y; Sutoh K, 2003, PLANT J, V34, P635, DOI 10.1046/j.1365-313X.2003.01753.x; Tamagnone L, 1998, PLANT CELL, V10, P135, DOI 10.1105/tpc.10.2.135; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Tian CG, 2004, PLANT MOL BIOL, V54, P519, DOI 10.1023/B:PLAN.0000038256.89809.57; Torres-Galea P, 2006, MOL GENET GENOMICS, V276, P13, DOI 10.1007/s00438-006-0123-y; Torres-Galea P, 2013, PLANT PHYSIOL, V161, P291, DOI 10.1104/pp.112.206607; Wang L, 2010, MOL PLANT, V3, P794, DOI 10.1093/mp/ssq042; Wang Y, 2016, PEERJ, V4, DOI 10.7717/peerj.2388; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xu W, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071004; Zhang L, 2016, CHIN J NAT MEDICINES, V14, P161, DOI 10.1016/S1875-5364(16)30013-9	68	46	50	8	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185418	10.1371/journal.pone.0185418	http://dx.doi.org/10.1371/journal.pone.0185418			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957440	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200054
J	Lambrecht, C; Libbrecht, L; Sagaert, X; Pauwels, P; Hoorne, Y; Crowther, J; Louis, JV; Sents, W; Sablina, A; Janssens, V				Lambrecht, C.; Libbrecht, L.; Sagaert, X.; Pauwels, P.; Hoorne, Y.; Crowther, J.; Louis, J., V; Sents, W.; Sablina, A.; Janssens, V			Loss of protein phosphatase 2A regulatory subunit B56 delta promotes spontaneous tumorigenesis in vivo	ONCOGENE			English	Article							HUMAN CELL-TRANSFORMATION; LI-FRAUMENI-SYNDROME; C-MYC; TUMOR-SUPPRESSOR; HEPATOCELLULAR-CARCINOMA; PP2A COMPLEXES; RNA-SEQ; CANCER; MICE; GENE	Protein Phosphatase 2A (PP2A) enzymes counteract diverse kinase-driven oncogenic pathways and their function is frequently impaired in cancer. PP2A inhibition is indispensable for full transformation of human cells, but whether loss of PP2A is sufficient for tumorigenesis in vivo has remained elusive. Here, we describe spontaneous tumor development in knockout mice for Ppp2r5d, encoding the PP2A regulatory B56 delta subunit. Several primary tumors were observed, most commonly, hematologic malignancies and hepatocellular carcinomas (HCCs). Targeted immunoblot and immunohistochemistry analysis of the HCCs revealed heterogeneous activation of diverse oncogenic pathways known to be suppressed by PP2A-B56. RNA sequencing analysis unveiled, however, a common role for oncogenic c-Myc activation in the HCCs, independently underscored by c-Myc Ser62 hyperphosphorylation. Upstream of c-Myc, GSK-3 beta Ser9 hyperphosphorylation occurred both in the HCCs and non-cancerous B56 delta-null livers. Thus, uncontrolled c-Myc activity due to B56 delta-driven GSK-3 beta inactivation is the likely tumor predisposing factor. Our data provide the first compelling mouse genetics evidence sustaining the tumor suppressive activity of a single PP2A holoenzyme, constituting the final missing incentive for full clinical development of PP2A as cancer biomarker and therapy target.	[Lambrecht, C.; Hoorne, Y.; Louis, J., V; Sents, W.; Janssens, V] Katholieke Univ Leuven, Lab Prot Phosphorylat & Prote, Dept Cellular & Mol Med, Leuven, Belgium; [Libbrecht, L.] Ghent Univ Hosp, Dept Pathol, Ghent, Belgium; [Sagaert, X.] Katholieke Univ Leuven, Translat Cell & Tissue Res, Dept Imaging & Pathol, Leuven, Belgium; [Pauwels, P.] Univ Hosp Antwerp, Dept Pathol, Antwerp, Belgium; [Crowther, J.; Sablina, A.] Katholieke Univ Leuven, Dept Human Genet, VIB Ctr Biol Dis, Leuven, Belgium; [Sablina, A.; Janssens, V] Leuven Canc Inst, LKI, Leuven, Belgium	KU Leuven; Ghent University; Ghent University Hospital; KU Leuven; University of Antwerp; Flanders Institute for Biotechnology (VIB); KU Leuven	Janssens, V (corresponding author), Univ Leuven, Dept Cellular & Mol Med, Lab Prot Phosphorylat & Prote, KU Leuven, Herestr 49,POB 901,Gasthuisberg O&N1, B-3000 Leuven, Belgium.	veerle.janssens@kuleuven.be	Sablina, Anna/B-2217-2017; Sablina, Anna/P-2818-2019; Janssens, Veerle/I-7059-2016	Sablina, Anna/0000-0001-9526-4014; Sablina, Anna/0000-0001-9526-4014; Janssens, Veerle/0000-0002-6772-8448	KU Leuven Research Fund [GOA/08/016, OT/13/094]; Research Foundation-Flanders [G.0582.11, G.0B01.16N]; Belgian IAP program [P7/13]; Flemish Agency for Innovation by Science and Technology; Flemish Cancer League (Emmanuel van der Schueren fellowship)	KU Leuven Research Fund(KU Leuven); Research Foundation-Flanders(FWO); Belgian IAP program; Flemish Agency for Innovation by Science and Technology; Flemish Cancer League (Emmanuel van der Schueren fellowship)	We thank Y El-Aalamat (KU Leuven, ESAT) for help with statistical analysis, and P Vermaelen (KU Leuven, MOSAIC) for PET-scan analysis. Funding was provided by KU Leuven Research Fund (GOA/08/016 to VJ; OT/13/094 to VJ and AS), Research Foundation-Flanders (G.0582.11 to VJ; G.0B01.16N to VJ), Belgian IAP program (P7/13 to VJ), Flemish Agency for Innovation by Science and Technology (to CL) and the Flemish Cancer League (Emmanuel van der Schueren fellowship to WS).	Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Arriazu E, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00078; Bluemn EG, 2013, MOL CANCER RES, V11, P568, DOI 10.1158/1541-7786.MCR-12-0710; Cadoret A, 2002, ONCOGENE, V21, P8293, DOI 10.1038/sj.onc.1206118; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; Chen LP, 2011, ONCOGENE, V30, P2943, DOI 10.1038/onc.2011.20; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Cheng YS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005561; Cheng Y, 2011, CANCER GENET-NY, V204, P375, DOI 10.1016/j.cancergen.2011.05.002; Cristobal I, 2013, HAEMATOLOGICA, V98, pE103, DOI [10.3324/haematol.2043.084731, 10.3324/haematol.2013.084731]; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Haesen D, 2016, CANCER RES, V76, P5719, DOI 10.1158/0008-5472.CAN-15-3342; Hahn K, 2010, CELL METAB, V11, P438, DOI 10.1016/j.cmet.2010.03.015; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; He H, 2012, DIAGN MOL PATHOL, V21, P143, DOI 10.1097/PDM.0b013e318249fd8b; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HU NP, 1994, ONCOGENE, V9, P1021; Hung MH, 2016, ONCOGENE, V35, P4891, DOI 10.1038/onc.2016.21; Hydbring P, 2010, P NATL ACAD SCI USA, V107, P58, DOI 10.1073/pnas.0900121106; Jackson JB, 2012, NEOPLASIA, V14, P585, DOI 10.1593/neo.12768; Janghorban M, 2014, P NATL ACAD SCI USA, V111, P9157, DOI 10.1073/pnas.1317630111; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kaposi-Novak P, 2009, CANCER RES, V69, P2775, DOI 10.1158/0008-5472.CAN-08-3357; Khanna A, 2013, CANCER RES, V73, P6548, DOI 10.1158/0008-5472.CAN-13-1994; Khanna A, 2009, JNCI-J NATL CANCER I, V101, P793, DOI 10.1093/jnci/djp103; Lai TY, 2016, ONCOTARGET, V7, P4542, DOI 10.18632/oncotarget.6609; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liu Lingfeng, 2012, Genes Cancer, V3, P23, DOI 10.1177/1947601912448067; Louis JV, 2011, P NATL ACAD SCI USA, V108, P6957, DOI 10.1073/pnas.1018777108; Low ICC, 2014, BLOOD, V124, P2223, DOI 10.1182/blood-2014-03-563296; Martens E, 2004, J MOL BIOL, V336, P971, DOI 10.1016/j.jmb.2003.12.047; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Miller JP, 2012, J BIOL CHEM, V287, P19775, DOI 10.1074/jbc.M112.361972; Nobumori Y, 2013, MOL CANCER RES, V11, P995, DOI 10.1158/1541-7786.MCR-12-0633; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Perrotti D, 2013, LANCET ONCOL, V14, pE229, DOI 10.1016/S1470-2045(12)70558-2; Pinyol R, 2014, SEMIN LIVER DIS, V34, P363, DOI 10.1055/s-0034-1394137; Puustinen P, 2009, CANCER RES, V69, P2870, DOI 10.1158/0008-5472.CAN-08-2760; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruediger R, 2011, MOL CELL BIOL, V31, P3832, DOI 10.1128/MCB.05744-11; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Sangodkar J, 2016, FEBS J, V283, P1004, DOI 10.1111/febs.13573; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Sents W, PP2A INACTIVATION TR; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Shih IM, 2011, J PATHOL, V224, P1, DOI 10.1002/path.2884; Shouse GP, 2010, ONCOGENE, V29, P3933, DOI 10.1038/onc.2010.161; Singal AG, 2015, CLIN GASTROENTEROL H, V13, P2140, DOI 10.1016/j.cgh.2015.08.014; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varadkar P, 2014, DEV DYNAM, V243, P778, DOI 10.1002/dvdy.24111; Wandzioch E, 2014, CANCER RES, V74, P4295, DOI 10.1158/0008-5472.CAN-13-3130; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Ward JM, 2006, EXP TOXICOL PATHOL, V57, P377, DOI 10.1016/j.etp.2006.01.007; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110	64	28	29	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 25	2018	37	4					544	552		10.1038/onc.2017.350	http://dx.doi.org/10.1038/onc.2017.350			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT7KP	28967903				2022-12-26	WOS:000423331600012
J	Marmont, LS; Whitfield, GB; Rich, JD; Yip, P; Giesbrecht, LB; Stremick, CA; Whitney, JC; Parsek, MR; Harrison, JJ; Howell, PL				Marmont, Lindsey S.; Whitfield, Gregory B.; Rich, Jacquelyn D.; Yip, Patrick; Giesbrecht, Laura B.; Stremick, Carol A.; Whitney, John C.; Parsek, Matthew R.; Harrison, Joe J.; Howell, P. Lynne			PelA and PelB proteins form a modification and secretion complex essential for Pel polysaccharide-dependent biofilm formation in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biofilm; polysaccharide; protein-protein interaction; Pseudomonas aeruginosa (P; aeruginosa); X-ray crystallography	GRAM-NEGATIVE BACTERIA; STRUCTURAL BASIS; OUTER-MEMBRANE; ALGINATE; EXOPOLYSACCHARIDE; COMPONENT; SYSTEM; MATRIX; PA14; PSL	The pellicle (PEL) polysaccharide is synthesized by the opportunistic pathogen Pseudomonas aeruginosa and is an important biofilm constituent critical for bacterial virulence and persistence. PEL is a cationic polymer that promotes cell-cell interactions within the biofilm matrix through electrostatic interactions with extracellular DNA. Translocation of PEL across the outer membrane is proposed to occur via PelB, a membrane-embedded porin with a large periplasmic domain predicted to contain 19 tetratricopeptide repeats (TPRs). TPR-containing domains are typically involved in protein-protein interactions, and we therefore sought to determine whether PelB serves as a periplasmic scaffold that recruits other components of the PEL secretion apparatus. In this study, we show that the TPR domain of PelB interacts with PelA, an enzyme with PEL deacetylase and hydrolase activities. Structure determination of PelB TPRs 8-11 enabled us to design systematic deletions of individual TPRs and revealed that repeats 9-14, which are required for the cellular localization of PelA with PelB are also essential for PEL-dependent biofilm formation. Copurification experiments indicated that the interaction between PelA and PelB is direct and that the deacetylase activity of PelA increases and its hydrolase activity decreases when these proteins interact. Combined, our results indicate that the TPR-containing domain of PelB localizes PelA to the PEL secretion apparatus within the periplasm and that this may allow for efficient deacetylation of PEL before its export from the cell.	[Marmont, Lindsey S.; Whitfield, Gregory B.; Yip, Patrick; Giesbrecht, Laura B.; Whitney, John C.; Howell, P. Lynne] Hosp Sick Children, Program Mol Med, Toronto, ON M5G 0A4, Canada; [Marmont, Lindsey S.; Whitfield, Gregory B.; Whitney, John C.; Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Rich, Jacquelyn D.; Stremick, Carol A.; Harrison, Joe J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Parsek, Matthew R.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Calgary; University of Washington; University of Washington Seattle	Howell, PL (corresponding author), Hosp Sick Children, Program Mol Med, Toronto, ON M5G 0A4, Canada.; Howell, PL (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.	howell@sickkids.ca	Harrison, Joe/AAV-6071-2021	Harrison, Joe/0000-0003-0368-9539	Canadian Institutes of Health Research [43998]; National Institute of Health [2R01AI077628]; Natural Sciences and Engineering Research Council (NSERC); NSERC Canada graduate scholarship; Ontario Graduate Scholarship Program; Cystic Fibrosis Canada; Canada Research Chair; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077628] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Canada graduate scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship Program(Ontario Graduate Scholarship); Cystic Fibrosis Canada; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by Canadian Institutes of Health Research Grant 43998 (to P. L. H.), National Institute of Health Grant 2R01AI077628 (to M. R. P.), and a Natural Sciences and Engineering Research Council (NSERC) Grant (to J. J. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by an NSERC Canada graduate scholarship and the Ontario Graduate Scholarship Program.; Supported by an NSERC Canada graduate scholarship and a graduate scholarship from Cystic Fibrosis Canada.; Recipient of a Canada Research Chair.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Almblad H, 2015, J BACTERIOL, V197, P2190, DOI 10.1128/JB.00193-15; Ayers M, 2009, J MOL BIOL, V394, P128, DOI 10.1016/j.jmb.2009.09.034; Baker P, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501632; BERRY A, 1989, J BACTERIOL, V171, P2312, DOI 10.1128/jb.171.5.2312-2317.1989; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Colvin KM, 2013, J BACTERIOL, V195, P2329, DOI 10.1128/JB.02150-12; Colvin KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001264; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Green MR, 2012, MOL CLONING LAB MANU, V1; Hmelo LR, 2015, NAT PROTOC, V10, P1820, DOI 10.1038/nprot.2015.115; Jackson KD, 2004, J BACTERIOL, V186, P4466, DOI 10.1128/JB.186.14.4466-4475.2004; Jennings LK, 2015, P NATL ACAD SCI USA, V112, P11353, DOI 10.1073/pnas.1503058112; Job V, 2010, J BIOL CHEM, V285, P23222, DOI 10.1074/jbc.M110.111278; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Keiski CL, 2010, STRUCTURE, V18, P265, DOI 10.1016/j.str.2009.11.015; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khakimova M, 2013, J BACTERIOL, V195, P2011, DOI 10.1128/JB.02061-12; Koo J, 2008, J BACTERIOL, V190, P6961, DOI 10.1128/JB.00996-08; Krachler AM, 2010, J MOL BIOL, V403, P270, DOI 10.1016/j.jmb.2010.08.050; Laskowski RA, 2009, FEBS LETT, V583, P1692, DOI 10.1016/j.febslet.2009.03.019; Lee JE, 2001, STRUCTURE, V9, P941, DOI 10.1016/S0969-2126(01)00656-6; Little DJ, 2012, J BIOL CHEM, V287, P31126, DOI 10.1074/jbc.M112.390005; Marmont LS, 2017, P NATL ACAD SCI USA, V114, P2892, DOI 10.1073/pnas.1613606114; Mazur O, 2011, J BIOL CHEM, V286, P17601, DOI 10.1074/jbc.M111.227660; Moradali MF, 2015, MBIO, V6, DOI 10.1128/mBio.00453-15; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramsey DM, 2005, MOL MICROBIOL, V56, P309, DOI 10.1111/j.1365-2958.2005.04552.x; Rehman ZU, 2013, APPL ENVIRON MICROB, V79, P3264, DOI 10.1128/AEM.00460-13; Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Thein M, 2010, J PROTEOME RES, V9, P6135, DOI 10.1021/pr1002438; Wang Y, 2016, J BIOL CHEM, V291, P10046, DOI 10.1074/jbc.M115.711762; Whitney JC, 2011, P NATL ACAD SCI USA, V108, P13083, DOI 10.1073/pnas.1104984108; Wozniak DJ, 2003, P NATL ACAD SCI USA, V100, P7907, DOI 10.1073/pnas.1231792100; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006; Zhao K, 2013, NATURE, V497, P388, DOI 10.1038/nature12155	46	24	27	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19411	19422		10.1074/jbc.M117.812842	http://dx.doi.org/10.1074/jbc.M117.812842			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972168	hybrid, Green Published			2022-12-26	WOS:000416226700022
J	Nam, KW; Kwon, HM; Lim, JS; Han, MK; Nam, H; Lee, YS				Nam, Ki-Woong; Kwon, Hyung-Min; Lim, Jae-Sung; Han, Moon-Ku; Nam, Hyunwoo; Lee, Yong-Seok			The presence and severity of cerebral small vessel disease increases the frequency of stroke in a cohort of patients with large artery occlusive disease	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; WHITE-MATTER LESIONS; RISK-FACTORS; RECURRENT STROKE; ROTTERDAM SCAN; LEUKOARAIOSIS; MICROBLEEDS; INFARCTS; HEALTH; TRIAL	Background Cerebral small vessel disease (SVD) commonly coexists with large artery atherosclerosis (LAA). Aim We evaluate the effect of SVD on stroke recurrence in patients for ischemic stroke with LAA. Methods We consecutively collected first-ever ischemic stroke patients who were classified as LAA mechanism between Jan 2010 and Dec 2013. Univariate and multivariate Cox analyses were performed to evaluate the association between the 2-year recurrence and demographic, clinical, and radiological factors. To evaluate the impact of SVD and its components on recurrent stroke, we used the Kaplan-Meier analysis. SVD was defined as the presence of severe white matter hyperintensity (WMH) or old lacunar infarction (OLI) or cerebral microbleeds (CMB). We also compared frequency and burden of SVD among recurrent stroke groups with different mechanisms. Results Among a total of 956 participants, 92 patients had recurrent events. Recurrence group showed a higher frequency of severe WMH, OLI, asymptomatic territorial infarction, and severe stenosis on the relevant vessel in multivariate analysis. The impact of SVD and its components on recurrent stroke was significant in any ischemic recurrent stroke, and the presence of SVD was continuously important in stroke recurrence regardless of its mechanism, including recurrent LAA stroke, recurrent small vessel occlusion stroke, and even recurrent cardioembolic stroke. Additionally, the recurrence rate increased in doseresponse manner with the increased number of SVD components. Conclusions Cerebral SVD is associated with recurrent stroke in patients with LAA. Additionally, it may affect any mechanisms of recurrent stroke and even with a dose response manner.	[Nam, Ki-Woong; Kwon, Hyung-Min; Lim, Jae-Sung; Nam, Hyunwoo; Lee, Yong-Seok] Seoul Natl Univ, Dept Neurol, Coll Med, Seoul, South Korea; [Nam, Ki-Woong; Kwon, Hyung-Min; Nam, Hyunwoo; Lee, Yong-Seok] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Neurol, Seoul, South Korea; [Lim, Jae-Sung] Hallym Univ, Dept Neurol, Sacred Heart Hosp, Anyang, South Korea; [Han, Moon-Ku] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Hallym University; Seoul National University (SNU)	Kwon, HM (corresponding author), Seoul Natl Univ, Dept Neurol, Coll Med, Seoul, South Korea.; Kwon, HM (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Neurol, Seoul, South Korea.	hmkwon@snu.ac.kr	Lim, Jae-Sung/D-5555-2012	Lim, Jae-Sung/0000-0001-6157-2908; Kwon, Hyung-Min/0000-0002-6101-7127				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; [Anonymous], 2014, HLTH NIO; Arenillas JF, 2011, STROKE, V42, pS20, DOI 10.1161/STROKEAHA.110.597278; Arsava EM, 2009, NEUROLOGY, V72, P1403, DOI 10.1212/WNL.0b013e3181a18823; Bernick C, 2001, NEUROLOGY, V57, P1222, DOI 10.1212/WNL.57.7.1222; Chutinet A, 2012, AM J NEURORADIOL, V33, P1591, DOI 10.3174/ajnr.A3015; Fazekas F, 2002, CEREBROVASC DIS, V13, P31, DOI 10.1159/000049147; Fu JH, 2005, J NEUROL NEUROSUR PS, V76, P793, DOI 10.1136/jnnp.2003.032771; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Helenius J, 2016, STROKE, V47, P24, DOI 10.1161/STROKEAHA.115.011771; HIER DB, 1991, STROKE, V22, P155, DOI 10.1161/01.STR.22.2.155; Inzitari D, 2003, STROKE, V34, P2067, DOI 10.1161/01.STR.0000080934.68280.82; Kato H, 2002, STROKE, V33; Kim GM, 2014, STROKE, V45, P479, DOI 10.1161/STROKEAHA.113.003004; Kwon HM, 2016, JAMA NEUROL, V73, P36, DOI 10.1001/jamaneurol.2015.3145; Lee SJ, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-31; Lim JS, 2015, JAMA NEUROL, V72, P301, DOI 10.1001/jamaneurol.2014.3958; O'Sullivan M, 2002, NEUROLOGY, V59, P321, DOI 10.1212/WNL.59.3.321; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; van Dijk EJ, 2008, STROKE, V39, P2712, DOI 10.1161/STROKEAHA.107.513176; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Weimar C, 2009, STROKE, V40, P350, DOI 10.1161/STROKEAHA.108.521419	23	16	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0184944	10.1371/journal.pone.0184944	http://dx.doi.org/10.1371/journal.pone.0184944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	28991905	gold, Green Published, Green Submitted			2022-12-26	WOS:000412601800010
J	Fleckenstein, J; Simon, P; Konig, M; Vogt, L; Banzer, W				Fleckenstein, Johannes; Simon, Perikles; Koenig, Matthias; Vogt, Lutz; Banzer, Winfried			The pain threshold of high-threshold mechanosensitive receptors subsequent to maximal eccentric exercise is a potential marker in the prediction of DOMS associated impairment	PLOS ONE			English	Article							ONSET MUSCLE SORENESS; HUMAN SKELETAL-MUSCLE; LENGTHENING CONTRACTIONS; MECHANICAL HYPERALGESIA; INJURY; DAMAGE; FIBERS; RAT; BRADYKININ; PRESSURE	Background Delayed-onset muscle soreness (DOMS) refers to dull pain and discomfort in people after participating in exercise, sport or recreational physical activities. The aim of this study was to detect underlying mechanical thresholds in an experimental model of DOMS. Methods Randomised study to detect mechanical pain thresholds in a randomised order following experimentally induced DOMS of the non-dominant arm in healthy participants. Main outcome was the detection of the pressure pain threshold (PPT), secondary thresholds included mechanical detection (MDT) and pain thresholds (MPT), pain intensity, pain perceptions and the maximum isometric voluntary force (MIVF). Results Twenty volunteers (9 female and 11 male, age 25.2 +/- 3.2 years, weight 70.5 +/- 10.8 kg, height 177.4 +/- 9.4 cm) participated in the study. DOMS reduced the PPT (at baseline 5.9 +/- 0.4 kg/cm(2)) by a maximum of 1.5 +/- 1.4 kg/cm(2) (-24%) at 48 hours (p < 0.001). This correlated with the decrease in MIVF (r = -0.48, p = 0.033). Whereas subjective pain was an indicator of the early 48 hours, the PPT was still present after 72 hours (r = 0.48, p = 0.036). Other mechanical thresholds altered significantly due to DOMS, but did show no clinically or physiologically remarkable changes. Conclusions Functional impairment following DOMS seems related to the increased excitability of high-threshold mechanosensitive nociceptors. The PPT was the most valid mechanical threshold to quantify the extent of dysfunction. Thus PPT rather than pain intensity should be considered a possible marker indicating the athletes potential risk of injury	[Fleckenstein, Johannes; Koenig, Matthias; Vogt, Lutz; Banzer, Winfried] Goethe Univ Frankfurt, Inst Sports Sci, Dept Sports Med, Frankfurt, Germany; [Simon, Perikles] Johannes Gutenberg Univ Mainz, Dept Sports Med, Mainz, Germany; [Koenig, Matthias] London South Bank Univ, Sch Appl Sci, Sport & Exercise Sci Res Ctr, London, England; [Koenig, Matthias] German Sport Univ Cologne, Inst Movement & Sport Gerontol, Sportpark Mungersdorf 6, Cologne, Germany	Goethe University Frankfurt; Johannes Gutenberg University of Mainz; London South Bank University; German Sport University Cologne	Fleckenstein, J (corresponding author), Goethe Univ Frankfurt, Inst Sports Sci, Dept Sports Med, Frankfurt, Germany.	johannes.fleckenstein@sport.uni-frankfurt.de	Simon, Perikles D/B-2293-2013; Fleckenstein, Johannes/AAL-1315-2021	Simon, Perikles D/0000-0002-7996-4034; Konig, Matthias/0000-0001-9785-3058; Fleckenstein, Johannes/0000-0003-3442-0380	Vereinigung von Freunden; Forderern der Goethe-Universitat	Vereinigung von Freunden; Forderern der Goethe-Universitat	This study was funded in part by a grant by the Vereinigung von Freunden and Forderern der Goethe-Universitat [Association of friends and sponsors of the Goethe-University Frankfurt] awarded to JF assuring independent research and publication of the data.	ARMSTRONG RB, 1990, MED SCI SPORT EXER, V22, P429; Barnett A, 2006, SPORTS MED, V36, P781, DOI 10.2165/00007256-200636090-00005; Basbaum A. I, 2000, PRINCIPLES NEURAL SC, P472; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; BROOKS SV, 1995, J PHYSIOL-LONDON, V488, P459, DOI 10.1113/jphysiol.1995.sp020980; CARLSON BM, 1983, MED SCI SPORT EXER, V15, P187; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; CHAN AW, 1992, J NEUROL NEUROSUR PS, V55, P56, DOI 10.1136/jnnp.55.1.56; Cheung K, 2003, SPORTS MED, V33, P145, DOI 10.2165/00007256-200333020-00005; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Close GL, 2005, COMP BIOCHEM PHYS A, V142, P257, DOI 10.1016/j.cbpa.2005.08.005; Dannecker EA, 2014, SPORTS MED, V44, P921, DOI 10.1007/s40279-014-0172-z; Dannecker EA, 2011, CLIN J PAIN, V27, P42, DOI 10.1097/AJP.0b013e3181f04818; DIEHL B, 1993, EXP BRAIN RES, V92, P431; Dostrovsky JO, 2013, WALL MELZACKS TXB PA, P182; DOTSON RM, 1993, MUSCLE NERVE, V16, P1049, DOI 10.1002/mus.880161008; DUBNER R, 1989, J NEUROPHYSIOL, V62, P450, DOI 10.1152/jn.1989.62.2.450; DUNCAN CJ, 1987, J CELL SCI, V87, P183; Fernandez-Carnero J, 2010, MED SCI SPORT EXER, V42, P922, DOI 10.1249/MSS.0b013e3181c29eab; Fleckenstein J, 2016, CLIN J SPORT MED, V26, P471, DOI 10.1097/JSM.0000000000000259; FRIDEN J, 1984, CELL TISSUE RES, V236, P365; Friden J, 2001, ACTA PHYSIOL SCAND, V171, P321, DOI 10.1046/j.1365-201x.2001.00834.x; FRIDEN J, 1983, INT J SPORTS MED, V4, P170, DOI 10.1055/s-2008-1026030; Fujii Y, 2008, PAIN, V140, P292, DOI 10.1016/j.pain.2008.08.013; Gibson W, 2009, EXP BRAIN RES, V194, P299, DOI 10.1007/s00221-008-1699-8; Gosselin LE, 2002, MUSCLE NERVE, V25, P822, DOI 10.1002/mus.10112; Graven-Nielsen T, 2004, EXP BRAIN RES, V159, P273, DOI 10.1007/s00221-004-1937-7; Greenspan JD, 2007, PAIN, V132, pS26, DOI 10.1016/j.pain.2007.10.014; Hoheisel U, 2005, PAIN, V114, P168, DOI 10.1016/j.pain.2004.12.020; Hu J, 2006, PAIN, V120, P3, DOI 10.1016/j.pain.2005.11.002; Hubscher M, 2008, J ALTERN COMPLEM MED, V14, P1011, DOI 10.1089/acm.2008.0173; Hunter KD, 1997, J APPL PHYSIOL, V82, P278, DOI 10.1152/jappl.1997.82.1.278; JENSEN K, 1990, PEPTIDES, V11, P1127, DOI 10.1016/0196-9781(90)90141-Q; Lewis PB, 2012, CLIN SPORT MED, V31, P255, DOI 10.1016/j.csm.2011.09.009; Lieber Richard L, 2002, J Am Acad Orthop Surg, V10, P67; LIEBER RL, 1993, J APPL PHYSIOL, V74, P520, DOI 10.1152/jappl.1993.74.2.520; LIEBER RL, 1988, ACTA PHYSIOL SCAND, V133, P587, DOI 10.1111/j.1748-1716.1988.tb08446.x; Liedtke W, 2005, J PHYSIOL-LONDON, V567, P53, DOI 10.1113/jphysiol.2005.088963; MACINTYRE DL, 1995, SPORTS MED, V20, P24, DOI 10.2165/00007256-199520010-00003; Maffulli N, 2015, TRANSL MED UNISA, V12, P14; Mann MK, 2006, J OROFAC PAIN, V20, P325; McMahon S.B., 2008, WALL MELZACKS TXB PA, P49; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; MENSE S, 1977, J PHYSIOLOGY PARIS, V73, P233; Mense S, 2013, WALL MELZACKS TXB PA, P620; MISHRA DK, 1995, J BONE JOINT SURG AM, V77, P1510, DOI 10.2106/00004623-199510000-00005; MORGAN DL, 1990, BIOPHYS J, V57, P209, DOI 10.1016/S0006-3495(90)82524-8; Murase S, 2010, J NEUROSCI, V30, P3752, DOI 10.1523/JNEUROSCI.3803-09.2010; Nagi SS, 2013, J PAIN, V14, P538, DOI 10.1016/j.jpain.2013.01.009; Nicol C, 2006, SPORTS MED, V36, P977, DOI 10.2165/00007256-200636110-00004; Nosaka K, 2001, MED SCI SPORT EXER, V33, P22; Ota H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065751; Park G, 2011, ANN REHABIL MED-ARM, V35, P412, DOI 10.5535/arm.2011.35.3.412; Patel TJ, 2004, J APPL PHYSIOL, V97, P1803, DOI 10.1152/japplphysiol.00505.2003; Peirs C, 2015, NEURON, V87, P797, DOI 10.1016/j.neuron.2015.07.029; Perl ER, 2007, NAT REV NEUROSCI, V8, P71, DOI 10.1038/nrn2042; Queme F, 2013, J PAIN, V14, P1425, DOI 10.1016/j.jpain.2013.07.010; Ra SG, 2013, ADV EXP MED BIOL, V776, P179, DOI 10.1007/978-1-4614-6093-0_18; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; SCHMIDT R, 1995, J NEUROSCI, V15, P333; Taguchi T, 2005, J NEUROPHYSIOL, V94, P2822, DOI 10.1152/jn.00470.2005; Taguchi T, 2008, PAIN, V138, P119, DOI 10.1016/j.pain.2007.11.015; Takekura H, 2001, J PHYSIOL-LONDON, V533, P571, DOI 10.1111/j.1469-7793.2001.0571a.x; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0	64	14	14	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0185463	10.1371/journal.pone.0185463	http://dx.doi.org/10.1371/journal.pone.0185463			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ1QR	28985238	gold, Green Published, Green Submitted			2022-12-26	WOS:000412493000005
J	Shen, AL; Moran, SM; Glover, EA; Teixeira, LB; Bradfield, CA				Shen, Anna L.; Moran, Susan M.; Glover, Edward A.; Teixeira, Leandro B.; Bradfield, Christopher A.			Retinal pathology in the PPCD1 mouse	PLOS ONE			English	Article							POLYMORPHOUS CORNEAL-DYSTROPHY; IRIDOCORNEAL ENDOTHELIAL SYNDROME; DBA/2J MICE; IRIS ATROPHY; GLAUCOMA; MUTATIONS; DETACHMENT; MODEL; NEURODEGENERATION; METAPLASIA	Retinal phenotypes of the PPCD1 mouse, a mouse model of posterior polymorphous corneal dystrophy, have been characterized. PPCD1 mice on the DBA/2J background (D2. Ppcd1) have previously been reported to develop an enlarged anterior chamber due to epithelialization and proliferation of the corneal endothelium and subsequent blockage of the iridocorneal angle. Results presented here show that D2. Ppcd1 mice develop increased intraocular pressure (IOP), with measurements at three months of age revealing significant increases in IOP. Significant retinal ganglion cell layer cell loss is observed at five months of age. D2. Ppcd1 animals also exhibit marked degeneration of the outer nuclear layer in association with hyperplasia of the retinal pigment epithelium. Evidence of retinal detachment is present as early as three weeks of age. By 3.5 months of age, focal areas of outer nuclear layer loss are observed. Although the Gpnmb(R150X) mutation leads to increased IOP and glaucoma in DBA/2J mice, development of anterior segment and retinal defects in D2. Ppcd1 animals does not depend upon presence of the Gpnmb(R150X) mutation.	[Shen, Anna L.; Moran, Susan M.; Glover, Edward A.; Bradfield, Christopher A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, McArdle Lab Canc Res, Madison, WI 53706 USA; [Shen, Anna L.; Teixeira, Leandro B.; Bradfield, Christopher A.] Univ Wisconsin, McPherson Eye Res Inst, Madison, WI 53706 USA; [Teixeira, Leandro B.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Bradfield, Christopher A.] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shen, AL; Bradfield, CA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, McArdle Lab Canc Res, Madison, WI 53706 USA.; Shen, AL; Bradfield, CA (corresponding author), Univ Wisconsin, McPherson Eye Res Inst, Madison, WI 53706 USA.; Bradfield, CA (corresponding author), Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53706 USA.	alshen@wisc.edu; bradfield@oncology.wisc.edu	Teixeira, Leandro B C/H-9272-2015; Teixeira, Leandro/AAU-6094-2021	Teixeira, Leandro B C/0000-0001-9960-678X; Teixeira, Leandro/0000-0001-9960-678X	NIH from the National Eye Institute, National Institutes of Health (NIH) [EY021376]; Core Grant for Vision Research - National Eye Institute, NIH, to the University of Wisconsin Madison [P30 EY016665]; NATIONAL EYE INSTITUTE [P30EY016665] Funding Source: NIH RePORTER	NIH from the National Eye Institute, National Institutes of Health (NIH); Core Grant for Vision Research - National Eye Institute, NIH, to the University of Wisconsin Madison; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by NIH Grant EY021376 from the National Eye Institute, National Institutes of Health (NIH) (nei.nih.gov) to CAB. We gratefully acknowledge support for this study from Nate and Kate Mahr to CAB. Portions of this study utilized shared resources supported by the Core Grant for Vision Research funded by the National Eye Institute, NIH, to the University of Wisconsin Madison (P30 EY016665). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldave AJ, 2013, JAMA OPHTHALMOL, V131, P1583, DOI 10.1001/jamaophthalmol.2013.5036; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Bayer AU, 2001, INVEST OPHTH VIS SCI, V42, P1258; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Blake JA, 2017, NUCL ACIDS RES, V45; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; Chung DD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169215; Ciralsky Jessica, 2007, Semin Ophthalmol, V22, P241, DOI 10.1080/08820530701745157; Davidson AE, 2016, AM J HUM GENET, V98, P75, DOI 10.1016/j.ajhg.2015.11.018; Del Turco C, 2015, EUR J OPHTHALMOL, V25, P177, DOI 10.5301/ejo.5000526; Fernaandez-Saanchez L, 2014, INVEST OPHTH VIS SCI, V55, P6059, DOI 10.1167/iovs.14-14421; Guelman S, 2009, MOL CELL BIOL, V29, P1176, DOI 10.1128/MCB.01599-08; Gwilliam R, 2005, INVEST OPHTH VIS SCI, V46, P4480, DOI 10.1167/iovs.05-0269; Harazny J, 2009, DOC OPHTHALMOL, V119, P181, DOI 10.1007/s10633-009-9194-5; Heiduschka P, 2010, EXP EYE RES, V91, P779, DOI 10.1016/j.exer.2010.09.001; HEON E, 1995, HUM MOL GENET, V4, P485, DOI 10.1093/hmg/4.3.485; Hidayat AA, 2006, CORNEA, V25, P956, DOI 10.1097/01.ico.0000228786.84581.ee; HIRST LW, 1995, INVEST OPHTH VIS SCI, V36, P820; Howell DN, 1997, INVEST OPHTH VIS SCI, V38, P1896; Howell GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-45; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Khan AK, 2015, EXP EYE RES, V130, P29, DOI 10.1016/j.exer.2014.11.007; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; Le DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158467; Li Y, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-19; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Liskova P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045495; Nork TM, 2000, ARCH OPHTHALMOL-CHIC, V118, P235; Roca H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076773; Saika S, 2004, LAB INVEST, V84, P1245, DOI 10.1038/labinvest.3700156; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157577; Shen AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012213; Smith R.S., 2002, SYSTEMATIC EVALUATIO; Teixeira LBC, 2014, MOL VIS, V20, P376; Wang YX, 2015, J GLAUCOMA, V24, pe16, DOI 10.1097/IJG.0000000000000102; Zeng R, 2012, INVEST OPHTH VIS SCI, V53, P1685, DOI 10.1167/iovs.11-8241	37	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185094	10.1371/journal.pone.0185094	http://dx.doi.org/10.1371/journal.pone.0185094			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981549	Green Submitted, Green Published, gold			2022-12-26	WOS:000412360300027
J	Mulbry, W; Selmer, K; Lansing, S				Mulbry, Walter; Selmer, Kaitlyn; Lansing, Stephanie			Effect of liquid surface area on hydrogen sulfide oxidation during micro-aeration in dairy manure digesters	PLOS ONE			English	Article							REMOVAL; TEMPERATURE	Although there are a variety of commercially available biological and chemical treatments for removal of hydrogen sulfide (H2S) from biogas, managing biogas H2S remains a significant challenge for agricultural digesters where labor and operational funds are very limited compared to municipal and industrial digesters. The objectives of this study were to evaluate headspace aeration for reducing H2S levels in low cost plug flow digesters and to characterize the relationship between the liquid surface area and H2S oxidation rates. Experiments with replicate field scale plug flow digesters showed that H2S levels decreased from 3500 ppmv to < 100 ppmv when headspace oxygen levels were 0.5 to 1%. Methane production was not affected by aeration rates that resulted in headspace oxygen levels of up to 1%. Pilot scale experiments using 65 to 104 L desulfurization units showed that H2S oxidation rates increased with increases in liquid surface area. These results support the hypothesis that H2S oxidation rates are limited, in part, by the surface area available for oxygen transfer, and can be increased by growth of biofilms containing H2S oxidizing bacteria. Maximum removal rates corresponded to 40 to 100 g S m(-2) d(-1) of liquid surface area at biogas retention times of 30 to 40 min.	[Mulbry, Walter; Selmer, Kaitlyn] ARS, USDA, Beltsville, MD 20705 USA; [Lansing, Stephanie] Univ Maryland, Dept Environm Sci & Technol, College Pk, MD 20742 USA	United States Department of Agriculture (USDA); University System of Maryland; University of Maryland College Park	Mulbry, W (corresponding author), ARS, USDA, Beltsville, MD 20705 USA.	walter.mulbry@ars.usda.gov			USDA Agricultural Research Service	USDA Agricultural Research Service(United States Department of Agriculture (USDA))	This work was funded by the USDA Agricultural Research Service. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APHA, 2005, STAND METH EXAM WAT; Arikan OA, 2015, WASTE MANAGE, V43, P108, DOI 10.1016/j.wasman.2015.06.005; Horejs J, 2017, ANAEROBE, V46, P41; Krayzelova L, 2015, REV ENVIRON SCI BIO, V14, P703, DOI 10.1007/s11157-015-9386-2; Lansing SA, 2015, T ASABE, V58, P441; Munoz R, 2015, REV ENVIRON SCI BIO, V14, P727, DOI 10.1007/s11157-015-9379-1; Nghiem LD, 2014, BIORESOURCE TECHNOL, V173, P443, DOI 10.1016/j.biortech.2014.09.052; R Core Team, 2014, R LANG ENV STAT COMP; Ramos I, 2013, BIORESOURCE TECHNOL, V142, P633, DOI 10.1016/j.biortech.2013.05.084; SAFLEY LM, 1994, BIORESOURCE TECHNOL, V47, P165, DOI 10.1016/0960-8524(94)90116-3; van der Zee FP, 2007, BIORESOURCE TECHNOL, V98, P518, DOI 10.1016/j.biortech.2006.02.011; Weiland P, 2010, APPL MICROBIOL BIOT, V85, P849, DOI 10.1007/s00253-009-2246-7; Wilkie AC, 2005, DAIRY MANURE MANAGEM, P63	13	12	12	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185738	10.1371/journal.pone.0185738	http://dx.doi.org/10.1371/journal.pone.0185738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976998	Green Submitted, gold, Green Published			2022-12-26	WOS:000412163100041
J	Tempesta, C; Hijazi, A; Moussian, B; Roch, F				Tempesta, Camille; Hijazi, Assia; Moussian, Bernard; Roch, Fernando			Boudin trafficking reveals the dynamic internalisation of specific septate junction components in Drosophila	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; TUBE-SIZE CONTROL; OCCLUDING JUNCTIONS; TRACHEAL MORPHOGENESIS; LIPOPROTEIN PARTICLES; TAGGED PROTEINS; NERVOUS-SYSTEM; NA+/K+ ATPASE; ORGANIZATION; MEMBER	The maintenance of paracellular barriers in invertebrate epithelia depends on the integrity of specific cell adhesion structures known as septate junctions (SJ). Multiple studies in Drosophila have revealed that these junctions have a stereotyped architecture resulting from the association in the lateral membrane of a large number of components. However, little is known about the dynamic organisation adopted by these multi-protein complexes in living tissues. We have used live imaging techniques to show that the Ly6 protein Boudin is a component of these adhesion junctions and can diffuse systemically to associate with the SJ of distant cells. We also observe that this protein and the claudin Kune-kune are endocytosed in epidermal cells during embryogenesis. Our data reveal that the SJ contain a set of components exhibiting a high membrane turnover, a feature that could contribute in a tissuespecific manner to the morphogenetic plasticity of these adhesion structures.	[Tempesta, Camille; Roch, Fernando] Univ Toulouse, CBI, CBD, CNRS,UPS, Toulouse, France; [Hijazi, Assia] Lebanese Univ, Fac Sci 1&5, Doctorate Sch Sci & Technol PRASE, Campus Rafic Hariri, Hadath Beirut, Lebanon; [Moussian, Bernard] Univ Tubingen, Interfac Inst Cell Biol, Sect Anim Genet, Tubingen, Germany	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Lebanese University; Eberhard Karls University of Tubingen	Roch, F (corresponding author), Univ Toulouse, CBI, CBD, CNRS,UPS, Toulouse, France.	fernando.roch@univ-tlse3.fr			Agence Nationale de la Recherche (France) [ANR-13-ISV7-0001-01]; research grant of the Lebanese University	Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); research grant of the Lebanese University	CT and FR were supported by the Agence Nationale de la Recherche (France) ANR-13-ISV7-0001-01. AH was funded by a research grant of the Lebanese University.	Araujo SJ, 2005, DEV BIOL, V288, P179, DOI 10.1016/j.ydbio.2005.09.031; Banerjee S, 2006, J NEUROSCI, V26, P3319, DOI 10.1523/JNEUROSCI.5383-05.2006; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; Brankatschk M, 2010, J NEUROSCI, V30, P10441, DOI 10.1523/JNEUROSCI.5943-09.2010; Chalmers AD, 2012, ESSAYS BIOCHEM, V53, P41, DOI [10.1042/bse0530041, 10.1042/BSE0530041]; Couturier L, 2014, J CELL BIOL, V207, P351, DOI 10.1083/jcb.201407071; Faivre-Sarrailh C, 2004, DEVELOPMENT, V131, P4931, DOI 10.1242/dev.01372; FRISTROM DK, 1982, J CELL BIOL, V94, P77, DOI 10.1083/jcb.94.1.77; Fujihara Y, 2016, J LIPID RES, V57, P538, DOI 10.1194/jlr.R063032; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Genova JL, 2003, J CELL BIOL, V161, P979, DOI 10.1083/jcb.200212054; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Haecker A, 2008, DEVELOPMENT, V135, P1745, DOI 10.1242/dev.020891; Hijazi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017763; Hijazi A, 2009, DEVELOPMENT, V136, P2199, DOI 10.1242/dev.033845; Izumi Y, 2014, SEMIN CELL DEV BIOL, V36, P186, DOI 10.1016/j.semcdb.2014.09.009; Jaspers MHJ, 2012, J BIOL CHEM, V287, P36756, DOI 10.1074/jbc.M112.399410; Jonusaite S, 2016, J COMP PHYSIOL B, V186, P17, DOI 10.1007/s00360-015-0937-1; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Laprise P, 2009, NATURE, V459, P1141, DOI 10.1038/nature08067; Laval M, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-38; Lye CM, 2014, DEVELOPMENT, V141, P4006, DOI 10.1242/dev.111310; Macdonald PJ, 2012, ANAL BIOCHEM, V421, P291, DOI 10.1016/j.ab.2011.10.040; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; McGough IJ, 2016, DEVELOPMENT, V143, P2482, DOI 10.1242/dev.126516; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Moussian B., 2010, DROSOPHILA INF SERV, V93, P215; Nelson KS, 2010, GENETICS, V185, P831, DOI 10.1534/genetics.110.114959; Nilton A, 2010, DEVELOPMENT, V137, P2427, DOI 10.1242/dev.052605; Oshima K, 2011, J CELL SCI, V124, P2861, DOI 10.1242/jcs.087700; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Paul SM, 2003, DEVELOPMENT, V130, P4963, DOI 10.1242/dev.00691; Pfeiffer S, 2000, CURR BIOL, V10, P321, DOI 10.1016/S0960-9822(00)00381-X; Ryoo HD, 2007, CELL CYCLE, V6, P830, DOI 10.4161/cc.6.7.4064; Schimmelpfeng K, 2006, MECH DEVELOP, V123, P487, DOI 10.1016/j.mod.2006.03.004; Stork T, 2008, J NEUROSCI, V28, P587, DOI 10.1523/JNEUROSCI.4367-07.2008; Syed MH, 2011, J NEUROSCI, V31, P7876, DOI 10.1523/JNEUROSCI.0766-11.2011; Takats S, 2014, MOL BIOL CELL, V25, P1338, DOI 10.1091/mbc.E13-08-0449; THUMMEL CS, 1991, DROSOPHILA INFORM NE, V2; Tiklova K, 2010, NAT CELL BIOL, V12, P1071, DOI 10.1038/ncb2111; Tonning A, 2006, DEVELOPMENT, V133, P331, DOI 10.1242/dev.02206; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Weavers H, 2009, NATURE, V457, P322, DOI 10.1038/nature07526; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930; WOOD RL, 1959, J BIOPHYS BIOCHEM CY, V6, P343, DOI 10.1083/jcb.6.3.343; Wu VM, 2007, DEVELOPMENT, V134, P999, DOI 10.1242/dev.02785; Wu VM, 2004, J CELL BIOL, V164, P313, DOI 10.1083/jcb.200309134; Zihni C, 2016, NAT REV MOL CELL BIO, V17, P564, DOI 10.1038/nrm.2016.80	51	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185897	10.1371/journal.pone.0185897	http://dx.doi.org/10.1371/journal.pone.0185897			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977027	Green Submitted, Green Published, gold			2022-12-26	WOS:000412163100052
J	Yu, EA; John, SH; Tablante, EC; King, CA; Kenneth, J; Russell, DG; Mehta, S				Yu, Elaine A.; John, Serene H.; Tablante, Elizabeth C.; King, Christine A.; Kenneth, John; Russell, David G.; Mehta, Saurabh			Host transcriptional responses following ex vivo re-challenge with Mycobacterium tuberculosis vary with disease status	PLOS ONE			English	Article							INTERFERON-GAMMA; BIOMARKERS; EXPRESSION; IDENTIFY; RELAPSE; CHEMOKINES; RESISTANCE; DEFENSE; BIOLOGY; RISK	The identification of immune correlates that are predictive of disease outcome for tuberculosis remains an ongoing challenge. To address this issue, we evaluated gene expression profiles from peripheral blood mononuclear cells following ex vivo challenge with Mycobacterium tuberculosis, among participants with active TB disease (ATBD, n = 10), latent TB infection (LTBI, n = 10), and previous active TB disease (after successful treatment; PTBD, n = 10), relative to controls (n = 10). Differential gene expression profiles were assessed by suppression-subtractive hybridization, dot blot, real-time polymerase chain reaction, and the comparative cycle threshold methods. Comparing ATBD to control samples, greater fold-increases of gene expression were observed for a number of chemotactic factors (CXCL1, CXCL3, IL8, MCP1, MIP1 alpha). ATBD was also associated with higher IL1B gene expression, relative to controls. Among LTBI samples, gene expression of several chemotactic factors (CXCL2, CXCL3, IL8) was similarly elevated, compared to individuals with PTBD. Our results demonstrated that samples from participants with ATBD and LTBI have distinct gene expression profiles in response to ex vivo M. tuberculosis infection. These findings indicate the value in further characterizing the peripheral responses to M. tuberculosis challenge as a route to defining immune correlates of disease status or outcome.	[Yu, Elaine A.; Tablante, Elizabeth C.; Mehta, Saurabh] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [John, Serene H.; Kenneth, John] St Johns Res Inst, Div Infect Dis, Bangalore, Karnataka, India; [King, Christine A.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA; [Russell, David G.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Mehta, Saurabh] Cornell Univ, Inst Nutr Sci Global Hlth & Technol, Ithaca, NY 14853 USA	Cornell University; St. John's National Academy of Health Sciences; St. John's Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Cornell University; Cornell University	Mehta, S (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.; Mehta, S (corresponding author), Cornell Univ, Inst Nutr Sci Global Hlth & Technol, Ithaca, NY 14853 USA.	smehta@cornell.edu	Russell, David G/D-4533-2009; Russell, David G/N-5280-2019; Mehta, Saurabh/L-8490-2017	Russell, David G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X; Mehta, Saurabh/0000-0003-3788-0665; Yu, Elaine A./0000-0003-2433-9562	National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases) [T32-DK007158]; Mario Einaudi Center for International Studies (South Asia Program), Human Ecology Alumni Association, Graduate School, Division of Nutritional Sciences at Cornell University; National Institutes of Health (National Institute of Allergy and Infectious Diseases) [AI118582]	National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Mario Einaudi Center for International Studies (South Asia Program), Human Ecology Alumni Association, Graduate School, Division of Nutritional Sciences at Cornell University; National Institutes of Health (National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases; T32-DK007158 award); the Mario Einaudi Center for International Studies (South Asia Program), Human Ecology Alumni Association, Graduate School, Division of Nutritional Sciences at Cornell University (for E.A.Y. research and travel support). D.G.R. is supported by National Institutes of Health (National Institute of Allergy and Infectious Diseases; AI118582 award). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Allergy and Infectious Diseases, or the National Institutes of Health.	Achkar JM, 2015, EBIOMEDICINE, V2, P1160, DOI 10.1016/j.ebiom.2015.07.039; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Cliff JM, 2016, J INFECT DIS, V213, P485, DOI 10.1093/infdis/jiv447; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cox HS, 2008, BMJ-BRIT MED J, V336, P484, DOI 10.1136/bmj.39463.640787.BE; Doherty M, 2009, CURR OPIN PULM MED, V15, P181, DOI 10.1097/MCP.0b013e328326f42c; Doherty TM, 2007, EXPERT OPIN BIOL TH, V7, P1539, DOI 10.1517/14712598.7.10.1539; Doherty TM, 2009, CLIN CHEST MED, V30, P783, DOI 10.1016/j.ccm.2009.08.008; Dwivedi VP, 2012, J BIOL CHEM, V287, P33656, DOI 10.1074/jbc.M112.375154; Ferrero E, 2003, IMMUNOLOGY, V108, P365, DOI 10.1046/j.1365-2567.2003.01600.x; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Fritzsch FSO, 2012, ANNU REV CHEM BIOMOL, V3, P129, DOI 10.1146/annurev-chembioeng-062011-081056; Goletti D, 2014, J RHEUMATOL, V41, P24, DOI 10.3899/jrheum.140099; Jacobsen M, 2008, BIOL CHEM, V389, P487, DOI 10.1515/BC.2008.053; Kaufmann SHE, 2011, LANCET INFECT DIS, V11, P633, DOI 10.1016/S1473-3099(11)70146-3; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Lambert ML, 2003, LANCET INFECT DIS, V3, P282, DOI 10.1016/S1473-3099(03)00607-8; Lin MY, 2008, BIOL CHEM, V389, P497, DOI 10.1515/BC.2008.057; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mistry R, 2007, J INFECT DIS, V195, P357, DOI 10.1086/510397; Monin L, 2014, SEMIN IMMUNOL, V26, P552, DOI 10.1016/j.smim.2014.09.004; Neff L, 2007, J BACTERIOL, V189, P4739, DOI 10.1128/JB.01889-06; Parida SK, 2010, DRUG DISCOV TODAY, V15, P148, DOI 10.1016/j.drudis.2009.10.005; Petruccioli E, 2016, EUR RESPIR J, V48, P1751, DOI 10.1183/13993003.01012-2016; RHOADES ER, 1995, INFECT IMMUN, V63, P3871, DOI 10.1128/IAI.63.10.3871-3877.1995; Rubakhin SS, 2011, NAT METHODS, V8, pS20, DOI [10.1038/NMETH.1549, 10.1038/nmeth.1549]; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Strieter RM, 2002, J CLIN INVEST, V109, P699, DOI 10.1172/JCI200215277; Su WL, 2010, CLIN VACCINE IMMUNOL, V17, P223, DOI 10.1128/CVI.00381-09; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization (WHO), 2008, ANT DRUG RES WORLD 4	41	3	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185640	10.1371/journal.pone.0185640	http://dx.doi.org/10.1371/journal.pone.0185640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977039	Green Published, gold, Green Submitted			2022-12-26	WOS:000412163100036
J	Choi, YJ; Lee, DH; Han, KD; Kim, HS; Yoon, H; Shin, CM; Park, YS; Kim, N				Choi, Yoon Jin; Lee, Dong Ho; Han, Kyung-Do; Kim, Hyun Soo; Yoon, Hyuk; Shin, Cheol Min; Park, Young Soo; Kim, Nayoung			The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea	PLOS ONE			English	Article							MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; RISK; METAANALYSIS; CONSUMPTION; MORTALITY; TOBACCO; ADENOCARCINOMA; ALDH2	Background Epidemiologic findings of low-volume alcohol consumption in relation to gastrointestinal cancers including gastric cancer are inconsistent. Methods The association between alcohol intake and esophageal, gastric and colorectal cancer risk was examined in a population-based prospective cohort of 23,323,730 adults in Korea who had undergone a biennial evaluation provided by the National Health Insurance Corporation between the years 2009 and 2012. After median 5.4 years of follow-up, 9,171 esophageal, 135,382 gastric and 154,970 colorectal cancer cases were identified. Cox regression models were used to estimate hazard ratios (HR) and corresponding 95% confidence intervals (95% CI). Results Light drinking as well as moderate to heavy alcohol consumption significantly increased the risks of the three gastrointestinal cancers (HR 1.51; 95% CI, 1.43 -1.60; HR 1.08; 95% CI, 1.06 -1.09; HR 1.12; 95% CI, 1.11 -1.14) compared with non-drinkers after adjusting for age, sex, smoking, exercise, income, body mass index, and diabetes. The synergistically increased cancer risk between excessive amount of alcohol consumption and currently smoking or underweight individuals was observed only in the esophageal cancers. Conclusions Light drinking including even one alcoholic drink a day is associated with increased risks of esophageal, gastric and colorectal cancer.	[Choi, Yoon Jin; Lee, Dong Ho; Kim, Hyun Soo; Yoon, Hyuk; Shin, Cheol Min; Park, Young Soo; Kim, Nayoung] Dept Internal Med, Seongnam, Gyeonggi Do, South Korea; [Choi, Yoon Jin; Lee, Dong Ho; Kim, Hyun Soo; Yoon, Hyuk; Shin, Cheol Min; Park, Young Soo; Kim, Nayoung] Seoul Natl Univ, Bundang Hosp, Seongnam, Gyeonggi Do, South Korea; [Lee, Dong Ho; Park, Young Soo; Kim, Nayoung] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Lee, Dong Ho; Park, Young Soo; Kim, Nayoung] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Han, Kyung-Do] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Catholic University of Korea	Lee, DH (corresponding author), Dept Internal Med, Seongnam, Gyeonggi Do, South Korea.; Lee, DH (corresponding author), Seoul Natl Univ, Bundang Hosp, Seongnam, Gyeonggi Do, South Korea.; Lee, DH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Lee, DH (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.	dhljohn@yahoo.com	Yoon, Hyuk/AAT-4978-2020	Yoon, Hyuk/0000-0002-2657-0349; Shin, Cheol Min/0000-0003-2265-9845; Kim, Nayoung/0000-0002-9397-0406; Choi, Yoon Jin/0000-0002-1922-9388	Ministry of Science, ICT and Future Planning (MSIP) [2011-0030001]	Ministry of Science, ICT and Future Planning (MSIP)(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by No. 2011-0030001 from http://english.msip.go.kr/english/main/main.do, Ministry of Science, ICT and Future Planning (MSIP) to DHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnardi V, 2013, ANN ONCOL, V24, P301, DOI 10.1093/annonc/mds337; Cao Y, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4238; Castellsague X, 1999, INT J CANCER, V82, P657, DOI 10.1002/(SICI)1097-0215(19990827)82:5&lt;657::AID-IJC7&gt;3.0.CO;2-C; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Fedirko V, 2011, ANN ONCOL, V22, P1958, DOI 10.1093/annonc/mdq653; Fillmore KM, 2007, ANN EPIDEMIOL, V17, pS16, DOI 10.1016/j.annepidem.2007.01.005; Freedman ND, 2007, AM J EPIDEMIOL, V165, P1424, DOI 10.1093/aje/kwm051; Freedman ND, 2011, GUT, V60, P1029, DOI 10.1136/gut.2010.233866; Friedenreich CM, 2013, CANCER CAUSE CONTROL, V24, P1995, DOI 10.1007/s10552-013-0275-0; Giovannucci E, 2004, J NUTR, V134, p2475S, DOI 10.1093/jn/134.9.2475S; GOEDDE HW, 1992, HUM GENET, V88, P344; Hashibe M, 2007, INT J CANCER, V120, P1518, DOI 10.1002/ijc.22507; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V92, P1; International Agency for Research on Cancer, 1998, REEV SOM ORG CHEM HY; Kontou N, 2012, DIS COLON RECTUM, V55, P703, DOI 10.1097/DCR.0b013e31824e612a; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Lewis SJ, 2005, CANCER EPIDEM BIOMAR, V14, P1967, DOI 10.1158/1055-9965.EPI-05-0196; Lindblad M, 2005, CANCER CAUSE CONTROL, V16, P285, DOI 10.1007/s10552-004-3485-7; Ma S-H, 2015, BRIT J CANC; Naimi TS, 2017, ADDICTION, V112, P207, DOI 10.1111/add.13451; Ogino S, 2016, EPIDEMIOLOGY, V27, P602, DOI 10.1097/EDE.0000000000000471; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Oh CM, 2016, CANCER RES TREAT, V48, P436, DOI 10.4143/crt.2016.089; Organization WH, 1988, IARC MONOGRAPHS EVAL; Pandeya N, 2009, GASTROENTEROLOGY, V136, P1215, DOI 10.1053/j.gastro.2008.12.052; Parkin DM, 2011, BRIT J CANCER, V105, pS2, DOI 10.1038/bjc.2011.474; Peng Q, 2016, ONCOL LETT, V11, P3231, DOI 10.3892/ol.2016.4401; Poschl G, 2004, ALCOHOL ALCOHOLISM, V39, P155, DOI 10.1093/alcalc/agh057; Razzak AA, 2011, CANCER PREV RES, V4, P2035, DOI 10.1158/1940-6207.CAPR-11-0276; Schernhammer ES, 2010, GUT, V59, P794, DOI 10.1136/gut.2009.183707; Shin CM, 2011, EUR J GASTROEN HEPAT, V23, P411, DOI 10.1097/MEG.0b013e328343b7f5; Son Ju Ik, 2001, Korean Journal of Internal Medicine, V16, P250; Steevens J, 2010, GUT, V59, P39, DOI 10.1136/gut.2009.191080; Tramacere I, 2011, ANN ONCOL; Tramacere I, 2010, INT J CANCER, V126, P1474, DOI 10.1002/ijc.24936; Varela-Rey M, 2013, ALCOHOL RES-CURR REV, V35, P25; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Yang HK, 2016, SCI REP-UK, V6, DOI 10.1038/srep30329; Yokoyama A, 1998, CARCINOGENESIS, V19, P1383, DOI 10.1093/carcin/19.8.1383	40	49	51	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185778	10.1371/journal.pone.0185778	http://dx.doi.org/10.1371/journal.pone.0185778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973012	gold, Green Published, Green Submitted			2022-12-26	WOS:000412131900048
J	Chang, SK; Liu, HI; Fukuda, H; Maunder, MN				Chang, Shui-Kai; Liu, Hung-I; Fukuda, Hiromu; Maunder, Mark N.			Data reconstruction can improve abundance index estimation: An example using Taiwanese longline data for Pacific bluefin tuna	PLOS ONE			English	Article							VESSEL MONITORING SYSTEMS; UNIT-EFFORT DATA; THUNNUS-ORIENTALIS; STANDARDIZING CATCH; FISHING EFFORT; VMS DATA; FISHERY; AREA; PREDICTION; WESTERN	Catch-per-unit-effort (CPUE) is often the main piece of information used in fisheries stock assessment; however, the catch and effort data that are traditionally compiled from commercial logbooks can be incomplete or unreliable due to many reasons. Pacific bluefin tuna (PBF) is a seasonal target species in the Taiwanese longline fishery. Since 2010, detailed catch information for each PBF has been made available through a catch documentation scheme. However, previously, only market landing data with a low coverage of logbooks were available. Therefore, several nontraditional procedures were performed to reconstruct catch and effort data from many alternative data sources not directly obtained from fishers for 2001-2015: (1) Estimating the catch number from the landing weight for 2001-2003, for which the catch number information was incomplete, based on Monte Carlo simulation; (2) deriving fishing days for 2007-2009 from voyage data recorder data, based on a newly developed algorithm; and (3) deriving fishing days for 2001-2006 from vessel trip information, based on linear relationships between fishing and at-sea days. Subsequently, generalized linear mixed models were developed with the delta-lognormal assumption for standardizing the CPUE calculated from the reconstructed data, and three-stage model evaluation was performed using (1) Akaike and Bayesian information criteria to determine the most favorable variable composition of standardization models, (2) overall R-2 via cross-validation to compare fitting performance between area-separated and area-combined standardizations, and (3) system-based testing to explore the consistency of the standardized CPUEs with auxiliary data in the PBF stock assessment model. The last stage of evaluation revealed high consistency among the data, thus demonstrating improvements in data reconstruction for estimating the abundance index, and consequently the stock assessment.	[Chang, Shui-Kai] Natl Sun Yat Sen Univ, Inst Marine Affairs, Kaohsiung, Taiwan; [Liu, Hung-I] Overseas Fisheries Dev Council Republ China, Taipei, Taiwan; [Fukuda, Hiromu] Japan Fisheries Res & Educ Agcy, Natl Res Inst Far Seas Fisheries, Shizuoka, Japan; [Maunder, Mark N.] Interamer Trop Tuna Commiss, La Jolla, CA USA	National Sun Yat Sen University; Japan Fisheries Research & Education Agency (FRA)	Chang, SK (corresponding author), Natl Sun Yat Sen Univ, Inst Marine Affairs, Kaohsiung, Taiwan.	skchang@faculty.nsysu.edu.tw	Chang, Shui-Kai/B-5038-2010	Chang, Shui-Kai/0000-0003-2929-1510	Fisheries Agency of Taiwan [104AS-11.1.2-FA-F1, 105AS-11.1.2-FA-F1, 106AS-10.1.2-FA-F1]	Fisheries Agency of Taiwan	SKC acknowledges funding supports of the Fisheries Agency of Taiwan under Project Number: 104AS-11.1.2-FA-F1, 105AS-11.1.2-FA-F1 and 106AS-10.1.2-FA-F1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2014, JAPAN INFORM PAPERS, P26; BAYLIFF W H, 1991, Inter-American Tropical Tuna Commission Bulletin, V20, P3; Bayliff WM, 1994, FAO FISHERIES TECHNI, V336, P244; Bez N, 2011, CAN J FISH AQUAT SCI, V68, P1998, DOI 10.1139/F2011-114; Bordalo-Machado P, 2006, REV FISH SCI, V14, P369, DOI 10.1080/10641260600893766; Boustany AM, 2010, PROG OCEANOGR, V86, P94, DOI 10.1016/j.pocean.2010.04.015; Brodziak J, 2013, CAN J FISH AQUAT SCI, V70, P1723, DOI 10.1139/cjfas-2013-0111; Campbell RA, 2015, FISH RES, V161, P109, DOI 10.1016/j.fishres.2014.07.004; Chang SK, 2016, MAR POLICY, V74, P99, DOI 10.1016/j.marpol.2016.09.017; Chang SK, 2014, CAN J FISH AQUAT SCI, V71, P1363, DOI 10.1139/cjfas-2013-0552; Chang SK, 2014, MAR POLICY, V43, P338, DOI 10.1016/j.marpol.2013.07.003; Chang SK, 2011, FISH RES, V107, P210, DOI 10.1016/j.fishres.2010.11.004; Chen KS, 2006, FISHERIES SCI, V72, P985, DOI 10.1111/j.1444-2906.2006.01247.x; Conners ME, 2009, SAMPLING ESTIMATION; Efron B, 2004, J AM STAT ASSOC, V99, P619, DOI 10.1198/016214504000000692; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fujioka K., 2015, BIOL ECOLOGY BLUEFIN, P101, DOI [10.1201/b18714, DOI 10.1201/B18714]; Fukuda S, 2011, ECOL MODEL, V222, P1401, DOI 10.1016/j.ecolmodel.2011.01.023; Gerritsen H, 2011, ICES J MAR SCI, V68, P245, DOI 10.1093/icesjms/fsq137; HILBORN R, 1992; Hinton M. G., 2004, ICCAT COL VOL SCI PA, V56, P169; ISC, 2014, 14 M INT SCI COMM TU, P121; ISC, 2016, 16 M INT SCI COMM TU; Itoh T, 2006, FISHERIES SCI, V72, P53, DOI 10.1111/j.1444-2906.2006.01116.x; Itoh T, 2003, FISH B-NOAA, V101, P514; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Joo R, 2011, ECOL MODEL, V222, P1048, DOI 10.1016/j.ecolmodel.2010.08.039; Kitagawa T, 2004, FISH OCEANOGR, V13, P161, DOI 10.1111/j.1365-2419.2004.00282.x; Kutner M., 2005, APPL LINEAR STAT MOD; Lee J, 2010, ICES J MAR SCI, V67, P1260, DOI 10.1093/icesjms/fsq010; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; LO NCH, 1992, CAN J FISH AQUAT SCI, V49, P2515, DOI 10.1139/f92-278; Lourenco S, 2006, FISH RES, V78, P89, DOI 10.1016/j.fishres.2005.12.007; Lynch PD, 2012, FISH RES, V125, P27, DOI 10.1016/j.fishres.2012.02.005; Marrs SJ, 2002, FISH RES, V58, P109, DOI 10.1016/S0165-7836(01)00362-9; Maunder MN, 2006, ICES J MAR SCI, V63, P1373, DOI 10.1016/j.icesjms.2006.05.008; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; Maunder MN, 2014, 5 IATTC SCI ADVISORY; Methot RD, 2013, FISH RES, V142, P86, DOI 10.1016/j.fishres.2012.10.012; Moran D, 2011, AQUAT BIOL, V11, P229, DOI 10.3354/ab00314; Mullowney DR, 2009, FISH RES, V100, P248, DOI 10.1016/j.fishres.2009.08.006; Ohta I., 2015, BIOL ECOLOGY BLUEFIN, P123; Palmer MC, 2009, N AM J FISH MANAGE, V29, P928, DOI 10.1577/M08-135.1; Piner K., 2012, SELECTION ASYMPTOTIC; Poos JJ, 2007, CAN J FISH AQUAT SCI, V64, P304, DOI 10.1139/F06-177; Rodriguez-Marin E, 2003, ICES J MAR SCI, V60, P1216, DOI 10.1016/S1054-3139(03)00139-5; Rossiter T, 2003, MAR POLICY, V27, P281, DOI 10.1016/S0308-597X(03)00006-X; Russell BM, 2011, HDB MARKOV CHAIN MON; Sakai O, 2016, JAPANESE COASTAL LON; SAS (Statistical Analysis Systems) Institute Inc, 2013, SAS US GUID; Shiao JC, 2017, ICES J MAR SCI, V74, P204, DOI 10.1093/icesjms/fsw142; Shimose T., 2015, BIOL ECOLOGY BLUEFIN, P47; Smith PJ, 2001, NEW ZEAL J MAR FRESH, V35, P843, DOI 10.1080/00288330.2001.9517046; Sokal R.R., 2012, BIOMETRY; Su NJ, 2008, FISH RES, V90, P235, DOI 10.1016/j.fishres.2007.10.024; Suzuki N, 2014, BULL FISH RES AGENCY, P87; Tanaka Y, 2007, FISHERIES SCI, V73, P534, DOI 10.1111/j.1444-2906.2007.01365.x; Tanaka Y, 2006, MAR ECOL PROG SER, V319, P225, DOI 10.3354/meps319225; Tseng HS, 2010, MAR POLICY, V34, P1156, DOI 10.1016/j.marpol.2010.03.015; UCLA. FAQ, 2016, FAQ WHY AR R2 F SO L; Walter JF, 2014, N AM J FISH MANAGE, V34, P1095, DOI 10.1080/02755947.2014.932865; Wang H-Y, 2014, N PAC OC PAC BLUEF T; Witt MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001111; Yu Q, 2014, NEUROCOMPUTING, V129, P153, DOI 10.1016/j.neucom.2013.08.041; Zhang YL, 2015, J ECONOMETRICS, V187, P95, DOI 10.1016/j.jeconom.2015.02.006	65	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185784	10.1371/journal.pone.0185784	http://dx.doi.org/10.1371/journal.pone.0185784			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MY	28968434	Green Submitted, Green Published, gold			2022-12-26	WOS:000412029600048
J	Chemin, J; Taiakina, V; Monteil, A; Piazza, M; Guan, W; Stephens, RF; Kitmitto, A; Pang, ZPP; Dolphin, AC; Perez-Reyes, E; Dieckmann, T; Guillemette, JG; Spafford, JD				Chemin, Jean; Taiakina, Valentina; Monteil, Arnaud; Piazza, Michael; Guan, Wendy; Stephens, Robert F.; Kitmitto, Ashraf; Pang, Zhiping P.; Dolphin, Annette C.; Perez-Reyes, Edward; Dieckmann, Thorsten; Guillemette, Joseph Guy; Spafford, J. David			Calmodulin regulates Ca(v)3 T-type channels at their gating brake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; circular dichroism (CD); cryo-electron microscopy; gating; isothermal titration calorimetry (ITC); nuclear magnetic resonance (NMR); patch clamp; short hairpin RNA (shRNA)	VOLTAGE-GATED CALCIUM; CHILDHOOD ABSENCE EPILEPSY; PROTEIN SECONDARY STRUCTURE; PLASMA-MEMBRANE EXPRESSION; I-II LOOP; CA2+ CHANNEL; DEPENDENT INACTIVATION; SODIUM-CHANNEL; CA2+-DEPENDENT INACTIVATION; FUNCTIONAL-CHARACTERIZATION	Calcium (Ca(v)1 and Ca(v)2) and sodium channels possess homologous CaM-binding motifs, known as IQ motifs in their C termini, which associate with calmodulin (CaM), a universal calcium sensor. Ca(v)3 T-type channels, which serve as pacemakers of the mammalian brain and heart, lack a C-terminal IQ motif. We illustrate that T-type channels associate with CaM using co-immunoprecipitation experiments and single particle cryo-electron microscopy. We demonstrate that protostome invertebrate (LCa(v)3) and human Ca(v)3.1, Ca(v)3.2, and Ca(v)3.3 T-type channels specifically associate with CaM at helix 2 of the gating brake in the I-II linker of the channels. Isothermal titration calorimetry results revealed that the gating brake and CaM bind each other with high-nanomolar affinity. We show that the gating brake assumes a helical conformation upon binding CaM, with associated conformational changes to both CaM lobes as indicated by amide chemical shifts of the amino acids of CaM in H-1-N-15 HSQC NMR spectra. Intact Ca2+-binding sites on CaM and an intact gating brake sequence (first 39 amino acids of the I-II linker) were required in Ca(v)3.2 channels to prevent the runaway gating phenotype, a hyperpolarizing shift in voltage sensitivities and faster gating kinetics. We conclude that the presence of high-nanomolar affinity binding sites for CaM at its universal gating brake and its unique form of regulation via the tuning of the voltage range of activity could influence the participation of Ca(v)3 T-type channels in heart and brain rhythms. Our findings may have implications for arrhythmia disorders arising from mutations in the gating brake or CaM.	[Chemin, Jean; Monteil, Arnaud] Univ Montpellier, CNRS, INSERM, Inst Genom Fonct, F-34094 Montpellier, France; [Taiakina, Valentina; Piazza, Michael; Dieckmann, Thorsten; Guillemette, Joseph Guy] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada; [Guan, Wendy; Stephens, Robert F.; Spafford, J. David] Univ Waterloo, Dept Biol, B1-173, Waterloo, ON N2L 3G1, Canada; [Kitmitto, Ashraf] Univ Manchester, Fac Biol Med & Hlth, Div Cardiovasc Sci, Manchester M13 9NT, Lancs, England; [Pang, Zhiping P.] Rutgers Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, New Brunswick, NJ 08901 USA; [Dolphin, Annette C.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Perez-Reyes, Edward] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Waterloo; University of Waterloo; University of Manchester; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of London; University College London; University of Virginia	Spafford, JD (corresponding author), Univ Waterloo, Dept Biol, B1-173, Waterloo, ON N2L 3G1, Canada.	spafford@uwaterloo.ca	Pang, Zhiping/AAF-5757-2020; Monteil, Arnaud/G-3113-2012; Dolphin, Annette/F-7416-2010	Monteil, Arnaud/0000-0003-1632-7318; Dolphin, Annette/0000-0003-4626-4856; Perez-Reyes, Edward/0000-0001-6237-3863; Pang, Zhiping/0000-0002-6183-1233; chemin, jean/0000-0002-6089-5964; Kitmitto, Ashraf/0000-0001-8971-017X	Heart and Stroke Foundation of Canada; Natural Sciences and Engineering Research Council of Canada; British Heart Foundation; LabEx "Ion Channel Science and Therapeutics"; National Institutes of Health [NS067456]; NSERC Canada Graduate Scholarship; University of Waterloo;  [ANR-10-BLAN-1601]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067456] Funding Source: NIH RePORTER; Medical Research Council [G0901758, G0801756] Funding Source: researchfish; MRC [G0801756, G0901758] Funding Source: UKRI	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); British Heart Foundation(British Heart Foundation); LabEx "Ion Channel Science and Therapeutics"; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSERC Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Waterloo; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Heart and Stroke Foundation of Canada grant-in-aid (to J.D.S.), Natural Sciences and Engineering Research Council of Canada Discovery grants (to J.D.S., T.D., and J.G.G.), British Heart Foundation (to A. K.), LabEx "Ion Channel Science and Therapeutics" and ANR-10-BLAN-1601 (to J.C. and A.M.), National Institutes of Health Grant NS067456 (to E.P.-R.), an NSERC Canada Graduate Scholarship (to V.T.), and research incentive funds from University of Waterloo. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANDERSON PAV, 1993, P NATL ACAD SCI USA, V90, P7419, DOI 10.1073/pnas.90.15.7419; Arias JM, 2005, FEBS LETT, V579, P3907, DOI 10.1016/j.febslet.2005.06.008; Arias-Olguin II, 2008, J BIOL CHEM, V283, P8136, DOI 10.1074/jbc.M708761200; Bae J, 2010, MOL CELLS, V30, P185, DOI 10.1007/s10059-010-0106-z; Baumgart JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002976; Ben-Johny M, 2015, CURR MOL PHARMACOL, V8, P188, DOI 10.2174/1874467208666150507110359; Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; Ben-Johny M, 2014, CELL, V157, P1657, DOI 10.1016/j.cell.2014.04.035; BREHM P, 1978, J PHYSIOL-LONDON, V274, P639, DOI 10.1113/jphysiol.1978.sp012171; BREHM P, 1978, J PHYSIOL-LONDON, V283, P557, DOI 10.1113/jphysiol.1978.sp012519; BREHM P, 1978, SCIENCE, V202, P1203, DOI 10.1126/science.103199; Broecker J, 2011, ANAL BIOCHEM, V418, P307, DOI 10.1016/j.ab.2011.07.027; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Carbone E, 2014, PFLUG ARCH EUR J PHY, V466, P677, DOI 10.1007/s00424-014-1489-z; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; CHEN RF, 1968, ANAL BIOCHEM, V25, P412, DOI 10.1016/0003-2697(68)90116-4; Chen YC, 2003, ANN NEUROL, V54, P239, DOI 10.1002/ana.10607; Cheong E, 2013, PHYSIOL REV, V93, P961, DOI 10.1152/physrev.00010.2012; Cribbs LL, 2010, CHANNELS, V4, P447, DOI 10.4161/chan.4.6.12870; Dawson TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092941; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dreyfus FM, 2010, J NEUROSCI, V30, P99, DOI 10.1523/JNEUROSCI.4305-09.2010; Dubel SJ, 2004, J BIOL CHEM, V279, P29263, DOI 10.1074/jbc.M313450200; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Ernst Orna, 2010, J Vis Exp, DOI 10.3791/1918; Findeisen F, 2010, CHANNELS, V4, P459, DOI 10.4161/chan.4.6.12867; Freiburger LA, 2009, CHEMBIOCHEM, V10, P2871, DOI 10.1002/cbic.200900614; GAGNE SM, 1994, PROTEIN SCI, V3, P1961, DOI 10.1002/pro.5560031108; Gray LS, 2013, EXPERT REV ANTICANC, V13, P589, DOI [10.1586/ERA.13.34, 10.1586/era.13.34]; Halling D Brent, 2006, Sci STKE, V2006, per1; JASANOFF A, 1994, BIOCHEMISTRY-US, V33, P2129, DOI 10.1021/bi00174a020; Jeziorski MC, 1998, J BIOL CHEM, V273, P22792, DOI 10.1074/jbc.273.35.22792; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; Kim EY, 2008, STRUCTURE, V16, P1455, DOI 10.1016/j.str.2008.07.010; KINCAID RL, 1982, J BIOL CHEM, V257, P638; KINK JA, 1990, CELL, V62, P165, DOI 10.1016/0092-8674(90)90250-I; Kovalevskaya NV, 2013, PFLUG ARCH EUR J PHY, V465, P1507, DOI 10.1007/s00424-013-1278-0; Kuo IYT, 2014, PFLUG ARCH EUR J PHY, V466, P767, DOI 10.1007/s00424-013-1430-x; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee N, 2017, MOL PHARMACOL, V92, P347, DOI 10.1124/mol.117.108530; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Liang J, 2007, ANN HUM GENET, V71, P325, DOI 10.1111/j.1469-1809.2006.00332.x; Liebeskind BJ, 2011, P NATL ACAD SCI USA, V108, P9154, DOI 10.1073/pnas.1106363108; Liu ZH, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00038; Mesirca P, 2014, PFLUG ARCH EUR J PHY, V466, P791, DOI 10.1007/s00424-014-1482-6; Pang ZP, 2010, J BIOL CHEM, V285, P33930, DOI 10.1074/jbc.M110.150151; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Perez-Reyes E, 2014, PFLUG ARCH EUR J PHY, V466, P627, DOI 10.1007/s00424-013-1419-5; Perez-Reyes E, 2010, CHANNELS, V4, P453, DOI 10.4161/chan.4.6.12889; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Piazza M, 2014, BIOCHEMISTRY-US, V53, P1241, DOI 10.1021/bi401466s; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Potet F, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M806871200; Romoser VA, 1997, J BIOL CHEM, V272, P13270, DOI 10.1074/jbc.272.20.13270; Sarhan MF, 2012, P NATL ACAD SCI USA, V109, P3558, DOI 10.1073/pnas.1114748109; Sarhan MF, 2009, J BIOL CHEM, V284, P33265, DOI 10.1074/jbc.M109.052910; Schauer-Vukasinovic V, 2002, ANAL BIOANAL CHEM, V373, P501, DOI 10.1007/s00216-002-1351-6; Senatore A, 2014, PFLUG ARCH EUR J PHY, V466, P645, DOI 10.1007/s00424-014-1449-7; Senatore A, 2014, J BIOL CHEM, V289, P11952, DOI 10.1074/jbc.M114.551473; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Smith CL, 2017, J GEN PHYSIOL, V149, P483, DOI 10.1085/jgp.201611683; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; Spafford J. D., 2011, JOVE-J VIS EXP, V47, P2314; Spafford JD, 1998, BIOCHEM BIOPH RES CO, V244, P772, DOI 10.1006/bbrc.1998.8332; Splawski I, 2006, J BIOL CHEM, V281, P22085, DOI 10.1074/jbc.M603316200; Stephens RF, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00153; Sun T, 2010, J NEUROSCI, V30, P11838, DOI 10.1523/JNEUROSCI.1481-10.2010; Taiakina V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061765; Tan BZ, 2011, J BIOL CHEM, V286, P42725, DOI 10.1074/jbc.M111.265207; Tan GMY, 2012, J BIOL CHEM, V287, P832, DOI 10.1074/jbc.M111.268722; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Vitko I, 2005, J NEUROSCI, V25, P4844, DOI 10.1523/JNEUROSCI.0847-05.2005; Vitko I, 2007, J NEUROSCI, V27, P322, DOI 10.1523/JNEUROSCI.1817-06.2007; Walsh CP, 2009, J BIOL CHEM, V284, P22310, DOI 10.1074/jbc.M109.017152; Wang CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5896; Wang CJ, 2012, STRUCTURE, V20, P1167, DOI 10.1016/j.str.2012.05.001; Whitmore L., 2004, NUCLEIC ACIDS RES, V89, pW668; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yang PS, 2014, NAT CHEM BIOL, V10, P231, DOI [10.1038/NCHEMBIO.1436, 10.1038/nchembio.1436]; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	91	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20010	20031		10.1074/jbc.M117.807925	http://dx.doi.org/10.1074/jbc.M117.807925			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	28972185	Green Published, hybrid			2022-12-26	WOS:000417696400008
J	Acosta-Sampson, L; Doring, K; Lin, YP; Yu, VY; Bukau, B; Kramer, G; Cate, JHD				Acosta-Sampson, Ligia; Doering, Kristina; Lin, Yuping; Yu, Vivian Y.; Bukau, Bernd; Kramer, Guenter; Cate, Jamie H. D.			Role for ribosome-associated complex and stress-seventy subfamily B (RAC-Ssb) in integral membrane protein translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; membrane protein; protein synthesis; translation control; unfolded protein response (UPR); stress-seventy subfamily B (Ssb); major facilitator superfamily (MFS); ribosome associated complex (RAC)	SIGNAL RECOGNITION PARTICLE; POLYPEPTIDE-ASSOCIATED COMPLEX; MAJOR FACILITATOR SUPERFAMILY; NASCENT CHAIN-LENGTH; GENOME-WIDE ANALYSIS; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; CODON USAGE; QUALITY-CONTROL; IN-VIVO	Targeting of most integral membrane proteins to the endoplasmic reticulum is controlled by the signal recognition particle, which recognizes a hydrophobic signal sequence near the protein N terminus. Proper folding of these proteins is monitored by the unfolded protein response and involves protein degradation pathways to ensure quality control. Here, we identify a new pathway for quality control of major facilitator superfamily transporters that occurs before the first transmembrane helix, the signal sequence recognized by the signal recognition particle, is made by the ribosome. Increased rates of translation elongation of the N-terminal sequence of these integral membrane proteins can divert the nascent protein chains to the ribosome-associated complex and stress-seventy subfamily B chaperones. We also show that quality control of integral membrane proteins by ribosome-associated complex-stress-seventy subfamily B couples translation rate to the unfolded protein response, which has implications for understanding mechanisms underlying human disease and protein production in biotechnology.	[Acosta-Sampson, Ligia; Lin, Yuping; Yu, Vivian Y.; Cate, Jamie H. D.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doering, Kristina; Bukau, Bernd; Kramer, Guenter] Heidelberg Univ ZMBH, DKFZ ZMBH Alliance, Ctr Mol Biol, Neuenheimer Feld 282, D-69120 Heidelberg, Germany; [Doering, Kristina; Bukau, Bernd; Kramer, Guenter] German Canc Res Ctr, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Cate, Jamie H. D.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Lin, Yuping] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin 300308, Peoples R China	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Cate, JHD (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.	jcate@lbl.gov		Bukau, Bernd/0000-0003-0521-7199; Kramer, Gunter/0000-0001-7552-8393; Cate, Jamie/0000-0001-5965-7902	Energy Biosciences Institute; National Institutes of Health [R01-GM065050]; Deutsche Forschungsgemeinschaft [SFB638, FOR1805]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065050] Funding Source: NIH RePORTER	Energy Biosciences Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the Energy Biosciences Institute (to J. H. D. C.), National Institutes of Health Grant R01-GM065050 (to J. H. D. C), and Deutsche Forschungsgemeinschaft Grants SFB638 and FOR1805 (to G. K. and B. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albanese V, 2010, J CELL BIOL, V189, P69, DOI 10.1083/jcb.201001054; Ashe MP, 2011, BIOTECHNOL J, V6, P707, DOI 10.1002/biot.201000333; Berndt U, 2009, P NATL ACAD SCI USA, V106, P1398, DOI 10.1073/pnas.0808584106; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Buck TM, 2015, PHYSIOL GENOMICS, V47, P198, DOI 10.1152/physiolgenomics.00101.2014; Buziol S, 2008, J BIOTECHNOL, V134, P203, DOI 10.1016/j.jbiotec.2008.02.002; Chartron JW, 2016, NATURE, V536, P224, DOI 10.1038/nature19309; Clarke TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003412; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; Dinh PX, 2012, VIROLOGY, V432, P460, DOI 10.1016/j.virol.2012.07.004; Doring K, 2017, CELL, V170, P298, DOI 10.1016/j.cell.2017.06.038; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010; Fluman N, 2014, ELIFE, V3, DOI 10.7554/eLife.03440; Fung KL, 2014, CANCER RES, V74, P598, DOI 10.1158/0008-5472.CAN-13-2064; Galazka JM, 2010, SCIENCE, V330, P84, DOI 10.1126/science.1192838; Gardin J, 2014, ELIFE, V3, DOI 10.7554/eLife.03735; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; Gautschi M, 2002, P NATL ACAD SCI USA, V99, P4209, DOI 10.1073/pnas.062048599; Gerashchenko MV, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku671; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; HOSAKA K, 1992, J BIOCHEM-TOKYO, V111, P352, DOI 10.1093/oxfordjournals.jbchem.a123761; Hundley H, 2002, P NATL ACAD SCI USA, V99, P4203, DOI 10.1073/pnas.062048399; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kahm M, 2010, J STAT SOFTW, V33, P1; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kirchner S, 2015, NAT REV GENET, V16, P98, DOI 10.1038/nrg3861; Koplin A, 2010, J CELL BIOL, V189, P57, DOI 10.1083/jcb.200910074; Lakkaraju AKK, 2008, CELL, V133, P440, DOI 10.1016/j.cell.2008.02.049; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Lazrak A, 2013, FASEB J, V27, P4630, DOI 10.1096/fj.13-227330; Lin YP, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0126-6; Madej MG, 2014, P NATL ACAD SCI USA, V111, pE719, DOI 10.1073/pnas.1400336111; Mahlab S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003294; Mason N, 2000, EMBO J, V19, P4164, DOI 10.1093/emboj/19.15.4164; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Noriega TR, 2014, ELIFE, V3, DOI 10.7554/eLife.04418; Noriega TR, 2014, J BIOL CHEM, V289, P19294, DOI 10.1074/jbc.M114.563239; Nyathi Y, 2015, J CELL BIOL, V210, P287, DOI 10.1083/jcb.201410086; Nyathi Y, 2013, BBA-MOL CELL RES, V1833, P2392, DOI 10.1016/j.bbamcr.2013.02.021; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Pang YLJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku945; Pechmann S, 2014, NAT STRUCT MOL BIOL, V21, P1100, DOI 10.1038/nsmb.2919; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Pfund C, 1998, EMBO J, V17, P3981, DOI 10.1093/emboj/17.14.3981; Pop C, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145524; Power PM, 2004, BIOCHEM BIOPH RES CO, V322, P1038, DOI 10.1016/j.bbrc.2004.08.022; Powers T, 1996, CURR BIOL, V6, P331, DOI 10.1016/S0960-9822(02)00484-0; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Puigbo P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-38; Raue U, 2007, J BIOL CHEM, V282, P7809, DOI 10.1074/jbc.M611436200; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Reimann B, 1999, YEAST, V15, P397, DOI 10.1002/(SICI)1097-0061(19990330)15:5<397::AID-YEA384>3.3.CO;2-L; Roy A, 2014, BBA-GEN SUBJECTS, V1840, P2878, DOI 10.1016/j.bbagen.2014.05.004; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097; Schibich D, 2016, NATURE, V536, P219, DOI 10.1038/nature19070; Shah K, 2015, J MOL BIOL, V427, P1464, DOI 10.1016/j.jmb.2015.02.003; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SIEGEL V, 1988, EMBO J, V7, P1769, DOI 10.1002/j.1460-2075.1988.tb03007.x; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Teugjas H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-104; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Verwaal R, 2002, YEAST, V19, P1029, DOI 10.1002/yea.895; Voorhees RM, 2015, ELIFE, V4, DOI 10.7554/eLife.07975; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; WALTER P, 1981, J CELL BIOL, V91, P557, DOI 10.1083/jcb.91.2.557; Wang F, 2013, MOL CELL, V50, P368, DOI 10.1016/j.molcel.2013.03.009; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003; Yu CH, 2015, MOL CELL, V59, P744, DOI 10.1016/j.molcel.2015.07.018; Zhang X, 2010, SCIENCE, V328, P757, DOI 10.1126/science.1186743; Zhang Y, 2012, MOL BIOL CELL, V23, P3027, DOI 10.1091/mbc.E12-02-0112; Zhang YX, 2014, NAT STRUCT MOL BIOL, V21, P1042, DOI 10.1038/nsmb.2908; Znameroski EA, 2012, P NATL ACAD SCI USA, V109, P6012, DOI 10.1073/pnas.1118440109	91	2	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19610	19627		10.1074/jbc.M117.813857	http://dx.doi.org/10.1074/jbc.M117.813857			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972146	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000416911300010
J	Umezawa, Y; Akiyama, H; Okada, K; Ishida, S; Nogami, A; Oshikawa, G; Kurosu, T; Miura, O				Umezawa, Yoshihiro; Akiyama, Hiroki; Okada, Keigo; Ishida, Shinya; Nogami, Ayako; Oshikawa, Gaku; Kurosu, Tetsuya; Miura, Osamu			Molecular mechanisms for enhancement of stromal cell-derived factor 1-induced chemotaxis by platelet endothelial cell adhesion molecule 1 (PECAM-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C-X-C chemokine receptor type 4 (CXCR-4); cell migration; chemokine; myeloid cell; platelet endothelial cell adhesion molecule (PECAM-1); Ras-related protein 1 (Rap1); receptor internalization; signal transduction; tyrosine-protein kinase (tyrosine kinase); SDF-1	INTERNAL TANDEM DUPLICATION; TYROSINE PHOSPHORYLATION; INTEGRIN ACTIVATION; SIGNALING PATHWAYS; INDUCED APOPTOSIS; MAMMALIAN TARGET; DRUG-RESISTANCE; LEUKEMIA-CELLS; MIGRATION; CXCR4	Platelet endothelial cell adhesion molecule 1 (PECAM-1) is a cell adhesion protein involved in the regulation of cell adhesion and migration. Interestingly, several PECAM-1-deficient hematopoietic cells exhibit impaired chemotactic responses to stromal cell-derived factor 1 (SDF-1), a chemokine essential for B lymphopoiesis and bone marrow myelopoiesis. However, whether PECAM-1 is involved in SDF-1-regulated chemotaxis is unknown. We report here that SDF-1 induces tyrosine phosphorylation of PECAM-1 at its immunoreceptor tyrosine-based inhibition motifs in several hematopoietic cell lines via the Src family kinase Lyn, Bruton's tyrosine kinase, and JAK2 and that inhibition of these kinases reduced chemotaxis. Overexpression and knockdown of PECAM-1 enhanced and down-regulated, respectively, SDF-1-induced G(i)-dependent activation of the PI3K/Akt/mTORC1 pathway and small GTPase Rap1 in hematopoietic 32Dcl3 cells, and these changes in activation correlated with chemotaxis. Furthermore, pharmacological or genetic inhibition of the PI3K/Akt/mTORC1 pathway or Rap1, respectively, revealed that these pathways are independently activated and required for SDF-1-induced chemotaxis. When coexpressed in 293T cells, PECAM-1 physically associated with the SDF-1 receptor CXCR4. Moreover, PECAM-1 overexpression and knockdown reduced and enhanced SDF-1-induced endocytosis of CXCR4, respectively. Furthermore, when expressed in 32Dcl3 cells, an endocytosis-defective CXCR4 mutant, CXCR4-S324A/S325A, could activate the PI3K/Akt/mTORC1 pathway as well as Rap1 and induce chemotaxis in a manner similar to PECAM-1 overexpression. These findings suggest that PECAM-1 enhances SDF-1-induced chemotaxis by augmenting and prolonging activation of the PI3K/Akt/mTORC1 pathway and Rap1 and that PECAM-1, at least partly, exerts its activity by inhibiting SDF-1-induced internalization of CXCR4.	[Umezawa, Yoshihiro; Akiyama, Hiroki; Okada, Keigo; Ishida, Shinya; Nogami, Ayako; Oshikawa, Gaku; Kurosu, Tetsuya; Miura, Osamu] Tokyo Med & Dent Univ, Dept Hematol, Grad Sch Med & Dent Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan	Tokyo Medical & Dental University (TMDU)	Miura, O (corresponding author), Tokyo Med & Dent Univ, Dept Hematol, Grad Sch Med & Dent Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	miura.hema@tmd.ac.jp		Miura, Osamu/0000-0002-0981-3054; Umezawa, Yoshihiro/0000-0003-1027-1552	Ministry of Education, Culture, Sports, Science and Technology of Japan [15K09467, 24591384, 26461416]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology of Japan Grants 15K09467, 24591384, and 26461416. The authors declare that they have no conflicts of interest with the contents of this article.	Arai A, 2005, CELL SIGNAL, V17, P497, DOI 10.1016/j.cellsig.2004.09.007; Arai A, 2001, J BIOL CHEM, V276, P10453, DOI 10.1074/jbc.M004627200; Arai A, 2006, CELL SIGNAL, V18, P2162, DOI 10.1016/j.cellsig.2006.05.001; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Cao Y, 2015, LEUKEMIA, V29, P169, DOI 10.1038/leu.2014.187; Melo RDC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085926; de Gorter DJJ, 2007, IMMUNITY, V26, P93, DOI 10.1016/j.immuni.2006.11.012; dela Paz NG, 2014, J BIOL CHEM, V289, P7413, DOI 10.1074/jbc.M113.542514; Delgado-Martin C, 2011, J BIOL CHEM, V286, P37222, DOI 10.1074/jbc.M111.294116; Dhanjal TS, 2007, BLOOD, V109, P4237, DOI 10.1182/blood-2006-10-050740; Dillenburg-Pilla P, 2015, FASEB J, V29, P1056, DOI 10.1096/fj.14-260083; Ferrero E, 2003, BLOOD, V101, P186, DOI 10.1182/blood-2002-03-0768; Gallay N, 2007, CANCER RES, V67, P8624, DOI 10.1158/0008-5472.CAN-07-0402; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Hunter ZR, 2014, BLOOD, V123, P1637, DOI 10.1182/blood-2013-09-525808; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jackson DE, 1997, J BIOL CHEM, V272, P24868, DOI 10.1074/jbc.272.40.24868; Jin A, 2006, ONCOGENE, V25, P4332, DOI 10.1038/sj.onc.1209459; KOMATSU N, 1991, CANCER RES, V51, P341; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Martz CA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa1877; McLeod SJ, 2002, J IMMUNOL, V169, P1365, DOI 10.4049/jimmunol.169.3.1365; MIURA O, 1991, MOL CELL BIOL, V11, P4895, DOI 10.1128/MCB.11.10.4895; MIURA O, 1993, MOL CELL BIOL, V13, P1788, DOI 10.1128/MCB.13.3.1788; Montresor A, 2013, J CELL BIOL, V203, P1003, DOI 10.1083/jcb.201303067; Nagao T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084746; Nagao T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027397; Nagasawa T, 2015, FRONT IMMUNOL, V6, DOI [10.3389/fimmu.2015.00301, 10.3389/fimmu.2014.00445]; Nakata Y, 2006, BLOOD, V107, P4234, DOI 10.1182/blood-2005-08-3343; Newman DK, 2001, BLOOD, V97, P2351, DOI 10.1182/blood.V97.8.2351; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Nosaka Y, 2001, BIOCHEM BIOPH RES CO, V285, P675, DOI 10.1006/bbrc.2001.5222; Onish C, 2014, J BIOL CHEM, V289, P31053, DOI 10.1074/jbc.M114.568287; Oshikawa G, 2011, J BIOL CHEM, V286, P30263, DOI 10.1074/jbc.M111.232348; Pawig L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00429; Pellegatta F, 1998, J BIOL CHEM, V273, P27768, DOI 10.1074/jbc.273.43.27768; Pozzobon T, 2016, IMMUNOL LETT, V177, P6, DOI 10.1016/j.imlet.2016.06.006; Privratsky JR, 2014, CELL TISSUE RES, V355, P607, DOI 10.1007/s00441-013-1779-3; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Roccaro AM, 2014, BLOOD, V123, P4120, DOI 10.1182/blood-2014-03-564583; Ross EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002338; Sahin AO, 2012, CELL ADHES MIGR, V6, P39, DOI 10.4161/cam.18975; Schmid MC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060226, 10.1371/journal.pone.0061623]; Seeger FH, 2012, CIRC RES, V111, P854, DOI 10.1161/CIRCRESAHA.112.265678; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Tonino SH, 2008, BLOOD, V112, P840, DOI 10.1182/blood-2008-03-144576; Tourdot BE, 2013, BIOCHEMISTRY-US, V52, P2597, DOI 10.1021/bi301461t; Tsukamoto N, 1999, J BIOL CHEM, V274, P18463, DOI 10.1074/jbc.274.26.18463; Valles AM, 2004, J BIOL CHEM, V279, P44490, DOI 10.1074/jbc.M405144200; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Wheadon H, 2003, BIOCHEM J, V376, P147, DOI 10.1042/BJ20031160; Wu N, 2013, INT J ONCOL, V42, P419, DOI 10.3892/ijo.2012.1729; Zhang XF, 2001, BLOOD, V97, P3342, DOI 10.1182/blood.V97.11.3342	55	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19639	19655		10.1074/jbc.M117.779603	http://dx.doi.org/10.1074/jbc.M117.779603			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28974577	Green Published, hybrid			2022-12-26	WOS:000416911300012
J	Emptage, RP; Schoenberger, MJ; Ferguson, KM; Marmorstein, R				Emptage, Ryan P.; Schoenberger, Megan J.; Ferguson, Kathryn M.; Marmorstein, Ronen			Intramolecular autoinhibition of checkpoint kinase 1 is mediated by conserved basic motifs of the C-terminal kinase-associated 1 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; checkpoint control; crystal structure; DNA damage response; enzyme inactivation; enzyme mechanism; protein domain; serine; threonine protein kinase; structural biology	DNA-DAMAGE; CHK1; PHOSPHORYLATION; POLARITY; PATHWAY	Precise control of the cell cycle allows for timely repair of genetic material prior to replication. One factor intimately involved in this process is checkpoint kinase 1 (Chk1), a DNA damage repair inducing Ser/Thr protein kinase that contains an N-terminal kinase domain and a C-terminal regulatory region consisting of a approximate to 100-residue linker followed by a putative kinase-associated 1 (KA1) domain. We report the crystal structure of the human Chk1 KA1 domain, demonstrating striking structural homology with other sequentially diverse KA1 domains. Separately purified Chk1 kinase and KA1 domains are intimately associated in solution, which results in inhibition of Chk1 kinase activity. Using truncation mutants and site-directed mutagenesis, we define the inhibitory face of the KA1 domain as a series of basic residues residing on two conserved regions of the primary structure. These findings point to KA1-mediated intramolecular autoinhibition as a key regulatory mechanism of human Chk1, and provide new therapeutic possibilities with which to attack this validated oncology target with small molecules.	[Emptage, Ryan P.; Marmorstein, Ronen] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Emptage, Ryan P.; Marmorstein, Ronen] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Schoenberger, Megan J.; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Ferguson, Kathryn M.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Ferguson, Kathryn M.] Yale Univ, Sch Med, Canc Biol Inst, New Haven, CT 06520 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Yale University; Yale University	Emptage, RP; Marmorstein, R (corresponding author), 421 Curie Blvd, Philadelphia, PA 19104 USA.	emptage@upenn.edu; marmor@upenn.edu			National Institutes of Health Postdoctoral Fellowship [F32-GM115098]; National Institutes of Health [P01-CA114046]; NATIONAL CANCER INSTITUTE [P01CA114046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM115098] Funding Source: NIH RePORTER	National Institutes of Health Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Postdoctoral Fellowship F32-GM115098 (to R. P. E.) and National Institutes of Health Grant P01-CA114046 (to R. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Caparelli ML, 2013, CELL CYCLE, V12, P916, DOI 10.4161/cc.23881; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Copeland Robert A, 2005, Methods Biochem Anal, V46, P1; Emptage RP, 2017, BIOCHEM J, V474, P385, DOI 10.1042/BCJ20160792; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garrett MD, 2011, TRENDS PHARMACOL SCI, V32, P308, DOI 10.1016/j.tips.2011.02.014; Gong EY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10856; Han XZ, 2016, J BIOL CHEM, V291, P12951, DOI 10.1074/jbc.M115.713248; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Jiang KC, 2003, J BIOL CHEM, V278, P25207, DOI 10.1074/jbc.M300070200; Katsuragi Y, 2004, MOL BIOL CELL, V15, P1680, DOI 10.1091/mbc.E03-12-0874; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kosoy A, 2008, MOL BIOL CELL, V19, P4546, DOI 10.1091/mbc.E08-04-0444; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee J, 2001, MOL BIOL CELL, V12, P551, DOI 10.1091/mbc.12.3.551; Marx A, 2010, FASEB J, V24, P1637, DOI 10.1096/fj.09-148064; Marx A, 2006, J BIOL CHEM, V281, P27586, DOI 10.1074/jbc.M604865200; Moravcevic K, 2010, CELL, V143, P966, DOI 10.1016/j.cell.2010.11.028; Okita N, 2012, FEBS LETT, V586, P3974, DOI 10.1016/j.febslet.2012.09.048; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palermo C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001427; Rundle S, 2017, CANCERS, V9, DOI 10.3390/cancers9050041; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sanchez-Barrena MJ, 2007, MOL CELL, V26, P427, DOI 10.1016/j.molcel.2007.04.013; Scorah J, 2008, J BIOL CHEM, V283, P17250, DOI 10.1074/jbc.M800369200; Smits VAJ, 2015, FEBS J, V282, P3681, DOI 10.1111/febs.13387; Tapia-Alveal C, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-8; Tassan JP, 2004, BIOL CELL, V96, P193, DOI 10.1016/j.biolcel.2003.10.009; Tochio N, 2006, PROTEIN SCI, V15, P2534, DOI 10.1110/ps.062391106; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Wang JN, 2012, CANCER RES, V72, P3786, DOI 10.1158/0008-5472.CAN-12-0523; Wang JN, 2012, J BIOL CHEM, V287, P25501, DOI 10.1074/jbc.M112.350397; Wu JX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9953; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Yang ZQ, 2012, MOL CELL, V47, P469, DOI 10.1016/j.molcel.2012.06.037; Zhang Y, 2016, ONCOTARGET, V7, P34688, DOI 10.18632/oncotarget.9156; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zhang YW, 2014, INT J CANCER, V134, P1013, DOI 10.1002/ijc.28226	41	10	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19024	19033		10.1074/jbc.M117.811265	http://dx.doi.org/10.1074/jbc.M117.811265			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972186	hybrid, Green Published			2022-12-26	WOS:000415848000025
J	Brifault, C; Gilder, AS; Laudati, E; Banki, M; Gonias, SL				Brifault, Coralie; Gilder, Andrew S.; Laudati, Emilia; Banki, Michael; Gonias, Steven L.			Shedding of membrane-associated LDL receptor-related protein-1 from microglia amplifies and sustains neuroinflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipoprotein receptor-related protein (LRP); metalloprotease; microglia; neuroinflammation; shedding; receptor-associated protein	NF-KAPPA-B; ALPHA-2-MACROGLOBULIN RECEPTOR; PLASMINOGEN-ACTIVATOR; INFLAMMATORY RESPONSE; ALZHEIMERS-DISEASE; NEUROPATHIC PAIN; INNATE IMMUNITY; NERVOUS-SYSTEM; SCHWANN-CELLS; GLIAL-CELLS	In the CNS, microglia are activated in response to injury or infection and in neurodegenerative diseases. The endocytic and cell signaling receptor, LDL receptor-related protein-1 (LRP1), is reported to suppress innate immunity in macrophages and oppose microglial activation. The goal of this study was to identify novel mechanisms by which LRP1 may regulate microglial activation. Using primary cultures of microglia isolated from mouse brains, we demonstrated that LRP1 gene silencing increases expression of proinflammatory mediators; however, the observed response was modest. By contrast, the LRP1 ligand, receptor-associated protein (RAP), robustly activated microglia, and its activity was attenuated in LRP1-deficient cells. An important element of the mechanism by which RAP activated microglia was its ability to cause LRP1 shedding from the plasma membrane. This process eliminated cellular LRP1, which is anti-inflammatory, and generated a soluble product, shed LRP1 (sLRP1), which is potently proinflammatory. Purified sLRP1 induced expression of multiple proinflammatory cytokines and the mRNA encoding inducible nitric-oxide synthase in both LRP1-expressing and -deficient microglia. LPS also stimulated LRP1 shedding, as did the heat-shock protein and LRP1 ligand, calreticulin. Other LRP1 ligands, including (2)-macroglobulin and tissue-type plasminogen activator, failed to cause LRP1 shedding. Treatment of microglia with a metalloproteinase inhibitor inhibited LRP1 shedding and significantly attenuated RAP-induced cytokine expression. RAP and sLRP1 both caused neuroinflammation in vivo when administered by stereotaxic injection into mouse spinal cords. Collectively, these results suggest that LRP1 shedding from microglia may amplify and sustain neuroinflammation in response to proinflammatory stimuli.	[Brifault, Coralie; Gilder, Andrew S.; Laudati, Emilia; Banki, Michael; Gonias, Steven L.] Univ Calif San Diego, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Gonias, SL (corresponding author), Univ Calif San Diego, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	sgonias@ucsd.edu		brifault, coralie/0000-0002-9831-4491; Banki, Michael/0000-0002-8910-4695	National Institutes of Health [R01 HL136395, R01 NS097590]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS097590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Grants R01 HL136395 and R01 NS097590 from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Campana WM, 2017, FASEB J, V31, P1744, DOI 10.1096/fj.201601121R; Chuang TY, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0343-2; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Costales P, 2013, ATHEROSCLEROSIS, V227, P79, DOI 10.1016/j.atherosclerosis.2012.12.021; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; Duus K, 2010, FEBS J, V277, P3526, DOI 10.1111/j.1742-4658.2010.07762.x; Fernandez-Castaneda A, 2013, J BIOL CHEM, V288, P4538, DOI 10.1074/jbc.M112.384693; Flutsch A, 2016, NEUROREPORT, V27, P1305, DOI 10.1097/WNR.0000000000000691; Fricker M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-196; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gaultier A, 2008, BLOOD, V111, P5316, DOI 10.1182/blood-2007-12-127613; Gaultier A, 2008, J CLIN INVEST, V118, P161, DOI 10.1172/JCI32371; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gonias SL, 2014, AM J PATHOL, V184, P18, DOI 10.1016/j.ajpath.2013.08.029; Gorovoy M, 2010, J LEUKOCYTE BIOL, V88, P769, DOI 10.1189/jlb.0410220; Grimsley PG, 1999, THROMB RES, V94, P153, DOI 10.1016/S0049-3848(98)00208-4; Guillot-Sestier MV, 2015, TRENDS NEUROSCI, V38, P674, DOI 10.1016/j.tins.2015.08.008; Hendrickx DAE, 2013, J NEUROPATH EXP NEUR, V72, P106, DOI 10.1097/NEN.0b013e31827fd9e8; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; HUSSAINI IM, 1990, J BIOL CHEM, V265, P19441; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kavanagh E, 2015, AGING-US, V7, P673, DOI 10.18632/aging.100805; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LAMARRE J, 1993, J CLIN INVEST, V91, P1219, DOI 10.1172/JCI116283; Lillis AP, 2008, J IMMUNOL, V181, P364, DOI 10.4049/jimmunol.181.1.364; Liu Q, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-17; LOPES MBS, 1994, FEBS LETT, V338, P301, DOI 10.1016/0014-5793(94)80288-2; Mantuano E, 2017, BLOOD, V130, P1364, DOI 10.1182/blood-2017-04-780205; Mantuano E, 2016, P NATL ACAD SCI USA, V113, P1369, DOI 10.1073/pnas.1515480113; Mantuano E, 2013, J BIOL CHEM, V288, P34009, DOI 10.1074/jbc.M113.509133; Marzolo MP, 2000, J NEUROSCI RES, V60, P401, DOI 10.1002/(SICI)1097-4547(20000501)60:3<401::AID-JNR15>3.3.CO;2-C; May P, 2013, CELL TISSUE RES, V354, P887, DOI 10.1007/s00441-013-1699-2; MOESTRUP SK, 1992, CELL TISSUE RES, V269, P375, DOI 10.1007/BF00353892; Murphy S, 2000, GLIA, V29, P1, DOI 10.1002/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N; Ni M, 2010, CURR PROTOC TOXICOL; Overton CD, 2007, CIRC RES, V100, P670, DOI 10.1161/01.RES.0000260204.40510.aa; Pawaria S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1524; Pocivavsek A, 2009, J NEUROIMMUNOL, V214, P25, DOI 10.1016/j.jneuroim.2009.06.010; Pocivavsek A, 2009, GLIA, V57, P444, DOI 10.1002/glia.20772; Quinn KA, 1997, J BIOL CHEM, V272, P23946, DOI 10.1074/jbc.272.38.23946; Quinn KA, 1999, EXP CELL RES, V251, P433, DOI 10.1006/excr.1999.4590; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Schomberg D, 2012, EXP NEUROL, V234, P262, DOI 10.1016/j.expneurol.2011.12.021; Scilabra SD, 2013, J BIOL CHEM, V288, P332, DOI 10.1074/jbc.M112.393322; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Staudt ND, 2013, CANCER RES, V73, P3902, DOI 10.1158/0008-5472.CAN-12-4233; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Van Gool B, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00271; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; Webb DJ, 1999, J BIOL CHEM, V274, P7412, DOI 10.1074/jbc.274.11.7412; WOLF BB, 1992, AM J PATHOL, V141, P37; Wygrecka M, 2011, AM J RESP CRIT CARE, V184, P438, DOI 10.1164/rccm.201009-1422OC; Yamamoto K, 2017, ARTHRITIS RHEUMATOL, V69, P1246, DOI 10.1002/art.40080; Yang LY, 2017, NAT PROD RES, V31, P487, DOI 10.1080/14786419.2016.1190719; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263	64	27	29	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18699	18712		10.1074/jbc.M117.798413	http://dx.doi.org/10.1074/jbc.M117.798413			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28972143	hybrid, Green Published			2022-12-26	WOS:000414958100026
J	Goin, DE; Rudolph, KE; Ahern, J				Goin, Dana E.; Rudolph, Kara E.; Ahern, Jennifer			Impact of drought on crime in California: A synthetic control approach	PLOS ONE			English	Article							LEVEL UCR DATA; CLIMATE-CHANGE; VIOLENT CONFLICT; AMBIENT-TEMPERATURE; POLICE CALLS; WEATHER; RATES; SERVICE; DALLAS; HEAT	Climate and weather have been linked to criminal activity. The connection between climatological conditions and crime is of growing importance as we seek to understand the societal implications of climate change. This study describes the mechanisms theorized to link annual variations in climate to crime in California and examines the effect of drought on statewide crime rates from 2011-2015. California has suffered severe drought since 2011, resulting in intensely dry winters and several of the hottest days on record. It is likely that the drought increased economic stress and shifted routine activities of the population, potentially increasing the likelihood of crime. We used a synthetic control method to estimate the impact of California's drought on both property and violent crimes. We found a significant increase in property crimes during the drought, but no effect on violent crimes. This result was robust to several sensitivity analyses, including a negative control.	[Goin, Dana E.; Rudolph, Kara E.; Ahern, Jennifer] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Goin, DE (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA.	degoin@berkeley.edu		Ahern, Jennifer/0000-0002-3853-9760	National Institutes of Health [DP2 HD080350]; University of California, Berkeley Committee on Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP2HD080350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, Berkeley Committee on Research(University of California System); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institutes of Health Director's New Innovator Award Program DP2 HD080350. JA received the grant, https://commonfund.nih.gov/newinnovator/ index. KER was a Post-Doctoral Scholar of the Robert Wood Johnson Health and Society Scholars Program, http://www.healthandsocietyscholars. org/. The University of California, Berkeley Committee on Research provided JA initial funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of th emanuscript.	Abadie A, 2003, AM ECON REV, V93, P113, DOI 10.1257/000282803321455188; Abadie A, 2010, J AM STAT ASSOC, V105, P493, DOI 10.1198/jasa.2009.ap08746; Anderson CA, 2001, CURR DIR PSYCHOL SCI, V10, P33, DOI 10.1111/1467-8721.00109; ANDERSON CA, 1984, J PERS SOC PSYCHOL, V46, P91, DOI 10.1037/0022-3514.46.1.91; ANDERSON CA, 1987, J PERS SOC PSYCHOL, V52, P1161, DOI 10.1037/0022-3514.52.6.1161; [Anonymous], 2014, AM COMMUNITY SURVEY; [Anonymous], CAL WAT US; [Anonymous], CLIM AT A GLANC; Barnett J, 2007, POLIT GEOGR, V26, P639, DOI 10.1016/j.polgeo.2007.03.003; Barnett-Ryan C., 2016, WILEY HDB PSYCHOL VI, P5; Bertrand M, 2002, 8841 NBER; Bliss L, HIST DROUGHT MEETS C; Boxall Bettina, 2015, LOS ANGELES TIMES; Brown EG, 2015, EXECUTIVE ORDER B 29; Brunsdon C, 2009, ENVIRON PLANN B, V36, P906, DOI 10.1068/b32133; Bureau of Economic Analysis, 2014, EC IND STAT; Bureau of Labor Statistics, 2014, OCC EMPL STAT; Butke P, 2010, WEATHER CLIM SOC, V2, P127, DOI 10.1175/2010WCAS1043.1; Coffman M, 2012, ENVIRON DEV ECON, V17, P187, DOI 10.1017/S1355770X11000350; COHEN LE, 1979, AM SOCIOL REV, V44, P588, DOI 10.2307/2094589; COHN EG, 1993, J ENVIRON PSYCHOL, V13, P71, DOI 10.1016/S0272-4944(05)80216-6; Cohn EG, 2000, J ENV PSYCHOL, V20; COTTON JL, 1986, J APPL SOC PSYCHOL, V16, P786, DOI 10.1111/j.1559-1816.1986.tb01168.x; Department of Agricultural and Resource Economics UD, 2015, EC DROUGHT CAL FOOD, V18; Feinstein Laura., 2017, DROUGHT EQUITY CALIF; Field C.B., 2012, MANAGING RISKS EXTRE; FIELD S, 1992, BRIT J CRIMINOL, V32, P340, DOI 10.1093/oxfordjournals.bjc.a048222; Gillis J, 2015, NY TIMES; Gould ED, 2002, REV ECON STAT, V84, P45, DOI 10.1162/003465302317331919; HARRIES KD, 1988, J APPL SOC PSYCHOL, V18, P129, DOI 10.1111/j.1559-1816.1988.tb00010.x; Horrocks J., 2011, NZ EC PAPERS, V45, P231, DOI DOI 10.1080/00779954.2011.572544; Howard B.C., 2014, CALIFORNIA DROUGHT S; Howitt R.E., EC ANAL 2015 DROUGHT; Hsiang SM, 2014, CLIMATIC CHANGE, V123, P39, DOI 10.1007/s10584-013-0868-3; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Kreif Noemi, 2015, HLTH EC; Lab SP, 1988, JUSTICE Q, V5, P281; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Lovett I., 2015, NY TIMES; Maltz MD, 2003, J QUANT CRIMINOL, V19, P199, DOI 10.1023/A:1023006321454; Maltz MD, 2002, J QUANT CRIMINOL, V18, P297, DOI 10.1023/A:1016060020848; Mares D, 2013, J URBAN HEALTH, V90, P768, DOI 10.1007/s11524-013-9791-1; Mares D, 2013, CRIME LAW SOCIAL CH, V59, P185, DOI 10.1007/s10611-013-9411-8; Nagourney A., 2015, NY TIMES; NOAA, CLIM RANK; Office of Governor Edmund G. Brown Jr, 2014, GOV BROWN DECL DROUG; Press A, 2015, WALL STREET J; Ranson M, 2014, J ENVIRON ECON MANAG, V67, P274, DOI 10.1016/j.jeem.2013.11.008; Reuveny R, 2007, POLIT GEOGR, V26, P656, DOI 10.1016/j.polgeo.2007.05.001; Richtel Matt, 2015, NY TIMES; Rotton J, 2000, J PERS SOC PSYCHOL, V78, P1074, DOI 10.1037//0022-3514.78.6.1074; Rudolph KE, 2015, AM J PUBLIC HEALTH, V105, pE49, DOI 10.2105/AJPH.2015.302703; Salehyan I, 2014, POLIT GEOGR, V43, P1, DOI 10.1016/j.polgeo.2014.10.004; Scheffran J, 2012, SCIENCE, V336, P869, DOI 10.1126/science.1221339; Simister J, 2005, STRESS HEALTH, V21, P3, DOI 10.1002/smi.1029; Sorg ET, 2011, J CRIM JUST, V39, P463, DOI 10.1016/j.jcrimjus.2011.08.004; Substance Abuse and Mental Health Services Administration, 2014, NAT SURV DRUG US HLT; U.S. Energy Information Administration, 2014, STAT EN DAT SYST SED; United States Census Bureau, 2014, POPULATION ESTIMATES	60	9	9	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185629	10.1371/journal.pone.0185629	http://dx.doi.org/10.1371/journal.pone.0185629			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI7FU	28977002	Green Published, Green Submitted, gold			2022-12-26	WOS:000412163100034
J	Lewis, B; Lough, JM; Nash, MC; Diaz-Pulido, G				Lewis, Bonnie; Lough, Janice M.; Nash, Merinda C.; Diaz-Pulido, Guillermo			Presence of skeletal banding in a reef-building tropical crustose coralline alga	PLOS ONE			English	Article							OCEAN ACIDIFICATION; GROWTH-RATES; RED ALGAE; RHODOPHYTA; SEA; DOLOMITE; RECONSTRUCTION; LUMINESCENCE; RHODOLITHS; MICROPROBE	The presence of banding in the skeleton of coralline algae has been reported in many species, primarily from temperate and polar regions. Similar to tree rings, skeletal banding can provide information on growth rate, age, and longevity; as well as records of past environmental conditions and the coralline alga's growth responses to such changes. The aim of this study was to explore the presence and characterise the nature of banding in the tropical coralline alga Porolithon onkodes, an abundant and key reef-building species on the Great Barrier Reef (GBR) Australia, and the Indo-Pacific in general. To achieve this we employed various methods including X-ray diffraction (XRD) to determine seasonal mol% magnesium (Mg), mineralogy mapping to investigate changes in dominant mineral phases, scanning electron microscopy-electron dispersive spectroscopy (SEM-EDS), and micro-computed tomography (micro-CT) scanning to examine changes in cell size and density banding, and UV light to examine reproductive (conceptacle) banding. Seasonal variation in the Mg content of the skeleton did occur and followed previously recorded variations with the highest mol% MgCO3 in summer and lowest in winter, confirming the positive relationship between seawater temperature and mol% MgCO3. Rows of conceptacles viewed under UV light provided easily distinguishable bands that could be used to measure vertical growth rate (1.4 mm year(-1)) and age of the organism. Micro-CT scanning showed obvious banding patterns in relation to skeletal density, and mineralogical mapping revealed patterns of banding created by changes in Mg content. Thus, we present new evidence for seasonal banding patterns in the tropical coralline alga P. onkodes. This banding in the P. onkodes skeleton can provide valuable information into the present and past life history of this important reef-building species, and is essential to assess and predict the response of these organisms to future climate and environmental changes.	[Lewis, Bonnie; Diaz-Pulido, Guillermo] Griffith Univ, Griffith Sch Environm, Nathan, Qld, Australia; [Lewis, Bonnie; Diaz-Pulido, Guillermo] Griffith Univ, Australian Rivers Inst Coast & Estuaries, Nathan, Qld, Australia; [Lough, Janice M.; Diaz-Pulido, Guillermo] ARC Ctr Excellence Coral Reef Studies, Douglas, Qld, Australia; [Lough, Janice M.] Australian Inst Marine Sci, Townsville, Qld, Australia; [Nash, Merinda C.] Australian Natl Univ, Res Sch Phys & Engn, Canberra, ACT, Australia	Griffith University; Griffith University; Australian Institute of Marine Science; Australian National University	Lewis, B (corresponding author), Griffith Univ, Griffith Sch Environm, Nathan, Qld, Australia.; Lewis, B (corresponding author), Griffith Univ, Australian Rivers Inst Coast & Estuaries, Nathan, Qld, Australia.	bonnie.lewis@griffithuni.edu.au	Diaz-Pulido, Guillermo/B-3648-2013; Lough, Janice M/L-1682-2013	Lough, Janice M/0000-0002-3789-1009; Diaz-Pulido, Guillermo/0000-0002-0901-3727; Lewis, Bonnie/0000-0002-0624-3359	Great Barrier Reef Foundation; Australian Research Council [DP 120101778]	Great Barrier Reef Foundation; Australian Research Council(Australian Research Council)	This research was funded by the Great Barrier Reef Foundation (https:/www/barrier.reef.org/) and the Australian Research Council (DP 120101778) grants awarded to GDP.	Adey W, 2013, ADEY BIOL PHYSL ECOL; Adey W, 2015, PALAIOS, V30, P281, DOI 10.2110/palo.2014.075; ADEY WH, 1978, PHYCOLOGIA, V17, P361, DOI 10.2216/i0031-8884-17-4-361.1; Agegian C. R., 1981, P 4 INT COR REEF S M, V2, P419; AIMS, 2016, REEF MON HERS ISL LO; ALEXANDERSSON T, 1974, J SEDIMENT PETROL, V44, P7; ANDRAKE W, 1980, J PHYCOL, V16, P620, DOI 10.1111/j.1529-8817.1980.tb03081.x; [Anonymous], 2011, QUATERNARY AUSTRALAS; Barnes DJ, 2003, J EXP MAR BIOL ECOL, V295, P91, DOI 10.1016/S0022-0981(03)00274-0; Blake C, 2003, PHYCOLOGIA, V42, P606, DOI 10.2216/i0031-8884-42-6-606.1; Burdett H, 2011, PALAEOGEOGR PALAEOCL, V302, P65, DOI 10.1016/j.palaeo.2010.07.027; Caswell, 2000, MATRIX POPULATION MO; CHAVE KE, 1965, SCIENCE, V147, P621, DOI 10.1126/science.147.3658.621; CHIHARA M, 1974, J PHYCOL, V10, P266, DOI 10.1111/j.1529-8817.1974.tb02712.x; Darrenougue N, 2014, QUATERNARY SCI REV, V93, P34, DOI 10.1016/j.quascirev.2014.03.005; Darrenougue N, 2013, MAR ECOL PROG SER, V474, P105, DOI 10.3354/meps10085; Dean AJ, 2015, CORAL REEFS, V34, P581, DOI 10.1007/s00338-015-1263-5; Diaz-Pulido G, 2007, CLIMATE CHANGE GREAT; Diaz-Pulido G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4310; Diaz-Pulido G, 2012, J PHYCOL, V48, P32, DOI 10.1111/j.1529-8817.2011.01084.x; EDYVEAN RGJ, 1984, BOT MAR, V27, P391, DOI 10.1515/botm.1984.27.9.391; Foster MS, 2001, J PHYCOL, V37, P659, DOI 10.1046/j.1529-8817.2001.00195.x; Frantz BR, 2000, LIMNOL OCEANOGR, V45, P1773, DOI 10.4319/lo.2000.45.8.1773; FREIWALD A, 1994, SEDIMENTOLOGY, V41, P963, DOI 10.1111/j.1365-3091.1994.tb01435.x; Gamboa G, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006262; Halfar J, 2008, GEOLOGY, V36, P463, DOI 10.1130/G24635A.1; Halfar J, 2011, PALAEOGEOGR PALAEOCL, V302, P71, DOI 10.1016/j.palaeo.2010.04.009; Halfar J, 2000, J GEOPHYS RES-OCEANS, V105, P22107, DOI 10.1029/1999JC000128; Halfar J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028811; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Harvey A.S., 2005, CORALLINE ALGAE CENT; Hetzinger S, 2009, PALAIOS, V24, P406, DOI 10.2110/palo.2008.p08-116r; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Kamenos NA, 2008, GEOCHIM COSMOCHIM AC, V72, P771, DOI 10.1016/j.gca.2007.11.019; Kamenos NA, 2009, GEOCHIM COSMOCHIM AC, V73, P1901, DOI 10.1016/j.gca.2009.01.010; Kamenos NA, 2017, COAST RES LIBR, V15, P27, DOI 10.1007/978-3-319-29315-8_2; Kamenos NA, 2010, J PHYCOL, V46, P331, DOI 10.1111/j.1529-8817.2009.00780.x; Krayesky-Self S, 2016, J PHYCOLOGY; Lewis B, 2017, MAR ECOL PROG SER, V568, P73, DOI 10.3354/meps12074; Lewis B, 2017, J EXP MAR BIOL ECOL, V490, P64, DOI 10.1016/j.jembe.2017.02.004; Littler M.M., 1984, PROGR PHYCOLOGICAL R, V3, P323; LITTLER MM, 1985, SCIENCE, V227, P57, DOI 10.1126/science.227.4682.57; Lough JM, 2015, CORAL REEFS, V34, P739, DOI 10.1007/s00338-015-1297-8; Lough JM, 2011, CORAL REEFS, V30, P169, DOI 10.1007/s00338-010-0688-0; Lough JM, 2011, EARTH-SCI REV, V108, P170, DOI 10.1016/j.earscirev.2011.07.001; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; MOBERLY R, 1970, SEDIMENTOLOGY, V14, P113, DOI 10.1111/j.1365-3091.1970.tb00185.x; MOBERLY R, 1968, SEDIMENTOLOGY, V11, P61, DOI 10.1111/j.1365-3091.1968.tb00841.x; Nash MC, 2015, BIOGEOSCIENCES, V12, P5247, DOI 10.5194/bg-12-5247-2015; Nash MC, 2013, NAT CLIM CHANGE, V3, P268, DOI 10.1038/NCLIMATE1760; Nash MC, 2011, BIOGEOSCIENCES, V8, P3331, DOI 10.5194/bg-8-3331-2011; Nash MC, 2013, J SEDIMENT RES, V83, P1085, DOI 10.2110/jsr.2013.67; NORO T, 1983, Bulletin of the Faculty of Fisheries Hokkaido University, V34, P1; Ordonez A, 2014, BIOL BULL-US, V226, P255, DOI 10.1086/BBLv226n3p255; Ragazzola F, 2016, SCI REP-UK, V6, DOI 10.1038/srep20572; Ringeltaube P, 2000, BOT MAR, V43, P431, DOI 10.1515/BOT.2000.045; Rivera MG, 2004, CIENC MAR, V30, P235, DOI 10.7773/cm.v30i12.104; Schafer P, 2011, PALAIOS, V26, P420, DOI 10.2110/palo.2010.p10-138r; Sletten HR, 2017, PALAEOGEOGR PALAEOCL, V465, P264, DOI 10.1016/j.palaeo.2016.10.038; Steneck R, CRUSTOSE CORALLINE A; STENECK RS, 1986, ANNU REV ECOL SYST, V17, P273, DOI 10.1146/annurev.es.17.110186.001421; Steneck RS, 1997, P 8 INT COR REEF S J; Torrano-Silva BN, 2015, MICRON, V72, P34, DOI 10.1016/j.micron.2015.02.004	63	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185124	10.1371/journal.pone.0185124	http://dx.doi.org/10.1371/journal.pone.0185124			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976988	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000412163100017
J	Lee, S; Harwood, M; Girouard, D; Meyers, MJ; Campbell, MA; Beamer, G; Tzipori, S				Lee, Sangun; Harwood, Melanie; Girouard, Don; Meyers, Marvin J.; Campbell, Mary A.; Beamer, Gillian; Tzipori, Saul			The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominis	PLOS ONE			English	Article							PARVUM; CHILDREN; PAROMOMYCIN; INFECTION; DIARRHEA; COMMUNITY; RIFABUTIN; DISEASE; CULTURE; BOVINE	Recent reports highlighting the global significance of cryptosporidiosis among children, have renewed efforts to develop control measures. We have optimized the gnotobiotic piglet model of acute diarrhea to evaluate azithromycin (AZR), nitazoxanide (NTZ), or treatment with both against Cryptosporidium hominis, the species responsible for most human cases. Piglets, animals reproducibly clinically susceptible to C. hominis, when inoculated with 10(6) oocysts, developed acute diarrhea with oocyst excretion in feces within 3 days. Ten day-treatment with recommended doses for children, commencing at onset of diarrhea, showed that treatment with AZR or NTZ relieved symptoms early in the treatment compared with untreated animals. Piglets treated with AZR exhibited no reduction of oocyst excretion whereas treatment with NTZ significantly reduced oocyst shedding early, increasing however after 5 days. While treatment with AZR+NTZ led to considerable symptomatic improvement, it had a modest effect on reducing mucosal injury, and did not completely eliminate oocyst excretion. Doubling the dose of AZR and/or NTZ did not improve the clinical outcome, confirming clinical observations that NTZ is only partially effective in reducing duration of diarrhea in children. This investigation confirms the gnotobiotic piglet as a useful tool for drug evaluation for the treatment of cryptosporidiosis in children.	[Lee, Sangun; Harwood, Melanie; Girouard, Don; Beamer, Gillian; Tzipori, Saul] Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA; [Meyers, Marvin J.; Campbell, Mary A.] St Louis Univ, Sch Med, Ctr World Hlth & Med, St Louis, MO USA	Tufts University; Saint Louis University	Tzipori, S (corresponding author), Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA.	saul.tzipori@tufts.edu		Meyers, Marvin/0000-0001-5484-619X; Girouard Jr., Donald/0000-0001-9935-0470	Bill & Melinda Gates Foundation [OPP1132800]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation, OPP1132800 (www.gatesfoundation.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar I, 2007, BRIT J CLIN PHARMACO, V63, P387, DOI 10.1111/j.1365-2125.2007.02873.x; Abubakar I, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004932.pub2; Akiyoshi DE, 2002, INFECT IMMUN, V70, P5670, DOI 10.1128/IAI.70.10.5670-5675.2002; Allam Amal F., 2002, Journal of the Egyptian Society of Parasitology, V32, P969; Amadi B, 2002, LANCET, V360, P1375, DOI 10.1016/S0140-6736(02)11401-2; Baker DR, 1997, ADV EXP MED BIOL, V412, P53; Blanshard C, 1997, INT J STD AIDS, V8, P124, DOI 10.1258/0956462971919543; Bowers M, 1998, BETA, P30; Chappell CL, 2006, AM J TROP MED HYG, V75, P851, DOI 10.4269/ajtmh.2006.75.851; Cooper CA, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-5; Engelking L. R, 2015, TXB VET PHYSL CHEM; Fielder SE, 2016, MERCK VET MANUAL, P11; Fox LM, 2005, CLIN INFECT DIS, V40, P1173, DOI 10.1086/428839; Gargala G, 2000, J ANTIMICROB CHEMOTH, V46, P57, DOI 10.1093/jac/46.1.57; Giacometti A, 2000, J ANTIMICROB CHEMOTH, V45, P453, DOI 10.1093/jac/45.4.453; Giacometti A, 1999, EUR J CLIN MICROBIOL, V18, P885, DOI 10.1007/s100960050424; Guerrant DI, 1999, AM J TROP MED HYG, V61, P707, DOI 10.4269/ajtmh.1999.61.707; Holmberg SD, 1998, JAMA-J AM MED ASSOC, V279, P384, DOI 10.1001/jama.279.5.384; Hong DK, 2007, PEDIATR TRANSPLANT, V11, P94, DOI 10.1111/j.1399-3046.2006.00593.x; Ifeonu OO, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw137; Jackson P., 2002, CLIN EXAMINATION FAR, V1rd; Jeong KI, 2010, J INFECT DIS, V201, P903, DOI 10.1086/650995; Kadappu K K, 2002, J Postgrad Med, V48, P179; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Mead JR, 2014, HUM VACC IMMUNOTHER, V10, P1505, DOI 10.4161/hv.28485; Molbak K, 1997, AM J CLIN NUTR, V65, P149, DOI 10.1093/ajcn/65.1.149; Morada M, 2016, INT J PARASITOL, V46, P21, DOI 10.1016/j.ijpara.2015.07.006; Nasir A, 2013, J PARASITOL, V99, P715, DOI 10.1645/12-42.1; Ollivett TL, 2009, J DAIRY SCI, V92, P1643, DOI 10.3168/jds.2008-1474; Pozio E, 2004, APMIS, V112, P309, DOI 10.1111/j.1600-0463.2004.apm11204-0513.x; REHG JE, 1991, J INFECT DIS, V163, P1293, DOI 10.1093/infdis/163.6.1293; Rossignol JF, 2010, EXP PARASITOL, V124, P45, DOI 10.1016/j.exppara.2009.07.005; Saif LJ, 1996, ARCH VIROL, P153; Schnyder M, 2009, VET PARASITOL, V160, P149, DOI 10.1016/j.vetpar.2008.10.094; Sow SO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004729; Steele J, 2010, J INFECT DIS, V201, P428, DOI 10.1086/649799; Theodos CM, 1998, ANTIMICROB AGENTS CH, V42, P1959, DOI 10.1128/AAC.42.8.1959; Tumwine JK, 2003, AM J TROP MED HYG, V68, P710, DOI 10.4269/ajtmh.2003.68.710; TZIPORI S, 1994, CLIN DIAGN LAB IMMUN, V1, P450, DOI 10.1128/CDLI.1.4.450-463.1994; VARGAS SL, 1993, J PEDIATR-US, V123, P154, DOI 10.1016/S0022-3476(05)81562-8; Viel H, 2007, PARASITOL RES, V102, P163, DOI 10.1007/s00436-007-0744-z; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Yeom Su-Cheong, 2012, Lab Anim Res, V28, P245, DOI 10.5625/lar.2012.28.4.245	43	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185906	10.1371/journal.pone.0185906	http://dx.doi.org/10.1371/journal.pone.0185906			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973041	Green Published, Green Submitted, gold			2022-12-26	WOS:000412131900065
J	Theron, A; Roth, RL; Hoppe, H; Parkinson, C; van der Westhuyzen, CW; Stoychev, S; Wiid, I; Pietersen, RD; Baker, B; Kenyon, CP				Theron, A.; Roth, R. L.; Hoppe, H.; Parkinson, C.; van der Westhuyzen, C. W.; Stoychev, S.; Wiid, I.; Pietersen, R. D.; Baker, B.; Kenyon, C. P.			Differential inhibition of adenylylated and deadenylylated forms of M. tuberculosis glutamine synthetase as a drug discovery platform	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; KLEBSIELLA-AEROGENES; SALMONELLA-TYPHIMURIUM; ENZYME; GROWTH; AVIUM; GENE; PURIFICATION; EXPRESSION	Glutamine synthetase is a ubiquitous central enzyme in nitrogen metabolism that is controlled by up to four regulatory mechanisms, including adenylylation of some or all of the twelve subunits by adenylyl transferase. It is considered a potential therapeutic target for the treatment of tuberculosis, being essential for the growth of Mycobacterium tuberculosis, and is found extracellularly only in the pathogenic Mycobacterium strains. Human glutamine synthetase is not regulated by the adenylylation mechanism, so the adenylylated form of bacterial glutamine synthetase is of particular interest. Previously published reports show that, when M. tuberculosis glutamine synthetase is expressed in Escherichia coli, the E. coli adenylyl transferase does not optimally adenylylate the M. tuberculosis glutamine synthetase. Here, we demonstrate the production of soluble adenylylated M. tuberulosis glutamine synthetase in E. coli by the co-expression of M. tuberculosis glutamine synthetase and M. tuberculosis adenylyl transferase. The differential inhibition of adenylylated M. tuberulosis glutamine synthetase and deadenylylated M. tuberulosis glutamine synthetase by ATP based scaffold inhibitors are reported. Compounds selected on the basis of their enzyme inhibition were also shown to inhibit M. tuberculosis in the BACTEC 460TB T assay as well as the intracellular inhibition of M. tuberculosis in a mouse bone-marrow derived macrophage assay.	[Theron, A.; Roth, R. L.; Hoppe, H.; van der Westhuyzen, C. W.; Stoychev, S.; Kenyon, C. P.] CSIR Biosci, Pretoria, South Africa; [Parkinson, C.] Charles Sturt Univ, Sch Biomed Sci, Orange, NSW, Australia; [Wiid, I.; Pietersen, R. D.; Baker, B.; Kenyon, C. P.] Stellenbosch Univ, DST NRF Ctr Excellence Biomed TB Res, SAMRC Ctr TB Res, Div Mol Biol & Human Genet,Fac Med & Hlth Sci, Cape Town, South Africa; [Hoppe, H.] Rhodes Univ, Dept Biochem Microbiol & Biotechnol, Grahamstown, South Africa	Council for Scientific & Industrial Research (CSIR) - South Africa; Charles Sturt University; National Research Foundation - South Africa; Stellenbosch University; Rhodes University	Kenyon, CP (corresponding author), CSIR Biosci, Pretoria, South Africa.; Kenyon, CP (corresponding author), Stellenbosch Univ, DST NRF Ctr Excellence Biomed TB Res, SAMRC Ctr TB Res, Div Mol Biol & Human Genet,Fac Med & Hlth Sci, Cape Town, South Africa.	kenyon@sun.ac.za	Baker, Bienyameen/F-9150-2015; Theron, Anjo/Q-5565-2018	Baker, Bienyameen/0000-0002-2158-6763; Theron, Anjo/0000-0002-0497-4473; Pietersen, Ray-Dean/0000-0002-3794-8503; Kenyon, Colin/0000-0003-1590-7230; Parkinson, Christopher/0000-0003-4547-7091; van der Westhuyzen, Chris/0000-0002-2873-6234; Stoychev, Stoyan/0000-0001-7504-4313; Roth, Robyn/0000-0002-6486-7549	Innovation Fund [T80051]	Innovation Fund	This work forms part of a project (T80051) funded by The Innovation Fund, which is managed by the National Research Foundation (NRF) in South Africa.	BACKMAN K, 1981, P NATL ACAD SCI-BIOL, V78, P3743, DOI 10.1073/pnas.78.6.3743; BENDER RA, 1977, J BACTERIOL, V129, P1001, DOI 10.1128/JB.129.2.1001-1009.1977; BLOOM FR, 1977, J BACTERIOL, V130, P983, DOI 10.1128/JB.130.3.983-990.1977; BROWN JR, 1994, J MOL EVOL, V38, P566; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; Couturier C, 2015, BIOORG MED CHEM LETT, V25, P1455, DOI 10.1016/j.bmcl.2015.02.035; DECHASTELLIER C, 1995, EUR J CELL BIOL, V68, P167; FOOR F, 1975, P NATL ACAD SCI USA, V72, P4844, DOI 10.1073/pnas.72.12.4844; GAILLARDIN CM, 1978, J BACTERIOL, V133, P1329, DOI 10.1128/JB.133.3.1329-1338.1978; George G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021007; Ginsburg A, 1973, ENZYMES GLUTAMINE ME, P9; Gising J, 2012, J MED CHEM, V55, P2894, DOI 10.1021/jm201212h; Harth G, 1997, J BIOL CHEM, V272, P22728, DOI 10.1074/jbc.272.36.22728; Harth G, 1999, J EXP MED, V189, P1425, DOI 10.1084/jem.189.9.1425; Harth G, 2003, INFECT IMMUN, V71, P456, DOI 10.1128/IAI.71.1.456-464.2003; Held D, 2003, INNOVATIONS, V18, P406; HIRSCHFIELD GR, 1990, J BACTERIOL, V172, P1005, DOI 10.1128/jb.172.2.1005-1013.1990; HOLZER H, 1968, P NATL ACAD SCI USA, V60, P721, DOI 10.1073/pnas.60.2.721; JANSSEN KA, 1977, J BACTERIOL, V129, P993, DOI 10.1128/JB.129.2.993-1000.1977; Johnson R, 2010, INT J TUBERC LUNG D, V14, P119; Kenyon CP, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-36; KINGDON HS, 1967, P NATL ACAD SCI USA, V58, P1703, DOI 10.1073/pnas.58.4.1703; Kosikowska P, 2016, J ENZYM INHIB MED CH, V31, P931, DOI 10.3109/14756366.2015.1070846; KUMADA Y, 1993, P NATL ACAD SCI USA, V90, P3009, DOI 10.1073/pnas.90.7.3009; KUSTU SG, 1975, J BACTERIOL, V122, P1006, DOI 10.1128/JB.122.3.1006-1016.1975; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagerlund O, 2007, COMB CHEM HIGH T SCR, V10, P783, DOI 10.2174/138620707783018478; Leisching G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153079; LUDDEN PW, 1978, BIOCHEM J, V175, P251, DOI 10.1042/bj1750251; MECKE D, 1966, BIOCHEM BIOPH RES CO, V24, P452, DOI 10.1016/0006-291X(66)90182-3; Mehta R, 2004, J BIOL CHEM, V279, P22477, DOI 10.1074/jbc.M401652200; Mowbray SL, 2014, MOLECULES, V19, P13161, DOI 10.3390/molecules190913161; Nilsson MT, 2009, J MOL BIOL, V393, P504, DOI 10.1016/j.jmb.2009.08.028; Odell LR, 2009, BIOORG MED CHEM LETT, V19, P4790, DOI 10.1016/j.bmcl.2009.06.045; Pethe K, 2013, NAT MED, V19, P1157, DOI 10.1038/nm.3262; Raynaud C, 1998, MICROBIOL-SGM, V144, P577, DOI 10.1099/00221287-144-2-577; Reitzer L.J., 1987, E COLI SALMONELLA CE, P302; SENIOR PJ, 1975, J BACTERIOL, V123, P407, DOI 10.1128/JB.123.2.407-418.1975; Shapiro B., 1970, METHOD ENZYMOL, V17A, P910, DOI 10.1016/0076-6879(71)17305-3; SHAPIRO BM, 1968, J BIOL CHEM, V243, P3769; SHAPIRO BM, 1970, ANNU REV MICROBIOL, V24, P501, DOI 10.1146/annurev.mi.24.100170.002441; SHAPIRO BM, 1968, BIOCHEMISTRY-US, V7, P2153, DOI 10.1021/bi00846a018; SHAPIRO BM, 1967, P NATL ACAD SCI USA, V58, P642, DOI 10.1073/pnas.58.2.642; SIDDIQI SH, 1993, J CLIN MICROBIOL, V31, P2332, DOI 10.1128/JCM.31.9.2332-2338.1993; Singh J, 2004, BIOCHEM BIOPH RES CO, V317, P634, DOI 10.1016/j.bbrc.2004.03.094; Tullius MV, 2003, INFECT IMMUN, V71, P3927, DOI 10.1128/IAI.71.7.3927-3936.2003; TYLER B, 1978, ANNU REV BIOCHEM, V47, P1127, DOI 10.1146/annurev.bi.47.070178.005403; WIETZERBIN J, 1975, BIOCHEM BIOPH RES CO, V62, P246, DOI 10.1016/S0006-291X(75)80130-6; WOLHEUTER RM, 1973, ENZYMES GLUTAMINE ME, P45; WOOLFOLK CA, 1966, ARCH BIOCHEM BIOPHYS, V116, P177, DOI 10.1016/0003-9861(66)90026-9	50	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185068	10.1371/journal.pone.0185068	http://dx.doi.org/10.1371/journal.pone.0185068			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972974	Green Published, gold, Green Submitted			2022-12-26	WOS:000412131900010
J	Whiteley, L; Haug, M; Klein, K; Willmann, M; Bohn, E; Chiantia, S; Schwarz, S				Whiteley, Liam; Haug, Maria; Klein, Kristina; Willmann, Matthias; Bohn, Erwin; Chiantia, Salvatore; Schwarz, Sandra			Cholesterol and host cell surface proteins contribute to cell-cell fusion induced by the Burkholderia type VI secretion system 5	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INTRACELLULAR LIFE-CYCLE; MEMBRANE CURVATURE; LIPID RAFTS; PSEUDOMALLEI; PATHOGENESIS; RECEPTORS; INFECTION; IDENTIFICATION; MECHANISM	Following escape into the cytoplasm of host cells, Burkholderia pseudomallei and the related species Burkholderia thailandensis employ the type VI secretion system 5 ( T6SS-5) to induce plasma membrane fusion with an adjacent host cell. This process leads to the formation of multinucleated giant cells and facilitates bacterial access to an uninfected host cell in a direct manner. Despite its importance in virulence, the mechanism of the T6SS-5 and the role of host cell factors in cell-cell fusion remain elusive. To date, the T6SS-5 is the only system of bacterial origin known to induce host-cell fusion. To gain insight into the nature of T6SS-5-stimulated membrane fusion, we investigated the contribution of cholesterol and proteins exposed on the host cell surface, which were shown to be critically involved in virus-mediated giant cell formation. In particular, we analyzed the effect of host cell surface protein and cholesterol depletion on the formation of multinucleated giant cells induced by B. thailandensis. Acute protease treatment of RAW264.7 macrophages during infection with B. thailandensis followed by agarose overlay assays revealed a strong reduction in the number of cell-cell fusions compared with EDTA treated cells. Similarly, proteolytic treatment of specifically infected donor cells or uninfected recipient cells significantly decreased multinucleated giant cell formation. Furthermore, modulating host cell cholesterol content by acute cholesterol depletion from cellular membranes by methyl-beta-cyclodextrin treatment or exogenous addition of cholesterol impaired the ability of B. thailandensis to induce cell-cell fusions. The requirement of physiological cholesterol levels suggests that the membrane organization or mechanical properties of the lipid bilayer influence the fusion process. Altogether, our data suggest that membrane fusion induced by B. pseudomallei and B. thailandensis involves a complex interplay between the T6SS-5 and the host cell.	[Whiteley, Liam; Haug, Maria; Klein, Kristina; Willmann, Matthias; Bohn, Erwin; Schwarz, Sandra] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany; [Chiantia, Salvatore] Potsdam Univ, Dept Biochem, Potsdam, Germany	Eberhard Karls University of Tubingen; University of Potsdam	Schwarz, S (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany.	sandra.schwarz@med.uni-tuebingen.de	Chiantia, Salvatore/U-6363-2019	Chiantia, Salvatore/0000-0003-0791-967X	German Research Foundation (DFG) [SCHWS 1517/2-1]; German Excellence Initiative [ZUK63]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Excellence Initiative	This work was supported by the German Research Foundation (DFG;http://www.dfg.de/) SCHWS 1517/2-1 to SS, and the German Excellence Initiative (http://www.dfg.de/en/ research_funding/programmes/excellenceinitiative/) ZUK63 to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar S, 2006, J VIROL, V80, P2815, DOI 10.1128/JVI.80.6.2815-2822.2006; BLANK H, 1951, JAMA-J AM MED ASSOC, V146, P1410, DOI 10.1001/jama.1951.63670150005012b; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; Chen Z, 1997, BIOPHYS J, V73, P267, DOI 10.1016/S0006-3495(97)78067-6; Churchward MA, 2005, J CELL SCI, V118, P4833, DOI 10.1242/jcs.02601; Compton AA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006099; Corcoran JA, 2006, J BIOL CHEM, V281, P31778, DOI 10.1074/jbc.M602566200; Currie BJ, 2015, SEMIN RESP CRIT CARE, V36, P111, DOI 10.1055/s-0034-1398389; Domanska MK, 2013, BIOPHYS J, V105, P1383, DOI 10.1016/j.bpj.2013.08.003; Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Ganesh L, 2004, J VIROL, V78, P11980, DOI 10.1128/JVI.78.21.11980-11987.2004; Harley VS, 1998, MICROBIOS, V94, P35; HART TK, 1991, P NATL ACAD SCI USA, V88, P2189, DOI 10.1073/pnas.88.6.2189; Imhoff H, 2007, J VIROL, V81, P4158, DOI 10.1128/JVI.02647-06; Jarsch IK, 2016, J CELL BIOL, V214, P375, DOI 10.1083/jcb.201604003; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Kondo Y, 2009, CLIN EXP IMMUNOL, V158, P84, DOI 10.1111/j.1365-2249.2009.03990.x; Koseoglu S, 2011, ANAL BIOANAL CHEM, V400, P2963, DOI 10.1007/s00216-011-5002-7; Lai AL, 2012, J MOL BIOL, V418, P3, DOI 10.1016/j.jmb.2012.02.010; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Liao ZH, 2003, AIDS RES HUM RETROV, V19, P675, DOI 10.1089/088922203322280900; LIFSON J, 1986, J EXP MED, V164, P2101, DOI 10.1084/jem.164.6.2101; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Matsuyama S, 2002, J VIROL, V76, P11819, DOI 10.1128/JVI.76.23.11819-11826.2002; McChesney MB, 1997, VIROLOGY, V233, P74, DOI 10.1006/viro.1997.8576; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Moreno JL, 2007, J LEUKOCYTE BIOL, V82, P1542, DOI 10.1189/jlb.0107058; Morizono K, 2011, CURR OPIN VIROL, V1, P13, DOI 10.1016/j.coviro.2011.05.001; Nguyen DH, 2005, EXP CELL RES, V304, P559, DOI 10.1016/j.yexcr.2004.11.022; Pilatz S, 2006, INFECT IMMUN, V74, P3576, DOI 10.1128/IAI.01262-05; Powers KA, 2006, J EXP MED, V203, P1951, DOI 10.1084/jem.20060943; SalasBenito JS, 1997, J VIROL, V71, P7246, DOI 10.1128/JVI.71.10.7246-7252.1997; Schwarz S, 2014, INFECT IMMUN, V82, P1445, DOI 10.1128/IAI.01368-13; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Toesca IJ, 2014, INFECT IMMUN, V82, P1436, DOI 10.1128/IAI.01367-13; Vishwanathan SA, 2008, BIOCHEMISTRY-US, V47, P124, DOI 10.1021/bi7018892; Viswanathan G, 2015, CHEM PHYS LIPIDS, V189, P19, DOI 10.1016/j.chemphyslip.2015.05.006; Whiteley L, 2017, INFECT IMMUN, V85, DOI [10.1128/IAI.00468-17, 10.1128/iai.00468-17]; Wong J, 2015, CELL HOST MICROBE, V18, P38, DOI 10.1016/j.chom.2015.06.002	45	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185715	10.1371/journal.pone.0185715	http://dx.doi.org/10.1371/journal.pone.0185715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973030	gold, Green Published, Green Submitted			2022-12-26	WOS:000412131900040
J	Kurian, SM; Ferreri, K; Wang, CH; Todorov, I; Al-Abdullah, IH; Rawson, J; Mullen, Y; Salomon, DR; Kandeel, F				Kurian, Sunil M.; Ferreri, Kevin; Wang, Chia-Hao; Todorov, Ivan; Al-Abdullah, Ismail H.; Rawson, Jeffrey; Mullen, Yoko; Salomon, Daniel R.; Kandeel, Fouad			Gene expression signature predicts human islet integrity and transplant functionality in diabetic mice	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; APOPTOSIS-INDUCING LIGAND; ENDOCRINE PANCREAS; OXYGEN-CONSUMPTION; GRAFT FUNCTION; TISSUE FACTOR; DIFFERENTIATION; MELLITUS; RECEPTOR; PATHWAY	There is growing evidence that transplantation of cadaveric human islets is an effective therapy for type 1 diabetes. However, gauging the suitability of islet samples for clinical use remains a challenge. We hypothesized that islet quality is reflected in the expression of specific genes. Therefore, gene expression in 59 human islet preparations was analyzed and correlated with diabetes reversal after transplantation in diabetic mice. Analysis yielded 262 differentially expressed probesets, which together predict islet quality with 83% accuracy. Pathway analysis revealed that failing islet preparations activated inflammatory pathways, while functional islets showed increased regeneration pathway gene expression. Gene expression associated with apoptosis and oxygen consumption showed little overlap with each other or with the 262 probeset classifier, indicating that the three tests are measuring different aspects of islet cell biology. A subset of 36 probesets surpassed the predictive accuracy of the entire set for reversal of diabetes, and was further reduced by logistic regression to sets of 14 and 5 without losing accuracy. These genes were further validated with an independent cohort of 16 samples. We believe this limited number of gene classifiers in combination with other tests may provide complementary verification of islet quality prior to their clinical use.	[Kurian, Sunil M.; Salomon, Daniel R.] Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Ferreri, Kevin; Wang, Chia-Hao; Todorov, Ivan; Al-Abdullah, Ismail H.; Rawson, Jeffrey; Mullen, Yoko; Kandeel, Fouad] City Hope Natl Med Ctr, Diabet & Metab Res Inst, Dept Translat Res & Cellular Therapeut, 1500 E Duarte Rd, Duarte, CA 91010 USA	Scripps Research Institute; City of Hope	Kandeel, F (corresponding author), City Hope Natl Med Ctr, Diabet & Metab Res Inst, Dept Translat Res & Cellular Therapeut, 1500 E Duarte Rd, Duarte, CA 91010 USA.	fkandeel@coh.org	Kurian, Sunil/C-4493-2008	Kurian, Sunil/0000-0002-7782-7263	National Institute of Diabetes and Digestive and Kidney Diseases, Southern California Islet Cell Resources (SC-ICR) Center [U42RR016607]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR016607] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, Southern California Islet Cell Resources (SC-ICR) Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for this work is from the National Institute of Diabetes and Digestive and Kidney Diseases, Southern California Islet Cell Resources (SC-ICR) Center, grant U42RR016607.	Ahn YB, 2007, DIABETOLOGIA, V50, P334, DOI 10.1007/s00125-006-0536-5; Alejandro R, 2008, TRANSPLANTATION, V86, P1783, DOI 10.1097/TP.0b013e3181913f6a; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Bertuzzi F, 2004, J CLIN ENDOCR METAB, V89, P5724, DOI 10.1210/jc.2004-0659; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonnefond A, 2013, DIABETES METAB, V39, P276, DOI 10.1016/j.diabet.2013.02.007; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Carr AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037640; Cheung SSC, 2005, PANCREAS, V30, P105, DOI 10.1097/01.mpa.0000148515.77497.4b; Cras-Meneur C, 2009, GENE DEV, V23, P2088, DOI 10.1101/gad.1800209; Dayeh T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004160; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Dufer M, 2011, DIABETOLOGIA, V54, P423, DOI 10.1007/s00125-010-1936-0; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Ejarque M, 2013, J BIOL CHEM, V288, P11705, DOI 10.1074/jbc.M112.388173; El-Gohary Y, 2013, DEV BIOL, V378, P83, DOI 10.1016/j.ydbio.2013.04.003; Fiorina P, 2008, AM J TRANSPLANT, V8, P1990, DOI 10.1111/j.1600-6143.2008.02353.x; Fiorina P, 2003, DIABETES CARE, V26, P1129, DOI 10.2337/diacare.26.4.1129; Fiorina P, 2003, J AM SOC NEPHROL, V14, P2150, DOI 10.1097/01.ASN.0000077339.20759.A3; Fiorina P, 2007, DIABETES, V56, P912, DOI 10.2337/db06-1445; Firestein GS, 1999, ARTHRITIS RHEUM-US, V42, P609, DOI 10.1002/1529-0131(199904)42:4<609::AID-ANR3>3.0.CO;2-I; Frumento D, 2017, J ENDOCRINOL INVEST, V40, P803, DOI 10.1007/s40618-017-0641-y; Gaber AO, 2004, TRANSPL P, V36, P1108, DOI 10.1016/j.transproceed.2004.04.055; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Grieco FA, 2011, DIABETES-METAB RES, V27, P755, DOI 10.1002/dmrr.1247; Hanson MS, 2010, TRANSPLANTATION, V89, P1178, DOI 10.1097/TP.0b013e3181d54bce; Hoffmann DC, 2011, J BIOL CHEM, V286, P28889, DOI 10.1074/jbc.M111.249979; Igoillo-Esteve M, 2010, DIABETOLOGIA, V53, P1395, DOI 10.1007/s00125-010-1707-y; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jamiolkowski Ryan M., 2012, Yale Journal of Biology and Medicine, V85, P37; Jeon J, 2009, J HISTOCHEM CYTOCHEM, V57, P811, DOI 10.1369/jhc.2009.953307; Johansson H, 2005, DIABETES, V54, P1755, DOI 10.2337/diabetes.54.6.1755; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kissler HJ, 2010, CLIN TRANSPLANT, V24, P236, DOI 10.1111/j.1399-0012.2009.01052.x; Lammert E, 2000, MECH DEVELOP, V94, P199, DOI 10.1016/S0925-4773(00)00317-8; Lantz KA, 2004, J CLIN INVEST, V114, P512, DOI 10.1172/JCI200421149; Loweth AC, 1998, DIABETES, V47, P727, DOI 10.2337/diabetes.47.5.727; Lyttle BM, 2008, DIABETOLOGIA, V51, P1169, DOI 10.1007/s00125-008-1006-z; Maedler K, 2001, DIABETES, V50, P1683, DOI 10.2337/diabetes.50.8.1683; Martin AP, 2008, DIABETES, V57, P3025, DOI 10.2337/db08-0625; Mellitzer G, 2006, EMBO J, V25, P1344, DOI 10.1038/sj.emboj.7601011; Melzi R, 2004, TRANSPLANTATION, V78, P1564, DOI 10.1097/01.TP.0000144184.20085.41; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Nakayama S, 2008, DIABETOLOGIA, V51, P1883, DOI 10.1007/s00125-008-1080-2; Nano R, 2005, DIABETOLOGIA, V48, P906, DOI 10.1007/s00125-005-1725-3; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Ou D, 2002, DIABETOLOGIA, V45, P1678, DOI 10.1007/s00125-002-0926-2; Papas KK, 2009, CURR OPIN ORGAN TRAN, V14, P674, DOI 10.1097/MOT.0b013e328332a489; Piemonti L, 2013, DIABETES, V62, P1656, DOI 10.2337/db12-1258; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Rush BT, 2004, TRANSPLANTATION, V77, P1147, DOI 10.1097/01.TP.0000116769.94299.F4; Russell MA, 2013, ISLETS, V5, P95, DOI 10.4161/isl.24249; Schaffer AE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003274; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shibasaki S, 2010, ENDOCR J, V57, P211, DOI 10.1507/endocrj.K09E-291; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sussel L, 1998, DEVELOPMENT, V125, P2213; Sweet IR, 2008, AM J TRANSPLANT, V8, P183, DOI 10.1111/j.1600-6143.2007.02041.x; Sweet IR, 2005, TRANSPLANTATION, V80, P1003, DOI 10.1097/01.tp.0000178381.35014.37; Todorov I, 2010, TRANSPLANTATION, V90, P836, DOI 10.1097/TP.0b013e3181f1db5d; Westermark GT, 2003, UPSALA J MED SCI, V108, P193, DOI 10.3109/2000-1967-113; Xiao XW, 2013, DIABETES, V62, P1217, DOI 10.2337/db12-1428; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhang B, 2010, P NATL ACAD SCI USA, V107, P6900, DOI 10.1073/pnas.0906764107; Zhang HJ, 2009, MECH DEVELOP, V126, P958, DOI 10.1016/j.mod.2009.09.006; Zhang T, 2010, ENDOCRINOLOGY, V151, P2030, DOI 10.1210/en.2009-1224	68	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185331	10.1371/journal.pone.0185331	http://dx.doi.org/10.1371/journal.pone.0185331			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968432	gold, Green Published, Green Submitted			2022-12-26	WOS:000412029600019
J	Stokes, A; Berry, KM; Mchiza, Z; Parker, WA; Labadarios, D; Chola, L; Hongoro, C; Zuma, K; Brennan, AT; Rockers, PC; Rosen, S				Stokes, Andrew; Berry, Kaitlyn M.; Mchiza, Zandile; Parker, Whadi-ah; Labadarios, Demetre; Chola, Lumbwe; Hongoro, Charles; Zuma, Khangelani; Brennan, Alana T.; Rockers, Peter C.; Rosen, Sydney			Prevalence and unmet need for diabetes care across the care continuum in a national sample of South African adults: Evidence from the SANHANES-1, 2011-2012	PLOS ONE			English	Article							THERAPY; CASCADE	South Africa faces an epidemic of chronic non-communicable diseases (NCDs), yet national surveillance is limited due to the lack of recent data. We used data from the first comprehensive national survey on NCDs-the South African National Health and Nutrition Examination Survey (SANHANES-1 (2011-2012))-to evaluate the prevalence of and health system response to diabetes through a diabetes care cascade. We defined diabetes as a Hemoglobin A1c equal to or above 6.5% or currently on treatment for diabetes. We constructed a diabetes care cascade by categorizing the population with diabetes into those who were unscreened, screened but undiagnosed, diagnosed but untreated, treated but uncontrolled, and treated and controlled. We then used multivariable logistic regression models to explore factors associated with diagnosed and undiagnosed diabetes. The age-standardized prevalence of diabetes in South Africans aged 15+ was 10.1%. Prevalence rates were higher among the non-white population and among women. Among individuals with diabetes, a total of 45.4% were unscreened, 14.7% were screened but undiagnosed, 2.3% were diagnosed but untreated, 18.1% were treated but uncontrolled, and 19.4% were treated and controlled, suggesting that 80.6% of the diabetic population had unmet need for care. The diabetes care cascade revealed significant losses from lack of screening, between screening and diagnosis, and between treatment and control. These results point to significant unmet need for diabetes care in South Africa. Additionally, this analysis provides a benchmark for evaluating efforts to manage the rising burden of diabetes in South Africa.	[Stokes, Andrew; Berry, Kaitlyn M.; Brennan, Alana T.; Rockers, Peter C.; Rosen, Sydney] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Mchiza, Zandile; Parker, Whadi-ah; Labadarios, Demetre; Chola, Lumbwe; Hongoro, Charles; Zuma, Khangelani] Human Sci Res Council, Populat Hlth Hlth Syst & Innovat, Cape Town, South Africa; [Brennan, Alana T.; Rosen, Sydney] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa	Boston University; Human Sciences Research Council-South Africa; University of Witwatersrand	Stokes, A (corresponding author), Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA.	acstokes@bu.edu	Chola, Lumbwe/AFX-3377-2022	Parker, Whadi-ah/0000-0001-8308-8447; Berry, Kaitlyn/0000-0002-2928-6773; Hongoro, Charles/0000-0002-9715-4940; Rosen, Sydney/0000-0002-6560-2964; Brennan, Alana/0000-0002-7746-0668; Zuma, Khangelani/0000-0003-4492-5083; Chola, Lumbwe/0000-0001-6488-2813; Stokes, Andrew/0000-0002-8502-3636				Ali MK, 2014, ANN INTERN MED, V161, P681, DOI 10.7326/M14-0019; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 2016, DIABETES CARE, V39, pS1, DOI 10.2337/dc16-S001; [Anonymous], 2000, NON TRADITIONAL REF; Booysen BL, 2015, S AFRICAN FAM PRACT, P57; Bradshaw D, 2007, JEMDSA, V12, P65, DOI 10.1080/22201009.2007.10872159; Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP ES; Clouse K, 2013, J ACQ IMMUN DEF SYND, V62, P22, DOI DOI 10.1097/QAI.0B013E318273AC48.PATIENT; Department of Health; Republic of South Africa, 2013, STRAT PLAN PREV CONT; Fox MP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002268; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Gardner EM, 2014, LANCET INFECT DIS, V14, P5, DOI 10.1016/S1473-3099(13)70272-X; Harris B, 2011, J PUBLIC HEALTH POL, V32, pS102, DOI 10.1057/jphp.2011.35; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; International Diabetes Federation, 2015, IDF DIABETES ATLAS; International Diabetes Federation, 2011, IDF DIABETES ATLAS, DOI [10.1007/978-90-481-3271-3, DOI 10.1007/978-90-481-3271-3]; International Diabetes Federation, 2012, DIAB AT A GLANC, DOI [10.1080/03071845709419205, DOI 10.1080/03071845709419205]; Isaacs A, 2015, S AFRICAN FAM PRACT, P6190; Labadarios D, 2014, SAMJ S AFR MED J, V104, P675, DOI [10.7196/SAMJ.8842, 10.7196/samj.8842]; Matsebula V, 2016, SOCIOECONOMIC CORREL; McLaren Z, 2013, DISTANCE BARRIER HLT; Mendenhall E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2615-3; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; Moodley L, 2007, S AFRICAN FAM PRACT, P49; Peer N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043336; Perlman DC, 2017, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00296; Rosen S, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002015, 10.1371/journal.pmed.1002106]; Rowe KA, 2005, INT J TUBERC LUNG D, V9, P263; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shisana O, 2014, S AFRICAN NATL HLTH; Shisana O, 2014, S AFRICAN NATL HLTH; Statistics South Africa, 2014, PRETORIA, V3, P1; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	33	38	38	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0184264	10.1371/journal.pone.0184264	http://dx.doi.org/10.1371/journal.pone.0184264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968435	gold, Green Submitted, Green Published			2022-12-26	WOS:000412029600006
J	Cordioli, RL; Costa, ELV; Azevedo, LCP; Gomes, S; Amato, MBP; Park, M				Cordioli, Ricardo Luiz; Vieira Costa, Eduardo Leite; Pontes Azevedo, Luciano Cesar; Gomes, Susimeire; Passos Amato, Marcelo Britto; Park, Marcelo			Physiologic effects of alveolar recruitment and inspiratory pauses during moderately-high-frequency ventilation delivered by a conventional ventilator in a severe lung injury model	PLOS ONE			English	Article							END-EXPIRATORY PRESSURE; CO2 ELIMINATION; OSCILLATORY VENTILATION; MECHANICAL VENTILATION; POSITIVE-PRESSURE; TIDAL VOLUME; MORTALITY; PULMONARY; ADULTS	Background and aims To investigate whether performing alveolar recruitment or adding inspiratory pauses could promote physiologic benefits (VT) during moderately-high-frequency positive pressure ventilation (MHFPPV) delivered by a conventional ventilator in a porcine model of severe acute respiratory distress syndrome (ARDS). Methods Prospective experimental laboratory study with eight pigs. Induction of acute lung injury with sequential pulmonary lavages and injurious ventilation was initially performed. Then, animals were ventilated on a conventional mechanical ventilator with a respiratory rate (RR) = 60 breaths/minute and PEEP titrated according to ARDS Network table. The first two steps consisted of a randomized order of inspiratory pauses of 10 and 30% of inspiratory time. In final step, we removed the inspiratory pause and titrated PEEP, after lung recruitment, with the aid of electrical impedance tomography. At each step, PaCO2 was allowed to stabilize between 57-63 mmHg for 30 minutes. Results The step with RR of 60 after lung recruitment had the highest PEEP when compared with all other steps (17 [16,19] vs 14 [10, 17]cmH(2)O), but had lower driving pressures (13 [13,11] vs 16 [14, 17]cmH(2)O), higher P/F ratios (212 [191,243] vs 141 [105, 184] mmHg), lower shunt (23 [20, 23] vs 32 [27, 49]%), lower dead space ventilation (10 [0, 15] vs 30 [20, 37]%), and a more homogeneous alveolar ventilation distribution. There were no detrimental effects in terms of lung mechanics, hemodynamics, or gas exchange. Neither the addition of inspiratory pauses or the alveolar recruitment maneuver followed by decremental PEEP titration resulted in further reductions in VT. Conclusions During MHFPPV set with RR of 60 bpm delivered by a conventional ventilator in severe ARDS swine model, neither the inspiratory pauses or PEEP titration after recruitment maneuver allowed reduction of VT significantly, however the last strategy decreased driving pressures and improved both shunt and dead space.	[Cordioli, Ricardo Luiz; Vieira Costa, Eduardo Leite; Pontes Azevedo, Luciano Cesar; Park, Marcelo] Hosp Sino Libanes, Res & Educ Inst, Sao Paulo, Brazil; [Cordioli, Ricardo Luiz; Vieira Costa, Eduardo Leite; Gomes, Susimeire; Passos Amato, Marcelo Britto] Univ Sao Paulo, Heart Inst Incor, Pulm Div, Cardiopulm Dept, Sao Paulo, Brazil; [Cordioli, Ricardo Luiz] Hosp Israelite Albert Einstein, Intens Care Unit, Sao Paulo, Brazil; [Cordioli, Ricardo Luiz] Hosp Alemao Oswaldo Cruz, Intens Care Unit, Sao Paulo, Brazil; [Pontes Azevedo, Luciano Cesar; Park, Marcelo] Univ Sao Paulo, Emergency Med Discipline, Sao Paulo, Brazil	Hospital Sirio Libanes; Universidade de Sao Paulo; Hospital Israelita Albert Einstein; Universidade de Sao Paulo	Cordioli, RL (corresponding author), Hosp Sino Libanes, Res & Educ Inst, Sao Paulo, Brazil.; Cordioli, RL (corresponding author), Univ Sao Paulo, Heart Inst Incor, Pulm Div, Cardiopulm Dept, Sao Paulo, Brazil.; Cordioli, RL (corresponding author), Hosp Israelite Albert Einstein, Intens Care Unit, Sao Paulo, Brazil.; Cordioli, RL (corresponding author), Hosp Alemao Oswaldo Cruz, Intens Care Unit, Sao Paulo, Brazil.	rlcordioli@gmail.com	Costa, Eduardo/K-5841-2012; amato, Marcelo Britto Passo/L-5001-2016; Azevedo, Luciano CP/H-2652-2012	Costa, Eduardo/0000-0002-6941-3626; amato, Marcelo Britto Passo/0000-0003-3525-8282; Azevedo, Luciano CP/0000-0001-6759-3910	Research and Education Institute, Hospital Sirio-Libanes, Sao Paulo Brazil; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Sao Paulo, Brazil	Research and Education Institute, Hospital Sirio-Libanes, Sao Paulo Brazil; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors are grateful to the Research and Education Institute, Hospital Sirio-Libanes, Sao Paulo Brazil and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Sao Paulo, Brazil for the Grant offered to the study development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; [Anonymous], 1980, ANESTH ANALG, V59, P585; Astrom E, 2008, INTENS CARE MED, V34, P377, DOI 10.1007/s00134-007-0840-7; BARZILAY E, 1987, CRIT CARE MED, V15, P118, DOI 10.1097/00003246-198702000-00007; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Cordioli RL, 2014, INTENS CARE MED EXP, V2, DOI 10.1186/2197-425X-2-13; Devaquet J, 2008, J APPL PHYSIOL, V105, P1944, DOI 10.1152/japplphysiol.90682.2008; Fan E, 2008, AM J RESP CRIT CARE, V178, P1156, DOI 10.1164/rccm.200802-335OC; Ferguson ND, 2013, NEW ENGL J MED, V368, P795, DOI 10.1056/NEJMoa1215554; Gates KL, 2013, AM J RESP CELL MOL, V49, P821, DOI 10.1165/rcmb.2012-0487OC; Guervilly C, 2012, CRIT CARE MED, V40, P1539, DOI 10.1097/CCM.0b013e3182451b4a; Hager DN, 2007, CRIT CARE MED, V35, P1522, DOI 10.1097/01.CCM.0000266586.04676.55; Laffey JG, 2000, AM J RESP CRIT CARE, V162, P2287, DOI 10.1164/ajrccm.162.6.2003066; Marini JJ, 2014, RESP CARE, V59, P1808, DOI 10.4187/respcare.03687; Mercat A, 2001, CRIT CARE MED, V29, P40, DOI 10.1097/00003246-200101000-00011; Mireles-Cabodevila E, 2014, RESP CARE, V59, P1619, DOI 10.4187/respcare.03105; Phoenix SI, 2009, ANESTHESIOLOGY, V110, P1098, DOI 10.1097/ALN.0b013e31819fae06; Ranieri VM, 2000, JAMA-J AM MED ASSOC, V284, P43, DOI 10.1001/jama.284.1.43; Retamal J, 2013, CRIT CARE, V17, DOI 10.1186/cc12487; Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976; SLUTSKY AS, 1988, AM REV RESPIR DIS, V138, P175, DOI 10.1164/ajrccm/138.1.175; Tusman G, 2010, ANESTH ANALG, V111, P968, DOI 10.1213/ANE.0b013e3181f0c2da; Wang Wenfei, 2015, Intensive Care Med Exp, V3, P33, DOI 10.1186/s40635-015-0068-8; WEBB HH, 1974, AM REV RESPIR DIS, V110, P556; Young D, 2013, NEW ENGL J MED, V368, P806, DOI 10.1056/NEJMoa1215716	26	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185769	10.1371/journal.pone.0185769	http://dx.doi.org/10.1371/journal.pone.0185769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961282	Green Published, Green Submitted, gold			2022-12-26	WOS:000412027700036
J	Tang, L; Wang, MM; Liu, DH; Gong, MT; Ying, QL; Ye, SD				Tang, Ling; Wang, Manman; Liu, Dahai; Gong, Mengting; Ying, Qi-Long; Ye, Shoudong			Sp5 induces the expression of Nanog to maintain mouse embryonic stem cell self-renewal	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; PATHWAYS CONVERGE; WNT/BETA-CATENIN; GENE-EXPRESSION; RAT BLASTOCYSTS; ES CELLS; PLURIPOTENCY; DIFFERENTIATION; TARGET; STAT3	Activation of signal transducer and activator of transcription 3 (STAT3) by leukemia inhibitory factor (LIF) maintains mouse embryonic stem cell (mESC) self-renewal. Our previous study showed that trans-acting transcription factor 5 (Sp5), an LIF/STAT3 downstream target, supports mESC self-renewal. However, the mechanism by which Sp5 exerts these effects remains elusive. Here, we found that Nanog is a direct target of Sp5 and mediates the self-renewal-promoting effect of Sp5 in mESCs. Overexpression of Sp5 induced Nanog expression, while knockdown or knockout of Sp5 decreased the Nanog level. Moreover, chromatin immunoprecipitation (ChIP) assays showed that Sp5 directly bound to the Nanog promoter. Functional studies revealed that knockdown of Nanog eliminated the mESC self-renewal-promoting ability of Sp5. Finally, we demonstrated that the self-renewal-promoting function of Sp5 was largely dependent on its zinc finger domains. Taken together, our study provides unrecognized functions of Sp5 in mESCs and will expand our current understanding of the regulation of mESC pluripotency.	[Tang, Ling; Wang, Manman; Liu, Dahai; Gong, Mengting; Ye, Shoudong] Anhui Univ, Sch Life Sci, Ctr Stem Cell & Translat Med, Hefei, Anhui, Peoples R China; [Ying, Qi-Long] Univ Southern Calif, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Stem Cell Biol & Regenerat Med, Keck Sch Med, Los Angeles, CA USA	Anhui University; University of Southern California	Ye, SD (corresponding author), Anhui Univ, Sch Life Sci, Ctr Stem Cell & Translat Med, Hefei, Anhui, Peoples R China.	shdye@126.com			Natural Science Foundation of China and Anhui Province [31501191, 31671535, 1508085SQC204]; Anhui University [J01006068, J01006045]	Natural Science Foundation of China and Anhui Province; Anhui University(Anhui University)	This work was supported by the Natural Science Foundation of China and Anhui Province [31501191, 31671535, 1508085SQC204] and the Scientific Research Startup Fund of Anhui University [J01006068, J01006045]. We aim to find out the molecular mechanism of embryonic self-renewal under these funding supports. Shoudong Ye, the corresponding author, is the leader of these fundings.	Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Aksoy I, 2007, STEM CELLS, V25, P2996, DOI 10.1634/stemcells.2007-0066; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Casanova EA, 2011, STEM CELLS, V29, P474, DOI 10.1002/stem.588; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen XL, 2012, INT J PHARMACEUT, V426, P248, DOI 10.1016/j.ijpharm.2012.01.043; ELBARADI T, 1991, MECH DEVELOP, V35, P155, DOI 10.1016/0925-4773(91)90015-X; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Harrison SM, 2000, DEV BIOL, V227, P358, DOI 10.1006/dbio.2000.9878; Hu Q, 2013, ONCOGENE, V32, P3933, DOI 10.1038/onc.2012.414; Ilias M, 2012, PLANTA MED, V78, P1690, DOI 10.1055/s-0032-1315213; Jeon H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150715; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kooistra SM, 2010, STEM CELLS, V28, P1703, DOI 10.1002/stem.497; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Martello G, 2013, EMBO J, V32, P2561, DOI 10.1038/emboj.2013.177; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Newcomer LN, 2012, AM J MANAG CARE, V18; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Qiu DB, 2015, STEM CELL REP, V5, P314, DOI 10.1016/j.stemcr.2015.07.014; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Tai CI, 2013, J CELL SCI, V126, P1093, DOI 10.1242/jcs.118273; Treichel D, 2001, MECH DEVELOP, V101, P175, DOI 10.1016/S0925-4773(00)00544-X; Waaler J, 2011, CANCER RES, V71, P197, DOI 10.1158/0008-5472.CAN-10-1282; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; WIMMER EA, 1993, NATURE, V366, P690, DOI 10.1038/366690a0; Ye SD, 2016, J CELL SCI, V129, P269, DOI 10.1242/jcs.177675; Ye SD, 2013, EMBO J, V32, P2548, DOI 10.1038/emboj.2013.175; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958	43	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185714	10.1371/journal.pone.0185714	http://dx.doi.org/10.1371/journal.pone.0185714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961274	Green Published, gold, Green Submitted			2022-12-26	WOS:000412027700034
J	Yao, BZ; Yan, QQ; Zhang, MJ; Yang, YN				Yao, Baozhen; Yan, Qianqian; Zhang, Mengjie; Yang, Yunong			Improved artificial bee colony algorithm for vehicle routing problem with time windows	PLOS ONE			English	Article							SCHEDULING PROBLEMS; OPTIMIZATION; NETWORK; SOLVE	This paper investigates a well-known complex combinatorial problem known as the vehicle routing problem with time windows (VRPTW). Unlike the standard vehicle routing problem, each customer in the VRPTW is served within a given time constraint. This paper solves the VRPTW using an improved artificial bee colony (IABC) algorithm. The performance of this algorithm is improved by a local optimization based on a crossover operation and a scanning strategy. Finally, the effectiveness of the IABC is evaluated on some well-known benchmarks. The results demonstrate the power of IABC algorithm in solving the VRPTW.	[Yao, Baozhen; Yan, Qianqian; Zhang, Mengjie] Dalian Univ Technol, Automot Engn Coll, Dalian, Peoples R China; [Yang, Yunong] Dalian Maritime Univ, Transportat Management Coll, Dalian, Peoples R China	Dalian University of Technology; Dalian Maritime University	Yao, BZ (corresponding author), Dalian Univ Technol, Automot Engn Coll, Dalian, Peoples R China.	yaobaozhen@sohu.com	yao, Baozhen/I-9650-2014		National Natural Science Foundation of China [51578112];  [DUT16YQ104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This research was supported in National Natural Science Foundation of China 51578112 to BY and the fundamental research funds for the central universities (DUT16YQ104) to BY.	AlMuhaideb S, 2014, APPL INTELL, V41, P282, DOI 10.1007/s10489-014-0519-z; Backer BD, 2000, J HEURISTICS, V6, P501, DOI 10.1023/A:1009621410177; Chen BY, 2013, NETW SPAT ECON, V13, P123, DOI 10.1007/s11067-012-9175-1; Chen GY, 2015, APPL INTELL, V42, P276, DOI 10.1007/s10489-014-0593-2; Cuevas E, 2012, APPL INTELL, V37, P321, DOI 10.1007/s10489-011-0330-z; DANTZIG GB, 1959, MANAGE SCI, V6, P80, DOI 10.1287/mnsc.6.1.80; DESROCHERS M, 1992, OPER RES, V40, P342, DOI 10.1287/opre.40.2.342; Du WB, 2016, TRANSPORT RES E-LOG, V89, P108, DOI 10.1016/j.tre.2016.03.009; Du WB, 2015, APPL MATH COMPUT, V268, P832, DOI 10.1016/j.amc.2015.06.062; Du WB, 2017, CHINESE J AERONAUT, V30, P330, DOI 10.1016/j.cja.2016.12.001; Gambardella L. M., 1999, NEW IDEAS OPTIMIZATI, P63; Ghoseiri K, 2010, APPL SOFT COMPUT, V10, P1096, DOI 10.1016/j.asoc.2010.04.001; Guimarans D, 2011, ANN MATH ARTIF INTEL, V62, P299, DOI 10.1007/s10472-011-9261-y; Huo Y, 2015, APPL INTELL, V42, P661, DOI 10.1007/s10489-014-0617-y; Jih W., 2004, B COLL ENG NATL TAIW, V90, P89; Karaboga D, 2008, APPL SOFT COMPUT, V8, P687, DOI 10.1016/j.asoc.2007.05.007; Karaboga D., 2005, IDEA BASED HONEY BEE, DOI 10.1.1.714.4934; Karaboga D, 2007, LECT NOTES COMPUT SC, V4529, P789, DOI 10.1007/978-3-540-72950-1_77; Karaboga N, 2013, APPL INTELL, P1; Koudil M, 2007, APPL MATH COMPUT, V186, P1710, DOI 10.1016/j.amc.2006.08.166; Kumar N, 2012, INT J LATEST RES SCI, V1, P144; Laporte G, 2009, TRANSPORT SCI, V43, P408, DOI 10.1287/trsc.1090.0301; Lau HC, 2001, DIVERSIFICATION NEIG; LENSTRA JK, 1981, NETWORKS, V11, P221, DOI 10.1002/net.3230110211; Liu H, 2015, APPL INTELL, V43, P162, DOI 10.1007/s10489-014-0640-z; Misevicius A., 2005, Information Technology and Control, V34, P109; Ombuki B, 2006, APPL INTELL, V24, P17, DOI 10.1007/s10489-006-6926-z; Ozbakir L, 2010, APPL MATH COMPUT, V215, P3782, DOI 10.1016/j.amc.2009.11.018; Ozfirat PM, 2010, APPL ARTIF INTELL, V24, P277, DOI 10.1080/08839511003715196; Peng ZX, 2016, TRANSPORT RES E-LOG, V95, P76, DOI 10.1016/j.tre.2016.08.007; Potvin J.-Y., 1996, INFORMS Journal of Computing, V8, P158, DOI 10.1287/ijoc.8.2.158; Rochat Y., 1995, Journal of Heuristics, V1, P147, DOI 10.1007/BF02430370; Szeto WY, 2011, EUR J OPER RES, V215, P126, DOI 10.1016/j.ejor.2011.06.006; Taillard E, 1997, TRANSPORT SCI, V31, P170, DOI 10.1287/trsc.31.2.170; Tan KC, 2006, COMPUT OPTIM APPL, V34, P115, DOI 10.1007/s10589-005-3070-3; Tavares J, 2003, P 2003 ACM S APPL CO, P753, DOI [10.1145/952532.952679, DOI 10.1145/952532.952679]; Thangiah S. R., 1994, UKCIMSOR944; Vaira G, 2013, BALT J MOD COMPUT, V1, P161; Wainwright RL, 1993, MULTIPLE VEHICLE ROU, P452; Wen-Chyuan Chiang, 1997, INFORMS Journal on Computing, V9, P417, DOI 10.1287/ijoc.9.4.417; Yao BZ, 2017, COMPUT-AIDED CIV INF, V32, P154, DOI 10.1111/mice.12221; Yao BZ, 2014, TRANSPORT RES C-EMER, V43, P233, DOI 10.1016/j.trc.2013.12.005; Yao BZ, 2013, SIMUL-T SOC MOD SIM, V89, P762, DOI 10.1177/0037549713481503; Yu B, 2016, J TRANSP ENG, V142, DOI 10.1061/(ASCE)TE.1943-5436.0000816; Yu B, 2015, TRANSPORT RES C-EMER, V55, P310, DOI 10.1016/j.trc.2015.02.014; Yu B, 2013, J TRANSP GEOGR, V33, P62, DOI 10.1016/j.jtrangeo.2013.09.008; Zhang JL, 2016, EUR J OPER RES, V249, P144, DOI 10.1016/j.ejor.2015.08.050; Zhang JL, 2013, NETW SPAT ECON, V13, P471, DOI 10.1007/s11067-013-9190-x; Zhang P, 2014, APPL INTELL, V40, P427, DOI 10.1007/s10489-013-0471-3	50	12	12	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0181275	10.1371/journal.pone.0181275	http://dx.doi.org/10.1371/journal.pone.0181275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961252	gold, Green Submitted, Green Published			2022-12-26	WOS:000412027700001
J	Cooke, D; Ouattara, A; Ables, GP				Cooke, Diana; Ouattara, Amadou; Ables, Gene P.			Dietary methionine restriction modulates renal response and attenuates kidney injury in mice	FASEB JOURNAL			English	Article						5/6 nephrectomy; osmotic homeostasis; ion transport; inflammation; fibrosis	GLOMERULAR-FILTRATION-RATE; SODIUM-CHANNEL ENAC; SERUM CYSTATIN C; URINARY CLUSTERIN; PROTEIN; ALBUMINURIA; DISEASE; TISSUE; MODEL; NEPHROPATHY	Methionine restriction (MR) extends the lifespan across several species, such as rodents, fruit flies, roundworms, and yeast. MR studies have been conducted on various rodent organs, such as liver, adipose tissue, heart, bones, and skeletal muscle, to elucidate its benefits to the healthspan; however, studies of the direct effect of MR on kidneys are lacking. To investigate the renal effects of MR, we used young and aged unilateral nephrectomized and 5/6 nephrectomized (5/6Nx) mice. Our studies indicated that MR mice experienced polydipsia and polyuria compared with control-fed counterparts. Urine albumin, creatinine, albumin-to-creatinine ratio, sulfur amino acids, and electrolytes were reduced in MR mice. Kidneys of MR mice up-regulated genes that are involved in ion transport, such as Aqp2, Scnn1a, and Slc6a19, which indicated a response to maintain osmotic balance. In addition, we identified renoprotective biomarkers that are affected by MR, such as clusterin and cystatin C. Of importance, MR attenuated kidney injury in 5/6Nx mice by down-regulating inflammation and fibrosis mechanisms. Thus, our studies in mice show the important role of kidneys during MR in maintaining osmotic homeostasis. Moreover, our studies also show that the MR diet delays the progression of kidney disease.	[Cooke, Diana; Ouattara, Amadou; Ables, Gene P.] Orentreich Fdn Adv Sci, 855 Route 301, Cold Spring on Hudson, NY 10516 USA		Ables, GP (corresponding author), Orentreich Fdn Adv Sci, 855 Route 301, Cold Spring on Hudson, NY 10516 USA.	gables@orentreich.org			Orentreich Foundation for the Advancement of Science	Orentreich Foundation for the Advancement of Science	This work was funded by the Orentreich Foundation for the Advancement of Science. The authors thank Dr. Arthur Cooper (New York Medical College, Valhalla, NY, USA) and Angela Tremain (Orentreich Foundation for the Advancement of Science) for help in editing the manuscript. The authors declare no conflicts of interest.	Ables GP, 2017, EXP GERONTOL, V94, P83, DOI 10.1016/j.exger.2017.01.012; Ables GP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08886; Andrukhova O, 2014, EMBO J, V33, P229, DOI 10.1002/embj.201284188; Bohmer C, 2005, BIOCHEM J, V389, P745; Brown-Borg Holly M, 2014, Longev Healthspan, V3, P10, DOI 10.1186/2046-2395-3-10; Butterworth MB, 2010, BBA-MOL BASIS DIS, V1802, P1166, DOI 10.1016/j.bbadis.2010.03.010; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Caro P, 2009, REJUV RES, V12, P421, DOI 10.1089/rej.2009.0902; Cheng Q, 2017, BRIT J PHARMACOL, V174, P468, DOI 10.1111/bph.13711; Collins A, 2014, AM J KIDNEY DIS, V63, pE1; Dieterle F, 2010, NAT BIOTECHNOL, V28, P463, DOI 10.1038/nbt.1622; DULLAART RPF, 1993, DIABETES CARE, V16, P483, DOI 10.2337/diacare.16.2.483; Elshorbagy AK, 2010, NUTRITION, V26, P1201, DOI 10.1016/j.nut.2009.09.017; Ferlizza E, 2015, VET J, V204, P73, DOI 10.1016/j.tvjl.2015.01.023; Forney LA, 2017, OBESITY, V25, P730, DOI 10.1002/oby.21806; Gao XA, 2011, KIDNEY INT, V79, P987, DOI 10.1038/ki.2010.539; Gava Agata L, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P167; Ge SW, 2013, CIRC RES, V113, P965, DOI 10.1161/CIRCRESAHA.113.301934; Grant L, 2016, MECH AGEING DEV, V157, P35, DOI 10.1016/j.mad.2016.07.003; Hanukoglu I, 2016, GENE, V579, P95, DOI 10.1016/j.gene.2015.12.061; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Hoerger TJ, 2015, AM J KIDNEY DIS, V65, P403, DOI 10.1053/j.ajkd.2014.09.023; Jheng HF, 2015, DIS MODEL MECH, V8, P1311, DOI 10.1242/dmm.019398; Johnson JI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106014; Kaucsar T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148043; Kujal P, 2008, Cesk Fysiol, V57, P104; Lee BC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4592; Leelahavanichkul A, 2014, AM J PHYSIOL-RENAL, V307, pF939, DOI 10.1152/ajprenal.00025.2013; Maddineni S, 2013, EXP BIOL MED, V238, P392, DOI 10.1177/1535370213477988; Mallipattu SK, 2014, AM J PHYSIOL-RENAL, V306, pF1008, DOI 10.1152/ajprenal.00597.2013; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Nagasu H, 2012, AM J PHYSIOL-RENAL, V302, pF1402, DOI 10.1152/ajprenal.00459.2011; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; ORENTREICH N, 1993, J NUTR, V123, P269; Ouattara Amadou, 2016, Bone Rep, V5, P33, DOI 10.1016/j.bonr.2016.02.002; Ozcan A, 2012, AM J NEPHROL, V35, P356, DOI 10.1159/000337918; Perrone CE, 2013, EXP GERONTOL, V48, P654, DOI 10.1016/j.exger.2012.07.005; Perrone CE, 2012, J NUTRIGENET NUTRIGE, V5, P132, DOI 10.1159/000339347; Ramalingam A, 2010, AM J PHYSIOL-CELL PH, V299, pC1028, DOI 10.1152/ajpcell.00482.2009; RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743; Rizzetto F, 2017, RENAL FAILURE, V39, P357, DOI 10.1080/0886022X.2017.1282374; Skrovanek S, 2007, AM J PHYSIOL-REG I, V293, pR1046, DOI 10.1152/ajpregu.00072.2007; Song S, 2009, NEPHROL DIAL TRANSPL, V24, P1157, DOI 10.1093/ndt/gfn626; Tang BQ, 2010, NUTRITION, V26, P1170, DOI 10.1016/j.nut.2009.10.006; Vinken P, 2012, TOXICOL PATHOL, V40, P1049, DOI 10.1177/0192623312444765; Watanabe S, 2017, P JPN ACAD B-PHYS, V93, P1, DOI 10.2183/pjab.93.001; Wolf MTF, 2014, J BIOL CHEM, V289, P35849, DOI 10.1074/jbc.M114.616649; Wolfgram DF, 2017, AM J NEPHROL, V45, P172, DOI 10.1159/000455388; Xiang DJ, 2014, INT J CLIN EXP PATHO, V7, P7172; Zhao LW, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0368-z	51	21	21	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					693	702		10.1096/fj.201700419R	http://dx.doi.org/10.1096/fj.201700419R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28970255				2022-12-26	WOS:000425146900014
J	Zhang, BL; Xu, D; She, LL; Wang, ZX; Yang, N; Sun, RB; Zhang, YR; Yan, CX; Wei, QL; Aa, JY; Liu, BL; Wang, GJ; Xie, Y				Zhang, Bangling; Xu, Dan; She, Linlin; Wang, Zixia; Yang, Na; Sun, Runbin; Zhang, Yirui; Yan, Caixia; Wei, Qingli; Aa, Jiye; Liu, Baolin; Wang, Guangji; Xie, Yuan			Silybin inhibits NLRP3 inflammasome assembly through the NAD(+)/SIRT2 pathway in mice with nonalcoholic fatty liver disease	FASEB JOURNAL			English	Article						cytokine; microtubule; alpha-tubulin; ER stress	ACTIVATION; MITOCHONDRIA; SILYMARIN; CELLS; HEPATITIS; SILIBININ; CIRRHOSIS; MARIANUM; TISSUE; MODEL	Silybin is one of the effective, traditional Chinese medicines used as a hepatoprotective agent in nonalcoholic fatty liver disease (NAFLD) therapy worldwide, and the NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome has been recognized as an important factor involved in NAFLD development. However, little is known about the mechanisms of silybin in the regulation of high-fat diet (HFD)-induced liver inflammation. In our study, we found that silybin inhibited endoplasmic reticulum stress and NLRP3 inflammasome activation in the livers of HFD-fed mice and in cultured hepatocytes. Phosphorylation of inositol-requiring enzyme (IRE)1 alpha and eIF2 alpha, expression of thioredoxin-interacting protein and cleaved caspase-1, and release of IL-1 beta were reduced by silybin. In addition, silybin inhibited the approach of calreticulin and translocase of outer membrane 20 (Tom20), prevented assembly of the NLRP3 inflammasome complex, and suppressed the accumulation of acetylated alpha-tubulin in the perinuclear region. Both MEC-17 and sirtuin 2 (SIRT2) were influenced by palmitate and silybin, whereas histone deacetylase 6 was not affected. In addition, supplementing NAD(+) directly or increasing NAD(+) concentration with silybin could maintain the activity of SIRT2. The anti-inflammatory effect of silybin was blocked by SIRT2 silencing or by the SIRT2 inhibitor AGK2, as evidenced by NLRP3/ASC colocalization, AC-alpha-tubulin expression, and IL-1 beta release. These findings indicate that the NAD(+)/SIRT2 pathway is an important mediator through which silybin prevents NLRP3 inflammasome activation during NAFLD.	[Zhang, Bangling; Yang, Na; Sun, Runbin; Zhang, Yirui; Yan, Caixia; Wei, Qingli; Aa, Jiye; Wang, Guangji; Xie, Yuan] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, State Key Lab Nat Med, Tongjia Xiang 24, Nanjing 210009, Jiangsu, Peoples R China; [She, Linlin; Wang, Zixia; Liu, Baolin] China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, Jiangsu Key Lab Tradit Chinese Med TCM Evaluat &, Nanjing, Jiangsu, Peoples R China; [Xu, Dan] Nanjing Chia Tai Tianqing Pharmaceut, Res & Dev Ctr, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; China Pharmaceutical University	Wang, GJ (corresponding author), China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, State Key Lab Nat Med, Tongjia Xiang 24, Nanjing 210009, Jiangsu, Peoples R China.; Xie, Y (corresponding author), China Pharmaceut Univ, Tongjia Xiang 24, Nanjing 210009, Jiangsu, Peoples R China.	guangjiwang@hotmail.com; yuanxie58@yahoo.com		Wang, Guangji/0000-0002-0777-3896	National Natural Science Foundation of China [81673679, 81202590]; Natural Science Foundation of Jiangsu Province of China [BK2012350]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province)	The authors thank the Cellular and Molecular Biology Center of China Pharmaceutical University for assistance with confocal microscopy work and are grateful to Xiao-Nan Ma (China Pharmaceutical University) for her technical help. This work was supported by the National Natural Science Foundation of China (Grants 81673679, 81202590) and the Natural Science Foundation of Jiangsu Province of China (Grant BK2012350). The authors declare no conflicts of interest.	Benetti E, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/678627; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341; Davis-Searles PR, 2005, CANCER RES, V65, P4448, DOI 10.1158/0008-5472.CAN-04-4662; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dulai PS, 2017, HEPATOLOGY, V65, P1557, DOI 10.1002/hep.29085; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; FERENCI P, 1989, J HEPATOL, V9, P105, DOI 10.1016/0168-8278(89)90083-4; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Gurung P, 2015, TRENDS MOL MED, V21, P193, DOI 10.1016/j.molmed.2014.11.008; Hawke RL, 2010, J CLIN PHARMACOL, V50, P434, DOI 10.1177/0091270009347475; Huseini HF, 2006, PHYTOTHER RES, V20, P1036, DOI 10.1002/ptr.1988; Jangra A, 2015, BIOL TRACE ELEM RES, V168, P462, DOI 10.1007/s12011-015-0375-7; Li L, 2015, CELL MOL LIFE SCI, V72, P4237, DOI 10.1007/s00018-015-2000-5; Liu HY, 2016, ONCOTARGET, V7, P62503, DOI 10.18632/oncotarget.11526; Lu A, 2015, FEBS J, V282, P435, DOI 10.1111/febs.13133; Man SM, 2015, IMMUNOL REV, V265, P6, DOI 10.1111/imr.12296; Matsuzaka T, 2012, HEPATOLOGY, V56, P2199, DOI 10.1002/hep.25932; Merkwirth C, 2008, CELL, V135, P1165, DOI 10.1016/j.cell.2008.12.005; Mesquita I, 2016, CELL MOL LIFE SCI, V73, P1225, DOI 10.1007/s00018-015-2119-4; MIGUEZ MP, 1994, CHEM-BIOL INTERACT, V91, P51, DOI 10.1016/0009-2797(94)90006-X; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Miyake Y, 2016, NAT CHEM BIOL, V12, P748, DOI 10.1038/nchembio.2140; Mohamed IN, 2014, DIABETOLOGIA, V57, P413, DOI 10.1007/s00125-013-3101-z; OLMSTED JB, 1973, ANNU REV BIOCHEM, V42, P507, DOI 10.1146/annurev.bi.42.070173.002451; Oufi HG, 2014, EUR J PHARMACOL, V730, P36, DOI 10.1016/j.ejphar.2014.02.010; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Serviddio G, 2014, FREE RADICAL BIO MED, V73, P117, DOI 10.1016/j.freeradbiomed.2014.05.002; Sodhi RK, 2010, VASC PHARMACOL, V53, P77, DOI 10.1016/j.vph.2010.06.003; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Trappoliere M, 2005, Eur Rev Med Pharmacol Sci, V9, P299; Wan XY, 2016, CAN J GASTROENTEROL, V2016, DOI 10.1155/2016/6489012; Wang LL, 2016, J LIPID RES, V57, P1243, DOI 10.1194/jlr.M067397; Wree A, 2014, J MOL MED, V92, P1069, DOI 10.1007/s00109-014-1170-1; Wu XX, 2012, BIOCHEM PHARMACOL, V84, P1164, DOI 10.1016/j.bcp.2012.08.006; Yang G, 2016, SCI REP-UK, V6, DOI 10.1038/srep24399; Yuan Q, 2015, EUR J PHARMACOL, V764, P554, DOI 10.1016/j.ejphar.2015.07.045; Zhou CC, 2016, BRIT J PHARMACOL, V173, P2352, DOI 10.1111/bph.13513	42	57	64	3	48	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					757	767		10.1096/fj.201700602R	http://dx.doi.org/10.1096/fj.201700602R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28970254	Bronze			2022-12-26	WOS:000425146900019
J	Chang, C; Liu, J; He, W; Qu, M; Huang, X; Deng, Y; Shen, L; Zhao, X; Guo, H; Jiang, J; Fu, XY; Huang, R; Zhang, D; Yan, J				Chang, C.; Liu, J.; He, W.; Qu, M.; Huang, X.; Deng, Y.; Shen, L.; Zhao, X.; Guo, H.; Jiang, J.; Fu, X. Y.; Huang, R.; Zhang, D.; Yan, J.			A regulatory circuit HP1 gamma/miR-451a/c-Myc promotes prostate cancer progression	ONCOGENE			English	Article							C-MYC ONCOGENE; CELL; HETEROCHROMATIN; HP1-GAMMA; OVEREXPRESSION; CARCINOMA; MICRORNAS; MIR-451A; COMPLEX; PROTEIN	Heterochromatin protein 1 gamma (HP1 gamma) has been implicated in carcinogenesis of various cancer types. However, the role of HP1 gamma in prostate cancer (PCa) progression and the underlying molecular mechanisms remain largely unknown. We found that HP1 gamma is upregulated in PCa and elevated levels of HP1 gamma in PCa predict poor outcome. In addition, depletion of HP1 gamma in PCa cells not only repressed proliferation and induced apoptosis but also impaired tumorigenicity. We also found that c-Myc was capable of upregulating HP1 gamma by directly binding to the E-box element in the first intron of HP1 gamma gene, and the upregulated HP1 gamma, in turn, repressed the expression of miR-451a by enhancing H3K9 methylation at the promoter region of miR-451a. Furthermore, reduction of miR-451a significantly reversed HP1 gamma loss-induced PCa cell apoptosis, whereas miR-451a overexpression repressed cell survival by targeting and downregulating c-Myc. The association among c-Myc, HP1 gamma and miR-451a was further confirmed in human clinical samples. Therefore, we propose that an HP1 gamma/miR-451a/c-Myc regulatory circuitry exists in PCa cells and this circuit has a crucial role in PCa progression.	[Chang, C.; Liu, J.; He, W.; Huang, X.; Shen, L.; Fu, X. Y.; Yan, J.] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Chang, C.; Liu, J.; He, W.; Huang, X.; Shen, L.; Fu, X. Y.; Yan, J.] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China; [Chang, C.; Liu, J.; Huang, X.; Shen, L.; Yan, J.] Collaborat Innovat Ctr Genet & Dev, Shanghai, Peoples R China; [Qu, M.] Nanjing Univ, Jinling Coll, Sch Chem & Life Sci, Dept Biosci & Bioengn, Nanjing, Jiangsu, Peoples R China; [Deng, Y.; Zhao, X.; Guo, H.] Nanjing Univ, Nanjing Drum Tower Hosp, Dept Urol, Med Sch,Inst Urol, Nanjing, Jiangsu, Peoples R China; [Jiang, J.] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Urol, Chongqing, Peoples R China; [Huang, R.] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai, Peoples R China; [Zhang, D.] Philadelphia Coll Osteopath Med, Dept Biomed Sci, Philadelphia, PA USA; [Yan, J.] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University; Army Medical University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Yan, J (corresponding author), Nanjing Univ, Model Anim Res Ctr, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China.	yanjun@nju.edu.cn	Yan, Jun/Q-3031-2017	Yan, Jun/0000-0002-1303-1952	National Key Research and Development Plan of China [2016YFC0902202]; National Natural Science Foundation of China [81172009, 81672873, 81372168, 81172442]; Doctoral Fund of Ministry of Education of China [20110091120028]; Natural Science Foundation for Universities in Jiangsu Province, China [BK20151396]; Center for Chronic Disorders of Aging (CCDA) at Philadelphia College of Osteopathic Medicine; 'Personalized Medicines-Molecular Signature-based Drug Discovery and Development', Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12020108]; One Hundred Talent Program of Chinese Academy of Sciences; Program sponsored for Scientific Innovation Research of College Graduate in Jiangsu province [KYZZ_ 0037]; Open Foundation of State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University [KF-GN-201602]; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences [SIMM1705KF-02]	National Key Research and Development Plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Natural Science Foundation for Universities in Jiangsu Province, China; Center for Chronic Disorders of Aging (CCDA) at Philadelphia College of Osteopathic Medicine; 'Personalized Medicines-Molecular Signature-based Drug Discovery and Development', Strategic Priority Research Program of the Chinese Academy of Sciences; One Hundred Talent Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Program sponsored for Scientific Innovation Research of College Graduate in Jiangsu province; Open Foundation of State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was financially supported by the National Key Research and Development Plan of China (2016YFC0902202 to JY), the National Natural Science Foundation of China (81172009, 81672873 and 81372168 to JY, and 81172442 to JJ), Doctoral Fund of Ministry of Education of China (20110091120028 to JY), Natural Science Foundation for Universities in Jiangsu Province, China (BK20151396 to JY), the Center for Chronic Disorders of Aging (CCDA) at Philadelphia College of Osteopathic Medicine (to DZ), the 'Personalized Medicines-Molecular Signature-based Drug Discovery and Development', Strategic Priority Research Program of the Chinese Academy of Sciences, Grant No. XDA12020108 (to RH), One Hundred Talent Program of Chinese Academy of Sciences (to RH), Program sponsored for Scientific Innovation Research of College Graduate in Jiangsu province (KYZZ_ 0037 to CC), the Open Foundation of State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University (KF-GN-201602) and the State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (SIMM1705KF-02). We also thank Jun Qin and Min Jiang for their help in data retrieval from TCGA database.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Babapoor S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107502; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Benetti R, 2007, NAT GENET, V39, P243, DOI 10.1038/ng1952; Bertoli G, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030421; Bian HB, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-20; Black JC, 2010, MOL CELL, V40, P736, DOI 10.1016/j.molcel.2010.11.008; Borsos BN, 2017, SCI REP-UK, V7, DOI 10.1038/srep40960; Canzio D, 2014, TRENDS CELL BIOL, V24, P377, DOI 10.1016/j.tcb.2014.01.002; Chen DQ, 2014, EUR J CANCER, V50, P3050, DOI 10.1016/j.ejca.2014.09.008; Choi JD, 2012, NUCLEIC ACIDS RES, V40, P11321, DOI 10.1093/nar/gks947; Follis AV, 2008, CHEM BIOL, V15, P1149, DOI 10.1016/j.chembiol.2008.09.011; Fukumoto I, 2014, BRIT J CANCER, V111, P386, DOI 10.1038/bjc.2014.293; Gabay M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014241; Guan XW, 2016, BIOORG MED CHEM LETT, V26, P1561, DOI 10.1016/j.bmcl.2016.02.013; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Hawksworth D, 2010, PROSTATE CANCER P D, V13, P311, DOI 10.1038/pcan.2010.31; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Itsumi M, 2013, J MOL ENDOCRINOL, V50, P401, DOI 10.1530/JME-13-0024; Jackstadt R, 2015, BBA-GENE REGUL MECH, V1849, P544, DOI 10.1016/j.bbagrm.2014.04.003; Jenkins RB, 1997, CANCER RES, V57, P524; Kang H, 2016, METHODS MOL BIOL, V1344, P313, DOI 10.1007/978-1-4939-2966-5_20; Khanmi K, 2015, CLIN CHIM ACTA, V451, P154, DOI 10.1016/j.cca.2015.09.022; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Koh Cheryl M, 2010, Genes Cancer, V1, P617, DOI 10.1177/1947601910379132; Laitinen VH, 2015, INT J CANCER, V136, P2316, DOI 10.1002/ijc.29276; Lee Young-Ho, 2015, J Nat Sci, V1, pe127; Lemaitre C, 2014, DNA REPAIR, V19, P163, DOI 10.1016/j.dnarep.2014.03.015; Li XY, 2011, J EXP MED, V208, P663, DOI 10.1084/jem.20102384; Liu M, 2015, CANCER RES, V75, P4593, DOI 10.1158/0008-5472.CAN-14-3735; Liu ZR, 2016, LIFE SCI, V149, P104, DOI 10.1016/j.lfs.2016.02.059; Liu ZR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/207684; Lu SZ, 2015, J BIOL CHEM, V290, P24178, DOI 10.1074/jbc.M115.648212; Luoto KR, 2010, CANCER RES, V70, P8748, DOI 10.1158/0008-5472.CAN-10-0944; Minna E, 2016, ONCOTARGET, V7, P12731, DOI 10.18632/oncotarget.7262; Mongiardi MP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15494; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Pazin MJ, 2010, PLOS ONE, V5; Pierorazio PM, 2012, BJU INT, V109, P988, DOI 10.1111/j.1464-410X.2011.10514.x; Rastogi S, 2006, MOL CELL BIOL, V26, P4161, DOI 10.1128/MCB.02142-05; Riquelme I, 2016, CELL ONCOL, V39, P23, DOI 10.1007/s13402-015-0247-3; Rizzardi AE, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-42; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Shapiro E, 2008, J UROLOGY, V179, P2435, DOI 10.1016/j.juro.2008.01.091; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Shiota M, 2010, ENDOCR-RELAT CANCER, V17, P455, DOI 10.1677/ERC-09-0321; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Slezak J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-148; Supino R, 2007, ANN NY ACAD SCI, V1095, P175, DOI 10.1196/annals.1397.021; Takanashi M, 2009, AM J PATHOL, V174, P309, DOI 10.2353/ajpath.2009.080148; Tao JC, 2014, CELL CYCLE, V13, P191, DOI 10.4161/cc.27646; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Tsai LH, 2015, ONCOGENE, V34, P1641, DOI 10.1038/onc.2014.118; Vad-Nielsen J, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2059-x; Vicent GP, 2013, GENE DEV, V27, P1179, DOI 10.1101/gad.215293.113; Wang HB, 2007, MOL CANCER THER, V6, P2399, DOI 10.1158/1535-7163.MCT-07-0005; Yamamoto S, 2010, GENE CHROMOSOME CANC, V49, P487, DOI 10.1002/gcc.20759; Zhang XW, 2012, CANCER CELL, V22, P506, DOI 10.1016/j.ccr.2012.09.003; Zhou J, 2014, TUMOR BIOL, V35, P9777, DOI 10.1007/s13277-014-2182-8	61	29	30	1	17	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 25	2018	37	4					415	426		10.1038/onc.2017.332	http://dx.doi.org/10.1038/onc.2017.332			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT7KP	28967902				2022-12-26	WOS:000423331600001
J	Piscitello, D; Varshney, D; Lilla, S; Vizioli, MG; Reid, C; Gorbunova, V; Seluanov, A; Gillespie, DA; Adams, PD				Piscitello, D.; Varshney, D.; Lilla, S.; Vizioli, M. G.; Reid, C.; Gorbunova, V; Seluanov, A.; Gillespie, D. A.; Adams, P. D.			AKT overactivation can suppress DNA repair via p70S6 kinase-dependent downregulation of MRE11	ONCOGENE			English	Article							ONCOGENE-INDUCED SENESCENCE; CELL-CYCLE CHECKPOINT; HEMATOPOIETIC-CELLS; TUMOR-SUPPRESSOR; DAMAGE RESPONSE; ACTIVATION; CANCER; PTEN; PATHWAY; TUMORIGENESIS	Deregulated AKT kinase activity due to PTEN deficiency in cancer cells contributes to oncogenesis by incompletely understood mechanisms. Here, we show that PTEN deletion in HCT116 and DLD1 colon carcinoma cells leads to suppression of CHK1 and CHK2 activation in response to irradiation, impaired G2 checkpoint proficiency and radiosensitization. These defects are associated with reduced expression of MRE11, RAD50 and NBS1, components of the apical MRE11/RAD50/NBS1 (MRN) DNA damage response complex. Consistent with reduced MRN complex function, PTEN-deficient cells fail to resect DNA double-strand breaks efficiently after irradiation and show greatly diminished proficiency for DNA repair via the error-free homologous recombination (HR) repair pathway. MRE11 is highly unstable in PTEN-deficient cells but stability can be significantly restored by inhibiting mTORC1 or p70S6 kinase (p70S6K), downstream kinases whose activities are stimulated by AKT, or by mutating a residue in MRE11 that we show is phosphorylated by p70S6K in vitro. In primary human fibroblasts, activated AKT suppresses MRN complex expression to escalate RAS-induced DNA damage and thereby reinforce oncogene-induced senescence. Taken together, our data demonstrate that deregulation of the PI3K-AKT/mTORC1/p70S6K pathways, an event frequently observed in cancer, exert profound effects on genome stability via MRE11 with potential implications for tumour initiation and therapy.	[Piscitello, D.; Lilla, S.] Beatson Inst Canc Res, Garscube Estate, Glasgow, Lanark, Scotland; [Varshney, D.] Univ Dundee, Sch Life Sci, Ctr Gene Regulat & Express, Dundee, Scotland; [Vizioli, M. G.; Reid, C.; Adams, P. D.] Univ Glasgow, Epigenet Canc & Ageing, Univ Ave, Glasgow G12 8QQ, Lanark, Scotland; [Gorbunova, V; Seluanov, A.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Gillespie, D. A.] Univ La Laguna, Fac Med, Ctr Invest Biomed Canarias, Inst Tecnol Biomed, Campus Ciencias Salud, Tenerife 38071, Spain	Beatson Institute; University of Dundee; University of Glasgow; University of Rochester; Universidad de la Laguna	Adams, PD (corresponding author), Univ Glasgow, Epigenet Canc & Ageing, Univ Ave, Glasgow G12 8QQ, Lanark, Scotland.; Gillespie, DA (corresponding author), Univ La Laguna, Fac Med, Ctr Invest Biomed Canarias, Inst Tecnol Biomed, Campus Ciencias Salud, Tenerife 38071, Spain.; Adams, PD (corresponding author), Sanford Burnham Prebys Med Discovery Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dgillesp@ull.es; p.adams@beatson.gla.ac.uk	Gillespie, David/R-4771-2019	Gillespie, David/0000-0002-6338-0544; Adams, Peter/0000-0002-0684-1770; Seluanov, Andrei/0000-0003-3400-538X; Varshney, Dhaval/0000-0001-9197-9821; Gorbunova, Vera/0000-0001-8979-0333; Piscitello, Desiree/0000-0002-2510-4717	CRUK programme grant [C10652/A16566]; IMBRAIN Project [FP7-REGPOT-2012-CT2012-31637-IMBRAIN]; NIA [P01AG047200]; Cancer Research UK [16566] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R01AG027237, P01AG047200, R03AG052365] Funding Source: NIH RePORTER	CRUK programme grant; IMBRAIN Project; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Gillespie and Adams labs for critical discussions. Work in the Adams lab was supported by the CRUK programme grant C10652/A16566. DA Gillespie acknowledges the IMBRAIN Project (FP7-REGPOT-2012-CT2012-31637-IMBRAIN: EU FP7 and Gobierno de Canarias) for financial support. V Gorbunova acknowledges the NIA P01AG047200.	Ali SM, 1999, BIODRUGS, V12, P138, DOI 10.2165/00063030-199912020-00006; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Chow LML, 2006, CANCER LETT, V241, P184, DOI 10.1016/j.canlet.2005.11.042; Cristofalo VJ, 2004, MECH AGEING DEV, V125, P827, DOI 10.1016/j.mad.2004.07.010; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Guo F, 2013, LEUKEMIA, V27, P2040, DOI 10.1038/leu.2013.93; Harlow E, 1988, ANTIBODIES LAB MANUA; Henry MK, 2001, BLOOD, V98, P834, DOI 10.1182/blood.V98.3.834; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jastrzebski K, 2007, GROWTH FACTORS, V25, P209, DOI 10.1080/08977190701779101; Kandel ES, 2002, MOL CELL BIOL, V22, P7831, DOI 10.1128/MCB.22.22.7831-7841.2002; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kennedy AL, 2011, MOL CELL, V42, P36, DOI 10.1016/j.molcel.2011.02.020; King FW, 2004, CELL CYCLE, V3, P634; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Liu PD, 2015, MOL CELL, V57, P648, DOI 10.1016/j.molcel.2015.01.005; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Ma YY, 2000, ONCOGENE, V19, P2739, DOI 10.1038/sj.onc.1203597; McGarry DJ, 2016, ACS CHEM BIOL, V11, P3300, DOI 10.1021/acschembio.6b00742; Miller TW, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3039; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Plo I, 2008, CANCER RES, V68, P9404, DOI 10.1158/0008-5472.CAN-08-0861; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Robinson HMR, 2006, ONCOGENE, V25, P5359, DOI 10.1038/sj.onc.1209532; Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113; Seluanov Andrei, 2010, J Vis Exp, DOI 10.3791/2002; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Sieber OM, 2003, NAT REV CANCER, V3, P701, DOI 10.1038/nrc1170; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Tonic I, 2010, J BIOL CHEM, V285, P23790, DOI 10.1074/jbc.M110.104372; Vogt PK, 2007, TRENDS BIOCHEM SCI, V32, P342, DOI 10.1016/j.tibs.2007.05.005; Vredeveld LCW, 2012, GENE DEV, V26, P1055, DOI 10.1101/gad.187252.112; Wen Q, 2008, MOL BIOL CELL, V19, P1693, DOI 10.1091/mbc.E07-09-0975; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060	49	28	28	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 25	2018	37	4					427	438		10.1038/onc.2017.340	http://dx.doi.org/10.1038/onc.2017.340			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT7KP	28967905	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000423331600002
J	Khuong, MT; Fei, J; Cruz-Becerra, G; Kadonaga, JT				Khuong, Mai T.; Fei, Jia; Cruz-Becerra, Grisel; Kadonaga, James T.			A simple and versatile system for the ATP-dependent assembly of chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; chromatin structure; histone; histone chaperone; nucleosome	CHROMOSOMAL-PROTEINS HMG-14; HMGN PROTEINS; NUCLEOSOME MOBILITY; REMODELING FACTOR; HISTONE VARIANTS; CORE HISTONES; DROSOPHILA; ACF; RECONSTITUTION; TRANSCRIPTION	Chromatin is the natural form of DNA in the eukaryotic nucleus and is the substrate for diverse biological phenomena. The functional analysis of these processes ideally would be carried out with nucleosomal templates that are assembled with customized core histones, DNA sequences, and chromosomal proteins. Here we report a simple, reliable, and versatile method for the ATP-dependent assembly of evenly spaced nucleosome arrays. This minimal chromatin assembly system comprises the Drosophila nucleoplasmin-like protein (dNLP) histone chaperone, the imitation switch (ISWI) ATP-driven motor protein, core histones, template DNA, and ATP. The dNLP and ISWI components were synthesized in bacteria, and each protein could be purified in a single step by affinity chromatography. We show that the dNLP-ISWI system can be used with different DNA sequences, linear or circular DNA, bulk genomic DNA, recombinant or native Drosophila core histones, native human histones, the linker histone H1, the non-histone chromosomal protein HMGN2, and the core histone variants H3.3 and H2A.V. The dNLP-ISWI system should be accessible to a wide range of researchers and enable the assembly of customized chromatin with specifically desired DNA sequences, core histones, and other chromosomal proteins.	[Khuong, Mai T.; Fei, Jia; Cruz-Becerra, Grisel; Kadonaga, James T.] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kadonaga, JT (corresponding author), Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA.	jkadonaga@ucsd.edu		Cruz Becerra, Grisel/0000-0001-6297-4132	National Institutes of Health [R35 GM 118060]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R35 GM 118060 (to J. T. K.). The authors declare potential competing financial interests with the contents of this article. The chromatin assembly system described in this article could potentially be sold commercially as a research reagent. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBRIGHT LM, 1988, J BACTERIOL, V170, P1279, DOI 10.1128/jb.170.3.1279-1289.1988; ALBRIGHT SC, 1980, J BIOL CHEM, V255, P3673; ALFONSO PJ, 1994, J MOL BIOL, V236, P189, DOI 10.1006/jmbi.1994.1128; BATES DL, 1981, NUCLEIC ACIDS RES, V9, P5883, DOI 10.1093/nar/9.22.5883; BECKER PB, 1992, MOL CELL BIOL, V12, P2241, DOI 10.1128/MCB.12.5.2241; Bulger M., 1994, METH MOL G, V5, P241; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; Craig N., 2014, MOL BIOL PRINCIPLES; Crevel G, 1997, J STRUCT BIOL, V118, P9, DOI 10.1006/jsbi.1996.3836; Croston G.E., 1991, Protein Expression and Purification, V2, P162, DOI 10.1016/1046-5928(91)90066-R; David Y, 2017, J AM CHEM SOC, V139, P9090, DOI 10.1021/jacs.7b03430; ELFRING LK, 1994, MOL CELL BIOL, V14, P2225, DOI 10.1128/MCB.14.4.2225; Fyodorov D. V., 2002, CURR PROTOC MOL BIOL, V21, P7; Fyodorov DV, 2003, METHOD ENZYMOL, V371, P499; Fyodorov DV, 2002, NATURE, V418, P897, DOI 10.1038/nature00929; GERMOND JE, 1975, P NATL ACAD SCI USA, V72, P1843, DOI 10.1073/pnas.72.5.1843; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Ito T, 1996, MOL CELL BIOL, V16, P3112; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Ito T, 1996, J BIOL CHEM, V271, P25041, DOI 10.1074/jbc.271.40.25041; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kalashnikova AA, 2016, BBA-GENE REGUL MECH, V1859, P455, DOI 10.1016/j.bbagrm.2015.10.004; KAWASAKI K, 1994, J BIOL CHEM, V269, P10169; Khuong MT, 2015, COLD SH Q B, V80, P65, DOI 10.1101/sqb.2015.80.027300; KUEHL L, 1984, J CELL BIOL, V99, P648, DOI 10.1083/jcb.99.2.648; Levenstein ME, 2002, J BIOL CHEM, V277, P8749, DOI 10.1074/jbc.M111212200; Loyola A, 2003, METHODS, V31, P96, DOI 10.1016/S1046-2023(03)00093-8; Luger K, 1999, METH MOL B, V119, P1; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Lusser A, 2004, NAT METHODS, V1, P19, DOI 10.1038/nmeth709; MARDIAN JKW, 1980, SCIENCE, V209, P1534, DOI 10.1126/science.7433974; Maze I, 2014, NAT REV GENET, V15, P259, DOI 10.1038/nrg3673; Namboodiri VMH, 2003, STRUCTURE, V11, P175, DOI 10.1016/S0969-2126(03)00007-8; NOLL M, 1977, J MOL BIOL, V109, P393, DOI 10.1016/S0022-2836(77)80019-3; PARANJAPE SM, 1995, GENE DEV, V9, P1978, DOI 10.1101/gad.9.16.1978; PAZIN MJ, 1994, SCIENCE, V266, P2007, DOI 10.1126/science.7801129; PECK LJ, 1983, P NATL ACAD SCI-BIOL, V80, P6206, DOI 10.1073/pnas.80.20.6206; Postnikov Y, 2010, BBA-GENE REGUL MECH, V1799, P62, DOI 10.1016/j.bbagrm.2009.11.016; Rattner BP, 2009, MOL CELL, V34, P620, DOI 10.1016/j.molcel.2009.04.014; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; RODRIGUEZCAMPOS A, 1989, J MOL BIOL, V209, P135, DOI 10.1016/0022-2836(89)90177-0; SANDEEN G, 1980, NUCLEIC ACIDS RES, V8, P3757, DOI 10.1093/nar/8.17.3757; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; STEIN A, 1989, METHOD ENZYMOL, V170, P585; VANDAAL A, 1988, NUCLEIC ACIDS RES, V16, P7487, DOI 10.1093/nar/16.15.7487; VARSHAVSKY AJ, 1976, NUCLEIC ACIDS RES, V3, P477, DOI 10.1093/nar/3.2.477; Weber CM, 2014, GENE DEV, V28, P672, DOI 10.1101/gad.238873.114; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Zhu N, 2010, BBA-GENE REGUL MECH, V1799, P74, DOI 10.1016/j.bbagrm.2009.11.006	51	12	12	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19478	19490		10.1074/jbc.M117.815365	http://dx.doi.org/10.1074/jbc.M117.815365			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28982979	Green Published, hybrid			2022-12-26	WOS:000416226700027
J	Seth, B; Yadav, A; Agarwal, S; Tiwari, SK; Chaturvedi, RK				Seth, Brashket; Yadav, Anuradha; Agarwal, Swati; Tiwari, Shashi Kant; Chaturvedi, Rajnish Kumar			Inhibition of the transforming growth factor-/SMAD cascade mitigates the anti-neurogenic effects of the carbamate pesticide carbofuran	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neural stem cell (NSC); neurite outgrowth; neurodegeneration; neurogenesis; neuroprotection; stem cells; toxicity; toxicology; neurotoxicity; pesticide	STEM-CELL PROLIFERATION; TGF-BETA; HIPPOCAMPAL NEUROGENESIS; ALZHEIMERS-DISEASE; BISPHENOL-A; CEREBROSPINAL-FLUID; COGNITIVE DEFICITS; ADULT NEUROGENESIS; INTERFERON-GAMMA; MEMORY DEFICITS	The widely used carbamate pesticide carbofuran causes neurophysiological and neurobehavioral deficits in rodents and humans and therefore poses serious health hazards around the world. Previously, we reported that gestational carbofuran exposure has detrimental effects on hippocampal neurogenesis, the generation of new neurons from neural stem cells (NSC), in offspring. However, the underlying cellular and molecular mechanisms for carbofuran-impaired neurogenesis remain unknown. Herein, we observed that chronic carbofuran exposure from gestational day 7 to postnatal day 21 altered expression of genes and transcription factors and levels of proteins involved in neurogenesis and the TGF- pathway (i.e. TGF-; SMAD-2, -3, and -7; and SMURF-2) in the rat hippocampus. We found that carbofuran increases TGF- signaling (i.e. increased phosphorylated SMAD-2/3 and reduced SMAD-7 expression) in the hippocampus, which reduced NSC proliferation because of increased p21 levels and reduced cyclin D1 levels. Moreover, the carbofuran-altered TGF- signaling impaired neuronal differentiation (BrdU/DCX+ and BrdU/NeuN(+) cells) and increased apoptosis and neurodegeneration in the hippocampus. Blockade of the TGF- pathway with the specific inhibitor SB431542 and via SMAD-3 siRNA prevented carbofuran-mediated inhibition of neurogenesis in both hippocampal NSC cultures and the hippocampus, suggesting the specific involvement of this pathway. Of note, both in vitro and in vivo studies indicated that TGF- pathway attenuation reverses carbofuran's inhibitory effects on neurogenesis and associated learning and memory deficits. These results suggest that carbofuran inhibits NSC proliferation and neuronal differentiation by altering TGF- signaling. Therefore, we conclude that TGF- may represent a potential therapeutic target against carbofuran-mediated neurotoxicity and neurogenesis disruption.	[Seth, Brashket; Yadav, Anuradha; Agarwal, Swati; Tiwari, Shashi Kant; Chaturvedi, Rajnish Kumar] CSIR IITR, Dev Toxicol Lab, Syst Toxicol & Hlth Risk Assessment Grp, Vishvigyan Bhavan 31,Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India; [Seth, Brashket; Yadav, Anuradha; Chaturvedi, Rajnish Kumar] CSIR IITR, Acad Sci & Innovat Res AcSIR, Lucknow Campus, Lucknow 226001, Uttar Pradesh, India; [Agarwal, Swati] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Tiwari, Shashi Kant] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Johns Hopkins University; University of California System; University of California San Diego	Chaturvedi, RK (corresponding author), CSIR IITR, Dev Toxicol Lab, Syst Toxicol & Hlth Risk Assessment Grp, Vishvigyan Bhavan 31,Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.	itrcrajnish@gmail.com	Chaturvedi, Rajnish/AAZ-9955-2020; Tiwari, Shashi Kant/R-8533-2018	Tiwari, Shashi Kant/0000-0002-6121-6249; Chaturvedi, Rajnish Kumar/0000-0001-9591-7636	Lady Tata Memorial-UK Young Scientist Grant; Science and Engineering Research Board (SERB), New Delhi, EMR [EMR/2016/001933]; Department of Biotechnology, New Delhi [BT/PR15819/MED/31/322/2015]; Senior Research Fellowship from CSIR, New Delhi; Senior Research Fellowship from UGC, New Delhi	Lady Tata Memorial-UK Young Scientist Grant; Science and Engineering Research Board (SERB), New Delhi, EMR; Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); Senior Research Fellowship from CSIR, New Delhi; Senior Research Fellowship from UGC, New Delhi	This work was supported by the Lady Tata Memorial-UK Young Scientist Grant; Science and Engineering Research Board (SERB), New Delhi, EMR Grant EMR/2016/001933; and Department of Biotechnology, New Delhi, Research Grant BT/PR15819/MED/31/322/2015 (to R. K. C.). This is CSIR-IITR manuscript communication 3483. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Senior Research Fellowship from CSIR, New Delhi.; Recipient of a Senior Research Fellowship from UGC, New Delhi.	Abrous DN, 2002, J NEUROSCI, V22, P3656; Agarwal S, 2016, J BIOL CHEM, V291, P15923, DOI 10.1074/jbc.M115.709493; Agarwal S, 2015, J BIOL CHEM, V290, P21163, DOI 10.1074/jbc.M115.648998; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Angbohang A, 2016, STEM CELLS DEV, V25, P1, DOI 10.1089/scd.2015.0262; Apelt J, 2001, BRAIN RES, V894, P21, DOI 10.1016/S0006-8993(00)03176-0; Baligar PN, 2002, IND HEALTH, V40, P345, DOI 10.2486/indhealth.40.345; Betancourt AM, 2006, TOXICOL SCI, V92, P500, DOI 10.1093/toxsci/kfl004; Bizet AA, 2012, J CELL BIOCHEM, V113, P238, DOI 10.1002/jcb.23349; Boschen KE, 2016, NEUROSCIENCE, V324, P355, DOI 10.1016/j.neuroscience.2016.03.033; Broadwater MA, 2014, DEV NEUROSCI-BASEL, V36, P297, DOI 10.1159/000362874; Buckwalter MS, 2006, AM J PATHOL, V169, P154, DOI 10.2353/ajpath.2006.051272; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chauhan LKS, 2000, MUTAT RES-GEN TOX EN, V465, P123, DOI 10.1016/S1383-5718(99)00219-3; Chen NN, 2012, J ALZHEIMERS DIS, V30, P585, DOI 10.3233/JAD-2012-111946; D'Amico LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066487; Daynac M, 2014, STEM CELLS, V32, P3257, DOI 10.1002/stem.1815; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dutto I, 2015, ARCH TOXICOL, V89, P155, DOI 10.1007/s00204-014-1430-4; Endo F, 2015, CELL REP, V11, P592, DOI 10.1016/j.celrep.2015.03.053; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Falk S, 2008, CELL STEM CELL, V2, P472, DOI 10.1016/j.stem.2008.03.006; FUKUTO TR, 1990, ENVIRON HEALTH PERSP, V87, P245, DOI 10.2307/3431032; Gammon DW, 2012, PEST MANAG SCI, V68, P362, DOI 10.1002/ps.2270; Goad RT, 2004, TOXICOL MECH METHOD, V14, P233, DOI 10.1080/15376520490434476; GOULD E, 1992, J NEUROSCI, V12, P3642; Grammas P, 2002, AM J PATHOL, V160, P1583, DOI 10.1016/S0002-9440(10)61105-4; Gupta RC, 2007, TOXICOL APPL PHARM, V219, P97, DOI 10.1016/j.taap.2006.10.028; GUPTA RC, 1994, J TOXICOL ENV HEALTH, V43, P383, DOI 10.1080/15287399409531931; Hagedorn L, 2000, DEV BIOL, V228, P57, DOI 10.1006/dbio.2000.9936; Hensley K, 2003, NEUROBIOL DIS, V14, P74, DOI 10.1016/S0969-9961(03)00087-1; Hicks SD, 2011, EXP NEUROL, V229, P372, DOI 10.1016/j.expneurol.2011.03.003; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jaako-Movits K, 2005, INT J DEV NEUROSCI, V23, P627, DOI 10.1016/j.ijdevneu.2005.07.005; Kamboj A, 2007, NEUROCHEM RES, V32, P507, DOI 10.1007/s11064-006-9264-y; Kandasamy M, 2010, J NEUROPATH EXP NEUR, V69, P717, DOI 10.1097/NEN.0b013e3181e4f733; Karnboj A, 2006, MOL CELL BIOCHEM, V286, P107, DOI 10.1007/s11010-005-9100-8; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Klincumhom N, 2014, NEUROSCI LETT, V578, P1, DOI 10.1016/j.neulet.2014.06.001; Ko TC, 1998, ONCOGENE, V16, P3445, DOI 10.1038/sj.onc.1201902; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Li H, 2009, J APPL TOXICOL, V29, P149, DOI 10.1002/jat.1392; LINK J, 1994, ANN NEUROL, V36, P379, DOI 10.1002/ana.410360309; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; MACHEMER LH, 1994, TOXICOLOGY, V91, P29, DOI 10.1016/0300-483X(94)90237-2; Madhu V, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1035374; Martinez-Canabal A, 2013, HIPPOCAMPUS, V23, P1198, DOI 10.1002/hipo.22159; Milatovic D, 2005, TOXICOLOGY, V208, P13, DOI 10.1016/j.tox.2004.11.004; Miller JA, 2013, DEVELOPMENT, V140, P4633, DOI 10.1242/dev.097212; Mirescu C, 2006, P NATL ACAD SCI USA, V103, P19170, DOI 10.1073/pnas.0608644103; Mishra D, 2012, TOXICOL SCI, V127, P84, DOI 10.1093/toxsci/kfs004; MOGI M, 1995, NEUROSCI LETT, V193, P129, DOI 10.1016/0304-3940(95)11686-Q; Moser VC, 2010, TOXICOL SCI, V114, P113, DOI 10.1093/toxsci/kfp286; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Okado N, 2001, BRAIN DEV-JPN, V23, pS11, DOI 10.1016/S0387-7604(01)00371-0; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; Palazuelos J, 2014, J NEUROSCI, V34, P7917, DOI 10.1523/JNEUROSCI.0363-14.2014; PANT N, 1995, HUM EXP TOXICOL, V14, P889, DOI 10.1177/096032719501401106; Pant N, 1997, HUM EXP TOXICOL, V16, P267, DOI 10.1177/096032719701600506; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; Pineda JR, 2013, M S-MED SCI, V29, P572, DOI 10.1051/medsci/2013296006; Pineda JR, 2013, EMBO MOL MED, V5, P548, DOI 10.1002/emmm.201202197; Reilly JF, 1998, GLIA, V22, P202, DOI 10.1002/(SICI)1098-1136(199802)22:2<202::AID-GLIA11>3.0.CO;2-1; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Schmuck G, 2004, ARCH TOXICOL, V78, P330, DOI 10.1007/s00204-004-0546-3; Siegenthaler JA, 2005, J NEUROSCI, V25, P8627, DOI 10.1523/JNEUROSCI.1876-05.2005; Spampanato J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041029; Stipursky J, 2007, GLIA, V55, P1023, DOI 10.1002/glia.20522; Stipursky J, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00393; Strain JJ, 2015, AM J CLIN NUTR, V101, P530, DOI 10.3945/ajcn.114.100503; Sudai E, 2011, ADDICT BIOL, V16, P251, DOI 10.1111/j.1369-1600.2010.00241.x; Sun J, 2014, BIOCHEM BIOPH RES CO, V443, P1066, DOI 10.1016/j.bbrc.2013.12.097; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Tanaka T, 2003, CELL STRUCT FUNCT, V28, P165; Tiwari SK, 2016, MOL NEUROBIOL, V53, P3010, DOI 10.1007/s12035-015-9197-z; Tiwari SK, 2015, J BIOL CHEM, V290, P28540, DOI 10.1074/jbc.M115.652586; Tiwari SK, 2015, MOL NEUROBIOL, V52, P1735, DOI 10.1007/s12035-014-8940-1; Tiwari SK, 2014, ACS NANO, V8, P76, DOI 10.1021/nn405077y; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Tyler CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073720; Ueda K, 2013, EUR J PHARMACOL, V699, P188, DOI 10.1016/j.ejphar.2012.11.054; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wachs FP, 2006, J NEUROPATH EXP NEUR, V65, P358, DOI 10.1097/01.jnen.0000218444.53405.f0; Walter J, 2011, NEUROBIOL AGING, V32, P1906, DOI 10.1016/j.neurobiolaging.2009.11.011; Wang FW, 2011, STEM CELL RES, V7, P41, DOI 10.1016/j.scr.2011.03.004; Wyss-Coray T, 2000, AM J PATHOL, V156, P139, DOI 10.1016/S0002-9440(10)64713-X; WyssCoray T, 1997, J NEUROIMMUNOL, V77, P45, DOI 10.1016/S0165-5728(97)00049-0; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yousef H, 2015, ONCOTARGET, V6, P11959, DOI 10.18632/oncotarget.3851; Zetterberg H, 2004, NEUROSCI LETT, V367, P194, DOI 10.1016/j.neulet.2004.06.001; Zhang Shuchen, 2014, World J Stem Cells, V6, P305, DOI 10.4252/wjsc.v6.i3.305; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	94	23	24	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19423	19440		10.1074/jbc.M117.798074	http://dx.doi.org/10.1074/jbc.M117.798074			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28982980	Green Published, hybrid			2022-12-26	WOS:000416226700023
J	Tse, H; Gu, QS; Sze, KH; Chu, IK; Kao, RYT; Lee, KC; Lam, CW; Yang, D; Tai, SSC; Ke, YH; Chan, E; Chan, WM; Dai, J; Leung, SP; Leung, SY; Yuen, KY				Tse, Herman; Gu, Qiangshuai; Sze, Kong-Hung; Chu, Ivan K.; Kao, Richard Y. -T.; Lee, Kam-Chung; Lam, Ching-Wan; Yang, Dan; Tai, Sherlock Shing-Chiu; Ke, Yihong; Chan, Elaine; Chan, Wan-Mui; Dai, Jun; Leung, Sze-Pui; Leung, Suet-Yi; Yuen, Kwok-Yung			A tricyclic pyrrolobenzodiazepine produced by Klebsiella oxytoca is associated with cytotoxicity in antibiotic-associated hemorrhagic colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotics; apoptosis; bacterial toxin; colitis; infectious disease	ESCHERICHIA-COLI; RECOMBINATION; TILIVALLINE; METABOLITE; BACTERIA; CELLS; SET; DNA	Cytotoxin-producing Klebsiella oxytoca is the causative agent of antibiotic-associated hemorrhagic colitis (AAHC). Recently, the cytotoxin associated with AAHC was identified as tilivalline, a known pentacyclic pyrrolobenzodiazepine (PBD) metabolite produced by K. oxytoca. Although this assertion of tilivalline's role in AAHC is supported by evidence from animal experiments, some key aspects of this finding appear to be incompatible with toxicity mechanisms of known PBD toxins. We therefore hypothesized that K. oxytoca may produce some other uncharacterized cytotoxins. To address this question, we investigated whether tilivalline alone is indeed necessary and sufficient to induce cytotoxicity or whether K. oxytoca also produces other cytotoxins. LC-MS- and NMR-based metabolomic analyses revealed the presence of an abundant tricyclic PBD, provisionally designated kleboxymycin, in the supernatant of toxigenic K. oxytoca strains. Moreover, by generating multiple mutants with gene deletions affecting tilivalline biosynthesis, we show that a tryptophanase-deficient, tilivalline-negative K. oxytoca mutant induced cytotoxicity in vitro similar to tilivalline-positive K. oxytoca strains. Furthermore, synthetic kleboxymycin exhibited greater than 9-fold higher cytotoxicity than tilivalline in TC50 cell culture assays. We also found that the biosynthetic pathways for kleboxymycin and tilivalline appear to overlap, as tilivalline is an indole derivative of kleboxymycin. In summary, our results indicate that tilivalline is not essential for inducing cytotoxicity observed in K. oxytoca-associated AAHC and that kleboxymycin is a tilivalline-related bacterial metabolite with even higher cytotoxicity.	[Tse, Herman; Sze, Kong-Hung; Kao, Richard Y. -T.; Lee, Kam-Chung; Ke, Yihong; Chan, Elaine; Chan, Wan-Mui; Dai, Jun; Leung, Sze-Pui; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Pok Fu Lam, Hong Kong, Peoples R China; [Tse, Herman; Sze, Kong-Hung; Kao, Richard Y. -T.; Lee, Kam-Chung; Yuen, Kwok-Yung] Univ Hong Kong, Res Ctr Infect & Immun, Pok Fu Lam, Hong Kong, Peoples R China; [Tse, Herman; Sze, Kong-Hung; Kao, Richard Y. -T.; Lee, Kam-Chung; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, Pok Fu Lam, Hong Kong, Peoples R China; [Gu, Qiangshuai; Chu, Ivan K.; Yang, Dan; Tai, Sherlock Shing-Chiu] Univ Hong Kong, Dept Chem, Pok Fu Lam, Hong Kong, Peoples R China; [Lam, Ching-Wan; Leung, Suet-Yi] Univ Hong Kong, Dept Pathol, Pok Fu Lam, Hong Kong, Peoples R China; [Tse, Herman; Sze, Kong-Hung; Kao, Richard Y. -T.; Lee, Kam-Chung; Yuen, Kwok-Yung] State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Yuen, KY (corresponding author), Univ Hong Kong, Dept Microbiol, Pok Fu Lam, Hong Kong, Peoples R China.; Yuen, KY (corresponding author), Univ Hong Kong, Res Ctr Infect & Immun, Pok Fu Lam, Hong Kong, Peoples R China.; Yuen, KY (corresponding author), Univ Hong Kong, Carol Yu Ctr Infect, Pok Fu Lam, Hong Kong, Peoples R China.; Yuen, KY (corresponding author), State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	kyyuen@hku.hk	Gu, Qiang-Shuai/C-3956-2008; Chan, Elaine/GRR-5490-2022; YANG, Dan/HHD-2733-2022; Leung, Suet Yi/T-9620-2019	Gu, Qiang-Shuai/0000-0002-3840-425X; Yuen, Kwok-yung/0000-0002-2083-1552; Leung, Suet Yi/0000-0001-8614-4619	Commissioned Research on Control of Infectious Diseases (Phase III) Project of the Health and Medical Research Fund under the Food and Health Bureau, the Government of the Hong Kong Special Administrative Region [HKM-15-M06]	Commissioned Research on Control of Infectious Diseases (Phase III) Project of the Health and Medical Research Fund under the Food and Health Bureau, the Government of the Hong Kong Special Administrative Region	This work was supported by a donation from Michael Tong and the Providence Foundation in memory of Lui Hac Minh and the Commissioned Research on Control of Infectious Diseases (Phase III) Project Number HKM-15-M06 of the Health and Medical Research Fund under the Food and Health Bureau, the Government of the Hong Kong Special Administrative Region. The authors declare that they have no conflicts of interest with the contents of this article.	Beaugerie L, 2003, CLIN GASTROENTEROL H, V1, P370, DOI 10.1053/S1542-3565(03)00183-6; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P3118, DOI 10.1093/nar/24.15.3118; Chen J, 2004, GASTROINTEST ENDOSC, V60, P142, DOI 10.1016/S0016-5107(04)01537-8; Cheng VCC, 2012, J CLIN MICROBIOL, V50, P1571, DOI 10.1128/JCM.00163-12; Chimerel C, 2014, CELL REP, V9, P1202, DOI 10.1016/j.celrep.2014.10.032; Chua LS, 2011, J CHROMATOGR B, V879, P3909, DOI 10.1016/j.jchromb.2011.11.002; Darby A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100542; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Donnenberg M. S, 2014, MANDELL DOUGLAS BENN, P2503; Falagas ME, 2009, J HOSP INFECT, V73, P345, DOI 10.1016/j.jhin.2009.02.021; Gerratana B, 2012, MED RES REV, V32, P254, DOI 10.1002/med.20212; HIGAKI M, 1990, MICROBIOL IMMUNOL, V34, P147, DOI 10.1111/j.1348-0421.1990.tb00999.x; Hogenauer C, 2006, NEW ENGL J MED, V355, P2418, DOI 10.1056/NEJMoa054765; HURLEY LH, 1984, PHARMACEUT RES, P52, DOI 10.1023/A:1016395113085; KIM DH, 1995, ARCH PHARM RES, V18, P351, DOI 10.1007/BF02976331; Kim K, 2009, MOL CELL PROTEOMICS, V8, P558, DOI 10.1074/mcp.M800165-MCP200; MINAMI J, 1992, J GEN MICROBIOL, V138, P1921, DOI 10.1099/00221287-138-9-1921; MINAMI J, 1989, MICROB PATHOGENESIS, V7, P203, DOI 10.1016/0882-4010(89)90056-9; MOHR N, 1982, TETRAHEDRON, V38, P147, DOI 10.1016/0040-4020(82)85058-8; Nagasaka T, 1998, J ORG CHEM, V63, P6797, DOI 10.1021/jo972158g; Nemet Z, 2011, Vet Rec, V168, P243, DOI 10.1136/vr.c6350; Philbrick AM, 2007, PHARMACOTHERAPY, V27, P1603, DOI 10.1592/phco.27.11.1603; Pitout JDD, 2015, ANTIMICROB AGENTS CH, V59, P5873, DOI 10.1128/AAC.01019-15; Schneditz G, 2014, P NATL ACAD SCI USA, V111, P13181, DOI 10.1073/pnas.1403274111; Shinjoh M, 2010, PEDIATR INT, V52, P132, DOI 10.1111/j.1442-200X.2009.02949.x; Sweetser S, 2009, AM J GASTROENTEROL, V104, P2366, DOI 10.1038/ajg.2009.289; Takanabe A., 1980, Patent No. [4,185,016, 4185016]; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092; Yamada M, 2014, GLOB PEDIAT HLTH, V1; Yilmaz M, 2012, EUR J GASTROEN HEPAT, V24, P688, DOI 10.1097/MEG.0b013e328352721a; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	34	24	27	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19503	19520		10.1074/jbc.M117.791558	http://dx.doi.org/10.1074/jbc.M117.791558			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972161	Green Published, hybrid			2022-12-26	WOS:000416226700029
J	Brieno-Enriquez, MA; Moak, SL; Holloway, JK; Cohen, PE				Brieno-Enriquez, Miguel A.; Moak, Stefannie L.; Holloway, J. Kim; Cohen, Paula E.			NIMA-related kinase 1 (NEK1) regulates meiosis I spindle assembly by altering the balance between alpha-Adducin and Myosin X	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; CALMODULIN-BINDING DOMAIN; SEXUAL-DIMORPHISM; CHROMOSOME SEGREGATION; MICROTUBULE-BINDING; MAMMALIAN MEIOSIS; PROTEIN-KINASE; GERM-CELLS; CENTROSOME; PHOSPHORYLATION	NIMA-related kinase 1 (NEK1) is a serine/threonine and tyrosine kinase that is highly expressed in mammalian germ cells. Mutations in Nek1 induce anemia, polycystic kidney and infertility. In this study we evaluated the role of NEK1 in meiotic spindle formation in both male and female gametes. Our results show that the lack of NEK1 provokes an abnormal organization of the meiosis I spindle characterized by elongated and/or multipolar spindles, and abnormal chromosome congression. The aberrant spindle structure is concomitant with the disruption in localization and protein levels of myosin X (MYO10) and alpha-adducin (ADD1), both of which are implicated in the regulation of spindle formation during mitosis. Interaction of ADD1 with MYO10 is dependent on phosphorylation, whereby phosphorylation of ADD1 enables its binding to MYO10 on mitotic spindles. Reduction in ADD1 protein in NEK1 mutant mice is associated with hyperphosphorylation of ADD1, thereby preventing the interaction with MYO10 during meiotic spindle formation. Our results reveal a novel regulatory role for NEK1 in the regulation of spindle architecture and function during meiosis.	[Brieno-Enriquez, Miguel A.] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA; Cornell Univ, Ctr Reprod Genom, Ithaca, NY USA	Cornell University; Cornell University	Brieno-Enriquez, MA (corresponding author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA.	mab587@cornell.edu		Brieno-Enriquez, Miguel Angel/0000-0002-8806-0918; Holloway, Courtney Jean/0000-0003-3661-1957	Empire State Stem Cell Fund through New York State Department of Health [C30293GG]; National Institute of Child Health and Human Development (NICHD) [5R00HD065870]; National Institute of General Medical Sciences (NIGMS); March of Dimes [1R01GM097263, MOD2006-844]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD090289, K99HD090289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097263] Funding Source: NIH RePORTER	Empire State Stem Cell Fund through New York State Department of Health; National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); March of Dimes(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.A.B-E is supported by a Postdoctoral fellowship by the Empire State Stem Cell Fund through New York State Department of Health Contract # C30293GG. This project is funded by grants from the National Institute of Child Health and Human Development (NICHD) to J.K.H (5R00HD065870), and from National Institute of General Medical Sciences (NIGMS) and March of Dimes to P.E.C. (1R01GM097263, MOD2006-844). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi KM, 2008, MOL BIOL CELL, V19, P536, DOI 10.1091/mbc.E07-08-0818; Anong WA, 2009, BLOOD, V114, P1904, DOI 10.1182/blood-2009-02-203216; Bennabi I, 2016, J CELL BIOL, V215, P611, DOI 10.1083/jcb.201607062; Brieno-Enriquez MA, 2016, CELL REP, V17, P977, DOI 10.1016/j.celrep.2016.09.059; Chan PC, 2014, J CELL BIOL, V204, P19, DOI 10.1083/jcb.201306083; Chen YM, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-5; Duro E, 2015, GENE DEV, V29, P109, DOI 10.1101/gad.255554.114; Franco T, 2016, BIOCH J; Fry AM, 2012, J CELL SCI, V125, P4423, DOI 10.1242/jcs.111195; Gorbsky GJ, 2015, FEBS J, V282, P2458, DOI 10.1111/febs.13166; Gray S, 2016, ANNU REV GENET, V50, P175, DOI 10.1146/annurev-genet-120215-035111; Hames RS, 2005, MOL BIOL CELL, V16, P1711, DOI 10.1091/mbc.E04-08-0688; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hayashi T, 2000, BIOL REPROD, V62, P1722, DOI 10.1095/biolreprod62.6.1722; Herran Y, 2011, EMBO J, V30, P3091, DOI 10.1038/emboj.2011.222; Hilton LK, 2009, BIOCHEM BIOPH RES CO, V389, P52, DOI 10.1016/j.bbrc.2009.08.086; Hirano Y, 2011, EMBO J, V30, P2734, DOI 10.1038/emboj.2011.177; Holloway K, 2011, GENES-BASEL, V2, P260, DOI 10.3390/genes2010260; Janaswami PM, 1997, GENOMICS, V40, P101, DOI 10.1006/geno.1996.4567; KAISER HW, 1989, J CELL BIOL, V109, P557, DOI 10.1083/jcb.109.2.557; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Kwon MJ, 2015, DEV CELL, V34, P323, DOI 10.1016/j.devcel.2015.06.013; LETWIN K, 1992, EMBO J, V11, P3521, DOI 10.1002/j.1460-2075.1992.tb05435.x; Liu SZ, 2013, P NATL ACAD SCI USA, V110, P2175, DOI 10.1073/pnas.1217781110; Matsuoka Y, 1996, J BIOL CHEM, V271, P25157, DOI 10.1074/jbc.271.41.25157; MCKIM KS, 1995, SCIENCE, V270, P1595, DOI 10.1126/science.270.5242.1595; Meirelles Gabriela Vaz, 2014, World J Biol Chem, V5, P141, DOI 10.4331/wjbc.v5.i2.141; Morelli MA, 2005, REPRODUCTION, V130, P761, DOI 10.1530/rep.1.00865; OAKLEY BR, 1983, J CELL BIOL, V96, P1155, DOI 10.1083/jcb.96.4.1155; Ohkura H., 2015, COLD SPRING HARB PER, V7, P7; Page J, 1998, CHROMOSOME RES, V6, P639, DOI 10.1023/A:1009209628300; Patil M, 2013, CELL CYCLE, V12, P2608, DOI 10.4161/cc.25624; Sandquist JC, 2016, CYTOSKELETON, V73, P351, DOI 10.1002/cm.21311; SCARAMUZZINO DA, 1993, P NATL ACAD SCI USA, V90, P3398, DOI 10.1073/pnas.90.8.3398; Sdelci S, 2012, CURR BIOL, V22, P1516, DOI 10.1016/j.cub.2012.06.027; Sun Xianfei, 2013, Methods Mol Biol, V957, P1, DOI 10.1007/978-1-62703-191-2_1; Bertran MT, 2011, EMBO J, V30, P2634, DOI 10.1038/emboj.2011.179; Upadhya P, 2000, P NATL ACAD SCI USA, V97, P217, DOI 10.1073/pnas.97.1.217; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; White MC, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-29; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062	41	8	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185780	10.1371/journal.pone.0185780	http://dx.doi.org/10.1371/journal.pone.0185780			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982183	gold, Green Submitted, Green Published			2022-12-26	WOS:000412360300068
J	Cros, MJ; Aubertot, JN; Peyrard, N; Sabbadin, R				Cros, Marie-Josee; Aubertot, Jean-Noel; Peyrard, Nathalie; Sabbadin, Regis			GMDPtoolbox: A Matlab library for designing spatial management policies. Application to the long-term collective management of an airborne disease	PLOS ONE			English	Article							PHOMA STEM CANKER; OILSEED RAPE; RESISTANCE MANAGEMENT; BIODIVERSITY	Designing management policies in ecology and agroecology is complex. Several components must be managed together while they strongly interact spatially. Decision choices must be made under uncertainty on the results of the actions and on the system dynamics. Furthermore, the objectives pursued when managing ecological systems or agroecosystems are usually long term objectives, such as biodiversity conservation or sustainable crop production. The framework of Graph-Based Markov Decision Processes (GMDP) is well adapted to the qualitative modeling of such problems of sequential decision under uncertainty. Spatial interactions are easily modeled and integrated control policies (combining several action levers) can be designed through optimization. The provided policies are adaptive, meaning that management actions are decided at each time step (for instance yearly) and the chosen actions depend on the current system state. This framework has already been successfully applied to forest management and invasive species management. However, up to now, no "easy-to-use" implementation of this framework was available. We present GMDPtoolbox, a Matlab toolbox which can be used both for the design of new management policies and for comparing policies by simulation. We provide an illustration of the use of the toolbox on a realistic crop disease management problem: the design of long term management policy of blackleg of canola using an optimal combination of three possible cultural levers. This example shows how GMDPtoolbox can be used as a tool to support expert thinking.	[Cros, Marie-Josee; Peyrard, Nathalie; Sabbadin, Regis] INRA, MIAT UR 875, Toulouse, France; [Aubertot, Jean-Noel] INRA INPT, AGIR UMR 1248, Toulouse, France	INRAE; INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse	Cros, MJ (corresponding author), INRA, MIAT UR 875, Toulouse, France.	Marie-Josee.Cros@inra.fr			European Union [265865- PURE]; ANR project AGROBIOSE [ANR-13-AGRO-0001]	European Union(European Commission); ANR project AGROBIOSE(French National Research Agency (ANR))	This work has been partly supported by the European Union Seventh Framework Program (FP7/2007-2013) under the grant agreement n265865- PURE (https://ec.europa.eu/research/fp7). This study was also funded by the ANR project AGROBIOSE (ANR-13-AGRO-0001) (http://www.agence-nationale-recherche.fr/?Projet=ANR-13-AGRO-0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, NEURO DYNAMIC PROGRA; Attoumani-Ronceux A, 2012, NOTICE CALCULATEUR S; Aubertot JN, 2006, EUR J PLANT PATHOL, V114, P91, DOI 10.1007/s10658-005-3628-z; Aubertot JN, 2004, CROP PROT, V23, P635, DOI 10.1016/j.cropro.2003.11.015; Chapron G, 2014, ECOGRAPHY, V37, P916; Cheng Q., 2013, P INT C NEUR INF PRO, P2976; Choisy M, 2007, P EUR C COMPL SYST E; Coble HD, 2016, WEED SCI, V64, P661, DOI 10.1614/WS-D-15-00032.1; Cordwell S., MARKOV DECISION PROC; De Farias DP, 2003, OPER RES, V51, P850, DOI 10.1287/opre.51.6.850.24925; Duru M, 2015, AGRON SUSTAIN DEV, V35, P1259, DOI 10.1007/s13593-015-0306-1; Fackler P., MDPSOLVE SOFTWARE DY; Forsell N, 2011, ANN OPER RES, V190, P57, DOI 10.1007/s10479-009-0522-7; Guestrin C, 2002, ADV NEUR IN, V14, P1523; Hoey J, 1999, P INT C UNC ART INT; Jin L, 2015, NAT BIOTECHNOL, V33, P169, DOI 10.1038/nbt.3100; Kee-Eung Kim, 2002, PRICAI 2002: Trends in Artificial Intelligence. 7th Pacific Rim International Conference on Artificial Intelligence. Proceedings (Lecture Notes in Artificial Intelligence Vol.2417), P80; Lescourret F, 2015, CURR OPIN ENV SUST, V14, P68, DOI 10.1016/j.cosust.2015.04.001; Lo-Pelzer E, 2010, FIELD CROP RES, V118, P73, DOI 10.1016/j.fcr.2010.04.007; Marcroft SJ, 2004, AUST J EXP AGR, V44, P601, DOI 10.1071/EA03087; Meir E, 2004, ECOL LETT, V7, P615, DOI 10.1111/j.1461-0248.2004.00624.x; Murphy K., MARKOV DECISION PROC; Murphy KP., 2002, DYNAMIC BAYESIAN NET; Nicol S, 2015, P 27 INT C CONS BIOL; Peyrard N, 2007, P AM PHYT SOC SOC NE; Polasky S, 2008, BIOL CONSERV, V141, P1505, DOI 10.1016/j.biocon.2008.03.022; Puech T, 2015, ACTUALISATION BASE D; Puterman ML., 2014, MARKOV DECISION PROC; Radoszycki J, 2015, P INT C PRINC PRACT; Sabbadin R, 2012, INT J APPROX REASON, V53, P66, DOI 10.1016/j.ijar.2011.09.007; Schneider O, 2006, SOIL TILL RES, V85, P115, DOI 10.1016/j.still.2004.12.007; Sigaud O., 2010, MARKOV DECISION PROC; Souchere V, 2010, ENVIRON MODELL SOFTW, V25, P1359, DOI 10.1016/j.envsoft.2009.03.002; Sridhar V, 2014, CURR SCI INDIA, V107, P1640; St-Aubin R, 2000, P C NEUR INF PROC SY, P1089; Thind, 2012, PLANT PATHOL, V61, P820, DOI [10.1111/j.1365, DOI 10.1111/J.1365-3059.2012.02623.X]; West JS, 2001, PLANT PATHOL, V50, P10, DOI 10.1046/j.1365-3059.2001.00546.x; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366	38	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186014	10.1371/journal.pone.0186014	http://dx.doi.org/10.1371/journal.pone.0186014			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982151	gold, Green Published, Green Submitted			2022-12-26	WOS:000412360300107
J	Shrestha, CL; Assani, KD; Rinehardt, H; Albastroiu, F; Zhang, SZ; Shell, R; Amer, AO; Schlesinger, LS; Kopp, BT				Shrestha, Chandra L.; Assani, Kaivon D.; Rinehardt, Hannah; Albastroiu, Florentina; Zhang, Shuzhong; Shell, Richard; Amer, Amal O.; Schlesinger, Larry S.; Kopp, Benjamin T.			Cysteamine-mediated clearance of antibiotic-resistant pathogens in human cystic fibrosis macrophages	PLOS ONE			English	Article							BURKHOLDERIA-CENOCEPACIA; LUNG INFLAMMATION; AUTOPHAGY; CFTR; MACHINERY; INFECTION; MUTATION; IMMUNITY; STRAINS; RESCUE	Members of the Burkholderia cepacia complex are virulent, multi-drug resistant pathogens that survive and replicate intracellularly in patients with cystic fibrosis (CF). We have discovered that B. cenocepacia cannot be cleared from CF macrophages due to defective autophagy, causing continued systemic inflammation and infection. Defective autophagy in CF is mediated through constitutive reactive oxygen species (ROS) activation of transglutaminase-2 (TG2), which causes the sequestration (accumulation) of essential autophagy initiating proteins. Cysteamine is a TG2 inhibitor and proteostasis regulator with the potential to restore autophagy. Therefore, we sought to examine the impact of cysteamine on CF macrophage autophagy and bacterial killing. Human peripheral blood monocyte-derived macrophages (MDMs) and alveolar macrophages were isolated from CF and non-CF donors. Macrophages were infected with clinical isolates of relevant CF pathogens. Cysteamine caused direct bacterial growth killing of live B. cenocepacia, B. multivorans, P. aeruginosa and MRSA in the absence of cells. Additionally, B. cenocepacia, B. multivorans, and P. aeruginosa invasion were significantly decreased in CF MDMs treated with cysteamine. Finally, cysteamine decreased TG2, p62, and beclin-1 accumulation in CF, leading to increased Burkholderia uptake into autophagosomes, increased macrophage CFTR expression, and decreased ROS and IL-1 beta production. Cysteamine has direct anti-bacterial growth killing and improves human CF macrophage autophagy resulting in increased macrophage-mediated bacterial clearance, decreased inflammation, and reduced constitutive ROS production. Thus, cysteamine may be an effective adjunct to antibiotic regimens in CF.	[Shrestha, Chandra L.; Assani, Kaivon D.; Rinehardt, Hannah; Albastroiu, Florentina; Zhang, Shuzhong; Kopp, Benjamin T.] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA; [Shell, Richard; Kopp, Benjamin T.] Nationwide Childrens Hosp, Sect Pediat Pulmonol, Columbus, OH 43205 USA; [Amer, Amal O.; Schlesinger, Larry S.; Kopp, Benjamin T.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Amer, Amal O.] Ohio State Univ, Dept Internal Med, Davis Heart & Lung Res Inst, Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Schlesinger, Larry S.] Texas Biomed Res Inst, San Antonio, TX USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Texas Biomedical Research Institute	Kopp, BT (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA.; Kopp, BT (corresponding author), Nationwide Childrens Hosp, Sect Pediat Pulmonol, Columbus, OH 43205 USA.; Kopp, BT (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.	Benjamin.Kopp@NationwideChildrens.org		kopp, Benjamin/0000-0002-2021-7990; Rinehardt, Hannah/0000-0003-2571-0239	NIH NIAID [1K08AI108792-01A1]; CTSA [UL1TR001070]; NIH [P30 DK089507]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI124121, K08AI108792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by NIH NIAID 1K08AI108792-01A1 (BTK) and CTSA UL1TR001070 (The Ohio State University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thank you to Richard Montione from the Campus Microscopy and Imaging Facility at OSU for assistance with EM images. The authors thank Dr. Mark Wewers for kindly donating the IL-1 beta antibody, Dr. Miguel Valvano for kindly donating the B. cenocepacia strains, and Dr. Michael Bailey for kindly donating the enteric bacterial strains. The authors thank Dr. Jane Burns at the CF Isolate Core at Seattle Children's Research Institute for provision of the B. multivorans strain (Seattle CF Isolate Core supported by NIH P30 DK089507). Thank you to Amy Mackos for assistance in handling of enteric bacterial strains.	Abdulrahman BA, 2013, J BIOL CHEM, V288, P2049, DOI 10.1074/jbc.M112.411728; Abdulrahman BA, 2011, AUTOPHAGY, V7, P1359, DOI 10.4161/auto.7.11.17660; Akhter A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000361; Al-Khodor S, 2014, CELL MICROBIOL, V16, P378, DOI 10.1111/cmi.12223; Assani K, 2017, J IMMUNOL; Assani K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096681; Mestre MB, 2012, AUTOPHAGY, V8, P1865, DOI 10.4161/auto.22161; Bruscia EM, 2016, J INNATE IMMUN, V8, P550, DOI 10.1159/000446825; Charrier C, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0189-2; De Stefano D, 2014, AUTOPHAGY, V10, P2053, DOI 10.4161/15548627.2014.973737; Devereux G, 2016, CLIN DRUG INVEST, V36, P605, DOI 10.1007/s40261-016-0405-z; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Elmonem MA, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0426-y; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Ferrari E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.476; Fraser-Pitt D, 2016, ANTIMICROB AGENTS CH; Gustave JE, 2013, J CYST FIBROS, V12, P384, DOI 10.1016/j.jcf.2012.10.011; Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107; Junkins RD, 2014, AUTOPHAGY, V10, P538, DOI 10.4161/auto.27750; Junkins RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072263; Kopp BT, 2012, BIOCHEM BIOPH RES CO, V424, P221, DOI 10.1016/j.bbrc.2012.06.066; Kotrange S, 2011, J LEUKOCYTE BIOL, V89, P481, DOI 10.1189/jlb.0910513; Langman CB, 2012, CLIN J AM SOC NEPHRO, V7, P1112, DOI 10.2215/CJN.12321211; Luciani A, 2012, AUTOPHAGY, V8, P1657, DOI 10.4161/auto.21483; Luciani A, 2011, AUTOPHAGY, V7, P104, DOI 10.4161/auto.7.1.13987; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Mahenthiralingam E, 2000, J CLIN MICROBIOL, V38, P910, DOI 10.1128/JCM.38.2.910-913.2000; Mihai MM, 2015, CURR TOP MED CHEM, V15, P1552; O'Keeffe KM, 2015, INFECT IMMUN, V83, P3445, DOI 10.1128/IAI.00358-15; Park JM, 2013, NUTR RES, V33, P677, DOI 10.1016/j.nutres.2013.05.019; Ralhan A, 2016, J INNATE IMMUN, V8, P531, DOI 10.1159/000446840; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; Tazi MF, 2016, AUTOPHAGY, V12, P2026, DOI 10.1080/15548627.2016.1217370; Tosco A, 2016, CELL DEATH DIFFER, V23, P1380, DOI 10.1038/cdd.2016.22; Vij N, 2017, EXPERT OPIN DRUG DEL, V14, P483, DOI 10.1080/17425247.2016.1223040	36	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186169	10.1371/journal.pone.0186169	http://dx.doi.org/10.1371/journal.pone.0186169			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982193	Green Submitted, gold, Green Published			2022-12-26	WOS:000412360300131
J	Osipowicz, G; Witas, H; Lisowska-Gaczorek, A; Reitsema, L; Szostek, K; Ploszaj, T; Kuriga, J; Makowiecki, D; Jedrychowska-Danska, K; Cienkosz-Stepanczak, B				Osipowicz, Grzegorz; Witas, Henryk; Lisowska-Gaczorek, Aleksandra; Reitsema, Laurie; Szostek, Krzysztof; Ploszaj, Tomasz; Kuriga, Justyna; Makowiecki, Daniel; Jedrychowska-Danska, Krystyna; Cienkosz-Stepanczak, Beata			Origin of the ornamented baton perce from the Golebiewo site 47 as a trigger of discussion on long-distance exchange among Early Mesolithic communities of Central Poland and Northern Europe	PLOS ONE			English	Article							REINDEER RANGIFER-TARANDUS; ISOTOPE RATIOS; OXYGEN ISOTOPES; BONE-COLLAGEN; STABLE-ISOTOPES; FAUNAL CHANGE; COLONIZATION; SCANDINAVIA; ENVIRONMENT; DEGLACIATION	This article describes evidence for contact and exchange among Mesolithic communities in Poland and Scandinavia, based on the interdisciplinary analysis of an ornamented baton perce A from Golebiewo site 47 (Central Poland). Typological and chronological-cultural analyses show the artefact to be most likely produced in the North European Plain, during the Boreal period. Carbon-14 dating confirms the antiquity of the artefact. Ancient DNA analysis shows the artefact to be of Rangifer tarandus antler. Following this species designation, a dispersion analysis of Early-Holocene reindeer remains in Europe was conducted, showing this species to exist only in northern Scandinavia and north-western Russia in this period. Therefore, the baton from Golebiewo constitutes the youngest reindeer remains in the European Plain and south-western Scandinavia known to date. An attempt was made to determine the biogeographic region from which the antler used to produce the artefact originates from. To this end, comprehensive delta(18) O, delta C-13 and delta N-15 isotope analyses were performed. North Karelia and South Lapland were determined as the most probable regions in terms of isotopic data, results which correspond to the known distribution range of Rangifer tarandus at this time. In light of these finds, the likelihood of contact between Scandinavia and Central Europe in Early Holocene is evaluated. The baton perce A from Golebiewo is likely key evidence for long-distance exchange during the Boreal period.	[Osipowicz, Grzegorz; Kuriga, Justyna; Makowiecki, Daniel] Nicolaus Copernicus Univ, Inst Archaeol, Torun, Kuyavian Pomera, Poland; [Witas, Henryk; Ploszaj, Tomasz; Jedrychowska-Danska, Krystyna] Med Univ Lodz, Dept Mol Biol, Lodz, Lodz Voivodeshi, Poland; [Lisowska-Gaczorek, Aleksandra; Szostek, Krzysztof; Cienkosz-Stepanczak, Beata] Jagiellonian Univ, Inst Zool, Krakow, Lesser Poland V, Poland; [Reitsema, Laurie] Univ Georgia, Bioarcheol & Biochem Lab, Athens, GA 30602 USA	Nicolaus Copernicus University; Medical University Lodz; Jagiellonian University; University System of Georgia; University of Georgia	Osipowicz, G (corresponding author), Nicolaus Copernicus Univ, Inst Archaeol, Torun, Kuyavian Pomera, Poland.	grezegor@umk.pl	Osipowicz, Grzegorz/O-5013-2015; Makowiecki, Daniel/AAA-9506-2021; Ploszaj, Tomasz/S-9849-2016	Osipowicz, Grzegorz/0000-0002-4393-655X; Makowiecki, Daniel/0000-0002-1821-4627; Szostek, Krzysztof/0000-0001-7815-928X; Reitsema, Laurie/0000-0003-1127-3496; Ploszaj, Tomasz/0000-0002-9503-278X; Jedrychowska-Danska, Krystyna/0000-0001-9262-4010	National Science Center (NCN) in Cracow (Poland) [N 2013/08/M/HS3/00379, 2016/23/B/HS3/00689]	National Science Center (NCN) in Cracow (Poland)	The work was funded by the scientific projects from the National Science Center (NCN) in Cracow (Poland) no. N 2013/08/M/HS3/00379 and 2016/23/B/HS3/00689.; We would like to thank Wojciech Sosnowski and Ma o gorzata Kurzynska for passing on the artefact for analysis, all participants of the discussion that held at Research Gate, in connection to the presentation of the preliminary results of the study and Mikael A. Manninen for making available the map used at article. The work was funded by the scientific projects from the National Science Center (NCN) in Cracow (Poland) no. N 2013/08/M/HS3/00379 and 2016/23/B/HS3/00689.	Aaris-Sorensen K, 2007, J ARCHAEOL SCI, V34, P914, DOI 10.1016/j.jas.2006.09.014; Allain J., 1985, GALLIA PR HIST, V28, P37; Baales M, 2002, ARCHAEOMETRY S1, V44, P30; Bergman I, 2004, J WORLD PREHIST, V18, P155, DOI 10.1007/s10963-004-2880-z; Bergsvik KA, 2015, EUR J ARCHAEOL, V18, P190, DOI 10.1179/1461957114Y.0000000073; Bjornstad G, 2012, J ARCHAEOL SCI, V39, P102, DOI 10.1016/j.jas.2011.09.006; Bokiniec AZ, 1987, NEOLIT POCZATKI EPOK, p[11, 223]; Bondestam K, 1994, THESIS, V234, P161; Britton K, 2009, J ARCHAEOL SCI, V36, P1163, DOI 10.1016/j.jas.2009.01.003; Chaix L., 2003, 6 INT C MES EUR STOC, P645; Chaix L., 2009, 7 INT C MES EUR BELF, P190; Clark JGD, 1936, MESOLITHIC SETTLEMEN; Coard R, 1999, HOLOCENE, V9, P372, DOI 10.1191/095968399672435429; Costamagno S, 2016, QUATERN INT, V414, P34, DOI 10.1016/j.quaint.2015.11.103; Cyrek Krzysztof, 2000, Folia Quaternaria, V71, P5; Darling WG, 2004, QUATERNARY SCI REV, V23, P743, DOI 10.1016/j.quascirev.2003.06.016; Daux V, 2008, J HUM EVOL, V55, P1138, DOI 10.1016/j.jhevol.2008.06.006; DENIRO MJ, 1985, J ARCHAEOL SCI, V12, P1, DOI 10.1016/0305-4403(85)90011-1; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Drucker D, 2004, INT J OSTEOARCHAEOL, V14, P162, DOI 10.1002/oa.753; Drucker D, 2011, DERNIERS RENNES DORD, P22; Drucker D, 2000, PALEO, V12, P127; Drucker DG, 2011, QUATERN INT, V245, P218, DOI 10.1016/j.quaint.2011.05.007; Drucker DG, 2009, MEMOIRE SOC PREHISTO, P73; Drucker DG, 2015, QUATERN INT, V359, P304, DOI 10.1016/j.quaint.2014.11.028; Dupras TL, 2001, J ARCHAEOL SCI, V28, P1199, DOI 10.1006/jasc.2001.0640; Foss M. E., 1952, MAT ISSLEDOVANIYA AR, pEastern; Galinski T, 2002, SPOLECZENSTWA MEZOLI; Gizejewski Z, 2004, POLAND EUR J WILDLIF, V50, P2017; Gramsch B., 1979, VEROFFENTLICHUNGEN P, V12, P39; Gron O, 2003, ANTIQUITY, V77, P685, DOI 10.1017/S0003598X00061640; Gron O, 1995, BAR INT SERIES, V616; Gurina NN, 1956, OLENEOSTROVSKI MOGIL; Hartz S., 2010, QUARTAR, V57, P155, DOI DOI 10.7485/QU57_08; Henton E, 2010, ARCHAEOMETRY, V52, P429, DOI 10.1111/j.1475-4754.2009.00492.x; Hoogewerff J, 2001, J ARCHAEOL SCI, V28, P983, DOI 10.1006/jasc.2001.0659; IAEA, 2006, GLOB NETW IS PREC GN; Jacobi RM, 2009, QUATERNARY SCI REV, V28, P1895, DOI 10.1016/j.quascirev.2009.03.006; Kabaciriski J., 2009, POLAND QUARTAR, V56, P119; Kabaciriski J, 2011, ELKS EARLY STONE AGE, V86, P151; Kankaanpaa J., 2011, MONOGRAPH ARCHAEOLOG, P43; Kind CJ, 2003, THESIS; Kleppe JI, 2014, BAR INT SERIES, V2599, P121; Knudson KJ, 2009, AM J PHYS ANTHROPOL, V138, P473, DOI 10.1002/ajpa.20965; Kobusiewicz M., 1975, ARCHAEOLOGIA POLONA, V16, P7; Kortelainen NM, 2004, J HYDROL, V285, P143, DOI 10.1016/j.jhydrol.2003.08.014; Kozlowski SK, 1972, PRADZIEJE ZIEM POLSK; Kriiska A., 2016, COMP PERSPECTIVES CO, P19; Kriiska A., 1999, ENV CULTURAL HIST E, V57, P157; Kukawka S., 1997, RUBIEZY SRODKOWOEURO; Kunkel O., 1936, MONATSBLATTER GESELL, V50, P47; lacumin P, 2002, EARTH PLANET SC LETT, V201, P213; lacumin P, 2000, PALAEOGEOGR PALAEOCL, V163, P33; LARSSON L, 1990, J WORLD PREHIST, V4, P257, DOI 10.1007/BF00974882; LINDGREN C., 2007, ROAD STUDIES L LARSS, P161; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; Lorenc Michal, 2006, Acta Zoologica Cracoviensia, V49A, P41, DOI 10.3409/000000006783995508; Loze I., 1973, MESOLITHIC EUROPE, P381; Malinowski B., 1961, ARGONAUTS W PACIFIC; Mannermaa K., 2016, MESOLITHIC MISCELLAN, V2, P19; Manninen M. A., 2011, MESOLITHIC INTERFACE, P143; Marciniak M., 1993, MESOLITHIC MISCELLAN, V14, P7; Mauss M., 2001, IDEM SOCIOLOGIA ANTR, P165; Moller P, 2013, HOLOCENE, V23, P104, DOI 10.1177/0959683612455546; Mowat F., 1973, TUNDRA SELECTIONS GR; Musil R., 2003, NEANDERTHALS MODERN, P167; O'Neil J.R., 1994, ISR J EARTH SCI, V43, P203; Olofsson A., 2003, ARCHAEOLOGY ENV; Oshibkina S. V., 1983, MEZOLIT BASSEYNA SUK; Osipowicz G., 2015, 9 INT C MES EUR MESO; Osipowicz G., 2010, NARZEDZIA KRZEMIENNE; Osipowicz G., 2014, WIAD ARCHEOL 65, P149; OSIPOWICZ G., 2015, PRZEGLAD ARCHEOLOGIC, V63, P59; Osipowicz G, 2017, SPOLECZNOSCI MEZOLIT; Osipowicz G., 2013, PRZEGLAD ARCHEOLOGIC, V61, P145; Osipowicz G, 2014, J LITHIC STUD, V1, P213, DOI 10.2218/jls.v1i1.774; Passe T, 2010, P SEM SEA LEV DISPL, P47; Peltier A, 1992, FICHES TYPOLOGIQUES, P7; Pesonen P., 1996, HELSINKI PAPERS ARCH, V9, P9; Piel-Desruisseaux JL, 2007, OUTILS PREHISTORIQUE; Piskorska T, 2014, QUATERN INT, p[359, 157]; Plaza DK, 2013, PRACE ARCHEOLOGICZNE, V66, P159; Plonka T., 2003, PORTABLE ART MESOLIT; Pokutta DA, 2013, POPULATION DYNAMICS; Pozzi E., 2004, MAGDALENIENS ART CIV; PRICE TD, 1990, ANTIQUITY, V64, P849, DOI 10.1017/S0003598X00078960; Prowse TL, 2007, AM J PHYS ANTHROPOL, V132, P510, DOI 10.1002/ajpa.20541; Rankama T, 2001, BOREAS, V30, P131; Rankama T., 2011, QUARTAR, V58, P183; Rankama T, 2008, ANTIQUITY, V82, P884, DOI 10.1017/S0003598X00097659; Reitsema LJ, 2013, J ARCHAEOL SCI, V40, P3636, DOI 10.1016/j.jas.2013.04.015; Riede F., 2014, OXFORD HDB ARCHAEOLO, P556; Ringsjoholm Sjostrom A., 1997, SWEDEN LUND ARCHAEOL, V3, P5; Roed KH, 2011, QUATERN INT, V238, P83, DOI 10.1016/j.quaint.2010.07.031; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Sawicki L., 1921, WIADOMO 101 ARCHEOLO, V6, P47; Schurr MR, 2008, ANALYSIS OF BURNED HUMAN REMAINS, P95, DOI 10.1016/B978-012372510-3.50007-1; Shaw B, 2010, J ARCHAEOL SCI, V37, P605, DOI 10.1016/j.jas.2009.10.025; Sommer RS, 2014, J BIOGEOGR, V41, P298, DOI 10.1111/jbi.12193; Sommer RS, 2011, GLOBAL CHANGE BIOL, V17, P2049, DOI 10.1111/j.1365-2486.2011.02388.x; Sorensen M, 2013, NOR ARCHAEOL REV, V46, P19, DOI 10.1080/00293652.2013.770416; Stevens RE, 2009, J HUM EVOL, V57, P131, DOI 10.1016/j.jhevol.2009.01.011; Subetto DA, 2002, BOREAS, V31, P1, DOI 10.1080/03009480210647; Sulgostowska Z, 1984, WIADOMOSCI ARCHEOLOG, V49, P191; Tallavaara M., 2014, BAR INT SERIES, V2599, P161; Terberger T., 2000, BODENDENKMALPFLEGE M, V48, P7; Ukkonen P, 2006, BOREAS, V35, P222, DOI 10.1080/03009480600578065; Volokitin A. V., 2004, ARCHAEOLOGY ETHNOLOG, P2; Volokitin AV, 2015, 4 NO ARCH C P OCT 19, P8; Volokitin AV, 2016, URO RAN, V4, P155; Volokitin AV, 2013, URO RAN, V8, P13; White C, 2004, J ARCHAEOL SCI, V31, P233, DOI 10.1016/j.jas.2003.08.007; White CD, 2004, J ANTHROPOL ARCHAEOL, V23, P385, DOI 10.1016/j.jaa.2004.08.002; White CD, 1998, J ARCHAEOL SCI, V25, P643, DOI 10.1006/jasc.1997.0259; Winters M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021247; Wygal BT, 2014, J WORLD PREHIST, V27, P111, DOI 10.1007/s10963-014-9075-z; Zagorska I., 2007, ROAD STUDIES L LARSS, V26, P193; Zhilin M.G, 2001, KOSTYANAYA IND MEZOL	118	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0184560	10.1371/journal.pone.0184560	http://dx.doi.org/10.1371/journal.pone.0184560			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI7FU	28977014	Green Submitted, Green Published, gold			2022-12-26	WOS:000412163100006
J	Carnwath, G; Nelson, C				Carnwath, Gunnar; Nelson, Cara			Effects of biotic and abiotic factors on resistance versus resilience of Douglas fir to drought	PLOS ONE			English	Article							RING GROWTH-RESPONSES; TREE MORTALITY; CLIMATE-CHANGE; FOREST GROWTH; NORTHERN ARIZONA; RADIAL GROWTH; MIXED-CONIFER; STAND; VARIABILITY; TEMPERATURE	Significant increases in tree mortality due to drought-induced physiological stress have been documented worldwide. This trend is likely to continue with increased frequency and severity of extreme drought events in the future. Therefore, understanding the factors that influence variability in drought responses among trees will be critical to predicting ecosystem responses to climate change and developing effective management actions. In this study, we used hierarchical mixed-effects models to analyze drought responses of Pseudotsuga menziesii in 20 unmanaged forests stands across a broad range of environmental conditions in northeastern Washington, USA. We aimed to 1) identify the biotic and abiotic attributes most closely associated with the responses of individual trees to drought and 2) quantify the variability in drought responses at different spatial scales. We found that growth rates and competition for resources significantly affected resistance to a severe drought event in 2001: slow-growing trees and trees growing in subordinate canopy positions and/or with more neighbors suffered greater declines in radial growth during the drought event. In contrast, the ability of a tree to return to normal growth when climatic conditions improved (resilience) was unaffected by competition or relative growth rates. Drought responses were significantly influenced by tree age: older trees were more resistant but less resilient than younger trees. Finally, we found differences between resistance and resilience in spatial scale: a significant proportion (approximately 50%) of the variability in drought resistance across the study area was at broad spatial scales (i.e. among different forest types), most likely due to differences in the total amount of precipitation received at different elevations; in contrast, variation in resilience was overwhelmingly (82%) at the level of individual trees within stands and there was no difference in drought resilience among forest types. Our results suggest that for Pseudotsuga menziesii resistance and resilience to drought are driven by different factors and vary at different spatial scales.	[Carnwath, Gunnar; Nelson, Cara] Univ Montana, WA Franke Coll Forestry & Conservat, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA; [Carnwath, Gunnar] US Forest Serv, Custer Gallatin Natl Forest, Bozeman, MT 59715 USA	University of Montana System; University of Montana; United States Department of Agriculture (USDA); United States Forest Service	Carnwath, G (corresponding author), Univ Montana, WA Franke Coll Forestry & Conservat, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA.; Carnwath, G (corresponding author), US Forest Serv, Custer Gallatin Natl Forest, Bozeman, MT 59715 USA.	gcarnwath@fs.fed.us	Nelson, Cara/AAC-2493-2020	Nelson, Cara/0000-0001-7508-0859	USDA Forest Service (Region 6 Area Ecology Program and Student Career Experience Program); Montana Institute on Ecosystems by the National Science Foundation EPSCoR program grant [EPS-1101342]	USDA Forest Service (Region 6 Area Ecology Program and Student Career Experience Program); Montana Institute on Ecosystems by the National Science Foundation EPSCoR program grant	This work was supported by McIntire-Stennis appropriations to the University of Montana, USDA Forest Service (Region 6 Area Ecology Program and Student Career Experience Program), and the Montana Institute on Ecosystems by the National Science Foundation EPSCoR program grant EPS-1101342. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank the USDA Forest Service Region 6 Area Ecology Program and Colville National Forest, especially M. Borysewicz, for logistical support; M. Yager, J. Bohlert, K. Bednarczyk, P. Stothart, T. Anfinson, and B. Maddox for data collection and core processing; and E. Sutherland, S. Running, J. Goodburn, and A. Sala for help with study design and manuscript review. This material is based on work supported by McIntire-Stennis appropriations to the University of Montana, USDA Forest Service (Region 6 Area Ecology Program and Student Career Experience Program), and the Montana Institute on Ecosystems by the National Science Foundation EPSCoR program grant EPS-1101342. Any opinions, findings and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the Montana Institute on Ecosystems or the National Science Foundation.	Adams HD, 2005, J BIOGEOGR, V32, P1629, DOI 10.1111/j.1365-2699.2005.01292.x; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; APPLEQUIST M. B., 1958, JOUR FOREST, V56, P141; Aussenac G, 2000, ANN FOR SCI, V57, P287; Battles JJ, 2008, CLIMATIC CHANGE, V87, pS193, DOI 10.1007/s10584-007-9358-9; Benito D, 2008, TREES-STRUCT FUNCT, V22, P363; BIGING GS, 1992, FOREST SCI, V38, P695; Bigler C, 2007, OIKOS, V116, P1983, DOI 10.1111/j.2007.0030-1299.16034.x; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Brooker RW, 2006, NEW PHYTOL, V171, P271, DOI 10.1111/j.1469-8137.2006.01752.x; Linares JC, 2010, J ECOL, V98, P592, DOI 10.1111/j.1365-2745.2010.01645.x; Linares JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P485, DOI 10.1111/j.1466-8238.2009.00465.x; Carnicer J, 2011, P NATL ACAD SCI USA, V108, P1474, DOI 10.1073/pnas.1010070108; Carnwath GC, 2016, J ECOL, V104, P1421, DOI 10.1111/1365-2745.12604; Carrer M, 2004, ECOLOGY, V85, P730, DOI 10.1890/02-0478; Case MJ, 2005, CAN J FOREST RES, V35, P2743, DOI 10.1139/X05-191; Cook E. R., 1981, Tree-Ring Bulletin, V41, P45; Crookston NL, 2010, FOREST ECOL MANAG, V260, P1198, DOI 10.1016/j.foreco.2010.07.013; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; DeClerck FAJ, 2006, ECOLOGY, V87, P2787, DOI 10.1890/0012-9658(2006)87[2787:SRASSI]2.0.CO;2; DEKORT I, 1993, CAN J FOREST RES, V23, P1480, DOI 10.1139/x93-185; Dobbertin M, 2005, EUR J FOREST RES, V124, P319, DOI 10.1007/s10342-005-0085-3; Domec JC, 2003, PLANT CELL ENVIRON, V26, P471, DOI 10.1046/j.1365-3040.2003.00978.x; Eis S., 1974, Canadian Journal of Forest Research, V4, P28, DOI 10.1139/x74-005; Fekedulegn D, 2003, FOREST ECOL MANAG, V177, P409, DOI 10.1016/S0378-1127(02)00446-2; Floyd ML, 2009, ECOL APPL, V19, P1223, DOI 10.1890/08-1265.1; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Fritts H. C., 1976, TREE RINGS CLIMATE; Galiano L, 2011, NEW PHYTOL, V190, P750, DOI 10.1111/j.1469-8137.2010.03628.x; Ganey JL, 2011, FOREST ECOL MANAG, V261, P162, DOI 10.1016/j.foreco.2010.09.048; Gazol A, 2016, J ECOL, V104, P1063, DOI 10.1111/1365-2745.12575; Gimeno TE, 2008, TREE PHYSL; Gitlin AR, 2006, CONSERV BIOL, V20, P1477, DOI 10.1111/j.1523-1739.2006.00424.x; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Holman ML, 2006, CAN J FOREST RES, V36, P92, DOI 10.1139/X05-225; Holmes R.L., 1986, TREE RING CHRONOLOGI, P41; IPCC, 2007, CLIM CHANG 2007 IPCC; Klos RJ, 2009, ECOL APPL, V19, P699, DOI 10.1890/08-0330.1; Koepke DF, 2010, OECOLOGIA, V163, P1079, DOI 10.1007/s00442-010-1671-8; Kramer P. G., 1983, PLANT SOIL WATER REL; Larsson L.A., 2003, CDENDRO CYBIS DENDRO; Larsson L-A, 2003, COORECORDER IMAGE CO; Littell JS, 2008, ECOL MONOGR, V78, P349, DOI 10.1890/07-0712.1; Lloret F, 2011, OIKOS, V120, P1909, DOI 10.1111/j.1600-0706.2011.19372.x; Ma ZH, 2012, P NATL ACAD SCI USA, V109, P2423, DOI 10.1073/pnas.1111576109; MACGILLIVRAY CW, 1995, FUNCT ECOL, V9, P640, DOI 10.2307/2390156; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; Manion PD, 1981, TREE DIS CONCEPT ENG; Martinez-Meier A, 2008, FOREST ECOL MANAG, V256, P837, DOI 10.1016/j.foreco.2008.05.041; Martinez-Vilalta J, 2012, OECOLOGIA, V168, P877, DOI 10.1007/s00442-011-2132-8; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; Merlin M, 2015, FOREST ECOL MANAG, V339, P22, DOI 10.1016/j.foreco.2014.11.032; MONSERUD RA, 1984, FOREST SCI, V30, P943; Monserud RA, 1979, RELATIONS INSIDE OUT; Moreno-Gutierrez C, 2012, PLANT CELL ENVIRON, V35, P1026, DOI 10.1111/j.1365-3040.2011.02469.x; Mueller RC, 2005, J ECOL, V93, P1085, DOI 10.1111/j.1365-2745.2005.01042.x; Oberhuber W, 2000, PLANT ECOL, V146, P231; Ogle K, 2000, ECOLOGY, V81, P3237, DOI 10.1890/0012-9658(2000)081[3237:TRVIPP]2.0.CO;2; Orwig DA, 1997, TREES-STRUCT FUNCT, V11, P474, DOI 10.1007/s004680050110; Orwin KH, 2004, SOIL BIOL BIOCHEM, V36, P1907, DOI 10.1016/j.soilbio.2004.04.036; Peterson DW, 2001, ECOLOGY, V82, P3330, DOI 10.1890/0012-9658(2001)082[3330:MHGRTC]2.0.CO;2; PHIPPS R L, 1982, Tree-Ring Bulletin, V42, P11; Pichler P, 2003, FOREST ECOL MANAG, P688; Pinheiro JC, 2009, MIXED EFFECTS MODELS; Pretzsch H, 2013, PLANT BIOLOGY, V15, P483, DOI 10.1111/j.1438-8677.2012.00670.x; Rich PM, 2008, ECOLOGY, V89, P342, DOI 10.1890/06-2137.1; Ryan MG, 1997, ADV ECOL RES, V27, P213, DOI 10.1016/S0065-2504(08)60009-4; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Stokes M.A., 1968, INTRO TREE RING DATI; Stout DL, 2003, TREE PHYSIOL, V23, P43, DOI 10.1093/treephys/23.1.43; SZEICZ JM, 1994, CAN J FOREST RES, V24, P120, DOI 10.1139/x94-017; Tardif J, 1997, CAN J FOREST RES, V27, P108, DOI 10.1139/cjfr-27-1-108; Tilman D., 1982, Monographs in Population Biology, pi; van der Molen MK, 2011, AGR FOREST METEOROL, V151, P765, DOI 10.1016/j.agrformet.2011.01.018; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; vandenBrakel JA, 1996, FOREST SCI, V42, P206; VILLALBA R, 1994, ECOLOGY, V75, P1450, DOI 10.2307/1937468; VOSE JM, 1994, FOREST ECOL MANAG, V64, P25, DOI 10.1016/0378-1127(94)90124-4; WHITE TL, 1987, FOREST SCI, V33, P283; Williams C., 1995, FORESTED PLANT ASS C; Zang C, 2014, GLOBAL CHANGE BIOL, V20, P3767, DOI 10.1111/gcb.12637; Zhang YX, 2010, FOREST ECOL MANAG, V260, P1076, DOI 10.1016/j.foreco.2010.06.034; Zimmermann M.H., 1984, XYLEM STRUCTURE ASCE, V26, P165	85	12	12	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185604	10.1371/journal.pone.0185604	http://dx.doi.org/10.1371/journal.pone.0185604			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973008	gold, Green Submitted, Green Published			2022-12-26	WOS:000412131900031
J	Hofmann, S; Everaars, J; Schweiger, O; Frenzel, M; Bannehr, L; Cord, AF				Hofmann, Sylvia; Everaars, Jeroen; Schweiger, Oliver; Frenzel, Mark; Bannehr, Lutz; Cord, Anna F.			Modelling patterns of pollinator species richness and diversity using satellite image texture	PLOS ONE			English	Article							FLOWER-VISITING BEES; AGRICULTURAL LANDSCAPES; ENVIRONMENTAL HETEROGENEITY; BIRD COMMUNITIES; BIODIVERSITY; VEGETATION; CONFIGURATION; PRODUCTIVITY; ASSEMBLAGES; RESOLUTION	Assessing species richness and diversity on the basis of standardised field sampling effort represents a cost-and time-consuming method. Satellite remote sensing (RS) can help overcome these limitations because it facilitates the collection of larger amounts of spatial data using cost-effective techniques. RS information is hence increasingly analysed to model biodiversity across space and time. Here, we focus on image texture measures as a proxy for spatial habitat heterogeneity, which has been recognized as an important determinant of species distributions and diversity. Using bee monitoring data of four years (2010-2013) from six 4 x 4 km field sites across Central Germany and a multimodel inference approach we test the ability of texture features derived from Landsat-TM imagery to model local pollinator biodiversity. Textures were shown to reflect patterns of bee diversity and species richness to some extent, with the first-order entropy texture and terrain roughness being the most relevant indicators. However, the texture measurements accounted for only 3-5% of up to 60% of the variability that was explained by our final models, although the results are largely consistent across different species groups (bumble bees, solitary bees). While our findings provide indications in support of the applicability of satellite imagery textures for modeling patterns of bee biodiversity, they are inconsistent with the high predictive power of texture metrics reported in previous studies for avian biodiversity. We assume that our texture data captured mainly heterogeneity resulting from landscape configuration, which might be functionally less important for wild bees than compositional diversity of plant communities. Our study also highlights the substantial variability among taxa in the applicability of texture metrics for modelling biodiversity.	[Hofmann, Sylvia] Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany; [Everaars, Jeroen] German Ctr Integrat Biodivers Res Halle Jena Leip, Leipzig, Germany; [Everaars, Jeroen; Schweiger, Oliver; Frenzel, Mark] Helmholtz Ctr Environm Res, Dept Community Ecol, Halle Sa, Germany; [Bannehr, Lutz] Inst Geoinformat & Surveying, Facil Management & Geoinformat, Dept Architecture, Dessau, Germany; [Cord, Anna F.] Helmholtz Ctr Environm Res, Dept Computat Landscape Ecol, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Hofmann, S (corresponding author), Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany.	sylvia.hofmann@ufz.de	Cord, Anna/AAE-8327-2022; Everaars, Jeroen/AAR-6131-2021; Everaars, Jeroen/AGP-5653-2022; Hofmann, Sylvia/AAO-4802-2021; Frenzel, Mark/ABB-9845-2021; Schweiger, Oliver/B-4909-2008; Frenzel, Mark/D-4778-2015	Everaars, Jeroen/0000-0001-8569-7377; Everaars, Jeroen/0000-0001-8569-7377; Schweiger, Oliver/0000-0001-8779-2335; Hofmann, Dr. S./0000-0003-0621-9049; Frenzel, Mark/0000-0003-1068-2394; Cord, Anna F./0000-0003-3183-8482	Helmholtz long-range strategic research funding (POF III)	Helmholtz long-range strategic research funding (POF III)	This work was supported by the Helmholtz long-range strategic research funding (POF III). However, the authors received no specific funding for this work.	Gallardo-Cruz JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030506; Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; [Anonymous], 2021, LANG ENV STAT COMP; Anys H., 1994, P 1 INT AIRB REM SEN, V3; Arellano G, 2017, GLOBAL ECOL BIOGEOGR, V26, P191, DOI 10.1111/geb.12531; BAKER WL, 1992, LANDSCAPE ECOL, V7, P291, DOI 10.1007/BF00131258; Baldi G, 2008, ECOL SOC, V13; Barton K., 2016, MUMIN MULTIMODEL INF; Batary P, 2011, P ROY SOC B-BIOL SCI, V278, P1894, DOI 10.1098/rspb.2010.1923; Beyer HL, 2012, GEOSPATIAL MODELLING; Bjornstad ON, 2001, ENVIRON ECOL STAT, V8, P53, DOI 10.1023/A:1009601932481; Bjornstad ON, 2016, NCF SPATIAL NONPARAM; Blaszczynski JS, 1997, PHOTOGRAMM ENG REM S, V63, P183; Boscolo D, 2017, PERSPECT ECOL CONSER, V15, P18, DOI 10.1016/j.pecon.2017.03.002; Breitbach N, 2012, OECOLOGIA, V168, P425, DOI 10.1007/s00442-011-2090-1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chapman RN, 2004, AGR ECOSYST ENVIRON, V104, P577, DOI 10.1016/j.agee.2004.01.026; Coblentz DD, 2004, J BIOGEOGR, V31, P1125, DOI 10.1111/j.1365-2699.2004.00981.x; Culbert PD, 2012, REMOTE SENS ENVIRON, V118, P140, DOI 10.1016/j.rse.2011.11.004; Culbert PD, 2009, IEEE J-STARS, V2, P299, DOI 10.1109/JSTARS.2009.2021959; do Carmo FF, 2016, J VEG SCI, V27, P50, DOI 10.1111/jvs.12342; Duelli P, 1999, AGR ECOSYST ENVIRON, V74, P33, DOI 10.1016/S0167-8809(99)00029-8; Dufour A, 2006, ECOGRAPHY, V29, P573, DOI 10.1111/j.0906-7590.2006.04605.x; Duro D. C., 2007, PROGR PHYS GEOGRAPHY, V31, P1; Duro DC, 2014, REMOTE SENS ENVIRON, V144, P214, DOI 10.1016/j.rse.2014.01.001; Evans J.S., ARCGIS TOOLBOX SURFA; Fox J, 2016, PACKAGECAR, DOI DOI 10.1177/0049124105277200; Frenzel M, 2016, ECOL INDIC, V65, P113, DOI 10.1016/j.ecolind.2015.11.020; Garibaldi L., 2011, ECOSYSTEM SERVICES A, P119; Hall-Beyer M., 2016, GLCM TUTORIAL HOME P; Hall-Beyer M., 2007, GLCM TUTORIAL HOME P; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Henry PY, 2008, BIODIVERS CONSERV, V17, P3357, DOI 10.1007/s10531-008-9417-1; Herkul K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055624; Holzschuh A, 2007, J APPL ECOL, V44, P41, DOI 10.1111/j.1365-2664.2006.01259.x; Holzschuh A, 2013, OECOLOGIA, V172, P477, DOI 10.1007/s00442-012-2515-5; Hsieh TC, 2016, INT SYMP WIREL; Jayapal R, 2009, FOREST ECOL MANAG, V257, P2287, DOI 10.1016/j.foreco.2009.03.010; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kuemmerle T, 2009, J LAND USE SCI, V4, P85, DOI 10.1080/17474230802648786; Lau MK, 2015, DIVERSITYSAMPLER FUN; Lee PY, 2005, J BIOGEOGR, V32, P1139, DOI 10.1111/j.1365-2699.2005.01254.x; Hernandez-Stefanoni JL, 2012, INT J APPL EARTH OBS, V19, P359, DOI 10.1016/j.jag.2012.04.002; Luoto M, 2004, ECOL APPL, V14, P1946, DOI 10.1890/02-5176; MAC ARTHUR ROBERT H., 1967; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Marini L, 2011, J BIOGEOGR, V38, P78, DOI 10.1111/j.1365-2699.2010.02376.x; Masek J.G., 2012, LEDAPS LANDSAT CALIB; MCGARIGAL K, 1995, PNW351 USDA FOR SERV; Muller J, 2009, J APPL ECOL, V46, P897, DOI 10.1111/j.1365-2664.2009.01677.x; Murray TE, 2012, J APPL ECOL, V49, P998, DOI 10.1111/j.1365-2664.2012.02175.x; Palmer MW, 2002, ENVIRONMETRICS, V13, P121, DOI 10.1002/env.516; Papanikolaou AD, 2017, J APPL ECOL, V54, P527, DOI 10.1111/1365-2664.12763; PATEL D, 1992, 11TH IAPR INTERNATIONAL CONFERENCE ON PATTERN RECOGNITION, PROCEEDINGS, VOL III, P92, DOI 10.1109/ICPR.1992.201935; Pinheiro J., 2016, NLME LINEAR NONLINEA; Riedinger V, 2015, ECOLOGY, V96, P1351, DOI 10.1890/14-1124.1; Riley S. J., 1999, INTERMOUNTAIN J SCI, V5, P1; Ripley R, 2016, MASS SUPPORT FUNCTIO; Rocchini D, 2010, MEASURING SPATIAL DI; Rocchini D, 2007, REMOTE SENS ENVIRON, V111, P423, DOI 10.1016/j.rse.2007.03.018; Rocchini D, 2016, REMOTE SENS ECOL CON, V2, P25, DOI 10.1002/rse2.9; Rocchini D, 2010, ECOL INFORM, V5, P318, DOI 10.1016/j.ecoinf.2010.06.001; Rocchini D, 2010, J ENVIRON MONITOR, V12, P825, DOI 10.1039/b921835a; Roulston TH, 2011, ANNU REV ENTOMOL, V56, P293, DOI 10.1146/annurev-ento-120709-144802; Schweiger O, 2005, J APPL ECOL, V42, P1129, DOI 10.1111/j.1365-2664.2005.01085.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; St-Louis V, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0197; St-Louis V, 2006, REMOTE SENS ENVIRON, V105, P299, DOI 10.1016/j.rse.2006.07.003; St-Louis V, 2009, ECOGRAPHY, V32, P468, DOI 10.1111/j.1600-0587.2008.05512.x; Steckel J, 2014, BIOL CONSERV, V172, P56, DOI 10.1016/j.biocon.2014.02.015; Torne-Noguera A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097255; Tuanmu MN, 2015, GLOBAL ECOL BIOGEOGR, V24, P1329, DOI 10.1111/geb.12365; Vierling KT, 2011, ECOL APPL, V21, P577, DOI 10.1890/09-2155.1; Wallis CIB, 2017, ECOL INDIC; Warner T, 2011, GEOGR COMPASS, V5, P781, DOI 10.1111/j.1749-8198.2011.00451.x; Wood EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063211; Wood EM, 2012, REMOTE SENS ENVIRON, V121, P516, DOI 10.1016/j.rse.2012.01.003; Wrbka T, 2004, LAND USE POLICY, V21, P289, DOI 10.1016/j.landusepol.2003.10.012; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	81	11	12	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185591	10.1371/journal.pone.0185591	http://dx.doi.org/10.1371/journal.pone.0185591			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973006	gold, Green Published, Green Submitted			2022-12-26	WOS:000412131900030
J	Knapp, J; Damy, S; Brillaud, J; Tissot, JD; Navion, J; Melior, R; Afonsol, E; Hormaz, V; Gottstein, B; Umhang, G; Casulli, A; Dadeau, F; Millon, L; Raoul, F				Knapp, Jenny; Damy, Sylvie; Brillaud, Jonathan; Tissot, Jean-Daniel; Navion, Jeremy; Melior, Raphael; Afonsol, Eve; Hormaz, Vanessa; Gottstein, Bruno; Umhang, Gerald; Casulli, Adriano; Dadeau, Frederic; Millon, Laurence; Raoul, Francis			EWET: Data collection and interface for the genetic analysis of Echinococcus multilocularis based on EmsB microsatellite	PLOS ONE			English	Article							GENUS ECHINOCOCCUS; CESTODA TAENIIDAE; TAPEWORM; LOCI; INVESTIGATE; DIVERSITY; ESTONIA; AREA	Evolution and dispersion history on Earth of organisms can best be studied through biological markers in molecular epidemiological studies. The biological diversity of the cestode Echinococcus multilocularis was investigated in different cladistic approaches. First the morphological aspects were explored in connection with its ecology. More recently, molecular aspects were investigated to better understand the nature of the variations observed among isolates. The study of the tandemly repeated multilocus microsatellite EmsB allowed us to attain a high genetic diversity level where other classic markers have failed. Since 2006, EmsB data have been collected on specimens from various endemic foci of the parasite in Europe (in historic and newly endemic areas), Asia (China, Japan and Kyrgyzstan), and North America (Canada and Alaska). Biological data on the isolates and metadata were also recorded (e.g. host, geographical location, EmsB analysis, citation in the literature). In order to make available the data set of 1,166 isolates from classic and aberrant domestic and wild animal hosts (larval lesions and adult worms) and from human origin, an open web access interface, developed in PHP, and connected to a PostgreSQL database, was developed in the EmsB Website for the Echinococcus Typing (EWET) project. It allows researchers to access data collection, perform genetic analyses online (e.g. defining the genetic distance between their own samples and the samples in the database), consult distribution maps of EmsB profiles, and record and share their new EmsB genotyping data. In order to standardize the EmsB analyses performed in the different laboratories throughout the world, a calibrator was developed. The final aim of this project was to gather and arrange available data to permit to better understand the dispersion and transmission patterns of the parasite among definitive and intermediate hosts, in order to organize control strategies on the ground.	[Knapp, Jenny; Damy, Sylvie; Brillaud, Jonathan; Tissot, Jean-Daniel; Navion, Jeremy; Afonsol, Eve; Millon, Laurence; Raoul, Francis] Univ Bourgogne Franche Comte, UMR CNRS 6249, Lab Chronoenvironm, Besancon, France; [Melior, Raphael] Observ Besancon, UMS OSU THETA Bourgogne Franche Comte 3245, Besancon, France; [Gottstein, Bruno] Inst Parasitol Bern, Bern, Switzerland; [Hormaz, Vanessa; Umhang, Gerald] Anses Nancy Lab Rabies & Wildlife, Wildlife Surveillance & Ecoepidemiol Unit, Natl Reference Lab Echinococcus Spp, Technopole Agr & Vet, Malzeville, France; [Casulli, Adriano] Ist Super Sanita, WHO Collaborating Ctr Epidemiol Detect & Control, Rome, Italy; [Casulli, Adriano] Ist Super Sanita, European Reference Lab Parasites, Rome, Italy; [Dadeau, Frederic] Univ Bourgogne Franche Comte, FEMTO ST Inst, CNRS, Besancon, France	Universite de Franche-Comte; Universite de Franche-Comte; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Technopole Agricole et Veterinaire; Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; Universite de Technologie de Belfort-Montbeliard (UTBM)	Knapp, J (corresponding author), Univ Bourgogne Franche Comte, UMR CNRS 6249, Lab Chronoenvironm, Besancon, France.	jenny.knapp@univ-comte.fr	Raoul, Francis/H-7706-2012; UMHANG, Gérald/K-6513-2019; Afonso, Eve/L-1286-2013; CASULLI, ADRIANO/O-2278-2015; Millon, laurence/AAK-5980-2020	Raoul, Francis/0000-0001-9566-9599; UMHANG, Gérald/0000-0001-6944-7474; Afonso, Eve/0000-0001-5836-9909; CASULLI, ADRIANO/0000-0001-9183-7591; Damy, Sylvie/0000-0002-1524-0862	Conseil Regional de Franche-Comte by the OREAS (Observatoire des Relations Ecosystemes - anthropisation- sante) project [2013C-09405]; Centre National de Reference des Echinococcoses	Conseil Regional de Franche-Comte by the OREAS (Observatoire des Relations Ecosystemes - anthropisation- sante) project; Centre National de Reference des Echinococcoses	The Conseil Regional de Franche-Comte by the OREAS (Observatoire des Relations Ecosystemes - anthropisation- sante) project (Grant No: 2013C-09405) and the Centre National de Reference des Echinococcoses have permitted to develop the website (student allowances).	Archak S, 2007, NUCLEIC ACIDS RES, V35, pD36, DOI 10.1093/nar/gkl778; Bart JM, 2006, INFECT GENET EVOL, V6, P390, DOI 10.1016/j.meegid.2006.01.006; Bhattacharjee K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094088; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; BOWLES J, 1993, INT J PARASITOL, V23, P969, DOI 10.1016/0020-7519(93)90065-7; BOWLES J, 1992, MOL BIOCHEM PARASIT, V54, P165, DOI 10.1016/0166-6851(92)90109-W; Brunetti E, 2010, ACTA TROP, V114, P1, DOI 10.1016/j.actatropica.2009.11.001; Budke CM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005477; Budke CM, 2006, EMERG INFECT DIS, V12, P296; Casulli A, 2010, VET PARASITOL, V174, P241, DOI 10.1016/j.vetpar.2010.08.023; Casulli A, 2009, INT J PARASITOL, V39, P837, DOI 10.1016/j.ijpara.2008.12.001; Charbonnier A, 2014, PARASITE, V21, DOI 10.1051/parasite/2014075; Eckert J., 2001, WHO OIE MANUAL ECHIN; Haag KL, 1997, PARASITOLOGY, V115, P521, DOI 10.1017/S0031182097001649; Hahn M, 2001, ELECTROPHORESIS, V22, P2691, DOI 10.1002/1522-2683(200108)22:13<2691::AID-ELPS2691>3.0.CO;2-S; Jenkins DJ, 2005, INT J PARASITOL, V35, P1205, DOI 10.1016/j.ijpara.2005.07.014; Knapp J, 2008, INFECT GENET EVOL, V8, P367, DOI 10.1016/j.meegid.2008.02.010; Knapp J, 2007, J CLIN MICROBIOL, V45, P2943, DOI 10.1128/JCM.02107-06; Knapp J, 2012, INFECT GENET EVOL, V12, P1270, DOI 10.1016/j.meegid.2012.03.008; Knapp J, 2011, MOL PHYLOGENET EVOL, V61, P628, DOI 10.1016/j.ympev.2011.07.022; Knapp J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000452; Kobayashi Y, 2008, THEOR POPUL BIOL, V74, P84, DOI 10.1016/j.tpb.2008.05.001; Laurimaa L, 2015, VET PARASITOL, V212, P200, DOI 10.1016/j.vetpar.2015.06.004; Laurimaa L, 2015, EMERG INFECT DIS, V21, P163, DOI 10.3201/eid2101.140136; Lavikainen A, 2008, PARASITOLOGY, V135, P1457, DOI 10.1017/S003118200800499X; Maillard S, 2009, J CLIN MICROBIOL, V47, P3608, DOI 10.1128/JCM.00938-09; Nakao M, 2013, INT J PARASITOL, V43, P1017, DOI 10.1016/j.ijpara.2013.06.002; Nakao M, 2003, INFECT GENET EVOL, V3, P159, DOI 10.1016/S1567-1348(03)00070-4; Nakao M, 2009, PARASITOL INT, V58, P384, DOI 10.1016/j.parint.2009.07.010; Roussel S, 2011, INT J MED MICROBIOL, V301, P150, DOI 10.1016/j.ijmm.2010.07.002; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tardieu H, 2000, METHODE MERISE PRINC; Torgerson PR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000722; Umhang G, 2014, INFECT GENET EVOL, V22, P142, DOI 10.1016/j.meegid.2014.01.018; Valot B, 2015, INFECT GENET EVOL, V32, P338, DOI 10.1016/j.meegid.2015.03.040	35	10	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0183849	10.1371/journal.pone.0183849	http://dx.doi.org/10.1371/journal.pone.0183849			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972978	Green Published, gold, Green Submitted			2022-12-26	WOS:000412131900003
J	Wu, LC; Li, MN; Tian, L; Wang, SX; Wu, LJ; Ku, LX; Zhang, J; Song, XH; Liu, HP; Chen, YH				Wu, Liancheng; Li, Mingna; Tian, Lei; Wang, Shunxi; Wu, Liuji; Ku, Lixia; Zhang, Jun; Song, Xiaoheng; Liu, Haiping; Chen, Yanhui			Global transcriptome analysis of the maize (Zea mays L.) inbred line 08LF during leaf senescence initiated by pollination-prevention	PLOS ONE			English	Article							ABSCISIC-ACID; JASMONIC ACID; GENE-EXPRESSION; ARABIDOPSIS; DEFENSE; STRESS; IDENTIFICATION; REVEALS; BIOSYNTHESIS; CONVERGENCE	In maize (Zea mays), leaf senescence acts as a nutrient recycling process involved in proteins, lipids, and nucleic acids degradation and transport to the developing sink. However, the molecular mechanisms of pre-maturation associated with pollination-prevention remain unclear in maize. To explore global gene expression changes during the onset and progression of senescence in maize, the inbred line 08LF, with severe early senescence caused by pollination prevention, was selected. Phenotypic observation showed that the onset of leaf senescence of 08LF plants occurred approximately 14 days after silking (DAS) by pollination prevention. Transcriptional profiling analysis of the leaf at six developmental stages during induced senescence revealed that a total of 5,432 differentially expressed genes (DEGs) were identified, including 2314 up-regulated genes and 1925 down-regulated genes. Functional annotation showed that the up-regulated genes were mainly enriched in multi-organism process and nitrogen compound transport, whereas down-regulated genes were involved in photosynthesis. Expression patterns and pathway enrichment analyses of early-senescence related genes indicated that these DEGs are involved in complex regulatory networks, especially in the jasmonic acid pathway. In addition, transcription factors from several families were detected, particularly the CO-like, NAC, ERF, GRAS, WRKY and ZF-HD families, suggesting that these transcription factors might play important roles in driving leaf senescence in maize as a result of pollination-prevention.	[Wu, Liancheng; Li, Mingna; Tian, Lei; Wang, Shunxi; Wu, Liuji; Ku, Lixia; Song, Xiaoheng; Chen, Yanhui] Henan Agr Univ, Coll Agron, Synerget Innovat Ctr Henan Grain Crops, Zhengzhou, Henan, Peoples R China; [Wu, Liancheng; Li, Mingna; Tian, Lei; Wang, Shunxi; Wu, Liuji; Ku, Lixia; Song, Xiaoheng; Chen, Yanhui] Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou, Henan, Peoples R China; [Zhang, Jun] Henan Acad Agr Sci, Inst 3Cereal, Henan Prov Key Lab Maize Biol, Zhengzhou, Henan, Peoples R China; [Liu, Haiping] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA	Henan Agricultural University; Henan Agricultural University; Henan Academy of Agricultural Sciences; Michigan Technological University	Chen, YH (corresponding author), Henan Agr Univ, Coll Agron, Synerget Innovat Ctr Henan Grain Crops, Zhengzhou, Henan, Peoples R China.; Chen, YH (corresponding author), Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou, Henan, Peoples R China.	chy9953@163.com		Tian, Lei/0000-0001-5374-0641	national key research and development program of China [2016YFD0101205-3]; Major Science and Technology Projects of Henan Province, China [161100110500]; Basic and Frontier Project of Henan Province, China [142300413218]	national key research and development program of China; Major Science and Technology Projects of Henan Province, China; Basic and Frontier Project of Henan Province, China	This work was supported by the national key research and development program of China (2016YFD0101205-3), the Major Science and Technology Projects of Henan Province, China (No.161100110500), and the Basic and Frontier Project of Henan Province, China (No.142300413218).	ALLISON JCS, 1970, PLANT PHYSIOL, V46, P435, DOI 10.1104/pp.46.3.435; Balazadeh S, 2011, MOL PLANT, V4, P346, DOI 10.1093/mp/ssq080; Balazadeh S, 2010, PLANT J, V62, P250, DOI 10.1111/j.1365-313X.2010.04151.x; Berberich T, 1999, MOL GEN GENET, V262, P534, DOI 10.1007/s004380051115; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Breeze E, 2011, PLANT CELL, V23, P873, DOI 10.1105/tpc.111.083345; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; CEPPI D, 1987, PLANT PHYSIOL, V85, P720, DOI 10.1104/pp.85.3.720; Christ B, 2014, J PLANT GROWTH REGUL, V33, P4, DOI 10.1007/s00344-013-9392-y; De Michele R, 2009, NEW PHYTOL, V181, P563, DOI 10.1111/j.1469-8137.2008.02684.x; Desclos M, 2009, PROTEOMICS, V9, P3580, DOI 10.1002/pmic.200800984; Dong HH, 2008, J EXP BOT, V59, P1295, DOI 10.1093/jxb/ern035; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Gao XQ, 2008, MOL PLANT MICROBE IN, V21, P98, DOI 10.1094/MPMI-21-1-0098; Gaudet P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000431; Gnanasekaran T, 2016, J EXP BOT, V67, P2495, DOI 10.1093/jxb/erw067; Goetz S, 2012, PLANT PHYSIOL, V158, P1715, DOI 10.1104/pp.111.192658; Greenboim-Wainberg Y, 2005, PLANT CELL, V17, P92, DOI 10.1105/tpc.104.028472; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Guo YF, 2005, CURR TOP DEV BIOL, V71, P83, DOI 10.1016/S0070-2153(05)71003-6; Guo YF, 2012, PLANT CELL ENVIRON, V35, P644, DOI 10.1111/j.1365-3040.2011.02442.x; Hao da C, 2011, PLOS ONE, V6; He P, 2005, J EXP BOT, V56, P1117, DOI 10.1093/jxb/eri103; He YH, 2002, PLANT PHYSIOL, V128, P876, DOI 10.1104/pp.010843; Huang CK, 2015, PLANT MOL BIOL, V88, P269, DOI 10.1007/s11103-015-0321-2; Jiang YJ, 2014, PLANT CELL, V26, P230, DOI 10.1105/tpc.113.117838; Jung C, 2007, PLANT CELL REP, V26, P1053, DOI 10.1007/s00299-007-0311-1; Khan AL, 2013, WORLD J MICROB BIOT, V29, P2133, DOI 10.1007/s11274-013-1378-1; Kong XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069847; Koyama T, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00650; Ku LX, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0930-1; Lee HN, 2015, BIOCHEM BIOPH RES CO, V463, P24, DOI 10.1016/j.bbrc.2015.05.010; Lee SH, 2015, J INTEGR PLANT BIOL, V57, P562, DOI 10.1111/jipb.12276; LEOPOLD AC, 1961, SCIENCE, V134, P1727, DOI 10.1126/science.134.3492.1727; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Li ZH, 2014, NUCLEIC ACIDS RES, V42, pD1200, DOI 10.1093/nar/gkt1061; Li ZH, 2012, J INTEGR PLANT BIOL, V54, P526, DOI 10.1111/j.1744-7909.2012.01136.x; Liang CZ, 2014, P NATL ACAD SCI USA, V111, P10013, DOI 10.1073/pnas.1321568111; Lim PO, 2005, CURR TOP DEV BIOL, V67, P49, DOI 10.1016/S0070-2153(05)67002-0; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Lin M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0433-5; Liu L, 2008, PLANT MOL BIOL, V67, P37, DOI 10.1007/s11103-008-9300-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McLaughlin JE, 2004, ANN BOT-LONDON, V94, P675, DOI 10.1093/aob/mch193; Meguro M, 2011, PLANT CELL, V23, P3442, DOI 10.1105/tpc.111.089714; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Miao Y, 2007, PLANT CELL, V19, P819, DOI 10.1105/tpc.106.042705; Nagarajan VK, 2011, PLANT PHYSIOL, V156, P1149, DOI 10.1104/pp.111.174805; Nooden LD, 1988, PHENOMENA SENESCENCE, P1; Okada K, 1998, PLANT CELL PHYSIOL, V39, P394, DOI 10.1093/oxfordjournals.pcp.a029382; OuYang FQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127896; Palmer NA, 2015, FUNCT INTEGR GENOMIC, V15, P1, DOI 10.1007/s10142-014-0393-0; PARTHIER B, 1990, J PLANT GROWTH REGUL, V9, P57, DOI 10.1007/BF02041942; Reinbothe C, 2009, FEBS J, V276, P4666, DOI 10.1111/j.1742-4658.2009.07193.x; Ren GD, 2010, J INTEGR PLANT BIOL, V52, P496, DOI 10.1111/j.1744-7909.2010.00945.x; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; Robatzek S, 2001, PLANT J, V28, P123, DOI 10.1046/j.1365-313X.2001.01131.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sarwat M, 2013, BIOTECHNOL ADV, V31, P1153, DOI 10.1016/j.biotechadv.2013.02.003; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Sekhon RS, 2012, PLANT PHYSIOL, V159, P1730, DOI 10.1104/pp.112.199224; Seltmann MA, 2010, PLANT PHYSIOL, V152, P1940, DOI 10.1104/pp.110.153114; Shan XY, 2011, PLANT PHYSIOL, V155, P751, DOI 10.1104/pp.110.166595; Song Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep29843; Song YW, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00181; STONE JM, 1995, PLANT PHYSIOL, V108, P451, DOI 10.1104/pp.108.2.451; Tanaka M, 2006, PLANT J, V45, P1028, DOI 10.1111/j.1365-313X.2006.02656.x; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thomson WW, 1987, ULTRASTRUCTURE SENES; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; UEDA J, 1980, PLANT PHYSIOL, V66, P246, DOI 10.1104/pp.66.2.246; Ulker B, 2007, PLANTA, V226, P125, DOI 10.1007/s00425-006-0474-y; Van der Graaff E, 2006, PLANT PHYSIOL, V141, P776, DOI 10.1104/pp.106.079293; Wang Y, 2012, J EXP BOT, V63, P5887, DOI 10.1093/jxb/ers238; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wei SS, 2015, PLANT SCI, V233, P72, DOI 10.1016/j.plantsci.2015.01.002; WEILER EW, 1981, PLANTA, V153, P561, DOI 10.1007/BF00385542; Woo HR, 2016, PLANT PHYSIOL, V171, P452, DOI 10.1104/pp.15.01929; Wu L., 2016, ACM T INTEL SYST TEC, V7, DOI DOI 10.18632/0NC0TARGET.8489; Wu XY, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0755-y; Wu XY, 2016, PLANT MOL BIOL, V92, P555, DOI 10.1007/s11103-016-0532-1; Wu XY, 2012, J INTEGR PLANT BIOL, V54, P936, DOI 10.1111/jipb.12005; Xiao S, 2004, PLANT CELL, V16, P1132, DOI 10.1105/tpc.020370; Xie Y, 2014, DEVELOPMENT, V141, P4772, DOI 10.1242/dev.117689; Yan YX, 2012, PLANT CELL, V24, P1420, DOI 10.1105/tpc.111.094151; Yoshida S, 2003, CURR OPIN PLANT BIOL, V6, P79, DOI 10.1016/S1369526602000092; Young TE, 2004, PLANT J, V38, P910, DOI 10.1111/j.1365-313X.2004.02093.x; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zhang WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115617	94	7	8	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185838	10.1371/journal.pone.0185838	http://dx.doi.org/10.1371/journal.pone.0185838			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973044	Green Submitted, Green Published, gold			2022-12-26	WOS:000412131900060
J	Buffinton, CM; Benjamin, AK; Firment, AN; Moon, AM				Buffinton, Christine Miller; Benjamin, Alyssa K.; Firment, Ashley N.; Moon, Anne M.			Myocardial wall stiffening in a mouse model of persistent truncus arteriosus	PLOS ONE			English	Article							LEFT-HEART HYPOPLASIA; CHICK-EMBRYO; OUTFLOW TRACT; PIPETTE ASPIRATION; MECHANICAL-PROPERTIES; BLOOD-FLOW; TISSUE; MORPHOGENESIS; EXPRESSION; STRESS	Background Genetic and epigenetic programs regulate dramatic structural changes during cardiac morphogenesis. Concurrent biomechanical forces within the heart created by blood flow and pressure in turn drive downstream cellular, molecular and genetic responses. Thus, a genetic-morphogenetic-biomechanical feedback loop is continually operating to regulate heart development. During the evolution of a congenital heart defect, concomitant abnormalities in blood flow, hemodynamics, and patterns of mechanical loading would be predicted to change the output of this feedback loop, impacting not only the ultimate morphology of the defect, but potentially altering tissue-level biomechanical properties of structures that appear structurally normal. Aim The goal of this study was to determine if abnormal hemodynamics present during outflow tract formation and remodeling in a genetically engineered mouse model of persistent truncus arteriosus (PTA) causes tissue-level biomechanical abnormalities. Methods The passive stiffness of surface locations on the left ventricle (LV), right ventricle (RV), and outflow tract (OFT) was measured with a pipette aspiration technique in Fgf8; Isl1Cre conditional mutant embryonic mouse hearts and controls. Control and mutant experimental results were compared by a strain energy metric based on the measured relationship between pressure and aspirated height, and also used as target behavior for finite element models of the ventricles. Model geometry was determined from 3D reconstructions of whole-mount, confocal-imaged hearts. The stress-strain relationship of the model was adjusted to achieve an optimal match between model and experimental behavior. Results and conclusion Although the OFT is the most severely affected structure in Fgf8; Isl1Cre hearts, its passive stiffness was the same as in control hearts. In contrast, both the LV and RV showed markedly increased passive stiffness, doubling in LVs and quadrupling in RVs of mutant hearts. These differences are not attributable to differences in ventricular volume, wall thickness, or trabecular density. Excellent agreement was obtained between the model and experimental results. Overall our findings show that hearts developing PTA have early changes in ventricular tissue biomechanics relevant to cardiac function and ongoing development.	[Buffinton, Christine Miller] Bucknell Univ, Dept Mech Engn, Lewisburg, PA 17837 USA; [Benjamin, Alyssa K.] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA; [Firment, Ashley N.; Moon, Anne M.] Geisinger Med Ctr, Weis Ctr Res, Dept Mol & Funct Genom, Danville, PA 17822 USA	Bucknell University; Bucknell University; Geisinger Medical Center	Buffinton, CM (corresponding author), Bucknell Univ, Dept Mech Engn, Lewisburg, PA 17837 USA.	christine.buffinton@bucknell.edu		Buffinton, Christine/0000-0001-7369-3651; moon, anne/0000-0002-9090-1093	BucknellGeisinger Research Initiation	BucknellGeisinger Research Initiation	This work was supported by a BucknellGeisinger Research Initiation Grant to CMB and AMM (website: httplAwfw.bucknell.edu/BGR I). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 1997, ANN BIOMED ENG, V25, P581, DOI 10.1007/BF02684197; Azaripour A, 2016, PROG HISTOCHEM CYTO, V51, P9, DOI 10.1016/j.proghi.2016.04.001; Bharadwaj KN, 2012, ANN BIOMED ENG, V40, P2212, DOI 10.1007/s10439-012-0574-8; Boudou T, 2006, J BIOMECH, V39, P1677, DOI 10.1016/j.jbiomech.2005.04.026; Buffinton CM, 2013, BIOMECH MODEL MECHAN, V12, P1037, DOI 10.1007/s10237-012-0461-0; Buffinton CM, 2015, J MECH BEHAV BIOMED, V51, P367, DOI 10.1016/j.jmbbm.2015.07.022; Buskohl P. R., 2011, J BIOMECH; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; CLARK EB, 1989, AM J PHYSIOL, V257, pH55, DOI 10.1152/ajpheart.1989.257.1.H55; CLARK EB, 1984, AM J CARDIOL, V53, P324, DOI 10.1016/0002-9149(84)90447-8; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Groenendijk BCW, 2007, PHYSIOLOGY, V22, P380, DOI 10.1152/physiol.00023.2007; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hirschy A, 2006, DEV BIOL, V289, P430, DOI 10.1016/j.ydbio.2005.10.046; Hogers B, 1999, CARDIOVASC RES, V41, P87, DOI 10.1016/S0008-6363(98)00218-1; Hogers B, 1997, CIRC RES, V80, P473, DOI 10.1161/01.RES.80.4.473; Hu N, 2009, ANAT REC, V292, P652, DOI 10.1002/ar.20885; Jacot JG, 2010, J BIOMECH, V43, P93, DOI 10.1016/j.jbiomech.2009.09.014; Jahrling N, 2009, ORGANOGENESIS, V5, P227, DOI 10.4161/org.5.4.10403; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kolesova H, 2016, HISTOCHEM CELL BIOL, V146, P141, DOI 10.1007/s00418-016-1441-8; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Li P, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2153851; Lindsey SE, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00318; Lucitti JL, 2005, J EXP BIOL, V208, P1877, DOI 10.1242/jeb.01574; Macatee TL, 2003, DEVELOPMENT, V130, P6361, DOI 10.1242/dev.00850; Majkut S, 2013, CURR BIOL, V23, P2434, DOI 10.1016/j.cub.2013.10.057; Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166; Mavroudis C, 2015, WORLD J PEDIATR CONG, V6, P226, DOI 10.1177/2150135115572375; Mekkaoui C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072795; Midgettand M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00287; Miller CE, 2005, MICROSC MICROANAL, V11, P216, DOI 10.1017/S1431927605050464; Miller CE, 2003, AM J PHYSIOL-HEART C, V285, pH1849, DOI 10.1152/ajpheart.00384.2002; Mjaatvedt CH, 2001, DEV BIOL, V238, P97, DOI 10.1006/dbio.2001.0409; Ohashi T, 2005, J BIOMECH, V38, P2248, DOI 10.1016/j.jbiomech.2004.09.019; Park EJ, 2008, DEVELOPMENT, V135, P3599, DOI 10.1242/dev.025437; Park EJ, 2006, DEVELOPMENT, V133, P2419, DOI 10.1242/dev.02367; Schroder EA, 2002, CIRC RES, V91, P353, DOI 10.1161/01.RES.0000030179.78135.FA; Sedmera D, 1999, ANAT RECORD, V254, P238, DOI 10.1002/(SICI)1097-0185(19990201)254:2<238::AID-AR10>3.0.CO;2-V; Sedmera D, 1997, ANAT RECORD, V248, P421; Sedmera D, 2002, ANAT REC, V267, P137, DOI 10.1002/ar.10098; Sissman N J, 1970, Am J Cardiol, V25, P141, DOI 10.1016/0002-9149(70)90575-8; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tobita K, 2000, AM J PHYSIOL-HEART C, V279, pH959, DOI 10.1152/ajpheart.2000.279.3.H959; Tobita K, 2002, AM J PHYSIOL-HEART C, V282, pH2386, DOI 10.1152/ajpheart.00879.2001; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Wang YJ, 2009, ANN BIOMED ENG, V37, P1069, DOI 10.1007/s10439-009-9682-5; Wyczalkowski MA, 2012, BIRTH DEFECTS RES C, V96, P132, DOI 10.1002/bdrc.21013; Yalcin HC, 2011, DEV DYNAM, V240, P23, DOI 10.1002/dvdy.22512; Yancy CW, 2006, J AM COLL CARDIOL, V47, P76, DOI 10.1016/j.jacc.2005.09.022; Zhao RG, 2011, ACTA BIOMATER, V7, P1220, DOI 10.1016/j.actbio.2010.11.004; Zile MR, 2015, CIRCULATION, V131, P1247, DOI 10.1161/CIRCULATIONAHA.114.013215	56	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0184678	10.1371/journal.pone.0184678	http://dx.doi.org/10.1371/journal.pone.0184678			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961240	Green Submitted, Green Published, gold			2022-12-26	WOS:000412027700009
J	Ogata, T; Ito, K; Shindo, T; Hatanaka, K; Eguchi, K; Kurosawa, R; Kagaya, Y; Monma, Y; Ichijo, S; Taki, H; Kanai, H; Shimokawa, H				Ogata, Tsuyoshi; Ito, Kenta; Shindo, Tomohiko; Hatanaka, Kazuaki; Eguchi, Kumiko; Kurosawa, Ryo; Kagaya, Yuta; Monma, Yuto; Ichijo, Sadamitsu; Taki, Hirofumi; Kanai, Hiroshi; Shimokawa, Hiroaki			Low-intensity pulsed ultrasound enhances angiogenesis and ameliorates contractile dysfunction of pressure-overloaded heart in mice	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; RHO-KINASE; IN-VIVO; FAILURE; EPIDEMIOLOGY; PROMOTES; CONTRIBUTES; TRANSITION; BLOCKADE; FIBROSIS	Introduction Chronic left ventricular (LV) pressure overload causes relative ischemia with resultant LV dysfunction. We have recently demonstrated that low-intensity pulsed ultrasound (LIPUS) improves myocardial ischemia in a pig model of chronic myocardial ischemia through enhanced myocardial angiogenesis. In the present study, we thus examined whether LIPUS also ameliorates contractile dysfunction in LV pressure-overloaded hearts. Methods and results Chronic LV pressure overload was induced with transverse aortic constriction (TAC) in mice. LIPUS was applied to the whole heart three times in the first week after TAC and was repeated once a week for 7 weeks thereafter (n = 22). Animals in the control groups received the sham treatment without LIPUS (n = 23). At 8 weeks after TAC, LV fractional shortening was depressed in the TAC-Control group, which was significantly ameliorated in the TAC-LIPUS group (30.4 +/- 0.5 vs. 36.2 +/- 3.8%, P < 0.05). Capillary density was higher and perivascular fibrosis was less in the LV in the TAC-LIPUS group than in the TAC-Control group. Myocardial relative ischemia evaluated with hypoxyprobe was noted in the TAC-Control group, which was significantly attenuated in the TAC-LIPUS group. In the TAC-LIPUS group, as compared with the control group, mRNA expressions of BNP and collagen III were significantly lower (both P < 0.05) and protein expressions of VEGF and eNOS were significantly up-regulated associated with Akt activation (all P < 0.05). No adverse effect related to the LIPUS therapy was noted. Conclusions These results indicate that the LIPUS therapy ameliorates contractile dysfunction in chronically pressure-overloaded hearts through enhanced myocardial angiogenesis and attenuated perivascular fibrosis. Thus, the LIPUS therapy may be a promising, non-invasive treatment for cardiac dysfunction due to chronic pressure overload.	[Ogata, Tsuyoshi; Ito, Kenta; Shindo, Tomohiko; Hatanaka, Kazuaki; Eguchi, Kumiko; Kurosawa, Ryo; Kagaya, Yuta; Monma, Yuto; Ichijo, Sadamitsu; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi, Japan; [Taki, Hirofumi; Kanai, Hiroshi] Tohoku Univ, Grad Sch Engn, Dept Elect Engn, Sendai, Miyagi, Japan; [Taki, Hirofumi; Kanai, Hiroshi] Tohoku Univ, Grad Sch Biomed Engn, Div Biomed Measurements & Diagnost, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University	Ito, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi, Japan.	ito-kenta@cardio.med.tohoku.ac.jp	Kanai, Hiroshi/T-4996-2019; Ito, Kenta/AAX-4906-2020	Kanai, Hiroshi/0000-0002-6567-1687; Ito, Kenta/0000-0002-9725-399X; Shimokawa, Hiroaki/0000-0001-7534-4826	Japanese Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan; Japanese Ministry of Health, Labor, and Welfare, Tokyo, Japan	Japanese Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor, and Welfare, Tokyo, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan, and the Japanese Ministry of Health, Labor, and Welfare, Tokyo, Japan.	Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; Asimakopoulos G, 1997, CIRCULATION, V96, P3403; Barzelai S, 2006, ULTRASOUND MED BIOL, V32, P139, DOI 10.1016/j.ultrasmedbio.2005.08.010; Carnell DM, 2006, INT J RADIAT ONCOL, V65, P91, DOI 10.1016/j.ijrobp.2005.11.044; Chaanine AH, 2011, EUR J HEART FAIL, V13, P825, DOI 10.1093/eurjhf/hfr080; Chintalgattu V, 2010, J CLIN INVEST, V120, P472, DOI 10.1172/JCI39434; Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939; Dorn GW, 2007, CELL METAB, V5, P326, DOI 10.1016/j.cmet.2007.04.003; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Friehs I, 2006, CIRCULATION, V114, pI290, DOI 10.1161/CIRCULATIONAHA.105.001289; Godecke A, 2001, J PHYSIOL-LONDON, V532, P195, DOI 10.1111/j.1469-7793.2001.0195g.x; Hanawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104863; Harada K, 1996, AM J PHYSIOL-HEART C, V270, pH1791, DOI 10.1152/ajpheart.1996.270.5.H1791; Higashikuni Y, 2012, ARTERIOSCL THROM VAS, V32, P654, DOI 10.1161/ATVBAHA.111.240341; Ikeda S, 2014, ARTERIOSCL THROM VAS, V34, P1260, DOI 10.1161/ATVBAHA.114.303320; Izumiya Y, 2006, HYPERTENSION, V47, P887, DOI 10.1161/01.HYP.0000215207.54689.31; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Lin WY, 2011, WORLD J UROL, V29, P165, DOI 10.1007/s00345-008-0369-6; Miura K, 2013, CIRC J, V77, P2226, DOI 10.1253/circj.CJ-13-0847; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nazer B, 2015, CIRC J, V79, P2043, DOI 10.1253/circj.CJ-15-0366; Oka T, 2014, CIRC RES, V114, P565, DOI 10.1161/CIRCRESAHA.114.300507; PEARLMAN JD, 1995, NAT MED, V1, P1085, DOI 10.1038/nm1095-1085; Raleigh JA, 2001, INT J RADIAT ONCOL, V49, P569, DOI 10.1016/S0360-3016(00)01505-4; Ramli R, 2009, INT J ORAL MAX IMPL, V24, P591; Roger VL, 2013, CIRC RES, V113, P646, DOI 10.1161/CIRCRESAHA.113.300268; Ruetten H, 2005, CARDIOVASC RES, V66, P444, DOI 10.1016/j.cardiores.2005.01.021; Sakata Y, 2013, CIRC J, V77, P2209, DOI 10.1253/circj.CJ-13-0971; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Santana LD, 2013, ULTRASONICS, V53, P870, DOI 10.1016/j.ultras.2012.12.009; Sato M, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0798-8; Scherrer-Crosbie M, 2001, CIRCULATION, V104, P1286, DOI 10.1161/hc3601.094298; Shimokawa H, 2015, EUR J HEART FAIL, V17, P884, DOI 10.1002/ejhf.319; Shindo T, 2016, ARTERIOSCL THROM VAS, V36, P1220, DOI 10.1161/ATVBAHA.115.306477; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shiojima I, 2012, AM J PATHOL, V181, P1969, DOI 10.1016/j.ajpath.2012.08.020; Shiroto T, 2009, J AM COLL CARDIOL, V54, P2321, DOI 10.1016/j.jacc.2009.07.045; Simons M, 2005, CIRCULATION, V111, P1556, DOI 10.1161/01.CIR.0000159345.00591.8F; Simons M, 2003, NAT REV DRUG DISCOV, V2, P863, DOI 10.1038/nrd1226; Suzuki K, 2016, ARTERIOSCL THROM VAS, V36, P636, DOI 10.1161/ATVBAHA.115.306686; ter Haar G, 2007, PROG BIOPHYS MOL BIO, V93, P111, DOI 10.1016/j.pbiomolbio.2006.07.005; Tomita H, 1998, HYPERTENSION, V32, P273, DOI 10.1161/01.HYP.32.2.273	42	15	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185555	10.1371/journal.pone.0185555	http://dx.doi.org/10.1371/journal.pone.0185555			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957396	Green Submitted, Green Published, gold			2022-12-26	WOS:000411985200084
J	Romero, AN; Herlin, M; Finnila, M; Korkalainen, M; Hakansson, H; Viluksela, M; Sholts, SB				Romero, Ashly N.; Herlin, Maria; Finnila, Mikko; Korkalainen, Merja; Hakansson, Helen; Viluksela, Matti; Sholts, Sabrina B.			Skeletal and dental effects on rats following in utero/lactational exposure to the non-dioxin-like polychlorinated biphenyl PCB 180	PLOS ONE			English	Article							2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; TOOTH DEVELOPMENT; RECEPTOR CAR; HALF-LIVES; BONE; INDUCTION; UTERO; TEETH; EXPRESSION; BIOMARKER	Polychlorinated biphenyls (PCBs) are a large class of persistent organic pollutants that are potentially harmful to human and wildlife health. Although a small number of dioxin-like (DL) PCBs are well characterized, the majority of PCBs have non-dioxin-like (NDL) modes of action and biological effects that are less understood. We conducted a dose-response study of the skeletal and dental effects of in utero/lactational exposure to 2,2', 3,4,4', 5,5'-hepta-chlorobiphenyl (PCB 180), a NDL PCB congener that is abundantly present in the environment and foods, including mother's milk. In a sample of 35-and 84-day-old male and female offspring from pregnant rats exposed to different doses of PCB 180 (0, 10, 30, 100, 300, and 1000 mg/kg bw), we measured the three-dimensional (3D) coordinates of 27 landmarks on the craniofacial skeleton with a Microscribe G2X system, the buccolingual width of all molars with digital sliding calipers, and a variety of tibial parameters with peripheral quantitative computed tomography (pQCT) and a biomechanical testing apparatus. The landmark coordinates were analyzed for variation in size, shape, and fluctuating asymmetry (FA) using MorphoJ software, showing no effects on cranial size, on FA in females only (i.e., decreased asymmetry), and on shape in both sexes (i.e., decreased facial length and shift in the palatal suture). In the maxillary teeth, females in the highest dose group showed a significant decrease of 0.1 mm (p = 0.033) of the second molar only, whereas males in most dose groups showed average increases of 0.1 mm (p = 0.006-0.044) in all three molars. In the mandibular teeth, the only significant response to PCB 180 exposure was the average increase of 0.1 mm (p = 0.001-0.025) in the third molars of males only. Males also shower greater sensitivity in postcranial effects of increased tibial length and decreased cortical bone mass density, although only females showed significant effects on tibial bone area and thickness. These results demonstrate marked sex differences in effects of PCB 180, which can be attributed to differences in their underlying biological mechanisms of toxicity. Furthermore, although tooth and bone development are targets of both DL and NDL compounds, this study shows that there are marked differences in their mechanisms and effects.	[Romero, Ashly N.] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA; [Herlin, Maria; Hakansson, Helen] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Finnila, Mikko] Univ Oulu, Res Grp Med Imaging Phys & Technol, Oulu, Finland; [Finnila, Mikko] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Korkalainen, Merja; Viluksela, Matti] Natl Inst Hlth & Welf, Chem & Hlth Unit, Kuopio, Finland; [Viluksela, Matti] Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland; [Sholts, Sabrina B.] Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Washington, DC 20560 USA	University of Arkansas System; University of Arkansas Fayetteville; Karolinska Institutet; University of Oulu; University of Eastern Finland; Finland National Institute for Health & Welfare; University of Eastern Finland; Smithsonian Institution; Smithsonian National Museum of Natural History	Sholts, SB (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Washington, DC 20560 USA.	sholtss@si.edu	Romero, Ashly Noel/GPX-2819-2022; Finnila, Mikko/X-6492-2019; Romero, Ashly/AGZ-0957-2022	Sholts, Sabrina/0000-0003-4168-0578; Finnila, Mikko/0000-0002-3348-5759; Romero, Ashly/0000-0002-9571-2099; Hakansson, Helen/0000-0002-7524-8209	European Commission (ATHON (Assessing the toxicity and hazards of NDL-PCBs present in food)) [FOOD-CT-2005-022923]; National Science Foundation (REU Site) [EAR 1062692]	European Commission (ATHON (Assessing the toxicity and hazards of NDL-PCBs present in food)); National Science Foundation (REU Site)(National Science Foundation (NSF))	This study was funded by the European Commission (ATHON (Assessing the toxicity and hazards of NDL-PCBs present in food), FOOD-CT-2005-022923) to Matti Viluksela, and by the National Science Foundation (REU Site, EAR 1062692) to Ashly N. Romero. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AK, 1996, MOL PHARMACOL, V49, P523; Alaluusua S, 1999, LANCET, V353, P206, DOI 10.1016/S0140-6736(05)77214-7; Alaluusua S, 2004, ENVIRON HEALTH PERSP, V112, P1313, DOI 10.1289/ehp.6920; Allen DE, 2001, ECOTOXICOLOGY, V10, P167, DOI 10.1023/A:1016693911300; Assessment ME, 2005, ECOSYSTEMS HUMAN WEL; Carpenter David O., 2006, Reviews on Environmental Health, V21, P1; Carreira SC, 2011, PLACENTA, V32, P283, DOI 10.1016/j.placenta.2010.12.024; EFSA, 2005, EFSA J, V263, P1, DOI DOI 10.2903/J.EFSA.2005.284; Faroon O., 2000, TOXICOLOGICAL PROFIL; Fiedler H, 2002, PERSISTENT ORGANIC P; FRITZ H, 1970, TERATOLOGY, V3, P331, DOI 10.1002/tera.1420030409; Gahrs M, 2013, TOXICOL APPL PHARM, V272, P77, DOI 10.1016/j.taap.2013.05.034; Galliford T M, 2005, Minerva Endocrinol, V30, P237; Hamers T, 2011, TOXICOL SCI, V121, P88, DOI 10.1093/toxsci/kfr043; Hansen LG, 2012, ORTHO SIDE PCBS OCCU; HEBEL R, 1986, ANATOMY EMBRIOLOGY L; Jamsa T, 1998, BONE, V23, P155, DOI 10.1016/S8756-3282(98)00076-3; Jamsa T, 1999, J BONE MINER RES, V14, P1708, DOI 10.1359/jbmr.1999.14.10.1708; Jan J, 2000, CARIES RES, V34, P469, DOI 10.1159/000016625; JECFA, 2016, WHO FOOD ADD SER; Jepson PD, 2016, SCI REP-UK, V6, DOI 10.1038/srep18573; Kattainen H, 2001, TOXICOL APPL PHARM, V174, P216, DOI 10.1006/taap.2001.9216; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Leppaniemi A, 2001, CARIES RES, V35, P36; Lind PM, 2000, TOXICOLOGY, V151, P11, DOI 10.1016/S0300-483X(00)00262-6; Miettinen HM, 2006, TOXICOL SCI, V91, P568, DOI 10.1093/toxsci/kfj158; Miettinen HM, 2002, TOXICOL APPL PHARM, V184, P57, DOI 10.1006/taap.2002.9490; Miettinen HM, 2005, TOXICOL SCI, V85, P1003, DOI 10.1093/toxsci/kfi136; Mourier B, 2014, SCI TOTAL ENVIRON, V476, P568, DOI 10.1016/j.scitotenv.2014.01.026; Murtomaa M, 2007, CHEMOSPHERE, V68, P951, DOI 10.1016/j.chemosphere.2007.01.030; Oberg M, 2002, TOXICOL SCI, V70, P171, DOI 10.1093/toxsci/70.2.171; Ritter R, 2011, ENVIRON HEALTH PERSP, V119, P225, DOI 10.1289/ehp.1002211; Roos A, 2010, ECOTOX ENVIRON SAFE, V73, P1063, DOI 10.1016/j.ecoenv.2010.02.008; Roos R, 2011, TOXICOLOGY, V284, P42, DOI 10.1016/j.tox.2011.03.013; Sakai H, 2006, TOXICOL SCI, V94, P57, DOI 10.1093/toxsci/kfl088; Schecter A, 2010, ENVIRON HEALTH PERSP, V118, P796, DOI 10.1289/ehp.0901347; Shellis P, 1981, DENT ANATOMY EMBRYOL, P432; Sholts SB, 2015, TOXICOL REP, V2, P472, DOI 10.1016/j.toxrep.2014.12.007; Sholts SB, 2015, TOXICOLOGY, V337, P30, DOI 10.1016/j.tox.2015.08.010; Slob W, 2002, TOXICOL SCI, V66, P298, DOI 10.1093/toxsci/66.2.298; Squadrone S, 2015, FOOD CHEM, V175, P10, DOI 10.1016/j.foodchem.2014.11.107; Van den Berg M, 1998, ENVIRON HEALTH PERSP, V106, P775, DOI 10.1289/ehp.98106775; Viluksela M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104639; Wang SL, 2003, ENVIRON RES, V93, P131, DOI 10.1016/S0013-9351(03)00040-9; Warmlander SKTS, 2011, ENVIRON HEALTH PERSP, V119, P1203, DOI 10.1289/ehp.1103478; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Wimmerova S, 2011, CHEMOSPHERE, V82, P687, DOI 10.1016/j.chemosphere.2010.10.099; Yasuda I, 2005, REPROD TOXICOL, V20, P21, DOI 10.1016/j.reprotox.2004.12.016; Yoshinari K, 2001, MOL PHARMACOL, V59, P278, DOI 10.1124/mol.59.2.278; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007	51	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185241	10.1371/journal.pone.0185241	http://dx.doi.org/10.1371/journal.pone.0185241			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957439	Green Published, gold			2022-12-26	WOS:000411985200037
J	Wang, WP; Li, P; Li, W; Jiang, JZ; Cui, YY; Li, SR; Wang, ZX				Wang, Wenping; Li, Pei; Li, Wei; Jiang, Junzi; Cui, Yanyan; Li, Shirong; Wang, Zhenxiang			Osteopontin activates mesenchymal stem cells to repair skin wound	PLOS ONE			English	Article							BONE-MARROW; NEUTROPHIL INFILTRATION; STROMAL CELLS; IN-VITRO; DIFFERENTIATION; CD44; MIGRATION; CANCER; VIVO; INFLAMMATION	Mesenchymal stem cells (MSCs) are promising candidates for skin wound repair due to their capabilities of accumulating at wounds and differentiating into multiple types of skin cells. However, the underlying mechanisms responsible for these processes remain unclear. In this study, we found that osteopontin (OPN) stimulated the migration of MSCs in vitro, and observed the recruitment of endogenous MSCs to a skin wound and their differentiation into keratinocytes and endothelial cells. In OPN knock-out mice, the recruitment of MSCs to the skin wound was significantly inhibited, and wound closure was hampered after an intradermal injection of exogenous MSCs compared to wild-type mice. Consistent with these observations, the expressions of adhesion molecule CD44 and its receptor E-selectin were significantly decreased in the lesions of OPN knock-out mice compared with wild-type mice suggesting that OPN may regulate the migration of MSCs through its interactions with CD44 during skin wound recovery. In summary, our data demonstrated that OPN played a critical role in activating the migration of MSCs to injured sites and their differentiation into specific skin cell types during skin wound healing.	[Wang, Wenping; Jiang, Junzi; Li, Shirong; Wang, Zhenxiang] Third Mil Med Univ, Southwest Hosp, Dept Plast & Aesthet Surg, Chongqing, Peoples R China; [Li, Pei] 89 Hosp Peoples Liberat Army, Dept Orthoped, Weifang, Shandong, Peoples R China; [Li, Wei] Bengbu Med Coll, Affiliated Hosp 1, Dept Plast & Burn Surg, Bengbu, Peoples R China; [Cui, Yanyan] Chongqing Med Univ, Dept Genet & Cell Biol, Chongqing, Peoples R China	Army Medical University; Bengbu Medical College; Chongqing Medical University	Li, SR; Wang, ZX (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Plast & Aesthet Surg, Chongqing, Peoples R China.	xinanzhengxing@126.com; wangzx0921@126.com			National Natural Science Foundation of China [81071563, 81272102]; Chongqing Application Development Grant [CSTC2014yykfA110015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Application Development Grant	The study is supported by the National Natural Science Foundation of China (No.81071563 and 81272102) and the Chongqing Application Development Grant(NO.CSTC2014yykfA110015) to ZW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Al-Shami R, 2005, J CELL BIOCHEM, V94, P1218, DOI 10.1002/jcb.20379; Anjos-Afonso F, 2004, J CELL SCI, V117, P5655, DOI 10.1242/jcs.01488; Apte UM, 2005, TOXICOL APPL PHARM, V207, P25, DOI 10.1016/j.taap.2004.12.018; Banerjee A, 2006, J PATHOL, V208, P473, DOI 10.1002/path.1917; BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303; Chinh Chung Doan, 2014, Iranian Biomedical Journal, V18, P67, DOI 10.6091/ibj.12612.2013; de la Fuente R, 2010, CANCER RES, V70, P6682, DOI 10.1158/0008-5472.CAN-10-2451; Denhardt DT, 2003, CLIN EXP METASTAS, V20, P77, DOI 10.1023/A:1022550721404; Denhardt DT, 2001, BIOCHEM BIOPH RES CO, V288, P448, DOI 10.1006/bbrc.2001.5780; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; El-Tanani MK, 2006, CYTOKINE GROWTH F R, V17, P463, DOI 10.1016/j.cytogfr.2006.09.010; Gebler A, 2012, TRENDS MOL MED, V18, P128, DOI 10.1016/j.molmed.2011.10.004; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kang SK, 2004, J CELL SCI, V117, P4289, DOI 10.1242/jcs.01264; Katayama Y, 2005, J EXP MED, V201, P1183, DOI 10.1084/jem.20042014; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Khan SA, 2005, CLIN EXP METASTAS, V22, P663, DOI 10.1007/s10585-006-9007-0; Liaw L, 1998, J CLIN INVEST, V101, P1468; Mahdavishahri N, 2012, IRAN J BASIC MED SCI, V15, P1185; Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018; Mazzini L, 2006, NEUROL RES, V28, P523, DOI 10.1179/016164106X116791; Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412; Moviglia GA, 2006, CYTOTHERAPY, V8, P202, DOI 10.1080/14653240600736048; Nuschke A, 2014, ORGANOGENESIS, V10, P29, DOI 10.4161/org.27405; Paquet-Fifield S, 2009, J CLIN INVEST, V119, P2795, DOI 10.1172/JCI38535; Ramaiah SK, 2008, TOXICOL SCI, V103, P4, DOI 10.1093/toxsci/kfm246; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Rittling SR, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001839; ROWE PSN, 1994, HUM GENET, V94, P457; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Sgodda M, 2007, EXP CELL RES, V313, P2875, DOI 10.1016/j.yexcr.2007.05.020; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Standal T, 2004, EXP ONCOL, V26, P179; Steck E, 2005, STEM CELLS, V23, P403, DOI 10.1634/stemcells.2004-0107; Tropel P, 2006, STEM CELLS, V24, P2868, DOI 10.1634/stemcells.2005-0636; Wang QH, 2016, MOL MED REP, V14, P5551, DOI 10.3892/mmr.2016.5953; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509	40	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185346	10.1371/journal.pone.0185346	http://dx.doi.org/10.1371/journal.pone.0185346			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957406	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200047
J	Ziegler, TE; Sosa, ME; Colman, RJ				Ziegler, Toni E.; Sosa, Megan E.; Colman, Ricki J.			Fathering style influences health outcome in common marmoset (Callithrix jacchus) offspring	PLOS ONE			English	Article							INFANT; CARE; GROWTH; RESPONSIVENESS; TESTOSTERONE; EXPERIENCE; CHILDHOOD; PRIMATES; SUCCESS; MONKEYS	In the cooperative breeding common marmoset monkey, Callithrix jacchus, fathers share the care responsibility and energetic load with their mate from the time their infants are born. However, not all fathers show the same level of participation in direct infant care. Here we present the first results demonstrating that fathering style can improve both survival and growth trajectory of a male's offspring during the first 30 weeks of life and that these infant outcomes are consistent within a father throughout successive births. Twenty-four marmoset fathers were tested for their responsiveness to an infant distress call when their infants were approximately two weeks old. These fathers were categorized as either responsive (RS) or nonresponsive (NRS) based on their response to the calls. Survival past 1 month was then determined and bi-monthly weights of current infants through 30 weeks of age were taken. Infant survival to the first month was significantly higher with RS fathers than with NRS fathers during this critical time period. Infants from RS fathers also had a higher growth trajectory with significant differences in body weight in the 28th and 30th week after birth. Only the RS fathers showed a significant increase in serum testosterone in response to infant cries suggesting a physiological role of testosterone in the motivation to search for the infant. Furthermore, all offspring born to RS fathers from subsequent births also showed a significantly higher survival rate and higher growth trajectory than for offspring of NRS fathers. These results suggest that fathering style is a consistent trait and responsive fathers improve infant survival rate and growth during the first 30 weeks. Such fathering style traits may be passed on to the male offspring due to environmental or genetic factors.	[Ziegler, Toni E.; Sosa, Megan E.; Colman, Ricki J.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA; [Colman, Ricki J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ziegler, TE (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.	ziegler@primate.wisc.edu		Ziegler, Toni/0000-0003-2598-730X; Colman, Ricki/0000-0001-9706-0525	NIH [HD057684, MH070423]; Wisconsin National Primate Research Center [P51OD011106, R21]; Institute for Clinical and Translational Research at the University of Wisconsin-Madison [UL1TR000427]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wisconsin National Primate Research Center; Institute for Clinical and Translational Research at the University of Wisconsin-Madison	Funding for these data were provided by the following grants: NIH: HD057684 and MH070423 to TEZ as research R21 grants, P51OD011106 to the Wisconsin National Primate Research Center in part for Institutional support, salary support in part and infrastructure, and UL1TR000427 to the Institute for Clinical and Translational Research at the University of Wisconsin-Madison for partial salary support for TEZ.	Albuquerque ACSR, 2001, INT J PRIMATOL, V22, P631, DOI 10.1023/A:1010741702831; Alonzo SH, 2010, TRENDS ECOL EVOL, V25, P99, DOI 10.1016/j.tree.2009.07.012; Boyce WT, 2006, J AM ACAD CHILD PSY, V45, P1510, DOI 10.1097/01.chi.0000237706.50884.8b; Brown GR, 2005, AM J PRIMATOL, V65, P301, DOI 10.1002/ajp.20117; Burkart JM, 2009, EVOL ANTHROPOL, V18, P175, DOI 10.1002/evan.20222; Burkart JM, 2015, NEUROSCI RES, V93, P8, DOI 10.1016/j.neures.2014.09.003; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Fernandez-Duque E, 2009, ANNU REV ANTHROPOL, V38, P115, DOI 10.1146/annurev-anthro-091908-164334; Finkenwirth C, 2016, HORM BEHAV, V80, P10, DOI 10.1016/j.yhbeh.2016.01.008; Fleming AS, 2002, HORM BEHAV, V42, P399, DOI 10.1006/hbeh.2002.1840; Garfield CF, 2006, PEDIATRICS, V117, pE637, DOI 10.1542/peds.2005-1612; Gustafsson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2713; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Hrdy SB, 2016, HORM BEHAV, V77, P272, DOI 10.1016/j.yhbeh.2015.10.016; Hrdy SarahBlaffer., 2009, MOTHERS OTHERS EVOLU; INGRAM J C, 1975, Laboratory Animals (London), V9, P249, DOI 10.1258/002367775780957205; Jaquish CE, 1997, AM J PRIMATOL, V42, P269, DOI 10.1002/(SICI)1098-2345(1997)42:4<269::AID-AJP2>3.0.CO;2-V; Johnson EO, 1996, PEDIATR RES, V39, P999, DOI 10.1203/00006450-199606000-00012; Kramer KL, 2010, ANNU REV ANTHROPOL, V39, P417, DOI 10.1146/annurev.anthro.012809.105054; LEVYSHIFF R, 1990, PEDIATRICS, V86, P289; Lukas D, 2016, P ROY SOC LOND B BIO, V279, P4065; Mascaro JS, 2014, SOC COGN AFFECT NEUR, V9, P1704, DOI 10.1093/scan/nst166; Soltis J, 2004, BEHAV BRAIN SCI, V27, P443, DOI 10.1017/S0140525X0400010X; Stafford M, 2016, J POSIT PSYCHOL, V11, P326, DOI 10.1080/17439760.2015.1081971; Tardif S, 1998, LAB ANIM SCI, V48, P264; TARDIF SD, 1984, AM J PRIMATOL, V6, P377, DOI 10.1002/ajp.1350060408; TARDIF SD, 1993, BIOL REPROD, V48, P1113, DOI 10.1095/biolreprod48.5.1113; van Anders SM, 2012, HORM BEHAV, V61, P31, DOI 10.1016/j.yhbeh.2011.09.012; West HER, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11854; Williams E, 1999, AM J ORTHOPSYCHIAT, V69, P328, DOI 10.1037/h0080407; WOODROFFE R, 1994, TRENDS ECOL EVOL, V9, P294, DOI 10.1016/0169-5347(94)90033-7; Yogman M., 1995, J AM ACAD CHILD ADOL, V34, P66, DOI DOI 10.1097/00004583-; Zahed SR, 2008, AM J PRIMATOL, V70, P84, DOI 10.1002/ajp.20460; Ziegler TE, 2005, HORM BEHAV, V47, P56, DOI 10.1016/j.yhbeh.2004.08.009; Ziegler TE, 1986, CURRENT PERSPECTIVES; Ziegler TE, 2016, HORM BEHAV, V78, P13, DOI 10.1016/j.yhbeh.2015.10.004; Ziegler TE, 2009, HORM BEHAV, V56, P436, DOI 10.1016/j.yhbeh.2009.07.012	37	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185695	10.1371/journal.pone.0185695	http://dx.doi.org/10.1371/journal.pone.0185695			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957433	gold, Green Published, Green Submitted			2022-12-26	WOS:000411985200107
J	Chiang, CK; Tworak, A; Kevany, BM; Xu, B; Mayne, J; Ning, ZB; Figeys, D; Palczewski, K				Chiang, Cheng-Kang; Tworak, Aleksander; Kevany, Brian M.; Xu, Bo; Mayne, Janice; Ning, Zhibin; Figeys, Daniel; Palczewski, Krzysztof			Quantitative phosphoproteomics reveals involvement of multiple signaling pathways in early phagocytosis by the retinal pigmented epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						eye; receptor recycling; retina; retinal degeneration; retinal metabolism	PHOTORECEPTOR OUTER SEGMENTS; FOCAL ADHESION KINASE; ARREST-SPECIFIC GENE; PHOSPHATIDYLINOSITOL 3-KINASE; ALPHA-V-BETA-5 INTEGRIN; PROMOTES PHAGOCYTOSIS; ROD; PHOSPHORYLATION; CELLS; ACTIVATION	One of the major biological functions of the retinal pigmented epithelium (RPE) is the clearance of shed photoreceptor outer segments (POS) through a multistep process resembling phagocytosis. RPE phagocytosis helps maintain the viability of photoreceptors that otherwise could succumb to the high metabolic flux and photo-oxidative stress associated with visual processing. The regulatory mechanisms underlying phagocytosis in the RPE are not fully understood, although dysfunction of this process contributes to the pathogenesis of multiple human retinal degenerative disorders, including age-related macular degeneration. Here, we present an integrated transcriptomic, proteomic, and phosphoproteomic analysis of phagocytosing RPE cells, utilizing three different experimental models: the human-derived RPE-like cell line ARPE-19, cultured murine primary RPE cells, and RPE samples from live mice. Our combined results indicated that early stages of phagocytosis in the RPE are mainly characterized by pronounced changes in the protein phosphorylation level. Global phosphoprotein enrichment analysis revealed involvement of PI3K/Akt, mechanistic target of rapamycin (mTOR), and MEK/ERK pathways in the regulation of RPE phagocytosis, confirmed by immunoblot analyses and in vitro phagocytosis assays. Most strikingly, phagocytosis of POS by cultured RPE cells was almost completely blocked by pharmacological inhibition of phosphorylation of Akt. Our findings, along with those of previous studies, indicate that these phosphorylation events allow the RPE to integrate multiple signals instigated by shed POS at different stages of the phagocytic process.	[Chiang, Cheng-Kang; Xu, Bo; Mayne, Janice; Ning, Zhibin; Figeys, Daniel] Univ Ottawa, Ottawa Inst Syst Biol, Fac Med, Ottawa, ON K1H 8M5, Canada; [Chiang, Cheng-Kang; Xu, Bo; Mayne, Janice; Ning, Zhibin; Figeys, Daniel] Univ Ottawa, Dept Biochem Microbiol & Immunol, Fac Med, Ottawa, ON K1H 8M5, Canada; [Chiang, Cheng-Kang] Natl Dong Hwa Univ, Dept Chem, 1 Sec 2 Da Hsueh Rd, Hualien 97401, Taiwan; [Tworak, Aleksander; Kevany, Brian M.; Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Palczewski, Krzysztof] Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Sch Med, Cleveland, OH 44106 USA; [Figeys, Daniel] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada	University of Ottawa; University of Ottawa; National Dong Hwa University; Case Western Reserve University; Case Western Reserve University; Canadian Institute for Advanced Research (CIFAR)	Figeys, D (corresponding author), Univ Ottawa, Ottawa Inst Syst Biol, Fac Med, Ottawa, ON K1H 8M5, Canada.; Palczewski, K (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA.; Palczewski, K (corresponding author), Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Sch Med, Cleveland, OH 44106 USA.; Figeys, D (corresponding author), Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada.	dfigeys@uottawa.ca; kxp65@case.edu	Chiang, Cheng-Kang/AAQ-7472-2021	Figeys, Daniel/0000-0002-5373-7546; Tworak, Aleksander/0000-0002-3256-8990	National Institutes of Health [EY009339, EY024864, EY011373]; National Sciences and Engineering Research Council (NSERC) of Canada; Canadian Institute for Advanced Research (CIFAR); Canadian Institutes of Health Research (CIHR); Arnold and Mabel Beckman Foundation; Canadian Foundation for Innovation (CFI); Ontario Research Fund; la Fondation J.-Louis Levesque; NATIONAL EYE INSTITUTE [R01EY009339, P30EY011373, R24EY024864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Arnold and Mabel Beckman Foundation; Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Research Fund; la Fondation J.-Louis Levesque; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health Grants EY009339 and EY024864 (to K. P.) and EY011373 (VSRC CORE grant); the National Sciences and Engineering Research Council (NSERC) of Canada (to D. F.); the Canadian Institute for Advanced Research (CIFAR) and the Canadian Institutes of Health Research (CIHR) (to D. F.); the Arnold and Mabel Beckman Foundation (to K. P.); and the Canadian Foundation for Innovation (CFI), the Ontario Research Fund, and la Fondation J.-Louis Levesque (to D. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ablonczy Z, 2011, INVEST OPHTH VIS SCI, V52, P8614, DOI 10.1167/iovs.11-8021; Ainscough SL, 2009, EXP EYE RES, V89, P629, DOI 10.1016/j.exer.2009.06.005; Bennis A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141597; Bulloj A, 2013, EXP EYE RES, V113, P9, DOI 10.1016/j.exer.2013.05.002; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Diemer T, 2008, ADV EXP MED BIOL, V613, P321, DOI 10.1007/978-0-387-74904-4_37; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Filippi S, 2016, CELL REP, V15, P2524, DOI 10.1016/j.celrep.2016.05.024; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Fox R, 2007, EMBO J, V26, P505, DOI 10.1038/sj.emboj.7601522; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Freeman SA, 2014, IMMUNOL REV, V262, P193, DOI 10.1111/imr.12212; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P107; Garg Tarun K, 2003, BMC Ophthalmol, V3, P5, DOI 10.1186/1471-2415-3-5; Glotin AL, 2006, INVEST OPHTH VIS SCI, V47, P4614, DOI 10.1167/iovs.06-0297; Goruppi S, 1997, MOL CELL BIOL, V17, P4442, DOI 10.1128/MCB.17.8.4442; Hall MO, 2002, EXP EYE RES, V75, P391, DOI 10.1006/exer.2002.2030; HETH CA, 1991, CURR EYE RES, V10, P1049, DOI 10.3109/02713689109020343; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; Ishimoto Y, 2000, J BIOCHEM-TOKYO, V127, P411, DOI 10.1093/oxfordjournals.jbchem.a022622; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kiser PD, 2016, ANNU REV VIS SCI, V2, P197, DOI 10.1146/annurev-vision-111815-114407; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; Kyosseva SV, 2016, OPHTHALMOL EYE DIS, V8, P23, DOI 10.4137/OED.S32200; Lande-Diner L, 2013, P NATL ACAD SCI USA, V110, P16021, DOI 10.1073/pnas.1305980110; Law AL, 2009, MOL BIOL CELL, V20, P3896, DOI 10.1091/mbc.E08-12-1204; Lee H, 2011, INT J BIOL MACROMOL, V48, P194, DOI 10.1016/j.ijbiomac.2010.11.006; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Makino-Okamura C, 2014, PIGM CELL MELANOMA R, V27, P1063, DOI [10.1111/pcmr.12284, 10.1111/pcmr.12287]; Mao YY, 2012, MOL BIOL CELL, V23, P1104, DOI 10.1091/mbc.E11-10-0840; May RC, 2001, J CELL SCI, V114, P1061; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Nakano T, 1997, J BIOL CHEM, V272, P29411, DOI 10.1074/jbc.272.47.29411; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; Olchawa MM, 2016, FREE RADICAL RES, V50, P887, DOI 10.1080/10715762.2016.1194519; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Onishi Y, 2008, MOL CELL BIOL, V28, P3477, DOI 10.1128/MCB.02227-07; Palczewska G, 2016, J BIOL CHEM, V291, P26937, DOI 10.1074/jbc.M116.764563; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Parsa KVL, 2008, MOL IMMUNOL, V45, P3012, DOI 10.1016/j.molimm.2008.01.011; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Rizzolo LJ, 2014, EXP EYE RES, V126, P16, DOI 10.1016/j.exer.2013.12.018; Ruggiero L, 2012, P NATL ACAD SCI USA, V109, P8145, DOI 10.1073/pnas.1121101109; Ryeom SW, 1996, J CELL SCI, V109, P387; Ryeom SW, 1996, J BIOL CHEM, V271, P20536, DOI 10.1074/jbc.271.34.20536; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasore T, 2014, ADV EXP MED BIOL, V801, P805, DOI 10.1007/978-1-4614-3209-8_101; Song CX, 2012, MOL CELL PROTEOMICS, V11, P1070, DOI 10.1074/mcp.M111.012625; TATE DJ, 1995, INVEST OPHTH VIS SCI, V36, P1271; Wang XM, 2016, EXP CELL RES, V344, P219, DOI 10.1016/j.yexcr.2016.04.017; Wrann CD, 2007, J IMMUNOL, V178, P5940, DOI 10.4049/jimmunol.178.9.5940; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yang P, 2006, INVEST OPHTH VIS SCI, V47, P4598, DOI 10.1167/iovs.06-0140; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Yu B, 2014, INVEST OPHTH VIS SCI, V55, P8638, DOI 10.1167/iovs.14-14758; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303; Zhou HJ, 2013, NAT PROTOC, V8, P461, DOI 10.1038/nprot.2013.010	64	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19826	19839		10.1074/jbc.M117.812677	http://dx.doi.org/10.1074/jbc.M117.812677			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28978645	hybrid, Green Published			2022-12-26	WOS:000416911300026
J	Zhu, QY; Pan, XT; Sun, YB; Wang, ZB; Liu, FG; Li, AQ; Zhao, ZH; Wang, YL; Li, K; Mi, LY				Zhu, Qingyun; Pan, Xinting; Sun, Yunbo; Wang, Zhengbin; Liu, Fuguo; Li, Aiqin; Zhao, Zhihui; Wang, Yunlong; Li, Kun; Mi, Liangyu			Biological nanoparticles carrying the Hmda-7 gene are effective in inhibiting pancreatic cancer in vitro and in vivo	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DELIVERY; MDA-7/IL-24; ANGIOGENESIS; MORTALITY; VEGF	Objectives Pancreatic cancer is one of the most common malignancies of the digestive system, and remains a clinical challenge. This study aimed to assess the effects of bovine serum albumin (BSA) nanoparticles carrying the hMDA-7 gene (BSA-NP-hMDA-7) in the treatment of pancreatic cancer. Methods BSA-NP-hMDA-7 was generated by nanotechnology and gene recombination technology. A total of 5 BXPC-3 or PANC-1 pancreatic cancer cell groups were examined, including Control, BSA-NPs, Empty vector, hMDA-7 plasmid, and hMDA-7 BSA-NPs groups, respectively. Proliferation and apoptosis of cultured cells were assessed by the MTT method and flow-cytometry, respectively. In addition, pancreatic cancer models were established with both cell lines in nude mice, and the expression profiles of hMDA-7 and VEGF in cancer tissues were measured by Western blot and immunohistochemistry. Results BSA-NP-hMDA-7 nanoparticles were successfully generated, and significantly inhibited the proliferation of BXPC-3 and PANC-1 cells; in addition, apoptosis rates were higher in both cell lines after treatment with BSA-NP-hMDA-7 (P < 0.05). Nude mouse xenograft studies indicated that treatment with BSA-NP-hMDA-7 nanoparticles resulted in decreased tumor size. Moreover, the hMDA-7 protein was found in tumor tissues after hMDA-7 gene transfection, while BSA-NP-hMDA-7 significantly suppressed VEGF expression in tumor tissues. Similar results were obtained for both BXPC-3 and PANC-1 xenograft models. Conclusion BSA nanoparticles carrying the hMDA-7 gene effectively transfected BXPC-3 and PANC-1 pancreatic cancer cells, causing reduced cell proliferation and enhanced apoptosis in vitro. In mouse xenografts, BSA-NP-hMDA-7 treatment decreased tumor size and reduced VEGF expression. These findings indicated that BSA-NP-hMDA-7 might exert anticancer effects via VEGF suppression.	[Zhu, Qingyun; Pan, Xinting; Sun, Yunbo; Wang, Zhengbin; Liu, Fuguo; Li, Aiqin; Li, Kun] Qingdao Univ, Affiliated Hosp, Qingdao, Peoples R China; [Zhao, Zhihui; Wang, Yunlong] Qingdao Univ, Nano New Mat Key Labs, Qingdao, Peoples R China; [Mi, Liangyu] Qingdao Univ, Affiliated Hosp, Dept ICU, Qingdao, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Pan, XT (corresponding author), Qingdao Univ, Affiliated Hosp, Qingdao, Peoples R China.	0536pxt@163.com						Abu Lila AS, 2010, PHARM RES-DORDR, V27, P1171, DOI 10.1007/s11095-010-0110-1; Azab B, 2012, J CELL PHYSIOL, V227, P2145, DOI 10.1002/jcp.22947; Berruti A, 2011, NEW ENGL J MED, V364, P1871, DOI 10.1056/NEJMc1102746; Cabral H, 2013, P NATL ACAD SCI USA, V110, P11397, DOI 10.1073/pnas.1301348110; Chada S, 2005, MOL THER, V11, P724, DOI 10.1016/j.ymthe.2004.12.021; Chitkara D, 2014, DRUG DELIV TRANSL RE, V4, P439, DOI 10.1007/s13346-014-0206-y; Colilla M, 2008, INT J NANOMED, V3, P403; Dash R, 2014, CANCER RES, V74, P563, DOI 10.1158/0008-5472.CAN-13-1062; Dent P, 2010, PHARMACOL THERAPEUT, V128, P375, DOI 10.1016/j.pharmthera.2010.08.001; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; He YT, 2015, CHINESE J CANCER RES, V27, P29, DOI 10.3978/j.issn.1000-9604.2015.02.05; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Ishima Y, 2016, YAKUGAKU ZASSHI, V136, P39, DOI 10.1248/yakushi.15-00227-1; Koffie RM, 2011, P NATL ACAD SCI USA, V108, P18837, DOI 10.1073/pnas.1111405108; Lammers T, 2008, BRIT J CANCER, V99, P392, DOI 10.1038/sj.bjc.6604483; Lin QJ, 2015, WORLD J GASTROENTERO, V21, P7988, DOI 10.3748/wjg.v21.i26.7988; Menezes ME, 2014, ADV EXP MED BIOL, V818, P127, DOI 10.1007/978-1-4471-6458-6_6; Michaud D S, 2004, Minerva Chir, V59, P99; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Patani N, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-29; Takai E, 2015, WORLD J GASTRO ONCOL, V7, P250, DOI 10.4251/wjgo.v7.i10.250; Wang QB, 2015, INT J NANOMED, V10, P4479, DOI 10.2147/IJN.S84930; Yang XJ, 2013, P NATL ACAD SCI USA, V110, P13932, DOI 10.1073/pnas.1309629110; Yeo D, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2057-z; Yu XZ, 2015, INT J NANOMED, V10, P6825, DOI 10.2147/IJN.S93835; Zhou H, 2012, ANGIOGENESIS, V15, P391, DOI 10.1007/s10456-012-9268-y	26	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0185507	10.1371/journal.pone.0185507	http://dx.doi.org/10.1371/journal.pone.0185507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ1QR	28985230	Green Submitted, gold, Green Published			2022-12-26	WOS:000412493000006
J	Castel, AD; Terzian, A; Hart, R; Rayeed, N; Kalmin, MM; Young, H; Greenberg, AE				Castel, Amanda D.; Terzian, Arpi; Hart, Rachel; Rayeed, Nabil; Kalmin, Mariah M.; Young, Heather; Greenberg, Alan E.		DC Cohort Executive Comm	Use of national standards to monitor HIV care and treatment in a high prevalence city-Washington, DC	PLOS ONE			English	Article							VIRAL SUPPRESSION; UNITED-STATES; MEDICAL-CARE; RETENTION; HOMELESSNESS; DISPARITIES; ENGAGEMENT; INDICATORS; GONORRHEA; HEALTH	We sought to benchmark the quality of HIV care being received by persons living with HIV in care in Washington, DC and identify individual-level and structural-level differences. Data from the DC Cohort, an observational HIV cohort of persons receiving outpatient care in DC, were used to estimate the Institute of Medicine (IOM) and Department of Health and Human Services (HHS) quality of care measures. Differences in care by demographics and clinic type were assessed using chi(2) tests and multivariable regression models. Among 8,047 participants, by HHS standards, 69% of participants were retained in care (RIC), 95% were prescribed antiretroviral therapy (ART), and 84% were virally suppressed (VS). By IOM standards, 84% were in continuous care; and 78% and 80% underwent regular CD4 and VL monitoring, respectively. Screening for syphilis, chlamydia, and gonorrhea was 51%, 31%, and 26%, respectively. Older participants were 1.5 times more likely to be RIC compared to younger participants (OR: 1.5; 95% CI: 1.3, 1.8). Participants enrolled in community-based clinics were more likely to be RIC (OR: 1.7; 95% CI: 1.4, 2.0) versus those enrolled at hospital-based clinics. Older participants were more likely to achieve VS than younger participants (OR: 1.8; 95% CI: 1.5, 2.2) while Black participants were less likely compared to white participants (OR: 0.4; 95% CI: 0.3, 0.5). Despite high measures of quality of care, disparities remain. Continued monitoring of the quality of HIV care and treatment can inform the development of public health programs and interventions to optimize care delivery.	[Castel, Amanda D.; Terzian, Arpi; Kalmin, Mariah M.; Young, Heather; Greenberg, Alan E.] George Washington Univ, Milken Inst, Dept Epidemiol & Biostat, Sch Publ Hlth, Washington, DC 20052 USA; [Hart, Rachel; Rayeed, Nabil] Cerner Corp, Kansas City, MO USA	George Washington University	Castel, AD (corresponding author), George Washington Univ, Milken Inst, Dept Epidemiol & Biostat, Sch Publ Hlth, Washington, DC 20052 USA.	acastel@gwu.edu		Castel, Amanda/0000-0002-9095-2413; Young, Heather/0000-0002-0225-4894	George Washington University (GWU) from the National Institutes of Health (NIH); GWU; NIH	George Washington University (GWU) from the National Institutes of Health (NIH); GWU; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for the DC Cohort is received by George Washington University (GWU) from the National Institutes of Health (NIH). Subcontracts from GWU are issued to participating sites and to Cerner Corporation, a commercial affiliate. Through an established contract between GWU and Cerner Corporation, staff from Cerner are responsible for assisting with data collection, management and analyses. GWU therefore provided support in the form of salaries for Cerner authors [RH, NR]. NIH provided support in the form of salaries for authors [ADC, HAY, MK, AT, and AEG]. The specific roles of each author are articulated in the 'author contributions' section. The funder of the study, NIH, did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and or research materials.	Aidala AA, 2016, AM J PUBLIC HLTH, V7; Althoff KN, 2014, CLIN INFECT DIS, V58, P1185, DOI 10.1093/cid/ciu044; Berry SA, 2015, JAIDS-J ACQ IMM DEF, V70, P275, DOI 10.1097/QAI.0000000000000711; Burchell AN, 2015, JAIDS-J ACQ IMM DEF, V70, pE10, DOI 10.1097/QAI.0000000000000690; Castel A, 2015, INCREASING COMPLETEN; Castel AD, 2012, 19 INT AIDS CONFEREN; Castel AD, 2016, AIDS CARE, V28, P1355, DOI 10.1080/09540121.2016.1189496; Chu C, 2010, AIDS CARE, V22, P1522, DOI 10.1080/09540121.2010.484456; Cohen SM, 2014, JAIDS-J ACQ IMM DEF, V67, P519, DOI 10.1097/QAI.0000000000000349; Dean BB, 2015, JAIDS-J ACQ IMM DEF, V68, P133, DOI 10.1097/QAI.0000000000000406; District of Columbia Department of Health HIV/AIDS H STD and TB Administration, 2016, HIV CAR RYAN WHIT DY; District of Columbia Department of Health HIV/AIDS Hepatitis STDs and Tuberculosis Administration, 2015, DISTR COL DEP HLTH H; Dorsey K, 2016, C RETR OPP INF; Ford M, 2012, MONITORING HIV CARE, V1, P150; Gray KM, 2013, AM J PUBLIC HEALTH, V103, P141, DOI 10.2105/AJPH.2012.300859; Greenberg AE, 2016, J AM MED INFORM ASSN, V23, P635, DOI 10.1093/jamia/ocv176; Greer GA, 2015, AIDS PATIENT CARE ST, V29, P474, DOI 10.1089/apc.2015.0028; Hall H, 1824, JAIDS-J ACQ IMM DEF, V60, P77; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; Health Resources Services Administration, HIV AIDS PROGR HAB P; Herwehe J, 2012, J AM MED INFORM ASSN, V19, P448, DOI 10.1136/amiajnl-2011-000412; Horberg M, 2016, CONTINUITY CARE TRAC; Korthuis PT, 2016, CLIN INFECT DIS, V62, P233, DOI 10.1093/cid/civ762; Lachowsky N., 2016, C RETR OPP INF; Marks G, 2010, AIDS, V24, P2665, DOI 10.1097/QAD.0b013e32833f4b1b; Mattson CL, 2017, CLIN INFECT DIS, V64, P629, DOI 10.1093/cid/ciw834; Milloy MJ, 2012, AIDS PATIENT CARE ST, V26, P60, DOI 10.1089/apc.2011.0169; Office of National AIDS Policy, 2015, NAT HIV AIDS STRAT U; Rebeiro P, 2016, PLOS ONE, V11; Rebeiro PF, 2015, AM J EPIDEMIOL, V182, P952, DOI 10.1093/aje/kwv181; Riley ED NT, 2012, PLOS ONE, V7; Sabharwal CJ, 2014, JAIDS-J ACQ IMM DEF, V65, P571, DOI 10.1097/QAI.0000000000000077; Schranz AJ, 2015, AIDS PATIENT CARE ST, V29, P117, DOI 10.1089/apc.2014.0199; Skinner JM, 2014, PUBLIC HEALTH REP, V129, P85, DOI 10.1177/00333549141291S113; Thakarar K, 2016, J HEALTH CARE POOR U, V27, P145, DOI 10.1353/hpu.2016.0020; Valdiserri Ronald O, 2013, Public Health Rep, V128, P354; Xia Q, 2016, JAIDS-J ACQ IMM DEF, V72, P552, DOI 10.1097/QAI.0000000000001008; Yehia BR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129376; Yehia BR, 2015, JAIDS-J ACQ IMM DEF, V68, P413, DOI 10.1097/QAI.0000000000000489; Zanoni BC, 2014, AIDS PATIENT CARE ST, V28, P128, DOI 10.1089/apc.2013.0345	40	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186036	10.1371/journal.pone.0186036	http://dx.doi.org/10.1371/journal.pone.0186036			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28982127	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300114
J	Chen, HH; Huang, CC; Cheng, EH; Lee, TH; Chien, LF; Lee, MS				Chen, Hsiu-Hui; Huang, Chun-Chia; Cheng, En-Hui; Lee, Tsung-Hsien; Chien, Lee-Feng; Lee, Maw-Sheng			Optimal timing of blastocyst vitrification after trophectoderm biopsy for preimplantation genetic screening	PLOS ONE			English	Article							CYTOGENETIC ANALYSIS; JUNCTION BIOGENESIS; BOVINE EMBRYOS; STAGE; CRYOPRESERVATION; DIAGNOSIS; DILUTION; CYCLES; BIRTHS; MOUSE	Is the timing of vitrification after trophectoderm (TE) biopsy associated with successful implantation and pregnancy after the embryo transfer of blastocysts subjected to preimplantation genetic screening (PGS)? In this retrospective cohort study, 1329 blastocysts from 223 patients were subjected to TE biopsy for performing array comparative genomic hybridization (CGH) tests. The PGS and frozen blastocyst transfer (FET) cycles were performed from December 2012 to May 2015. Only the good quality and expanded blastocysts on day 5 or 6 were selected for biopsy. After TE biopsy, the re-expansion grades relative to the original blastocoel were (1) collapsed blastocysts (CB), (2) 3/4 re-expansion but not full expansion (RE), and (3) full re-expansion or hatching (FE). All biopsied blastocysts were subjected to vitrification within 0.5-6 h after biopsy; the time intervals between TE biopsy and vitrification and the expansion grades at the time of vitrification were recorded. By combining two factors, namely the expansion grades and culture intervals between biopsy and vitrification, the patients were further divided into four groups, namely CB with a <3 h culture interval (n = 34 cycles, Group I), RE and FE blastocysts with a < 3 h culture interval (n = 10 cycles, Group II); CB blastocysts with a >= 3 h culture interval (n = 6 cycles, Group III); and RE or FE blastocysts with a >= 3 h culture interval (n = 173 cycles, Group IV). The implantation (63.7%, 179/281) and clinical pregnancy (74.0%, 128/173) rates in Group IV were significantly higher than those in Group I (45.3%, 24/53; 50.0%, 17/34; P = 0.012 and 0.005, respectively). According to our findings, optimal vitrification timing >3 hours to enable blastocysts to reach RE or FE provides improved implantation and pregnancy rates after FET.	[Chen, Hsiu-Hui; Huang, Chun-Chia; Cheng, En-Hui; Lee, Tsung-Hsien; Lee, Maw-Sheng] Lee Womens Hosp, Div Infertil, Taichung, Taiwan; [Chen, Hsiu-Hui; Chien, Lee-Feng] Natl Chung Hsing Univ, Coll Life Sci, Dept Life Sci, Taichung, Taiwan; [Lee, Tsung-Hsien; Lee, Maw-Sheng] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Lee, Tsung-Hsien; Lee, Maw-Sheng] Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Lee, Tsung-Hsien] Natl Taiwan Univ, Coll Med, Dept Obstet & Gynecol, Taipei, Taiwan	National Chung Hsing University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; National Taiwan University	Lee, MS (corresponding author), Lee Womens Hosp, Div Infertil, Taichung, Taiwan.; Chien, LF (corresponding author), Natl Chung Hsing Univ, Coll Life Sci, Dept Life Sci, Taichung, Taiwan.; Lee, MS (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Lee, MS (corresponding author), Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan.	lfchien@dragon.nchu.edu.tw; msleephd@gmail.com	Lee, Tsung-Hsien/X-1098-2019	Lee, Tsung-Hsien/0000-0001-8858-0916; Lee, Maw-Sheng/0000-0001-6234-5432				Ahlstrom A, 2013, HUM REPROD, V28, P1199, DOI 10.1093/humrep/det054; Baltz JM, 1997, ZYGOTE, V5, P1; Capalbo A, 2015, EUR J HUM GENET, V23, P901, DOI 10.1038/ejhg.2014.222; Capalbo A, 2013, HUM REPROD, V28, P2298, DOI 10.1093/humrep/det245; Cho HJ, 2002, HUM REPROD, V17, P2419, DOI 10.1093/humrep/17.9.2419; Cockburn K, 2010, J CLIN INVEST, V120, P995, DOI 10.1172/JCI41229; Davidson AF, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-13; Du QY, 2016, FERTIL STERIL, V105, P910, DOI 10.1016/j.fertnstert.2015.12.014; Eckert JJ, 2008, BBA-BIOMEMBRANES, V1778, P717, DOI 10.1016/j.bbamem.2007.09.031; Eckert JJ, 2007, HUM REPROD, V22, P2214, DOI 10.1093/humrep/dem147; Forman EJ, 2012, HUM REPROD, V27, P1217, DOI 10.1093/humrep/des020; Fragouli E, 2008, HUM REPROD, V23, P2596, DOI 10.1093/humrep/den287; Fragouli E, 2011, HUM REPROD, V26, P480, DOI 10.1093/humrep/deq344; Gajda B, 2002, CRYOLETTERS, V23, P385; Gardner DK, 1999, CURR OPIN OBSTET GYN, V11, P307, DOI 10.1097/00001703-199906000-00013; Goto S, 2011, FERTIL STERIL, V95, P948, DOI 10.1016/j.fertnstert.2010.06.067; Gutnisky C, 2013, CRYOBIOLOGY, V67, P391, DOI 10.1016/j.cryobiol.2013.08.006; HARDY K, 1989, DEVELOPMENT, V107, P597; Harper JC, 2012, HUM GENET, V131, P175, DOI 10.1007/s00439-011-1056-z; Kader A, 2010, FERTIL STERIL, V93, P2640, DOI 10.1016/j.fertnstert.2009.07.991; Kaidi S, 1999, THERIOGENOLOGY, V52, P515, DOI 10.1016/S0093-691X(99)00148-X; Kokkali G, 2005, HUM REPROD, V20, P1855, DOI 10.1093/humrep/deh893; Lai D, 2015, HUM REPROD, V30, P37, DOI 10.1093/humrep/deu284; Leeh TH, 2008, HUM REPROD, V23, P160, DOI 10.1093/humrep/dem254; Marikawa Yusuke, 2012, Results Probl Cell Differ, V55, P165, DOI 10.1007/978-3-642-30406-4_9; McArthur SJ, 2005, FERTIL STERIL, V84, P1628, DOI 10.1016/j.fertnstert.2005.05.063; Oh YS, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.115.138099; Schoolcraft WB, 2010, FERTIL STERIL, V94, P1700, DOI 10.1016/j.fertnstert.2009.10.015; Scott KL, 2013, FERTIL STERIL, V100, P608, DOI 10.1016/j.fertnstert.2013.07.004; Scott RT, 2012, FERTIL STERIL, V97, P870, DOI 10.1016/j.fertnstert.2012.01.104; Shu Y, 2009, FERTIL STERIL, V91, P401, DOI 10.1016/j.fertnstert.2007.11.083; Ugajin T, 2010, FERTIL STERIL, V93, P2723, DOI 10.1016/j.fertnstert.2009.06.056; Vanderzwalmen P, 2003, HUM REPROD, V18, P1504, DOI 10.1093/humrep/deg298; Vanderzwalmen P, 2002, HUM REPROD, V17, P744, DOI 10.1093/humrep/17.3.744; Watson AJ, 2001, FRONT BIOSCI-LANDMRK, V6, pD708, DOI 10.2741/Watson; Yang ZH, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-24; Yavin S, 2007, THERIOGENOLOGY, V67, P81, DOI 10.1016/j.theriogenology.2006.09.029; Zheng WT, 2005, HUM REPROD, V20, P1615, DOI 10.1093/humrep/deh808	38	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185747	10.1371/journal.pone.0185747	http://dx.doi.org/10.1371/journal.pone.0185747			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982142	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300065
J	Coetzee, J; Jewkes, R; Gray, GE				Coetzee, Jenny; Jewkes, Rachel; Gray, Glenda E.			Cross-sectional study of female sex workers in Soweto, South Africa: Factors associated with HIV infection	PLOS ONE			English	Article							DRIVEN SAMPLING METHODOLOGY; BEHAVIORAL SURVEILLANCE; RISK-FACTORS; CONDOM USE; WOMEN; EXPERIENCES; VIOLENCE; POWER; HIV/AIDS; PATTERNS	Introduction In South Africa, the rate of HIV in the sex worker (SW) population is exceedingly high, but critical gaps exist in our understanding of SWs and the factors that make them vulnerable to HIV. This study aimed to estimate HIV prevalence among female sex workers (FSWs) in Soweto, South Africa, and to describe their sexual behavior and other factors associated with HIV infection. Methods A cross-sectional, respondent-driven sampling (RDS) recruitment methodology was used to enroll 508 FSWs based in Soweto. Data were collected using a survey instrument, followed by two HIV rapid tests. Raw and RDS adjusted data were analyzed using a chi-squared test of association and multivariate logistic regression to show factors associated with HIV infection. Findings HIV prevalence among FSWs was 53.6% (95% CI 47.5-59.9). FSWs were almost exclusively based in taverns (85.6%) and hostels (52.0%). Less than a quarter (24.4%) were under 25 years of age. Non-partner violence was reported by 55.5%, 59.6% of whom were HIV-infected. Advancing age, incomplete secondary schooling, migrancy and multiple clients increased the likelihood of HIV acquisition: >30 years of age was associated with a 4.9 times (95% CI 2.6-9.3) increased likelihood of HIV; incomplete secondary schooling almost tripled the likelihood (AOR 2.8, 95% CI 1.6-5.0); being born outside of the Gauteng province increased the likelihood of HIV 2.3 times (95% CI 1.3-4.0); and having more than five clients per day almost doubled the likelihood (AOR 1.9, 95% CI 1.1-3.2). Conclusion Our findings highlight the extreme vulnerability of FSWs to HIV. Advancing age, limited education and multiple clients were risk factors associated with HIV, strongly driven by a combination of structural, biological and behavioral determinants. Evidence suggests that interventions need to be carefully tailored to the varying profiles of SW populations across South Africa. Soweto could be considered a microcosm of South Africa in terms of the epidemic of violence and HIV experienced by the SW population, which is influenced by factors often beyond an individual level of control. While describing a hitherto largely undocumented population of FSWs, our findings confirm the urgent need to scale up innovative HIV prevention and treatment programs for this population.	[Coetzee, Jenny; Gray, Glenda E.] Univ Witwatersrand, Chris Hani Baragwanath Acad Hosp, Perinatal HIV Res Unit, Johannesburg, South Africa; [Coetzee, Jenny; Jewkes, Rachel] Univ Witwatersrand, Dept Publ Hlth, Johannesburg, South Africa; [Jewkes, Rachel] South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa; [Gray, Glenda E.] South African Med Res Council, Off President, Cape Town, South Africa	University of Witwatersrand; University of Witwatersrand; South African Medical Research Council; South African Medical Research Council	Coetzee, J (corresponding author), Univ Witwatersrand, Chris Hani Baragwanath Acad Hosp, Perinatal HIV Res Unit, Johannesburg, South Africa.; Coetzee, J (corresponding author), Univ Witwatersrand, Dept Publ Hlth, Johannesburg, South Africa.	coetzeej@phru.co.za		Jewkes, Rachel/0000-0002-4330-6267; Coetzee, Jenny/0000-0002-6145-6816	Medical Research Council of South Africa; National Department of Health/Public Health Enhancement Fund; Albert Wessels' Trust; Global Fund; Networking HIV/AIDS Community of 'South Africa (NACOSA) [NAC-SW-2016-1]	Medical Research Council of South Africa(South African Medical Research Council); National Department of Health/Public Health Enhancement Fund; Albert Wessels' Trust; Global Fund; Networking HIV/AIDS Community of 'South Africa (NACOSA)	The study was funded by the Medical Research Council of South Africa in terms of the National Health Scholars Programme from funds provided for the purpose of a PhD by the National Department of Health/Public Health Enhancement Fund, http://www.mrc.ac.za/researchdevelopment/opportunity.htm. In addition, funding was received through The Albert Wessels' Trust. The Global Fund and Networking HIV/AIDS Community of 'South Africa (NACOSA) provided support to the project, NAC-SW-2016-1.; The study was funded by the Medical Research Council of South Africa in terms of the National Health Scholars Programme, from funds provided for the purpose of a PhD by the National Department of Health/Public Health Enhancement Fund. In addition, funding was received through The Albert Wessels Trust. Both the Global Fund and the Networking HIV/AIDS Community of South Africa (NACOSA) also provided support for the project.	[Anonymous], 1992, BMJ, V304, P809; Arora P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044094; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Bekker LG, 2015, LANCET, V385, P72, DOI 10.1016/S0140-6736(14)60974-0; Cleland J., 2001, ILLUSTRATIVE QUESTIO; Coetzee J, 2016, AIDS 2016; Creighton D., 2003, HOUSING IN SOWETO; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Dunkle KL, 2004, AM J EPIDEMIOL, V160, P230, DOI 10.1093/aje/kwh194; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Glynn JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015334; Handcock MS, INVENTORSRDS ANAL SO; Harcourt C, 2005, SEX TRANSM INFECT, V81, P201, DOI 10.1136/sti.2004.012468; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Hunter M, 2010, HEALTH PLACE, V16, P25, DOI 10.1016/j.healthplace.2009.08.003; Hunter M, 2007, SOC SCI MED, V64, P689, DOI 10.1016/j.socscimed.2006.09.015; Johnston LG, 2008, AIDS BEHAV, V12, pS131, DOI 10.1007/s10461-008-9413-1; Karamouzian M, 2016, CULT HEALTH SEX, V18, P58, DOI 10.1080/13691058.2015.1059487; Karim SSA, 1998, AM J PUBLIC HEALTH, V88, P1265, DOI 10.2105/AJPH.88.8.1265-a; Lane T, 2015, SAAIDS C; Leggett T., 2001, SOC TRANSITION, V32, P101; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; McClelland RS, 2006, AIDS, V20, P269, DOI 10.1097/01.aids.0000196165.48518.7b; Mchisa M, 2011, WAR HOME GBV INDICAT; Mmari K, 2013, J ADOLESCENT HEALTH, V53, P562, DOI 10.1016/j.jadohealth.2013.07.018; Morrell R, 2012, MEN MASC, V15, P11, DOI 10.1177/1097184X12438001; Myer L, 2006, AM J EPIDEMIOL, V163, P552, DOI 10.1093/aje/kwj071; Nattrass N, 2001, DAEDALUS, V130, P45; Ngugi EN, 2012, HUM ECOL, V40, P397, DOI 10.1007/s10745-012-9478-3; Pretorius G, 2011, J PSYCHOL AFR, V21, P33, DOI 10.1080/14330237.2011.10820427; Ramjee G, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-30; Rekart ML, 2005, LANCET, V366, P2123, DOI 10.1016/S0140-6736(05)67732-X; Richter M., 2008, EROTIC LABOUR HILLBR; Richter M, 2008, AJAR-AFR J AIDS RES, V7, P323, DOI 10.2989/AJAR.2008.7.3.9.656; Rosa EM, 2013, J FAM THEOR REV, V5, P243, DOI 10.1111/jftr.12022; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; SANAC, 2016, S AFR NAT SEX WORK H; SARACCO A, 1993, J ACQ IMMUN DEF SYND, V6, P497; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Scorgie F, 2012, AIDS BEHAV, V16, P920, DOI 10.1007/s10461-011-9985-z; Shai NJ, 2010, AIDS CARE, V22, P1379, DOI 10.1080/09540121003758465; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; Shannon K, 2010, JAMA-J AM MED ASSOC, V304, P573, DOI 10.1001/jama.2010.1090; Shisana O., 2009, S AFRICAN NATL HIV P; Shisana O., 2014, AFRICAN NATL HIV P; Sinha S, 2015, SEX CULT, V19, P216, DOI 10.1007/s12119-014-9256-z; Stadler J, 2006, CULT HEALTH SEX, V8, P451, DOI 10.1080/13691050600872107; Statistics South Africa, 2016, COMMUNITY SURVEY 201; Statistics South Africa, 2016, Q LAB FORC SURV Q3 2; Stoebenhau K, 2011, GLOBALIZATION HLTH, V7; Thurman TR, 2006, AIDS BEHAV, V10, P627, DOI 10.1007/s10461-006-9104-8; UCSF Anova Health Institute Wits RHI, 2015, S AFR HLTH MON SURV; van Loggerenberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030669; Varga C A, 1997, Afr J Reprod Health, V1, P74, DOI 10.2307/3583277; Volz E, 2012, INVENTORSRESPONDENT; Vuylsteke B, 2009, HIV PREVENTION: A COMPREHENSIVE APPROACH, P376, DOI 10.1016/B978-0-12-374235-3.00014-5; WHO, 2013, INTR HIV AIDS SEX TR; Williams BG, 2003, AIDS, V17, P2099, DOI 10.1097/00002030-200309260-00011; Wojcicki JM, 2001, SOC SCI MED, V53, P99, DOI 10.1016/S0277-9536(00)00315-4; Wojcicki JM, 2002, CULT MED PSYCHIAT, V26, P339, DOI 10.1023/A:1021291922026; Wojcicki JM, 2002, MED ANTHROPOL Q, V16, P267, DOI 10.1525/maq.2002.16.3.267; World Health Organisation, 2013, MOD 4 INTR RESP DRIV; World Health Organisation, 2002, WHO MULT STUD WOM HL; World Health Organization, 2004, RAP HIV TESTS GUID U	65	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184775	10.1371/journal.pone.0184775	http://dx.doi.org/10.1371/journal.pone.0184775			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28981511	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300017
J	Diana, A; Manzanilla, EG; Diaz, JAC; Leonard, FC; Boyle, LA				Diana, Alessia; Manzanilla, Edgar G.; Diaz, Julia A. Calderon; Leonard, Finola C.; Boyle, Laura A.			Do weaner pigs need in-feed antibiotics to ensure good health and welfare?	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; SPACE ALLOWANCE; MEAT INSPECTION; ANIMAL HEALTH; TAIL; PERFORMANCE; RESPONSES; LESIONS; USAGE; PRODUCTIVITY	Antibiotics (AB) are used in intensive pig production systems to control infectious diseases and they are suspected to be a major source of antibiotic resistance. Following the ban on AB use as growth promoters in the EU, their prophylactic use in-feed is now under review. The aim of this study was to evaluate the effect of removing prophylactic in-feed AB on pig health and welfare indicators. Every Monday for six weeks, a subset of 70 pigs were weaned, tagged and sorted into two groups of 35 pigs according to weight (9.2 +/- 0.6 kg). AB were removed from the diet of one group (NO, n = 6) and maintained in the other group (AB, n = 6) for nine weeks. Ten focal pigs were chosen per group. After c. five weeks each group was split into two pens of c. 17 pigs for the following 4 weeks. Data were recorded weekly. Skin, tail, ear, flank and limb lesions of focal pigs were scored according to severity. The number of animals per group affected by health deviations was also recorded. The number of fights and harmful behaviours (ear, tail bites) per group was counted during 3x5min observations once per week. Data were analysed using mixed model equations and binomial logistic regression. At group level, AB pigs were more likely to have tail (OR = 1.70; P = 0.05) but less likely to have ear lesions than NO pigs (OR = 0.46; P<0.05). The number of ear bites (21.4 +/- 2.15 vs. 17.3 +/- 1.61; P<0.05) and fights (6.91 +/- 0.91 vs. 5.58 +/- 0.72; P = 0.09) was higher in AB than in NO pigs. There was no effect of treatment on health deviations and the frequency of these was low. Removing AB from the feed of weaner pigs had minimal effects on health and welfare indicators.	[Diana, Alessia; Manzanilla, Edgar G.; Diaz, Julia A. Calderon; Boyle, Laura A.] Teagasc Anim & Grassland Res & Innovat Ctr, Pig Dev Dept, Fermoy, Cork, Ireland; [Diana, Alessia; Leonard, Finola C.] UCD, Sch Vet Med, Dublin 4, Ireland; [Diaz, Julia A. Calderon] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Anim Behav & Welf, Ul Postepu 36A, Jastrzebiec, Magdalenka, Poland	Teagasc; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences	Diana, A (corresponding author), Teagasc Anim & Grassland Res & Innovat Ctr, Pig Dev Dept, Fermoy, Cork, Ireland.; Diana, A (corresponding author), UCD, Sch Vet Med, Dublin 4, Ireland.	alessia.diana@teagasc.ie	Diana, Alessia/W-2392-2019; Manzanilla, Edgar Garcia/B-2974-2012	Manzanilla, Edgar Garcia/0000-0002-2301-2560; Boyle, Laura/0000-0001-7080-1776; Diana, Alessia/0000-0002-8571-1295	Teagasc funds; Department of Agriculture Food and the Marine [PathSurvPigs 14/S/832]	Teagasc funds; Department of Agriculture Food and the Marine	This study was part of the WELPIG project which was funded from internal Teagasc funds. During the writing of this paper JACD's position was funded by the Department of Agriculture Food and the Marine under the Research Stimulus Fund (PathSurvPigs 14/S/832) as part of the National Development Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2005, BASIC CLIN PHARMACOL, V96, P271, DOI 10.1111/j.1742-7843.2005.pto960401.x; Aarestrup FM, 2010, AM J VET RES, V71, P726, DOI 10.2460/ajvr.71.7.726; Alban L, 2013, PREV VET MED, V108, P334, DOI 10.1016/j.prevetmed.2012.11.010; Andersen IL, 2000, APPL ANIM BEHAV SCI, V68, P107, DOI 10.1016/S0168-1591(00)00092-7; [Anonymous], 2005, EPA600R06021; Baxter M., 1985, SOCIAL SPACE DOMESTI, P116; Bengtsson B, 2014, UPSALA J MED SCI, V119, P96, DOI 10.3109/03009734.2014.901445; BLACKSHAW JK, 1981, ANIM PROD, V33, P325, DOI 10.1017/S000335610003172X; BLATCHFORD D, 1978, BRIT J PHARMACOL, V62, P241, DOI 10.1111/j.1476-5381.1978.tb08452.x; Breuer K, 2005, LIVEST PROD SCI, V93, P87, DOI 10.1016/j.livprodsci.2004.11.009; Burch D. G. S., 2012, THESIS; Chantziaras I, 2014, J ANTIMICROB CHEMOTH, V69, P827, DOI 10.1093/jac/dkt443; Conte S, 2010, THESIS; Cromwell GL, 2002, ANIM BIOTECHNOL, V13, P7, DOI 10.1081/ABIO-120005767; Daera NIE, 2012, CODE PRACTICE WELFAR; Dawkins MS, 2006, TRENDS ECOL EVOL, V21, P77, DOI 10.1016/j.tree.2005.10.017; De Briyne N, 2014, VET REC, V175, DOI 10.1136/vr.102462; De Jong IC, 1998, PHYSIOL BEHAV, V64, P303, DOI 10.1016/S0031-9384(98)00066-3; de Koning R, 1985, THESIS; Demain AL, 2015, ANTIBIOTICS: CURRENT INNOVATIONS AND FUTURE TRENDS, P65; Desbonnet L, 2015, BRAIN BEHAV IMMUN, V48, P165, DOI 10.1016/j.bbi.2015.04.004; Desrosiers R, 2013, LOND SWIN C MAN PROD; Diana A, 2016, 50 C INT SOC APPL ET; Diaz JAC, 2013, J ANIM SCI, V91, P3940, DOI 10.2527/jas.2012-5913; Ekkel ED, 1997, THESIS; Gibbons JF, 2016, ZOONOSES PUBLIC HLTH, V63, P241, DOI 10.1111/zph.12225; Harley S, 2012, VET REC, V171, P621, DOI 10.1136/vr.100986; Laine T, 2004, PREV VET MED, V66, P163, DOI 10.1016/j.prevetmed.2004.09.001; Lee C, 2005, LIVEST PROD SCI, V93, P255, DOI 10.1016/j.livprodsci.2004.10.003; Meyer-Hamme SEK1, 2015, ANIMAL, P1; Murphy D, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4666; O'Driscoll K, 2013, ANIMAL, V7, P1017, DOI 10.1017/S1751731112002431; Page SW, 2012, REV SCI TECH OIE, V31, P145; Petherick J. C., 1983, Farm animal housing and welfare. A Seminar in the CEC Programme of Coordination of Research on Animal Welfare, Aberdeen, Scotland, July 28-30, 1982, P103; Pettigrew JE, 2012, ECOLOGY ANIMAL HLTH, V2, P214; RANDOLPH JH, 1981, J ANIM SCI, V53, P922, DOI 10.2527/jas1981.534922x; Schokker D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116523; Sjolund M, 2016, PREV VET MED, V130, P41, DOI 10.1016/j.prevetmed.2016.06.003; Smulders D, 2008, ANIM WELFARE, V17, P61; Stein HH, 2002, ANIM BIOTECHNOL, V13, P85, DOI 10.1081/ABIO-120005772; Stukenborg A, 2011, THESIS; Taylor NR, 2010, VET J, V186, P137, DOI 10.1016/j.tvjl.2009.08.028; Turner SP, 2000, LIVEST PROD SCI, V66, P47, DOI 10.1016/S0301-6226(00)00159-7; Weissenbacher-Lang C, 2012, VET J, V194, P392, DOI 10.1016/j.tvjl.2012.05.026; Wierup M, 2001, MICROB DRUG RESIST, V7, P183, DOI 10.1089/10766290152045066	46	32	32	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185622	10.1371/journal.pone.0185622	http://dx.doi.org/10.1371/journal.pone.0185622			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982114	gold, Green Published, Green Submitted			2022-12-26	WOS:000412360300049
J	Hu, YC				Hu, Yi-Chung			A genetic-algorithm-based remnant grey prediction model for energy demand forecasting	PLOS ONE			English	Article							ELECTRICITY CONSUMPTION; NEURAL-NETWORK; CHINA; OPTIMIZATION; GM(1,1); TURKEY; NET	Energy demand is an important economic index, and demand forecasting has played a significant role in drawing up energy development plans for cities or countries. As the use of large datasets and statistical assumptions is often impractical to forecast energy demand, the GM(1,1) model is commonly used because of its simplicity and ability to characterize an unknown system by using a limited number of data points to construct a time series model. This paper proposes a genetic-algorithm-based remnant GM(1,1) (GARGM(1,1)) with sign estimation to further improve the forecasting accuracy of the original GM(1,1) model. The distinctive feature of GARGM(1,1) is that it simultaneously optimizes the parameter specifications of the original and its residual models by using the GA. The results of experiments pertaining to a real case of energy demand in China showed that the proposed GARGM (1,1) outperforms other remnant GM(1,1) variants.	[Hu, Yi-Chung] Fujian Agr & Forestry Univ, Coll Management, Fuzhou, Fujian, Peoples R China; [Hu, Yi-Chung] Fujian Agr & Forestry Univ, Coll Tourism, Fuzhou, Fujian, Peoples R China; [Hu, Yi-Chung] Chung Yuan Christian Univ, Dept Business Adm, Taoyuan, Taiwan	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Chung Yuan Christian University	Hu, YC (corresponding author), Fujian Agr & Forestry Univ, Coll Management, Fuzhou, Fujian, Peoples R China.; Hu, YC (corresponding author), Fujian Agr & Forestry Univ, Coll Tourism, Fuzhou, Fujian, Peoples R China.; Hu, YC (corresponding author), Chung Yuan Christian Univ, Dept Business Adm, Taoyuan, Taiwan.	ychu@cycu.edu.tw	Hu, Yi-Chung/GON-3857-2022	Hu, Yi-Chung/0000-0003-3090-1515	Ministry of Science and Technology, Taiwan [MOST 104-2410-H-033-023-MY2, MOST 106-2410-H-033-006-MY2]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This research is partially supported by the Ministry of Science and Technology, Taiwan under grant MOST 104-2410-H-033-023-MY2 and MOST 106-2410-H-033-006-MY2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ENERGY TRANSFORMED S; Cantu-Paz E, 2000, COMPUT METHOD APPL M, V186, P221, DOI 10.1016/S0045-7825(99)00385-0; Chang CJ, 2016, J OPER RES SOC, V67, P1439, DOI 10.1057/jors.2016.31; Chiang JH, 1999, IEEE T FUZZY SYST, V7, P63, DOI 10.1109/91.746311; Cui J, 2013, APPL MATH MODEL, V37, P4399, DOI 10.1016/j.apm.2012.09.052; DENG JL, 1982, SYST CONTROL LETT, V1, P288, DOI 10.1016/S0167-6911(82)80025-X; Duran M, 2009, ENERG POLICY, P1181; Ediger VS, 2007, ENERG POLICY, V35, P1701, DOI 10.1016/j.enpol.2006.05.009; Ene S, 2017, TECHNOL FORECAST SOC, V115, P155, DOI 10.1016/j.techfore.2016.09.030; Feng SJ, 2012, ENERG SOURCE PART B, V7, P376, DOI 10.1080/15567240903330426; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Gonzalez PA, 2005, ENERG BUILDINGS, V37, P595, DOI 10.1016/j.enbuild.2004.09.006; Hsu CC, 2003, ENERG CONVERS MANAGE, V44, P2241, DOI 10.1016/S0196-8904(02)00248-0; Hsu CI, 1998, TRANSPORT PLAN TECHN, V22, P87, DOI 10.1080/03081069808717622; Hsu LC, 2003, TECHNOL FORECAST SOC, V70, P563, DOI 10.1016/S0040-1625(02)00195-6; Hu YC, 2016, J OPERATIONAL RES SO; HU YC, 2017, SUSTAINABILITY-BASEL, V9, DOI DOI 10.3390/SU9071166; HU YC, 2017, SUSTAINABILITY-BASEL, V9, DOI DOI 10.3390/SU9071228; Hu YC, 2007, NEUROCOMPUTING, V70, P2959, DOI 10.1016/j.neucom.2006.10.111; Hu YC, 2017, J OPER RES SOC, V68, P556, DOI 10.1057/s41274-016-0130-2; Hu YC, 2014, INFORM SCIENCES, V284, P18, DOI 10.1016/j.ins.2014.06.043; Hu YC, 2012, NEUROCOMPUTING, V91, P86, DOI 10.1016/j.neucom.2012.02.022; Ishibuchi H., 2004, CLASSIFICATION MODEL; Lauret P, 2008, ENERG CONVERS MANAGE, V49, P1156, DOI 10.1016/j.enconman.2007.09.009; Lee YS, 2011, ENERG CONVERS MANAGE, V52, P147, DOI 10.1016/j.enconman.2010.06.053; Lewis CD, 1982, IND BUSINESS FORECAS; Li DC, 2012, OMEGA-INT J MANAGE S, V40, P767, DOI 10.1016/j.omega.2011.07.007; Lim D, 2007, FUTURE GENER COMP SY, V23, P658, DOI 10.1016/j.future.2006.10.008; Liu S.F., 2006, GREY INFORM THEORY P; Liu YY, 2015, PARALLEL COMPUT, V46, P98, DOI 10.1016/j.parco.2014.04.008; Liu Zhenya, 2015, GLOBAL ENERGY INTERN; Lu JS, 2016, NEUROCOMPUTING, V177, P206, DOI 10.1016/j.neucom.2015.11.032; Mao MZ, 2006, TECHNOL FORECAST SOC, V73, P588, DOI 10.1016/j.techfore.2004.08.004; Osyczka A., 2003, EVOLUTIONARY ALGORIT; Pao Y.H., 1989, ADAPTIVE PATTERN REC; Pao Y.-H., 1992, IEEE COMPUT J, V25, P76, DOI DOI 10.1109/2.144401; Pi D, 2010, ENERG SOURCE PART A, V32, P1517, DOI 10.1080/15567030902780360; Suganthi L, 2012, RENEW SUST ENERG REV, V16, P1223, DOI 10.1016/j.rser.2011.08.014; Sun W, 2017, ENERGY, V118, P969, DOI 10.1016/j.energy.2016.10.120; Tsaur RC, 2007, INT J UNCERTAIN FUZZ, V15, P753, DOI 10.1142/S0218488507004984; Tsoulos IG, 2016, COMPUT PHYS COMMUN, V209, P183, DOI 10.1016/j.cpc.2016.09.006; Tutun S, 2015, ENERGY, V93, P2406, DOI 10.1016/j.energy.2015.10.064; Wang CH, 2008, APPL MATH COMPUT, V195, P256, DOI 10.1016/j.amc.2007.04.080; Wang ZX, 2016, APPL MATH MODEL, V40, P5745, DOI 10.1016/j.apm.2016.01.012; Wei JC, 2015, APPL MATH MODEL, V39, P924, DOI 10.1016/j.apm.2014.06.017; Wen K-. L, 2004, GREY SYSTEMS MODELIN; Xia CH, 2010, INT J ELEC POWER, V32, P743, DOI 10.1016/j.ijepes.2010.01.009; Xu N, 2017, ENERGY, V118, P473, DOI 10.1016/j.energy.2016.10.003; Yu WJ, 2017, APPL SOFT COMPUT, V59, P258, DOI 10.1016/j.asoc.2017.06.008	49	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185478	10.1371/journal.pone.0185478	http://dx.doi.org/10.1371/journal.pone.0185478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28981548	Green Submitted, gold, Green Published			2022-12-26	WOS:000412360300042
J	Poncini, L; Wyrsch, I; Tendon, VD; Vorley, T; Boller, T; Geldner, N; Metraux, JP; Lehmann, S				Poncini, Lorenzo; Wyrsch, Ines; Tendon, Valerie Denervaud; Vorley, Thomas; Boller, Thomas; Geldner, Niko; Metraux, Jean-Pierre; Lehmann, Silke			In roots of Arabidopsis thaliana, the damage-associated molecular pattern AtPep1 is a stronger elicitor of immune signalling than flg22 or the chitin heptamer	PLOS ONE			English	Article							FUSARIUM-OXYSPORUM; PLANT DEFENSE; DISEASE-RESISTANCE; RECOGNITION RECEPTORS; TRANSCRIPTION FACTORS; FLAGELLIN PERCEPTION; EXPRESSION PATTERNS; OXIDATIVE STRESS; GENE-EXPRESSION; INNATE IMMUNITY	Plants interpret their immediate environment through perception of small molecules. Microbe-associated molecular patterns (MAMPs) such as flagellin and chitin are likely to be more abundant in the rhizosphere than plant-derived damage-associated molecular patterns (DAMPs). We investigated how the Arabidopsis thaliana root interprets MAMPs and DAMPs as danger signals. We monitored root development during exposure to increasing concentrations of the MAMPs flg22 and the chitin heptamer as well as of the DAMP AtPep1. The tissue-specific expression of defence-related genes in roots was analysed using a toolkit of promoter:: YFPN lines reporting jasmonic acid (JA)-, salicylic acid (SA)-, ethylene (ET)-and reactive oxygen species (ROS)-dependent signalling. Finally, marker responses were analysed during invasion by the root pathogen Fusarium oxysporum. The DAMP AtPep1 triggered a stronger activation of the defence markers compared to flg22 and the chitin heptamer. In contrast to the tested MAMPs, AtPep1 induced SA-and JA-signalling markers in the root and caused a severe inhibition of root growth. Fungal attack resulted in a strong activation of defence genes in tissues close to the invading fungal hyphae. The results collectively suggest that AtPep1 presents a stronger danger signal to the Arabidopsis root than the MAMPs flg22 and chitin heptamer.	[Poncini, Lorenzo; Tendon, Valerie Denervaud; Vorley, Thomas; Metraux, Jean-Pierre; Lehmann, Silke] Univ Fribourg, Dept Biol, Fribourg, Switzerland; [Wyrsch, Ines; Boller, Thomas] Univ Basel, Dept Environm Sci, Basel, Switzerland; [Tendon, Valerie Denervaud; Geldner, Niko] Univ Lausanne, Dept Plant Mol Biol, Lausanne, Switzerland; [Lehmann, Silke] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England	University of Fribourg; University of Basel; University of Lausanne; University of Warwick	Lehmann, S (corresponding author), Univ Fribourg, Dept Biol, Fribourg, Switzerland.; Lehmann, S (corresponding author), Univ Warwick, Sch Life Sci, Coventry, W Midlands, England.	s.lehmann@warwick.ac.uk	Boller, Thomas/G-3500-2012; Geldner, Niko/Y-2481-2019	Boller, Thomas/0000-0001-6768-7503; Geldner, Niko/0000-0002-2300-9644	Swiss National Foundation [CRSII3_136278]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was made possible by funds to J.-P. Metraux, T. Boller and N. Geldner by the Swiss National Foundation (CRSII3_136278). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bartels S, 2015, J EXP BOT, V66, P5183, DOI 10.1093/jxb/erv180; Bartels S, 2013, J EXP BOT, V64, P5309, DOI 10.1093/jxb/ert330; Beck M, 2014, J EXP BOT, V65, P6487, DOI 10.1093/jxb/eru366; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Czymmek KJ, 2007, FUNGAL GENET BIOL, V44, P1011, DOI 10.1016/j.fgb.2007.01.012; De Vleesschauwer D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00611; Diener AC, 2005, GENETICS, V171, P305, DOI 10.1534/genetics.105.042218; Edgar CI, 2006, AUSTRALAS PLANT PATH, V35, P581, DOI 10.1071/AP06060; Ferrari S., 2013, Frontiers in Plant Science, V4, P49; Flury P, 2013, PLANT PHYSIOL, V161, P2023, DOI 10.1104/pp.113.216077; Geldner N, 2013, ANNU REV PLANT BIOL, V64, P531, DOI 10.1146/annurev-arplant-050312-120050; Gigolashvili T, 2007, PLANT J, V50, P886, DOI 10.1111/j.1365-313X.2007.03099.x; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Gully K, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00014; Gupta KJ, 2014, MOL PLANT MICROBE IN, V27, P307, DOI 10.1094/MPMI-06-13-0160-R; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huffaker A, 2007, P NATL ACAD SCI USA, V104, P10732, DOI 10.1073/pnas.0703343104; Huffaker A, 2006, P NATL ACAD SCI USA, V103, P10098, DOI 10.1073/pnas.0603727103; Huffaker A, 2013, P NATL ACAD SCI USA, V110, P5707, DOI 10.1073/pnas.1214668110; Huffaker A, 2011, PLANT PHYSIOL, V155, P1325, DOI 10.1104/pp.110.166710; Jacobs S, 2011, PLANT PHYSIOL, V156, P726, DOI 10.1104/pp.111.176446; Journot-Catalino N, 2006, PLANT CELL, V18, P3289, DOI 10.1105/tpc.106.044149; Kidd BN, 2011, MOL PLANT MICROBE IN, V24, P733, DOI 10.1094/MPMI-08-10-0194; KISTLER HC, 1986, J BACTERIOL, V167, P587, DOI 10.1128/jb.167.2.587-593.1986; Klauser D, 2015, J EXP BOT, V66, P5327, DOI 10.1093/jxb/erv250; Klauser D, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25346; Krol E, 2010, J BIOL CHEM, V285, P13471, DOI 10.1074/jbc.M109.097394; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Liu ZX, 2013, P NATL ACAD SCI USA, V110, P6205, DOI 10.1073/pnas.1215543110; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lori M, 2015, J EXP BOT, V66, P5315, DOI 10.1093/jxb/erv236; Luna E, 2011, MOL PLANT MICROBE IN, V24, P183, DOI 10.1094/MPMI-07-10-0149; Ma CL, 2014, J INTEGR PLANT BIOL, V56, P684, DOI 10.1111/jipb.12171; Ma Y, 2012, P NATL ACAD SCI USA, V109, P19852, DOI 10.1073/pnas.1205448109; MASACHIS S, 2016, NAT MICROBIOL, V1; Meindl T, 2000, PLANT CELL, V12, P1783, DOI 10.1105/tpc.12.9.1783; Michielse CB, 2009, MOL PLANT PATHOL, V10, P311, DOI [10.1111/J.1364-3703.2009.00538.X, 10.1111/j.1364-3703.2009.00538.x]; Millet YA, 2010, PLANT CELL, V22, P973, DOI 10.1105/tpc.109.069658; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; Nawrath Christiane, 2013, Arabidopsis Book, V11, pe0167, DOI 10.1199/tab.0167; Ortiz-Morea FA, 2016, P NATL ACAD SCI USA, V113, P11028, DOI 10.1073/pnas.1605588113; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; POTTER S, 1993, MOL PLANT MICROBE IN, V6, P680, DOI 10.1094/MPMI-6-680; Proietti S, 2011, J EXP BOT, V62, P1975, DOI 10.1093/jxb/erq396; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; Rizhsky L, 2004, J BIOL CHEM, V279, P11736, DOI 10.1074/jbc.M313350200; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Ross A, 2014, EMBO J, V33, P62, DOI 10.1002/embj.201284303; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Segonzac C, 2011, CURR OPIN MICROBIOL, V14, P54, DOI 10.1016/j.mib.2010.12.005; Seo PJ, 2008, PLANT CELL PHYSIOL, V49, P334, DOI 10.1093/pcp/pcn011; Sloan SS, 2015, CURR OPIN PLANT BIOL, V26, P32, DOI 10.1016/j.pbi.2015.05.026; Thatcher LF, 2009, PLANT J, V58, P927, DOI 10.1111/j.1365-313X.2009.03831.x; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Tintor N, 2013, P NATL ACAD SCI USA, V110, P6211, DOI 10.1073/pnas.1216780110; Tognolli M, 2002, GENE, V288, P129, DOI 10.1016/S0378-1119(02)00465-1; Trevors JT, 2010, ANTON LEEUW INT J G, V97, P99, DOI 10.1007/s10482-009-9397-5; Tsuchisaka A, 2004, PLANT PHYSIOL, V136, P2982, DOI 10.1104/pp.104.049999; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; Vermeer JEM, 2014, SCIENCE, V343, P178, DOI 10.1126/science.1245871; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wyrsch I, 2015, NEW PHYTOL, V206, P774, DOI 10.1111/nph.13280; Yamada K, 2016, EMBO J, V35, P46, DOI 10.15252/embj.201591807; Yamaguchi Y, 2006, P NATL ACAD SCI USA, V103, P10104, DOI 10.1073/pnas.0603729103; Yamaguchi Y, 2011, CURR OPIN PLANT BIOL, V14, P351, DOI 10.1016/j.pbi.2011.05.001; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	74	42	44	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185808	10.1371/journal.pone.0185808	http://dx.doi.org/10.1371/journal.pone.0185808			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973025	Green Published, Green Submitted, gold			2022-12-26	WOS:000412131900056
J	Zhang, HR; Kunadia, A; Lin, YF; Fondell, JD; Seidel, D; Fan, HZ				Zhang, Huirong; Kunadia, Anuj; Lin, Yingfu; Fondell, Joseph D.; Seidel, Daniel; Fan, Huizhou			Identification of a strong and specific antichlamydial N-acylhydrazone	PLOS ONE			English	Article							RESISTANT CHLAMYDIA-SUIS; SMALL-MOLECULE INHIBITOR; III SECRETION; PEPTIDE DEFORMYLASE; GENITAL-TRACT; TRACHOMATIS; MICE; INFECTION; GROWTH; ANTIBIOTICS	Sexually transmitted Chlamydia trachomatis is an extremely common infection and often leads to serious complications including infertility and pelvic inflammatory syndrome. Several broad-spectrum antibiotics are currently used to treat C. trachomatis. Although effective, they also kill beneficial vaginal lactobacilli. Two N-acylhydrazones, CF0001 and CF0002, have been shown previously to inhibit chlamydial growth without toxicity to human cells and Lactobacillus spp. Of particular significance, the rate of random mutation leading to resistance of these inhibitors appears to be extremely low. Here, we report three analogs of CF0001 and CF0002 with significantly stronger inhibitory effects on chlamydiae. Even though the new compounds (termed SF1, SF2 and SF3) displayed slightly decreased inhibition efficiencies for a rare Chlamydia variant selected for CF0001 resistance (Chlamydia muridarum MCR), they completely overcame the resistance when used at concentrations of 75 - 100 mu M. Importantly, SF1, SF2 and SF3 did not shown any toxic effect on lactobacilli, whereas SF3 was also well tolerated by human host cells. An effort to isolate SF3-resistant variants was unsuccessful. By comparison, variants resistant to rifampin or spectinomycin were obtained from smaller numbers of chlamydiae. Our findings suggest that SF3 utilizes an antichlamydial mechanism similar to that of CF0001 and CF0002, and will be more difficult for chlamydiae to develop resistance to, potentially making it a more effective antichlamydial agent.	[Zhang, Huirong; Fondell, Joseph D.; Fan, Huizhou] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Kunadia, Anuj; Lin, Yingfu; Seidel, Daniel] Rutgers State Univ, Sch Arts & Sci, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; Univ Florida, Dept Chem, Gainesville, FL 32611 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; State University System of Florida; University of Florida	Fan, HZ (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.; Seidel, D (corresponding author), Rutgers State Univ, Sch Arts & Sci, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.	seidel@chem.ufl.edu; huizhou.fan@rutgers.edu	Seidel, Daniel/G-3291-2018	Seidel, Daniel/0000-0001-6725-111X; FAN, HUIZHOU/0000-0002-4903-926X	National Institutes of Health [AI122034]; New Jersey Health Foundation [PC45-16]; Busch Biomedical Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI122034] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Health Foundation; Busch Biomedical Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (Grant # AI122034 to HF), New Jersey Health Foundation (PC45-16 to HF) and the Busch Biomedical Research Program (to HF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Deborah, 2015, MMWR Morb Mortal Wkly Rep, V62, P1, DOI 10.15585/mmwr.mm6253a1; Adams Deborah A, 2016, MMWR Morb Mortal Wkly Rep, V63, P1, DOI 10.15585/mmwr.mm6354a1; Balakrishnan A, 2006, J BIOL CHEM, V281, P16691, DOI 10.1074/jbc.M513648200; Balakrishnan A, 2009, MICROBIOL RES, V164, P338, DOI 10.1016/j.micres.2007.05.002; Balin BJ, 2008, J ALZHEIMERS DIS, V13, P371; Bao XF, 2014, J BACTERIOL, V196, P2989, DOI 10.1128/JB.01677-14; Bao XF, 2011, MICROBIOL-SGM, V157, P2569, DOI 10.1099/mic.0.049668-0; Borel N, 2012, VET MICROBIOL, V156, P143, DOI 10.1016/j.vetmic.2011.10.011; BULLEN JJ, 1981, REV INFECT DIS, V3, P1127; Burton MJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000460; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Campbell LA, 1998, EMERG INFECT DIS, V4, P571, DOI 10.3201/eid0404.980407; CDC, 2013, MMWR-MORBID MORTAL W, V62, P424; CDC, 2014, CDC FACT SHEET STD T; CDC, 2013, CDC FACT SHEET STD T; Chen LL, 2010, J IMMUNOL, V184, P2602, DOI 10.4049/jimmunol.0901593; Cotter TW, 1997, INFECT IMMUN, V65, P2067, DOI 10.1128/IAI.65.6.2067-2073.1997; Dan M, 2003, ISRAEL MED ASSOC J, V5, P629; DELAMAZA LM, 1994, INFECT IMMUN, V62, P2094, DOI 10.1128/IAI.62.5.2094-2097.1994; Donders GGG, 2010, GYNECOL OBSTET INVES, V70, P306, DOI 10.1159/000314022; Dutra LA, 2014, ANTIMICROB AGENTS CH, V58, P4837, DOI 10.1128/AAC.00052-14; Engstrom P, 2013, J BACTERIOL, V195, P4221, DOI 10.1128/JB.00506-13; Fan HZ, 2012, INVEST OPHTH VIS SCI, V53, P2560, DOI 10.1167/iovs.12-9835; Gong Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107758; HILL LVH, 1986, CAN MED ASSOC J, V134, P321; Joseph SJ, 2016, GENOME BIOL EVOL, V8, P2613, DOI 10.1093/gbe/evw182; Kauppi AM, 2003, ADV EXP MED BIOL, V529, P97; Keeney KM, 2014, ANNU REV MICROBIOL, V68, P217, DOI 10.1146/annurev-micro-091313-103456; Knight JL, 2005, BIOPHYS J, V88, P925, DOI 10.1529/biophysj.104.050187; Lange K, 2016, DIGEST DIS, V34, P260, DOI 10.1159/000443360; Lenart J, 2001, ANTIMICROB AGENTS CH, V45, P2198, DOI 10.1128/AAC.45.8.2198-2203.2001; Little CS, 2004, NEUROBIOL AGING, V25, P419, DOI 10.1016/S0197-4580(03)00127-1; Martin HL, 1998, J INFECT DIS, V178, P1053, DOI 10.1086/515654; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mueller KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135295; Muschiol S, 2006, P NATL ACAD SCI USA, V103, P14566, DOI 10.1073/pnas.0606412103; PETERSON EM, 1990, PLASMID, V23, P144, DOI 10.1016/0147-619X(90)90033-9; Pirotta MV, 2006, J CLIN MICROBIOL, V44, P3213, DOI 10.1128/JCM.00218-06; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rohde G, 2010, DTSCH ARZTEBL INT, V107, P174, DOI 10.3238/arztebl.2010.0174; Schachter J, 1999, CHLAMYDIA, P139; Shapiro RA, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e72; Slepenkin A, 2007, INFECT IMMUN, V75, P3478, DOI 10.1128/IAI.00023-07; Somani Jyoti, 2000, Journal of Infectious Diseases, V181, P1421, DOI 10.1086/315372; Spinillo A, 1999, AM J OBSTET GYNECOL, V180, P14, DOI 10.1016/S0002-9378(99)70141-9; Srivastava A, 2012, ANTIMICROB AGENTS CH, V56, P6250, DOI 10.1128/AAC.01060-12; Stephens RS, 2009, FEMS IMMUNOL MED MIC, V55, P115, DOI 10.1111/j.1574-695X.2008.00516.x; Wickstrum J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076743; Wolf K, 2006, MOL MICROBIOL, V61, P1543, DOI 10.1111/j.1365-2958.2006.05347.x; Xu Shuang, 2013, BMC Res Notes, V6, P377, DOI 10.1186/1756-0500-6-377	50	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185783	10.1371/journal.pone.0185783	http://dx.doi.org/10.1371/journal.pone.0185783			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973037	Green Submitted, Green Published, gold			2022-12-26	WOS:000412131900050
J	Sanchez-Del Cojo, M; Lopez-Huertas, MR; Diez-Fuertes, F; Rodriguez-Mora, S; Bermejo, M; Lopez-Campos, G; Mateos, E; Jimenez-Tormo, L; Gomez-Esquer, F; Diaz-Gil, G; Alcami, J; Coiras, M				Sanchez-Del Cojo, Maria; Rosa Lopez-Huertas, Maria; Diez-Fuertes, Francisco; Rodriguez-Mora, Sara; Bermejo, Mercedes; Lopez-Campos, Guillermo; Mateos, Elena; Jimenez-Tormo, Laura; Gomez-Esquer, Francisco; Diaz-Gil, Gema; Alcami, Jose; Coiras, Mayte			Changes in the cellular microRNA profile by the intracellular expression of HIV-1 Tat regulator: A potential mechanism for resistance to apoptosis and impaired proliferation in HIV-1 infected CD4+T cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; CD4(+) T-LYMPHOCYTES; NONCODING RNAS; INFECTED-CELLS; CYCLE ARREST; RAT-BRAIN; C-JUN; PROTEIN; PATHWAY	HIV-1 induces changes in the miRNA expression profile of infected CD4+ T cells that could improve viral replication. HIV-1 regulator Tat modifies the cellular gene expression and has been appointed as an RNA silencing suppressor. Tat is a 101-residue protein codified by two exons that regulates the elongation of viral transcripts. The first exon of Tat (amino acids 1-72) forms the transcriptionally active protein Tat72, but the presence of the second exon (amino acids 73-101) results in a more competent regulatory protein (Tat101) with additional functions. Intracellular, full-length Tat101 induces functional and morphological changes in CD4+ T cells that contribute to HIV-1 pathogenesis such as delay in T-cell proliferation and protection against FasL-mediated apoptosis. But the precise mechanism by which Tat produces these changes remains unknown. We analyzed how the stable expression of intracellular Tat101 and Tat72 modified the miRNA expression profile in Jurkat cells and if this correlated with changes in apoptotic pathways and cell cycle observed in Tat-expressing cells. Specifically, the enhanced expression of hsa-miR-21 and hsa-miR-222 in Jurkat-Tat101 cells was associated with the reduced expression of target mRNAs encoding proteins related to apoptosis and cell cycle such as PTEN, PDCD4 and CDKN1B. We developed Jurkat cells with stable expression of hsa-miR-21 or hsa-miR-222 and observed a similar pattern to Jurkat-Tat101 in resistance to FasL-mediated apoptosis, cell cycle arrest in G2/M and altered cell morphology. Consequently, upregulation of hsa-miR-21 and hsa-miR-222 by Tat may contribute to protect against apoptosis and to anergy observed in HIV-infected CD4+ T cells.	[Sanchez-Del Cojo, Maria; Diez-Fuertes, Francisco; Rodriguez-Mora, Sara; Bermejo, Mercedes; Mateos, Elena; Alcami, Jose; Coiras, Mayte] Inst Salud Carlos III, Natl Ctr Microbiol, AIDS Immunopathol Unit, Madrid, Spain; [Rosa Lopez-Huertas, Maria; Jimenez-Tormo, Laura] Hosp Ramon & Cajal, IRYCIS, Dept Infect Dis, Madrid, Spain; [Rodriguez-Mora, Sara] UCL, Div Infect & Immun, London, England; [Lopez-Campos, Guillermo] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland; [Gomez-Esquer, Francisco; Diaz-Gil, Gema] Univ Rey Juan Carlos, Fac Ciencias Salud, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Hospital Universitario Ramon y Cajal; University of London; University College London; Queens University Belfast; Universidad Rey Juan Carlos	Alcami, J; Coiras, M (corresponding author), Inst Salud Carlos III, Natl Ctr Microbiol, AIDS Immunopathol Unit, Madrid, Spain.	ppalcami@iscii.es; mcoiras@isciii.es	Diaz-Gil, Gema/ABG-6454-2020; Esquer, Francisco Gomez/K-8236-2017; Alcami, Pepe/T-2242-2018; Campos, Guillermo H Lopez/G-2883-2015; Díez-Fuertes, Francisco/AAA-9427-2019; Coiras, Mayte/R-9530-2019; Lopez-Campos, Guillermo/O-4349-2017; Lopez Huertas, Maria Rosa/J-6282-2014	Alcami, Pepe/0000-0003-0023-7377; Díez-Fuertes, Francisco/0000-0003-2413-9229; Rodriguez Mora, Sara/0000-0003-2467-116X; Bermejo, Mercedes/0000-0001-9909-8578; Gomez-Esquer, Francisco/0000-0002-5426-4349; Lopez-Campos, Guillermo/0000-0003-3011-0940; Diaz Gil, Gema/0000-0003-3480-1490; Coiras, Mayte/0000-0001-6464-5770; Lopez Huertas, Maria Rosa/0000-0002-4183-2773	Spanish Ministry of Economy and Competitiveness [SAF2010-18388, SAF2013-44677-R, PI12/00506, PIE 13/00040]; Spanish AIDS Research Network [RD12/0017/0015]; ISCIII-Subdireccion General de Evaluacion; European Funding for Regional Development (FEDER); Fondo de Investigaciones Sanitarias [FI09/00347]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish AIDS Research Network; ISCIII-Subdireccion General de Evaluacion; European Funding for Regional Development (FEDER)(European Commission); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was supported by the Spanish Ministry of Economy and Competitiveness (SAF2010-18388, SAF2013-44677-R, PI12/00506, PIE 13/00040); the Spanish AIDS Research Network RD12/0017/0015 that is included in the Spanish I+D-I Plan and is co-financed by ISCIII-Subdireccion General de Evaluacion and European Funding for Regional Development (FEDER). The work of Maria Sanchez del Cojo is supported by a fellowship of Fondo de Investigaciones Sanitarias (FI09/00347). The Spanish Ministry of Economy and Competitiveness supported the work of Maria Rosa Lopez-Huertas (PIE 13/00040), Elena Mateos (SAF2010-18388), Sara Rodriguez-Mora (Sara Borrell fellowship) and Francisco Diez-Fuertes (Sara Borrell fellowship).	ALCAMI J, 1995, EMBO J, V14, P1552, DOI 10.1002/j.1460-2075.1995.tb07141.x; ARENZANASEISDEDOS F, 1993, J VIROL, V67, P6596, DOI 10.1128/JVI.67.11.6596-6604.1993; BACHELERIE F, 1991, NATURE, V350, P709, DOI 10.1038/350709a0; Bannwarth S, 2005, CURR HIV RES, V3, P61, DOI 10.2174/1570162052772924; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bennasser Y, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-95; Bera A, 2013, CELL SIGNAL, V25, P2575, DOI 10.1016/j.cellsig.2013.08.005; Bruce-Keller AJ, 2003, J NEUROSCI, V23, P8417; Chiang K, 2012, J VIROL, V86, P3244, DOI 10.1128/JVI.05065-11; Chu EC, 2004, MED SCI MONITOR, V10, pRA235; Coiras M, 2006, PROTEOMICS, V6, pS63, DOI 10.1002/pmic.200500437; Costin JM, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-100; Cummins NW, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.77; Cunningham L, 2012, P NATL ACAD SCI USA, V109, P14592, DOI 10.1073/pnas.1200037109; Detsika MG, 2012, AIDS REV, V14, P188; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Di Leva G, 2010, JNCI-J NATL CANCER I, V102, P706, DOI 10.1093/jnci/djq102; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Felekkis K, 2010, HIPPOKRATIA, V14, P236; Fevrier M, 2011, VIRUSES-BASEL, V3, P586, DOI 10.3390/v3050586; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Fiume G, 2012, NUCLEIC ACIDS RES, V40, P3548, DOI 10.1093/nar/gkr1224; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Galardi S, 2011, NUCLEIC ACIDS RES, V39, P3892, DOI 10.1093/nar/gkr006; Gatignol A, 2000, Adv Pharmacol, V48, P209; Gibellini D, 2005, J CELL PHYSIOL, V203, P547, DOI 10.1002/jcp.20252; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hernandez JC, 2011, AIDS RES HUM RETROV, V27, P1099, DOI [10.1089/aid.2010.0302, 10.1089/AID.2010.0302]; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Jiang L, 2013, EXP CELL RES, V319, P2254, DOI 10.1016/j.yexcr.2013.06.007; Kaikkonen MU, 2011, CARDIOVASC RES, V90, P430, DOI 10.1093/cvr/cvr097; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kim VN, 2005, MOL CELLS, V19, P1; Klockow LC, 2013, VIROLOGY, V444, P191, DOI 10.1016/j.virol.2013.06.010; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P237, DOI 10.1152/physiolgenomics.00141.2011; KROWKA JF, 1989, J CLIN INVEST, V83, P1198, DOI 10.1172/JCI114001; Kumar A, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0137-6; Laguette N, 2014, CELL, V156, P134, DOI 10.1016/j.cell.2013.12.011; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993; Li DY, 2009, J CEREBR BLOOD F MET, V29, P1903, DOI 10.1038/jcbfm.2009.102; Li JCB, 2007, IMMUNOLOGY, V121, P337, DOI 10.1111/j.1365-2567.2007.02580.x; Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07; Lopez-Huertas MR, 2010, NUCLEIC ACIDS RES, V38, P3287, DOI 10.1093/nar/gkq037; Lopez-Huertas MR, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00069; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; MADORE SJ, 1993, J VIROL, V67, P3703, DOI 10.1128/JVI.67.7.3703-3711.1993; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; MEYAARD L, 1993, IMMUNOL TODAY, V14, P161, DOI 10.1016/0167-5699(93)90279-T; Musgrove EA, 2004, J MAMMARY GLAND BIOL, V9, P55, DOI 10.1023/B:JOMG.0000023588.55733.84; Nagy G, 2006, J BIOL CHEM, V281, P34574, DOI 10.1074/jbc.M606301200; Nallamshetty S, 2005, FEBS LETT, V579, P6529, DOI 10.1016/j.febslet.2005.10.028; NARDELLI B, 1995, P NATL ACAD SCI USA, V92, P7312, DOI 10.1073/pnas.92.16.7312; Orecchini E, 2014, RNA BIOL, V11, P334, DOI 10.4161/rna.28372; Panner A, 2010, CANCER RES, V70, P5046, DOI 10.1158/0008-5472.CAN-09-3979; Patel P, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0108-6; Popik W, 1996, MOL CELL BIOL, V16, P6532; Qian S, 2009, P NATL ACAD SCI USA, V106, P605, DOI 10.1073/pnas.0806822106; RASHEED S, 1986, VIROLOGY, V154, P395, DOI 10.1016/0042-6822(86)90465-4; Reed M, 2010, J SURG ONCOL, V102, P282, DOI 10.1002/jso.21590; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Rodriguez-Mora S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0203-3; Lopez-Huertas MR, 2013, J BIOL CHEM, V288, P7626, DOI 10.1074/jbc.M112.408294; Rosca A, 2016, J MED VIROL, V88, P2132, DOI 10.1002/jmv.24586; Ruelas DS, 2015, J BIOL CHEM, V290, P13736, DOI 10.1074/jbc.M115.641837; Sanghvi VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017246; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sgarbanti M, 2008, J VIROL, V82, P3632, DOI 10.1128/JVI.00599-07; Shen CJ, 2012, FASEB J, V26, P4755, DOI 10.1096/fj.12-209023; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057652; Song LP, 2011, PROTEIN CELL, V2, P273, DOI 10.1007/s13238-011-1037-y; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Sun GH, 2012, NUCLEIC ACIDS RES, V40, P2181, DOI 10.1093/nar/gkr961; Sung TL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000263; Swaminathan G, 2014, J MOL BIOL, V426, P1178, DOI 10.1016/j.jmb.2013.12.017; TAKEYA M, 1991, ACTA PATHOL JAPON, V41, P212; Thierry S, 2004, J VIROL, V78, P12198, DOI 10.1128/JVI.78.22.12198-12206.2004; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Tumaneng K, 2012, NAT CELL BIOL, V14, P1322, DOI 10.1038/ncb2615; VAGO L, 1993, J ACQ IMMUN DEF SYND, V6, P42; Villa C, 2013, J ALZHEIMERS DIS, V35, P487, DOI 10.3233/JAD-122263; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Weng LP, 2001, HUM MOL GENET, V10, P237, DOI 10.1093/hmg/10.3.237; Willard-Gallo KE, 2001, EUR J IMMUNOL, V31, P969, DOI 10.1002/1521-4141(200104)31:4<969::AID-IMMU969>3.0.CO;2-2; Wu YR, 2016, TUMOR BIOL, V37, P12061, DOI 10.1007/s13277-016-5074-2; Xiao HQ, 2009, AM J NEPHROL, V30, P34, DOI 10.1159/000200769; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zhang GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135339	93	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185677	10.1371/journal.pone.0185677	http://dx.doi.org/10.1371/journal.pone.0185677			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968466	Green Published, gold			2022-12-26	WOS:000412029600036
J	Adams, RA; Carter, RT				Adams, Rick A.; Carter, Richard T.			Megachiropteran bats profoundly unique from microchiropterans in climbing and walking locomotion: Evolutionary implications	PLOS ONE			English	Article							TERRESTRIAL LOCOMOTION; ECHOLOCATION; SHREW; ENERGETICS; MECHANICS; MEGABATS; DYNAMICS; ARBOREAL; PRIMATES	Understandably, most locomotor analyses of bats have focused on flight mechanics and behaviors. However, we investigated nonflight locomotion in an effort to glean deeper insights into the evolutionary history of bats. We used high-speed video (300 Hz) to film and compare walking and climbing mechanics and kinematics between several species of the suborders Megachiroptera (Pteropodidae) versus Microchiroptera (Vespertilionidae and Phyllostomatidae). We found fundamentally distinctive behaviors, functional abilities, and performance outcomes between groups, but nearly homogeneous outcomes within groups. Megachiropterans exhibited climbing techniques and skills not found in microchiropterans and which aligned with other fully arboreal mammals. Megachiropterans climbed readily when placed in a head-up posture on a vertical surface, showed significantly greater ability than microchiropterans to abduct and extend the reach of their limbs, and climbed at a greater pace by using a more aggressive ipsilateral gait, at times being supported by only a single contact point. In addition, megachiropterans showed little ability to employ basic walking mechanics when placed on the ground, also a pattern observed in some highly adapted arboreal mammals. Conversely, microchiropterans resisted climbing vertical surfaces in a head-up posture, showed significantly less extension of their limbs, and employed a less-aggressive, slower contralateral gait with three points of contact. When walking, microchiropterans used the same gait they did when climbing which is representative of basic tetrapod terrestrial mechanics. Curiously, megachiropterans cycled their limbs significantly faster when climbing than when attempting to walk, whereas microchiropterans cycled their limbs at significantly faster rates when walking than when climbing. We contend that nonflight locomotion mechanics give a deep evolutionary view into the ancestral es locomotor platform on which flight was built in each of these groups.	[Adams, Rick A.] Univ Northen Colorado, Sch Biol Sci, Greeley, CO 80639 USA; [Carter, Richard T.] Univ Dayton, Dept Biol, Dayton, OH 45469 USA	University of Northern Colorado; University of Dayton	Adams, RA (corresponding author), Univ Northen Colorado, Sch Biol Sci, Greeley, CO 80639 USA.	rick.adams@unco.edu		Adams, Rick/0000-0002-0119-5052	University of Northern Colorado;  [UNC-FRPB-RAA15]	University of Northern Colorado; 	Funded by UNC-FRPB-RAA15, travel	Achmidt S, 2010, J EXP BIOL, V214, P2544; Adams RA, 2013, TIMES ARROW EVOLUTIO, P21; Alexander R. M., 1971, SIZE SHAPE; Altringham JD, 2011, BATS: FROM EVOLUTION TO CONSERVATION, 2ND EDITION, P1; BUCHLER ER, 1976, ANIM BEHAV, V24, P858, DOI 10.1016/S0003-3472(76)80016-4; Byrnes G, 2011, J MAMMAL, V92, P444, DOI 10.1644/10-MAMM-A-048.1; Carter RT, 2014, ANAT REC, V297, P1270, DOI 10.1002/ar.22934; DEFREES S L, 1988, Mammalian Species, P1, DOI 10.2307/3504095; DIETZ CL, 1973, J MAMMAL, V54, P790, DOI 10.2307/1378988; Fischer MS, 2006, J EXP ZOOL PART A, V305A, P935, DOI 10.1002/jez.a.333; FORSMAN KA, 1988, J ZOOL, V216, P655, DOI 10.1111/j.1469-7998.1988.tb02463.x; Frobisch J, 2009, P ROY SOC B-BIOL SCI, V276, P3611, DOI 10.1098/rspb.2009.0911; Greenhall Arthur M., 1996, Mammalian Species, V533, P1; Halsey LG, 2016, J EXP BIOL, V219, P1424, DOI 10.1242/jeb.133256; Hildebrand M., 1966, Folia Biotheoretica, VNo. 6, P9; Hoffmann AA, 2014, PRINCETON GUIDE EVOL, P247; Jepsen G. L., 1970, P1; LAWRENCE MJ, 1969, J ZOOL, V157, P309; Lim NTL., 2007, COLUGO FLYING LEMUR; McMahon TA, 1983, ON SIZE AND LIFE; MENDEL FC, 1981, J MAMMAL, V62, P413, DOI 10.2307/1380728; Meng QJ, 2015, SCIENCE, V347, P764, DOI 10.1126/science.1260879; Mondajem A, 2001, BATS SO CENTRAL AFRI; PETTIGREW JD, 1989, PHILOS T ROY SOC B, V325, P489, DOI 10.1098/rstb.1989.0102; PETTIGREW JD, 1986, SCIENCE, V231, P1304, DOI 10.1126/science.3945827; Ponzer H, 2004, J HUM EVOL, V46, P315; Reilly SM, 2006, P ROY SOC B-BIOL SCI, V273, P1563, DOI 10.1098/rspb.2006.3489; Riskin DK, 2006, J EXP BIOL, V209, P1725, DOI 10.1242/jeb.02186; Rose KD., 2009, BEGINNING AGE MAMMAL; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Schmitt D, 2010, J EXP BIOL, V213, P3615; Schutt W.A., 2006, FUNCTIONAL EVOLUTION, P145; Siemers BM, 2009, BIOL LETTERS, V5, P593, DOI 10.1098/rsbl.2009.0378; TAYLOR CR, 1982, J EXP BIOL, V97, P1; TOMASI TE, 1979, J MAMMAL, V60, P751, DOI 10.2307/1380190; Van Den Brink F. H, 1967, FIELD GUIDE MAMMALS; Vogel S., 1988, LIFES DEVICES PHYS W; Voigt CC, 2012, J EXP BIOL, V215, P4340, DOI 10.1242/jeb.076224; WATKINS L C, 1972, Mammalian Species, V23, P1; Witte H, 2000, P INT S AD MOT AN MA; Wunderlich RE, 2014, INTEGR COMP BIOL, V54, P1148, DOI 10.1093/icb/icu110	41	3	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185634	10.1371/journal.pone.0185634	http://dx.doi.org/10.1371/journal.pone.0185634			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957404	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200098
J	Pilling, LC; Atkins, JL; Duff, MO; Beaumont, RN; Jones, SE; Tyrrell, J; Kuo, CL; Ruth, KS; Tuke, MA; Yaghootkar, H; Wood, AR; Murray, A; Weedon, MN; Harries, LW; Kuchel, GA; Ferrucci, L; Frayling, TM; Melzer, D				Pilling, Luke C.; Atkins, Janice L.; Duff, Michael O.; Beaumont, Robin N.; Jones, Samuel E.; Tyrrell, Jessica; Kuo, Chia-Ling; Ruth, Katherine S.; Tuke, Marcus A.; Yaghootkar, Hanieh; Wood, Andrew R.; Murray, Anna; Weedon, Michael N.; Harries, Lorna W.; Kuchel, George A.; Ferrucci, Luigi; Frayling, Timothy M.; Melzer, David			Red blood cell distribution width: Genetic evidence for aging pathways in 116,666 volunteers	PLOS ONE			English	Article							TELOMERE LENGTH; ASSOCIATION; POPULATION; DISEASE; RISK	Introduction Variability in red blood cell volumes (distribution width, RDW) increases with age and is strongly predictive of mortality, incident coronary heart disease and cancer. We investigated inherited genetic variation associated with RDW in 116,666 UK Biobank human volunteers. Results A large proportion RDW is explained by genetic variants (29%), especially in the older group (60+ year olds, 33.8%, < 50 year olds, 28.4%). RDW was associated with 194 independent genetic signals; 71 are known for conditions including autoimmune disease, certain cancers, BMI, Alzheimer's disease, longevity, age at menopause, bone density, myositis, Parkinson's disease, and age-related macular degeneration. Exclusion of anemic participants did not affect the overall findings. Pathways analysis showed enrichment for telomere maintenance, ribosomal RNA, and apoptosis. The majority of RDW-associated signals were intronic (119 of 194), including SNP rs6602909 located in an intron of oncogene GAS6, an eQTL in whole blood. Conclusions Although increased RDW is predictive of cardiovascular outcomes, this was not explained by known CVD or related lipid genetic risks, and a RDW genetic score was not predictive of incident disease. The predictive value of RDW for a range of negative health outcomes may in part be due to variants influencing fundamental pathways of aging.	[Pilling, Luke C.; Atkins, Janice L.; Melzer, David] Univ Exeter, Epidemiol & Publ Hlth Grp, Sch Med, Royal Devon & Exeter Hosp, RILD Level 3, Exeter EX2 5DW, Devon, England; [Duff, Michael O.] Univ Connecticut, Ctr Hlth, Dept Genet & Genome Sci, Inst Syst Genom, Farmington, CT USA; [Beaumont, Robin N.; Jones, Samuel E.; Tyrrell, Jessica; Ruth, Katherine S.; Tuke, Marcus A.; Yaghootkar, Hanieh; Wood, Andrew R.; Murray, Anna; Weedon, Michael N.; Frayling, Timothy M.] Univ Exeter, Genet Complex Traits Grp, Sch Med, Royal Devon & Exeter Hosp, RILD Level 3, Exeter EX2 5DW, Devon, England; [Kuo, Chia-Ling] Univ Connecticut, Ctr Hlth, Dept Community Med & Hlth Care, Connecticut Inst Clin & Translat Sci,Inst Syst Ge, Farmington, CT USA; [Harries, Lorna W.] Univ Exeter, Inst Biomed & Clin Sci, Sch Med, Royal Devon & Exeter Hosp, RILD Level 3, Exeter, Devon, England; [Kuchel, George A.; Melzer, David] Univ Connecticut, Ctr Aging, Farmington, CT USA; [Ferrucci, Luigi] NIA, Baltimore, MD 21224 USA	University of Exeter; University of Connecticut; University of Exeter; University of Connecticut; University of Exeter; University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Pilling, LC (corresponding author), Univ Exeter, Epidemiol & Publ Hlth Grp, Sch Med, Royal Devon & Exeter Hosp, RILD Level 3, Exeter EX2 5DW, Devon, England.	L.Pilling@exeter.ac.uk	Atkins, Janice L/R-5886-2019; Ruth, Katherine/K-2745-2019; Wood, Andrew R/AAB-3807-2019; Jones, Samuel/AAF-3100-2019; Pilling, Luke/E-4917-2013	Atkins, Janice L/0000-0003-4919-9068; Ruth, Katherine/0000-0003-4966-9170; Wood, Andrew R/0000-0003-1726-948X; Jones, Samuel/0000-0003-0153-922X; Weedon, Michael/0000-0002-6174-6135; Kuchel, George/0000-0001-8387-7040; Murray, Anna/0000-0002-2351-2522; , Hanieh/0000-0001-9672-9477; Beaumont, Robin/0000-0003-0750-8248; Pilling, Luke/0000-0002-3332-8454	UK Medical Research Council [MR/M023095/1]; Medical Research Council [MR/M005070/1]; Diabetes Research and Wellness Foundation Fellowship; Wellcome Trust; Royal Society [104150/Z/14/Z]; Wellcome Trust Institutional Strategic Support Award [WT097835MF]; European Research Council [323195:GLUCOSEGENES-FP7-IDEAS-ERC]; Intramural Research Program of the National Institute on Aging; U.S. National Institutes of Health; University of Connecticut Health Center; MRC [MR/M023095/1] Funding Source: UKRI; Medical Research Council [MR/M023095/1, MC_qA137853] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes Research and Wellness Foundation Fellowship; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Wellcome Trust Institutional Strategic Support Award(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Connecticut Health Center; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by an award to DM, TF, AM and LH by the UK Medical Research Council (grant number MR/M023095/1). SEJ is funded by the Medical Research Council (grant: MR/M005070/1). JT is funded by a Diabetes Research and Wellness Foundation Fellowship. RB is funded by the Wellcome Trust and Royal Society grant: 104150/Z/14/Z. MAT, MNW and AM are supported by the Wellcome Trust Institutional Strategic Support Award (WT097835MF). ARW, HY, and TF are supported by the European Research Council grant: 323195:GLUCOSEGENES-FP7-IDEAS-ERC. LF is supported by the Intramural Research Program of the National Institute on Aging, U.S. National Institutes of Health. Input from MD, CLK and GK was supported by the University of Connecticut Health Center. This research has been conducted using the UK Biobank Resource under Application Number 14631. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093766; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Burdett T, 2016, NHGRI EBI CATALOG PU; Chakrabarti RS, 2017, ELIFE, V6, DOI 10.7554/eLife.23355; Cheng Calvino Ka-Wing, 2004, Lab Hematol, V10, P42, DOI 10.1532/LH96.04010; Danese E, 2015, J THORAC DIS, V7, pE402, DOI 10.3978/j.issn.2072-1439.2015.10.04; Fyhrquist FY, 2016, OXID STRESS APPL BAS, P67, DOI 10.1007/978-3-319-33486-8_4; Harries LW, 2011, AGING CELL, V10, P868, DOI 10.1111/j.1474-9726.2011.00726.x; Haycock PC, 2017, JAMA ONCOL, V3, P636, DOI 10.1001/jamaoncol.2016.5945; Inuzuka R, 2015, CIRC J, V79, P974, DOI 10.1253/circj.CJ-15-0254; Kato N, 2015, NAT GENET, V47, P1282, DOI 10.1038/ng.3405; Kozlitina J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051046; Lippi G, 2016, INT J CARDIOL, V206, P129, DOI 10.1016/j.ijcard.2016.01.122; Lippi G, 2013, KARDIOL POL, V71, P931, DOI 10.5603/KP.2013.0228; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Manolio TA, 2010, JAMA-J AM MED ASSOC, V304, P2290, DOI 10.1001/jama.2010.1686; Megel C, 2015, INT J MOL SCI, V16, P1873, DOI 10.3390/ijms16011873; NCBI ClinVar, CLINVAR REC RS738409; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Patel KV, 2010, J GERONTOL A-BIOL, V65, P258, DOI 10.1093/gerona/glp163; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Pilling LC, 2016, AGING-US, V8, P547, DOI 10.18632/aging.100930; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Salvagno GL, 2015, CRIT REV CL LAB SCI, V52, P86, DOI 10.3109/10408363.2014.992064; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Sharma R., 2015, INT CARDIOVASC FORUM, V2, P27, DOI 10.17987/icfj.v2i1.68; Sheard S, 2016, UK BIOBANK HAEMATOLO; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Turcato G, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.06.35; UK Biobank, 2015, UK BIOB IMP 150K PAR; UK Biobank, 2014, UK BIOB GEN COLL QC; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; *WHO, WHO DEF AN HEM CONC; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39	39	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185083	10.1371/journal.pone.0185083	http://dx.doi.org/10.1371/journal.pone.0185083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957414	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200028
J	Banerjee, T; Zheng, ZL; Abolafia, J; Harper, S; Oliver, D				Banerjee, Tithi; Zheng, Zeliang; Abolafia, Jane; Harper, Shelby; Oliver, Donald			The SecA protein deeply penetrates into the SecYEG channel during insertion, contacting most channel transmembrane helices and periplasmic regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Sec system	ESCHERICHIA-COLI SECA; IN-VIVO; PREPROTEIN TRANSLOCATION; MEMBRANE; COMPLEX; ATPASE; PHOSPHOLIPIDS; COMPONENT; MECHANISM; TOPOLOGY	The bacterial Sec-dependent system is the major protein-biogenic pathway for protein secretion across the cytoplasmic membrane or insertion of integral membrane proteins into the phospholipid bilayer. The mechanism of SecA-driven protein transport across the SecYEG channel complex has remained controversial with conflicting claims from biochemical and structural studies regarding the depth and extent of SecA insertion into SecYEG during ongoing protein transport. Here we utilized site-specific in vivo photo-crosslinking to thoroughly map SecY regions that are in contact with SecA during its insertion cycle. An arabinose-inducible, rapidly folding OmpA-GFP chimera was utilized to jam the SecYEG channels with an arrested substrate protein to freeze them in their SecA-inserted state. Examination of 117 sites distributed throughout SecY indicated that SecA not only interacts extensively with the cytosolic regions of SecY as shown previously, but it also interacts with most of the transmembrane helices and periplasmic regions of SecY, with a clustering of interaction sights around the lateral gate and pore ring regions. Our observations support previous reports of SecA membrane insertion during in vitro protein transport as well as those documenting the membrane penetration properties of this protein. They suggest that one or more SecA regions transiently integrate into the heart of the SecY channel complex to span the membrane to promote the protein transport cycle. These findings indicate that high-resolution structural information about the membrane-inserted state of SecA is still lacking and will be critical for elucidating the bacterial protein transport mechanism.	[Banerjee, Tithi; Zheng, Zeliang; Abolafia, Jane; Harper, Shelby; Oliver, Donald] Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06459 USA; [Harper, Shelby] Duke Univ, Sch Med, Durham, NC 27710 USA	Wesleyan University; Duke University	Oliver, D (corresponding author), Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06459 USA.	doliver@wesleyan.edu	Banerjee, Tithi/ABB-7530-2021		National Institutes of Health [GM110552]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM110552] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM110552 (to D. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AHN T, 1994, BIOCHEM BIOPH RES CO, V203, P326, DOI 10.1006/bbrc.1994.2185; Allen WJ, 2016, ELIFE, V5, DOI 10.7554/eLife.15598; Banerjee T, 2017, MOL MICROBIOL, V103, P439, DOI 10.1111/mmi.13567; Bauer BW, 2014, CELL, V157, P1416, DOI 10.1016/j.cell.2014.03.063; Bonardi F, 2011, P NATL ACAD SCI USA, V108, P7775, DOI 10.1073/pnas.1101705108; BREUKINK E, 1992, BIOCHEMISTRY-US, V31, P1119, DOI 10.1021/bi00119a021; CABELLI RJ, 1991, J BIOL CHEM, V266, P24420; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chen XC, 1996, J BIOL CHEM, V271, P29698, DOI 10.1074/jbc.271.47.29698; Chen XC, 1998, J BACTERIOL, V180, P527, DOI 10.1128/JB.180.3.527-537.1998; CROOKE E, 1988, CELL, V54, P1003, DOI 10.1016/0092-8674(88)90115-8; Das S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182931; Ding HY, 2003, BIOCHEMISTRY-US, V42, P8729, DOI 10.1021/bi0342057; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; Eichler J, 1998, J BACTERIOL, V180, P5776, DOI 10.1128/JB.180.21.5776-5779.1998; Eichler J, 1998, J BIOL CHEM, V273, P21675, DOI 10.1074/jbc.273.34.21675; Erlandson KJ, 2008, NATURE, V455, P984, DOI 10.1038/nature07439; Flower AM, 2007, TRENDS MICROBIOL, V15, P203, DOI 10.1016/j.tim.2007.03.001; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Hsieh YH, 2013, BIOCHEM BIOPH RES CO, V431, P388, DOI 10.1016/j.bbrc.2013.01.042; Hsieh YH, 2011, J BIOL CHEM, V286, P44702, DOI 10.1074/jbc.M111.300111; Jilaveanu LB, 2007, J BIOL CHEM, V282, P4661, DOI 10.1074/jbc.M610828200; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kusters I, 2011, STRUCTURE, V19, P430, DOI 10.1016/j.str.2010.12.016; Lee HC, 2001, P NATL ACAD SCI USA, V98, P3471, DOI 10.1073/pnas.051484198; Li L, 2016, NATURE, V531, P395, DOI 10.1038/nature17163; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; Matsumoto G, 1998, P NATL ACAD SCI USA, V95, P13567, DOI 10.1073/pnas.95.23.13567; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Park E, 2012, J CELL BIOL, V198, P881, DOI 10.1083/jcb.201205140; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Ramamurthy V, 1997, J BIOL CHEM, V272, P23239, DOI 10.1074/jbc.272.37.23239; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; RHOADS DB, 1984, J BACTERIOL, V159, P63, DOI 10.1128/JB.159.1.63-70.1984; Sachelaru I, 2013, J BIOL CHEM, V288, P16295, DOI 10.1074/jbc.M112.446583; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Tanaka Y, 2015, CELL REP, V13, P1561, DOI 10.1016/j.celrep.2015.10.025; Tian P, 2006, BIOPHYS J, V90, P2718, DOI 10.1529/biophysj.105.073304; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; ULBRANDT ND, 1992, J BIOL CHEM, V267, P15184; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Does C, 1998, BIOCHEMISTRY-US, V37, P201, DOI 10.1021/bi972105t; van Voorst F, 1998, BIOCHEMISTRY-US, V37, P12261, DOI 10.1021/bi9809021; vanderDoes C, 1996, MOL MICROBIOL, V22, P619, DOI 10.1046/j.1365-2958.1996.d01-1712.x; Wang HW, 2003, P NATL ACAD SCI USA, V100, P4221, DOI 10.1073/pnas.0737415100; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Whitehouse S, 2012, J CELL BIOL, V199, P919, DOI 10.1083/jcb.201205191; Zheng ZL, 2016, J BIOL CHEM, V291, P5997, DOI 10.1074/jbc.M115.694844; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	55	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19693	19707		10.1074/jbc.RA117.000130	http://dx.doi.org/10.1074/jbc.RA117.000130			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28986446	Green Published, hybrid			2022-12-26	WOS:000416911300015
J	Cornella, N; Tebaldi, T; Gasperini, L; Singh, J; Padgett, RA; Rossi, A; Macchi, P				Cornella, Nicola; Tebaldi, Toma; Gasperini, Lisa; Singh, Jarnail; Padgett, Richard A.; Rossi, Annalisa; Macchi, Paolo			The hnRNP RALY regulates transcription and cell proliferation by modulating the expression of specific factors including the proliferation marker E2F1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; E2F transcription factor; heterogeneous nuclear ribonucleoprotein (hnRNP); RNA; RNA metabolism; hnRNP-associated with lethal yellow homolog (RALY)	RNA-POLYMERASE-II; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; BREAST-CANCER CELLS; MESSENGER-RNA; BINDING PROTEINS; IN-VITRO; NONCODING RNA; GENE; DISEASE; FUS	The heterogeneous nuclear ribonucleoproteins (hnRNP) form a large family of RNA-binding proteins that exert numerous functions in RNA metabolism. RALY is a member of the hnRNP family that binds poly-U-rich elements within several RNAs and regulates the expression of specific transcripts. RALY is up-regulated in different types of cancer, and its down-regulation impairs cell cycle progression. However, the RALY's role in regulating RNA levels remains elusive. Here, we show that numerous genes coding for factors involved in transcription and cell cycle regulation exhibit an altered expression in RALY-down-regulated HeLa cells, consequently causing impairments in transcription, cell proliferation, and cell cycle progression. Interestingly, by comparing the list of RALY targets with the list of genes affected by RALY down-regulation, we found an enrichment of RALY mRNA targets in the down-regulated genes upon RALY silencing. The affected genes include the E2F transcription factor family. Given its role as proliferation-promoting transcription factor, we focused on E2F1. We demonstrate that E2F1 mRNA stability and E2F1 protein levels are reduced in cells lacking RALY expression. Finally, we also show that RALY interacts with transcriptionally active chromatin in both an RNA-dependent and -independent manner and that this association is abolished in the absence of active transcription. Taken together, our results highlight the importance of RALY as an indirect regulator of transcription and cell cycle progression through the regulation of specific mRNA targets, thus strengthening the possibility of a direct gene expression regulation exerted by RALY.	[Cornella, Nicola; Gasperini, Lisa; Rossi, Annalisa; Macchi, Paolo] Univ Trento, Ctr Integrat Biol, Lab Mol & Cellular Neurobiol, Via Sommar 9, I-38123 Trento, Italy; [Tebaldi, Toma] Univ Trento, Ctr Integrat Biol, Lab Translat Genom, Via Sommar 9, I-38123 Trento, Italy; [Padgett, Richard A.] Lerner Res Inst, Cleveland, OH 44195 USA; [Singh, Jarnail] Deciphera Pharmaceut, Lawrence, KS 66044 USA	University of Trento; University of Trento; Cleveland Clinic Foundation	Rossi, A; Macchi, P (corresponding author), Univ Trento, Ctr Integrat Biol, Lab Mol & Cellular Neurobiol, Via Sommar 9, I-38123 Trento, Italy.	annalisa.rossi-1@unitn.it; paolo.macchi@unitn.it	Tebaldi, Toma/AAX-6869-2020; Tebaldi, Toma/AAZ-5955-2020	Tebaldi, Toma/0000-0002-0625-1631; Tebaldi, Toma/0000-0002-0625-1631	University of Trento (Progetto Biotecnologie); Autonomous Province of Trento (MaDEleNA Project)	University of Trento (Progetto Biotecnologie); Autonomous Province of Trento (MaDEleNA Project)	This work was supported by the University of Trento (Progetto Biotecnologie) and the Autonomous Province of Trento (MaDEleNA Project) (to P. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Baldwin RM, 2012, CELL CYCLE, V11, P4597, DOI 10.4161/cc.22871; Bondy-Chorney E, 2017, INT J BIOCHEM CELL B, V91, P124, DOI 10.1016/j.biocel.2017.07.008; Brinegar AE, 2016, BRAIN RES, V1647, P1, DOI 10.1016/j.brainres.2016.02.050; Busch A, 2012, WIRES RNA, V3, P1, DOI 10.1002/wrna.100; CALVIO C, 1995, RNA, V1, P724; Castello A, 2013, TRENDS GENET, V29, P318, DOI 10.1016/j.tig.2013.01.004; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chen Y, 2016, NUCLEIC ACIDS RES, V44, P4381, DOI 10.1093/nar/gkw177; Cirillo D, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r13; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Daigle JG, 2013, HUM MOL GENET, V22, P1193, DOI 10.1093/hmg/dds526; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Dickhuth J, 2015, OR SURG OR MED OR PA, V120, P429, DOI 10.1016/j.oooo.2015.06.001; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Dowling CM, 2014, BIOSCIENCE REP, V34, P415, DOI 10.1042/BSR20140031; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; FACKELMAYER FO, 1994, EUR J BIOCHEM, V221, P749, DOI 10.1111/j.1432-1033.1994.tb18788.x; Farra R, 2011, DIGEST LIVER DIS, V43, P1006, DOI 10.1016/j.dld.2011.07.007; Fasken MB, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005044; Fredericks AM, 2015, BIOMOLECULES, V5, P893, DOI 10.3390/biom5020893; Geuens T, 2016, HUM GENET, V135, P851, DOI 10.1007/s00439-016-1683-5; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Huang YS, 2004, CURR OPIN CELL BIOL, V16, P308, DOI 10.1016/j.ceb.2004.03.002; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Jiang WP, 1998, BBA-GENE STRUCT EXPR, V1399, P229, DOI 10.1016/S0167-4781(98)00114-6; Johnson DG, 2000, MOL CARCINOGEN, V27, P151, DOI 10.1002/(SICI)1098-2744(200003)27:3<151::AID-MC1>3.0.CO;2-C; Kang MJ, 2014, CELL REP, V7, P1401, DOI 10.1016/j.celrep.2014.04.050; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kim MK, 1999, MOL CELL BIOL, V19, P6833; Korotayev K, 2008, CELL DEATH DIFFER, V15, P1813, DOI 10.1038/cdd.2008.155; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lemieux B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126654; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lindqvist A, 2007, PLOS BIOL, V5, P1127, DOI 10.1371/journal.pbio.0050123; Lu XD, 2016, NUCLEIC ACIDS RES, V44, P6853, DOI 10.1093/nar/gkw571; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Luo ZJ, 2012, MOL CELL BIOL, V32, P2608, DOI 10.1128/MCB.00182-12; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Massey AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134306; Masuda A, 2015, GENE DEV, V29, P1045, DOI 10.1101/gad.255737.114; McAfee JG, 1996, RNA, V2, P1139; McCloskey A, 2012, SCIENCE, V335, P1643, DOI 10.1126/science.1218469; Meng P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.326; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Mikula M, 2013, J BIOL CHEM, V288, P24788, DOI 10.1074/jbc.M113.496679; Muller H, 2000, BBA-REV CANCER, V1470, pM1, DOI 10.1016/S0304-419X(99)00030-X; Nam HJ, 2014, NAT CELL BIOL, V16, P535, DOI 10.1038/ncb2952; NORTON PA, 1994, J CELL SCI, V107, P1; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Pellicelli M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165951; PETERSON MG, 1991, NATURE, V354, P369; Philips AV, 2000, CELL MOL LIFE SCI, V57, P235, DOI 10.1007/PL00000687; Pineda Gabriel, 2015, BMC Res Notes, V8, P616, DOI 10.1186/s13104-015-1569-y; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Putzer BM, 2013, TRENDS MOL MED, V19, P89, DOI 10.1016/j.molmed.2012.10.009; Rajagopalan LE, 1998, NUCLEIC ACIDS RES, V26, P3418, DOI 10.1093/nar/26.14.3418; Rhodes GH, 1997, J AUTOIMMUN, V10, P447, DOI 10.1006/jaut.1997.9996; Rossi A, 2017, NUCLEIC ACIDS RES, V45, P6775, DOI 10.1093/nar/gkx235; Roworth AP, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.970480; Russo AJ, 2006, CANCER RES, V66, P7253, DOI 10.1158/0008-5472.CAN-05-3725; Safina A, 2013, CELL CYCLE, V12, P2423, DOI 10.4161/cc.25452; Sainsbury S, 2015, NAT REV MOL CELL BIO, V16, P129, DOI 10.1038/nrm3952; Sallam T, 2016, NATURE, V534, P124, DOI 10.1038/nature17674; Sama RR, 2014, ASN NEURO, V6; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swinburne IA, 2006, GENOME RES, V16, P912, DOI 10.1101/gr.5211806; TAKIMOTO M, 1993, J BIOL CHEM, V268, P18249; Tenzer S, 2013, J PROTEOME RES, V12, P2869, DOI 10.1021/pr400193j; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Weighardt F, 1996, BIOESSAYS, V18, P747, DOI 10.1002/bies.950180910; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Wu MH, 2015, ONCOTARGET, V6, P11252, DOI 10.18632/oncotarget.3594; Yang LQ, 2014, P NATL ACAD SCI USA, V111, P17809, DOI 10.1073/pnas.1414004111; Yasuda K, 2013, J CELL BIOL, V203, P737, DOI 10.1083/jcb.201306058; Ye JQ, 2015, P NATL ACAD SCI USA, V112, pE3020, DOI 10.1073/pnas.1508461112; Yu Y, 2015, P NATL ACAD SCI USA, V112, P8608, DOI 10.1073/pnas.1506282112	82	15	15	4	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19674	19692		10.1074/jbc.M117.795591	http://dx.doi.org/10.1074/jbc.M117.795591			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972179	Green Published, hybrid			2022-12-26	WOS:000416911300014
J	Chang, JY; Kim, SE; Kim, TH; Woo, SY; Ryu, MS; Joo, YH; Lee, KE; Lee, J; Lee, KH; Moon, CM; Jung, HK; Shim, KN; Jung, SA				Chang, Ji Young; Kim, Seong-Eun; Kim, Tae Hun; Woo, So-Youn; Ryu, Min Sun; Joo, Yang-Hee; Lee, Ko Eun; Lee, Jihyun; Lee, Kang Hoon; Moon, Chang Mo; Jung, Hye-Kyung; Shim, Ki-Nam; Jung, Sung-Ae			Emergence of rifampin-resistant staphylococci after rifaximin administration in cirrhotic patients	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; CROSS-RESISTANCE; RPOB MUTATIONS; MYCOBACTERIUM-TUBERCULOSIS; CLOSTRIDIUM-DIFFICILE; TRAVELERS DIARRHEA; IN-VITRO; AUREUS; RIFAMYCIN	Objectives Rifaximin, a poorly absorbed antibiotics, has gut-specific therapeutic effects. Although frequently prescribed to manipulate intestinal luminal bacterial population in various diseases, the possible induction of antibacterial cross-resistance to a target pathogen is a major concern in long-term rifaximin administration. We aimed to evaluate whether rifampin-resistant staphylococci could evolve after rifaximin treatment in cirrhotic patients. Method A total of 25 cirrhotic patients who were administered rifaximin for the prevention of hepatic encephalopathy were enrolled. Swabs from both hands and the perianal skin were acquired on day 0 (before rifaximin treatment), period 1 (1-7 weeks after treatment), and period 2 (8-16 weeks after treatment) the staphylococcal strain identification and rifampin-resistance testing. Results A total of 198 staphylococcal isolates from 15 species were identified. Staphylococcus epidermidis was isolated most frequently, and Staphylococcus haemolyticus was the most common resistant species both from hands and perianal skin. Eleven patients (44.0%) developed rifampin-resistant staphylococcal isolates in period 1. Among these patients, only six (54.5%) were found to have rifampin-resistant isolates in period 2, with no significant infectious events. Rifampin-resistant staphylococcal isolates were more frequently found in perianal skin than from the hands. No patients acquired a newly resistant strain in period 2. Conclusions About one-half of cirrhotic patients in this study developed rifampin-resistant staphylococcal isolates after rifaximin treatment. Although the resistant strains were no longer detected in about half of the patients in the short-term, the long-term influence of this drug treatment should be determined.	[Chang, Ji Young; Kim, Seong-Eun; Kim, Tae Hun; Ryu, Min Sun; Lee, Ko Eun; Lee, Jihyun; Lee, Kang Hoon; Moon, Chang Mo; Jung, Hye-Kyung; Shim, Ki-Nam; Jung, Sung-Ae] Ewha Womans Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Woo, So-Youn] Ewha Womans Univ, Coll Med, Dept Microbiol, Seoul, South Korea; [Joo, Yang-Hee] Ewha Womans Univ, Coll Med, Dept Ewha Med Inst, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Kim, SE; Kim, TH (corresponding author), Ewha Womans Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	kimse@ewha.ac.kr; thkmewha@gmail.com						Adachi JA, 2006, CLIN INFECT DIS, V42, P541, DOI 10.1086/499950; BLUMBERG HM, 1991, J INFECT DIS, V163, P1279, DOI 10.1093/infdis/163.6.1279; CALVORI C, 1965, NATURE, V207, P417, DOI 10.1038/207417a0; Curry SR, 2009, CLIN INFECT DIS, V48, P425, DOI 10.1086/596315; DESCOMBE JJ, 1994, INT J CLIN PHARM RES, V14, P51; Farrell DJ, 2013, J CLIN GASTROENTEROL, V47, P205, DOI 10.1097/MCG.0b013e31827559a3; Huang DB, 2005, J INFECTION, V50, P97, DOI 10.1016/j.jinf.2004.05.019; Kane JS, 2016, EXPERT REV GASTROENT, V10, P431, DOI 10.1586/17474124.2016.1140571; Kim ET, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103308; Kim MS, 2013, DIGEST DIS SCI, V58, P1676, DOI 10.1007/s10620-013-2675-0; Kothary V, 2013, ANTIMICROB AGENTS CH, V57, P811, DOI 10.1128/AAC.02163-12; Lembo A, 2016, GASTROENTEROLOGY; LUCCHESI M, 1984, CHEMIOTERAPIA, V3, P371; Marchese A, 2000, CHEMOTHERAPY, V46, P253, DOI 10.1159/000007297; Mernelius S, 2016, EUR J CLIN MICROBIOL, V35, P1355, DOI 10.1007/s10096-016-2672-2; Mihailescu R, 2014, ANTIMICROB AGENTS CH, V58, P2547, DOI 10.1128/AAC.02420-12; Mullen KD, 2014, CLIN GASTROENTEROL H, V12, P1390, DOI 10.1016/j.cgh.2013.12.021; O'Connor JR, 2008, ANTIMICROB AGENTS CH, V52, P2813, DOI 10.1128/AAC.00342-08; Otto Michael, 2010, Expert Rev Dermatol, V5, P183, DOI 10.1586/edm.10.6; Rana F., 2013, INT J RES PHARM CHEM, V3, P83; Rivkin A, 2011, CLIN THER, V33, P812, DOI 10.1016/j.clinthera.2011.06.007; Rizzello F, 1998, EUR J CLIN PHARMACOL, V54, P91, DOI 10.1007/s002280050426; Robins GW, 2005, DRUGS, V65, P1697, DOI 10.2165/00003495-200565120-00011; Scarpellini E, 2007, ALIMENT PHARM THER, V25, P781, DOI 10.1111/j.1365-2036.2007.03259.x; Scarpignato C, 2005, CHEMOTHERAPY, V51, P36, DOI 10.1159/000081990; SENSI P, 1983, REV INFECT DIS, V5, pS402; Soro Ornella, 1997, Clin Microbiol Infect, V3, P147; Steffen R, 2003, AM J GASTROENTEROL, V98, P1073, DOI [10.1016/S0002-9270(02)06005-7, 10.1111/j.1572-0241.2003.07283.x]; The European Committee on Antimicrobial Susceptibility Testing, 2017, BREAKP TABL INT MICS; Valentin T, 2014, J INFECTION, V69, P295, DOI 10.1016/j.jinf.2014.04.003; Valentin T, 2011, J INFECTION, V62, P34, DOI 10.1016/j.jinf.2010.11.004; Villar M, 2011, J ANTIMICROB CHEMOTH, V66, P997, DOI 10.1093/jac/dkr059; Wichelhaus TA, 1999, ANTIMICROB AGENTS CH, V43, P2813, DOI 10.1128/AAC.43.11.2813; Williams DL, 1998, ANTIMICROB AGENTS CH, V42, P1853, DOI 10.1128/AAC.42.7.1853; Yang B, 1998, J ANTIMICROB CHEMOTH, V42, P621, DOI 10.1093/jac/42.5.621; Zhou WJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-240	36	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186120	10.1371/journal.pone.0186120	http://dx.doi.org/10.1371/journal.pone.0186120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982166	Green Submitted, Green Published, gold			2022-12-26	WOS:000412360300127
J	Ellison, MA; Gearheart, CM; Porter, CC; Ambruso, DR				Ellison, Michael A.; Gearheart, Christy M.; Porter, Christopher C.; Ambruso, Daniel R.			IFN-gamma alters the expression of diverse immunity related genes in a cell culture model designed to represent maturing neutrophils	PLOS ONE			English	Article							MHC CLASS-II; CHRONIC GRANULOMATOUS-DISEASE; COLONY-STIMULATING FACTOR; TOLL-LIKE RECEPTORS; NOD-LIKE RECEPTORS; INTERFERON-GAMMA; POLYMORPHONUCLEAR NEUTROPHILS; INNATE IMMUNITY; T-LYMPHOCYTES; RECOGNITION RECEPTOR	The cytokine interferon-gamma (IFN-gamma) is approved as a drug to treat chronic granulomatous disease (CGD) and osteopetrosis and is also used in hyperimmunoglobulin E syndromes. Patients with CGD have defects in proteins of the NOX2 NADPH oxidase system. This leads to reduced production of microbicidal ROS by PMNs and recurrent life threatening infections. The goal of this study was to better understand how IFN-gamma might support phagocyte function in these diseases, and to obtain information that might expand potential uses for IFN-gamma. Neutrophils mature in the bone marrow and then enter the blood where they quickly undergo apoptotic cell death with a half-life of only 5-10 hours. Therefore we reasoned that IFN-gamma might exert its effects on neutrophils via prolonged exposure to cells undergoing maturation in the marrow rather than by its brief exposure to short-lived circulating cells. To explore this possibility we made use of PLB-985 cells, a myeloblast-like myeloid cell line that can be differentiated into a mature, neutrophil-like state by treatment with various agents including DMSO. In initial studies we investigated transcription and protein expression in PLB-985 cells undergoing maturation in the presence or absence of IFN-gamma. We observed IFN-gamma induced differences in expression of genes known to be involved in classical aspects of neutrophil function (transmigration, chemotaxis, phagocytosis, killing and pattern recognition) as well as genes involved in apoptosis and other mechanisms that regulating neutrophil number. We also observed differences for genes involved in the major histocompatibility complex I (MHCI) and MHCII systems whose involvement in neutrophil function is controversial and not well defined. Finally, we observed significant changes in expression of genes encoding guanylate binding proteins (Gbps) that are known to have roles in immunity but which have not as yet been linked to neutrophil function. We propose that changes in the expression within these classes of genes could help explain the immune supportive effects of IFN-gamma. Next we explored if the effect of IFN-gamma on expression of these genes is dependent on whether the cells are undergoing maturation; to do this we compared the effects of IFN-gamma on cells cultured with and without DMSO. For a subset of genes the expression level changes caused by IFN-gamma were much greater in maturing cells than non-maturing cells. These findings indicate that developmental changes associated with cell maturation can modulate the effects of IFN-gamma but that this is gene specific. Since the effects of IFN-gamma depend on whether cells are maturing, the gene expression changes observed in this study must be due to more than just prolonged application of IFN-gamma and are instead the result of interplay between cell maturation and changes caused by the chemokine. This supports our hypothesis that the effects of IFN-gamma on developing neutrophils in the bone marrow may be very different from its effects on mature cells in the blood. Collectively the findings in this study enhance our understanding of the effects of IFN-gamma on maturing myeloid cells and indicate possible mechanisms by which this cytokine could support immune function.	[Ellison, Michael A.; Gearheart, Christy M.; Ambruso, Daniel R.] Univ Colorado Denver, Dept Pediat, Anschutz Med Campus, Aurora, CO 80204 USA; [Porter, Christopher C.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Ambruso, Daniel R.] Univ Colorado Denver, Dept Pathol, Anschutz Med Campus, Aurora, CO 80204 USA; [Ambruso, Daniel R.] Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Transfus Serv, Aurora, CO 80045 USA; [Ambruso, Daniel R.] Hematol Oncol & Bone Marrow Transplantat Labs, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Emory University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado	Ambruso, DR (corresponding author), Univ Colorado Denver, Dept Pediat, Anschutz Med Campus, Aurora, CO 80204 USA.; Ambruso, DR (corresponding author), Univ Colorado Denver, Dept Pathol, Anschutz Med Campus, Aurora, CO 80204 USA.; Ambruso, DR (corresponding author), Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Transfus Serv, Aurora, CO 80045 USA.; Ambruso, DR (corresponding author), Hematol Oncol & Bone Marrow Transplantat Labs, Aurora, CO 80045 USA.	Daniel.ambruso@ucdenver.edu	Porter, Christopher/AAE-8918-2020	Porter, Christopher/0000-0001-8774-0180	Horizon Pharma Ireland Ltd; Stacey True Memorial Trust; Genomics and Microarray Shared Resource of Colorado's National Institute of Health/National Cancer Institute Cancer Center [P30CA046934]	Horizon Pharma Ireland Ltd; Stacey True Memorial Trust; Genomics and Microarray Shared Resource of Colorado's National Institute of Health/National Cancer Institute Cancer Center	This work was supported by the Horizon Pharma Ireland Ltd to DRA, the Stacey True Memorial Trust to DRA and the Genomics and Microarray Shared Resource of Colorado's National Institute of Health/National Cancer Institute Cancer Center Support Grant P30CA046934. No funding to any authors, the funding was to the core facility where microarray studies were carried out. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlin A, 1997, BLOOD, V89, P3396, DOI 10.1182/blood.V89.9.3396; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Almkvist J, 2002, GLYCOCONJUGATE J, V19, P575, DOI 10.1023/B:GLYC.0000014088.21242.e0; Auvynet C, 2013, GLYCOBIOLOGY, V23, P32, DOI 10.1093/glycob/cws128; BARGATZE RF, 1994, J EXP MED, V180, P1785, DOI 10.1084/jem.180.5.1785; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; BERTON G, 1986, BIOCHEM BIOPH RES CO, V138, P1276, DOI 10.1016/S0006-291X(86)80421-1; Borges WG, 2000, J PEDIATR-US, V136, P176, DOI 10.1016/S0022-3476(00)70098-9; Brown SB, 1999, J IMMUNOL, V162, P480; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Burns JA, 2001, J IMMUNOL, P166; Cabrini M, 2010, CURR OPIN HEMATOL, V17, P31, DOI 10.1097/MOH.0b013e3283333b29; CASSATELLA MA, 1988, IMMUNOLOGY, V63, P499; Chatzigeorgiou A, 2009, BIOFACTORS, V35, P474, DOI 10.1002/biof.62; COLOTTA F, 1992, BLOOD, V80, P2012; Conus S, 2010, SWISS MED WKLY, V140, P4, DOI 10.4414/smw.2010.13042; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; DeLeo FR, 2004, APOPTOSIS, V9, P399, DOI 10.1023/B:APPT.0000031448.64969.fa; Doerschuk C M, 2000, Respir Res, V1, P136, DOI 10.1186/rr24; Drexler HG, 2003, LEUKEMIA, V17, P416, DOI 10.1038/sj.leu.2402799; Drummond RA, 2011, CURR OPIN MICROBIOL, V14, P392, DOI 10.1016/j.mib.2011.07.001; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; Ekman AK, 2010, IMMUNOLOGY, V130, P55, DOI 10.1111/j.1365-2567.2009.03212.x; Ellison MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136766; EZEKOWITZ RAB, 1991, NEW ENGL J MED, V324, P509, DOI 10.1056/NEJM199102213240801; Fanger NA, 1997, BLOOD, V89, P4128, DOI 10.1182/blood.V89.11.4128; Feuk-Lagerstedt E, 1999, J IMMUNOL, P163; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P1185, DOI 10.1016/j.intimp.2013.11.010; Geering B, 2011, CELL DEATH DIFFER, V18, P1457, DOI 10.1038/cdd.2011.75; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GOSSELIN EJ, 1993, J IMMUNOL, V151, P1482; Harris ES, 2000, J BIOL CHEM, V275, P23409, DOI 10.1074/jbc.R000004200; Harton JA, 1999, SCIENCE, V285, P1402, DOI 10.1126/science.285.5432.1402; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Huysamen C, 2009, FEMS MICROBIOL LETT, V290, P121, DOI 10.1111/j.1574-6968.2008.01418.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JACK RM, 1988, J IMMUNOL, V140, P4286; Jozsef L, 2004, FASEB J, V18, P1776, DOI 10.1096/fj.04-2048fje; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KEY LL, 1992, J PEDIATR-US, V121, P119, DOI 10.1016/S0022-3476(05)82557-0; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; KLEBANOFF SJ, 1992, BLOOD, V80, P225; Klos A, 2013, PHARMACOL REV, V65, P500, DOI 10.1124/pr.111.005223; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kobayashi S, 2002, J BIOL CHEM, V277, P33968, DOI 10.1074/jbc.M203350200; KOEFFLER HP, 1984, P NATL ACAD SCI-BIOL, V81, P4080, DOI 10.1073/pnas.81.13.4080; Kuwabara I, 1996, J IMMUNOL, V156, P3939; Langereis JD, 2013, CELL ADHES MIGR, V7, P476, DOI 10.4161/cam.27293; Lee WB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002614; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; Liu ZH, 2005, MOL CANCER RES, V3, P21; LLOYD AR, 1992, IMMUNOL TODAY, V13, P169, DOI 10.1016/0167-5699(92)90121-M; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Mankan AK, 2012, EUR J IMMUNOL, V42, P710, DOI 10.1002/eji.201141921; Marshall ASJ, 2006, EUR J IMMUNOL, V36, P2159, DOI 10.1002/eji.200535628; Marshall ASJ, 2004, J BIOL CHEM, V279, P14792, DOI 10.1074/jbc.M313127200; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; Martin U, 1997, J EXP MED, V186, P199, DOI 10.1084/jem.186.2.199; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Moldoveanu T, 2014, TRENDS BIOCHEM SCI, V39, P101, DOI 10.1016/j.tibs.2013.12.006; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Neildez-Nguyen TMA, 1998, BRIT J HAEMATOL, V103, P79, DOI 10.1046/j.1365-2141.1998.00931.x; NEUMAN E, 1992, J IMMUNOL, V148, P3520; NEWBURGER PE, 1988, P NATL ACAD SCI USA, V85, P5215, DOI 10.1073/pnas.85.14.5215; Notarangelo L, 2006, J ALLERGY CLIN IMMUN, V117, P883, DOI 10.1016/j.jaci.2005.12.1347; PEACH RJ, 1995, J BIOL CHEM, V270, P21181, DOI 10.1074/jbc.270.36.21181; Pedruzzi E, 2002, BRIT J HAEMATOL, V117, P719, DOI 10.1046/j.1365-2141.2002.03521.x; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Pfistershammer K, 2006, EUR J IMMUNOL, V36, P1104, DOI 10.1002/eji.200535344; Potter NS, 2001, J IMMUNOL, V167, P2538, DOI 10.4049/jimmunol.167.5.2538; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Radsak M, 2000, IMMUNOLOGY, V101, P521, DOI 10.1046/j.1365-2567.2000.00140.x; Reali E, 1996, J LEUKOCYTE BIOL, V60, P207, DOI 10.1002/jlb.60.2.207; Reinisch W, 2003, CLIN EXP IMMUNOL, V133, P476, DOI 10.1046/j.1365-2249.2003.02245.x; Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818; Rupper AC, 2008, INFECT IMMUN, V76, P2304, DOI 10.1128/IAI.01437-07; Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156; Sato S, 2002, J IMMUNOL, P168; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Shi JL, 2001, BLOOD, V98, P1226, DOI 10.1182/blood.V98.4.1226; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; TENNENBERG SD, 1993, J LEUKOCYTE BIOL, V53, P301, DOI 10.1002/jlb.53.3.301; Tietzel I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006499; Tsuboi N, 2008, IMMUNITY, V28, P833, DOI 10.1016/j.immuni.2008.04.013; TUCKER KA, 1987, BLOOD, V70, P372; Turner SM, 2011, BLOOD, V117, P6052, DOI 10.1182/blood-2010-12-322271; van Kessel KPM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00467; Wilkinson JC, 2004, MOL CELL BIOL, V24, P7003, DOI 10.1128/MCB.24.16.7003-7014.2004; WRIGHT SD, 1987, P NATL ACAD SCI USA, V84, P1965, DOI 10.1073/pnas.84.7.1965; YAMAOKA A, 1995, J IMMUNOL, V154, P3479; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	104	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185956	10.1371/journal.pone.0185956	http://dx.doi.org/10.1371/journal.pone.0185956			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982143	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300097
J	Raya-Diaz, S; Sanchez-Rodriguez, AR; Segura-Fernandez, JM; del Campillo, MD; Quesada-Moraga, E				Raya-Diaz, Silvia; Sanchez-Rodriguez, Antonio Rafael; Manuel Segura-Fernandez, Jose; del Carmen del Campillo, Maria; Quesada-Moraga, Enrique			Entomopathogenic fungi-based mechanisms for improved Fe nutrition in sorghum plants grown on calcareous substrates	PLOS ONE			English	Article							ENDOPHYTIC BEAUVERIA-BASSIANA; METARHIZIUM-ANISOPLIAE; PHOSPHATE ADSORPTION; BIOCONTROL AGENTS; VICIA-FABA; IRON; SOIL; ROOT; COLONIZATION; TOLERANCE	Although entomopathogenic fungi (EPF) are best known for their ability to protect crops against insect pests, they may have other beneficial effects on their host plants. These effects, which include promoting plant growth and conferring resistance against abiotic stresses, have been examined in recent years to acquire a better understanding of them. The primary purposes of the present study were (i) to ascertain in vitro whether three different strains of EPF (viz., Metarhizium, Beauveria and Isaria) would increase the Fe bioavailability in calcareous or non-calcareous media containing various Fe sources (ferrihydrite, hematite and goethite) and (ii) to assess the influence of the EPF inoculation method (seed dressing, soil treatment or leaf spraying) on the extent of the endophytic colonization of sorghum and the improvement in the Fe nutrition of pot-grown sorghum plants on an artificial calcareous substrate. All the EPFs studied were found to increase the Fe availability during the in vitro assay. The most efficient EPF was M. brunneum EAMa 01/58-Su, which lowered the pH of the calcareous medium, suggesting that it used a different strategy (organic acid release) than the other two fungi that raised the pH of the non-calcareous medium. The three methods used to inoculate sorghum plants with B. bassiana and M. brunneum in the pot experiment led to differences in re-isolation from plant tissues and in the plant height. These three inoculation methods increased the leaf chlorophyll content of young leaves when the Fe deficiency symptoms were most apparent in the control plants (without fungal inoculation) as well as the Fe content of the above-ground biomass in the plants at the end of the experiment. The total root lengths and fine roots were also increased in response to fungal applications with the three inoculation methods. However, the soil treatment was the most efficient method; thus, its effect on the leaf chlorophyll content was the most persistent, and the effects on the total root length and fine roots were the most apparent. In conclusion, EPF improved the Fe nutrition of the sorghum plants, but their effects depended on the inoculation method.	[Raya-Diaz, Silvia; Manuel Segura-Fernandez, Jose; Quesada-Moraga, Enrique] Univ Cordoba, ETSIAM, Dept Ciencias & Recursos Agr & Forestales, Cordoba, Spain; [Sanchez-Rodriguez, Antonio Rafael] Environm Ctr Wales, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales; [del Carmen del Campillo, Maria] Univ Cordoba, ETSIAM, Dept Agron, Cordoba, Spain	Universidad de Cordoba; Universidad de Cordoba	Sanchez-Rodriguez, AR (corresponding author), Environm Ctr Wales, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales.	l02saroa@uco.es	Raya, Silvia/AAI-1015-2019; QUESADA-MORAGA, ENRIQUE/K-3419-2014; Sánchez-Rodríguez, Antonio Rafael/K-9824-2014; del Campillo, Maria Carmen/C-3606-2015	Raya, Silvia/0000-0001-5641-5000; QUESADA-MORAGA, ENRIQUE/0000-0003-4021-3900; Sánchez-Rodríguez, Antonio Rafael/0000-0001-8734-2035; del Campillo, Maria Carmen/0000-0001-5098-2290	Innovation, Science and Enterprise Council of the Andalusian Regional Government [AGR- 7681]	Innovation, Science and Enterprise Council of the Andalusian Regional Government	This work was funded by the Innovation, Science and Enterprise Council of the Andalusian Regional Government (project AGR- 7681) to EQM, http://www.juntadeandalucia.es/servicios/ayudas/detalle/69962.html. The funders played no role in the study design, data collection and analysis.	Akello J, 2009, BIOL CONTROL, V49, P6, DOI 10.1016/j.biocontrol.2008.06.002; Akutse KS, 2013, FUNGAL ECOL, V6, P293, DOI 10.1016/j.funeco.2013.01.003; Bayat F, 2009, RUSS J PLANT PHYSL+, V56, P510, DOI 10.1134/S1021443709040104; Behie SW, 2012, SCIENCE, V336, P1576, DOI 10.1126/science.1222289; Behie SW, 2014, APPL ENVIRON MICROB, V80, P1553, DOI 10.1128/AEM.03338-13; Behl RK, 2007, J APPL BOT FOOD QUAL, V81, P95; Bennett AJ, 2003, SOIL BIOL BIOCHEM, V35, P1565, DOI 10.1016/j.soilbio.2003.08.001; Benton J, 1991, PLANT ANAL HDB GIORG; Bidochka MJ, 2001, APPL ENVIRON MICROB, V67, P1335, DOI 10.1128/AEM.67.3.1335-1342.2001; BING LA, 1991, ENVIRON ENTOMOL, V20, P1207, DOI 10.1093/ee/20.4.1207; Bouma TJ, 2000, PLANT SOIL, V218, P185, DOI 10.1023/A:1014905104017; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; CHEN Y, 1982, ADV AGRON, V35, P217, DOI 10.1016/S0065-2113(08)60326-0; COLOMBO C, 1994, GEOCHIM COSMOCHIM AC, V58, P1261, DOI 10.1016/0016-7037(94)90380-8; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; DELCAMPILLO MC, 1992, COMMUN SOIL SCI PLAN, V23, P399, DOI 10.1080/00103629209368598; Elena G.J., 2011, ADV BIOL RES, V5, P22; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Fitter A., 2002, PLANT ROOTS HIDDEN H, P15; Fomina M, 2005, APPL ENVIRON MICROB, V71, P371, DOI 10.1128/AEM.71.1.371-381.2005; GARNIER E, 1992, J ECOL, V80, P665, DOI 10.2307/2260858; Garrido-Jurado I, 2011, BIOL CONTROL, V58, P277, DOI 10.1016/j.biocontrol.2011.05.017; GEORGATSOU E, 1994, MOL CELL BIOL, V14, P3065, DOI 10.1128/MCB.14.5.3065; Greenfield M, 2016, BIOL CONTROL, V95, P40, DOI 10.1016/j.biocontrol.2016.01.002; Gruber B, 2002, J PLANT NUTR SOIL SC, V165, P111, DOI 10.1002/1522-2624(200202)165:1<111::AID-JPLN111>3.0.CO;2-B; Grusak MA, 1999, FIELD CROP RES, V60, P41, DOI 10.1016/S0378-4290(98)00132-4; Gurulingappa P, 2010, BIOL CONTROL, V55, P34, DOI 10.1016/j.biocontrol.2010.06.011; Harman G, 2007, MECH APPL SYMBIOTIC; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Humber Richard A., 1997, P153, DOI 10.1016/B978-012432555-5/50011-7; Hummel I, 2007, NEW PHYTOL, V173, P313, DOI 10.1111/j.1469-8137.2006.01912.x; Hussein Rana H. M., 2014, Journal of Entomology, V11, P338, DOI 10.3923/je.2014.338.344; Imsande J, 1998, PHYSIOL PLANTARUM, V103, P139, DOI 10.1034/j.1399-3054.1998.1030117.x; Issaly N, 2005, PROCESS BIOCHEM, V40, P1425, DOI 10.1016/j.procbio.2004.06.029; Jaber LR, 2016, BIOL CONTROL, V103, P187, DOI 10.1016/j.biocontrol.2016.09.008; Jimenez C, 2004, KURU REV FORESTAL, V1; Jirakkakul J, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu032; Joseph E, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00270; Kabaluk JT, 2007, AGRON J, V99, P1377, DOI 10.2134/agronj2007.0017N; Kaplan CD, 2009, CHEM REV, V109, P4536, DOI 10.1021/cr9001676; Katznelson H, 1940, SOIL SCI, V49, P211, DOI 10.1097/00010694-194003000-00006; Klepper B., 1991, PLANT ROOTS HIDDEN H, P265; Korcak R., 1987, IRON DEFICIENCY CHLO; Krasnoff SB, 2014, J NAT PROD, V77, P1685, DOI 10.1021/np500300s; Landa BB, 2013, J INVERTEBR PATHOL, V114, P128, DOI 10.1016/j.jip.2013.06.007; Leger RJS, 2008, J INVERTEBR PATHOL, V98, P271, DOI 10.1016/j.jip.2008.01.007; Lesuisse E, 2001, MICROBIOL-UK, V147, P289, DOI 10.1099/00221287-147-2-289; Li Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep25313; Liao XG, 2014, APPL MICROBIOL BIOT, V98, P7089, DOI 10.1007/s00253-014-5788-2; Liaud N., 2014, FUNGAL BIOL BIOTECHN, V1, P1, DOI [DOI 10.1186/S40694-014-0001-Z, 10.1186/s40694-014-0001-z]; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Maniania NK, 2003, CROP PROT, V22, P553, DOI 10.1016/S0261-2194(02)00221-1; Marschner H., 1995, MARSCHNERS MINERAL N, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; MEHRA O. P., 1960, Proceedings 7th nat. Conf. Clays, V5, P317; Montilla I, 2003, PLANT SOIL, V257, P227, DOI 10.1023/A:1026289807917; Mukherjee PK, 2013, ANNU REV PHYTOPATHOL, V51, P105, DOI 10.1146/annurev-phyto-082712-102353; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; OLSEN SR, 1954, SOIL SCI, V78, P141, DOI 10.1097/00010694-195408000-00008; Otgonjargal K, 2015, BEAUVERIA BASSIANA G, V4; Padmavathi J, 2003, WORLD J MICROB BIOT, V19, P469, DOI 10.1023/A:1025151000398; Parsa S, 2016, PHASEOLUS VULGARIS B; Parsa S, 2013, JOVE-J VIS EXP, V74, P1; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Posada F, 2005, MYCOLOGIA, V97, P1195, DOI 10.3852/mycologia.97.6.1195; Quesada-Moraga E, 2006, MYCOPATHOLOGIA, V161, P323, DOI 10.1007/s11046-006-0014-0; Quesada-Moraga E., 2014, ADV ENDOPHYTIC RES, P85; Quesada-Moraga E, 2007, MYCOL RES, V111, P947, DOI 10.1016/j.mycres.2007.06.006; Quesada-Moraga E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089278; Rahmatullah, 2000, SOIL SCI, V165, P803, DOI 10.1097/00010694-200010000-00005; Resquin-Romero G, 2016, J INVERTEBR PATHOL, V136, P23, DOI 10.1016/j.jip.2016.03.003; Reyes I, 1997, SOIL SCI SOC AM J, V61, P1647, DOI 10.2136/sssaj1997.03615995006100060015x; Rombola AD, 2006, IRON NUTRITION IN PLANTS AND RHIZOSPHERIC MICROORGANISMS, P61, DOI 10.1007/1-4020-4743-6_3; RYSER P, 1995, PLANT SOIL, V170, P251, DOI 10.1007/BF00010478; Salazar AM, 2007, AGR TEC, V67, P236; Sanchez-Rodriguez AR, 2015, SCI HORTIC-AMSTERDAM, V197, P193, DOI 10.1016/j.scienta.2015.09.029; Sanchez-Rodriguez AR, 2017, BIOL CONTROL; Sanchez-Rodriguez AR, 2016, PLANT SOIL, V406, P1; Sanvisens N., 2011, BIOL STARVATION HUMA, P245; Sasan RK, 2012, AM J BOT, V99, P101, DOI 10.3732/ajb.1100136; Sazanova K, 2015, CURR MICROBIOL, V70, P520, DOI 10.1007/s00284-014-0751-0; Scheepmaker JWA, 2010, BIOCONTROL SCI TECHN, V20, P503, DOI 10.1080/09583150903545035; SCHWERTMANN U., 1964, Zeitschrift fur Pflanzenernahrung, Dungung und Bodenkunde, V105, P194, DOI 10.1002/jpln.3591050303; Schwertmann U., 2000, IRON OXIDES LAB PREP, DOI DOI 10.1002/9783527613229; Silva-Stenico ME, 2005, MICROBIOL RES, V160, P429, DOI 10.1016/j.micres.2005.03.007; Soundarapandian P., 2007, Research Journal of Microbiology, V2, P690; Tagliavini M, 2001, EUR J AGRON, V15, P71, DOI 10.1016/S1161-0301(01)00125-3; Tefera T, 2009, BIOCONTROL, V54, P663, DOI 10.1007/s10526-009-9216-y; TORRENT J, 1990, SOIL SCI SOC AM J, V54, P1007, DOI 10.2136/sssaj1990.03615995005400040012x; Torrent J., 2003, APPL STUDY CULTURAL, P377; Trevors JT, 1996, J MICROBIOL METH, V26, P53, DOI 10.1016/0167-7012(96)00843-3; Vega FE, 2012, INSECT PATHOLOGY, 2ND EDITION, P171, DOI 10.1016/B978-0-12-384984-7.00006-3; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; VEMPATI RK, 1986, J PLANT NUTR, V9, P1039, DOI 10.1080/01904168609363504; Villegas J, 1996, MYCORRHIZA, V6, P247, DOI 10.1007/s005720050132; Wahl S, 2000, NEW PHYTOL, V148, P459, DOI 10.1046/j.1469-8137.2000.00775.x; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; Warcup J. H., 1950, TRAN BR MYCOL SOC, V34, P519; WINTERMANS JF, 1965, BIOCHIM BIOPHYS ACTA, V109, P448, DOI 10.1016/0926-6585(65)90170-6; Wraight S. P., 2001, Fungi as biocontrol agents: progress, problems and potential, P253, DOI 10.1079/9780851993560.0253; Wyrebek M, 2011, MICROBIOL-SGM, V157, P2904, DOI 10.1099/mic.0.051102-0; ZASOSKI RJ, 1977, COMMUN SOIL SCI PLAN, V8, P425, DOI 10.1080/00103627709366735	101	30	33	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185903	10.1371/journal.pone.0185903	http://dx.doi.org/10.1371/journal.pone.0185903			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982140	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300083
J	Zholobenko, AV; Mouithys-Mickalad, A; Dostal, Z; Serteyn, D; Modriansky, M				Zholobenko, Aleksey V.; Mouithys-Mickalad, Ange; Dostal, Zdenek; Serteyn, Didier; Modriansky, Martin			On the causes and consequences of the uncoupler-like effects of quercetin and dehydrosilybin in H9c2 cells	PLOS ONE			English	Article							SERUM-ALBUMIN; MITOCHONDRIA; OXIDATION; FCCP; CARDIOPROTECTION; PERMEABILITY; ABSORPTION; BINDING; SILYBIN; DAMAGE	Quercetin and dehydrosilybin are polyphenols which are known to behave like uncouplers of respiration in isolated mitochondria. Here we investigated whether the effect is conserved in whole cells. Following short term incubation, neither compound uncouples mitochondrial respiration in whole H9c2 cells below 50aeM. However, following hypoxia, or long term incubation, leak (state IV with oligomycin) oxygen consumption is increased by quercetin. Both compounds partially protected complex I respiration, but not complex II in H9c2 cells following hypoxia. In a permeabilised H9c2 cell model, the increase in leak respiration caused by quercetin is lowered by increased [ADP] and is increased by adenine nucleotide transporter inhibitor, atractyloside, but not bongkrekic acid. Both quercetin and dehydrosilybin dissipate mitochondrial membrane potential in whole cells. In the case of quercetin, the effect is potentiated post hypoxia. Genetically encoded Ca++ sensors, targeted to the mitochondria, enabled the use of fluorescence microscopy to show that quercetin decreased mitochondrial [Ca++] while dehydrosilybin did not. Likewise, quercetin decreases accumulation of [Ca++] in mitochondria following hypoxia. Fluorescent probes were used to show that both compounds decrease plasma membrane potential and increase cytosolic [Ca++]. We conclude that the uncoupler-like effects of these polyphenols are attenuated in whole cells compared to isolated mitochondria, but downstream effects are nevertheless apparent. Results suggest that the effect of quercetin observed in whole and permeabilised cells may originate in the mitochondria, while the mechanism of action of cardioprotection by dehydrosilybin may be less dependent on mitochondrial uncoupling than originally thought. Rather, protective effects may originate due to interactions at the plasma membrane.	[Zholobenko, Aleksey V.; Dostal, Zdenek; Modriansky, Martin] Palacky Univ, Fac Med & Dent, Dept Med Chem & Biochem, Olomouc, Czech Republic; [Mouithys-Mickalad, Ange; Serteyn, Didier] Univ Liege, CORD, Inst Chim, Liege, Belgium; [Serteyn, Didier] Fac Med Vet, Sart Tilman Par Liege, Belgium	Palacky University Olomouc; University of Liege	Modriansky, M (corresponding author), Palacky Univ, Fac Med & Dent, Dept Med Chem & Biochem, Olomouc, Czech Republic.	martin.modriansky@upol.cz	Modriansky, Martin/A-6338-2008; DOSTÁL, Zdeněk/F-4510-2018	Modriansky, Martin/0000-0001-7692-0338; Dostal, Zdenek/0000-0002-4002-8468	GACR [16-16667S]; Czech Ministry of Education [LO1304]; FNRS; University of Liege	GACR(Grant Agency of the Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); FNRS(Fonds de la Recherche Scientifique - FNRS); University of Liege(University of Liege)	Funded by GACR (16-16667S), Czech Ministry of Education (LO1304), FNRS, University of Liege. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGULLO G, 1994, CANCER LETT, V87, P55, DOI 10.1016/0304-3835(94)90409-X; Akhlaghi M, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/782321; Bartekova M, 2010, CAN J PHYSIOL PHARM, V88, P465, DOI [10.1139/y10-025, 10.1139/Y10-025]; Blasina F, 2015, NEUROCHEM INT, V89, P149, DOI 10.1016/j.neuint.2015.08.007; Brennan JP, 2006, CARDIOVASC RES, V72, P313, DOI 10.1016/j.cardiores.2006.07.019; Brennan JP, 2006, CARDIOVASC RES, V72, P322, DOI 10.1016/j.cardiores.2006.08.006; Cho JY, 2006, NEUROSCI LETT, V404, P330, DOI 10.1016/j.neulet.2006.06.010; Day AJ, 2000, FREE RADICAL BIO MED, V29, P1234, DOI 10.1016/S0891-5849(00)00416-0; Dufour C, 2005, BBA-GEN SUBJECTS, V1721, P164, DOI 10.1016/j.bbagen.2004.10.013; Fiorani M, 2010, J NUTR BIOCHEM, V21, P397, DOI 10.1016/j.jnutbio.2009.01.014; Gabrielova E, 2015, PHYSIOL RES, V64, P79, DOI 10.33549/physiolres.932703; Gabrielova E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139208; Gabrielova E, 2010, J BIOENERG BIOMEMBR, V42, P499, DOI 10.1007/s10863-010-9319-2; Gabrielova E, 2010, BBA-BIOENERGETICS, V1797, P87, DOI 10.1016/j.bbabio.2010.04.262; Gazak R, 2013, TETRAHEDRON LETT, V54, P315, DOI 10.1016/j.tetlet.2012.11.049; Gurney AM, 2000, CELL CALCIUM, V27, P339, DOI 10.1054/ceca.2000.0124; Inal M, 2002, CELL BIOCHEM FUNCT, V20, P291, DOI 10.1002/cbf.953; Ishii K., 2014, NAT COMMUN, V5; Jaburek M, 2014, FREE RADICAL BIO MED, V76, pS82, DOI 10.1016/j.freeradbiomed.2014.10.290; Jagadeeswaran R, 2000, FITOTERAPIA, V71, P395, DOI 10.1016/S0367-326X(00)00138-6; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Khoo NKH, 2010, FREE RADICAL BIO MED, V49, P339, DOI 10.1016/j.freeradbiomed.2010.04.022; LANG DR, 1974, BIOCHIM BIOPHYS ACTA, V333, P180, DOI 10.1016/0005-2728(74)90002-4; Lu XY, 2016, CIRC RES, V118, P834, DOI 10.1161/CIRCRESAHA.115.308093; Marhol P, 2015, J FUNCT FOODS, V14, P570, DOI 10.1016/j.jff.2015.02.031; Miyawaki H, 1997, AM J PHYSIOL-HEART C, V272, pH927, DOI 10.1152/ajpheart.1997.272.2.H927; Modriansky M, 2009, J BIOENERG BIOMEMBR, V41, P133, DOI 10.1007/s10863-009-9212-z; Nadtochiy SM, 2012, J BIOL CHEM, V287, P3573, DOI 10.1074/jbc.M111.298406; Nadtochiy SM, 2009, CARDIOVASC RES, V82, P333, DOI 10.1093/cvr/cvn323; Ortega R, 2009, J BIOENERG BIOMEMBR, V41, P41, DOI 10.1007/s10863-009-9198-6; Silva BA, 2010, NEUROTOX RES, V17, P75, DOI 10.1007/s12640-009-9082-5; Tang L, 2013, MOL CELL BIOCHEM, V382, P145, DOI 10.1007/s11010-013-1729-0; Terao J, 2014, ARCH BIOCHEM BIOPHYS, V559, P12, DOI 10.1016/j.abb.2014.04.002; To MS, 2010, ARCH BIOCHEM BIOPHYS, V495, P152, DOI 10.1016/j.abb.2010.01.004; Ulrichova J, 2016, J INT SOC ANTIOXID N, V3; Walle T, 2004, FREE RADICAL BIO MED, V36, P829, DOI 10.1016/j.freeradbiomed.2004.01.002; Wu JH, 2013, ACS CHEM NEUROSCI, V4, P963, DOI 10.1021/cn400012b; Zheng JB, 2000, BRIT J PHARMACOL, V130, P1115, DOI 10.1038/sj.bjp.0703397; Zsila F, 2003, BIOCHEM PHARMACOL, V65, P447, DOI 10.1016/S0006-2952(02)01521-6	39	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185691	10.1371/journal.pone.0185691	http://dx.doi.org/10.1371/journal.pone.0185691			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977033	Green Published, gold, Green Submitted			2022-12-26	WOS:000412163100037
J	Hulur, I; Skol, AD; Gamazon, ER; Cox, NJ; Onel, K				Hulur, Imge; Skol, Andrew D.; Gamazon, Eric R.; Cox, Nancy J.; Onel, Kenan			Integrative genetic analysis suggests that skin color modifies the genetic architecture of melanoma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CUTANEOUS MALIGNANT-MELANOMA; TUMOR-SUPPRESSOR; ULTRAVIOLET-RADIATION; SUSCEPTIBILITY LOCUS; IDENTIFIES 3; RISK-FACTORS; COMMON SNPS; CELL-LINE; HERITABILITY	Melanoma is the deadliest form of skin cancer and presents a significant health care burden in many countries. In addition to ultraviolet radiation in sunlight, the main causal factor for melanoma, genetic factors also play an important role in melanoma susceptibility. Although genome-wide association studies have identified many single nucleotide polymorphisms associated with melanoma, little is known about the proportion of disease risk attributable to these loci and their distribution throughout the genome. Here, we investigated the genetic architecture of melanoma in 1,888 cases and 990 controls of European non-Hispanic ancestry. We estimated the overall narrow-sense heritability of melanoma to be 0.18 (P < 0.03), indicating that genetics contributes significantly to the risk of sporadically-occurring melanoma. We then demonstrated that only a small proportion of this risk is attributable to known risk variants, suggesting that much remains unknown of the role of genetics in melanoma. To investigate further the genetic architecture of melanoma, we partitioned the heritability by chromosome, minor allele frequency, and functional annotations. We showed that common genetic variation contributes significantly to melanoma risk, with a risk model defined by a handful of genomic regions rather than many risk loci distributed throughout the genome. We also demonstrated that variants affecting gene expression in skin account for a significant proportion of the heritability, and are enriched among melanoma risk loci. Finally, by incorporating skin color into our analyses, we observed both a shift in significance for melanoma-associated loci and an enrichment of expression quantitative trait loci among melanoma susceptibility variants. These findings suggest that skin color may be an important modifier of melanoma risk. We speculate that incorporating skin color and other non-genetic factors into genetic studies may allow for an improved understanding of melanoma susceptibility and guide future investigations to identify melanoma risk genes.	[Hulur, Imge] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Skol, Andrew D.; Gamazon, Eric R.; Cox, Nancy J.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Onel, Kenan] Hofstra Northwell Sch Med, Dept Pediat, Hempstead, NY 11549 USA; [Onel, Kenan] Feinstein Inst Med Res, Dept Genet & Genom, Manhasset, NY 11030 USA; [Hulur, Imge] Albert Einstein Coll Med, Dept Med, Div Dermatol, Bronx, NY 10467 USA; [Gamazon, Eric R.; Cox, Nancy J.] Vanderbilt Univ, Dept Med, Div Med Genet, Nashville, TN USA	University of Chicago; University of Chicago; Northwell Health; Northwell Health; Yeshiva University; Albert Einstein College of Medicine; Vanderbilt University	Onel, K (corresponding author), Hofstra Northwell Sch Med, Dept Pediat, Hempstead, NY 11549 USA.; Onel, K (corresponding author), Feinstein Inst Med Res, Dept Genet & Genom, Manhasset, NY 11030 USA.	konel@northwell.edu	Gamazon, Eric/I-6873-2018	Gamazon, Eric/0000-0003-4204-8734; Hulur, Imge/0000-0001-6252-0771				Aitken J, 1999, JNCI-J NATL CANCER I, V91, P446, DOI 10.1093/jnci/91.5.446; AITKEN JF, 1994, AM J EPIDEMIOL, V140, P961, DOI 10.1093/oxfordjournals.aje.a117203; American Cancer Society, 2016, CANC FACTS FIG 2015; Amos CI, 2011, HUM MOL GENET, V20, P5012, DOI 10.1093/hmg/ddr415; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Berking C, 2004, CANCER RES, V64, P807, DOI 10.1158/0008-5472.CAN-03-3438; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; BLISS JM, 1995, INT J CANCER, V62, P367, DOI 10.1002/ijc.2910620402; Brown KM, 2008, NAT GENET, V40, P838, DOI 10.1038/ng.163; CADET J, 1992, J PHOTOCH PHOTOBIO B, V15, P277, DOI 10.1016/1011-1344(92)85135-H; Chang YM, 2009, INT J EPIDEMIOL, V38, P814, DOI 10.1093/ije/dyp166; Chatzinasiou F, 2011, JNCI-J NATL CANCER I, V103, P1227, DOI 10.1093/jnci/djr219; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cormier JN, 2006, ARCH INTERN MED, V166, P1907, DOI 10.1001/archinte.166.17.1907; Cress RD, 1997, CANCER CAUSE CONTROL, V8, P246, DOI 10.1023/A:1018432632528; D'Orazio J, 2013, INT J MOL SCI, V14, P12222, DOI 10.3390/ijms140612222; Davis LK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003864; Davis LK, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-3; Ekwueme DU, 2011, J AM ACAD DERM S1, V65, pS133; Gamazon ER, 2013, MOL PSYCHIATR, V18, P340, DOI 10.1038/mp.2011.174; Gamazon ER, 2013, BLOOD, V121, P4366, DOI 10.1182/blood-2012-10-464149; Gamazon ER, 2010, P NATL ACAD SCI USA, V107, P9287, DOI 10.1073/pnas.1001827107; Gandini S, 2005, EUR J CANCER, V41, P2040, DOI 10.1016/j.ejca.2005.03.034; Geller AC, 2002, JAMA-J AM MED ASSOC, V288, P1719, DOI 10.1001/jama.288.14.1719; Geller AC, 2007, J AM ACAD DERMATOL, V57, P555, DOI 10.1016/j.jaad.2007.06.032; Gerstenblith MR, 2010, PIGM CELL MELANOMA R, V23, P587, DOI 10.1111/j.1755-148X.2010.00730.x; Goldberg EK, 2000, AM J HUM GENET, V67, P417, DOI 10.1086/302999; Goldstein AM, 2007, J MED GENET, V44, P99, DOI 10.1136/jmg.2006.043802; Goldstein AM, 2006, CANCER RES, V66, P9818, DOI 10.1158/0008-5472.CAN-06-0494; Goldstein AM, 2001, ARCH DERMATOL, V137, P1493; Guy GP, 2012, AM J PREV MED, V43, P537, DOI 10.1016/j.amepre.2012.07.031; Hall HI, 1999, J AM ACAD DERMATOL, V40, P35, DOI 10.1016/S0190-9622(99)70562-1; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jhappan C, 2003, ONCOGENE, V22, P3099, DOI 10.1038/sj.onc.1206450; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; Law MH, 2015, NAT GENET, V47, P987, DOI 10.1038/ng.3373; Law MH, 2012, J INVEST DERMATOL, V132, P1763, DOI 10.1038/jid.2012.75; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lu Y, 2014, HUM MOL GENET, V23, P6112, DOI 10.1093/hmg/ddu312; MacGregor S, 2011, NAT GENET, V43, P1114, DOI 10.1038/ng.958; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Matichard E, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011536; Mitchell JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep12473; MOLENDIJK A, 1987, IMMUNOLOGY, V62, P299; Mucci LA, 2016, JAMA-J AM MED ASSOC, V315, P68, DOI 10.1001/jama.2015.17703; Newton-Bishop JA, 2011, EUR J CANCER, V47, P732, DOI 10.1016/j.ejca.2010.10.008; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; NOONAN FP, 1981, IMMUNOLOGY, V43, P527; Paco L, 2007, INT J CANCER, V121, P2023, DOI 10.1002/ijc.22925; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Robertson G, 1996, CANCER RES, V56, P4487; Robertson GP, 1999, ONCOGENE, V18, P3173, DOI 10.1038/sj.onc.1202664; Rouhani Panta, 2008, Cancer Control, V15, P248; Shekar SN, 2009, J INVEST DERMATOL, V129, P2211, DOI 10.1038/jid.2009.48; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Song FJ, 2014, CARCINOGENESIS, V35, P2097, DOI 10.1093/carcin/bgu140; Stratigos AJ, 2006, J INVEST DERMATOL, V126, P399, DOI 10.1038/sj.jid.5700078; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Tornaletti S, 1996, BIOESSAYS, V18, P221, DOI 10.1002/bies.950180309; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Wheeler HE, 2013, CLIN CANCER RES, V19, P491, DOI 10.1158/1078-0432.CCR-12-2618; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	71	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185730	10.1371/journal.pone.0185730	http://dx.doi.org/10.1371/journal.pone.0185730			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973033	Green Published, Green Submitted, gold			2022-12-26	WOS:000412131900043
J	Tenan, S; Pedrini, P; Bragalanti, N; Groff, C; Sutherland, C				Tenan, Simone; Pedrini, Paolo; Bragalanti, Natalia; Groff, Claudio; Sutherland, Chris			Data integration for inference about spatial processes: A model-based approach to test and account for data inconsistency	PLOS ONE			English	Article							CAPTURE-RECAPTURE MODELS; CITIZEN SCIENCE; ECOLOGICAL RESEARCH; DENSITY-ESTIMATION; CAMERA TRAPS; ABUNDANCE; SELECTION; CONNECTIVITY; INFORMATION; POPULATIONS	Recently-developed methods that integrate multiple data sources arising from the same ecological processes have typically utilized structured data from well-defined sampling protocols (e.g., capture-recapture and telemetry). Despite this new methodological focus, the value of opportunistic data for improving inference about spatial ecological processes is unclear and, perhaps more importantly, no procedures are available to formally test whether parameter estimates are consistent across data sources and whether they are suitable for integration. Using data collected on the reintroduced brown bear population in the Italian Alps, a population of conservation importance, we combined data from three sources: traditional spatial capture-recapture data, telemetry data, and opportunistic data. We developed a fully integrated spatial capture-recapture (SCR) model that included a model-based test for data consistency to first compare model estimates using different combinations of data, and then, by acknowledging data-type differences, evaluate parameter consistency. We demonstrate that opportunistic data lend itself naturally to integration within the SCR framework and highlight the value of opportunistic data for improving inference about space use and population size. This is particularly relevant in studies of rare or elusive species, where the number of spatial encounters is usually small and where additional observations are of high value. In addition, our results highlight the importance of testing and accounting for inconsistencies in spatial information from structured and unstructured data so as to avoid the risk of spurious or averaged estimates of space use and consequently, of population size. Our work supports the use of a single modeling framework to combine spatially-referenced data while also accounting for parameter consistency.	[Tenan, Simone; Pedrini, Paolo; Bragalanti, Natalia] MUSE Museo Sci, Vertebrate Zool Sect, Corso Lavoro & Sci 3, I-38122 Trento, Italy; [Bragalanti, Natalia; Groff, Claudio] Serv Foreste & Fauna, Prov Autonoma Trento, Via Trener 3, I-38100 Trento, Italy; [Sutherland, Chris] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Tenan, S (corresponding author), MUSE Museo Sci, Vertebrate Zool Sect, Corso Lavoro & Sci 3, I-38122 Trento, Italy.	simone.tenan@muse.it	Tenan, Simone/N-5246-2014; Sutherland, Chris/H-6624-2019	Tenan, Simone/0000-0001-5055-9193; Sutherland, Chris/0000-0003-2073-1751				Besbeas P, 2002, BIOMETRICS, V58, P540, DOI 10.1111/j.0006-341X.2002.00540.x; Besbeas P, 2017, ASTA-ADV STAT ANAL; Bischof R, 2009, J ANIM ECOL, V78, P656, DOI 10.1111/j.1365-2656.2009.01524.x; Blanc L, 2014, J APPL ECOL, V51, P1733, DOI 10.1111/1365-2664.12319; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Chandler RB, 2014, METHODS ECOL EVOL, V5, P1351, DOI 10.1111/2041-210X.12153; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Conroy MJ, 2008, ECOLOGY, V89, P3362, DOI 10.1890/07-2145.1; De Barba M, 2010, MOL ECOL, V19, P3938, DOI 10.1111/j.1365-294X.2010.04791.x; De Barba M, 2010, J APPL ECOL, V47, P172, DOI 10.1111/j.1365-2664.2009.01752.x; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Dupre E, 2000, STUDIO FATTIBILITA R; Efford M, 2004, OIKOS, V106, P598, DOI 10.1111/j.0030-1299.2004.13043.x; Fuller AK, 2016, ECOL APPL, V26, P1125, DOI 10.1890/15-0315; Gardner B, 2010, J WILDLIFE MANAGE, V74, P318, DOI 10.2193/2009-101; Gimenez O, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0698; Gopalaswamy AM, 2012, ECOLOGY, V93, P1741, DOI 10.1890/11-2110.1; Groff C, 2014, 2013 BEAR REPORT; Kamp J, 2016, DIVERS DISTRIB, V22, P1024, DOI 10.1111/ddi.12463; Linden D. W, 2017, BIORXIV; Murphy SM, 2016, J WILDLIFE MANAGE, V80, P1390, DOI 10.1002/jwmg.21144; Mustoni Andrea, 2003, Hystrix, V14, P3; Newman G, 2012, FRONT ECOL ENVIRON, V10, P298, DOI 10.1890/110294; O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Popescu VD, 2014, ECOL EVOL, V4, P933, DOI 10.1002/ece3.997; R Core Team, 2012, R LANG ENV STAT COMP; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; Royle JA, 2016, POPUL ECOL, V58, P53, DOI 10.1007/s10144-015-0524-z; Royle JA, 2013, METHODS ECOL EVOL, V4, P520, DOI 10.1111/2041-210X.12039; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Royle JA, 2017, BIORXIV103341, V40, DOI [10.1111/ecog.03170, DOI 10.1111/ECOG.03170]; Schaub M, 2011, J ORNITHOL, V152, P227, DOI 10.1007/s10336-010-0632-7; Sollmann R, 2013, BIOL CONSERV, V167, P242, DOI 10.1016/j.biocon.2013.08.003; Sollmann R, 2013, J APPL ECOL, V50, P961, DOI 10.1111/1365-2664.12098; Sollmann R, 2013, ECOLOGY, V94, P553, DOI 10.1890/12-1256.1; Sollmann R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034575; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Sutherland CS, 2014, ECOLOGY, V95, P3149; Sutherland C, 2015, METHODS ECOL EVOL, V6, P169, DOI 10.1111/2041-210X.12316; Tenan S, 2016, CONSERV BIOL, V30, P1307, DOI 10.1111/cobi.12736; Tenan S, 2014, ECOL MODEL, V283, P62, DOI 10.1016/j.ecolmodel.2014.03.017; Tenan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049187; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; van Strien AJ, 2013, J APPL ECOL, V50, P1450, DOI 10.1111/1365-2664.12158; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Woods JG, 1999, WILDLIFE SOC B, V27, P616	51	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185588	10.1371/journal.pone.0185588	http://dx.doi.org/10.1371/journal.pone.0185588			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973034	Green Published, Green Submitted, gold			2022-12-26	WOS:000412131900028
J	de Vries, EM; Oosterman, JE; Eggink, HM; de Goede, P; Sen, S; Foppen, E; Boudzovitch-Surovtseva, O; Boelen, A; Romijn, JA; LaFleur, SE; Kalsbeek, A				de Vries, E. M.; Oosterman, J. E.; Eggink, H. M.; de Goede, P.; Sen, S.; Foppen, E.; Boudzovitch-Surovtseva, O.; Boelen, A.; Romijn, J. A.; LaFleur, S. E.; Kalsbeek, A.			Effects of meal composition and meal timing on the expression of genes involved in hepatic drug metabolism in rats	PLOS ONE			English	Article							HIGH-SUGAR DIET; HIGH-FAT DIET; CIRCADIAN CLOCK; NUCLEAR RECEPTORS; CYTOCHROME-P450 GENES; MOUSE; RHYTHM; LIVER; IDENTIFICATION; ACETAMINOPHEN	Introduction With chronotherapy, drug administration is synchronized with daily rhythms in drug clearance and pharmacokinetics. Daily rhythms in gene expression are centrally mastered by the suprachiasmatic nucleus of the hypothalamus as well as by tissue clocks containing similar molecular mechanisms in peripheral organs. The central timing system is sensitive to changes in the external environment such as those of the light-dark cycle, meal timing and meal composition. We investigated how changes in diet composition and meal timing would affect the daily hepatic expression rhythms of the nuclear receptors PXR and CAR and of enzymes involved in P450 mediated drug metabolism, as such changes could have consequences for the practice of chronotherapy. Materials and methods Rats were subjected to either a regular chow or a free choice high-fat-high-sugar (fcHFHS) diet. These diets were provided ad libitum, or restricted to either the light phase or the dark phase. In a second experiment, rats had access to chow either ad libitum or in 6 meals equally distributed over 24 hours. Results Pxr, Alas1 and Por displayed significant day-night rhythms under ad libitum chow fed conditions, which for Pxr was disrupted under fcHFHS diet conditions. Although no daily rhythms were detected in expression of CAR, Cyp2b2 and Cyp3a2, the fcHFHS diet did affect basal expression of these genes. In chow fed rats, dark phase feeding induced a diurnal rhythm in Cyp2b2 expression while light phase feeding induced a diurnal rhythm in Car expression and completely shifted the peak expression of Pxr, Car, Cyp2b2, Alas1 and Por. The 6-meals-a-day feeding only abolished the Pxr rhythm but not the rhythms of the other genes. Conclusion We conclude that although nuclear receptors and enzymes involved in the regulation of hepatic drug metabolism are sensitive to meal composition, changes in meal timing are mainly effectuated via changes in the molecular clock.	[de Vries, E. M.; Romijn, J. A.] Acad Med Ctr, Dept Med, Amsterdam, Netherlands; [Oosterman, J. E.; Eggink, H. M.; de Goede, P.; Boudzovitch-Surovtseva, O.; Boelen, A.; LaFleur, S. E.; Kalsbeek, A.] Acad Med Ctr, Dept Endocrinol & Metab, Amsterdam, Netherlands; [Sen, S.; Foppen, E.; Kalsbeek, A.] Netherlands Inst Neurosci, Hypothalam Integrat Mech, Amsterdam, Netherlands; [LaFleur, S. E.] Netherlands Inst Neurosci, Metab & Reward Grp, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	de Vries, EM (corresponding author), Acad Med Ctr, Dept Med, Amsterdam, Netherlands.	e.m.devries@amc.uva.nl	Kalsbeek, Andries/H-3076-2019	Kalsbeek, Andries/0000-0001-9606-8453	Technology Foundation STW [12195]; AMC PhD Scholarship	Technology Foundation STW(Technologiestichting STW); AMC PhD Scholarship	This work was supported by the Technology Foundation STW grant "Feeding OnTime" (#12195) for SEF and AK and an AMC PhD Scholarship for JOE.	Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chiba T, 2016, J PHARM PHARMACOL, V68, P1567, DOI 10.1111/jphp.12646; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Froy O, 2009, CURR DRUG METAB, V10, P104, DOI 10.2174/138920009787522179; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Ghoneim RH, 2015, BRIT J NUTR, V113, P507, DOI 10.1017/S0007114514003717; Ghose R, 2011, LIFE SCI, V89, P57, DOI 10.1016/j.lfs.2011.05.005; Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Johnson BP, 2014, P NATL ACAD SCI USA, V111, P18757, DOI 10.1073/pnas.1421708111; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Kumar GN, 2001, MED RES REV, V21, P397, DOI 10.1002/med.1016; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; la Fleur SE, 2007, INT J OBESITY, V31, P1286, DOI 10.1038/sj.ijo.0803570; la Fleur SE, 2014, INT J OBESITY, V38, P643, DOI 10.1038/ijo.2013.159; la Fleur SE, 2011, INT J OBESITY, V35, P595, DOI 10.1038/ijo.2010.164; Lammers LA, 2015, DRUG METAB DISPOS, V43, P819, DOI 10.1124/dmd.114.062299; Lu YF, 2013, CHRONOBIOL INT, V30, P1135, DOI 10.3109/07420528.2013.805762; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Matsunaga N, 2004, J PHARMACOL EXP THER, V311, P594, DOI 10.1124/jpet.104.069062; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Murray M, 2006, CURR DRUG METAB, V7, P67, DOI 10.2174/138920006774832569; OHDO S, 1991, CHRONOBIOL INT, V8, P35, DOI 10.3109/07420529109063917; Ohdo S, 2010, ADV DRUG DELIVER REV, V62, P859, DOI 10.1016/j.addr.2010.01.006; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Oosterman JE, 2015, AM J PHYSIOL-REG I, V308, pR337, DOI 10.1152/ajpregu.00322.2014; Opperhuizen AL, 2016, EUR J NEUROSCI, V44, P2795, DOI 10.1111/ejn.13377; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; SONAWANE B R, 1983, Drug-Nutrient Interactions, V2, P7; STEPHAN FK, 1972, PHYSIOL BEHAV, V8, P315, DOI 10.1016/0031-9384(72)90379-4; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Su Y, 2016, MOL CELL ENDOCRINOL, V422, P125, DOI 10.1016/j.mce.2015.12.011; Takiguchi T, 2007, PHARMACOGENET GENOM, V17, P1047, DOI 10.1097/FPC.0b013e3282f12a61; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Wieneke N, 2007, FEBS LETT, V581, P5617, DOI 10.1016/j.febslet.2007.11.011; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	40	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185520	10.1371/journal.pone.0185520	http://dx.doi.org/10.1371/journal.pone.0185520			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968417	Green Published, gold, Green Submitted			2022-12-26	WOS:000412029600023
J	Moruzzi, S; Guarini, P; Udali, S; Ruzzenente, A; Guglielmi, A; Conci, S; Pattini, P; Martinelli, N; Olivieri, O; Tammen, SA; Choi, SW; Friso, S				Moruzzi, Sara; Guarini, Patrizia; Udali, Silvia; Ruzzenente, Andrea; Guglielmi, Alfredo; Conci, Simone; Pattini, Patrizia; Martinelli, Nicola; Olivieri, Oliviero; Tammen, Stephanie A.; Choi, Sang-Woon; Friso, Simonetta			One-carbon genetic variants and the role of MTHFD1 1958G>A in liver and colon cancer risk according to global DNA methylation	PLOS ONE			English	Article							DEHYDROGENASE-METHENYLTETRAHYDROFOLATE-CYCLOHYDROLASE; PLASMA HOMOCYSTEINE LEVELS; NEURAL-TUBE DEFECTS; TRIFUNCTIONAL ENZYME; COLORECTAL-CANCER; METHIONINE SYNTHASE; METABOLIC PATHWAY; COMMON MUTATION; FOLATE; POLYMORPHISM	Several polymorphic gene variants within one-carbon metabolism, an essential pathway for nucleotide synthesis and methylation reactions, are related to cancer risk. An aberrant DNA methylation is a common feature in cancer but whether the link between one-carbon metabolism variants and cancer occurs through an altered DNA methylation is yet unclear. Aims of the study were to evaluate the frequency of one-carbon metabolism gene variants in hepato-cellular-carcinoma, cholangiocarcinoma and colon cancer, and their relationship to cancer risk together with global DNA methylation status. Genotyping for BHMT 716A>G, DHFR 19bp ins/del, MTHFD1 1958G>A, MTHFR 677C>T, MTR 2756A>G, MTRR 66A>G, RFC1 80G>A, SHMT1 1420C>T, TCII 776C>G and TS 2rpt-3rpt was performed in 102 cancer patients and 363 cancer-free subjects. Methylcytosine (mCyt) content was measured by LC/MS/MS in peripheral blood mononuclear cells (PBMCs) DNA. The MTHFD1 1958AA genotype was significantly less frequent among cancer patients as compared to controls (p = 0.007) and related to 63% reduction of overall cancer risk (p = 0.003) and 75% of colon cancer risk (p = 0.006). When considering PBMCs mCyt content, carriers of the MTHFD1 1958GG genotype showed a lower DNA methylation as compared to carriers of the A allele (p = 0.048). No differences were highlighted by evaluating a possible relationship between the other polymorphisms analyzed with cancer risk and DNA methylation. The MTHFD1 1958AA genotype is linked to a significantly reduced cancer risk. The 1958GG genotype is associated to PBMCs DNA hypomethylation as compared to the A allele carriership that may exert a protective effect for cancer risk by preserving from DNA hypomethylation.	[Moruzzi, Sara; Guarini, Patrizia; Pattini, Patrizia; Martinelli, Nicola; Olivieri, Oliviero; Friso, Simonetta] Univ Verona, Sch Med, Dept Med, Verona, Italy; [Ruzzenente, Andrea; Guglielmi, Alfredo; Conci, Simone] Univ Verona, Sch Med, Dept Surg, Div Gen & Hepatobiliary Surg, Verona, Italy; [Tammen, Stephanie A.; Choi, Sang-Woon] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA USA; [Choi, Sang-Woon] CHA Univ, Chaum Life Ctr, Seoul, South Korea	University of Verona; University of Verona; Tufts University; Pochon Cha University	Friso, S (corresponding author), Univ Verona, Sch Med, Dept Med, Verona, Italy.	simonetta.friso@univr.it	Friso, Simonetta/K-4715-2016; conci, simone/AAB-6516-2022; Ruzzenente, Andrea/R-5850-2019; Olivieri, Oliviero/A-9126-2008	conci, simone/0000-0001-7110-1974; Ruzzenente, Andrea/0000-0001-6911-563X; Olivieri, Oliviero/0000-0001-8209-9056				ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; Babyshkina N, 2013, GENE, V518, P397, DOI 10.1016/j.gene.2012.12.095; Brody LC, 2002, AM J HUM GENET, V71, P1207, DOI 10.1086/344213; Chang SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109235; Chango A, 2000, MOL GENET METAB, V70, P310, DOI 10.1006/mgme.2000.3034; Chen J, 2004, INT J CANCER, V110, P617, DOI 10.1002/ijc.20148; Choi SW, 2002, J NUTR, V132, p2413S, DOI 10.1093/jn/132.8.2413S; Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129; Christensen KE, 2013, HUM MOL GENET, V22, P3705, DOI 10.1093/hmg/ddt223; Christensen KE, 2009, HUM MUTAT, V30, P212, DOI 10.1002/humu.20830; Ehrlich M, 2006, CURR TOP MICROBIOL, V310, P251; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Eussen SJPM, 2010, CANCER EPIDEM BIOMAR, V19, P1328, DOI 10.1158/1055-9965.EPI-09-0841; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Friso S, 2002, J NUTR, V132, p2382S, DOI 10.1093/jn/132.8.2382S; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Friso S, 2002, ANAL CHEM, V74, P4526, DOI 10.1021/ac020050h; Friso S, 2013, ONCOLOGY; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Girelli D, 1998, BLOOD, V91, P4158, DOI 10.1182/blood.V91.11.4158.411k23_4158_4163; Han SS, 2012, CANCER EPIDEM BIOMAR, V21, P417, DOI 10.1158/1055-9965.EPI-11-0782; Heil SG, 2001, MOL GENET METAB, V73, P164, DOI 10.1006/mgme.2001.3175; Hol FA, 1998, CLIN GENET, V53, P119; HUM DW, 1988, J BIOL CHEM, V263, P15946; Jacques PF, 2003, ATHEROSCLEROSIS, V166, P49, DOI 10.1016/S0021-9150(02)00204-6; Johnson WG, 2004, AM J MED GENET A, V124A, P339, DOI 10.1002/ajmg.a.20505; Klerk M, 2003, THROMB RES, V110, P87, DOI 10.1016/S0049-3848(03)00341-4; Lautner-Csorba O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069843; Levine AJ, 2010, CANCER EPIDEM BIOMAR, V19, P1812, DOI 10.1158/1055-9965.EPI-10-0151; Moruzzi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167534; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Parle-McDermott A, 2006, EUR J HUM GENET, V14, P768, DOI 10.1038/sj.ejhg.5201603; Galbiatti ALS, 2012, EUR J CANCER, V48, P1525, DOI 10.1016/j.ejca.2011.09.025; Tammen SA, 2014, ALCOHOL CLIN EXP RES, V38, P2178, DOI 10.1111/acer.12477; Udali S, 2015, HEPATOLOGY, V62, P496, DOI 10.1002/hep.27823; Ulrich CM, 2002, CANCER RES, V62, P3361; Wang LN, 2007, CLIN CANCER RES, V13, P2526, DOI 10.1158/1078-0432.CCR-06-2293; Woo HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034615; Zee RYL, 2013, CLIN CHIM ACTA, V418, P33, DOI 10.1016/j.cca.2012.11.030; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	41	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185792	10.1371/journal.pone.0185792	http://dx.doi.org/10.1371/journal.pone.0185792			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968444	gold, Green Submitted, Green Published			2022-12-26	WOS:000412029600049
J	Reijnierse, EM; de van der Schueren, MAE; Trappenburg, MC; Doves, M; Meskers, CGM; Majer, AB				Reijnierse, Esmee M.; de van der Schueren, Marian A. E.; Trappenburg, Marijke C.; Doves, Marjan; Meskers, Carel G. M.; Majer, Andrea B.			Lack of knowledge and availability of diagnostic equipment could hinder the diagnosis of sarcopenia and its management	PLOS ONE			English	Article							MUSCLE MASS; ELDERLY INDIVIDUALS; BODY-COMPOSITION; CONTROLLED-TRIAL; OLDER-PEOPLE; EXERCISE; SUPPLEMENTATION; RECOMMENDATIONS; HEALTH; OUTPATIENTS	Objectives Sarcopenia is an emerging clinical challenge in an ageing population and is associated with serious negative health outcomes. This study aimed to assess the current state of the art regarding the knowledge about the concept of sarcopenia and practice of the diagnostic strategy and management of sarcopenia in a cohort of Dutch healthcare professionals (physicians, physiotherapists, dietitians and others) attending a lecture cycle on sarcopenia. Material and methods This longitudinal study included Dutch healthcare professionals (n = 223) who were asked to complete a questionnaire before, directly after and five months after (n = 80) attending a lecture cycle on the pathophysiology of sarcopenia, diagnostic strategy and management of sarcopenia, i.e. interventions and collaboration. Results Before attendance, 69.7% of healthcare professionals stated to know the concept of sarcopenia, 21.4% indicated to know how to diagnose sarcopenia and 82.6% had treated patients with suspected sarcopenia. 47.5% used their clinical view as diagnostic strategy. Handgrip strength was the most frequently used objective diagnostic measure (33.9%). Five months after attendance, reported use of diagnostic tests was increased, i.e. handgrip strength up to 67.4%, gait speed up to 72.1% and muscle mass up to 20.9%. Bottlenecks during implementation of the diagnostic strategy were experienced by 67.1%; lack of awareness among other healthcare professionals, acquisition of equipment and time constraints to perform the diagnostic measures were reported most often. Before attendance, 36.4% stated not to consult a physiotherapists or exercise therapists (PT/ET) or dietitian for sarcopenia interventions, 10.5% consulted a PT/ET, 32.7% a dietitian and 20.5% both a PT/ET and dietitian. Five months after attendance, these percentages were 28.3%, 21.7%, 30.0% and 20.0% respectively. Conclusion The concept of sarcopenia is familiar to most Dutch healthcare professionals but application in practice is hampered, mostly by lack of knowledge, availability of equipment, time constraints and lack of collaboration.	[Reijnierse, Esmee M.; Trappenburg, Marijke C.] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Sect Gerontol & Geriatr, Amsterdam, Netherlands; [Reijnierse, Esmee M.; Majer, Andrea B.] Univ Melbourne, Royal Melbourne Hosp, Dept Med & Aged Care, Melbourne, Vic, Australia; [de van der Schueren, Marian A. E.] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Sect Nutr & Dietet, Amsterdam, Netherlands; [de van der Schueren, Marian A. E.] HAN Univ Appl Sci, Fac Hlth & Social Studies, Dept Nutr Sports & Hlth, Nijmegen, Netherlands; [Trappenburg, Marijke C.] Amstelland Hosp, Dept Internal Med, Amstelveen, Netherlands; [Doves, Marjan] Univ Appl Sci Utrecht, Inst Human Movement Studies, Fac Hlth Care, Utrecht, Netherlands; [Meskers, Carel G. M.] Vrije Univ Amsterdam Med Ctr, Dept Rehabil Med, Amsterdam, Netherlands; [Meskers, Carel G. M.; Majer, Andrea B.] Vrije Univ, MOVE Res Inst Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Royal Melbourne Hospital; University of Melbourne; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam	Majer, AB (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med & Aged Care, Melbourne, Vic, Australia.; Majer, AB (corresponding author), Vrije Univ, MOVE Res Inst Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands.	andrea.maier@mh.org.au	Maier, Andrea B./Q-5548-2019; Maier, Andrea/W-7060-2019; de van der Schueren, Marian A.E./AAM-5713-2021	Maier, Andrea/0000-0001-7206-1724; de van der Schueren, Marian A.E./0000-0001-5693-0811; Meskers, Carel/0000-0002-5056-5611; Reijnierse, Esmee M./0000-0002-4197-4800	European Union's Horizon research program PreventIT [689238]; Marie Curie, Sklodowska, Innovative Training Network PANINI [675003]	European Union's Horizon research program PreventIT; Marie Curie, Sklodowska, Innovative Training Network PANINI	This study was supported by the European Union's Horizon 2020 research program PreventIT (No 689238) to Andrea B. Maier and the Marie Curie, Sklodowska, Innovative Training Network PANINI (No 675003) to Andrea B. Maier. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batsis JA, 2014, EUR J CLIN NUTR, V68, P1001, DOI 10.1038/ejcn.2014.117; Bauer J, 2013, J AM MED DIR ASSOC, V14, P542, DOI 10.1016/j.jamda.2013.05.021; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Beaudart C, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-45; Bijlsma AY, 2013, J AM MED DIR ASSOC, V14, P493, DOI 10.1016/j.jamda.2013.02.001; Bonnefoy M, 2003, BRIT J NUTR, V89, P731, DOI 10.1079/BJN2003836; Bunout D, 2001, J NUTR, V131, p2441S, DOI 10.1093/jn/131.9.2441S; Bunout D, 2011, AUSTRALAS J AGEING, V30, P89, DOI 10.1111/j.1741-6612.2010.00448.x; Cao L, 2016, J AM MED DIR ASSOC, V17, P675, DOI 10.1016/j.jamda.2016.06.001; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Durlak JA, 2008, AM J COMMUN PSYCHOL, V41, P327, DOI 10.1007/s10464-008-9165-0; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Green LW, 2008, FAM PRACT, V25, pI20, DOI 10.1093/fampra/cmn055; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kim HK, 2012, J AM GERIATR SOC, V60, P16, DOI 10.1111/j.1532-5415.2011.03776.x; Landi F, 2012, CLIN NUTR, V31, P652, DOI 10.1016/j.clnu.2012.02.007; Montero-Fernandez N, 2013, EUR J PHYS REHAB MED, V49, P131; Paddon-Jones D, 2009, CURR OPIN CLIN NUTR, V12, P86, DOI 10.1097/MCO.0b013e32831cef8b; Reijnierse EM, 2015, GERONTOLOGY, V61, P491, DOI 10.1159/000377699; Scott D, 2014, OSTEOPOROSIS INT, V25, P187, DOI 10.1007/s00198-013-2431-5; Studenski SA, 2014, J GERONTOL A-BIOL, V69, P547, DOI 10.1093/gerona/glu010; ter Beek L, 2016, CLIN NUTR, V35, P1450, DOI 10.1016/j.clnu.2016.03.023; Tieland M, 2012, J AM MED DIR ASSOC, V13, P713, DOI 10.1016/j.jamda.2012.05.020	24	38	38	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185837	10.1371/journal.pone.0185837	http://dx.doi.org/10.1371/journal.pone.0185837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MY	28968456	gold, Green Published			2022-12-26	WOS:000412029600057
J	van Ettinger-Veenstra, H; Widen, C; Engstrom, M; Karlsson, T; Leijon, I; Nelson, N				van Ettinger-Veenstra, Helene; Widen, Carin; Engstrom, Maria; Karlsson, Thomas; Leijon, Ingemar; Nelson, Nina			Neuroimaging of decoding and language comprehension in young very low birth weight (VLBW) adolescents: Indications for compensatory mechanisms	PLOS ONE			English	Article							SIMPLE VIEW; PRETERM CHILDREN; PREMATURELY BORN; CATCH-UP; BRAIN; FMRI; ORGANIZATION; ABILITIES; DYSLEXIA; DEFICITS	In preterm children with very low birth weight (VLBW <= 1500 g), reading problems are often observed. Reading comprehension is dependent on word decoding and language comprehension. We investigated neural activation-within brain regions important for reading-related to components of reading comprehension in young VLBW adolescents in direct comparison to normal birth weight (NBW) term-born peers, with the use of functional magnetic resonance imaging (fMRI). We hypothesized that the decoding mechanisms will be affected by VLBW, and expect to see increased neural activity for VLBW which may be modulated by task performance and cognitive ability. The study investigated 13 (11 included in fMRI) young adolescents (ages 12 to 14 years) born preterm with VLBW and in 13 NBW controls (ages 12-14 years) for performance on the Block Design and Vocabulary subtests of the Wechsler Intelligence Scale for Children; and for semantic, orthographic, and phonological processing during an fMRI paradigm. The VLBW group showed increased phonological activation in left inferior frontal gyrus, decreased orthographic activation in right supramarginal gyrus, and decreased semantic activation in left inferior frontal gyrus. Block Design was related to altered right-hemispheric activation, and VLBW showed lower WISC Block Design scores. Left angular gyrus showed activation increase specific for VLBW with high accuracy on the semantic test. Young VLBW adolescents showed no accuracy and reaction time performance differences on our fMRI language tasks, but they did exhibit altered neural activation during these tasks. This altered activation for VLBW was observed as increased activation during phonological decoding, and as mainly decreased activation during orthographic and semantic processing. Correlations of neural activation with accuracy on the semantic fMRI task and with decreased WISC Block Design performance were specific for the VLBW group. Together, results suggest compensatory mechanisms by recruiting additional brain regions upon altered neural development of decoding for VLBW.	[van Ettinger-Veenstra, Helene; Engstrom, Maria] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [van Ettinger-Veenstra, Helene; Engstrom, Maria; Karlsson, Thomas] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden; [Widen, Carin; Leijon, Ingemar; Nelson, Nina] Linkoping Univ, Dept Clin & Expt Med, Pediat, Linkoping, Sweden; [Karlsson, Thomas] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Karlsson, Thomas] Linkoping Univ, Linnaeus Ctr HEAD, Linkoping, Sweden; [Nelson, Nina] Karolinska Univ Hosp, Dept Qual & Patient Safety, Stockholm, Sweden	Linkoping University; Linkoping University; Linkoping University; Linkoping University; Linkoping University; Karolinska Institutet; Karolinska University Hospital	van Ettinger-Veenstra, H (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden.; van Ettinger-Veenstra, H (corresponding author), Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden.	helenevanettinger@gmail.com	Van Ettinger-Veenstra, Helene/AAT-7322-2020; Van Ettinger-Veenstra, Helene/ABD-6049-2020	Van Ettinger-Veenstra, Helene/0000-0003-3587-3568; 	FORSS-the Medical Research Council of Southeast Sweden [FORSS-159881]	FORSS-the Medical Research Council of Southeast Sweden	NN received funding from FORSS-the Medical Research Council of Southeast Sweden to perform the current study, grant number FORSS-159881, (http://www.researchweb.org/is/forss/ansokan/159881). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, J ABNORM CHILD PSYCH, V37, P981, DOI 10.1007/s10802-009-9327-z; [Anonymous], 2015, READ RES Q, V50, P151, DOI DOI 10.1002/rrq.99; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barre N, 2011, J PEDIATR-US, V158, P766, DOI 10.1016/j.jpeds.2010.10.032; Bitan T, 2007, HUM BRAIN MAPP, V28, P880, DOI 10.1002/hbm.20313; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Cartwright KB, 2007, J LIT RES, V39, P173, DOI 10.1080/10862960701331902; Catts HW, 2006, J SPEECH LANG HEAR R, V49, P278, DOI 10.1044/1092-4388(2006/023); Coltheart M., 2000, READING PERCEPTUAL P, P475, DOI [DOI 10.1016/B978-008043642-5/50022-X, 10.1016/B978-008043642-5/50022-X]; Crystal David., 2010, CAMBRIDGE ENCY LANGU, V3rd ed.; Gaddlin PO, 2011, ACTA PAEDIATR, V100, P940, DOI 10.1111/j.1651-2227.2011.02288.x; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hartwigsen G, 2010, P NATL ACAD SCI USA, V107, P16494, DOI 10.1073/pnas.1008121107; HOOVER WA, 1990, READ WRIT, V2, P127, DOI 10.1007/BF00401799; Horowitz-Kraus T, 2015, ACTA PAEDIATR, V104, P648, DOI 10.1111/apa.13018; Kovachy VN, 2015, DEV MED CHILD NEUROL, V57, P410, DOI 10.1111/dmcn.12652; Kwon SH, 2016, DEV MED CHILD NEUROL, V58, P28, DOI 10.1111/dmcn.13043; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lee ES, 2011, NEUROPSYCHOLOGIA, V49, P906, DOI 10.1016/j.neuropsychologia.2010.12.038; Leijon I, 2016, ACTA PAEDIATR, V105, P60, DOI 10.1111/apa.13094; Lundberg I, STOCK HOGREFE PSYKOL; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Manis FR, 1996, COGNITION, V58, P157, DOI 10.1016/0010-0277(95)00679-6; Ment LR, 2006, J PEDIATR-US, V149, P490, DOI 10.1016/j.jpeds.2006.06.007; Ment LR, 2003, JAMA-J AM MED ASSOC, V289, P705, DOI 10.1001/jama.289.6.705; Neubauer AC, 2009, NEUROSCI BIOBEHAV R, V33, P1004, DOI 10.1016/j.neubiorev.2009.04.001; Perfetti C.A, 1985, READING ABILITY; Peterson BS, 2002, PEDIATRICS, V110, P1153, DOI 10.1542/peds.110.6.1153; Prat CS, 2007, J COGNITIVE NEUROSCI, V19, P1950, DOI 10.1162/jocn.2007.19.12.1950; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Reidy N, 2013, J PEDIATR-US, V162, P719, DOI 10.1016/j.jpeds.2012.10.017; Rushe T.M., 2004, FETAL NEONATAL EDITI, V89, pF112, DOI DOI 10.1136/ADC.2001.005314; Samuelsson S, 2006, J PEDIATR PSYCHOL, V31, P967, DOI 10.1093/jpepsy/jsj108; Sandak R, 2004, SCI STUD READ, V8, P273, DOI 10.1207/s1532799xssr0803_6; Scheinost D, 2015, CEREB CORTEX, V25, P1858, DOI 10.1093/cercor/bht430; Shaywitz BA, 2006, DEV NEUROPSYCHOL, V30, P613, DOI 10.1207/s15326942dn3001_5; Socialstyrelsen, 2015, OFF STAT SWED STAT H; Luu TM, 2011, PEDIATRICS, V128, P313, DOI 10.1542/peds.2010-2655; Wadsby M, 2014, NORD J PSYCHIAT, V68, P626, DOI 10.3109/08039488.2014.907341	39	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185571	10.1371/journal.pone.0185571	http://dx.doi.org/10.1371/journal.pone.0185571			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MY	28968426	Green Published, Green Submitted, gold			2022-12-26	WOS:000412029600026
J	Adamczyk, M; Szatkowska, R				Adamczyk, Malgorzata; Szatkowska, Roza			Low RNA Polymerase III activity results in up regulation of HXT2 glucose transporter independently of glucose signaling and despite changing environment	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; SNF1 PROTEIN-KINASE; HEXOSE TRANSPORTERS; GENE-EXPRESSION; CARBON SOURCE; DNA-BINDING; TRANSCRIPTION FACTOR; IN-VIVO; TERMINAL DOMAIN; MIG1 REPRESSOR	Background Saccharomyces cerevisiae responds to glucose availability in the environment, inducing the expression of the low-affinity transporters and high-affinity transporters in a concentration dependent manner. This cellular decision making is controlled through finely tuned communication between multiple glucose sensing pathways including the Snf1-Mig1, Snf3/Rgt2Rgt1 (SRR) and cAMP-PKA pathways. Results We demonstrate the first evidence that RNA Polymerase III (RNAP III) activity affects the expression of the glucose transporter HXT2 (RNA Polymerase II dependent D RNAP II) at the level of transcription. Down-regulation of RNAP III activity in an rpc128-1007 mutant results in a significant increase in HXT2 mRNA, which is considered to respond only to low extracellular glucose concentrations. HXT2 expression is induced in the mutant regardless of the growth conditions either at high glucose concentration or in the presence of a non-fermentable carbon source such as glycerol. Using chromatin immunoprecipitation (ChIP), we found an increased association of Rgt1 and Tup1 transcription factors with the highly activated HXT2 promoter in the rpc128-1007 strain. Furthermore, by measuring cellular abundance of Mth1 corepressor, we found that in rpc128-1007, HXT2 gene expression was independent from Snf3/Rgt2-Rgt1 (SRR) signaling. The Snf1 protein kinase complex, which needs to be active for the release from glucose repression, also did not appear perturbed in the mutated strain. Conclusions/Significance These findings suggest that the general activity of RNAP III can indirectly affect the RNAP II transcriptional machinery on the HXT2 promoter when cellular perception transduced via the major signaling pathways, broadly recognized as on/off switch essential to either positive or negative HXT gene regulation, remain entirely intact. Further, Rgt1/Ssn6-Tup1 complex, which has a dual function in gene transcription as a repressor-activator complex, contributes to HXT2 transcriptional activation.	[Adamczyk, Malgorzata; Szatkowska, Roza] Warsaw Univ Technol, Inst Biotechnol, Fac Chem, Warsaw, Poland	Warsaw University of Technology	Adamczyk, M (corresponding author), Warsaw Univ Technol, Inst Biotechnol, Fac Chem, Warsaw, Poland.	madamczyk@ch.pw.edu.pl		Adamczyk, Malgorzata/0000-0003-3979-0364; Szatkowska, Roza/0000-0003-4494-5236	National Science Centre, Poland [2012/05/E/NZ2/00583]; Warsaw University of Technology	National Science Centre, Poland(National Science Centre, Poland); Warsaw University of Technology	Funding provided by the National Science Centre, Poland grant 2012/05/E/NZ2/00583, Warsaw University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilles J, 2004, CYTOM PART A, V61A, P88, DOI 10.1002/cyto.a.20035; Ahuatzi D, 2007, J BIOL CHEM, V282, P4485, DOI 10.1074/jbc.M606854200; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BALASUBRAMANIAN B, 1993, MOL CELL BIOL, V13, P6071, DOI 10.1128/MCB.13.10.6071; Boguta M, 2011, TRENDS BIOCHEM SCI, V36, P451, DOI 10.1016/j.tibs.2011.06.008; Boles E, 1997, FEMS MICROBIOL REV, V21, P85, DOI 10.1016/S0168-6445(97)00052-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Brown JCS, 2009, GENE DEV, V23, P2320, DOI 10.1101/gad.1839109; Bu Y, 1998, NUCLEIC ACIDS RES, V26, P1002, DOI 10.1093/nar/26.4.1002; Buck MJ, 2006, NAT GENET, V38, P1446, DOI 10.1038/ng1917; Ciesla M, 2007, MOL CELL BIOL, V27, P7693, DOI 10.1128/MCB.01051-07; Ciesla M, 2015, MOL CELL BIOL, V35, P1169, DOI 10.1128/MCB.01230-14; Conlan RS, 1999, J BIOL CHEM, V274, P205, DOI 10.1074/jbc.274.1.205; Conlan RS, 2001, J MOL BIOL, V309, P1007, DOI 10.1006/jmbi.2001.4742; Coons DM, 1997, YEAST, V13, P9, DOI 10.1002/(SICI)1097-0061(199701)13:1<9::AID-YEA51>3.0.CO;2-U; Davie JK, 2003, J BIOL CHEM, V278, P50158, DOI 10.1074/jbc.M309753200; DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X; Diderich JA, 1999, J BIOL CHEM, V274, P15350, DOI 10.1074/jbc.274.22.15350; Dietzel KL, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-107; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Fernandez-Garcia P, 2012, J BIOL CHEM, V287, P42151, DOI 10.1074/jbc.M112.401679; Ferreira C, 2007, FEBS LETT, V581, P1923, DOI 10.1016/j.febslet.2007.03.086; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Gancedo JM, 2015, BBA-GEN SUBJECTS, V1850, P1362, DOI 10.1016/j.bbagen.2015.03.006; Ghavidel A, 2007, CELL, V131, P915, DOI 10.1016/j.cell.2007.09.042; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Han BK, 2011, GENE DEV, V25, P984, DOI 10.1101/gad.1998611; Hanlon SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019060; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Horak J, 2013, CURR GENET, V59, P1, DOI 10.1007/s00294-013-0388-8; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jouandot D, 2011, J CELL BIOCHEM, V112, P3268, DOI 10.1002/jcb.23253; Kaminska J, 2000, GENE, V242, P133, DOI 10.1016/S0378-1119(99)00535-1; Kaniak A, 2004, EUKARYOT CELL, V3, P221, DOI 10.1128/EC.3.1.221-231.2004; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; Kim D, 2015, APPL ENVIRON MICROB, V81, P8392, DOI 10.1128/AEM.02056-15; Kim JH, 2006, J BIOL CHEM, V281, P26144, DOI 10.1074/jbc.M603636200; Kim JH, 2009, BIOCHIMIE, V91, P300, DOI 10.1016/j.biochi.2008.09.002; Kim JH, 2003, MOL CELL BIOL, V23, P5208, DOI 10.1128/MCB.23.15.5208-5216.2003; Kim JW, 2004, MOL CELL BIOL, V24, P8104, DOI 10.1128/MCB.24.18.8104-8112.2004; Kim SJ, 2005, MOL CELL BIOL, V25, P11171, DOI 10.1128/MCB.25.24.11171-11183.2005; Kolkman A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100069; KOMACHI K, 1994, GENE DEV, V8, P2857, DOI 10.1101/gad.8.23.2857; Kresnowati MTAP, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100083; Kruckeberg AL, 1999, BIOCHEM J, V339, P299, DOI 10.1042/0264-6021:3390299; Kwapisz M, 2002, CURR GENET, V42, P147, DOI 10.1007/s00294-002-0342-7; Lafuente MJ, 2000, MOL MICROBIOL, V35, P161, DOI 10.1046/j.1365-2958.2000.01688.x; Lakshmanan J, 2003, CURR GENET, V44, P19, DOI 10.1007/s00294-003-0423-2; Lee SB, 2013, BIOCHEM BIOPH RES CO, V439, P501, DOI 10.1016/j.bbrc.2013.09.015; Liang H, 1996, MOL BIOL CELL, V7, P1953, DOI 10.1091/mbc.7.12.1953; Lin X, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-48; Lin X, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0093-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Maier A, 2002, FEMS YEAST RES; Matsumura H, 2012, J BIOL CHEM, V287, P26528, DOI 10.1074/jbc.M112.369652; McCartney RR, 2014, GENETICS, V198, P635, DOI 10.1534/genetics.114.169060; Metzger DE, 2014, DIABETES, V63, P1804, DOI 10.2337/db13-0867; Mierzejewska J, 2016, FEBS LETT, V590, P93, DOI 10.1002/1873-3468.12033; Morawiec E, 2013, GENE, V526, P16, DOI 10.1016/j.gene.2013.04.055; Moriya H, 2004, P NATL ACAD SCI USA, V101, P1572, DOI 10.1073/pnas.0305901101; Mosley AL, 2003, J BIOL CHEM, V278, P10322, DOI 10.1074/jbc.M212802200; NEHLIN JO, 1991, EMBO J, V10, P3373, DOI 10.1002/j.1460-2075.1991.tb04901.x; O'Donnell AF, 2015, MOL CELL BIOL, V35, P939, DOI 10.1128/MCB.01183-14; Ostling J, 1998, EUR J BIOCHEM, V252, P162, DOI 10.1046/j.1432-1327.1998.2520162.x; Ozcan S, 1998, EMBO J, V17, P2566, DOI 10.1093/emboj/17.9.2566; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; OZCAN S, 1995, MOL CELL BIOL, V15, P1564; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; Ozcan S, 1996, MOL CELL BIOL, V16; Palian BM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004789; Palomino A, 2006, NUCLEIC ACIDS RES, V34, P1427, DOI 10.1093/nar/gkl028; Papamichos-Chronakis M, 2002, MOL CELL, V9, P1297, DOI 10.1016/S1097-2765(02)00545-2; Pluta K, 2001, MOL CELL BIOL, V21, P5031, DOI 10.1128/MCB.21.15.5031-5040.2001; Polish JA, 2005, GENETICS, V169, P583, DOI 10.1534/genetics.104.034512; Proft M, 2002, MOL CELL; Reifenberger E, 1997, EUR J BIOCHEM, V245, P324, DOI 10.1111/j.1432-1033.1997.00324.x; Reijenga KA, 2001, BIOPHYS J, V80, P626, DOI 10.1016/S0006-3495(01)76043-2; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Ronen M, 2006, P NATL ACAD SCI USA, V103, P389, DOI 10.1073/pnas.0509978103; Roy A, 2014, FEBS OPEN BIO, V4, P105, DOI 10.1016/j.fob.2013.12.004; Roy A, 2013, MOL BIOL CELL, V24, P1493, DOI 10.1091/mbc.E13-01-0047; Sabina J, 2009, J BIOL CHEM, V284, P29635, DOI 10.1074/jbc.M109.032102; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schneper L, 2004, CURR OPIN MICROBIOL, V7, P624, DOI 10.1016/j.mib.2004.10.002; Schulte F, 2000, J BACTERIOL, V182, P540, DOI 10.1128/JB.182.2.540-542.2000; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Silveira MCF, 1996, ANAL BIOCHEM, V238, P26, DOI 10.1006/abio.1996.0244; Simpson-Lavy KJ, 2015, CELL REP, V12, P1865, DOI 10.1016/j.celrep.2015.08.025; Slattery MG, 2008, EUKARYOT CELL, V7, P358, DOI 10.1128/EC.00334-07; Smith FC, 1999, FEBS LETT, V453, P219, DOI 10.1016/S0014-5793(99)00725-5; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Snowdon C, 2016, MOL BIOL CELL, V27, P3369, DOI 10.1091/mbc.E16-05-0342; Snowdon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050458; Tanaka N, 2015, BIOCHEM BIOPH RES CO, V468, P32, DOI 10.1016/j.bbrc.2015.11.001; Tao JY, 2016, BIOCHEMISTRY-US, V55, P2578, DOI 10.1021/acs.biochem.5b01286; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; TRUMBLY RJ, 1992, MOL MICROBIOL, V6, P15, DOI 10.1111/j.1365-2958.1992.tb00832.x; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; van Oevelen CJC, 2006, J BIOL CHEM, V281, P4523, DOI 10.1074/jbc.M509330200; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vannini A, 2010, CELL, V143, P59, DOI 10.1016/j.cell.2010.09.002; Vega M, 2016, J BIOL CHEM, V291, P7267, DOI 10.1074/jbc.M115.711408; Wang JF, 1997, J BIOL CHEM, V272, P4613, DOI 10.1074/jbc.272.7.4613; Weinhandl K, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-5; WENDELL DL, 1994, J BACTERIOL, V176, P3730, DOI 10.1128/JB.176.12.3730-3737.1994; WILLIAMS FE, 1990, MOL CELL BIOL, V10, P6500, DOI 10.1128/MCB.10.12.6500; Wollman AJM, 2015, FARADAY DISCUSS, V184, P401, DOI 10.1039/c5fd00077g; Wong KH, 2011, GENE DEV, V25, P2525, DOI 10.1101/gad.179275.111; Ye L, 2001, YEAST, V18, P1257, DOI 10.1002/yea.771.abs; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0; Zaman S, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.2; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127	122	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185516	10.1371/journal.pone.0185516	http://dx.doi.org/10.1371/journal.pone.0185516			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961268	gold, Green Published, Green Submitted			2022-12-26	WOS:000412027700022
J	Bomfim, L; Vieira, P; Fonseca, A; Ramos, I				Bomfim, Larissa; Vieira, Priscila; Fonseca, Ariene; Ramos, Isabela			Eggshell ultrastructure and delivery of pharmacological inhibitors to the early embryo of R. prolixus by ethanol permeabilization of the extraembryonic layers	PLOS ONE			English	Article							INSECT RHODNIUS-PROLIXUS; RNA INTERFERENCE; EMBRYOGENESIS; REDUVIIDAE; HEMIPTERA; DSRNA; INJECTION; ELEGANS; GENE	Most vectors of arthropod-borne diseases produce large eggs with hard and opaque eggshells. In several species, it is still not possible to induce molecular perturbations to the embryo by delivery of molecules using microinjections or eggshell permeabilization without losing embryo viability, which impairs basic studies regarding development and population control. Here we tested the properties and permeability of the eggshell of R. prolixus, a Chagas disease vector, with the aim to deliver pharmacological inhibitors to the egg cytoplasm and allow controlled molecular changes to the embryo. Using field emission scanning and transmission electron microscopy we found that R. prolixus egg is coated by three main layers: exochorion, vitelline layer and the plasma membrane, and that the pores that allow gas exchange (aeropiles) have an average diameter of 10 mu m and are found in the rim of the operculum at the anterior pole of the egg. We tested if different solvents could permeate through the aeropiles and reach the egg cytoplasm/embryo and found that immersions of the eggs in ethanol lead to its prompt penetration through the aeropiles. A single five minute-immersion of the eggs/embryos in pharmacological inhibitors, such as azide, cyanide and cycloheximide, solubilized in ethanol resulted in impairment of embryogenesis in a dose dependent manner and DAPI-ethanol solutions were also able to label the embryo cells, showing that ethanol penetration was able to deliver those molecules to the embryo cells. Multiple immersions of the embryo in the same solutions increased the effect and tests using bafilomycin A1 and Pepstatin A, known inhibitors of the yolk proteolysis, were also able to impair embryogenesis and the yolk protein degradation. Additionally, we found that ethanol pre-treatments of the egg make the aeropiles more permeable to aqueous solutions, so drugs diluted in water can be carried after the eggs are pre-treated with ethanol. Thus, we found that delivery of pharmacological inhibitors to the embryo of R. prolixus can be performed simply by submersing the fertilized eggs in ethanol with no need for additional methods such as microinjections or electroporation. We discuss the potential importance of this methodology to the study of this vector developmental biology and population control.	[Bomfim, Larissa; Vieira, Priscila; Fonseca, Ariene; Ramos, Isabela] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Lab Bioquim Insetos, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Ramos, I (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Lab Bioquim Insetos, Rio De Janeiro, Brazil.	isabela@bioqmed.ufrj.br	Ramos, Isabela B/N-7091-2017	Ramos, Isabela B/0000-0003-0874-7902; Bomfim, Larissa/0000-0003-0901-3118	CNPq, Universal; FAPERJ, APQ1; CNPq/FAPERJ, INCT-EM	CNPq, Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ, APQ1(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq/FAPERJ, INCT-EM	This work was supported by CNPq, Universal to IR; FAPERJ, APQ1 to IR; and CNPq/FAPERJ, INCT-EM to IR.	Andersen S.O., 1985, COMPREHENSIVE INSECT, V3, P59, DOI 10.1016/0020-711X(85)90033-3; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Azambuja P, 2016, J INSECT PHYSL; Balakrishna Pillai A, 2016, INSECT MOL BIOL; Beament JW, 1947, Q J MICROSCOPICAL SC, V87, P393; BEAMENT JWL, 1948, B ENTOMOL RES, V39, P359, DOI 10.1017/S0007485300022471; BEAMENT JWL, 1946, PROC R SOC SER B-BIO, V133, P407, DOI 10.1098/rspb.1946.0021; BEAMENT JWL, 1945, J EXP BIOL, V21, P115; BEAMENT JWL, 1946, NATURE, V157, P370, DOI 10.1038/157370c0; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; Berkowitz Laura A, 2008, J Vis Exp, DOI 10.3791/833; Berni M, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-38; Brust-Mascher Ingrid, 2009, J Vis Exp, DOI 10.3791/1382; Dias FA, 2013, J BIOL CHEM, V288, P35058, DOI 10.1074/jbc.M113.522201; GARCIA ES, 1975, AN ACAD BRAS CIENC, V47, P580; Gilbert S.F., 2000, DEV BIOL; HARIDASS ET, 1986, P INDIAN AS-ANIM SCI, V95, P447, DOI 10.1007/BF03179381; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; KELLY GM, 1989, J MORPHOL, V199, P175, DOI 10.1002/jmor.1051990205; KELLY GM, 1986, CAN J ZOOL, V64, P2425, DOI 10.1139/z86-362; KELLY GM, 1987, INSECT BIOCHEM, V17, P1079, DOI 10.1016/0020-1790(87)90124-7; Khila A, 2007, DEV GENES EVOL, V217, P241, DOI 10.1007/s00427-007-0132-9; Lavore A, 2012, DEV BIOL, V361, P147, DOI 10.1016/j.ydbio.2011.06.038; Marre J, 2016, P NATL ACAD SCI USA, V113, P12496, DOI 10.1073/pnas.1608959113; May RC, 2005, METHOD ENZYMOL, V392, P308, DOI 10.1016/S0076-6879(04)92018-6; MERRIL CR, 1981, ANAL BIOCHEM, V110, P201, DOI 10.1016/0003-2697(81)90136-6; Mesquita RD, 2015, P NATL ACAD SCI USA, V112, P14936, DOI 10.1073/pnas.1506226112; Ons S, 2016, J INSECT PHYSL; Paim RMM, 2013, INSECT BIOCHEM MOLEC, V43, P1015, DOI 10.1016/j.ibmb.2013.08.008; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Silva-Neto MAC, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00062; Sive HL, 2010, COLD SPRING HARBOR P, V2010; Sive HL, 2010, COLD SPRING HARBOR P, V2010; Souza-Ferreira PS, 2014, INSECT BIOCHEM MOLEC, V51, P101, DOI 10.1016/j.ibmb.2013.12.004; TUFT PH, 1950, J EXP BIOL, V26, P327; Walter-Nuno AB, 2013, J BIOL CHEM, V288, P29323, DOI 10.1074/jbc.M113.504985; Xu QL, 1999, METH MOL B, V127, P125, DOI 10.1385/1-59259-678-9:125	37	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185770	10.1371/journal.pone.0185770	http://dx.doi.org/10.1371/journal.pone.0185770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961275	Green Published, gold, Green Submitted			2022-12-26	WOS:000412027700037
J	Kato, K; Kanosue, K				Kato, Kouki; Kanosue, Kazuyuki			Corticospinal excitability for hand muscles during motor imagery of foot changes with imagined force level	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; VOLUNTARY MOVEMENT; EVOKED-POTENTIALS; CORTICAL PLASTICITY; FOREARM MUSCLES; MENTAL PRACTICE; FUNCTIONAL MRI; CONTRACTION; FACILITATION; MODULATION	The object of this study was to clarify whether corticospinal excitability controlling hand muscles changes concurrently with increases in the imagined contraction level of foot dorsiflexion. Twelve participants performed actual and imagined dorsiflexion of their right foot at three different EMG levels (10, 40 or 80% of the maximum voluntary contraction). During isometric actual-or imagined-dorsiflexion, transcranial magnetic stimulation (TMS) was delivered to the right hand area of the left primary motor cortex. Motor evoked potentials (MEPs) were recorded from the right extensor carpi radialis (ECR) and flexor carpi radialis (FCR). During actual contraction, MEP amplitudes of ECR and FCR increased with an increased EMG level of dorsiflexion. Similarly, during imagery contraction, MEP amplitudes of ECR and FCR increased with the intensity of imagery contraction. Furthermore, a correlation between MEP amplitude during actual contraction and imagery contraction was observed for both ECR and FCR. Motor imagery of foot contraction induced an enhancement of corticospinal excitability for hand muscles that was dependent on the imagined contraction levels, just as what was observed when there was an actual contraction.	[Kato, Kouki; Kanosue, Kazuyuki] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan	Waseda University	Kato, K (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.	kato.k@aoni.waseda.jp		Kato, Kouki/0000-0002-4922-3120	JSPS KAKENHI [15K16494, JP26242065]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grant numbers 15K16494 to K Kato and JP26242065 to K Kanosue.; The authors thank Dr. Larry Crawshaw for English editing. This work was supported by JSPS KAKENHI Grant Numbers 15K16494 to K Kato and JP26242065 to K Kanosue. All authors declare no conflicts of interest.	Allami N, 2008, EXP BRAIN RES, V184, P105, DOI 10.1007/s00221-007-1086-x; Allison T, 1996, EVOKED POTENTIAL, V100, P126, DOI 10.1016/0013-4694(95)00226-X; Baldissera F, 2002, J PHYSIOL-LONDON, V539, P903, DOI 10.1113/jphysiol.2001.013282; Borroni P, 2004, BRAIN RES, V1022, P117, DOI 10.1016/j.brainres.2004.07.003; BROWN P, 1991, BRAIN, V114, P2333, DOI 10.1093/brain/114.5.2333; Byblow WD, 2007, J NEUROPHYSIOL, V98, P414, DOI 10.1152/jn.00325.2007; Cauda F, 2011, HUM BRAIN MAPP, V32, P1566, DOI 10.1002/hbm.21132; Dai TH, 2001, EXP BRAIN RES, V140, P290, DOI 10.1007/s002210100815; DECETY J, 1989, BEHAV BRAIN RES, V34, P35, DOI 10.1016/S0166-4328(89)80088-9; DELWAIDE PJ, 1981, BRAIN, V104, P701, DOI 10.1093/brain/104.4.701; DRISKELL JE, 1994, J APPL PSYCHOL, V79, P481, DOI 10.1037/0021-9010.79.4.481; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; EVARTS EV, 1983, J NEUROPHYSIOL, V49, P1199, DOI 10.1152/jn.1983.49.5.1199; FELTZ DL, 1983, J SPORT PSYCHOL, V5, P25, DOI 10.1123/jsp.5.1.25; Fourkas AD, 2006, BEHAV BRAIN RES, V168, P190, DOI 10.1016/j.bbr.2005.10.015; Guillot A, 2009, HUM BRAIN MAPP, V30, P2157, DOI 10.1002/hbm.20658; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Holmes P, 2008, J MOTOR BEHAV, V40, P433, DOI 10.3200/JMBR.40.5.433-445; Hortobagyi T, 2003, J NEUROPHYSIOL, V90, P2451, DOI 10.1152/jn.01001.2002; Huang X, 2017, MOL PSYCHIATR, V22, P1274, DOI 10.1038/mp.2017.143; HUNTLEY GW, 1991, J NEUROPHYSIOL, V66, P390, DOI 10.1152/jn.1991.66.2.390; Isaac AR., 1992, SPORT PSYCHOL, V6, P192, DOI [10.1123/tsp.6.2.192, DOI 10.1123/TSP.6.2.192, DOI 10.1123/tsp.6.2.192]; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Jendr?ssik, 1883, DTSCH ARCH KLIN MED, V33, P177; Kasai T, 1997, BRAIN RES, V744, P147, DOI 10.1016/S0006-8993(96)01101-8; Kato K, 2015, PHYSL REP, V3, P1; Kato K, 2016, FRONT HUM NEUROSCI, V10, DOI [10.3389/fnhum.2016.00218, 10.3389/fnhum.2016.00131]; Kato K, 2016, NEUROSCI LETT, V633, P252, DOI 10.1016/j.neulet.2016.09.019; Kato K, 2015, NEUROSCI RES, V92, P39, DOI 10.1016/j.neures.2014.10.013; Kato K, 2014, EXP BRAIN RES, V232, P181, DOI 10.1007/s00221-013-3730-y; KAWAKITA H, 1991, J ELECTROMYOGR KINES, V1, P96, DOI 10.1016/1050-6411(91)90003-N; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Makary MM, 2017, NEUROREPORT, V28, P610, DOI 10.1097/WNR.0000000000000809; Marconi B, 2007, CLIN NEUROPHYSIOL, V118, P2468, DOI 10.1016/j.clinph.2007.08.021; Mizuguchi N., 2012, J PHYS FIT SPORT MED, V1, P103, DOI 10.7600/jpfsm.1.103; Mizuguchi N, 2013, EXP BRAIN RES, V230, P243, DOI 10.1007/s00221-013-3649-3; Mizuguchi N, 2009, EXP BRAIN RES, V196, P529, DOI 10.1007/s00221-009-1875-5; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Perez MA, 2009, CORTEX, V45, P1065, DOI 10.1016/j.cortex.2008.12.006; Roberts R, 2008, J SPORT EXERCISE PSY, V30, P200, DOI 10.1123/jsep.30.2.200; Shen Y, 2017, BIOL PSYCHIAT, V81, pE49, DOI 10.1016/j.biopsych.2016.06.013; Shen Y, 2016, BIOL PSYCHIAT, V80, pE13, DOI 10.1016/j.biopsych.2016.02.006; Stedman A, 1998, MUSCLE NERVE, V21, P1033, DOI 10.1002/(SICI)1097-4598(199808)21:8<1033::AID-MUS7>3.0.CO;2-9; Stein RB Zehr, 1999, EXP BRAIN RES, V159, P382; Stinear CM, 2004, EXP BRAIN RES, V157, P351, DOI 10.1007/s00221-004-1851-z; Takada Y, 2000, J NEUROPHYSIOL, V83, P2063, DOI 10.1152/jn.2000.83.4.2063; Tazoe T, 2007, CLIN NEUROPHYSIOL, V118, P1204, DOI 10.1016/j.clinph.2007.03.005; Tazoe T, 2009, EUR J NEUROSCI, V30, P1297, DOI 10.1111/j.1460-9568.2009.06895.x; TOULOUSE P, 1980, ARCH PHYS MED REHAB, V61, P511; van Duinen H, 2008, HUM BRAIN MAPP, V29, P281, DOI 10.1002/hbm.20388; WERNER W, 1991, EXP BRAIN RES, V86, P293; Yazawa S, 1999, BRAIN, V122, P1357, DOI 10.1093/brain/122.7.1357	53	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185547	10.1371/journal.pone.0185547	http://dx.doi.org/10.1371/journal.pone.0185547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957398	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200083
J	Chhabra, Y; Wong, HY; Nikolajsen, LF; Steinocher, H; Papadopulos, A; Tunny, KA; Meunier, FA; Smith, AG; Kragelund, BB; Brooks, AJ; Waters, MJ				Chhabra, Y.; Wong, H. Y.; Nikolajsen, L. F.; Steinocher, H.; Papadopulos, A.; Tunny, K. A.; Meunier, F. A.; Smith, A. G.; Kragelund, B. B.; Brooks, A. J.; Waters, M. J.			A growth hormone receptor SNP promotes lung cancer by impairment of SOCS2-mediated degradation	ONCOGENE			English	Article							SIGNALING PATHWAY; FACTOR-I; EXPRESSION; PROTEIN; PHOSPHORYLATION; MAMMARY; SOCS; IDENTIFICATION; SUPPRESSOR; STAT5	Both humans and mice lacking functional growth hormone (GH) receptors are known to be resistant to cancer. Further, autocrine GH has been reported to act as a cancer promoter. Here we present the first example of a variant of the GH receptor (GHR) associated with cancer promotion, in this case lung cancer. We show that the GHRP495T variant located in the receptor intracellular domain is able to prolong the GH signal in vitro using stably expressing mouse pro-B-cell and human lung cell lines. This is relevant because GH secretion is pulsatile, and extending the signal duration makes it resemble autocrine GH action. Signal duration for the activated GHR is primarily controlled by suppressor of cytokine signalling 2 (SOCS2), the substrate recognition component of the E3 protein ligase responsible for ubiquitinylation and degradation of the GHR. SOCS2 is induced by a GH pulse and we show that SOCS2 binding to the GHR is impaired by a threonine substitution at Pro 495. This results in decreased internalisation and degradation of the receptor evident in TIRF microscopy and by measurement of mature (surface) receptor expression. Mutational analysis showed that the residue at position 495 impairs SOCS2 binding only when a threonine is present, consistent with interference with the adjacent Thr494. The latter is key for SOCS2 binding, together with nearby Tyr487, which must be phosphorylated for SOCS2 binding. We also undertook nuclear magnetic resonance spectroscopy approach for structural comparison of the SOCS2 binding scaffold Ile455-Ser588, and concluded that this single substitution has altered the structure of the SOCS2 binding site. Importantly, we find that lung BEAS-2B cells expressing GHRP495T display increased expression of transcripts associated with tumour proliferation, epithelial-mesenchymal transition and metastases (TWIST1, SNAI2, EGFR, MYC and CCND1) at 2 h after a GH pulse. This is consistent with prolonged GH signalling acting to promote cancer progression in lung cancer.	[Chhabra, Y.; Tunny, K. A.; Brooks, A. J.; Waters, M. J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Chhabra, Y.; Tunny, K. A.; Brooks, A. J.] Univ Queensland, Translat Res Inst, Diamantina Inst, Woolloongabba, Qld 4102, Australia; [Wong, H. Y.] Univ Queensland, Ctr Clin Res, Herston, Qld, Australia; [Nikolajsen, L. F.; Steinocher, H.; Kragelund, B. B.] Univ Copenhagen, Dept Biol, Struct Biol & NMR Lab SBiNLab, Copenhagen, Denmark; [Papadopulos, A.; Meunier, F. A.] Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld, Australia; [Smith, A. G.] Queensland Univ Technol, Translat Res Inst, Sch Biomed Sci, Inst Hlth & Biomed Innovat, Woolloongabba, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; University of Copenhagen; University of Queensland; Queensland University of Technology (QUT)	Brooks, AJ (corresponding author), Univ Queensland, Translat Res Inst, Diamantina Inst, Woolloongabba, Qld 4102, Australia.	abrooks@uq.edu.au	Chhabra, Yash/C-8801-2018; Brooks, Andrew/A-9969-2011; Meunier, Frederic A/C-8161-2009	Chhabra, Yash/0000-0003-2883-4675; Brooks, Andrew/0000-0002-2691-1668; Meunier, Frederic A/0000-0001-6400-1107; Wong, Ho Yi/0000-0002-1245-4056; Smith, Aaron/0000-0003-2937-1713; Nikolajsen, Louise Fletcher/0000-0002-7573-213X	National Health and Medical Research Council (NHMRC) of Australia [APP1084797, APP1002893, APP1025082]; Lundbeck Foundation; Novo Nordisk Foundation; Australian Research Council [LE0882864, DP170100125]; University of Queensland IPRS scholarship; Novo Nordisk Fonden [NNF15OC0016670, NNF15OC0016076, NNF14OC0010211] Funding Source: researchfish	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Australian Research Council(Australian Research Council); University of Queensland IPRS scholarship; Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank Professor John J Kopchick (Ohio) for ghr-/- mice. We thank Queensland Brain Institute's (QBI) Advanced Microimaging and Analysis Facility for help with TIRF and the Translational Research Institute Microscopy Core Facility for help with imaging. This work was supported by project grants APP1084797, APP1002893 and APP1025082 from the National Health and Medical Research Council (NHMRC) of Australia grants to MJW and AJB, and by the Lundbeck Foundation and the Novo Nordisk Foundation to BBK. FAM is a NHMRC Senior Research Fellow (569596) and supported by Australian Research Council LIEF grant (LE0882864) and Discovery Project Grant (DP170100125). YC is supported by University of Queensland IPRS scholarship. This work is dedicated to Andrew Mitchell.	Adams TE, 1998, J BIOL CHEM, V273, P1285, DOI 10.1074/jbc.273.3.1285; Brooks AJ, 2014, SCIENCE, V344, P710, DOI 10.1126/science.1249783; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Bullock AN, 2007, STRUCTURE, V15, P1493, DOI 10.1016/j.str.2007.09.016; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cao GC, 2008, JPN J CLIN ONCOL, V38, P308, DOI 10.1093/jjco/hyn007; Chhabra Y, 2011, EXPERT REV ENDOCRINO, V6, P71, DOI [10.1586/eem.10.73, 10.1586/EEM.10.73]; Conway-Campbell BL, 2007, P NATL ACAD SCI USA, V104, P13331, DOI 10.1073/pnas.0600181104; Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374; Dinkel H, 2016, NUCLEIC ACIDS RES, V44, pD294, DOI 10.1093/nar/gkv1291; Divisova J, 2006, BREAST CANCER RES TR, V98, P315, DOI 10.1007/s10549-006-9168-1; Du L, 2003, ENDOCRINOLOGY, V144, P868, DOI 10.1210/en.2002-220830; Flores-Morales A, 2006, MOL ENDOCRINOL, V20, P241, DOI 10.1210/me.2005-0170; Fujimoto M, 2003, TRENDS IMMUNOL, V24, P659, DOI 10.1016/j.it.2003.10.008; Greenhalgh CJ, 2002, MOL ENDOCRINOL, V16, P1394, DOI 10.1210/me.16.6.1394; Guevara-Aguirre J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001845; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Haura EB, 2005, CLIN CANCER RES, V11, P8288, DOI 10.1158/1078-0432.CCR-05-0827; Haxholm GW, 2015, BIOCHEM J, V468, P495, DOI 10.1042/BJ20141243; Hodge C, 1998, J BIOL CHEM, V273, P31327, DOI 10.1074/jbc.273.47.31327; Huang HL, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0463-x; Hung JJ, 2009, THORAX, V64, P1082, DOI 10.1136/thx.2009.115691; Iavnilovitch E, 2004, INT J CANCER, V112, P607, DOI 10.1002/ijc.20484; Ikeno Y, 2009, J GERONTOL A-BIOL, V64, P522, DOI 10.1093/gerona/glp017; Jaffe CA, 1998, J CLIN INVEST, V102, P153, DOI 10.1172/JCI2908; Jiang RC, 2011, MOL DIAGN THER, V15, P347, DOI 10.2165/11599190-000000000-00000; Krebs DL, 2000, J CELL SCI, V113, P2813; Kuner R, 2009, LUNG CANCER, V63, P32, DOI 10.1016/j.lungcan.2008.03.033; Li Y, 2006, ONCOGENE, V25, P1896, DOI 10.1038/sj.onc.1209214; Lin XX, 2014, TOXICOL MECH METHOD, V24, P575, DOI 10.3109/15376516.2014.956909; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Lu TP, 2010, CANCER EPIDEM BIOMAR, V19, P2590, DOI 10.1158/1055-9965.EPI-10-0332; Malaney P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02035; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mukhina S, 2004, P NATL ACAD SCI USA, V101, P15166, DOI 10.1073/pnas.0405881101; Ocaranza P, 2012, J PEDIATR ENDOCR MET, V25, P273, DOI 10.1515/jpem-2011-0491; Papadopulos A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7297; Paul C, 2000, EUR J BIOCHEM, V267, P5849, DOI 10.1046/j.1432-1327.2000.01395.x; Plotnikov A, 2008, CANCER RES, V68, P1354, DOI 10.1158/0008-5472.CAN-07-6094; Rudd MF, 2006, GENOME RES, V16, P693, DOI 10.1101/gr.5120106; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SOUZA SC, 1995, P NATL ACAD SCI USA, V92, P959, DOI 10.1073/pnas.92.4.959; Stajduhar E, 2014, TUMOR BIOL, V35, P6425, DOI 10.1007/s13277-014-1827-y; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Tollet-Egnell P, 1999, ENDOCRINOLOGY, V140, P3693, DOI 10.1210/en.140.8.3693; Trengove MC, 2013, AM J CLIN EXP IMMUNO, V2, P1; Uyttendaele I, 2007, MOL ENDOCRINOL, V21, P2821, DOI 10.1210/me.2006-0541; Van Dyke AL, 2009, J CANCER EPIDEMIOL, V2009, DOI 10.1155/2009/242151; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200; VANCE ML, 1985, J CLIN INVEST, V75, P1584, DOI 10.1172/JCI111864; Veldhuis JD, 1998, GROWTH HORM IGF RES, V8, P49, DOI 10.1016/S1096-6374(98)80024-5; Vesterlund M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025358; Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132; Wan Y, 2004, J BIOL CHEM, V279, P44775, DOI 10.1074/jbc.M406092200; Wang XZ, 1996, MOL ENDOCRINOL, V10, P1249, DOI 10.1210/me.10.10.1249; Wikman H, 2002, ONCOGENE, V21, P5804, DOI 10.1038/sj.onc.1205726; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Wu ZS, 2011, J CLIN ENDOCR METAB, V96, pE1619, DOI 10.1210/jc.2011-1245; Yamauchi T, 1997, NATURE, V390, P91, DOI 10.1038/36369; Yang XXO, 2013, NAT IMMUNOL, V14, P732, DOI 10.1038/ni.2633; Yip PY, 2015, TRANSL LUNG CANCER R, V4, P165, DOI 10.3978/j.issn.2218-6751.2015.01.04; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151; Yu Y, 2015, CANCER CHEMOTH PHARM, V75, P917, DOI 10.1007/s00280-015-2710-2; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055	67	32	34	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 25	2018	37	4					489	501		10.1038/onc.2017.352	http://dx.doi.org/10.1038/onc.2017.352			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT7KP	28967904	hybrid, Green Published			2022-12-26	WOS:000423331600007
J	da Silva, CMG; Franz-Montan, M; Limia, CEG; Ribeiro, LND; Braga, MA; Guilherme, VA; da Silva, CB; Casadei, BR; Cereda, CMS; de Paula, E				Goncalves da Silva, Camila Morais; Franz-Montan, Michelle; Gomez Limia, Cintia Elisabeth; de Morais Ribeiro, Ligia Nunes; Braga, Mario Antonio; Guilherme, Viviane Aparecida; da Silva, Camila Batista; Casadei, Bruna Renata; Saia Cereda, Cintia Maria; de Paula, Eneida			Encapsulation of ropivacaine in a combined (donor-acceptor, ionic-gradient) liposomal system promotes extended anesthesia time	PLOS ONE			English	Article							LOCAL-ANESTHETICS; BUPIVACAINE; DELIVERY; FORMULATION; ANALGESIA; PRILOCAINE; TOXICITY; RELEASE	Ropivacaine is a local anesthetic with similar potency but lower systemic toxicity than bupivacaine, the most commonly used spinal anesthetic. The present study concerns the development of a combined drug delivery system for ropivacaine, comprised of two types of liposomes: donor multivesicular vesicles containing 250 mM (NH4)(2)SO4 plus the anesthetic, and acceptor large unilamellar vesicles with internal pH of 5.5. Both kinds of liposomes were composed of hydrogenated soy-phosphatidylcholine: cholesterol (2: 1 mol%) and were prepared at pH 7.4. Dynamic light scattering, transmission electron microscopy and electron paramagnetic resonance techniques were used to characterize the average particle size, polydispersity, zeta potential, morphology and fluidity of the liposomes. In vitro dialysis experiments showed that the combined liposomal system provided significantly longer (72 h) release of ropivacaine, compared to conventional liposomes (similar to 45 h), or plain ropivacaine (similar to 4 h) (p<0.05). The pre-formulations tested were significantly less toxic to 3T3 cells, with toxicity increasing in the order: combined system < ropivacaine in donor or acceptor liposomes < ropivacaine in conventional liposomes < plain ropivacaine. The combined formulation, containing 2% ropivacaine, increased the anesthesia duration up to 9 h after subcutaneous infiltration in mice. In conclusion, a promising drug delivery system for ropivacaine was described, which can be loaded with large amounts of the anesthetic (2%), with reduced in vitro cytotoxicity and extended anesthesia time.	[Goncalves da Silva, Camila Morais; Gomez Limia, Cintia Elisabeth; de Morais Ribeiro, Ligia Nunes; Braga, Mario Antonio; Guilherme, Viviane Aparecida; Casadei, Bruna Renata; Saia Cereda, Cintia Maria; de Paula, Eneida] Univ Estadual Campinas, Inst Biol, Dept Biochem & Tissue Biol, UNICAMP, Campinas, SP, Brazil; [Franz-Montan, Michelle; da Silva, Camila Batista] Univ Estadual Campinas, UNICAMP, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas	de Paula, E (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Biochem & Tissue Biol, UNICAMP, Campinas, SP, Brazil.	depaula@unicamp.br	Franz-Montan, Michelle/E-2865-2010; de Paula, Eneida/C-3031-2013; Ribeiro, Lígia/AAJ-2820-2020; Franz-Montan, Michelle/V-3301-2019; Franz-Montan, Michelle/AAN-1071-2021; Casadei, Bruna R/D-5658-2015; da Silva de Araujo Candido, Camila Batista/C-5918-2014; Guilherme, Viviane Ap./Q-4155-2017; Cereda, Cintia/E-4182-2013	de Paula, Eneida/0000-0003-4504-5723; Ribeiro, Lígia/0000-0001-6097-5449; Franz-Montan, Michelle/0000-0003-0760-1389; Franz-Montan, Michelle/0000-0003-0760-1389; Casadei, Bruna R/0000-0002-4103-0084; da Silva de Araujo Candido, Camila Batista/0000-0003-1897-3567; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [14/14457-5, 2011/21735-3]; Conselho Nacional de Ciencia e Tecnologia (CNPq) [464708/2014-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Ciencia e Tecnologia (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grant # 14/14457-5 and fellowship to CMGS # 2011/21735-3) and Conselho Nacional de Ciencia e Tecnologia (CNPq, # 464708/2014-1).	ADADE AB, 1984, J BIOENERG BIOMEMBR, V16, P353, DOI 10.1007/BF00743231; Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Barenholz Y, Method of amphiphatic drug loading in liposomes by pH gradient. US Patent, Patent No. 51993192549; Barenholz Y, 2007, A liposomal combination and uses thereof. Patent, Patent No. 2007/; BROCKWAY MS, 1991, BRIT J ANAESTH, V66, P31, DOI 10.1093/bja/66.1.31; Cereda CMS, 2004, J PHARM PHARM SCI, V7, P235; Christie LE, 2014, BJA ED, P136; Cohen R, 2012, J CONTROL RELEASE, V160, P346, DOI 10.1016/j.jconrel.2011.12.030; Crepaldi Domingues C, 2009, J MEMBRANE BIOL, V227, P39, DOI 10.1007/s00232-008-9142-4; de Araujo DR, 2008, J PHARM PHARMACOL, V60, P1449, DOI 10.1211/jpp/60.11.0005; DE PAULA E, 1995, BBA-BIOMEMBRANES, V1240, P25, DOI 10.1016/0005-2736(95)00155-6; de Paula E, 2012, EXPERT OPIN DRUG DEL, V9, P1505, DOI 10.1517/17425247.2012.738664; de Paula Eneida, 2010, Recent Pat Drug Deliv Formul, V4, P23; Epstein-Barash H, 2009, P NATL ACAD SCI USA, V106, P7125, DOI 10.1073/pnas.0900598106; Fraceto LF, 2005, BIOPHYS CHEM, V115, P11, DOI 10.1016/j.bpc.2004.12.003; Franz-Montan M, 2013, J LIPOSOME RES, V23, P54, DOI 10.3109/08982104.2012.742536; Ginosar Y, 2016, ANESTH ANALG, V122, P1673, DOI 10.1213/ANE.0000000000001217; da Silva CMG, 2016, J LIPOSOME RES, V26, P1, DOI 10.3109/08982104.2015.1022555; Grant GJ, 2004, ANESTHESIOLOGY, V101, P133, DOI 10.1097/00000542-200407000-00021; Grant GJ, 1997, ACTA ANAESTH SCAND, V41, P204, DOI 10.1111/j.1399-6576.1997.tb04666.x; Grant Stuart A, 2002, Best Pract Res Clin Anaesthesiol, V16, P345, DOI 10.1053/bean.2002.0242; Gubernator J, 2011, EXPERT OPIN DRUG DEL, V8, P565, DOI 10.1517/17425247.2011.566552; Howell BA, 2009, ANESTH ANALG, V109, P678, DOI 10.1213/ane.0b013e3181a8da61; Malheiros SVP, 2004, BIOPHYS CHEM, V110, P213, DOI 10.1016/j.bpc.2004.01.013; Martinov T, 2013, JOVE-J VIS EXP, DOI 10.3791/51212; Mendyk A, 2007, EXPERT SYST APPL, V32, P1124, DOI 10.1016/j.eswa.2006.02.019; Mohanraj V. J., 2006, Tropical Journal of Pharmaceutical Research, V5, P561; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mowat JJ, 1996, ANESTHESIOLOGY, V85, P635, DOI 10.1097/00000542-199609000-00024; Papadopoulou V, 2006, INT J PHARMACEUT, V309, P44, DOI 10.1016/j.ijpharm.2005.10.044; PLANAS ME, 1992, ANESTH ANALG, V75, P615; Ribeiro LNM, 2016, EUR J PHARM SCI, V93, P192, DOI 10.1016/j.ejps.2016.08.030; Cereda CMS, 2013, J LIPOSOME RES, V23, P228, DOI 10.3109/08982104.2013.796975; SCHREIER S, 1978, BIOCHIM BIOPHYS ACTA, V515, P375; Shen Y, 2011, DRUG DELIV, V18, P361, DOI 10.3109/10717544.2011.557788; Tu S, 2010, J PHARM SCI-US, V99, P2672, DOI 10.1002/jps.22017; Wei YM, 2014, INT J NANOMED, V9, P3623, DOI 10.2147/IJN.S66312; Weiniger CF, 2010, EXPERT OPIN DRUG DEL, V7, P737, DOI 10.1517/17425241003767383; Wiles MD, 2010, ANAESTHESIA, V65, P22, DOI 10.1111/j.1365-2044.2009.06201.x; Zhang XK, 2009, J DRUG TARGET, V17, P399, DOI 10.1080/10611860902795407; Zucker D, 2009, J CONTROL RELEASE, V139, P73, DOI 10.1016/j.jconrel.2009.05.036	41	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185828	10.1371/journal.pone.0185828	http://dx.doi.org/10.1371/journal.pone.0185828			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982145	gold, Green Published, Green Submitted			2022-12-26	WOS:000412360300072
J	Iotzova-Weiss, G; Freiberger, SN; Johansen, P; Kamarachev, J; Guenova, E; Dziunycz, PJ; Roux, GA; Neu, J; Hofbauer, GFL				Iotzova-Weiss, Guergana; Freiberger, Sandra N.; Johansen, Pal; Kamarachev, Jivko; Guenova, Emmanuella; Dziunycz, Piotr J.; Roux, Guillaume A.; Neu, Johannes; Hofbauer, Gunther F. L.			TLR4 as a negative regulator of keratinocyte proliferation	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; H-CADHERIN EXPRESSION; UP-REGULATION; DIFFERENTIAL EXPRESSION; INHIBITS EXPRESSION; ATOPIC-DERMATITIS; MELANOMA-CELLS; TISSUE FACTOR; T-CADHERIN; SKIN	TLR4 is an innate immune receptor with expression in human skin, keratinocytes as well as squamous cell carcinoma (SCC) of the skin. In the present study we investigate the role of TLR4 as a negative regulator of keratinocyte proliferation. We present here that the expression of TLR4 increased with the differentiation of cultured keratinocytes in a passage-dependent manner or under calcium-rich conditions. Moreover, the down-regulation of TLR4 by specific knockdown increased the proliferation of HaCaT keratinocytes in vitro. In addition, subcutaneously injected HaCaT keratinocytes with shTLR4 formed growing tumors in nude mice. In contrast, we observed lower proliferation and increased migration in vitro of the SCC13 cell line stably overexpressing TLR4 in comparison to SCC13 TLR4 negative cells. In vivo, SCC13 TLR4-overexpressing tumors showed delayed growth in comparison to TLR4 negative tumors. The overexpression of TLR4 in SCC13 tumor cells was followed by phosphorylation of ERK1/2 and JNK and increased expression of ATF3. In gene expression arrays, the overexpression of TLR4 in tumor cells correlated with gene expression of ATF-3, IL-6, CDH13, CXCL-1 and TFPI. In summary, TLR4 negatively regulates the proliferation of keratinocytes and its overexpression reduces tumor growth of SCC cells.	[Iotzova-Weiss, Guergana; Freiberger, Sandra N.; Johansen, Pal; Kamarachev, Jivko; Guenova, Emmanuella; Dziunycz, Piotr J.; Roux, Guillaume A.; Neu, Johannes; Hofbauer, Gunther F. L.] Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland	University of Zurich; University Zurich Hospital	Iotzova-Weiss, G (corresponding author), Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland.	geri.weiss@web.de	Freiberger, Sandra/AAT-5527-2020; Hofbauer, Gunther/B-2671-2010; Guenova, Emmanuella/G-7441-2017	Hofbauer, Gunther/0000-0003-0542-7989; Johansen, Pal/0000-0002-5055-6299; Guenova, Emmanuella/0000-0001-5478-8735	Swiss National Fund [135766]	Swiss National Fund(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Fund, Grant Number 135766 (http://p3.snf.ch/Project-135766).	Almeida S, 2011, J INVEST DERMATOL, V131, P349, DOI 10.1038/jid.2010.329; Baker BS, 2003, BRIT J DERMATOL, V148, P670, DOI 10.1046/j.1365-2133.2003.05287.x; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Barbieri CE, 2006, EXP CELL RES, V312, P695, DOI 10.1016/j.yexcr.2005.11.028; Begon E, 2007, EUR J DERMATOL, V17, P497; Brooks YS, 2014, J CLIN INVEST, V124, P2260, DOI 10.1172/JCI72718; Calton CM, 2013, CELL MICROBIOL, V15, P1837, DOI 10.1111/cmi.12153; Chen L, 2013, J INVEST DERMATOL, V133, P258, DOI 10.1038/jid.2012.267; Choi SR, 2014, EXP DERMATOL, V23, P718, DOI 10.1111/exd.12515; de la Garza G, 2013, J INVEST DERMATOL, V133, P68, DOI 10.1038/jid.2012.269; de Oliveira CB, 2015, REV INST MED TROP SP, V57, P57, DOI 10.1590/S0036-46652015000100008; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Dotto GP, 2011, CANCER RES, V71, P2029, DOI 10.1158/0008-5472.CAN-10-3750; Dziunycz PJ, 2014, J INVEST DERMATOL, V134, P1998, DOI 10.1038/jid.2014.77; Guenova E, 2015, P NATL ACAD SCI USA, V112, P2163, DOI 10.1073/pnas.1416922112; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Ilmarinen T, 2014, OTOLARYNGOL HEAD NEC; Ivanov VN, 2011, J CELL BIOCHEM, V112, P463, DOI 10.1002/jcb.22934; Kageshita T, 2002, PIGM CELL RES, V15, P212, DOI 10.1034/j.1600-0749.2002.01081.x; Kalinin A, 2001, J CELL SCI, V114, P3069; Kolar M, 2012, BIOL CELL, V104, P738, DOI 10.1111/boc.201200018; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Kuphal S, 2009, PIGM CELL MELANOMA R, V22, P296, DOI 10.1111/j.1755-148X.2009.00568.x; Kypriotou M, 2012, EXP DERMATOL, V21, P643, DOI 10.1111/j.1600-0625.2012.01472.x; Lai YH, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0237-7; Lambertini C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010369; Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530; Lefort K, 2004, SEMIN CANCER BIOL, V14, P374, DOI 10.1016/j.semcancer.2004.04.017; Lim X, 2013, WNT SIGNALING SKIN D, V5; Loryman C, 2008, WOUND REPAIR REGEN, V16, P45, DOI 10.1111/j.1524-475X.2007.00290.x; Massi D, 2012, ADV EXP MED BIOL, V727, P131, DOI 10.1007/978-1-4614-0899-4_10; Mittal D, 2010, EMBO J, V29, P2242, DOI 10.1038/emboj.2010.94; Muehleisen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040754; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Okuyama R, 2008, J DERMATOL SCI, V49, P187, DOI 10.1016/j.jdermsci.2007.05.017; Panzer R, 2014, EXP DERMATOL, V23, P364, DOI 10.1111/exd.12383; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Pivarcsi A, 2005, CURR ALLERGY ASTHM R, V5, P284, DOI 10.1007/s11882-005-0068-y; Prasad NB, 2014, MODERN PATHOL, V27, P945, DOI 10.1038/modpathol.2013.217; Restivo G, 2011, EMBO J, V30, P4571, DOI 10.1038/emboj.2011.325; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Ruf W, 2003, PATHOPHYSIOL HAEMO T, V33, P28, DOI 10.1159/000073286; Ruf W, 2003, CANC RES, V63; Suga H, 2014, J DERMATOL SCI, V73, P117, DOI 10.1016/j.jdermsci.2013.10.009; Szczepanski MJ, 2009, CANCER RES, V69, P3105, DOI 10.1158/0008-5472.CAN-08-3838; Takazawa Y, 2014, TOHOKU J EXP MED, V234, P57, DOI 10.1620/tjem.234.57; Takeuchi T, 2002, MOL CARCINOGEN, V35, P173, DOI 10.1002/mc.10088; Takeuchi T, 2002, LAB INVEST, V82, P1023, DOI 10.1097/01.LAB.0000025391.35798.F1; Takii R, 2010, J IMMUNOL, V184, P1041, DOI 10.4049/jimmunol.0902579; Toll A, 2013, J DERMATOL SCI, V72, P93, DOI 10.1016/j.jdermsci.2013.07.001; Weng H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-311; Widmer DS, 2013, J INVEST DERMATOL, V133, P2436, DOI 10.1038/jid.2013.115; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996; Yusuf N, 2008, CANCER RES, V68, P615, DOI 10.1158/0008-5472.CAN-07-5219	54	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185668	10.1371/journal.pone.0185668	http://dx.doi.org/10.1371/journal.pone.0185668			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982115	Green Published, gold, Green Accepted			2022-12-26	WOS:000412360300055
J	Nagaty, A; Abd El-Wahab, EW				Nagaty, Ahmed; Abd El-Wahab, Ekram W.			Real-life results of sofosbuvir based therapy in chronic hepatitis C-naive and -experienced patients in Egypt	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; GENOTYPE 4 PATIENTS; VIRUS-INFECTION; CHRONIC HCV; COMBINATION THERAPY; PLUS RIBAVIRIN; INTERFERON THERAPY; INSULIN-RESISTANCE; LATE RELAPSE; PEGINTERFERON ALPHA-2A	Background More than ten million Egyptians are infected with HCV. Every one of them is going to infect about three to four persons every year. Treating those patients is a matter of national security. A dramatic improvement in hepatitis C virus (HCV) infection treatment was achieved in the last five years. A new era of direct-acting antivirals is now dawning in Egypt. Objective(s) We share in this report our clinical experience in treating chronic HCV Egyptian patients with Sofosbuvir based regimens to evaluate its safety and efficacy on real life practical ground. Methods A total of 205 chronic HCV patients (195 naive and 15 experienced) were enrolled in the study. Patient were treated with Sofosbuvir+Ribavirin 24 weeks as standard of care. Two interferon eligible patients were treated with PEG-INF+Sofosbuvir+Ribavirin for 12 weeks. The primary efficacy endpoint was the proportion of patients with sustained virologic response at 24 weeks after cessation of therapy. Results The overall response rate was 97.1%. Sustained virological response rate did not differ among treatment-naive patients and patients with previous history of IFN-based therapy. Portal hypertension, prediabetes, and lack of early virologic response were predictors of non response. No clinically significant treatment- emergent adverse effects were noted. No treatment discontinuation was encountered. Conclusion In the real-life setting, Sofosbuvir based regimens for 24 weeks has established an efficacious and well tolerated treatment in naive and experienced patients with chronic HCV genotype 4 infection; although shorter treatment durations may be possible. However, patient follow up should extent to at least 6 months post-treatment and verifying viral load on yearly basis is warranted to track any late relapse.	[Nagaty, Ahmed] Minist Hlth, Consultant Hepatol & Infect Dis, Alexandria, Egypt; [Abd El-Wahab, Ekram W.] Alexandria Univ, High Inst Publ Hlth, Trop Hlth Dept, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; Egyptian Knowledge Bank (EKB); Alexandria University	Abd El-Wahab, EW (corresponding author), Alexandria Univ, High Inst Publ Hlth, Trop Hlth Dept, Alexandria, Egypt.	ekramwassim@mail.com	El-Wahab, Ekram Abd/V-8831-2017	El-Wahab, Ekram Abd/0000-0003-4220-5859				Abd El-Wahab EW, 2015, J MED VIROL, V87, P428, DOI 10.1002/jmv.24092; Abd El-Wahab EW, 2014, IRAN J PUBLIC HEALTH, V43, P1510; Abdel-Ghaffar TY, 2015, WORLD J HEPATOL, V7, P2792, DOI 10.4254/wjh.v7.i28.2792; Akahoshi T, 2002, J GASTROEN HEPATOL, V17, P59, DOI 10.1046/j.1440-1746.2002.02667.x; Backus LI, 2015, ALIMENT PHARM THER, V42, P559, DOI 10.1111/apt.13300; Butt AA, 2016, LIVER INT; Cheng W, 2014, J HEPATOL, V60, pS449, DOI 10.1016/S0168-8278(14)61272-1; Cholongitas E, 2014, ANN GASTROENTEROL, V27, P331; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; Desbois AC, 2017, WORLD J GASTROENTERO, V23, P1697, DOI 10.3748/wjg.v23.i9.1697; Doss W, 2015, J HEPATOL, V63, P581, DOI 10.1016/j.jhep.2015.04.023; El Raziky M, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.10069; El Sayed Nasr, 2012, Morbidity and Mortality Weekly Report, V61, P545; El-Akel W, 2017, J VIRAL HEPATITIS, V24, P262, DOI 10.1111/jvh.12668; El-Ghitany EM, 2015, LIVER INT, V35, P489, DOI 10.1111/liv.12617; El-Zanaty F, 2015, EGYPT HLTH ISSUE SUR; Elgharably A, 2017, INT J GEN MED, V10, P1, DOI 10.2147/IJGM.S119301; Elsharkawy A, 2017, ALIMENT PHARM THER, V45, P681, DOI 10.1111/apt.13923; Esmat G., 2012, Current Hepatitis Reports, V11, P250, DOI 10.1007/s11901-012-0146-2; European Ass Study Liver, 2017, J HEPATOL, V66, P153, DOI 10.1016/j.jhep.2016.09.001; Feng B, 2014, WORLD J GASTROENTERO, V20, P15387, DOI 10.3748/wjg.v20.i41.15387; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; George SL, 2009, HEPATOLOGY, V49, P729, DOI 10.1002/hep.22694; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Guerra J, 2012, J VIRAL HEPATITIS, V19, P560, DOI 10.1111/j.1365-2893.2011.01576.x; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hsu CS, 2013, NEW ENGL J MED, V369, P678, DOI 10.1056/NEJMc1307641; Inagaki Y, 2014, MOL MED REP, V9, P487, DOI 10.3892/mmr.2013.1856; Ioannou GN, 2016, GASTROENTEROLOGY, V151, P457, DOI 10.1053/j.gastro.2016.05.049; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Ji FP, 2013, BRAZ J INFECT DIS, V17, P601, DOI 10.1016/j.bjid.2013.02.004; Kamal SM, 2000, J HEPATOL, V32, P172, DOI 10.1016/S0168-8278(00)80207-X; Kedia S, 2012, ANN HEPATOL, V11, P921, DOI 10.1016/S1665-2681(19)31419-X; Khattab M, 2010, LIVER INT, V30, P447, DOI 10.1111/j.1478-3231.2009.02171.x; Khattab MA, 2011, J HEPATOL, V54, P1250, DOI 10.1016/j.jhep.2010.11.016; Klag T, 2017, J HEPATOL, V66, P862, DOI 10.1016/j.jhep.2017.01.002; Koff RS, 2014, ALIMENT PHARM THER, V39, P478, DOI 10.1111/apt.12601; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kowdley KV, 2013, LANCET, V381, P2100, DOI 10.1016/S0140-6736(13)60247-0; Kramer JR, 2012, J HEPATOL, V56, P320, DOI 10.1016/j.jhep.2011.05.032; Lalezari JP, 2013, J HEPATOL INT, V58; Lawitz E, 2013, LANCET INFECT DIS, V13, P401, DOI 10.1016/S1473-3099(13)70033-1; Mangia A, 2014, DIGEST LIVER DIS, V46, pS179, DOI 10.1016/j.dld.2014.09.026; Maylin S, 2008, GASTROENTEROLOGY, V135, P821, DOI 10.1053/j.gastro.2008.05.044; Morihara D, 2009, HEPATOL RES, V39, P439, DOI 10.1111/j.1872-034X.2008.00481.x; Morimoto H, 2014, TRANSPL P, V46, P770, DOI 10.1016/j.transproceed.2013.12.034; Morisco F, 2013, WORLD J GASTROENTERO, V19, P2793, DOI 10.3748/wjg.v19.i18.2793; Murata K, 2008, HEPATO-GASTROENTEROL, V55, P1407; Parana R, 2001, HEPATOLOGY, V33, P1340, DOI 10.1053/jhep.2001.24451; Pearlman BL, 2011, CLIN INFECT DIS, V52, P889, DOI 10.1093/cid/cir076; Poordad F, 2012, GASTROENTEROLOGY, V143, P608, DOI 10.1053/j.gastro.2012.05.011; Ray SC, 2000, J INFECT DIS, V182, P698, DOI 10.1086/315786; Romero-Gomez M, 2006, WORLD J GASTROENTERO, V12, P7075, DOI 10.3748/wjg.v12.i44.7075; Ruane PJ, 2015, J HEPATOL, V62, P1040, DOI 10.1016/j.jhep.2014.10.044; Sarrazin C, 2017, CLIN INFECT DIS, V64, P44, DOI 10.1093/cid/ciw676; Serfaty L, 2015, LIVER INT, V35, P18, DOI 10.1111/liv.12722; Simmons B, 2016, CLIN INFECT DIS, V62, P683, DOI 10.1093/cid/civ948; Steinebrunner N, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0328-9; Sterling RK, 2015, ALIMENT PHARM THER, V41, P671, DOI 10.1111/apt.13095; Tamai H, 2015, HEPATOL INT, V9, P67, DOI 10.1007/s12072-014-9586-9; Vallet-Pichard A, 2006, HEPATOLOGY, V44, P769, DOI 10.1002/hep.21334; World Health Organization, 2016, GUID SCREEN CAR TREA; Zeuzem S, 2015, ALIMENT PHARM THER, V42, P829, DOI 10.1111/apt.13342	64	12	12	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184654	10.1371/journal.pone.0184654	http://dx.doi.org/10.1371/journal.pone.0184654			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981513	Green Submitted, gold, Green Published			2022-12-26	WOS:000412360300016
J	Wang, HH; Hung, SY; Chang, MY; Lee, YC; Lin, HF; Lin, TM; Yang, SP; Lin, HH; Yang, SC; Wang, JL				Wang, Hsi-Hao; Hung, Shih-Yuan; Chang, Min-Yu; Lee, Yi-Che; Lin, Hsiu-Fang; Lin, Tsun-Mei; Yang, Su-Pen; Lin, Hsi-Hsun; Yang, Su-Ching; Wang, Jiun-Ling			Bacterial colonization patterns in daily chlorhexidine care at the exit site in peritoneal dialysis patients-A prospective, randomized controlled trial	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; CATHETER-RELATED INFECTIONS; GRAM-NEGATIVE BACTERIA; METHICILLIN-RESISTANT; NASAL CARRIAGE; MUPIROCIN OINTMENT; LOCAL APPLICATION; PREVENTION; STRATEGIES; BIOCIDES	Bacterial colonization patterns in daily chlorhexidine care at the exit site in peritoneal dialysis (PD) patients were not known. We performed a prospective, randomized controlled trial enrolling 89 PD patients. After stratification by initial Staphylococcus aureus (SA) carrier status, patients were randomly assigned to receive daily 4% chlorhexidine care (intervention group) or normal saline (control group) at the exit site. Monthly, we cultured bacteria from the exit site and nasal swabs for 1 year. The SA colonization rates at exit site at 6 and 12 months were significantly lower in the intervention group than the control group (5.0% vs. 22.9%, p = 0.023 and 8.6% vs. 28.1%, p = 0.037 for 6 and 12 months, respectively). The Methicillin-resistant SA (MRSA) colonization rate at exit site at 6 months was similar (5.7% vs. 2.5%, p = 0.596) in control and intervention group, but significantly lower in the intervention group than the control group at exit site at 12months (0% vs. 12.5%, p = 0.047). The gram-negative bacilli (GNB) colonization rates were similar between the intervention and control groups at 6 and 12 months. Genotyping of all MRSA isolates showed ST (sequence type) 59 was the most predominant clone. In conclusion, chlorhexidine care at the exit site in PD patients may be a good strategy for SA and MRSA decolonization.	[Wang, Hsi-Hao; Hung, Shih-Yuan; Chang, Min-Yu; Lee, Yi-Che; Yang, Su-Pen; Lin, Hsi-Hsun] E DA Hosp, Internal Med Dept, Kaohsiung, Taiwan; [Wang, Hsi-Hao; Hung, Shih-Yuan; Chang, Min-Yu; Lee, Yi-Che; Yang, Su-Pen; Lin, Hsi-Hsun] I Shou Univ, Sch Med, Kaohsiung, Taiwan; [Lin, Hsiu-Fang; Lin, Tsun-Mei] I Shou Univ, E DA Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Yang, Su-Ching] Natl Tainan Inst Nursing, Dept Nursing, Tainan, Taiwan; [Wang, Jiun-Ling] Natl Cheng Kung Univ, Dept Internal Med, Tainan, Taiwan; [Wang, Jiun-Ling] Natl Cheng Kung Univ, Dept Med, Tainan, Taiwan	E-Da Hospital; I Shou University; E-Da Hospital; I Shou University; National Cheng Kung University; National Cheng Kung University	Wang, JL (corresponding author), Natl Cheng Kung Univ, Dept Internal Med, Tainan, Taiwan.; Wang, JL (corresponding author), Natl Cheng Kung Univ, Dept Med, Tainan, Taiwan.	jiunlingwang@gmail.com	Wang, 竣令王 Jiun-Ling/L-9627-2015	Wang, 竣令王 Jiun-Ling/0000-0002-9465-8692	E-DA Hospital [EDAHP99020]; Taiwan National Science Council [100-2314-B-214-005]	E-DA Hospital; Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the E-DA Hospital (No. EDAHP99020) and Taiwan National Science Council (No. 100-2314-B-214-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the E-DA Hospital (No. EDAHP99020) and Taiwan National Science Council (No. 100-2314-B-214-005). The authors declare that there are no conflicts of interest in this study. Some content of this study has been presented in the 7th International Congress. of the Asia Pacific Society of Infection Control.	Akoh Jacob A, 2012, World J Nephrol, V1, P106, DOI 10.5527/wjn.v1.i4.106; Al-Hwiesh AK, 2013, INT J ARTIF ORGANS, V36, P473, DOI 10.5301/ijao.5000207; Bernardini J, 1996, AM J KIDNEY DIS, V27, P695, DOI 10.1016/S0272-6386(96)90105-5; Bernardini J, 2005, J AM SOC NEPHROL, V16, P539, DOI 10.1681/ASN.2004090773; Campbell D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004679.pub3; Chu KH, 2008, PERITON DIALYSIS INT, V28, P505; Crawford S, 2014, REN SOC AUSTRALAS J, V10, P116; DAVIES SJ, 1989, PERITON DIALYSIS INT, V9, P61; Derde LPG, 2012, INTENS CARE MED, V38, P931, DOI 10.1007/s00134-012-2542-z; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; FUCHS J, 1990, DIALYSIS TRANSPLANT, V19, P81; Higgins CS, 2001, CLIN MICROBIOL INFEC, V7, P308, DOI 10.1046/j.1198-743x.2001.00253.x; Kang YC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-284; Lee SM, 2014, KIDNEY RES CLIN PRAC, V33, P144, DOI 10.1016/j.krcp.2014.05.030; LUZAR MA, 1990, NEW ENGL J MED, V322, P505, DOI 10.1056/NEJM199002223220804; McCormack K, 2007, HEALTH TECHNOL ASSES, V11, P1; McQuillan RF, 2012, CLIN J AM SOC NEPHRO, V7, P297, DOI 10.2215/CJN.07970811; Milstone AM, 2008, CLIN INFECT DIS, V46, P274, DOI 10.1086/524736; Mullany LC, 2008, PEDIATR INFECT DIS J, V27, P505, DOI 10.1097/INF.0b013e31816791a2; Mullany LC, 2012, PEDIATR INFECT DIS J, V31, P444, DOI 10.1097/INF.0b013e3182468ff0; Piraino B, 2005, PERITON DIALYSIS INT, V25, P107; Piraino B, 2000, ASAIO J, V46, pS13, DOI 10.1097/00002480-200011000-00031; Piraino B, 2011, PERITON DIALYSIS INT, V31, P614, DOI 10.3747/pdi.2011.00057; Ques AAM, 2013, JBI DATABASE SYSTEMA, V11, P133; Ritzau J, 2001, PERITON DIALYSIS INT, V21, P471; Rosenblum A, 2014, AM J KIDNEY DIS, V63, P259, DOI 10.1053/j.ajkd.2013.08.019; Safdar N, 2014, CRIT CARE MED, V42, P1703, DOI 10.1097/CCM.0000000000000319; Sandri AM, 2006, INFECT CONT HOSP EP, V27, P185, DOI 10.1086/500625; Schaefer F, 1999, J AM SOC NEPHROL, V10, P136; Smith K, 2008, J MED MICROBIOL, V57, P966, DOI 10.1099/jmm.0.47668-0; STICKLER DJ, 1987, J HOSP INFECT, V10, P28, DOI 10.1016/0195-6701(87)90029-6; Stickler DJ, 2002, J APPL MICROBIOL, V92, p163S, DOI 10.1046/j.1365-2672.92.5s1.6.x; Szeto CC, 2007, CLIN J AM SOC NEPHRO, V2, P245, DOI 10.2215/CJN.03180906; Thodis E, 1998, PERITON DIALYSIS INT, V18, P261; Thomas L, 2000, J HOSP INFECT, V46, P297, DOI 10.1053/jhin.2000.0851; Uttley L, 2004, J NEPHROL, V17, P242; Vychytil A, 1998, J AM SOC NEPHROL, V9, P669; Wang JL, 2008, CLIN INFECT DIS, V46, P799, DOI 10.1086/527389; Wanten GJA, 1996, PERITON DIALYSIS INT, V16, P352; WONG FS-Y, 2002, HONG KONG J NEPHROL, V4, p54 ~ 9	40	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184859	10.1371/journal.pone.0184859	http://dx.doi.org/10.1371/journal.pone.0184859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981543	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300021
J	Holm, KL; Syljuasen, RG; Hasvold, G; Alsoe, L; Nilsen, H; Ivanauskiene, K; Collas, P; Shaposhnikov, S; Collins, A; Indrevaer, RL; Aukrust, P; Fevang, B; Blomhoff, HK				Holm, Kristine Lillebo; Syljuasen, Randi Gussgard; Hasvold, Grete; Alsoe, Lene; Nilsen, Hilde; Ivanauskiene, Kristina; Collas, Philippe; Shaposhnikov, Sergey; Collins, Andrew; Indrevaer, Randi Larsen; Aukrust, Pal; Fevang, Borre; Blomhoff, Heidi Kiil			TLR9 stimulation of B-cells induces transcription of p53 and prevents spontaneous and irradiation-induced cell death independent of DNA damage responses. Implications for Common variable immunodeficiency	PLOS ONE			English	Article							RETINOIC ACID; H2AX PHOSPHORYLATION; HISTONE H2AX; COMET ASSAY; RADIATION; REPAIR; GAMMA-H2AX; PROTOONCOGENES; LYMPHOCYTES; DEFICIENCY	In the present study, we address the important issue of whether B-cells protected from irradiation-induced cell death, may survive with elevated levels of DNA damage. If so, such cells would be at higher risk of gaining mutations and undergoing malignant transformation. We show that stimulation of B-cells with the TLR9 ligands CpG-oligodeoxynucleotides (CpG-ODN) prevents spontaneous and irradiation-induced death of normal peripheral blood B-cells, and of B-cells from patients diagnosed with Common variable immunodeficiency (CVID). The TLR9-mediated survival is enhanced by the vitamin A metabolite retinoic acid (RA). Importantly, neither stimulation of B-cells via TLR9 alone or with RA increases irradiation-induced DNA strand breaks and DNA damage responses such as activation of ATM and DNA-PKcs. We prove that elevated levels of gamma H2AX imposed by irradiation of stimulated B-cells is not due to induction of DNA double strand breaks, but merely reflects increased levels of total H2AX upon stimulation. Interestingly however, we unexpectedly find that TLR9 stimulation of B-cells induces low amounts of inactive p53, explained by transcriptional induction of TP53. Taken together, we show that enhanced survival of irradiated B-cells is not accompanied by elevated levels of DNA damage. Our results imply that TLR9-mediated activation of B-cells not only promotes cell survival, but may via p53 provide cells with a barrier against harmful consequences of enhanced activation and proliferation. As CVID-derived B-cells are more radiosensitive and prone to undergo apoptosis than normal B-cells, our data support treatment of CVID patients with CpG-ODN and RA.	[Holm, Kristine Lillebo; Ivanauskiene, Kristina; Collas, Philippe; Indrevaer, Randi Larsen; Blomhoff, Heidi Kiil] Univ Oslo, Inst Basic Med Sci, Dept Mol Med, Oslo, Norway; [Syljuasen, Randi Gussgard; Hasvold, Grete] Oslo Univ Hosp, Inst Canc Res, Dept Radiat Biol, Radiumhosp, Oslo, Norway; [Alsoe, Lene; Nilsen, Hilde] Univ Oslo, Dept Clin Mol Biol, Lorenskog, Norway; [Alsoe, Lene; Nilsen, Hilde] Akershus Univ Hosp, Lorenskog, Norway; [Shaposhnikov, Sergey; Collins, Andrew] Norgenotech AS, Comet Biotech AS, Oslo, Norway; [Shaposhnikov, Sergey; Collins, Andrew] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Aukrust, Pal; Fevang, Borre] Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, Rikshosp, Oslo, Norway; [Aukrust, Pal; Fevang, Borre] Oslo Univ Hosp, Res Inst Internal Med, Rikshosp, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Blomhoff, HK (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Mol Med, Oslo, Norway.	h.k.blomhoff@medisin.uio.no		Collins, Andrew/0000-0001-5916-6871; Shaposhnikov, Sergey/0000-0002-3957-703X	University of Oslo; Norwegian Cancer Society [420156]; Anders Jahre Foundation; Blix Family Foundation; Freia Foundation; Nansen Foundation; UNIFOR FRIMED Legacy	University of Oslo; Norwegian Cancer Society(Norwegian Cancer Society); Anders Jahre Foundation; Blix Family Foundation; Freia Foundation; Nansen Foundation; UNIFOR FRIMED Legacy	This work has been supported by the University of Oslo (vow; up no), the Norwegian Cancer Society (grant number 420156, krefiforeningen.no), the Anders Jahre Foundation (www.unifor.no/Fund.aspx?site=1&fund=290), the Blix Family Foundation, the Freia Foundation, the Nansen Foundation (www.nansenfondet.no) and the UNIFOR FRIMED Legacy (www.unifor.no/fund.aspx?fund=310). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this work. Norgenotech & Comet Biotech financial involvement in the study: salary for SS and coverage of the reagents, materials, lab rent and technical assistance connected with carrying out the experiments (these actual costs of Norgenotech were covered by the University of Oslo with no commercial profit or overheads).	Aghamohammadi A, 2008, IMMUNOBIOLOGY, V213, P447, DOI 10.1016/j.imbio.2007.10.018; Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; AUKRUST P, 1994, CLIN EXP IMMUNOL, V97, P232; AUKRUST P, 1995, BLOOD, V86, P1383, DOI 10.1182/blood.V86.4.1383.bloodjournal8641383; Aukrust P, 2000, EUR J CLIN INVEST, V30, P252, DOI 10.1046/j.1365-2362.2000.00619.x; Azqueta A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00288; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chen MC, 2014, BIOMEDICINE-TAIWAN, V4, DOI 10.7603/s40681-014-0022-1; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Clemente A, 2013, CLIN EXP IMMUNOL, V174, P97, DOI 10.1111/cei.12150; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Cunningham-Rundles C, 2006, J IMMUNOL, V176, P1978, DOI 10.4049/jimmunol.176.3.1978; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Goldstein M, 2015, ANNU REV MED, V66, P129, DOI 10.1146/annurev-med-081313-121208; Grossman SA, 2015, J NATL COMPR CANC NE, V13, P1225, DOI 10.6004/jnccn.2015.0151; Heylmann D, 2014, BBA-REV CANCER, V1846, P121, DOI 10.1016/j.bbcan.2014.04.009; Holm KL, 2016, IMMUNOLOGY, V149, P62, DOI 10.1111/imm.12629; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Indrevaer RL, 2015, J IMMUNOL, V195, P2601, DOI 10.4049/jimmunol.1500250; Indrevaer RL, 2013, J IMMUNOL, V191, P3624, DOI 10.4049/jimmunol.1300213; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jirapongsananuruk O, 1999, CLIN EXP IMMUNOL, V118, P1; Kamran SC, 2016, CANCER-AM CANCER SOC, V122, P1809, DOI 10.1002/cncr.29841; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kilic SS, 2005, J CLIN IMMUNOL, V25, P275, DOI 10.1007/s10875-005-4090-6; Kracikova M, 2013, CELL DEATH DIFFER, V20, P576, DOI 10.1038/cdd.2012.155; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kumar Y, 2013, EXPERT REV CLIN IMMU, V9, P959, DOI 10.1586/1744666X.2013.836967; Kuo LJ, 2008, IN VIVO, V22, P305; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Loughery J, 2014, NUCLEIC ACIDS RES, V42, P7664, DOI 10.1093/nar/gku501; Marechal A., 2013, COLD SPRING HARB PER, V5; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Qin M, 2014, IMMUNOPHARM IMMUNOT, V36, P251, DOI 10.3109/08923973.2013.861481; REED JC, 1986, P NATL ACAD SCI USA, V83, P3982, DOI 10.1073/pnas.83.11.3982; Resnick ES, 2012, BLOOD, V119, P1650, DOI 10.1182/blood-2011-09-377945; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; SAXON A, 1995, CLIN EXP IMMUNOL, V102, P17; SMELAND EB, 1988, EUR J IMMUNOL, V18, P1847, DOI 10.1002/eji.1830181131; Tanaka T, 2007, CYTOM PART A, V71A, P648, DOI 10.1002/cyto.a.20426; Tkacz-Stachowska K, 2011, RADIOTHER ONCOL, V101, P24, DOI 10.1016/j.radonc.2011.05.060; Tu WZ, 2013, FEBS LETT, V587, P3437, DOI 10.1016/j.febslet.2013.08.028; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Yazdani R, 2016, MOL IMMUNOL, V71, P1, DOI 10.1016/j.molimm.2015.12.016; Yu JE, 2009, J ALLERGY CLIN IMMUN, V124, P349, DOI 10.1016/j.jaci.2009.05.019; Yuan JS, 2010, FEBS LETT, V584, P3717, DOI 10.1016/j.febslet.2010.05.021	52	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185708	10.1371/journal.pone.0185708	http://dx.doi.org/10.1371/journal.pone.0185708			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973009	Green Published, Green Submitted, gold			2022-12-26	WOS:000412131900038
J	Mitic, S; Strampraad, MJF; Hagen, WR; de Vries, S				Mitic, Sandra; Strampraad, Marc J. F.; Hagen, Wilfred R.; de Vries, Simon			Microsecond time-scale kinetics of transient biochemical reactions	PLOS ONE			English	Article								To afford mechanistic studies in enzyme kinetics and protein folding in the microsecond time domain we have developed a continuous-flow microsecond time-scale mixing instrument with an unprecedented dead-time of 3.8 +/- 0.3 mu s. The instrument employs a micromixer with a mixing time of 2.7 mu s integrated with a 30 mm long flow-cell of 109 nm optical path length constructed from two parallel sheets of silver foil; it produces ultraviolet-visible spectra that are linear in absorbance up to 3.5 with a spectral resolution of 0.4 nm. Each spectrum corresponds to a different reaction time determined by the distance from the mixer outlet, and by the fluid flow rate. The reaction progress is monitored in steps of 0.35 mu s for a total duration of similar to 600 mu s. As a proof of principle the instrument was used to study spontaneous protein refolding of pH-denatured cytochrome c. Three folding intermediates were determined: after a novel, extremely rapid initial phase with tau = 4.7 mu s, presumably reflecting histidine re-binding to the iron, refolding proceeds with time constants of 83 mu s and 345 mu s to a coordinatively saturated low-spin iron form in quasi steady state. The time-resolution specifications of our spectrometer for the first time open up the general possibility for comparison of real data and molecular dynamics calculations of biomacromolecules on overlapping time scales.	[Mitic, Sandra; Strampraad, Marc J. F.; Hagen, Wilfred R.; de Vries, Simon] Delft Univ Technol, Dept Biotechnol, Delft, Netherlands	Delft University of Technology	Hagen, WR (corresponding author), Delft Univ Technol, Dept Biotechnol, Delft, Netherlands.	w.r.hagen@tudelft.nl	Hagen, Wilfred R./H-8918-2017	Hagen, Wilfred R./0000-0002-1609-6671	NanoNed, the nanotechnology research and development initiative of Dutch government [TAC.6380]	NanoNed, the nanotechnology research and development initiative of Dutch government	This work was supported by NanoNed, the nanotechnology research and development initiative of Dutch government via a grant to S. de Vries (project TAC.6380). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila K, 2011, SCIENCE, V333, P192, DOI 10.1126/science.1203223; BABUL J, 1972, BIOCHEMISTRY-US, V11, P1195, DOI 10.1021/bi00757a013; Brand K. G., 1996, J BIOL CHEM, V241, P4180; Cherepanov AV, 2004, BBA-BIOENERGETICS, V1656, P1, DOI 10.1016/j.bbabio.2004.02.006; Evans MR, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3263913; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Malinowski E. R., 1980, FACTOR ANAL CHEM; MARGOLIASH E., 1966, ADVANCE PROTEIN CHEM, V21, P113, DOI 10.1016/S0065-3233(08)60128-X; Mitic S, 2011, COMPREHENSIVE BIOPHYSICS, VOL 1: BIOPHYSICAL TECHNIQUES FOR STRUCTURAL CHARACTERIZATION OF MACROMOLECULES, P514, DOI 10.1016/B978-0-12-374920-8.00127-2; Mitic S, 2015, ANAL BIOCHEM, V469, P19, DOI 10.1016/j.ab.2014.10.003; Post CB, 2017, CURR OPIN STRUC BIOL, V43, pIV, DOI 10.1016/j.sbi.2017.04.008; Roder H, 2006, CHEM REV, V106, P1836, DOI 10.1021/cr040430y; ROSENBERG RC, 1976, J AM CHEM SOC, V98, P6364, DOI 10.1021/ja00436a049; Shastry MCR, 1998, BIOPHYS J, V74, P2714, DOI 10.1016/S0006-3495(98)77977-9; Shastry MCR, 1998, NAT STRUCT BIOL, V5, P385, DOI 10.1038/nsb0598-385; Spry DB, 2007, J PHYS CHEM A, V111, P230, DOI 10.1021/jp066041k; Takahashi S, 1997, NAT STRUCT BIOL, V4, P44, DOI 10.1038/nsb0197-44; Yeh SR, 1997, NAT STRUCT BIOL, V4, P51, DOI 10.1038/nsb0197-51; Yeh SR, 1998, ACCOUNTS CHEM RES, V31, P727, DOI 10.1021/ar970084p; Yeh SR, 1998, NAT STRUCT BIOL, V5, P222, DOI 10.1038/nsb0398-222	20	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185888	10.1371/journal.pone.0185888	http://dx.doi.org/10.1371/journal.pone.0185888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973014	Green Published, Green Submitted, gold			2022-12-26	WOS:000412131900064
J	Cappuccio, G; Pinelli, M; Alagia, M; Donti, T; Day-Salvatore, DL; Veggiotti, P; De Giorgis, V; Lunghi, S; Vari, MS; Striano, P; Brunetti-Pierri, N; Kennedy, AD; Elsea, SH				Cappuccio, Gerarda; Pinelli, Michele; Alagia, Marianna; Donti, Taraka; Day-Salvatore, Debra-Lynn; Veggiotti, Pierangelo; De Giorgis, Valentina; Lunghi, Simona; Vari, Maria Stella; Striano, Pasquale; Brunetti-Pierri, Nicola; Kennedy, Adam D.; Elsea, Sarah H.			Biochemical phenotyping unravels novel metabolic abnormalities and potential biomarkers associated with treatment of GLUT1 deficiency with ketogenic diet	PLOS ONE			English	Article							MUTATIONS; CARNITINE; EPILEPSY; CHILDREN; REVEALS	Global metabolomic profiling offers novel opportunities for the discovery of biomarkers and for the elucidation of pathogenic mechanisms that might lead to the development of novel therapies. GLUT1 deficiency syndrome (GLUT1-DS) is an inborn error of metabolism due to reduced function of glucose transporter type 1. Clinical presentation of GLUT1-DS is heterogeneous and the disorder mirrors patients with epilepsy, movement disorders, or any paroxysmal events or unexplained neurological manifestation triggered by exercise or fasting. The diagnostic biochemical hallmark of the disease is a reduced cerebrospinal fluid (CSF)/blood glucose ratio and the only available treatment is ketogenic diet. This study aimed at advancing our understanding of the biochemical perturbations in GLUT1-DS pathogenesis through biochemical phenotyping and the treatment of GLUT1-DS with a ketogenic diet. Metabolomic analysis of three CSF samples from GLUT1-DS patients not on ketogenic diet was feasible inasmuch as CSF sampling was used for diagnosis before to start with ketogenic diet. The analysis of plasma and urine samples obtained from GLUT1-DS patients treated with a ketogenic diet showed alterations in lipid and amino acid profiles. While subtle, these were consistent findings across the patients with GLUT1-DS on ketogenic diet, suggesting impacts on mitochondrial physiology. Moreover, low levels of free carnitine were present suggesting its consumption in GLUT1-DS on ketogenic diet. 3-hydroxybutyrate, 3-hydroxybutyrylcarnitine, 3-methyladipate, and N-acetylglycine were identified as potential biomarkers of GLUT1-DS on ketogenic diet. This is the first study to identify CSF, plasma, and urine metabolites associated with GLUT1-DS, as well as biochemical changes impacted by a ketogenic diet. Potential biomarkers and metabolic insights deserve further investigation.	[Cappuccio, Gerarda; Pinelli, Michele; Alagia, Marianna; Brunetti-Pierri, Nicola] Univ Naples Federico II, Sect Pediat, Dept Translat Med, Naples, Italy; [Cappuccio, Gerarda; Pinelli, Michele; Alagia, Marianna; Brunetti-Pierri, Nicola] Telethon Inst Genet & Med, Naples, Italy; [Cappuccio, Gerarda; Donti, Taraka; Elsea, Sarah H.] Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA; [Donti, Taraka] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Day-Salvatore, Debra-Lynn] St Peters Univ Hosp, Dept Med Genet & Genom Med, New Brunswick, NJ USA; [Veggiotti, Pierangelo; De Giorgis, Valentina; Lunghi, Simona] Fdn IRCCS C, Dept Brain & Behav Sci, Mondino, Italy; [Vari, Maria Stella; Striano, Pasquale] Univ Genoa, Gaslini Inst, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, G Gaslini Inst,Pediat Neurol & Muscular Dis Unit, Genoa, Italy; [Kennedy, Adam D.] Metabolon, Morrisville, NC USA	University of Naples Federico II; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Baylor College of Medicine; Greenwood Genetic Center; Saint Peter's University Hospital; University of Genoa; IRCCS Istituto Giannina Gaslini; Metabolon	Elsea, SH (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA.	Sarah.Elsea@bcm.edu	De Giorgis, Valentina/AAB-7643-2019; Striano, Pasquale/F-9117-2014; Vari, Maria Stella/AAJ-9154-2020; De Giorgis, Valentina/K-4730-2018; Cappuccio, Gerarda/W-3576-2018; Pinelli, Michele/A-1584-2010; Donti, Taraka/K-5648-2013; Brunetti-Pierri, Nicola/K-8465-2016	De Giorgis, Valentina/0000-0002-5828-7070; Striano, Pasquale/0000-0002-6065-1476; De Giorgis, Valentina/0000-0002-5828-7070; Cappuccio, Gerarda/0000-0003-3934-2342; Pinelli, Michele/0000-0002-5927-1185; Donti, Taraka/0000-0002-3830-155X; Elsea, Sarah/0000-0002-1400-8519; Brunetti-Pierri, Nicola/0000-0002-6895-8819				Amaral AI, 2013, J INHERIT METAB DIS, V36, P621, DOI 10.1007/s10545-012-9553-3; Atwal PS, 2015, MOL GENET METAB, V115, P91, DOI 10.1016/j.ymgme.2015.04.008; Berry-Kravis T, 2001, EPILEPSIA, V42, P1445; Bertoli S, 2015, NUTRITION, V31, P981, DOI 10.1016/j.nut.2015.02.017; Bough KJ, 2006, ANN NEUROL, V60, P223, DOI 10.1002/ana.20899; Burrage LC, 2016, J PEDIATR-US, V169, P208, DOI 10.1016/j.jpeds.2015.10.045; Dahlin M, 2007, EPILEPSY RES, V73, P199, DOI 10.1016/j.eplepsyres.2006.10.005; Dashti Hussein M, 2004, Exp Clin Cardiol, V9, P200; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Donti TR, 2016, MOL GENET METAB REP, V8, P61, DOI 10.1016/j.ymgmr.2016.07.007; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Evans M., 2014, METABOLOMICS, V4, P1, DOI DOI 10.4172/2153-0769.1000132; Guay C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077097; Haces ML, 2010, NEUROSCIENCE, V165, P28, DOI 10.1016/j.neuroscience.2009.10.003; Isaev NK, 2007, BIOCHEMISTRY-MOSCOW+, V72, P471, DOI 10.1134/S0006297907050021; Kennedy AD, 2016, GENET TEST MOL BIOMA, V20, P485, DOI 10.1089/gtmb.2015.0291; Klepper J, 2004, PROSTAG LEUKOTR ESS, V70, P321, DOI 10.1016/j.plefa.2003.07.004; Larsen J, 2015, EPILEPSIA, V56, pE203, DOI 10.1111/epi.13222; Leen WG, 2013, JAMA NEUROL, V70, P1440, DOI 10.1001/jamaneurol.2013.3090; Leen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042745; Makowski L, 2009, FASEB J, V23, P586, DOI 10.1096/fj.08-119420; Marin-Valencia I, 2012, NEUROBIOL DIS, V48, P92, DOI 10.1016/j.nbd.2012.04.011; Mescka CP, 2015, METAB BRAIN DIS, V30, P1167, DOI 10.1007/s11011-015-9686-9; Miller M, 2015, J INHERIT METAB DIS, P1; Miller MJ, 2016, J INHERIT METAB DIS, V39, P757, DOI 10.1007/s10545-016-9944-y; Mochel F, 2015, TRIHEPTANOIN DRAMATI, pS479; Mugabo Y, 2016, P NATL ACAD SCI USA, V113, pE430, DOI 10.1073/pnas.1514375113; Neal EG, 2012, EPILEPSY RES, V100, P267, DOI 10.1016/j.eplepsyres.2012.04.021; Nguyen NHT, 2003, J NEUROCHEM, V85, P831, DOI 10.1046/j.1471-4159.2003.01762.x; Roe CR, 2006, J INHERIT METAB DIS, V29, P332, DOI 10.1007/s10545-006-0290-3; Ruskin DN, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00033; Sato T, 2016, METABOLISM, V65, P1646, DOI 10.1016/j.metabol.2016.08.005; Soeters MR, 2012, METABOLISM, V61, P966, DOI 10.1016/j.metabol.2011.11.009; Striano P, 2012, NEUROLOGY, V78, P557, DOI 10.1212/WNL.0b013e318247ff54; Szczepanik E, 2014, DEV PERIOD MED, V19, P454; Veggiotti P, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0291-8; Verbeek MM, 2016, J CEREBR BLOOD F MET, V36, P899, DOI 10.1177/0271678X16637612; Yamada KA, 2005, NEUROSCI LETT, V385, P210, DOI 10.1016/j.neulet.2005.05.038; Yazdani A, 2016, OMICS, V20, P480, DOI 10.1089/omi.2016.0071; Yubero D, 2014, BMC PEDIATR, V14, DOI 10.1186/s12887-014-0284-5	40	18	18	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0184022	10.1371/journal.pone.0184022	http://dx.doi.org/10.1371/journal.pone.0184022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961260	Green Published, Green Submitted, gold			2022-12-26	WOS:000412027700003
J	Bechshoft, CL; Schjerling, P; Borno, A; Holm, L				Bechshoft, Cecilie Leidesdorff; Schjerling, Peter; Borno, Andreas; Holm, Lars			Existence of life-time stable proteins in mature rats-Dating of proteins' age by repeated short-term exposure to labeled amino acids throughout age	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; IN-VIVO; COLLAGEN-SYNTHESIS; CONNECTIVE-TISSUE; QUADRICEPS MUSCLE; TENDON; TURNOVER; EXERCISE; MICRODIALYSIS; MYOFIBRILLAR	In vivo turnover rates of proteins covering the processes of protein synthesis and breakdown rates have been measured in many tissues and protein pools using various techniques. Connective tissue and collagen protein turnover is of specific interest since existing results are rather diverging. The aim of this study is to investigate whether we can verify the presence of protein pools within the same tissue with very distinct turnover rates over the life-span of rats with special focus on connective tissue. Male and female Lewis rats (n = 35) were injected with five different isotopically labeled amino acids tracers. The tracers were injected during fetal development (Day - 10 to -2), after birth (Day 5-9), at weaning (Day 25- 32) at puberty (Day 54-58) and at adulthood (Day 447-445). Subgroups of rats were euthanized three days after every injection period, at different time point between injection periods and lastly at day 472. Tissue (liver, muscle, eye lens and patellar tendon) and blood samples were collected after euthanization. The enrichment of the labeled amino acids in the tissue or blood samples was measured using GC-MS-MS. In muscle and liver we demonstrated a rapid decrease of tracer enrichments throughout the rat's life, indicating that myofibrillar and cytoskeleton proteins have a high turnover. In contrast, the connective tissue protein in the eye lens and patellar tendon of the mature rat showed detainment of tracer enrichment injected during fetal development and first living days, indicating very slow turnover. The data support the hypothesis that some proteins synthesized during the early development and growth still exist much later in life of animals and hence has a very slow turnover rate.	[Bechshoft, Cecilie Leidesdorff; Schjerling, Peter; Holm, Lars] Univ Copenhagen, Inst Sports Med, Dept Orthoped Surg M, Bispebjerg Hosp, Copenhagen, Denmark; [Bechshoft, Cecilie Leidesdorff; Schjerling, Peter; Holm, Lars] Univ Copenhagen, Ctr Hlth Aging, Fac Hlth & Med Sci, Copenhagen, Denmark; [Borno, Andreas; Holm, Lars] Rigshosp, Dept Clin Biochem, Clin Metabol Core Facil, Copenhagen, Denmark; [Holm, Lars] Univ Copenhagen, Inst Biomed Sci, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Bechshoft, CL (corresponding author), Univ Copenhagen, Inst Sports Med, Dept Orthoped Surg M, Bispebjerg Hosp, Copenhagen, Denmark.; Bechshoft, CL (corresponding author), Univ Copenhagen, Ctr Hlth Aging, Fac Hlth & Med Sci, Copenhagen, Denmark.	cjleidersdorff@gmail.com	Schjerling, Peter/F-6194-2011; Holm, Lars/AAI-1320-2020	Schjerling, Peter/0000-0001-7138-3211; 	Danish Research Council for Independent Research, Health and Disease [09-073587]; Lundbeck Foundation [R198-2015-207] Funding Source: researchfish; Novo Nordisk Fonden [NNF16OC0022846, NNF14OC0012491] Funding Source: researchfish	Danish Research Council for Independent Research, Health and Disease; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	Danish Research Council for Independent Research, Health and Disease, grant number: 09-073587 to Mr Lars Holm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Britt Tranberg and Ann-Marie Sedstrom for their technical assistance in the laboratory. We would also like to thank the animal facility (The Campus Stable, University of Copenhagen) for taking good care of the animals, answering theoretical questions and assisting with technical challenges. This work was supported by the Danish Research Council for Independent Research, Health and Disease 09-073587.	Alkass K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069597; Babraj J, 2002, BIOCHEM SOC T, V30, P61, DOI 10.1042/bst0300061; Bohe J, 2001, J PHYSIOL-LONDON, V532, P575, DOI 10.1111/j.1469-7793.2001.0575f.x; de Boer MD, 2007, J PHYSIOL-LONDON, V585, P241, DOI 10.1113/jphysiol.2007.142828; Decaris ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123311; Decaris ML, 2014, MOL CELL PROTEOMICS, V13, P1741, DOI 10.1074/mcp.M113.037267; Dideriksen KJ, 2011, SCAND J MED SCI SPOR, V21, pE372, DOI 10.1111/j.1600-0838.2011.01318.x; GARLICK PJ, 1973, BIOCHEM J, V136, P935, DOI 10.1042/bj1360935; Hanada M, 2014, CONNECT TISSUE RES, V55, P378, DOI 10.3109/03008207.2014.957283; Hansen M, 2009, J APPL PHYSIOL, V106, P1435, DOI 10.1152/japplphysiol.90933.2008; Hansen M, 2009, J APPL PHYSIOL, V106, P1385, DOI 10.1152/japplphysiol.90935.2008; Hart W, 1976, CLIN NEPHROLPGY, V6; Heinemeier KM, 2013, FASEB J, V27, P2074, DOI 10.1096/fj.12-225599; HELFMAN PM, 1976, NATURE, V262, P279, DOI 10.1038/262279b0; Holm L, 2017, MUSCLE NERVE, V55, P128, DOI 10.1002/mus.25398; Holm L, 2013, AM J PHYSIOL-ENDOC M, V304, pE895, DOI 10.1152/ajpendo.00579.2012; Holm L, 2010, AM J PHYSIOL-ENDOC M, V298, pE257, DOI 10.1152/ajpendo.00609.2009; Langberg H, 1999, J PHYSIOL-LONDON, V521, P299, DOI 10.1111/j.1469-7793.1999.00299.x; LEWIS SEM, 1984, BIOCHEM J, V217, P517, DOI 10.1042/bj2170517; LIBBY WF, 1964, SCIENCE, V146, P1171; Lynnerup N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001529; Miller BF, 2011, SCAND J MED SCI SPOR, V21, pE1, DOI 10.1111/j.1600-0838.2010.01105.x; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; MOLNAR JA, 1986, BIOCHEM J, V240, P431, DOI 10.1042/bj2400431; Moore DR, 2005, AM J PHYSIOL-ENDOC M, V288, pE1153, DOI 10.1152/ajpendo.00387.2004; MOSONI L, 1993, MECH AGEING DEV, V68, P209, DOI 10.1016/0047-6374(93)90152-H; NEUBERGER A, 1951, BIOCHEM J, V49, P199, DOI 10.1042/bj0490199; Nielsen RH, 1985, J APPL PHYSIOL, V116, P42, DOI DOI 10.1152/JAPPLPHYSI0L.01084.2013; Shinmei M, 1993, Osteoarthritis Cartilage, V1, P121, DOI 10.1016/S1063-4584(05)80027-5; Thorpe CT, 2010, J BIOL CHEM, V285, P15674, DOI 10.1074/jbc.M109.077503; Toffolo G, 2003, AM J PHYSIOL-ENDOC M, V285, pE1142, DOI 10.1152/ajpendo.00106.2003; Weiss PH, 1969, J CLIN INVEST, P48	32	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185605	10.1371/journal.pone.0185605	http://dx.doi.org/10.1371/journal.pone.0185605			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957442	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200092
J	Chua, NK; Howe, V; Jatana, N; Thukral, L; Brown, AJ				Chua, Ngee Kiat; Howe, Vicky; Jatana, Nidhi; Thukral, Lipi; Brown, Andrew J.			A conserved degron containing an amphipathic helix regulates the cholesterol-mediated turnover of human squalene monooxygenase, a rate-limiting enzyme in cholesterol synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; cholesterol regulation; endoplasmic reticulum (ER); membrane protein; protein degradation; degron; squalene monooxygenase	UBIQUITIN-PROTEASOME SYSTEM; NUCLEAR-QUALITY CONTROL; ENDOPLASMIC-RETICULUM; WEB SERVER; HEDGEHOG ACYLTRANSFERASE; DEGRADATION SIGNALS; DISORDERED REGION; FORCE-FIELD; PROTEIN; MEMBRANE	Cholesterol biosynthesis in the endoplasmic reticulum (ER) is tightly controlled by multiple mechanisms to regulate cellular cholesterol levels. Squalene monooxygenase (SM) is the second rate-limiting enzyme in cholesterol biosynthesis and is regulated both transcriptionally and post-translationally. SM undergoes cholesterol-dependent proteasomal degradation when cholesterol is in excess. The first 100 amino acids of SM (designated SM N100) are necessary for this degradative process and represent the shortest cholesterol-regulated degron identified to date. However, the fundamental intrinsic characteristics of this degron remain unknown. In this study, we performed a series of deletions, point mutations, and domain swaps to identify a 12-residue region (residues Gln-62-Leu-73), required for SM cholesterol-mediated turnover. Molecular dynamics and circular dichroism revealed an amphipathic helix within this 12-residue region. Moreover, 70% of the variation in cholesterol regulation was dependent on the hydrophobicity of this region. Of note, the earliest known Doa10 yeast degron, Deg1, also contains an amphipathic helix and exhibits 42% amino acid similarity with SM N100. Mutating SM residues Phe-35/Ser-37/Leu-65/Ile-69 into alanine, based on the key residues in Deg1, blunted SM cholesterol-mediated turnover. Taken together, our results support a model whereby the amphipathic helix in SM N100 attaches reversibly to the ER membrane depending on cholesterol levels; with excess, the helix is ejected and unravels, exposing a hydrophobic patch, which then serves as a degradation signal. Our findings shed new light on the regulation of a key cholesterol synthesis enzyme, highlighting the conservation of critical degron features from yeast to humans.	[Chua, Ngee Kiat; Howe, Vicky; Brown, Andrew J.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Biol Sci Bldg D26, Sydney, NSW 2052, Australia; [Jatana, Nidhi; Thukral, Lipi] CSIR, Inst Genom & Integrat Biol, Mathura Rd, New Delhi 110020, India	University of New South Wales Sydney; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Brown, AJ (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Biol Sci Bldg D26, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au	Chua, Ngee Kiat/AAG-6793-2021	Chua, Ngee Kiat/0000-0003-2785-2767; Howe, Vicky/0000-0002-7319-0664	National Health and Medical Research Council [1060515]; Australian Research Council [DP170101178]; Department of Biotechnology, Government of India; DST-INSPIRE Faculty Grant [LSBM-45]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); DST-INSPIRE Faculty Grant	This work was supported in part by National Health and Medical Research Council Grant 1060515 and the Australian Research Council Grant DP170101178. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Department of Biotechnology, Government of India, Research associateship.; Supported by DST-INSPIRE Faculty Grant LSBM-45.	Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown DN, 2016, SCI REP-UK, V6, DOI 10.1038/srep19435; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Buchovecky CM, 2013, NAT GENET, V45, P1013, DOI 10.1038/ng.2714; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ding JZ, 2015, DIABETES, V64, P3464, DOI 10.2337/db14-1314; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Fishbain S, 2015, NAT STRUCT MOL BIOL, V22, P214, DOI 10.1038/nsmb.2958; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; Forman-Kay JD, 2013, STRUCTURE, V21, P1492, DOI 10.1016/j.str.2013.08.001; Fredrickson EK, 2011, MOL BIOL CELL, V22, P2384, DOI 10.1091/mbc.E11-03-0256; Furth N, 2011, MOL BIOL CELL, V22, P4726, DOI 10.1091/mbc.E11-05-0463; Garcia-Boronat M, 2008, NUCLEIC ACIDS RES, V36, pW35, DOI 10.1093/nar/gkn211; Garner, 1999, Genome Inform Ser Workshop Genome Inform, V10, P41; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Giang H, 2014, BIOPHYS J, V107, P2337, DOI 10.1016/j.bpj.2014.10.012; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Gilon T, 2000, MOL CELL BIOL, V20, P7214, DOI 10.1128/MCB.20.19.7214-7219.2000; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Guharoy M, 2016, J BIOL CHEM, V291, P6723, DOI 10.1074/jbc.R115.692665; Guharoy M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10239; Halbleib K, 2017, MOL CELL, V67, P673, DOI 10.1016/j.molcel.2017.06.012; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Howe V, 2015, J BIOL CHEM, V290, P27533, DOI 10.1074/jbc.M115.675181; HUBBARD SR, 1990, J MOL BIOL, V213, P215, DOI 10.1016/S0022-2836(05)80181-0; Hung WC, 2007, BIOPHYS J, V92, P3960, DOI 10.1529/biophysj.106.099234; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; Konitsiotis AD, 2015, J BIOL CHEM, V290, P3293, DOI 10.1074/jbc.M114.614578; Lamiable A, 2016, NUCLEIC ACIDS RES, V44, pW449, DOI 10.1093/nar/gkw329; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Matevossian A, 2015, J BIOL CHEM, V290, P2235, DOI 10.1074/jbc.M114.625764; Melo SP, 2011, J BIOL CHEM, V286, P36559, DOI 10.1074/jbc.M111.274258; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Sanchis J, 2008, APPL MICROBIOL BIOT, V81, P387, DOI 10.1007/s00253-008-1678-9; Smith N, 2016, J BIOL CHEM, V291, P12420, DOI 10.1074/jbc.M116.724930; Stevenson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083888; Stopsack KH, 2016, CANCER RES, V76, P4785, DOI 10.1158/0008-5472.CAN-16-0903; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tanaka H, 2016, FEBS J, V283, P662, DOI 10.1111/febs.13618; Taylor MS, 2013, J BIOL CHEM, V288, P32211, DOI 10.1074/jbc.M113.510313; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13; Zerenturk EJ, 2014, BIOSCIENCE REP, V34, P107, DOI 10.1042/BSR20130127; Zhang YX, 2013, J BIOL CHEM, V288, P14059, DOI 10.1074/jbc.M113.469528	66	35	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					19959	19973		10.1074/jbc.M117.794230	http://dx.doi.org/10.1074/jbc.M117.794230			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	28972164	Green Published, hybrid			2022-12-26	WOS:000417696400002
J	Sun, JF; Han, ZX; Qi, TM; Zhao, R; Liu, SW				Sun, Junfeng; Han, Zongxi; Qi, Tianming; Zhao, Ran; Liu, Shengwang			Chicken galectin-1B inhibits Newcastle disease virus adsorption and replication through binding to hemagglutinin-neuraminidase (HN) glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						galectin; glycoprotein; viral replication; virus; virus entry; Chicken galectin-1B; HN glycoprotein; Newcastle disease virus; adsorption; replication	N-LINKED GLYCOSYLATION; WEST-NILE-VIRUS; DC-SIGN; OLIGOSACCHARIDE CHAINS; ENVELOPE GLYCOPROTEINS; MONOCLONAL-ANTIBODIES; FUSION ACTIVATION; INFLUENZA-VIRUSES; PROTEIN; INFECTION	Galectin-1 is an important immunoregulatory factor and can mediate the host-pathogen interaction via binding glycans on the surface of various viruses. We previously reported that avian respiratory viruses, including lentogenic Newcastle disease virus (NDV), can induce up-regulation of chicken galectin (CG)-1B in the primary target organ. In this study, we investigated whether CG-1B participated in the infectious process of NDV in chickens. We demonstrated that velogenic NDV induced up-regulation of CG-1B in target organs. We also found that CG-1B directly bound to NDV virions and inhibited their hemagglutination activity in vitro. We confirmed that CG-1B interacted with NDV hemagglutinin-neuraminidase (HN) glycoprotein, in which the specific G4 N-glycans significantly contributed to the interaction between CG-1B and HN glycoprotein. The presence of extracellular CG-1B, rather than the internalization process, inhibited adsorption of NDV. The interaction between intracellular CG-1B and NDV HN glycoproteins inhibited cell-surface expression of HN glycoprotein and reduced the titer of progeny virus in NDV-infected DF-1 cells. Significantly, the replication of parental and HN glycosylation mutant viruses in CG-1B knockdown and overexpression cells demonstrated that the replication of NDV was correlated with the expression of CG-1B in a specific glycan-dependent manner. Collectively, our results indicate that CG-1B has anti-NDV activity by binding to N-glycans on HN glycoprotein.	[Sun, Junfeng; Han, Zongxi; Qi, Tianming; Zhao, Ran; Liu, Shengwang] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin 150001, Heilongjiang, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Liu, SW (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin 150001, Heilongjiang, Peoples R China.	swliu@hvri.ac.cn			National Natural Science Foundation of China [31502088]; Special Fund for Agro-scientific Research in the Public Interest [201303033]; Natural Science Foundation of Heilongjiang Province [QC2015038]; China Agriculture Research System [CARS-40-K18]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); China Agriculture Research System	This work was supported by the National Natural Science Foundation of China Grant 31502088, Special Fund for Agro-scientific Research in the Public Interest Grant 201303033, Natural Science Foundation of Heilongjiang Province Grant QC2015038, and the China Agriculture Research System Grant CARS-40-K18. The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar HC, 2006, J VIROL, V80, P4878, DOI 10.1128/JVI.80.10.4878-4889.2006; Alexander DJ, 2000, REV SCI TECH OIE, V19, P443, DOI 10.20506/rst.19.2.1231; Birnbaum ME, 2014, P NATL ACAD SCI USA, V111, P17576, DOI 10.1073/pnas.1420936111; Bose S, 2014, J VIROL, V88, P3925, DOI 10.1128/JVI.03741-13; Bose S, 2012, P NATL ACAD SCI USA, V109, pE2625, DOI 10.1073/pnas.1213813109; Bousse TL, 2004, J VIROL, V78, P13351, DOI 10.1128/JVI.78.23.13351-13355.2004; Brown CC, 2013, AVIAN DIS, V57, P36, DOI 10.1637/10299-070312-Reg.1; Cedeno-Laurent F, 2012, J IMMUNOL, V188, P3127, DOI 10.4049/jimmunol.1103433; Cedeno-Laurent F, 2012, CLIN IMMUNOL, V142, P107, DOI 10.1016/j.clim.2011.09.011; Chen MS, 2001, VIRUS RES, V79, P91, DOI 10.1016/S0168-1702(01)00322-7; Connaris H, 2002, J VIROL, V76, P1816, DOI 10.1128/JVI.76.4.1816-1824.2002; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; El Najjar F, 2014, VIRUSES-BASEL, V6, P3019, DOI 10.3390/v6083019; Garner OB, 2015, J VIROL, V89, P2520, DOI 10.1128/JVI.02435-14; Garner OB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000993; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Ge JY, 2007, J VIROL, V81, P150, DOI 10.1128/JVI.01514-06; Hogenkamp A, 2008, VET MICROBIOL, V130, P37, DOI 10.1016/j.vetmic.2007.12.008; Huang ZH, 2004, J VIROL, V78, P4176, DOI 10.1128/JVI.78.8.4176-4184.2004; IORIO RM, 1992, J GEN VIROL, V73, P1167, DOI 10.1099/0022-1317-73-5-1167; Iorio RM, 2001, J VIROL, V75, P1918, DOI 10.1128/JVI.75.4.1918-1927.2001; Irie T, 2002, J GEN VIROL, V83, P3045, DOI 10.1099/0022-1317-83-12-3045; Ji X, 2005, J GEN VIROL, V86, P2535, DOI 10.1099/vir.0.81199-0; Kaltner H, 2011, ANAT REC, V294, P427, DOI 10.1002/ar.21341; Koishi AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051089; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Levroney EL, 2005, J IMMUNOL, V175, P413, DOI 10.4049/jimmunol.175.1.413; Liu SD, 2009, J IMMUNOL, V182, P5283, DOI 10.4049/jimmunol.0803811; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Lucendo MF, 2009, J MOL BIOL, V386, P366, DOI 10.1016/j.jmb.2008.09.054; MCGINNES LW, 1995, VIROLOGY, V212, P398, DOI 10.1006/viro.1995.1497; Mercier S, 2008, VIROLOGY, V371, P121, DOI 10.1016/j.virol.2007.09.034; Motran CC, 2008, EUR J IMMUNOL, V38, P3015, DOI 10.1002/eji.200838295; Nason EL, 2001, J VIROL, V75, P6625, DOI 10.1128/JVI.75.14.6625-6634.2001; NG DTW, 1990, MOL CELL BIOL, V10, P1989, DOI 10.1128/MCB.10.5.1989; Ng WC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/732191; Panda A, 2004, J VIROL, V78, P4965, DOI 10.1128/JVI.78.10.4965-4975.2004; Peeters BPH, 1999, J VIROL, V73, P5001, DOI 10.1128/JVI.73.6.5001-5009.1999; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rajasagi NK, 2012, J IMMUNOL, V188, P4631, DOI 10.4049/jimmunol.1103063; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; REED L. J., 1938, AMER JOUR HYG, V27, P493; Seal BS, 2000, DEV COMP IMMUNOL, V24, P257, DOI 10.1016/S0145-305X(99)00077-4; SHAKINESHLEMAN SH, 1992, J BIOL CHEM, V267, P10690; Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0; St-Pierre C, 2011, J VIROL, V85, P11742, DOI 10.1128/JVI.05351-11; Sun JF, 2014, PROTEOMICS, V14, P1403, DOI 10.1002/pmic.201300404; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Toledo KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112474; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Wise MG, 2004, J CLIN MICROBIOL, V42, P329, DOI 10.1128/JCM.42.1.329-338.2004; Yang ML, 2011, J VIROL, V85, P10010, DOI 10.1128/JVI.00301-11; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yuan P, 2011, P NATL ACAD SCI USA, V108, P14920, DOI 10.1073/pnas.1111691108; Zaitsev V, 2004, J VIROL, V78, P3733, DOI 10.1128/JVI.78.7.3733-3741.2004; Zhang XT, 2013, ARCH VIROL, V158, P2115, DOI 10.1007/s00705-013-1723-6	58	12	13	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20141	20161		10.1074/jbc.M116.772897	http://dx.doi.org/10.1074/jbc.M116.772897			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	28978647	Green Published, hybrid			2022-12-26	WOS:000417696400020
J	Powell, CJ; Jenkins, ML; Parker, ML; Ramaswamy, R; Kelsen, A; Warshaw, DM; Ward, GE; Burke, JE; Boulanger, MJ				Powell, Cameron J.; Jenkins, Meredith L.; Parker, Michelle L.; Ramaswamy, Raghavendran; Kelsen, Anne; Warshaw, David M.; Ward, Gary E.; Burke, John E.; Boulanger, Martin J.			Dissecting the molecular assembly of the Toxoplasma gondii MyoA motility complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell motility; crystal structure; isothermal titration calorimetry (ITC); myosin; protein structure; Toxoplasma gondii; X-ray crystallography; host cell invasion	HOST-CELL INVASION; MOTOR COMPLEX; APICOMPLEXAN GLIDEOSOME; PROTEIN SECRETION; GLIDING MOTILITY; GLOBAL BURDEN; LIGHT-CHAIN; MYOSIN-A; PHOSPHORYLATION; RESOLUTION	Apicomplexan parasites such as Toxoplasma gondii rely on a unique form of locomotion known as gliding motility. Generating the mechanical forces to support motility are divergent class XIV myosins (MyoA) coordinated by accessory proteins known as light chains. Although the importance of the MyoA-light chain complex is well-established, the detailed mechanisms governing its assembly and regulation are relatively unknown. To establish a molecular blueprint of this dynamic complex, we first mapped the adjacent binding sites of light chains MLC1 and ELC1 on the MyoA neck (residues 775-818) using a combination of hydrogen-deuterium exchange mass spectrometry and isothermal titration calorimetry. We then determined the 1.85 resolution crystal structure of MLC1 in complex with its cognate MyoA peptide. Structural analysis revealed a bilobed architecture with MLC1 clamping tightly around the helical MyoA peptide, consistent with the stable 10 nmK(d) measured by isothermal titration calorimetry. We next showed that coordination of calcium by an EF-hand in ELC1 and prebinding of MLC1 to the MyoA neck enhanced the affinity of ELC1 for the MyoA neck 7- and 8-fold, respectively. When combined, these factors enhanced ELC1 binding 49-fold (to a K-d of 12 nm). Using the full-length MyoA motor (residues 1-831), we then showed that, in addition to coordinating the neck region, ELC1 appears to engage the MyoA converter subdomain, which couples the motor domain to the neck. These data support an assembly model where staged binding events cooperate to yield high-affinity complexes that are able to maximize force transduction.	[Powell, Cameron J.; Jenkins, Meredith L.; Parker, Michelle L.; Ramaswamy, Raghavendran; Burke, John E.; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, 200 Petch,3800 Finnerty Rd, Victoria, BC V8P 5C2, Canada; [Kelsen, Anne; Ward, Gary E.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Warshaw, David M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	University of Victoria; University of Vermont; University of Vermont	Boulanger, MJ (corresponding author), Univ Victoria, Dept Biochem & Microbiol, 200 Petch,3800 Finnerty Rd, Victoria, BC V8P 5C2, Canada.	mboulang@uvic.ca	Burke, John/H-3922-2019	Burke, John/0000-0001-7904-9859; Jenkins, Meredith/0000-0002-0685-5048; Ward, Gary/0000-0003-4138-3055	Canadian Institutes of Health Research [MOP82916, 148596]; U. S. Public Health Service [AI054961, GM094229]; Natural Sciences and Engineering Research Council of Canada [NSERC-2014-05218]; Canada Research Chair program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI054961, R01AI054961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094229] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); U. S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair program(Canada Research Chairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Canadian Institutes of Health Research Grants MOP82916 and 148596 (to M. J. B.), U. S. Public Health Service Grants AI054961 (to G. E. W.) and GM094229 (to D. M. W.), and Natural Sciences and Engineering Research Council of Canada Grant NSERC-2014-05218 (to J. E. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of salary support from the Canada Research Chair program. To whom correspondence should be addressed: Dept. of Biochemistry and Microbiology, University of Victoria, 200 Petch, 3800 Finnerty Rd., Victoria, BC V8P 5C2, Canada. Tel.: 250-721-7072; E-mail:mboulang@uvic.ca.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Bookwalter C. S., 2017, BIORXIV, DOI [10.1101/127118, DOI 10.1101/127118]; Bookwalter CS, 2014, J BIOL CHEM, V289, P30832, DOI 10.1074/jbc.M114.572453; Borges-Pereira L, 2015, J BIOL CHEM, V290, P26914, DOI 10.1074/jbc.M115.652511; Bosch J, 2006, P NATL ACAD SCI USA, V103, P4852, DOI 10.1073/pnas.0510907103; Boucher LE, 2015, J STRUCT BIOL, V190, P93, DOI 10.1016/j.jsb.2015.02.008; Carey KL, 2004, P NATL ACAD SCI USA, V101, P7433, DOI 10.1073/pnas.0307769101; Checkley W, 2015, LANCET INFECT DIS, V15, P85, DOI 10.1016/S1473-3099(14)70772-8; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Debreczeni JE, 2005, J BIOL CHEM, V280, P41458, DOI 10.1074/jbc.M506315200; Denessiouk K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109287; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Douse CH, 2015, CHEMMEDCHEM, V10, P134, DOI 10.1002/cmdc.201402357; Douse CH, 2012, J BIOL CHEM, V287, P36968, DOI 10.1074/jbc.M112.379842; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Frenal K, 2008, MYOS SUP MOL MOT, P421; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Gaji RY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005268; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; Heintzelman MB, 2006, INT REV CYTOL, V251, P79, DOI 10.1016/S0074-7696(06)51003-4; Heintzelman MB, 2015, SEMIN CELL DEV BIOL, V46, P135, DOI 10.1016/j.semcdb.2015.09.020; Heintzelman MB, 2001, J PARASITOL, V87, P429, DOI 10.1645/0022-3395(2001)087[0429:MDIA]2.0.CO;2; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Houdusse A, 1996, STRUCTURE, V4, P1475, DOI 10.1016/S0969-2126(96)00154-2; Houdusse A, 1996, STRUCTURE, V4, P21, DOI 10.1016/S0969-2126(96)00006-8; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Kortagere S, 2011, J COMPUT AID MOL DES, V25, P403, DOI 10.1007/s10822-011-9420-6; Leung JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098056; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meissner M, 2002, J CELL SCI, V115, P563; Nagamune K, 2007, EUKARYOT CELL, V6, P2147, DOI 10.1128/EC.00262-07; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Shirley DAT, 2012, CURR OPIN INFECT DIS, V25, P555, DOI 10.1097/QCO.0b013e328357e569; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Soldati-Favre D, 2008, PARASITE, V15, P197, DOI 10.1051/parasite/2008153197; Tardieux I, 2016, J CELL BIOL, V214, P507, DOI 10.1083/jcb.201605100; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495; Williams MJ, 2015, MBIO, V6, DOI 10.1128/mBio.00845-15; World Health Organization, 2015, GUID TREATM MAL, Vthird	47	11	11	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19469	19477		10.1074/jbc.M117.809632	http://dx.doi.org/10.1074/jbc.M117.809632			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972141	Green Published, hybrid			2022-12-26	WOS:000416226700026
J	He, RY; Yang, KJ; Li, ZJ; Schadler, M; Yang, WQ; Wu, FZ; Tan, B; Zhang, L; Xu, ZF				He, Ruoyang; Yang, Kaijun; Li, Zhijie; Schaedler, Martin; Yang, Wanqin; Wu, Fuzhong; Tan, Bo; Zhang, Li; Xu, Zhenfeng			Effects of forest conversion on soil microbial communities depend on soil layer on the eastern Tibetan Plateau of China	PLOS ONE			English	Article							GROSS NITROGEN TRANSFORMATIONS; SUB-ALPINE FORESTS; NATURAL FOREST; SUBTROPICAL AUSTRALIA; BACTERIAL COMMUNITY; PINUS-SYLVESTRIS; WESTERN SICHUAN; BETULA-PENDULA; CARBON STOCK; MINERAL SOIL	Forest land-use changes have long been suggested to profoundly affect soil microbial communities. However, how forest type conversion influences soil microbial properties remains unclear in Tibetan boreal forests. The aim of this study was to explore variations of soil microbial profiles in the surface organic layer and subsurface mineral soil among three contrasting forests (natural coniferous forest, NF; secondary birch forest, SF and spruce plantation, PT). Soil microbial biomass, activity and community structure of the two layers were investigated by chloroform fumigation, substrate respiration and phospholipid fatty acid analysis (PLFA), respectively. In the organic layer, both NF and SF exhibited higher soil nutrient levels (carbon, nitrogen and phosphorus), microbial biomass carbon and nitrogen, microbial respiration, PLFA contents as compared to PT. However, the measured parameters in the mineral soils often did not differ following forest type conversion. Irrespective of forest types, the microbial indexes generally were greater in the organic layer than in the mineral soil. PLFAs biomarkers were significantly correlated with soil substrate pools. Taken together, forest land-use change remarkably altered microbial community in the organic layer but often did not affect them in the mineral soil. The microbial responses to forest land-use change depend on soil layer, with organic horizons being more sensitive to forest conversion.	[He, Ruoyang; Yang, Kaijun; Li, Zhijie; Yang, Wanqin; Wu, Fuzhong; Zhang, Li; Xu, Zhenfeng] Sichuan Agr Univ, Inst Ecol & Forest, Chengdu, Sichuan, Peoples R China; [Schaedler, Martin] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Tan, Bo] Sichuan Agr Univ, Coll Forestry, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Sichuan Agricultural University	Xu, ZF (corresponding author), Sichuan Agr Univ, Inst Ecol & Forest, Chengdu, Sichuan, Peoples R China.	xuzf@sicau.edu.cn	Schädler, Martin/H-3176-2011; Li, Zhijie/AAJ-7247-2020; 杨, 开军/AAQ-6563-2021	Schädler, Martin/0000-0001-9700-0311; 杨, 开军/0000-0003-0085-9395	National Key Research and Development Program of China [2016YFC0502505-03]; Natural Science Foundation of China [31570601, 31570445, 31500509]; China Postdoctoral Science Foundation Special Financial Grant [2014T70880]	National Key Research and Development Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation Special Financial Grant(China Postdoctoral Science Foundation)	This research was financially supported by the National Key Research and Development Program of China (no. 2016YFC0502505-03) and the Natural Science Foundation of China (no. 31570601, 31570445, 31500509) and China Postdoctoral Science Foundation Special Financial Grant (no. 2014T70880).	Bailey VL, 2002, SOIL BIOL BIOCHEM, V34, P1385, DOI 10.1016/S0038-0717(02)00070-6; Burton J, 2007, SOIL BIOL BIOCHEM, V39, P426, DOI 10.1016/j.soilbio.2006.08.011; Chapin FS., 2011, PRINCIPLES TERRESTRI, V2nd ed.; Chen FL, 2013, FOREST ECOL MANAG, V291, P65, DOI 10.1016/j.foreco.2012.11.016; Denef K, 2009, SOIL BIOL BIOCHEM, V41, P144, DOI 10.1016/j.soilbio.2008.10.008; Fierer N, 2005, ECOLOGY, V86, P320, DOI 10.1890/04-1254; Gleixner G, 2005, ECOL STUD-ANAL SYNTH, V176, P165; Hackl E, 2005, SOIL BIOL BIOCHEM, V37, P661, DOI 10.1016/j.soilbio.2004.08.023; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Han Shi-zhong, 2015, Yingyong Shengtai Xuebao, V26, P2151; Hu Jianli, 2009, Chinese Journal of Applied and Environmental Biology, V15, P313, DOI 10.3724/SP.J.1145.2009.00313; Huang ZQ, 2013, SOIL BIOL BIOCHEM, V62, P68, DOI 10.1016/j.soilbio.2013.03.008; IUSS, 2006, WORLD SOIL RESOURCES; Koranda M, 2013, SOIL BIOL BIOCHEM, V60, P95, DOI 10.1016/j.soilbio.2013.01.025; Krashevska V, 2015, BIOL FERT SOILS, V51, P697, DOI 10.1007/s00374-015-1021-4; Li H, 2014, PLANT SOIL, V383, P203, DOI 10.1007/s11104-014-2165-y; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Liu L, 2012, SOIL BIOL BIOCHEM, V44, P31, DOI 10.1016/j.soilbio.2011.08.017; Liu Q, 2001, WORLD SCIENTIF TECHN, V2, P63, DOI [10.16507/j.issn.1006-6055.2001.02.024, DOI 10.16507/J.ISSN.1006-6055.2001.02.024]; [庞学勇 Pang Xueyong], 2002, [应用与环境生物学报, Chinese journal of applied and environmental biology], V8, P1; Priha O, 2001, BIOL FERT SOILS, V33, P17, DOI 10.1007/s003740000281; Priha O, 1999, FEMS MICROBIOL ECOL, V30, P187, DOI 10.1111/j.1574-6941.1999.tb00647.x; Romaniuk R, 2011, SOIL RES, V49, P733, DOI 10.1071/SR11147; Sanchez FG, 2001, FOREST ECOL MANAG, V152, P85, DOI 10.1016/S0378-1127(00)00592-2; Tang Shi-shan, 2015, Yingyong Shengtai Xuebao, V26, P363; Tornberg K, 2003, BIOL FERT SOILS, V37, P190, DOI 10.1007/s00374-002-0574-1; Trumbore SE, 1997, J GEOPHYS RES-ATMOS, V102, P28817, DOI 10.1029/97JD02231; Ushio M, 2013, PLANT SOIL, V365, P157, DOI 10.1007/s11104-012-1365-6; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; White DC, 1996, J IND MICROBIOL, V17, P185, DOI 10.1007/BF01574692; Wu N, 1998, CHINESE J APPL ENV B, V4, P290; [邢韶华 XING Shaohua], 2010, [山地学报, Journal of Mountain Science], V28, P218; Xu WH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06512; Xu ZF, 2010, APPL SOIL ECOL, V46, P291, DOI 10.1016/j.apsoil.2010.07.005; Xu ZF, 2015, GEODERMA, V239, P223, DOI 10.1016/j.geoderma.2014.10.018; Xu ZF, 2010, PLANT SOIL, V336, P183, DOI 10.1007/s11104-010-0461-8; Xu ZH, 2008, J SOIL SEDIMENT, V8, P99, DOI 10.1065/jss2008.02.276; Yang K, 2013, PLANT SOIL, V368, P535, DOI 10.1007/s11104-012-1535-6; [Yang Wanqin 杨万勤], 2007, [生态学报, Acta Ecologica Sinica], V27, P4157; Yin K, 2016, SCI REP-UK, V6, DOI 10.1038/srep27066; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533; Zhang YD, 2013, FOREST ECOL MANAG, V300, P88, DOI 10.1016/j.foreco.2012.06.010; Zhang ZH, 2017, ENVIRONMENTAL DATA ANALYSIS: METHODS AND APPLICATIONS, P1, DOI 10.1515/9783110424904-002; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x	45	8	10	6	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186053	10.1371/journal.pone.0186053	http://dx.doi.org/10.1371/journal.pone.0186053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982191	Green Submitted, gold, Green Published			2022-12-26	WOS:000412360300116
J	Li, CW; Ai, DH				Li, Chengwu; Ai, Dihao			Automatic crack detection method for loaded coal in vibration failure process	PLOS ONE			English	Article							SEGMENTATION; INSPECTION	In the coal mining process, the destabilization of loaded coal mass is a prerequisite for coal and rock dynamic disaster, and surface cracks of the coal and rock mass are important indicators, reflecting the current state of the coal body. The detection of surface cracks in the coal body plays an important role in coal mine safety monitoring. In this paper, a method for detecting the surface cracks of loaded coal by a vibration failure process is proposed based on the characteristics of the surface cracks of coal and support vector machine (SVM). A large number of cracked images are obtained by establishing a vibration-induced failure test system and industrial camera. Histogram equalization and a hysteresis threshold algorithm were used to reduce the noise and emphasize the crack; then, 600 images and regions, including cracks and non-cracks, were manually labelled. In the crack feature extraction stage, eight features of the cracks are extracted to distinguish cracks from other objects. Finally, a crack identification model with an accuracy over 95% was trained by inputting the labelled sample images into the SVM classifier. The experimental results show that the proposed algorithm has a higher accuracy than the conventional algorithm and can effectively identify cracks on the surface of the coal and rock mass automatically.	[Li, Chengwu; Ai, Dihao] China Univ Min & Technol, Fac Resources & Safety Engn, Beijing, Peoples R China	China University of Mining & Technology	Ai, DH (corresponding author), China Univ Min & Technol, Fac Resources & Safety Engn, Beijing, Peoples R China.	aixi1020@163.com			National Natural Science Foundation of China [51274206, 51404277]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the National Natural Science Foundation of China (51274206, 51404277). This support is greatly acknowledged and appreciated.	Abdel-Qader I, 2006, ADV ENG SOFTW, V37, P771, DOI 10.1016/j.advengsoft.2006.06.002; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Cao S, 2015, J ROCK MECH ENG, V34, P3074; Chen S., 2010, METAL MINE, V11, P43; [陈新 Chen Xin], 2014, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V33, P1149; Cho HW, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16101646; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Hall MA, 1999, CORRELATION BASED FE, V19; Iyer S, 2005, IMAGE VISION COMPUT, V23, P921, DOI 10.1016/j.imavis.2005.05.017; Jiang Feng, 2017, Journal of Software, V28, P160, DOI 10.13328/j.cnki.jos.005136; [李德建 Li Dejian], 2014, [煤炭学报, Journal of China Coal Society], V39, P307; Li G, 2014, AUTOMAT CONSTR, V41, P83, DOI 10.1016/j.autcon.2013.10.021; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Nashat S, 2014, J FOOD ENG, V120, P233, DOI 10.1016/j.jfoodeng.2013.08.006; [彭守建 Peng Shoujian], 2015, [煤炭学报, Journal of China Coal Society], V40, P801; Scholkopf B., 1999, ADV KERNEL METHODS S; Senliol B, 2008, 23RD INTERNATIONAL SYMPOSIUM ON COMPUTER AND INFORMATION SCIENCES, P500; Sinha SK, 2006, AUTOMAT CONSTR, V15, P47, DOI 10.1016/j.autcon.2005.02.007; Sinha SK, 2006, AUTOMAT CONSTR, V15, P58, DOI 10.1016/j.autcon.2005.02.006; Sun H, 2016, INT J NUMER METH ENG, V105, P1014, DOI 10.1002/nme.5006; Sun H, 2014, INT J NUMER METH ENG, V100, P477, DOI 10.1002/nme.4741; Szeliski R., 2010, COMPUTER VISION ALGO, DOI DOI 10.1007/978-3-030-34372-9; Talab AMA, 2016, OPTIK, V127, P1030, DOI 10.1016/j.ijleo.2015.09.147; Vapnik VN, STAT LEARNING THEORY, V1; XU Jiang, 2013, CHINESE J ROCK MECH, V32, P33; Zhang WY, 2014, SENSORS-BASEL, V14, P19307, DOI 10.3390/s141019307	26	3	3	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185750	10.1371/journal.pone.0185750	http://dx.doi.org/10.1371/journal.pone.0185750			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973032	Green Submitted, gold, Green Published			2022-12-26	WOS:000412131900045
J	Song, SB; Bokkers, RPH; Luby, M; Edwardson, MA; Brown, T; Shah, S; Cox, RW; Saad, ZS; Reynolds, RC; Glen, DR; Cohen, LG; Latour, LL				Song, Sunbin; Bokkers, Reinoud P. H.; Luby, Marie; Edwardson, Matthew A.; Brown, Tyler; Shah, Shreyansh; Cox, Robert W.; Saad, Ziad S.; Reynolds, Richard C.; Glen, Daniel R.; Cohen, Leonardo G.; Latour, Lawrence L.			Temporal similarity perfusion mapping: A standardized and model-free method for detecting perfusion deficits in stroke	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; ENDOVASCULAR TREATMENT; INFARCT GROWTH; DCE-MRI; DIFFUSION; CT; PENUMBRA; TIME; SEGMENTATION; ASSOCIATION	Introduction Interpretation of the extent of perfusion deficits in stroke MRI is highly dependent on the method used for analyzing the perfusion-weighted signal intensity time-series after gadolinium injection. In this study, we introduce a new model-free standardized method of temporal similarity perfusion (TSP) mapping for perfusion deficit detection and test its ability and reliability in acute ischemia. Materials and methods Forty patients with an ischemic stroke or transient ischemic attack were included. Two blinded readers compared real-time generated interactive maps and automatically generated TSP maps to traditional TTP/MTT maps for presence of perfusion deficits. Lesion volumes were compared for volumetric inter-rater reliability, spatial concordance between perfusion deficits and healthy tissue and contrast-to-noise ratio (CNR). Results Perfusion deficits were correctly detected in all patients with acute ischemia. Inter-rater reliability was higher for TSP when compared to TTP/MTT maps and there was a high similarity between the lesion volumes depicted on TSP and TTP/MTT (r(18) = 0.73). The Pearson's correlation between lesions calculated on TSP and traditional maps was high (r(18) = 0.73, p< 0.0003), however the effective CNR was greater for TSP compared to TTP (352.3 vs 283.5, t(19) = 2.6, p< 0.03.) and MTT (228.3, t(19) = 2.8, p< 0.03). Discussion TSP maps provide a reliable and robust model-free method for accurate perfusion deficit detection and improve lesion delineation compared to traditional methods. This simple method is also computationally faster and more easily automated than model-based methods. This method can potentially improve the speed and accuracy in perfusion deficit detection for acute stroke treatment and clinical trial inclusion decision-making.	[Song, Sunbin; Cohen, Leonardo G.] NINDS, NIH, Human Cort Physiol & Neurorehabil Sect, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Bokkers, Reinoud P. H.] Univ Groningen, Univ Med Ctr Groningen, Med Imaging Ctr, Dept Radiol, Groningen, Netherlands; [Luby, Marie; Edwardson, Matthew A.; Brown, Tyler; Shah, Shreyansh; Latour, Lawrence L.] NINDS, NIH, Stroke Branch, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Cox, Robert W.; Saad, Ziad S.; Reynolds, Richard C.; Glen, Daniel R.] NIMH, NIH, Sci & Stat Comp Core, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Groningen; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Bokkers, RPH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Med Imaging Ctr, Dept Radiol, Groningen, Netherlands.	r.p.h.bokkers@umcg.nl	Latour, Larry/AAH-5663-2021; Bokkers, Reinoud P H/ABD-2928-2020; Luby, Marie/AEX-9494-2022; Glen, Daniel/HCG-8456-2022	Latour, Larry/0000-0001-6160-5263; Bokkers, Reinoud P H/0000-0001-6130-7311; Shah, Shreyansh/0000-0001-8441-6326; Glen, Daniel/0000-0001-8456-5647; Edwardson, Matthew/0000-0002-0327-5531; Cox, Robert/0000-0002-0031-1568	Intramural Research Program of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health; Dutch Heart Foundation [2013T047]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZICMH002888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003030, ZIANS003043, ZICNS003044] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health; Dutch Heart Foundation(Netherlands Heart Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health. R.P.H. Bokkers receives support from the Dutch Heart Foundation (Grant 2013T047).	Barber PA, 1999, STROKE, V30, P2059, DOI 10.1161/01.STR.30.10.2059; Bivard A, 2013, RADIOLOGY, V267, P543, DOI 10.1148/radiol.12120971; Calamante F, 2006, MAGN RESON MED, V55, P1180, DOI 10.1002/mrm.20873; Copen WA, 2011, NEUROIMAG CLIN N AM, V21, P259, DOI 10.1016/j.nic.2011.02.007; Cox RW, 2012, NEUROIMAGE, V62, P743, DOI 10.1016/j.neuroimage.2011.08.056; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Ferreira RM, 2010, AM J ROENTGENOL, V194, P1330, DOI 10.2214/AJR.09.2845; Fiebach JB, 2002, STROKE, V33, P2206, DOI 10.1161/01.STR.0000026864.20339.CB; Fransen PSS, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-343; Grandin CB, 2002, RADIOLOGY, V223, P361, DOI 10.1148/radiol.2232010673; Haacke EM, 2013, MAGN RESON IMAGING, V31, P481, DOI 10.1016/j.mri.2012.10.005; Ingrisch M, 2014, INVEST RADIOL, V49, P382, DOI 10.1097/RLI.0000000000000020; Karonen JO, 1999, STROKE, V30, P1583, DOI 10.1161/01.STR.30.8.1583; Kidwell CS, 2013, STROKE, V44, P73, DOI 10.1161/STROKEAHA.112.670034; Latchaw RE, 2009, STROKE, V40, P3646, DOI 10.1161/STROKEAHA.108.192616; Li S, 2012, COMPUT MED IMAG GRAP, V36, P108, DOI 10.1016/j.compmedimag.2011.06.005; Neumann-Haefelin T, 1999, STROKE, V30, P1591, DOI 10.1161/01.STR.30.8.1591; Ostergaard L, 2005, J MAGN RESON IMAGING, V22, P710, DOI 10.1002/jmri.20460; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074; Schellinger PD, 2006, NEURORADIOLOGY, V48, P69, DOI 10.1007/s00234-005-0012-9; Schlaug G, 1999, NEUROLOGY, V53, P1528, DOI 10.1212/WNL.53.7.1528; Straka M, 2010, J MAGN RESON IMAGING, V32, P1024, DOI 10.1002/jmri.22338; Warach S, 1996, J CEREBR BLOOD F MET, V16, P53, DOI 10.1097/00004647-199601000-00006; Wismuller A, 2006, IEEE T MED IMAGING, V25, P62, DOI 10.1109/TMI.2005.861002; Yamada K, 2002, STROKE, V33, P87, DOI 10.1161/hs0102.101893; Zollner FG, 2015, MAGN RESON IMAGING, V33, P1345, DOI 10.1016/j.mri.2015.08.003	27	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185552	10.1371/journal.pone.0185552	http://dx.doi.org/10.1371/journal.pone.0185552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973000	Green Published, gold, Green Submitted			2022-12-26	WOS:000412131900024
J	Wang, GF; Zhang, PY; Liang, LW; Zhang, SQ				Wang, Gefei; Zhang, Peiyun; Liang, Liwen; Zhang, Shiqiang			Evaluation of precipitation from CMORPH, GPCP-2, TRMM 3B43, GPCC, and ITPCAS with ground-based measurements in the QinlingDaba Mountains, China	PLOS ONE			English	Article							MEASURING MISSION TRMM; CLIMATOLOGY PROJECT; TEMPORAL RESOLUTION; PRODUCTS; VALIDATION; REGION; PERFORMANCE; DATASET; ASIA	The correspondence between five precipitation products, including CMORPH, GPCP-2, TRMM 3B43, GPCC, and ITPCAS, and ground-based measurements of precipitation were evaluated on annual, seasonal, and monthly scales during 2000-2014 in the Qinling-Daba Mountains over China, which is a significant area with vital value of climate and hydrology. Performances of the precipitation products in the relatively arid/humid years were also analyzed. In general, ITPCAS data displayed the highest accuracy, GPCP-2 and CMORPH data showed relatively poor performance, and GPCC and TRMM 3B43 data were average at different temporal scales among the five precipitation products. The Pearson correlation coefficient of each station had minor fluctuations for the five precipitation products. A larger deviation was found at Wudu station, most likely due to the undulating terrain. The performances of the precipitation products from highest to least accuracy are as follows: ITPCAS > TRMM 3B43 > GPCC > GPCP-2 > CMORPH. Except for CMORPH (-20.76%), the percentage precipitation differences (PPDs) of the other four precipitation products fluctuated in the range of 10% during the relatively arid (2001) and humid (2011) years. In addition, all precipitation products and ground gauge observed precipitation did not show an obvious gradient with altitude, which is different from that in other mountainous areas and is perhaps due to complex terrain, lack of observation in high altitudes, and precipitation undercatch. In consideration of the significance of Qinling-Daba Mountains as the geographic and ecological dividing lines, the present study may provide a new perspective for hydrological, climatic, and ecological researches and practices in local and other mountainous areas.	[Wang, Gefei; Zhang, Peiyun; Liang, Liwen; Zhang, Shiqiang] Northwest Univ, Shaanxi Key Lab Earth Surface Syst & Environm Car, Xian, Shaanxi, Peoples R China; [Wang, Gefei; Zhang, Peiyun; Liang, Liwen; Zhang, Shiqiang] Northwest Univ, Coll Urban & Environm Sci, Xian, Shaanxi, Peoples R China	Northwest University Xi'an; Northwest University Xi'an	Zhang, SQ (corresponding author), Northwest Univ, Shaanxi Key Lab Earth Surface Syst & Environm Car, Xian, Shaanxi, Peoples R China.; Zhang, SQ (corresponding author), Northwest Univ, Coll Urban & Environm Sci, Xian, Shaanxi, Peoples R China.	zhangsq@nwu.edu.cn		Zhang, Shiqiang/0000-0003-3407-6356	National Nature Science Foundation of China	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Nature Science Foundation of China, http://www. nsfc.gov.cn.	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Almazroui M, 2011, ATMOS RES, V99, P400, DOI 10.1016/j.atmosres.2010.11.006; ARKIN PA, 1994, B AM METEOROL SOC, V75, P401, DOI 10.1175/1520-0477(1994)075<0401:TGPCPF>2.0.CO;2; Bai H., 2014, RESPONSE FOREST VEGE; [白红英 Bai Hongying], 2012, [地理学报, Acta Geographica Sinica], V67, P1443; Blacutt LA, 2015, ATMOS RES, V163, P117, DOI 10.1016/j.atmosres.2015.02.002; Chen GX, 2014, J CLIMATE, V27, P5517, DOI 10.1175/JCLI-D-14-00005.1; Chen M., 1983, CLIMATE ALGRICULTURE; Chen YY, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015921; Condom T, 2011, HYDROL PROCESS, V25, P1924, DOI 10.1002/hyp.7949; Dai Y, 2016, QUATERN INT, P1; Darand M, 2017, ATMOS RES, V190, P121, DOI 10.1016/j.atmosres.2017.02.011; Dinku T, 2007, INT J REMOTE SENS, V28, P1503, DOI 10.1080/01431160600954688; Feidas H, 2010, THEOR APPL CLIMATOL, V99, P193, DOI 10.1007/s00704-009-0135-8; Guo DL, 2013, J GEOPHYS RES-ATMOS, V118, P5216, DOI 10.1002/jgrd.50457; Guo H, 2015, REMOTE SENS-BASEL, V7, P7181, DOI 10.3390/rs70607181; Hirpa FA, 2010, J APPL METEOROL CLIM, V49, P1044, DOI 10.1175/2009JAMC2298.1; Hu QF, 2014, INT J REMOTE SENS, V35, P1272, DOI 10.1080/01431161.2013.876118; [胡增运 Hu Zengyun], 2013, [干旱区地理, Arid Land Geography], V36, P700; Huang C, 2014, GUANGDONG METEOROLOG, V36, P19; Huffman GJ, 1997, B AM METEOROL SOC, V78, P5, DOI 10.1175/1520-0477(1997)078<0005:TGPCPG>2.0.CO;2; Janjai S, 2015, PHYS GEOGR, V36, P282, DOI 10.1080/02723646.2015.1045286; Janowiak JE, 1998, J CLIMATE, V11, P2960, DOI 10.1175/1520-0442(1998)011<2960:ACOTNN>2.0.CO;2; Jiang SH, 2012, J HYDROL, V452, P213, DOI 10.1016/j.jhydrol.2012.05.055; Joyce RJ, 2004, J HYDROMETEOROL, V5, P487, DOI 10.1175/1525-7541(2004)005<0487:CAMTPG>2.0.CO;2; [阚宝云 Kan Baoyun], 2013, [冰川冻土, Journal of Glaciology and Geocryology], V35, P710; Karaseva MO, 2012, THEOR APPL CLIMATOL, V108, P147, DOI 10.1007/s00704-011-0509-6; Kidd C, 2011, HYDROL EARTH SYST SC, V15, P1109, DOI 10.5194/hess-15-1109-2011; Kummerow C, 1998, J ATMOS OCEAN TECH, V15, P809, DOI 10.1175/1520-0426(1998)015<0809:TTRMMT>2.0.CO;2; Kummerow C, 2000, J APPL METEOROL, V39, P1965, DOI 10.1175/1520-0450(2001)040<1965:TSOTTR>2.0.CO;2; Leng GY, 2015, REG ENVIRON CHANGE, V15, P251, DOI 10.1007/s10113-014-0640-x; Liechti TC, 2012, HYDROL EARTH SYST SC, V16, P489, DOI 10.5194/hess-16-489-2012; [刘俊峰 LIU Junfeng], 2011, [水科学进展, Advances in Water Science], V22, P447; [刘宪锋 Liu Xianfeng], 2015, [地理学报, Acta Geographica Sinica], V70, P705; Lu ZhongYan, 2006, Journal of Nanjing Institute of Meteorology, V29, P408; Ma LJ, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011178; Mantas VM, 2015, ATMOS RES, V163, P132, DOI 10.1016/j.atmosres.2014.11.012; Michaelides S, 2009, ATMOS RES, V94, P512, DOI 10.1016/j.atmosres.2009.08.017; New M, 2001, INT J CLIMATOL, V21, P1899, DOI 10.1002/joc.680; Pan XD, 2014, J HYDROMETEOROL, V15, P1560, DOI 10.1175/JHM-D-13-0202.1; Pombo S, 2015, METEOROL APPL, V22, P395, DOI 10.1002/met.1467; Romilly TG, 2011, HYDROL EARTH SYST SC, V15, P1505, DOI 10.5194/hess-15-1505-2011; Sapiano MRP, 2009, J HYDROMETEOROL, V10, P149, DOI 10.1175/2008JHM1052.1; Scheel MLM, 2011, HYDROL EARTH SYST SC, V15, P2649, DOI 10.5194/hess-15-2649-2011; Schneider U., 2020, GPCC MONITORING PROD, DOI [10.5676/DWD_GPCC/MP_M_V2020_100, DOI 10.5676/DWD_GPCC/MP_M_V2020_100]; Schneider U, 2014, THEOR APPL CLIMATOL, V115, P15, DOI 10.1007/s00704-013-0860-x; Shen Y, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012097; Sun AJ, 1989, GEOGRAPH RES, V8, P32; [孙葭 Sun Jia], 2015, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V24, P1850; Tang M., 1985, ACTA GEOGRAPHICA SIN, V40, P323; Yamamoto MK, 2011, J METEOROL SOC JPN, V89, P597, DOI 10.2151/jmsj.2011-601; Yang D., 1988, J GLACIOL GEOCRYOL, V10, P384; Yang D, 1989, METEOROLOGICAL MONTH, V15, P22; Yang D., 1987, METEOROL MON, V13, P16; Yue LW, 2017, ISPRS J PHOTOGRAMM, V123, P20, DOI 10.1016/j.isprsjprs.2016.11.002; Yue TX, 2007, GEOMORPHOLOGY, V91, P161, DOI 10.1016/j.geomorph.2007.02.006; Zeweldi DA, 2009, J HYDROMETEOROL, V10, P300, DOI 10.1175/2008JHM1041.1; [赵天保 ZHAO TianBao], 2006, [气候与环境研究, Climatic and environmental research], V11, P14; [周旗 ZHOU Qi], 2011, [地理学报, Acta Geographica Sinica], V66, P1211; [朱智 Zhu Zhi], 2015, [冰川冻土, Journal of Glaciology and Geocryology], V37, P614	60	24	25	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185147	10.1371/journal.pone.0185147	http://dx.doi.org/10.1371/journal.pone.0185147			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968442	Green Published, Green Submitted, gold			2022-12-26	WOS:000412029600014
J	Van Slooten, JC; Jahfari, S; Knapen, T; Theeuwes, J				Van Slooten, Joanne C.; Jahfari, Sara; Knapen, Tomas; Theeuwes, Jan			Individual differences in eye blink rate predict both transient and tonic pupil responses during reversal learning	PLOS ONE			English	Article							LOCUS-COERULEUS; PARKINSONS-DISEASE; DOPAMINE FUNCTION; DECISION-MAKING; ADAPTIVE GAIN; REWARD; MODULATION; MODELS; PUPILLOMETRY; SENSITIVITY	The pupil response under constant illumination can be used as a marker of cognitive processes. In the past, pupillary responses have been studied in the context of arousal and decision-making. However, recent work involving Parkinson's patients suggested that pupillary responses are additionally affected by reward sensitivity. Here, we build on these findings by examining how pupil responses are modulated by reward and loss while participants (N = 30) performed a Pavlovian reversal learning task. In fast (transient) pupil responses, we observed arousal-based influences on pupil size both during the expectation of upcoming value and the evaluation of unexpected monetary outcomes. Importantly, after incorporating eye blink rate (EBR), a behavioral correlate of striatal dopamine levels, we observed that participants with lower EBR showed stronger pupil dilation during the expectation of upcoming reward. Subsequently, when reward expectations were violated, participants with lower EBR showed stronger pupil responses after experiencing unexpected loss. Across trials, the detection of a reward contingency reversal was reflected in a slow (tonic) dilatory pupil response observed already several trials prior to the behavioral report. Interestingly, EBR correlated positively with this tonic detection response, suggesting that variability in the arousal-based detection response may reflect individual differences in striatal dopaminergic tone. Our results provide evidence that a behavioral marker of baseline striatal dopamine level (EBR) can potentially be used to describe the differential effects of value-based learning in the arousal-based pupil response.	[Van Slooten, Joanne C.; Jahfari, Sara; Knapen, Tomas; Theeuwes, Jan] Vrije Univ Amsterdam, Dept Appl & Expt Psychol, Amsterdam, Noord Holland, Netherlands	Vrije Universiteit Amsterdam	Van Slooten, JC (corresponding author), Vrije Univ Amsterdam, Dept Appl & Expt Psychol, Amsterdam, Noord Holland, Netherlands.	joannevslooten@gmail.com	Knapen, Tomas/H-4431-2019; Theeuwes, Jan/ABF-3771-2020	Knapen, Tomas/0000-0001-5863-8689; Theeuwes, Jan/0000-0002-5849-7721	European Research Council [ERC-2012-AdG-323413]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by ERC-2012-AdG-323413, https://erc.europa.eu, European Research Council, to JT.	[Anonymous], 1993, INTRO BOOTSTRAP; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; AstonJones G, 1997, NEUROSCIENCE, V80, P697, DOI 10.1016/S0306-4522(97)00060-2; Balleine B. W., 2008, NEUROECONOMICS DECIS, V36, P7; Barbato G, 2000, PSYCHIAT RES, V93, P145, DOI 10.1016/S0165-1781(00)00108-6; Braem S, 2015, COGN AFFECT BEHAV NE, V15, P374, DOI 10.3758/s13415-014-0333-4; Bray S, 2008, J NEUROSCI, V28, P5861, DOI 10.1523/JNEUROSCI.0897-08.2008; Browning M, 2015, NAT NEUROSCI, V18, P590, DOI 10.1038/nn.3961; CASEY DE, 1980, BRAIN RES BULL, V5, P269, DOI 10.1016/0361-9230(80)90044-1; Cavanagh JF, 2014, J EXP PSYCHOL GEN, V143, P1476, DOI 10.1037/a0035813; Cavanagh JF, 2014, NATURE COMMUNICATION, V5, P1; Chen WH, 2003, CLIN NEUROL NEUROSUR, V105, P90, DOI 10.1016/S0303-8467(02)00107-5; Cohen MX, 2014, ISS CLIN COGN NEUROP, P1; Colzato LS, 2008, NEUROPSYCHOLOGIA, V46, P3179, DOI 10.1016/j.neuropsychologia.2008.07.006; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Cools R, 2015, CURR OPIN BEHAV SCI, V4, P152, DOI 10.1016/j.cobeha.2015.05.007; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Dang LC, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0211-17.2017; de Gee JW, 2014, P NATL ACAD SCI USA, V111, pE618, DOI 10.1073/pnas.1317557111; Dirnberger G, 2013, J NEUROPSYCHOL, V7, P193, DOI 10.1111/jnp.12028; Doughty Michael J, 2006, Eye Contact Lens, V32, P294, DOI 10.1097/01.icl.0000224359.32709.4d; Doughty MJ, 2001, OPTOMETRY VISION SCI, V78, P712, DOI 10.1097/00006324-200110000-00011; Durstewitz D, 2008, BIOL PSYCHIAT, V64, P739, DOI 10.1016/j.biopsych.2008.05.015; Eldar E, 2013, NAT NEUROSCI, V16, P1146, DOI 10.1038/nn.3428; ELSWORTH JD, 1991, J PHARMACOL EXP THER, V259, P595; Frank MJ, 2006, BEHAV NEUROSCI, V120, P497, DOI 10.1037/0735-7044.120.3.497; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Fruend I, 2011, J VISION, V11, DOI 10.1167/11.6.16; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Giza E, 2011, INT J NEUROSCI, V121, P37, DOI 10.3109/00207454.2010.526730; GRAMFORT A, 2013, FRONTIERS NEUROSCI, V7, P1, DOI DOI 10.3389/FNINS.2013.00267; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; Gratwicke J, 2015, BRAIN, V138, P1454, DOI 10.1093/brain/awv104; Groman SM, 2014, J NEUROSCI, V34, P14443, DOI 10.1523/JNEUROSCI.3037-14.2014; HOEKS B, 1993, BEHAV RES METH INSTR, V25, P16, DOI 10.3758/BF03204445; Hupe JM, 2009, J VISION, V9, DOI 10.1167/9.7.10; Jepma M, 2011, J COGNITIVE NEUROSCI, V23, P1587, DOI 10.1162/jocn.2010.21548; Jiang XT, 2013, BEHAV RES METHODS, V45, P656, DOI 10.3758/s13428-012-0294-x; Jongkees BJ, 2016, NEUROSCI BIOBEHAV R, V71, P58, DOI 10.1016/j.neubiorev.2016.08.020; Joshi S, 2016, NEURON, V89, P221, DOI 10.1016/j.neuron.2015.11.028; Jutkiewicz EM, 2004, J PHARMACOL EXP THER, V311, P1008, DOI 10.1124/jpet.104.071092; Kahneman D, 1979, ECONOMETRICA, V2, P1; Kaminer J, 2011, J NEUROSCI, V31, P11256, DOI 10.1523/JNEUROSCI.6218-10.2011; KARSON CN, 1983, BRAIN, V106, P643, DOI 10.1093/brain/106.3.643; Kleven MS, 1996, J PHARMACOL EXP THER, V279, P1211; Knapen T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155574; Korn CW, 2016, J VISION, V16, DOI 10.1167/16.3.28; Kruis A, 2016, PSYCHOPHYSIOLOGY, V53, P749, DOI 10.1111/psyp.12619; LAWRENCE MS, 1991, PHARMACOL BIOCHEM BE, V38, P869, DOI 10.1016/0091-3057(91)90255-Z; Macmillan NA, 2005, DETECTION THEORY USE; Maia TV, 2011, NAT NEUROSCI, V14, P154, DOI 10.1038/nn.2723; Manohar SG, 2015, NPJ PARKINSONS DIS, V1, P1; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Micieli G, 1991, Clin Auton Res, V1, P55, DOI 10.1007/BF01826058; Muhammed K, 2016, BRAIN, V139, P2706, DOI 10.1093/brain/aww188; Murphy PR, 2014, HUM BRAIN MAPP, V35, P4140, DOI 10.1002/hbm.22466; Nassar MR, 2012, NAT NEUROSCI, V15, P1040, DOI 10.1038/nn.3130; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2006, NEURON, V49, P157, DOI 10.1016/j.neuron.2005.11.014; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2008, ENCY NEUROSCIENCE, P4158; O'Reilly JX, 2013, P NATL ACAD SCI USA, V110, pE3660, DOI 10.1073/pnas.1305373110; Pauli WM, 2015, J NEUROSCI, V35, P14220, DOI 10.1523/JNEUROSCI.2277-15.2015; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Preuschoff K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00115; Prevost C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002918; Raisig S, 2010, INT J PSYCHOPHYSIOL, V76, P1, DOI 10.1016/j.ijpsycho.2010.01.006; Rajkowski J., 1993, Society for Neuroscience Abstracts, V19, P974; Rudebeck PH, 2014, P NATL ACAD SCI USA, V111, P5391, DOI 10.1073/pnas.1317695111; Sadacca BF, 2017, NEUROSCIENCE, V345, P124, DOI 10.1016/j.neuroscience.2016.04.017; SAID SE, 1984, BIOMETRIKA, V71, P599; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Satterthwaite TD, 2007, NEUROIMAGE, V37, P1017, DOI 10.1016/j.neuroimage.2007.04.066; Seymour B, 2007, J NEUROSCI, V27, P4826, DOI 10.1523/JNEUROSCI.0400-07.2007; Sforza C, 2008, OPHTHAL PHYSL OPT, V28, P345, DOI 10.1111/j.1475-1313.2008.00577.x; Slagter HA, 2015, NEUROPSYCHOLOGIA, V71, P126, DOI 10.1016/j.neuropsychologia.2015.03.028; Sun WS, 1997, INVEST OPHTH VIS SCI, V38, P92; Taylor JR, 1999, EXP NEUROL, V158, P214, DOI 10.1006/exnr.1999.7093; Wang CA, 2015, CURR OPIN NEUROBIOL, V33, P134, DOI 10.1016/j.conb.2015.03.018	82	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185665	10.1371/journal.pone.0185665	http://dx.doi.org/10.1371/journal.pone.0185665			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MG	28961277	Green Published, Green Submitted, gold			2022-12-26	WOS:000412027700031
J	Lee, S; Jung, M; Jung, J; Park, K; Ryu, JW; Kim, J; Kim, DS				Lee, Sugi; Jung, Minah; Jung, Jaeeun; Park, Kunhyang; Ryu, Jea-Woon; Kim, Jeongkil; Kim, Dae-soo			Gene selection tool (GST): A R-based tool for genetic disorders based on the sliding-window proportion test using whole-exome sequencing data	PLOS ONE			English	Article							LINKAGE	Whole-exome sequencing (WES) can identify causative mutations in hereditary diseases. However, WES data might have a large candidate variant list, including false positives. Moreover, in families, it is more difficult to select disease-associated variants because many variants are shared among members. To reduce false positives and extract accurate candidates, we used a multilocus variant instead of a single-locus variant (SNV). We set up a specific window to analyze the multilocus variant and devised a sliding-window approach to observe all variants. We developed the gene selection tool (GST) based on proportion tests for linkage analysis using WES data. This tool is R program coded and has high sensitivity. We tested our code to find the gene for hereditary spastic paraplegia using SNVs from a specific family and identified the gene known to cause the disease in a significant gene list. The list identified other genes that might be associated with the disease.	[Lee, Sugi; Jung, Minah; Jung, Jaeeun; Kim, Jeongkil; Kim, Dae-soo] Korea Univ Sci & Technol UST, KRIBB Sch Biosci, Dept Bioinformat, Daejeon, South Korea; [Lee, Sugi; Jung, Minah; Jung, Jaeeun; Ryu, Jea-Woon; Kim, Jeongkil; Kim, Dae-soo] KRIBB, Dept Rare Dis Res Ctr, Daejeon, South Korea; [Park, Kunhyang] KRIBB, Core Facil Management Ctr, Daejeon, South Korea	University of Science & Technology (UST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, DS (corresponding author), Korea Univ Sci & Technol UST, KRIBB Sch Biosci, Dept Bioinformat, Daejeon, South Korea.; Kim, DS (corresponding author), KRIBB, Dept Rare Dis Res Ctr, Daejeon, South Korea.	kds2465@kribb.re.kr			Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2014M3C9A2064618]; KRIBB Research Initiative Program; Ministry of Education, Science and Technology [NRF-2014M3C9A2064618]	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea); KRIBB Research Initiative Program; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2014M3C9A2064618 to DK), and by the KRIBB Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to researchers at KRIBB's Rare Disease Research Center for your help. All authors read and approved the final manuscript. The work was supported by Ministry of Education, Science and Technology NRF-2014M3C9A2064618.	Finch SJ, 2001, GENET EPIDEMIOL, V21, P315, DOI 10.1002/gepi.1037; Flaquer Antonia, 2012, BMC Res Notes, V5, P411, DOI 10.1186/1756-0500-5-411; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; MORTON NE, 1955, AM J HUM GENET, V7, P277; Ott J, 2015, NAT REV GENET, V16, P275, DOI 10.1038/nrg3908; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Penrose LS, 1935, ANN EUGENIC, V4, P133; Rijsdijk FV, 2001, EUR J HUM GENET, V9, P335, DOI 10.1038/sj.ejhg.5200634; Yang HC, 2006, GENET EPIDEMIOL, V30, P531, DOI 10.1002/gepi.20165	9	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185514	10.1371/journal.pone.0185514	http://dx.doi.org/10.1371/journal.pone.0185514			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957403	gold, Green Published, Green Submitted			2022-12-26	WOS:000411985200073
J	Moran, EV; Reid, A; Levine, JM				Moran, Emily V.; Reid, Andrea; Levine, Jonathan M.			Population genetics and adaptation to climate along elevation gradients in invasive Solidago canadensis	PLOS ONE			English	Article							RANGE EXPANSION; SPECIES RANGE; EXPERIMENTAL DEMOGRAPHY; SEXUAL REPRODUCTION; MICROSATELLITE LOCI; INCREASES FITNESS; FOREST TREES; PLANT; EVOLUTION; FLOW	Gene flow between populations may either support local adaptation by supplying genetic variation on which selection may act, or counteract it if maladapted alleles arrive faster than can be purged by selection. Although both such effects have been documented within plant species' native ranges, how the balance of these forces influences local adaptation in invasive plant populations is less clear, in part because introduced species often have lower genetic variation initially but also tend to have good dispersal abilities. To evaluate the extent of gene flow and adaptation to local climate in invasive populations of Solidago canadensis, and the implications of this for range expansion, we compared population differentiation at microsatellite and chloroplast loci for populations across Switzerland and assessed the effect of environmental transfer distance using common gardens. We found that while patterns of differentiation at neutral genetic markers suggested that populations are connected through extensive pollen and seed movement, common-garden plants nonetheless exhibited modest adaptation to local climate conditions. Growth rate and flower production declined with climatic distance from a plant's home site, with clones from colder home sites performing better at or above the range limit. Such adaptation in invasive species is likely to promote further spread, particularly under climate change, as the genotypes positioned near the range edge may be best able to take advantage of lengthening growing seasons to expand the range.	[Moran, Emily V.] Univ Calif Merced, Life & Environm Sci, Merced, CA 95340 USA; [Reid, Andrea; Levine, Jonathan M.] Swiss Fed Inst Technol, Biol, Zurich, Switzerland	University of California System; University of California Merced; Swiss Federal Institutes of Technology Domain; ETH Zurich	Moran, EV (corresponding author), Univ Calif Merced, Life & Environm Sci, Merced, CA 95340 USA.	emoran5@ucmerced.edu	Levine, Jonathan/A-7167-2014	Moran, Emily/0000-0003-4624-1910	CCES (ETH Competence Center for Environment and Sustainability project GeneMig); Zurich-Basel Plant Science Center	CCES (ETH Competence Center for Environment and Sustainability project GeneMig); Zurich-Basel Plant Science Center	This work was supported by CCES (ETH Competence Center for Environment and Sustainability project GeneMig) and the Plant Fellows program of the Zurich-Basel Plant Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by CCES (ETH Competence Center for Environment and Sustain ability project GeneMig) and the Plant Fellows program of the Zurich-Basel Plant Science Center. We would also like to thank the Gemeinde of Untervaz and BAFU (Swiss Federal Office for the Environment) for allowing us to conduct the common garden experiment, and to Janine Bolliger at WSL for providing the climate data. All molecular work was conducted at the ETH Genetic Diversity Centre (GDC) in Zurich.	Alexander JM, 2009, DIVERS DISTRIB, V15, P502, DOI 10.1111/j.1472-4642.2008.00555.x; Beck JB, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1500014; Becker T, 2005, PERSPECT PLANT ECOL, V7, P173, DOI 10.1016/j.ppees.2005.09.006; Bell G, 2009, ECOL LETT, V12, P942, DOI 10.1111/j.1461-0248.2009.01350.x; Bolliger J, 2000, REG ENVIRON CHANGE, V1, P99, DOI 10.1007/s101130000018; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Bridle JR, 2010, ECOL LETT, V13, P485, DOI 10.1111/j.1461-0248.2010.01442.x; Bridle JR, 2009, P ROY SOC B-BIOL SCI, V276, P1507, DOI 10.1098/rspb.2008.1601; Chun YJ, 2010, NEW PHYTOL, V185, P1100, DOI 10.1111/j.1469-8137.2009.03129.x; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Clark JS, 2001, AM NAT, V157, P537, DOI 10.1086/319934; Colautti RI, 2013, SCIENCE, V342, P364, DOI 10.1126/science.1242121; Dawson MN, 2010, MOL ECOL, V19, P1585, DOI 10.1111/j.1365-294X.2010.04588.x; Diniz JAF, 2013, GENET MOL BIOL, V36, P475, DOI 10.1590/S1415-47572013000400002; Dlugosch KM, 2008, ECOL LETT, V11, P701, DOI 10.1111/j.1461-0248.2008.01181.x; Dong M, 2006, PLANT SPEC BIOL, V21, P13, DOI 10.1111/j.1442-1984.2006.00146.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Ellstrand NC, 2014, AM J BOT, V101, P737, DOI 10.3732/ajb.1400024; Ferrer MM, 2007, NEW PHYTOL, V173, P401, DOI 10.1111/j.1469-8137.2006.01905.x; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; Gelfand AE, 1998, BIOMETRIKA, V85, P1, DOI 10.1093/biomet/85.1.1; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Griffith TM, 2006, AM NAT, V167, P153, DOI 10.1086/498945; Hamrick JL, 2004, FOREST ECOL MANAG, V197, P323, DOI 10.1016/j.foreco.2004.05.023; HARTNETT DC, 1985, J ECOL, V73, P407, DOI 10.2307/2260483; Hobbs N.T., 2015, BAYESIAN MODELS, DOI [DOI 10.1515/9781400866557, 10.1515/9781400866557]; Holderegger R, 2006, LANDSCAPE ECOL, V21, P797, DOI 10.1007/s10980-005-5245-9; Holt RD, 2004, AM NAT, V163, P253, DOI 10.1086/381408; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Keller SR, 2010, J EVOLUTION BIOL, V23, P1720, DOI 10.1111/j.1420-9101.2010.02037.x; Kimbrell T, 2007, AM NAT, V169, P370, DOI 10.1086/511314; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lambrinos JG, 2004, ECOLOGY, V85, P2061, DOI 10.1890/03-8013; Leites LP, 2012, ECOL APPL, V22, P154, DOI 10.1890/11-0150.1; Lembrechts JJ, 2016, ECOGRAPHY; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; MELVILLE MR, 1982, CAN J BOT, V60, P976, DOI 10.1139/b82-123; Meyer AH, 1999, J ECOL, V87, P17, DOI 10.1046/j.1365-2745.1999.00315.x; Meyer AH, 1999, J ECOL, V87, P42, DOI 10.1046/j.1365-2745.1999.00317.x; MILLIGAN BG, 1994, MOL ECOL, V3, P423, DOI 10.1111/j.1365-294X.1994.tb00082.x; Moran EV, 2014, ECOL LETT, V17, P637, DOI 10.1111/ele.12262; Muller G., 2013, THESIS; North A, 2011, EVOLUTION, V65, P79, DOI 10.1111/j.1558-5646.2010.01107.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Polechova J, 2015, P NATL ACAD SCI USA, V112, P6401, DOI 10.1073/pnas.1421515112; PONS O, 1995, THEOR APPL GENET, V90, P462, DOI 10.1007/BF00221991; Pons O, 1996, GENETICS, V144, P1237; PORS B, 1989, AM J BOT, V76, P1681, DOI 10.2307/2444406; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Rasanen K, 2008, ECOL LETT, V11, P624, DOI 10.1111/j.1461-0248.2008.01176.x; Rehfeldt GE, 2002, GLOBAL CHANGE BIOL, V8, P912, DOI 10.1046/j.1365-2486.2002.00516.x; REHFELDT GE, 1984, BOT GAZ, V145, P229, DOI 10.1086/337451; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Rousset F, 1997, GENETICS, V145, P1219; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sambatti JBM, 2006, EVOLUTION, V60, P696, DOI 10.1111/j.0014-3820.2006.tb01149.x; Schlaepfer DR, 2008, MOL ECOL, V17, P5245, DOI 10.1111/j.1365-294X.2008.03980.x; Seipel T, 2016, PERSPECT PLANT ECOL, V20, P46, DOI 10.1016/j.ppees.2016.04.001; Seipel T, 2012, GLOBAL ECOL BIOGEOGR, V21, P236, DOI 10.1111/j.1466-8238.2011.00664.x; Sexton JP, 2014, EVOLUTION, V68, P1, DOI 10.1111/evo.12258; Sexton JP, 2011, P NATL ACAD SCI USA, V108, P11704, DOI 10.1073/pnas.1100404108; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Tackenberg O, 2003, ECOL MONOGR, V73, P191, DOI 10.1890/0012-9615(2003)073[0191:AOWDPI]2.0.CO;2; Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9; Thuillet AC, 2002, MOL BIOL EVOL, V19, P122, DOI 10.1093/oxfordjournals.molbev.a003977; Torriani DS, 2007, CLIM RES, V34, P59, DOI 10.3354/cr034059; Trapnell DW, 2004, MOL ECOL, V13, P2655, DOI 10.1111/j.1365-294X.2004.02281.x; van Kleunen M, 2003, ECOLOGY, V84, P2816, DOI 10.1890/02-0494; van Kleunen M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1487; Wang IJ, 2013, EVOLUTION, V67, P3403, DOI 10.1111/evo.12134; Weber E, 1998, AM J BOT, V85, P1110, DOI 10.2307/2446344; Weber E, 1997, BOT J LINN SOC, V123, P197, DOI 10.1006/bojl.1996.0086; Weber E, 2001, CONSERV BIOL, V15, P122, DOI 10.1046/j.1523-1739.2001.99424.x; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Wieczorek AM, 2002, MOL ECOL NOTES, V2, P554, DOI 10.1046/j.1471-8286.2002.00316.x; YANG SS, 1995, AGR FOREST METEOROL, V74, P61, DOI 10.1016/0168-1923(94)02185-M; Zhang YY, 2013, NEW PHYTOL, V197, P314, DOI 10.1111/nph.12010; Zhang YY, 2010, MOL ECOL, V19, P1774, DOI 10.1111/j.1365-294X.2010.04609.x; Zhao SY, 2012, GENET MOL RES, V11, P421, DOI 10.4238/2012.February.17.4	85	19	19	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185539	10.1371/journal.pone.0185539	http://dx.doi.org/10.1371/journal.pone.0185539			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957402	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200080
J	Mett, V; Komarova, EA; Greene, K; Bespalov, I; Brackett, C; Gillard, B; Gleiberman, AS; Toshkov, IA; Aygun-Sunar, S; Johnson, C; Karasik, E; Bapardekar-Nair, M; Kurnasov, OV; Osterman, AL; Stanhope-Baker, PS; Morrison, C; Moser, MT; Foster, BA; Gudkov, AV				Mett, V; Komarova, E. A.; Greene, K.; Bespalov, I; Brackett, C.; Gillard, B.; Gleiberman, A. S.; Toshkov, I. A.; Aygun-Sunar, S.; Johnson, C.; Karasik, E.; Bapardekar-Nair, M.; Kurnasov, O., V; Osterman, A. L.; Stanhope-Baker, P. S.; Morrison, C.; Moser, M. T.; Foster, B. A.; Gudkov, A., V			Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy	ONCOGENE			English	Article							RESISTANT PROSTATE-CANCER; TRANSGENIC MOUSE MODEL; ANTITUMOR IMMUNITY; HEPATIC METASTASES; CTLA-4 BLOCKADE; GENE-THERAPY; MURINE MODEL; FLAGELLIN; MELANOMA; AGONIST	Toll-like receptor 5 (TLR5) is considered an attractive target for anticancer immunotherapy. TLR5 agonists, bacterial flagellin and engineered flagellin derivatives, have been shown to have potent antitumor and metastasis-suppressive effects in multiple animal models and to be safe in both animals and humans. Anticancer efficacy of TLR5 agonists stems from TLR5-dependent activation of nuclear factor-kappa B (NF-kappa B) that mediates innate and adaptive antitumor immune responses. To extend application of TLR5-targeted anticancer immunotherapy to tumors that do not naturally express TLR5, we created an adenovirus-based vector for intratumor delivery, named Mobilan that drives expression of self-activating TLR5 signaling cassette comprising of human TLR5 and a secreted derivative of Salmonella flagellin structurally analogous to a clinical stage TLR5 agonist, entolimod. Co-expression of TLR5 receptor and agonist in Mobilan-infected cells established an autocrine/paracrine TLR5 signaling loop resulting in constitutive activation of NF-kappa B both in vitro and in vivo. Injection of Mobilan into primary tumors of the prostate cancer-prone transgenic adenocarcinoma of the mouse prostate (TRAMP) mice resulted in a strong induction of multiple genes involved in inflammatory responses and mobilization of innate immune cells into the tumors including neutrophils and NK cells and suppressed tumor progression. Intratumoral injection of Mobilan into subcutaneously growing syngeneic prostate tumors in immunocompetent hosts improved animal survival after surgical resection of the tumors, by suppression of tumor metastasis. In addition, vaccination of mice with irradiated Mobilan-transduced prostate tumor cells protected mice against subsequent tumor challenge. These results provide proof-of-concept for Mobilan as a tool for antitumor vaccination that directs TLR5-mediated immune response toward cancer cells and does not require identification of tumor antigens.	[Mett, V; Bespalov, I; Gleiberman, A. S.; Toshkov, I. A.; Aygun-Sunar, S.; Bapardekar-Nair, M.; Stanhope-Baker, P. S.; Gudkov, A., V] Cleveland Biolabs Inc, Buffalo, NY USA; [Komarova, E. A.; Greene, K.; Brackett, C.; Johnson, C.; Gudkov, A., V] Roswell Pk Canc Inst, Dept Cell Stress Biol, CGP L3-310,Elm & Carlton St, Buffalo, NY 14263 USA; [Gillard, B.; Karasik, E.; Moser, M. T.; Foster, B. A.] Roswell Pk Canc Inst, Dept Mol Pharmacol & Canc Therapeut, Buffalo, NY 14263 USA; [Kurnasov, O., V; Osterman, A. L.] Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA USA; [Morrison, C.] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Sanford Burnham Prebys Medical Discovery Institute; Roswell Park Cancer Institute	Gudkov, AV (corresponding author), Roswell Pk Canc Inst, Dept Cell Stress Biol, CGP L3-310,Elm & Carlton St, Buffalo, NY 14263 USA.	andrei.gudkov@roswellpark.org		gleiberman, anatoli/0000-0001-8491-0826	Panacela Labs, LLC; National Cancer Institute (NCI) Cancer Center Core Grant [P30CA016056]; DOD the Roswell Park Alliance Foundation [BC140507]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Panacela Labs, LLC; National Cancer Institute (NCI) Cancer Center Core Grant; DOD the Roswell Park Alliance Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Cellecta, Inc. and O.D.260, Inc. help with for adenoviral vector construction and manufacturing. This work was supported by contract from Panacela Labs (a biotech company that possesses intellectual property rights for Mobilan), LLC, National Cancer Institute (NCI) Cancer Center Core Grant P30CA016056 and by grants from DOD (BC140507 to AVG) the Roswell Park Alliance Foundation to EAK and AVG.	Akira S, 2004, CR BIOL, V327, P581, DOI 10.1016/j.crvi.2004.04.002; Arlen PM, 2007, J UROLOGY, V178, P1515, DOI 10.1016/j.juro.2007.05.117; Brackett CM, 2016, P NATL ACAD SCI USA, V113, pE874, DOI 10.1073/pnas.1521359113; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Burdelya LG, 2013, P NATL ACAD SCI USA, V110, pE1857, DOI 10.1073/pnas.1222805110; Burdelya LG, 2012, INT J RADIAT ONCOL, V83, P228, DOI 10.1016/j.ijrobp.2011.05.055; Cai ZY, 2011, CANCER RES, V71, P2466, DOI 10.1158/0008-5472.CAN-10-1993; Carvalho FA, 2011, MUCOSAL IMMUNOL, V4, P102, DOI 10.1038/mi.2010.57; Cuadros C, 2004, INFECT IMMUN, V72, P2810, DOI 10.1128/IAI.72.5.2810-2816.2004; de Melo FM, 2015, IMMUNOL CELL BIOL, V93, P86, DOI 10.1038/icb.2014.74; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Eaves-Pyles TD, 2001, J IMMUNOL, V167, P7009, DOI 10.4049/jimmunol.167.12.7009; Faham A, 2010, J IMMUNOL, V185, P1744, DOI 10.4049/jimmunol.1000027; Fernandez-Garcia EM, 2015, CLIN TRANSL ONCOL, V17, P339, DOI 10.1007/s12094-014-1259-6; Forde PM, 2013, ONCOLOGIST, V18, P1203, DOI 10.1634/theoncologist.2013-0171; Foster BA, 1997, CANCER RES, V57, P3325; Fougere-Deschatrette C, 2006, STEM CELLS, V24, P2098, DOI 10.1634/stemcells.2006-0009; Galli R, 2010, J IMMUNOL, V184, P6658, DOI 10.4049/jimmunol.0902401; Garaude J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002868; Gingrich JR, 1996, TOXICOL PATHOL, V24, P502, DOI 10.1177/019262339602400414; Glavan TM, 2014, CURR PHARM DESIGN, V20, P6555, DOI 10.2174/1381612820666140826153347; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Gupta S, 2000, CANCER RES, V60, P5125; Hemmi S, 1998, HUM GENE THER, V9, P2363, DOI 10.1089/hum.1998.9.16-2363; Hurwitz AA, 2000, CANCER RES, V60, P2444; Kaczanowska S, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1076609; Kaczanowska S, 2013, J LEUKOCYTE BIOL, V93, P847, DOI 10.1189/jlb.1012501; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Korman AJ, 2006, ADV IMMUNOL, V90, P297, DOI 10.1016/S0065-2776(06)90008-X; Krivokrysenko VI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135388; Kwon ED, 1999, P NATL ACAD SCI USA, V96, P15074, DOI 10.1073/pnas.96.26.15074; Kwon ED, 2014, LANCET ONCOL, V15, P700, DOI 10.1016/S1470-2045(14)70189-5; Lee SE, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1081328; Leigh ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085587; Lubaroff DM, 2009, CLIN CANCER RES, V15, P7375, DOI 10.1158/1078-0432.CCR-09-1910; Mamalis A, 2014, ARCH DERMATOL RES, V306, P511, DOI 10.1007/s00403-014-1457-7; Marini FC, 2000, CANCER GENE THER, V7, P816, DOI 10.1038/sj.cgt.7700174; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Mentor-Marcel R, 2001, CANCER RES, V61, P6777; Meyer T, 2008, EXPERT OPIN INV DRUG, V17, P1051, DOI [10.1517/13543784.17.7.1051, 10.1517/13543784.17.7.1051 ]; Michael A, 2005, CLIN CANCER RES, V11, P4469, DOI 10.1158/1078-0432.CCR-04-2337; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Ott PA, 2013, CLIN CANCER RES, V19, P5300, DOI 10.1158/1078-0432.CCR-13-0143; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Patil SA, 2014, GLYCOCONJUGATE J, V31, P509, DOI 10.1007/s10719-014-9548-4; Rauen KA, 2002, CANCER RES, V62, P3812; Rhee SH, 2008, GASTROENTEROLOGY, V135, P518, DOI 10.1053/j.gastro.2008.04.022; Rhee SH, 2011, J NEUROGASTROENTEROL, V17, P28, DOI 10.5056/jnm.2011.17.1.28; Rodriguez GM, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1151593; Sfondrini L, 2006, J IMMUNOL, V176, P6624, DOI 10.4049/jimmunol.176.11.6624; Shi YF, 2006, CELL RES, V16, P126, DOI 10.1038/sj.cr.7310017; Simons JW, 2006, UROL ONCOL-SEMIN ORI, V24, P419, DOI 10.1016/j.urolonc.2005.08.021; Soto LJ, 2003, J PEDIATR SURG, V38, P1075, DOI 10.1016/S0022-3468(03)00196-9; Sullivan RJ, 2013, CLIN CANCER RES, V19, P5283, DOI 10.1158/1078-0432.CCR-13-2151; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tosch C, 2009, CANCER GENE THER, V16, P310, DOI 10.1038/cgt.2008.85; Vijay-Kumar M, 2010, EUR J IMMUNOL, V40, P3528, DOI 10.1002/eji.201040421; Yam C, 2010, J SURG RES, V164, P248, DOI 10.1016/j.jss.2009.02.023; Yang H, 2016, ONCOTARGET, V7, P2936, DOI 10.18632/oncotarget.6500; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584; Yu XF, 2013, CANCER RES, V73, P2093, DOI 10.1158/0008-5472.CAN-12-1740	63	20	23	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 25	2018	37	4					439	449		10.1038/onc.2017.346	http://dx.doi.org/10.1038/onc.2017.346			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT7KP	28967901	Green Published, hybrid			2022-12-26	WOS:000423331600003
J	Nielsen, BS; Alstrom, JS; Nicholson, BJ; Nielsen, MS; MacAulay, N				Nielsen, Brian Skriver; Alstrom, Jette Skov; Nicholson, Bruce J.; Nielsen, Morten Schak; MacAulay, Nanna			Permeant-specific gating of connexin 30 hemichannels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; connexin; connexon (hemichannel); fluorescence; gating; ion channel; permeability	GAP-JUNCTION CHANNELS; 1ST EXTRACELLULAR LOOP; PORE-LINING RESIDUES; SELECTIVE PERMEABILITY; XENOPUS OOCYTES; ATP RELEASE; INTERSUBUNIT INTERACTIONS; METABOLIC INHIBITION; CX26 HEMICHANNELS; MOLECULAR-BASIS	Gap junctions confer interconnectivity of the cytoplasm in neighboring cells via docking of two connexons expressed in each of the adjacent membranes. Undocked connexons, referred to as hemichannels, may open and connect the cytoplasm with the extracellular fluid. The hemichannel configuration of connexins (Cxs) displays isoform-specific permeability profiles that are not directly determined by the size and charge of the permeant. To further explore Ca2+-mediated gating and permeability features of connexin hemichannels, we heterologously expressed Cx30 hemichannels in Xenopus laevis oocytes. The sensitivity toward divalent cation-mediated gating differed between small atomic ions (current) and fluorescent dye permeants, indicating that these permeants are distinctly gated. Three aspartate residues in Cx30 (Asp-50, Asp-172, and Asp-179) have been implicated previously in the Ca2+ sensitivity of other hemichannel isoforms. Although the aspartate at position Asp-50 was indispensable for divalent cation-dependent gating of Cx30 hemichannels, substitutions of the two other residues had no significant effect on gating, illustrating differences in the gating mechanisms between connexin isoforms. Using the substituted cysteine accessibility method (SCAM), we evaluated the role of possible pore-lining residues in the permeation of ions and ethidium through Cx30 hemichannels. Of the cysteine-substituted residues, interaction of a proposed pore-lining cysteine at position 37 with the positively charged compound [2-(trimethylammonium)ethyl] methane thiosulfonate bromide (MTS-ET) increased Cx30-mediated currents with unperturbed ethidium permeability. In summary, our results demonstrate that the permeability of hemichannels is regulated in a permeant-specific manner and underscores that hemichannels are selective rather than non-discriminating and freely diffusable pores.	[Nielsen, Brian Skriver; Alstrom, Jette Skov; MacAulay, Nanna] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Neurosci, DK-2200 Copenhagen N, Denmark; [Nielsen, Morten Schak] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, DK-2200 Copenhagen N, Denmark; [Nicholson, Bruce J.] Univ Texas Hlth Sci Ctr San Antonio, Sch Med, Dept Biochem, San Antonio, TX 78229 USA	University of Copenhagen; University of Copenhagen; University of Texas System; University of Texas Health San Antonio	MacAulay, N (corresponding author), Univ Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	macaulay@sund.ku.dk	MacAulay, Nanna/AER-7709-2022; Nielsen, Morten Schak/C-1494-2009	MacAulay, Nanna/0000-0002-7800-6600; Nielsen, Morten Schak/0000-0002-9718-5421; Nielsen, Brian Skriver/0000-0002-3018-3309	Faculty of Health and Medical Sciences (University of Copenhagen)	Faculty of Health and Medical Sciences (University of Copenhagen)	This work was predominantly supported by the Faculty of Health and Medical Sciences (University of Copenhagen). The authors declare that they have no conflicts of interest with the contents of this article.	Abbaci M, 2008, BIOTECHNIQUES, V45, P33, DOI 10.2144/000112810; Alstrom JS, 2015, J NEUROPHYSIOL, V114, P3014, DOI 10.1152/jn.00575.2015; Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Bahima L, 2006, J CELL PHYSIOL, V206, P95, DOI 10.1002/jcp.20440; Bao L, 2004, AM J PHYSIOL-CELL PH, V287, pC1389, DOI 10.1152/ajpcell.00220.2004; Bennett BC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms9770; Bone LJ, 1997, NEUROBIOL DIS, V4, P221, DOI 10.1006/nbdi.1997.0152; Bukauskas FF, 2002, J GEN PHYSIOL, V119, P171, DOI 10.1085/jgp.119.2.171; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Common JEA, 2002, BIOCHEM BIOPH RES CO, V298, P651, DOI 10.1016/S0006-291X(02)02517-2; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Ebihara L, 1996, BIOPHYS J, V71, P742, DOI 10.1016/S0006-3495(96)79273-1; Ek-Vitorin JF, 2006, CIRC RES, V98, P1498, DOI 10.1161/01.RES.0000227572.45891.2c; Ek-Vitorin JF, 2013, BBA-BIOMEMBRANES, V1828, P51, DOI 10.1016/j.bbamem.2012.02.003; Fenton RA, 2010, CELL MOL LIFE SCI, V67, P829, DOI 10.1007/s00018-009-0218-9; Froger N, 2010, MOL CELL NEUROSCI, V45, P37, DOI 10.1016/j.mcn.2010.05.007; Garre JM, 2010, P NATL ACAD SCI USA, V107, P22659, DOI 10.1073/pnas.1013793107; Goldberg GS, 1999, NAT CELL BIOL, V1, P457, DOI 10.1038/15693; Goldberg GS, 2004, BBA-BIOMEMBRANES, V1662, P96, DOI 10.1016/j.bbamem.2003.11.022; Goldberg GS, 2002, J BIOL CHEM, V277, P36725, DOI 10.1074/jbc.M109797200; Gomez-Hernandez JM, 2003, P NATL ACAD SCI USA, V100, P16030, DOI 10.1073/pnas.2530348100; Gonzalez D, 2006, FASEB J, V20, P2329, DOI 10.1096/fj.06-5828com; Hansen DB, 2014, J BIOL CHEM, V289, P26058, DOI 10.1074/jbc.M114.582155; Hansen DB, 2014, FEBS LETT, V588, P1446, DOI 10.1016/j.febslet.2014.01.036; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Jan AY, 2004, J INVEST DERMATOL, V122, P1108, DOI 10.1111/j.0022-202X.2004.22518.x; John SA, 1999, J BIOL CHEM, V274, P236, DOI 10.1074/jbc.274.1.236; Kanaporis G, 2011, AM J PHYSIOL-CELL PH, V300, pC600, DOI 10.1152/ajpcell.00316.2010; Kronengold J, 2003, J GEN PHYSIOL, V122, P389, DOI 10.1085/jgp.200308861; Kronengold J, 2012, J MEMBRANE BIOL, V245, P453, DOI 10.1007/s00232-012-9457-z; KWAK BR, 1995, EXP CELL RES, V220, P456, DOI 10.1006/excr.1995.1337; Lee JR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001276; Lee JR, 2009, J INVEST DERMATOL, V129, P870, DOI 10.1038/jid.2008.335; Lopez W, 2016, P NATL ACAD SCI USA, V113, pE7986, DOI 10.1073/pnas.1609378113; Lopez W, 2014, CHANNELS, V8, P1, DOI 10.4161/chan.26789; Lopez W, 2013, J GEN PHYSIOL, V142, P23, DOI 10.1085/jgp.201210893; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Moeller HB, 2009, AM J PHYSIOL-RENAL, V296, pF649, DOI 10.1152/ajprenal.90682.2008; Nicholson BJ, 2000, BRAZ J MED BIOL RES, V33, P369, DOI 10.1590/S0100-879X2000000400002; Nielsen BS, 2017, NEUROCHEM RES, V42, P2537, DOI 10.1007/s11064-017-2243-7; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; Niessen H, 2000, J CELL SCI, V113, P1365; Orellana JA, 2011, BIOCHEM BIOPH RES CO, V409, P603, DOI 10.1016/j.bbrc.2011.05.031; Oviedo-Orta E, 2004, BBA-BIOMEMBRANES, V1662, P102, DOI 10.1016/j.bbamem.2003.10.021; Ramachandran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000712; Saez JC, 2010, EXP CELL RES, V316, P2377, DOI 10.1016/j.yexcr.2010.05.026; Sanchez HA, 2013, J GEN PHYSIOL, V142, P3, DOI 10.1085/jgp.201310962; Sanchez HA, 2010, J GEN PHYSIOL, V136, P47, DOI 10.1085/jgp.201010433; Skerrett IM, 2002, J CELL BIOL, V159, P349, DOI 10.1083/jcb.200207060; Sohl G, 2003, CELL COMMUN ADHES, V10, P173, DOI 10.1080/15419060390262877; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Tang QX, 2009, J GEN PHYSIOL, V133, P555, DOI 10.1085/jgp.200910207; Toloue M. M., 2007, THESIS; Valiunas V, 2000, PFLUG ARCH EUR J PHY, V440, P366, DOI 10.1007/s004240000294; Vavrusova M, 2013, J AGR FOOD CHEM, V61, P5380, DOI 10.1021/jf400741e; Verselis VK, 2009, J BIOL CHEM, V284, P4484, DOI 10.1074/jbc.M807430200; WHITE TW, 1992, MOL BIOL CELL, V3, P711, DOI 10.1091/mbc.3.7.711; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Yum SW, 2007, AM J PHYSIOL-CELL PH, V293, pC1032, DOI 10.1152/ajpcell.00011.2007; Zhou XW, 1997, BIOPHYS J, V72, P1946, DOI 10.1016/S0006-3495(97)78840-4	61	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					19999	20009		10.1074/jbc.M117.805986	http://dx.doi.org/10.1074/jbc.M117.805986			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	28982982	hybrid, Green Published			2022-12-26	WOS:000417696400007
J	Gururaj, S; Evely, KM; Pryce, KD; Li, J; Qu, J; Bhattacharjee, A				Gururaj, Sushmitha; Evely, Katherine M.; Pryce, Kerri D.; Li, Jun; Qu, Jun; Bhattacharjee, Arin			Protein kinase A-induced internalization of Slack channels from the neuronal membrane occurs by adaptor protein-2/clathrin-mediated endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; clathrin; endocytosis; neuron; pain; potassium channel; trafficking	ACTIVATED POTASSIUM CHANNEL; ROOT GANGLION NEURONS; K-NA CHANNELS; SENSORY NEURONS; NEUROPATHIC PAIN; CAMP; RAT; HYPEREXCITABILITY; PHOSPHORYLATION; RECOGNITION	The sodium-activated potassium (K-Na) channel Kcnt1 (Slack) is abundantly expressed in nociceptor (pain-sensing) neurons of the dorsal root ganglion (DRG), where they transmit the large outward conductance I-KNa and arbitrate membrane excitability. Slack channel expression at the DRG membrane is necessary for their characteristic firing accommodation during maintained stimulation, and reduced membrane channel density causes hyperexcitability. We have previously shown that in a pro-inflammatory state, a decrease in membrane channel expression leading to reduced Slack-mediated I-KNa expression underlies DRG neuronal sensitization. An important component of the inflammatory milieu, PKA internalizes Slack channels from the DRG membrane, reduces I-KNa, and produces DRG neuronal hyperexcitability when activated in cultured primary DRG neurons. Here, we show that this PKA-induced retrograde trafficking of Slack channels also occurs in intact spinal cord slices and that it is carried out by adaptor protein-2 (AP-2) via clathrin-mediated endocytosis. We provide mass spectrometric and biochemical evidence of an association of native neuronal AP-2 adaptor proteins with Slack channels, facilitated by a dileucine motif housed in the cytoplasmic Slack C terminus that binds AP-2. By creating a competitive peptide blocker of AP-2-Slack binding, we demonstrated that this interaction is essential for clathrin recruitment to the DRG membrane, Slack channel endocytosis, and DRG neuronal hyperexcitability after PKA activation. Together, these findings uncover AP-2 and clathrin as players in Slack channel regulation. Given the significant role of Slack in nociceptive neuronal excitability, the AP-2 clathrin-mediated endocytosis trafficking mechanism may enable targeting of peripheral and possibly, central neuronal sensitization.	[Gururaj, Sushmitha; Pryce, Kerri D.; Bhattacharjee, Arin] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA; [Evely, Katherine M.; Bhattacharjee, Arin] SUNY Buffalo, Program Neurosci, Buffalo, NY 14214 USA; [Li, Jun; Qu, Jun] New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Bhattacharjee, A (corresponding author), SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA.	ab68@buffalo.edu		Pryce, Kerri/0000-0001-6771-2000	National Institutes of Health [NS078184]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM095459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in whole by National Institutes of Health Grant NS078184. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilar RC, 2001, J BIOL CHEM, V276, P13145, DOI 10.1074/jbc.M010591200; Barcia G, 2012, NAT GENET, V44, P1255, DOI 10.1038/ng.2441; BARDE YA, 1980, P NATL ACAD SCI-BIOL, V77, P1199, DOI 10.1073/pnas.77.2.1199; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Bischoff U, 1998, J PHYSIOL-LONDON, V510, P743, DOI 10.1111/j.1469-7793.1998.743bj.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Boucrot E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010597; Brattacharjee A, 2005, J COMP NEUROL, V484, P80, DOI 10.1002/cne.20462; Brown MR, 2008, J PHYSIOL-LONDON, V586, P5161, DOI 10.1113/jphysiol.2008.160861; Bucelli RC, 2008, J PHARMACOL EXP THER, V324, P1172, DOI 10.1124/jpet.107.132795; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Ensenat-Waser R, 2002, IUBMB LIFE, V54, P33, DOI 10.1080/15216540213823; Gururaj S, 2016, NEUROPHARMACOLOGY, V103, P279, DOI 10.1016/j.neuropharm.2015.12.016; Huang F, 2013, NAT NEUROSCI, V16, P1284, DOI 10.1038/nn.3468; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kostich W, 2016, J PHARMACOL EXP THER, V358, P371, DOI 10.1124/jpet.116.235333; Lu RR, 2015, J NEUROSCI, V35, P1125, DOI 10.1523/JNEUROSCI.2423-14.2015; Lundby A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1871; Malmberg AB, 1997, J NEUROSCI, V17, P7462; Mason AK, 2008, J BIOL CHEM, V283, P5973, DOI 10.1074/jbc.M709756200; Moser B, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201600332; Nuwer MO, 2010, J NEUROSCI, V30, P14165, DOI 10.1523/JNEUROSCI.3150-10.2010; Nuwer MO, 2009, NEUROPHARMACOLOGY, V57, P219, DOI 10.1016/j.neuropharm.2009.06.006; Park SY, 2014, BIOSCIENCE REP, V34, P381, DOI 10.1042/BSR20140069; Popova NV, 2013, ACTA NATURAE, V5, P62, DOI 10.32607/20758251-2013-5-3-62-73; RUEFF A, 1993, NEUROSCIENCE, V54, P527, DOI 10.1016/0306-4522(93)90272-H; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Tamsett TJ, 2009, J NEUROSCI, V29, P5127, DOI 10.1523/JNEUROSCI.0859-09.2009; Tomasello DL, 2015, J BIOL CHEM, V290, P18575, DOI 10.1074/jbc.M115.643536; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Ye B, 2006, PHYSIOL RES, V55, P617, DOI 10.33549/physiolres.930866; Zheng JH, 2007, J NEUROPHYSIOL, V97, P15, DOI 10.1152/jn.00559.2006	38	5	6	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19304	19314		10.1074/jbc.M117.804716	http://dx.doi.org/10.1074/jbc.M117.804716			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28982974	Green Published, hybrid			2022-12-26	WOS:000416226700013
J	Minko, IG; Rizzo, CJ; Lloyd, RS				Minko, Irina G.; Rizzo, Carmelo J.; Lloyd, R. Stephen			Mutagenic potential of nitrogen mustard-induced formamidopyrimidine DNA adduct: Contribution of the non-canonical -anomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						8-Oxoguanine (8-oxoG); cancer therapy; DNA damage; DNA polymerase; Escherichia coli (E; coli); mutagenesis; COS7 cells; DNA alkylation; Fapy lesion; replication bypass	N,N-BIS(2-CHLOROETHYL)-P-AMINOPHENYLBUTYRIC ACID CHLORAMBUCIL; RING-OPENED FORMAMIDOPYRIMIDINE; ERROR-PRONE REPLICATION; PROTEIN CROSS-LINKING; CENTER-DOT-DG; PHOSPHORAMIDE MUSTARD; TRANSLESION SYNTHESIS; 8-OXO-7,8-DIHYDRO-2'-DEOXYGUANOSINE BYPASS; POLYMERASE BETA; FIDELITY	Nitrogen mustards (NMs) are DNA-alkylating compounds that represent the earliest anticancer drugs. However, clinical use of NMs is limited because of their own mutagenic properties. The mechanisms of NM-induced mutagenesis remain unclear. The major product of DNA alkylation by NMs is a cationic NM-N7-dG adduct that can yield the imidazole ring-fragmented lesion, N-5-NM-substituted formamidopyrimidine (NM-Fapy-dG). Characterization of this adduct is complicated because it adopts different conformations, including both a canonical - and an unnatural -anomeric configuration. Although formation of NM-Fapy-dG in cellular DNA has been demonstrated, its potential role in NM-induced mutagenesis is unknown. Here, we created site-specifically modified single-stranded vectors for replication in primate (COS7) or Escherichia coli cells. In COS7 cells, NM-Fapy-dG caused targeted mutations, predominantly G T transversions, with overall frequencies of approximate to 11-12%. These frequencies were approximate to 2-fold higher than that induced by 8-oxo-dG adduct. Replication in E. coli was essentially error-free. To elucidate the mechanisms of bypass of NM-Fapy-dG, we performed replication assays in vitro with a high-fidelity DNA polymerase, Saccharomyces cerevisiae polymerase (pol) . It was found that pol could catalyze high-fidelity synthesis past NM-Fapy-dG, but only on a template subpopulation, presumably containing the -anomeric adduct. Consistent with the low mutagenic potential of the -anomer in vitro, the mutation frequency was significantly reduced when conditions for vector preparation were modified to favor this configuration. Collectively, these data implicate the -anomer as a major contributor to NM-Fapy-dG-induced mutagenesis in primate cells.	[Minko, Irina G.; Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97239 USA; [Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA; [Rizzo, Carmelo J.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Dept Chem, Nashville, TN 37235 USA; [Rizzo, Carmelo J.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Dept Biochem, Nashville, TN 37235 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Vanderbilt University; Vanderbilt University	Lloyd, RS (corresponding author), Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97239 USA.; Lloyd, RS (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA.; Lloyd, RS (corresponding author), Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA.	lloydst@ohsu.edu		Lloyd, R. Stephen/0000-0001-7273-372X; Rizzo, Carmelo/0000-0001-9005-611X	National Institutes of Health; NCI [T32 CA106195, P01 CA160032, P30 CA068485]; NIEHS [P30 ES000267, T32 ES0007060]; NATIONAL CANCER INSTITUTE [T32CA106195, P01CA160032, P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, T32ES007060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health, NCI Grants T32 CA106195, P01 CA160032, and P30 CA068485 and NIEHS Grants P30 ES000267 and T32 ES0007060. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amato NJ, 2015, NUCLEIC ACIDS RES, V43, P8314, DOI 10.1093/nar/gkv725; Avkin S, 2002, P NATL ACAD SCI USA, V99, P3764, DOI 10.1073/pnas.062038699; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; BROOKES P, 1961, BIOCHEM J, V80, P496, DOI 10.1042/bj0800496; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; CHETSANGA CJ, 1982, CANCER RES, V42, P2616; Choi JY, 2010, J MOL BIOL, V404, P34, DOI 10.1016/j.jmb.2010.09.015; Christov PP, 2014, CHEM RES TOXICOL, V27, P1610, DOI 10.1021/tx5002354; Christov PP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/850234; Christov PP, 2012, CHEM RES TOXICOL, V25, P1652, DOI 10.1021/tx300113e; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Earley LF, 2013, CHEM RES TOXICOL, V26, P1108, DOI 10.1021/tx4001495; Efrati E, 1997, J BIOL CHEM, V272, P2559; Einolf HJ, 2001, J BIOL CHEM, V276, P3764, DOI 10.1074/jbc.M006696200; Florea-Wang D, 2004, CHEM RES TOXICOL, V17, P383, DOI 10.1021/tx034233q; Florea-Wang D, 2003, CHEM RES TOXICOL, V16, P403, DOI 10.1021/tx0256735; Florea-Wang D, 2009, CHEM BIODIVERS, V6, P1002, DOI 10.1002/cbdv.200800327; Fortune JM, 2006, NUCLEIC ACIDS RES, V34, P4335, DOI 10.1093/nar/gkl403; Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363; Gruppi F, 2015, CHEM RES TOXICOL, V28, P1850, DOI 10.1021/acs.chemrestox.5b00297; Haapala E, 2001, CHEM RES TOXICOL, V14, P988, DOI 10.1021/tx000249u; HEMMINKI K, 1987, CHEM-BIOL INTERACT, V61, P75, DOI 10.1016/0009-2797(87)90020-2; Hosing C, 2002, ANN ONCOL, V13, P450, DOI 10.1093/annonc/mdf109; Hsu GW, 2004, NATURE, V431, P217, DOI 10.1038/nature02908; Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749; IDE H, 1994, BIOCHEMISTRY-US, V33, P7842, DOI 10.1021/bi00191a011; Ishchenko AA, 2004, BIOCHEMISTRY-US, V43, P15210, DOI 10.1021/bi049214+; Kalam MA, 2006, NUCLEIC ACIDS RES, V34, P2305, DOI 10.1093/nar/gkl099; KALLAMA S, 1986, CHEM-BIOL INTERACT, V57, P85, DOI 10.1016/0009-2797(86)90051-7; KALLAMA S, 1984, ACTA PHARMACOL TOX, V54, P214; Kanuri M, 2002, J BIOL CHEM, V277, P18257, DOI 10.1074/jbc.M112419200; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; Loeber RL, 2009, CHEM RES TOXICOL, V22, P1151, DOI 10.1021/tx900078y; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; Markkanen E, 2012, P NATL ACAD SCI USA, V109, P20401, DOI 10.1073/pnas.1211532109; McCulloch SD, 2009, NUCLEIC ACIDS RES, V37, P2830, DOI 10.1093/nar/gkp103; Michaelson-Richie ED, 2011, J PROTEOME RES, V10, P2785, DOI 10.1021/pr200042u; Minko IG, 2008, MUTAT RES-FUND MOL M, V637, P161, DOI 10.1016/j.mrfmmm.2007.08.001; Minko IG, 2014, ENVIRON MOL MUTAGEN, V55, P601, DOI 10.1002/em.21882; Mohamed D, 2009, CHEM RES TOXICOL, V22, P1435, DOI 10.1021/tx900123r; MORIYA M, 1993, P NATL ACAD SCI USA, V90, P1122, DOI 10.1073/pnas.90.3.1122; OSBORNE MR, 1993, CHEM-BIOL INTERACT, V89, P49, DOI 10.1016/0009-2797(93)03197-3; OSBORNE MR, 1995, CHEM RES TOXICOL, V8, P316, DOI 10.1021/tx00044a018; Pande P, 2015, BIOCHEMISTRY-US, V54, P1859, DOI 10.1021/acs.biochem.5b00119; Patra A, 2014, J BIOL CHEM, V289, P16867, DOI 10.1074/jbc.M114.551820; Patro JN, 2007, BIOCHEMISTRY-US, V46, P10202, DOI 10.1021/bi700628c; Patro JN, 2004, BIOCHEMISTRY-US, V43, P13397, DOI 10.1021/bi049035s; POVIRK LF, 1994, MUTAT RES-REV GENET, V318, P205, DOI 10.1016/0165-1110(94)90015-9; Rajski SR, 1998, CHEM REV, V98, P2723, DOI 10.1021/cr9800199; Sha Y, 2017, ENVIRON MOL MUTAGEN, V58, P182, DOI 10.1002/em.22089; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Taggart DJ, 2014, CHEM RES TOXICOL, V27, P931, DOI 10.1021/tx500088e; Valdez BC, 2010, ENVIRON MOL MUTAGEN, V51, P659, DOI 10.1002/em.20603; Weerasooriya S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107915; Williams NL, 2017, CHEM RES TOXICOL, V30, P1127, DOI 10.1021/acs.chemrestox.6b00439; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200	57	7	7	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18790	18799		10.1074/jbc.M117.802520	http://dx.doi.org/10.1074/jbc.M117.802520			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972137	Green Published, hybrid			2022-12-26	WOS:000415848000005
J	Elmas, A; Wang, XD; Dresch, JM				Elmas, Abdulkadir; Wang, Xiaodong; Dresch, Jacqueline M.			The folded k-spectrum kernel: A machine learning approach to detecting transcription factor binding sites with gapped nucleotide dependencies	PLOS ONE			English	Article							CIS-REGULATORY MODULES; DNA RECOGNITION; DATABASE; SEQUENCES; PROTEINS; MODELS; CLASSIFICATION; IDENTIFICATION; PREDICTION; ALGORITHM	Understanding the molecular machinery involved in transcriptional regulation is central to improving our knowledge of an organism's development, disease, and evolution. The building blocks of this complex molecular machinery are an organism's genomic DNA sequence and transcription factor proteins. Despite the vast amount of sequence data now available for many model organisms, predicting where transcription factors bind, often referred to as 'motif detection' is still incredibly challenging. In this study, we develop a novel bioinformatic approach to binding site prediction. We do this by extending pre-existing SVM approaches in an unbiased way to include all possible gapped k-mers, representing different combinations of complex nucleotide dependencies within binding sites. We show the advantages of this new approach when compared to existing SVM approaches, through a rigorous set of cross-validation experiments. We also demonstrate the effectiveness of our new approach by reporting on its improved performance on a set of 127 genomic regions known to regulate gene expression along the anterio-posterior axis in early Drosophila embryos.	[Elmas, Abdulkadir; Wang, Xiaodong] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA; [Dresch, Jacqueline M.] Clark Univ, Dept Math & Comp Sci, Worcester, MA 01610 USA	Columbia University; Clark University	Dresch, JM (corresponding author), Clark Univ, Dept Math & Comp Sci, Worcester, MA 01610 USA.	jdresch@clarku.edu	Elmas, Abdulkadir/AAH-5958-2021	Elmas, Abdulkadir/0000-0002-7999-5770	National Institutes of Health [GM110571]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM110571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by a National Institutes of Health (GM110571) grant (https://www.nih.gov) to JMD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Annala M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020059; Attwood TK, 1998, NUCLEIC ACIDS RES, V26, P304, DOI 10.1093/nar/26.1.304; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Baird-Titus JM, 2006, J MOL BIOL, V356, P1137, DOI 10.1016/j.jmb.2005.12.007; Bairoch A, 1996, NUCLEIC ACIDS RES, V24, P189, DOI 10.1093/nar/24.1.189; Batista G.E., 2004, ACM SIGKDD EXPLOR NE, V6, P20, DOI 10.1145/1007730.1007735; Benos PV, 2002, J MOL BIOL, V323, P701, DOI 10.1016/S0022-2836(02)00917-8; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Borok MJ, 2010, DEVELOPMENT, V137, P5, DOI 10.1242/dev.036160; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Cristianini N, 2000, INTRO SUPPORT VECTOR; Crocker J, 2008, PLOS BIOL, V6, P2576, DOI 10.1371/journal.pbio.0060263; DESPLAN C, 1988, CELL, V54, P1081, DOI 10.1016/0092-8674(88)90123-7; Dresch JM, 2016, GENE REGULATION SYST; Eddy S R, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P114; Erwin GD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003677; Gallo SM, 2011, NUCLEIC ACIDS RES, V39, pD118, DOI 10.1093/nar/gkq999; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Ghandi M., 2014, PLOS COMPUTATIONAL B, V10, P15, DOI DOI 10.1371/; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hardison RC, 2012, NAT REV GENET, V13, P469, DOI 10.1038/nrg3242; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Jaakkola T, 2000, J COMPUT BIOL, V7, P95, DOI 10.1089/10665270050081405; Joachims T Thorsten, 2002, LEARNING CLASSIFY TE; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Lassig M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S7; Lee D, 2011, GENOME RES, V21, P2167, DOI 10.1101/gr.121905.111; Leslie C., 2003, ADV NEURAL INFORMATI, P1417; Leslie Christina, 2002, Pac Symp Biocomput, P564; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; LIAO L, 2002, P 6 ANN INT C COMP M, P225, DOI DOI 10.1145/565196.565225; Liu B, 2015, J THEOR BIOL, V385, P153, DOI 10.1016/j.jtbi.2015.08.025; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2015, BIOINFORMATICS, V31, P1307, DOI 10.1093/bioinformatics/btu820; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691; Magbanua JP, 2014, PLOS ONE, V9; Man TK, 2001, NUCLEIC ACIDS RES, V29, P2471, DOI 10.1093/nar/29.12.2471; Martinez CA, 2013, METHODS, V62, P91, DOI 10.1016/j.ymeth.2013.05.014; Mathelier A, 2013, J BIOINF COMPUT BIOL, V9; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mathew J, 2015, IEEE IND ELEC, P1127, DOI 10.1109/IECON.2015.7392251; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Noyes MB, 2008, NUCLEIC ACIDS RES, V36, P2547, DOI 10.1093/nar/gkn048; Siddharthan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009722; STADEN R, 1984, NUCLEIC ACIDS RES, V12, P505, DOI 10.1093/nar/12.1Part2.505; Starr MO, 2011, DEV BIOL, V359, P290, DOI 10.1016/j.ydbio.2011.07.028; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; Stringham JL, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-298; Turatsinze JV, 2008, NAT PROTOC, V3, P1578, DOI 10.1038/nprot.2008.97; Vapnik V., 1998, STAT LEARNING THEORY; VEROPOULOS K, 1999, P INT JOINT C ART IN, P55; Wang L, 2005, IEEE I CONF COMP VIS, P1355; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; WATERMAN MS, 1991, PHYLOGENETIC ANALYSIS OF DNA SEQUENCES, P59; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Wu X., 2004, P 10 ACM SIGKDD INT, P326, DOI [10.1145/1014052.1014089, DOI 10.1145/1014052.1014089]; Yang L, 2014, NUCLEIC ACIDS RES, V42, pD148, DOI 10.1093/nar/gkt1087; Zadrozny B, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P435, DOI 10.1109/icdm.2003.1250950; Zellers RG, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-014-0446-3; Zhang HQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00899-x; Zhou TY, 2013, NUCLEIC ACIDS RES, V41, pW56, DOI 10.1093/nar/gkt437; Zhu L, 2017, IEEE ACM T COMPUT BI	67	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185570	10.1371/journal.pone.0185570	http://dx.doi.org/10.1371/journal.pone.0185570			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982128	gold, Green Published, Green Submitted			2022-12-26	WOS:000412360300046
J	Li, PC; Dong, HL; Zheng, CS; Sun, M; Liu, AZ; Wang, GP; Liu, SD; Zhang, SP; Chen, J; Li, YB; Pang, CY; Zhao, XH				Li, Pengcheng; Dong, Helin; Zheng, Cangsong; Sun, Miao; Liu, Aizhong; Wang, Guoping; Liu, Shaodong; Zhang, Siping; Chen, Jing; Li, Yabing; Pang, Chaoyou; Zhao, Xinhua			Optimizing nitrogen application rate and plant density for improving cotton yield and nitrogen use efficiency in the North China Plain	PLOS ONE			English	Article							FIELD-GROWN COTTON; PHOTOSYNTHETIC USE EFFICIENCY; POPULATION DENSITIES; IRRIGATED COTTON; LEAF SENESCENCE; COMPONENTS; LIGHT; ACCUMULATION; MANAGEMENT; QUALITY	Plant population density (PPD) and nitrogen (N) application rate (NAR) are two controllable factors in cotton production. We conducted field experiments to investigate the effects of PPD, NAR and their interaction (PPD x NAR) on yield, N uptake and N use efficiency (NUE) of cotton using a split-plot design in the North China Plain during 2013 and 2014. The main plots were PPDs (plants m(-2)) of 3.00 (low), 5.25 (medium) and 7.50 (high) and the subplots were NARs of 0 (N-free), 112.5 (low), 225.0 (moderate) and 337.5 (high). During both 2013 and 2014, biological yield and N uptake of cotton increased significantly, but harvesting index decreased significantly with NAR and PPD increasing. With NAR increasing, internal nitrogen use efficiency(NUE) decreased significantly under three PPDs and agronomical NUE, physiologilal NUE, nitrogen recovery efficiency(NRE) and partial factor productivity from applied nitrogen (PFPN) also decreased significantly under high PPD between two years. Lint yield increment varied during different PPDs and years, but NAR enhancement showed less function under higher PPD than lower PPD in general. Taken together, moderate NAR under medium PPD combined higher lint yield with higher agronomic NUE, physiological NUE, and NRE, while low NAR with high PPD would achieve a comparable yield with superior NRE and PFPN and high NAR under high PPD and medium PPD produced higher biological yield but lower harvest index, lint yield and NUE compared to moderate NAR with medium PPD. Our overall results indicated that, in this region, increasing PPD and decreasing NAR properly would enhance both lint yield and NUE of cotton.	[Li, Pengcheng; Dong, Helin; Zheng, Cangsong; Sun, Miao; Liu, Aizhong; Wang, Guoping; Liu, Shaodong; Zhang, Siping; Chen, Jing; Li, Yabing; Pang, Chaoyou; Zhao, Xinhua] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Dong, HL; Zhao, XH (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	donghl668@sina.com; zhaoxinhua1968@126.com	Zheng, Cangsong/HCI-1365-2022; Yabing, Li/GLU-9964-2022	chen, jing/0000-0003-0644-5871	China Agricultural Research System of China [CARS-18-17]; National Natural Science Foundation of China [31371561]; Professional (Agricultural) Researching Project for Public Interests, China [201503121, 201203096]	China Agricultural Research System of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Professional (Agricultural) Researching Project for Public Interests, China	This work was supported by the earmarked fund of the China Agricultural Research System of China (CARS-18-17), the National Natural Science Foundation of China (31371561) and the Professional (Agricultural) Researching Project for Public Interests, China (201503121, 201203096). The funders Yabing Li and Guoping Wang took part in study design, data collection and analysis and preparation of the manuscript.	Chen BS, 1994, COTTON CULTIVATION P; CRI (Cotton Research Institute Chinese Academy of Agricultural Sciences), 2013, CULT COTT CHIN; Dai JL, 2015, FIELD CROP RES, V180, P207, DOI 10.1016/j.fcr.2015.06.008; Darawsheh MK, 2009, J FOOD AGRIC ENVIRON, V7, P258; Devkota M, 2013, SOIL TILL RES, V134, P72, DOI 10.1016/j.still.2013.07.009; Dong HZ, 2012, FIELD CROP RES, V126, P137, DOI 10.1016/j.fcr.2011.10.005; Dong HZ, 2010, FIELD CROP RES, V119, P106, DOI 10.1016/j.fcr.2010.06.019; Francisco E., 2013, Better Crops with Plant Food, V97, P15; Guo RQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33539; ISFAN D, 1990, J PLANT NUTR, V13, P907, DOI 10.1080/01904169009364125; Kakar N. U., 2012, Sarhad Journal of Agriculture, V28, P531; [李鹏程 Li Pengcheng], 2015, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V21, P81; [刘瑞显 Liu Ruixian], 2010, [棉花学报, Cotton Science], V22, P634; [娄善伟 Lou Shanwei], 2010, [棉花学报, Cotton Science], V22, P260; Lou ShanWei, 2010, Plant Nutrition and Fertilizer Science, V16, P953; Lu DJ, 2015, FIELD CROP RES, V171, P157, DOI 10.1016/j.fcr.2014.10.012; Mao LL, 2015, FIELD CROP RES, V179, P63, DOI 10.1016/j.fcr.2015.04.011; Mei YJ, 2014, EUPHYTICA, V196, P95, DOI 10.1007/s10681-013-1016-x; NOVOA R, 1981, PLANT SOIL, V58, P177, DOI 10.1007/BF02180053; Rochester IJ, 2011, NUTR CYCL AGROECOSYS, V90, P147, DOI 10.1007/s10705-010-9418-9; Tan CS, 1992, HIGH QUALITY HIGH YI; [王子胜 Wang Zisheng], 2012, [棉花学报, Cotton Science], V24, P35; Witt C, 1999, FIELD CROP RES, V63, P113, DOI 10.1016/S0378-4290(99)00031-3; Xu GH, 2012, ANNU REV PLANT BIOL, V63, P153, DOI 10.1146/annurev-arplant-042811-105532; Xue HY, 2015, FIELD CROP RES, V184, P17, DOI 10.1016/j.fcr.2015.09.004; Yang G., 2014, MATH PROBL ENG, V2014, P13; Yao HS, 2017, FIELD CROP RES, V203, P192, DOI 10.1016/j.fcr.2016.12.018; Yao HS, 2016, FIELD CROP RES, V188, P10, DOI 10.1016/j.fcr.2016.01.012; Yao HS, 2015, FIELD CROP RES, V184, P39, DOI 10.1016/j.fcr.2015.09.005; Yeates SJ, 2010, FIELD CROP RES, V116, P278, DOI 10.1016/j.fcr.2010.01.005; Zhang HJ, 2012, J AGRON CROP SCI, V198, P27, DOI 10.1111/j.1439-037X.2011.00481.x; Zhi XY, 2016, J INTEGR AGR, V15, P1469, DOI 10.1016/S2095-3119(15)61174-1	32	14	16	7	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185550	10.1371/journal.pone.0185550	http://dx.doi.org/10.1371/journal.pone.0185550			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981538	gold, Green Published, Green Submitted			2022-12-26	WOS:000412360300043
J	Nishihara, M; Aoki, H; Ohno, S; Furusho, A; Hirakata, S; Nishida, N; Ito, S; Hayashi, M; Imaizumi, T; Fukumoto, Y				Nishihara, Michihide; Aoki, Hiroki; Ohno, Satoko; Furusho, Aya; Hirakata, Saki; Nishida, Norifumi; Ito, Sohei; Hayashi, Makiko; Imaizumi, Tsutomu; Fukumoto, Yoshihiro			The role of IL-6 in pathogenesis of abdominal aortic aneurysm in mice	PLOS ONE			English	Article							RECEPTOR ANTIBODY; INTERLEUKIN-6; MATRIX-METALLOPROTEINASE-9; EXPRESSION; REGRESSION; INFLAMMATION; INHIBITION; PROTEIN; BETA	Although the pathogenesis of abdominal aortic aneurysm (AAA) remains unclear, evidence is accumulating to support a central role for inflammation. Inflammatory responses are coordinated by various soluble cytokines of which IL-6 is one of the major proinflammatory cytokines. In this study we examined the role of IL-6 in the pathogenesis of experimental AAA induced by a periaortic exposure to CaCl2 in mice. We now report that the administration of MR16-1, a neutralizing monoclonal antibody specific for the mouse IL-6 receptor, mildly suppressed the development of AAA. The inhibition of IL-6 signaling provoked by MR16-1 also resulted in a suppression of Stat3 activity. Conversely, no significant changes in either NF kappa B activity, Jnk activity or the expression of matrix metalloproteinases (Mmp) -2 and -9 were identified. Transcriptome analyses revealed that MR16-1-sensitive genes encode chemokines and their receptors, as well as factors that regulate vascular permeability and cell migration. Imaging cytometric analyses then consistently demonstrated reduced cellular infiltration for MR16-1-treated AAA. These results suggest that IL-6 plays an important but limited role in AAA pathogenesis, and primarily regulates cell migration and infiltration. These data would also suggest that IL-6 activity may play an important role in scenarios of continuous cellular infiltration, possibly including human AAA.	[Nishihara, Michihide; Ohno, Satoko; Furusho, Aya; Hirakata, Saki; Nishida, Norifumi; Ito, Sohei; Hayashi, Makiko; Fukumoto, Yoshihiro] Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Kurume, Fukuoka, Japan; [Aoki, Hiroki] Kurume Univ, Cardiovasc Res Inst, Kurume, Fukuoka, Japan; [Imaizumi, Tsutomu] Int Univ Hlth & Welf, Fukuoka, Japan	Kurume University; Kurume University; International University of Health & Welfare	Aoki, H (corresponding author), Kurume Univ, Cardiovasc Res Inst, Kurume, Fukuoka, Japan.	haoki@med.kurume-u.ac.jp		Ito, Sohei/0000-0003-1374-2946	Japan Society for the Promotion of Science [25861238, 21390367, 24390334, 24659640, 26670621, 16H05428]; Daiichi Sankyo Foundation of Life Science; Uehara Memorial Foundation; Vehicle Racing Commemorative Foundation; Grants-in-Aid for Scientific Research [15K10249] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Daiichi Sankyo Foundation of Life Science; Uehara Memorial Foundation(Uehara Memorial Foundation); Vehicle Racing Commemorative Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (http://www.jsps.go.jp/index.html) 25861238 (MN), 21390367 (HA), 24390334 (HA), 24659640 (HA), 26670621 (HA), 16H05428 (HA); Daiichi Sankyo Foundation of Life Science (http://www.ds-fdn.or.jp) (HA); Uehara Memorial Foundation (http://www.ueharazaidan.or.jp) (HA); Vehicle Racing Commemorative Foundation (http://www.vecof.or.jp) (HA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 2016, MOUSE MODELS VASCULA, P211; Aoki H, 2007, J MOL MED, V85, P1077, DOI 10.1007/s00109-007-0213-2; Araki Y, 2016, ARTHRITIS RHEUMATOL, V68, P1111, DOI 10.1002/art.39563; Arnaoutoglou E, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/945035; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Chen XF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153811; Emeto TI, 2014, CURR DRUG TARGETS, V15, P860; Harrison SC, 2013, EUR HEART J, V34, P3707, DOI 10.1093/eurheartj/ehs354; Hartman MHT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167195; Hashimoto-Kataoka T, 2015, P NATL ACAD SCI USA, V112, pE2677, DOI 10.1073/pnas.1424774112; Henaut L, 2016, EXPERT OPIN THER TAR, V20, P89, DOI 10.1517/14728222.2015.1081685; Hingorani A, 1998, J VASC SURG, V28, P522, DOI 10.1016/S0741-5214(98)70139-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ijaz T, 2016, J THORAC DIS, V8, pE746, DOI 10.21037/jtd.2016.06.37; Ishibashi M, 2004, ARTERIOSCL THROM VAS, V24, pE174, DOI 10.1161/01.ATV.0000143384.69170.2d; Johnston WF, 2013, ARTERIOSCL THROM VAS, V33, P294, DOI 10.1161/ATVBAHA.112.300432; Kimura T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04051; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Ma ZD, 2001, J IMMUNOL, V167, P5150, DOI 10.4049/jimmunol.167.9.5150; Mihara M, 2002, IMMUNOL LETT, V84, P223, DOI 10.1016/S0165-2478(02)00201-8; Miyake T, 2007, CIRC RES, V101, P1175, DOI 10.1161/CIRCRESAHA.107.148668; Moehle CW, 2011, J THORAC CARDIOV SUR, V142, P1567, DOI 10.1016/j.jtcvs.2011.07.053; Nagahama KY, 2013, AM J RESP CELL MOL, V49, P582, DOI 10.1165/rcmb.2012-0460OC; Niida T, 2012, CARDIOVASC RES, V93, P371, DOI 10.1093/cvr/cvr323; Qu T, 2009, CYTOKINE, V46, P319, DOI 10.1016/j.cyto.2009.02.015; Rabkin SW, 2017, PROG MOL BIOL TRANSL, V147, P239, DOI 10.1016/bs.pmbts.2017.02.002; Senemaud J, 2017, ARTERIOSCLER THROMB; Shteinberg D, 2000, EUR J VASC ENDOVASC, V20, P462, DOI 10.1053/ejvs.2000.1210; Sporri B, 1999, INT IMMUNOL, V11, P1053, DOI 10.1093/intimm/11.7.1053; TAMURA T, 1993, P NATL ACAD SCI USA, V90, P11924, DOI 10.1073/pnas.90.24.11924; Timlin H, 2014, EXPERT OPIN BIOL TH, V14, P893, DOI 10.1517/14712598.2014.900536; Wang YT, 2013, ATHEROSCLEROSIS, V226, P29, DOI 10.1016/j.atherosclerosis.2012.09.010; Xiong WF, 2009, J IMMUNOL, V183, P2741, DOI 10.4049/jimmunol.0803164; Yoshida H, 2011, RHEUMATOL INT, V31, P1445, DOI 10.1007/s00296-010-1500-8; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; Yoshizaki T, 1998, P NATL ACAD SCI USA, V95, P3621, DOI 10.1073/pnas.95.7.3621	36	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185923	10.1371/journal.pone.0185923	http://dx.doi.org/10.1371/journal.pone.0185923			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982132	Green Submitted, gold, Green Published			2022-12-26	WOS:000412360300088
J	Ruiz-Blanco, YB; Almeida, Y; Sotomayor-Torres, CM; Garcia, Y				Ruiz-Blanco, Y. B.; Almeida, Y.; Sotomayor-Torres, C. M.; Garcia, Y.			Unveiled electric profiles within hydrogen bonds suggest DNA base pairs with similar bond strengths	PLOS ONE			English	Article							AB-INITIO CALCULATIONS; SINGLE-MOLECULE; NANOCONTACTS; RECOGNITION; CRISPR-CAS9; TRANSPORT; STACKING; DYNAMICS; ACID	Electrical forces are the background of all the interactions occurring in biochemical systems. From here and by using a combination of ab-initio and ad-hoc models, we introduce the first description of electric field profiles with intrabond resolution to support a characterization of single bond forces attending to its electrical origin. This fundamental issue has eluded a physical description so far. Our method is applied to describe hydrogen bonds (HB) in DNA base pairs. Numerical results reveal that base pairs in DNA could be equivalent considering HB strength contributions, which challenges previous interpretations of thermodynamic properties of DNA based on the assumption that Adenine/Thymine pairs are weaker than Guanine/Cytosine pairs due to the sole difference in the number of HB. Thus, our methodology provides solid foundations to support the development of extended models intended to go deeper into the molecular mechanisms of DNA functioning.	[Ruiz-Blanco, Y. B.] Univ Cent Marta Abreu Las Villas, Fac Quim & Farm, Santa Clara, Villa Clara, Cuba; [Almeida, Y.] Ctr Mol Immunol, Syst Biol Direct, Havana, Cuba; [Sotomayor-Torres, C. M.] CSIC, ICN2, Campus UAB, Barcelona, Spain; [Sotomayor-Torres, C. M.] BIST, Campus UAB, Barcelona, Spain; [Sotomayor-Torres, C. M.] ICREA, Barcelona, Spain; [Almeida, Y.] Hamburg Ctr Ultrafast Imaging, Hamburg, Germany; [Almeida, Y.] Univ Hamburg, Dept Chem, Inst Biochem & Mol Biol, Hamburg, Germany; [Garcia, Y.] Univ Politecn Cataluna, Dept Math, ESAB, Esteve Terradas, Castelldefels, Spain	Universidad Central "Marta Abreu" de Las Villas; Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Catalan Institute of Nanoscience & Nanotechnology (ICN2); Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Barcelona; Barcelona Institute of Science & Technology; ICREA; University of Hamburg; University of Hamburg; Universitat Politecnica de Catalunya	Garcia, Y (corresponding author), Univ Politecn Cataluna, Dept Math, ESAB, Esteve Terradas, Castelldefels, Spain.	yamila.garcia@uv.es	Blanco, Yasser Bruno Ruiz/U-1044-2019; Almeida-Hernandez, Yasser/AAH-9870-2020; Torres, Clivia M Sotomayor/E-8418-2010	Blanco, Yasser Bruno Ruiz/0000-0001-5400-4427; Almeida-Hernandez, Yasser/0000-0001-9832-3534; Torres, Clivia M Sotomayor/0000-0001-9986-2716	Spanish MINECO [FIS2015-70862-P]; programme Severo Ochoa [SEV-2013-0295]; CERCA Programme/Generalitat de Catalunya; Spanish MINECO [FIS2015-70862-P]; programme Severo Ochoa [SEV-2013-0295]; CERCA Programme/Generalitat de Catalunya	Spanish MINECO(Spanish Government); programme Severo Ochoa; CERCA Programme/Generalitat de Catalunya; Spanish MINECO(Spanish Government); programme Severo Ochoa; CERCA Programme/Generalitat de Catalunya	CMST acknowledges the financial support from the Spanish MINECO project PHENTOM (FIS2015-70862-P), the programme Severo Ochoa (Grant SEV-2013-0295) and funding from the CERCA Programme/Generalitat de Catalunya. Computational facilities have been provided by "Centro de Supercomputacion de Galicia" (CESGA).	Al Ahmad M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29089; Alberts B, 2003, NATURE, V421, P431, DOI 10.1038/nature01407; Arunan E, 2011, PURE APPL CHEM, V83, P1619, DOI 10.1351/PAC-REP-10-01-01; Bockelmann U, 1997, PHYS REV LETT, V79, P4489, DOI 10.1103/PhysRevLett.79.4489; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; Castro CE, 2015, NANOSCALE, V7, P5913, DOI 10.1039/c4nr07153k; Ceron-Carrasco JP, 2013, CHEM COMMUN, V49, P7578, DOI 10.1039/c3cc42593b; Chang S, 2009, NAT NANOTECHNOL, V4, P297, DOI [10.1038/nnano.2009.48, 10.1038/NNANO.2009.48]; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Feynman R.P., 1992, J MICROELECTROMECH S, V1, P60, DOI 10.1109/84.128057; Frisch G. W., 2013, GAUSSIAN 09; Garcia Y, 2008, INT J QUANTUM CHEM, V108, P1637, DOI 10.1002/qua.21636; Garcia Y, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.041402; Garcia Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep34616; Garcia Y, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2953459; Garcia Y, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3158606; Garcia Y, 2013, J MODERN PHYS, V4-4, P522; Gorodetskaya IA, 2015, NAT CHEM, V7, P541, DOI 10.1038/nchem.2290; Guerra CF, 1999, CHEM-EUR J, V5, P3581; Heller I, 2014, CHEM REV, V114, P3087, DOI 10.1021/cr4003006; Hobza P, 1999, CHEM REV, V99, P3247, DOI 10.1021/cr9800255; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Ke YG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10935; Kelley SO, 2014, NAT NANOTECHNOL, V9, P969, DOI [10.1038/nnano.2014.261, 10.1038/NNANO.2014.261]; Kilchherr F, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5508; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poater J, 2014, ORG BIOMOL CHEM, V12, P4691, DOI 10.1039/c4ob00427b; Poater J, 2011, CHEM COMMUN, V47, P7326, DOI 10.1039/c0cc04707d; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Schork NJ, 2015, NATURE, V520, P609, DOI 10.1038/520609a; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Sponer J, 2001, BIOPOLYMERS, V61, P3, DOI 10.1002/1097-0282(2001)61:1<3::AID-BIP10048>3.0.CO;2-4; Steiner T, 2002, ANGEW CHEM INT EDIT, V41, P48, DOI 10.1002/1521-3773(20020104)41:1<48::AID-ANIE48>3.0.CO;2-U; Szatylowicz H, 2010, J CHEM INF MODEL, V50, P2151, DOI 10.1021/ci100288h; Vollmer F, 2008, NAT METHODS, V5, P591, DOI 10.1038/nmeth.1221; WATSON JD, 1953, NATURE, V171, P964, DOI 10.1038/171964b0; Weymouth AJ, 2014, SCIENCE, V343, P1120, DOI 10.1126/science.1249502; Wong IY, 2013, GENE DEV, V27, P2397, DOI 10.1101/gad.226837.113; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454	42	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185638	10.1371/journal.pone.0185638	http://dx.doi.org/10.1371/journal.pone.0185638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982182	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300052
J	Ree, IMC; Fustolo-Gunnink, SF; Bekker, V; Fijnvandraat, KJ; Steggerda, SJ; Lopriore, E				Ree, Isabelle M. C.; Fustolo-Gunnink, Suzanne F.; Bekker, Vincent; Fijnvandraat, Karin J.; Steggerda, Sylke J.; Lopriore, Enrico			Thrombocytopenia in neonatal sepsis: Incidence, severity and risk factors	PLOS ONE			English	Article							ORGANISM-SPECIFIC RESPONSE; INTENSIVE-CARE-UNIT; LATE-ONSET SEPSIS; PLATELET TRANSFUSIONS; INFANTS; THROMBOPOIESIS; MANAGEMENT; INSIGHTS	Objectives Thrombocytopenia is a frequent problem in neonatal sepsis and is among the most predictive, independent risk factors for sepsis-associated mortality. This study aims to clarify the occurrence, severity and duration of thrombocytopenia in neonatal sepsis. Study design A cohort study was carried out among all neonates with proven culture positive sepsis that were admitted to a tertiary NICU between 2006 and 2015 (n = 460). The occurrence, severity and duration of thrombocytopenia were recorded, as well as major bleedings and potential risk factors for mortality in neonatal sepsis. Results Sepsis was diagnosed in 460 of 6551 neonates (7%). Severe thrombocytopenia (platelets <= 50*10(9)/L) occurred in 20% (92/460) of septic neonates. The median time for platelets to rise >100*10(9) was 6.0 days (interquartile range 4.0-7.0). On multivariate analysis, maternal hypertension, intravascular thrombosis and Gram negative (as opposed to Gram positive) sepsis were independently associated with thrombocytopenia in neonatal sepsis. In severe thrombocytopenia, 10% (9/92) suffered a severe IVH, compared to 5% (20/356) in neonates with platelets >50*109/L (p = 0.125). 10% (9/92) suffered a pulmonary hemorrhage, compared to 2% (9/368) in neonates with platelets >50*109/L (p = 0.001). On multivariate analysis, thrombocytopenia and Gram negative (as opposed to Gram positive) sepsis were independently associated with neonatal mortality. Conclusions Thrombocytopenia is independently associated with maternal hypertension, intravascular thrombosis and Gram negative sepsis. Thrombocytopenia in neonatal sepsis increases the risk of mortality nearly four-fold, with another six-fold increase in mortality in case of Gram negative sepsis.	[Ree, Isabelle M. C.; Steggerda, Sylke J.; Lopriore, Enrico] Leiden Univ, Div Neonatol, Dept Pediat, Med Ctr, Leiden, Netherlands; [Fustolo-Gunnink, Suzanne F.; Fijnvandraat, Karin J.] Acad Med Ctr, Dept Pediat Hematol, Amsterdam, Netherlands; [Fustolo-Gunnink, Suzanne F.] Sanquin Blood Supply, Dept Clin Transfus Res, Leiden, Netherlands; [Bekker, Vincent] Leiden Univ, Div Hematol Immunol, Dept Pediat, Med Ctr, Leiden, Netherlands; [Fijnvandraat, Karin J.] Sanquin Blood Supply, Dept Plasma Prot, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ree, IMC (corresponding author), Leiden Univ, Div Neonatol, Dept Pediat, Med Ctr, Leiden, Netherlands.	i.m.c.ree@lumc.nl	Bekker, Vincent/GWU-6464-2022; Lopriore, Enrico/ABE-3576-2021	Bekker, Vincent/0000-0002-6543-5537; Lopriore, Enrico/0000-0002-3513-5066				Akarsu S, 2005, J TROP PEDIATRICS, V51, P388, DOI 10.1093/tropej/fmi031; Bhat MA, 2009, J PERINATOL, V29, P702, DOI 10.1038/jp.2009.72; Bolat F, 2012, PEDIATR HEMAT ONCOL, V29, P710, DOI 10.3109/08880018.2012.725454; Brown RE, 2008, PEDIATR RES, V64, P399, DOI 10.1203/PDR.0b013e318181ad49; CBO DIfHI, 2011, NAT GUID BLOOD TRANS; Christensen RD, 2006, J PERINATOL, V26, P348, DOI 10.1038/sj.jp.7211509; Claushuis TAM, 2016, BLOOD, V127, P3062, DOI 10.1182/blood-2015-11-680744; Eissa DS, 2013, PLATELETS, V24, P122, DOI 10.3109/09537104.2012.696748; Guida JD, 2003, PEDIATRICS, V111, P1411, DOI 10.1542/peds.111.6.1411; Gunnink SF, 2014, EXPERT REV HEMATOL, V7, P387, DOI 10.1586/17474086.2014.902301; Haque Khalid N, 2005, Pediatr Crit Care Med, V6, pS45, DOI 10.1097/01.PCC.0000161946.73305.0A; Kloosterman G J, 1969, Maandschr Kindergeneeskd, V37, P209; Levit O, 2014, PEDIATR INFECT DIS J, V33, P143, DOI 10.1097/INF.0000000000000024; Lieberman L, 2014, BLOOD, V123, P1146, DOI 10.1182/blood-2013-02-435693; Manzoni P, 2015, CLIN PERINATOL, V42, P587, DOI 10.1016/j.clp.2015.04.012; Manzoni P, 2009, PEDIATR INT, V51, P206, DOI 10.1111/j.1442-200X.2008.02689.x; Murray NA, 2002, TRANSFUSION MED, V12, P35, DOI 10.1046/j.1365-3148.2002.00343.x; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Roberts I, 2008, BLOOD REV, V22, P173, DOI 10.1016/j.blre.2008.03.004; Sola-Visner M, 2016, TRANSFUS MED REV, V30, P183, DOI 10.1016/j.tmrv.2016.05.009; Sola-Visner M, 2009, SEMIN PERINATOL, V33, P43, DOI 10.1053/j.semperi.2008.10.008; Stanworth SJ, 2009, PEDIATRICS, V124, pE826, DOI 10.1542/peds.2009-0332; Venkatesh V, 2013, ARCH DIS CHILD-FETAL, V98, pF260, DOI 10.1136/archdischild-2012-302443; Yeaman MR, 2010, CELL MOL LIFE SCI, V67, P525, DOI 10.1007/s00018-009-0210-4	24	37	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185581	10.1371/journal.pone.0185581	http://dx.doi.org/10.1371/journal.pone.0185581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977011	gold, Green Published, Green Submitted			2022-12-26	WOS:000412163100032
J	Ben Abdelkrim, A; Hattab, T; Fakhfakh, H; Belkadhi, MS; Gorsane, F				Ben Abdelkrim, Ahmed; Hattab, Tarek; Fakhfakh, Hatem; Belkadhi, Mohamed Sadok; Gorsane, Faten			A landscape genetic analysis of important agricultural pest species in Tunisia: The whitefly Bemisia tabaci	PLOS ONE			English	Article							HEMIPTERA ALEYRODIDAE BIOTYPES; MICROSATELLITE-LOCI; MITOCHONDRIAL-DNA; CLIMATE-CHANGE; HOST PLANTS; POPULATIONS; RANGE; DIVERSITY; PATTERNS; SURFACES	Combining landscape ecology and genetics provides an excellent framework to appreciate pest population dynamics and dispersal. The genetic architectures of many species are always shaped by environmental constraints. Because little is known about the ecological and genetic traits of Tunisian whitefly populations, the main objective of this work is to highlight patterns of biodiversity, genetic structure and migration routes of this pest. We used nuclear microsatellite loci to analyze B. tabaci populations collected from various agricultural areas across the country and we determine their biotype status. Molecular data were subsequently interpreted in an ecological context supplied from a species distribution model to infer habitat suitability and hereafter the potential connection paths between sampling localities. An analysis of landscape resistance to B. tabaci genetic flow was thus applied to take into account habitat suitability, genetic relatedness and functional connectivity of habitats within a varied landscape matrix. We shed light on the occurrence of three geographically delineated genetic groups with high levels of genetic differentiation within each of them. Potential migration corridors of this pest were then established providing significant advances toward the understanding of genetic features and the dynamic dispersal of this pest. This study supports the hypothesis of a long-distance dispersal of B. tabaci followed by infrequent long-term isolations. The Inference of population sources and colonization routes is critical for the design and implementation of accurate management strategies against this pest.	[Ben Abdelkrim, Ahmed; Fakhfakh, Hatem; Gorsane, Faten] Univ Tunis El Manar, Fac Sci Tunis, Lab Genet Mol Immunol & Biotechnol, Tunis, Tunisia; [Ben Abdelkrim, Ahmed] Univ Paris Diderot, Sorbonne Paris Cite, CNRS UMR 7592, Inst Jacques Monod, Paris, France; [Hattab, Tarek] IFREMER, UMR MARBEC 248, Inst Francais Rech Exploitat Mer, Ave Jean Monnet CS, Sete, France; [Fakhfakh, Hatem; Gorsane, Faten] Univ Carthage, Fac Sci Bizerte, Bizerte, Tunisia; [Belkadhi, Mohamed Sadok] Ctr Tech Cultures Protegees & Geotherm Gabes, Gabes, Tunisia	Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Ifremer; Universite de Montpellier; Universite de Carthage	Gorsane, F (corresponding author), Univ Tunis El Manar, Fac Sci Tunis, Lab Genet Mol Immunol & Biotechnol, Tunis, Tunisia.; Gorsane, F (corresponding author), Univ Carthage, Fac Sci Bizerte, Bizerte, Tunisia.	fatengorsane@gmail.com	Ben Abdelkrim, Ahmed/X-2878-2018	Ben Abdelkrim, Ahmed/0000-0002-5721-0944; fakhfakh, hatem/0000-0002-0441-7511	Ministry of Higher Education and Scientific Research of Tunisia [LR 99 ES 12]; USA MERC (Middle East Research Coorporation) project [TA-MOU-08-M28-048]	Ministry of Higher Education and Scientific Research of Tunisia; USA MERC (Middle East Research Coorporation) project	This study was partially supported by the Ministry of Higher Education and Scientific Research of Tunisia (LR 99 ES 12) and the USA MERC (Middle East Research Coorporation) project TA-MOU-08-M28-048.	Abd-Rabou S, 2010, ENTOMOL NEWS, V121, P456, DOI 10.3157/021.121.0507; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bayhan E, 2006, J PEST SCI, V79, P233, DOI 10.1007/s10340-006-0139-4; Beheregaray Luciano B, 2007, J Biol, V6, P9, DOI 10.1186/jbiol60; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boivin G, 2006, INTRA INTERSPECIFIC, P123; Bosco D, 2006, PHYTOPARASITICA, V34, P243, DOI 10.1007/BF02980951; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boykin LM, 2014, PEST MANAG SCI, V70, P1454, DOI 10.1002/ps.3709; Brower AVZ, 2006, SYST BIODIVERS, V4, P127, DOI 10.1017/S147720000500191X; Brown JK, 2010, POPULAR POLITICS RES, P31; Byrne DN, 1996, OECOLOGIA, V105, P320, DOI 10.1007/BF00328734; Cornuet JM, 1996, GENETICS, V144, P2001; Dalmon A, 2008, HEREDITY, V100, P316, DOI 10.1038/sj.hdy.6801080; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; De Barro PJ, 2005, MOL ECOL, V14, P3695, DOI 10.1111/j.1365-294X.2005.02700.x; De Barro PJ, 2003, MOL ECOL NOTES, V3, P40, DOI 10.1046/j.1471-8286.2003.00344.x; Delatte H, 2006, GENET RES, V87, P109, DOI 10.1017/S0016672306008135; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Etherington TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088293; Fresia P, 2014, ACTA TROP, V138, pS34, DOI 10.1016/j.actatropica.2014.04.003; Frohlich D., 1999, MOL ECOL, V8, P1593, DOI DOI 10.1046/J.1365-294X.1999.00754.X; Gauthier N, 2008, MOL ECOL RESOUR, V8, P1004, DOI 10.1111/j.1755-0998.2008.02163.x; Gauthier N, 2014, PEST MANAG SCI, V70, P1477, DOI 10.1002/ps.3733; Gilioli G, 2014, PEST MANAG SCI, V70, P1611, DOI 10.1002/ps.3734; Gorsane F, 2011, ENVIRON ENTOMOL, V40, P809, DOI 10.1603/EN10162; Hadjistylli M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165105; Hall LA, 2014, LANDSCAPE ECOL, V29, P1487, DOI 10.1007/s10980-014-0082-3; Hattab T, 2017, DIVERS DISTRIB, V23, P806, DOI 10.1111/ddi.12566; Hattab T, 2014, GLOBAL ECOL BIOGEOGR, V23, P1417, DOI 10.1111/geb.12217; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; Holderegger R, 2008, EVOLUTION, V62, P2922, DOI 10.1111/j.1558-5646.2008.00498.x; Horne JB, 2011, MOL ECOL, V20, P2291, DOI 10.1111/j.1365-294X.2011.05097.x; Jaworski CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082231; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Laarif A, 2015, PHYTOPARASITICA, V43, P135, DOI 10.1007/s12600-014-0437-y; Laloe D, 2007, GENET SEL EVOL, V39, P545, DOI 10.1051/gse:2007021; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; McKenzie CL, 2009, J ECON ENTOMOL, V102, P670, DOI 10.1603/029.102.0227; McKenzie CL, 2012, J ECON ENTOMOL, V105, P753, DOI 10.1603/EC11337; Mirande L, 2015, J PEST SCI, V88, P155, DOI 10.1007/s10340-014-0597-z; Naranjo SE, 2009, POPULATION DYNAMICS, P185; Navas-Castillo J, 2011, ANNU REV PHYTOPATHOL, V49, P219, DOI 10.1146/annurev-phyto-072910-095235; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; R Core Team, 2013, R LANG ENV STAT COMP, P3; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; Russo IRM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29168; Saleh D, 2012, POPUL ECOL, V54, P261, DOI 10.1007/s10144-012-0303-z; Simon B, 2007, ENTOMOL EXP APPL, V124, P327, DOI 10.1111/j.1570-7458.2007.00586.x; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; Stevenson-Holt CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112119; Tan XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep28245; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Tsagkarakou A, 2007, B ENTOMOL RES, V97, P29, DOI 10.1017/S000748530700466X; Tsagkarakou A, 2012, B ENTOMOL RES, V102, P353, DOI 10.1017/S0007485311000757; Tsagkarakou A, 2003, MOL ECOL NOTES, V3, P196, DOI 10.1046/j.1471-8286.2003.00393.x; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Xu J, 2011, J APPL ENTOMOL, V135, P771, DOI 10.1111/j.1439-0418.2010.01581.x; Zidon R, 2016, ECOL APPL, V26, P1198, DOI 10.1890/15-1045	67	7	7	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185724	10.1371/journal.pone.0185724	http://dx.doi.org/10.1371/journal.pone.0185724			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972992	Green Published, Green Submitted, gold			2022-12-26	WOS:000412131900042
J	Lin, YC; Lin, CY; Chee, SY; Yen, HR; Tsai, FJ; Chen, CY; Wang, CH				Lin, Yi-Chun; Lin, Chih-Ying; Chee, Siew-Yin; Yen, Hung-Rong; Tsai, Fuu-Jen; Chen, Chiu-Ying; Wang, Chung-Hsing			Improved final predicted height with the injection of leuprolide in children with earlier puberty: A retrospective cohort study	PLOS ONE			English	Article							PRECOCIOUS PUBERTY; HORMONE AGONIST; ANALOG TREATMENT; ADULT HEIGHT; GIRLS; GROWTH; DIAGNOSIS; ONSET; THERAPY; AGE	The adult height of children with early onset puberty is limited by the premature maturation of hypothalamic-pituitary-gonadal axis. To evaluate the effects of gonadotropin-releasing hormone analog (GnRHa) treatment on the final height (FH) and bone maturation rate (BMR) in girls with early puberty (EP) or idiopathic central precocious puberty (ICPP), we examined data from girls who were diagnosed with EP or ICPP and underwent GnRHa (Leuplin Depot: 3.75 mg/month) at China Medical University Hospital, in Taiwan, between 2006 and 2015. Patients were observed until the achievement of FH and divided into an "EP group" (T-ep) and "ICPP group" (T-icpp) according to the age of onset of puberty. Eighty-seven patients were enrolled (T-ep, N = 44, puberty onset at 8-10 years; T-icpp, N = 43, puberty onset before 8 years). The demographic data of girls with EP or IPP was characterized. BMR, change in predicted final height (PFH) after GnRHa treatment, target height (TH) and FH were measured. After GnRHa treatment, the study groups (T-ep: 160.24 +/- 6.18 cm, T-icpp: 158.99 +/- 5.92 cm) both had higher PFH than at initiation (T-ep: 159.83 +/- 7.19 cm, T-icpp: 158.58 +/- 5.93 cm). There was deceleration of BMR in both groups (T-ep: 0.57 +/- 0.39; T-icpp: 0.97 +/- 0.97) and a significant difference between the groups (p = 0.027). The gap in FH standard deviation scores (SDS) and TH SDS had a significant difference in T-ep (p = 0.045) but not in T-icpp. Moreover, there was no difference in the gap of PFH SDS between the 1st and final treatment in both groups. We concluded that GnRHa decelerated BMR in girls with earlier puberty. Further prospective clinical studies are warranted.	[Lin, Yi-Chun; Yen, Hung-Rong] China Med Univ Hosp, Dept Chinese Med, Taichung, Taiwan; [Lin, Chih-Ying] China Med Univ, Dept Publ Hlth, Doctoral Program, Taichung, Taiwan; [Chee, Siew-Yin; Tsai, Fuu-Jen; Wang, Chung-Hsing] China Med Univ, Dept Genet & Metab, Childrens Hosp, Taichung, Taiwan; [Yen, Hung-Rong; Tsai, Fuu-Jen] China Med Univ Hosp, Dept Med Res, Res Ctr Tradit Chinese Med, Taichung, Taiwan; [Yen, Hung-Rong; Tsai, Fuu-Jen] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan; [Yen, Hung-Rong] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Chen, Chiu-Ying] China Med Univ, Dept Publ Hlth, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan	Wang, CH (corresponding author), China Med Univ, Dept Genet & Metab, Childrens Hosp, Taichung, Taiwan.; Chen, CY (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.	yichunlin1228@gmail.com; a2340961@yahoo.com.tw	Yen, Hung-Rong/M-1373-2013	Yen, Hung-Rong/0000-0002-0131-1658	China Medical University Hospital [DMR-103-040]	China Medical University Hospital	The study was supported by grants from the China Medical University Hospital (DMR-103-040).	Abreu AP, 2016, LANCET DIABETES ENDO, V4, P254, DOI 10.1016/S2213-8587(15)00418-0; [Anonymous], 2014, LANCET, V384, P1159, DOI DOI 10.1016/S0140-6736(14)61707-4; BAYLEY N, 1952, J PEDIATR-US, V40, P423, DOI 10.1016/S0022-3476(52)80205-7; Bentham J, 2016, ELIFE, V5, DOI 10.7554/eLife.13410.001; Bouvattier C, 1999, J CLIN ENDOCR METAB, V84, P3575, DOI 10.1210/jc.84.10.3575; Carel JC, 2008, NEW ENGL J MED, V358, P2366, DOI 10.1056/NEJMcp0800459; Carel JC, 2009, PEDIATRICS, V123, pE752, DOI 10.1542/peds.2008-1783; Cassio A, 1999, ARCH DIS CHILD, V81, P329, DOI 10.1136/adc.81.4.329; Cesario SK, 2007, JOGNN-J OBST GYN NEO, V36, P263, DOI 10.1111/J.1552-6909.2007.00145.x; Chalumeau M, 2003, J PEDIATR-US, V143, P445, DOI 10.1067/S0022-3476(03)00328-7; Chemaitilly W, 2001, CLIN ENDOCRINOL, V54, P289, DOI 10.1046/j.1365-2265.2001.01229.x; Chulani VL, 2014, PRIMARY CARE, V41, P465, DOI 10.1016/j.pop.2014.05.002; Day FR, 2015, SCI REP-UK, V5, DOI 10.1038/srep11208; Galvao TF, 2014, J AFFECT DISORDERS, V155, P13, DOI 10.1016/j.jad.2013.10.034; Khadgawat R, 2016, INDIAN PEDIATR, V53, P383, DOI 10.1007/s13312-016-0857-5; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; Latronico AC, 2016, LANCET DIABETES ENDO, V4, P265, DOI 10.1016/S2213-8587(15)00380-0; Martins CS, 2014, GROWTH HORM IGF RES, V24, P123, DOI 10.1016/j.ghir.2014.04.005; MARTORELL R, 1995, J NUTR, V125, pS1127, DOI 10.1093/jn/125.suppl_4.1127S; Mauras N, 2000, J CLIN ENDOCR METAB, V85, P3653, DOI 10.1210/jc.85.10.3653; Mogensen SS, 2011, J CLIN ENDOCR METAB, V96, P1393, DOI 10.1210/jc.2010-2745; Mul D, 2005, CLIN ENDOCRINOL, V63, P185, DOI 10.1111/j.1365-2265.2005.02323.x; Nacinovich R, 2016, MINERVA PEDIATR, V68, P11; Neely EK, 2014, CURR OPIN OBSTET GYN, V26, P332, DOI 10.1097/GCO.0000000000000099; NEELY EK, 1995, J PEDIATR-US, V127, P40, DOI 10.1016/S0022-3476(95)70254-7; Pienkowski C, 2016, ENDOCR DEV, V29, P214, DOI 10.1159/000438893; Pucarelli I, 2003, J PEDIATR ENDOCR MET, V16, P1005; Roberts C, 2016, LANCET DIABETES ENDO, V4, P195, DOI 10.1016/S2213-8587(16)00038-3; Sagodi Laszlo, 2012, Orvosi Hetilap, V153, P418, DOI 10.1556/OH.2012.29320; Savas-Erdeve S, 2016, J CLIN RES PEDIATR E, V8, P211, DOI 10.4274/jcrpe.2356; Schor KSSG, 2015, NELSON TXB PEDIAT DI; Somod ME, 2016, INT J PEDIATR ENDOCR, DOI 10.1186/s13633-016-0022-x; Sorensen K, 2012, HORM RES PAEDIAT, V77, P137, DOI 10.1159/000336325; Sun L, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0543-9; Tanner J M, 1987, Acta Paediatr Jpn, V29, P96; Willemsen RH, 2014, NAT REV ENDOCRINOL, V10, P352, DOI 10.1038/nrendo.2014.40	36	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185080	10.1371/journal.pone.0185080	http://dx.doi.org/10.1371/journal.pone.0185080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973010	Green Published, gold, Green Submitted			2022-12-26	WOS:000412131900012
J	Chiang, HY; Chu, PH; Lee, TH				Chiang, Hou-Yu; Chu, Pao-Hsien; Lee, Ting-Hein			R1R2 peptide ameliorates pulmonary fibrosis in mice through fibrocyte migration and differentiation	PLOS ONE			English	Article							PERIPHERAL-BLOOD FIBROCYTES; CIRCULATING FIBROCYTES; MATRIX METALLOPROTEINASES; GELATINASE-A; I COLLAGEN; MOLECULAR-MECHANISMS; STREPTOCOCCUS-EQUI; BINDING DOMAIN; LUNG INJURY; FIBRONECTIN	Circulating fibrocytes play a key role in the pathogenesis of pulmonary fibrosis. Fibrocytes are bone marrow-derived leukocytes, which enter the lungs in response to their chemoattractant CXCL12 and differentiate into fibroblasts or myofibroblasts, leading to excess deposition of the collagen-rich extracellular matrix. Matrix metalloproteinase (MMP)-9 and MMP-2, secreted by fibrocytes, degrade the subendothelial basement membrane and promote fibrocyte influx into the lungs. Here, we demonstrate that R1R2, a novel peptide derived from the bacterial adhesin SFS, attenuates pulmonary fibrosis by preventing the differentiation of fibrocytes into myofibroblasts and by reducing the invasion of fibrocytes through basement membrane-like proteins. Moreover, our findings reveal dual regulation of R1R2 on MMP-9 through reduced enzymatic activity on gelatin and increased cleavage of CXCL12. These data suggest that R1R2 has potent anti-fibrotic effects against pulmonary fibrosis.	[Chiang, Hou-Yu; Lee, Ting-Hein] Chang Gung Univ, Dept Anat, Coll Med, Taoyuan, Taiwan; [Chiang, Hou-Yu; Lee, Ting-Hein] Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan, Taiwan; [Chiang, Hou-Yu; Chu, Pao-Hsien; Lee, Ting-Hein] Chang Gung Mem Hosp, Div Cardiol, Dept Internal Med, Taoyuan, Taiwan; [Chu, Pao-Hsien] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Lee, TH (corresponding author), Chang Gung Univ, Dept Anat, Coll Med, Taoyuan, Taiwan.; Lee, TH (corresponding author), Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan, Taiwan.; Lee, TH (corresponding author), Chang Gung Mem Hosp, Div Cardiol, Dept Internal Med, Taoyuan, Taiwan.	tingheinlee@mail.cgu.edu.tw	Chu, Pao-Hsien/P-5249-2019	Chu, Pao-Hsien/0000-0003-0361-6348; Lee, Ting-Hein/0000-0001-7077-3138	Chang Gung Memorial Hospital [CMRPD3E0051, CMRPD3E0052, CMRPD3E0053, CMRPD1F0271, CMRPD1F0272, BMRPE27, CMRPD1F0261, BMRPC00]; Ministry of Science and Technology, Taiwan [104-2320-B-182-003-MY2, 105-2320-B-182-002, 102-2320-B-182-007-MY3, 105-2320-B-182-022]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by research grants from Chang Gung Memorial Hospital (CMRPD3E0051, CMRPD3E0052, CMRPD3E0053, CMRPD1F0271, CMRPD1F0272 and BMRPE27 to TL and CMRPD1F0261 and BMRPC00 to HC) and the Ministry of Science and Technology, Taiwan (104-2320-B-182-003-MY2 and 105-2320-B-182-002 to TL and 102-2320-B-182-007-MY3 and 105-2320-B-182 -022 to HC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; ALLAN JA, 1995, BIOCHEM J, V309, P299, DOI 10.1042/bj3090299; Andersson-Sjoland A, 2008, INT J BIOCHEM CELL B, V40, P2129, DOI 10.1016/j.biocel.2008.02.012; Andersson-Sjoland A, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-76; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; Bhan U, 2008, INFECT IMMUN, V76, P2895, DOI 10.1128/IAI.01489-07; BORKAKOTI N, 1999, PROG INFLAM RES, P1; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Chesney J, 1998, J IMMUNOL, V160, P419; Demedts M, 2005, NEW ENGL J MED, V353, P2229, DOI 10.1056/NEJMoa042976; Epperly MW, 2003, AM J RESP CELL MOL, V29, P213, DOI 10.1165/rcmb.2002-0069OC; Eyden B, 2008, J CELL MOL MED, V12, P22, DOI 10.1111/j.1582-4934.2007.00213.x; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; FRIDMAN R, 1995, CANCER RES, V55, P2548; Garcia-de-Alba C, 2010, AM J RESP CRIT CARE, V182, P1144, DOI 10.1164/rccm.201001-0028OC; Gharaee-Kermani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049278; Gioia M, 2009, J MOL BIOL, V386, P419, DOI 10.1016/j.jmb.2008.12.021; GOLDBERG GI, 1989, P NATL ACAD SCI USA, V86, P8207, DOI 10.1073/pnas.86.21.8207; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Harris DA, 2013, J THORAC CARDIOV SUR, V145, P854, DOI 10.1016/j.jtcvs.2012.03.079; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Herold S, 2013, AM J PHYSIOL-LUNG C, V305, pL665, DOI 10.1152/ajplung.00232.2013; Hong KM, 2007, J BIOL CHEM, V282, P22910, DOI 10.1074/jbc.M703597200; Hynes RO, 1990, FIBRONECTINS; Katagiri Y, 2003, J BIOL CHEM, V278, P11897, DOI 10.1074/jbc.M212512200; Keeley EC, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-2; Lattouf R, 2014, J HISTOCHEM CYTOCHEM, V62, P751, DOI 10.1369/0022155414545787; Lee TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117356; Lindmark H, 1999, INFECT IMMUN, V67, P2383, DOI 10.1128/IAI.67.5.2383-2388.1999; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma WJ, 2015, J BIOL CHEM, V290, P4866, DOI 10.1074/jbc.M114.612259; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Mehrad B, 2007, BIOCHEM BIOPH RES CO, V353, P104, DOI 10.1016/j.bbrc.2006.11.149; Mehrad B, 2009, INT J BIOCHEM CELL B, V41, P1708, DOI 10.1016/j.biocel.2009.02.020; Metz CN, 2003, CELL MOL LIFE SCI, V60, P1342, DOI 10.1007/s00018-003-2328-0; Monaco S, 2006, PROTEIN SCI, V15, P2805, DOI 10.1110/ps.062430706; Moore BB, 2005, AM J PATHOL, V166, P675, DOI 10.1016/S0002-9440(10)62289-4; MURPHY G, 1994, J BIOL CHEM, V269, P6632; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nho RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061017; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Shu HKG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079768; Siefert SA, 2012, VASCULAR, V20, P210, DOI 10.1258/vasc.2011.201202; Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007; STEFFENSEN B, 1995, J BIOL CHEM, V270, P11555, DOI 10.1074/jbc.270.19.11555; Strieter Robert M, 2009, Trans Am Clin Climatol Assoc, V120, P49; Strieter RM, 2009, CHEST, V136, P1364, DOI 10.1378/chest.09-0510; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21; Wallace WAH, 2007, INT J EXP PATHOL, V88, P103, DOI 10.1111/j.1365-2613.2006.00515.x; Wang MY, 2006, ARTERIOSCL THROM VAS, V26, P1503, DOI 10.1161/01.ATV.0000225777.58488.f2; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Xu XP, 2004, MATRIX BIOL, V23, P171, DOI 10.1016/j.matbio.2004.05.002	61	13	16	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185811	10.1371/journal.pone.0185811	http://dx.doi.org/10.1371/journal.pone.0185811			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968441	Green Published, gold, Green Submitted			2022-12-26	WOS:000412029600052
J	Arbieu, U; Grunewald, C; Schleuning, M; Bohning-Gaese, K				Arbieu, Ugo; Gruenewald, Claudia; Schleuning, Matthias; Boehning-Gaese, Katrin			The importance of vegetation density for tourists' wildlife viewing experience and satisfaction in African savannah ecosystems	PLOS ONE			English	Article							NATIONAL-PARK; CLIMATE-CHANGE; CONSERVATION; LANDSCAPE; ENCROACHMENT; IMPACTS	Southern African protected areas (PAs) harbour a great diversity of animals, which represent a large potential for wildlife tourism. In this region, global change is expected to result in vegetation changes, such as bush encroachment and increases in vegetation density. However, little is known on the influence of vegetation structure on wildlife tourists' wildlife viewing experience and satisfaction. In this study, we collected data on vegetation structure and perceived mammal densities along 196 road transects (each 5 km long) and conducted a social survey with 651 questionnaires across four PAs in three Southern African countries. Our objectives were 1) to assess visitors' attitude towards vegetation, 2) to test the influence of perceived mammal density and vegetation structure on the easiness to spot animals, and 3) on visitors' satisfaction during their visit to PAs. Using a Boosted Regression Tree procedure, we found mostly negative non-linear relationships between vegetation density and wildlife tourists' experience, and positive relationships between perceived mammal densities and wildlife tourists' experience. In particular, wildlife tourists disliked road transects with high estimates of vegetation density. Similarly, the easiness to spot animals dropped at thresholds of high vegetation density and at perceived mammal densities lower than 46 individuals per road transect. Finally, tourists' satisfaction declined linearly with vegetation density and dropped at mammal densities smaller than 26 individuals per transect. Our results suggest that vegetation density has important impacts on tourists' wildlife viewing experience and satisfaction. Hence, the management of PAs in savannah landscapes should consider how tourists perceive these landscapes and their mammal diversity in order to maintain and develop a sustainable wildlife tourism.	[Arbieu, Ugo; Gruenewald, Claudia; Schleuning, Matthias; Boehning-Gaese, Katrin] Senckenberg Biodivers & Climate Res Ctr SBiK F, Frankfurt, Germany; [Arbieu, Ugo; Boehning-Gaese, Katrin] Goethe Univ, Dept Biol Sci, Frankfurt, Germany	Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt	Arbieu, U (corresponding author), Senckenberg Biodivers & Climate Res Ctr SBiK F, Frankfurt, Germany.; Arbieu, U (corresponding author), Goethe Univ, Dept Biol Sci, Frankfurt, Germany.	ugo.arbieu@senckenberg.de	Arbieu, Ugo/Q-3408-2019; Schleuning, Matthias/H-2154-2015; Böhning-Gaese, Katrin/W-2601-2019	Arbieu, Ugo/0000-0002-0655-8756; Schleuning, Matthias/0000-0001-9426-045X; Böhning-Gaese, Katrin/0000-0003-0477-5586	Deutsche Forsch ungsgemeinschaft (DFG) [BO 1221/19-1]; Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE excellence initiative) of Hesse's Ministry of Higher Education, Research, and the Arts	Deutsche Forsch ungsgemeinschaft (DFG)(German Research Foundation (DFG)); Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE excellence initiative) of Hesse's Ministry of Higher Education, Research, and the Arts	This work was supported by the Deutsche Forsch ungsgemeinschaft (DFG, grant number BO 1221/19-1, http://www.dfg.de/) and the Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE excellence initiative) of Hesse's Ministry of Higher Education, Research, and the Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald S, 2005, ECOL APPL, V15, P96, DOI 10.1890/03-5210; Balmford A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002074; Beerling DJ, 2006, GLOBAL CHANGE BIOL, V12, P2023, DOI 10.1111/j.1365-2486.2006.01239.x; Bellan SE, 2012, J WILDLIFE DIS, V48, P371, DOI 10.7589/0090-3558-48.2.371; Boshoff AF, 2007, S AFR J WILDL RES, V37, P189, DOI 10.3957/0379-4369-37.2.189; Brand R, 2007, EVOL ECOL; Buckley R, 2013, ANIM CONSERV, V16, P259, DOI 10.1111/acv.12057; Buckley R, 2010, NATURE, V467, P1047, DOI 10.1038/4671047d; Buckley R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000143; Caro TM, 1999, ANIM CONSERV, V2, P305, DOI 10.1111/j.1469-1795.1999.tb00077.x; Charles-Dominique T, 2015, S AFR J BOT, V101, P82, DOI 10.1016/j.sajb.2015.05.005; Daniel TC, 2012, P NATL ACAD SCI USA, V109, P8812, DOI 10.1073/pnas.1114773109; Di Minin E, 2013, ANIM CONSERV, V16, P249, DOI 10.1111/j.1469-1795.2012.00595.x; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Eygelaar D, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0627-y; Frank S, 2013, ECOL INDIC, V32, P222, DOI 10.1016/j.ecolind.2013.03.026; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Fullman TJ, 2013, AFR J ECOL, V51, P235, DOI 10.1111/aje.12026; Gandiwa E, 2014, AFR J ECOL, V52, P274, DOI 10.1111/aje.12114; Gillson L, 2015, ECOL COMPLEX, V21, P78, DOI 10.1016/j.ecocom.2014.12.005; Gossling S, 2012, ANN TOURISM RES, V39, P36, DOI 10.1016/j.annals.2011.11.002; Gray EF, 2013, KOEDOE, V55, DOI 10.4102/koedoe.v55i1.1106; Hempson GP, 2015, SCIENCE, V350, P1056, DOI 10.1126/science.aac7978; Hopcraft JGC, 2010, TRENDS ECOL EVOL, V25, P119, DOI 10.1016/j.tree.2009.08.001; Lee DJ, 2014, TOURISM MANAGE, V45, P171, DOI 10.1016/j.tourman.2014.04.002; Lindemann-Matthies P, 2010, BIOL CONSERV, V143, P195, DOI 10.1016/j.biocon.2009.10.003; Lindsey Peter A., 2007, Journal of Ecotourism, V6, P19, DOI 10.2167/joe133.0; Moncrieff GR, 2015, S AFR J BOT, V101, P16, DOI 10.1016/j.sajb.2015.02.004; Naidoo R, 2011, ENVIRON RESOUR ECON, V48, P321, DOI 10.1007/s10640-010-9412-3; O'Connor TG, 2014, AFR J RANGE FOR SCI, V31, P67, DOI 10.2989/10220119.2014.939996; Owen-Smith N, 2012, J MAMMAL, V93, P698, DOI 10.1644/11-MAMM-A-350.1; Parr CL, 2014, TRENDS ECOL EVOL, V29, P205, DOI 10.1016/j.tree.2014.02.004; Parr CL, 2012, DIVERS DISTRIB, V18, P493, DOI 10.1111/j.1472-4642.2012.00882.x; Pettorelli N, 2012, ECOL INDIC, V20, P269, DOI 10.1016/j.ecolind.2012.02.014; Rossello-Nadal J, 2014, TOURISM MANAGE, V42, P334, DOI 10.1016/j.tourman.2013.11.006; Scheiter S, 2009, GLOBAL CHANGE BIOL, V15, P2224, DOI 10.1111/j.1365-2486.2008.01838.x; Smit IPJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137857; Smith MD, 2013, J PLANT ECOL, V6, P71, DOI 10.1093/jpe/rts014; Steven R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062598; Torres-Sovero C, 2012, TOURISM MANAGE, V33, P545, DOI 10.1016/j.tourman.2011.06.008; Wiegand K, 2006, PERSPECT PLANT ECOL, V7, P229, DOI 10.1016/j.ppees.2005.10.001; Willemen L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129785; Winterbach CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135595; Wood SA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02976	44	9	9	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185793	10.1371/journal.pone.0185793	http://dx.doi.org/10.1371/journal.pone.0185793			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957420	gold, Green Published, Green Submitted			2022-12-26	WOS:000411985200115
J	Malaspina, DC; Longo, G; Szleifer, I				Malaspina, David C.; Longo, Gabriel; Szleifer, Igal			Behavior of ligand binding assays with crowded surfaces: Molecular model of antigen capture by antibody-conjugated nanoparticles	PLOS ONE			English	Article							THERAPEUTIC ANTIBODIES; RECEPTOR INTERACTIONS; POLYMERS; AFFINITY; IMMOBILIZATION; TECHNOLOGIES; COVERAGE; KINETICS; HIV-1	Ligand-receptor binding is of utmost importance in several biologically related disciplines. Ligand binding assays (LBA) use the high specificity and high affinity of ligands to detect, target or measure a specific receptors. One particular example of ligand binding assays are Antibody conjugated Nanoparticles (AcNPs), edge-cutting technologies that are present in several novel biomedical approaches for imaging, detection and treatment of diseases. However, the nano-confinement in AcNPs and LBA nanostructures introduces extra complexity in the analysis of ligand-receptor equilibriums. Because antibodies are large voluminous ligands, the effective affinity in AcNPs is often determined by antibody orientation and surface coverage. Moreover, antibodies have two binding sites introducing an extra ligand-receptor binding equilibrium. As consequence of all this, experimental or theoretical studies providing a guidelines for the prediction of the binding behavior in AcNPs are scarce. In this work, we present a set of theoretical calculations to shed light into the complex binding behavior of AcNPs and its implications in biomedical applications. To investigate the ligand-receptor binding on AcNPs, we have used a molecular theory that predicts the probability of different molecular conformations of the system depending on the local environment. We have considered two different pathways for designing these devices: covalently conjugated antibodies and streptavidin-biotin conjugated antibodies. We also explore the effects of surface coverage, bulk concentrations, nanoparticle size and antibody-antigen affinity. Overall, this work offers a series of theoretical predictions that can be used as a guide in the design of antibody conjugated nanoparticles for different applications.	[Malaspina, David C.; Szleifer, Igal] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Longo, Gabriel] UNLP, CONICET, Inst Invest Fisicoquim Teor & Aplicadas INIFTA, La Plata, Buenos Aires, Argentina; [Szleifer, Igal] Dept Chem, Evanston, IL 60208 USA; [Szleifer, Igal] Chem Life Proc Inst, Evanston, IL 60208 USA	Northwestern University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; INIFTA	Szleifer, I (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.; Szleifer, I (corresponding author), Dept Chem, Evanston, IL 60208 USA.; Szleifer, I (corresponding author), Chem Life Proc Inst, Evanston, IL 60208 USA.	igalsz@northwestern.edu	malaspina, david c/I-9578-2016; Szleifer, Igal/B-6920-2009; Longo, Gabriel S./S-5945-2019; Longo, Gabriel S./E-8823-2012	malaspina, david c/0000-0002-5420-9534; Longo, Gabriel S./0000-0001-8353-5163; Longo, Gabriel S./0000-0001-8353-5163	National Institute of Biomedical Imaging and Bio-engineering (NIBIB) at the National Institutes of Health (NIH) [EB005772]; National Science Foundation [CBET-1403058]; ANPCyT; Argentina [PICT-2014-3377]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005772] Funding Source: NIH RePORTER; Directorate For Engineering [1403058] Funding Source: National Science Foundation	National Institute of Biomedical Imaging and Bio-engineering (NIBIB) at the National Institutes of Health (NIH); National Science Foundation(National Science Foundation (NSF)); ANPCyT(ANPCyT); Argentina; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was supported by Grant No. EB005772 from the National Institute of Biomedical Imaging and Bio-engineering (NIBIB) at the National Institutes of Health (NIH) to IS. This research was supported by National Science Foundation CBET-1403058 (to IS). G.L. thanks the support from the ANPCyT, Argentina (PICT-2014-3377). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Grant No. EB005772 from the National Institute of Biomedical Imaging and Bio-engineering (NIBIB) at the National Institutes of Health (NIH). We also thanks the support from the ANPCyT, Argentina (PICT-2014-3377).	Arruebo M, 2009, J NANOMATER, V2009, DOI 10.1155/2009/439389; Bonanno LM, 2007, LANGMUIR, V23, P5817, DOI 10.1021/la063659c; Brogan KL, 2005, LANGMUIR, V21, P3054, DOI 10.1021/la047922q; Cardoso MM, 2012, CURR MED CHEM, V19, P3103; CARIGNANO MA, 1993, J CHEM PHYS, V98, P5006, DOI 10.1063/1.464954; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Chinen AB, 2015, CHEM REV, V115, P10530, DOI 10.1021/acs.chemrev.5b00321; Cooper GM, 2000, CELL MOL APPROACH; de Jong LAA, 2005, J CHROMATOGR B, V829, P1, DOI 10.1016/j.jchromb.2005.10.002; Fay F, 2011, IMMUNOTHERAPY-UK, V3, P381, DOI 10.2217/IMT.11.5; Flory PJ, 1969, INTERSCIENCE; GILBERT M, 1991, J CLIN MICROBIOL, V29, P142, DOI 10.1128/JCM.29.1.142-147.1991; Jung LS, 2000, LANGMUIR, V16, P9421, DOI 10.1021/la000144r; Klasse PJ, 2004, VIROLOGY, V323, P1, DOI 10.1016/j.virol.2004.03.003; Klein JS, 2009, P NATL ACAD SCI USA, V106, P7385, DOI 10.1073/pnas.0811427106; Koh I, 2006, J PHYS CHEM B, V110, P1553, DOI 10.1021/jp0556310; Landry JP, 2012, ASSAY DRUG DEV TECHN, V10, P250, DOI 10.1089/adt.2011.0406; Longo G, 2005, LANGMUIR, V21, P11342, DOI 10.1021/la051685p; Longo GS, 2008, LANGMUIR, V24, P10324, DOI 10.1021/la8009699; Montenegro JM, 2013, ADV DRUG DELIVER REV, V65, P677, DOI 10.1016/j.addr.2012.12.003; Moore NW, 2006, LANGMUIR, V22, P8485, DOI 10.1021/la0608462; Mora J, 2014, AAPS J, V16, P1175, DOI 10.1208/s12248-014-9660-1; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Ren CL, 2009, LANGMUIR, V25, P12283, DOI 10.1021/la901735d; Saha B, 2014, ANAL CHEM, V86, P8158, DOI 10.1021/ac501536z; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Soukka T, 2001, ANAL CHEM, V73, P2254, DOI 10.1021/ac001287l; Sperling RA, 2008, CHEM SOC REV, V37, P1896, DOI 10.1039/b712170a; Szleifer I, 1997, BIOPHYS J, V72, P595, DOI 10.1016/S0006-3495(97)78698-3; Tagliazucchi M, 2010, J AM CHEM SOC, V132, P12404, DOI 10.1021/ja104152g; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Zhang HD, 2006, BIOTECHNOL BIOENG, V95, P812, DOI 10.1002/bit.21024; Zhao Z, 2007, SMALL, V3, P1390, DOI 10.1002/smll.200700006; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu CL, 2012, CHEM REV, V112, P4687, DOI 10.1021/cr200263w	36	21	21	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185518	10.1371/journal.pone.0185518	http://dx.doi.org/10.1371/journal.pone.0185518			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957393	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200074
J	Khandokar, YB; Srivastava, P; Cowieson, N; Sarker, S; Aragao, D; Das, S; Smith, KM; Raidal, SR; Forwood, JK				Khandokar, Yogesh B.; Srivastava, Parul; Cowieson, Nathan; Sarker, Subir; Aragao, David; Das, Shubagata; Smith, Kate M.; Raidal, Shane R.; Forwood, Jade K.			Structural insights into GDP-mediated regulation of a bacterial acyl-CoA thioesterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); coenzyme A (CoA); enzyme kinetics; enzyme structure; hydrolase; Neisseria meningitidis; enzyme regulation; hotdog-fold; thioesterase	FUNCTIONAL-CHARACTERIZATION; PURIFICATION; SPECIFICITY; HYDROLASE; MECHANISM; REVEALS	Thioesterases catalyze the cleavage of thioester bonds within many activated fatty acids and acyl-CoA substrates. They are expressed ubiquitously in both prokaryotes and eukaryotes and are subdivided into 25 thioesterase families according to their catalytic active site, protein oligomerization, and substrate specificity. Although many of these enzyme families are well-characterized in terms of function and substrate specificity, regulation across most thioesterase families is poorly understood. Here, we characterized a TE6 thioesterase from the bacterium Neisseria meningitidis. Structural analysis with X-ray crystallographic diffraction data to 2.0- revealed that each protein subunit harbors a hot dog-fold and that the TE6 enzyme forms a hexamer with D3 symmetry. An assessment of thioesterase activity against a range of acyl-CoA substrates revealed the greatest activity against acetyl-CoA, and structure-guided mutagenesis of putative active site residues identified Asn(24) and Asp(39) as being essential for activity. Our structural analysis revealed that six GDP nucleotides bound the enzyme in close proximity to an intersubunit disulfide bond interactions that covalently link thioesterase domains in a double hot dog dimer. Structure-guided mutagenesis of residues within the GDP-binding pocket identified Arg(93) as playing a key role in the nucleotide interaction and revealed that GDP is required for activity. All mutations were confirmed to be specific and not to have resulted from structural perturbations by X-ray crystallography. This is the first report of a bacterial GDP-regulated thioesterase and of covalent linkage of thioesterase domains through a disulfide bond, revealing structural similarities with ADP regulation in the human ACOT12 thioesterase.	[Khandokar, Yogesh B.; Srivastava, Parul; Smith, Kate M.; Forwood, Jade K.] Charles Sturt Univ, Sch Biomed Sci, Boorooma St, Wagga Wagga, NSW 2678, Australia; [Das, Shubagata; Raidal, Shane R.] Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW 2678, Australia; [Cowieson, Nathan] Diamond Light Source, Div Life Sci, Didcot OX11 0DE, Oxon, England; [Sarker, Subir] La Trobe Univ, Sch Life Sci, Dept Physiol Anat & Microbiol, Melbourne, Vic 3086, Australia; [Aragao, David] Australian Natl Synchrotron, Melbourne, Vic 3168, Australia	Charles Sturt University; Charles Sturt University; Diamond Light Source; La Trobe University	Forwood, JK (corresponding author), Sch Biomed Sci, Wagga Wagga, NSW 2678, Australia.	jforwood@csu.edu.au	Raidal, Shane/C-4632-2008; Aragao, David/A-1695-2012; Aragao, David/AAV-5514-2021; Sarker, Subir/U-8444-2019	Raidal, Shane/0000-0001-7917-8976; Aragao, David/0000-0002-6551-4657; Aragao, David/0000-0002-6551-4657; Sarker, Subir/0000-0002-2685-8377; Das, Shubhagata/0000-0003-0795-2752; Smith, Kate/0000-0002-1183-8832; Forwood, Jade/0000-0003-3267-9997; KHANDOKAR, YOGESH/0000-0002-4630-8508				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angelini A, 2008, PROTEINS, V72, P1212, DOI 10.1002/prot.22014; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Cantu DC, 2014, CHEM-EUR J, V20, P9045, DOI 10.1002/chem.201304228; Cantu DC, 2010, PROTEIN SCI, V19, P1281, DOI 10.1002/pro.417; Cao J, 2009, BIOCHEMISTRY-US, V48, P1293, DOI 10.1021/bi801879z; Dillon SC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Rodriguez-Rodriguez MF, 2014, PHYTOCHEMISTRY, V107, P7, DOI 10.1016/j.phytochem.2014.08.014; Forwood JK, 2007, P NATL ACAD SCI USA, V104, P10382, DOI 10.1073/pnas.0700974104; Han SX, 2012, J LIPID RES, V53, P2620, DOI 10.1194/jlr.M029538; Hunt MC, 2012, BBA-MOL BASIS DIS, V1822, P1397, DOI 10.1016/j.bbadis.2012.03.009; Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0; Jeong JH, 2012, J BIOL CHEM, V287, P29648, DOI 10.1074/jbc.C112.384420; Khandokar YB, 2016, J BIOL CHEM, V291, P1866, DOI 10.1074/jbc.M115.677484; Khandokar YB, 2013, ACTA CRYSTALLOGR F, V69, P1303, DOI 10.1107/S1744309113028042; Kirkby B, 2010, PROG LIPID RES, V49, P366, DOI 10.1016/j.plipres.2010.04.001; Koglin A, 2008, NATURE, V454, P907, DOI 10.1038/nature07161; Kotowska M, 2014, APPL MICROBIOL BIOT, V98, P7735, DOI 10.1007/s00253-014-5952-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kunishima N, 2005, J MOL BIOL, V352, P212, DOI 10.1016/j.jmb.2005.07.008; Labonte JW, 2013, CHEM REV, V113, P2182, DOI 10.1021/cr300169a; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Marfori M, 2011, J BIOL CHEM, V286, P35643, DOI 10.1074/jbc.M111.225953; Park H, 2014, PLANT BIOTECHNOL J, V12, P1035, DOI 10.1111/pbi.12209; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rabbani N, 2014, BIOCHEM SOC T, V42, P419, DOI 10.1042/BST20140008; Swarbrick CMD, 2014, J BIOL CHEM, V289, P24263, DOI 10.1074/jbc.M114.589408; Weeks AM, 2012, P NATL ACAD SCI USA, V109, P19667, DOI 10.1073/pnas.1212591109; Willis MA, 2008, BIOCHEMISTRY-US, V47, P2797, DOI 10.1021/bi702336d; Wu R, 2014, BIOCHEMISTRY-US, V53, P4788, DOI 10.1021/bi500334v; Yamada J, 1996, ARCH BIOCHEM BIOPHYS, V326, P106, DOI 10.1006/abbi.1996.0053	32	6	6	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20461	20471		10.1074/jbc.M117.800227	http://dx.doi.org/10.1074/jbc.M117.800227			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	28972175	Green Published, hybrid			2022-12-26	WOS:000418267000010
J	Brannmark, C; Lovfors, W; Komai, AM; Axelsson, T; El Hachmane, MF; Musovic, S; Paul, A; Nyman, E; Olofsson, CS				Brannmark, Cecilia; Lovfors, William; Komai, Ali M.; Axelsson, Tom; El Hachmane, Mickael F.; Musovic, Saliha; Paul, Alexandra; Nyman, Elin; Olofsson, Charlotta S.			Mathematical modeling of white adipocyte exocytosis predicts adiponectin secretion and quantifies the rates of vesicle exo- and endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; adipokine; adiponectin; electrophysiology; endocytosis; exocytosis; mathematical modeling	ADRENAL CHROMAFFIN CELLS; PANCREATIC BETA-CELLS; 3T3-L1 ADIPOCYTES; INSULIN-RESISTANCE; CAMP CONCENTRATIONS; GLUCOSE-TRANSPORT; SYSTEMS-BIOLOGY; CA2+; ATP; CALCIUM	Adiponectin is a hormone secreted from white adipocytes and takes part in the regulation of several metabolic processes. Although the pathophysiological importance of adiponectin has been thoroughly investigated, the mechanisms controlling its release are only partly understood. We have recently shown that adiponectin is secreted via regulated exocytosis of adiponectin-containing vesicles, that adiponectin exocytosis is stimulated by cAMP-dependent mechanisms, and that Ca2+ and ATP augment the cAMP-triggered secretion. However, much remains to be discovered regarding the molecular and cellular regulation of adiponectin release. Here, we have used mathematical modeling to extract detailed information contained within our previously obtained high-resolution patch-clamp time-resolved capacitance recordings to produce the first model of adiponectin exocytosis/secretion that combines all mechanistic knowledge deduced from electrophysiological experimental series. This model demonstrates that our previous understanding of the role of intracellular ATP in the control of adiponectin exocytosis needs to be revised to include an additional ATP-dependent step. Validation of the model by introduction of data of secreted adiponectin yielded a very close resemblance between the simulations and experimental results. Moreover, we could show that Ca2+-dependent adiponectin endocytosis contributes to the measured capacitance signal, and we were able to predict the contribution of endocytosis to the measured exocytotic rate under different experimental conditions. In conclusion, using mathematical modeling of published and newly generated data, we have obtained estimates of adiponectin exo- and endocytosis rates, and we have predicted adiponectin secretion. We believe that our model should have multiple applications in the study of metabolic processes and hormonal control thereof.	[Brannmark, Cecilia; Komai, Ali M.; El Hachmane, Mickael F.; Musovic, Saliha; Olofsson, Charlotta S.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol Metab Physiol, Medicinaregatan 11, SE-40530 Gothenburg, Sweden; [Lovfors, William; Axelsson, Tom; Nyman, Elin] Linkoping Univ, Dept Biomed Engn, SE-58183 Linkoping, Sweden; [Lovfors, William] Linkoping Univ, Dept Math, SE-58183 Linkoping, Sweden; [Paul, Alexandra] Chalmers Univ Technol, Dept Biol & Biol Engn, Kemivagen 10, SE-41296 Gothenburg, Sweden; [Nyman, Elin] AstraZeneca R&D, Cardiovasc & Metab Dis iMed Biotech Unit, S-43183 Gothenburg, Sweden	University of Gothenburg; Linkoping University; Linkoping University; Chalmers University of Technology; AstraZeneca	Nyman, E (corresponding author), Dept Biomed Engn, SE-58183 Linkoping, Sweden.; Olofsson, CS (corresponding author), Gothenburg Univ, Dept Physiol Metab Physiol, Box 432, S-40530 Gothenburg, Sweden.	elin.nyman@liu.se; charlotta.olofsson@gu.se	Nyman, Elin/I-3363-2019; Paul, Alexandra/L-8289-2017	Nyman, Elin/0000-0002-4261-0291; Paul, Alexandra/0000-0002-8368-9880; Lovfors, William/0000-0002-9058-7049; Olofsson, Charlotta/0000-0001-8824-3151; Brannmark, Cecilia/0000-0003-4848-0480	Swedish Diabetes Foundation [DIA2015-062]; Goljes Memory Fund; Swedish Medical Research Council [2010-2656, 2013-7107]; AstraZeneca; European Union [607842]	Swedish Diabetes Foundation; Goljes Memory Fund; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); AstraZeneca(AstraZeneca); European Union(European Commission)	This work was supported by Swedish Diabetes Foundation Grant DIA2015-062, the Goljes Memory Fund, Swedish Medical Research Council Grants 2010-2656 and 2013-7107, and AstraZeneca. AstraZeneca provided support in the form of salary for author E. N.; Recipient of funding from the European Union Seventh Framework Programme FP7/2007-2013 under Grant Agreement 607842.	Amatore C, 2000, BIOCHIMIE, V82, P481, DOI 10.1016/S0300-9084(00)00213-3; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Borner S, 2011, NAT PROTOC, V6, P427, DOI 10.1038/nprot.2010.198; Bogan JS, 1999, J CELL BIOL, V146, P609, DOI 10.1083/jcb.146.3.609; Bose A, 2005, J BIOL CHEM, V280, P36946, DOI 10.1074/jbc.M508317200; Brackmann C, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3505024; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Cedersund G, 2012, FEBS J, V279, P3513, DOI 10.1111/j.1742-4658.2012.08725.x; Cedersund G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000096; El Hachmane MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119530; Eliasson L, 1996, J PHYSIOL-LONDON, V493, P755, DOI 10.1113/jphysiol.1996.sp021420; Engisch KL, 1998, J PHYSIOL-LONDON, V506, P591, DOI 10.1111/j.1469-7793.1998.591bv.x; Galvanovskis J, 2011, INTERFACE FOCUS, V1, P143, DOI 10.1098/rsfs.2010.0006; Goforth PB, 2002, J GEN PHYSIOL, V120, P307, DOI 10.1085/jgp.20028581; He ZX, 2008, TRAFFIC, V9, P910, DOI 10.1111/j.1600-0854.2008.00730.x; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; Hresko RC, 1998, J BIOL CHEM, V273, P20658, DOI 10.1074/jbc.273.32.20658; Iancu RV, 2008, AM J PHYSIOL-CELL PH, V295, pC414, DOI 10.1152/ajpcell.00038.2008; Jarukanont D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144045; KEIZER J, 1989, BIOPHYS J, V56, P229, DOI 10.1016/S0006-3495(89)82669-4; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; KLIP A, 1987, J BIOL CHEM, V262, P9141; Komai AM, 2016, DIABETES, V65, P3301, DOI 10.2337/db15-1597; Komai AM, 2014, J PHYSIOL-LONDON, V592, P5169, DOI 10.1113/jphysiol.2014.280388; Lee AK, 2001, J PHYSIOL-LONDON, V533, P389, DOI 10.1111/j.1469-7793.2001.0389a.x; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Nyman E, 2015, FEBS J, V282, P951, DOI 10.1111/febs.13194; Nyman E, 2014, J BIOL CHEM, V289, P33215, DOI 10.1074/jbc.M114.608927; Nyman E, 2011, J BIOL CHEM, V286, P26028, DOI 10.1074/jbc.M110.188987; Rajan MR, 2016, J BIOL CHEM, V291, P15806, DOI 10.1074/jbc.M116.715763; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Schmidt H, 2007, BIOINFORMATICS, V23, P646, DOI 10.1093/bioinformatics/btl668; SCHWABE U, 1973, N-S ARCH PHARMACOL, V276, P133, DOI 10.1007/BF00501186; Sips FLP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135665; Sun L, 2009, BIOPHYS J, V97, P1832, DOI 10.1016/j.bpj.2009.06.042; Sun T, 2010, J NEUROSCI, V30, P11838, DOI 10.1523/JNEUROSCI.1481-10.2010; Xie LL, 2008, BBA-MOL BASIS DIS, V1782, P99, DOI 10.1016/j.bbadis.2007.12.003; Zu LX, 2008, MOL PHARMACOL, V73, P215, DOI 10.1124/mol.107.039479	39	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20032	20043		10.1074/jbc.M117.801225	http://dx.doi.org/10.1074/jbc.M117.801225			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	28972187	hybrid, Green Published			2022-12-26	WOS:000417696400009
J	Geilfus, CM; Tenhaken, R; Carpentier, SC				Geilfus, Christoph-Martin; Tenhaken, Raimund; Carpentier, Sebastien Christian			Transient alkalinization of the leaf apoplast stiffens the cell wall during onset of chloride salinity in corn leaves	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						abscisic acid (ABA); chloride transport; extracellular matrix; proteomics; ribosome; sodium transport; tubulin	DOWN-REGULATION; ABSCISIC-ACID; CELLULOSE MICROFIBRILS; ARABIDOPSIS CONTAINS; SMALL GENOME; GUARD-CELLS; SALT STRESS; MAIZE; GROWTH; PH	During chloride salinity, the pH of the leaf apoplast (pH(apo)) transiently alkalizes. There is an ongoing debate about the physiological relevance of these stress-induced pH(apo) changes. Using proteomic analyses of expanding leaves of corn (Zea mays L.), we show that this transition in pH(apo) conveys functionality by (i) adjusting protein abundances and (ii) affecting the rheological properties of the cell wall. pH(apo) was monitored in planta via microscopy-based ratio imaging, and the leaf-proteomic response to the transient leaf apoplastic alkalinization was analyzed via ultra-high performance liquid chromatography-MS. This analysis identified 1459 proteins, of which 44 exhibited increased abundance specifically through the chloride-induced transient rise in pH(apo). These elevated protein abundances did not directly arise from high tissue concentrations of Cl- or Na+ but were due to changes in the pH(apo). Most of these proteins functioned in growth-relevant processes and in the synthesis of cell wall-building components such as arabinose. Measurements with a linear-variable differential transducer revealed that the transient alkalinization rigidified (i.e. stiffened) the cell wall during the onset of chloride salinity. A decrease in t-coumaric and t-ferulic acids indicates that the wall stiffening arises from cross-linkage to cell wall polymers. We conclude that the pH of the apoplast represents a dynamic factor that is mechanistically coupled to cellular responses to chloride stress. By hardening the wall, the increased pH abrogates wall loosening required for cell expansion and growth. We conclude that the transient alkalinization of the leaf apoplast is related to salinity-induced growth reduction.	[Geilfus, Christoph-Martin; Carpentier, Sebastien Christian] Katholieke Univ Leuven, SYBIOMA, Prote Core Facil, O&N II Herestr 49,Bus 901, B-3000 Leuven, Belgium; [Geilfus, Christoph-Martin] Humboldt Univ, Albrecht Daniel Thaer Inst Agr & Hort Sci, Albrecht Thaer Weg 1, D-14195 Berlin, Germany; [Tenhaken, Raimund] Salzburg Univ, Div Plant Physiol, Dept Cell Biol, Salzburg, Austria; [Carpentier, Sebastien Christian] Katholieke Univ Leuven, Dept Biosyst, Div Crop Biotech, Willem Croylaan 42,Box 2455, B-3001 Leuven, Belgium	KU Leuven; Humboldt University of Berlin; Salzburg University; KU Leuven	Geilfus, CM (corresponding author), Humboldt Univ, Div Controlled Environm Hort, Fac Life Sci, Albrecht Daniel Thaer Inst Agr & Hort Sci, Albrecht Thaer Weg 1, D-14195 Berlin, Germany.	geilfusc@hu-berlin.de	Tenhaken, Raimund/O-6556-2019; carpentier, sebastien C.M./D-9482-2018	Tenhaken, Raimund/0000-0002-6764-4826; carpentier, sebastien C.M./0000-0002-7389-6405	Cooperation europeenne dans le domaine de la recherche scientifique et technique STSM scholarship COST Action [FA1306]	Cooperation europeenne dans le domaine de la recherche scientifique et technique STSM scholarship COST Action	This work was supported by a Cooperation europeenne dans le domaine de la recherche scientifique et technique STSM scholarship COST Action FA1306 (to C.-M. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Baroja-Fernandez E, 2012, P NATL ACAD SCI USA, V109, P321, DOI 10.1073/pnas.1117099109; Baskin TI, 2001, PROTOPLASMA, V215, P150, DOI 10.1007/BF01280311; Baucher M, 1996, PLANT PHYSIOL, V112, P1479, DOI 10.1104/pp.112.4.1479; Bindschedler LV, 2007, PHYTOCHEMISTRY, V68, P2635, DOI 10.1016/j.phytochem.2007.08.029; Blancaflor EB, 1997, PLANT PHYSIOL, V113, P1447, DOI 10.1104/pp.113.4.1447; BLATT MR, 1992, J GEN PHYSIOL, V99, P615, DOI 10.1085/jgp.99.4.615; Brinker M, 2010, PLANT PHYSIOL, V154, P1697, DOI 10.1104/pp.110.164152; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Burstenbinder K, 2017, PLANT PHYSIOL, V173, P1692, DOI 10.1104/pp.16.01743; Buts K, 2014, J PROTEOMICS, V105, P31, DOI 10.1016/j.jprot.2014.02.015; Carpentier SC, 2005, PROTEOMICS, V5, P2497, DOI 10.1002/pmic.200401222; Carpentier Sebastien Christian, 2008, V428, P327; Davies WJ, 2005, J PLANT GROWTH REGUL, V24, P285, DOI 10.1007/s00344-005-0103-1; Dhonukshe P, 2003, PLANT CELL, V15, P2666, DOI 10.1105/tpc.014977; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Felle HH, 2001, PLANT BIOLOGY, V3, P577, DOI 10.1055/s-2001-19372; Felle HH, 2008, J PLANT PHYSIOL, V165, P52, DOI 10.1016/j.jplph.2007.08.006; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Geilfus CM, 2015, NEW PHYTOL, V208, P803, DOI 10.1111/nph.13507; Geilfus CM, 2015, J BIOL CHEM, V290, P11235, DOI 10.1074/jbc.M114.619718; Geilfus CM, 2014, PLANT METHODS, V10, DOI 10.1186/1746-4811-10-31; Geilfus CM, 2013, NEW PHYTOL, V197, P1117, DOI 10.1111/nph.12046; Geilfus CM, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00013; Geilfus CM, 2012, PLANT CELL ENVIRON, V35, P578, DOI 10.1111/j.1365-3040.2011.02437.x; GREEN PB, 1962, SCIENCE, V138, P1404, DOI 10.1126/science.138.3548.1404; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Jabeen R, 2006, J PLANT PHYSIOL, V163, P538, DOI 10.1016/j.jplph.2005.05.004; KAKES P, 1985, PLANTA, V166, P156, DOI 10.1007/BF00397342; Karkonen A, 2005, BIOCHEM J, V391, P409, DOI 10.1042/BJ20050800; Kleczkowski LA, 2010, CRIT REV PLANT SCI, V29, P191, DOI 10.1080/07352689.2010.483578; KOPCZAK SD, 1992, PLANT CELL, V4, P539, DOI 10.1105/tpc.4.5.539; Kosova K, 2011, J PROTEOMICS, V74, P1301, DOI 10.1016/j.jprot.2011.02.006; KUTSCHERA U, 1994, NEW PHYTOL, V126, P549, DOI 10.1111/j.1469-8137.1994.tb02951.x; KUTSCHERA U, 1986, PLANTA, V167, P527, DOI [10.1007/BF00391229, 10.1007/BF00392142]; Lager I, 2010, PLANT CELL ENVIRON, V33, P1513, DOI 10.1111/j.1365-3040.2010.02161.x; Maathuis FJM, 1999, CURR OPIN PLANT BIOL, V2, P236, DOI 10.1016/S1369-5266(99)80041-7; Mellerowicz EJ, 2008, CURR OPIN PLANT BIOL, V11, P293, DOI 10.1016/j.pbi.2008.03.003; Monshausen GB, 2007, P NATL ACAD SCI USA, V104, P20996, DOI 10.1073/pnas.0708586104; MUELLER SC, 1982, PLANTA, V154, P489, DOI 10.1007/BF00402993; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; NEUMANN PM, 1994, PLANT CELL ENVIRON, V17, P303, DOI 10.1111/j.1365-3040.1994.tb00296.x; Neves-Piestun BG, 2001, PLANT PHYSIOL, V125, P1419, DOI 10.1104/pp.125.3.1419; Omidbakhshfard MA, 2012, PLANT SIGNAL BEHAV, V7, P1095, DOI 10.4161/psb.21218; Peleg Z, 2011, ADV BOT RES, V57, P405, DOI 10.1016/B978-0-12-387692-8.00012-6; Reboul R, 2011, J BIOL CHEM, V286, P39982, DOI 10.1074/jbc.M111.255695; Roach M, 2012, PLANT J, V70, P967, DOI 10.1111/j.1365-313X.2012.04929.x; Rosler J, 1997, PLANT PHYSIOL, V113, P175, DOI 10.1104/pp.113.1.175; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shoji T, 2006, PLANT CELL PHYSIOL, V47, P1158, DOI 10.1093/pcp/pcj090; SNUSTAD DP, 1992, PLANT CELL, V4, P549, DOI 10.1105/tpc.4.5.549; Sumer A, 2004, J APPL BOT FOOD QUAL, V78, P135; Vanhove AC, 2015, J PROTEOMICS, V119, P10, DOI 10.1016/j.jprot.2015.01.014; Waldron KW, 1996, PHYTOCHEM ANALYSIS, V7, P305, DOI 10.1002/(SICI)1099-1565(199611)7:6&lt;305::AID-PCA320&gt;3.0.CO;2-A; Wilkinson S, 1997, PLANT PHYSIOL, V113, P559, DOI 10.1104/pp.113.2.559; Wilkinson S, 2002, PLANT CELL ENVIRON, V25, P195, DOI 10.1046/j.0016-8025.2001.00824.x; Wilkinson S, 1999, PLANT GROWTH REGUL, V29, P87, DOI 10.1023/A:1006203715640; Yeats TH, 2016, PLANT PHYSIOL, V171, P110, DOI 10.1104/pp.16.00302	58	19	19	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18800	18813		10.1074/jbc.M117.799866	http://dx.doi.org/10.1074/jbc.M117.799866			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972176	Green Published, hybrid			2022-12-26	WOS:000415848000006
J	Rahman, S; Luetje, CW				Rahman, Suhaila; Luetje, Charles W.			Mutant cycle analysis identifies a ligand interaction site in an odorant receptor of the malaria vector Anopheles gambiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; insect; oocyte; receptor; Xenopus; olfaction; structure	DROSOPHILA-MELANOGASTER; OLFACTORY RECEPTORS; CARBON-DIOXIDE; CHANNEL; SUBUNIT; BINDING; SYSTEM; SPECIFICITY; INTERFACE; AFFINITY	Lack of information about the structure of insect odorant receptors (ORs) hinders the development of more effective repellants to control disease-transmitting insects. Mutagenesis and functional analyses using agonists to map the odorant-binding sites of these receptors have been limited because mutations distant from an agonist-binding site can alter agonist sensitivity. Here we use mutant cycle analysis, an approach for exploring the energetics of protein-protein or protein-ligand interactions, with inhibitors, to identify a component of the odorant-binding site of an OR from the malaria vector, Anopheles gambiae. The closely related odorant-specificity subunits Agam/Or15 and Agam/Or13 were each co-expressed with Agam/Orco (odorant receptor co-receptor subunit) in Xenopus oocytes and assayed by two-electrode voltage clamp electrophysiology. We identified (-)-fenchone as a competitive inhibitor with different potencies at the two receptors and used this difference to screen a panel of 37 Agam/Or15 mutants, surveying all positions that differ between Agam/Or15 and Agam/Or13 in the transmembrane and extracellular regions, identifying position 195 as a determinant of (-)-fenchone sensitivity. Inhibition by (-)-fenchone and six structurally related inhibitors of Agam/Or15 receptors containing each of four different hydrophobic residues at position 195 served as input data for mutant cycle analysis. Several mutant cycles, calculated from the inhibition of two receptors by each of two ligands, yielded coupling energies of 1 kcal/mol, indicating a close, physical interaction between the ligand and residue 195 of Agam/Or15. This approach should be useful in further expanding our knowledge of odorant-binding site structures in ORs of disease vector insects.	[Rahman, Suhaila; Luetje, Charles W.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33101 USA; [Rahman, Suhaila] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	University of Miami; Vanderbilt University	Luetje, CW (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, R-189,POB 016189, Miami, FL 33136 USA.	cluetje@med.miami.edu			National Institutes of Health [RO1 DC011091]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health Grant RO1 DC011091. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Carraher C, 2015, INSECT BIOCHEM MOLEC, V66, P31, DOI 10.1016/j.ibmb.2015.09.010; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Erdelyan CNG, 2012, INSECT MOL BIOL, V21, P119, DOI 10.1111/j.1365-2583.2011.01120.x; Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x; Guidobaldi F, 2014, J PHYSIOL-PARIS, V108, P96, DOI 10.1016/j.jphysparis.2014.04.006; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Hallem EA, 2004, NEURON, V42, P359, DOI 10.1016/S0896-6273(04)00256-9; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Hopf TA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7077; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; Hughes DT, 2014, CHEM SENSES, V39, P761, DOI 10.1093/chemse/bju048; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; KU HH, 1966, J RES NBS C ENG INST, VC 70, P263, DOI 10.6028/jres.070C.025; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leary GP, 2012, P NATL ACAD SCI USA, V109, P14081, DOI 10.1073/pnas.1204661109; LEFF P, 1993, TRENDS PHARMACOL SCI, V14, P110, DOI 10.1016/0165-6147(93)90080-4; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; McMeniman CJ, 2014, CELL, V156, P1060, DOI 10.1016/j.cell.2013.12.044; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Nichols AS, 2010, J BIOL CHEM, V285, P11854, DOI 10.1074/jbc.M109.058321; Nyce HL, 2010, BIOPHYS J, V98, P1847, DOI 10.1016/j.bpj.2010.01.034; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Penzotti JL, 2001, BIOPHYS J, V80, P698, DOI 10.1016/S0006-3495(01)76049-3; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Smallegange RC, 2011, TRENDS PARASITOL, V27, P143, DOI 10.1016/j.pt.2010.12.009; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; Thomas-Tran R, 2016, P NATL ACAD SCI USA, V113, P5856, DOI 10.1073/pnas.1603486113; Tondi D, 2014, J MED CHEM, V57, P5449, DOI 10.1021/jm5006572; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wicher D, 2009, ANN NY ACAD SCI, V1170, P164, DOI 10.1111/j.1749-6632.2009.04101.x; Willcockson IU, 2002, J BIOL CHEM, V277, P42249, DOI 10.1074/jbc.M205383200; Xu PX, 2013, BIOCHEM BIOPH RES CO, V435, P477, DOI 10.1016/j.bbrc.2013.05.015; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	48	9	9	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18916	18923		10.1074/jbc.M117.810374	http://dx.doi.org/10.1074/jbc.M117.810374			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972152	Green Published, hybrid			2022-12-26	WOS:000415848000016
J	Geyer, J; Kreft, S; Jeltsch, F; Ibisch, PL				Geyer, Juliane; Kreft, Stefan; Jeltsch, Florian; Ibisch, Pierre L.			Assessing climate change-robustness of protected area management plans-The case of Germany	PLOS ONE			English	Article							CHANGE ADAPTATION STRATEGIES; NATURAL-RESOURCE MANAGEMENT; BIODIVERSITY CONSERVATION; BIOLOGICAL DIVERSITY; GLOBAL CHANGE; FRAMEWORK; QUALITY; IMPLEMENTATION; BRANDENBURG; DIRECTIONS	Protected areas are arguably the most important instrument of biodiversity conservation. To keep them fit under climate change, their management needs to be adapted to address related direct and indirect changes. In our study we focus on the adaptation of conservation management planning, evaluating management plans of 60 protected areas throughout Germany with regard to their climate change-robustness. First, climate change-robust conservation management was defined using 11 principles and 44 criteria, which followed an approach similar to sustainability standards. We then evaluated the performance of individual management plans concerning the climate change-robustness framework. We found that climate change-robustness of protected areas hardly exceeded 50 percent of the potential performance, with most plans ranking in the lower quarter. Most Natura 2000 protected areas, established under conservation legislation of the European Union, belong to the sites with especially poor performance, with lower values in smaller areas. In general, the individual principles showed very different rates of accordance with our principles, but similarly low intensity. Principles with generally higher performance values included holistic knowledge management, public accountability and acceptance as well as systemic and strategic coherence. Deficiencies were connected to dealing with the future and uncertainty. Lastly, we recommended the presented principles and criteria as essential guideposts that can be used as a checklist for working towards more climate change-robust planning.	[Geyer, Juliane; Kreft, Stefan; Ibisch, Pierre L.] Eberswalde Univ Sustainable Dev, Fac Forest & Environm, Ctr Econ & Ecosyst Management, Eberswalde, Germany; [Jeltsch, Florian] Potsdam Univ, Inst Biochem & Biol, Potsdam, Germany	Eberswalde University for Sustainable Development; University of Potsdam	Geyer, J (corresponding author), Eberswalde Univ Sustainable Dev, Fac Forest & Environm, Ctr Econ & Ecosyst Management, Eberswalde, Germany.	juliane.geyer@hnee.de	Kreft, Stefan/AAE-5558-2021	Ibisch, Pierre/0000-0001-9820-9272	Faculty of Forest and Environment of the Eberswalde University; German Academic Scholarship Foundation; Potsdam University; Lincoln University (New Zealand); German Federal Ministry for Environment, Nature Conservation, Building and Nuclear Safety through German Federal Agency for Nature Conservation; German Federal Ministry of Education and Research (project INKA BB); Eberswalde University	Faculty of Forest and Environment of the Eberswalde University; German Academic Scholarship Foundation; Potsdam University; Lincoln University (New Zealand); German Federal Ministry for Environment, Nature Conservation, Building and Nuclear Safety through German Federal Agency for Nature Conservation; German Federal Ministry of Education and Research (project INKA BB); Eberswalde University	This research has been funded by contributions of several funders: Faculty of Forest and Environment of the Eberswalde University for Sustainable Development, German Academic Scholarship Foundation, Potsdam University, Lincoln University (New Zealand), German Federal Ministry for Environment, Nature Conservation, Building and Nuclear Safety through German Federal Agency for Nature Conservation, German Federal Ministry of Education and Research (project INKA BB). PI co-authored the study in the framework of his long-term research programme facilitated by the research professorships 'Biodiversity and natural resource management under global change' (2009-2015) as well as 'Ecosystem-based sustainable development' (since 2015) granted by Eberswalde University for Sustainable Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is one output of the cooperative graduate programme "Adaptive Nature Conservation under Climate Change" of the Eberswalde University for Sustainable Development, Potsdam University and Potsdam Institute for Climate Impact Research (PIK). We thank the Faculty of Forest and Environment at Eberswalde University for Sustainable Development for logistic support of the study. Pierre Ibisch co-conceived and supervised the study in the framework of his long-term research program facilitated by the research professorships "Biodiversity and Natural Resource Management under Global Change" (2009-2015) as well as "Ecosystem-based Sustainable Development" (since 2015) granted by Eberswalde University for Sustainable Development. We also thank all staff of protected area and other administrations that provided access to requested management plans. We cordially thank Lena Strixner, Daniela Aschenbrenner and Isabelle Wagner for their technical assistance in plan evaluation and Lisa Biber-Freudenberger for helping in the statistical analysis of the obtained data. We are also grateful to Kevin Beiler for substantial editing, to BrynErin Keverin for assistance in language revision as well as to three anonymous reviewers and the managing editor for constructive comments that greatly helped to improve the manuscript.	Amt fur das Biospharenreservat Schaalsee, 2003, RAHM REG AG; [Anonymous], 2016, IUCN GREEN LIST PROT; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Aschenbrenner D, 2012, REGIONALE ANPASSUNG, P168; Baker I, 2012, LANDSCAPE URBAN PLAN, V107, P127, DOI 10.1016/j.landurbplan.2012.05.009; Baron JS, 2009, ENVIRON MANAGE, V44, P1033, DOI 10.1007/s00267-009-9296-6; Baynham M, 2014, J ENVIRON PLANN MAN, V57, P557, DOI 10.1080/09640568.2012.756805; BfN, 2008, NAT DAT 2008; Brody SD, 2003, POPUL ENVIRON, V24, P511, DOI 10.1023/A:1025078715216; CBD, 2000, COP 5 DEC V 6; Clarke P., 2010, PRINCIPLES PRACTICE; Corson C, 2014, CONSERV SOC, V12, P190, DOI 10.4103/0972-4923.138421; Cote IM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000438; Cross MS, 2013, CONSERV BIOL, V27, P4, DOI 10.1111/j.1523-1739.2012.01954.x; Cross MS, 2012, ENVIRON MANAGE, V50, P341, DOI 10.1007/s00267-012-9893-7; Cybulla F, 2012, REGIONALE ANPASSUNG, P194; Dudley N., 2010, NATURAL SOLUTIONS PR; Ellwanger G, 2012, NATURSCHUTZ BIOL VIE; European Commission, 2017, NAT 2000 2017; Fazey I, 2006, ENVIRON CONSERV, V33, P1, DOI 10.1017/S037689290600275X; Federal Agency for Nature Conservation, 2014, MAN NAT 2000; Federal Agency for Nature Conservation, 2015, NAT 2000; Federal Agency for Nature Conservation, 2010, PROT AR; Fee E, 2009, J NAT CONSERV, V17, P212, DOI 10.1016/j.jnc.2009.04.005; Felton A, 2009, BIODIVERS CONSERV, V18, P2243, DOI 10.1007/s10531-009-9652-0; Forest Stewardship Council, 2019, POL PEST FSC; Geldmann J, 2015, BIOL CONSERV, V191, P692, DOI 10.1016/j.biocon.2015.08.029; Geyer J, 2015, REG ENVIRON CHANGE, V15, P139, DOI 10.1007/s10113-014-0609-9; Gillingham PK, 2015, BIOL J LINN SOC, V115, P707, DOI 10.1111/bij.12506; Godschalk D., 1999, NATURAL HAZARD MITIG; Hagerman S, 2010, GLOBAL ENVIRON CHANG, V20, P192, DOI 10.1016/j.gloenvcha.2009.10.005; Hallegatte S, 2009, GLOBAL ENVIRON CHANG, V19, P240, DOI 10.1016/j.gloenvcha.2008.12.003; Halpin PN, 1997, ECOL APPL, V7, P828; Hannah L, 2008, ANN NY ACAD SCI, V1134, P201, DOI 10.1196/annals.1439.009; Heiland S, 2013, MANAGEMENTQUALITAT D; Heller NE, 2014, CONSERV BIOL, V28, P696, DOI 10.1111/cobi.12269; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hockings M., 2006, EVALUATING EFFECTIVE, Vxiv; Huntley B., 2007, COUNCIL OF EUROPE; IBISCH P, 2008, ANLIEGEN NATUR, V32, P3; Ibisch P L., 2012, REGIONALE ANPASSUNG, P214; Ibisch P.L., 2011, CARPATHIAN BIOSPHERE; Ibisch P L., 2012, REGIONALE ANPASSUNG; Ibisch Pierre L., 2014, GUIDEBOOK RISK ROBUS; Ibisch PL, 2010, INTERDEPENDENCE BIOD, P15; Ibisch PL, 2015, LESSONS CASE STUDIES; Ibisch PL, 2009, STIMMT KLIMA NATURSC, P51; Ibisch PL, 2012, SERIES ECONICS ECOSY, P131; Ibisch PL, 2014, ANPASSUNG NATURSCHUT; Kharouba HM, 2010, BIOL CONSERV, V143, P1094, DOI 10.1016/j.biocon.2010.02.002; Knight AT, 2006, CONSERV BIOL, V20, P739, DOI 10.1111/j.1523-1739.2006.00452.x; Kreft S, 2013, NATURSCHUTZ HANDELN, P70; Kreft S, 2013, SCHUTZGEBIETE DEUTSC, P177; Kumar P, 2015, LAND USE POLICY, V42, P210, DOI 10.1016/j.landusepol.2014.07.016; Kunze B, 2013, NATURSCHUTZ BIOL VIE, V129, P123; Lawler JJ, 2009, ANN NY ACAD SCI, V1162, P79, DOI 10.1111/j.1749-6632.2009.04147.x; Lemieux C. J., 2010, 19 CCEA; Lemieux CJ, 2005, CAN GEOGR-GEOGR CAN, V49, P384, DOI 10.1111/j.0008-3658.2005.00103.x; LEVERINGTON F, 2008, 1 TNC WWF IUCNWCPA U; Leverington F, 2010, MANAGEMENT EFFECTIVE; LfU (Landesamt fu E r Umwelt), 2016, HDB MAN FFH GEB LAND; Lyles W, 2014, J PLAN EDUC RES, V34, P433, DOI 10.1177/0739456X14549752; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; Moser SC, 2010, P NATL ACAD SCI USA, V107, P22026, DOI 10.1073/pnas.1007887107; Nolte C., 2010, PROTECTED AREA MANAG; PETERS RL, 1985, BIOSCIENCE, V35, P707, DOI 10.2307/1310052; Pfeffer J, 1999, CALIF MANAGE REV, V42, P83, DOI 10.2307/41166020; Poiani KA, 2011, BIODIVERS CONSERV, V20, P185, DOI 10.1007/s10531-010-9954-2; Preston BL, 2011, MITIG ADAPT STRAT GL, V16, P407, DOI 10.1007/s11027-010-9270-x; R Development Core Team, R LANG ENV STAT COMP; Radtke Laura, 2015, Naturschutz und Landschaftsplanung, V47, P201; Reyer C, 2012, REG ENVIRON CHANGE, V12, P523, DOI 10.1007/s10113-011-0269-y; RSPO, 2013, PRINC CRIT PROD SUST; Sarmadi D., 2015, WENIG NATURSCHUTZ EU; Schaalsee Biosphere Reserve, 2016, UNESCO BIOSPH SCHAAL; Schick A, 2017, ECOSYST HEALTH SUST, V3, DOI 10.1002/ehs2.1267; Sieck Mungla, 2011, BMC Ecology, V11, P12, DOI 10.1186/1472-6785-11-12; Stein B.A., 2014, CLIMATE SMART CONSER; Stein BA, 2013, FRONT ECOL ENVIRON, V11, P502, DOI 10.1890/120277; Stevens MR, 2014, J PLAN EDUC RES, V34, P77, DOI 10.1177/0739456X13513614; Stevens MR, 2013, J PLAN EDUC RES, V33, P471, DOI 10.1177/0739456X13505649; Stoll-Kleemann Susanne, 2012, Naturschutz und Landschaftsplanung, V44, P37; Stolton S, 2011, MANAGING CLIMATE CHA; Tang ZH, 2010, J ENVIRON PLANN MAN, V53, P41, DOI 10.1080/09640560903399772; Tang ZH, 2009, ENVIRON PLANN B, V36, P522, DOI 10.1068/b34076; The Nature Conservancy Parks in Peril Program, 2002, MEAS SUCC PARKS PER; Thomas CD, 2012, P NATL ACAD SCI USA, V109, P14063, DOI 10.1073/pnas.1210251109; TNC, 2009, CONS ACT PLANN GUID; Umweltplan GmbH, 2008, REG BEW KLIM ENTW KL; Virkkala R, 2008, BIOL CONSERV, V141, P1343, DOI 10.1016/j.biocon.2008.03.007; Weidenhammer S., 2007, KRITERIEN ANERKENNUN; Welch D., 2005, G WRIGHT FORUM, V22, P75; Wilby RL, 2010, WEATHER, V65, P180, DOI 10.1002/wea.543; Wilke C., 2011, NATURSCHUTZ BIOL VIE, V109; Wilke C, 2014, ADV GLOB CHANGE RES, V58, P159, DOI 10.1007/978-94-007-7960-0_10	95	4	4	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185972	10.1371/journal.pone.0185972	http://dx.doi.org/10.1371/journal.pone.0185972			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28982187	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300100
J	Hobbs, MT; Brehme, CS				Hobbs, Michael T.; Brehme, Cheryl S.			An improved camera trap for amphibians, reptiles, small mammals, and large invertebrates	PLOS ONE			English	Article							PHOTO IDENTIFICATION; WILDLIFE; OCCUPANCY; LANDSCAPE; FEATURES; DESIGN	Camera traps are valuable sampling tools commonly used to inventory and monitor wildlife communities but are challenged to reliably sample small animals. We introduce a novel active camera trap system enabling the reliable and efficient use of wildlife cameras for sampling small animals, particularly reptiles, amphibians, small mammals and large invertebrates. It surpasses the detection ability of commonly used passive infrared (PIR) cameras for this application and eliminates problems such as high rates of false triggers and high variability in detection rates among cameras and study locations. Our system, which employs a HALT trigger, is capable of coupling to digital PIR cameras and is designed for detecting small animals traversing small tunnels, narrow trails, small clearings and along walls or drift fencing.	[Brehme, Cheryl S.] US Geol Survey, Western Ecol Res Ctr, San Diego, CA USA	United States Department of the Interior; United States Geological Survey		mhobbs2928@gmail.com		Hobbs, Michael/0000-0001-8469-1037; Brehme, Cheryl/0000-0001-8904-3354	California tiger salamander (Ambystoma californiense) (CTS) in the foothills at Stanford University (Santa Clara County, CA); Stanford Habitat Conservation Plan	California tiger salamander (Ambystoma californiense) (CTS) in the foothills at Stanford University (Santa Clara County, CA); Stanford Habitat Conservation Plan	The author received funding for the second field test conducted during seasonal breeding migrations of the California tiger salamander (Ambystoma californiense) (CTS) in the foothills at Stanford University (Santa Clara County, CA). This field test was funded by the Stanford Habitat Conservation Plan.	Barros CS, 2015, ZOOLOGIA-CURITIBA, V32, P334, DOI 10.1590/S1984-46702015000500002; Bluett Robert D., 2013, Transactions of the Illinois State Academy of Science, V106, P15; Brooks RT, 1996, WILDLIFE SOC B, V24, P298; Burnham K P, 2003, MODEL SELECT MULTIMO; Carbone C, 2001, ANIMAL CONSERVATION, V4; Cusack JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126373; De Bondi N, 2010, WILDLIFE RES, V37, P456, DOI 10.1071/WR10046; Edwards KE, 2014, WILDLIFE SOC B, V38, P530, DOI 10.1002/wsb.419; Enge KM, 2001, J HERPETOL, V35, P467, DOI 10.2307/1565965; Faber Lieke, 2013, Herpetological Review, V44, P600; Fisher R, 2008, HERPETOLOGICAL MONIT; Gamble L, 2008, J APPL ECOL, V45, P170, DOI 10.1111/j.1365-2664.2007.01368.x; Hamel S, 2013, METHODS ECOL EVOL, V4, P105, DOI 10.1111/j.2041-210x.2012.00262.x; Harlow HJ, 2010, INT J ZOOLOGY, V2010; Hines J., 2006, PRESENCE2 SOFTWARE E; Hughson DL, 2010, CALIF FISH GAME, V96, P101; Jenkins Christopher L., 2003, Herpetological Review, V91, P39; KUCERA TE, 1993, WILDLIFE SOC B, V21, P505; Lang SB, 2005, PHYS TODAY, V58, P31, DOI 10.1063/1.2062916; Luo  R.C., 2008, P IEEE WORKSH ADV RO, P1; Marcus Rowcliffe J, 2011, METHODS ECOLOGY EVOL, V2; McDonald PJ, 2015, BIOL CONSERV, V191, P93, DOI 10.1016/j.biocon.2015.06.027; Meek P, 2012, INTRO CAMERA TRAPPIN; Meek PD, 2012, WILDLIFE RES, V39, P649, DOI 10.1071/WR12138; Nebel S, 2013, NATURE ED KNOWLEDGE, V4, P3; Pagnucco KS, 2011, HERPETOL CONSERV BIO, V6, P277; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; RICE CG, 1995, WILDLIFE SOC B, V23, P110; Rovero F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103300; Rovero F, 2013, HYSTRIX, V24, P148, DOI 10.4404/hystrix-24.2-6316; Rovero Francesco, 2010, Abc Taxa, V8, P100; Ryan TJ, 2002, FOREST ECOL MANAG, V167, P83, DOI 10.1016/S0378-1127(01)00692-2; Schoen Alan, 2015, Herpetological Review, V46, P188; Sharifi M, 2013, RUSS J HERPETOL, V20, P264; Swann DE, 2004, WILDLIFE SOC B, V32, P357, DOI 10.2193/0091-7648(2004)32[357:ICFDWA]2.0.CO;2; Swinnen KRR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098881; Tchernihovski N, 1997, United States patent US, Patent No. [5,693,943, 5693943]; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Todd BD, 2007, AM MIDL NAT, V158, P292, DOI 10.1674/0003-0031(2007)158[292:GTDETE]2.0.CO;2; Welbourne DJ., 2013, PLOS ONE, V6; Yun J, 2014, SENSORS-BASEL, V14, P8057, DOI 10.3390/s140508057	41	27	31	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185026	10.1371/journal.pone.0185026	http://dx.doi.org/10.1371/journal.pone.0185026			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981533	Green Published, gold			2022-12-26	WOS:000412360300026
J	Shin, HJ; Franco, LH; Nair, VR; Collins, AC; Shiloh, MU				Shin, Hyun-Jin; Franco, Luis H.; Nair, Vidhya R.; Collins, Angela C.; Shiloh, Michael U.			A baculovirus-conjugated mimotope vaccine targeting Mycobacterium tuberculosis lipoarabinomannan	PLOS ONE			English	Article							PEPTIDE MIMOTOPES; IMMUNE-RESPONSES; ANTIBODIES; PROTECTION; CELLS; POLYSACCHARIDES; ARABINOMANNAN; INDUCTION; INFECTION; VIRULENT	Mycobacterium tuberculosis, the causative agent of tuberculosis, is a major cause of morbidity and mortality worldwide. However, an effective vaccine for M. tuberculosis is lacking. We panned a phage display library using monoclonal antibodies against M. tuberculosis liporabinomannan (LAM), an important component of the M. tuberculosis cell wall, and identified two peptide sequences, HSFKWLDSPRLR or SGVYKVAYDWQH, with high antibody affinity after multiple rounds of panning. Only the HSFKWLDSPRLR peptide induced an anti-LAM response when conjugated to either keyhole limpet hemocyanin (KLH) or to the baculovirus Autographa californica multicapsid nucleopolyherovirus (AcMNPV) when introduced into mice by injection or via intranasal inoculation, respectively. Vaccination with AcMNPV conjugated HSFKWLDSPRLR peptide delayed mortality in a mouse model of tuberculosis. Thus, we report a proof of principle M. tuberculosis vaccination strategy combining an anti-LAM mimotope with a baculovirus delivery system.	[Shin, Hyun-Jin; Nair, Vidhya R.; Collins, Angela C.; Shiloh, Michael U.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Franco, Luis H.] Univ Texas Southwestern Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA; [Nair, Vidhya R.; Shiloh, Michael U.] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Shin, Hyun-Jin] Chungnam Natl Univ, Coll Vet Med, 220 Gungdong, Yuseong, Daejon, South Korea	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Chungnam National University	Shiloh, MU (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.; Shiloh, MU (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	Michael.Shiloh@utsouthwestern.edu	Shiloh, Michael/AAS-8883-2020; Franco, Luis H/M-4636-2017	Shiloh, Michael/0000-0003-4329-2253; Franco, Luis H/0000-0002-8143-1384; Collins, Angela/0000-0001-6392-7151	UT Southwestern Medical Center; NIH [AI099439, AI125939, AI111023]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099439, U01AI125939, R21AI111023] Funding Source: NIH RePORTER	UT Southwestern Medical Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a High Risk-High Impact Award from UT Southwestern Medical Center, and NIH grants AI099439, AI125939, AI111023 (M.U.S.). Dr. Shiloh is a Disease Oriented Clinical Scholar at UT Southwestern. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2003, J IMMUNOL, V171, P1133, DOI 10.4049/jimmunol.171.3.1133; Achkar JM, 2015, IMMUNOL REV, V264, P167, DOI 10.1111/imr.12276; Ahi YS, 2011, CURR GENE THER, V11, P307; Bailo R, 2015, BIOCHEM PHARMACOL, V96, P159, DOI 10.1016/j.bcp.2015.05.001; Bakhshinejad B, 2016, AMINO ACIDS, V48, P2699, DOI 10.1007/s00726-016-2329-6; Balu S, 2011, J IMMUNOL, V186, P3113, DOI 10.4049/jimmunol.1003189; Barenholz A, 2007, J MED MICROBIOL, V56, P579, DOI 10.1099/jmm.0.46920-0; Baumann R, 2014, J INFECTION, V69, P581, DOI 10.1016/j.jinf.2014.05.014; Bohnsack RN, 2009, J BIOL CHEM, V284, P35215, DOI 10.1074/jbc.M109.056184; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Chen TT, 2016, J INFECT DIS, V214, P300, DOI 10.1093/infdis/jiw141; Chen ZJ, 2015, MOL PHARMACEUT, V12, P2180, DOI 10.1021/acs.molpharmaceut.5b00177; Collins AC, 2015, CELL HOST MICROBE, V17, P820, DOI 10.1016/j.chom.2015.05.005; Diaz-Perlas C, 2016, BIOPOLYMERS; Fleuridor R, 2001, J IMMUNOL, V166, P1087, DOI 10.4049/jimmunol.166.2.1087; Franco LH, 2017, CELL HOST MICROBE, V21, P59, DOI [10.1016/j.chom.2017.08.005, 10.1016/j.chom.2016.11.002]; Fratti RA, 2003, J BIOL CHEM, V278, P46961, DOI 10.1074/jbc.M305225200; Gevorkian G, 2005, BIOCHEM J, V387, P411, DOI 10.1042/BJ20041139; Grosse S, 2016, ANGEW CHEM INT EDIT, V55, P11266, DOI 10.1002/anie.201601603; Guo GN, 2016, BIOTECHNOL LETT, V38, P1867, DOI 10.1007/s10529-016-2172-6; Hamasur B, 2003, VACCINE, V21, P4081, DOI 10.1016/S0264-410X(03)00274-3; Hartman ZC, 2008, VIRUS RES, V132, P1, DOI 10.1016/j.virusres.2007.10.005; Hsu CS, 2004, BIOTECHNOL BIOENG, V88, P42, DOI 10.1002/bit.20213; Hu YC, 2006, ADV VIRUS RES, V68, P287, DOI 10.1016/S0065-3527(06)68008-1; Huang J, 2012, NUCLEIC ACIDS RES, V40, pD271, DOI 10.1093/nar/gkr922; Huang J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/101932; Jacobs AJ, 2016, TUBERCULOSIS, V101, P102, DOI 10.1016/j.tube.2016.08.001; Jankute M, 2015, ANNU REV MICROBIOL, V69, P405, DOI 10.1146/annurev-micro-091014-104121; Jordan KR, 2009, CURR PROTOC IMMUNOL; Kaufmann SH, 2016, INT J INFECT DIS; Kim JJP, 2009, CURR OPIN STRUC BIOL, V19, P534, DOI 10.1016/j.sbi.2009.09.002; Li H, 2017, P NATL ACAD SCI USA, V114, P5023, DOI 10.1073/pnas.1611776114; Lu LL, 2016, CELL, V167, P433, DOI 10.1016/j.cell.2016.08.072; Mangtani P, 2014, CLIN INFECT DIS, V58, P470, DOI 10.1093/cid/cit790; Nair VR, 2016, CELL REP, V16, P1253, DOI 10.1016/j.celrep.2016.06.080; Pirofski LA, 2001, TRENDS MICROBIOL, V9, P445, DOI 10.1016/S0966-842X(01)02134-5; Prados-Rosales R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006250; Principi N, 2015, TUBERCULOSIS, V95, P6, DOI 10.1016/j.tube.2014.10.004; Ren LN, 2016, BIOCHEM PHARMACOL, V107, P91, DOI 10.1016/j.bcp.2016.03.004; Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643; Schlesinger LS, 1996, J IMMUNOL, V157, P4568; SCHLESINGER LS, 1994, J IMMUNOL, V152, P4070; Sharma A, 2006, CLIN VACCINE IMMUNOL, V13, P1143, DOI 10.1128/CVI.00127-06; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; Strauss R, 2007, MOL THER, V15, P193, DOI 10.1038/sj.mt.6300008; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Teitelbaum R, 1998, P NATL ACAD SCI USA, V95, P15688, DOI 10.1073/pnas.95.26.15688; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; WHO, 2016, GLOB TUB REP; Williams A, 2004, IMMUNOLOGY, V111, P328, DOI 10.1111/j.1365-2567.2004.01809.x; Wilson S, 2008, VACCINE, V26, P2451, DOI 10.1016/j.vaccine.2008.03.027; Xing Z, 2014, CHEST, V146, P804, DOI 10.1378/chest.14-0439; XU SM, 1994, J IMMUNOL, V153, P2568; Yu X, 2012, CLIN VACCINE IMMUNOL, V19, P198, DOI 10.1128/CVI.05550-11; Zacharia VM, 2013, MBIO, V4, DOI 10.1128/mBio.00721-13; Zimmermann N, 2016, EMBO MOL MED, V8, P1325, DOI 10.15252/emmm.201606330	56	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185945	10.1371/journal.pone.0185945	http://dx.doi.org/10.1371/journal.pone.0185945			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982200	Green Submitted, Green Published, gold			2022-12-26	WOS:000412360300094
J	Vaiciukynas, E; Verikas, A; Gelzinis, A; Bacauskiene, M				Vaiciukynas, Evaldas; Verikas, Antanas; Gelzinis, Adas; Bacauskiene, Marija			Detecting Parkinson's disease from sustained phonation and speech signals	PLOS ONE			English	Article							AUTOMATIC DETECTION	This study investigates signals from sustained phonation and text-dependent speech modalities for Parkinson's disease screening. Phonation corresponds to the vowel /a/ voicing task and speech to the pronunciation of a short sentence in Lithuanian language. Signals were recorded through two channels simultaneously, namely, acoustic cardioid (AC) and smart phone (SP) microphones. Additional modalities were obtained by splitting speech recording into voiced and unvoiced parts. Information in each modality is summarized by 18 well-known audio feature sets. Random forest (RF) is used as a machine learning algorithm, both for individual feature sets and for decision-level fusion. Detection performance is measured by the out-of-bag equal error rate (EER) and the cost of log-likelihood-ratio. Essentia audio feature set was the best using the AC speech modality and YAAFE audio feature set was the best using the SP unvoiced modality, achieving EER of 20.30% and 25.57%, respectively. Fusion of all feature sets and modalities resulted in EER of 19.27% for the AC and 23.00% for the SP channel. Non-linear projection of a RF-based proximity matrix into the 2D space enriched medical decision support by visualization.	[Vaiciukynas, Evaldas; Verikas, Antanas; Gelzinis, Adas; Bacauskiene, Marija] Kaunas Univ Technol, Dept Elect Power Syst, Kaunas, Lithuania; [Vaiciukynas, Evaldas] Kaunas Univ Technol, Dept Informat Syst, Kaunas, Lithuania; [Verikas, Antanas] Halmstad Univ, CAISR, Halmstad, Sweden	Kaunas University of Technology; Kaunas University of Technology; Halmstad University	Vaiciukynas, E (corresponding author), Kaunas Univ Technol, Dept Elect Power Syst, Kaunas, Lithuania.; Vaiciukynas, E (corresponding author), Kaunas Univ Technol, Dept Informat Syst, Kaunas, Lithuania.	evaldas.vaiciukynas@ktu.lt		Vaiciukynas, Evaldas/0000-0002-4769-4527; verikas, antanas/0000-0003-2185-8973	Research Council of Lithuania [MIP-075/2015]	Research Council of Lithuania(Research Council of Lithuania (LMTLT))	This research was funded by a grant (No. MIP-075/2015) from the Research Council of Lithuania (http://www.lmt.lt/en) to Antanas Verikas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora G, 2013, P IEEE, V101, P2470, DOI 10.1109/JPROC.2013.2262913; An G., 2015, 16 ANN C INT SPEECH; Arora S, 2015, PARKINSONISM RELAT D, V21, P650, DOI 10.1016/j.parkreldis.2015.02.026; Belalcazar-Bolanos E. A., 2013, Natural and Artificial Models in Computation and Biology. 5th International Work-Conference on the Interplay Between Natural and Artificial Computation, IWINAC 2013. Proceedings, Part I: LNCS 7930, P283, DOI 10.1007/978-3-642-38637-4_29; Bogdanov D., 2013, 14 C INT SOC MUSIC I, P493; Bot BM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.11; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brummer N, 2013, ARXIV PREPRINT ARXIV; Caesarendra W, 2015, IEEE ASME INT C ADV, P802, DOI 10.1109/AIM.2015.7222636; Crysandt H, 2004, 3 MUSICNETWORK OP WO; de Rijk MC, 2000, NEUROLOGY, V54, pS21; Ellis D. P., 2005, PLP RASTA MFCC INVER; Eyben F., 2013, P 21 ACM INT C MULT, P835, DOI 10.1145/2502081.2502224; Faundez-Zanuy M, 2005, IEEE AERO EL SYS MAG, V20, P7, DOI 10.1109/MAES.2005.1432568; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Gelzinis A, 2008, COMPUT METH PROG BIO, V91, P36, DOI 10.1016/j.cmpb.2008.01.008; Harel B, 2004, BRAIN COGNITION, V56, P24, DOI 10.1016/j.bandc.2004.05.002; Hariharan M, 2014, COMPUT METH PROG BIO, V113, P904, DOI 10.1016/j.cmpb.2014.01.004; Heinmerling D, 2016, INTERSPEECH, P1190, DOI 10.21437/Interspeech.2016-1062; Jaiantilal A., 2012, RANDOM FOREST; Khan T, 2014, BIOCYBERN BIOMED ENG, V34, P25, DOI 10.1016/j.bbe.2013.06.001; Kordower JH, 2013, BRAIN, V136, P2419, DOI 10.1093/brain/awt192; Little MA, 2009, IEEE T BIO-MED ENG, V56, P1015, DOI 10.1109/TBME.2008.2005954; Ma C, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/985789; Mathieu B., 2010, P 11 INT SOC MUSIC I, P441; McEnnis D., 2006, P 7 INT C MUS ISMIR, P385; Memedi M, 2015, SENSORS-BASEL, V15, P23727, DOI 10.3390/s150923727; Naranjo L, 2016, EXPERT SYST APPL, V46, P286, DOI 10.1016/j.eswa.2015.10.034; Orozco-Arroyave JR, 2015, 16TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION (INTERSPEECH 2015), VOLS 1-5, P95; Orozco-Arroyave JR, 2016, J ACOUST SOC AM, V139, P481, DOI 10.1121/1.4939739; Ramani R. G., 2011, INT J COMPUT APPL, V32, P17, DOI DOI 10.5120/3932-5571]; Revett Kenneth, 2009, Proceedings of the 2009 International Multiconference on Computer Science and Information Technology (IMCSIT), P425, DOI 10.1109/IMCSIT.2009.5352688; Saenz-Lechon N, 2006, BIOMED SIGNAL PROCES, V1, P120, DOI 10.1016/j.bspc.2006.06.003; Sakar CO, 2010, J MED SYST, V34, P591, DOI 10.1007/s10916-009-9272-y; Tsanas A., 2012, ACCURATE TELEMONITOR; Tsanas A, 2014, IEEE T NEUR SYS REH, V22, P181, DOI 10.1109/TNSRE.2013.2293575; Tsanas A, 2012, IEEE T BIO-MED ENG, V59, P1264, DOI 10.1109/TBME.2012.2183367; Vaiciukynas E, 2016, FUSING VARIOUS AUDIO, P328; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vasquez-Correa JC, 2015, 16TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION (INTERSPEECH 2015), VOLS 1-5, P105; Verikas A, 2015, MED ENG PHYS, V37, P210, DOI 10.1016/j.medengphy.2014.12.005; Villa-Canas T, 2014, 19 S IM SIGN PROC AR, V1, P146; Wattenberg M, 2016, USE TSNE EFFECTIVELY; Yang SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088825	44	51	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185613	10.1371/journal.pone.0185613	http://dx.doi.org/10.1371/journal.pone.0185613			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982171	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300047
J	Lee, JE; Lim, JH; Jang, HM; Kim, YS; Kang, SW; Yang, CW; Kim, NH; Kwon, E; Kim, HJ; Park, JM; Jung, HY; Choi, JY; Park, SH; Kim, CD; Cho, JH; Kim, YL				Lee, Ji-Eun; Lim, Jeong-Hoon; Jang, Hye Min; Kim, Yon Su; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Kwon, Eugene; Kim, Hyun-Ji; Park, Jeung-Min; Jung, Hee-Yeon; Choi, Ji-Young; Park, Sun-Hee; Kim, Chan-Duck; Cho, Jang-Hee; Kim, Yong-Lim		Clinical Res Center End Stage	Low serum phosphate as an independent predictor of increased infection-related mortality in dialysis patients: A prospective multicenter cohort study	PLOS ONE			English	Article							MINERAL METABOLISM; HEMODIALYSIS-PATIENTS; KIDNEY-DISEASE; HYPOPHOSPHATEMIA; CALCIUM; CONSEQUENCES; PHOSPHORUS; OUTCOMES; DEATH; CKD	Background The role of mineral metabolism in mortality among dialysis patients has received increased attention, but some aspects remain unclear. The aim of the present study was to investigate the prognostic value of serum calcium and phosphate levels for all-cause mortality and cause-specific mortality in dialysis patients. Methods Patients on hemodialysis and peritoneal dialysis were enrolled from a multicenter prospective cohort study in Korea (NCT00931970). The patients were divided into low, normal, and high groups according to their baseline serum calcium or phosphate levels. Cox proportional analysis and a proportional hazards model for the subdistribution of a competing risk were used to calculate hazard ratios (HRs) for the association of serum calcium and phosphate levels with all-cause and cause-specific mortality. Time- dependent values of calcium and phosphate were also evaluated to assess the effect of longitudinal change in mineral metabolism parameters on mortality types. Results A total of 3,226 dialysis patients were followed up for a mean of 19.8 +/- 8.2 months. Infection was the most common cause of death. Low serum phosphate was significantly associated with all-cause and infection-related death using time-dependent values (HR, 1.43 [95% confidence interval (CI), 1.06-1.93], P = 0.02, and HR, 1.66 [95% CI, 1.02-2.70], P = 0.04, respectively). Low serum phosphate was associated with significantly higher infectionrelated mortality, especially in patients older than 65 years or on dialysis more than one year or with serum albumin lower than 3.9 g/dL (HR, 2.06 [95% CI, 1.13-3.75], P = 0.02, HR, 2.19 [95% CI, 1.20-4.01], P = 0.01, and HR, 1.77 [95% CI, 1.00-3.13], P = 0.05, respectively). Multinomial logistic regression analysis results suggested that low serum albumin, creatinine, and body mass index correlated with low serum phosphate. Conclusions Low serum phosphate in dialysis patients was an independent risk factor for infectionrelated death, especially in elderly patients. Persistently low serum phosphate might be a nutritional biomarker to predict increased susceptibility to infection and in turn worse outcomes in dialysis patients.	[Lee, Ji-Eun; Lim, Jeong-Hoon; Kwon, Eugene; Kim, Hyun-Ji; Park, Jeung-Min; Jung, Hee-Yeon; Choi, Ji-Young; Park, Sun-Hee; Kim, Chan-Duck; Cho, Jang-Hee; Kim, Yong-Lim] Kyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu, South Korea; [Lee, Ji-Eun; Jang, Hye Min; Kim, Yon Su; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Kwon, Eugene; Kim, Hyun-Ji; Park, Jeung-Min; Jung, Hee-Yeon; Choi, Ji-Young; Park, Sun-Hee; Kim, Chan-Duck; Cho, Jang-Hee; Kim, Yong-Lim] Clin Res Ctr End Stage Renal Dis, Daegu, South Korea; [Jang, Hye Min] Kyungpook Natl Univ, Dept Stat, Daegu, South Korea; [Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Yang, Chul Woo] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Nam-Ho] Chonnam Natl Univ, Med Sch, Dept Internal Med, Gwangju, South Korea	Kyungpook National University; Kyungpook National University; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Catholic University of Korea; Chonnam National University	Cho, JH; Kim, YL (corresponding author), Kyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu, South Korea.; Cho, JH; Kim, YL (corresponding author), Clin Res Ctr End Stage Renal Dis, Daegu, South Korea.	jh-cho@knu.ac.kr; ylkim@knu.ac.kr	Cho, Jang-hee/ABD-3534-2020; Lim, Jeong-Hoon/ABE-6003-2020; Park, Sun/GSD-9620-2022	Cho, Jang-hee/0000-0002-7031-5214; Lim, Jeong-Hoon/0000-0001-5517-9886; Jung, Hee-Yeon/0000-0003-0232-7202	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C0001, HC15C1129]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant numbers: HI15C0001 and HC15C1129, URL: https://www.khidi.or.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanzadeh J, 2006, NAT CLIN PRACT NEPHR, V2, P136, DOI 10.1038/ncpneph0124; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Choi JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084257; Chung S, 2012, OPEN J INT MED, V2, P89, DOI [DOI 10.4236/OJIM.2012.22018, 10.4236/ojim.2012.2201]; Collins AJ, 2009, AM J KIDNEY DIS, V55, pS1; Eknoyan G, 2003, AM J KIDNEY DIS, V42, pS1, DOI DOI 10.1016/S0272-6386(03)00905-3; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Haglin L, 2001, POSTGRAD MED J, V77, P305, DOI 10.1136/pmj.77.907.305; Kalantar-Zadeh K, 2006, KIDNEY INT, V70, P771, DOI 10.1038/sj.ki.5001514; Koch M, 2000, NEPHRON, V86, P552, DOI 10.1159/000045869; Liamis G, 2010, QJM-INT J MED, V103, P449, DOI 10.1093/qjmed/hcq039; Lin Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/430185; Locatelli F, 2002, NEPHROL DIAL TRANSPL, V17, P563, DOI 10.1093/ndt/17.4.563; London GM, 2004, J AM SOC NEPHROL, V15, P1943, DOI 10.1097/01.asn.0000129337.50739.48; Mazzaferro S, 2014, SEMIN NEPHROL, V34, P598, DOI 10.1016/j.semnephrol.2014.09.006; McDonald S, 2012, ANZDATA REGISTRY REP; Melamed ML, 2006, KIDNEY INT, V70, P351, DOI 10.1038/sj.ki.5001542; Moe SM, 2004, CIRC RES, V95, P560, DOI 10.1161/01.RES.0000141775.67189.98; Movilli E, 2005, NEPHRON CLIN PRACT, V101, pC161, DOI 10.1159/000087391; Noordzij M, 2005, AM J KIDNEY DIS, V46, P925, DOI 10.1053/j.ajkd.2005.08.013; Noordzij M, 2008, BLOOD PURIFICAT, V26, P231, DOI 10.1159/000118847; OECD Publishing, 2014, OECD OB UPD 2014; Panichi V, 2008, NEPHROL DIAL TRANSPL, V23, P2337, DOI 10.1093/ndt/gfm951; Reffelmann T, 2011, ATHEROSCLEROSIS, V219, P280, DOI 10.1016/j.atherosclerosis.2011.05.038; Rivara MB, 2015, J AM SOC NEPHROL, V26, P1671, DOI 10.1681/ASN.2014050472; Saleh FN, 2003, EUR HEART J, V24, P2054, DOI 10.1016/j.ehj.2003.09.010; Sarnak MJ, 2000, KIDNEY INT, V58, P1758, DOI 10.1111/j.1523-1755.2000.00337.x; Shinaberger CS, 2008, AM J CLIN NUTR, V88, P1511, DOI 10.3945/ajcn.2008.26665; Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x; Tangri N, 2011, AM J KIDNEY DIS, V57, P415, DOI 10.1053/j.ajkd.2010.08.037; US Renal Data System, 2013, USRDS 2013 ANN DAT R; Wald R, 2008, AM J KIDNEY DIS, V52, P531, DOI 10.1053/j.ajkd.2008.05.020; Young EW, 2005, KIDNEY INT, V67, P1179, DOI 10.1111/j.1523-1755.2005.00185.x	33	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185853	10.1371/journal.pone.0185853	http://dx.doi.org/10.1371/journal.pone.0185853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973026	gold, Green Published, Green Submitted			2022-12-26	WOS:000412131900062
J	Petersen, SE; Sanghvi, MM; Aung, N; Cooper, JA; Paiva, JM; Zemrak, F; Fung, K; Lukaschuk, E; Lee, AM; Carapella, V; Kim, YJ; Piechnik, SK; Neubauer, S				Petersen, Steffen E.; Sanghvi, Mihir M.; Aung, Nay; Cooper, Jackie A.; Paiva, Jose Miguel; Zemrak, Filip; Fung, Kenneth; Lukaschuk, Elena; Lee, Aaron M.; Carapella, Valentina; Kim, Young Jin; Piechnik, Stefan K.; Neubauer, Stefan			The impact of cardiovascular risk factors on cardiac structure and function: Insights from the UK Biobank imaging enhancement study	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; CONGESTIVE-HEART-FAILURE; PROGNOSTIC IMPLICATIONS; CORONARY; ATHEROSCLEROSIS; DISEASE; MORTALITY; MIDDLE; VOLUME; DEATH	Aims The UK Biobank is a large-scale population-based study utilising cardiovascular magnetic resonance (CMR) to generate measurements of atrial and ventricular structure and function. This study aimed to quantify the association between modifiable cardiovascular risk factors and cardiac morphology and function in individuals without known cardiovascular disease. Methods Age, sex, ethnicity (non-modifiable) and systolic blood pressure, diastolic blood pressure, smoking status, exercise, body mass index (BMI), high cholesterol, diabetes, alcohol intake (modifiable) were considered important cardiovascular risk factors. Multivariable regression models were built to ascertain the association of risk factors on left ventricular (LV), right ventricular (RV), left atrial (LA) and right atrial (RA) CMR parameters. Results 4,651 participants were included in the analysis. All modifiable risk factors had significant effects on differing atrial and ventricular parameters. BMI was the modifiable risk factor most consistently associated with subclinical changes to CMR parameters, particularly in relation to higher LV mass (+8.3% per SD [4.3 kg/m2], 95% CI: 7.6 to 8.9%), LV (EDV: +4.8% per SD, 95% CI: 4.2 to 5.4%); ESV: +4.4% per SD, 95% CI: 3.5 to 5.3%), RV (EDV: +5.3% per SD, 95% CI: 4.7 to 5.9%; ESV: +5.4% per SD, 95% CI: 4.5 to 6.4%) and LA maximal (+8.6% per SD, 95% CI: 7.4 to 9.7%) volumes. Increases in SBP were associated with higher LV mass (+6.8% per SD, 95% CI: 5.9 to 7.7%), LV (EDV: +4.5% per SD, 95% CI: 3.6 to 5.4%; ESV: +2.0% per SD, 95% CI: 0.8 to 3.3%) volumes. The presence of diabetes or high cholesterol resulted in smaller volumes and lower ejection fractions. Conclusions Modifiable risk factors are associated with subclinical alterations in structure and function in all four cardiac chambers. BMI and systolic blood pressure are the most important modifiable risk factors affecting CMR parameters known to be linked to adverse outcomes.	[Petersen, Steffen E.; Sanghvi, Mihir M.; Aung, Nay; Cooper, Jackie A.; Paiva, Jose Miguel; Zemrak, Filip; Fung, Kenneth; Lee, Aaron M.] Queen Mary Univ London, William Harvey Res Inst, NIHR Biomed Res Ctr Barts, Charterhouse Sq, London, England; [Lukaschuk, Elena; Carapella, Valentina; Kim, Young Jin; Piechnik, Stefan K.; Neubauer, Stefan] Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England; [Kim, Young Jin] Yonsei Univ, Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea	University of London; Queen Mary University London; University of Oxford; Yonsei University; Yonsei University Health System	Petersen, SE (corresponding author), Queen Mary Univ London, William Harvey Res Inst, NIHR Biomed Res Ctr Barts, Charterhouse Sq, London, England.	s.e.petersen@quml.ac.uk	Petersen, Steffen E/A-8389-2011; Kim, Young-jin/GSD-3168-2022	Petersen, Steffen E/0000-0003-4622-5160; Aung, Nay/0000-0001-5095-1611; Sanghvi, Mihir/0000-0002-1914-4149; Paiva, Jose Miguel/0000-0002-9369-6785; Zemrak, Filip/0000-0001-6730-4955; Carapella, Valentina/0000-0001-9750-9425; Neubauer, Stefan/0000-0001-9017-5645; Lee, Aaron/0000-0001-6008-5366	Medical College of Saint Bartholomew's Hospital Trust, an independent registered charity that promotes and advances medical and dental education and research at Barts; London School of Medicine and Dentistry; NIHR Cardiovascular Biomedical Research Centre at Barts; EPSRC [EP/P001009/1]; Oxford NIHR Biomedical Research Centre; Oxford British Heart Foundation Centre of Research Excellence; Medical Research Council [MR/L016311/1]; Wellcome Trust [203553/Z/Z]; British Heart Foundation (BHF) [PG/14/89/31194]; British Heart Foundation [PG/14/89/31194] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/P001009/1] Funding Source: researchfish; Medical Research Council [MC_qA137853] Funding Source: researchfish; MRC [MR/L016311/1] Funding Source: UKRI	Medical College of Saint Bartholomew's Hospital Trust, an independent registered charity that promotes and advances medical and dental education and research at Barts; London School of Medicine and Dentistry; NIHR Cardiovascular Biomedical Research Centre at Barts; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Oxford NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Oxford British Heart Foundation Centre of Research Excellence; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); British Heart Foundation (BHF)(British Heart Foundation); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the following institutions: KF is supported by The Medical College of Saint Bartholomew's Hospital Trust, an independent registered charity that promotes and advances medical and dental education and research at Barts and The London School of Medicine and Dentistry. AL and SEP acknowledge support from the NIHR Cardiovascular Biomedical Research Centre at Barts and from the "SmartHeart" EPSRC program grant (EP/P001009/1). SN and SKP are supported by the Oxford NIHR Biomedical Research Centre and the Oxford British Heart Foundation Centre of Research Excellence. This project was enabled through access to the MRC eMedLab Medical Bioinformatics infrastructure, supported by the Medical Research Council (g rant number MR/L016311/1). NA is supported by a Wellcome Trust Research Training Fellowship (203553/Z/Z). The authors SEP, SN and SKP acknowledge the British Heart Foundation (BHF) for funding the manual analysis to create a cardiovascular magnetic resonance imaging reference standard for the UK Biobank imaging resource in 5000 CMR scans (PG/14/89/31194).	[Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bombelli M, 2013, CURR HYPERTENS REP, V15, P238, DOI 10.1007/s11906-013-0348-1; Chahal H, 2010, AM J CARDIOL, V106, P110, DOI 10.1016/j.amjcard.2010.02.022; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Environment RCT, 2015, R LANG STAT COMP VIE; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; GARDIN JM, 1995, CIRCULATION, V92, P380, DOI 10.1161/01.CIR.92.3.380; Gardin JM, 2001, AM J CARDIOL, V87, P1051, DOI 10.1016/S0002-9149(01)01460-6; GHALI JK, 1992, ANN INTERN MED, V117, P831, DOI 10.7326/0003-4819-117-10-831; Health and Social Care Information Centre, 2016, STAT SMOK ENGL 2016; Health CO on S and. Smoking and Tobacco Use, FACT SHEET; Heckbert SR, 2006, J AM COLL CARDIOL, V48, P2285, DOI 10.1016/j.jacc.2006.03.072; Hoit BD, 2014, J AM COLL CARDIOL, V63, P493, DOI 10.1016/j.jacc.2013.10.055; Kawel-Boehm N, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0111-7; Konstam MA, 2011, JACC-CARDIOVASC IMAG, V4, P98, DOI 10.1016/j.jcmg.2010.10.008; Laukkanen JA, 2005, ARCH INTERN MED, V165, P1788, DOI 10.1001/archinte.165.15.1788; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lip GYH, 2007, HEART, V93, P542, DOI 10.1136/hrt.2006.110791; Lorell BH, 2000, CIRCULATION, P102; McGill HC, 2008, CIRCULATION, P117; McManus DD, 2009, J AM SOC ECHOCARDIOG, V22, P190, DOI 10.1016/j.echo.2008.11.005; Nham E, 2016, INT J CARDIOVAS IMAG, V32, pS173, DOI 10.1007/s10554-016-0885-1; PETERSEN SE, 2017, J CARD MAGN RES, V19; Petersen SE, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0227-4; Petersen SE, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-46; POLAK JF, 1983, J AM COLL CARDIOL, V2, P217, DOI 10.1016/S0735-1097(83)80156-9; Rider OJ, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002454; Rider OJ, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-9; ROSE G, 1977, LANCET, V1, P105; Sallach JA, 2009, JACC-CARDIOVASC IMAG, V2, P527, DOI 10.1016/j.jcmg.2009.01.012; SHAH PK, 1986, AM J CARDIOL, V58, P387, DOI 10.1016/0002-9149(86)90001-9; SIGURDSSON E, 1993, EUR HEART J, V14, P584, DOI 10.1093/eurheartj/14.5.584; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Taylor HA, 2005, ETHNIC DIS, V15, pS4; TEJADA C, 1968, LAB INVEST, V18, P509; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; unpuu S, 2004, LANCET, V364, P937; Voelkel NF, 2006, CIRCULATION, P114; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wong ND, 2014, NAT REV CARDIOL, V11, P276, DOI 10.1038/nrcardio.2014.26; World Health Organization, 2016, CARDIOVASCULAR DIS	43	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185114	10.1371/journal.pone.0185114	http://dx.doi.org/10.1371/journal.pone.0185114			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973022	Green Published, Green Submitted, gold			2022-12-26	WOS:000412131900013
J	Chiu, HY; Huang, WY; Ho, CH; Wang, JJ; Lin, SJ; Hsu, YW; Chen, PJ				Chiu, Hsien-Yi; Huang, Wen-Yen; Ho, Chung-Han; Wang, Jhi-Joung; Lin, Sung-Jan; Hsu, Ya-Wen; Chen, Ping-Jen			Increased risk of chronic kidney disease in patients with rosacea: A nationwide population-based matched cohort study	PLOS ONE			English	Article							METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; INFLAMMATION; MORTALITY; ASSOCIATION; ACTIVATION; PSORIASIS; SEVERITY; TAIWAN	Background Rosacea is a chronic inflammatory skin disorder. Inflammation and oxidative stress are involved in the etiopathogenesis of rosacea and chronic kidney disease (CKD). This study aimed to investigate the association between rosacea and CKD. Methods This population-based cohort study identified 277 patients with rosacea in the Taiwan National Health Insurance Research Database during 2001-2005. These patients were matched for age, sex, and comorbidities with 2216 patients without rosacea. All subjects were individually followed-up for 8-12 years to identify those who subsequently developed CKD Results The incidence rates of CKD per 1000 person-years were 16.02 in patients with rosacea and 10.63 in the non-rosacea reference population. After adjusting for other covariates and considering the competing risk of mortality, patients with rosacea remained at increased risk of CKD (adjusted sub-distribution hazard ratio (aSD-HR) 2.00; 95% confidence interval (CI) 1.05-3.82). The aSD-HRs (95% CI) for CKD were 1.82 (0.83-4.00) and 2.53 (1.11-5.75) for patients with mild and moderate-to-severe rosacea, respectively. Conclusions Rosacea is an independent risk factor for CKD. High rosacea severity and old age further increased CKD risk in patients with rosacea. Careful monitoring for CKD development should be included as part of integrated care for patients with rosacea.	[Chiu, Hsien-Yi; Huang, Wen-Yen; Lin, Sung-Jan] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei, Taiwan; [Chiu, Hsien-Yi; Huang, Wen-Yen; Lin, Sung-Jan] Natl Taiwan Univ, Coll Engn, Taipei, Taiwan; [Chiu, Hsien-Yi] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Dermatol, Hsinchu, Taiwan; [Chiu, Hsien-Yi; Lin, Sung-Jan] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Chiu, Hsien-Yi; Lin, Sung-Jan] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Ho, Chung-Han; Wang, Jhi-Joung; Hsu, Ya-Wen] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Ho, Chung-Han; Hsu, Ya-Wen] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Pharm, Tainan, Taiwan; [Lin, Sung-Jan] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei, Taiwan; [Chen, Ping-Jen] Chi Mei Med Ctr, Dept Geriatr & Gerontol, Tainan, Taiwan; [Chen, Ping-Jen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chia Nan University of Pharmacy & Science; National Taiwan University; Chi Mei Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chen, PJ (corresponding author), Chi Mei Med Ctr, Dept Geriatr & Gerontol, Tainan, Taiwan.; Chen, PJ (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan.	pingjen.chen@gmail.com	huang, wen/GXW-0661-2022; Chen, Ping-Jen/AAG-8548-2021	Chen, Ping-Jen/0000-0001-7636-0801; Chiu, Hsien-Yi/0000-0002-0493-9707; Ho, Chung-Han/0000-0001-5925-8477; /0000-0001-9625-0802	National Taiwan University Hospital Hsin-Chu Branch [106-HCH002]	National Taiwan University Hospital Hsin-Chu Branch	This work was supported in part by a grant from the National Taiwan University Hospital Hsin-Chu Branch (106-HCH002). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Belli AA, 2016, EUR J DERMATOL, V26, P260, DOI 10.1684/ejd.2016.2748; Aldrich N, 2015, JAMA DERMATOL, V151, P1213, DOI 10.1001/jamadermatol.2015.2230; Arici M, 2001, KIDNEY INT, V59, P407, DOI 10.1046/j.1523-1755.2001.059002407.x; Bakar O, 2007, CLIN EXP DERMATOL, V32, P197, DOI 10.1111/j.1365-2230.2006.02322.x; Buhl T, 2015, J INVEST DERMATOL, V135, P2198, DOI 10.1038/jid.2015.141; Carrero JJ, 2009, CLIN J AM SOC NEPHRO, V4, pS49, DOI 10.2215/CJN.02720409; Casas C, 2012, EXP DERMATOL, V21, P906, DOI 10.1111/exd.12030; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Chiu HY, 2015, BRIT J DERMATOL, V173, P146, DOI 10.1111/bjd.13599; Chiu HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136508; Chiu HY, 2012, DERMATOL SIN, V30, P136, DOI 10.1016/j.dsi.2012.08.002; Duman N, 2014, J EUR ACAD DERMATOL, V28, P1165, DOI 10.1111/jdv.12234; Egeberg A, 2016, J AM ACAD DERMATOL, V75, P336, DOI 10.1016/j.jaad.2016.02.1158; Egeberg A, 2016, DERMATOLOGY, V232, P208, DOI 10.1159/000444082; Egeberg A, 2016, JAMA NEUROL, V73, P529, DOI 10.1001/jamaneurol.2016.0022; Granata S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122272; Hua TC, 2015, J AM ACAD DERMATOL, V73, P249, DOI 10.1016/j.jaad.2015.04.028; Hung SC, 2015, LANCET DIABETES ENDO, V3, P605, DOI 10.1016/S2213-8587(15)00123-0; Kang HT, 2012, J KOREAN MED SCI, V27, P630, DOI 10.3346/jkms.2012.27.6.630; Kawaguchi Yoshiaki, 2009, Tokai J Exp Clin Med, V34, P80; Kaysen GA, 2004, J AM SOC NEPHROL, V15, P538, DOI 10.1097/01.ASN.0000111744.00916.E6; Kronbichler A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-95; Li YW, 2007, J FORMOS MED ASSOC, V106, P975, DOI 10.1016/S0929-6646(08)60071-6; Oztas MO, 2003, CLIN EXP DERMATOL, V28, P188, DOI 10.1046/j.1365-2230.2003.01179.x; Rainer BM, 2015, J AM ACAD DERMATOL, V73, P604, DOI 10.1016/j.jaad.2015.07.009; Said Sarmad, 2014, J Nephropathol, V3, P99, DOI 10.12860/jnp.2014.19; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Shankar A, 2006, AM J EPIDEMIOL, V164, P263, DOI 10.1093/aje/kwj173; Small DM, 2012, NEPHROLOGY, V17, P311, DOI 10.1111/j.1440-1797.2012.01572.x; Spoendlin J, 2013, J AM ACAD DERMATOL, V69, P399, DOI 10.1016/j.jaad.2013.03.027; Steinhoff M, 2011, J INVEST DERM SYMP P, V15, P2, DOI 10.1038/jidsymp.2011.7; Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x; Tisma VS, 2009, J AM ACAD DERMATOL, V60, P270, DOI 10.1016/j.jaad.2008.10.014; Tseng CW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169070; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Wan J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5961; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Yamasaki K, 2009, J DERMATOL SCI, V55, P77, DOI 10.1016/j.jdermsci.2009.04.007; Zhong SM, 2015, DERMATOL SIN, V33, P112, DOI 10.1016/j.dsi.2015.04.012	39	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0180446	10.1371/journal.pone.0180446	http://dx.doi.org/10.1371/journal.pone.0180446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968402	Green Published, gold, Green Submitted			2022-12-26	WOS:000412029600003
J	Lin, JD; Yang, SF; Wang, YH; Fang, WF; Lin, YC; Liou, BC; Lin, YF; Tang, KT; Cheng, CW				Lin, Jiunn-Diann; Yang, Shun-Fa; Wang, Yuan-Hung; Fang, Wen-Fang; Lin, Ying-Chin; Liou, Bing-Chun; Lin, Yuh-Feng; Tang, Kam-Tsun; Cheng, Chao-Wen			Associations of melatonin receptor gene polymorphisms with Graves' disease	PLOS ONE			English	Article							AUTOIMMUNE THYROID-DISEASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PROTEIN-COUPLED RECEPTORS; MESSENGER-RNA; IN-VITRO; AUTOANTIBODIES; LYMPHOCYTES; EXPRESSION; MEMBRANE; CANCER	Background Melatonin plays an important role in immunity and has been linked to autoimmune diseases. Possible associations of single-nucleotide polymorphisms (SNPs) of melatonin receptor type 1A (MTNR1A) and 1B (MTNR1B), with autoimmune thyroid disease in an ethnic Chinese (i.e., Taiwanese) population were examined. Materials and methods Totally, 83 Hashimoto's thyroiditis patients, 319 Graves' disease (GD), and 369 controls were recruited. Three SNPs (rs6553010, rs13140012, and rs2119882) of MTNR1A and three SNPs (rs1387153, rs10830963, and rs1562444) of MTNR1B were genotyped. Results There were a reduced frequency of the C allele of rs2119882 and a reduced percentage of the CC+CT genotype in the GD group compared to the control group (p = 0.039, odds ratio (OR) = 0.79, 95% confidence interval (CI) = 0.63 similar to 0.99, and p = 0.032, OR = 0.72, 95% CI = 0.53 similar to 0.97, respectively). There was a significant difference in the percentage of the AT haplotype of the combination of rs13140012 and rs2119882 between the GD and control groups (p = 0.010, OR = 1.34, 95% CI = 1.07 similar to 1.67). In addition, there were significant associations of anti-thyroid peroxidase antibody titers with rs13140012 and rs2119882, and the AATT genotype of the combination of rs13140012 and rs2119882 (p = 0.003, 0.003, and 0.004, respectively). There were no significant associations of SNPs and possible haplotypes of MTNR1B with susceptibility to GD. Conclusions Genetic variants of rs2119882 of MTNR1A and the AT haplotype of the combination of rs2119882 and rs13140012 were associated with GD susceptibility in an ethnic Chinese population. The results support the involvement of the melatonin pathway in the pathogenesis of GD.	[Lin, Jiunn-Diann; Wang, Yuan-Hung; Liou, Bing-Chun; Lin, Yuh-Feng; Cheng, Chao-Wen] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Lin, Jiunn-Diann] Taipei Med Univ, Shuang Ho Hosp, Div Endocrinol, Dept Internal Med, New Taipei, Taiwan; [Lin, Jiunn-Diann] Taipei Med Univ, Sch Med, Div Endocrinol & Metab, Dept Internal Med,Coll Med, Taipei, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Wang, Yuan-Hung] Taipei Med Univ, Shuang Ho Hosp, Dept Med Res, New Taipei, Taiwan; [Fang, Wen-Fang; Lin, Ying-Chin] Taipei Med Univ, Shuang Ho Hosp, Dept Family Med, New Taipei, Taiwan; [Lin, Yuh-Feng] Taipei Med Univ, Shuang Ho Hosp, Div Nephrol, Dept Internal Med, New Taipei, Taiwan; [Tang, Kam-Tsun] Taipei Vet Gen Hosp, Div Endocrinol & Metab, Dept Internal Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Veterans General Hospital	Cheng, CW (corresponding author), Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.	ccheng@tmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927	Ministry of Science and Technology of Taiwan [MOST 104-2314-B-038-048, MOST 106-2314-B-038-059]; Taipei Medical University and Shuang-Ho Hospital [104TMU-SHH-09]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University and Shuang-Ho Hospital	This work was supported by a grant from the Ministry of Science and Technology of Taiwan (MOST 104-2314-B-038-048 and MOST 106-2314-B-038-059) to Jiunn-Diann Lin, and was partly supported by a grant from Taipei Medical University and Shuang-Ho Hospital (104TMU-SHH-09) to Chao-Wen Cheng.	BEEVER K, 1989, CLIN CHEM, V35, P1949; Bizzarri M, 2013, EXPERT OPIN THER TAR, V17, P1483, DOI 10.1517/14728222.2013.834890; Carrillo-Vico A, 2003, CELL MOL LIFE SCI, V60, P2272, DOI 10.1007/s00018-003-3207-4; Cernysiov V, 2010, INT IMMUNOL, V22, P25, DOI 10.1093/intimm/dxp109; Chen CR, 2007, ENDOCRINOLOGY, V148, P2375, DOI 10.1210/en.2006-1754; Drazen DL, NEUROENDOCRINOLOGY; Esposito T, 2012, NEPHROL DIAL TRANSPL, V27, P210, DOI 10.1093/ndt/gfr216; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Garcia-Marin R, 2015, J PHYSIOL PHARMACOL, V66, P643; Garcia-Marin R, 2012, HISTOL HISTOPATHOL, V27, P1429, DOI 10.14670/HH-27.1429; GORDON J, 1980, HORM METAB RES, V12, P71, DOI 10.1055/s-2007-996203; Ha EY, 2005, J PINEAL RES, V39, P201, DOI 10.1111/j.1600-079X.2005.00237.x; Iglesias P, 2010, CLIN ENDOCRINOL, V72, P551, DOI 10.1111/j.1365-2265.2009.03682.x; Jimenez-Caliani AJ, 2006, ENDOCRINOLOGY, V147, P1717, DOI 10.1210/en.2005-0648; Jimenez-Caliani AJ, 2005, J PINEAL RES, V38, P93, DOI 10.1111/j.1600-079X.2004.00175.x; LEWINSKI A, 1986, J PINEAL RES, V3, P291, DOI 10.1111/j.1600-079X.1986.tb00752.x; LEWONTIN RC, 1964, GENETICS, V49, P49; Lin FY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121677; Lin GJ, 2013, INT J MOL SCI, V14, P11742, DOI 10.3390/ijms140611742; Lin JD, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.02.26; Lin JD, 2016, CLIN CHIM ACTA, V462, P96, DOI 10.1016/j.cca.2016.09.004; Lin JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154436; Lin JD, 2015, EUR J CLIN INVEST, V45, P711, DOI 10.1111/eci.12463; Malpaux B, 2001, J BIOL RHYTHM, V16, P336, DOI 10.1177/074873001129002051; Manchester LC, 2015, J PINEAL RES, V59, P403, DOI 10.1111/jpi.12267; MARIOTTI S, 1990, J CLIN ENDOCR METAB, V71, P661, DOI 10.1210/jcem-71-3-661; Medrano-Campillo P, 2015, J PINEAL RES, V58, P219, DOI 10.1111/jpi.12208; Miller SC, 2006, INT J EXP PATHOL, V87, P81, DOI 10.1111/j.0959-9673.2006.00474.x; Morcuende JA, 2003, SPINE, V28, P2025, DOI 10.1097/01.BRS.0000083235.74593.49; Nakamura E, 2008, CANCER SCI, V99, P1390, DOI 10.1111/j.1349-7006.2008.00838.x; PANG CS, 1992, J PINEAL RES, V12, P167, DOI 10.1111/j.1600-079X.1992.tb00044.x; PIOLI C, 1993, INT J IMMUNOPHARMACO, V15, P463, DOI 10.1016/0192-0561(93)90060-C; Pozo D, 1997, FASEB J, V11, P466, DOI 10.1096/fasebj.11.6.9194527; RAFIIELIDRISSI M, 1995, J NEUROIMMUNOL, V57, P171, DOI 10.1016/0165-5728(94)00182-N; Raghavendra V, 2001, CLIN EXP IMMUNOL, V124, P414, DOI 10.1046/j.1365-2249.2001.01519.x; Reiter RJ, 2004, J PINEAL RES, V37, P213, DOI 10.1111/j.1600-079X.2004.00165.x; REPPERT SM, 1994, NEURON, V13, P1177, DOI 10.1016/0896-6273(94)90055-8; Reppert SM, 1997, J BIOL RHYTHM, V12, P528, DOI 10.1177/074873049701200606; RODRIGUEZ IR, 1994, J BIOL CHEM, V269, P31969; Samimi-Fard S, 2011, J PINEAL RES, V51, P400, DOI 10.1111/j.1600-079X.2011.00903.x; Slominski RM, 2012, MOL CELL ENDOCRINOL, V351, P152, DOI 10.1016/j.mce.2012.01.004; Srinivasan V, 2008, NEUROIMMUNOMODULAT, V15, P93, DOI 10.1159/000148191; Tanev D, 2016, ACTA REUMATOL PORT, V41, P62; Tang XL, 2005, PHARMAZIE, V60, P696; Tomer Y, 2003, ENDOCR REV, V24, P694, DOI 10.1210/er.2002-0030; WEETMAN AP, 1982, CLIN EXP IMMUNOL, V48, P196; WEETMAN AP, 1986, IMMUNOL LETT, V13, P335, DOI 10.1016/0165-2478(86)90068-4; Wright ML, 1997, GEN COMP ENDOCR, V108, P298, DOI 10.1006/gcen.1997.6979; Wright ML, 2000, J EXP ZOOL, V286, P625, DOI 10.1002/(SICI)1097-010X(20000501)286:6<625::AID-JEZ9>3.0.CO;2-Q	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185529	10.1371/journal.pone.0185529	http://dx.doi.org/10.1371/journal.pone.0185529			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961261	Green Published, gold, Green Submitted			2022-12-26	WOS:000412027700023
J	Kelly, NJ; Varga, JFA; Specker, EJ; Romeo, CM; Coomber, BL; Uniacke, J				Kelly, N. J.; Varga, J. F. A.; Specker, E. J.; Romeo, C. M.; Coomber, B. L.; Uniacke, J.			Hypoxia activates cadherin-22 synthesis via eIF4E2 to drive cancer cell migration, invasion and adhesion	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; DOWN-REGULATION; STEM-CELLS; EXPRESSION; GLIOBLASTOMA; METASTASIS; SNAIL; PROTEINS; NECROSIS	Hypoxia is a driver of cell movement in processes such as development and tumor progression. The cellular response to hypoxia involves a transcriptional program mediated by hypoxia-inducible factors, but translational control has emerged as a significant contributor. In this study, we demonstrate that a cell-cell adhesion molecule, cadherin-22, is upregulated in hypoxia via mTORC1-independent translational control by the initiation factor eIF4E2. We identify new functions of cadherin-22 as a hypoxia-specific cell-surface molecule involved in cancer cell migration, invasion and adhesion. Silencing eIF4E2 or cadherin-22 significantly impaired MDA-MB-231 breast carcinoma and U87MG glioblastoma cell migration and invasion only in hypoxia, while reintroduction of the respective exogenous gene restored the normal phenotype. Cadherin-22 was evenly distributed throughout spheroids and required for their formation and support of a hypoxic core. Conversely, E-cadherin translation was repressed by hypoxia and only expressed in the oxygenated cells of U87MG spheroids. Furthermore, immunofluorescence on paraffin-embedded human tissue from 40 glioma and 40 invasive ductal breast carcinoma patient specimens revealed that cadherin-22 expression colocalized with areas of hypoxia and significantly correlated with tumor grade and progression-free survival or stage and tumor size, respectively. This study broadens our understanding of tumor progression and metastasis by highlighting cadherin-22 as a potential new target of cancer therapy to disable hypoxic cancer cell motility and adhesion.	[Kelly, N. J.; Varga, J. F. A.; Specker, E. J.; Romeo, C. M.; Uniacke, J.] Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada; [Coomber, B. L.] Univ Guelph, Dept Biomed Sci, Ontario Vet Coll, Guelph, ON, Canada	University of Guelph; University of Guelph	Uniacke, J (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	juniacke@uoguelph.ca	Varga, Joseph/ABD-2277-2021	Varga, Joseph/0000-0001-8516-225X	Canadian Institutes of Health Research [PJT 152925]; Cancer Research Society	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research Society	We thank Terry Van Raay for the use of his microscope, Scott Ryan and John Vessey for the use of their cryostat, and Marc Coppolino for technical advice and reagents. This work was funded by grants from the Canadian Institutes of Health Research (PJT 152925) and the Cancer Research Society to JU.	Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Beasley GM, 2009, CANCER-AM CANCER SOC, V115, P4766, DOI 10.1002/cncr.24509; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; Blaschuk OW, 2009, EUR J PHARMACOL, V625, P195, DOI 10.1016/j.ejphar.2009.05.033; Chaudary N, 2009, LAB INVEST, V89, P587, DOI 10.1038/labinvest.2009.16; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; DeLeeuw WJF, 1997, J PATHOL, V183, P404, DOI 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Espina V, 2013, WOMENS HEALTH, V9, P157, DOI [10.2217/whe.13.5, 10.2217/WHE.13.5]; Feng MY, 2015, P NATL ACAD SCI USA, V112, P2145, DOI 10.1073/pnas.1424907112; FRANKO AJ, 1979, RADIAT RES, V79, P439, DOI 10.2307/3575173; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Grabmaier K, 2004, ONCOGENE, V23, P5624, DOI 10.1038/sj.onc.1207764; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Ho JJD, 2016, CELL REP, V14, P1293, DOI 10.1016/j.celrep.2016.01.036; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hwang-Verslues WW, 2011, ONCOGENE, V30, P2463, DOI 10.1038/onc.2010.618; Imai T, 2003, AM J PATHOL, V163, P1437, DOI 10.1016/S0002-9440(10)63501-8; Indovina P, 2008, ANTICANCER RES, V28, P1013; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Kitamura T, 2007, NAT GENET, V39, P467, DOI 10.1038/ng1997; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Krishnamachary B, 2003, CANCER RES, V63, P1138; Kuehn BM, 2010, JAMA-J AM MED ASSOC, V303, P925, DOI 10.1001/jama.2010.236; Labernadie A, 2017, NAT CELL BIOL, V19, P224, DOI 10.1038/ncb3478; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Lundgren K, 2009, BRIT J CANCER, V101, P1769, DOI 10.1038/sj.bjc.6605369; Martinez-Gonzalez A, 2012, B MATH BIOL, V74, P2875, DOI 10.1007/s11538-012-9786-1; Perotti A, 2009, ANN ONCOL, V20, P741, DOI 10.1093/annonc/mdn695; Piche B, 2011, AM J CANCER RES, V1, P233; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rom E, 1998, J BIOL CHEM, V273, P13104, DOI 10.1074/jbc.273.21.13104; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Russell J, 2009, INT J RADIAT ONCOL, V73, P1177, DOI 10.1016/j.ijrobp.2008.12.004; Sawada K, 2008, CANCER RES, V68, P2329, DOI 10.1158/0008-5472.CAN-07-5167; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Sugimoto K, 1996, J BIOL CHEM, V271, P11548, DOI 10.1074/jbc.271.19.11548; Tee AR, 2004, FEBS LETT, V564, P58, DOI 10.1016/S0014-5793(04)00313-8; Timpano S, 2016, J BIOL CHEM, V291, P10772, DOI 10.1074/jbc.M116.717363; Uniacke J, 2014, CANCER RES, V74, P1379, DOI 10.1158/0008-5472.CAN-13-2278; Uniacke J, 2012, NATURE, V486, P126, DOI 10.1038/nature11055; Vinci M, 2015, JOVE-J VIS EXP, DOI 10.3791/52686; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wu J, 2003, J ENDOCRINOL, V176, P381, DOI 10.1677/joe.0.1760381; Zagzag D, 2006, LAB INVEST, V86, P1221, DOI 10.1038/labinvest.3700482; Zhong H, 1999, CANCER RES, V59, P5830; Zhou J, 2009, TUMOR BIOL, V30, P130, DOI 10.1159/000225242; Zhu Y, 2013, ANAT REC, V296, P1850, DOI 10.1002/ar.22821	60	27	27	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 1	2018	37	5					651	662		10.1038/onc.2017.372	http://dx.doi.org/10.1038/onc.2017.372			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FU4GT	28991229	Green Accepted			2022-12-26	WOS:000423812200010
J	Mummler, C; Burgy, O; Hermann, S; Mutze, K; Gunther, A; Konigshoff, M				Muemmler, Carlo; Burgy, Olivier; Hermann, Sarah; Mutze, Kathrin; Guenther, Andreas; Koenigshoff, Melanie			Cell-specific expression of runt-related transcription factor 2 contributes to pulmonary fibrosis	FASEB JOURNAL			English	Article						RUNX2; IPF; alveolar epithelial cells; fibroblast	ALVEOLAR EPITHELIAL-CELLS; HUMAN LUNG FIBROBLASTS; MESENCHYMAL TRANSITION; SIGNALING PATHWAY; OSTEOBLAST DIFFERENTIATION; MOLECULAR-MECHANISMS; GENE-EXPRESSION; BREAST-CANCER; BETA; PROLIFERATION	Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease with limited therapeutic options and unknown etiology. IPF is characterized by epithelial cell injury, impaired cellular crosstalk between epithelial cells and fibroblasts, and the formation of fibroblast foci with increased extracellular matrix deposition (ECM). We investigated the role of runt-related transcription factor 2 (RUNX2), a master regulator of bone development that has been linked to profibrotic signaling. RUNX2 expression was up-regulated in lung homogenates from patients with IPF and in experimental bleomycin-induced lung fibrosis. The RUNX2 level correlated with disease severity as measured by decreased diffusing capacity and increased levels of the IPF biomarker, matrix metalloproteinase 7. Nuclear RUNX2 was observed in prosurfactant protein C-positive hyperplastic epithelial cells and was rarely found in myofibroblasts. We discovered an up-regulation of RUNX2 in fibrotic alveolar epithelial type II (ATII) cells as well as an increase of RUNX2-negative fibroblasts in experimental and human pulmonary fibrosis. Functionally, small interfering RNA-mediated RUNX2 knockdown decreased profibrotic ATII cell function, such as proliferation and migration, whereas fibroblasts displayed activation markers and increased ECM expression after RUNX2 knockdown. This study reveals that RUNX2 is differentially expressed in ATII cells vs. fibroblasts in lung fibrosis, which contributes to profibrotic cell function. Cell-specific targeting of RUNX2 pathways may represent a therapeutic approach for IPF.	[Muemmler, Carlo; Hermann, Sarah; Mutze, Kathrin; Koenigshoff, Melanie] Ludwig Maximilians Univ Munchen, Univ Hosp Grosshadern, Helmholtz Ctr Munich, Comprehens Pneumol Ctr, Munich, Germany; [Burgy, Olivier; Koenigshoff, Melanie] Univ Colorado, Dept Med, Div Pulm Sci & Crit Care Med, Denver, CO 80045 USA; [Guenther, Andreas] Univ Giessen, Lung Ctr, Dept Internal Med, Giessen, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Justus Liebig University Giessen	Konigshoff, M (corresponding author), Univ Colorado, Dept Med, Div Pulm Sci & Crit Care Med, AMC, Res 2,9th Floor,12700 East 19th Ave, Denver, CO 80045 USA.	melanie.koenigshoff@ucdenver.edu	Burgy, Olivier/V-8709-2018	Mutze, Kathrin/0000-0002-5577-4500	German Center of Lung Research; Helmholtz Association; European Respiratory Society; European Molecular Biology Organization [ERS LTRF 2016-7481]	German Center of Lung Research; Helmholtz Association(Helmholtz Association); European Respiratory Society; European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	The authors are grateful to all members of the M.G. Laboratory for stimulating discussions. The authors thank Darcy E. Wagner for helping with dataset analysis, Nadine Adam, Anastasia van den Berg, Julia Kipp and Marlene Stein (all of the Comprehensive Pneumology Center Munich, Ludwig Maximillians University) for excellent technical assistance and Nicole Manning (University of Colorado) for proofreading the manuscript. This work was funded by grants from the German Center of Lung Research and the Helmholtz Association. Helmholtz Center Munich and University of Giessen Lung Center are members of the German Center for Lung Research. O.B. is supported by a postdoctoral fellowship from the European Respiratory Society and the European Molecular Biology Organization (Fellowship ERS LTRF 2016-7481). The authors declare no conflicts of interest.	Baarsma HA, 2017, THORAX, V72, P746, DOI 10.1136/thoraxjnl-2016-209753; Baarsma HA, 2017, J EXP MED, V214, P143, DOI 10.1084/jem.20160675; Baarsma HA, 2013, PHARMACOL THERAPEUT, V138, P66, DOI 10.1016/j.pharmthera.2013.01.002; Baniwal SK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-258; Bellaye PS, 2015, AM J RESP CELL MOL, V52, P244, DOI 10.1165/rcmb.2014-0011OC; Blackwell TS, 2014, AM J RESP CRIT CARE, V189, P214, DOI 10.1164/rccm.201306-1141WS; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Bridges RS, 2009, AM J PATHOL, V175, P2351, DOI 10.2353/ajpath.2009.080954; Burgy O, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0475-8; Chang CH, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0257-3; Chimge NO, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3073; Chuang LSH, 2013, INT J CANCER, V132, P1260, DOI 10.1002/ijc.27964; Emblom-Callahan MC, 2010, GENOMICS, V96, P134, DOI 10.1016/j.ygeno.2010.04.005; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; Ferrari N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15658; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Horowitz JC, 2016, EUR RESPIR J, V47, P1842, DOI 10.1183/13993003.01201-2015; Hsu YL, 2011, J BIOL CHEM, V286, P37335, DOI 10.1074/jbc.M111.256156; Huang XM, 1999, NAT STRUCT BIOL, V6, P624; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; Ito Y, 2015, NAT REV CANCER, V15, P81, DOI 10.1038/nrc3877; Jenkins RG, 2017, AM J RESP CELL MOL, V56, P667, DOI 10.1165/rcmb.2017-0096ST; Ji CH, 1998, J CELL BIOCHEM, V69, P353, DOI 10.1002/(SICI)1097-4644(19980601)69:3<353::AID-JCB12>3.3.CO;2-W; Kim JI, 2013, BBA-MOL BASIS DIS, V1832, P1520, DOI 10.1016/j.bbadis.2013.04.021; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim W, 2014, P NATL ACAD SCI USA, V111, P16389, DOI 10.1073/pnas.1407097111; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Klee S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20547; Konigshoff M, 2014, AM J RESP CRIT CARE, V190, P1339, DOI 10.1164/rccm.201411-2030ED; Konigshoff M, 2011, RESPIRATION, V81, P353, DOI 10.1159/000326299; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Lansley SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep36349; Lawson WE, 2005, AM J RESP CRIT CARE, V171, P899, DOI 10.1164/rccm.200311-1535OC; Lee KS, 2010, ONCOGENE, V29, P3349, DOI 10.1038/onc.2010.79; Li H, 2013, TUMOR BIOL, V34, P1807, DOI 10.1007/s13277-013-0720-4; Lomas NJ, 2012, INT J CLIN EXP PATHO, V5, P58; Marmai C, 2011, AM J PHYSIOL-LUNG C, V301, pL71, DOI 10.1152/ajplung.00212.2010; McCarthy TL, 2010, MOL ENDOCRINOL, V24, P587, DOI 10.1210/me.2009-0379; Mutze K, 2015, DIS MODEL MECH, V8, P877, DOI 10.1242/dmm.019117; Nasreen N, 2009, AM J PHYSIOL-LUNG C, V297, pL115, DOI 10.1152/ajplung.90587.2008; Niu DF, 2012, LAB INVEST, V92, P1181, DOI 10.1038/labinvest.2012.84; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Onodera Y, 2010, CANCER SCI, V101, P2670, DOI 10.1111/j.1349-7006.2010.01742.x; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Owens TW, 2014, CANCER RES, V74, P5277, DOI 10.1158/0008-5472.CAN-14-0053; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; Pratap J, 2006, CANCER METAST REV, V25, P589, DOI 10.1007/s10555-006-9032-0; Pullamsetti SS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001725; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Ruffenach G, 2016, AM J RESP CRIT CARE, V194, P1273, DOI 10.1164/rccm.201512-2380OC; Sally ML, 2011, J CELL MOL MED, V15, P2095, DOI 10.1111/j.1582-4934.2010.01212.x; Selman Moises, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Shi N, 2017, FASEB J, V31, P412, DOI [10.1096/fj.201600954R, 10.1096/fj.201600954r]; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Tsuji K, 1998, BONE, V22, P87, DOI 10.1016/S8756-3282(97)00267-6; van Dijk EM, 2016, AM J PHYSIOL-LUNG C, V310, pL1166, DOI 10.1152/ajplung.00226.2015; Weng TT, 2014, AM J RESP CRIT CARE, V190, P1402, DOI 10.1164/rccm.201404-0744OC; White ES, 2016, AM J RESP CRIT CARE, V194, P1242, DOI 10.1164/rccm.201505-0862OC; Xia H, 2017, J CLIN INVEST, V127, P2586, DOI 10.1172/JCI90832; Yang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027324; Yang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023965; Yang J, 2013, AM J PATHOL, V183, P1559, DOI 10.1016/j.ajpath.2013.07.016	65	16	16	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					703	716		10.1096/fj.201700482R	http://dx.doi.org/10.1096/fj.201700482R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28986417	Bronze, Green Submitted			2022-12-26	WOS:000425146900015
J	Muratori, C; Pakhomov, AG; Gianulis, E; Meads, J; Casciola, M; Mollica, PA; Pakhomova, ON				Muratori, Claudia; Pakhomov, Andrei G.; Gianulis, Elena; Meads, Jade; Casciola, Maura; Mollica, Peter A.; Pakhomova, Olga N.			Activation of the phospholipid scramblase TMEM16F by nanosecond pulsed electric fields (nsPEF) facilitates its diverse cytophysiological effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; chloride channel; electroporation; phosphatidylserine; plasma membrane; Anoctamin 6; TMEM16F; nanosecond pulsed electric fields (nsPEF)	CA2+-ACTIVATED CL-CHANNEL; PSEUDOPOD-LIKE BLEBS; MEMBRANE PERMEABILIZATION; INTRACELLULAR CA2+; CALCIUM-ENTRY; ANOCTAMIN 6; CELL-DEATH; PHOSPHATIDYLSERINE TRANSLOCATION; ENDOTHELIAL-CELLS; CHROMAFFIN CELLS	Nanosecond pulsed electric fields (nsPEF) are emerging as a novel modality for cell stimulation and tissue ablation. However, the downstream protein effectors responsible for nsPEF bioeffects remain to be established. Here we demonstrate that nsPEF activate TMEM16F (or Anoctamin 6), a protein functioning as a Ca2+-dependent phospholipid scramblase and Ca2+-activated chloride channel. Using confocal microscopy and patch clamp recordings, we investigated the relevance of TMEM16F activation for several bioeffects triggered by nsPEF, including phosphatidylserine (PS) externalization, nanopore-conducted currents, membrane blebbing, and cell death. In HEK 293 cells treated with a single 300-ns pulse of 25.5 kV/cm, Tmem16f expression knockdown and TMEM16F-specific inhibition decreased nsPEF-induced PS exposure by 49 and 42%, respectively. Moreover, the Tmem16f silencing significantly decreased Ca2+-dependent chloride channel currents activated in response to the nanoporation. Tmem16f expression also affected nsPEF-induced cell blebbing, with only 20% of the silenced cells developing blebs compared with 53% of the control cells. This inhibition of cellular blebbing correlated with a 25% decrease in cytosolic free Ca2+ transient at 30 s after nanoporation. Finally, in TMEM16F-overexpressing cells, a train of 120 pulses (300 ns, 20 Hz, 6 kV/cm) decreased cell survival to 34% compared with 51% in control cells (*, p < 0.01). Taken together, these results indicate that TMEM16F activation by nanoporation mediates and enhances the diverse cellular effects of nsPEF.	[Muratori, Claudia; Pakhomov, Andrei G.; Gianulis, Elena; Meads, Jade; Casciola, Maura; Pakhomova, Olga N.] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23508 USA; [Mollica, Peter A.] Old Dominion Univ, Dept Med Diagnost & Translat Sci, Norfolk, VA 23508 USA	Old Dominion University; Old Dominion University	Muratori, C (corresponding author), 4211 Monarch Way, Norfolk, VA 23508 USA.	cmurator@odu.edu	Mollica, Peter/AAT-9553-2021	Mollica, Peter/0000-0002-0621-2819; Pakhomov, Andrei/0000-0003-3816-3860; Muratori, Claudia/0000-0002-3359-164X	Air Force Office of Scientific Research MURI grant on Nanoelectropulse-induced Electromechanical Signaling and Control of Biological Systems	Air Force Office of Scientific Research MURI grant on Nanoelectropulse-induced Electromechanical Signaling and Control of Biological Systems	This work was supported by a 2015 Air Force Office of Scientific Research MURI grant (to A. G. P.) on Nanoelectropulse-induced Electromechanical Signaling and Control of Biological Systems, administered through Old Dominion University. The authors declare that they have no conflicts of interest with the contents of this article.	Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; ARNOULD T, 1992, J CELL PHYSIOL, V152, P215, DOI 10.1002/jcp.1041520127; Berghofer T, 2009, BIOCHEM BIOPH RES CO, V387, P590, DOI 10.1016/j.bbrc.2009.07.072; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Bowman AM, 2010, J MEMBRANE BIOL, V236, P15, DOI 10.1007/s00232-010-9269-y; Carr L, 2017, SCI REP-UK, V7, DOI 10.1038/srep41267; Castoldi E, 2011, BLOOD, V117, P4399, DOI 10.1182/blood-2011-01-332502; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; Craviso GL, 2012, BIOELECTROCHEMISTRY, V87, P244, DOI 10.1016/j.bioelechem.2011.11.016; Craviso GL, 2010, CELL MOL NEUROBIOL, V30, P1259, DOI 10.1007/s10571-010-9573-1; Garon EB, 2007, INT J CANCER, V121, P675, DOI 10.1002/ijc.22723; GEERAERTS MD, 1991, AM J PHYSIOL, V261, pC889, DOI 10.1152/ajpcell.1991.261.5.C889; Gianulis EC, 2017, CELL MOL LIFE SCI, V74, P1741, DOI 10.1007/s00018-016-2434-4; Gowrishankar TR, 2006, BIOCHEM BIOPH RES CO, V349, P643, DOI 10.1016/j.bbrc.2006.08.097; Grubb S, 2013, J GEN PHYSIOL, V141, P585, DOI 10.1085/jgp.201210861; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Hu Q, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031902; Ibey BL, 2010, BBA-GEN SUBJECTS, V1800, P1210, DOI 10.1016/j.bbagen.2010.07.008; Ibey BL, 2010, BIOELECTROCHEMISTRY, V79, P114, DOI 10.1016/j.bioelechem.2010.01.001; JEWELL SA, 1982, SCIENCE, V217, P1257, DOI 10.1126/science.7112127; Jiang N, 2011, BIOELECTROMAGNETICS, V32, P148, DOI 10.1002/bem.20620; Juul CA, 2014, PFLUG ARCH EUR J PHY, V466, P1899, DOI 10.1007/s00424-013-1428-4; Kunzelmann K, 2016, CELL MOL LIFE SCI, V73, P2387, DOI 10.1007/s00018-016-2208-z; Kunzelmann K, 2014, PFLUG ARCH EUR J PHY, V466, P407, DOI 10.1007/s00424-013-1305-1; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; Mattheij NJA, 2016, FASEB J, V30, P727, DOI 10.1096/fj.15-280446; Munnix ICA, 2003, THROMB HAEMOSTASIS, V89, P687, DOI 10.1055/s-0037-1613576; MURATORI C, 2016, SCI REP UK, V6; Muratori C, 2017, J MEMBRANE BIOL, V250, P217, DOI 10.1007/s00232-017-9952-3; Muratori C, 2016, SCI REP-UK, V6, DOI 10.1038/srep23225; Napotnik TB, 2012, BIOELECTROMAGNETICS, V33, P257, DOI 10.1002/bem.20707; Nesin OM, 2011, BBA-BIOMEMBRANES, V1808, P792, DOI 10.1016/j.bbamem.2010.12.012; Nesin V, 2012, BIOELECTROMAGNETICS, V33, P443, DOI 10.1002/bem.21703; Nesin V, 2012, BIOELECTROMAGNETICS, V33, P394, DOI 10.1002/bem.21696; Ousingsawat J, 2017, CELL MOL LIFE SCI, V74, P173, DOI 10.1007/s00018-016-2338-3; Ousingsawat J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7245; Pakhomov A.G., 2010, ADV ELECTROPORATION, P178; Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354; Pakhomov AG, 2007, ARCH BIOCHEM BIOPHYS, V465, P109, DOI 10.1016/j.abb.2007.05.003; Pakhomov AG, 2017, BBA-BIOMEMBRANES, V1859, P1273, DOI 10.1016/j.bbamem.2017.04.016; Pakhomov AG, 2015, BBA-BIOMEMBRANES, V1848, P958, DOI 10.1016/j.bbamem.2014.12.026; Pakhomov AG, 2014, BIOELECTROCHEMISTRY, V100, P88, DOI 10.1016/j.bioelechem.2014.01.004; Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035; Pakhomova ON, 2014, BBA-BIOMEMBRANES, V1838, P2547, DOI 10.1016/j.bbamem.2014.06.015; Pakhomova ON, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070278; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Pletjushkina OJ, 2001, CELL MOTIL CYTOSKEL, V48, P235, DOI 10.1002/cm.1012.abs; Rassokhin MA, 2014, CELL BIOCHEM BIOPHYS, V69, P555, DOI 10.1007/s12013-014-9831-9; Rassokhin MA, 2012, J MEMBRANE BIOL, V245, P521, DOI 10.1007/s00232-012-9433-7; Ren W, 2012, BIOCHEM BIOPH RES CO, V421, P808, DOI 10.1016/j.bbrc.2012.04.094; Ren W, 2011, APOPTOSIS, V16, P382, DOI 10.1007/s10495-010-0572-y; Schoenbach KH, 2007, IEEE T DIELECT EL IN, V14, P1088, DOI 10.1109/TDEI.2007.4339468; Scudieri P, 2015, J PHYSIOL-LONDON, V593, P3829, DOI 10.1113/JP270691; Semenov I, 2015, BIOELECTROCHEMISTRY, V105, P65, DOI 10.1016/j.bioelechem.2015.05.013; Semenov I, 2013, CELL CALCIUM, V54, P145, DOI 10.1016/j.ceca.2013.05.008; Semenov I, 2013, BBA-BIOMEMBRANES, V1828, P981, DOI 10.1016/j.bbamem.2012.11.032; Shimizu T, 2004, P NATL ACAD SCI USA, V101, P6770, DOI 10.1073/pnas.0401604101; Shimizu T, 2013, AM J PHYSIOL-CELL PH, V304, pC748, DOI 10.1152/ajpcell.00228.2012; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Suzuki T, 2014, J BIOL CHEM, V289, P7438, DOI 10.1074/jbc.M113.542324; Szteyn K, 2012, CELL PHYSIOL BIOCHEM, V30, P1319, DOI 10.1159/000343321; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thompson GL, 2014, BIOELECTROMAGNETICS, V35, P262, DOI 10.1002/bem.21845; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Ullery JC, 2015, BIOCHEM BIOPH RES CO, V458, P411, DOI 10.1016/j.bbrc.2015.01.131; Vernier PT, 2006, PHYS BIOL, V3, P233, DOI 10.1088/1478-3975/3/4/001; Vernier PT, 2008, BIOELECTROCHEMISTRY, V73, P1, DOI 10.1016/j.bioelechem.2008.02.003; Vernier PT, 2006, J AM CHEM SOC, V128, P6288, DOI 10.1021/ja0588306; Vernier PT, 2004, FEBS LETT, V572, P103, DOI 10.1016/j.febslet.2004.07.021; Vernier PT, 2004, BIOPHYS J, V86, P4040, DOI 10.1529/biophysj.103.037945; Vernier PT, 2003, BIOCHEM BIOPH RES CO, V310, P286, DOI 10.1016/j.bbrc.2003.08.140; Vincelette RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063122; Wang SF, 2009, BIOPHYS J, V96, P1640, DOI 10.1016/j.bpj.2008.11.011; White JA, 2004, J BIOL CHEM, V279, P22964, DOI 10.1074/jbc.M311135200; Whitlock JM, 2016, PFLUG ARCH EUR J PHY, V468, P455, DOI 10.1007/s00424-015-1777-2; Xiao QH, 2011, P NATL ACAD SCI USA, V108, P8891, DOI 10.1073/pnas.1102147108; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang W, 2011, TECHNOL CANCER RES T, V10, P281, DOI 10.7785/tcrt.2012.500204; Yarmush ML, 2014, ANNU REV BIOMED ENG, V16, P295, DOI 10.1146/annurev-bioeng-071813-104622; Yu K, 2015, ELIFE, V4, DOI 10.7554/eLife.06901	81	24	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19381	19391		10.1074/jbc.M117.803049	http://dx.doi.org/10.1074/jbc.M117.803049			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28982976	hybrid, Green Published			2022-12-26	WOS:000416226700019
J	Kim, E; Akimoto, S; Tokutsu, R; Yokono, M; Minagawa, J				Kim, Eunchul; Akimoto, Seiji; Tokutsu, Ryutaro; Yokono, Makio; Minagawa, Jun			Fluorescence lifetime analyses reveal how the high light-responsive protein LHCSR3 transforms PSII light-harvesting complexes into an energy-dissipative state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						algae; bioenergetics; light-harvesting complex (antenna complex); photobiology; photosynthesis; photosystem II; quenching	ALGA CHLAMYDOMONAS-REINHARDTII; CORE ANTENNA PROTEIN; PHOTOSYSTEM-II; EXCITATION-ENERGY; PSBS PROTEIN; SPECTROSCOPIC PROPERTIES; THYLAKOID MEMBRANES; CONTAINING CYANOBACTERIUM; BINDING PROTEIN; EXCESS LIGHT	In green algae, light-harvesting complex stress-related 3 (LHCSR3) is responsible for the pH-dependent dissipation of absorbed light energy, a function vital for survival under high-light conditions. LHCSR3 binds the photosystem II and light-harvesting complex II (PSII-LHCII) supercomplex and transforms it into an energy-dissipative form under acidic conditions, but the molecular mechanism remains unclear. Here we show that in the green alga Chlamydomonas reinhardtii, LHCSR3 modulates the excitation energy flow and dissipates the excitation energy within the light-harvesting complexes of the PSII supercomplex. Using fluorescence decay-associated spectra analysis, we found that, when the PSII supercomplex is associated with LHCSR3 under high-light conditions, excitation energy transfer from light-harvesting complexes to chlorophyll-binding protein CP43 is selectively inhibited compared with that to CP47, preventing excess excitation energy from overloading the reaction center. By analyzing femtosecond up-conversion fluorescence kinetics, we further found that pH- and LHCSR3-dependent quenching of the PSIILHCII-LHCSR3 supercomplex is accompanied by a fluorescence emission centered at 684 nm, with a decay time constant of 18.6 ps, which is equivalent to the rise time constant of the lutein radical cation generated within a chlorophyll-lutein heterodimer. These results suggest a mechanism in which LHCSR3 transforms the PSII supercomplex into an energy-dissipative state and provide critical insight into the molecular events and characteristics in LHCSR3-dependent energy quenching.	[Kim, Eunchul; Tokutsu, Ryutaro; Minagawa, Jun] Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi 4448585, Japan; [Akimoto, Seiji] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 6578501, Japan; [Yokono, Makio] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Kobe University; Hokkaido University	Minagawa, J (corresponding author), Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi 4448585, Japan.	minagawa@nibb.ac.jp	Tokutsu, Ryutaro/GRF-0208-2022; Kim, Eunchul/E-9565-2013; Yokono, Makio/N-8425-2015; Tokutsu, Ryutaro/V-7596-2019	Kim, Eunchul/0000-0003-3380-3953; Tokutsu, Ryutaro/0000-0003-2037-255X; Yokono, Makio/0000-0002-4813-2120; Minagawa, Jun/0000-0002-3028-3203	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP16H06553, JP26251033, JP16F16087]; International Research Fellowship of the JSPS; Grants-in-Aid for Scientific Research [15H05599] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); International Research Fellowship of the JSPS; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aids JP16H06553 (to J. M., R. T., S. A., and E. K.), JP26251033 (to J. M. and R. T.), and JP16F16087 (to E. K.), and a International Research Fellowship of the JSPS (to E. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Akimoto S, 2015, PHOTOSYNTH RES, V125, P115, DOI 10.1007/s11120-015-0091-3; Akimoto S, 2012, BBA-BIOENERGETICS, V1817, P1483, DOI 10.1016/j.bbabio.2012.01.006; Allorent G, 2016, P NATL ACAD SCI USA, V113, P14864, DOI 10.1073/pnas.1607695114; Amarnath K, 2012, P NATL ACAD SCI USA, V109, P8405, DOI 10.1073/pnas.1205303109; Andrizhiyevskaya EG, 2005, PHOTOSYNTH RES, V84, P173, DOI 10.1007/s11120-005-0478-7; Avenson TJ, 2009, J BIOL CHEM, V284, P2830, DOI 10.1074/jbc.M807192200; Ballottari M, 2016, J BIOL CHEM, V291, P7334, DOI 10.1074/jbc.M115.704601; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Caffarri S, 2011, BIOPHYS J, V100, P2094, DOI 10.1016/j.bpj.2011.03.049; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Cheng YC, 2008, J PHYS CHEM B, V112, P13418, DOI 10.1021/jp802730c; Connelly JP, 1997, J PHYS CHEM B, V101, P1902, DOI 10.1021/jp9619651; Correa-Galvis V, 2016, J BIOL CHEM, V291, P17478, DOI 10.1074/jbc.M116.737312; Correa-Galvis V, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.225, 10.1038/nplants.2015.225]; de Weerd FL, 2002, BIOCHEMISTRY-US, V41, P15224, DOI 10.1021/bi0261948; Dinc E, 2016, P NATL ACAD SCI USA, V113, P7673, DOI 10.1073/pnas.1605380113; Erickson E, 2015, PLANT J, V82, P449, DOI 10.1111/tpj.12825; Fan MR, 2015, NAT STRUCT MOL BIOL, V22, P729, DOI 10.1038/nsmb.3068; GAGNE G, 1992, PLANT MOL BIOL, V18, P429, DOI 10.1007/BF00040659; Gerotto C, 2015, PLANT PHYSIOL, V168, P1747, DOI 10.1104/pp.15.00361; Goral TK, 2012, PLANT J, V69, P289, DOI 10.1111/j.1365-313X.2011.04790.x; Groot ML, 1999, BIOPHYS J, V77, P3328, DOI 10.1016/S0006-3495(99)77164-X; Hamada F, 2015, J PHYS CHEM B, V119, P15593, DOI 10.1021/acs.jpcb.5b10073; Hamada F, 2012, BBA-BIOENERGETICS, V1817, P1992, DOI 10.1016/j.bbabio.2012.06.008; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Horton P, 2012, PHILOS T R SOC B, V367, P3455, DOI 10.1098/rstb.2012.0069; Jarvi S, 2015, BBA-BIOENERGETICS, V1847, P900, DOI 10.1016/j.bbabio.2015.01.006; Johnson MP, 2011, J BIOL CHEM, V286, P19973, DOI 10.1074/jbc.M111.237255; Kirchhoff H, 2003, BBA-BIOENERGETICS, V1606, P105, DOI 10.1016/S0005-2728(03)00105-1; Kiss AZ, 2008, J BIOL CHEM, V283, P3972, DOI 10.1074/jbc.M707410200; Komura M, 2006, BBA-BIOENERGETICS, V1757, P1657, DOI 10.1016/j.bbabio.2006.09.007; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, J BIOL CHEM, V277, P33590, DOI 10.1074/jbc.M204797200; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Liguori N, 2016, BBA-BIOENERGETICS, V1857, P1514, DOI 10.1016/j.bbabio.2016.04.285; Liguori N, 2013, J AM CHEM SOC, V135, P18339, DOI 10.1021/ja4107463; Maruyama S, 2014, PLANT CELL PHYSIOL, V55, P1304, DOI 10.1093/pcp/pcu068; Mimuro M, 2007, BBA-BIOENERGETICS, V1767, P327, DOI 10.1016/j.bbabio.2007.02.012; Minagawa J, 2015, PLANT J, V82, P413, DOI 10.1111/tpj.12805; Miura K, 2004, PLANT PHYSIOL, V135, P1595, DOI 10.1104/pp.104.041400; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Nagao R, 2014, J PHYS CHEM LETT, V5, P2983, DOI 10.1021/jz501496p; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; Niyogi KK, 2005, J EXP BOT, V56, P375, DOI 10.1093/jxb/eri056; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Novoderezhkin V, 2011, PHYS CHEM CHEM PHYS, V13, P17093, DOI 10.1039/c1cp21079c; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Petroutsos D, 2016, NATURE, V537, P563, DOI 10.1038/nature19358; Petroutsos D, 2011, PLANT CELL, V23, P2950, DOI 10.1105/tpc.111.087973; Pinnola A, 2016, BBA-BIOENERGETICS, V1857, P1870, DOI 10.1016/j.bbabio.2016.09.001; Raszewski G, 2008, J AM CHEM SOC, V130, P4431, DOI 10.1021/ja7099826; Richard C, 2000, PLANT MOL BIOL, V42, P303, DOI 10.1023/A:1006340308077; Ruban AV, 2016, PLANT PHYSIOL, V170, P1903, DOI 10.1104/pp.15.01935; Semchonok DA, 2017, BBA-BIOENERGETICS, V1858, P379, DOI 10.1016/j.bbabio.2017.02.015; Shibata Y, 2013, J AM CHEM SOC, V135, P6903, DOI 10.1021/ja312586p; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; SUEOKA N, 1960, P NATL ACAD SCI USA, V46, P83, DOI 10.1073/pnas.46.1.83; Tibiletti T, 2016, PLANT PHYSIOL, V171, P2717, DOI 10.1104/pp.16.00572; Tilbrook K, 2016, PLANT CELL, V28, P966, DOI 10.1105/tpc.15.00287; Tokutsu R, 2013, P NATL ACAD SCI USA, V110, P10016, DOI 10.1073/pnas.1222606110; Tokutsu R, 2012, J BIOL CHEM, V287, P31574, DOI 10.1074/jbc.M111.331991; van Bezouwen LS, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.80; VANDORSSEN RJ, 1987, BIOCHIM BIOPHYS ACTA, V893, P267, DOI 10.1016/0005-2728(87)90048-X; VANDORSSEN RJ, 1987, BIOCHIM BIOPHYS ACTA, V890, P134, DOI 10.1016/0005-2728(87)90014-4; Wang LY, 2016, P NATL ACAD SCI USA, V113, P12586, DOI 10.1073/pnas.1606519113; Wei XP, 2016, NATURE, V534, P69, DOI 10.1038/nature18020; Yokono M, 2015, BBA-BIOENERGETICS, V1847, P1274, DOI 10.1016/j.bbabio.2015.07.006; Yokono M, 2012, BBA-BIOENERGETICS, V1817, P754, DOI 10.1016/j.bbabio.2012.02.009	73	21	23	3	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18951	18960		10.1074/jbc.M117.805192	http://dx.doi.org/10.1074/jbc.M117.805192			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972177	Green Published, hybrid			2022-12-26	WOS:000415848000019
J	Szabo, SM; Hirji, I; Johnston, KM; Juarez-Garcia, A; Connors, JM				Szabo, Shelagh M.; Hirji, Ishan; Johnston, Karissa M.; Juarez-Garcia, Ariadna; Connors, Joseph M.			Treatment patterns and costs of care for patients with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin in the United States: A retrospective cohort study	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; CLAIMS DATA; RISK; THERAPY; PROGRAM; IMPACT	Objectives Although brentuximab vedotin (BV) has changed the management of patients with relapsed or refractory Hodgkin lymphoma (RRHL), little information is available on routine clinical practice. We identified treatment patterns and costs of care among RRHL patients in the United States (US) treated with BV. Methods A retrospective observational study of adults initiating BV for RRHL from 2011 - 2015, with >= 6 months of data prior to and following BV initiation, was conducted. Treatments were classified based on dispensations and chemotherapy administration. Median total and monthly costs were estimated based on all-cause healthcare resource use in 2015 US dollars (USD). Results The cohort comprised 289 patients (59% male; mean age at diagnosis, 42 years) with a mean follow-up of 250 weeks. Eleven percent had BV salvage therapy prior to ASCT, and 32% had BV for a relapse post-ASCT. 43% received treatment post-BV, most commonly allogeneic stem cell transplant (SCT) and bendamustine (both 10.2%). Median (IQR) total costs from BV initiation to censoring were 294,790 (142,110-483,360) USD; and were highest among those treated with BV prior to ASCT (up to 421,900 [300,940-778,970] USD). Median monthly costs were almost 20,000 USD per month, and up to 25,000 USD per month among those with BV and ASCT. Medications were the greatest driver of median monthly costs. Conclusions Median total all-cause costs were almost 300,000 USD, and median monthly costs approximately 20,000 USD, per patient treated. Patients requiring treatment following BV continue to incur high costs, highlighting the economic burden associated with managing patients in the RRHL setting.	[Szabo, Shelagh M.; Johnston, Karissa M.] Broadstr HEOR, Vancouver, BC, Canada; [Hirji, Ishan; Juarez-Garcia, Ariadna] Bristol Myers Squibb Co, Princeton, NJ USA; [Connors, Joseph M.] BC Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC, Canada	Bristol-Myers Squibb; British Columbia Cancer Agency	Szabo, SM (corresponding author), Broadstr HEOR, Vancouver, BC, Canada.	sszabo@broadstreetheor.com	Connors, Joseph/AAF-5284-2019	Connors, Joseph/0000-0002-1361-7531; Szabo, Shelagh M/0000-0002-9044-3192	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	This research was sponsored by Bristol-Myers Squibb; and two co-authors (IH and AJG) were employees of BMS at the time of the conduct of the study; AJG is presently an employee of BMS. While both IH and AJG participated in the study design, interpretation of the findings, and development of the manuscript, the publication of the research was not contingent on the sponsors approval or censorship of the manuscript.	Andrews AL, 2017, ACAD PEDIATR, V17, P212, DOI 10.1016/j.acap.2016.10.016; [Anonymous], 2013, NCCN CLIN PRACT GUID; Broulette Jonah Y H, 2013, INCIDENCE RATE EC BU; Calip GS, 2017, J ONCOL PRACT; Chen R, 2016, BLOOD, V128, P1562, DOI 10.1182/blood-2016-02-699850; Elsamadicy AA, 2017, NEUROMODULATION; Eyre TA, 2013, BRIT J HOSP MED, V74, P612, DOI 10.12968/hmed.2013.74.11.612; Garciaz S, 2014, HEMATOL ONCOL, V32, P187, DOI 10.1002/hon.2119; Gibson TB, 2014, AM J MANAG CARE, V20, pE208; Gobbi PG, 2013, CRIT REV ONCOL HEMAT, V85, P216, DOI 10.1016/j.critrevonc.2012.07.002; Gopal AK, 2015, BLOOD, V125, P1236, DOI 10.1182/blood-2014-08-595801; Hansen R.N., 2014, COST RELAPSE HODGKIN; Hess LM, 2016, GASTRIC CANCER, V19, P607, DOI 10.1007/s10120-015-0486-z; Kuo DZ, 2015, PEDIATRICS, V136, pE1521, DOI 10.1542/peds.2015-0871; Kuruvilla J, 2011, BLOOD, V117, P4208, DOI 10.1182/blood-2010-09-288373; Kutikova L, 2006, LEUKEMIA LYMPHOMA, V47, P1535, DOI 10.1080/10428190600573325; Lin J, 2017, CLIN THER, V39, P303, DOI 10.1016/j.clinthera.2016.12.010; Lip GYH, 2016, INT J CLIN PRACT, V70, P752, DOI 10.1111/ijcp.12863; Macalalad AR, 2015, CURR MED RES OPIN, V31, P537, DOI 10.1185/03007995.2015.1008131; Majhail NS, 2006, BIOL BLOOD MARROW TR, V12, P1065, DOI 10.1016/j.bbmt.2006.06.006; Mediwake H, 2017, INTERNAL MED J; Moskowitz CH, 2015, LANCET, V385, P1853, DOI 10.1016/S0140-6736(15)60165-9; Schneeweiss S, 2009, DERMATOLOGY, V219, P7, DOI 10.1159/000209289; Shao C, 2016, UTILIZATION PATTERNS; Shao C, 2016, REAL WORLD TREATMENT; Siddiqi T, 2014, PHARMACOGEN PERS MED, V7, P79, DOI 10.2147/PGPM.S57700; Szabo SM, 2017, LINES THERAPY COSTS; Truven Health Analytics, 2011, MULT MED DAT US GUID; U.S. Food & Drug Administration, 2016, ADCETRIS BRENT VED F; Vassilakopoulos TP, 2013, SEMIN HEMATOL, V50, P4, DOI 10.1053/j.seminhematol.2013.02.002; Yasenchak CA, 2015, LEUKEMIA LYMPHOMA, V56, P3143, DOI 10.3109/10428194.2015.1030639; Zinzani PL, 2016, CRIT REV ONCOL HEMAT, V104, P65, DOI 10.1016/j.critrevonc.2016.04.019; Zinzani PL, 2015, CRIT REV ONCOL HEMAT, V95, P359, DOI 10.1016/j.critrevonc.2015.03.011	33	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0180261	10.1371/journal.pone.0180261	http://dx.doi.org/10.1371/journal.pone.0180261			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	28991893	Green Submitted, Green Published, gold			2022-12-26	WOS:000412601800002
J	Brandt, LP; Albers, J; Hejhal, T; Catalano, A; Wild, PJ; Frew, IJ				Brandt, Laura P.; Albers, Joachim; Hejhal, Tomas; Catalano, Antonella; Wild, Peter J.; Frew, Ian J.			Oncogenic Hras(G12V) expression plus knockdown of Cdkn2a using ecotropic lentiviral vectors induces high-grade endometrial stromal sarcoma	PLOS ONE			English	Article							CANCER; SYSTEM; MOUSE; CELLS; MODEL	The uterine corpus represents the most common site for tumour development in the female genital system. Uterine neoplasms are categorised as epithelial, mesenchymal, mixed epithelial-mesenchymal or trophoblastic tumours. In this study we employed a mouse genetic approach using the MuLE lentiviral gene regulatory system to functionally test the ability of ecotropic lentiviruses to model epithelial and mesenchymal uterine malignancies ex vivo and in vivo. We discovered that MuLE lentiviruses efficiently infect uterine stromal cells but not endometrial epithelial cells when injected into the uterus of cycling, pseudopregnant or ovarectomized mice. Consistent with this cellular infection spectrum, we show that intrauterine injection of ecotropic MuLE viruses expressing oncogenic Hras(G12V) together with knockdown of Cdkn2a induce high-grade endometrial stromal sarcomas. These findings establish this approach as an efficient method of generating autochthonous mouse models of uterine sarcomas and in general for performing genetic manipulations of uterine stromal cells in vivo.	[Brandt, Laura P.; Albers, Joachim; Hejhal, Tomas; Catalano, Antonella; Frew, Ian J.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Brandt, Laura P.; Frew, Ian J.] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Catalano, Antonella; Frew, Ian J.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Catalano, Antonella; Frew, Ian J.] Univ Freiburg, Med Ctr, Fac Med, Clin Internal Med Hematol Oncol & Stem Cell Trans, Freiburg, Germany; [Wild, Peter J.] Univ Hosp Zurich, Inst Pathol & Mol Pathol, Zurich, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Freiburg; University of Freiburg; University of Zurich; University Zurich Hospital	Frew, IJ (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.; Frew, IJ (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland.; Frew, IJ (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany.; Frew, IJ (corresponding author), Univ Freiburg, Med Ctr, Fac Med, Clin Internal Med Hematol Oncol & Stem Cell Trans, Freiburg, Germany.	ian.frew@uniklinik-freiburg.de		Frew, Ian/0000-0003-2735-5509; Albers, Joachim/0000-0003-0582-1863; Wild, Peter Johannes/0000-0002-1017-3744				Albers J, 2015, J CLIN INVEST, V125, P1603, DOI 10.1172/JCI79743; [Anonymous], 2014, UNDIFFERENTIATED UTE, V290, P993; [Anonymous], 2009, MOL BIOL ENDOMETRICA, V16, P8; [Anonymous], 2012, DIAGNOSIS TREATMENT, V51, P694; [Anonymous], 1991, TRANSPORT CATIONIC A, V352, P725; [Anonymous], 1998, PTEN MUTATIONS MICRO, V58, P3254; [Anonymous], 2015, UTERINE SARCOMAS S2, V131, pS105; [Anonymous], 2006, ANAL FUMARATE HYDRAT, V119, P283; [Anonymous], 2011, FREQUENCY KNOWN GENE, V35, P1364; [Anonymous], 2005, LOSS DNA COPY NUMBER, V161, P20; [Anonymous], 1997, ONCOGENIC RAS PROVOK, V88, P593; [Anonymous], 2000, ELSEVIER, P273; [Anonymous], 2012, HIGH GRADE UNDIFFERE, V127, P27; [Anonymous], 1997, MUC1 OTH SIAL INH AD, V17, P422; [Anonymous], 2007, AKT MTOR PATHWAY PLA, V13, P748; [Anonymous], 2011, CONG HYP FEM PAX8 DE, V148, P719; [Anonymous], 2012, GENOMICS GENETICS EN, V2, P33; [Anonymous], 2015, MODELLING BREAST CAN, V6, P6927; [Anonymous], 2013, REV TREATMENT UTERIN, V15, P581; Beauparlant SL, 2004, GYNECOL ONCOL, V94, P713, DOI 10.1016/j.ygyno.2004.06.008; Bertsch E, 2014, MODERN PATHOLOGY, P1; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; Eritja N, 2010, AM J PATHOL, V176, P2722, DOI 10.2353/ajpath.2010.090974; Fadare O, 2006, AM J SURG PATHOL, V30, P1519, DOI 10.1097/01.pas.0000213296.88778.db; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Grant KS, 2003, BIOL REPROD, V69, P1091, DOI 10.1095/biolreprod.103.015495; Joshi A, 2011, EXP CELL RES, V317, P1580, DOI 10.1016/j.yexcr.2011.03.006; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kim TH, 2010, J ONCOL, V2010, DOI 10.1155/2010/139087; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Koontz JI, 2001, P NATL ACAD SCI USA, V98, P6348, DOI 10.1073/pnas.101132598; Kuhn E, 2012, JNCI-J NATL CANCER I, V104, P1503, DOI 10.1093/jnci/djs345; Kyo S, 2003, AM J PATHOL, V163, P2259, DOI 10.1016/S0002-9440(10)63583-3; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mito JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008075; Traykova-Brauch M, 2008, NAT MED, V14, P979, DOI 10.1038/nm.1865; Wild PJ, 2012, EMBO MOL MED, V4, P808, DOI 10.1002/emmm.201101063; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302	39	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186102	10.1371/journal.pone.0186102	http://dx.doi.org/10.1371/journal.pone.0186102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982163	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000412360300122
J	Chen, YC; Zhao, JL; Deng, QQ; Duan, FQ				Chen, Yucong; Zhao, Junli; Deng, Qingqiong; Duan, Fuqing			3D craniofacial registration using thin-plate spline transform and cylindrical surface projection	PLOS ONE			English	Article							FACE RECONSTRUCTION; RECOGNITION; SKULL	Craniofacial registration is used to establish the point-to-point correspondence in a unified coordinate system among human craniofacial models. It is the foundation of craniofacial reconstruction and other craniofacial statistical analysis research. In this paper, a non-rigid 3D craniofacial registration method using thin-plate spline transform and cylindrical surface projection is proposed. First, the gradient descent optimization is utilized to improve a cylindrical surface fitting (CSF) for the reference craniofacial model. Second, the thin-plate spline transform (TPST) is applied to deform a target craniofacial model to the reference model. Finally, the cylindrical surface projection (CSP) is used to derive the point correspondence between the reference and deformed target models. To accelerate the procedure, the iterative closest point ICP algorithm is used to obtain a rough correspondence, which can provide a possible intersection area of the CSP. Finally, the inverse TPST is used to map the obtained corresponding points from the deformed target craniofacial model to the original model, and it can be realized directly by the correspondence between the original target model and the deformed target model. Three types of registration, namely, reflexive, involutive and transitive registration, are carried out to verify the effectiveness of the proposed craniofacial registration algorithm. Comparison with the methods in the literature shows that the proposed method is more accurate.	[Chen, Yucong; Deng, Qingqiong; Duan, Fuqing] Beijing Normal Univ, Coll Informat Sci & Technol, Beijing, Peoples R China; [Zhao, Junli] Qingdao Univ, Sch Data Sci & Software Engn, Qingdao, Peoples R China	Beijing Normal University; Qingdao University	Duan, FQ (corresponding author), Beijing Normal Univ, Coll Informat Sci & Technol, Beijing, Peoples R China.	fqduan@bnu.edu.cn		Zhao, Junli/0000-0002-2034-6426	National Natural Science Foundation of China [61572078, 61702293]; Open Research Fund of the Ministry of Education Engineering Research Center of Virtual Reality Application [MEOBNUEVRA201601]; Program for New Century Excellent Talents in University [NCET-13-0051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Research Fund of the Ministry of Education Engineering Research Center of Virtual Reality Application; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was funded by the National Natural Science Foundation of China (No. 61572078, No. 61702293) and the Open Research Fund of the Ministry of Education Engineering Research Center of Virtual Reality Application (MEOBNUEVRA201601). It was also partially supported by grants from the Program for New Century Excellent Talents in University (NCET-13-0051).	Alyuz N, 2012, LECT NOTES COMPUT SC, V7585, P557, DOI 10.1007/978-3-642-33885-4_56; Alyuz N, 2010, IEEE T INF FOREN SEC, V5, P425, DOI 10.1109/TIFS.2010.2054081; Amberg Brian, 2007, CVPR '07. IEEE Conference on Computer Vision and Pattern Recognition, P1; [Anonymous], 2003, ACM T GRAPHIC, V22, P587; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Blanz V, 2003, IEEE T PATTERN ANAL, V25, P1063, DOI 10.1109/TPAMI.2003.1227983; Booth J, 2016, PROC CVPR IEEE, P5543, DOI 10.1109/CVPR.2016.598; Brown BJ, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1276377.1276404; Cao C, 2014, IEEE T VIS COMPUT GR, V20, P413, DOI 10.1109/TVCG.2013.249; Chui HL, 2003, COMPUT VIS IMAGE UND, V89, P114, DOI 10.1016/S1077-3142(03)00009-2; Deng QQ, 2011, FORENSIC SCI INT, V208, P95, DOI 10.1016/j.forsciint.2010.11.011; Duan FQ, 2015, NEUROCOMPUTING, V151, P674, DOI [10.1016/j.neucom.2014.04.989, 10.1016/j.neucom.2014.04.089]; Duan FQ, 2014, IEEE T INF FOREN SEC, V9, P1322, DOI 10.1109/TIFS.2014.2332981; Guo JY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-232; Hu Y, 2009, INT J COMPUTER GAMES, V2009, P3; Hu YL, 2013, MULTIMED TOOLS APPL, V64, P345, DOI 10.1007/s11042-012-1005-4; Hutton T. J., 2003, BMVC 03 P 14 BRIT MA, P439; Mahoor MH, 2009, PATTERN RECOGN, V42, P445, DOI 10.1016/j.patcog.2008.08.012; Rusinkiewicz S, 2001, THIRD INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P145, DOI 10.1109/IM.2001.924423; Schneider DC, 2010, J VIRTUAL REALITY BR, V7, P1; Song ML, 2012, IEEE T IMAGE PROCESS, V21, P2887, DOI 10.1109/TIP.2012.2183882; Spreeuwers L, 2011, INT J COMPUT VISION, V93, P389, DOI 10.1007/s11263-011-0426-2; Wang S, 2007, IEEE T PATTERN ANAL, V29, P1209, DOI 10.1109/TPAMI.2007.1050; Yang JL, 2013, IEEE I CONF COMP VIS, P1457, DOI 10.1109/ICCV.2013.184; Yin LJ, 2006, PROCEEDINGS OF THE SEVENTH INTERNATIONAL CONFERENCE ON AUTOMATIC FACE AND GESTURE RECOGNITION - PROCEEDINGS OF THE SEVENTH INTERNATIONAL CONFERENCE, P211	25	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185567	10.1371/journal.pone.0185567	http://dx.doi.org/10.1371/journal.pone.0185567			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982117	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300045
J	Islam, S; Nazeer, G; Ying, ZC; Islam, Z; Manzoor, R				Islam, Shamsul; Nazeer, Ghazala; Ying, Zhou Chao; Islam, Ziaul; Manzoor, Raheela			Transitions in the flow patterns and aerodynamic characteristics of the flow around staggered rows of cylinders	PLOS ONE			English	Article							SIDE SQUARE CYLINDERS; CIRCULAR-CYLINDERS; PAIR; INTERFERENCE	A two-dimensional numerical study of flow across rows of identical square cylinders arranged in staggered fashion is carried out. This study will unreveal complex flow physics depending upon the Reynolds number (R-e) and gap spacing (g) between the cylinders. The combined effect of Reynolds number and gap spacing on the flow physics around staggered rows of cylinders are numerically studied for 20 <= Re <= 140 and 1 <= g <= 6. We use the lattice Boltzmann method for numerical computations. It is found that with increase in gap spacing between the cylinders the critical Reynolds number for the onset of vortex shedding also increases. We observed a strong effect of Reynolds number at g = 2 and 4. Secondary cylinder interaction frequency disappears for large Reynolds number at g = 6 and 5 and the flow around cylinders are fully dominated by the primary vortex shedding frequency. This ensures that at large gap spacing with an increase in the Reynolds number the wakes interaction between and behind the cylinders is weaken. Furthermore, it also ensures that the wake interaction behind the cylinders is strongly influenced by the jets in the gap spacing between the cylinders. We also found that g = 2 is the critical gap spacing for flow across rows of staggered square cylinders for the considered range of Reynolds number. Depending on the Reynolds number we observed; synchronous, quasi-periodic-I, quasi-periodic-II, and chaotic flow patterns. In synchronous flow pattern, an in-phase and anti-phase characteristics of consecutive cylinders has been observed. The important physical parameters are also analyzed and discussed in detail.	[Islam, Shamsul; Nazeer, Ghazala] COMSATS Inst Informat Technol Islamabad, Math Dept, Islamabad, Pakistan; [Ying, Zhou Chao] Shenzhen Univ Town, Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen, Peoples R China; [Islam, Ziaul] Swedish Inst Technol, Mech Engn Dept, Rawalpindi, Pakistan; [Manzoor, Raheela] Sardar Bakhadur Khan Womens Univ, Math Dept, Quetta, Baluchistan, Pakistan	COMSATS University Islamabad (CUI); Harbin Institute of Technology; University Town of Shenzhen	Islam, S (corresponding author), COMSATS Inst Informat Technol Islamabad, Math Dept, Islamabad, Pakistan.	islam_shams@comsats.edu.pk	Nazeer, Ghazala/K-3109-2019					Abbasi WS, 2014, J MECH SCI TECHNOL, V28, P539, DOI 10.1007/s12206-013-1121-8; Agrawal A, 2006, COMPUT FLUIDS, V35, P1093, DOI 10.1016/j.compfluid.2005.05.008; Alam MM, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4817670; BEARMAN PW, 1973, J FLUID MECH, V61, P499, DOI 10.1017/S0022112073000832; Chatterjee D, 2015, J WIND ENG IND AEROD, V136, P1, DOI 10.1016/j.jweia.2014.10.019; CHAUVE MP, 1992, PHYSICA D, V58, P407, DOI 10.1016/0167-2789(92)90127-9; Chen S, 1998, ANNU REV FLUID MECH, V30, P329, DOI 10.1146/annurev.fluid.30.1.329; DAVIS RW, 1982, J FLUID MECH, V116, P475, DOI 10.1017/S0022112082000561; Gera B., 2010, International Journal of Applied Engineering Research, V1, P602; Gu ZF, 1999, J WIND ENG IND AEROD, V80, P287, DOI 10.1016/S0167-6105(98)00205-0; Guillaume DW, 1999, EXP FLUIDS, V27, P145, DOI 10.1007/s003480050339; Guo ZL, 2008, J COMPUT PHYS, V227, P4955, DOI 10.1016/j.jcp.2008.01.024; Inoue O, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2714080; Islam SU, 2016, ALEX ENG J, V55, P2351, DOI 10.1016/j.aej.2016.05.003; Kang SM, 2004, KSME INT J, V18, P1869, DOI 10.1007/BF02984335; Khanduri AC, 1998, ENG STRUCT, V20, P617, DOI 10.1016/S0141-0296(97)00066-7; Kruger T, 2017, GRAD TEXTS PHYS, P1, DOI 10.1007/978-3-319-44649-3; Kumar SR, 2008, J FLUID MECH, V606, P369, DOI 10.1017/S0022112008001924; Mizushima J, 1996, J PHYS SOC JPN, V65, P1673, DOI 10.1143/JPSJ.65.1673; Mohammad A.A., 2011, LATTICE BOLTZMANN ME; Moussaoui MA, 2011, INT J THERM SCI, V50, P1532, DOI 10.1016/j.ijthermalsci.2011.03.011; Norberg C., 1995, 12 AUSTR FLUID MECH, P517; Rahman H, 2015, KSCE J CIV ENG, V19, P233, DOI 10.1007/s12205-012-0535-7; Ravoux JF, 2003, THEOR COMP FLUID DYN, V16, P433, DOI 10.1007/s00162-003-0090-4; Saha AK, 2000, J ENG MECH-ASCE, V126, P523, DOI 10.1061/(ASCE)0733-9399(2000)126:5(523); Sewatkar CM, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3210769; Succi S., 2000, LATTICE BOLTZMANN EQ; Sukop M.C., 2007, LATTICE BOLTZMANN MO; Ul Islam S, 2016, OCEAN ENG, V119, P1, DOI 10.1016/j.oceaneng.2016.04.022; Ul Islam S, 2012, J MECH SCI TECHNOL, V26, P1027, DOI 10.1007/s12206-012-0328-4; Ul Islam S, 2016, J BRAZ SOC MECH SCI, V38, P843, DOI 10.1007/s40430-014-0297-x; WILLIAMSON CHK, 1985, J FLUID MECH, V159, P1, DOI 10.1017/S002211208500307X; Yan WW, 2016, EUR J MECH B-FLUID, V60, P48, DOI 10.1016/j.euromechflu.2016.07.006; Zhang HJ, 2001, PHYS FLUIDS, V13, P3675, DOI 10.1063/1.1412245; Zhang Y, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-2014-6; Zhou Y, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3275846	36	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184169	10.1371/journal.pone.0184169	http://dx.doi.org/10.1371/journal.pone.0184169			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981539	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300008
J	Pruyne, D				Pruyne, David			Probing the origins of metazoan formin diversity: Evidence for evolutionary relationships between metazoan and non-metazoan formin subtypes	PLOS ONE			English	Article							ACTIN NUCLEATION; PROTEIN; DOMAIN; BINDING; RHO; PHYLOGENY; ALIGNMENT; DELPHILIN; FILAMENTS; DYNAMICS	Formins are proteins that assist in regulating cytoskeletal organization through interactions with actin filaments and microtubules. Metazoans encode nine distinct formin subtypes based on sequence similarity, potentially allowing for great functional diversity for these proteins. Through the evolution of the eukaryotes, formins are believed to have repeatedly undergone rounds of gene duplications, followed by diversification and domain shuffling, but previous phylogenetic analyses have shed only a little light on the specific origins of different formin subtypes. To improve our understanding of this in the case of the metazoan formins, phylogenetic comparisons were made here of a broad range of metazoan and non-metazoan formin sequences. This analysis suggests a model in which eight of the nine metazoan formin subtypes arose from two ancestral proteins that were present in an ancient unikont ancestor. Additionally, evidence is shown suggesting the common ancestor of unikonts and bikonts was likely to have encoded at least two formins, a canonical Drf-type protein and a formin bearing a PTEN-like domain.	[Pruyne, David] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Pruyne, D (corresponding author), SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA.	pruyned@upstate.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R01AR064760-01A1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064760] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, https://www.niams.nih.gov/, Grant# 1R01AR064760-01A1 (DP).	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Breitsprecher D, 2013, J CELL SCI, V126, P1, DOI 10.1242/jcs.107250; Brown MW, 2009, MOL BIOL EVOL, V26, P2699, DOI 10.1093/molbev/msp185; Carlier MF, 2015, CELL MOL LIFE SCI, V72, P3051, DOI 10.1007/s00018-015-1914-2; Carlier MF, 2013, CYTOSKELETON, V70, P540, DOI 10.1002/cm.21124; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; Chalkia D, 2008, MOL BIOL EVOL, V25, P2717, DOI 10.1093/molbev/msn215; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Cvrckova F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-44; Cvrckova F, 2015, INT J MOL SCI, V16, P1, DOI 10.3390/ijms16010001; Dames SA, 2011, J BIOL CHEM, V286, P36907, DOI 10.1074/jbc.M111.225052; Dominguez R, 2016, TRENDS BIOCHEM SCI, V41, P478, DOI 10.1016/j.tibs.2016.03.004; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Grikscheit K, 2016, TRENDS BIOCHEM SCI, V41, P148, DOI 10.1016/j.tibs.2015.12.002; Grunt M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-115; Gunning PW, 2015, J CELL SCI, V128, P2009, DOI 10.1242/jcs.165563; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kuhn Sonja, 2014, Small GTPases, V5, pe29513, DOI 10.4161/sgtp.29513; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Lang BF, 2002, CURR BIOL, V12, P1773, DOI 10.1016/S0960-9822(02)01187-9; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Liu Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-272; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Matsuda K, 2006, J BIOL CHEM, V281, P25577, DOI 10.1074/jbc.M602044200; Miyagi Y, 2002, J NEUROSCI, V22, P803, DOI 10.1523/JNEUROSCI.22-03-00803.2002; Nei M., 2000, MOL EVOLUTION PHYLOG; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Paps J, 2013, PROTIST, V164, P2, DOI 10.1016/j.protis.2012.09.002; Pruyne D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164067; Rivero F, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-28; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Schulte A, 2008, STRUCTURE, V16, P1313, DOI 10.1016/j.str.2008.06.008; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaillant DC, 2008, J BIOL CHEM, V283, P33750, DOI 10.1074/jbc.M803156200; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396	45	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186081	10.1371/journal.pone.0186081	http://dx.doi.org/10.1371/journal.pone.0186081			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982189	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300121
J	Schmid, BC; Carlson, J; Rezniczek, GA; Wyllie, J; Jaaback, K; Vencovsky, F				Schmid, Bernd C.; Carlson, Jamie; Rezniczek, Gunther A.; Wyllie, Jessica; Jaaback, Kenneth; Vencovsky, Filip			Examining word association networks: A cross-country comparison of women's perceptions of HPV testing and vaccination	PLOS ONE			English	Article							HEALTH; QUALITY	In this study, we examined the perceptual associations women hold with regard to cervical cancer testing and vaccination across two countries, the U.S. and Australia. In a large-scale online survey, we presented participants with 'trigger' words, and asked them to state sequentially other words that came to mind. We used this data to construct detailed term cooccurrence network graphs, which we analyzed using basic topological ranking techniques. The results showed that women hold divergent perceptual associations regarding trigger words relating to cervical cancer screening tools, i.e. human papillomavirus (HPV) testing and vaccination, which indicate health knowledge deficiencies with non-HPV related associations emerging from the data. This result was found to be consistent across the country groups studied. Our findings are critical in optimizing consumer education and public service announcements to minimize misperceptions relating to HPV testing and vaccination in order to maximize adoption of cervical cancer prevention tools.	[Schmid, Bernd C.] Royal Hosp Women, Dept Gynaecol Oncol, Randwick, NSW, Australia; [Carlson, Jamie; Wyllie, Jessica] Univ Newcastle, Fac Business & Law, Newcastle Business Sch, Newcastle, NSW, Australia; [Rezniczek, Gunther A.] Ruhr Univ Bochum, Marien Hosp Herne, Dept Obstet & Gynecol, Dungelstr 33, Herne, Germany; [Jaaback, Kenneth] Univ Newcastle, Dept Gynaecol Oncol, Sch Med & Publ Hlth, John Hunter Hosp, New Lambton Hts, Australia; [Vencovsky, Filip] Univ Econ, Fac Informat & Stat, Prague, Czech Republic	University of Newcastle; Ruhr University Bochum; St. Marien Hospital; John Hunter Hospital; University of Newcastle; Prague University of Economics & Business	Carlson, J (corresponding author), Univ Newcastle, Fac Business & Law, Newcastle Business Sch, Newcastle, NSW, Australia.	Jamie.carlson@newcastle.edu.au	Carlson, Jamie/AAP-5387-2020; Carlson, Jamie/G-7535-2013; Rezniczek, Günther/AAO-2963-2020; Rezniczek, Günther/Q-9318-2016	Carlson, Jamie/0000-0002-1622-5939; Rezniczek, Günther/0000-0002-0852-6002; Rezniczek, Günther/0000-0002-0852-6002; Schmid, Bernd C./0000-0003-2510-0537; Wyllie, Jessica/0000-0001-5178-8860				American Cancer Society, WHAT AR RISK FACT CE; Bastian M, 2009, P INT AAAI C WEB SOC, V2009, P361, DOI 10.13140/2.1.1341.1520; Belei N, 2012, J MARKETING RES, V49, P900, DOI 10.1509/jmr.10.0155; Bennett C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001069; Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1145/1656274.1656280; Binka C, 2016, J CANCER EDUC, V31, P322, DOI 10.1007/s13187-015-0852-x; Boh B, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1280-x; Bruni L, 2017, ICO INFORM CTR HPV C; CDC, CERV CANC SCREEN GUI; Centre for Disease, HUM PAP HPV HPV VACC; Choi D, 2014, INT INTERDISCIPLINAR, V14, P3583; Culotta A, 2016, MARKET SCI, V35, P343, DOI 10.1287/mksc.2015.0968; De Deyne S, 2013, P 35 ANN C COGN SCI, P2142; De Deyne S, 2008, BEHAV RES METHODS, V40, P213, DOI 10.3758/BRM.40.1.213; de Martel C, 2017, INT J CANCER, V141, P664, DOI 10.1002/ijc.30716; Driscoll SD, 2016, WOMEN HEALTH, V56, P448, DOI 10.1080/03630242.2015.1101742; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Janssen E, 2011, BRIT J HEALTH PSYCH, V16, P92, DOI 10.1348/135910710X514120; John DR, 2006, J MARKETING RES, V43, P549, DOI 10.1509/jmkr.43.4.549; Kitchens B, 2014, DECIS SUPPORT SYST, V57, P454, DOI 10.1016/j.dss.2012.10.050; Lee TY, 2011, J MARKETING RES, V48, P881, DOI 10.1509/jmkr.48.5.881; Leon-Maldonado L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153367; Li HJ, 2016, PHYSICA A, V450, P657, DOI 10.1016/j.physa.2016.01.017; Lohmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010232; McColl-Kennedy JR, 2012, J SERV RES-US, V15, P370, DOI 10.1177/1094670512442806; Narayanan A, 2016, BIG DATA-US, V4, P31, DOI 10.1089/big.2016.0010; NORTHOUSE P G, 1987, Journal of Psychosocial Oncology, V5, P17; OECD, 2013, CANC CAR ASS QUAL IM; Organization WH, GUID PREV CONTR CERV; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Prah P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135203; Schermel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086000; Schneider F, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1863; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Song H, 2016, J MED INTERNET RES, V18, DOI [10.2196/jmir.4193, 10.21075/kacsn.2016.18.1.1]; Spanakis G, 2016, LECT NOTES COMPUT SC, V9545, P43, DOI 10.1007/978-3-319-29175-8_5; Sweeney JC, 2015, J SERV RES-US, V18, P318, DOI 10.1177/1094670515572128; Totet M., 2016, LETS PLAY GEPHI UNDE; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; U. S. Preventative Services, CERV CANC SCREEN; Van Rensbergen B, 2015, PSYCHON B REV, V22, P1717, DOI 10.3758/s13423-015-0832-5; Vanni T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093376; Widder S, 2014, P NATL ACAD SCI USA, V111, P12799, DOI 10.1073/pnas.1411723111; Wyllie J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163914; Youn H, 2016, P NATL ACAD SCI USA, V113, P1766, DOI 10.1073/pnas.1520752113	46	1	1	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185669	10.1371/journal.pone.0185669	http://dx.doi.org/10.1371/journal.pone.0185669			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28982130	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300056
J	Young, BE; Auer, S; Ormes, M; Rapacciuolo, G; Schweitzer, D; Sears, N				Young, Bruce E.; Auer, Stephanie; Ormes, Margaret; Rapacciuolo, Giovanni; Schweitzer, Dale; Sears, Nicole			Are pollinating hawk moths declining in the Northeastern United States? An analysis of collection records	PLOS ONE			English	Article							ORCHID PLATANTHERA-PRAECLARA; CONCINNATA MEIGEN DIPTERA; AMERICAN BUMBLE BEES; SPECIES RICHNESS; SATURNIIDAE CERATOCAMPINAE; SPHINGIDAE LEPIDOPTERA; NORTH-AMERICA; MANDUCA-SEXTA; NEW-ENGLAND; PRAIRIE	Increasing attention to pollinators and their role in providing ecosystem services has revealed a paucity of studies on long-term population trends of most insect pollinators in many parts of the world. Because targeted monitoring programs are resource intensive and unlikely to be performed on most insect pollinators, we took advantage of existing collection records to examine long-term trends in northeastern United States populations of 26 species of hawk moths (family Sphingidae) that are presumed to be pollinators. We compiled over 6,600 records from nine museum and 14 private collections that spanned a 112-year period, and used logistic generalized linear mixed models (GLMMs) to examine long-term population trends. We controlled for uneven sampling effort by adding a covariate for list length, the number of species recorded during each sampling event. We found that of the 22 species for which there was sufficient data to assess population trends, eight species declined and four species increased in detection probability (the probability of a species being recorded during each year while accounting for effort, climate, and spatial effects in the GLMMs). Of the four species with too few records to statistically assess, two have disappeared from parts of their ranges. None of the four species with diurnal adults showed a trend in detection probability. Two species that are pests of solanaceous crops declined, consistent with a seven-fold drop in the area planted in tobacco and tomato crops. We found some evidence linking susceptibility to parasitoidism by the introduced fly Compsilura concinnata (Tachinidae) to declines. Moths with larvae that feed on vines and trees, where available evidence indicates that the fly is most likely to attack, had a greater propensity to decline than species that use herbs and shrubs as larval host plants. Species that develop in the spring, before Compsilura populations have increased, did not decline. However, restricting the analysis to hawk moth records from areas outside of a "refuge" area where Compsilura does not occur did not significantly increase the intensity of the declines as would be predicted if Compsilura was the primary cause of declines. Forests have recovered over the study period across most of the northeastern U.S., but this does not appear to have been a major factor because host plants of several of the declining species have increased in abundance with forest expansion and maturation. Climate variables used in the GLMMs were not consistently related to moth detection probability. Hawk moth declines may have ecological effects on both the plants pollinated by these species and vertebrate predators of the moths.	[Young, Bruce E.; Auer, Stephanie; Ormes, Margaret; Rapacciuolo, Giovanni; Schweitzer, Dale; Sears, Nicole] NatureServe, Arlington, VA 22203 USA; [Rapacciuolo, Giovanni] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	Nature Conservancy; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Young, BE (corresponding author), NatureServe, Arlington, VA 22203 USA.	bruce_young@natureserve.org		Rapacciuolo, Giovanni/0000-0003-1494-9017	Sarah K. de Coizart Perpetual Charitable Trust; U.S. National Science Foundation [1136586]	Sarah K. de Coizart Perpetual Charitable Trust; U.S. National Science Foundation(National Science Foundation (NSF))	This study was supported by the Sarah K. de Coizart Perpetual Charitable Trust and the U.S. National Science Foundation (award 1136586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2016, USDA CENS AGR HIST A; [Anonymous], 2012, US GEOL SURV DATA SE, DOI DOI 10.1016/J.MIMET.2011.04.001; [Anonymous], 2021, LANG ENV STAT COMP; ARNAUD P H JR, 1978, U S Department of Agriculture Miscellaneous Publication, P1; Atwater MM, 2013, J NAT HIST, V47, P2719, DOI 10.1080/00222933.2013.791944; Banza P, 2015, INSECT CONSERV DIVER; Barnes M, 2015, DIVERS DISTRIB, V21, P368, DOI 10.1111/ddi.12274; Bartomeus I, 2013, P NATL ACAD SCI USA, V110, P4656, DOI 10.1073/pnas.1218503110; Bent A. C, 1940, LIFE HIST N AM BIRDS; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Boettner GH, 2000, CONSERV BIOL, V14, P1798, DOI 10.1046/j.1523-1739.2000.99193.x; Borkowsky C, 2009, J LEPID SOC, V63, P110; Breed GA, 2013, NAT CLIM CHANGE, V3, P142, DOI [10.1038/nclimate1663, 10.1038/NCLIMATE1663]; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Colla SR, 2008, BIODIVERS CONSERV, V17, P1379, DOI 10.1007/s10531-008-9340-5; Colla SR, 2012, BIODIVERS CONSERV, V21, P3585, DOI 10.1007/s10531-012-0383-2; Coyle JR, 2016, GLOBAL ECOL BIOGEOGR, V25, P406, DOI 10.1111/geb.12420; Cuthrell DL, 1997, THESIS; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Elkinton JS, 2006, ECOLOGY, V87, P2664, DOI 10.1890/0012-9658(2006)87[2664:IAIGPI]2.0.CO;2; Faegri K., 1979, PRINCIPLES POLLINATI; Federal Pollinator Health Task Force, 2015, NAT STRAT PROM HLTH; Foster DR., 1995, PRINCIPLES PATTERNS, P253; Fox K, 2015, ANN ENTOMOL SOC AM, V108, P1000, DOI 10.1093/aesa/sav093; Fox K, 2013, BIOL CONSERV, V167, P316, DOI 10.1016/j.biocon.2013.08.026; Goldstein PZ, 2015, P ENTOMOL SOC WASH, V117, P347, DOI 10.4289/0013-8797.117.3.347; Goldstein Paul Z., 2010, Journal of Research on the Lepidoptera, V42, P34; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; GRANT V, 1983, BOT GAZ, V144, P439, DOI 10.1086/337395; Grunert LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127988; HABER WA, 1989, BIOTROPICA, V21, P155, DOI 10.2307/2388706; Hahn M, 2016, ARTHROPOD-PLANT INTE, V10, P21, DOI 10.1007/s11829-016-9414-3; Hayes MB, 2015, INSECT SCI, V22, P424, DOI 10.1111/1744-7917.12109; HESSEL S A, 1976, Atala, V4, P19; Hortal J, 2006, J ANIM ECOL, V75, P274, DOI 10.1111/j.1365-2656.2006.01048.x; Isaac NJB, 2014, METHODS ECOL EVOL, V5, P1052, DOI 10.1111/2041-210X.12254; Isaac NJ, 2015, BIOL J LINN SOC, P115; Ives AR, 2006, ECOL APPL, V16, P20, DOI 10.1890/04-0702; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Johnson SD, 2016, FUNCT ECOL; Karuppaiah V., 2012, World Journal of Agricultural Sciences, V8, P240; Kawahara AY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005719; Kellogg SK, 2003, ENVIRON ENTOMOL, V32, P1019, DOI 10.1603/0046-225X-32.5.1019; Klots A. B., 1964, Journal of the New York Entomological Society, V72, P142; KRITSKY G, 1991, American Entomologist, V37, P206; Lovfll JH, 1900, AM NAT, V34, P37; Macgregor CJ, 2015, ECOL ENTOMOL, V40, P187, DOI 10.1111/een.12174; Macgregor CJ, 2016, GLOB CHANG BIOL; McCarthy MA, 1998, BIOL CONSERV, V83, P9, DOI 10.1016/S0006-3207(97)00048-7; Miller William E., 1997, Journal of the Lepidopterists' Society, V51, P9; MuMIn K., 2015, MMUMIN MULTIMODEL IN; National Aeronautics and Space Administration (NASA), 2012, NASA VIS EARTH NIGHT; National Oceanic and Atmospheric Administration (NOAA), 2016, DEF MET SAT PROGR DM; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; NILSSON LA, 1988, NATURE, V334, P147, DOI 10.1038/334147a0; Ollerton J, 2009, ANN BOT-LONDON, V103, P1471, DOI 10.1093/aob/mcp031; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peacock JW, 1998, ENVIRON ENTOMOL, V27, P450, DOI 10.1093/ee/27.2.450; Petersen FT, 2003, BIODIVERS CONSERV, V12, P687, DOI 10.1023/A:1022464710930; Potts S.G., 2016, SUMM POL ASS REP INT; PRISM Climate Group, 2013, PRISM GRIDD CLIM DAT; Rapacciuolo G., 2017, BIODIVERS CONSERV, P1; Roberts RL, 2007, ANIM CONSERV, V10, P332, DOI 10.1111/j.1469-1795.2007.00117.x; Sauer J. R., 2014, N AM BREEDING BIRD S, P3; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; SCHREIBER H, 1978, BIOGEOGRAPHICA, V10; Schweitzer D., 1988, News of the Lepidopterists' Society, V1988, P4; SCHWEITZER D. F., 2011, RARE DECLINING POORL; Schweitzer D, 2014, J INSECT CONSERV, V18, P561, DOI 10.1007/s10841-014-9658-0; Schweitzer Dale F., 2006, Journal of the Lepidopterists' Society, V60, P101; SHEVIAK CJ, 1986, RHODORA, V88, P267; St Laurent R, 2016, J LEPID SOC, V70, P9, DOI 10.18473/lepi.70i1.a3; Szabo JK, 2010, ECOL APPL, V20, P2157, DOI 10.1890/09-0877.1; Tartaglia Elena S., 2014, Journal of Pollination Ecology, V13, P184; TUTTLE JP, 2007, HAWK MOTHS N AM; USDA National Agricultural Statistics Service (USDA-NASS), 2014, CROPL DAT LAYER 2014; van Strien AJ, 2013, BIODIVERS CONSERV, V22, P673, DOI 10.1007/s10531-013-0436-1; Wagner, 2012, NEWS LEPID SOC, V54, P52; Wagner D.L., 2015, BIOL CONTROL EMERALD, P15; Watanabe ME, 2013, BIOSCIENCE, V64, P5; Wehi PM, 2012, MOL ECOL, V21, P3103, DOI 10.1111/j.1365-294X.2012.05589.x; WESELOH RM, 1982, CAN ENTOMOL, V114, P617, DOI 10.4039/Ent114617-7; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; Zeilinger AR, 2017, ECOL APPL	86	10	11	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185683	10.1371/journal.pone.0185683	http://dx.doi.org/10.1371/journal.pone.0185683			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982152	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300058
J	Bjorkum, AA; Oveland, E; Stuhr, L; Havnes, MB; Berven, F; Gronning, M; Hope, A				Bjorkum, Alvhild Alette; Oveland, Eystein; Stuhr, Linda; Havnes, Marianne Bjordal; Berven, Frode; Gronning, Marit; Hope, Arvid			Fast hyperbaric decompression after heliox saturation altered the brain proteome in rats	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; CYCLIN-DEPENDENT KINASE-5; S100B PROTEIN; WHITE-MATTER; SPINAL-CORD; SICKNESS; DIVERS; MRI; INJURY; CDK5	Better understanding of the physiological mechanisms and neurological symptoms involved in the development of decompression sickness could contribute to improvements of diving procedures. The main objective of the present study was to determine effects on the brain proteome of fast decompression (1 bar/20 s) compared to controls (1 bar/10 min) after heliox saturation diving, using rats in a model system. The protein S100B, considered a biomarker for brain injury, was not significantly different in serum samples from one week before, immediately after, and one week after the dive. Alterations in the rat brain proteome due to fast decompression were investigated using both iontrap and orbitrap LC-MS, and 967 and 1062 proteins were quantified, respectively. Based on the significantly regulated proteins in the iontrap (56) and orbitrap (128) datasets, the networks "synaptic vesicle fusion and recycling in nerve terminals" and "translation initiation" were significantly enriched in a system biological database analysis (Metacore). Ribosomal proteins (RLA2, RS10) and the proteins hippocalcin-like protein 4 and proteasome subunit beta type-7 were significantly upregulated in both datasets. The heat shock protein 105 kDa, Rho-associated protein kinase 2 and Dynamin-1 were significantly downregulated in both datasets. Another main effect of hyperbaric fast decompression in our experiment is inhibition of endocytosis and stimulation of exocytosis of vesicles in the presynaptic nerve terminal. In addition, fast decompression affected several proteins taking parts in these two main mechanisms of synaptic strength, especially alteration in CDK5/calcineurin are associated with a broad range of neurological disorders. In summary, fast decompression after heliox saturation affected the brain proteome in a rat model for diving, potentially disturbing protein homeostasis, e.g. in synaptic vesicles, and destabilizing cytoskeletal components. Data are available via ProteomeXchange with identifier PXD006349	[Bjorkum, Alvhild Alette] Western Norway Univ Appl Sci, Dept Biomed Lab Sci & Chem Engn, Bergen, Norway; [Oveland, Eystein; Berven, Frode] Univ Bergen, Fac Med & Dent, Dept Biomed, Prote Unit, Bergen, Norway; [Oveland, Eystein; Gronning, Marit] Univ Bergen, Fac Med & Dent, Dept Clin Med, Bergen, Norway; [Stuhr, Linda] Univ Bergen, Fac Med & Dent, Dept Biomed, Bergen, Norway; [Havnes, Marianne Bjordal] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Circulat & Med Imaging, Trondheim, Norway; [Gronning, Marit] Haukeland Hosp, Dept Occupat Med, Bergen, Norway; [Hope, Arvid] NUI AS, Bergen, Norway	Western Norway University of Applied Sciences; University of Bergen; University of Bergen; University of Bergen; Norwegian University of Science & Technology (NTNU); University of Bergen; Haukeland University Hospital	Bjorkum, AA (corresponding author), Western Norway Univ Appl Sci, Dept Biomed Lab Sci & Chem Engn, Bergen, Norway.	Alvhild.Bjorkum@hvl.no	Oveland, Eystein/X-6006-2019	Oveland, Eystein/0000-0003-2206-1480	Norwegian Research Council [220546]; NUI AS	Norwegian Research Council(Research Council of NorwayEuropean Commission); NUI AS	The project was supported by grants from the Norwegian Research Council (project number 220546). NUI AS did provide support in the form of salary for Arvid Hope, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balestra C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00696; Berle M, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-8; Berle M, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-19; Calcagnile O, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0723-z; Cheung ZH, 2012, TRENDS CELL BIOL, V22, P169, DOI 10.1016/j.tcb.2011.11.003; Connolly DM, 2015, AEROSP MED HUM PERF, V86, P928, DOI 10.3357/AMHP.4392.2015; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Dadas A, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0045-y; Dutka AJ, 2003, PHYSL MED DIVING; Eftedal I, 2013, PHYSIOL GENOMICS, V45, P965, DOI 10.1152/physiolgenomics.00164.2012; Fassio Anna, 2016, Front Synaptic Neurosci, V8, P10, DOI 10.3389/fnsyn.2016.00010; Ferrazzano PA, 2008, MAGNETIC RESONANCE I; Fletcher AI, 1999, J BIOL CHEM, V274, P4027, DOI 10.1074/jbc.274.7.4027; Forestier A, 2015, HEMOGLOBIN, V39, P438, DOI 10.3109/03630269.2015.1065882; Gempp E, 2014, DIVING HYPERB MED, V44, P26; Gronning M, 2005, UNDERSEA HYPERBAR M, V32, P397; Gronning M, 2011, J NEUROL SCI, V304, P17, DOI 10.1016/j.jns.2011.01.021; Haslene-Hox H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019217; Havnes MB, 2013, EUR J APPL PHYSIOL, V113, P1405, DOI 10.1007/s00421-012-2565-8; Hemelryck W, 2014, SCAND J MED SCI SPOR, V24, P928, DOI 10.1111/sms.12100; Hennedige T, 2012, J MED IMAG RADIAT ON, V56, P282, DOI 10.1111/j.1754-9485.2012.02386.x; Hope A, 2006, 1993 CONS C REV; Hope A, 2015, UNDERSEA HYPERBAR M, V42, P57; Jallul S, 2007, SPINAL CORD, V45, P116, DOI 10.1038/sj.sc.3101923; KAJIMOTO Y, 1993, J NEUROCHEM, V61, P1091, DOI 10.1111/j.1471-4159.1993.tb03624.x; Kei PL, 2007, J NEUROIMAGING, V17, P378, DOI 10.1111/j.1552-6569.2007.00122.x; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; McLinden Kristina A, 2012, Brain Disord Ther, V2012, P001; Moen G, 2010, ACTA RADIOL, V51, P1050, DOI 10.3109/02841851.2010.515245; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Roy PK, 2015, COMPUT MED IMAG GRAP, V45, P102, DOI 10.1016/j.compmedimag.2015.08.005; Skogland S, 2002, J APPL PHYSIOL, V92, P2633, DOI 10.1152/japplphysiol.00795.2001; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Takei K, 2001, TRENDS CELL BIOL, V11, P385, DOI 10.1016/S0962-8924(01)02082-7; Thompson WH, 2016, NEUROIMAGE-CLIN, V12, P1004, DOI 10.1016/j.nicl.2016.05.005; TODNEM K, 1991, BRIT J IND MED, V48, P258; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Vaudel M, 2015, NAT BIOTECHNOL, V33, P22, DOI 10.1038/nbt.3109; Vaudel M, 2011, PROTEOMICS, V11, P996, DOI 10.1002/pmic.201000595; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Yardan T, 2011, J PAK MED ASSOC, V61, P276	43	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185765	10.1371/journal.pone.0185765	http://dx.doi.org/10.1371/journal.pone.0185765			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977037	Green Published, Green Submitted, gold			2022-12-26	WOS:000412163100043
J	Kondili, LA; Gaeta, GB; Brunetto, MR; Di Leo, A; Iannone, A; Santantonio, TA; Giammario, A; Raimondo, G; Filomia, R; Coppola, C; Amoruso, DC; Blanc, P; Del Pin, B; Chemello, L; Cavalletto, L; Morisco', F; Donnarummall, L; Rumi, MG; Gasbarrini, A; Siciliane, M; Massari, M; Corsini, R; Cocoa, B; Madonia, S; Cannizzaro, M; Zignego, AL; Monti, M; Russo, FP; Zanetto, A; Persico, M; Masarone, M; Villa, E; Bernabucci, V; Taliani, G; Biliotti, E; Chessa, L; Pasetto, MC; Andreone, P; Margotti, M; Brancaccio, G; Leluzzi, D; Borgia', G; Zappuloll, E; Calvaruso, V; Petta, S; Falzano, L; Quaranta, MG; Weimer, LE; Rosato, S; Vella, S; Giannini, EG				Kondili, Loreta A.; Gaeta, Giovanni Battista; Brunetto, Maurizia Rossana; Di Leo, Alfredo; Iannone, Andrea; Santantonio, Teresa Antonia; Giammario, Adele; Raimondo, Giovanni; Filomia, Roberto; Coppola, Carmine; Amoruso, Daniela Caterina; Blanc, Pierluigi; Del Pin, Barbara; Chemello, Liliana; Cavalletto, Luisa; Morisco', Filomena; Donnarummall, Laura; Rumi, Maria Grazia; Gasbarrini, Antonio; Siciliano, Massimo; Massari, Marco; Corsini, Romina; Coco, Barbara; Madonia, Salvatore; Cannizzaro, Marco; Zignego, Anna Linda; Monti, Monica; Russo, Francesco Paolo; Zanetto, Alberto; Persico, Marcello; Masarone, Mario; Villa, Erica; Bernabucci, Veronica; Taliani, Gloria; Biliotti, Elisa; Chessa, Luchino; Pasetto, Maria Cristina; Andreone, Pietro; Margotti, Marzia; Brancaccio, Giuseppina; Leluzzi, Donatella; Borgia', Guglielmo; Zappuloll, Emanuela; Calvaruso, Vincenza; Petta, Salvatore; Falzano, Loredana; Quaranta, Maria Giovanna; Weimer, Liliana Elena; Rosato, Stefano; Vella, Stefano; Giannini, Edoardo Giovanni			Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SUSTAINED VIROLOGICAL RESPONSE; SOFOSBUVIR PLUS RIBAVIRIN; ALL-CAUSE MORTALITY; HCV INFECTION; CIRRHOSIS; RISK; FIBROSIS; OUTCOMES; ERADICATION	Background Few data are available on the virological and clinical outcomes of advanced liver disease patients retreated after first-line DAA failure. Aim To evaluate DAA failure incidence and the retreatment clinical impact in patients treated in the advanced liver disease stage. Methods Data on HCV genotype, liver disease severity, and first and second line DAA regimens were prospectively collected in consecutive patients who reached the 12-week post-treatment and retreatment evaluations from January 2015 to December 2016 in 23 of the PITER network centers. Results Among 3,830 patients with advanced fibrosis (F3) or cirrhosis, 139 (3.6%) failed to achieve SVR. Genotype 3, bilirubin levels > 1.5mg/dl, platelet count < 120,000/mm(3) and the sofosbuvir+ribavirin regimen were independent predictors of failure by logistic regression analysis. The failure rate was 7.6% for patients treated with regimens that are no longer recommended or considered suboptimal (sofosbuvir+ ribavirin or simeprevir+sofosbuvir +/- ribavirin), whereas 1.4% for regimens containing sofosbuvir combined with daclatasvir or ledipasvir or other DAAs. Of the patients who failed to achieve SVR, 72 (51.8%) were retreated with a second DAA regimen, specifically 38 (52.7%) with sofosbuvir+ daclatasvir, 27 (37.5%) with sofosbuvir+ ledipasvir, and 7 (9.7%) with other DAAs +/- ribavirin. Among these, 69 (96%) patients achieved SVR12 and 3 (4%) failed. During a median time of 6 months (range: 5-14 months) between failure and the second DAA therapy, the Child-Pugh class worsened in 12 (16.7%) patients: from A to B in 10 patients (19.6%) and from B to C in 2 patients (10.5%), whereas it did not change in the remaining 60 patients. Following the retreatment SVR12 (median time of 6 months; range: 3 +/- 12 months), the Child-Pugh class improved in 17 (23.6%) patients: from B to A in 14 (19.4%) patients, from C to A in 1 patient (1.4%) and from C to B in 2 (2.9%) patients; it remained unchanged in 53 patients (73.6%) and worsened in 2 (2.8%) patients. Of patients who were retreated, 3 (4%) had undergone OLT before retreatment (all reached SVR12 following retreatment) and 2 (2.8%) underwent OLT after having achieved retreatment SVR12. Two (70%) of the 3 patients who failed to achieve SVR12 after retreatment, and 2 (2.8%) of the 69 patients who achieved retreatment SVR12 died from liver failure (Child-Pugh class deteriorated from B to C) or HCC complications. Conclusions Failure rate following the first DAA regimen in patients with advanced disease is similar to or lower than that reported in clinical trials, although the majority of patients were treated with suboptimal regimens. Interim findings showed that worsening of liver function after failure, in terms of Child Pugh class deterioration, was improved by successful retreatment in about one third of retreated patients within a short follow-up period; however, in some advanced liver disease patients, clinical outcomes (Child Pugh class, HCC development, liver failure and death) were independent of viral eradication.	[Kondili, Loreta A.; Falzano, Loredana; Quaranta, Maria Giovanna; Weimer, Liliana Elena; Rosato, Stefano; Vella, Stefano] Ist Super Sanit, Rome, Italy; [Gaeta, Giovanni Battista; Brancaccio, Giuseppina] Univ Naples 2, Naples, Italy; [Brunetto, Maurizia Rossana; Coco, Barbara] Univ Hosp Pisa, Pisa, Italy; [Brunetto, Maurizia Rossana] Univ Pisa, Pisa, Italy; [Di Leo, Alfredo; Iannone, Andrea] Univ Bari, Bari, Italy; [Santantonio, Teresa Antonia; Giammario, Adele] Univ Foggia, Foggia, Italy; [Raimondo, Giovanni; Filomia, Roberto] Univ Hosp Messina, Messina, Italy; [Coppola, Carmine; Amoruso, Daniela Caterina] Gragnano Hosp, Gragnano, Italy; [Blanc, Pierluigi; Del Pin, Barbara] SM Annunziata Hosp, Florence, Italy; [Chemello, Liliana; Cavalletto, Luisa] Univ Hosp Padua, Padua, Italy; [Morisco', Filomena; Donnarummall, Laura; Borgia', Guglielmo; Zappuloll, Emanuela] Univ Naples Federico II, Naples, Italy; [Rumi, Maria Grazia] Univ Milan, Milan, Italy; [Gasbarrini, Antonio; Siciliano, Massimo] Univ Cattolica Sacro Cuore, Rome, Italy; [Massari, Marco; Corsini, Romina] Arcispedale S Maria Nuova IRCCS, Reggio Emilia, Italy; [Madonia, Salvatore; Cannizzaro, Marco] Villa Sofia Cervello Hosp, Palermo, Italy; [Zignego, Anna Linda; Monti, Monica] Univ Florence, Florence, Italy; [Russo, Francesco Paolo; Zanetto, Alberto] Univ Padua, Padua, Italy; [Persico, Marcello; Masarone, Mario] Univ Salerno, Salerno, Italy; [Villa, Erica; Bernabucci, Veronica] Univ Modena & Reggio Emilia, Modena, Italy; [Taliani, Gloria; Biliotti, Elisa] Sapienza Univ Rome, Rome, Italy; [Chessa, Luchino; Pasetto, Maria Cristina] Univ Cagliari, Cagliari, Italy; [Andreone, Pietro; Margotti, Marzia] Univ Bologna, Bologna, Italy; [Leluzzi, Donatella] Univ Hosp Verona, Verona, Italy; [Calvaruso, Vincenza; Petta, Salvatore] Univ Palermo, Palermo, Italy; [Giannini, Edoardo Giovanni] Univ Genoa, Genoa, Italy	Istituto Superiore di Sanita (ISS); Universita della Campania Vanvitelli; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Pisa; Universita degli Studi di Bari Aldo Moro; University of Foggia; AOU Policlinico Gaetano Martino; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Naples Federico II; University of Milan; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Arcispedale S. Maria Nuova; University of Florence; University of Padua; University of Salerno; Universita di Modena e Reggio Emilia; Sapienza University Rome; University of Cagliari; University of Bologna; University of Palermo; University of Genoa	Kondili, LA (corresponding author), Ist Super Sanit, Rome, Italy.	loreta.kondili@iss.it	Gaeta, Giovanni/AAQ-4294-2021; KONDILI, LORETA/J-8784-2016; Chessa, Luchino/K-4255-2019; Brunetto, Maurizia/AAU-2906-2020; persico, marcello/AAB-3562-2019; Filomia, Roberto/AIA-8302-2022; chemello, liliana/AAU-9414-2020; Gasbarrini, Antonio/AAB-8487-2019; Vella, Stefano/GZM-0519-2022; Corsini, Romina/ABB-4619-2021; VELLA, STEFANO/ABI-3368-2020; Massari, Marco/AAA-9907-2021; VELLA, STEFANO/V-8440-2019; Morisco, Filomena/AHI-0851-2022; Andreone, Pietro/K-8050-2016; Zignego, Anna Linda/AAL-8205-2021; Villa, Erica/A-7576-2012; Kondili, Loreta/AAY-6360-2020; Masarone, Mario/H-8633-2017; Giannini, Edoardo Giovanni/E-1120-2012; RUSSO, FRANCESCO PAOLO/AAO-4597-2020	KONDILI, LORETA/0000-0003-2656-224X; Chessa, Luchino/0000-0002-9474-0995; Brunetto, Maurizia/0000-0001-8364-9152; Massari, Marco/0000-0002-0745-7519; VELLA, STEFANO/0000-0003-2347-5984; Andreone, Pietro/0000-0002-4794-9809; Villa, Erica/0000-0001-6388-7022; Masarone, Mario/0000-0003-0550-8201; Giannini, Edoardo Giovanni/0000-0001-8526-837X; RUSSO, FRANCESCO PAOLO/0000-0003-4127-8941; Di Leo, Alfredo/0000-0003-2026-1200; IANNONE, ANDREA/0000-0002-5468-9515; Crisanti, Andrea/0000-0002-2406-4426; zappulo, emanuela/0000-0002-7660-7939; Gasbarrini, Antonio/0000-0003-4863-6924; Persico, Marcello/0000-0002-1399-6498; Filomia, Roberto/0000-0002-8335-6816; Brancaccio, Giuseppina/0000-0001-5643-0139; Zanetto, Alberto/0000-0002-6734-7178	Italian Ministry of health Grant "Research project PITER" [RF-2010-2315839]; Bristol-Myers Squibb; Merck (MSD Italia)	Italian Ministry of health Grant "Research project PITER"; Bristol-Myers Squibb(Bristol-Myers Squibb); Merck (MSD Italia)	The authors received no specific funding for this work. However, the PITER platform has been supported by Italian Ministry of health Grant "Research project PITER2010" RF-2010-2315839 to SV and by unconditioned partial support from Bristol-Myers Squibb and Merck (MSD Italia).	AASLD, REC TEST MAN TREAT H; [Anonymous], 2016, J HEPATOL; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Belli LS, 2016, J HEPATOL, V65, P524, DOI 10.1016/j.jhep.2016.05.010; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Bruno S, 2009, AM J GASTROENTEROL, V104, P1147, DOI 10.1038/ajg.2009.31; Calvaruso V, EASL INT LIV C AMST; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Charlton M, 2015, GASTROENTEROLOGY, V149, P649, DOI 10.1053/j.gastro.2015.05.010; Conti F, 2016, J HEPATOL, V65, P727, DOI 10.1016/j.jhep.2016.06.015; D'Ambrosio R, 2012, HEPATOLOGY, V56, P532, DOI 10.1002/hep.25606; Di Marco V, 2016, GASTROENTEROLOGY, V151, P130, DOI 10.1053/j.gastro.2016.03.036; George SL, 2009, HEPATOLOGY, V49, P729, DOI 10.1002/hep.22694; Kondili LA, 2015, DIGEST LIVER DIS, V47, P741, DOI 10.1016/j.dld.2015.05.022; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu M, 2016, J VIRAL HEPATITIS, V23, P718, DOI 10.1111/jvh.12538; Manns M, 2016, LANCET INFECT DIS, V16, P685, DOI 10.1016/S1473-3099(16)00052-9; Modi AA, 2016, LIVER TRANSPLANT, V22, P281, DOI 10.1002/lt.24324; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Omata M, 2016, HEPATOL INT, V10, P702, DOI 10.1007/s12072-016-9717-6; Petta S, 2016, LIVER INT, V36, P1765, DOI 10.1111/liv.13156; Pol S, 2016, J HEPATOL, V65, P734, DOI DOI 10.1016/J.JHEP.2016.05.045; Prenner S, 2017, J HEPATOL; Rosen HR, 2017, HEPATOLOGY, V65, P341, DOI 10.1002/hep.28848; Saxena V, 2015, HEPATOLOGY, V62, P715, DOI 10.1002/hep.27922; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Simmons B, 2015, CLIN INFECT DIS, V61, P730, DOI 10.1093/cid/civ396; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; van der Meer AJ, 2017, J HEPATOL, V66, P485, DOI 10.1016/j.jhep.2016.10.017; van der Meer AJ, 2014, JAMA-J AM MED ASSOC, V312, P1927, DOI 10.1001/jama.2014.12627; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; WHO, GLOB HLTH SECT STRAT; World Health Organization, HEPATITIS C; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	35	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185728	10.1371/journal.pone.0185728	http://dx.doi.org/10.1371/journal.pone.0185728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977040	Green Submitted, gold, Green Published			2022-12-26	WOS:000412163100039
J	Myung, DS; Kweon, SS; Lee, J; Shin, IS; Kim, SW; Seo, GS; Kim, HS; Joo, YE				Myung, Dae-Seong; Kweon, Sun-Seog; Lee, Jun; Shin, Ik-Sang; Kim, Sang-Wook; Seo, Geom-Seog; Kim, Hyun-Soo; Joo, Young-Eun			Clinicopathological features of laterally spreading colorectal tumors and their association with advanced histology and invasiveness: An experience from Honam province of South Korea: A Honam Association for the Study of Intestinal Diseases (HASID)	PLOS ONE			English	Article							ENDOSCOPIC SUBMUCOSAL DISSECTION; TERM-FOLLOW-UP; MUCOSAL RESECTION; CLINICAL-OUTCOMES; NEOPLASIA; CANCER; PREVALENCE; PROGNOSIS; SUBTYPES; STRATEGY	Background and aims Laterally spreading colorectal tumors (LSTs) are divided into four subtypes, including homogenous (HG), nodular mixed (NM), flat elevated (FE), and pseudo-depressed (PD), based on their different endoscopic morphologies. The aim of this study was to investigate the clinicopathological significance of LST subtypes and their association with advanced histology. Methods We investigated the medical records of consecutive patients with LST who initially underwent endoscopic resection at five university hospitals in Honam province of South Korea between January 2012 and December 2013. A total of 566LST lesions removed via endoscopic procedures were collected retrospectively for data analysis. Results The PD, FE, and NM subtypes were more common in the distal colon and the HG subtype in the proximal colon. The PD subtype had the biggest tumor size, followed by the NM subtype. The frequency of adenomatous pit pattern was significantly higher in the HG, NM, and FE subtypes than in the PD subtype. In contrast, the frequency of cancerous pit pattern was significantly higher in the PD subtype than in the other three subtypes. The rate of advanced histology (high-grade dysplasia or carcinoma) among the LSTs was 36.0%. The risk of advanced histology increased in the distal colon compared with the proximal colon. The PD subtype had the highest incidence of villous component, advanced histology, submucosal invasion, and postprocedure perforation among the four subtypes. The distal colon as tumor site, larger tumor size, PD subtype, and villous component were associated with a statistically significant increased risk of advanced histology. Conclusion Our results indicate that the location, size, endoscopic subtype, and histologic component of the LSTs are associated with an increased risk of advanced histology. Therefore, these clinicopathological parameters may be useful in selecting therapeutic strategies in the clinical setting.	[Myung, Dae-Seong; Kim, Hyun-Soo; Joo, Young-Eun] Chonnam Natl Univ, Med Sch, Dept Internal Med, Gwangju, South Korea; [Kweon, Sun-Seog] Chonnam Natl Univ, Med Sch, Dept Prevent Med, Gwangju, South Korea; [Lee, Jun] Chosun Univ, Coll Med, Dept Internal Med, Gwangju, South Korea; [Shin, Ik-Sang; Kim, Sang-Wook] Chonbuk Natl Univ, Med Sch, Dept Internal Med, Jeonju, South Korea; [Seo, Geom-Seog] Wonkwang Univ, Coll Med, Dept Internal Med, Iksan, South Korea	Chonnam National University; Chonnam National University; Chosun University; Jeonbuk National University; Wonkwang University	Joo, YE (corresponding author), Chonnam Natl Univ, Med Sch, Dept Internal Med, Gwangju, South Korea.	yejoo@chonnam.ac.kr	Kweon, Sun-Seog/AAZ-4732-2021; Lee, Jun/AAC-6941-2022	Kweon, Sun-Seog/0000-0003-2378-8550; Lee, Jun/0000-0002-8060-9646				Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Choi Y, 2017, SEMIN ONCOL, V44, P34, DOI 10.1053/j.seminoncol.2017.02.002; Cong ZJ, 2016, GASTROINTEST ENDOSC, V83, P800, DOI 10.1016/j.gie.2015.08.043; De Ceglie A, 2016, CRIT REV ONCOL HEMAT, V104, P138, DOI 10.1016/j.critrevonc.2016.06.008; Dixon MF, 2002, GUT, V51, P130, DOI 10.1136/gut.51.1.130; Facciorusso A, 2015, WORLD J GASTROENTERO, V21, P5149, DOI 10.3748/wjg.v21.i17.5149; Hamilton SR, 2000, WHO CLASSIFICATION T, P314; Huang YL, 2009, INT J COLORECTAL DIS, V24, P1441, DOI 10.1007/s00384-009-0749-4; Imai K, 2014, SURG ENDOSC, V28, P2167, DOI [10.1007/s00464-014-3855-5, 10.1007/s00464-014-3449-2]; Jung DH, 2015, GASTROINTEST ENDOSC, V81, P614, DOI 10.1016/j.gie.2014.09.001; Kaku E, 2011, CLIN GASTROENTEROL H, V9, P503, DOI 10.1016/j.cgh.2011.03.018; Kim BC, 2011, ENDOSCOPY, V43, P100, DOI 10.1055/s-0030-1256027; Kim KO, 2013, INT J COLORECTAL DIS, V28, P1661, DOI 10.1007/s00384-013-1741-6; Kobayashi N, 2009, J GASTROEN HEPATOL, V24, P1387, DOI 10.1111/j.1440-1746.2009.05893.x; Kudo S, 2001, ENDOSCOPY, V33, P367; Kudo Shin-ei, 2008, Gastrointest Endosc Clin N Am, V18, P581, DOI 10.1016/j.giec.2008.05.013; Lambert R, 2012, EUR J GASTROEN HEPAT, V24, P1123, DOI 10.1097/MEG.0b013e328355e2d9; Mahasneh A, 2017, EXP MOL PATHOL, V102, P475, DOI 10.1016/j.yexmp.2017.05.005; Metz AJ, 2013, EUR J GASTROEN HEPAT, V25, P319, DOI 10.1097/MEG.0b013e32835b57e7; Miyamoto H, 2014, INT J COLORECTAL DIS, V29, P1069, DOI 10.1007/s00384-014-1931-x; Nishiyama H, 2010, SURG ENDOSC, V24, P2881, DOI 10.1007/s00464-010-1071-5; Oka S, 2009, DIGEST ENDOSC, V21, pS43, DOI 10.1111/j.1443-1661.2009.00869.x; Rotondano G, 2011, ENDOSCOPY, V43, P856, DOI 10.1055/s-0030-1256639; Saito Y, 2007, GASTROINTEST ENDOSC, V66, P966, DOI 10.1016/j.gie.2007.02.053; Sugimoto T, 2010, INT J CANCER, V127, P1562, DOI 10.1002/ijc.25180; Tantau AI, 2008, J GASTROINTEST LIVER, V17, P419; Terasaki M, 2012, J GASTROEN HEPATOL, V27, P734, DOI 10.1111/j.1440-1746.2011.06977.x; Toyonaga T, 2010, ENDOSCOPY, V42, P714, DOI 10.1055/s-0030-1255654; Uraoka T, 2006, GUT, V55, P1592, DOI 10.1136/gut.2005.087452; Xu MD, 2013, INT J COLORECTAL DIS, V28, P63, DOI 10.1007/s00384-012-1543-2; Yoon JY, 2013, SURG ENDOSC, V27, P487, DOI 10.1007/s00464-012-2462-6; Zhao XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094552	32	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0184205	10.1371/journal.pone.0184205	http://dx.doi.org/10.1371/journal.pone.0184205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977010	Green Submitted, Green Published, gold			2022-12-26	WOS:000412163100005
J	Faria, NS; Urbano, JJ; Santos, IR; Silva, AS; Perez, EA; Souza, AH; Nascimento, OA; Jardim, JR; Insalaco, G; Oliveira, LVF; Stirbulov, R				Faria Junior, Newton Santos; Urbano, Jessica Julioti; Santos, Israel Reis; Silva, Anderson Soares; Perez, Eduardo Araujo; Souza, Angela Honda; Nascimento, Oliver Augusto; Jardim, Jose Roberto; Insalaco, Giuseppe; Franco Oliveira, Luis Vicente; Stirbulov, Roberto			Evaluation of obstructive sleep apnea in non-cystic fibrosis bronchiectasis: A crosssectional study	PLOS ONE			English	Article							QUALITY-OF-LIFE; DAYTIME SLEEPINESS; PULMONARY-DISEASE; COMPUTED-TOMOGRAPHY; SYMPTOMS; ADULTS; EPIDEMIOLOGY; ASSOCIATION; PREDICTORS; MORTALITY	The relationship between sleep disorders and bronchiectasis has not been well described. We hypothesize that, due to the irreversible dilatation of the bronchi, the presence of secretions, and airflow obstruction, patients with non-cystic fibrosis bronchiectasis may be predisposed to hypoxemia during sleep, or to symptoms that may lead to arousal. A cross-sectional observational study was performed involving 49 patients with a clinical diagnosis of non-cystic fibrosis bronchiectasis (NCFB). All patients underwent clinical evaluation, spirometry, and polysomnography, and were evaluated for the presence of excessive daytime sleepiness (EDS) and risk of obstructive sleep apnea (OSA). The mean age of the participants was 50.3 +/- 13.6 years; 51.1% of patients were male and had a mean body mass index of 23.8 +/- 3.4 kg/m(2). The mean total sleep time (TST) was 325.15 +/- 64.22 min with a slight reduction in sleep efficiency (84.01 +/- 29.2%). Regarding sleep stages, stage 1 sleep and REM sleep were abnormal. OSA was present in 40.82% of the patients. The mean arousal index was 5.6 +/- 2.9/h and snoring was observed in 71.43% of the patients. The oxygen desaturation index (ODI) was 14.35 +/- 15.36/h, mean minimum oxygen saturation (SpO(2) nadir) was 83.29 +/- 7.99%, and mean TST with an SpO(2) less than 90% was 30.21 +/- 60.48 min. EDS was exhibited by 53.06% of the patients and 55.1% were at high risk of developing OSA. The patients infected by Pseudomonas aeruginosa had higher apnea-hypopnea indices, ODI, and TST with SpO(2) < 90%, and lower values of SpO(2) nadir. Adult patients with clinically stable NCFB, especially those infected by Pseudomonas aeruginosa, display EDS and a high prevalence of OSA, associated with considerable oxygen desaturation during sleep.	[Faria Junior, Newton Santos; Perez, Eduardo Araujo; Stirbulov, Roberto] Santa Casa Sao Paulo Sch Med Sci, FCMSCSP, Masters Degree & PhD Program Surg Res, Sao Paulo, SP, Brazil; [Urbano, Jessica Julioti; Santos, Israel Reis; Silva, Anderson Soares] Nove de Julho Univ UNINOVE, Rehabil Sci Masters Degree & PhD Program, Sao Paulo, SP, Brazil; [Souza, Angela Honda; Nascimento, Oliver Augusto; Jardim, Jose Roberto] Univ Fed Sao Paulo, Pulm Rehabil Ctr, UNIFESP, Sao Paulo, Brazil; [Insalaco, Giuseppe] Natl Res Council Italy, Inst Biomed & Mol Immunol Alberto Monroy, Palermo, SI, Italy; [Franco Oliveira, Luis Vicente] Univ Ctr Anapolis UniEVANGELICA, Med Sch, Anapolis, Go, Brazil	Faculdade de Ciencias Medicas Santa Casa de Sao Paulo; Universidade Nove de Julho; Universidade Federal de Sao Paulo (UNIFESP); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); Centro Universitario de Anapolis	Faria, NS (corresponding author), Santa Casa Sao Paulo Sch Med Sci, FCMSCSP, Masters Degree & PhD Program Surg Res, Sao Paulo, SP, Brazil.	nsdfj@yahoo.com.br	Nascimento, Oliver A./B-3039-2011; Júnior, Newton Santos Faria/K-7191-2016; Oliveira, Luis V F/K-8838-2013; Santos, Israel dos Reis dos/AAQ-8941-2021; Insalaco, Giuseppe/AAY-3841-2020	Nascimento, Oliver A./0000-0003-3138-2219; Júnior, Newton Santos Faria/0000-0002-6817-2576; Oliveira, Luis V F/0000-0002-3852-9415; 	Nove de Julho University (Sao Paulo, Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [313053/2014-6]; JJU; EAP; ASS; CAPES	Nove de Julho University (Sao Paulo, Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); JJU; EAP; ASS; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The sleep laboratory received funding from the Nove de Julho University (Sao Paulo, Brazil). LVFO receive grants of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; research productivity modality PQIB; process no. 313053/2014-6) and JJU, EAP, ASS and NSFJ receive grants by CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEDT T, 1994, PERCEPT MOTOR SKILL, V79, P287, DOI 10.2466/pms.1994.79.1.287; American Academy of Sleep Medicine, 2007, AASM MAN SCOR SLEEP; Barker AF, 2002, NEW ENGL J MED, V346, P1383, DOI 10.1056/NEJMra012519; Bertolazi AN, 2009, J BRAS PNEUMOL, V35, P877, DOI 10.1590/S1806-37132009000900009; Bouka A, 2012, RESP MED, V106, P1244, DOI 10.1016/j.rmed.2012.06.010; Boyton RJ, 2012, MEDICINE, V40, P267, DOI DOI 10.1016/J.MPMED.2012.02.003; BRADLEY TD, 1986, AM REV RESPIR DIS, V134, P920, DOI 10.1164/arrd.1986.134.5.920; CHAOUAT A, 1995, AM J RESP CRIT CARE, V151, P82, DOI 10.1164/ajrccm.151.1.7812577; COOKE JC, 1987, THORAX, V42, P272, DOI 10.1136/thx.42.4.272; Dancey DR, 2002, EUR RESPIR J, V19, P504, DOI 10.1183/09031936.02.00088702; Erdem E, 2011, PEDIATR PULM, V46, P919, DOI 10.1002/ppul.21454; Fan LC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0872-5; Faria NS, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008183; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Gao Y, 2014, PLOS ONE, V9, P1, DOI DOI 10.HTTP://DX.D0I.0RG/10; Guan WJ, 2015, J THORAC DIS, V7, P625, DOI 10.3978/j.issn.2072-1439.2015.04.04; Jankelowitz L, 2005, CHEST, V127, P1593, DOI 10.1378/chest.127.5.1593; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Katz ES, 2014, CLIN CHEST MED, V35, P495, DOI 10.1016/j.ccm.2014.06.005; Kim Jung-Soo, 2007, COPD, V4, P163, DOI 10.1080/15412550701341228; King P, 2011, PAEDIATR RESPIR REV, V12, P104, DOI 10.1016/j.prrv.2010.10.011; KLINK ME, 1994, CHEST, V105, P151, DOI 10.1378/chest.105.1.151; Krishnan V, 2008, CHEST, V134, P693, DOI 10.1378/chest.08-0173; Lambrecht BN, 2011, EUR RESPIR MONOGR, P11, DOI 10.1183/1025448x.10003210; Larsson LG, 2001, RESP MED, V95, P423, DOI 10.1053/rmed.2001.1054; Loebinger MR, 2009, EUR RESPIR J, V34, P843, DOI 10.1183/09031936.00003709; Marin JM, 2010, AM J RESP CRIT CARE, V182, P325, DOI 10.1164/rccm.200912-1869OC; Martinez-Garcia MA, 2005, CHEST, V128, P739, DOI 10.1378/chest.128.2.739; Martinez-Garcia MA, 2014, EUR RESPIR J, V43, P1357, DOI 10.1183/09031936.00026313; Martinez-Garcia MA, 2007, CHEST, V132, P1565, DOI 10.1378/chest.07-0490; McShane PJ, 2013, AM J RESP CRIT CARE, V188, P647, DOI 10.1164/rccm.201303-0411CI; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Milross Maree A, 2002, Sleep Med, V3, P205, DOI 10.1016/S1389-9457(01)00157-5; Moreira José da Silva, 2003, J. Pneumologia, V29, P258, DOI 10.1590/S0102-35862003000500003; NAIDICH DP, 1982, J COMPUT ASSIST TOMO, V6, P437, DOI 10.1097/00004728-198206000-00001; Naqvi SK, 2008, SLEEP BREATH, V12, P77, DOI 10.1007/s11325-007-0123-0; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; O'Donnell AE, 2008, CHEST, V134, P815, DOI 10.1378/chest.08-0776; O'Donnell AE, 2012, CLIN CHEST MED, V33, P381, DOI 10.1016/j.ccm.2012.03.005; Pasteur MC, 2010, THORAX, V65, pI1, DOI 10.1136/thx.2010.136119; Pereira CAC, 2002, J PNEUMOL S3, V28, pS1; Perin C, 2012, SLEEP BREATH, V16, P1041, DOI 10.1007/s11325-011-0599-5; Onen ZP, 2007, RESP MED, V101, P1390, DOI 10.1016/j.rmed.2007.02.002; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Ringshausen FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082005; Roberts HJ, 2010, RESP MED, V104, P981, DOI 10.1016/j.rmed.2010.02.022; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.12273; Santos Carlos Eduardo Ventura Gaio dos, 2003, J. Pneumologia, V29, P69, DOI 10.1590/S0102-35862003000200005; Sateia MJ, 2014, CHEST, V146, P1387, DOI 10.1378/chest.14-0970; Saynajakangas O, 1997, RESP MED, V91, P395, DOI 10.1016/S0954-6111(97)90251-1; Scharf SM, 2011, INT J CHRONIC OBSTR, V6, P1, DOI 10.2147/COPD.S15666; Shen TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128461; Slater G, 2012, J THORAC DIS, V4, P608, DOI 10.3978/j.issn.2072-1439.2012.10.07; Stranges S, 2012, SLEEP, V35, P1173, DOI 10.5665/sleep.2012; Tufik S, 2010, SLEEP MED, V11, P441, DOI 10.1016/j.sleep.2009.10.005; Twiss J, 2005, ARCH DIS CHILD, V90, P737, DOI 10.1136/adc.2004.066472; Vendrell M, 2008, ARCH BRONCONEUMOL, V44, P629, DOI 10.1016/S1579-2129(08)60117-2; Venkateswaran S, 2014, SINGAP MED J, V55, P488, DOI 10.11622/smedj.2014117; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Weitzenblum E, 2004, SLEEP MED REV, V8, P281, DOI 10.1016/j.smrv.2004.03.006; Weycker D., 2005, Clinical Pulmonary Medicine, V12, P205, DOI 10.1097/01.cpm.0000171422.98696.ed; Wong C, 2012, LANCET, V380, P660, DOI 10.1016/S0140-6736(12)60953-2; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Zen V, 2012, AM J CARDIOVASC DIS, V2, P323	66	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185413	10.1371/journal.pone.0185413	http://dx.doi.org/10.1371/journal.pone.0185413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972989	Green Submitted, Green Published, gold			2022-12-26	WOS:000412131900016
J	Leandro-Munoz, ME; Tixier, P; Germon, A; Rakotobe', V; Phillips-Moral, W; Maximova, S; Avelino, J				Leandro-Munoz, Mariela E.; Tixier, Philippe; Germon, Amandine; Rakotobe', Veromanitra; Phillips-Moral, Wilbert; Maximova, Siela; Avelino, Jacques			Effects of microclimatic variables on the symptoms and signs onset of Moniliophthora roreri, causal agent of Moniliophthora pod rot in cacao	PLOS ONE			English	Article							MONILIA-RORERI; FROSTY POD; COCOA; TEMPERATURE; DISEASES; ECUADOR; MODELS; LATENT	Moniliophthora Pod Rot (MPR) caused by the fungus Moniliophthora roreri (Cif.) Evans et al., is one of the main limiting factors of cocoa production in Latin America. Currently insufficient information on the biology and epidemiology of the pathogen limits the development of efficient management options to control MPR. This research aims to elucidate MPR development through the following daily microclimatic variables: minimum and maximum temperatures, wetness frequency, average temperature and relative humidity in the highly susceptible cacao clone Pound-7 (incidence = 86% 2008-2013 average). A total of 55 cohorts totaling 2,268 pods of 3-10 cm length, one to two months of age, were tagged weekly. Pods were assessed throughout their lifetime, every one or two weeks, and classified in 3 different categories: healthy, diseased with no sporulation, diseased with sporulating lesions. As a first step, we used Generalized Linear Mixed Models (GLMM) to determine with no a priori the period (when and for how long) each climatic variable was better related with the appearance of symptoms and sporulation. Then the significance of the candidate variables was tested in a complete GLMM. Daily average wetness frequency from day 14 to day 1, before tagging, and daily average maximum temperature from day 4 to day 21, after tagging, were the most explanatory variables of the symptoms appearance. The former was positively linked with the symptoms appearance when the latter exhibited a maximum at 30 degrees C. The most important variables influencing sporulation were daily average minimum temperature from day 35 to day 58 and daily average maximum temperature from day 37 to day 48, both after tagging. Minimum temperature was negatively linked with the sporulation while maximum temperature was positively linked. Results indicated that the fungal microclimatic requirements vary from the early to the late cycle stages, possibly due to the pathogen's long latent period. This information is valuable for development of new conceptual models for MPR and improvement of control methods.	[Leandro-Munoz, Mariela E.; Tixier, Philippe; Phillips-Moral, Wilbert; Avelino, Jacques] Trop Agr Res & Higher Educ Ctr, Div Res & Dev, Agroforestry & Sustainable Agr Dept, Turrialba, Cartago, Costa Rica; [Tixier, Philippe] CIRAD, UPR GECO, Montpellier, France; [Germon, Amandine] ENSAIA, Vandoeuvre Les Nancy, France; [Germon, Amandine; Rakotobe', Veromanitra; Avelino, Jacques] CIRAD, UPR Bioagresseurs, Montpellier, France; [Rakotobe', Veromanitra] AgroSup Dijon, Dijon, France; [Maximova, Siela] Penn State Univ, Dept Plant Sci, University Pk, PA 16802 USA; [Avelino, Jacques] IICA PROMECAFE, Guatemala City, Guatemala	CATIE - Centro Agronomico Tropical de Investigacion y Ensenanza; CIRAD; Universite de Lorraine; CIRAD; Institut Agro; AgroSup Dijon; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Leandro-Munoz, ME (corresponding author), Trop Agr Res & Higher Educ Ctr, Div Res & Dev, Agroforestry & Sustainable Agr Dept, Turrialba, Cartago, Costa Rica.	mleandro@catie.ac.cr	Tixier, Philippe/C-2119-2008; Germon, Amandine/M-4403-2015; Avelino, Jacques/C-5624-2009	Tixier, Philippe/0000-0001-5147-9777; Germon, Amandine/0000-0001-8687-294X; Avelino, Jacques/0000-0003-1983-9431; Leandro-Munoz, Mariela E./0000-0001-6153-8662	Centre de cooperation internationale en recherche agronomique pour le developpement	Centre de cooperation internationale en recherche agronomique pour le developpement	This research was fully funded by Centre de cooperation internationale en recherche agronomique pour le developpement, http://www.cirad.fr/, within the framework of the doctoral thesis of ML, with the co-advising of JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; AMPUERO C. E., 1967, Cocoa Growers' Bulletin, P15; Anco DJ, 2013, PLANT DIS, V97, P579, DOI 10.1094/PDIS-07-12-0666-RE; Aranzazu LF, 2000, SCOBA BRUJA COLOMBIA, P85; AYLOR DE, 1990, ANNU REV PHYTOPATHOL, V28, P73, DOI 10.1146/annurev.py.28.090190.000445; Barros Nieves O., 1977, C INT INV CAC; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bejarano Villacreces G., 1961, METODOS INOCULACION; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bowers J.H., 2001, PLANT HLTH PROGR; Bugaud C, 2015, J SCI FOOD AGR; Campuzano H., 1981, 8 INT COC RES C CART, P493; Campuzano Londono H., 1980, CACAOTERO COLOMBIANO, P21; Carval D, 2015, J APPL ENTOMOL, V139, P510, DOI 10.1111/jen.12190; Castro O., 1989, 8 C AGR NAC 1989 SAN, P29; Chacin L., 1975, ALGUNOS ASPECTOS BIO; Desrosiers R, 1957, 6 C INT CAC, P331; Desrosiers R, 1974, MONILIA POD ROT CACA, P273; Enriquez G, 2004, CACAO ORGANICO GUIA, P360; Evans H. C., 1981, Phytopathological Papers; EVANS H C, 1977, PANS (Pest Articles and News Summaries), V23, P68; EVANS HC, 1978, CAN J BOT, V56, P2528, DOI 10.1139/b78-305; EVANS HC, 1987, OUTLOOK AGR, V16, P35, DOI 10.1177/003072708701600106; Galindo J., 1985, 25 REUN AN AM PHYT S; Garrett KA, 2006, ANNU REV PHYTOPATHOL, V44, P489, DOI 10.1146/annurev.phyto.44.070505.143420; Garrett KA, 2004, PHYTOPATHOLOGY, V94, P999, DOI 10.1094/PHYTO.2004.94.9.999; Hawker L.E., 1950, PHYSL OF FUNGI; Herrera F., 1986, U AGR NAC C SOC AM C; Herrera F., 1988, EFECTO FACTORES NUTR; Holdridge LR, 1967, LIFE ZONE ECOLOGY; ICCO, 2014, ICCO ANN REP 2012 20; Lalancette N, 2003, PHYTOPATHOLOGY, V93, P1165, DOI 10.1094/PHYTO.2003.93.9.1165; Leach AW, 2002, CROP PROT, V21, P317, DOI 10.1016/S0261-2194(01)00148-X; LOPEZ F. R., 1954, Cacao en Colombia, V3, P183; Lopez-Bravo DF, 2012, CROP PROT, V38, P21, DOI 10.1016/j.cropro.2012.03.011; Maddison AC, 1995, PLANT PATHOL, V44, P982, DOI 10.1111/j.1365-3059.1995.tb02657.x; Merchan V. V. M., 1981, Cacaotero Colombiano, P26; Merchan VM, 1978, FITOPATOLOGIA COLOMB, V7, P127; Naundorf G., 1954, CONTRIBUCIONES PROBL; Ndoumbe-Nkeng M, 2009, CAN J PLANT PATHOL, V31, P309, DOI 10.1080/07060660909507605; Phillips W., 1986, EVALUACION RESISTENC; Phillips-Mora W., 2013, CATALOGUE CACAO CLON; Phillips-Mora W, 2006, 15 INT COC RES C SAN; Phillips-Mora W, 2003, THESIS U READING REA; PHILLIPSMORA W, 2007, PHYTOPATHOLOGY, V97, P1644, DOI DOI 10.1094/PHYTO-97-12-1644; PORRAS VH, 1985, PHYTOPATHOLOGY, V75, P1178; Porras VH, 1998, AVANCE MONILIASIS CA; Ram A, 1989, THESIS U LONDON LOND; Rorer JB, 1918, ENFERMEDADES PLAGAS, P17; SCHERM H, 1994, PHYTOPATHOLOGY, V84, P853, DOI 10.1094/Phyto-84-853; Schmitz WH, 1984, STUDIES ATLANTIC COA; Suarez C., 1971, ESTUDIO MECANISMO PE; Thevenin JM, 1996, MONILIOSE CACAOYER M, P397; TOMERLIN JR, 1983, PHYTOPATHOLOGY, V73, P414, DOI 10.1094/Phyto-73-414; de la Cruz MT, 2011, J PLANT PATHOL, V93, P31; Zuur Alain F., 2009, P1; [No title captured]; [No title captured]	58	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0184638	10.1371/journal.pone.0184638	http://dx.doi.org/10.1371/journal.pone.0184638			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972981	Green Submitted, Green Published, gold			2022-12-26	WOS:000412131900006
J	Oklander, LI; Mino, CI; Fernandez, G; Caputo, M; Corach, D				Ines Oklander, Luciana; Isabel Mino, Carolina; Fernandez, Gabriela; Caputo, Mariela; Corach, Daniel			Genetic structure in the southernmost populations of black-and-gold howler monkeys (Alouatta caraya) and its conservation implications	PLOS ONE			English	Article							SPATIAL AUTOCORRELATION ANALYSIS; HABITAT FRAGMENTATION; MICROSATELLITE LOCI; GUARIBA-CLAMITANS; ATLANTIC FOREST; SOFTWARE; SIZE; GROWTH; DEFORESTATION; NEUTRALITY	Black-and-gold howler monkeys Alouatta caraya, are arboreal primates, inhabitants of Neotropical forests, highly susceptible to the yellow fever virus, considered early 'sentinels' of outbreaks, and thus, of major epidemiological importance. Currently, anthropogenic habitat loss and modifications threatens their survival. Habitat modification can prevent, reduce or change dispersal behavior, which, in turn, may influence patterns of gene flow. We explored past and contemporary levels of genetic diversity, elucidated genetic structure and identified its possible drivers, in ten populations (n = 138) located in the southernmost distribution range of the species in South America, in Argentina and Paraguay. Overall, genetic variability was moderate (ten microsatellites: 3.16 +/- 0.18 alleles per locus, allelic richness of 2.93 +/- 0.81, 0.443 +/- 0.025 unbiased expected heterozygosity; 22 haplotypes of 491-bp mitochondrial Control Region, haplotypic diversity of 0.930 +/- 0.11, and nucleotide diversity of 0.01 +/- 0.007). Significant evidence of inbreeding was found in a population that was, later, decimated by yellow fever. Population-based gene flow measures (FST = 0.13;. ST = 018), hierarchical analysis of molecular variance and Bayesian clustering methods revealed significant genetic structure, grouping individuals into four clusters. Shared haplotypes and lack of mitochondrial differentiation (non-significant. ST) among some populations seem to support the hypothesis of historical dispersal via riparian forests. Current resistance analyses revealed a significant role of landscape features in modeling contemporary gene flow: continuous forest and riparian forests could promote genetic exchange, whereas disturbed forests or crop/grassland fields may restrict it. Estimates of effective population size allow anticipating that the studied populations will lose 75% of heterozygosity in less than 50 generations. Our findings suggest that anthropogenic modifications on native forests, increasingly ongoing in Northeastern Argentina, Southern Paraguay and Southeastern Brazil, might prevent the dispersal of howlers, leading to population isolation. To ensure long-term viability and maintain genetic connectivity of A. caraya remnant populations, we recommend preserving and restoring habitat continuity. To conserve the species genetic pool, as well, the four genetic clusters identified here should be considered separate Management Units and given high conservation priority. In light of our findings and considering complementary non-genetic information, we suggest upgrading the international conservation status of A. caraya to "Vulnerable".	[Ines Oklander, Luciana; Isabel Mino, Carolina] Univ Nacl Misiones UNaM, CONICET, Inst Biol Subtrop IBS, Nodo Iguazu, Puerto Iguazu, Misiones, Argentina; [Ines Oklander, Luciana; Isabel Mino, Carolina] Asociac Civil Ctr Invest Bosque Atlantico CeIBA, Puerto Iguazu, Misiones, Argentina; [Ines Oklander, Luciana; Isabel Mino, Carolina; Fernandez, Gabriela] Univ Nacl Noroeste Prov Buenos Aires UNNOBA, CONICET, Ctr Bioinvest CeBio, Buenos Aires, DF, Argentina; [Caputo, Mariela; Corach, Daniel] Univ Buenos Aires, CONICET, Fac Farm & Bioquim, Serv Huellas Digitales Genet, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Noroeste de la Provincia de Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Oklander, LI (corresponding author), Univ Nacl Misiones UNaM, CONICET, Inst Biol Subtrop IBS, Nodo Iguazu, Puerto Iguazu, Misiones, Argentina.; Oklander, LI (corresponding author), Asociac Civil Ctr Invest Bosque Atlantico CeIBA, Puerto Iguazu, Misiones, Argentina.; Oklander, LI (corresponding author), Univ Nacl Noroeste Prov Buenos Aires UNNOBA, CONICET, Ctr Bioinvest CeBio, Buenos Aires, DF, Argentina.	lioklander@conicet.gov.ar	Miño, Carolina Isabel/K-7120-2019; Oklander, Luciana/O-6818-2019	Oklander, Luciana/0000-0003-1751-6313; Mino, Carolina Isabel/0000-0002-9098-583X	PIP CONICET Research Grant [114 201101 00322]	PIP CONICET Research Grant	This project was funded by a PIP CONICET Research Grant to LIO (no. 114 201101 00322; www.conicet.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamack AT, 2014, METHODS ECOL EVOL, V5, P384, DOI 10.1111/2041-210X.12158; Agostini I., 2012, LIBRO ROJO MAMIFEROS, P81; Agostini I, 2015, INT J PRIMATOL, V36, P244, DOI 10.1007/s10764-015-9821-9; Aguirre LF, 2009, LIBRO ROJO FAUNA SIL, P204; Alfaro JWL, 2015, MOL PHYLOGENET EVOL, V82, P518, DOI 10.1016/j.ympev.2014.09.027; Allendorf FW, 2010, CONSERV GENET, P587; Anderson DE, 2013, GLOBAL ENV QUATERNAR, V2, P424; Arandjelovic M, 2009, MOL ECOL RESOUR, V9, P28, DOI 10.1111/j.1755-0998.2008.02387.x; Ascunce MS, 2007, MOL PHYLOGENET EVOL, V43, P202, DOI 10.1016/j.ympev.2006.10.004; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; de Almeida MAB, 2012, AM J PRIMATOL, V74, P68, DOI 10.1002/ajp.21010; Batalha H, 2012, MOL PHYLOGENET EVOL, V65, P892, DOI 10.1016/j.ympev.2012.08.010; Bauni V., 2015, REMOTE SENSING APPL, V1, P50, DOI [10.1016/J.RSASE.2015.06.003, DOI 10.1016/J.RSASE.2015.06.003]; Bicca-Marques JC, 2013, PRIMATES FRAGMENTS C, P283; Bicca-Marques JC, 2017, SCI ADV E LETT; Blouin MS, 1996, MOL ECOL, V5, P393, DOI 10.1111/j.1365-294X.1996.tb00329.x; Boletta PE, 2006, FOREST ECOL MANAG, V228, P108, DOI 10.1016/j.foreco.2006.02.045; Brown A., 1994, VIDA SILVESTRE NEOTR, V3, P30; Chiappero MB, 2016, J MAMMAL, V97, P424, DOI 10.1093/jmammal/gyv186; Soto-Calderon ID, 2014, MOL PHYLOGENET EVOL, V81, P61, DOI 10.1016/j.ympev.2014.08.018; De Angelo C, 2013, BIOL CONSERV, V159, P422, DOI 10.1016/j.biocon.2012.12.021; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Estrada A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600946; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fernandez-Duque E., 2008, IUCN RED LIST THREAT; Francis RM, 2017, MOL ECOL RESOUR, V17, P27, DOI 10.1111/1755-0998.12509; Fu YX, 1997, GENETICS, V147, P915; Goncalves EC, 2004, MOL ECOL NOTES, V4, P406, DOI 10.1111/j.1471-8286.2004.00667.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Green M. R., 2012, MOL CLONING LAB MANU, V4, P47; Groves CP., 2005, MAMMAL SPECIES WORLD, P148; HARPENDING HC, 1994, HUM BIOL, V66, P591; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; Holzmann I, 2010, AM J PRIMATOL, V72, P475, DOI 10.1002/ajp.20796; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Gasparri NI, 2009, FOREST ECOL MANAG, V258, P913, DOI 10.1016/j.foreco.2009.02.024; Oklander LI, 2010, INT J PRIMATOL, V31, P813, DOI 10.1007/s10764-010-9430-6; Kean S, 2017, SCIENCE, V357, P637, DOI 10.1126/science.357.6352.637; Kowalewski MM, 2010, AM J PRIMATOL, V72, P734, DOI 10.1002/ajp.20838; Lecompte E, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22660; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Ludwig G, 1812, AVALIAC ALOUATTA CAR, P1; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Milton K, 2009, CONSERV GENET, V10, P347, DOI 10.1007/s10592-008-9584-3; Moreno ES, 2015, MEM I OSWALDO CRUZ, V110, P865, DOI 10.1590/0074-02760150075; MORITZ C, 1994, MOL ECOL, V3, P401, DOI 10.1111/j.1365-294X.1994.tb00080.x; Oklander LI, 2007, MOL ECOL NOTES, V7, P117, DOI 10.1111/j.1471-8286.2006.01529.x; Oklander Luciana Ines, 2004, Neotropical Primates, V12, P59; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Paviolo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep37147; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Puechmaille SJ, 2016, MOL ECOL RESOUR, V16, P608, DOI 10.1111/1755-0998.12512; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; R Core Team, 2021, R LANGUAGE ENV STAT; Ramesh V, 2017, BIOL CONSERV, V210, P205, DOI 10.1016/j.biocon.2017.03.019; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Grau HR, 2008, ECOL SOC, V13; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruiz-Garcia M, 2016, PHYLOGENY MOL POPULA, P669; RUMIZ DI, 1990, AM J PRIMATOL, V21, P279, DOI 10.1002/ajp.1350210404; Silva FE, 2013, DEV PRIMATOL-PROG PR, P137, DOI 10.1007/978-1-4614-8839-2_10; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Van Belle S, 2012, AM J PRIMATOL, V74, P948, DOI 10.1002/ajp.22047; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vigilant L, 2009, PRIMATES, V50, P105, DOI 10.1007/s10329-008-0124-z; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wang WR, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22635; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Willoughby JR, 2015, BIOL CONSERV, V191, P495, DOI 10.1016/j.biocon.2015.07.025; Winkler LA, 2004, INT J PRIMATOL, V25, P197, DOI 10.1023/B:IJOP.0000014650.86577.b4; Zunino G. E., 2001, PRIMATE REPORT; Zunino GE, 2007, AM J PRIMATOL, V69, P966, DOI 10.1002/ajp.20389	82	14	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185867	10.1371/journal.pone.0185867	http://dx.doi.org/10.1371/journal.pone.0185867			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968440	Green Submitted, gold, Green Published			2022-12-26	WOS:000412029600062
J	Scotson, L; Fredriksson, G; Ngoprasert, D; Wong, WM; Fieberg, J				Scotson, Lorraine; Fredriksson, Gabriella; Ngoprasert, Dusit; Wong, Wai-Ming; Fieberg, John			Projecting range-wide sun bear population trends using tree cover and camera-trap bycatch data	PLOS ONE			English	Article							EAST KALIMANTAN; HABITAT; DYNAMICS; DENSITY; MAMMALS; DEFORESTATION; EXTINCTION; ABUNDANCE; IMPACT; THREAT	Monitoring population trends of threatened species requires standardized techniques that can be applied over broad areas and repeated through time. Sun bears Helarctos malayanus are a forest dependent tropical bear found throughout most of Southeast Asia. Previous estimates of global population trends have relied on expert opinion and cannot be systematically replicated. We combined data from 1,463 camera traps within 31 field sites across sun bear range to model the relationship between photo catch rates of sun bears and tree cover. Sun bears were detected in all levels of tree cover above 20%, and the probability of presence was positively associated with the amount of tree cover within a 6-km 2 buffer of the camera traps. We used the relationship between catch rates and tree cover across space to infer temporal trends in sun bear abundance in response to tree cover loss at country and global-scales. Our model-based projections based on this "space for time" substitution suggested that sun bear population declines associated with tree cover loss between 2000- 2014 in mainland southeast Asia were similar to 9%, with declines highest in Cambodia and lowest in Myanmar. During the same period, sun bear populations in insular southeast Asia (Malaysia, Indonesia and Brunei) were projected to have declined at a much higher rate (22%). Cast forward over 30-years, from the year 2000, by assuming a constant rate of change in tree cover, we projected population declines in the insular region that surpassed 50%, meeting the IUCN criteria for endangered if sun bears were listed on the population level. Although this approach requires several assumptions, most notably that trends in abundance across space can be used to infer temporal trends, population projections using remotely sensed tree cover data may serve as a useful alternative (or supplement) to expert opinion. The advantages of this approach is that it is objective, data-driven, repeatable, and it requires that all assumptions be clearly stated.	[Scotson, Lorraine; Fieberg, John] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Fredriksson, Gabriella] Pro Natura Fdn, East Kalimantan, Indonesia; [Ngoprasert, Dusit] King Mongkuts Univ Technol Thonburi, Conservat Ecol Program, Bangkok, Thailand; [Wong, Wai-Ming] Panthera, New York, NY USA	University of Minnesota System; University of Minnesota Twin Cities; King Mongkuts University of Technology Thonburi	Scotson, L (corresponding author), Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.	scotsonuk@gmail.com	Fieberg, John/Y-3988-2019	Fieberg, John/0000-0002-3180-7021	University of Minnesota Doctoral Dissertation Fellowship; University of Minnesota Conservation Biology Summer Grant; Perth Zoo's Wildlife Conservation Action Program; Margaret Dawbarn Foundation; state Robin Under Rothwell Account Wildlife Preservation Trust; National Science and Technology Development Agency [NSTDA P-11-00390]; International Association for Bear Research and Management (Research & Conservation grant)	University of Minnesota Doctoral Dissertation Fellowship(University of Minnesota System); University of Minnesota Conservation Biology Summer Grant; Perth Zoo's Wildlife Conservation Action Program; Margaret Dawbarn Foundation; state Robin Under Rothwell Account Wildlife Preservation Trust; National Science and Technology Development Agency; International Association for Bear Research and Management (Research & Conservation grant)	L.S was funded by The University of Minnesota Doctoral Dissertation Fellowship, The University of Minnesota Conservation Biology Summer Grant, Perth Zoo's Wildlife Conservation Action Program, The Margaret Dawbarn Foundation and Estate Robin Under Rothwell Account Wildlife Preservation Trust, managed by Perpetual. D.N was funded by The National Science and Technology Development Agency (NSTDA P-11-00390), International Association for Bear Research and Management (Research & Conservation grant).	Aarts G, 2012, METHODS ECOL EVOL, V3, P177, DOI 10.1111/j.2041-210X.2011.00141.x; Ahumada JA, 2011, COMMUNITY STRUCTURE, p2703 ; Apps CD, 2007, J WILDLIFE MANAGE, V68, P138; Apps CD, 2016, J WILDLIFE MANAGE, V80, P396, DOI 10.1002/jwmg.1037; Avgar T, 2017, ECOL EVOL, V7, P5322, DOI 10.1002/ece3.3122; Banet AI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081025; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Bird JP, 2012, DIVERS DISTRIB, V18, P273, DOI 10.1111/j.1472-4642.2011.00843.x; Blois JL, 2013, P NATL ACAD SCI USA, V110, P9374, DOI 10.1073/pnas.1220228110; Boyce MS, 2012, WILDLIFE SOC B, V31, P670; Buchanan GM, 2008, BIOL CONSERV, V141, P56, DOI 10.1016/j.biocon.2007.08.023; Buckland S. T., 2005, ENCY BIOSTATISTICS; Cheah C.P.I., 2013, THESIS U PUTRA MALAY; Chutipong W, 2014, RAFFLES B ZOOL, V62, P521; Dahle B, 2003, J ZOOL, V260, P329, DOI 10.1017/S0952836903003753; Donald PF, 2015, CONSERV BIOL, V29, P1485, DOI 10.1111/cobi.12501; Erdbrink DP., 1953, REV FOSSIL RECENT BE; Foley KE, 2011, POWERS VIALS FLAKES; Franca F, 2016, J APPL ECOL; Fredrikkson G, 2005, URSUS, V16, P130, DOI 10.2192/1537-6176(2005)016[0130:HBCIEK]2.0.CO;2; Fredriksson GM, 2006, BIOL J LINN SOC, V89, P489, DOI 10.1111/j.1095-8312.2006.00688.x; GRIFFITHS M, 1993, CONSERV BIOL, V7, P623, DOI 10.1046/j.1523-1739.1993.07030623.x; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hilton-Taylor C., 2000, IUCN RED LIST THREAT; Hoffmann M., 2008, Endangered Species Research, V6, P113, DOI 10.3354/esr00087; Islam MA, 2013, URSUS, V24, P83, DOI 10.2192/URSUS-D-12-00010.1; IUCN Standards and Petitions Committee, 2022, GUID US IUCN RED LIS; Jackson HB, 2012, LANDSC ECOL, V27; Joshi AR, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501675; Kanchanasakha B, 2010, STATUS LARGE MAMMALS; Keenan RJ, 2015, FOREST ECOL MANAG, V352, P9, DOI 10.1016/j.foreco.2015.06.014; Kendall KC, 2008, J WILDLIFE MANAGE, V72, P1693, DOI 10.2193/2008-007; Kniewel, 2012, THESIS; Linkie M, 2013, BIOL CONSERV, V162, P107, DOI 10.1016/j.biocon.2013.03.028; Mathai J, 2016, RAFFLES B ZOOL, P186; Matthiopoulos J, 2015, ECOL MONOGR, V85, P413, DOI 10.1890/14-2244.1; Matthiopoulos J, 2011, ECOLOGY, V92, P583, DOI 10.1890/10-0751.1; McCullough P, 1989, GEN LINEAR MODELS; MCLELLAN BN, 1989, CAN J ZOOL, V67, P1865, DOI 10.1139/z89-266; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Mormua F, 2004, URSUS, V15, P227; Nazeri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048104; Ngoprasert D., 2015, POPULATION DEMOGRAPH; Ngoprasert D, 2012, URSUS, V23, P117, DOI 10.2192/URSUS-D-11-00009.1; PICKETT S T A, 1989, P110; R Development Core T, LANG ENV STAT COMP, V2012; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Riitters K, 2016, LANDSCAPE ECOL, V31, P137, DOI 10.1007/s10980-015-0270-9; Rowcliffe JM, 2008, ANIM CONSERV, V11, P185, DOI 10.1111/j.1469-1795.2008.00180.x; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Scotson L, 2017, REMOTE SENS ECOL CON; Scotson L., 2017, IUCN RED LIST THREAT; Scotson L, 2014, WILDLIFE SOC B, V38, P783, DOI 10.1002/wsb.466; Scotson Lorraine, 2013, International Bear News, V22, P22; Staddon P, 2010, ECOL LETT, V13, P543, DOI 10.1111/j.1461-0248.2010.01450.x; Steinmetz R., 2011, ECOLOGY CONSERVATION; Steinmetz R, 2006, CONSERV BIOL, V20, P1391, DOI 10.1111/j.1523-1739.2006.00505.x; Steinmetz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014509; Tracewski L, 2016, CONSERV BIOL, V30, P1070, DOI 10.1111/cobi.12715; Wen C, 2013, UPDATE STATUS SUN BE; Wong ST, 2004, BIOL CONSERV, V119, P169, DOI 10.1016/j.biocon.2003.10.029; Wong WM, 2013, ANIM CONSERV, V16, P216, DOI 10.1111/j.1469-1795.2012.00587.x; Wong WM, 2013, DIVERS DISTRIB, V19, P700, DOI 10.1111/ddi.12020	65	20	21	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185336	10.1371/journal.pone.0185336	http://dx.doi.org/10.1371/journal.pone.0185336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961243	Green Submitted, Green Published, gold			2022-12-26	WOS:000412027700017
J	Sumankuuro, J; Crockett, J; Wang, SY				Sumankuuro, Joshua; Crockett, Judith; Wang, Shaoyu			The use of antenatal care in two rural districts of Upper West Region, Ghana	PLOS ONE			English	Article							HEALTH; PREGNANCY; DELIVERY; SERVICES; BARRIERS; BIRTH; LABOR	Background Despite decades of implementation of maternity healthcare programmes, including a focus on increasing the use of antenatal care (ANC) and concomitant birth preparedness and complication readiness (BPCR), the uptake of ANC continues to be below expectations in many developing countries. This has attendant implications for maternal and infant morbidity and mortality rates. Known barriers to ANC use include cost, distance to health care services and forces of various socio-cultural beliefs and practices. As part of a larger study on BPCR in rural Ghana, this paper reflects on the use of ANC in the study areas from rights-based and maternal engagement theoretical perspectives, with a focus on the barriers to ANC use. Methods Mixed methods approach was adopted to collect data from 8 study communities from individual in-depth interviews with 80 expectant mothers and 13 health care professionals, and 24 focus groups comprising 240 community members. The qualitative data followed a thematic analytical method, while the quantitative data was analysed using descriptive statistics. Results The average number of ANC visits were 3.34 +/- 1.292, and the majority of expectant mothers (71.3%) enrolled for ANC at the 8(th) week or later, with the longest delay recorded at the 6 th month of gestation. Traditional norms significantly influenced this delay. Likewise, overall use of ANC during pregnancy was shaped by cultural factors related to perceptions of pregnancy, gender-based roles and responsibilities and concerns that ANC would result in an overweighed baby and culturally inappropriate delivery at a health care facility. Conclusion Greater understanding of the sociocultural barriers to ANC is essential if proposed changes in community-specific health education programs are to facilitate early commencement and increased use of ANC.	[Sumankuuro, Joshua; Crockett, Judith; Wang, Shaoyu] Charles Sturt Univ, Sch Community Hlth, Fac Sci, Orange, NSW, Australia	Charles Sturt University	Sumankuuro, J (corresponding author), Charles Sturt Univ, Sch Community Hlth, Fac Sci, Orange, NSW, Australia.	jsumankuuro@csu.edu.au	Sumankuuro, Joshua/AAD-9951-2019; Wang, Shaoyu/M-5948-2015	Sumankuuro, Joshua/0000-0002-8967-1091; Crockett, Judith/0000-0003-2039-4345; Wang, Shaoyu/0000-0001-8674-8965	Ghana Education Trust Fund (GETFUND) Doctorate Studentship	Ghana Education Trust Fund (GETFUND) Doctorate Studentship	This research was funded by Ghana Education Trust Fund (GETFUND) Doctorate Studentship to JS, http://www.getfund.gov.gh/. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aborigo RA, 2014, AFR J REPROD HEALTH, V18, P78; Afulani PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117996; Amzat J, 2015, J BIOETHIC INQ, V12, P283, DOI 10.1007/s11673-015-9607-y; Andrew EVW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093025; Atekyereza PR, 2014, TANZANIA J HLTH RES, V16; Atuoye KN, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1005-y; Audet CM, 2016, QUAL HEALTH RES, V26, P1721, DOI 10.1177/1049732315580302; Bayu H, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.28082; Bazzano AN, 2008, INT J GYNECOL OBSTET, V102, P91, DOI 10.1016/j.ijgo.2008.02.004; Bohren MA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001847; Caputi Mary, 2013, FEMINISM POWER NEED; Cofie LE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0604-2; D'Ambruoso L, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-140; Finlayson K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001373; Ganle JK, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0590-4; Ganle JK, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0425-8; Government L, 2014, PROF NAODW DISTR ASS; GSS, 2014, 2010 POP HOUS CENS N; GSS (Ghana Statistical Services), 2014, 2010 POP HOUS CENS D; [Issa Bussie Daffiama], 2015, COMP BUDG DAFF BUSS, P55; Jack SM, 2005, J ADV NURS, V49, P182, DOI 10.1111/j.1365-2648.2004.03278.x; KRUEGER RA, 2000, FOCUS GROUPS; Lincetto O, 2006, ANTENATAL CARE OPPOR; Mrisho M, 2007, TROP MED INT HEALTH, V12, P862, DOI 10.1111/j.1365-3156.2007.01855.x; Ochako R, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-1; Peters PJ, 2007, DRUG SAFETY, V30, P481, DOI 10.2165/00002018-200730060-00003; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Sumankuuro J, 2016, INT J COMMUNITY MED, V3, P3297, DOI DOI 10.18203/2394-6040.IJCMPH20164251; Sumankuuro J, 2017, PLOS ONE, V12; Sumankuuro J, 2016, INT J INNOVATION APP, V18, P341; Witter S, 2007, INT J HEALTH PLAN M, V22, P133, DOI 10.1002/hpm.867; World Health Organization, 2017, MAT MORT FACT SHEET; World Health Organization (WHO), 2006, BIRTH EM PREP ANT CA	33	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185537	10.1371/journal.pone.0185537	http://dx.doi.org/10.1371/journal.pone.0185537			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957422	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200079
J	Cui, GH; Wu, J; Mou, FF; Xie, WH; Wang, FB; Wang, QL; Fang, J; Xu, YW; Dong, YR; Liu, JR; Guo, HD				Cui, Guo-Hong; Wu, Jing; Mou, Fang-Fang; Xie, Wei-Hua; Wang, Fu-Bo; Wang, Qiang-Li; Fang, Jie; Xu, Yan-Wu; Dong, You-Rong; Liu, Jian-Ren; Guo, Hai-Dong			Exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP/PS1 mice	FASEB JOURNAL			English	Article						Alzheimer disease; microRNA; inflammatory cytokine	NF-KAPPA-B; ALZHEIMERS-DISEASE; STEM-CELLS; DELIVERY; BRAIN; DIFFERENTIATION; TRANSPLANTATION; CONTRIBUTES; MICRORNA-21; SUPPRESSION	Administration of exosomes derived from mesenchymal stromal cells (MSCs) could improve some neurologic conditions by transferring functional biomolecules to recipient cells. Furthermore, exosomes from hypoxic progenitor cells exerted better therapeutic effects in organ injury through specific cargoes. However, there are no related reports about whether exosomes derived from MSCs or hypoxia-preconditioned MSCs (PC-MSCs) could prevent memory deficits in Alzheimer disease (AD). In this study, the exosomes derived from MSCs or PC-MSCs were systemically administered to transgenic APP/PS1 mice. The expression of miR-21 in MSCs was significantly increased after hypoxic treatment. Injection of exosomes from normoxic MSCs could rescue cognition and memory impairment according to results of the Morris water maze test, reduced plaque deposition, and Ab levels in the brain; could decrease the activation of astrocytes and microglia; could down-regulate proinflammatory cytokines (TNF-alpha and IL-1 beta); and could up-regulate anti-inflammatory cytokines (IL-4 and -10) in AD mice, as well as reduce the activation of signal transducer and activator of transcription 3 (STAT3) and NF-kappa B. Compared to the group administered exosomes from normoxic MSCs, in the group administered exosomes from PC-MSCs, learning and memory capabilities were significantly improved; the plaque deposition and Ab levels were lower, and expression of growth-associated protein 43, synapsin 1, and IL-10 was increased; and the levels of glial fibrillary acidic protein, ionized calcium-binding adaptor molecule 1, TNF-alpha, IL-1 beta, and activation of STAT3 and NF-kappa B were sharply decreased. More importantly, exosomes from PC-MSCs effectively increased the level of miR-21 in the brain of AD mice. Additionally, replenishment of miR-21 restored the cognitive deficits in APP/PS1 mice and prevented pathologic features. Taken together, these findings suggest that exosomes from PC-MSCs could improve the learning and memory capabilities of APP/PS1 mice, and that the underlying mechanism may lie in the restoration of synaptic dysfunction and regulation of inflammatory responses through regulation of miR-21.	[Cui, Guo-Hong; Wu, Jing; Fang, Jie; Dong, You-Rong; Liu, Jian-Ren] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Neurol, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China; [Mou, Fang-Fang; Wang, Fu-Bo; Wang, Qiang-Li; Xu, Yan-Wu; Guo, Hai-Dong] Shanghai Univ Tradit Chinese Med, Sch Basic Med, Dept Anat, 1200 Cailun Rd, Shanghai 201203, Peoples R China; [Xie, Wei-Hua] Hosp Anhui Prov, Dept Constipat Acupuncture & Moxibust, Hefei, Anhui, Peoples R China	Shanghai Jiao Tong University; Shanghai University of Traditional Chinese Medicine	Liu, JR (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Neurol, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.; Guo, HD (corresponding author), Shanghai Univ Tradit Chinese Med, Sch Basic Med, Dept Anat, 1200 Cailun Rd, Shanghai 201203, Peoples R China.	liujr021@vip.163.com; hdguo8@hotmail.com	wang, fubo/GPF-4834-2022; wang, qiangli/GVU-4045-2022; Xu, Yanwu/AAK-6357-2020	Xu, Yanwu/0000-0002-9253-7790	National Natural Science Foundation of China [31400838, 81102670]; Shanghai People's Hospital [2013A05, 9]; Shanghai Jiaotong University Biomedical Engineering Crossover Project [YG2011MS12]; Research Fund for the Doctoral Program Construction of Shanghai [B201706]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai People's Hospital; Shanghai Jiaotong University Biomedical Engineering Crossover Project; Research Fund for the Doctoral Program Construction of Shanghai	This work was supported, in part, by grants from the National Natural Science Foundation of China (31400838 and 81102670), the Program of No. 9 Shanghai People's Hospital (2013A05), the Shanghai Jiaotong University Biomedical Engineering Crossover Project (YG2011MS12), and the Research Fund for the Doctoral Program Construction of Shanghai (B201706). The authors declare no conflicts of interest.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Carlson C, 2011, ALZHEIMERS DEMENT, V7, P396, DOI 10.1016/j.jalz.2011.05.2353; Carta MG, 2002, PSYCHOTHER PSYCHOSOM, V71, P233, DOI 10.1159/000063649; Chatterjee N, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.83; Chever O, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0596; Choi DS, 2015, MASS SPECTROM REV, V34, P474, DOI 10.1002/mas.21420; Cui GH, 2016, MOL NEUROBIOL, V53, P1108, DOI 10.1007/s12035-014-9069-y; Das A, 2014, J IMMUNOL, V192, P1120, DOI 10.4049/jimmunol.1300613; Dong LY, 2014, J CELL MOL MED, V18, P2213, DOI 10.1111/jcmm.12353; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Garo LP, 2016, CELL MOL LIFE SCI, V73, P2041, DOI 10.1007/s00018-016-2167-4; Granic I, 2009, J ALZHEIMERS DIS, V16, P809, DOI 10.3233/JAD-2009-0976; Gray WD, 2015, CIRC RES, V116, P255, DOI 10.1161/CIRCRESAHA.116.304360; Haney MJ, 2015, J CONTROL RELEASE, V207, P18, DOI 10.1016/j.jconrel.2015.03.033; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Kamphuis W, 2016, BBA-MOL BASIS DIS, V1862, P1847, DOI 10.1016/j.bbadis.2016.07.007; Katsuda T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01197; Kim EA, 2014, J NEUROIMMUNE PHARM, V9, P461, DOI 10.1007/s11481-014-9542-4; Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045757; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277; Lee SY, 2005, MOL BRAIN RES, V140, P45, DOI 10.1016/j.molbrainres.2005.07.009; Lee YJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-132; Li X, 2016, EBIOMEDICINE, V8, P72, DOI 10.1016/j.ebiom.2016.04.030; Liu YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17543; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Paris D, 2013, EUR J PHARMACOL, V698, P145, DOI 10.1016/j.ejphar.2012.11.017; Peng J, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt73; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Sandhir R, 2014, NEUROCHEM INT, V78, P117, DOI 10.1016/j.neuint.2014.09.009; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SELKOE DJ, 1989, ANN MED, V21, P73, DOI 10.3109/07853898909149187; Theriault P, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0125-2; Verma M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128224; Wang F, 2014, MOL NEUROBIOL, V50, P305, DOI 10.1007/s12035-013-8609-1; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Xiao SH, 2016, BIOMATERIALS, V106, P98, DOI 10.1016/j.biomaterials.2016.08.021; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Yu J, 2016, EXP THER MED, V12, P1822, DOI 10.3892/etm.2016.3535; Zhou HM, 2016, J NEUROL SCI, V367, P3, DOI 10.1016/j.jns.2016.05.038	41	173	183	11	49	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					654	668		10.1096/fj.201700600R	http://dx.doi.org/10.1096/fj.201700600R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28970251	Bronze			2022-12-26	WOS:000425146900011
J	O'Leime, CS; Kozareva, DA; Hoban, AE; Long-Smith, CM; Cryan, JF; Nolan, YM				O'Leime, Ciaran S.; Kozareva, Danka A.; Hoban, Alan E.; Long-Smith, Caitriona M.; Cryan, John F.; Nolan, Yvonne M.			TLX is an intrinsic regulator of the negative effects of IL-1 beta on proliferating hippocampal neural progenitor cells	FASEB JOURNAL			English	Article						neurogenesis; nuclear receptor; inflammation; Nr2e1	NF-KAPPA-B; NUCLEAR RECEPTOR TLX; LONG-TERM POTENTIATION; SPATIAL-PATTERN SEPARATION; STEM-CELLS; INTERLEUKIN-1 RECEPTORS; ADULT NEUROGENESIS; PRECURSOR CELLS; DENTATE GYRUS; TAILLESS GENE	Hippocampal neurogenesis is a lifelong process whereby new neurons are produced and integrate into the host circuitry within the hippocampus. It is regulated by a multitude of extrinsic and intrinsic regulators and is believed to contribute to certain hippocampal-dependent cognitive tasks. Hippocampal neurogenesis and associated cognition have been demonstrated to be impaired after increases in the levels of proinflammatory cytokine IL-1 beta in the hippocampus, such as that which occurs in various neurodegenerative and psychiatric disorders. IL-1 beta also suppresses the expression of TLX(orphan nuclear receptor tailless homolog), which is an orphan nuclear receptor that functions to promote neural progenitor cell (NPC) proliferation and suppress neuronal differentiation; therefore, manipulation of TLX represents a potential strategy with which to prevent the antiproliferative effects of IL-1 beta. In this study, we assessed the mechanism that underlies IL-1 beta-induced changes in TLX expression and determined the protective capacity of TLX to mitigate the effects of IL-1 beta on embryonic rat hippocampal neurosphere expansion. We demonstrate that IL-1 beta activated the NF-kappa B pathway in proliferating NPCs and that this activation was responsible for IL-1 beta-induced changes in TLX expression. In addition, we report that enhancing TLX expression prevented the IL-1 beta-induced suppression of neurosphere expansion. Thus, we highlight TLX as a potential protective regulator of the antiproliferative effects of IL-1 beta on hippocampal neurogenesis.	[O'Leime, Ciaran S.; Kozareva, Danka A.; Hoban, Alan E.; Long-Smith, Caitriona M.; Cryan, John F.; Nolan, Yvonne M.] Univ Coll Cork, Dept Anat & Neurosci, Western Gate Bldg,Western Rd, Cork T12 YN60, Ireland; [Long-Smith, Caitriona M.; Cryan, John F.; Nolan, Yvonne M.] Univ Coll Cork, Alimentary Pharmabiot Ctr, Microbiome Inst, Cork, Ireland	University College Cork; University College Cork	Nolan, YM (corresponding author), Univ Coll Cork, Dept Anat & Neurosci, Western Gate Bldg,Western Rd, Cork T12 YN60, Ireland.	y.nolan@ucc.ie	Cryan, John F./A-6950-2013; Long-Smith, Caitriona/AAD-1936-2022	Cryan, John F./0000-0001-5887-2723; Nolan, Yvonne/0000-0003-2426-234X; Kozareva, Danka/0000-0001-7627-0312; Leime, Ciaran/0000-0002-7420-4159	Science Foundation Ireland [12/IA/1537]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by the Science Foundation Ireland (Grant 12/IA/1537). The authors declare no conflicts of interest.	Arias-Salvatierra D, 2011, CELL SIGNAL, V23, P425, DOI 10.1016/j.cellsig.2010.10.017; Bekinschtein P, 2011, SEMIN CELL DEV BIOL, V22, P536, DOI 10.1016/j.semcdb.2011.07.002; Benod C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099440; Chen F, 2006, J BIOL CHEM, V281, P37142, DOI 10.1074/jbc.M603631200; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; de Vries EM, 2014, ENDOCRINOLOGY, V155, P2000, DOI 10.1210/en.2013-2018; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Drapeau E, 2007, J NEUROSCI, V27, P6037, DOI 10.1523/JNEUROSCI.1031-07.2007; FARRAR WL, 1987, J IMMUNOL, V139, P459; Godbout JP, 2009, IMMUNOL ALLERGY CLIN, V29, P321, DOI 10.1016/j.iac.2009.02.007; Goshen I, 2008, MOL PSYCHIATR, V13, P717, DOI 10.1038/sj.mp.4002055; Green HF, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.117; Green HF, 2012, NEUROCHEM INT, V61, P666, DOI 10.1016/j.neuint.2012.07.003; Green HF, 2012, MOL CELL NEUROSCI, V49, P311, DOI 10.1016/j.mcn.2012.01.001; Griffin BD, 2006, J BIOL CHEM, V281, P10316, DOI 10.1074/jbc.M509973200; Hodge RD, 2011, DEV NEUROBIOL, V71, P680, DOI 10.1002/dneu.20882; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Keohane A, 2010, MOL CELL NEUROSCI, V43, P127, DOI 10.1016/j.mcn.2009.10.003; Kesanakurti D, 2013, ONCOGENE, V32, P5144, DOI 10.1038/onc.2012.546; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kohman RA, 2013, BRAIN BEHAV IMMUN, V27, P22, DOI 10.1016/j.bbi.2012.09.003; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Koo JW, 2010, P NATL ACAD SCI USA, V107, P2669, DOI 10.1073/pnas.0910658107; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kumar A, 2011, DIABETES OBES METAB, V13, P750, DOI 10.1111/j.1463-1326.2011.01402.x; Lazarov O, 2010, TRENDS NEUROSCI, V33, P569, DOI 10.1016/j.tins.2010.09.003; Leonard BE, 2007, NEUROCHEM RES, V32, P1749, DOI 10.1007/s11064-007-9385-y; Li WW, 2008, MOL ENDOCRINOL, V22, P56, DOI 10.1210/me.2007-0290; Liu CM, 2009, NEUROMOL MED, V11, P141, DOI 10.1007/s12017-009-8077-y; Liu HK, 2010, GENE DEV, V24, P683, DOI 10.1101/gad.560310; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Maes M, 2012, EXPERT OPIN THER TAR, V16, P1097, DOI 10.1517/14728222.2012.718331; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; MONAGHAN AP, 1995, DEVELOPMENT, V121, P839; Monaghan AP, 1997, NATURE, V390, P515, DOI 10.1038/37364; Murai K, 2014, P NATL ACAD SCI USA, V111, P9115, DOI 10.1073/pnas.1406779111; Na KS, 2014, PROG NEURO-PSYCHOPH, V48, P277, DOI 10.1016/j.pnpbp.2012.10.022; Nolan YM, 2013, TRENDS MOL MED, V19, P187, DOI 10.1016/j.molmed.2012.12.003; O'Leary JD, 2018, GENES BRAIN BEHAV, V17, DOI 10.1111/gbb.12357; O'Leary JD, 2016, BEHAV BRAIN RES, V306, P36, DOI 10.1016/j.bbr.2016.03.022; O'Leime CS, 2017, BRAIN BEHAV IMMUN, V66, P394, DOI 10.1016/j.bbi.2017.07.153; Park HJ, 2010, MOL CELLS, V30, P403, DOI 10.1007/s10059-010-0122-z; PARNET P, 1994, MOL BRAIN RES, V27, P63, DOI 10.1016/0169-328X(94)90185-6; Pechnick RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027290; Pugh CR, 1999, BEHAV BRAIN RES, V106, P109, DOI 10.1016/S0166-4328(99)00098-4; Qu QH, 2009, J CELL PHYSIOL, V221, P5, DOI 10.1002/jcp.21862; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rothwell NJ, 1996, PHARMACOL THERAPEUT, V69, P85, DOI 10.1016/0163-7258(95)02033-0; Roy K, 2002, PHYSIOL BEHAV, V77, P595, DOI 10.1016/S0031-9384(02)00902-2; Ryan SM, 2013, BRAIN BEHAV IMMUN, V33, P7, DOI 10.1016/j.bbi.2013.03.005; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Seitz CS, 2000, CANCER RES, V60, P4085; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Shin HM, 2004, FEBS LETT, V571, P50, DOI 10.1016/j.febslet.2004.06.056; SIMS JE, 1993, P NATL ACAD SCI USA, V90, P6155, DOI 10.1073/pnas.90.13.6155; Song Juhyun, 2013, Exp Neurobiol, V22, P268, DOI 10.5607/en.2013.22.4.268; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Tanti A, 2013, CELL TISSUE RES, V354, P203, DOI 10.1007/s00441-013-1612-z; Tong LQ, 2012, J NEUROSCI, V32, P17714, DOI 10.1523/JNEUROSCI.1253-12.2012; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vereker E, 2000, J NEUROSCI, V20, P6811, DOI 10.1523/JNEUROSCI.20-18-06811.2000; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Wang XF, 2007, MOL CELL NEUROSCI, V36, P343, DOI 10.1016/j.mcn.2007.07.005; Widera D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-64; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Xie ZX, 2016, CELL MOL NEUROBIOL, V36, P1343, DOI 10.1007/s10571-016-0333-8; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107; Zhu JX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131782; Zonis S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0281-0; Zunszain PA, 2012, NEUROPSYCHOPHARMACOL, V37, P939, DOI 10.1038/npp.2011.277	82	10	10	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					613	624		10.1096/fj.201700495R	http://dx.doi.org/10.1096/fj.201700495R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28970252				2022-12-26	WOS:000425146900008
J	Al-Saedi, F; Vaz, DP; Stones, DH; Krachler, AM				Al-Saedi, Fitua; Vaz, Diana Pereira; Stones, Daniel H.; Krachler, Anne Marie			3-Sulfogalactosyl-dependent adhesion of Escherichia coli HS multivalent adhesion molecule is attenuated by sulfatase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesin; intestinal epithelium; mucin; mucus; protein-lipid interaction; Multivalent Adhesion Molecule; commensal; foraging; mammalian cell entry domain	COLONIC MUCUS BARRIER; 3-DERIVED O-GLYCANS; PSEUDOMONAS-AERUGINOSA; ULCERATIVE-COLITIS; INTESTINAL-MUCOSA; IN-VIVO; MUCIN; CELLS; MICE; MICROBIOTA	Bacterial adhesion to host receptors is an early and essential step in bacterial colonization, and the nature of adhesin-receptor interactions determines bacterial localization and thus the outcome of these interactions. Here, we determined the host receptors for the multivalent adhesion molecule (MAM) from the gut commensal Escherichia coli HS (MAM(HS)), which contains an array of seven mammalian cell entry domains. The MAM(HS) adhesin interacted with a range of host receptors, through recognition of a shared 3-O-sulfogalactosyl moiety. This functional group is also found in mucin, a component of the intestinal mucus layer and thus one of the prime adherence targets for commensal E. coli. Mucin gels impeded the motility of E. coli by acting as a physical barrier, and the barrier effect was enhanced by specific interactions between mucin and MAM(HS) in a sulfation-dependent manner. Desulfation of mucin by pure sulfatase or the sulfatase-producing commensal Bacteroides thetaiotaomicron decreased binding of E. coli to mucin and increased the attachment of bacteria to the epithelial surface via interactions with surface-localized sulfated lipid and protein receptors. Together, our results demonstrate that the E. coli adhesin MAM(HS) facilitates retention of a gut commensal by attachment to mucin. They further suggest that the amount of sulfatase secreted by mucin-foraging bacteria such as B. thetaiotaomicron, inhabiting the same niche, may affect the capacity of the mucus barrier to retain commensal E. coli.	[Al-Saedi, Fitua; Vaz, Diana Pereira; Stones, Daniel H.] Univ Birmingham, Inst Microbiol & Infect, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Vaz, Diana Pereira; Krachler, Anne Marie] Univ Texas McGovern Med Sch Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Birmingham	Krachler, AM (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, 6431 Fannin St, Houston, TX 77030 USA.	anne.marie.krachler@uth.tmc.edu	Al-Saedi, Fitua/H-1690-2019; Krachler, Anne-Marie/C-8645-2014	Al-Saedi, Fitua/0000-0003-0734-8192; Krachler, Anne Marie/0000-0002-0936-0016; Stones, Daniel H./0000-0002-8981-7943; Pereira Vaz, Diana/0000-0002-8957-5913	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L007916/1, BB/M021513/1]; University of Texas Science and Technology Acquisition and Retention (STAR) award; Iraq Ministry of Higher Education and Scientific Research Postgraduate Scholarship; BBSRC [BB/M021513/1, BB/L007916/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M021513/1, BB/L007916/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Texas Science and Technology Acquisition and Retention (STAR) award; Iraq Ministry of Higher Education and Scientific Research Postgraduate Scholarship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Biotechnology and Biological Sciences Research Council (BBSRC) Grants BB/L007916/1 and BB/M021513/1 (to A. M. K., D. P. V., and D. H. S.) and a University of Texas Science and Technology Acquisition and Retention (STAR) award (to A. M. K. and D. P. V.). A. M. K. is a co-inventor on the patent "Modulating bacterial MAM polypeptides in pathogenic disease" (U.S. Patent 9529005, issued Dec. 27, 2016).; Supported by an Iraq Ministry of Higher Education and Scientific Research Postgraduate Scholarship.	Al-Saedi F, 2016, INFECT IMMUN, V84, P1704, DOI 10.1128/IAI.00020-16; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Baron W, 2014, GLIA, V62, P927, DOI 10.1002/glia.22650; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Benjdia A, 2011, J BIOL CHEM, V286, P25973, DOI 10.1074/jbc.M111.228841; Bergstrom K, 2017, MUCOSAL IMMUNOL, V10, P91, DOI 10.1038/mi.2016.45; Chen SJ, 2014, WORLD J GASTROENTERO, V20, P9468, DOI 10.3748/wjg.v20.i28.9468; COLBURN P, 1987, BIOCHEM BIOPH RES CO, V147, P920, DOI 10.1016/S0006-291X(87)80158-4; CORFIELD AP, 1993, GLYCOCONJUGATE J, V10, P72, DOI 10.1007/BF00731190; Dawson PA, 2009, GUT, V58, P910, DOI 10.1136/gut.2007.147595; de Souza HL, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-21; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Hawley CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081216; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Larsson JMH, 2013, AM J PHYSIOL-GASTR L, V305, pG357, DOI 10.1152/ajpgi.00048.2013; Huebinger RM, 2016, SCI REP-UK, V6, DOI 10.1038/srep39341; Hummel S, 2007, J BIOL CHEM, V282, P8011, DOI 10.1074/jbc.M606029200; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Ishizuka I, 1997, PROG LIPID RES, V36, P245, DOI 10.1016/S0163-7827(97)00011-8; Jakobsson HE, 2015, EMBO REP, V16, P164, DOI 10.15252/embr.201439263; Jansson L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004487; Johansson MEV, 2014, INFLAMM BOWEL DIS, V20, P2124, DOI 10.1097/MIB.0000000000000117; Johansson MEV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041009; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Krachler AM, 2011, J BIOL CHEM, V286, P38939, DOI 10.1074/jbc.M111.291377; Krachler AM, 2011, P NATL ACAD SCI USA, V108, P11614, DOI 10.1073/pnas.1102360108; Larsson JMH, 2011, INFLAMM BOWEL DIS, V17, P2299, DOI 10.1002/ibd.21625; Laux D C, 1982, Recomb DNA Tech Bull, V5, P1; Li H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9292; Mahmoud RY, 2016, MOL MICROBIOL, V99, P658, DOI 10.1111/mmi.13255; Maltby R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053957; Molist A, 1997, BIOCHEM BIOPH RES CO, V238, P874, DOI 10.1006/bbrc.1997.7192; Nishiyama K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083703; ROBERTS DD, 1985, P NATL ACAD SCI USA, V82, P1306, DOI 10.1073/pnas.82.5.1306; Scharfman A, 2001, INFECT IMMUN, V69, P5243, DOI 10.1128/IAI.69.9.5243-5248.2001; Schutte A, 2014, P NATL ACAD SCI USA, V111, P12396, DOI 10.1073/pnas.1407597111; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Tailford LE, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00081; Takahashi T, 2012, J LIPID RES, V53, P1437, DOI 10.1194/jlr.R026682; Thomsson KA, 2000, ANAL CHEM, V72, P4543, DOI 10.1021/ac000631b; Thornton David J, 2004, Proc Am Thorac Soc, V1, P54, DOI 10.1513/pats.2306016; Tobisawa Y, 2010, J BIOL CHEM, V285, P6750, DOI 10.1074/jbc.M109.067082; Uchida H, 2006, BIOSCI BIOTECH BIOCH, V70, P3073, DOI 10.1271/bbb.60407; Uchida H, 2006, RES MICROBIOL, V157, P659, DOI 10.1016/j.resmic.2006.03.001; Xia BY, 2005, GLYCOBIOLOGY, V15, P747, DOI 10.1093/glycob/cwi061; Xiao SY, 2013, ADV EXP MED BIOL, V991, P27, DOI 10.1007/978-94-007-6331-9_3	48	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19792	19803		10.1074/jbc.M117.817908	http://dx.doi.org/10.1074/jbc.M117.817908			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28982977	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000416911300023
J	Asjad, HMM; Kasture, A; El-Kasaby, A; Sackel, M; Hummel, T; Freissmuth, M; Sucic, S				Asjad, H. M. Mazhar; Kasture, Ameya; El-Kasaby, Ali; Sackel, Michael; Hummel, Thomas; Freissmuth, Michael; Sucic, Sonja			Pharmacochaperoning in a Drosophila model system rescues human dopamine transporter variants associated with infantile/juvenile parkinsonism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; dopamine; dopamine transporter; endoplasmic reticulum (ER); neurotransmitter transport; dopamine	HUMAN SEROTONIN TRANSPORTER; ENERGY-TRANSFER MICROSCOPY; RAT GABA TRANSPORTER-1; DEFICIENCY SYNDROME; PHARMACOLOGICAL CHAPERONES; BEHAVIORAL-RESPONSES; OLIGOMER FORMATION; SLC6 TRANSPORTERS; PLASMA-MEMBRANE; LIVING CELLS	Point mutations in the gene encoding the human dopamine transporter (hDAT, SLC6A3) cause a syndrome of infantile/juvenile dystonia and parkinsonism. To unravel the molecular mechanism underlying these disorders and investigate possible pharmacological therapies, here we examined 13 disease-causing DAT mutants that were retained in the endoplasmic reticulum when heterologously expressed in HEK293 cells. In three of these mutants, i.e. hDAT-V158F, hDAT-G327R, and hDAT-L368Q, the folding deficit was remedied with the pharmacochaperone noribogaine or the heat shock protein 70 (HSP70) inhibitor pifithrin- such that endoplasmic reticulum export of and radioligand binding and substrate uptake by these DAT mutants were restored. In Drosophila melanogaster, DAT deficiency results in reduced sleep. We therefore exploited the power of targeted transgene expression of mutant hDAT in Drosophila to explore whether these hDAT mutants could also be pharmacologically rescued in an intact organism. Noribogaine or pifithrin- treatment supported hDAT delivery to the presynaptic terminals of dopaminergic neurons and restored sleep to normal length in DAT-deficient (fumin) Drosophila lines expressing hDAT-V158F or hDAT-G327R. In contrast, expression of hDAT-L368Q in the Drosophila DAT mutant background caused developmental lethality, indicating a toxic action not remedied by pharmacochaperoning. Our observations identified those mutations most likely amenable to pharmacological rescue in the affected children. In addition, our findings also highlight the challenges of translating insights from pharmacochaperoning in cell culture to the clinical situation. Because of the evolutionary conservation in dopaminergic neurotransmission between Drosophila and people, pharmacochaperoning of DAT in D. melanogaster may allow us to bridge that gap.	[Asjad, H. M. Mazhar; Kasture, Ameya; El-Kasaby, Ali; Freissmuth, Michael; Sucic, Sonja] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringer Str 13A, A-1090 Vienna, Austria; [Asjad, H. M. Mazhar; Kasture, Ameya; El-Kasaby, Ali; Freissmuth, Michael; Sucic, Sonja] Med Univ Vienna, Gaston H Glock Res Labs Exploratory Drug Dev, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [Sackel, Michael; Hummel, Thomas] Univ Vienna, Dept Neurobiol, A-1090 Vienna, Austria	Medical University of Vienna; Medical University of Vienna; University of Vienna	Freissmuth, M (corresponding author), Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringer Str 13A, A-1090 Vienna, Austria.	michael.freissmuth@meduniwien.ac.at		Freissmuth, Michael/0000-0001-9398-1765; Sucic, Sonja/0000-0001-5136-8022; Asjad, Hafiz Muhammad Mazhar/0000-0001-6155-9113; Kasture, Ameya/0000-0002-2947-4803	Austrian Science Fund/Fonds zur Forderiung der wissenschaftlichen Forschung (FWF) [P27518-B27, SFB35 F3510]; Higher Education Commission of Pakistan; Austrian Agency for International Cooperation in Education and Research/Austrian Academic Exchange Service; doctoral program Cell Communication in Health and Disease; Austrian Science Fund/FWF [W1205]; Medical University of Vienna	Austrian Science Fund/Fonds zur Forderiung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Austrian Agency for International Cooperation in Education and Research/Austrian Academic Exchange Service; doctoral program Cell Communication in Health and Disease; Austrian Science Fund/FWF(Austrian Science Fund (FWF)); Medical University of Vienna	This work was supported by the Austrian Science Fund/Fonds zur Forderiung der wissenschaftlichen Forschung (FWF)-funded Project P27518-B27 (to S. S.) and Project Program Grant SFB35 F3510 (to M. F.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Ph.D. stipend jointly awarded by the Higher Education Commission of Pakistan and the Austrian Agency for International Cooperation in Education and Research/Austrian Academic Exchange Service.; Supported by the doctoral program Cell Communication in Health and Disease, which was jointly funded by Grant W1205 from the Austrian Science Fund/FWF and the Medical University of Vienna. This work is part of a dissertation submitted in partial fulfillment of the requirements of the Ph.D. degree.	Anderluh A, 2014, BIOPHYS J, V106, pL33, DOI 10.1016/j.bpj.2014.03.019; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Arribas-Gonzalez E, 2015, J BIOL CHEM, V290, P2150, DOI 10.1074/jbc.M114.587055; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Baumann MH, 2001, J PHARMACOL EXP THER, V297, P531; Beerepoot P, 2016, J BIOL CHEM, V291, P22053, DOI 10.1074/jbc.M116.749119; Bhat S, 2017, J BIOL CHEM, V292, P16773, DOI 10.1074/jbc.M117.794081; Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; Carta E, 2012, J BIOL CHEM, V287, P28975, DOI 10.1074/jbc.M112.372094; Chang HY, 2006, MOL PSYCHIATR, V11, P99, DOI 10.1038/sj.mp.4001742; Chiba P, 2014, PHARMACOL RES, V83, P63, DOI 10.1016/j.phrs.2013.11.009; El-Kasaby A, 2014, J BIOL CHEM, V289, P28987, DOI 10.1074/jbc.M114.595090; El-Kasaby A, 2010, J BIOL CHEM, V285, P39201, DOI 10.1074/jbc.M110.118000; Farhan H, 2004, J BIOL CHEM, V279, P28553, DOI 10.1074/jbc.M307325200; Fujiwara M, 2013, J PHARMACOL SCI, V122, P71, DOI 10.1254/jphs.12194FP; Germain DP, 2016, NEW ENGL J MED, V375, P545, DOI 10.1056/NEJMoa1510198; Gilestro GF, 2009, BIOINFORMATICS, V25, P1466, DOI 10.1093/bioinformatics/btp237; Glue P, 2016, CLIN PHARM DRUG DEV, V5, P460, DOI 10.1002/cpdd.254; Glue P, 2015, J CLIN PHARMACOL, V55, P189, DOI 10.1002/jcph.404; Hahn MK, 2003, J NEUROSCI, V23, P4470; Hastrup H, 2003, J BIOL CHEM, V278, P45045, DOI 10.1074/jbc.C300349200; Illiano P, 2017, EUR J NEUROSCI, V45, P207, DOI 10.1111/ejn.13366; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Kasture A, 2016, J BIOL CHEM, V291, P20876, DOI 10.1074/jbc.M116.737551; King LB, 2016, G3-GENES GENOM GENET, V6, P1083, DOI 10.1534/g3.115.026484; Koban F, 2015, J BIOL CHEM, V290, P13263, DOI 10.1074/jbc.M115.641357; Korkhov VM, 2006, J BIOL CHEM, V281, P13439, DOI 10.1074/jbc.M511382200; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Kurian MA, 2011, LANCET NEUROL, V10, P54, DOI 10.1016/S1474-4422(10)70269-6; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Li Y, 2017, J BIOL CHEM, V292, P4235, DOI 10.1074/jbc.M116.760140; Li Y, 2015, J BIOL CHEM, V290, P31069, DOI 10.1074/jbc.M115.688275; McClung C, 1998, CURR BIOL, V8, P109, DOI 10.1016/S0960-9822(98)70041-7; Ng J, 2014, BRAIN, V137, P1107, DOI 10.1093/brain/awu022; Pathak T, 2017, G3-GENES GENOM GENET, V7, P923, DOI 10.1534/g3.116.038539; Pendleton RG, 2005, PHARMACOL BIOCHEM BE, V81, P849, DOI 10.1016/j.pbb.2005.06.008; Pimentel D, 2016, NATURE, V536, P333, DOI 10.1038/nature19055; Pitmon E, 2016, GENES BRAIN BEHAV, V15, P327, DOI 10.1111/gbb.12264; Riemensperger T, 2011, P NATL ACAD SCI USA, V108, P834, DOI 10.1073/pnas.1010930108; Robinson SB, 2017, MOL CELL NEUROSCI, V78, P41, DOI 10.1016/j.mcn.2016.11.011; Rosenberg EH, 2004, AM J HUM GENET, V75, P97, DOI 10.1086/422102; Rudnick G, 2014, PFLUG ARCH EUR J PHY, V466, P25, DOI 10.1007/s00424-013-1410-1; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sucic Sonja, 2016, J Neurol Neuromedicine, V1, P34; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Van Swinderen B, 2011, P ROY SOC B-BIOL SCI, V278, P906, DOI 10.1098/rspb.2010.2564; Yellman C, 1997, P NATL ACAD SCI USA, V94, P4131, DOI 10.1073/pnas.94.8.4131	55	24	24	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19250	19265		10.1074/jbc.M117.797092	http://dx.doi.org/10.1074/jbc.M117.797092			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972153	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000416226700009
J	Kitamura, K; Watanabe, Y; Nakamura, K; Takahashi, A; Takachi, R; Oshiki, R; Kobayashi, R; Saito, T; Tsugane, S; Sasaki, A				Kitamura, Kaori; Watanabe, Yumi; Nakamura, Kazutoshi; Takahashi, Akemi; Takachi, Ribeka; Oshiki, Rieko; Kobayashi, Ryosaku; Saito, Toshiko; Tsugane, Shoichiro; Sasaki, Ayako			Weight loss from 20 years of age is associated with cognitive impairment in middle-aged and elderly individuals	PLOS ONE			English	Article							BODY-MASS INDEX; POPULATION-BASED COHORT; GREEN TEA CONSUMPTION; ALZHEIMER-DISEASE; DEMENTIA RISK; LATE-LIFE; JAPANESE; METAANALYSIS; PROJECT; MIDLIFE	Background Few empirical studies have been conducted to identify modifiable factors that may affect cognitive impairment in Japanese individuals. The present study aimed to clarify whether body mass and lifestyle are associated with cognitive impairment in Japanese middle-aged and elderly individuals. Methods Subjects were 1814 community-dwelling individuals aged 44-79 years, all of whom were participants of the Murakami Cohort Study baseline survey conducted in 2011-2013. Cognitive function was assessed using the Mini-Mental State Examination (MMSE) in 2014-2016, and cognitive impairment, the outcome measure, was defined as an MMSE score <24. Predictor variables were body mass index (BMI), long-term weight changes from 20 years of age, and lifestyle factors, such as smoking, drinking, and physical activity levels, which were obtained from a self-administered questionnaire in the baseline survey. Covariates were sex, age, education level, and histories of stroke and diabetes. Multiple logistic regression analysis was used to calculate the adjusted odds ratios (ORs). Results The prevalence of overall cognitive impairment was 6.2%. The adjusted ORs of cognitive impairment in the lowest (<[-4] kg) (OR = 2.70, 95% CI, 1.18-6.20) and second ([-4]-[0] kg) (OR = 2.37, 95% CI, 1.04-5.37) quintiles for long-term weight change were significantly higher than the reference 4th quintile ([+4]-[+7] kg). The adjusted OR in the highest quintile >=[+8] kg) was 2.24 (95% CI, 0.99-5.04). Current BMI was not associated with cognitive impairment. Conclusions Long-term weight loss is associated with cognitive impairment in Japanese middle-aged and elderly individuals. Because the present study was retrospective in nature, prospective studies should also be conducted for further characterization of this association.	[Kitamura, Kaori; Watanabe, Yumi; Nakamura, Kazutoshi; Takachi, Ribeka] Niigata Univ, Grad Sch Med & Dent Sci, Div Prevent Med, Niigata, Japan; [Takahashi, Akemi; Oshiki, Rieko] Niigata Univ Rehabil, Dept Phys Therapy, Murakami, Niigata, Japan; [Takachi, Ribeka] Nara Womens Univ, Grad Sch Humanities & Sci, Dept Food Sci & Nutr, Nara, Japan; [Kobayashi, Ryosaku] Niigata Univ Hlth & Welf, Dept Phys Therapy, Niigata, Japan; [Saito, Toshiko] Niigata Univ Hlth & Welf, Dept Hlth & Nutr, Niigata, Japan; [Tsugane, Shoichiro] Natl Canc Ctr, Ctr Publ Hlth Sci, Tokyo, Japan; [Sasaki, Ayako] Murakami Publ Hlth Ctr, Murakami, Niigata, Japan	Niigata University; Nara Womens University; Niigata University; Niigata University; National Cancer Center - Japan	Nakamura, K (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Prevent Med, Niigata, Japan.	kazun@med.niigata-u.ac.jp	Tsugane, Shoichiro/A-2424-2015	Tsugane, Shoichiro/0000-0003-4105-2774	JSPS KAKENHI [JP26860436, JP15H04782, 17K09198]; National Cancer Center [23-A31[toku], 26-A-2]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Cancer Center	This work was supported by JSPS KAKENHI Grants (JP26860436, JP15H04782 and 17K09198) and the National Cancer Center Research and Development Fund (23-A31[toku] and 26-A-2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS457, DOI 10.1097/00005768-200009001-00004; Alhurani RE, 2016, JAMA NEUROL, V73, P439, DOI 10.1001/jamaneurol.2015.4756; Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Bagger YZ, 2004, OBES RES, V12, P1519, DOI 10.1038/oby.2004.189; Beydoun MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-643; Buchman AS, 2005, NEUROLOGY, V65, P892, DOI 10.1212/01.wnl.0000176061.33817.90; Burns JM, 2010, ARCH NEUROL-CHICAGO, V67, P428, DOI 10.1001/archneurol.2010.38; Di Marco LY, 2014, J ALZHEIMERS DIS, V42, P119, DOI 10.3233/JAD-132225; Emmerzaal TL, 2015, J ALZHEIMERS DIS, V43, P739, DOI 10.3233/JAD-141086; Fan YC, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0236-z; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujii H, 2011, DIABETOL INT, V2, P47, DOI 10.1007/s13340-011-0025-z; Garcia-Ptacek S, 2014, EUR J CLIN NUTR, V68, P1204, DOI 10.1038/ejcn.2014.199; Health Labour and Welfare Statistics Association, 2016, KOK NO FUK TO KAIG N; Inoue M, 2005, BRIT J CANCER, V92, P182, DOI 10.1038/sj.bjc.6602277; Kitamura K, 2016, DEMENT GER COGN D EX, V6, P341, DOI 10.1159/000447963; Kuriyama S, 2006, AM J CLIN NUTR, V83, P355; Lin JS, 2013, SCREENING COGNITIVE, P25; Maki N, 2000, DEMENT GERIATR COGN, V11, P193, DOI 10.1159/000017236; Noguchi-Shinohara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096013; Okamoto N, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-77; Ozawa M, 2014, J AM GERIATR SOC, V62, P1224, DOI 10.1111/jgs.12887; Pedditizi E, 2016, AGE AGEING, V45, P14, DOI 10.1093/ageing/afv151; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Qizilbash N, 2015, LANCET DIABETES ENDO, V3, P431, DOI 10.1016/S2213-8587(15)00033-9; Taniguchi Yu, 2015, Nihon Ronen Igakkai Zasshi, V52, P86, DOI 10.3143/geriatrics.52.86; Tomata Y, 2016, AM J GERIAT PSYCHIAT, V24, P881, DOI 10.1016/j.jagp.2016.07.009; Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096; Vidoni ED, 2011, NEUROLOGY, V77, P1913, DOI 10.1212/WNL.0b013e318238eec1; Xu W, 2017, EUR J EPIDEMIOL, V32, P31, DOI 10.1007/s10654-017-0225-3	30	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185960	10.1371/journal.pone.0185960	http://dx.doi.org/10.1371/journal.pone.0185960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982190	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300099
J	Zhu, HJ; Xu, Y; Gong, FY; Shan, GL; Yang, HB; Xu, K; Zhang, DX; Cheng, XQ; Zhang, ZH; Chen, S; Wang, LJ; Pan, H				Zhu, Huijuan; Xu, Yuan; Gong, Fengying; Shan, Guangliang; Yang, Hongbo; Xu, Ke; Zhang, Dianxi; Cheng, Xinqi; Zhang, Zhihao; Chen, Shi; Wang, Linjie; Pan, Hui			Reference ranges for serum insulin-like growth factor I (IGF-I) in healthy Chinese adults	PLOS ONE			English	Article							FACTOR BINDING-PROTEIN-3 CONCENTRATIONS; BINDING PROTEIN-3 IGFBP-3; BODY-MASS INDEX; REFERENCE INTERVALS; CLINICAL-PRACTICE; ANOREXIA-NERVOSA; CENTILE CURVES; LIFE-STYLE; LMS METHOD; POPULATION	Purpose To determine serum insulin-like growth factor 1 (IGF-I) levels in healthy Chinese adults, establish reference ranges for serum IGF-I levels and observe the effects of age, sex, body mass index (BMI) and geographical region on serum IGF-I levels. Methods In total, 2791 healthy adults (1339 males and 1452 females) from the north (Beijing) and south (Guizhou Province) of China were recruited following a questionnaire survey, physical examination and laboratory examination. Both sexes were divided into 13 groups according to age (18, 19, 20-24, 25-29, 30-34, 35-39, 40-44, 45-49, 50-54, 55-59, 60-64, 65-69 and -70 years). The serum IGF-I levels were measured by performing a chemiluminescent assay (Immulite 2000 (R)), and the LMS (Lambda-Mu-Sigma) method was applied to construct smooth centile curves of age-specific IGF-I levels. Results Serum IGF-I levels in the adults gradually decreased with increasing age from 18 to 70 years in both the male and female participants. Although the decrease in the level of IGF-1 was more pronounced in females than in males, no significant difference was observed between the sexes, except in the 60-to 64-year-old age group (P = 0.0329). The multiple linear regression model showed that there was an inverse relationship between the serum IGF-I level and BMI (P<0.001), and the serum IGF-I level in the Guizhou population was higher than that in the Beijing population (P<0.05). Conclusion The normal reference ranges for age- and sex-specific serum IGF-I levels were established for the first time in a large sample of Chinese adults. The serum IGF-I levels were significantly influenced by age, BMI and geographical region.	[Zhu, Huijuan; Gong, Fengying; Yang, Hongbo; Xu, Ke; Chen, Shi; Wang, Linjie; Pan, Hui] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Natl Hlth & Family Planning Commiss, Dept Endocrinol,Key Lab Endocrinol, Beijing, Peoples R China; [Zhu, Huijuan; Xu, Yuan; Gong, Fengying; Shan, Guangliang; Yang, Hongbo; Xu, Ke; Zhang, Dianxi; Cheng, Xinqi; Chen, Shi; Wang, Linjie; Pan, Hui] Peking Union Med Coll, Beijing, Peoples R China; [Xu, Yuan] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Surg, Beijing, Peoples R China; [Shan, Guangliang] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Inst Basic Med Sci, Dept Epidemiol & Stat, Beijing, Peoples R China; [Zhang, Dianxi; Cheng, Xinqi] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Lab Med, Beijing, Peoples R China; [Zhang, Zhihao] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA; [Zhang, Zhihao] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Pan, H (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Natl Hlth & Family Planning Commiss, Dept Endocrinol,Key Lab Endocrinol, Beijing, Peoples R China.	panhui20111111@163.com	Zhang, Zhihao/I-8570-2019; wang, lin/HHM-2225-2022	Zhang, Zhihao/0000-0003-2643-6841; 	National Natural Science Foundation of China [81400774, 81673184]; National Science & Technology Pillar Program [2012BAI37B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program	This work was supported by National Natural Science Foundation of China (CN), 81400774, Hongbo Yang, National Natural Science Foundation of China, 81673184, Prof. Hui Pan, National Science & Technology Pillar Program during the Twelfth Five-year Plan Period, 2012BAI37B02, Guangliang Shan. Those funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algeciras-Schimnich A, 2013, CLIN CHEM, V59, P1187, DOI 10.1373/clinchem.2013.205070; Bayram F, 2011, ENDOCRINE, V40, P304, DOI 10.1007/s12020-011-9476-z; Bidlingmaier M, 2014, J CLIN ENDOCR METAB, V99, P1712, DOI 10.1210/jc.2013-3059; Borofsky ND, 2002, CLIN CHEM, V48, P2248; Bradbury KE, 2015, GROWTH HORM IGF RES, V25, P90, DOI 10.1016/j.ghir.2015.01.001; Chanson P, 2016, J CLIN ENDOCR METAB, P2016; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Cook DM, 2009, ENDOCR PRACT, V15, P580, DOI 10.4158/EP.15.6.580; COUNTS DR, 1992, J CLIN ENDOCR METAB, V75, P762, DOI 10.1210/jc.75.3.762; Crowe FL, 2011, ANN HUM BIOL, V38, P194, DOI 10.3109/03014460.2010.507221; DeLellis K, 2004, CANCER EPIDEM BIOMAR, V13, P1444; Elkazaz AY, 2015, ENDOCRINE, V48, P272, DOI 10.1007/s12020-014-0290-2; Elmlinger MW, 2004, CLIN CHEM LAB MED, V42, P654, DOI 10.1515/CCLM.2004.112; Faupel-Badger JM, 2009, ANN EPIDEMIOL, V19, P841, DOI 10.1016/j.annepidem.2009.08.005; Friedrich N, 2008, GROWTH HORM IGF RES, V18, P228, DOI 10.1016/j.ghir.2007.09.005; GoodmanGruen D, 1997, AM J EPIDEMIOL, V145, P970, DOI 10.1093/oxfordjournals.aje.a009065; Gram IT, 2006, INT J OBESITY, V30, P1623, DOI 10.1038/sj.ijo.0803324; Harris TB, 1997, J AM GERIATR SOC, V45, P133, DOI 10.1111/j.1532-5415.1997.tb04497.x; HILL KK, 1993, J AM COLL NUTR, V12, P475, DOI 10.1080/07315724.1993.10718338; Holmes MD, 2002, CANCER EPIDEM BIOMAR, V11, P862; Hong Y, 1997, J ENDOCRINOL, V153, P251, DOI 10.1677/joe.0.1530251; Isojima T, 2012, ENDOCR J, V59, P771, DOI 10.1507/endocrj.EJ12-0110; JUUL A, 1994, J CLIN ENDOCR METAB, V78, P744, DOI 10.1210/jc.78.3.744; Katznelson L, 2014, J CLIN ENDOCR METAB, V99, P3933, DOI 10.1210/jc.2014-2700; Krebs A, 2008, CLIN CHEM LAB MED, V46, P1776, DOI 10.1515/CCLM.2008.349; Kwan AYM, 2007, PITUITARY, V10, P151, DOI 10.1007/s11102-007-0028-8; Kwee TC, 2006, PEDIATR RADIOL, V36, P8, DOI 10.1007/s00247-005-0011-3; Landin-Wilhelmsen K, 2004, HORM RES, V62, P8, DOI 10.1159/000080753; LANDINWILHELMSEN K, 1994, CLIN ENDOCRINOL, V41, P351, DOI 10.1111/j.1365-2265.1994.tb02556.x; Leite DB, 2011, AFR J BIOTECHNOL, V10, P18027, DOI 10.5897/AJB11.2323; Leung KC, 2004, ENDOCR REV, V25, P693, DOI 10.1210/er.2003-0035; Liao ZH, 2016, ENDOCR J, V63, P1081, DOI 10.1507/endocrj.EJ16-0144; Lukanova A, 2002, CANCER CAUSE CONTROL, V13, P509, DOI 10.1023/A:1016392129279; McGreevy K, 2005, UROLOGY, V66, P587, DOI 10.1016/j.urology.2005.03.070; Pokrajac A, 2007, CLIN ENDOCRINOL, V67, P65, DOI 10.1111/j.1365-2265.2007.02836.x; Probst-Hensch NM, 2003, CANCER EPIDEM BIOMAR, V12, P739; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; Rosario PW, 2010, ARQ BRAS ENDOCRINOL, V54, P477, DOI 10.1590/S0004-27302010000500008; SALMON WD, 1957, J LAB CLIN MED, V49, P825; Scacchi M, 1999, INT J OBESITY, V23, P260, DOI 10.1038/sj.ijo.0800807; Schernhammer ES, 2007, ENDOCR-RELAT CANCER, V14, P721, DOI 10.1677/ERC-06-0080; Teramukai S, 2002, AM J EPIDEMIOL, V156, P344, DOI 10.1093/aje/kwf069; Vu HTV, 2002, COMPUT STAT DATA AN, V40, P173, DOI 10.1016/S0167-9473(01)00099-8; Wang CT, 2012, CONTRACEPTION, V85, P570, DOI 10.1016/j.contraception.2011.10.014	45	39	42	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185561	10.1371/journal.pone.0185561	http://dx.doi.org/10.1371/journal.pone.0185561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976993	Green Published, gold, Green Submitted			2022-12-26	WOS:000412163100029
J	Zhou, WY; Wang, HY; Yu, WZ; Xie, WK; Zhao, M; Huang, LZ; Li, XX				Zhou, Weiyan; Wang, Hongya; Yu, Wenzhen; Xie, Wankun; Zhao, Min; Huang, Lvzhen; Li, Xiaoxin			The expression of the Slit-Robo signal in the retina of diabetic rats and the vitreous or fibrovascular retinal membranes of patients with proliferative diabetic retinopathy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PIGMENT EPITHELIAL-CELLS; TUMOR ANGIOGENESIS; AXON GUIDANCE; NEOVASCULARIZATION; ROUNDABOUT; MIGRATION; RECEPTOR; PATHOGENESIS; ADHESION	Purpose The Slit-Robo signal has an important role in vasculogenesis and angiogenesis. Our study examined the expression of Slit2 and its receptor, Robo1, in a rat model of streptozotocininduced diabetes and in patients with proliferative diabetic retinopathy. Methods Diabetes was induced in male Sprague-Dawley rats via a single, intraperitoneal injection of streptozotocin. The rats were sacrificed 1, 3 or 6 months after the injection. The expression of Slit2 and Robo1 in retinal tissue was measured by real-time reverse transcription polymerase chain reaction (RT-PCR), and protein levels were measured by western blotting and immunohistochemistry. Recombinant N-Slit2 protein was used to study the effects of Slit2 on the expression of VEGF in vivo. The concentration of Slit2 protein in human eyes was measured by enzyme-linked immunosorbent assay in 27 eyes with proliferative diabetic retinopathy and 28 eyes in control group. The expression of Slit2, Robo1 and VEGF in the excised human fibrovascular membranes was examined by fluorescence immunostaining and semi-quantitative RT-PCR. Results The expression of Slit2 and Robo1 in the retina was altered after STZ injection. Recombinant N-Slit2 protein did not increase the retinal VEGF expression. Vitreous concentrations of Slit2 were significantly higher in the study group than in the control group. In the human fibrovascular membranes of the study group, the co-localization of VEGF with the markers for Slit2 and Robo1was observed. The expression of Slit2 mRNA, Robo1 mRNA, and VEGF mRNA was significantly higher in human fibrovascular proliferative diabetic retinopathy membranes than in the control membranes. Conclusions The alteration of Slit2 and Robo1 expression in the retinas of diabetic rats and patients with proliferative diabetic retinopathy suggests a role for the Slit-Robo signal in the various stages diabetic retinopathy. Further studies should address the possible involvement of the Slit-Robo signal in the pathophysiological progress of diabetic retinopathy.	[Zhou, Weiyan] Shandong Univ, Dept Ophthalmol, Shandong Prov Hosp, Jinan, Shandong, Peoples R China; [Zhou, Weiyan; Yu, Wenzhen; Xie, Wankun; Zhao, Min; Huang, Lvzhen; Li, Xiaoxin] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing Key Lab Diag & Therapy Retinal & Choroid, Beijing, Peoples R China; [Wang, Hongya] Shandong Univ, Dept Clin Lab, Shandong Prov Hosp, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Peking University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Yu, WZ (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing Key Lab Diag & Therapy Retinal & Choroid, Beijing, Peoples R China.	wenzhen_yu@sina.com	Xie, Wankun/K-8623-2017	Xie, Wankun/0000-0003-0178-3361; Zhao, Min/0000-0003-0521-9186	Peking University People's Hospital Research and Development Fund [RDB2009-44]; Shangdong Province Young and Middle-Aged Scientists Research Awards Fund [BS2014YY060]; National Basic Research Program of China (973 Program) [2011CB510200]	Peking University People's Hospital Research and Development Fund; Shangdong Province Young and Middle-Aged Scientists Research Awards Fund; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research was supported by the Peking University People's Hospital Research and Development Fund (RDB2009-44); Shangdong Province Young and Middle-Aged Scientists Research Awards Fund (No.BS2014YY060); National Basic Research Program of China (973 Program, 2011CB510200).	Ahsan H, 2015, DIABETES METAB SYND, V9, P51, DOI 10.1016/j.dsx.2014.09.011; Ali TK, 2008, DIABETES, V57, P889, DOI 10.2337/db07-1669; Antonetti D A, 1999, Semin Ophthalmol, V14, P240, DOI 10.3109/08820539909069543; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; ENGERMAN RL, 1989, DIABETES, V38, P1203, DOI 10.2337/diabetes.38.10.1203; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Hammes HP, 1998, DIABETES, V47, P401, DOI 10.2337/diabetes.47.3.401; Huang LZ, 2010, INVEST OPHTH VIS SCI, V51, P3193, DOI 10.1167/iovs.09-3779; Huang LZ, 2009, CURR EYE RES, V34, P1019, DOI 10.3109/02713680903308495; Huang LZ, 2009, MOL VIS, V15, P1057; Huang LZ, 2009, EXP EYE RES, V88, P583, DOI 10.1016/j.exer.2008.11.016; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Legg JA, 2008, ANGIOGENESIS, V11, P13, DOI 10.1007/s10456-008-9100-x; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Li S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/186736; Liu ZJ, 2003, CANCER CELL, V4, P1, DOI 10.1016/S1535-6108(03)00166-1; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Matsuoka M, 2006, JPN J OPHTHALMOL, V50, P116, DOI 10.1007/s10384-005-0294-9; Mizutani M, 1996, J CLIN INVEST, V97, P2883, DOI 10.1172/JCI118746; Murugeswari P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107551; Paiva TF, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1648-4; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Park K, 2009, DIABETES, V58, P1902, DOI 10.2337/db08-1327; Rama N, 2015, NAT MED, V21, P483, DOI 10.1038/nm.3849; Rangasamy S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108508; Seth P, 2005, BIOCHEM BIOPH RES CO, V332, P533, DOI 10.1016/j.bbrc.2005.03.250; Suchting S, 2006, EXP CELL RES, V312, P668, DOI 10.1016/j.yexcr.2005.11.009; Tao Y, 2010, INVEST OPHTH VIS SCI, V51, P4237, DOI 10.1167/iovs.09-4466; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wang LJ, 2008, CANCER SCI, V99, P510, DOI 10.1111/j.1349-7006.2007.00721.x; Yang XC, 2017, ACTA DIABETOL, V54, P73, DOI 10.1007/s00592-016-0914-5; Yu DY, 2001, CLIN EXP OPHTHALMOL, V29, P164; Zhang B, 2009, BLOOD, V114, P4300, DOI 10.1182/blood-2008-12-193326; Zhang F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13517; Zhang JF, 2008, INVEST OPHTH VIS SCI, V49, P732, DOI 10.1167/iovs.07-0721; Zhao Y, 2016, MOL MED REP, V14, P1901, DOI 10.3892/mmr.2016.5518; Zhou WY, 2011, MOL VIS, V17, P1526	37	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185795	10.1371/journal.pone.0185795	http://dx.doi.org/10.1371/journal.pone.0185795			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973045	Green Published, gold, Green Submitted			2022-12-26	WOS:000412131900052
J	Akter, R; Naish, S; Hu, WB; Tong, SL				Akter, Rokeya; Naish, Suchithra; Hu, Wenbiao; Tong, Shilu			Socio-demographic, ecological factors and dengue infection trends in Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; AEDES-AEGYPTI; UNHOLY TRINITY; SUBANG JAYA; FEVER; DETERMINANTS; URBAN; URBANIZATION; TRANSMISSION; QUEENSLAND	Dengue has been a major public health concern in Australia. This study has explored the spatio-temporal trends of dengue and potential socio-demographic and ecological determinants in Australia. Data on dengue cases, socio-demographic, climatic and land use types for the period January 1999 to December 2010 were collected from Australian National Notifiable Diseases Surveillance System, Australian Bureau of Statistics, Australian Bureau of Meteorology, and Australian Bureau of Agricultural and Resource Economics and Sciences, respectively. Descriptive and linear regression analyses were performed to observe the spatio-temporal trends of dengue, socio-demographic and ecological factors in Australia. A total of 5,853 dengue cases (both local and overseas acquired) were recorded across Australia between January 1999 and December 2010. Most the cases (53.0%) were reported from Queensland, followed by New South Wales (16.5%). Dengue outbreak was highest (54.2%) during 2008-2010. A highest percentage of overseas arrivals (29.9%), households having rainwater tanks (33.9%), Indigenous population (27.2%), separate houses (26.5%), terrace house types (26.9%) and economically advantage people (42.8%) were also observed during 2008-2010. Regression analyses demonstrate that there was an increasing trend of dengue incidence, potential socio-ecological factors such as overseas arrivals, number of households having rainwater tanks, housing types and land use types (e.g. intensive uses and production from dryland agriculture). Spatial variation of socio-demographic factors was also observed in this study. In near future, significant increase of temperature was also projected across Australia. The projected increased temperature as well as increased socioecological trend may pose a future threat to the local transmission of dengue in other parts of Australia if Aedes mosquitoes are being established. Therefore, upgraded mosquito and disease surveillance at different ports should be in place to reduce the chance of mosquitoes and dengue cases being imported into all over Australia.	[Akter, Rokeya; Naish, Suchithra; Hu, Wenbiao; Tong, Shilu] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia; [Tong, Shilu] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Shanghai, Peoples R China; [Tong, Shilu] Anhui Med Univ, Sch Publ Hlth, Hefei, Anhui, Peoples R China; [Naish, Suchithra] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Rockhampton, Qld, Australia	Queensland University of Technology (QUT); Shanghai Jiao Tong University; Anhui Medical University; Central Queensland University	Akter, R (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia.	rokeya.akter@hdr.qut.edu.au		Hu, Wenbiao/0000-0001-6422-9240	Australian Government Research Training program (RTP); Australian Government	Australian Government Research Training program (RTP); Australian Government(Australian GovernmentCGIAR)	The study was funded by Australian Government Research Training program (RTP) previously known as Australian Postgraduate Award (APA).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Author (RA) is thankful to Australian Government for the financial support provided by Australian Government Research Training program (RTP) previously known as Australian Postgraduate Award (APA). Author acknowledges the contributions of state and territory communicable disease control units, Australia.	ABS, 2016, CENS DAT COMM PROF; Akter R, 2017, TROP MED INT HEALTH, V22, P656, DOI 10.1111/tmi.12868; Araujo RV, 2015, BRAZ J INFECT DIS, V19, P146, DOI 10.1016/j.bjid.2014.10.004; Arunachalam N, 2010, B WORLD HEALTH ORGAN, V88, P173, DOI 10.2471/BLT.09.067892; Astrom C, 2012, ECOHEALTH, V9, P448, DOI 10.1007/s10393-012-0808-0; Bambrick HJ, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.2059; Beebe NW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000429; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Buczak AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002771; Buczak AL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-124; Caprara A, 2009, CAD SAUDE PUBLICA, V25, pS125, DOI 10.1590/S0102-311X2009001300012; Cheong YL, 2014, SPAT SPATIO-TEMPORAL, V10, P75, DOI 10.1016/j.sste.2014.05.002; Cunningham R, 1996, J MED MICROBIOL, V44, P157, DOI 10.1099/00222615-44-3-157; Darbro J, 2017, ECOL ECON, V142, P203, DOI 10.1016/j.ecolecon.2017.06.015; Delmelle E, 2016, ACTA TROP, V164, P169, DOI 10.1016/j.actatropica.2016.08.028; Dom NC, 2013, GEOCARTO INT, V28, P258, DOI 10.1080/10106049.2012.696726; Eastin MD, 2014, AM J TROP MED HYG, V91, P598, DOI 10.4269/ajtmh.13-0303; Ebi KL, 2016, ENVIRON RES, V151, P115, DOI 10.1016/j.envres.2016.07.026; Gubler D, 2012, INT J INFECT DIS, V16, pE2, DOI 10.1016/j.ijid.2012.05.009; Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9; Hu WB, 2012, ENVIRON HEALTH PERSP, V120, P260, DOI 10.1289/ehp.1003270; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Kurucz N, 2014, TENNANT CREEK DENGUE; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Landau KI, 2012, J VECTOR ECOL, V37, P407, DOI 10.1111/j.1948-7134.2012.00245.x; Li S, 2013, ASIA-PAC J PUBLIC HE, V25, P239, DOI 10.1177/1010539511418819; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; McBride WJH, 1998, AM J EPIDEMIOL, V148, P1111, DOI 10.1093/oxfordjournals.aje.a009589; Mondini A, 2008, SCI TOTAL ENVIRON, V393, P241, DOI 10.1016/j.scitotenv.2008.01.010; Nazri C, 2011, HUMANITIES SCI ENG C; Nazri Che Dom, 2013, Asian Pacific Journal of Tropical Disease, V3, P352; Patz JA, 1998, ENVIRON HEALTH PERSP, V106, P147, DOI 10.1289/ehp.98106147; Pdnn S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0166806; Queensland Health, 2011, QUEENSL DENG MAN PLA, P1; Reiner RC, 2015, T ROY SOC TROP MED H, V109, P171, DOI 10.1093/trstmh/tru194; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874; Sarfraz MS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-853; Schmidt WP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001082; SHOPE R, 1991, ENVIRON HEALTH PERSP, V96, P171, DOI 10.2307/3431227; Sloan-Gardner T, 2011, COMMUN DIS INTELL, V35, P61; Teurlai M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004211; Trewin BJ, 2013, INT HEALTH, V5, P251, DOI 10.1093/inthealth/iht023; Troyo A, 2009, SINGAPORE J TROP GEO, V30, P265, DOI 10.1111/j.1467-9493.2009.00367.x; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; TunLin W, 1995, AM J TROP MED HYG, V53, P595, DOI 10.4269/ajtmh.1995.53.595; van den Hurk AF, 2016, ONE HEALTH-AMSTERDAM, V2, P19, DOI 10.1016/j.onehlt.2016.02.001; Vanwambeke SO, 2007, ECOHEALTH, V4, P37, DOI 10.1007/s10393-007-0085-5; Vanwambeke Sophie O, 2006, Int J Health Geogr, V5, P5, DOI 10.1186/1476-072X-5-5; Vanwambeke SO, 2011, TROP MED INT HEALTH, V16, P174, DOI 10.1111/j.1365-3156.2010.02671.x; Whelan Peter, 2001, Arbovirus Research in Australia, V8, P395; Wijayanti SPM, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0004964, 10.1371/journal.pntd.0004500]; Woodruff R, 2005, CLIMATE CHANGE HLTH; World Health Organization, 2012, GLOB STRAT DENG PREV; World Health Organization ROfS-EA, 2011, COMPR GUID PREV CONT; Wu PC, 2009, SCI TOTAL ENVIRON, V407, P2224, DOI 10.1016/j.scitotenv.2008.11.034	58	24	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185551	10.1371/journal.pone.0185551	http://dx.doi.org/10.1371/journal.pone.0185551			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968420	Green Published, gold, Green Submitted			2022-12-26	WOS:000412029600024
J	Chun, JH; Lee, CB				Chun, Jung-Hwa; Lee, Chang-Bae			Disentangling the local-scale drivers of taxonomic, phylogenetic and functional diversity in woody plant assemblages along elevational gradients in South Korea	PLOS ONE			English	Article							TROPICAL TREE COMMUNITIES; SPECIES-RICHNESS; BETA-DIVERSITY; SPATIAL SCALES; PATTERNS; MECHANISMS; TRAITS; DETERMINISM; TEMPERATE; FORESTS	Recently, new alternative matrices of biodiversity such as phylogenetic and functional diversity as a complement to species diversity have provided new insights into the mechanisms of community assembly. In this study, we analyzed the phylogenetic signals of five functional traits and the relative contribution of environmental variables and distance matrices to the alpha and beta components of taxonomic, phylogenetic and functional diversity in woody plant assemblages along four local elevational transects on two different mountains. We observed low but significant phylogenetic signals of functional traits, which suggest that phylogenetic dispersion can provide a rough approximation of functional dispersion but not perfect correlations between phylogenetic and functional diversity. Taxonomic alpha diversity showed a monotonic decline with elevation, and climatic variables were the main drivers of this pattern along all studied transects. Furthermore, although the phylogenetic and functional alpha dispersions showed different elevational patterns including increase, decrease and no relationship, the underlying processes driving the patterns of both types of alpha dispersion could be explained by the gradients of climatic and habitat variables as well as biotic interactions such as competition. These results suggest that both alpha dispersion patterns may be significantly controlled by niche-based deterministic processes such as biotic interactions and environmental filtering in our study areas. Moreover, the beta diversity with geographical distances showed distance-decay relationships for all transects. Although the relative importance of the environmental and geographical distances for beta diversity varied across the three facets of diversity and the transects, we generally found that environmental distances were more important for the beta components of the three facets of diversity. However, we cannot discriminate the effects of both distances on the three facets of diversity. Therefore, our study suggests that niche-based deterministic processes, potentially combined with neutral processes such as dispersal limitation and demographic stochasticity, may influence patterns of woody plant assemblage turnover in our study areas.	[Chun, Jung-Hwa] Natl Inst Forest Sci, Div Forest Ecol, Seoul, South Korea; [Lee, Chang-Bae] Korea Forestry Promot Inst, Global Resources Div, Seoul, South Korea	Korea Forest Research Institute (KFRI); National Institute of Forest Science (NIFOS), Republic of South Korea	Lee, CB (corresponding author), Korea Forestry Promot Inst, Global Resources Div, Seoul, South Korea.	cblee@kofpi.or.kr		Lee, Chang-Bae/0000-0002-3543-6440	Korea Green Promotion Agency, Korea Forest Service	Korea Green Promotion Agency, Korea Forest Service(Korea Forest Service)	This paper forms part of the Korea Big Tree Project funded by the Korea Green Promotion Agency, Korea Forest Service. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Braun-Blanquet J., PLANT SOCIOLOGY STUD; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; CHO H J, 1991, Journal of Korean Forestry Society, V80, P42; Chun JH, 2013, KOREAN J AGR FOR MET, V15, P291; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Culmsee H, 2013, J BIOGEOGR, V40, P1997, DOI 10.1111/jbi.12138; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Eiserhardt WL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01164; Garnier E., 2016, PLANT FUNCTIONAL DIV, DOI DOI 10.1093/ACPROF:OSO/9780198757368.001.0001; Gonzalez-Caro S, 2014, J PLANT ECOL, V7, P145, DOI 10.1093/jpe/rtt076; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; Hall JS, 2004, ECOLOGY, V85, P2171, DOI 10.1890/03-0043; Helmus MR, 2007, ECOL LETT, V10, P917, DOI 10.1111/j.1461-0248.2007.01083.x; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Kitagawa R, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv134; Kluge J, 2006, GLOBAL ECOL BIOGEOGR, V15, P358, DOI [10.1111/j.1466-822X.2006.00223.x, 10.1111/j.1466-822x.2006.00223.x]; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kong W. S., 2007, BIOGEOGRAPHY KOREA P; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Lee CB, 2014, NORD J BOT, V32, P347, DOI 10.1111/j.1756-1051.2013.00181.x; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P., 2012, NUMERICAL ECOLOGY; Li XH, 2014, J SYST EVOL, V52, P280, DOI 10.1111/jse.12027; Liu J, 2014, FOREST ECOL MANAG, V330, P75, DOI 10.1016/j.foreco.2014.06.045; Machac A, 2011, ECOGRAPHY, V34, P364, DOI 10.1111/j.1600-0587.2010.06629.x; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Moles AT, 2009, J ECOL, V97, P923, DOI 10.1111/j.1365-2745.2009.01526.x; Moles AT, 2006, OIKOS, V113, P91, DOI 10.1111/j.0030-1299.2006.14194.x; Myers JA, 2013, ECOL LETT, V16, P151, DOI 10.1111/ele.12021; Oommen MA, 2005, ECOLOGY, V86, P3039, DOI 10.1890/04-1837; Ordonez A, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1237; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PALMER MW, 1994, FOLIA GEOBOT PHYTOTX, V29, P511, DOI 10.1007/BF02883148; Pellissier L, 2013, GLOBAL ECOL BIOGEOGR, V22, P577, DOI 10.1111/geb.12026; Qian H, 2014, J PLANT ECOL, V7, P154, DOI 10.1093/jpe/rtt072; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rowe R, 2009, ECOGRAPHY, V32, P411, DOI 10.1111/j.1600-0587.2008.05538.x; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Stephenson NL, 2011, SCIENCE, V334, DOI 10.1126/science.1205740; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Storch D, 2005, SCIENCE, V307, P684, DOI 10.1126/science.1106935; Svenning JC, 2004, ECOLOGY, V85, P2526, DOI 10.1890/03-0396; Swenson NG, 2013, ECOGRAPHY, V36, P264, DOI 10.1111/j.1600-0587.2012.00121.x; Swenson NG, 2012, ECOLOGY, V93, P490, DOI 10.1890/11-1180.1; Swenson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021264; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; Tilman D., 1982, Monographs in Population Biology, pi; Wang JJ, 2012, ENV MICROBIOL REP, V4, P217, DOI 10.1111/j.1758-2229.2011.00324.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Weinstein BG, 2014, AM NAT, V184, P211, DOI 10.1086/676991; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Willis CG, 2010, ECOGRAPHY, V33, P565, DOI 10.1111/j.1600-0587.2009.05975.x; Yang JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10068; Yang J, 2014, FUNCT ECOL, V28, P520, DOI 10.1111/1365-2435.12176; Yun Jin, 2010, [Korean Journal of Agricultural and Forest Meteorology, 한국농림기상학회지], V12, P63	64	15	15	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185763	10.1371/journal.pone.0185763	http://dx.doi.org/10.1371/journal.pone.0185763			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968448	Green Published, gold, Green Submitted			2022-12-26	WOS:000412029600044
J	Lemez, S; Wattie, N; Baker, J				Lemez, Srdjan; Wattie, Nick; Baker, Joseph			Do "big guys" really die younger? An examination of height and lifespan in former professional basketball players	PLOS ONE			English	Article							MORTALITY; LONGEVITY; MEN; WEIGHT; CANCER; COHORT; WOMEN; BODY; RISK	While factors such as genetics may mediate the relationship between height and mortality, evidence suggests that larger body size may be an important risk indicator of reduced lifespan longevity in particular. This study critically examined this relationship in professional basketball players. We examined living and deceased players who have played in the National Basketball Association (debut between 1946-2010) and/or the American Basketball Association (1967-1976) using descriptive and Kaplan-Meier and Cox regression analyses. The cut-off date for death data collection was December 11, 2015. Overall, 3,901 living and deceased players were identified and had a mean height of 197.78 cm (+/- 9.29, Range: 160.02-231.14), and of those, 787 former players were identified as deceased with a mean height of 193.88 cm (+/- 8.83, Range: 167.6-228.6). Descriptive findings indicated that the tallest players (top 5%) died younger than the shortest players (bottom 5%) in all but one birth decade (1941-1950). Similarly, survival analyses showed a significant relationship between height and lifespan longevity when both dichotomizing [chi(2) (1) = 13.04, p < .05] and trichotomizing [chi(2) (2) = 18.05, p < .05] the predictor variable height per birth decade, where taller players had a significantly higher mortality risk compared to shorter players through median (HR: 1.30, 95% CI: 1.13-1.50, p < .05) and trichotomized tertile split (HR: 1.40, 95% CI: 1.18-1.68, p <. 05; tallest 33.3% compared to shortest 33.3%) analyses. The uniqueness of examining the height-longevity hypothesis in this relatively homogeneous sub-population should be considered when interpreting these results. Further understanding of the potential risks of early mortality can help generate discourse regarding potential at-risk cohorts of the athlete population.	[Lemez, Srdjan] Calif State Univ Los Angeles, Sch Kinesiol & Nutr Sci, Los Angeles, CA 90032 USA; [Wattie, Nick] Univ Ontario Inst Technol, Fac Hlth Sci, Oshawa, ON, Canada; [Baker, Joseph] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada	California State University System; California State University Los Angeles; Ontario Tech University; York University - Canada	Lemez, S (corresponding author), Calif State Univ Los Angeles, Sch Kinesiol & Nutr Sci, Los Angeles, CA 90032 USA.	slemez@calstatela.edu	PAN, ZEQIANG/X-6341-2018	Baker, Joseph/0000-0002-5686-1737; Lemez, Srdjan/0000-0002-6770-7778				[Anonymous], 2016, NATL VITAL STAT REPO, V64; Epstein D., 2016, WHAT DOES HIST HEIGH; EPSTEIN DAVID, 2014, SPORTS GENE INSIDE S; Gavrilov LA, 2012, BIODEMOGR SOC BIOL, V58, P14, DOI 10.1080/19485565.2012.666121; Giovannelli L, 2002, CARCINOGENESIS, V23, P1483, DOI 10.1093/carcin/23.9.1483; He QM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105839; Kabat GC, 2013, CANCER EPIDEM BIOMAR, V22, P1353, DOI 10.1158/1055-9965.EPI-13-0305; Koppett L, 2003, TOTAL BASKETBALL ULT; Lawler T, 2012, ANN EPIDEMIOL, V22, P406, DOI 10.1016/j.annepidem.2012.04.009; Lemez S, 2016, SCAND J MED SCI SPOR, V26, P544, DOI 10.1111/sms.12480; Lemez S, 2015, SPORTS MED OPEN, V1; MacMullan J., 2016, LARRY BIRD WILL DIE; Noymer A, 2000, POPUL DEV REV, V26, P565, DOI 10.1111/j.1728-4457.2000.00565.x; Powell-Morse A., 2015, HIST PROFILE NBA PLA; Salaris L, 2012, BIODEMOGR SOC BIOL, V58, P1, DOI 10.1080/19485565.2012.666118; Samaras TT, 2009, S AFR J CLIN NUTR, V22, P171; Samaras T.T., 2014, J SCI RES REP, V3, P2150, DOI DOI 10.9734/JSRR/2014/11268; Samaras Thomas T., 2012, Nutrition and Health (Bicester), V21, P247, DOI 10.1177/0260106013510996; Samaras TT, 2009, EXP GERONTOL, V44, P83, DOI 10.1016/j.exger.2008.02.002; SAMARAS TT, 1992, B WORLD HEALTH ORGAN, V70, P259; Samaras TT, 2002, WESTERN J MED, V176, P206, DOI 10.1136/ewjm.176.3.206; Samaras TT, 2012, INDIAN HEART J, V65, P66; Samaras TT, 1996, TOWNSEND LETT DOCTOR, V159, P78; Samaras TT, 2007, HUMAN BODY SIZE LAWS; Samaras TT., 2017, JSRR, V15, P1; SAMARAS TT, 1996, J WASHINGTON ACAD SC, V84, P131; Smith GD, 2000, J EPIDEMIOL COMMUN H, V54, P97, DOI 10.1136/jech.54.2.97; Suzuki M, 2001, ASIA PAC J CLIN NUTR, V10, P165, DOI 10.1046/j.1440-6047.2001.00219.x; Willcox BJ, 2004, J GERONTOL A-BIOL, V59, P789	29	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185617	10.1371/journal.pone.0185617	http://dx.doi.org/10.1371/journal.pone.0185617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968418	Green Submitted, Green Published, gold			2022-12-26	WOS:000412029600029
J	He, Y; Zhao, Y; Wang, L; Bohrer, LR; Pan, Y; Huang, H				He, Y.; Zhao, Y.; Wang, L.; Bohrer, L. R.; Pan, Y.; Huang, H.			LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation	ONCOGENE			English	Article							ONCOGENE-INDUCED SENESCENCE; LARGE GENE LISTS; HISTONE DEMETHYLASE; DNA-DAMAGE; CELLULAR SENESCENCE; STRUCTURAL BASIS; PHOSPHORYLATION; TRANSCRIPTION; MECHANISM; COMPLEX	Histone H3 lysine-9 (H3K9) methylation is essential for retinoblastoma protein (RB)-mediated heterochromatin formation, epigenetic silencing of S-phase genes and permanent cell cycle arrest or cellular senescence. Besides as an H3K4 demethylase, lysine-specific demethylase-1 (LSD1) has been shown to promote H3K9 demethylation. However, it is unexplored whether LSD1 has a causal role in regulating cell cycle entry and senescence. Here we demonstrate that genetic depletion or pharmacological inhibition of LSD1 triggers G1 arrest and cellular senescence. Genome-wide chromatin immunoprecipitation-sequencing analysis reveals that LSD1 binding sites overlap significantly with those bound by the S-phase gene transcription factor E2F1. Gene ontology analysis demonstrates that a large portion of E2F1 and LSD1 cotargeted genes are involved in cell cycle and proliferation. Further analyses show that depletion of LSD1 increases the level of H3K9me2 and thereby represses expression of the LSD1-E2F1 cotarget genes, but has no effects on H3K4me2 level in those loci. In contrast, knockdown of the H3K4me2 reader PHF8 decreases the H3K4me2 level at the LSD1-E2F1 cotargeted loci, but this effect is rescued by codepletion of LSD1. Furthermore, the enzymatic activity of LSD1 is essential for H3K9me2 demethylation at cell cycle gene loci. Notably, cotreatment of chemotherapeutic agent camptothecin enhanced LSD1 inhibitor-induced senescence and growth inhibition of cancer cells in vitro and in mice. Our data reveal LSD1 as a molecular rheostat selectively regulating H3K9 demethylation at cell cycle gene loci, thereby representing a key player in oncogenesis and a viable target for cancer therapy.	[He, Y.; Zhao, Y.; Wang, L.; Pan, Y.; Huang, H.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 First St SW,Gugg 1311B, Rochester, MN 55905 USA; [Bohrer, L. R.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Wang, L.] Mayo Clin, Coll Med, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Huang, H.] Mayo Clin, Coll Med, Dept Urol, Rochester, MN 55905 USA; [Huang, H.] Mayo Clin, Coll Med, Canc Ctr, Rochester, MN 55905 USA	Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Mayo Clinic; Mayo Clinic	Huang, H (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 First St SW,Gugg 1311B, Rochester, MN 55905 USA.	huang.haojie@mayo.edu	Zhao, Yu/GQR-1394-2022; zhao, yu/AAD-9494-2021	Wang, Liguo/0000-0003-2072-4826	National Institutes of Health [CA134514, CA130908, CA193239]; Department of Defense [W81XWH-09-1-622]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense)	We thank Binhua Zhou for plasmids. This work was supported in part by grants from the National Institutes of Health (CA134514, CA130908 and CA193239 to HH) and the Department of Defense (W81XWH-09-1-622 to HH).	Adamo A, 2011, NAT CELL BIOL, V13, P652, DOI 10.1038/ncb2246; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005; Chau CM, 2008, J VIROL, V82, P3428, DOI 10.1128/JVI.01412-07; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Forneris F, 2007, J BIOL CHEM, V282, P20070, DOI 10.1074/jbc.C700100200; Forneris F, 2006, J BIOL CHEM, V281, P35289, DOI 10.1074/jbc.M607411200; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Gargiulo G, 2013, CANCER CELL, V23, P660, DOI 10.1016/j.ccr.2013.03.030; Gu L, 2015, NAT GENET, V47, P22, DOI 10.1038/ng.3165; Haberle V, 2014, NATURE, V507, P381, DOI 10.1038/nature12974; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hou HF, 2010, CURR OPIN STRUC BIOL, V20, P739, DOI 10.1016/j.sbi.2010.09.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kuppuswamy M, 2008, MOL CELL BIOL, V28, P269, DOI 10.1128/MCB.01077-07; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laurent B, 2015, MOL CELL, V57, P957, DOI 10.1016/j.molcel.2015.01.010; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Liang Y, 2009, NAT MED, V15, P1312, DOI 10.1038/nm.2051; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lin YW, 2010, EMBO J, V29, P1803, DOI 10.1038/emboj.2010.63; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2010, NATURE, V464, P792, DOI 10.1038/nature08839; Mohammad HP, 2015, CANCER CELL, V28, P57, DOI 10.1016/j.ccell.2015.06.002; Nair SS, 2010, EMBO REP, V11, P438, DOI 10.1038/embor.2010.62; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Stavropoulos P, 2006, NAT STRUCT MOL BIOL, V13, P626, DOI 10.1038/nsmb1113; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012; Zhang BJ, 2016, NATURE, V537, P553, DOI 10.1038/nature19361; Zhang L, 2006, ONCOGENE, V25, P2615, DOI 10.1038/sj.onc.1209286; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	52	30	30	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 25	2018	37	4					534	543		10.1038/onc.2017.353	http://dx.doi.org/10.1038/onc.2017.353			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT7KP	28991226				2022-12-26	WOS:000423331600011
J	Visvanathan, A; Patil, V; Arora, A; Hegde, AS; Arivazhagan, A; Santosh, V; Somasundaram, K				Visvanathan, A.; Patil, V; Arora, A.; Hegde, A. S.; Arivazhagan, A.; Santosh, V; Somasundaram, K.			Essential role of METTL3-mediated m(6)A modification in glioma stem-like cells maintenance and radioresistance	ONCOGENE			English	Article							MESSENGER-RNA METHYLATION; ACUTE MYELOID-LEUKEMIA; HOMOLOGOUS RECOMBINATION; PROTEIN EXPRESSION; POINT MUTATION; DNA-DAMAGE; GLIOBLASTOMA; N-6-METHYLADENOSINE; TRANSLATION; CANCER	Despite advances in biology and therapeutic modalities, existence of highly tumorigenic glioma stem-like cells (GSCs) makes glioblastomas (GBMs) invincible. N6-methyl adenosine (m(6)A), one of the abundant mRNA modifications catalyzed by methyltransferase-like 3 and 14 (METTL3/14), influences various events in RNA metabolism. Here, we report the crucial role of METTL3-mediated m(6)A modification in GSC (neurosphere) maintenance and dedifferentiation of glioma cells. METTL3 expression is elevated in GSC and attenuated during differentiation. RNA immunoprecipitation studies identified SOX2 as a bonafide m(6)A target of METTL3 and the m(6)A modification of SOX2 mRNA by METTL3 enhanced its stability. The exogenous overexpression of 3' UTR-less SOX2 significantly alleviated the inhibition of neurosphere formation observed in METTL3 silenced GSCs. METTL3 binding and m(6)A modification in vivo required intact three METTL3/m(6)A sites present in the SOX2-3' UTR. Further, we found that the recruitment of Human antigen R (HuR) to m(6)A-modified RNA is essential for SOX2 mRNA stabilization by METTL3. In addition, we found a preferential binding by HuR to the m(6)A-modified transcripts globally. METTL3 silenced GSCs showed enhanced sensitivity to gamma-irradiation and reduced DNA repair as evidenced from the accumulation of gamma-H2AX. Exogenous overexpression of 3' UTR-less SOX2 in METTL3 silenced GSCs showed efficient DNA repair and also resulted in the significant rescue of neurosphere formation from METTL3 silencing induced radiosensitivity. Silencing METTL3 inhibited RasV12 mediated transformation of mouse immortalized astrocytes. GBM tumors have elevated levels of METTL3 transcripts and silencing METTL3 in U87/TIC inhibited tumor growth in an intracranial orthotopic mouse model with prolonged mice survival. METTL3 transcript levels predicted poor survival in GBMs which are enriched for GSC-specific signature. Thus our study reports the importance of m(6)A modification in GSCs and uncovers METTL3 as a potential molecular target in GBM therapy.	[Visvanathan, A.; Patil, V; Arora, A.; Somasundaram, K.] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore, Karnataka, India; [Hegde, A. S.] Sri Satya Sai Inst Higher Med Sci, Bangalore, Karnataka, India; [Arivazhagan, A.] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore, Karnataka, India; [Santosh, V] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India	Somasundaram, K (corresponding author), Indian Inst Sci, Microbiol & Cell Biol, CV Raman Ave, Bangalore 560012, Karnataka, India.	skumar@mcbl.iisc.ernet.in			IISc; DST, Government of India; DBT, Government of India	IISc; DST, Government of India(Department of Science & Technology (India)); DBT, Government of India(Department of Biotechnology (DBT) India)	The results published here are in part based upon data generated by The Cancer Genome Atlas (TCGA) pilot project established by the NCI and NHGRI. Information about TCGA and the investigators and institutions, which constitute the TCGA research network, can be found at http://cancergenome.nih.gov/. The use of data sets from Institute NC, GSE76976 and GSE22866 is acknowledged. We thank Dr Hiroaki Wakimoto and Dr Samuel Rabkin for providing GSCs and Dr Kenneth Kousik for 3 ' UTR-SOX2-Luc construct. KS thanks DST and DBT, Government of India for financial support. KS is a JC Bose Fellow of the Department of Science and Technology. AV acknowledges IISc for the fellowship.	Aguilo F, 2015, CELL STEM CELL, V17, P689, DOI 10.1016/j.stem.2015.09.005; Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; Allamand V, 2006, EMBO REP, V7, P450, DOI 10.1038/sj.embor.7400648; Azari H, 2011, JOVE-J VIS EXP, DOI 10.3791/3633; Bansal H, 2014, LEUKEMIA, V28, P1171, DOI 10.1038/leu.2014.16; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Chen T, 2015, CELL STEM CELL, V16, P289, DOI 10.1016/j.stem.2015.01.016; Cho DY, 2013, CELL TRANSPLANT, V22, P731, DOI 10.3727/096368912X655136; Choi J, 2016, NAT STRUCT MOL BIOL, V23, P110, DOI 10.1038/nsmb.3148; Cui Q, 2017, CELL REP, V18, P2622, DOI 10.1016/j.celrep.2017.02.059; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Filippova N, 2011, MOL CANCER RES, V9, P648, DOI 10.1158/1541-7786.MCR-10-0325; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Hongay CF, 2011, P NATL ACAD SCI USA, V108, P14855, DOI 10.1073/pnas.1111577108; Jackson M, 2015, CARCINOGENESIS, V36, P177, DOI 10.1093/carcin/bgu243; Kim BW, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-2015-1; Kwok CT, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0410-6; Lathia JD, 2015, GENE DEV, V29, P1203, DOI 10.1101/gad.261982.115; Lee G, 2016, MOL CANCER THER, V15, P3064, DOI 10.1158/1535-7163.MCT-15-0675; Lee YS, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/520578; Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017; Lim YC, 2014, MOL ONCOL, V8, P1603, DOI 10.1016/j.molonc.2014.06.012; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Martin ME, 1998, BLOOD, V91, P319, DOI 10.1182/blood.V91.1.319; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; Schildknecht S, 2012, ALTEX-ALTERN ANIM EX, V29, P261, DOI 10.14573/altex.2012.3.261; Shen LF, 2014, J HISTOCHEM CYTOCHEM, V62, P499, DOI 10.1369/0022155414532654; Spitale RC, 2015, NATURE, V519, P486, DOI 10.1038/nature14263; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tuck MT, 1996, CANCER LETT, V103, P107, DOI 10.1016/0304-3835(96)04203-6; Wakimoto H, 2012, NEURO-ONCOLOGY, V14, P132, DOI 10.1093/neuonc/nor195; Wang X, 2016, NATURE, V534, P575, DOI 10.1038/nature18298; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Xiang Y, 2017, NATURE, V543, P573, DOI 10.1038/nature21671; Yi CQ, 2011, ACCOUNTS CHEM RES, V44, P1380, DOI 10.1021/ar200057m; Zhang CZ, 2016, ONCOTARGET, V7, P64527, DOI 10.18632/oncotarget.11743; Zhang SC, 2017, CANCER CELL, V31, P591, DOI 10.1016/j.ccell.2017.02.013	49	336	356	10	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 25	2018	37	4					522	533		10.1038/onc.2017.351	http://dx.doi.org/10.1038/onc.2017.351			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT7KP	28991227	Green Published			2022-12-26	WOS:000423331600010
J	Beshr, G; Sikandar, A; Jemiller, EM; Klymiuk, N; Hauck, D; Wagner, S; Wolf, E; Koehnke, J; Titz, A				Beshr, Ghamdan; Sikandar, Asfandyar; Jemiller, Eva-Maria; Klymiuk, Nikolai; Hauck, Dirk; Wagner, Stefanie; Wolf, Eckhard; Koehnke, Jesko; Titz, Alexander			Photorhabdus luminescens lectin A (PllA): A new probe for detecting -galactoside-terminating glycoconjugates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate; carbohydrate-binding protein; glycobiology; lectin; protein structure; structural biology	BURKHOLDERIA-CENOCEPACIA LECTIN; COMPETITIVE-BINDING ASSAY; ALPHA-GAL EPITOPE; PSEUDOMONAS-AERUGINOSA; STRUCTURAL BASIS; SP NOV.; PA-IL; PROTEIN; SEQUENCE; XENORHABDUS	Lectins play important roles in infections by pathogenic bacteria, for example, in host colonization, persistence, and biofilm formation. The Gram-negative entomopathogenic bacterium Photorhabdus luminescens symbiotically lives in insect-infecting Heterorhabditis nematodes and kills the insect host upon invasion by the nematode. The P. luminescens genome harbors the gene plu2096, coding for a novel lectin that we named PllA. We analyzed the binding properties of purified PllA with a glycan array and a binding assay in solution. Both assays revealed a strict specificity of PllA for -galactoside-terminating glycoconjugates. The crystal structures of apo PllA and complexes with three different ligands revealed the molecular basis for the strict specificity of this lectin. Furthermore, we found that a 90 degrees twist in subunit orientation leads to a peculiar quaternary structure compared with that of its ortholog LecA from Pseudomonas aeruginosa. We also investigated the utility of PllA as a probe for detecting -galactosides. The -Gal epitope is present on wild-type pig cells and is the main reason for hyperacute organ rejection in pig to primate xenotransplantation. We noted that PllA specifically recognizes this epitope on the glycan array and demonstrated that PllA can be used as a fluorescent probe to detect this epitope on primary porcine cells in vitro. In summary, our biochemical and structural analyses of the P. luminescens lectin PllA have disclosed the structural basis for PllA's high specificity for -galactoside-containing ligands, and we show that PllA can be used to visualize the -Gal epitope on porcine tissues.	[Beshr, Ghamdan; Hauck, Dirk; Wagner, Stefanie; Titz, Alexander] Helmholtz Inst Pharmaceut Res Saarland HIPS, Div Chem Biol Carbohydrates, D-66123 Saarbrucken, Germany; [Sikandar, Asfandyar; Koehnke, Jesko] Helmholtz Inst Pharmaceut Res Saarland HIPS, Div Struct Biol Biosynth Enzymes, D-66123 Saarbrucken, Germany; [Beshr, Ghamdan; Hauck, Dirk; Wagner, Stefanie; Titz, Alexander] Saarland Univ, Standort Hannover Braunschweig, Deutsch Zentrum Infektionsforsch DZIF, D-66123 Saarbrucken, Germany; [Beshr, Ghamdan; Sikandar, Asfandyar; Koehnke, Jesko; Titz, Alexander] Saarland Univ, Dept Pharm, D-66123 Saarbrucken, Germany; [Jemiller, Eva-Maria; Klymiuk, Nikolai; Wolf, Eckhard] Ludwig Maximilian Univ Munich, Gene Ctr, Chair Mol Anim Breeding & Biotechnol, D-81377 Munich, Germany; [Jemiller, Eva-Maria; Klymiuk, Nikolai; Wolf, Eckhard] Ludwig Maximilian Univ Munich, Dept Vet Sci, D-81377 Munich, Germany	Helmholtz Association; Helmholtz Association; German Center for Infection Research; Saarland University; Saarland University; University of Munich; University of Munich	Titz, A (corresponding author), Helmholtz Inst Pharmaceut Res Saarland HIPS, Div Chem Biol Carbohydrates, D-66123 Saarbrucken, Germany.; Koehnke, J (corresponding author), Helmholtz Inst Pharmaceut Res Saarland HIPS, Div Struct Biol Biosynth Enzymes, D-66123 Saarbrucken, Germany.; Titz, A (corresponding author), Saarland Univ, Standort Hannover Braunschweig, Deutsch Zentrum Infektionsforsch DZIF, D-66123 Saarbrucken, Germany.; Koehnke, J; Titz, A (corresponding author), Saarland Univ, Dept Pharm, D-66123 Saarbrucken, Germany.	jesko.koehnke@helmholtz-hzi.de; alexander.titz@helmholtz-hzi.de	Koehnke, Jesko/M-4861-2017; Koehnke, Jesko/AAC-7363-2021; Wolf, Eckhard/AAT-7500-2021; Titz, Alexander/E-6701-2010; Klymiuk, Nikolai/AAB-8345-2022	Koehnke, Jesko/0000-0002-7153-1365; Koehnke, Jesko/0000-0002-7153-1365; Wolf, Eckhard/0000-0002-0430-9510; Titz, Alexander/0000-0001-7408-5084; Klymiuk, Nikolai/0000-0003-3532-1659; Wagner, Stefanie/0000-0002-3873-7011	National Institutes of Health [R24 GM098791]; Deutsche Forschungsgemeinschaft [TRR 127]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM098791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Prof. Rolf Muller (HIPS Saarbrucken) for providing the P. luminescens strain used in this study and to the Consortium for Functional Glycomics (Core H, Protein-Glycan Interaction Resource of the Consortium for Functional Glycomics and National Institutes of Health Supporting Grant R24 GM098791) for the glycan array analysis of PllA. We acknowledge use of the ESRF synchrotron (beamlines ID23-2 and ID30-B). GTKO pigs were produced with funding from Deutsche Forschungsgemeinschaft Grant TRR 127 "Biology of xenogeneic cell, tissue, and organ transplantation-from bench to bedside."	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akhurst R., 2012, PARASITES PATHOGENS, P1; Akhurst R. J., 1990, Entomopathogenic nematodes in biological control., P75; Beshr G, 2016, MEDCHEMCOMM, V7, P519, DOI 10.1039/c5md00557d; Blanchard B, 2008, J MOL BIOL, V383, P837, DOI 10.1016/j.jmb.2008.08.028; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; BOEMARE NE, 1993, INT J SYST BACTERIOL, V43, P249, DOI 10.1099/00207713-43-2-249; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; Chen CP, 1998, GLYCOBIOLOGY, V8, P7, DOI 10.1093/glycob/8.1.7; Cioci G, 2003, FEBS LETT, V555, P297, DOI 10.1016/S0014-5793(03)01249-3; DENNIS RD, 1985, EUR J BIOCHEM, V146, P51, DOI 10.1111/j.1432-1033.1985.tb08618.x; Diggle SP, 2006, ENVIRON MICROBIOL, V8, P1095, DOI 10.1111/j.1462-2920.2006.001001.x; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Duffy MS, 2006, GLYCOBIOLOGY, V16, P854, DOI 10.1093/glycob/cwl001; Eierhoff T, 2014, P NATL ACAD SCI USA, V111, P12895, DOI 10.1073/pnas.1402637111; Ekser B, 2010, EXPERT REV CLIN IMMU, V6, P219, DOI 10.1586/ECI.09.81; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferreira T, 2014, INT J SYST EVOL MICR, V64, P1540, DOI 10.1099/ijs.0.059840-0; Fischer-Le Saux M, 1999, INT J SYST BACTERIOL, V49, P1645, DOI 10.1099/00207713-49-4-1645; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Forst S, 1996, MICROBIOL REV, V60, P21, DOI 10.1128/MMBR.60.1.21-43.1996; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; Garber N, 1997, NOVA ACTA LEOPOLDINA, V1997, P75; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gerdt S, 1999, EUR J BIOCHEM, V266, P952, DOI 10.1046/j.1432-1327.1999.00937.x; Guo LN, 1999, J BIOL CHEM, V274, P9836, DOI 10.1074/jbc.274.14.9836; Hapeshi A, 2017, CURR TOP MICROBIOL, V402, P159, DOI 10.1007/82_2016_29; Hauck D, 2013, ACS CHEM BIOL, V8, P1775, DOI 10.1021/cb400371r; Imberty A, 2004, MICROBES INFECT, V6, P221, DOI 10.1016/j.micinf.2003.10.016; Joachim I, 2016, ORG BIOMOL CHEM, V14, P7933, DOI 10.1039/c6ob01313a; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khan F., 2002, MED SCI MONITOR, V8, P293; Kim HS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25318; Klymiuk N, 2012, J MOL MED, V90, P597, DOI 10.1007/s00109-011-0839-y; Klymiuk N, 2010, MOL REPROD DEV, V77, P209, DOI 10.1002/mrd.21127; Kumar A, 2016, J BIOL CHEM, V291, P25032, DOI 10.1074/jbc.M115.693473; Lameignere E, 2010, GLYCOBIOLOGY, V20, P87, DOI 10.1093/glycob/cwp151; Landsteiner K, 1927, P SOC EXP BIOL MED, V24, P941; Li SQ, 2009, TRANSPL IMMUNOL, V21, P70, DOI 10.1016/j.trim.2008.10.004; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Marchetti R, 2012, GLYCOBIOLOGY, V22, P1387, DOI 10.1093/glycob/cws105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon K, 2009, THESIS; Meldal BHM, 2007, MOL PHYLOGENET EVOL, V42, P622, DOI 10.1016/j.ympev.2006.08.025; Mitchell E, 2002, NAT STRUCT BIOL, V9, P918, DOI 10.1038/nsb865; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Obukhova P, 2007, XENOTRANSPLANTATION, V14, P627, DOI 10.1111/j.1399-3089.2007.00436.x; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; POINAR GO, 1977, NEMATOLOGICA, V23, P97, DOI 10.1163/187529277X00273; Richter A, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-84; Schrodinger LLC, 2015, JYMOL MOL GRAPH DEV; Sommer R, 2016, BEILSTEIN J ORG CHEM, V12, P2828, DOI 10.3762/bjoc.12.282; Sommer R, 2016, CHEM SCI, V7, P4990, DOI 10.1039/c6sc00696e; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Sudakevitz D, 2004, MOL MICROBIOL, V52, P691, DOI 10.1111/j.1365-2958.2004.04020.x; Tempel W, 2002, J BIOL CHEM, V277, P6615, DOI 10.1074/jbc.M109919200; THOMAS GM, 1979, INT J SYST BACTERIOL, V29, P352, DOI 10.1099/00207713-29-4-352; Tielker D, 2005, MICROBIOL-SGM, V151, P1313, DOI 10.1099/mic.0.27701-0; van Stijn CMW, 2010, INT J PARASITOL, V40, P215, DOI 10.1016/j.ijpara.2009.07.009; Wagner S, 2016, J MED CHEM, V59, P5929, DOI 10.1021/acs.jmedchem.5b01698; Wicker N, 2001, MOL BIOL EVOL, V18, P1435, DOI 10.1093/oxfordjournals.molbev.a003929; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wohlschlager T, 2014, P NATL ACAD SCI USA, V111, pE2787, DOI 10.1073/pnas.1401176111; Yamada K, 2005, NAT MED, V11, P32, DOI 10.1038/nm1172; Yan S, 2015, J PROTEOME RES, V14, P5291, DOI 10.1021/acs.jproteome.5b00746; Yan S, 2015, MOL CELL PROTEOMICS, V14, P2111, DOI 10.1074/mcp.M115.049817; Yan S, 2012, J BIOL CHEM, V287, P28276, DOI 10.1074/jbc.M112.353128; Yung GLP, 2012, XENOTRANSPLANTATION, V19, P196, DOI 10.1111/j.1399-3089.2012.00705.x; Zinger-Yosovich K, 2006, MICROBIOL-SGM, V152, P457, DOI 10.1099/mic.0.28500-0	70	7	8	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19935	19951		10.1074/jbc.M117.812792	http://dx.doi.org/10.1074/jbc.M117.812792			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972138	Green Published, hybrid			2022-12-26	WOS:000416911300034
J	Hershberger, KA; Abraham, DM; Martin, AS; Mao, L; Liu, J; Gu, HB; Locasale, JW; Hirschey, MD				Hershberger, Kathleen A.; Abraham, Dennis M.; Martin, Angelical S.; Mao, Lan; Liu, Juan; Gu, Hongbo; Locasale, Jason W.; Hirschey, Matthew D.			Sirtuin 5 is required for mouse survival in response to cardiac pressure overload	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiac hypertrophy; cardiac metabolism; metabolomics; proteomics; sirtuin	CAMKII ACTIVATION; IN-VIVO; PHOSPHORYLATION; HYPERTROPHY; METABOLISM; METABOLOMICS; SUCCINYLATION; MALONYLATION; DYSFUNCTION; GLYCOLYSIS	In mitochondria, the sirtuin SIRT5 is an NAD(+)-dependent protein deacylase that controls several metabolic pathways. Although a wide range of SIRT5 targets have been identified, the overall function of SIRT5 in organismal metabolic homeostasis remains unclear. Given that SIRT5 expression is highest in the heart and that sirtuins are commonly stress-response proteins, we used an established model of pressure overload-induced heart muscle hypertrophy caused by transverse aortic constriction (TAC) to determine SIRT5's role in cardiac stress responses. Remarkably, SIRT5KO mice had reduced survival upon TAC compared with wild-type mice but exhibited no mortality when undergoing a sham control operation. The increased mortality with TAC was associated with increased pathological hypertrophy and with key abnormalities in both cardiac performance and ventricular compliance. By combining high-resolution MS-based metabolomic and proteomic analyses of cardiac tissues from wild-type and SIRT5KO mice, we found several biochemical abnormalities exacerbated in the SIRT5KO mice, including apparent decreases in fatty acid oxidation and glucose oxidation as well as an overall decrease in mitochondrial NAD(+)/NADH. Together, these abnormalities suggest that SIRT5 deacylates protein substrates involved in cellular oxidative metabolism to maintain mitochondrial energy production. Overall, the functional and metabolic results presented here suggest an accelerated development of cardiac dysfunction in SIRT5KO mice in response to TAC, explaining increased mortality upon cardiac stress. Our findings reveal a key role for SIRT5 in maintaining cardiac oxidative metabolism under pressure overload to ensure survival.	[Hershberger, Kathleen A.; Martin, Angelical S.; Liu, Juan; Locasale, Jason W.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27701 USA; [Hershberger, Kathleen A.; Martin, Angelical S.; Liu, Juan; Locasale, Jason W.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27701 USA; [Hershberger, Kathleen A.; Martin, Angelical S.; Liu, Juan; Locasale, Jason W.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Abraham, Dennis M.; Mao, Lan] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Abraham, Dennis M.; Mao, Lan] Duke Univ, Med Ctr, Duke Cardiovasc Physiol Core, Durham, NC 27710 USA; [Gu, Hongbo] Cell Signaling Technol Inc, Danvers, MA 01923 USA; [Hirschey, Matthew D.] Duke Univ, Med Ctr, Dept Med, Div Endocrinol Metab & Nutr, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Hirschey, MD (corresponding author), Duke Mol Physiol Inst, 300 N Duke St, Durham, NC 27701 USA.	matthew.hirschey@duke.edu	Locasale, Jason W/ABE-6505-2020; Hershberger, Kathleen/AAP-2098-2020	Locasale, Jason W/0000-0002-7766-3502; Hershberger, Kathleen/0000-0002-3349-6140; Hirschey, Matthew/0000-0003-4541-5376	NIGMS, the National Institutes of Health [5T32GM007105-40]; NATIONAL CANCER INSTITUTE [R00CA168997] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL125905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK096493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045351] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018164] Funding Source: NIH RePORTER	NIGMS, the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Kelsey Fisher-Wellman and also Howard Rockman and other members of the dissertation committee of K. A. H. for feedback on this work. The Duke University Pharmacological Sciences Training Program was supported by Training Grant 5T32GM007105-40 from the NIGMS, the National Institutes of Health.	Abel ED, 2011, CARDIOVASC RES, V90, P234, DOI 10.1093/cvr/cvr015; Akki A, 2008, MOL CELL BIOCHEM, V311, P215, DOI 10.1007/s11010-008-9711-y; ALLARD MF, 1994, AM J PHYSIOL, V267, pH742, DOI 10.1152/ajpheart.1994.267.2.H742; Anderson KA, 2017, CELL METAB, V25, P838, DOI 10.1016/j.cmet.2017.03.003; Anderson KA, 2014, CELL, V159, DOI 10.1016/j.cell.2014.10.045; [Anonymous], 2014, SCI AM; Boylston JA, 2015, J MOL CELL CARDIOL, V88, P73, DOI 10.1016/j.yjmcc.2015.09.005; Chhoy P, 2016, PROTEINS CELL REGUL, V10, P105, DOI 10.1007/978-94-024-0962-8_5; Das A. M., 2011, P WORLD MED C PRAG 2, P135; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Engelhardt S, 1996, J AM COLL CARDIOL, V27, P146, DOI 10.1016/0735-1097(95)00425-4; Erickson JR, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00059; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; FRITZ IB, 1961, PHYSIOL REV, V41, P52, DOI 10.1152/physrev.1961.41.1.52; Hershberger KA, 2017, NAT REV NEPHROL, V13, P213, DOI 10.1038/nrneph.2017.5; Hirschey MD, 2015, MOL CELL PROTEOMICS, V14, P2308, DOI 10.1074/mcp.R114.046664; Horton JL, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.84897; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Karamanlidis G, 2013, CELL METAB, V18, P239, DOI 10.1016/j.cmet.2013.07.002; Kolwicz SC, 2011, CARDIOVASC RES, V90, P194, DOI 10.1093/cvr/cvr071; Krebs H.A., 1971, ADV ENZYME REGUL, V9, P387, DOI [10.1016/S0065-2571(71)80055-9, DOI 10.1016/S0065-2571(71)80055-9]; Lamba S, 2000, Heart Fail Rev, V5, P7; Lee CF, 2016, CIRCULATION, V134, P883, DOI 10.1161/CIRCULATIONAHA.116.022495; Liu XJ, 2014, ANAL CHEM, V86, P2175, DOI 10.1021/ac403845u; Martin AS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93885; Nakamura Y, 2012, FEBS LETT, V586, P4076, DOI 10.1016/j.febslet.2012.10.009; Nishida Y, 2015, MOL CELL, V59, P321, DOI 10.1016/j.molcel.2015.05.022; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Polletta L, 2015, AUTOPHAGY, V11, P253, DOI 10.1080/15548627.2015.1009778; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rardin MJ, 2013, CELL METAB, V18, P920, DOI 10.1016/j.cmet.2013.11.013; Rardin MJ, 2009, ANAL BIOCHEM, V389, P157, DOI 10.1016/j.ab.2009.03.040; Riehle C, 2012, TRENDS CARDIOVAS MED, V22, P98, DOI 10.1016/j.tcm.2012.07.003; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Ruwhof C, 2000, CARDIOVASC RES, V47, P23, DOI 10.1016/S0008-6363(00)00076-6; Sadhukhan S, 2016, P NATL ACAD SCI USA, V113, P4320, DOI 10.1073/pnas.1519858113; Sankaralingam S, 2015, PULM CIRC, V5, P15, DOI 10.1086/679608; Stokes MP, 2015, PROTEOMES, V3, DOI [10.3390/proteomes3030160, 10.3390/proteomes3030159]; Sundaresan NR, 2016, MOL CELL BIOL, V36, P678, DOI 10.1128/MCB.00586-15; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; van Oort RJ, 2010, HYPERTENSION, V55, P932, DOI 10.1161/HYPERTENSIONAHA.109.146449; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Wagner GR, 2017, CELL METAB, V25, P823, DOI 10.1016/j.cmet.2017.03.006; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yoo B, 2009, AM J PHYSIOL-HEART C, V297, pH1377, DOI 10.1152/ajpheart.00504.2009; Yu JJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02806; Zhang WB, 2016, AGING CELL, V15, P39, DOI 10.1111/acel.12408; Zhang YX, 2017, J BIOL CHEM, V292, P10239, DOI 10.1074/jbc.M117.785022	55	50	51	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19767	19781		10.1074/jbc.M117.809897	http://dx.doi.org/10.1074/jbc.M117.809897			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972174	Green Published, hybrid			2022-12-26	WOS:000416911300021
J	Kinsella, RL; Lopez, J; Palmer, LD; Salinas, ND; Skaar, EP; Tolia, NH; Feldman, MF				Kinsella, Rachel L.; Lopez, Juvenal; Palmer, Lauren D.; Salinas, Nichole D.; Skaar, Eric P.; Tolia, Niraj H.; Feldman, Mario F.			Defining the interaction of the protease CpaA with its type II secretion chaperone CpaB and its contribution to virulence in Acinetobacter species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; bacterial toxin; chaperone; metalloprotease; type II secretion system (T2SS)	GRAM-NEGATIVE BACTERIA; STRUCTURAL INSIGHTS; BIOFILM FORMATION; BAUMANNII; SYSTEM; GLYCOSYLATION; EPIDEMIOLOGY; MEMBRANE; SURVIVAL	Acinetobacter baumannii, Acinetobacter nosocomialis, and Acinetobacter pittii are a frequent cause of multidrug-resistant, healthcare-associated infections. Our previous work demonstrated that A. nosocomialis M2 possesses a functional type II secretion system (T2SS) that is required for full virulence. Further, we identified the metallo-endopeptidase CpaA, which has been shown previously to cleave human Factor V and deregulate blood coagulation, as the most abundant type II secreted effector protein. We also demonstrated that its secretion is dependent on CpaB, a membrane-bound chaperone. In this study, we show that CpaA expression and secretion are conserved across several medically relevant Acinetobacter species. Additionally, we demonstrate that deletion of cpaA results in attenuation of A. nosocomialis M2 virulence in moth and mouse models. The virulence defects resulting from the deletion of cpaA were comparable with those observed upon abrogation of T2SS activity. The virulence defects resulting from the deletion of cpaA are comparable with those observed upon abrogation of T2SS activity. We also show that CpaA and CpaB strongly interact, forming a complex in a 1:1 ratio. Interestingly, deletion of the N-terminal transmembrane domain of CpaB results in robust secretion of CpaA and CpaB, indicating that the transmembrane domain is dispensable for CpaA secretion and likely functions to retain CpaB inside the cell. Limited proteolysis of spheroplasts revealed that the C-terminal domain of CpaB is exposed to the periplasm, suggesting that this is the site where CpaA and CpaB interact in vivo. Last, we show that CpaB does not abolish the proteolytic activity of CpaA against human Factor V. We conclude that CpaA is, to the best of our knowledge, the first characterized, bona fide virulence factor secreted by Acinetobacter species.	[Kinsella, Rachel L.; Lopez, Juvenal; Salinas, Nichole D.; Tolia, Niraj H.; Feldman, Mario F.] Washington Univ, Sch Med, Dept Mol Microbiol, Campus Box 8230, St Louis, MO 63110 USA; [Kinsella, Rachel L.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Palmer, Lauren D.; Skaar, Eric P.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Washington University (WUSTL); University of Alberta; Vanderbilt University	Feldman, MF (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, Campus Box 8230, St Louis, MO 63110 USA.	mariofeldman@wustl.edu	Tolia, Niraj H/D-2332-2014; Feldman, Mario/A-2637-2014	Tolia, Niraj H/0000-0002-2689-1337; Salinas, Nichole/0000-0003-4105-3718; Feldman, Mario/0000-0003-4497-0976; Lopez, Juvenal/0000-0002-3433-2412	Department of Molecular Microbiology at Washington University School of Medicine; Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarships-Doctoral Program (NSERC PGSD); Washington University Schleshinger awards; Washington University Chancellor's graduate fellowship; National Institutes of Health [F32AI122516, T32HL094296]; National Institutes of Health Grant [R01 AI101171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101171, F32AI122516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER	Department of Molecular Microbiology at Washington University School of Medicine; Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarships-Doctoral Program (NSERC PGSD)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Washington University Schleshinger awards; Washington University Chancellor's graduate fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a startup fund to M. F. F. from the Department of Molecular Microbiology at Washington University School of Medicine. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarships-Doctoral Program (NSERC PGSD) and Washington University Schleshinger awards.; Supported by a Washington University Chancellor's graduate fellowship.; Funded by National Institutes of Health Grants F32AI122516 and T32HL094296.; Funded by National Institutes of Health Grant R01 AI101171.	Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Bornhorst JA, 2000, METHOD ENZYMOL, V326, P245; Camire RM, 2009, J THROMB HAEMOST, V7, P1951, DOI 10.1111/j.1538-7836.2009.03622.x; Carruthers MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059388; Chusri S, 2014, ANTIMICROB AGENTS CH, V58, P4172, DOI 10.1128/AAC.02992-14; Cisneros JM, 2002, CLIN MICROBIOL INFEC, V8, P687, DOI 10.1046/j.1469-0691.2002.00487.x; Costa TRD, 2015, NAT REV MICROBIOL, V13, P343, DOI 10.1038/nrmicro3456; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Eijkelkamp BA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1020; El Khattabi M, 1999, MOL GEN GENET, V261, P770; Espinal P, 2012, J HOSP INFECT, V80, P56, DOI 10.1016/j.jhin.2011.08.013; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; FRENKEN LGJ, 1993, MOL MICROBIOL, V9, P579, DOI 10.1111/j.1365-2958.1993.tb01718.x; Fujieda M, 2012, INFECT IMMUN, V80, P2053, DOI 10.1128/IAI.06232-11; Green ER, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0012-2015; Harding CM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005391; Harding CM, 2015, MOL MICROBIOL, V96, P1023, DOI 10.1111/mmi.12986; Harding CM, 2013, MBIO, V4, DOI 10.1128/mBio.00360-13; Ho TD, 2008, INFECT IMMUN, V76, P1858, DOI 10.1128/IAI.01688-07; Howard A, 2012, VIRULENCE, V3, P243, DOI 10.4161/viru.19700; Johnson TL, 2016, J BACTERIOL, V198, P711, DOI 10.1128/JB.00622-15; Jyot J, 2011, J INFECT DIS, V203, P1369, DOI 10.1093/infdis/jir045; KESSLER E, 1994, J BIOL CHEM, V269, P22726; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; McCoy-Simandle K, 2011, INFECT IMMUN, V79, P1984, DOI 10.1128/IAI.01077-10; McLaughlin LS, 2012, CURR OPIN STRUC BIOL, V22, P208, DOI 10.1016/j.sbi.2012.02.005; Nivaskumar M, 2014, BBA-MOL CELL RES, V1843, P1568, DOI 10.1016/j.bbamcr.2013.12.020; Page AL, 2002, MOL MICROBIOL, V46, P1, DOI 10.1046/j.1365-2958.2002.03138.x; Park YK, 2012, INT J ANTIMICROB AG, V39, P81, DOI 10.1016/j.ijantimicag.2011.08.006; Pineau C, 2014, MOL MICROBIOL, V94, P126, DOI 10.1111/mmi.12744; Rosenau F, 2004, CHEMBIOCHEM, V5, P153, DOI 10.1002/cbic.200300761; SANDKVIST M, 1993, GENE, V123, P81, DOI 10.1016/0378-1119(93)90543-C; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; SCHNAITMAN CA, 1971, J BACTERIOL, V108, P553, DOI 10.1128/JB.108.1.553-563.1971; Shinde U, 2000, SEMIN CELL DEV BIOL, V11, P35, DOI 10.1006/scdb.1999.0349; Sikora AE, 2011, J BIOL CHEM, V286, P16555, DOI 10.1074/jbc.M110.211078; SUZUKI K, 1982, J BIOL CHEM, V257, P6556; Tilley D, 2014, FEMS MICROBIOL LETT, V356, P53, DOI 10.1111/1574-6968.12496; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Valencia R, 2009, INFECT CONT HOSP EP, V30, P257, DOI 10.1086/595977; Weber BS, 2017, TRENDS MICROBIOL, V25, P533, DOI 10.1016/j.tim.2017.01.005; Weber BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055142; Wendt C, 1997, J CLIN MICROBIOL, V35, P1394, DOI 10.1128/JCM.35.6.1394-1397.1997; WHO, 2017, WORLD HLTH ORG, P7, DOI DOI 10.1016/S1473-3099(09)70222-1; Yan ZF, 2017, NAT STRUCT MOL BIOL, V24, P177, DOI 10.1038/nsmb.3350	50	22	22	4	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19628	19638		10.1074/jbc.M117.808394	http://dx.doi.org/10.1074/jbc.M117.808394			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28982978	Green Published, hybrid			2022-12-26	WOS:000416911300011
J	Chen, CH; Adler, L; Goletz, P; Gonzalez-Fernandez, F; Thompson, DA; Koutalos, Y				Chen, Chunhe; Adler, Leopold; Goletz, Patrice; Gonzalez-Fernandez, Federico; Thompson, Debra A.; Koutalos, Yiannis			Interphotoreceptor retinoid-binding protein removes all-trans-retinol and retinal from rod outer segments, preventing lipofuscin precursor formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence; photoreceptor; retina; retinoid-binding protein; retinol	PHYSIOLOGICALLY RELEVANT CARRIER; VISUAL PIGMENT REGENERATION; TARGETED DISRUPTION; KNOCKOUT MICE; MOUSE RETINA; PHOTORECEPTORS; CYCLE; RDH12; EPITHELIUM; REDUCTION	Interphotoreceptor retinoid-binding protein (IRBP) is a specialized lipophilic carrier that binds the all-trans and 11-cis isomers of retinal and retinol, and this facilitates their transport between photoreceptors and cells in the retina. One of these retinoids, all-trans-retinal, is released in the rod outer segment by photoactivated rhodopsin after light excitation. Following its release, all-trans-retinal is reduced by the retinol dehydrogenase RDH8 to all-trans-retinol in an NADPH-dependent reaction. However, all-trans-retinal can also react with outer segment components, sometimes forming lipofuscin precursors, which after conversion to lipofuscin accumulate in the lysosomes of the retinal pigment epithelium and display cytotoxic effects. Here, we have imaged the fluorescence of all-trans-retinol, all-trans-retinal, and lipofuscin precursors in real time in single isolated mouse rod photoreceptors. We found that IRBP removes all-trans-retinol from individual rod photoreceptors in a concentration-dependent manner. The rate constant for retinol removal increased linearly with IRBP concentration with a slope of 0.012 min(-1) m(-1). IRBP also removed all-trans-retinal, but with much less efficacy, indicating that the reduction of retinal to retinol promotes faster clearance of the photoisomerized rhodopsin chromophore. The presence of physiological IRBP concentrations in the extracellular medium resulted in lower levels of all-trans-retinal and retinol in rod outer segments following light exposure. It also prevented light-induced lipofuscin precursor formation, but it did not remove precursors that were already present. These findings reveal an important and previously unappreciated role of IRBP in protecting the photoreceptor cells against the cytotoxic effects of accumulated all-trans-retinal.	[Chen, Chunhe; Adler, Leopold; Goletz, Patrice; Koutalos, Yiannis] Med Univ South Carolina, Dept Ophthalmol, 167 Ashley Ave, Charleston, SC 29425 USA; [Chen, Chunhe; Adler, Leopold; Goletz, Patrice; Koutalos, Yiannis] Med Univ South Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Gonzalez-Fernandez, Federico] Univ Mississippi, Dept Ophthalmol, Jackson, MS 39216 USA; [Gonzalez-Fernandez, Federico] Univ Mississippi, Dept Pathol, Jackson, MS 39216 USA; [Gonzalez-Fernandez, Federico] GV Sonny Montgomery Vet Affairs Med Ctr, Jackson, MS 39216 USA; [Thompson, Debra A.] Univ Michigan, Dept Ophthalmol & Visual Sci, Sch Med, Ann Arbor, MI 48105 USA; [Thompson, Debra A.] Univ Michigan, Dept Biol Chem, Sch Med, Ann Arbor, MI 48105 USA	Medical University of South Carolina; Medical University of South Carolina; University of Mississippi; University of Mississippi; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Koutalos, Y (corresponding author), Med Univ South Carolina, Dept Ophthalmol, 167 Ashley Ave, Charleston, SC 29425 USA.	koutalo@musc.edu		Thompson, Debra/0000-0003-3485-0794	National Institutes of Health [R01-EY014850, R01-EY09412]; Merit Review Award from the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development [I01BX007080]; Research Mississippi, Inc.; Research to Prevent Blindness Senior Scientific Investigator Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY007003, R01EY014850, R01EY009412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Review Award from the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development; Research Mississippi, Inc.; Research to Prevent Blindness Senior Scientific Investigator Award(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health Grants R01-EY014850 (to Y. K.) and R01-EY09412 (to F. G.-F.), Merit Review Award I01BX007080 from the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development (to F. G.-F.), and a start-up award from Research Mississippi, Inc. (to F. G.-F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Veterans Affairs.; Recipient of Research to Prevent Blindness Senior Scientific Investigator Award.	ADLER AJ, 1985, INVEST OPHTH VIS SCI, V26, P273; Adler AJ, 2000, EXP EYE RES, V70, P227, DOI 10.1006/exer.1999.0780; Adler L, 2017, EXP EYE RES, V155, P121, DOI 10.1016/j.exer.2017.02.007; Adler L, 2014, J BIOL CHEM, V289, P1519, DOI 10.1074/jbc.M113.511295; Adler Leopold 4th, 2015, Methods Mol Biol, V1271, P327, DOI 10.1007/978-1-4939-2330-4_21; Ala-Laurila P, 2006, J GEN PHYSIOL, V128, P153, DOI 10.1085/jgp.200609557; Blakeley LR, 2011, INVEST OPHTH VIS SCI, V52, P3483, DOI 10.1167/iovs.10-6694; Boyer NP, 2012, J BIOL CHEM, V287, P22276, DOI 10.1074/jbc.M111.329235; Chen CH, 2005, BIOPHYS J, V88, P2278, DOI 10.1529/biophysj.104.054254; Chen CH, 2012, J BIOL CHEM, V287, P24662, DOI 10.1074/jbc.M112.354514; Chen CH, 2009, INVEST OPHTH VIS SCI, V50, P3589, DOI 10.1167/iovs.08-3336; CHEN Y, 1994, BIOCHEMISTRY-US, V33, P10658, DOI 10.1021/bi00201a013; Chrispell JD, 2009, J BIOL CHEM, V284, P21468, DOI 10.1074/jbc.M109.020966; den Hollander AI, 2009, INVEST OPHTH VIS SCI, V50, P1864, DOI 10.1167/iovs.08-2497; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; FUTTERMAN S, 1970, J NEUROCHEM, V17, P149, DOI 10.1111/j.1471-4159.1970.tb02195.x; Garlipp MA, 2013, EXP EYE RES, V113, P192, DOI 10.1016/j.exer.2013.02.003; Gonzalez-Fernandez F, 2003, VISION RES, V43, P3021, DOI 10.1016/j.visres.2003.09.019; Gonzalez-Fernandez F, 2008, EXP EYE RES, V86, P169, DOI 10.1016/j.exer.2006.09.003; Gonzalez-Fernandez F, 2015, PHOTOCHEM PHOTOBIOL, V91, P371, DOI 10.1111/php.12416; Gonzalez-Fernandez F, 2014, EXP EYE RES, V120, P167, DOI 10.1016/j.exer.2014.01.002; HO MTP, 1989, J BIOL CHEM, V264, P928; Janecke AR, 2004, NAT GENET, V36, P850, DOI 10.1038/ng1394; Jin MH, 2009, J NEUROSCI, V29, P1486, DOI 10.1523/JNEUROSCI.3882-08.2009; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lee M, 2016, INVEST OPHTH VIS SCI, V57, P1553, DOI 10.1167/iovs.15-18551; LIOU GI, 1986, VISION RES, V26, P1645, DOI 10.1016/0042-6989(86)90052-0; Liou GI, 1998, J NEUROSCI, V18, P4511; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Maeda A, 2009, INVEST OPHTH VIS SCI, V50, P5435, DOI 10.1167/iovs.09-3944; Moise AR, 2007, BIOCHEMISTRY-US, V46, P4449, DOI 10.1021/bi7003069; OKAJIMA TIL, 1989, EXP EYE RES, V49, P629, DOI 10.1016/S0014-4835(89)80059-4; OKAJIMA TIL, 1990, P NATL ACAD SCI USA, V87, P6907, DOI 10.1073/pnas.87.17.6907; Palczewski K, 1999, BIOCHEMISTRY-US, V38, P12012, DOI 10.1021/bi990504d; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Parker R, 2011, J NEUROSCI, V31, P4714, DOI 10.1523/JNEUROSCI.3722-10.2011; Perrault I, 2004, AM J HUM GENET, V75, P639, DOI 10.1086/424889; Quazi F, 2014, P NATL ACAD SCI USA, V111, P5024, DOI 10.1073/pnas.1400780111; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Ripps H, 2000, VISUAL NEUROSCI, V17, P97, DOI 10.1017/S095252380017110X; Saari JC, 2000, INVEST OPHTH VIS SCI, V41, P337; SAARI JC, 1985, J BIOL CHEM, V260, P195; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; SZUTS EZ, 1991, ARCH BIOCHEM BIOPHYS, V287, P297, DOI 10.1016/0003-9861(91)90482-X; Tang PH, 2013, PROG RETIN EYE RES, V32, P48, DOI 10.1016/j.preteyeres.2012.09.002; Tsina E, 2004, J GEN PHYSIOL, V124, P429, DOI 10.1085/jgp.200409078; Ueda K, 2016, P NATL ACAD SCI USA, V113, P6904, DOI 10.1073/pnas.1524774113; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wu QQ, 2007, BIOCHEMISTRY-US, V46, P8669, DOI 10.1021/bi7004619; Wu QQ, 2006, BIOPHYS J, V91, P4678, DOI 10.1529/biophysj.106.086728	55	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19356	19365		10.1074/jbc.M117.795187	http://dx.doi.org/10.1074/jbc.M117.795187			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972139	Green Published, hybrid			2022-12-26	WOS:000416226700017
J	Chen, C; Xia, SL; Deng, RB; Liu, CF; Shi, GR				Chen, Chu; Xia, Shenglan; Deng, Rubo; Liu, Caifeng; Shi, Gangrong			AhIRT1 and AhNRAMP1 metal transporter expression correlates with Cd uptake in peanuts under iron deficiency	PLOS ONE			English	Article							ARACHIS-HYPOGAEA L.; HYPERACCUMULATOR THLASPI-CAERULESCENS; 2 CONTRASTING ECOTYPES; DURUM-WHEAT CULTIVARS; CADMIUM ACCUMULATION; ROOT MORPHOLOGY; SEDUM-ALFREDII; GAS-EXCHANGE; ELEVATED CO2; TRANSLOCATION	Fe deficiency may increase Cd accumulation in peanuts. However, the mechanisms are not yet fully understood. In the present study, two contrasting peanut cultivars, Luhua 8 (low seed-Cd cultivar) and Zhenghong 3 (high seed-Cd cultivar) were used to investigate the effect of Fe deficiency on the uptake and accumulation of cadmium (Cd) by hydroponic experiments. Under Fe-sufficient conditions, compared with Luhua 8, Zhenghong 3 had higher specific root length (SRL) and proportion of fine roots with a lower K-m for Cd and showed slightly higher expression of AhIRT1 and AhNRAMP1 in the roots. These traits may be responsible for high capacity for Cd accumulation in Zhenghong 3. Under Fe deficiency, the increase of Cd accumulation was much larger in Zhenghong 3 than in Luhua 8. Kinetics studies revealed that the V-max for Cd influx was 1.56-fold higher in Fe-deficient plants than in Fe-sufficient plants for Zhenghong 3, versus 0.48-fold higher for Luhua 8. Moreover, the increased expression levels of AhIRT1 and AhNRAMP1 induced by Fe deficiency was higher in Zhenghong 3 than in Luhua 8. Yeast complementation assays suggested that the AhIRT1 and AhNRAMP1 may function as transporters involved in Cd uptake. In conclusion, the different Cd accumulation between the two cultivars under Fe deficiency may be correlated with V-max value for Cd uptake and the expression levels of AhIRT1 and AhNRAMP1 in the roots.	[Chen, Chu; Xia, Shenglan; Deng, Rubo; Liu, Caifeng; Shi, Gangrong] Huaibei Normal Univ, Coll Life Sci, Huaibei, Peoples R China	Huaibei Normal University	Shi, GR (corresponding author), Huaibei Normal Univ, Coll Life Sci, Huaibei, Peoples R China.	swsgr@126.com			National Natural Science Foundation of China [31671599, 31370515]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support from the National Natural Science Foundation of China (No. 31671599, 31370515) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Ronghua Xu (Anhui Science and Technology University) for kindly providing the vector pYES2 and the yeast strain BY4741. Financial support from the National Natural Science Foundation of China (No. 31671599, 31370515) is gratefully acknowledged.	Astolfi S, 2012, J EXP BOT, V63, P1241, DOI 10.1093/jxb/err344; Bell MJ, 1997, AUST J AGR RES, V48, P1151, DOI 10.1071/A97038; Berkelaar E, 2000, CAN J BOT, V78, P381, DOI 10.1139/cjb-78-3-381; Cohen CK, 1998, PLANT PHYSIOL, V116, P1063, DOI 10.1104/pp.116.3.1063; Connolly EL, 2002, PLANT CELL, V14, P1347, DOI 10.1105/tpc.001263; Curie C, 2000, BIOCHEM J, V347, P749, DOI 10.1042/0264-6021:3470749; Ding H, 2010, J PLANT PHYSIOL, V167, P996, DOI 10.1016/j.jplph.2009.12.019; Eissenstat DM, 1997, ADV ECOL RES, V27, P60; Gruber BD, 2013, PLANT PHYSIOL, V163, P161, DOI 10.1104/pp.113.218453; GUERINOT ML, 1994, PLANT PHYSIOL, V104, P815, DOI 10.1104/pp.104.3.815; Hansch R, 2009, CURR OPIN PLANT BIOL, V12, P259, DOI 10.1016/j.pbi.2009.05.006; Han F, 2006, PLANT SOIL, V289, P355, DOI 10.1007/s11104-006-9145-9; Harris Neil S., 2004, BMC Plant Biology, V4, P4, DOI 10.1186/1471-2229-4-4; Hart JJ, 1998, PLANT PHYSIOL, V116, P1413, DOI 10.1104/pp.116.4.1413; He JY, 2007, BIOL PLANTARUM, V51, P791, DOI 10.1007/s10535-007-0162-1; Imsande J, 1998, PHYSIOL PLANTARUM, V103, P139, DOI 10.1034/j.1399-3054.1998.1030117.x; Ishimaru Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00286; Kumari V, 2014, CROP J, V2, P110, DOI 10.1016/j.cj.2014.03.002; Li TQ, 2012, PLANT SOIL, V354, P325, DOI 10.1007/s11104-011-1068-4; Li TQ, 2005, J ENVIRON SCI HEAL A, V40, P1081, DOI 10.1081/ESE-200056163; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lombi E, 2002, PLANT PHYSIOL, V128, P1359, DOI 10.1104/pp.010731; Lombi E, 2001, NEW PHYTOL, V149, P53, DOI 10.1046/j.1469-8137.2001.00003.x; Lu LL, 2008, J EXP BOT, V59, P3203, DOI 10.1093/jxb/ern174; Lu ZW, 2013, ECOTOX ENVIRON SAFE, V91, P147, DOI 10.1016/j.ecoenv.2013.01.017; McLaughlin MJ, 2000, PLANT SOIL, V222, P51, DOI 10.1023/A:1004771712840; Nakanishi H, 2006, SOIL SCI PLANT NUTR, V52, P464, DOI 10.1111/j.1747-0765.2006.00055.x; Redjala T, 2009, ENVIRON EXP BOT, V67, P235, DOI 10.1016/j.envexpbot.2009.05.012; ROMHELD V, 1981, PHYSIOL PLANTARUM, V53, P354, DOI 10.1111/j.1399-3054.1981.tb04512.x; Shi GR, 2015, ENVIRON EXP BOT, V111, P127, DOI 10.1016/j.envexpbot.2014.11.008; Shi GR, 2014, ECOTOX ENVIRON SAFE, V110, P174, DOI 10.1016/j.ecoenv.2014.09.003; Shi GR, 2014, PLANT SOIL, V375, P99, DOI 10.1007/s11104-013-1953-0; Siedlecka A, 1996, PLANT PHYSIOL BIOCH, V34, P833; Su GQ, 2013, PLANT SOIL, V365, P337, DOI 10.1007/s11104-012-1394-1; Su Y, 2014, ENVIRON EXP BOT, V97, P40, DOI 10.1016/j.envexpbot.2013.10.001; Su Y, 2013, PLANT SOIL, V363, P201, DOI 10.1007/s11104-012-1310-8; Takahashi R, 2011, PLANT SIGNAL BEHAV, V6, P1813, DOI 10.4161/psb.6.11.17587; Takkar P, 1984, J PLANT NUTR; Thomine S, 2000, P NATL ACAD SCI USA, V97, P4991, DOI 10.1073/pnas.97.9.4991; Wang RG, 2012, ENVIRON EARTH SCI, V67, P1, DOI 10.1007/s12665-011-1475-0; Wang SS, 2014, ECOTOX ENVIRON SAFE, V108, P23, DOI 10.1016/j.ecoenv.2014.06.029; Xiong HC, 2012, J EXP BOT, V63, P4437, DOI 10.1093/jxb/ers117; Zamboni A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-101; Zhang Z, 2013, ACTA PHYSIOL PLANT, V35, P2105, DOI 10.1007/s11738-013-1247-4; Zhao FJ, 2006, NEW PHYTOL, V172, P646, DOI 10.1111/j.1469-8137.2006.01867.x; Zhao FJ, 2002, J EXP BOT, V53, P535, DOI 10.1093/jexbot/53.368.535	46	9	9	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185144	10.1371/journal.pone.0185144	http://dx.doi.org/10.1371/journal.pone.0185144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981520	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300028
J	Fayyaz, SSK; Liu, XYC; Zhang, GH				Fayyaz, S. Kiavash S.; Liu, Xiaoyue Cathy; Zhang, Guohui			An efficient General Transit Feed Specification (GTFS) enabled algorithm for dynamic transit accessibility analysis	PLOS ONE			English	Article							K-SHORTEST PATHS; PHYSICAL ACCESSIBILITY; PUBLIC TRANSPORT; NETWORK; GIS; PATTERNS; BENEFITS; JUSTICE; EQUITY	The social functions of urbanized areas are highly dependent on and supported by the convenient access to public transportation systems, particularly for the less privileged populations who have restrained auto ownership. To accurately evaluate the public transit accessibility, it is critical to capture the spatiotemporal variation of transit services. This can be achieved by measuring the shortest paths or minimum travel time between origin-destination (OD) pairs at each time-of-day (e.g. every minute). In recent years, General Transit Feed Specification (GTFS) data has been gaining popularity for between-station travel time estimation due to its interoperability in spatiotemporal analytics. Many software packages, such as ArcGIS, have developed toolbox to enable the travel time estimation with GTFS. They perform reasonably well in calculating travel time between OD pairs for a specific time-of-day (e.g. 8: 00 AM), yet can become computational inefficient and unpractical with the increase of data dimensions (e.g. all times-of-day and large network). In this paper, we introduce a new algorithm that is computationally elegant and mathematically efficient to address this issue. An open-source toolbox written in C++ is developed to implement the algorithm. We implemented the algorithm on City of St. George's transit network to showcase the accessibility analysis enabled by the toolbox. The experimental evidence shows significant reduction on computational time. The proposed algorithm and toolbox presented is easily transferable to other transit networks to allow transit agencies and researchers perform high resolution transit performance analysis.	[Fayyaz, S. Kiavash S.; Liu, Xiaoyue Cathy] Univ Utah, Dept Civil & Environm Engn, Salt Lake City, UT 84112 USA; [Zhang, Guohui] Univ Hawaii Manoa, Dept Civil & Environm Engn, Honolulu, HI USA	Utah System of Higher Education; University of Utah; University of Hawaii System; University of Hawaii Manoa	Liu, XYC (corresponding author), Univ Utah, Dept Civil & Environm Engn, Salt Lake City, UT 84112 USA.	cathy.liu@utah.edu			First Mile Last Mile Strategies for Transit Systems - U.S. Department of Transportation University Transportation Center [MPC-466]; UTA; Mountain Plain Consortium (MPC) of the U.S. DOT University Transportation Centers	First Mile Last Mile Strategies for Transit Systems - U.S. Department of Transportation University Transportation Center; UTA; Mountain Plain Consortium (MPC) of the U.S. DOT University Transportation Centers	This work was supported by MPC-466 First Mile Last Mile Strategies for Transit Systems, http://www.mountain-plains.org/research/projects/list.php?year=2014, sponsored by U.S. Department of Transportation University Transportation Center, PI: XL.; This paper is based on the research project entitled First Mile Last Mile Strategies for Transit Systems, jointly sponsored by UTA and the Mountain Plain Consortium (MPC) of the U.S. DOT University Transportation Centers program. The authors would like to thank Ali Shafiee Ardestani and Meysam Taassori for their input and feedback on the computing toolbox development. The work presented in this paper remains the sole responsibility of the authors.	Anderson P. A., 2013, 92 ANN M TRANSP RES; Barbeau SJ, 2011, TECHNICAL REPORT; Bauer R., 2009, J EXPT ALGORITHMICS, V14; Benenson I, 2010, TRANSPORT RES REC, P28, DOI 10.3141/2144-04; Bhat C., 2000, TX01749381 TEX DEP T; Bhat CR, 05178P3 TXDOT U TEX; Burns L. D., 1979, TRANSPORTATION TEMPO; Cao J, 2013, J TRANSP GEOGR, V28, P12, DOI 10.1016/j.jtrangeo.2012.10.008; Catal? M., 2011, EXPANDING GOOGLE TRA; Chen YL, 2004, COMPUT OPER RES, V31, P499, DOI 10.1016/S0305-0548(02)00230-7; Chuang TN, 2005, COMPUT OPER RES, V32, P1409, DOI 10.1016/j.cor.2003.11.011; Coffel K, 2012, 153 TCRP TRANSP RES; Delling D, 2009, LECT NOTES COMPUT SC, V5868, P182, DOI 10.1007/978-3-642-05465-5_7; Desaulniers G, 2003, INT J FLEX MANUF SYS, V15, P309, DOI 10.1023/B:FLEX.0000036032.41757.3d; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dill J., 2013, P 92 ANN M TRANSP RE; El-Geneidy A.M., ACCESS DESTINATIONS; Fan Y, IMPACT LIGHT RAIL IM; Farber S, 2016, TRAVEL BEHAV SOC, V4, P40, DOI 10.1016/j.tbs.2016.01.001; Farber S, 2014, APPL GEOGR, V53, P149, DOI 10.1016/j.apgeog.2014.06.012; Fayyaz SK, 2017, J TRANSP GEOGR, V59, P27, DOI 10.1016/j.jtrangeo.2017.01.006; Foth N, 2013, J TRANSP GEOGR, V29, P1, DOI 10.1016/j.jtrangeo.2012.12.008; Fransen K, 2015, J TRANSP GEOGR, V48, P176, DOI 10.1016/j.jtrangeo.2015.09.008; GEERTMAN SCM, 1995, INT J GEOGR INF SYST, V9, P67, DOI 10.1080/02693799508902025; Geurs K., 2001, ACCESSIBILITY MEASUR; Geurs K.T., 2004, J TRANSP GEOGR, V12, P127, DOI [10.1016/j.jtrangeo.2003.10.005, DOI 10.1016/J.JTRANGEO.2003.10.005]; Golub A, 2014, J TRANSP GEOGR, V41, P10, DOI 10.1016/j.jtrangeo.2014.07.014; Granat J, 2003, EUR J OPER RES, V151, P103, DOI 10.1016/S0377-2217(02)00594-5; Gutierrez J., 2001, J TRANSP GEOGR, V9, P229, DOI [DOI 10.1016/S0966-6923(01)00017-5, 10.1016/S0966-6923(01)00017-5]; Gutierrez J., 1996, J TRANSP GEOGR, V4, P227, DOI DOI 10.1016/S0966-6923(96)00033-6; HANSEN WG, 1959, J AM I PLANNERS, V25, P73, DOI 10.1080/01944365908978307; Jariyasunant J, 2011, TRANSPORT RES REC, P34, DOI 10.3141/2256-05; JOSEPH AE, 1982, SOC SCI MED, V16, P85, DOI 10.1016/0277-9536(82)90428-2; Koenig JG, 1980, TRANSPORTATION, P9; Krizek K., ACCESS DESTINATIONS; Lei TL, 2010, INT J GEOGR INF SCI, V24, P283, DOI 10.1080/13658810902835404; Litman T, 2003, AM J HEALTH PROMOT, V18, P103, DOI 10.4278/0890-1171-18.1.103; Litman T, 1999, TRANSPORT RES REC, V1670, P8, DOI DOI 10.3141/1670-02; Ma XL, 2017, J TRANSP GEOGR, V58, P135, DOI 10.1016/j.jtrangeo.2016.12.001; Ma XL, 2014, J TRANSP ENG, V140, DOI 10.1061/(ASCE)TE.1943-5436.0000714; Ma XL, 2013, TRANSPORT RES C-EMER, V36, P1, DOI 10.1016/j.trc.2013.07.010; Martens K., 2009, 88 ANN M TRANSP RES, P11; Martens K, 2012, TRANSPORT RES A-POL, V46, P684, DOI 10.1016/j.tra.2012.01.004; Mavoa S, 2012, J TRANSP GEOGR, V20, P15, DOI 10.1016/j.jtrangeo.2011.10.001; Miller HJ, 1999, GEOGR ANAL, V31, P1, DOI 10.1111/j.1538-4632.1999.tb00408.x; O'Sullivan D, 2000, INT J GEOGR INF SCI, V14, P85, DOI 10.1080/136588100240976; O'Sullivan S., 1996, TRANSPORT RES REC, V1538, P19, DOI DOI 10.3141/1538-03; Okada S, 2004, FUZZY SET SYST, V142, P335, DOI 10.1016/S0165-0114(03)00225-2; Owen A, 2015, TRANSPORT RES A-POL, V74, P110, DOI 10.1016/j.tra.2015.02.002; Pallottino S, 2003, OPER RES LETT, V31, P149, DOI 10.1016/S0167-6377(02)00192-X; Pettie S, 2004, THEOR COMPUT SCI, V312, P47, DOI 10.1016/S0304-3975(03)00402-X; Polzin SE, 2002, TRANSPORT RES REC, P35, DOI 10.3141/1799-05; Puchalsky C. M., 2012, 91 ANN M TRANSP RES; Pyrga E., 2007, J EXP ALGORITHMICS, V12, P1, DOI [10.1145/1227161.1227166, DOI 10.1145/1227161.1227166]; Sallis JF, 2004, TRANSPORT RES A-POL, V38, P249, DOI 10.1016/j.tra.2003.11.003; Scheuren J.M., 2007, ACCESSIBILITY MEASUR, P52; Schrijver A., 2002, SPRINGER SCI BU 1210; Shannon T, 2006, TRANSPORT POLICY, P13; Tan MC, 2007, J ADV TRANSPORT, V41, P285, DOI 10.1002/atr.5670410305; Thorup M., 2003, P 35 ANN ACM S THEOR, P149, DOI DOI 10.1016/J.JCSS.2004.04.003; Tremblay N, 2001, PARALLEL COMPUT, V27, P1569, DOI 10.1016/S0167-8191(01)00107-7; van der Zijpp NJ, 2005, TRANSPORT RES B-METH, V39, P545, DOI 10.1016/j.trb.2004.07.004; Van Wee B., 2001, J TRANSP GEOGR, V9, P199, DOI [10.1016/S0966-6923(01)00010-2, DOI 10.1016/S0966-6923(01)00010-2]; VICKERMARW, 1974, ENVIRON PLANN A, V6, P675; WACHS M, 1973, SOCIO ECON PLAN SCI, V7, P437, DOI 10.1016/0038-0121(73)90041-4; Wong JC, THESIS; Xu WT, 2012, COMPUT OPER RES, V39, P1812, DOI 10.1016/j.cor.2010.02.005; Zhao LY, 2008, LECT NOTES ARTIF INT, V5009, P747, DOI 10.1007/978-3-540-79721-0_99	68	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185333	10.1371/journal.pone.0185333	http://dx.doi.org/10.1371/journal.pone.0185333			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28981544	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300034
J	Ihara, K; Fukuda, S; Enkhtaivan, B; Trujillo, R; Perez-Bello, D; Nelson, C; Randolph, A; Alharbi, S; Hanif, H; Herndon, D; Prough, D; Enkhbaatar, P				Ihara, Koji; Fukuda, Satoshi; Enkhtaivan, Baigalmaa; Trujillo, Raul; Perez-Bello, Dannelys; Nelson, Christina; Randolph, Anita; Alharbi, Suzan; Hanif, Hira; Herndon, David; Prough, Donald; Enkhbaatar, Perenlei			Adipose-derived stem cells attenuate pulmonary microvascular hyperpermeability after smoke inhalation	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; STROMAL CELLS; BONE-MARROW; OXIDATIVE STRESS; NEUTROPHIL ACTIVATION; COMBINED BURN; NITRIC-OXIDE; SHEEP; SEPSIS	Background Pulmonary edema is a hallmark of acute respiratory distress syndrome (ARDS). Smoke inhalation causes ARDS, thus significantly increasing the mortality of burn patients. Adipose-derived stem cells (ASCs) exert potent anti-inflammatory properties. The goal of the present study was to test the safety and ecfficacy of ASCs, in a well-characterized clinically relevant ovine model of ARDS. Methods Female sheep were surgically prepared. ARDS was induced by cooled cotton smoke inhalation. Following injury, sheep were ventilated, resuscitated with lactated Ringer's solution, and cardiopulmonary hemodynamics were monitored for 48 hours in a conscious state. Pulmonary microvascular hyper-permeability was assessed by measuring lung lymph flow, extravascular lung water content, protein content in plasma and lung lymph fluid. Sheep were randomly allocated to two groups: 1) ASCs: infused with 200 million of ASCs in 200mL of PlasmaLyteA starting 1 hours post-injury, n = 5; 2) control, treated with 200mL of PlasmaLyteA in a similar pattern, n = 5. Results Lung lymph flow increased 9-fold in control sheep as compared to baseline. Protein in the plasma was significantly decreased, while it was increased in the lung lymph. The treatment with ASCs significantly attenuated these changes. Treatment with ASCs almost led to the reversal of increased pulmonary vascular permeability and lung water content. Pulmonary gas exchange was significantly improved by ASCs. Infusion of the ASCs did not negatively affect pulmonary artery pressure and other hemodynamic variables. Conclusions ASCs infusion was well tolerated. The results suggest that intravenous ASCs modulate pulmonary microvascular hyper-permeability and prevent the onset of ARDS in our experimental model.	[Ihara, Koji; Fukuda, Satoshi; Enkhtaivan, Baigalmaa; Trujillo, Raul; Perez-Bello, Dannelys; Nelson, Christina; Randolph, Anita; Alharbi, Suzan; Hanif, Hira; Prough, Donald; Enkhbaatar, Perenlei] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Ihara, Koji] Kagoshima City Hosp, Dept Plast & Reconstruct Surg, Kagoshima, Japan; [Ihara, Koji] Tokyo Womens Med Sch, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Herndon, David] Shriners Hosp Children, Dept Surg, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston; Kagoshima City Hospital; Tokyo Women's Medical University; University of Texas System; University of Texas Medical Branch Galveston	Ihara, K (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.; Ihara, K (corresponding author), Kagoshima City Hosp, Dept Plast & Reconstruct Surg, Kagoshima, Japan.; Ihara, K (corresponding author), Tokyo Womens Med Sch, Dept Plast & Reconstruct Surg, Tokyo, Japan.	ihara.koji@twmu.ac.jp	Prough, Donald S/G-5793-2013; Herndon, David/AAC-3354-2020; Alharbi, Suzan Abdulkarim/AAT-7519-2021	Prough, Donald S/0000-0001-7994-532X; Alharbi, Suzan Abdulkarim/0000-0002-4572-856X; Fukuda, Satoshi/0000-0003-3739-6494	Shriners of North America [SHC84050, 85100]	Shriners of North America	This study was supported by the Shriners of North America (grants SHC84050 and 85100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmussen S, 2014, THORAX, V69, P819, DOI 10.1136/thoraxjnl-2013-204980; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Cox RA, 2005, EXP LUNG RES, V31, P819, DOI 10.1080/01902140600574967; Cox RA, 2007, PULM PHARMACOL THER, V20, P172, DOI 10.1016/j.pupt.2006.03.013; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Enkhbaatar P, 2004, CLIN SCI, V107, P137, DOI 10.1042/CS20040135; Enkhbaatar P, 2003, AM J RESP CRIT CARE, V167, P1021, DOI 10.1164/rccm.200209-1031PP; Enkhbaatar P, 2016, LANCET, V388, P1437, DOI 10.1016/S0140-6736(16)31458-1; Fang XH, 2015, J IMMUNOL, V195, P875, DOI 10.4049/jimmunol.1500244; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Hao Q, 2015, STEM CELL TRANSL MED, V4, P832, DOI 10.5966/sctm.2015-0006; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; KIMURA R, 1988, J APPL PHYSIOL, V64, P1107, DOI 10.1152/jappl.1988.64.3.1107; Lai TS, 2015, CHINESE MED J-PEKING, V128, P361, DOI 10.4103/0366-6999.150106; Lange M, 2012, SHOCK, V37, P468, DOI 10.1097/SHK.0b013e31824b1793; Lange M, 2012, EXP LUNG RES, V38, P157, DOI 10.3109/01902148.2012.663453; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Lee JW, 2011, STEM CELLS, V29, P913, DOI 10.1002/stem.643; Li J, 2012, J ASIA TEFL, V9, P1, DOI 10.1186/1476-9255-9-33; Liu KD, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/s13613-014-0022-z; Manning E, 2010, HUM GENE THER, V21, P713, DOI 10.1089/hum.2009.147; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matthay MA, 2010, CHEST, V138, P965, DOI 10.1378/chest.10-0518; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Mohammadzadeh M, 2012, CELL STRESS CHAPERON, V17, P553, DOI 10.1007/s12192-012-0331-9; Orfanos SE, 2007, CRIT CARE MED, V35, P199, DOI 10.1097/01.CCM.0000251640.77679.D7; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Pati S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025171; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rehberg S, 2013, CRIT CARE MED, V41, pE439, DOI 10.1097/CCM.0b013e318298ad3a; Rehberg Sebastian, 2009, Expert Rev Respir Med, V3, P283, DOI 10.1586/ers.09.21; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Soejima K, 2001, AM J RESP CRIT CARE, V163, P745, DOI 10.1164/ajrccm.163.3.9912052; Soejima K, 2001, AM J PHYSIOL-LUNG C, V280, pL1233, DOI 10.1152/ajplung.2001.280.6.L1233; STAUB NC, 1975, J SURG RES, V19, P315, DOI 10.1016/0022-4804(75)90056-6; Traber DL, 2005, SHOCK, V24, P82, DOI 10.1097/01.shk.0000191338.39154.73; van der Heijden M, 2008, THORAX, V63, P903, DOI 10.1136/thx.2007.087387; Walter J, 2014, LANCET RESP MED, V2, P1016, DOI 10.1016/S2213-2600(14)70217-6; Wang Q, 2013, AM J RESP CELL MOL, V48, P610, DOI 10.1165/rcmb.2012-0274OC; Wilson JG, 2015, LANCET RESP MED, V3, P24, DOI [10.1016/S2213-2600(14)70291-7, 10.1016/s2213-2600(14)70291-7]; Zhang SJ, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt161	46	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185937	10.1371/journal.pone.0185937	http://dx.doi.org/10.1371/journal.pone.0185937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982177	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300092
J	Sasaki, Y; Kojima, A; Shibata, Y; Mitsuzawa, H				Sasaki, Yoshie; Kojima, Ayumi; Shibata, Yuriko; Mitsuzawa, Hiroshi			Filamentous invasive growth of mutants of the genes encoding ammonia-metabolizing enzymes in the fission yeast Schizosaccharomyces pombe	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GLUTAMATE SYNTHASE; CANDIDA-ALBICANS; TRANSPORTERS; TRANSITION; STARVATION; PERMEASES; STRAINS; MARKER; FAMILY	The fission yeast Schizosaccharomyces pombe undergoes a switch from yeast to filamentous invasive growth in response to certain environmental stimuli. Among them is ammonium limitation. Amt1, one of the three ammonium transporters in this yeast, is required for the ammonium limitation-induced morphological transition; however, the underlying molecular mechanism remains to be understood. Cells lacking Amt1 became capable of invasive growth upon increasing concentrations of ammonium in the medium, suggesting that the ammonium taken up into the cell or a metabolic intermediate in ammonium assimilation might serve as a signal for the ammonium limitation-induced morphological transition. To investigate the possible role of ammonium-metabolizing enzymes in the signaling process, deletion mutants were constructed for the gdh1, gdh2, gln1, and glt1 genes, which were demonstrated by enzyme assays to encode NADP-specific glutamate dehydrogenase, NAD-specific glutamate dehydrogenase, glutamine synthetase, and glutamate synthase, respectively. Growth tests on various nitrogen sources revealed that a gln1. mutant was a glutamine auxotroph and that a gdh1. mutant had a defect in growth on ammonium, particularly at high concentrations. The latter observation indicates that the NADP-specific glutamate dehydrogenase of S. pombe plays a major role in ammonium assimilation under high ammonium concentrations. Invasive growth assays showed that gdh1. and glt1. mutants underwent invasive growth to a lesser extent than did wild-type strains. Increasing the ammonium concentration in the medium suppressed the invasive growth defect of the glt1. mutant, but not the gdh1. mutant. These results suggest that the nitrogen status of the cell is important in the induction of filamentous invasive growth in S. pombe.	[Sasaki, Yoshie] Nihon Univ, Coll Bioresource Sci, Dept Appl Biol Sci, Fujisawa, Kanagawa, Japan; [Kojima, Ayumi; Shibata, Yuriko] Nihon Univ, Coll Bioresource Sci, Dept Food Biosci & Biotechnol, Fujisawa, Kanagawa, Japan; [Mitsuzawa, Hiroshi] Nihon Univ, Coll Bioresource Sci, Dept Biosci Daily Life, Fujisawa, Kanagawa, Japan	Nihon University; Nihon University; Nihon University	Mitsuzawa, H (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Biosci Daily Life, Fujisawa, Kanagawa, Japan.	mitsuzawa.hiroshi@nihon-u.ac.jp		Mitsuzawa, Hiroshi/0000-0001-6328-0247				Amoah-Buahin E, 2005, EUKARYOT CELL, V4, P1287, DOI 10.1128/EC.4.7.1287-1297.2005; Andrade SLA, 2007, MOL MEMBR BIOL, V24, P357, DOI 10.1080/09687680701388423; Bahn YS, 2007, NAT REV MICROBIOL, V5, P57, DOI 10.1038/nrmicro1578; BAREL I, 1988, CURR GENET, V13, P487, DOI 10.1007/BF02427754; BAREL I, 1993, FEMS MICROBIOL LETT, V113, P267, DOI 10.1016/0378-1097(93)90216-O; Biswas K, 2005, MOL MICROBIOL, V56, P649, DOI 10.1111/j.1365-2958.2005.04576.x; Bozsik A, 2002, YEAST, V19, P485, DOI 10.1002/yea.853; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Dodgson J, 2010, EUKARYOT CELL, V9, P1788, DOI 10.1128/EC.00084-10; Doherty D., 1970, METHOD ENZYMOL, V17, P850, DOI DOI 10.1016/0076-6879(71)17294-1; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; GOLD S, 1994, GENE DEV, V8, P2805, DOI 10.1101/gad.8.23.2805; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kriel J, 2011, BIOESSAYS, V33, P870, DOI 10.1002/bies.201100100; KRON SJ, 1994, MOL BIOL CELL, V5, P1003, DOI 10.1091/mbc.5.9.1003; Lee SC, 2012, EUKARYOT CELL, V11, P1391, DOI 10.1128/EC.00242-12; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Mitsuzawa H, 2006, GENES CELLS, V11, P1183, DOI 10.1111/j.1365-2443.2006.01014.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; PERYSINAKIS A, 1994, CURR GENET, V26, P315, DOI 10.1007/BF00310495; PERYSINAKIS A, 1995, CURR MICROBIOL, V30, P367, DOI 10.1007/BF00369864; Prevorovsky M, 2009, FEMS MICROBIOL LETT, V293, P130, DOI 10.1111/j.1574-6968.2009.01515.x; Rodkaer SV, 2014, FEMS YEAST RES, V14, P683, DOI 10.1111/1567-1364.12157; ROON RJ, 1974, J BACTERIOL, V118, P89, DOI 10.1128/JB.118.1.89-95.1974; Shapiro B., 1970, METHOD ENZYMOL, V17A, P910, DOI 10.1016/0076-6879(71)17305-3; Sipiczki M, 1998, MICROBIOL-SGM, V144, P3475, DOI 10.1099/00221287-144-12-3475; Sipiczki M, 1998, MICROBIOL-SGM, V144, P1319, DOI 10.1099/00221287-144-5-1319; Smith DG, 2003, MOL MICROBIOL, V50, P259, DOI 10.1046/j.1365-2958.2003.03680.x; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; ter Schure EG, 2000, FEMS MICROBIOL REV, V24, P67, DOI 10.1016/S0168-6445(99)00030-3; WADDELL S, 1995, NUCLEIC ACIDS RES, V23, P1836, DOI 10.1093/nar/23.10.1836	34	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186028	10.1371/journal.pone.0186028	http://dx.doi.org/10.1371/journal.pone.0186028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982178	gold, Green Submitted, Green Published			2022-12-26	WOS:000412360300111
J	Megias, DA; Anderson, SC; Smith, RJ; Verissimo, D				Megias, Diane A.; Anderson, Sean C.; Smith, Robert J.; Verissimo, Diogo			Investigating the impact of media on demand for wildlife: A case study of Harry Potter and the UK trade in owls	PLOS ONE			English	Article							INTERNATIONAL-TRADE	In recent decades, a substantial number of popular press articles have described an increase in demand for certain species in the pet trade due to films such as "Finding Nemo", "Ninja turtles", and "Harry Potter". Nevertheless, such assertions are largely supported only by anecdotal evidence. Given the role of the wildlife trade in the spread of pathogens and zoonosis, the introduction of invasive species, the overexploitation of biodiversity, and the neglect of animal welfare, it is crucial to understand what factors drive demand for a species. Here, we investigate the effect the movie industry may have on wildlife trade by examining the relationship between the "Harry Potter" cultural phenomenon and the trade in owls within the United Kingdom (UK). We gathered data from the UK box office, book sales, and newspaper mentions, and examined their relationship with data from three independent sources reflecting the legal ownership of owls in the UK, which is likely to involve several thousands of animals. Additionally, we conducted a questionnaire survey with UK animal sanctuaries to study the presumed mass abandonment of pet owls when the film series ended. Counter to common assertions, we find no evidence that the "Harry Potter" phenomenon increased the legal trade in owls within the UK, even when possible time-lag effects were taken into account. Only one indicator, the number of movie tickets sold, showed a weak but contradictory relationship with demand for owls, with a recorded drop of 13% (95% CI: 3-27%) per 1 SD in tickets sold in the original analysis but an increase of 4% (95% CI: 0-8%) with a one-year lag. In addition, our results suggest that the end of the Harry Potter series did not have a noticeable impact on the number of owls abandoned in UK wildlife sanctuaries, as only two of the 46 animal sanctuaries we contacted independently stated they had seen an increase in owls received and believed this was due to the Harry Potter series. We highlight the importance of further research on the drivers of demand for wildlife to better manage this global trade, and discuss the potential to use films to positively influence behaviour.	[Megias, Diane A.; Smith, Robert J.; Verissimo, Diogo] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Anderson, Sean C.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Verissimo, Diogo] Johns Hopkins Univ, Dept Geog & Environm Engn, Whiting Sch Engn, Baltimore, MD 21218 USA	University of Kent; University of Washington; University of Washington Seattle; Johns Hopkins University	Megias, DA; Verissimo, D (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England.; Verissimo, D (corresponding author), Johns Hopkins Univ, Dept Geog & Environm Engn, Whiting Sch Engn, Baltimore, MD 21218 USA.	dm323@kent.ac.uk; verissimodiogo@gmail.com	Smith, Robert J/D-9660-2011; Anderson, Sean C./AFN-3267-2022	Smith, Robert J/0000-0003-1599-9171; Anderson, Sean C./0000-0001-9563-1937; Verissimo, Diogo/0000-0002-3519-6782	David H. Smith Conservation Fellowship	David H. Smith Conservation Fellowship	We would like thank the British Bird Council, the Independent Bird Register and Nielsen Book Services for sharing their valuable data with us. Diogo Verissimo and Sean C. Anderson are funded by a David H. Smith Conservation Fellowship.	[Anonymous], 2010, WEEK; [Anonymous], 2009, TELEGRAPH; Baker SE, 2013, BIOSCIENCE, V63, P928, DOI 10.1525/bio.2013.63.12.6; Balmer DE, 2000, 250 BRIT TRUST ORN, P23; Bennett NJ, 2016, BIOL CONSERVATION; British Broadcasting Corporation, 2001, POTT SPARK PET OWL D; British Broadcasting Corporation, 2012, HARR POTT FILMS BLAM; British Broadcasting Corporation (BBC), 2010, BBC NEWS; Brown S, 2010, PSYCHOL MARKET, V27, P541, DOI 10.1002/mar.20343; Buncombe A., 2010, INDEPENDENT; Carter I., 2016, ECOHEALTH, V14, P1; Challender DWS, 2014, CONSERV LETT, V7, P484, DOI 10.1111/conl.12082; Child, 2016, GUARDIAN; Denham J., 2015, INDEPENDENT; Denham Jess, INDEPENDENT; Department for Environment FaRA, 2015, CAPT BRED BIRDS CHAN; Fox N, 2007, FALCONRY UK AUDIT CU, P42; Green M, 2001, REINTRODUCTION REPOR; Gunelius Susan, 2008, HARRY POTTER STORY G; Hinsley A, 2015, BIOL CONSERV, V190, P80, DOI 10.1016/j.biocon.2015.05.010; Militz TA, 2017, FISH FISHER IN PRESS; Militz TA, 2017, FISH FISHERIES; Moorhouse TP, 2016, CONSERVATION LETT; Nijman V, 2017, GLOB ECOL CONSERV, V11, P84, DOI 10.1016/j.gecco.2017.04.004; Oldfield S., 2014, TRADE WILDLIFE REGUL; Paul D., 2012, THE DAILY MIRROR; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; R Core Team, R LANG ENV STAT COMP; Rosen GE, 2010, ECOHEALTH, V7, P24, DOI 10.1007/s10393-010-0317-y; Shairp R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0134787; Smith KF, 2009, SCIENCE, V324, P594, DOI 10.1126/science.1174460; The Cinema Exhibitors' Association, 2013, UK CIN AV TICK PRIC; UNEP-WCMC, 2013, CHECKL CIT SPEC; Verissimo D., 2016, NATL GEOGRAPHIC VOIC; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yong DL, 2011, TROP CONSERV SCI, V4, P244, DOI 10.1177/194008291100400302	36	18	19	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0182368	10.1371/journal.pone.0182368	http://dx.doi.org/10.1371/journal.pone.0182368			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976986	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000412163100002
J	Bannon, CC; Campbell, DA				Bannon, Catherine C.; Campbell, Douglas A.			Sinking towards destiny: High throughput measurement of phytoplankton sinking rates through time-resolved fluorescence plate spectroscopy	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; MARINE DIATOMS; GENETIC-STRUCTURE; OCEAN; VARIABILITY; BUOYANCY; SILICA; ENERGY	Diatoms are marine primary producers that sink in part due to the density of their silica frustules. Sinking of these phytoplankters is crucial for both the biological pump that sequesters carbon to the deep ocean and for the life strategy of the organism. Sinking rates have been previously measured through settling columns, or with fluorimeters or video microscopy arranged perpendicularly to the direction of sinking. These side-view techniques require large volumes of culture, specialized equipment and are difficult to scale up to multiple simultaneous measures for screening. We established a method for parallel, large scale analysis of multiple phytoplankton sinking rates through top-view monitoring of chlorophyll a fluorescence in microtitre well plates. We verified the method through experimental analysis of known factors that influence sinking rates, including exponential versus stationary growth phase in species of different cell sizes; Thalassiosira pseudonana CCMP1335, chain-forming Skeletonema marinoi RO5A and Coscinodiscus radiatus CCMP312. We fit decay curves to an algebraic transform of the decrease in fluorescence signal as cells sank away from the fluorometer detector, and then used minimal mechanistic assumptions to extract a sinking rate (m d(-1)) using an RStudio script, SinkWORX. We thereby detected significant differences in sinking rates as larger diatom cells sank faster than smaller cells, and cultures in stationary phase sank faster than those in exponential phase. Our sinking rate estimates accord well with literature values from previously established methods. This well plate-based method can operate as a high throughput integrative phenotypic screen for factors that influence sinking rates including macromolecular allocations, nutrient availability or uptake rates, chain-length or cell size, degree of silification and progression through growth stages. Alternately the approach can be used to phenomically screen libraries of mutants.	[Bannon, Catherine C.; Campbell, Douglas A.] Mt Allison Univ, Biol Dept, Sackville, NB, Canada	Mount Allison University	Campbell, DA (corresponding author), Mt Allison Univ, Biol Dept, Sackville, NB, Canada.	cicampbell@mta.ca	Campbell, Douglas A./B-3768-2010	Campbell, Douglas A./0000-0001-8996-5463; Bannon, Catherine/0000-0002-8581-1069	Natural Sciences and Engineering Research Council of Canada; New Brunswick Innovation Foundation; Mount Allison University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); New Brunswick Innovation Foundation; Mount Allison University	This work was supported by Natural Sciences and Engineering Research Council of Canada Discovery grant (DC), http://nserccrsng.gc/; New Brunswick Innovation Foundation (DC), http://nbif.ca/en; and Mount Allison University (CB), www.mta.ca.	[Anonymous], 2021, LANG ENV STAT COMP; BIENFANG PK, 1981, CAN J FISH AQUAT SCI, V38, P1289, DOI 10.1139/f81-173; Boyd CM, 2002, MAR BIOL, V141, P605, DOI 10.1007/s00227-002-0872-z; Campbell D, 1998, MICROBIOL MOL BIOL R; Champely S., 2018, PACKAGE PWR; Eppley RW, 1967, J EXP MAR BIOL ECOL, V1, P191, DOI [10.1016/0022-0981(67)90014-7, DOI 10.1016/0022-0981(67)90014-7]; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Forster RM, 2004, MAR ECOL PROG SER, V284, P9, DOI 10.3354/meps284009; Fox J., 2019, R COMPANION APPL REG, V.; Gemmell BJ, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1126; Godhe A, 2010, MOL ECOL, V19, P4478, DOI 10.1111/j.1365-294X.2010.04841.x; Harnstrom K, 2011, P NATL ACAD SCI USA, V108, P4252, DOI 10.1073/pnas.1013528108; Iversen MH, 2013, BIOGEOSCIENCES, V10, P4073, DOI 10.5194/bg-10-4073-2013; Kahm M., 2010, J STAT SOFTW, V33; Lavaud J, 2016, PHOTOSYNTH RES, V127, P189, DOI 10.1007/s11120-015-0172-3; Lavaud J, 2013, BBA-BIOENERGETICS, V1827, P294, DOI 10.1016/j.bbabio.2012.11.012; McQuoid MR, 2002, EUR J PHYCOL, V37, P191, DOI 10.1017/S0967026202003670; Morales M, 2012, COMMUNITY GEN ADVICE; Muggeo V.M., 2008, R NEWS, V8, P20; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Richardson TL, 1995, MAR ECOL PROG SER, V128, P77, DOI 10.3354/meps128077; Round F. E., 1990, DIATOMS BIOL MORPHOL; Serodio J, 2004, AQUAT MICROB ECOL, V36, P137, DOI 10.3354/ame036137; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; SMETACEK VS, 1985, MAR BIOL, V84, P239, DOI 10.1007/BF00392493; Snedecor G.W., 1989, AMES IOWA STATE U PR; Sommer U, 2016, J PLANKTON RES; Treguer P, 2000, NATURE, V406, P358, DOI 10.1038/35019236; Waite A, 1997, MAR ECOL PROG SER, V157, P97, DOI 10.3354/meps157097; WAITE AM, 1992, LIMNOL OCEANOGR, V37, P468, DOI 10.4319/lo.1992.37.3.0468; Walsh J. J., 1983, CONTINENT SHELF RES, V12, P1; Ware MA, 2015, PHOTOSYNTH RES, V126, P261, DOI 10.1007/s11120-015-0102-4; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WISEMAN SW, 1983, BRIT PHYCOL J, V18, P425, DOI 10.1080/00071618300650401	36	6	6	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185166	10.1371/journal.pone.0185166	http://dx.doi.org/10.1371/journal.pone.0185166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972987	Green Published, Green Submitted, gold			2022-12-26	WOS:000412131900014
J	Brossas, JY; Gulin, JEN; Bisio, MMC; Chapelle, M; Marinach-Patrice, C; Bordessoules, M; Ruiz, GP; Vion, J; Paris, L; Altcheh, J; Mazier, D				Brossas, Jean-Yves; Nicolas Gulin, Julian Ernesto; Catalina Bisio, Margarita Maria; Chapelle, Manuel; Marinach-Patrice, Carine; Bordessoules, Mallaury; Ruiz, George Palazon; Vion, Jeremy; Paris, Luc; Altcheh, Jaime; Mazier, Dominique			Secretome analysis of Trypanosoma cruzi by proteomics studies	PLOS ONE			English	Article							TRANS-SIALIDASE; CHAGAS-DISEASE; EXPRESSION; POPULATIONS; BIOMARKERS; EFFICACY; PROTEIN	Background Chagas disease is a debilitating often fatal disease resulting from infection by the protozoan parasite Trypanosoma cruzi. Chagas disease is endemic in 21 countries of the Americas, and it is an emerging disease in other countries as a result of migration. Given the chronic nature of the infection where intracellular parasites persist for years, the diagnosis of T. cruzi by direct detection is difficult, whereas serologic tests though sensitive may yield falsepositive results. The development of new rapid test based on the identification of soluble parasitic antigens in serum would be a real innovation in the diagnosis of Chagas disease. Methods To identify new soluble biomarkers that may improve diagnostic tests, we investigated the proteins secreted by T. cruzi using mass spectrometric analyses of conditioned culture media devoid of serum collected during the emergence of trypomastigotes from infected Vero cells. In addition, we compared the secretomes of two T. cruzi strains from DTU Tc VI (VD and CL Brener). Results Analysis of the secretome collected during the emergence of trypomastigotes from Vero cells led to the identification of 591 T. cruzi proteins. Three hundred sixty three proteins are common to both strains and most belong to different multigenic super families (i. e. TcS, GP63, MASP, and DGF1). Ultimately we have established a list of 94 secreted proteins, common to both DTU Tc VI strains that do not belong to members of multigene families. Conclusions This study provides the first comparative analysis of the secretomes from two distinct T. cruzi strains of DTU TcVI. This led us to identify a subset of common secreted proteins that could potentially serve as serum markers for T. cruzi infection. Their potential could now be evaluated, with specific antibodies using sera collected from patients and residents from endemic regions.	[Brossas, Jean-Yves; Marinach-Patrice, Carine; Bordessoules, Mallaury; Ruiz, George Palazon; Vion, Jeremy; Mazier, Dominique] INSERM, U1135, Ctr Immunol & Malad Infect, Paris, France; [Brossas, Jean-Yves; Marinach-Patrice, Carine; Bordessoules, Mallaury; Paris, Luc; Mazier, Dominique] UPMC Univ Paris 06, Sorbonne Univ, Paris, France; [Brossas, Jean-Yves; Paris, Luc; Mazier, Dominique] Hop La Pitie Salpetriere, AP HP, Serv Parasitol Mycol, Paris, France; [Nicolas Gulin, Julian Ernesto; Catalina Bisio, Margarita Maria; Altcheh, Jaime] Hosp Ninos Dr Ricardo Gutierrez, Serv Parasitol & Enfermedad Chagas, Buenos Aires, DF, Argentina; [Nicolas Gulin, Julian Ernesto; Catalina Bisio, Margarita Maria; Altcheh, Jaime] Consejo Nacl Invest Cient & Tecn, Inst Invest Patol Pediat, Buenos Aires, DF, Argentina; [Chapelle, Manuel] Bruker Daltonics Inc, Champs Sur Marne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Brossas, JY (corresponding author), INSERM, U1135, Ctr Immunol & Malad Infect, Paris, France.; Brossas, JY (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, Paris, France.; Brossas, JY (corresponding author), Hop La Pitie Salpetriere, AP HP, Serv Parasitol Mycol, Paris, France.	jean-yves.brossas@upmc.fr		Altcheh, jaime/0000-0002-5865-7991	Ecos-Sud [A13S03]	Ecos-Sud	The Bruker Society provided support in the form of salary for M. Chapelle, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of M. Chapelle is articulated in the author contributions section. The study was also supported by Ecos-Sud (Grant number: A13S03; URL: www.univ-paris13.fr/cofecub-ecos/ecos-sud). Ecos-Sud had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFRANCHINO JL, 1989, MOL BIOCHEM PARASIT, V34, P221, DOI 10.1016/0166-6851(89)90050-9; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Bayer-Santos E, 2013, J PROTEOME RES, V12, P883, DOI 10.1021/pr300947g; Bernabo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071192; Carlier Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001250; Cestari I, 2012, J IMMUNOL, V188, P1942, DOI 10.4049/jimmunol.1102053; Cooley G, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000316; de Araujo FF, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003451; De Gaudenzi JG, 2011, ESSAYS BIOCHEM, V51, P31, DOI [10.1042/bse0510031, 10.1042/BSE0510031]; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Fernandez-Villegas A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-206; Franzen O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000984; FRASCH ACC, 1991, PARASITOL TODAY, V7, P148, DOI 10.1016/0169-4758(91)90284-U; FREILIJ H, 1995, CLIN INFECT DIS, V21, P551, DOI 10.1093/clinids/21.3.551; Freitas LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025914; FREVERT U, 1992, INFECT IMMUN, V60, P2349, DOI 10.1128/IAI.60.6.2349-2360.1992; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; Geiger A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-20; Grisard EC, 2014, GENOME ANNOUNC, V2; Gulin JEN, 2013, J ANTIMICROB CHEMOTH, V68, P888, DOI 10.1093/jac/dks478; HULKA BS, 1991, CANCER EPIDEM BIOMAR, V1, P13; Jain P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/852645; KRAUTZ GM, 1995, J CLIN MICROBIOL, V33, P2086, DOI 10.1128/JCM.33.8.2086-2090.1995; Mantel PY, 2013, CELL HOST MICROBE, V13, P521, DOI 10.1016/j.chom.2013.04.009; Martin DL, 2014, AM J TROP MED HYG, V90, P1074, DOI 10.4269/ajtmh.13-0391; McNerney R, 2012, J INFECT DIS, V205, pS147, DOI 10.1093/infdis/jir860; Meira WSF, 2004, J CLIN MICROBIOL, V42, P707, DOI 10.1128/JCM.42.2.707-712.2004; Mercier SK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003700; Messenger LA, 2015, ACTA TROP, V151, P150, DOI 10.1016/j.actatropica.2015.05.007; De Pablos LM, 2012, INFECT IMMUN, V80, P2258, DOI 10.1128/IAI.06225-11; Risso MG, 2004, J INFECT DIS, V189, P2250, DOI 10.1086/420831; Sant'Anna C, 2009, PROTEOMICS, V9, P1782, DOI 10.1002/pmic.200800730; SCHENKMAN S, 1994, ANNU REV MICROBIOL, V48, P499, DOI 10.1146/annurev.mi.48.100194.002435; Segovia M, 2013, EMERG INFECT DIS, V19, P1098, DOI 10.3201/eid1907.121576; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Stahl AL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004619; Steverding D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-317; Thezenas ML, 2013, J PROTEOME RES, V12, P1211, DOI 10.1021/pr300858g; Tibayrenc M, 2015, ACTA TROP, V151, P156, DOI 10.1016/j.actatropica.2015.05.006; Tonelli RR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000864; Umezawa ES, 2001, DIAGN MICR INFEC DIS, V39, P169, DOI 10.1016/S0732-8893(01)00216-4; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	43	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185504	10.1371/journal.pone.0185504	http://dx.doi.org/10.1371/journal.pone.0185504			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972996	Green Published, Green Submitted, gold			2022-12-26	WOS:000412131900022
J	Khan, MAH; Ullah, R; Rehman, A; Rehman, L; Shareef, PAA; Abidi, SMA				Khan, M. A. Hannan; Ullah, Rizwan; Rehman, Abdur; Rehman, Lubna; Shareef, Ahammed P. A.; Abidi, S. M. A.			Immunolocalization and immunodetection of the excretory/secretory (ES) antigens of Fasciola gigantica	PLOS ONE			English	Article							EXCRETORY-SECRETORY PRODUCTS; LINKED-IMMUNOSORBENT-ASSAY; INDIAN WATER-BUFFALO; GIGANTOCOTYLE-EXPLANATUM; GASTROTHYLAX-CRUMENIFER; MONOCLONAL-ANTIBODIES; CYSTEINE PROTEINASE; SCHISTOSOMA-MANSONI; DIAGNOSTIC EFFICACY; OVINE FASCIOLIASIS	The digenetic trematode Fasciola gigantica is a parasite of great agricultural and economic importance. Along with Fasciola hepatica, F. gigantica incurs huge economic losses to the agricultural sector. Because of unavailability of an effective and commercial vaccine, the earliest diagnosis of the disease is the only way to control the disease. The conventional coprological techniques are able to detect the disease only after the parasites get matured and starts releasing their eggs with the faeces of host, therefore prepatent infection remain undiagnosed. The alternative method is by serological tests that uses circulatory antigens. Despite high sensitivity, their reliability is quite low because of the common antigens shared between different helminth parasites. To overcome this, investigation was shifted to identify the copro-antigens which could be more sensitive and reliable. In the present study, we tried to identify some of the immunodominant proteins from the Excretory Secretory (ES) product of F. gigantica which can be further characterized and used for early detection of infection and also as drug and vaccine candidates. The ES products of F. gigantica were collected and used for raising the polyclonal antibody in rabbit. The polypeptide profile was generated as well as immunogenic polypeptides were identified. The Source of ES antigen was immunolocalized using confocal microscopy and dot blot assay was performed to diagnose field infection. The polypeptide profile of ES products revealed a total of 24 polypeptides out of which 12 immunogenic polypeptides were identified by western blotting. Confocal micrographs showed the immunolocalization of antigens in the intestinal caecae, vitalline glands, gonads as well as in the tegument of the worm. The dot blot assay confirmed the utility of ES products for the detection of field infection. Subsequently, cross reactivity was found negative with Gigantocotyle explanatum; an amphitome parasite of same habitat. However, the cross reactivity with other helminths needs to be worked out.	[Khan, M. A. Hannan; Ullah, Rizwan; Rehman, Abdur; Rehman, Lubna; Shareef, Ahammed P. A.; Abidi, S. M. A.] Aligarh Muslim Univ, Sect Parasitol, Dept Zool, Aligarh, Uttar Pradesh, India; [Khan, M. A. Hannan] BGSB Univ, Dept Zool, Sch Biosci & Biotechnol, Rajouri, JK, India	Aligarh Muslim University	Khan, MAH (corresponding author), Aligarh Muslim Univ, Sect Parasitol, Dept Zool, Aligarh, Uttar Pradesh, India.; Khan, MAH (corresponding author), BGSB Univ, Dept Zool, Sch Biosci & Biotechnol, Rajouri, JK, India.	hannan7334@gmail.com	Khan, M. A. Hannan/AAE-7567-2019	Khan, M. A. Hannan/0000-0002-0742-1372				Abdel-Rahman S, 1999, PARASITE IMMUNOL, V21, P279, DOI 10.1046/j.1365-3024.1999.00191.x; Adedokun Oyeduntan Adejoju, 2008, Veterinarski Arhiv, V78, P411; Valero MA, 2009, VET PARASITOL, V159, P77, DOI 10.1016/j.vetpar.2008.10.014; Ahammad Shareef PA, 2014, THESIS; Alirahmi Heshmatollah, 2010, Acta Med Iran, V48, P367; Anuracpreeda P, 2006, ACTA TROP, V100, P31, DOI 10.1016/j.actatropica.2006.09.006; Anuracpreeda P, 2013, ACTA TROP, V127, P38, DOI 10.1016/j.actatropica.2013.03.020; Anuracpreeda P, 2011, EXP PARASITOL, V127, P340, DOI 10.1016/j.exppara.2010.08.012; Anuracpreeda P, 2009, EXP PARASITOL, V123, P334, DOI 10.1016/j.exppara.2009.08.014; Beckham SA, 2009, INT J BIOCHEM CELL B, V41, P1601, DOI 10.1016/j.biocel.2009.02.003; Brockwell YM, 2013, VET PARASITOL, V196, P417, DOI 10.1016/j.vetpar.2013.04.012; Cakici O, 2013, B ENVIRON CONTAM TOX, V91, P96, DOI 10.1007/s00128-013-1010-y; Cancela M, 2004, PARASITOL RES, V92, P441, DOI 10.1007/s00436-003-1059-3; Cervi L, 1999, PARASITOLOGY, V119, P627, DOI 10.1017/S003118209900517X; Chantree P, 2012, EXP PARASITOL, V132, P249, DOI 10.1016/j.exppara.2012.07.011; CORNELISSEN JBWJ, 1992, VET QUART, V14, P152, DOI 10.1080/01652176.1992.9694354; Demerdash ZA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-176; Dixit AK, 2002, VET PARASITOL, V109, P233, DOI 10.1016/S0304-4017(02)00202-9; DUNN TS, 1987, INT J PARASITOL, V17, P1141, DOI 10.1016/0020-7519(87)90166-4; El Ridi R, 2007, VET PARASITOL, V149, P219, DOI 10.1016/j.vetpar.2007.08.024; Endah Estuningsih S, 2004, Trop Biomed, V21, P51; FAGBEMI BO, 1995, VET PARASITOL, V57, P309, DOI 10.1016/0304-4017(94)00684-5; FAGBEMI BO, 1991, VET PARASITOL, V40, P217, DOI 10.1016/0304-4017(91)90102-2; Ghosh S, 2005, VET RES COMMUN, V29, P123, DOI 10.1023/B:VERC.0000047497.57392.8c; HANNA REB, 1988, INT J PARASITOL, V18, P513, DOI 10.1016/0020-7519(88)90016-1; Hassan Aly A., 2008, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V38, P115; HAWKES R, 1982, ANAL BIOCHEM, V119, P142, DOI 10.1016/0003-2697(82)90677-7; Intapan Pewpan M., 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P713; Kamel HH, 2013, KOREAN J PARASITOL, V51, P177, DOI 10.3347/kjp.2013.51.2.177; Khan M A Hannan, 2017, J Parasit Dis, V41, P423, DOI 10.1007/s12639-016-0820-3; Khan YA, 2014, J PARASIT DIS; Krailas D, 1999, ASIAN PAC J ALLERGY, V17, P53; Krailas Duangduen, 2002, Southeast Asian J Trop Med Public Health, V33 Suppl 3, P92; Kumar N, 2008, PARASITOL RES, V103, P141, DOI 10.1007/s00436-008-0941-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Latchumikanthan A., 2012, Tamilnadu Journal of Veterinary and Animal Sciences, V8, P14; Leenaars M, 2005, ILAR J, V46, P269, DOI 10.1093/ilar.46.3.269; Mahmoud MM, 2010, PARASITOL UNITED J, V3, P39; Markakpo US, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0931-y; MARRERO CAR, 1988, J PARASITOL, V74, P646, DOI 10.2307/3282184; McGonigle L, 2008, INT J PARASITOL, V38, P149, DOI 10.1016/j.ijpara.2007.10.007; Meemon K, 2004, MOL BIOCHEM PARASIT, V136, P1, DOI 10.1016/j.molbiopara.2004.02.010; Meemon K, 2010, EXP PARASITOL, V125, P371, DOI 10.1016/j.exppara.2010.03.003; Mezo M, 2007, J PARASITOL, V93, P65, DOI 10.1645/GE-925R.1; Molina E. C, 2005, THESIS; Morphew RM, 2012, J PROTEOME RES, V11, P5876, DOI 10.1021/pr300654w; O'Neill SM, 1999, AM J TROP MED HYG, V60, P749, DOI 10.4269/ajtmh.1999.60.749; PETERS PA, 1980, AM J TROP MED HYG, V29, P217, DOI 10.4269/ajtmh.1980.29.217; Raina OK, 2006, ACTA TROP, V98, P145, DOI 10.1016/j.actatropica.2006.03.004; RODRIGUEZPEREZ J, 1995, VET PARASITOL, V56, P57, DOI 10.1016/0304-4017(94)00666-Z; Saifullah MK, 2000, J HELMINTHOL, V74, P271; Saifullah MK, 1999, DEV BIOCH STUDIES SO; Saifullah MK, 2013, VET PARASITOL, V191, P66, DOI 10.1016/j.vetpar.2012.08.019; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Sethadavit M, 2009, ACTA TROP, V112, P164, DOI 10.1016/j.actatropica.2009.07.016; Shareef PAA, 2014, ACTA TROP, V136, P108, DOI 10.1016/j.actatropica.2014.04.011; SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5; Spithill TW, 1999, FASCIOLOSIS, P465; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Ullah R, 2017, PLOS ONE, V12; Velusamy R, 2004, VET PARASITOL, V119, P187, DOI 10.1016/j.vetpar.2003.09.023; White RR, 2012, VIRULENCE, V3, P668, DOI 10.4161/viru.22832; WIEDOSARI E, 1991, J COMP PATHOL, V105, P147, DOI 10.1016/S0021-9975(08)80070-9; Wilson RA, 2011, INT J PARASITOL, V41, P1347, DOI 10.1016/j.ijpara.2011.08.003; Yadav C. L., 2009, Journal of Veterinary Parasitology, V23, P135	65	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185870	10.1371/journal.pone.0185870	http://dx.doi.org/10.1371/journal.pone.0185870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973017	Green Published, gold, Green Submitted			2022-12-26	WOS:000412131900063
J	Beda, A; Simpson, DM; Faes, L				Beda, Alessandro; Simpson, David M.; Faes, Luca			Estimation of confidence limits for descriptive indexes derived from autoregressive analysis of time series: Methods and application to heart rate variability	PLOS ONE			English	Article							MENTAL STRESS; COMPLEXITY; DECOMPOSITION; REPEATABILITY; BOOTSTRAP; ENTROPY	The growing interest in personalized medicine requires making inferences from descriptive indexes estimated from individual recordings of physiological signals, with statistical analyses focused on individual differences between/within subjects, rather than comparing supposedly homogeneous cohorts. To this end, methods to compute confidence limits of individual estimates of descriptive indexes are needed. This study introduces numerical methods to compute such confidence limits and perform statistical comparisons between indexes derived from autoregressive (AR) modeling of individual time series. Analytical approaches are generally not viable, because the indexes are usually nonlinear functions of the AR parameters. We exploit Monte Carlo (MC) and Bootstrap (BS) methods to reproduce the sampling distribution of the AR parameters and indexes computed from them. Here, these methods are implemented for spectral and information-theoretic indexes of heart-rate variability (HRV) estimated from AR models of heart-period time series. First, the MS and BC methods are tested in a wide range of synthetic HRV time series, showing good agreement with a gold-standard approach (i.e. multiple realizations of the "true" process driving the simulation). Then, real HRV time series measured from volunteers performing cognitive tasks are considered, documenting (i) the strong variability of confidence limits' width across recordings, (ii) the diversity of individual responses to the same task, and (iii) frequent disagreement between the cohort-average response and that of many individuals. We conclude that MC and BS methods are robust in estimating confidence limits of these AR-based indexes and thus recommended for short-term HRV analysis. Moreover, the strong inter-individual differences in the response to tasks shown by AR-based indexes evidence the need of individual-by-individual assessments of HRV features. Given their generality, MC and BS methods are promising for applications in biomedical signal processing and beyond, providing a powerful new tool for assessing the confidence limits of indexes estimated from individual recordings.	[Beda, Alessandro] Univ Fed Minas Gerais, Dept Elect Engn, Belo Horizonte, MG, Brazil; [Beda, Alessandro] Univ Fed Minas Gerais, Postgrad Program Elect Engn, Belo Horizonte, MG, Brazil; [Simpson, David M.] Univ Southampton, Inst Sound & Vibrat Res, Southampton, Hants, England; [Faes, Luca] Univ Trento, Bruno Kessler Fdn & BlOtech, Trento, Italy	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; University of Southampton; University of Trento	Beda, A (corresponding author), Univ Fed Minas Gerais, Dept Elect Engn, Belo Horizonte, MG, Brazil.; Beda, A (corresponding author), Univ Fed Minas Gerais, Postgrad Program Elect Engn, Belo Horizonte, MG, Brazil.	ale.beda@gmail.com	Faes, Luca/E-5156-2012; Beda, Alessandro/AAC-5519-2019	Faes, Luca/0000-0002-3271-5348; Beda, Alessandro/0000-0002-1867-9846	Fundacao de amparo a pesquisa do estado de Minas Gerais (Brazil) [PPM-00158-15]; Fundacao de amparo a pesquisa do estado de Minas Gerais (Brazil); University of Sothampton [APQ-0388714]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil) [400461/2013-7]; Autonomous Province of Trento (Italy) (IRCS); EPSRC (UK) [EP/K036157/1]; Engineering and Physical Sciences Research Council [EP/K036157/1, EP/G010420/1] Funding Source: researchfish; EPSRC [EP/K036157/1, EP/G010420/1] Funding Source: UKRI	Fundacao de amparo a pesquisa do estado de Minas Gerais (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de amparo a pesquisa do estado de Minas Gerais (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); University of Sothampton; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Autonomous Province of Trento (Italy) (IRCS); EPSRC (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the following grants, but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.: - AB: Fundacao de amparo a pesquisa do estado de Minas Gerais (Brazil, www.fapemig.br), grant nr PPM-00158-15 -AB and DMS: Fundacao de amparo a pesquisa do estado de Minas Gerais (Brazil, www.fapemig.br) and University of Sothampton (www.soton.a.c.uk), grant nr APQ-0388714-AB and DMS: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil, www.cnpq.br) grant nr 400461/2013-7 - LF: Autonomous Province of Trento (Italy, www.provincia.tn.it) IRCS program funding - The financial support from EPSRC (UK), grant number EP/K036157/1 is gratefully acknowledged.	[Anonymous], 1987, DIGITAL SPECTRAL ANA; Baselli G, 1997, IEEE T BIO-MED ENG, V44, P1092, DOI 10.1109/10.641336; Beda A, 2007, PSYCHOPHYSIOLOGY, V44, P767, DOI 10.1111/j.1469-8986.2007.00542.x; Beda A, 2014, PSYCHOPHYSIOLOGY, V51, P197, DOI 10.1111/psyp.12163; Bernardi L, 2000, J AM COLL CARDIOL, V35, P1462, DOI 10.1016/S0735-1097(00)00595-7; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Brown MJ, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4697; BUCKLAND ST, 1984, BIOMETRICS, V40, P811, DOI 10.2307/2530926; Camm AJ, 1996, EUR HEART J, V17, P354; Cohen MA, 2002, J PHYSIOL-LONDON, V542, P669, DOI 10.1113/jphysiol.2002.017483; Eckberg DL, 2003, J PHYSIOL-LONDON, V548, P339, DOI 10.1113/jphysiol.2002.037192; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Faes L, 2015, ENTROPY-SWITZ, V17, P277, DOI 10.3390/e17010277; Goldberger JJ, 2001, CIRCULATION, V103, P1977; Hyvarinen A, 2010, J MACH LEARN RES, V11, P1709; Jauregui-Renaud K, 2001, ARCH MED RES, V32, P21, DOI 10.1016/S0188-4409(00)00255-1; Kuipers NT, 2008, J APPL PHYSIOL, V104, P1129, DOI 10.1152/japplphysiol.01285.2007; Ljung L., 1987, SYSTEM IDENTIFICATIO; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; MARDIA KV, 1984, BIOMETRIKA, V71, P135, DOI 10.1093/biomet/71.1.135; Pinna GD, 1996, MED BIOL ENG COMPUT, V34, P142, DOI 10.1007/BF02520019; Politis DN, 2003, STAT SCI, V18, P219, DOI 10.1214/ss/1063994977; Porta A, 2001, IEEE T BIO-MED ENG, V48, P1282, DOI 10.1109/10.959324; Porta A, 2007, J APPL PHYSIOL, V103, P1143, DOI 10.1152/japplphysiol.00293.2007; Porta A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132851; Schroeder EB, 2004, J ELECTROCARDIOL, V37, P163, DOI 10.1016/j.jelectrocard.2004.04.004; SLOAN RP, 1991, PHYSIOL BEHAV, V50, P1039, DOI 10.1016/0031-9384(91)90434-P; Tandon N, 1999, TRIBOL INT, V32, P469, DOI 10.1016/S0301-679X(99)00077-8; Visnovcova Z, 2014, PHYSIOL MEAS, V35, P1319, DOI 10.1088/0967-3334/35/7/1319; Widjaja D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129112; Zoubir AM, 1998, IEEE SIGNAL PROC MAG, V15, P56, DOI 10.1109/79.647043	32	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0183230	10.1371/journal.pone.0183230	http://dx.doi.org/10.1371/journal.pone.0183230			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968394	gold, Green Published, Green Accepted			2022-12-26	WOS:000412029600005
J	Guo, YJ; Fu, SH; Li, LL				Guo, Ya-Jun; Fu, Shi-Hui; Li, Lu-Lin			Autographa californica multiple nucleopoly-hedrovirus ac75 is required for egress of nucleocapsids from the nucleus and formation of de novo intranuclear membrane microvesicles	PLOS ONE			English	Article							OCCLUSION-DERIVED VIRUS; POLYHEDROSIS-VIRUS; BUDDED-VIRUS; CELLULAR-LOCALIZATION; STRUCTURAL PROTEINS; ESCHERICHIA-COLI; EFFICIENT EGRESS; BODY FORMATION; CORE GENE; BACULOVIRUS	In this study, Autographa californica multiple nucleopolyhedrovirus ac75 was functionally characterized. Ac75 has homologs in all sequenced genomes of alphabaculoviruses, betabaculoviruses, and gammabaculoviruses. It was determined to encode a protein that is associated with the nucleocapsid of budded virus and with both envelope and nucleocapsids of occlusion-derived virus. Sf9 cells transfected by an ac75-knockout bacmid resulted in the infection being restricted to single cells. No budded virus were detected although viral DNA replication and late gene expression were unaffected. Electron microscopy revealed that the virogenic stroma, nucleocapsids and occlusion bodies appeared normal in the cells transfected by an ac75-knockout bacmid. However, the nucleocapsids were unenveloped, the occlusion bodies did not contain any virions or nucleocapsids, and no nucleocapsids were found outside the nucleus or spanning the nuclear membrane. In addition, de novo intranuclear membrane microvesicles that are the precursor of occlusion-derived virus envelopes were absent in the nuclei of transfected cells. Confocal microscopy showed that AC75 protein appeared in the cytoplasm as early as 6 hours post infection. It localized to the ring zone at the periphery of the nucleus from 15 to 24 hours post infection and demonstrated light blocky cloud-like distribution in the center of the nucleus. AC75 was found to co-immunoprecipitate with BV and ODV associated envelope protein ODV-E25. The data from this study suggest that ac75 is essential for induction of the intranuclear membrane microvesicles, it appears to be required for the intranuclear envelopment of nucleocapsids, and is also essential for egress of nucleocapsids from the nuclei, in infected cells.	[Guo, Ya-Jun; Fu, Shi-Hui; Li, Lu-Lin] Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Hubei, Peoples R China	Central China Normal University	Li, LL (corresponding author), Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Hubei, Peoples R China.	lilulin@mail.ccnu.edu.cn	LULIN, LI/W-3785-2019		National Key R&D Program of China [2017YFD0200400]	National Key R&D Program of China	This study was funded by a grant from National Key R&D Program of China, 2017YFD0200400, (service.most.gov.cn) to Lu-Lin Li.	AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Beniya H, 1998, VIROLOGY, V240, P64, DOI 10.1006/viro.1997.8903; Braunagel SC, 2003, P NATL ACAD SCI USA, V100, P9797, DOI 10.1073/pnas.1733972100; Braunagel SC, 1996, VIROLOGY, V217, P97, DOI 10.1006/viro.1996.0097; Braunagel SC, 1996, VIROLOGY, V222, P100, DOI 10.1006/viro.1996.0401; Braunagel SC, 2007, CURR DRUG TARGETS, V8, P1084, DOI 10.2174/138945007782151315; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fang M, 2007, J VIROL, V81, P9859, DOI 10.1128/JVI.00588-07; Fang MG, 2009, VIROLOGY, V389, P66, DOI 10.1016/j.virol.2009.04.003; HONG T, 1994, VIROLOGY, V204, P210, DOI 10.1006/viro.1994.1525; Hong T, 1997, P NATL ACAD SCI USA, V94, P4050, DOI 10.1073/pnas.94.8.4050; Hou DH, 2013, J VIROL, V87, P829, DOI 10.1128/JVI.02329-12; Hu ZY, 2010, J VIROL, V84, P7437, DOI 10.1128/JVI.02103-09; Kawasaki Y, 2004, J GEN VIROL, V85, P3575, DOI 10.1099/vir.0.80418-0; Ke JH, 2008, VIROLOGY, V374, P421, DOI 10.1016/j.virol.2007.12.033; KNUDSON DL, 1976, J VIROL, V17, P254, DOI 10.1128/JVI.17.1.254-268.1976; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; Luo XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065635; Nie YC, 2011, VIROLOGY, V409, P38, DOI 10.1016/j.virol.2010.09.023; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Ren HL, 2016, VIROL SIN, V31, P229, DOI 10.1007/s12250-015-3675-3; Rohrmann GF, 2013, BACULOVIRUS MOL BIOL, V3rd; Sambrook J., 2001, MOL CLONING LAB MANU; Shen HX, 2012, FEBS LETT, V586, P990, DOI 10.1016/j.febslet.2011.12.040; Shen HX, 2009, CURR MICROBIOL, V59, P65, DOI 10.1007/s00284-009-9399-6; Tao XY, 2013, J VIROL, V87, P8441, DOI 10.1128/JVI.01290-13; Vanarsdall AL, 2004, VIROLOGY, V326, P191, DOI 10.1016/j.virol.2004.06.003; Wang RR, 2010, J VIROL, V84, P7233, DOI 10.1128/JVI.00040-10; Wei DH, 2014, J VIROL, V88, P1090, DOI 10.1128/JVI.02392-13; Yang M, 2014, J VIROL, V88, P12586, DOI 10.1128/JVI.01313-14; Yang M, 2014, VIROLOGY, V464, P341, DOI 10.1016/j.virol.2014.07.030; Yuan MJ, 2008, VIROLOGY, V379, P87, DOI 10.1016/j.virol.2008.06.015; Yuan MJ, 2011, J VIROL, V85, P11664, DOI 10.1128/JVI.05275-11	33	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185630	10.1371/journal.pone.0185630	http://dx.doi.org/10.1371/journal.pone.0185630			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968422	Green Submitted, gold, Green Published			2022-12-26	WOS:000412029600032
J	Omulo, S; Thumbi, SM; Lockwood, S; Verani, JR; Bigogo, G; Masyongo, G; Call, DR				Omulo, Sylvia; Thumbi, Samuel M.; Lockwood, Svetlana; Verani, Jennifer R.; Bigogo, Godfrey; Masyongo, Geoffrey; Call, Douglas R.			Evidence of superficial knowledge regarding antibiotics and their use: Results of two cross-sectional surveys in an urban informal settlement in Kenya	PLOS ONE			English	Article							SOCIOECONOMIC-FACTORS; INCOME COUNTRIES; SURVEILLANCE; RESISTANCE; COMMUNITY; CHILDREN; AFRICA	We assessed knowledge and practices related to antibiotic use in Kibera, an urban informal settlement in Kenya. Surveys was employed at the beginning (entry) and again at the end (exit) of a 5-month longitudinal study of AMR. Two-hundred households were interviewed at entry, of which 149 were also interviewed at exit. The majority (> 65%) of respondents in both surveys could name at least one antibiotic, with amoxicillin and cotrimoxazole jointly accounting for 85% and 77% of antibiotics mentioned during entry and exit, respectively. More than 80% of respondents felt antibiotics should not be shared or discontinued following the alleviation of symptoms. Nevertheless, 66% and 74% of respondents considered antibiotics effective for treating colds and flu in the entry and exit surveys, respectively. There was a high (87%, entry; 70% exit) level of reported antibiotic use (past 12 months) mainly for colds/ flu, coughs and fever, with > 80% of respondents obtaining antibiotics from health facilities and pharmacies. Less than half of respondents remembered getting information on the correct use of antibiotics, although 100% of those who did reported improved attitudes towards antibiotic use. Clinicians and community pharmacists were highly trusted information sources. Paired household responses (n = 149) generally showed improved knowledge and attitudes by the exit survey although practices were largely unchanged. Weak agreement (K = -0.003 to 0.22) between survey responses suggest both that unintended learning had not occurred, and that participant responses were not based on established knowledge or behaviors. Targeted public education regarding antibiotics is needed to address this gap.	[Omulo, Sylvia; Thumbi, Samuel M.; Lockwood, Svetlana; Call, Douglas R.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Omulo, Sylvia; Call, Douglas R.] Washington State Univ, Community Hlth Analyt Initiat, Pullman, WA 99164 USA; [Thumbi, Samuel M.; Bigogo, Godfrey; Masyongo, Geoffrey] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Verani, Jennifer R.] Ctr Dis Control & Prevent CDC, Atlanta, GA USA; [Call, Douglas R.] Nelson Mandela African Inst Sci & Technol, Arusha, Tanzania	Washington State University; Washington State University; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; Nelson Mandela African Institution of Science & Technology	Call, DR (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.; Call, DR (corresponding author), Washington State Univ, Community Hlth Analyt Initiat, Pullman, WA 99164 USA.; Call, DR (corresponding author), Nelson Mandela African Inst Sci & Technol, Arusha, Tanzania.	drcall@wsc.edu	Mwangi, Thumbi/L-2216-2019; Bigogo, Godfrey/W-3591-2019	Mwangi, Thumbi/0000-0002-5754-0556; Call, Douglas/0000-0001-6791-055X	Paul G. Allen School for Global Animal Health at Washington State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007025] Funding Source: NIH RePORTER	Paul G. Allen School for Global Animal Health at Washington State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded by the Paul G. Allen School for Global Animal Health at Washington State University. The sponsor had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abera B, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-26; Aly HAA, 2015, WHO TECH REP SER, V994, P1; APHRC, 2014, POP HLTH DYN NAIR IN; Baker S, 2015, SCIENCE, V347, P1064, DOI 10.1126/science.aaa2868; Bebell LM, 2014, GLOB HEART, V9, P347, DOI 10.1016/j.gheart.2014.08.009; Breiman RF, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0827-x; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; Chandy SJ, 2013, J ANTIMICROB CHEMOTH, V68, P229, DOI 10.1093/jac/dks355; Ecumenical Pharmaceutical Network, 2010, EXPL PIL STUD KNOWL; Enato EFO, 2011, INT J HEAL RES, V4, P37; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; Feikin DR, 2011, PLOS ONE, P6; Genga EK, 2017, AFR J RESPIR MED, V12, P3; Henricson K, 1998, EUR J CLIN PHARMACOL, V54, P653, DOI 10.1007/s002280050529; Hove M, 2013, STABILITY, V2, DOI 10.5334/sta.ap; Kalungia AC, 2016, EXPERT REV ANTI-INFE, V14, P1215, DOI 10.1080/14787210.2016.1227702; Kandelaki Ketevan, 2015, BMC Res Notes, V8, P495, DOI 10.1186/s13104-015-1477-1; Kehinde OO., 2013, W AFR J PHARM, V24, P49; Kenealy T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000247.pub3; Kheder SI, 2013, INT J BIOASSAYS, V2, P751; Mendelson M, 2016, LANCET, V387, P188, DOI 10.1016/S0140-6736(15)00547-4; Njuguna HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058437; Omulo S, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-014-0041-4; Padget M, 2016, INT J ANTIMICROB AG, V48, P27, DOI 10.1016/j.ijantimicag.2016.04.024; R Core Team, 2016, R FDN STAT COMP; Ramin B, 2009, B WORLD HEALTH ORGAN, V87, P886, DOI 10.2471/BLT.09.073445; Thrane N, 2003, J ANTIMICROB CHEMOTH, V51, P683, DOI 10.1093/jac/dkg118; Vialle-Valentin CE, 2012, TROP MED INT HEALTH, V17, P211, DOI 10.1111/j.1365-3156.2011.02895.x; Wafula FN, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-223; Wise J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6117	30	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185827	10.1371/journal.pone.0185827	http://dx.doi.org/10.1371/journal.pone.0185827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968447	Green Published, gold, Green Submitted			2022-12-26	WOS:000412029600054
J	Fredriksson-Lidman, K; Van Itallie, CM; Tietgens, AJ; Anderson, JM				Fredriksson-Lidman, Karin; Van Itallie, Christina M.; Tietgens, Amber J.; Anderson, James M.			Sorbin and SH3 domain-containing protein 2 (SORBS2) is a component of the acto-myosin ring at the apical junctional complex in epithelial cells	PLOS ONE			English	Article							VINCULIN-BINDING PROTEIN; TIGHT JUNCTION; STRESS FIBERS; CYTOSKELETAL ORGANIZATION; INTERACTING PROTEIN; ADAPTER PROTEIN; ZONULA ADHERENS; ALPHA-ACTININ; LIPID RAFTS; E-CADHERIN	SORBS2 is a scaffolding protein associated with Abl/Arg non-receptor tyrosine kinase pathways and is known to interact with actin and several other cytoskeletal proteins in various cell types. Previous BioID proximity labeling of tight and adherens junction proteins suggested that SORBS2 is a component of the apical junction complex of epithelial cells. We asked whether SORBS2 plays a previously unappreciated role in controlling perijunctional actin and tight junction barrier function. Using super resolution imaging we confirmed that SORBS2 is localized at the apical junction complex but farther from the membrane than ZO-1 and located partially overlapping both the tight- and adherens junctions with a periodic concentration that alternates with myosin IIB in polarized epithelial cells. Overexpression of GFP-SORBS2 recruited alpha-actinin, vinculin and N-WASP, and possibly CIP4 to cellular junctions. However, CRISPR-Cas9 knock-out of SORBS2 did not alter the localization- or immunofluorescent staining intensity of these or several other junctional- and cytoskeletal proteins. SORBS2 knock-out also did not affect the barrier function as measured by TER and dextran flux; nor did it change actin-dependent junction re-assembly as measured by Ca2+-switch and Latrunculin-B wash-out assays. The kinetics of HGF-induced cell scattering and wound healing, and dextran flux increase induced by PDGF also were unaffected by SORBS2 knock-out. SORBS2 concentrates with apical junctional actin that accumulates in response to knock-down of ZO-1 and ZO-2. In spite of our finding that SORBS2 is clearly a component of the apical junction complex, it does not appear to be required for either normal tight- or adherens junction assembly, structure or function or for growth factor-mediated changes in tight junction dynamics.	[Fredriksson-Lidman, Karin; Van Itallie, Christina M.; Tietgens, Amber J.; Anderson, James M.] NHLBI, Lab Tight Junct Struct & Funct, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Fredriksson-Lidman, K (corresponding author), NHLBI, Lab Tight Junct Struct & Funct, NIH, Bldg 10, Bethesda, MD 20892 USA.	karin.fredriksson@nih.gov			Division of Intramural Research, National Institutes of Health (US) [ZIA HL006207]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006207] Funding Source: NIH RePORTER	Division of Intramural Research, National Institutes of Health (US); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the Division of Intramural Research, National Institutes of Health (US), ZIA HL006207, Dr. James M. Anderson.	ANDERSON JM, 1988, J CELL BIOL, V106, P1141, DOI 10.1083/jcb.106.4.1141; Anekal PV, 2015, J BIOL CHEM, V290, P2112, DOI 10.1074/jbc.M114.610725; Anekal PV, 2014, J BIOL CHEM; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Burridge K, 2013, J CELL BIOL, V200, P9, DOI 10.1083/jcb.201210090; Cestra G, 2005, P NATL ACAD SCI USA, V102, P1731, DOI 10.1073/pnas.0409376102; Chang YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107961; Chen VC, 2006, J PROTEOME RES, V5, P2123, DOI 10.1021/pr060216l; Choi W, 2016, J CELL BIOL, V213, P243, DOI 10.1083/jcb.201506115; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1; Ebrahim S, 2013, CURR BIOL, V23, P731, DOI 10.1016/j.cub.2013.03.039; Etournay R, 2007, J CELL SCI, V120, P2838, DOI 10.1242/jcs.002568; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Fredriksson K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117074; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Guo ZH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005473; Haglund K, 2004, J CELL SCI, V117, P2557, DOI 10.1242/jcs.01148; Hallock PT, 2016, MOL CELL BIOL, V36, P262, DOI 10.1128/MCB.00775-15; Harhaj NS, 2002, J CELL PHYSIOL, V193, P349, DOI 10.1002/jcp.10183; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hu SQ, 2017, NAT CELL BIOL, V19, P133, DOI 10.1038/ncb3466; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Kassianidou E, 2015, BBA-MOL CELL RES, V1853, P3065, DOI 10.1016/j.bbamcr.2015.04.006; Kawabe H, 1999, J BIOL CHEM, V274, P30914, DOI 10.1074/jbc.274.43.30914; Kimura A, 2001, P NATL ACAD SCI USA, V98, P9098, DOI 10.1073/pnas.151252898; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Kioka N, 2002, CELL STRUCT FUNCT, V27, P1, DOI 10.1247/csf.27.1; Lechuga S, 2015, AM J PHYSIOL-GASTR L, V308, pG745, DOI 10.1152/ajpgi.00446.2014; Li R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124960; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Murase K, 2012, MED MOL MORPHOL, V45, P22, DOI 10.1007/s00795-010-0537-9; Peterson LJ, 2004, MOL BIOL CELL, V15, P3497, DOI 10.1091/mbc.E03-09-0696; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roignot J, 2010, CANCER LETT, V288, P116, DOI 10.1016/j.canlet.2009.06.030; Ronty M, 2005, EXP CELL RES, V310, P88, DOI 10.1016/j.yexcr.2005.06.026; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Sanger JM, 2010, CYTOSKELETON, V67, P808, DOI 10.1002/cm.20490; Sheff DR, 2002, MOL BIOL CELL, V13, P262, DOI 10.1091/mbc.01-07-0320; Soubeyran P, 2003, BIOCHEM J, V370, P29, DOI 10.1042/BJ20021539; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Taieb D, 2008, CANCER RES, V68, P4588, DOI 10.1158/0008-5472.CAN-08-0958; Tang VW, 2012, J CELL BIOL, V196, P115, DOI 10.1083/jcb.201103116; Umeda K, 2004, J BIOL CHEM, V279, P44785, DOI 10.1074/jbc.M406563200; Van Itallie CM, 2015, MOL BIOL CELL, V26, P2769, DOI 10.1091/mbc.E15-04-0232; Van Itallie CM, 2014, J CELL SCI, V127, P885, DOI 10.1242/jcs.140475; Van Itallie CM, 2013, J BIOL CHEM, V288, P13775, DOI 10.1074/jbc.M113.466193; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wang BL, 1997, J BIOL CHEM, V272, P17542, DOI 10.1074/jbc.272.28.17542; Yuan ZQ, 2005, J BIOL CHEM, V280, P21483, DOI 10.1074/jbc.M500097200; Zhadanov AB, 1999, CURR BIOL, V9, P880, DOI 10.1016/S0960-9822(99)80392-3	56	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185448	10.1371/journal.pone.0185448	http://dx.doi.org/10.1371/journal.pone.0185448			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961272	Green Submitted, Green Published, gold			2022-12-26	WOS:000412027700019
J	Geurts, M; de Kort, FAS; de Kort, PLM; van Tuijl, JH; Kappelle, LJ; van der Worp, HB				Geurts, Marjolein; de Kort, Floor A. S.; de Kort, Paul L. M.; van Tuijl, Julia H.; Kappelle, L. Jaap; van der Worp, H. Bart			Predictive accuracy of physicians' estimates of outcome after severe stroke	PLOS ONE			English	Article							QUALITY-OF-LIFE; INTRACEREBRAL HEMORRHAGE; EXTERNAL VALIDATION; CEREBRAL INFARCTION; DISABILITY; SCORE; WITHDRAWAL; CLINICIAN; ORDERS; TRIAL	Introduction End-of-life decisions after stroke should be guided by accurate estimates of the patient's prognosis. We assessed the accuracy of physicians' estimates regarding mortality, functional outcome, and quality of life in patients with severe stroke. Methods Treating physicians predicted mortality, functional outcome (modified Rankin scale (mRS)), and quality of life (visual analogue scale (VAS)) at six months in patients with major disabling stroke who had a Barthel Index <= 6 (of 20) at day four. Unfavorable functional outcome was defined as mRS >3, non-satisfactory quality of life as VAS <60. Patients were followed-up at six months after stroke. We compared physicians' estimates with actual outcomes. Results Sixty patients were included, with a mean age of 72 years. Of fifteen patients who were predicted to die, one actually survived at six months (positive predictive value (PPV), 0.93; 95% CI, 0.66-0.99). Of thirty patients who survived, one was predicted to die (false positive rate (FPR), 0.03; 95% CI 0.00-0.20). Of forty-six patients who were predicted to have an unfavorable outcome, four had a favorable outcome (PPV, 0.93; 95% CI, 0.81-0.98; FPR, 0.30; 95% CI; 0.08-0.65). Prediction of non-satisfactory quality of life was less accurate (PPV, 0.63; 95% CI, 0.26-0.90; FPR, 0.18; 95% CI 0.05-0.44). Conclusions In patients with severe stroke, treating physicians' estimation of the risk of mortality or unfavorable functional outcome at six months is relatively inaccurate. Prediction of quality of life is even more imprecise.	[Geurts, Marjolein; de Kort, Floor A. S.; Kappelle, L. Jaap; van der Worp, H. Bart] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands; [de Kort, Paul L. M.; van Tuijl, Julia H.] Elisabeth Twee Steden Ziekenhuis, Dept Neurol, Tilburg, Netherlands	Utrecht University; Utrecht University Medical Center; Elisabeth-TweeSteden Ziekenhuis (ETZ)	Geurts, M (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands.	m.geurts-2@umcutrecht.nl	Geurts, Marjolein/AAP-4148-2020		Dutch Heart Foundation [20106239, 2010T075]	Dutch Heart Foundation(Netherlands Heart Foundation)	Marjolein Geurts and Bart van der Worp are supported by the Dutch Heart Foundation (20106239 and 2010T075, respectively). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Caulfield AF, 2010, NEUROLOGY, V74, P1096, DOI 10.1212/WNL.0b013e3181d8197f; Cerniauskaite M, 2012, AM J PHYS MED REHAB, V91, pS39, DOI 10.1097/PHM.0b013e31823d4df7; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clarke JL, 2004, NEUROCRIT CARE, V1, P53, DOI 10.1385/NCC:1:1:53; Geurts M, EUROPEAN STROKE J; Geurts M, 2014, LANCET NEUROL, V13, P515, DOI 10.1016/S1474-4422(14)70030-4; Geurts M, 2013, STROKE, V44, P2506, DOI 10.1161/STROKEAHA.113.002014; Hemphill JC, 2004, STROKE, V35, P1130, DOI 10.1161/01.STR.0000125858.71051.ca; Hwang DY, 2016, NEUROLOGY, V86, P126, DOI 10.1212/WNL.0000000000002266; Indredavik B, 1998, STROKE, V29, P895, DOI 10.1161/01.STR.29.5.895; Kelly AG, 2012, NEUROLOGY, V79, P941, DOI 10.1212/WNL.0b013e318266fc40; Luengo-Fernandez R, 2013, STROKE, V44, P2854, DOI 10.1161/STROKEAHA.113.001584; MAHONEY F I, 1965, Md State Med J, V14, P61; Navi BB, 2012, STROKE, V43, P702, DOI 10.1161/STROKEAHA.111.639161; Saposnik G, 2013, NEUROLOGY, V81, P448, DOI 10.1212/WNL.0b013e31829d874e; Saposnik G, 2011, CIRCULATION, V123, P739, DOI 10.1161/CIRCULATIONAHA.110.983353; Silvennoinen K, 2014, INT J STROKE, V9, P53, DOI 10.1111/ijs.12161; Ubel PA, 2005, HEALTH PSYCHOL, V24, pS57, DOI 10.1037/0278-6133.24.4.S57; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Ware J., 1993, SF 36 HLTH SURVEY MA; Weimar C, 2004, STROKE, V35, P158, DOI 10.1161/01.STR.0000106761.94985.8B; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd	24	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0184894	10.1371/journal.pone.0184894	http://dx.doi.org/10.1371/journal.pone.0184894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961255	Green Published, gold, Green Submitted			2022-12-26	WOS:000412027700012
J	Szikora, B; Hiripi, L; Bender, B; Kacskovics, I; Ilias, A				Szikora, Bence; Hiripi, Laszlo; Bender, Balazs; Kacskovics, Imre; Ilias, Attila			Characterization of the interactions of rabbit neonatal Fc receptor (FcRn) with rabbit and human IgG isotypes	PLOS ONE			English	Article							PH-DEPENDENT BINDING; I-RELATED RECEPTOR; SITE-DIRECTED MUTAGENESIS; PLACENTAL-TRANSFER; CRYSTAL-STRUCTURE; IMMUNOGLOBULIN-G; MONOCLONAL-ANTIBODY; NONHUMAN-PRIMATES; YOLK-SAC; COMPLEX	Despite the increasing importance of rabbit as an animal model in pharmacological studies like investigating placental transfer of therapeutic IgGs, little is known about the molecular interaction of the rabbit neonatal Fc receptor (FcRn) with rabbit and human IgG molecules. We analyzed the interactions of the rabbit and human FcRn with rabbit and human IgG isotypes using surface plasmon resonance assay. Similar to FcRn of other species, rabbit FcRn functions in pH-dependent manner, as it binds IgGs at pH 6.0, but no binding occurs at pH 7.4. We also showed that rabbit FcRn binds rabbit IgG and human IgG1 with nearly identical affinity, whereas it has stronger interactions with the other human IgG isotypes. The similar affinity of rabbit IgG and human IgG1 for rabbit FcRn was confirmed by in vitro FcRn-mediated recycling assay. These data verify that rabbit is an appropriate animal model for analyzing the pharmacokinetics of human therapeutic monoclonal antibodies.	[Szikora, Bence; Kacskovics, Imre; Ilias, Attila] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary; [Hiripi, Laszlo] Natl Agr Res & Innovat Ctr, Dept Anim Biotechnol, Godollo, Hungary; [Bender, Balazs; Kacskovics, Imre] ImmunoGenes ABS Ltd, Budakeszi, Hungary	Eotvos Lorand University	Ilias, A (corresponding author), Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary.	attila.ilias@ttk.elte.hu	Hiripi, Laszlo/AAL-8243-2021; Szikora, Bence/AAG-3544-2021; Kacskovics, Imre/J-8449-2013; Ilias, Attila/I-7072-2017	Hiripi, Laszlo/0000-0002-1023-0112; Kacskovics, Imre/0000-0002-0402-3862; Ilias, Attila/0000-0003-3196-0795; Szikora, Bence/0000-0002-0766-5684	Hungarian National Development Agency [KMOP-4.2.1./B-10-2011-0002]	Hungarian National Development Agency	This work was supported by the grant from the Hungarian National Development Agency [KMOP-4.2.1./B-10-2011-0002]. The funder provided support in the form of purchasing the ProteOn XPR36 biosensor instrument, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. BB is scientific researcher, IK is CEO of ImmunoGenes-ABS Ltd, Budakeszi, Hungary. The funder provided support in the form of salaries for authors BB and IK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdiche YN, 2015, MABS-AUSTIN, V7, P331, DOI 10.1080/19420862.2015.1008353; Akilesh S, 2007, J IMMUNOL, V179, P4580, DOI 10.4049/jimmunol.179.7.4580; Andersen JT, 2006, EUR J IMMUNOL, V36, P3044, DOI 10.1002/eji.200636556; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Baker K, 2014, FRONT IMMUNOL, V5, DOI [10.3389/fimmu.2014.00664, 10.3389/fimmu.2014.00408]; Bitonti AJ, 2004, P NATL ACAD SCI USA, V101, P9763, DOI 10.1073/pnas.0403235101; Bowman CJ, 2013, BIRTH DEFECTS RES B, V98, P459, DOI 10.1002/bdrb.21089; Brambell FWR., 1970, N HOLL RES MONOGR FR, V18; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Cervenak J, 2015, IMMUNOL REV, V268, P269, DOI 10.1111/imr.12364; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; DeSesso JM, 2012, CRIT REV TOXICOL, V42, P185, DOI 10.3109/10408444.2011.653487; GATES FT, 1979, BIOCHEMISTRY-US, V18, P2267, DOI 10.1021/bi00578a021; Gaton E, 1984, MACROPHAGE ACTIVATIO, P15; Ghetie V, 1997, NAT BIOTECHNOL, V15, P637, DOI 10.1038/nbt0797-637; HUBER AH, 1993, J MOL BIOL, V230, P1077, DOI 10.1006/jmbi.1993.1220; Kacskovics I, 2006, INT IMMUNOL, V18, P525, DOI 10.1093/intimm/dxh393; KIM JK, 1994, EUR J IMMUNOL, V24, P542, DOI 10.1002/eji.1830240308; KOBAYASHI Y, 1989, EUR J DRUG METAB PH, V14, P35, DOI 10.1007/BF03190840; Kuo TT, 2011, MABS-AUSTIN, V3, P422, DOI 10.4161/mabs.3.5.16983; Lemos APC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028869; Martin PL, 2010, INT J TOXICOL, V29, P552, DOI 10.1177/1091581810378896; Martin PL, 2010, BIRTH DEFECTS RES B, V89, P116, DOI 10.1002/bdrb.20232; Martin WL, 1999, BIOCHEMISTRY-US, V38, P12639, DOI 10.1021/bi9913505; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; MEADS TJ, 1994, PLACENTA, V15, P525, DOI 10.1016/S0143-4004(05)80421-7; Moffat GJ, 2014, BIRTH DEFECTS RES B, V101, P178, DOI 10.1002/bdrb.21105; Mohty M, 2007, LEUKEMIA, V21, P1387, DOI 10.1038/sj.leu.2404683; Nicholas KB., 1997, GENEDOC TOOL EDITING; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201; Popov S, 1996, MOL IMMUNOL, V33, P521, DOI 10.1016/0161-5890(96)00004-1; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; RODEWALD R, 1976, J CELL BIOL, V71, P666, DOI 10.1083/jcb.71.2.666; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; SABISTON BH, 1976, J IMMUNOL, V116, P106; Sanchez LM, 1999, BIOCHEMISTRY-US, V38, P9471, DOI 10.1021/bi9907330; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider Z, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00357; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; SMITH AES, 1962, DEV BIOL, V4, P339, DOI 10.1016/0012-1606(62)90047-7; SPIEGELB.HL, 1965, J EXP MED, V121, P323, DOI 10.1084/jem.121.3.323; Wang XD, 2017, MABS-AUSTIN, V9, P319, DOI 10.1080/19420862.2016.1261774; West AP, 2000, BIOCHEMISTRY-US, V39, P9698, DOI 10.1021/bi000749m; Zhou JC, 2003, J MOL BIOL, V332, P901, DOI 10.1016/S0022-2836(03)00952-5; Zhou JC, 2005, J MOL BIOL, V345, P1071, DOI 10.1016/j.jmb.2004.11.014	46	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185662	10.1371/journal.pone.0185662	http://dx.doi.org/10.1371/journal.pone.0185662			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957416	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200102
J	Umakoshi, H; Iwano, S; Inoue, T; Li, YZ; Naganawa, S				Umakoshi, Hiroyasu; Iwano, Shingo; Inoue, Tsutomu; Li, Yuanzhong; Naganawa, Shinji			Quantitative evaluation of interstitial pneumonia using 3D-curved high-resolution CT imaging parallel to the chest wall: A pilot study	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; COMPUTED-TOMOGRAPHY; CLASSIFICATION; EMPHYSEMA; DIAGNOSIS; DENSITY; INDEXES	Objectives To quantify the imaging findings of patients with interstitial pneumonia (IP) and emphysema using three-dimensional curved high-resolution computed tomography (3D-cHRCT) at a constant depth from the chest wall, and compare the results to visual assessment of IP and each patient's diffusing capacity of the lungs for carbon monoxide (DLco). Methods We retrospectively reviewed the axial CT findings and pulmonary function test results of 95 patients with lung cancer (72 men and 23 women, aged 45-84 years) with or without IP, as follows: non-IP (n = 47), mild IP (n = 31), and moderate IP (n = 17). The 3D-cHRCT images of the lung at a 1-cm depth from the chest wall were reconstructed automatically using original software; total area (TA), high-attenuation area (HAA) >-500 HU, and low-attenuation area (LAA) <-950 HU were calculated on a workstation. The % HAA and % LAA were calculated as follows: % HAA = HAA/TA x 100, and % LAA = LAA/TA x100. Results The % HAA and % LAA respective values were 3.2 +/- 0.9 and 27.7 +/- 8.2, 3.9 +/- 1.2 and 27.6 +/- 5.9, and 6.9 +/- 2.2 and 25.4 +/- 8.7 in non-IP, mild IP, and moderate IP patients, respectively. There were significant differences in % HAA between the 3 groups of patients (P<0.001), but no differences in % LAA (P = 0.558). Multiple linear regression analysis revealed that % HAA and % LAA were negatively correlated with predicted DLco (standard partial regression coefficient [b*] = -0.453, P<0.001; b* = -0.447, P<0.001, respectively). Conclusions The % HAA and % LAA values computed using 3D-cHRCT were significantly correlated with DLco and may be important quantitative parameters for both IP and emphysema.	[Umakoshi, Hiroyasu; Iwano, Shingo; Naganawa, Shinji] Nagoya Univ, Grad Sch Med, Dept Radiol, Nagoya, Aichi, Japan; [Inoue, Tsutomu; Li, Yuanzhong] Fujifilm Corp, Imaging Technol Ctr, Tokyo, Japan	Nagoya University; Fujifilm Corporation	Iwano, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Radiol, Nagoya, Aichi, Japan.	iwano45@med.nagoya-u.ac.jp	Naganawa, Shinji/I-1572-2012; Iwano, Shingo/I-7355-2014	Naganawa, Shinji/0000-0002-0214-613X; Iwano, Shingo/0000-0002-3256-0390	Japan Society for the Promotion of Science (JSPS); JSPS KAKENHI [15H01115, 17H05292]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study has received funding by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research on Innovative Areas (Multidisciplinary Computational Anatomy), JSPS KAKENHI Grant Number 15H01115; Grant Number 17H05292 to SI.) This study was also funded by Fujifilm corporation. Fujifilm corporation provided support in the form of salaries for authors [TI, YL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	ADAMS H, 1991, CLIN RADIOL, V43, P238, DOI 10.1016/S0009-9260(05)80245-4; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Ash SY, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0527-8; Bartholmai BJ, 2013, J THORAC IMAG, V28, P298, DOI 10.1097/RTI.0b013e3182a21969; Galban CJ, 2012, NAT MED, V18, P1711, DOI 10.1038/nm.2971; GEVENOIS PA, 1995, AM J RESP CRIT CARE, V152, P653, DOI 10.1164/ajrccm.152.2.7633722; GODDARD PR, 1982, CLIN RADIOL, V33, P379, DOI 10.1016/S0009-9260(82)80301-2; Iwano S, 2009, ACAD RADIOL, V16, P250, DOI 10.1016/j.acra.2008.09.019; Iwasawa T, 2009, J THORAC IMAG, V24, P216, DOI 10.1097/RTI.0b013e3181a6527d; Jacob J, 2016, J THORAC IMAG, V31, P304, DOI 10.1097/RTI.0000000000000220; Jankowich MD, 2012, CHEST, V141, P222, DOI 10.1378/chest.11-1062; Koyama Hisanobu, 2016, Eur J Radiol, V85, P352, DOI 10.1016/j.ejrad.2015.11.026; Koyama H, 2010, EUR J RADIOL, V74, P142, DOI 10.1016/j.ejrad.2009.02.006; Lynch DA, 2007, CHEST, V131, P643, DOI 10.1378/chest.06-2955; Margaritopoulos GA, 2015, EUR RESPIR REV, V24, P428, DOI 10.1183/16000617.0050-2015; Matsuoka S, 2015, J COMPUT ASSIST TOMO, V39, P153, DOI 10.1097/RCT.0000000000000184; Mimae T, 2015, ANN SURG ONCOL, V22, pS1371, DOI 10.1245/s10434-015-4577-1; Nambu A, 2015, EUR J RADIOL, V84, P980, DOI 10.1016/j.ejrad.2015.01.010; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Shin KE, 2011, J COMPUT ASSIST TOMO, V35, P266, DOI 10.1097/RCT.0b013e31820ccf18; Sverzellati N, 2007, RADIOL MED, V112, P1160, DOI 10.1007/s11547-007-0213-x; Sverzellati N, 2015, RADIOGRAPHICS, V35, P1849, DOI 10.1148/rg.2015140334; Tominaga J, 2015, EUR J RADIOL, V84, P2640, DOI 10.1016/j.ejrad.2015.08.016; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Watadani T, 2013, RADIOLOGY, V266, P936, DOI 10.1148/radiol.12112516; Yoon RG, 2013, EUR RADIOL, V23, P692, DOI 10.1007/s00330-012-2634-8	26	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185532	10.1371/journal.pone.0185532	http://dx.doi.org/10.1371/journal.pone.0185532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957390	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200078
J	Hoyte, AC; Jamin, AV; Koneru, PC; Kobe, MJ; Larue, RC; Fuchs, JR; Engelman, AN; Kvaratskhelia, M				Hoyte, Ashley C.; Jamin, Augusta V.; Koneru, Pratibha C.; Kobe, Matthew J.; Larue, Ross C.; Fuchs, James R.; Engelman, Alan N.; Kvaratskhelia, Mamuka			Resistance to pyridine-based inhibitor KF116 reveals an unexpected role of integrase in HIV-1 Gag-Pol polyprotein proteolytic processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); integrase; protein aggregation; protein drug interaction; viral replication; HIV; allosteric inhibitors	VIRUS TYPE-1 INTEGRASE; CATALYTIC DOMAIN; REPLICATION; MECHANISM; MATURE; MODEL; MULTIMERIZATION; MUTATIONS; KNOCKOUT; PROTEIN	The pyridine-based multimerization selective HIV-1 integrase (IN) inhibitors (MINIs) are a distinct subclass of allosteric IN inhibitors. MINIs potently inhibit HIV-1 replication during virion maturation by inducing hyper- or aberrant IN multimerization but are largely ineffective during the early steps of viral replication. Here, we investigated the mechanism for the evolution of a triple IN substitution (T124N/V165I/T174I) that emerges in cell culture with a representative MINI, KF116. We show that HIV-1 NL4-3(IN T124N/V165I/T174I) confers marked (>2000-fold) resistance to KF116. Two IN substitutions (T124N/T174I) directly weaken inhibitor binding at the dimer interface of the catalytic core domain but at the same time markedly impair HIV-1 replication capacity. Unexpectedly, T124N/T174I IN substitutions inhibited proteolytic processing of HIV-1 polyproteins Gag and Gag-Pol, resulting in immature virions. Strikingly, the addition of the third IN substitution (V165I) restored polyprotein processing, virus particle maturation, and significant levels of replication capacity. These results reveal an unanticipated role of IN for polyprotein proteolytic processing during virion morphogenesis. The complex evolutionary pathway for the emergence of resistant viruses, which includes the need for the compensatory V165I IN substitution, highlights a relatively high genetic barrier exerted by MINI KF116. Additionally, we have solved the X-ray structure of the drug-resistant catalytic core domain protein, which provides means for rational development of second-generation MINIs.	[Hoyte, Ashley C.; Koneru, Pratibha C.; Kobe, Matthew J.; Larue, Ross C.; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Fuchs, James R.] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Hoyte, Ashley C.; Koneru, Pratibha C.; Kvaratskhelia, Mamuka] Univ Colorado, Sch Med, Div Infect Dis, Aurora, CO 80045 USA; [Jamin, Augusta V.] Harvard Med Sch, Dept Canc Immunol & Virol, Dana Farber Canc Inst, Boston, MA 02215 USA; [Jamin, Augusta V.] Harvard Med Sch, Dept Med, Boston, MA 02215 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Kvaratskhelia, M (corresponding author), Univ Colorado, Sch Med, Div Infect Dis, Aurora, CO 80045 USA.	mamuka.kvaratskhelia@ucdenver.edu		Fuchs, James/0000-0002-8743-6389; Larue, Ross/0000-0002-0170-7345; Koneru, Pratibha Chowdary/0000-0003-3955-4548	National Institutes of Health [R01 AI110310, R01 AI062520, R01 AI039394, U54 GM103368, KL2 TR001068]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110310, R37AI039394, R01AI039394, R01AI062520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 AI110310 and R01 AI062520 (to M. K.), R01 AI039394 (to A. N. E.), U54 GM103368 (to A. N. E. and M. K.), and KL2 TR001068 (to R. C. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Accola MA, 2000, J VIROL, V74, P6198, DOI 10.1128/JVI.74.13.6198-6202.2000; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Balakrishnan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074163; Ballandras-Colas A, 2017, SCIENCE, V355, P93, DOI 10.1126/science.aah7002; Bukovsky A, 1996, J VIROL, V70, P6820, DOI 10.1128/JVI.70.10.6820-6825.1996; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Desimmie BA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-57; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engelman A, 1999, ADV VIRUS RES, V52, P411, DOI 10.1016/S0065-3527(08)60309-7; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; Fadel HJ, 2014, J VIROL, V88, P9704, DOI 10.1128/JVI.01397-14; Fader LD, 2014, ACS MED CHEM LETT, V5, P711, DOI 10.1021/ml500110j; Fader LD, 2014, ACS MED CHEM LETT, V5, P422, DOI 10.1021/ml500002n; Feng L, 2013, J BIOL CHEM, V288, P15813, DOI 10.1074/jbc.M112.443390; Fontana J, 2015, J VIROL, V89, P9765, DOI 10.1128/JVI.01522-15; Grawenhoff Julia, 2017, World J Biol Chem, V8, P32, DOI 10.4331/wjbc.v8.i1.32; Gupta K, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002584; Gupta K, 2014, J BIOL CHEM, V289, P20477, DOI 10.1074/jbc.M114.551119; JENKINS TM, 1995, P NATL ACAD SCI USA, V92, P6057, DOI 10.1073/pnas.92.13.6057; Johnson BC, 2013, J MOL BIOL, V425, P2133, DOI 10.1016/j.jmb.2013.03.027; Jurado KA, 2013, P NATL ACAD SCI USA, V110, P8690, DOI 10.1073/pnas.1300703110; Kessl JJ, 2016, CELL, V166, P1257, DOI 10.1016/j.cell.2016.07.044; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Le Rouzic E, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-144; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Passos DO, 2017, SCIENCE, V355, P89, DOI 10.1126/science.aah5163; Sharma A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004171; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Slaughter A, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0100-1; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Tsiang M, 2012, J BIOL CHEM, V287, P21189, DOI 10.1074/jbc.M112.347534; van Bel N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103552; Wang H, 2012, NUCLEIC ACIDS RES, V40, P11518, DOI 10.1093/nar/gks913; Welker R, 2000, J VIROL, V74, P1168, DOI 10.1128/JVI.74.3.1168-1177.2000; Wondrak EM, 1996, BIOCHEMISTRY-US, V35, P12957, DOI 10.1021/bi960984y; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162	41	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19814	19825		10.1074/jbc.M117.816645	http://dx.doi.org/10.1074/jbc.M117.816645			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972144	Green Published, hybrid			2022-12-26	WOS:000416911300025
J	Amo, C; De Santiago, L; Lucianez, DZ; Alonso-Cortes, JML; Alonso-Alonso, M; Barea, R; Boquete, L				Amo, Carlos; De Santiago, Luis; Zarza Lucianez, Daniel; Leon Alonso-Cortes, Jose Miguel; Alonso-Alonso, Miguel; Barea, Rafael; Boquete, Luciano			Induced gamma band activity from EEG as a possible index of training-related brain plasticity in motor tasks	PLOS ONE			English	Article							CORTICAL PLASTICITY; MOVEMENT; OSCILLATIONS; REPRESENTATION; EXERCISE; CORTEX; HAND	The aim of this study was proposing gamma band activity (GBA) as an index of training-related brain plasticity in the motor cortex. Sixteen controls underwent an experimental session where electroencephalography (EEG) activity was recorded at baseline (resting) and during a motor task (hand movements). GBA was obtained from the EEG data at baseline and during the task. Index of plasticity (IP) was defined as the relationship between GBA at the end of the motor task (GBA(M)_(FIN)), divided by GBA at the beginning of the task (GBA(M)_(INI)) for movements of both hands. There was a significant increase in GBA at the end of the task, compared to the initial GBA for the motor task (GBA(M)_(FIN) > GBA(M)_(INI)). No differences were found at baseline (GBA(B)_(FIN) approximate to GBA(B)_(INI)). Individual IP values had a positive (r = 0.624) and significant correlation with subject's handedness. Due to plastic changes, GBA could indirectly but objectively reveal changes in cerebral activity related to physical training. This method could be used as a future diagnostic test in the follow-up of patients undergoing rehabilitation. It could also have potential applications in the fields of sports medicine.	[Amo, Carlos; De Santiago, Luis; Barea, Rafael; Boquete, Luciano] Univ Alcala De Henares, Dept Elect, Alcala De Henares, Spain; [Amo, Carlos] Ecnis Sigma SL, Res Dept Clin Neurophysiol, Madrid, Spain; [Zarza Lucianez, Daniel] Hosp Nisa Pardo Aravaca, Dept Clin Neurophysiol, Madrid, Spain; [Leon Alonso-Cortes, Jose Miguel] Complejo Asistencial Univ Palencia, Hosp Rio Carr, Dept Clin Neurophysiol, Palencia, Spain; [Alonso-Alonso, Miguel] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Study Nutr Med, Lab Bariatr & Nutr Neurosci, Boston, MA USA	Universidad de Alcala; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Boquete, L (corresponding author), Univ Alcala De Henares, Dept Elect, Alcala De Henares, Spain.	luciano.boquete@uah.es	Boquete, Luciano/GXN-4674-2022	Alonso-Alonso, Miguel/0000-0003-3372-9933; Boquete, Luciano/0000-0001-8591-6103	Universidad de Alcala [UAH GC2016-004]; ISCIII [RETICS RD16/0008/0020]	Universidad de Alcala; ISCIII(Instituto de Salud Carlos III)	This research was partially supported by Universidad de Alcala grant: "Diagnostic precoz de neuropatias opticas mediante analisis de registros de potenciales evocados visuales multifocales" UAH GC2016-004 and ISCIII grant RETICS RD16/0008/0020 to LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Amo C, 2007, AM J PHYS MED REHAB, V86, P304, DOI 10.1097/PHM.0b013e3180383c0d; Amo C, 2006, ARQ NEURO-PSIQUIAT, V64, P394, DOI 10.1590/S0004-282X2006000300008; Amo C, 2016, MOTOR CONTROL, V20, P409, DOI 10.1123/mc.2015-0010; Ball T, 2008, NEUROIMAGE, V41, P302, DOI 10.1016/j.neuroimage.2008.02.032; Boninger ML, 2014, AM J PHYS MED REHAB, V93, pS145, DOI 10.1097/PHM.0000000000000128; Debarnot U, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00280; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Ermutlu N, 2015, COGN NEURODYNAMICS, V9, P257, DOI 10.1007/s11571-014-9320-2; ETNIER JL, 1995, SPORTS MED, V19, P81, DOI 10.2165/00007256-199519020-00001; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; Huang X, 2017, MOL PSYCHIATR, V22, P1274, DOI 10.1038/mp.2017.143; KARNI A, 1995, NATURE, V377, P155; Lardon MT, 1996, BIOL PSYCHOL, V44, P19, DOI 10.1016/S0301-0511(96)05198-8; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Ramon, 1899, TEXTURA SISTEMA NERV; Rossini P M, 2007, Eura Medicophys, V43, P241; Shen Y, 2017, BIOL PSYCHIAT, V81, pE49, DOI 10.1016/j.biopsych.2016.06.013; Shibata T, 1999, NEUROSCI RES, V33, P215, DOI 10.1016/S0168-0102(99)00003-6; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062	25	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186008	10.1371/journal.pone.0186008	http://dx.doi.org/10.1371/journal.pone.0186008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982173	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300105
J	Lamb, CT; Mowat, G; Gilbert, SL; McLellan, BN; Nielsen, SE; Boutin, S				Lamb, Clayton T.; Mowat, Garth; Gilbert, Sophie L.; McLellan, Bruce N.; Nielsen, Scott E.; Boutin, Stan			Density-dependent signaling: An alternative hypothesis on the function of chemical signaling in a non-territorial solitary carnivore	PLOS ONE			English	Article							GRIZZLY BEAR POPULATION; URSUS-ARCTOS; BROWN BEARS; ALBERTA; PROSPECTUS; BLACK	Brown bears are known to use rubbing behavior as a means of chemical communication, but the function of this signaling is unclear. One hypothesis that has gained support is that male bears rub to communicate dominance to other males. We tested the communication of dominance hypothesis in a low-density brown bear population in southeast British Columbia. We contrasted rubbing rates for male and female bears during and after the breeding season using ten years of DNA-mark-recapture data for 643 individuals. Here we demonstrate that male brown bears rub 60% more during the breeding than the non-breeding season, while female rubbing had no seasonal trends. Per capita rub rates by males were, on average, 2.7 times higher than females. Our results suggest that the function of rubbing in the Rocky Mountains may not only be to communicate dominance, but also to self-advertise for mate attraction. We propose that the role of chemical communication in this species may be density-dependent, where the need to self-advertise for mating is inversely related to population density and communicating for dominance increases with population density. We suggest that future endeavors to elucidate the function of rubbing should sample the behavior across a range of population densities using camera trap and genotypic data.	[Lamb, Clayton T.; Gilbert, Sophie L.; Boutin, Stan] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Mowat, Garth; McLellan, Bruce N.] Minist Forests Lands & Nat Resource Operat, Nelson, BC, Canada; [Mowat, Garth] Univ British Columbia, Dept Earth Environm & Geog Sci, Okanagan Campus, Kelowna, BC, Canada; [Nielsen, Scott E.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	University of Alberta; University of British Columbia; University of Alberta	Lamb, CT (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	ctlamb@ualberta.ca	Nielsen, Scott/C-2842-2013; Lamb, Clayton/H-9158-2019; Nielsen, Scott/O-7482-2019; Boutin, Stan/A-2619-2014	Nielsen, Scott/0000-0002-9754-0630; Lamb, Clayton/0000-0002-1961-0509; Nielsen, Scott/0000-0002-9754-0630; Boutin, Stan/0000-0001-6317-038X; Gilbert, Sophie/0000-0002-9974-5146	Vanier Canada Graduate Scholarships; Natural Science and Engineering Research Council of Canada; Ministry of Forests, Lands and Natural Resource Operations; Habitat Conservation Trust Foundation; Safari Club International; Columbia Basin Trust Fund; BP Canada; BC Conservation Corps; Teck Coal; Columbia Basin Trust Foundation	Vanier Canada Graduate Scholarships; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ministry of Forests, Lands and Natural Resource Operations; Habitat Conservation Trust Foundation; Safari Club International; Columbia Basin Trust Fund; BP Canada; BC Conservation Corps; Teck Coal; Columbia Basin Trust Foundation	Funded by Vanier Canada Graduate Scholarships, Natural Science and Engineering Research Council of Canada, Ministry of Forests, Lands and Natural Resource Operations, Habitat Conservation Trust Foundation, Safari Club International, Columbia Basin Trust Fund, BP Canada, BC Conservation Corps and Teck Coal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the many people who helped collect these data and to Kate Broadley and Abbey Wilson for insightful comments on this work. Gordon Stenhouse kindly provided information and data pertaining to grizzly bear movements and breeding season behavior. Thanks to Bill and Sue Hanlon for providing logistical support in the field. The following funders graciously provided funding for this work: Vanier Canada Graduate Scholarships, Natural Science and Engineering Research Council of Canada, Ministry of Forests, Lands and Natural Resource Operations, Habitat Conservation Trust Foundation, Safari Club International, Columbia Basin Trust Foundation, BP Canada, BC Conservation Corps and Teck Coal. The authors of this work have no competing interests to disclose.	Apps CD, 2016, J WILDLIFE MANAGE, V80, P396, DOI 10.1002/jwmg.1037; Bryan HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080537; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Clapham M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035404; Dumond M, 2015, WILDLIFE SOC B, V39, P390, DOI 10.1002/wsb.520; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Graham Karen, 2014, Canadian Field-Naturalist, V128, P223; Green GI, 2003, WILDLIFE BIOL, V9, P1; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; Karamanlidis AA, 2007, URSUS, V18, P54, DOI 10.2192/1537-6176(2007)18[54:USAPPT]2.0.CO;2; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Kendall KC, 2008, NONINVASIVE SURVEY M, P135; Lamb CT, 2017, J ANIM ECOL, V86, P55, DOI 10.1111/1365-2656.12589; Lamb CT, 2016, URSUS, V27, P31, DOI 10.2192/URSUS-D-15-00025.1; Martin J, 2007, FUNCT ECOL, V21, P568, DOI 10.1111/j.1365-2435.2007.01262.x; McLellan B., 2011, CAN J ZOOL, V558, P546, DOI DOI 10.1139/Z11-026; MCLELLAN BN, 1995, CAN J ZOOL, V73, P704, DOI 10.1139/z95-082; MCLELLAN BN, 1989, CAN J ZOOL, V67, P1856, DOI 10.1139/z89-264; Monnin T, 2002, NATURE, V419, P61, DOI 10.1038/nature00932; Morehouse AT, 2016, J WILDLIFE MANAGE, V80, P1152, DOI 10.1002/jwmg.21104; Mowat G, 2005, WILDLIFE BIOL, V11, P31, DOI 10.2981/0909-6396(2005)11[31:GUAABB]2.0.CO;2; MOWAT G, 2013, S ROCKIES FLATHEAD G; MOWAT G, 2016, POPULATION STATUS S; Mowat G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082757; Nevin OT, 2003, INFLUENCE PREY ABUND; Paetkau D, 2003, MOL ECOL, V12, P1375, DOI 10.1046/j.1365-294X.2003.01820.x; Roberts DR, 2014, ECOL APPL, V24, P1144, DOI 10.1890/13-0829.1; Sato Y, 2014, ACTA THERIOL, V59, P129, DOI 10.1007/s13364-013-0143-z; Sawaya MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034777; Schwartz C.C. S.D., 2003, WILD MAMMALS N AM BI, P556; Sergiel A, 2017, SCI REP, V7, P1; SERYODKIN I. V., 2014, ACHIEVEMENTS LIFE SC, V8, P153, DOI DOI 10.1016/J.ALS.2015.04.006; Stenhouse G, 2005, URSUS, V16, P31, DOI 10.2192/1537-6176(2005)016[0031:GBAATE]2.0.CO;2; Tattoni C, 2015, ITAL J MAMMAL ONLINE, V26, P1; Woods JG, 1999, WILDLIFE SOC B, V27, P616	35	11	12	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184176	10.1371/journal.pone.0184176	http://dx.doi.org/10.1371/journal.pone.0184176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981540	Green Submitted, Green Published, gold			2022-12-26	WOS:000412360300009
J	Neu, E; Featherston, J; Rees, J; Debener, T				Neu, Enzo; Featherston, Jonathan; Rees, Jasper; Debener, Thomas			A draft genome sequence of the rose black spot fungus Diplocarpon rosae reveals a high degree of genome duplication	PLOS ONE			English	Article							DISEASE RESISTANCE; GENETIC-ANALYSIS; TRIGGERED IMMUNITY; SIZE DETERMINATION; MASSIVE ANALYSIS; FLOW-CYTOMETRY; PHI-BASE; EVOLUTIONARY; DATABASE; ANNOTATION	Background Black spot is one of the most severe and damaging diseases of garden roses. We present the draft genome sequence of its causative agent Diplocarpon rosae as a working tool to generate molecular markers and to analyze functional and structural characteristics of this fungus. Results The isolate DortE4 was sequenced with 191x coverage of different read types which were assembled into 2457 scaffolds. By evidence supported genome annotation with the MAKER pipeline 14,004 gene models were predicted and transcriptomic data indicated that 88.5% of them are expressed during the early stages of infection. Analyses of k-mer distributions resulted in unexpectedly large genome size estimations between 72.5 and 91.4 Mb, which cannot be attributed to its repeat structure and content of transposable elements alone, factors explaining such differences in other fungal genomes. In contrast, different lines of evidences demonstrate that a huge proportion (approximately 80%) of genes are duplicated, which might indicate a whole genome duplication event. By PCR-RFLP analysis of six paralogous gene pairs of BUSCO orthologs, which are expected to be single copy genes, we could show experimentally that the duplication is not due to technical error and that not all isolates tested possess all of the paralogs. Conclusions The presented genome sequence is still a fragmented draft but contains almost the complete gene space. Therefore, it provides a useful working tool to study the interaction of D. rosae with the host and the influence of a genome duplication outside of the model yeast in the background of a phytopathogen.	[Neu, Enzo; Debener, Thomas] Leibniz Univ Hannover, Inst Plant Genet, Hannover, Germany; [Featherston, Jonathan; Rees, Jasper] Agr Res Council, Biotechnol Platform, Pretoria, South Africa	Leibniz University Hannover; Agricultural Research Council of South Africa	Debener, T (corresponding author), Leibniz Univ Hannover, Inst Plant Genet, Hannover, Germany.	debener@genetik.uni-hannover.de	Rees, David Jasper Gilbert/AAZ-8073-2020; Debener, Thomas/AAJ-9056-2020	Rees, David Jasper Gilbert/0000-0003-3321-1325; Debener, Thomas/0000-0002-2012-2246	DFG GRK [GRK 1798/1]; South Africa/Germany agreement on cooperation in science and technology [SUA 09/030]	DFG GRK(German Research Foundation (DFG)); South Africa/Germany agreement on cooperation in science and technology	This work was funded by the DFG GRK 1798 "Signaling at the Plant-Soil Interface (GRK 1798/1) (EK, TD) and the joint research grant under the South Africa/Germany agreement on cooperation in science and technology (SUA 09/030) (JF, JR, TD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertin W, 2012, P ROY SOC B-BIOL SCI, V279, P2497, DOI 10.1098/rspb.2012.0434; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; [Anonymous], 2016, NATURE REV GENETICS, V17, P379; Aragona M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-313; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Blechert O, 2005, PLANT PATHOL, V54, P82, DOI 10.1111/j.1365-3059.2005.01118.x; Bock CH, 2016, STAND GENOMIC SCI, V11, DOI 10.1186/s40793-016-0161-y; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boyd LA, 2013, TRENDS GENET, V29, P233, DOI 10.1016/j.tig.2012.10.011; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; del Pozo JC, 2015, J EXP BOT, V66, P6991, DOI 10.1093/jxb/erv432; Chand R, 2015, CURRENT SCI, V109; Collinge DB, 2010, ANNU REV PHYTOPATHOL, V48, P269, DOI 10.1146/annurev-phyto-073009-114430; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui HT, 2015, ANNU REV PLANT BIOL, V66, P487, DOI 10.1146/annurev-arplant-050213-040012; D'Hondt L, 2011, MOL PLANT PATHOL, V12, P815, DOI [10.1111/j.1364-3703.2011.00711.x, 10.1111/J.1364-3703.2011.00711.X]; Da Maia LC, 2008, INT J PLANT GENOMICS; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Debener T, 1998, PLANT BREEDING, V117, P267, DOI 10.1111/j.1439-0523.1998.tb01937.x; Debener T, 2014, PLANT SCI, V228, P107, DOI 10.1016/j.plantsci.2014.04.005; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FraissinetTachet L, 1996, CURR GENET, V29, P496, DOI 10.1007/BF02221520; Gachomo EW, 2006, PHYSIOL MOL PLANT P, V69, P86, DOI 10.1016/j.pmpp.2007.02.002; Gachomo EW, 2010, MOL BIOL REP, V37, P3583, DOI 10.1007/s11033-010-0007-4; Galagan JE, 2005, GENOME RES, V15, P1620, DOI 10.1101/gr.3767105; Gao S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0951-y; Grandaubert J, 2014, ADV BOT RES, V70, P79, DOI 10.1016/B978-0-12-397940-7.00003-3; Green P, PHRED 0 020425 C; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Hattendorf A, 2004, ACTA HORTIC, P123, DOI 10.17660/ActaHortic.2004.651.14; Horst R.K., 2007, COMPENDIUM ROSE DIS, V2nd ed.; Jiang C, 2014, AUSTRALAS PLANT PATH, V43, P615, DOI 10.1007/s13313-014-0316-5; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Karaoglu H, 2005, MOL BIOL EVOL, V22, P639, DOI [10.1093/molbev/mis057, 10.1093/molbev/msi057]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kaufmann H, 2003, MOL GENET GENOMICS, V268, P666, DOI 10.1007/s00438-002-0784-0; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kubicek CP, 2014, ANNU REV PHYTOPATHOL, V52, P427, DOI 10.1146/annurev-phyto-102313-045831; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Liu S, 2014, NAT PROD COMMUN, V9, P7, DOI 10.1038/ncomms4930; Lo Presti L, 2015, ANNU REV PLANT BIOL, V66, P513, DOI 10.1146/annurev-arplant-043014-114623; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Menz I, 2017, MOL PLANT PATHOLOGY; Mohanta TK, 2015, BIOL PROCED ONLINE, V17, DOI 10.1186/s12575-015-0020-z; Munnekhoff AK, 2017, PLANT PATHOLOGY; Naumov GI, 2000, SYST APPL MICROBIOL, V23, P442, DOI 10.1016/S0723-2020(00)80076-4; Okuno M, 2016, DNA RES, V23, P67, DOI 10.1093/dnares/dsv037; Panchy N, 2016, PLANT PHYSIOL, V171, P2294, DOI 10.1104/pp.16.00523; Pedro H, 2016, NUCLEIC ACIDS RES, V44, pD688, DOI 10.1093/nar/gkv1052; Scannell DR, 2007, P NATL ACAD SCI USA, V104, P8397, DOI 10.1073/pnas.0608218104; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Selin C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00600; Sharma KK, 2016, CRIT REV BIOTECHNOL, V36, P743, DOI 10.3109/07388551.2015.1015959; Shirke MD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162458; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smit A, REPEATMASKER OPEN 4; Smit AFA., REPEATMODELER OPEN 1; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Stukenbrock EH, 2014, FUNGAL BIOL REV, V28, P1, DOI 10.1016/j.fbr.2014.02.001; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Team RC. R, R LANG ENV STAT COMP; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; Terefe-Ayana D, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00035; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Veselska T, 2014, CYTOM PART A, V85A, P854, DOI 10.1002/cyto.a.22500; von Malek B, 1998, THEOR APPL GENET, V96, P228, DOI 10.1007/s001220050731; Vurture GW, 2017, BIOINFORMATICS, V33, P2202, DOI 10.1093/bioinformatics/btx153; Weber E, 1992, BIBLIOTHECA MYCOLOGI, V140, P1; Whitaker VM, 2010, PLANT PATHOL, V59, P745, DOI 10.1111/j.1365-3059.2010.02281.x; Whitaker VM, 2010, THEOR APPL GENET, V120, P573, DOI 10.1007/s00122-009-1177-0; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Williams TA, 2016, MOL BIOL EVOL, V33, P2002, DOI 10.1093/molbev/msw083; Winnenburg R, 2008, NUCLEIC ACIDS RES, V36, pD572, DOI 10.1093/nar/gkm858; Winnenburg R, 2006, NUCLEIC ACIDS RES, V34, pD459, DOI 10.1093/nar/gkj047; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zajac BK, 2015, FORENSIC SCI INT-GEN, V15, P137, DOI 10.1016/j.fsigen.2014.11.013; Zawada AM, 2014, EPIGENETICS-US, V9, P161, DOI 10.4161/epi.26931; Zhu S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-382	93	7	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185310	10.1371/journal.pone.0185310	http://dx.doi.org/10.1371/journal.pone.0185310			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981525	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300032
J	Miettinen, ME; Smart, MC; Kinnunen, L; Harjutsalo, V; Reinert-Hartwall, L; Ylivinkka, I; Surcel, HM; Lamberg-Allardt, C; Hitman, GA; Tuomilehto, J				Miettinen, Maija E.; Smart, Melissa C.; Kinnunen, Leena; Harjutsalo, Valma; Reinert-Hartwall, Linnea; Ylivinkka, Irene; Surcel, Helja-Marja; Lamberg-Allardt, Christel; Hitman, Graham A.; Tuomilehto, Jaakko			Genetic determinants of serum 25-hydroxyvitamin D concentration during pregnancy and type 1 diabetes in the child	PLOS ONE			English	Article							VITAMIN-D STATUS; COD-LIVER OIL; ISLET AUTOIMMUNITY; RISK-FACTORS; ASSOCIATION; METABOLISM; YOUNG; METAANALYSIS; VARIANTS; DISEASE	Objective The in utero environment plays an important role in shaping development and later life health of the fetus. It has been shown that maternal genetic factors in the metabolic pathway of vitamin D associate with type 1 diabetes in the child. In this study we analyzed the genetic determinants of serum 25-hydroxyvitamin D (25OHD) concentration during pregnancy in mothers whose children later developed type 1 diabetes and in control mothers. Study design 474 mothers of type 1 diabetic children and 348 mothers of non-diabetic children were included in the study. We previously selected 7 single nucleotide polymorphisms (SNPs) in four genes in the metabolic pathway of vitamin D vitamin based on our previously published data demonstrating an association between genotype and serum 25OHD concentration. In this re-analysis, possible differences in strength in the association between the SNPs and serum 25OHD concentration in mothers of type 1 diabetic and non-diabetic children were investigated. Serum 25OHD concentrations were previously shown to be similar between the mothers of type 1 diabetic and non-diabetic children and vitamin D deficiency prevalent in both groups. Results Associations between serum 25OHD concentration and 2 SNPs, one in the vitamin D receptor (VDR) gene (rs4516035) and one in the group-specific component (GC) gene (rs12512631), were stronger during pregnancy in mothers whose children later developed type 1 diabetes than in mothers whose children did not (p(interaction) = 0.03, 0.02, respectively). Conclusions We show for the first time that there are differences in the strength of genetic determinants of serum 25OHD concentration during pregnancy between the mothers of type 1 diabetic and non-diabetic children. Our results emphasize that the in utero environment including maternal vitamin D metabolism should be important lines of investigation when searching for factors that lead to early programming of type 1 diabetes.	[Miettinen, Maija E.; Harjutsalo, Valma; Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Chron Dis Prevent Unit, Helsinki, Finland; [Smart, Melissa C.; Hitman, Graham A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Smart, Melissa C.] Univ Essex, Colchester, Essex, England; [Kinnunen, Leena] Natl Inst Hlth & Welf, Genom & Biomarkers Unit, Helsinki, Finland; [Harjutsalo, Valma] Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland; [Harjutsalo, Valma] Univ Helsinki, Abdominal Ctr Nephrol, Helsinki, Finland; [Harjutsalo, Valma] Helsinki Univ Hosp, Helsinki, Finland; [Harjutsalo, Valma] Res Program Unit, Diabet & Obes, Helsinki, Finland; [Reinert-Hartwall, Linnea] Natl Inst Hlth & Welf, Vaccinat Programme Unit, Helsinki, Finland; [Ylivinkka, Irene] Univ Helsinki, Translat Canc Biol Res Program, Helsinki, Finland; [Surcel, Helja-Marja] Natl Inst Hlth & Welf, Impact Assessment Unit, Oulu, Finland; [Lamberg-Allardt, Christel] Dept Food & Environm Sci, Helsinki, Finland; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] South Ostrobothnia Cent Hosp, Seinajoki, Finland; [Tuomilehto, Jaakko] King Abdulaziz Univ, Diabet Res Grp, Jeddah, Saudi Arabia; [Tuomilehto, Jaakko] Dasman Diabet Inst, Dasman, Kuwait	Finland National Institute for Health & Welfare; University of London; Queen Mary University London; University of Essex; Finland National Institute for Health & Welfare; Folkhalsan Research Center; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Helsinki; Finland National Institute for Health & Welfare; Danube University Krems; King Abdulaziz University	Miettinen, ME (corresponding author), Natl Inst Hlth & Welf, Chron Dis Prevent Unit, Helsinki, Finland.	maija.miettinen@thl.fi	Kinnunen, Leena/B-7059-2012; Harjutsalo, Valma/AAL-6588-2021	Kinnunen, Leena/0000-0001-8739-4812; Harjutsalo, Valma/0000-0003-3568-9779; Lamberg-Allardt, Christel/0000-0001-7326-1904; Ylivinkka, Irene/0000-0001-5035-0445; Miettinen, Maija E/0000-0002-5587-7227; Smart, Melissa/0000-0002-2655-3880	Finnish Academy [127219]; European Foundation for the Study of Diabetes; Novo Nordisk Foundation; Diabetes Research Foundation; South Ostrobothnia Central Hospital [EV01107]; Biomedicum Helsinki Foundation; Jalmari and Rauha Ahokas Foundation; Yrjo Jahnsson Foundation; Suoma Loimaranta-Airila Fund; Onni and Hilja Tuovinen Foundation; Juho Vainio Foundation; Orion Research Foundation; Kyllikki and Uolevi Lehikoinen Foundation	Finnish Academy(Academy of Finland); European Foundation for the Study of Diabetes; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Diabetes Research Foundation; South Ostrobothnia Central Hospital; Biomedicum Helsinki Foundation; Jalmari and Rauha Ahokas Foundation; Yrjo Jahnsson Foundation; Suoma Loimaranta-Airila Fund; Onni and Hilja Tuovinen Foundation; Juho Vainio Foundation; Orion Research Foundation; Kyllikki and Uolevi Lehikoinen Foundation	Funded by The Finnish Academy (Grant No. 127219) (http://www.aka.fi/en/); The European Foundation for the Study of Diabetes (http://www. europeandiabetesfoundation.org); Novo Nordisk Foundation (http://novonordisklonderi.dk/en); Diabetes Research Foundation (https://www. diabetestutkiMUS.fi/); South Ostrobothnia Central Hospital (EV01107) (http://www.epshp.fi/en); Biomedicum Helsinki Foundation (http://www. biomecacum.fi/index.php?page=112& Jalmari and Rauha Ahokas Foundation (http:// www.ahokkaansaatio.org/); Yrjo Jahnsson Foundation (http://www.yjs.fi/ent); Suoma Loimaranta-Airila Fund (http://www.european-funding-guide.eu/scholarship/14903-scholarship); Onni and Hilja Tuovinen Foundation (http://www.tuovisensaatio.fi/); Juho Vainio Foundation (http:// juhovainionsaatio.fi/en/juho-vainio-foundation/); Orion Research Foundation (http://www.orion.fi/tutkimus/orionin-tutkimussaatiol; Kyllikki and Uolevi Lehikoinen Foundation (http://www.aurora-tietokanta.fi/grant/details/id/4096 /refc/foundation/refa/details). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Ahn J, 2009, CARCINOGENESIS, V30, P769, DOI 10.1093/carcin/bgp055; Altieri B, 2017, REV ENDOCR METAB DIS, V18, P335, DOI 10.1007/s11154-016-9405-9; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; [Anonymous], 2016, LANCET, V387, P2331; Bailey R, 2007, DIABETES, V56, P2616, DOI 10.2337/db07-0652; BARKER DJP, 1986, LANCET, V1, P1077; Cardwell CR, 2010, DIABETOLOGIA, V53, P641, DOI 10.1007/s00125-009-1648-5; Cardwell CR, 2010, DIABETES, V59, P486, DOI 10.2337/db09-1166; Cooper JD, 2011, DIABETES, V60, P1624, DOI 10.2337/db10-1656; DAHLQUIST G, 1994, INT J EPIDEMIOL, V23, P1234, DOI 10.1093/ije/23.6.1234; Dahlquist G, 1999, DIABETOLOGIA, V42, P51, DOI 10.1007/s001250051112; Elfving M, 2008, EXP DIABETES RES, DOI 10.1155/2008/271958; Frederiksen B, 2013, J STEROID BIOCHEM, V133, P51, DOI 10.1016/j.jsbmb.2012.08.012; Frederiksen BN, 2013, J CLIN ENDOCR METAB, V98, pE1845, DOI 10.1210/jc.2013-2256; Gale EAM, 2005, DIABETOLOGIA, V48, P1435, DOI 10.1007/s00125-005-1833-0; Goulielmos GN, 2016, PEDIATR RHEUMATOL, V14, DOI 10.1186/s12969-016-0087-3; Hansen CHF, 2014, DIABETES, V63, P2821, DOI 10.2337/db13-1612; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hunter D, 2001, J BONE MINER RES, V16, P371, DOI 10.1359/jbmr.2001.16.2.371; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Jacobsen R, 2016, DIABETOLOGIA, V59, P1871, DOI 10.1007/s00125-016-4002-8; Marjamaki L, 2010, DIABETOLOGIA, V53, P1599, DOI 10.1007/s00125-010-1734-8; McGrath JJ, 2010, J STEROID BIOCHEM, V121, P471, DOI 10.1016/j.jsbmb.2010.03.073; MENSER MA, 1978, LANCET, V1, P57; Miettinen ME, 2012, DIABETOLOGIA, V55, P1291, DOI 10.1007/s00125-012-2458-8; Miettinen ME, 2015, DIABETOLOGIA, V58, P2278, DOI 10.1007/s00125-015-3675-8; Nejentsev S, 2004, DIABETES, V53, P2709, DOI 10.2337/diabetes.53.10.2709; Nissen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089907; Orton SM, 2008, AM J CLIN NUTR, V88, P441, DOI 10.1093/ajcn/88.2.441; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Pociot F, 2016, LANCET, V387, P2331, DOI 10.1016/S0140-6736(16)30582-7; Ramos-Lopez E, 2007, DIABETES-METAB RES, V23, P631, DOI 10.1002/dmrr.719; Rewers M, 2016, LANCET, V387, P2340, DOI 10.1016/S0140-6736(16)30507-4; Saccone D, 2015, GENE, V561, P171, DOI 10.1016/j.gene.2015.02.024; Shea MK, 2009, EUR J CLIN NUTR, V63, P458, DOI 10.1038/sj.ejcn.1602959; Siljander HTA, 2009, DIABETES, V58, P2835, DOI 10.2337/db08-1305; Sorensen IM, 2012, DIABETES, V61, P175, DOI 10.2337/db11-0875; Stene LC, 2000, DIABETOLOGIA, V43, P1093, DOI 10.1007/s001250051499; Stene LC, 2003, AM J CLIN NUTR, V78, P1128, DOI 10.1093/ajcn/78.6.1128; Taylor AE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004799; Thomas D, 2010, ANNU REV PUBL HEALTH, V31, P21, DOI 10.1146/annurev.publhealth.012809.103619; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Winkler TW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005378; Zella JB, 2003, ARCH BIOCHEM BIOPHYS, V417, P77, DOI 10.1016/S0003-9861(03)00338-2; Zerwekh JE, 2004, ANN CLIN BIOCHEM, V41, P272, DOI 10.1258/0004563041201464	47	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0184942	10.1371/journal.pone.0184942	http://dx.doi.org/10.1371/journal.pone.0184942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976992	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000412163100014
J	Rosbrook, K; Erythropel, HC; DeWinter, TM; Falinski, M; O'Malley, S; Krishnan-Sarin, S; Anastas, PT; Zimmerman, JB; Green, BG				Rosbrook, Kathryn; Erythropel, Hanno C.; DeWinter, Tamara M.; Falinski, Mark; O'Malley, Stephanie; Krishnan-Sarin, Suchitra; Anastas, Paul T.; Zimmerman, Julie B.; Green, Barry G.			The effect of sucralose on flavor sweetness in electronic cigarettes varies between delivery devices	PLOS ONE			English	Article							TASTE; ODORS; MAGNITUDE; SCALE; ADOLESCENTS; PERCEPTION; SWEETENERS; SENSATIONS; DERIVATION; INTENSITY	The appeal of sweet electronic cigarette flavors makes it important to identify the chemical compounds that contribute to their sweetness. While volatile chemicals that produce sweet aromas have been identified in e-liquids, there are no published reports of sugars or artificial sweeteners in commercial e-liquids. However, the sweetener sucralose is marketed as an e-liquid additive to commercial flavors. The primary aims of the study were to determine if sucralose is delivered in sufficient concentration in the inhaled aerosol to enhance flavor sweetness, and whether the amount delivered depends on the e-liquid delivery system. Thirty-two adult smokers rated flavor intensity, sweetness, harshness and liking/disliking for 4 commercial flavors with and without sucralose (1%) using 2 e-cigarette delivery systems (cartridge and tank). Participants alternately vaped normally or with the nose pinched closed to block perception of volatile flavor components via olfaction. LC/MS was used to measure the concentration of sucralose in the e-liquid aerosols using a device that mimicked vaping. Sweetness and flavor intensity were perceived much more strongly when olfaction was permitted. The contribution of sucralose to sweetness was significant only for the cartridge system, and the chemical analysis showed that the concentration of sucralose in the aerosol was higher when the cartridge was used. Together these findings indicate that future regulation of sweet flavor additives should focus first on the volatile constituents of e-liquids with the recognition that artificial sweeteners may also contribute to flavor sweetness depending upon e-cigarette design.	[Rosbrook, Kathryn; Green, Barry G.] John B Pierce Lab, New Haven, CT 06519 USA; [Erythropel, Hanno C.; DeWinter, Tamara M.; Falinski, Mark; Anastas, Paul T.; Zimmerman, Julie B.] Yale Univ, Ctr Green Chem & Green Engn, New Haven, CT USA; [Erythropel, Hanno C.; Falinski, Mark; Zimmerman, Julie B.] Yale Univ, Dept Chem & Environm Engn, New Haven, CT USA; [DeWinter, Tamara M.; Anastas, Paul T.; Zimmerman, Julie B.] Yale Univ, Dept Forestry & Environm Studies, New Haven, CT USA; [O'Malley, Stephanie; Krishnan-Sarin, Suchitra] Yale Sch Med, Dept Psychiat, New Haven, CT USA; [Green, Barry G.] Yale Sch Med, Dept Surg Otolaryngol, New Haven, CT 06510 USA	Yale University; The John B Pierce Laboratory, Inc; Yale University; Yale University; Yale University; Yale University; Yale University	Green, BG (corresponding author), John B Pierce Lab, New Haven, CT 06519 USA.; Green, BG (corresponding author), Yale Sch Med, Dept Surg Otolaryngol, New Haven, CT 06510 USA.	green@jbpierce.org	Erythropel, Hanno/T-5737-2017; Anastas, Paul/L-3258-2013	Erythropel, Hanno/0000-0003-3443-9794; Krishnan-Sarin, Suchitra/0000-0002-3272-9782; Zimmerman, Julie/0000-0002-5392-312X; Anastas, Paul/0000-0003-4777-5172	Yale Tobacco Center of Regulatory Sciences (TCORS) of the National Institute of Health [P50-DA-036151]; Center for Tobacco products (CTP) of the Food and Drug Administration	Yale Tobacco Center of Regulatory Sciences (TCORS) of the National Institute of Health; Center for Tobacco products (CTP) of the Food and Drug Administration	This work was supported by the Yale Tobacco Center of Regulatory Sciences (TCORS) of the National Institute of Health (P50-DA-036151) and the Center for Tobacco products (CTP) of the Food and Drug Administration. The Co-PIs of the P50 are SKS and SO. An Administrative Supplement was awarded to BGG and JBZ to conduct the study reported in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvray M, 2008, CONSCIOUS COGN, V17, P1016, DOI 10.1016/j.concog.2007.06.005; Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; Berg CJ, 2016, INT J PUBLIC HEALTH, V61, P225, DOI 10.1007/s00038-015-0764-x; Bold K.W., 2016, NICOTINE TOB RES; Bonhomme MG, 2016, TOB CONTROL, V25, pii4, DOI 10.1136/tobaccocontrol-2016-053373; Farsalinos KE, 2013, INT J ENV RES PUB HE, V10, P7272, DOI 10.3390/ijerph10127272; Fernstrom JD, 2012, J NUTR, V142, p1134S, DOI 10.3945/jn.111.149567; Ford A, 2016, INT J PUBLIC HEALTH, V61, P215, DOI 10.1007/s00038-015-0769-5; FRANK RA, 1993, PERCEPT PSYCHOPHYS, V54, P343, DOI 10.3758/BF03205269; Goldenson NI, 2016, DRUG ALCOHOL DEPEN, V168, P176, DOI 10.1016/j.drugalcdep.2016.09.014; Grana RA, 2014, AM J PREV MED, V46, P395, DOI 10.1016/j.amepre.2013.12.010; Green BG, 2012, CHEM SENSES, V37, P77, DOI 10.1093/chemse/bjr068; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; GREEN BG, 1993, CHEM SENSES, V18, P683, DOI 10.1093/chemse/18.6.683; GREEN BG, 1993, PAIN, V53, P323, DOI 10.1016/0304-3959(93)90228-H; Harrell M B, 2017, Prev Med Rep, V5, P33; Kim H, 2016, TOB CONTROL, V25, pii55, DOI 10.1136/tobaccocontrol-2016-053221; Kosmider L, 2016, THORAX, V71, P376, DOI 10.1136/thoraxjnl-2015-207895; Krishnan-Sarin S, 2015, NICOTINE TOB RES, V17, P810, DOI 10.1093/ntr/ntu243; Lim JY, 2013, CHEM SENSES, V38, P45, DOI 10.1093/chemse/bjs080; Lim J, 2009, CHEM SENSES, V34, P739, DOI 10.1093/chemse/bjp054; Lisko JG, 2015, NICOTINE TOB RES, V17, P1270, DOI 10.1093/ntr/ntu279; Miao S, 2016, NICOTINE TOB RES, V18, P2169, DOI 10.1093/ntr/ntw141; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; PFAFFMANN C, 1954, J COMP PHYSIOL PSYCH, V47, P93, DOI 10.1037/h0053778; Schiffman SS, 2003, CHEM SENSES, V28, P219, DOI 10.1093/chemse/28.3.219; Sherwood CL, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0369-9; Small DM, 2005, EXP BRAIN RES, V166, P345, DOI 10.1007/s00221-005-2376-9; Soh L, 2011, ENVIRON SCI TECHNOL, V45, P1363, DOI 10.1021/es102719d; Spence C, 2016, FOOD QUAL PREFER, V50, P117, DOI 10.1016/j.foodqual.2016.02.006; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; STEVENSON RJ, 1995, LEARN MOTIV, V26, P433, DOI 10.1016/S0023-9690(05)80006-2; Talih S, 2015, NICOTINE TOB RES, V17, P150, DOI 10.1093/ntr/ntu174; Tieman D, 2012, CURR BIOL, V22, P1035, DOI 10.1016/j.cub.2012.04.016; Tierney PA, 2016, TOB CONTROL, V25, pE10, DOI 10.1136/tobaccocontrol-2014-052175; Yeomans MR, 2006, J EXP PSYCHOL ANIM B, V32, P215, DOI 10.1037/0097-7403.32.3.215	36	18	19	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185334	10.1371/journal.pone.0185334	http://dx.doi.org/10.1371/journal.pone.0185334			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MY	28968411	Green Published, gold, Green Submitted			2022-12-26	WOS:000412029600020
J	Di Franco, A; Kim, J; Rodriguez-Diego, S; Khalique, O; Siden, JY; Goldburg, SR; Mehta, NK; Srinivasan, A; Ratcliffe, MB; Levine, RA; Crea, F; Devereux, RB; Weinsaft, JW				Di Franco, Antonino; Kim, Jiwon; Rodriguez-Diego, Sara; Khalique, Omar; Siden, Jonathan Y.; Goldburg, Samantha R.; Mehta, Neil K.; Srinivasan, Aparna; Ratcliffe, Mark B.; Levine, Robert A.; Crea, Filippo; Devereux, Richard B.; Weinsaft, Jonathan W.			Multiplanar strain quantification for assessment of right ventricular dysfunction and non-ischemic fibrosis among patients with ischemic mitral regurgitation	PLOS ONE			English	Article							TIME 3-DIMENSIONAL ECHOCARDIOGRAPHY; EJECTION FRACTION; PROGNOSTIC IMPLICATIONS; SYSTOLIC DYSFUNCTION; HEART-FAILURE; INFARCTION; MORTALITY; VOLUMES; PATTERN; RECOMMENDATIONS	Background Ischemic mitral regurgitation (iMR) predisposes to right ventricular (RV) pressure and volume overload, providing a nidus for RV dysfunction (RVDYS) and non-ischemic fibrosis (NIF). Echocardiography (echo) is widely used to assess iMR, but performance of different indices as markers of RVDYS and NIF is unknown. Methods iMR patients prospectively underwent echo and cardiac magnetic resonance (CMR) within 72 hours. Echo quantified iMR, assessed conventional RV indices (TAPSE, RV-S', fractional area change [FAC]), and strain via speckle tracking in apical 4-chamber (global longitudinal strain [RV-GLS]) and parasternal long axis orientation (transverse strain). CMR volumetrically quantified RVEF, and assessed ischemic pattern myocardial infarction (MI) and septal NIF. Results 73 iMR patients were studied; 36% had RVDYS (EF<50%) on CMR among whom LVEF was lower, PA systolic pressure higher, and MI size larger (all p<0.05). CMR RVEF was paralleled by echo results; correlations were highest for RV-GLS (r = 0.73) and lowest for RV-S' (r = 0.43; all p<0.001). RVDYS patients more often had CMR-evidenced NIF (54% vs. 7%; p<0.001). Whereas all RV indices were lower among NIF-affected patients (all p <= 0.006), percent change was largest for transverse strain (48.3%). CMR RVEF was independently associated with RV-GLS (partial r = 0.57, p<0.001) and transverse strain (r = 0.38, p = 0.002) (R = 0.78, p<0.001). Overall diagnostic performance of RV-GLS and transverse strain were similar (AUC = 0.93[0.87-0.99]|0.91[0.84-0.99], both p<0.001), and yielded near equivalent sensitivity and specificity (85%| 83% and 80%|79% respectively). Conclusion Compared to conventional echo indices, RV strain parameters yield stronger correlation with CMR-defined RVEF and potentially constitute better markers of CMR-evidenced NIF in iMR.	[Di Franco, Antonino; Kim, Jiwon; Rodriguez-Diego, Sara; Siden, Jonathan Y.; Goldburg, Samantha R.; Mehta, Neil K.; Srinivasan, Aparna; Devereux, Richard B.; Weinsaft, Jonathan W.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Khalique, Omar] Columbia Univ, Dept Med, New York, NY USA; [Ratcliffe, Mark B.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Levine, Robert A.] Massachusetts Gen Hosp, Dept Cardiol, Boston, MA 02114 USA; [Crea, Filippo] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli, Dept Cardiol, Rome, Italy	Cornell University; Columbia University; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Weinsaft, JW (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.	jww2001@med.cornell.edu		Kim, Jiwon/0000-0002-8420-8604; Rodriguez Diego, Sara/0000-0002-1942-0457; Siden, Yoni/0000-0003-2743-6712	National Institutes of Health [1R01HL128278-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128278, R01HL128099] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by National Institutes of Health, grant # 1R01HL128278-01 (PI: Weinsaft M.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpendurada F, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-68; Beeri R, 2008, J AM COLL CARDIOL, V51, P476, DOI 10.1016/j.jacc.2007.07.093; Beeri R, 2007, CIRCULATION, V116, pI288, DOI 10.1161/CIRCULATIONAHA.106.681114; Codella NCF, 2008, RADIOLOGY, V248, P1004, DOI 10.1148/radiol.2482072016; Codella NCF, 2010, J MAGN RESON IMAGING, V31, P845, DOI 10.1002/jmri.22080; Devereux RB, 2004, JAMA-J AM MED ASSOC, V292, P2350, DOI 10.1001/jama.292.19.2350; Devereux RB, 2003, AM HEART J, V146, P527, DOI 10.1016/S0002-8703(03)00229-1; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Duncan AE, 2017, ANESTH ANALG, V124, P406, DOI 10.1213/ANE.0000000000001108; Freed BH, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-11; Grewal J, 2010, J AM SOC ECHOCARDIOG, V23, P127, DOI 10.1016/j.echo.2009.11.002; Grothues F, 2004, AM HEART J, V147, P218, DOI 10.1016/j.ahj.2003.10.005; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Jones EC, 2001, AM J CARDIOL, V87, P298, DOI 10.1016/S0002-9149(00)01362-X; Kawut SM, 2011, CIRCULATION, V123, P2542, DOI 10.1161/CIRCULATIONAHA.110.985515; Kim J, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.005115; Kim J, 2016, J AM SOC ECHOCARDIOG, V29, P861, DOI 10.1016/j.echo.2016.05.002; Kim J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147349; Kim J, 2015, ECHOCARDIOGR-J CARD, V32, P805, DOI 10.1111/echo.12715; Kim J, 2014, INT J CARDIOVAS IMAG, V30, P1559, DOI 10.1007/s10554-014-0487-8; Kjaergaard J, 2006, EUR J ECHOCARDIOGR, V7, P430, DOI 10.1016/j.euje.2005.10.009; Lai WW, 2008, INT J CARDIOVAS IMAG, V24, P691, DOI 10.1007/s10554-008-9314-4; Leibundgut G, 2010, J AM SOC ECHOCARDIOG, V23, P116, DOI 10.1016/j.echo.2009.11.016; Lemarie J, 2015, J AM SOC ECHOCARDIOG, V28, P818, DOI 10.1016/j.echo.2015.02.019; Lindqvist P, 2003, Eur J Echocardiogr, V4, P29, DOI 10.1053/euje.2002.0177; MCKENZIE JC, 1994, J MOL CELL CARDIOL, V26, P753, DOI 10.1006/jmcc.1994.1090; Muraru D, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.003866; Palmieri V, 1999, J AM COLL CARDIOL, V34, P1625, DOI 10.1016/S0735-1097(99)00396-4; Palmieri V, 2008, J AM SOC ECHOCARDIOG, V21, P66, DOI 10.1016/j.echo.2007.05.008; Park Jae-Hyeong, 2014, J Cardiovasc Ultrasound, V22, P113, DOI 10.4250/jcu.2014.22.3.113; Pavlicek M, 2011, EUR J ECHOCARDIOGR, V12, P871, DOI 10.1093/ejechocard/jer138; Pennell DJ, 2010, CIRCULATION, V121, P692, DOI 10.1161/CIRCULATIONAHA.108.811547; POLAK JF, 1983, J AM COLL CARDIOL, V2, P217, DOI 10.1016/S0735-1097(83)80156-9; Prakken NHJ, 2012, BRIT J SPORT MED, V46, P348, DOI 10.1136/bjsm.2010.077669; Rosner A, 2015, ECHOCARDIOGR-J CARD, V32, P1809, DOI 10.1111/echo.12973; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sievers B, 2007, CIRCULATION, V115, P236, DOI 10.1161/CIRCULATIONAHA.106.635409; Srinivasan A, 2017, ECHOCARDIOGR-J CARD, V34, P348, DOI 10.1111/echo.13438; Swift AJ, 2014, JACC-CARDIOVASC IMAG, V7, P1209, DOI 10.1016/j.jcmg.2014.08.014; Taylor RJ, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-015-0221-2; Volo SC, 2014, AM J CARDIOL, V114, P355, DOI 10.1016/j.amjcard.2014.05.008; Weinsaft JW, 2016, JACC-CARDIOVASC IMAG, V9, P505, DOI 10.1016/j.jcmg.2015.06.017; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3; Zornoff LAM, 2002, J AM COLL CARDIOL, V39, P1450, DOI 10.1016/S0735-1097(02)01804-1	44	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185657	10.1371/journal.pone.0185657	http://dx.doi.org/10.1371/journal.pone.0185657			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961271	Green Published, gold, Green Submitted			2022-12-26	WOS:000412027700030
J	Li, XD; Yang, YJ; Wang, LY; Qiao, SB; Lu, XF; Wu, YJ; Xu, B; Lie, HF; Gu, DF				Li, Xiang-Dong; Yang, Yue-Jin; Wang, Lai-Yuan; Qiao, Shu-Bin; Lu, Xiang-Feng; Wu, Yong-Jian; Xu, Bo; Lie, Hong-Fan; Gu, Dong-Feng			Elevated plasma miRNA-122,-140-3p,-720,-2861, and-3149 during early period of acute coronary syndrome are derived from peripheral blood mononuclear cells	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CIRCULATING MICRORNAS; EARLY-DIAGNOSIS; EXPRESSION; BIOMARKERS; CANCER	Objective Our previous study has found that circulating microRNA (miRNA, or miR) -122, -140-3p, -720, -2861, and -3149 are significantly elevated during early stage of acute coronary syndrome (ACS). This study was conducted to determine the origin of these elevated plasma miRNAs in ACS. Methods qRT-PCR was performed to detect the expression profiles of these 5 miRNAs in liver, spleen, lung, kidney, brain, skeletal muscles, and heart. To determine their origins, these miRNAs were detected in myocardium of acute myocardial infarction (AMI), and as well in platelets and peripheral blood mononuclear cells (PBMCs, including monocytes, circulating endothelial cells (CECs) and lymphocytes) of the AMI pigs and ACS patients. Results MiR-122 was specifically expressed in liver, and miR-140-3p, -720, -2861, and -3149 were highly expressed in heart. Compared with the sham pigs, miR-122 was highly expressed in the border zone of the ischemic myocardium in the AMI pigs without ventricular fibrillation (P < 0.01), miR-122 and -720 were decreased in platelets of the AMI pigs, and miR-122, -140-3p, -720, -2861, and -3149 were increased in PBMCs of the AMI pigs (all P < 0.05). Compared with the non-ACS patients, platelets miR-720 was decreased and PBMCs miR122, -140-3p, -720, -2861, and -3149 were increased in the ACS patients (all P < 0.01). Furthermore, PBMCs miR-122, -720, and -3149 were increased in the AMI patients compared with the unstable angina (UA) patients (all P < 0.05). Further origin identification revealed that the expression levels of miR-122 in CECs and lymphocytes, miR-140-3p and -2861 in monocytes and CECs, miR-720 in monocytes, and miR-3149 in CECs were greatly up-regulated in the ACS patients compared with the non-ACS patients, and were higher as well in the AMI patients than that in the UA patients except for the miR-122 in CECs (all P < 0.05). Conclusion The elevated plasma miR-122, -140-3p, -720, -2861, and -3149 in the ACS patients were mainly originated from CECs and monocytes.	[Li, Xiang-Dong; Yang, Yue-Jin; Qiao, Shu-Bin; Wu, Yong-Jian; Xu, Bo] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Cardiol, Beijing, Peoples R China; [Li, Xiang-Dong; Yang, Yue-Jin; Wang, Lai-Yuan; Qiao, Shu-Bin; Lu, Xiang-Feng; Wu, Yong-Jian; Xu, Bo; Lie, Hong-Fan; Gu, Dong-Feng] Peking Union Med Coll, Beijing, Peoples R China; [Wang, Lai-Yuan; Lu, Xiang-Feng; Lie, Hong-Fan; Gu, Dong-Feng] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp,Dept Epidemiol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Gu, DF (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.; Gu, DF (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp,Dept Epidemiol, Beijing, Peoples R China.	gudongfeng@vip.sina.com		Wu, Yongjian/0000-0002-5590-8396; Li, Xiangdong/0000-0001-6009-7105	National Basic Research Program (973 Program) in China [2011CB503901, 2012CB518602]; China Postdoctoral Science Foundation [2012M510355]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-1-009]; National Science Foundation of China [81270334]	National Basic Research Program (973 Program) in China(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); CAMS Innovation Fund for Medical Sciences (CIFMS); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Basic Research Program (973 Program) in China (No. 2011CB503901 to Dong-Feng Gu and 2012CB518602 to Yue-Jin Yang), China Postdoctoral Science Foundation (No. 2012M510355) to Xiang-Dong Li, CAMS Innovation Fund for Medical Sciences (CIFMS) (No. 2016-I2M-1-009) to Yue-Jin Yang, and the National Science Foundation of China (No. 81270334) to Lai-Yuan Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson P, 2012, SHOCK, V37, P234, DOI 10.1097/SHK.0b013e31823f1811; Caporali A, 2011, VASC PHARMACOL, V55, P79, DOI 10.1016/j.vph.2011.06.006; Collares Cristhianna V A, 2013, BMC Res Notes, V6, P491, DOI 10.1186/1756-0500-6-491; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Coskunpinar E, 2016, GENE, V591, P90, DOI 10.1016/j.gene.2016.06.059; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Donners MMPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035877; Fernandez-Hernando C, 2011, CURR OPIN LIPIDOL, V22, P86, DOI 10.1097/MOL.0b013e3283428d9d; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gacon J, 2016, KARDIOL POL, V74, P280, DOI 10.5603/KP.a2015.0174; Gao W, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-55; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Haver VG, 2010, TRENDS CARDIOVAS MED, V20, P65, DOI 10.1016/j.tcm.2010.04.002; Hoekstra M, 2010, BIOCHEM BIOPH RES CO, V394, P792, DOI 10.1016/j.bbrc.2010.03.075; Hu R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176099; Huang RS, 2010, J INVEST MED, V58, P961, DOI 10.231/JIM.0b013e3181ff46d7; Imamura T, 2011, CIRC J, V75, P1322, DOI 10.1253/circj.CJ-11-0382; Kelly AM, 2011, EMERG MED AUSTRALAS, V23, P181, DOI 10.1111/j.1742-6723.2011.01388.x; Kones R, 2010, VASC HEALTH RISK MAN, V6, P635; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Li LZ, 2014, CARCINOGENESIS, V35, P469, DOI 10.1093/carcin/bgt330; Li S, 2017, ONCOTARGET; Li XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125430; Liu W, 2015, SCI REP-UK, V5, DOI 10.1038/srep16099; Long GW, 2012, INT J BIOL SCI, V8, P811, DOI 10.7150/ijbs.4439; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; Pfutzner A, 2011, PPAR RES, V2011, DOI 10.1155/2011/647017; Pleister A, 2013, BIOMARK MED, V7, P287, DOI [10.2217/bmm.13.8, 10.2217/BMM.13.8]; Salem O, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2869-x; Sand M, 2012, BRIT J DERMATOL, V167, P847, DOI 10.1111/j.1365-2133.2012.11022.x; Satoh M, 2012, IMMUNOBIOLOGY, V217, P533, DOI 10.1016/j.imbio.2011.08.005; Taurino C, 2010, CLIN SCI, V119, P335, DOI 10.1042/CS20100043; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang Y, 2013, MOL MED REP, V7, P1506, DOI 10.3892/mmr.2013.1384; Wang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12159; Wang ZH, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0577-9; Woywodt A, 2006, J THROMB HAEMOST, V4, P671, DOI 10.1111/j.1538-7836.2006.01794.x; Wu XY, 2017, INFLAMMATION, V40, P708, DOI 10.1007/s10753-016-0488-y; Xu JF, 2016, SCI REP-UK, V6, DOI 10.1038/srep28968; Xue YX, 2015, ATHEROSCLEROSIS, V241, P671, DOI 10.1016/j.atherosclerosis.2015.06.031; Yao XL, 2015, INT J CLIN EXP PATHO, V8, P16014; Zernecke A, 2012, THROMB HAEMOSTASIS, V107, P626, DOI 10.1160/TH11-08-0603; Zhong Y, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160105; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697; Zhu N, 2011, ATHEROSCLEROSIS, V215, P286, DOI 10.1016/j.atherosclerosis.2010.12.024	46	20	21	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0184256	10.1371/journal.pone.0184256	http://dx.doi.org/10.1371/journal.pone.0184256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961259	Green Published, gold, Green Submitted			2022-12-26	WOS:000412027700005
J	Morishita, Y; Nomura, Y; Fukui, C; Kawakami, T; Ikeda, T; Mukai, T; Yuba, T; Inamura, K; Yamaoka, H; Miyazaki, K; Okazaki, H; Haishima, Y				Morishita, Yuki; Nomura, Yusuke; Fukui, Chie; Kawakami, Tsuyoshi; Ikeda, Toshiyuki; Mukai, Tomokazu; Yuba, Toshiyasu; Inamura, Ken-ichi; Yamaoka, Hisatoki; Miyazaki, Ken-ichi; Okazaki, Hitoshi; Haishima, Yuji			Pilot study on novel blood containers with alternative plasticizers for red cell concentrate storage	PLOS ONE			English	Article							PVC MEDICAL DEVICES; DI(2-ETHYLHEXYL) PHTHALATE; DI-2-ETHYLHEXYL PHTHALATE; POLYVINYL-CHLORIDE; IN-VITRO; TOXICITY; PRODUCTS; SYSTEMS; DEHP	Di (2-ethylhexyl) phthalate (DEHP), a typical plasticizer used for polyvinyl chloride (PVC) blood containers, is eluted from the blood containers and exerts protective effects on red blood cells. However, a concern for detrimental effects of DEHP on human health has led to the development of potential DEHP substitutes. Here, we compared the red blood cell preservation ability of two types of non-DEHP blood containers with safe alternative plasticizers to that of DEHP blood containers. Red cell concentrates in mannitol-adenine-phosphate solution (MAP/RCC) were stored for 6 weeks in PVC blood bags containing DEHP, diisononyl- cyclohexane-1,2-dicarboxylate (DINCH) and di (2-ethylhexyl) 4-cyclohexene-1,2-dicarboxylate (DOTH), or 4-cyclohexene-1,2-dicarboxylic acid dinonyl ester (DL9TH) and DOTH. There was no significant difference in the total amount of plasticizer eluted into MAP/RCC (till 3 weeks from the beginning of the experiment), hemolysis of MAP/RCC, and osmotic fragility of MAP/RCC between the non-DEHP blood containers and DEHP blood containers. Hematological and blood chemical indices of MAP/RCC in all containers were nearly the same. Thus, DOTH/DINCH and DOTH/DL9TH blood containers demonstrate the same quality of MAP/RCC storing as the DEHP blood containers. Since DOTH, DINCH, and DL9TH were reported to be safe, DOTH/DINCH and DOTH/DL9TH blood containers are promising candidate substitutes for DEHP blood containers.	[Morishita, Yuki; Nomura, Yusuke; Fukui, Chie; Haishima, Yuji] Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, Tokyo, Japan; [Kawakami, Tsuyoshi] Natl Inst Hlth Sci, Div Environm Chem, Setagaya Ku, Tokyo, Japan; [Ikeda, Toshiyuki; Okazaki, Hitoshi] Univ Tokyo, Dept Transfus Med, Bunkyo Ku, Tokyo, Japan; [Mukai, Tomokazu; Yuba, Toshiyasu; Inamura, Ken-ichi; Yamaoka, Hisatoki] Kawasumi Labs Inc, Corp Res & Dev Div, Minato Ku, Tokyo, Japan; [Miyazaki, Ken-ichi] New Japan Chem Co Ltd, Chuo Ku, Osaka, Japan	National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan; University of Tokyo	Haishima, Y (corresponding author), Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, Tokyo, Japan.	haishima@nihs.go.jp	Ikeda, Toshiyuki/GVS-5588-2022	Morishita, Yuki/0000-0001-5482-9701; Kawakami, Tsuyoshi/0000-0002-3661-7657	Japanese Ministry of Health, Labor, and Welfare; Health and Labor Sciences Research [H25-CHIKYUKIBO-SHITEI-008, H26-SOUYAKU-IPPAN-008]; Japan Agency for Medical Research and Development; Research on Development of New Drugs [15ak0101029h2602, 16ak0101029j2603]	Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Health and Labor Sciences Research(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Research on Development of New Drugs	This study was supported by funding to YH from the Japanese Ministry of Health, Labor, and Welfare (http://www.mhim.go.jp/english/); Health and Labor Sciences Research Grants (H25-CHIKYUKIBO-SHITEI-008 and H26-SOUYAKU-IPPAN-008), and from the Japan Agency for Medical Research and Development (http://www.amed.go.jp/en/); a grant for Research on Development of New Drugs (15ak0101029h2602, 16ak0101029j2603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Kawasumi Laboratories, Inc and New Japan Chemical Co., Ltd. are commercial companies. The companies did not provide research funds for this study. The companies provided salaries for authors [employees of the companies: TM, TY, KI, HY, and KM]. The specific roles of these authors are articulated in the 'Author Contributions' section.	Agency for Toxic Substances and Disease Registry, 2002, TOX PROF DI 2 ETH PH; Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101; AUBUCHON JP, 1988, BLOOD, V71, P448; Dumont LJ, 2012, TRANSFUSION, V52, P1439, DOI 10.1111/j.1537-2995.2011.03506.x; Haishima Y, 2005, INT J PHARM, V298, P126, DOI 10.1016/j.ijpharm.2005.04.009; Haishima Y, 2004, INT J PHARMACEUT, V274, P119, DOI 10.1016/j.ijpharm.2004.01.009; Haishima Y, 2016, J VINYL ADDIT TECHN, V22, P520, DOI 10.1002/vnl.21472; Haishima Y, 2014, J BIOMED MATER RES B, V102, P721, DOI 10.1002/jbm.b.33052; Hayashi Y, 2002, J PHARMACEUT BIOMED, V28, P421, DOI 10.1016/S0731-7085(01)00698-7; HOGMAN CF, 1987, VOX SANG, V53, P84; HOGMAN CF, 1991, TRANSFUSION, V31, P26, DOI 10.1046/j.1537-2995.1991.31191096180.x; Ito R, 2005, INT J PHARMACEUT, V303, P104, DOI 10.1016/j.ijpharm.2005.07.009; Kawakami T, 2011, J ENVIRON SCI HEAL A, V46, P855, DOI 10.1080/10934529.2011.579870; Lagerberg JW, 2015, TRANSFUSION, V55, P522, DOI 10.1111/trf.12870; Lamb JCt, 1987, APPL PHARM, V88, P255; Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202; Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852; Morishita Y, 2017, J BIOMED MAT RES B; National Industrial Chemicals Notification and Assessment Scheme (NICNAS), 2008, STD1259 NICNAS; Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6; Prowse CV, 2014, VOX SANG, V106, P1, DOI 10.1111/vox.12084; Sampson J, 2011, TRANSFUSION MED, V21, P73, DOI 10.1111/j.1365-3148.2010.01056.x; Sasakawa S, 1991, JPN J TRANSFUS MED, V37, P398; Scientific Committee on Emerging and Newly-Identified Health Risks (SCENIHR), FIN OP SAF MED DEV C; Simmchen J, 2012, TRANSFUS MED REV, V26, P27, DOI 10.1016/j.tmrv.2011.06.001; Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.3.CO;2-H; TYL RW, 1988, FUND APPL TOXICOL, V10, P395, DOI 10.1016/0272-0590(88)90286-2; US Food and Drug Administration, 2002, PUBL HLTH NOT PVC DE	28	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185737	10.1371/journal.pone.0185737	http://dx.doi.org/10.1371/journal.pone.0185737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957448	gold, Green Published, Green Submitted			2022-12-26	WOS:000411985200113
J	Cao, HC; Zhang, SJ; Shan, SF; Sun, C; Li, Y; Wang, H; Yu, SX; Liu, Y; Guo, FF; Zhai, QW; Wang, YC; Jiang, JJ; Wang, H; Yan, J; Liu, W; Ying, H				Cao, Hongchao; Zhang, Shengjie; Shan, Shifang; Sun, Chao; Li, Yan; Wang, Hui; Yu, Shuxian; Liu, Yi; Guo, Feifan; Zhai, Qiwei; Wang, Yu-cheng; Jiang, Jingjing; Wang, Hui; Yan, Jun; Liu, Wei; Ying, Hao			Ligand-dependent corepressor (LCoR) represses the transcription factor C/EBP during early adipocyte differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipogenesis; CCAAT-enhancer-binding protein (C; EBP); nuclear receptor; peroxisome proliferator-activated receptor (PPAR); transcription corepressor	MITOTIC CLONAL EXPANSION; RECEPTOR COREPRESSOR; 3T3-L1 PREADIPOCYTES; BINDING-PROTEINS; ADIPOGENESIS; COREGULATORS; BETA; HOMEOSTASIS; KINASE; GENE	Nuclear receptors (NRs) regulate gene transcription by recruiting coregulators, involved in chromatin remodeling and assembly of the basal transcription machinery. The NR-associated protein ligand-dependent corepressor (LCoR) has previously been shown to suppress hepatic lipogenesis by decreasing the binding of steroid receptor coactivators to thyroid hormone receptor. However, the role of LCoR in adipogenesis has not been established. Here, we show that LCoR expression is reduced in the early stage of adipogenesis in vitro. LCoR overexpression inhibited 3T3-L1 adipocyte differentiation, whereas LCoR knockdown promoted it. Using an unbiased affinity purification approach, we identified CCAAT/enhancer-binding protein (C/EBP), a key transcriptional regulator in early adipogenesis, and corepressor C-terminal binding proteins as potential components of an LCoR-containing complex in 3T3-L1 adipocytes. We found that LCoR directly interacts with C/EBP through its C-terminal helix-turn-helix domain, required for LCoR's inhibitory effects on adipogenesis. LCoR overexpression also inhibited C/EBP transcriptional activity, leading to inhibition of mitotic clonal expansion and transcriptional repression of C/EBP and peroxisome proliferator-activated receptor 2 (PPAR2). However, LCoR overexpression did not affect the recruitment of C/EBP to the promoters of C/EBP and PPAR2 in 3T3-L1 adipocytes. Of note, restoration of PPAR2 or C/EBP expression attenuated the inhibitory effect of LCoR on adipogenesis. Mechanistically, LCoR suppressed C/EBP-mediated transcription by recruiting C-terminal binding proteins to the C/EBP and PPAR2 promoters and by modulating histone modifications. Taken together, our results indicate that LCoR negatively regulates early adipogenesis by repressing C/EBP transcriptional activity and add LCoR to the growing list of transcriptional corepressors of adipogenesis.	[Cao, Hongchao; Zhang, Shengjie; Sun, Chao; Li, Yan; Wang, Hui; Yu, Shuxian; Wang, Hui; Liu, Wei; Ying, Hao] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci,Key Labs Food Safety Res, Shanghai 200031, Peoples R China; [Shan, Shifang; Liu, Yi; Guo, Feifan; Zhai, Qiwei] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci,Key Labs Nutr & Metab, Shanghai 200031, Peoples R China; [Wang, Yu-cheng; Ying, Hao] Chinese Acad Sci, Shanghai Xuhui Cent Hosp, Shanghai Clin Ctr, Shanghai 200031, Peoples R China; [Jiang, Jingjing] Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200031, Peoples R China; [Wang, Hui; Ying, Hao] Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing 100021, Peoples R China; [Yan, Jun] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China; [Yan, Jun] Nanjing Univ, Minist Educt, Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Fudan University; Nanjing University; Nanjing University	Liu, W; Ying, H (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	liuwei01@sibs.ac.cn; yinghao@sibs.ac.cn	Yan, Jun/Q-3031-2017	Yan, Jun/0000-0002-1303-1952; Zhai, Qiwei/0000-0002-9617-7403	Ministry of Science and Technology of China [2016YFA0500102, 2016YFC1304905]; National Natural Science Foundation [31371189, 31525012, 31100550, 81570768, 81471016]; Natural Science Foundation for Universities in Jiangsu Province, China [BK20151396]; Chinese Academy of Sciences/State Administration of Foreign Experts Affairs International Partnership Program for Creative Research Teams; Chinese Academy of Sciences [ZDBS-SSW-DQC-02]; Xuhui Central Hospital (Shanghai, China)	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation for Universities in Jiangsu Province, China; Chinese Academy of Sciences/State Administration of Foreign Experts Affairs International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Xuhui Central Hospital (Shanghai, China)	This work was supported by Ministry of Science and Technology of China Grants 2016YFA0500102 and 2016YFC1304905; National Natural Science Foundation Grants 31371189, 31525012, 31100550, 81570768, and 81471016; Natural Science Foundation for Universities in Jiangsu Province, China Grant BK20151396 (to J. Y.), Chinese Academy of Sciences/State Administration of Foreign Experts Affairs International Partnership Program for Creative Research Teams; Chinese Academy of Sciences Grant ZDBS-SSW-DQC-02; and Xuhui Central Hospital (Shanghai, China). The authors declare that they have no conflicts of interest with the contents of this article.	Asim M, 2011, J BIOL CHEM, V286, P37108, DOI 10.1074/jbc.M111.292771; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Calderon MR, 2012, J BIOL CHEM, V287, P8662, DOI 10.1074/jbc.M111.311605; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Collingwood TN, 1999, J MOL ENDOCRINOL, V23, P255, DOI 10.1677/jme.0.0230255; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Fowler Amy M, 2004, Sci STKE, V2004, ppe51, DOI 10.1126/stke.2562004pe51; Guo L, 2012, CELL DEATH DIFFER, V19, P1917, DOI 10.1038/cdd.2012.75; Hartig SM, 2011, J CELL BIOL, V192, P55, DOI 10.1083/jcb.201004026; Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Jack BHA, 2011, INT J BIOCHEM CELL B, V43, P693, DOI 10.1016/j.biocel.2011.01.017; Jack BHA, 2010, J BIOL CHEM, V285, P32405, DOI 10.1074/jbc.M110.141317; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Louet JF, 2007, CELL CYCLE, V6, P2448, DOI 10.4161/cc.6.20.4777; Louet JF, 2006, P NATL ACAD SCI USA, V103, P17868, DOI 10.1073/pnas.0608711103; Palijan A, 2009, J BIOL CHEM, V284, P30275, DOI 10.1074/jbc.M109.051201; Palijan A, 2009, J BIOL CHEM, V284, P30264, DOI 10.1074/jbc.M109.045526; Raghav SK, 2012, MOL CELL, V46, P335, DOI 10.1016/j.molcel.2012.03.017; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Song YY, 2012, J HEPATOL, V56, P248, DOI 10.1016/j.jhep.2011.07.014; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Ying H, 2007, MOL CELL BIOL, V27, P2359, DOI 10.1128/MCB.02189-06; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101	34	5	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18973	18987		10.1074/jbc.M117.793984	http://dx.doi.org/10.1074/jbc.M117.793984			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972158	Green Published, hybrid			2022-12-26	WOS:000415848000021
J	De Carolis, E; Paoletti, S; Nagel, D; Vella, A; Mello, E; Palucci, I; De Angelis, G; D'Inzeo, T; Sanguinetti, M; Posteraro, B; Spanu, T				De Carolis, Elena; Paoletti, Silvia; Nagel, Domenico; Vella, Antonietta; Mello, Enrica; Palucci, Ivana; De Angelis, Giulia; D'Inzeo, Tiziana; Sanguinetti, Maurizio; Posteraro, Brunella; Spanu, Teresa			A rapid diagnostic workflow for cefotaxime-resistant Escherichia coli and Klebsiella pneumoniae detection from blood cultures by MALDI-TOF mass spectrometry	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; SPECTRUM BETA-LACTAMASES; GRAM-NEGATIVE BACTERIA; IDENTIFICATION; MICROBIOLOGY	Background Nowadays, the global spread of resistance to oxyimino-cephalosporins in Enterobacteriaceae implies the need for novel diagnostics that can rapidly target resistant organisms from these bacterial species. Methods In this study, we developed and evaluated a Direct Mass Spectrometry assay for Beta-Lactamase (D-MSBL) that allows direct identification of (oxyimino) cephalosporin-resistant Escherichia coli or Klebsiella pneumoniae from positive blood cultures (BCs), by using the matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) technology. Results The D-MSBL assay was performed on 93 E. coli or K. pneumoniae growing BC samples that were shortly co-incubated with cefotaxime (CTX) as the indicator cephalosporin. Susceptibility and resistance defining peaks from the samples' mass spectra were analyzed by a novel algorithm for bacterial organism classification. The D-MSBL assay allowed discrimination between E. coli and K. pneumoniae that were resistant or susceptible to CTX with a sensitivity of 86.8% and a specificity of 98.2%. Conclusion The proposed algorithm-based D-MSBL assay, if integrated in the routine laboratory diagnostic workflow, may be useful to enhance the establishment of appropriate antibiotic therapy and to control the threat of oxyimino-cephalosporin resistance in hospital.	[De Carolis, Elena; Paoletti, Silvia; Nagel, Domenico; Vella, Antonietta; Mello, Enrica; Palucci, Ivana; De Angelis, Giulia; D'Inzeo, Tiziana; Sanguinetti, Maurizio; Spanu, Teresa] Univ Agostino Gemelli, Univ Cattolica Sacro Cuore, Inst Microbiol, Fdn Policlin, Rome, Italy; [Posteraro, Brunella] Univ Agostino Gemelli, Univ Cattolica Sacro Cuore, Inst Publ Hlth, Sect Hyg,Fdn Policlin, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Sanguinetti, M (corresponding author), Univ Agostino Gemelli, Univ Cattolica Sacro Cuore, Inst Microbiol, Fdn Policlin, Rome, Italy.	maurizio.sanguinetti@unicatt.it	Posteraro, Brunella/K-8499-2018; Sanguinetti, Maurizio/A-1453-2019; Vella, Antonietta/ABH-7693-2020; Vella, Antonietta/K-2816-2018; De+Carolis, Elena/ABD-9703-2020; De Angelis, Giulia/G-1905-2018; palucci, ivana/J-8542-2018	Posteraro, Brunella/0000-0002-1663-7546; Sanguinetti, Maurizio/0000-0002-9780-7059; Vella, Antonietta/0000-0002-0495-8959; De+Carolis, Elena/0000-0003-4757-7256; De Angelis, Giulia/0000-0002-7087-7399; palucci, ivana/0000-0003-2106-1761				Bevan ER, 2017, J ANTIMICROB CHEMOTH, V72, P2145, DOI 10.1093/jac/dkx146; De Carolis E, 2014, J INFECT DEV COUNTR, V8, P1081, DOI 10.3855/jidc.3623; EUCAST, BREAKP TABL INT MICS; European Centre for Disease Prevention and Control (ECDC), TABL ANT RES SURV EU; Fiori B, 2016, J CLIN MICROBIOL, V54, P576, DOI 10.1128/JCM.02590-15; Hawkey PM, 2015, J HOSP INFECT, V89, P241, DOI 10.1016/j.jhin.2015.01.008; Jung JS, 2014, J CLIN MICROBIOL, V52, P924, DOI 10.1128/JCM.02691-13; Kronenberg A, 2013, EURO SURVEILL, V18; Livermore DM, 2008, CLIN MICROBIOL INFEC, V14, P3, DOI 10.1111/j.1469-0691.2007.01857.x; Oviano M, 2014, CLIN MICROBIOL INFEC, V20, P1146, DOI 10.1111/1469-0691.12729; Papp-Wallace KM, 2011, ANTIMICROB AGENTS CH, V55, P4943, DOI 10.1128/AAC.00296-11; Perez KK, 2013, ARCH PATHOL LAB MED, V137, P1247, DOI 10.5858/arpa.2012-0651-OA; Rossolini GM, 2008, CLIN MICROBIOL INFEC, V14, P33, DOI 10.1111/j.1469-0691.2007.01867.x; Sanguinetti M, 2016, EXPERT REV PROTEOMIC, V13, P965, DOI 10.1080/14789450.2016.1231578; Sparbier K, 2016, METHODS, V104, P48, DOI 10.1016/j.ymeth.2016.01.008; Sparbier K, 2012, J CLIN MICROBIOL, V50, P927, DOI 10.1128/JCM.05737-11; Stewardson AJ, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.33.30319; Tuite N, 2014, J ANTIMICROB CHEMOTH, V69, P1729, DOI 10.1093/jac/dku083; van der Steen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138088; Ye QH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00096	20	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185935	10.1371/journal.pone.0185935	http://dx.doi.org/10.1371/journal.pone.0185935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982134	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300091
J	Foveau, A; Vaz, S; Desroy, N; Kostylev, VE				Foveau, Aurelie; Vaz, Sandrine; Desroy, Nicolas; Kostylev, Vladimir E.			Process-driven and biological characterisation and mapping of seabed habitats sensitive to trawling	PLOS ONE			English	Article							ENGLISH-CHANNEL; NORTH-SEA; BENTHIC COMMUNITIES; TAXONOMIC SUFFICIENCY; FISHING DISTURBANCE; SCOTIAN SHELF; IMPACT; BAY; BIODIVERSITY; MACROFAUNA	The increase of anthropogenic pressures on the marine environment together with the necessity of a sustainable management of marine living resources have underlined the need to map and model coastal environments, particularly for the purposes of spatial planning and for the implementation of integrated ecosystem-based management approach. The present study compares outputs of a process-driven benthic habitat sensitivity (PDS) model to the structure, composition and distribution of benthic invertebrates in the Eastern English Channel and southern part of the North Sea. Trawl disturbance indicators (TDI) computed from species biological traits and benthic community composition were produced from samples collected with a bottom trawl. The TDI was found to be highly correlated to the PDS further validating the latter's purpose to identify natural process-driven pattern of sensitivity. PDS was found to reflect an environmental potential that may no longer be fully observable in the field and difference with in situ biological observations could be partially explained by the spatial distribution of fishery pressure on the seafloor. The management implication of these findings are discussed and we suggest that, used in conjunction with TDI approaches, PDS may help monitor management effort by evaluating the difference between the current state and the presumed optimal environmental status of marine benthic habitats.	[Foveau, Aurelie; Desroy, Nicolas] IFREMER, Lab Environm & Ressources Bretagne Nord, Dinard, France; [Vaz, Sandrine] IFREMER, UMR MARBEC, Sete, France; [Kostylev, Vladimir E.] Nat Resources Canada, Geol Survey Canada Atlantic, Dartmouth, NS, Canada	Ifremer; Ifremer; Universite de Montpellier; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada	Foveau, A (corresponding author), IFREMER, Lab Environm & Ressources Bretagne Nord, Dinard, France.	aurelie.foveau@ifremer.fr		Foveau, Aurelie/0000-0001-6283-2214; Vaz, Sandrine/0000-0002-7365-8335; Nicolas, Desroy/0000-0002-9047-5637	INTERREG IV A project CHARM III (CHannel integrated Approach for marine Resource Management); French research agency (ANR), through project COMANCHE (Ecosystem interactions and anthropogenic impacts on great scallop populations in the English Channel) [ANR-2010-STRA-010]; European Union under INTERREG IVA CHARM III project (Channel integrated Approach for marine Resource Management)	INTERREG IV A project CHARM III (CHannel integrated Approach for marine Resource Management); French research agency (ANR), through project COMANCHE (Ecosystem interactions and anthropogenic impacts on great scallop populations in the English Channel)(French National Research Agency (ANR)); European Union under INTERREG IVA CHARM III project (Channel integrated Approach for marine Resource Management)	This study was partly supported by the INTERREG IV A project CHARM III (CHannel integrated Approach for marine Resource Management), the French research agency (ANR), through the project COMANCHE (Ecosystem interactions and anthropogenic impacts on great scallop populations in the English Channel) - ANR-2010-STRA-010.; The authors are grateful to all the scientists who brought help for the research of environmental layers, the projects leaders of CGFS, IBTS and CAMANOC scientific surveys, the scientific staff and vessel crews who participated to these surveys. They also acknowledge anonymous reviewers that provide great help in improving the manuscript. This study was partly supported by the European Union under INTERREG IVA CHARM III project (Channel integrated Approach for marine Resource Management) and the French research agency (ANR), through the project COMANCHE (Ecosystem interactions and anthropogenic impacts on great scallop populations in the English Channel)-ANR-2010-STRA-010.	Bacci T, 2009, MAR ECOL-EVOL PERSP, V30, P13, DOI 10.1111/j.1439-0485.2009.00324.x; BILYARD GR, 1987, MAR POLLUT BULL, V18, P581, DOI 10.1016/0025-326X(87)90277-3; Bolam SG, 2014, J SEA RES, V88, P47, DOI 10.1016/j.seares.2014.01.001; Bolam SG, 2014, J SEA RES, V85, P162, DOI 10.1016/j.seares.2013.05.003; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Borja A, 2011, MAR POLLUT BULL, V62, P889, DOI 10.1016/j.marpolbul.2011.03.031; Bradshaw C, 2003, MAR BIOL, V143, P783, DOI 10.1007/s00227-003-1115-7; Bremner J, 2006, J MARINE SYST, V60, P302, DOI 10.1016/j.jmarsys.2006.02.004; Brind'Amour A, 2014, CONT SHELF RES, V72, P1, DOI 10.1016/j.csr.2013.10.015; Brind'Amour A, 2009, CONT SHELF RES, V29, P1189, DOI 10.1016/j.csr.2009.01.003; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CABIOCH L, 1968, CAH BIOL MAR, V9, P493; Capasso E, 2010, J MAR BIOL ASSOC UK, V90, P1161, DOI 10.1017/S0025315409991020; Carpentier A., 2009, ATLAS HABITATS RESSO; CHURCHILL JH, 1989, CONT SHELF RES, V9, P841, DOI 10.1016/0278-4343(89)90016-2; Clarke K.R., 2006, PRIMER V6 USER MANUA; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Collie JS, 1997, MAR ECOL PROG SER, V155, P159, DOI 10.3354/meps155159; Coppin F., 1989, CGFS CHANNEL GROUND; Currie DR, 1999, CAN J FISH AQUAT SCI, V56, P539, DOI 10.1139/cjfas-56-4-539; CURRY D, 1989, Proceedings of the Geologists' Association, V100, P339; Dauvin JC, 2003, MAR POLLUT BULL, V46, P552, DOI 10.1016/S0025-326X(03)00033-X; Dauvin JC, 2015, J SEA RES, V100, P32, DOI 10.1016/j.seares.2014.11.005; Dauvin JC, 2012, MAR POLLUT BULL, V64, P463, DOI 10.1016/j.marpolbul.2011.12.010; Davies JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124815; de Juan S, 2013, ESTUAR COAST SHELF S, V117, P199, DOI 10.1016/j.ecss.2012.11.012; de Juan S, 2012, ECOL INDIC, V18, P183, DOI 10.1016/j.ecolind.2011.11.020; de Juan S, 2009, MAR POLICY, V33, P472, DOI 10.1016/j.marpol.2008.11.005; Demestre M., 2000, P121; Dinmore TA, 2003, ICES J MAR SCI, V60, P371, DOI 10.1016/S1054-3139(03)00010-9; Dolbeth M, 2007, MAR POLLUT BULL, V54, P576, DOI 10.1016/j.marpolbul.2006.12.005; Eastwood PD, 2007, ICES J MAR SCI, V64, P453, DOI 10.1093/icesjms/fsm001; Ehler C, 2009, MARINE SPATIAL PLANN, P53; Eigaard OR, 2016, ICES J MAR SCI, V73, P27, DOI 10.1093/icesjms/fsv099; EISMA D, 1987, J GEOL SOC LONDON, V144, P161, DOI 10.1144/gsjgs.144.1.0161; Ellis JR, DISTRIBUTION STRUCTU; European Union, MAR SPAT PLANN 2010; Fisher JAD, 2011, ICES J MAR SCI, V68, P2096, DOI 10.1093/icesjms/fsr147; Forbes E., 1958, PHYS ATLAS NATURAL P; Foster Smith B, MESH GUIDE WHAT IS H; Foveau A, 2016, ENGLISH CHANNEL PROC; Foveau A, 2016, LIFE HIST TRAITS SCO; Frid CLJ, 2000, ICES J MAR SCI, V57, P1303, DOI 10.1006/jmsc.2000.0900; Galparsoro I, 2013, ESTUAR COAST SHELF S, V131, P194, DOI 10.1016/j.ecss.2013.07.007; Garcia C., 2010, U LILLE, V1, P1; Girardin R, 2015, OCEAN COAST MANAGE, V106, P124, DOI 10.1016/j.ocecoaman.2015.01.017; Glegg G, 2015, MAR POLLUT BULL, V95, P707, DOI 10.1016/j.marpolbul.2015.02.020; Gogina M, 2010, J SEA RES, V64, P313, DOI 10.1016/j.seares.2010.04.005; GREEN MO, 1995, CONT SHELF RES, V15, P889, DOI 10.1016/0278-4343(95)80001-T; Gregr EJ, 2008, GEOHAB MARINE GEOLOG; Gregr EJ., 2016, CAN TECH REP HYDROGR, V312; Grime J. P., 1979, Plant strategies and vegetation processes.; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; GUNTHER CP, 1992, NETH J SEA RES, V30, P45, DOI 10.1016/0077-7579(92)90044-F; Habitats Foveau A., 2009, THESIS; HALL SJ, 1990, NETH J SEA RES, V27, P119, DOI 10.1016/0077-7579(90)90040-N; HALL SJ, 1994, OCEANOGR MAR BIOL, V32, P179; Heap AD, 2011, CONT SHELF RES, V31, pS1, DOI 10.1016/j.csr.2010.09.015; Hiddink JG, 2006, ICES J MAR SCI, V63, P822, DOI 10.1016/j.icesjms.2006.02.006; Hiscock K., 1999, ASSESSING SEABED SPE; Hjulstrom F., 1935, ETUD RHOD, V11, P255; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Huston M. A., 1994, BIOL DIVERSITY; ICES, 2017, ICES ADV 2016; ICES, 2015, 2015ICESCM2015SSGEPI; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 2012, ICES J MAR SCI, V69, P51, DOI 10.1093/icesjms/fsr173; Kaiser MJ, 2006, MAR ECOL PROG SER, V311, P1, DOI 10.3354/meps311001; Kaiser MJ, 2000, J ANIM ECOL, V69, P494, DOI 10.1046/j.1365-2656.2000.00412.x; KAISER MJ, 1994, MAR ECOL PROG SER, V112, P41, DOI 10.3354/meps112041; KAISER MJ, 1995, MAR ECOL PROG SER, V126, P31, DOI 10.3354/meps126031; Kostylev V., 2007, SPEC PAP GEOL ASS CA, V47, P171; Kostylev VE, 2015, CAN TECH REP HYDROGR, V305; Kostylev VE, 2005, BENTHIC HABITATS EFF, P890; Kroncke I, 2011, ESTUAR COAST SHELF S, V94, P1, DOI 10.1016/j.ecss.2011.04.008; Kube J, 1996, ARCH HYDROBIOL, V138, P213; La Riviere M, 2015, METHODOLOGIE EVALUAT, P69; Laffoley DA, 2000, NATL IMPORTANT SEASC; Lambert GI, 2011, MAR ECOL PROG SER, V430, P71, DOI 10.3354/meps09112; Lambert GI, 2014, J APPL ECOL, V51, P1326, DOI 10.1111/1365-2664.12277; LARSONNEUR C, 1982, SEDIMENTOLOGY, V29, P851, DOI 10.1111/j.1365-3091.1982.tb00088.x; Le Pape O, 2007, J SEA RES, V57, P126, DOI 10.1016/j.seares.2006.08.011; Lee J, 2010, ICES J MAR SCI, V67, P1260, DOI 10.1093/icesjms/fsq010; Legendre L, 1999, J PLANKTON RES, V21, P2067, DOI 10.1093/plankt/21.11.2067; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LEPROVOST C, 1985, J PHYS OCEANOGR, V15, P1009, DOI 10.1175/1520-0485(1985)015<1008:TSOTEC>2.0.CO;2; Lesourd S, 2001, ESTUARIES, V24, P940, DOI 10.2307/1353008; MAC ARTHUR ROBERT H., 1967; Marchal P., 2014, MECH CHANGE HUMAN BE, P193; Margalef R., 1979, P89; Martin CS, 2009, AQUAT LIVING RESOUR, V22, P499, DOI 10.1051/alr/2009051; McCullagh P., 1990, GEN LINEAR MODELS, V2nd; Mear Y, 2006, CONT SHELF RES, V26, P2335, DOI 10.1016/j.csr.2006.06.009; Nedelec C, 1990, DEFINITION CLASSIFIC, P222; Negrello OA, 2013, ZOOLOGIA-CURITIBA, V30, P266, DOI 10.1590/S1984-46702013000300003; O'Boyl R, DEV ECOSYSTEM BASED; Oksanen J., 2017, COMMUNITY ECOLOGY PA; OSPAR. Annex V to the OSPAR Convention, 200303171E OSPAR; Paphitis D, 2010, MICROPALEAEONTOLOGIC, P99, DOI 10.1144/TMS004.6; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; PINGREE RD, 1978, J GEOPHYS RES-OCEANS, V83, P4615, DOI 10.1029/JC083iC09p04615; PINGREE RD, 1980, OCEANOL ACTA, V3, P227; Queiros AM, 2006, J EXP MAR BIOL ECOL, V335, P91, DOI 10.1016/j.jembe.2006.03.001; Ramsay K, 1996, MAR ECOL PROG SER, V144, P63, DOI 10.3354/meps144063; Rees E.I.S., 1977, European Marine Biology Symposium, P465; Rees HL, 1999, ICES J MAR SCI, V56, P228, DOI 10.1006/jmsc.1998.0438; Rees HL, 2007, STRUCTURE DYNAMICS N; Reiss H, 2009, MAR ECOL PROG SER, V394, P201, DOI 10.3354/meps08243; Reynolds CS, 1999, AQUAT SCI, V61, P183, DOI 10.1007/s000270050061; Rice J, 24334 EUR EN; Rijnsdorp A.D., 2015, ICES J MAR SCI, V73, P27; Rijnsdorp AD, 1998, ICES J MAR SCI, V55, P403, DOI 10.1006/jmsc.1997.0326; Rivier A., 2010, EVALUATION ACTION HO; Roberts C., 2010, UNNATURAL HIST SEA; Roff JC, 2003, AQUAT CONSERV, V13, P77, DOI 10.1002/aqc.525; Salomon J. C., 1991, OCEANOL ACTA, V11, P47; Sanchez P, 2000, ICES J MAR SCI, V57, P1352, DOI 10.1006/jmsc.2000.0928; Sanvicente-Anorve L, 2002, BIODIVERS CONSERV, V11, P265, DOI 10.1023/A:1014583122765; Shephard S, 2009, FISH RES, V95, P206, DOI 10.1016/j.fishres.2008.08.021; Shumchenia EJ, 2010, CONT SHELF RES, V30, P1717, DOI 10.1016/j.csr.2010.07.007; SOUTHWOOD TRE, 1977, J ANIM ECOL, V46, P337; SOUTHWOOD TRE, 1988, OIKOS, V52, P3, DOI 10.2307/3565974; Svane I, 2009, ESTUAR COAST SHELF S, V82, P621, DOI 10.1016/j.ecss.2009.03.009; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Tillin H.M., 2010, DEV SENSITIVITY MATR; Tillin HM, 2014512B JNCC; Todd BJ, 2011, CONT SHELF RES, V31, pS54, DOI 10.1016/j.csr.2010.07.008; Travers-Trolet M, 2014, CAMANOC CRUISE RV TH; Tyler-Walters H, 2005, IMPACT HUMAN ACTIVIT; Van Hoey G, 2010, MAR POLLUT BULL, V60, P2187, DOI 10.1016/j.marpolbul.2010.09.015; Vanstaen K, 2008, SCALE ANDIMPACT FISH; Venables WN., 2002, MODERN APPL STAT S, V4; Verin Y, 1992, IBTS INT BOTTOM TRAW; Vermard Y, 2010, ECOL MODEL, V221, P1757, DOI 10.1016/j.ecolmodel.2010.04.005; Webber NB, 1980, SOLENT ESTUARINE SYS, P25	136	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184486	10.1371/journal.pone.0184486	http://dx.doi.org/10.1371/journal.pone.0184486			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981504	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300012
J	Karmous, I; Trevisan, R; El Ferjani, E; Chaoui, A; Sheehan, D				Karmous, Ines; Trevisan, Rafael; El Ferjani, Ezzeddine; Chaoui, Abdelilah; Sheehan, David			Redox biology response in germinating Phaseolus vulgaris seeds exposed to copper: Evidence for differential redox buffering in seedlings and cotyledon	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; HYDROGEN-PEROXIDE; THIOREDOXIN H; ANTIOXIDATIVE ENZYMES; GLUTATHIONE CYCLE; PLANT-RESPONSES; PISUM-SATIVUM; PROTEOMICS; PROTEINS; CADMIUM	In agriculture, heavy metal contamination of soil interferes with processes associated with plant growth, development and productivity. Here, we describe oxidative and redox changes, and deleterious injury within cotyledons and seedlings caused by exposure of germinating (Phaseolus vulgaris L. var. soisson nain hatif) seeds to copper (Cu). Cu induced a marked delay in seedling growth, and was associated with biochemical disturbances in terms of intracellular oxidative status, redox regulation and energy metabolism. In response to these alterations, modulation of activities of antioxidant proteins (thioredoxin and glutathione reductase, peroxiredoxin) occurred, thus preventing oxidative damage. In addition, oxidative modification of proteins was detected in both cotyledons and seedlings by one- and two-dimensional electrophoresis. These modified proteins may play roles in redox buffering. The changes in activities of redox proteins underline their fundamental roles in controlling redox homeostasis. However, observed differential redox responses in cotyledon and seedling tissues showed a major capacity of the seedlings' redox systems to protect the reduced status of protein thiols, thus suggesting quantitatively greater antioxidant protection of proteins in seedlings compared to cotyledon. To our knowledge, this is the first comprehensive redox biology investigation of the effect of Cu on seed germination.	[Karmous, Ines; El Ferjani, Ezzeddine; Chaoui, Abdelilah] Fac Sci Bizerte, Plant Toxicol & Mol Biol Microorganisms, Zarzouna, Tunisia; [Trevisan, Rafael] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Sheehan, David] Khalifa Univ Sci & Technol, Coll Sci, Abu Dhabi, U Arab Emirates; [Sheehan, David] Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland	Universite de Carthage; Duke University; Khalifa University of Science & Technology; University College Cork	Sheehan, D (corresponding author), Khalifa Univ Sci & Technol, Coll Sci, Abu Dhabi, U Arab Emirates.; Sheehan, D (corresponding author), Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland.	david.sheehan@kustar.ac.ae	Trevisan, Rafael/E-3235-2019; Sheehan, David/ABB-5315-2020; Chaoui, Abdelilah/Q-8292-2016	Trevisan, Rafael/0000-0003-4145-8299; Chaoui, Abdelilah/0000-0001-8168-6582				Aalen RB, 1999, SEED SCI RES, V9, P285, DOI 10.1017/S096025859900029X; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Ahsan N, 2007, CHEMOSPHERE, V67, P1182, DOI 10.1016/j.chemosphere.2006.10.075; Ahsan N, 2009, PROTEOMICS, V9, P2602, DOI 10.1002/pmic.200800935; Alkhalfioui F, 2007, PLANT PHYSIOL, V144, P1559, DOI 10.1104/pp.107.098103; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bergmeyer HU, 1974, METHODS ENZYMATIC AN; Bouazizi H, 2008, ACTA BIOL HUNG, V59, P233, DOI 10.1556/ABiol.59.2008.2.9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown JE, 1998, BIOCHEM J, V330, P1173; Chaoui A, 2005, CR BIOL, V328, P23, DOI 10.1016/j.crvi.2004.10.001; Chaoui A, 1997, PLANT SCI, V127, P139, DOI 10.1016/S0168-9452(97)00115-5; Chaoui A, 1997, PLANT SCI, V126, P21, DOI 10.1016/S0168-9452(97)00090-3; Chora S, 2010, CHEMOSPHERE, V81, P1212, DOI 10.1016/j.chemosphere.2010.09.038; Colville L, 2010, PLANT GROWTH REGUL, V62, P241, DOI 10.1007/s10725-010-9482-9; Cuypers A, 2000, PHYSIOL PLANTARUM, V110, P512, DOI 10.1111/j.1399-3054.2000.1100413.x; Dyballa Nadine, 2009, J Vis Exp, DOI 10.3791/1431; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FIELDING JL, 1978, J EXP BOT, V29, P969, DOI 10.1093/jxb/29.4.969; FLEMMING CA, 1989, WATER AIR SOIL POLL, V44, P143, DOI 10.1007/BF00228784; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Garnczarska M, 2008, ACTA PHYSIOL PLANT, V30, P427, DOI 10.1007/s11738-008-0138-6; GREEN LS, 1991, PLANT PHYSL, V96; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; ISHIDA A, 1987, PLANT CELL PHYSIOL, V28, P723; Ishiwatari Y, 2000, PHYSIOL PLANTARUM, V109, P90, DOI 10.1034/j.1399-3054.2000.100113.x; Jacquot JP, 2009, TRENDS PLANT SCI, V14, P336, DOI 10.1016/j.tplants.2009.03.005; JACQUOT JP, 1994, J MOL BIOL, V235, P1357, DOI 10.1006/jmbi.1994.1091; Janas KM, 2010, J PLANT PHYSIOL, V167, P270, DOI 10.1016/j.jplph.2009.09.016; Jimenez A, 1997, PLANT PHYSIOL, V114, P275, DOI 10.1104/pp.114.1.275; Karmous I, 2014, PLANT PHYSIOL BIOCH, V76, P77, DOI 10.1016/j.plaphy.2013.12.025; Karmous Ines, 2012, Physiology and Molecular Biology of Plants, V18, P337, DOI 10.1007/s12298-012-0128-4; Karmous I, 2011, BIOL TRACE ELEM RES, V144, P1251, DOI 10.1007/s12011-011-9115-9; Kranner I, 2013, FUNCT PLANT BIOL, V40, P848, DOI 10.1071/FP13017; Kultz D, 2007, J EXP BIOL, V210, P1593, DOI 10.1242/jeb.000141; Kumar Mukesh, 2014, Annals of Biology (Hissar), V30, P593; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lavid N, 2001, PLANTA, V212, P323, DOI 10.1007/s004250000400; Lemaire SD, 2004, PHOTOSYNTH RES, V79, P305, DOI 10.1023/B:PRES.0000017174.60951.74; Leon AM, 2002, PLANT PHYSIOL BIOCH, V40, P813, DOI 10.1016/S0981-9428(02)01444-4; Lin TK, 2002, J BIOL CHEM, V277, P17048, DOI 10.1074/jbc.M110797200; Lozano RM, 1996, PLANTA, V200, P100, DOI 10.1007/BF00196655; Maksymiec W, 2002, J PLANT PHYSIOL, V159, P509, DOI 10.1078/0176-1617-00610; Matsumura H., 1980, METHOD ENZYMOL, V69, P465, DOI DOI 10.1016/S0076-6879(80)69045-4; Mattioni C, 1997, J PLANT PHYSIOL, V150, P173, DOI 10.1016/S0176-1617(97)80198-8; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; Monferran MV, 2009, ENVIRON POLLUT, V157, P2570, DOI 10.1016/j.envpol.2009.02.034; Montrichard F, 2003, PLANT PHYSIOL, V132, P1707, DOI 10.1104/pp.102.019562; Nagalakshmi N, 2001, PLANT SCI, V160, P291, DOI 10.1016/S0168-9452(00)00392-7; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Navrot N, 2006, PLANT PHYSIOL, V142, P1364, DOI 10.1104/pp.106.089458; Posmyk MM, 2009, ECOTOX ENVIRON SAFE, V72, P596, DOI 10.1016/j.ecoenv.2008.04.024; Printz B, 2013, J PROTEOME RES, V12, P5160, DOI 10.1021/pr400590d; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Rouhier N, 2002, FEBS LETT, V511, P145, DOI 10.1016/S0014-5793(01)03302-6; Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811; Rouhier N, 2010, TRENDS BIOCHEM SCI, V35, P43, DOI 10.1016/j.tibs.2009.08.005; Schutzendubel A, 2002, J EXP BOT, V53, P1351, DOI 10.1093/jexbot/53.372.1351; Sergiev I, 1997, COMPTES RENDUS IACAD, V51, P121, DOI DOI 10.1046/J.1365-3040.2001.00778.X; Sharma SS, 2009, TRENDS PLANT SCI, V14, P43, DOI 10.1016/j.tplants.2008.10.007; Tedesco S, 2010, COMP BIOCHEM PHYS C, V151, P167, DOI 10.1016/j.cbpc.2009.10.002; Traverso JA, 2007, PLANT PHYSIOL, V143, P300, DOI 10.1104/pp.106.089524; Wang SH, 2011, J AGRON CROP SCI, V197, P418, DOI 10.1111/j.1439-037X.2011.00476.x; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yruela Inmaculada, 2005, Braz. J. Plant Physiol., V17, P145, DOI 10.1590/S1677-04202005000100012; Zhang HX, 2010, J HAZARD MATER, V178, P834, DOI 10.1016/j.jhazmat.2010.02.014; ZHAO ZF, 1987, PLANT PHYSIOL, V84, P987, DOI 10.1104/pp.84.4.987	70	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184396	10.1371/journal.pone.0184396	http://dx.doi.org/10.1371/journal.pone.0184396			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981522	gold, Green Submitted, Green Published			2022-12-26	WOS:000412360300011
J	Peters, J; van Dam, R; van Doorn, R; Katerere, D; Berthiller, F; Haasnoot, W; Nielen, MWF				Peters, Jeroen; van Dam, Ruud; van Doorn, Ronald; Katerere, David; Berthiller, Franz; Haasnoot, Willem; Nielen, Michel W. F.			Mycotoxin profiling of 1000 beer samples with a special focus on craft beer	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; CONJUGATED FUSARIUM MYCOTOXINS; LINKED-IMMUNOSORBENT-ASSAY; IMMUNOAFFINITY CLEANUP; IMPORTED BEERS; FUMONISIN B-1; DEOXYNIVALENOL; ZEARALENONE; OCHRATOXIN; BARLEY	Currently beer is booming, mainly due to the steady rise of craft breweries worldwide. Previous surveys for occurrence of mycotoxins in beer, were mainly focussed on industrial produced beer. The present survey reports the presence of mycotoxins in craft beer and how this compares to industrial produced beer. More than 1000 beers were collected from 47 countries, of which 60% were craft beers. A selection of 1000 samples were screened for the presence of aflatoxin B-1, ochratoxin A (OTA), zearalenone (ZEN), fumonisins (FBs), T-2 and HT-2 toxins (T-2 and HT-2) and deoxynivalenol (DON) using a mycotoxin 6-plex immunoassay. For confirmatory analysis, a liquid chromatography tandem mass spectrometry (LC-MS/MS) method was developed and applied. The 6-plex screening showed discrepancies with the LC-MS/MS analysis, possibly due to matrix interference and/or the presence of unknown mycotoxin metabolites. The major mycotoxins detected were DON and its plant metabolite deoxynivalenol-3-beta-D-glucopyranoside (D3G). The 6-plex immunoassay reported the sum of DON and D3G (DON+D3G) contaminations ranging from 10 to 475 mu g/L in 406 beers, of which 73% were craft beers. The popular craft beer style imperial stout, had the highest percentage of samples suspected positive (83%) with 29% of all imperial stout beers having DON+D3G contaminations above 100 mu g/L. LC-MS/MS analysis showed that industrial pale lagers from Italy and Spain, predominantly contained FBs (3-69 mu g/L). Besides FBs, African traditional beers also contained aflatoxins (0.1-1.2 mu g/L). The presence of OTA, T-2, HT-2, ZEN, beta-zearalenol, 3/15-acetyl-DON, nivalenol and the conjugated mycotoxin zearalenone 14-sulfate were confirmed in some beers. This study shows that in 27 craft beers, DON+D3G concentrations occurred above (or at) the Tolerable Daily Intake (TDI). Exceeding the TDI, may have a health impact. A better control of brewing malts for craft beer, should be put in place to circumvent this potential problem.	[Peters, Jeroen; van Dam, Ruud; Haasnoot, Willem; Nielen, Michel W. F.] RIKILT Wageningen Univ & Res, Inst Food Safety, Wageningen, Netherlands; [van Doorn, Ronald] Innosieve Diagnost BV, Wageningen, Netherlands; [Katerere, David] Tshwane Univ Technol, Dept Pharmaceut Sci, Pretoria, South Africa; [Berthiller, Franz] Univ Nat Resources & Life Sci, Dept Agrobiotechnol IFA Tulln, Christian Doppler Lab Mycotoxin Metab, Vienna, Tulln, Austria; [Berthiller, Franz] Univ Nat Resources & Life Sci, Dept Agrobiotechnol IFA Tulln, Ctr Analyt Chem, Vienna, Tulln, Austria; [Nielen, Michel W. F.] Wageningen Univ, Lab Organ Chem, Wageningen, Netherlands	Wageningen University & Research; Tshwane University of Technology; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; Wageningen University & Research	Peters, J (corresponding author), RIKILT Wageningen Univ & Res, Inst Food Safety, Wageningen, Netherlands.	jeroen.peters@wur.nl		Berthiller, Franz/0000-0001-5883-2879; Katerere, David/0000-0002-4606-294X	Dutch Ministry of Economic Affairs; SenterNovem; Province of Gelderland; Innosieve Diagnostics	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); SenterNovem; Province of Gelderland; Innosieve Diagnostics	Our research was partially financed by the Dutch Ministry of Economic Affairs, SenterNovem and the Province of Gelderland. There was no additional external funding received for this study. Innosieve Diagnostics provided support in the form of salary for author Ronald van Doom, whose role was limited to the collection of craft beer samples and valuable contributions to the introduction considering craft beer. Innosieve Diagnostics did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2006, EFSA J, V4, DOI 10.2903/j.efsa.2006.365; Alexander J, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2197; [Anonymous], 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2481; [Anonymous], EFSA J; [Anonymous], 2013, FOOD CONTROL; [Anonymous], 1999, TOXIC EFFECTS MYCOTO; Bauer JI, 2016, FOOD CONTROL, V63, P135, DOI 10.1016/j.foodcont.2015.11.040; Berthiller F, 2009, FOOD ADDIT CONTAM A, V26, P207, DOI 10.1080/02652030802399034; Berthiller F, 2011, TOXICOL LETT, V206, P264, DOI 10.1016/j.toxlet.2011.08.006; Bertuzzi T, 2011, FOOD CONTROL, V22, P2059, DOI 10.1016/j.foodcont.2011.06.002; Bonnet MS, 2012, TOXINS, V4, P1120, DOI 10.3390/toxins4111120; Burdaspal PA, 2013, WORLD MYCOTOXIN J, V6, P93, DOI 10.3920/WMJ2012.1465; Cano-Sancho G, 2012, FOOD ADDIT CONTAM A, V29, P799, DOI 10.1080/19440049.2011.644813; Claudia AM, 2009, REV APPL CANC RESE, V29, P102; EFSA, 2013, M20130260 EFSA; Fink-Gremmels J, 1999, VET QUART, V21, P115, DOI 10.1080/01652176.1999.9695005; FRANCESCHI S, 1990, J NATL CANCER I, V82, P1407, DOI 10.1093/jnci/82.17.1407; Fredlund E, 2013, INT J FOOD MICROBIOL, V167, P276, DOI 10.1016/j.ijfoodmicro.2013.06.026; Gratz SW, 2013, APPL ENVIRON MICROB, V79, P1821, DOI 10.1128/AEM.02987-12; Gumus T, 2004, J I BREWING, V110, P146, DOI 10.1002/j.2050-0416.2004.tb00194.x; Herias MV, 1999, CLIN EXP IMMUNOL, V116, P283; Hlywka JJ, 1999, FOOD ADDIT CONTAM, V16, P319, DOI 10.1080/026520399283885; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2002, IARC, V80, P1, DOI DOI 10.1002/FOOD.19940380335; Kirui M.C., 2014, KENYA AFR J BIOTECHN, V13, P2675, DOI DOI 10.5897/AJB2014.13754; Kostelanska M, 2009, J AGR FOOD CHEM, V57, P3187, DOI 10.1021/jf803749u; Lasram S, 2013, FOOD ADDIT CONTAM B, V6, P1, DOI 10.1080/19393210.2012.716453; Lattanzio VMT, 2012, J MASS SPECTROM, V47, P466, DOI 10.1002/jms.2980; Mably M, 2005, FOOD ADDIT CONTAM A, V22, P1252, DOI 10.1080/02652030500241884; Maenetje PW, 2007, J ENVIRON SCI HEAL B, V42, P229, DOI 10.1080/03601230601125644; Mateo EM, 2011, INT J FOOD MICROBIOL, V149, P118, DOI 10.1016/j.ijfoodmicro.2011.06.006; Matumba L, 2014, FOOD CONTROL, V36, P253, DOI 10.1016/j.foodcont.2013.08.032; Medina A, 2005, J CHROMATOGR A, V1083, P7, DOI 10.1016/j.chroma.2005.05.089; Medina A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00348; Mngqawa P, 2016, FOOD ADDIT CONTAM B, V9, P38, DOI 10.1080/19393210.2015.1121928; Muller HM, 1997, MYCOPATHOLOGIA, V137, P185, DOI 10.1023/A:1006805717043; Nagl V, 2014, TOXICOL LETT, V229, P190, DOI 10.1016/j.toxlet.2014.06.032; Nakajima M, 1999, J AOAC INT, V82, P897; Nkwe DO, 2005, MYCOPATHOLOGIA, V160, P177, DOI 10.1007/s11046-005-6867-9; Odhav B, 2002, FOOD ADDIT CONTAM, V19, P55, DOI 10.1080/02652030110053426; OKOYE ZSC, 1986, J FOOD SAFETY, V7, P233, DOI 10.1111/j.1745-4565.1986.tb00545.x; Olivi G, 2011, PEDIATRIC LASER DENTISTRY: A USER'S GUIDE, P1; Papadopoulou-Bouraoui A, 2004, FOOD ADDIT CONTAM A, V21, P607, DOI 10.1080/02652030410001677745; Pestka JJ, 2010, ARCH TOXICOL, V84, P663, DOI 10.1007/s00204-010-0579-8; Peters J, 2014, ANALYST, V139, P3968, DOI [10.1039/c4an00368c, 10.1039/C4AN00368C]; Peters J, 2013, ANAL BIOANAL CHEM, V405, P7783, DOI 10.1007/s00216-013-7095-7; Piacentini KC, 2015, FOOD CONTROL, V50, P925, DOI 10.1016/j.foodcont.2014.10.038; Protz R., 2014, CAMRAS GOOD BEER GUI; Rodriguez-Carrasco Y, 2015, FOOD CHEM, V178, P149, DOI 10.1016/j.foodchem.2015.01.092; Roger DD, 2011, AFR J MICROBIOL RES, V5, P1565; Scientific Committee on Food (SCF), 2003, UPD OP SCI COMM FOOD; SEGAL I, 1988, BRIT J CANCER, V58, P681, DOI 10.1038/bjc.1988.286; Shephard GS, 2005, J AGR FOOD CHEM, V53, P9634, DOI 10.1021/jf0516080; Stockmann-Juvala H, 2008, HUM EXP TOXICOL, V27, P799, DOI 10.1177/0960327108099525; Torres MR, 1998, INT J FOOD MICROBIOL, V39, P139, DOI 10.1016/S0168-1605(97)00113-X; Tralamazza SM, 2016, FOOD CHEM, V196, P445, DOI 10.1016/j.foodchem.2015.09.063; Uhlig S, 2013, TOXINS, V5, P1682, DOI 10.3390/toxins5101682; Varga E, 2013, FOOD ADDIT CONTAM A, V30, P137, DOI 10.1080/19440049.2012.726745; Vendl O, 2010, FOOD ADDIT CONTAM A, V27, P1148, DOI 10.1080/19440041003801166; Versilovskis A, 2008, WORLD MYCOTOXIN J, V1, P161, DOI 10.3920/WMJ2008.x012; Visconti A, 2000, J CHROMATOGR A, V888, P321, DOI 10.1016/S0021-9673(00)00549-5; Webb T, 2012, WORLD ATLAS BEER; WHO, 1993, IARC MONOGR EVAL CAR, V56, P246; Wu JW, 2011, FOOD ADDIT CONTAM B, V4, P52, DOI 10.1080/19393210.2010.535909; Yoshinari T, 2014, J FOOD PROTECT, V77, P1940, DOI 10.4315/0362-028X.JFP-14-185; Zachariasova M, 2008, ANAL CHIM ACTA, V625, P77, DOI 10.1016/j.aca.2008.07.014; Zachariasova M, 2012, J AGR FOOD CHEM, V60, P9280, DOI 10.1021/jf302069z; Zinedine A, 2007, FOOD CHEM TOXICOL, V45, P1, DOI 10.1016/j.fct.2006.07.030; Zollner P, 2000, J CHROMATOGR B, V738, P233, DOI 10.1016/S0378-4347(99)00521-6	68	56	56	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185887	10.1371/journal.pone.0185887	http://dx.doi.org/10.1371/journal.pone.0185887			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982162	Green Submitted, Green Published, gold			2022-12-26	WOS:000412360300080
J	Pourchez, J; Leclerc, L; Girardot, F; Riffard, S; Prevot, N; Allegra, S				Pourchez, Jeremie; Leclerc, Lara; Girardot, Francoise; Riffard, Serge; Prevot, Nathalie; Allegra, Severine			Experimental human-like model to assess the part of viable Legionella reaching the thoracic region after nebulization	PLOS ONE			English	Article							MICROBIAL RISK-ASSESSMENT; INTRASINUS DRUG DEPOSITION; ACOUSTIC AIR-FLOW; LEGIONNAIRES-DISEASE; GUINEA-PIGS; AEROSOL DEPOSITION; DOSE-RESPONSE; PNEUMOPHILA; INFECTION; EXPOSURE	The incidence of Legionnaires' disease (LD) in European countries and the USA has been constantly increasing since 1998. Infection of humans occurs through aerosol inhalation. To bridge the existing gap between the concentration of Legionella in a water network and the deposition of bacteria within the thoracic region (assessment of the number of viable Legionella), we validated a model mimicking realistic exposure through the use of (i) recent technology for aerosol generation and (ii) a 3D replicate of the human upper respiratory tract. The model's sensitivity was determined by monitoring the deposition of (i) aerosolized water and Tc-99m radio-aerosol as controls, and (ii) bioaerosols generated from both Escherichia coli and Legionella pneumophila sg 1 suspensions. The numbers of viable Legionella prior to and after nebulization were provided by culture, flow cytometry and qPCR. This study was designed to obtain more realistic data on aerosol inhalation (vs. animal experimentation) and deposition at the thoracic region in the context of LD. Upon nebulization, 40% and 48% of the initial Legionella inoculum was made of cultivable and non-cultivable cells, respectively; 0.7% of both populations reached the filter holder mimicking the thoracic region in this setup. These results are in agreement with experimental data based on quantitative microbial risk assessment methods and bring new methods that may be useful for preventing LD.	[Pourchez, Jeremie; Leclerc, Lara] Univ Lyon, Ecole Natl Super Mines St Etienne, CIS EMSE, SAINBIOSE,INSERM U1059, St Etienne, France; [Girardot, Francoise; Riffard, Serge; Allegra, Severine] Univ Lyon, UJM St Etienne, CNRS, EVS ISTHME UMR 5600, St Etienne, France; [Prevot, Nathalie] Univ Hosp St Etienne, Nucl Med Dept, St Etienne, France	IMT - Institut Mines-Telecom; Mines Saint-Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut National des Sciences Appliquees de Lyon - INSA Lyon; CHU de St Etienne	Allegra, S (corresponding author), Univ Lyon, UJM St Etienne, CNRS, EVS ISTHME UMR 5600, St Etienne, France.	severine.allegra@univ-st-etienne.fr	PREVOT, Nathalie/AAG-7682-2021; Pourchez, Jeremie/F-4976-2011; POURCHEZ, Jérémie/AAC-4612-2019	PREVOT, Nathalie/0000-0001-8442-2515; Pourchez, Jeremie/0000-0002-4573-6711; POURCHEZ, Jérémie/0000-0002-4573-6711; Severine, ALLEGRA/0000-0002-5894-3509; Leclerc, Lara/0000-0002-3467-659X	Jean Monnet University, France	Jean Monnet University, France	This study was supported by a grant from Jean Monnet University, France. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra S, 2011, J APPL MICROBIOL, V110, P952, DOI 10.1111/j.1365-2672.2011.04955.x; Allegra S, 2016, SCI REP-UK, V6, DOI 10.1038/srep33998; Allegra S, 2011, APPL ENVIRON MICROB, V77, P1268, DOI 10.1128/AEM.02225-10; Allegra S, 2008, APPL ENVIRON MICROB, V74, P7813, DOI 10.1128/AEM.01364-08; [Anonymous], 2013, RELATIF PRESCRIPTION; [Anonymous], 2005, 81992005 ISO; Ari A, 2014, EURASIAN J PULMONOL, V16, P1, DOI 10.5152/ejp.2014.00087; Armstrong TW, 2007, RISK ANAL, V27, P1581, DOI 10.1111/j.1539-6924.2007.00990.x; Armstrong TW, 2007, J OCCUP ENVIRON HYG, V4, P634, DOI 10.1080/15459620701487539; Bakker-Woudenberg IAJM, 2003, J MICROBIOL METH, V54, P295, DOI 10.1016/S0167-7012(03)00118-0; BASKERVILLE A, 1983, J PATHOL, V139, P349, DOI 10.1002/path.1711390310; Baskerville A, 1981, LANCET LOND ENG 1219, P2; Beer KD, 2015, MMWR-MORBID MORTAL W, V64, P849, DOI 10.15585/mmwr.mm6431a3; BERENDT RF, 1980, J INFECT DIS, V141, P186, DOI 10.1093/infdis/141.2.186; Blatny Janet Martha, 2011, Front Biosci (Elite Ed), V3, P1300; BREIMAN RF, 1987, J EXP MED, V165, P799, DOI 10.1084/jem.165.3.799; Buse HY, 2012, WATER RES, V46, P921, DOI 10.1016/j.watres.2011.12.022; Chen DQ, 2006, PLASMID, V56, P167, DOI 10.1016/j.plasmid.2006.05.008; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Deloge-Abarkan M, 2007, J ENVIRON MONITOR, V9, P91, DOI [10.1039/B610737K, 10.1039/b610737k]; Durand M, 2011, INT J PHARMACEUT, V421, P63, DOI 10.1016/j.ijpharm.2011.09.023; Epalle T, 2015, MICROB ECOL, V69, P215, DOI 10.1007/s00248-014-0470-x; Escoll P, 2014, CURR TOP MICROBIOL, V376, P1, DOI 10.1007/82_2013_351; European Centre for Disease Prevention and Control, 2016, LEG DIS EUR; FITZGEORGE RB, 1983, J HYG-CAMBRIDGE, V90, P81, DOI 10.1017/S0022172400063877; Gorny RL, 1999, ANN AGR ENV MED, V6, P105; Hines SA, 2014, WATER RES, V56, P203, DOI 10.1016/j.watres.2014.02.013; JEPRAS RI, 1985, J HYG-CAMBRIDGE, V95, P29, DOI 10.1017/S0022172400062252; Khodr A, 2016, INFECT GENET EVOL, V43, P108, DOI 10.1016/j.meegid.2016.04.033; Kohler R, 2000, MOL GEN GENET, V262, P1060, DOI 10.1007/PL00008649; Le Guellec S, 2014, PHARM RES-DORDR, V31, P228, DOI 10.1007/s11095-013-1157-6; Leclerc L, 2015, INT J PHARMACEUT, V494, P227, DOI 10.1016/j.ijpharm.2015.08.025; Mathieu L, 2006, J INFECT DIS, V193, P1333, DOI 10.1086/503115; Mustapha P, 2015, MONITORING LEGIONELL; Navarro L, 2015, PHARM RES       1230; Nguyen TMN, 2006, J INFECT DIS, V193, P102, DOI 10.1086/498575; Perinel S, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0395-7; Portier E, 2014, ENV MICROBIOL; Prasad B, 2016, RISK ANAL OFF P 0526; Robertson P, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00670; Schoen ME, 2011, WATER RES, V45, P5826, DOI 10.1016/j.watres.2011.08.031	41	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186042	10.1371/journal.pone.0186042	http://dx.doi.org/10.1371/journal.pone.0186042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982141	Green Submitted, Green Published, gold			2022-12-26	WOS:000412360300115
J	Smith, JM; Moss, JA; Srinivasan, P; Butkyavichene, I; Gunawardana, M; Fanter, R; Miller, CS; Sanchez, D; Yang, F; Ellis, S; Zhang, JN; Marzinke, MA; Hendrix, CW; Kapoor, A; Baum, MM				Smith, James M.; Moss, John A.; Srinivasan, Priya; Butkyavichene, Irina; Gunawardana, Manjula; Fanter, Rob; Miller, Christine S.; Sanchez, Debbie; Yang, Flora; Ellis, Shanon; Zhang, Jining; Marzinke, Mark A.; Hendrix, Craig W.; Kapoor, Amita; Baum, Marc M.			Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TENOFOVIR DISOPROXIL FUMARATE; SEXUALLY-TRANSMITTED INFECTIONS; CONTRACEPTIVE VAGINAL RING; HERPES-SIMPLEX VIRUS-2; PREEXPOSURE PROPHYLAXIS; ANTIRETROVIRAL PROPHYLAXIS; REVERSE-TRANSCRIPTASE; SIMULTANEOUS DELIVERY; SUSTAINED DELIVERY	Globally, women bear an uneven burden for sexual HIV acquisition. Results from two clinical trials evaluating intravaginal rings (IVRs) delivering the antiretroviral agent dapivirine have shown that protection from HIV infection can be achieved with this modality, but high adherence is essential. Multipurpose prevention technologies (MPTs) can potentially increase product adherence by offering protection against multiple vaginally transmitted infections and unintended pregnancy. Here we describe a coitally independent, long-acting pod-IVR MPT that could potentially prevent HIV and HSV infection as well as unintended pregnancy. The pharmacokinetics of MPT pod-IVRs delivering tenofovir alafenamide hemifumarate (TAF(2)) to prevent HIV, acyclovir (ACV) to prevent HSV, and etonogestrel (ENG) in combination with ethinyl estradiol (EE), FDA-approved hormonal contraceptives, were evaluated in pigtailed macaques (N = 6) over 35 days. Pod IVRs were exchanged at 14 days with the only modification being lower ENG release rates in the second IVR. Plasma progesterone was monitored weekly to determine the effect of ENG/EE on menstrual cycle. The mean in vivo release rates (mg d(-1)) for the two formulations over 30 days ranged as follows: TAF(2) 0.35-0.40; ACV 0.56-0.70; EE 0.03-0.08; ENG (high releasing) 0.63; and ENG (low releasing) 0.05. Mean peak progesterone levels were 4.4 +/- 1.8 ng mL(-1) prior to IVR insertion and 0.075 +/- 0.064 ng mL(-1) for 5 weeks after insertion, suggesting that systemic EE/ENG levels were sufficient to suppress menstruation. The TAF2 and ACV release rates and resulting vaginal tissue drug concentrations (medians: TFV, 2.4 ng mg(-1); ACV, 0.2 ng mg(-1)) may be sufficient to protect against HIV and HSV infection, respectively. This proof of principle study demonstrates that MPT-pod IVRs could serve as a potent biomedical prevention tool to protect women's sexual and reproductive health and may increase adherence to HIV PrEP even among younger high-risk populations.	[Smith, James M.; Srinivasan, Priya] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS, Div HIV AIDS Prevent, Lab Branch,Viral Hepatitis STD & TB Prevent, Atlanta, GA USA; [Moss, John A.; Butkyavichene, Irina; Gunawardana, Manjula; Fanter, Rob; Miller, Christine S.; Sanchez, Debbie; Yang, Flora; Baum, Marc M.] Oak Crest Inst Sci, Dept Chem, Monrovia, CA 91016 USA; [Ellis, Shanon; Zhang, Jining] Libra Management Grp, Decatur, GA USA; [Marzinke, Mark A.; Hendrix, Craig W.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Marzinke, Mark A.] Johns Hopkins Univ, Dept Pathol, Sheikh Zayed Tower, Baltimore, MD USA; [Kapoor, Amita] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Capitol Court, Madison, WI USA	Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins University; University of Wisconsin System; University of Wisconsin Madison	Baum, MM (corresponding author), Oak Crest Inst Sci, Dept Chem, Monrovia, CA 91016 USA.	m.baum@oak-crest.org	Hendrix, Craig W/G-4182-2014	Hendrix, Craig W/0000-0002-5696-8665; Moss, John/0000-0001-8091-3245; Baum, Marc/0000-0003-1558-5649	Oak Crest Institute of Science; Centers for Disease Control and Prevention; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [U19AI113048]; National Institute of Allergy and Infectious Diseases of the National Institutes of Health	Oak Crest Institute of Science; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part through institutional funds at the Oak Crest Institute of Science and the Centers for Disease Control and Prevention. Additional support was provided by the National Institute of Allergy and Infectious Diseases (www.niaid.nih.gov) of the National Institutes of Health under Award Number U19AI113048. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Libra Management Group, a commercial company, is the employer of several authors of this manuscript (SE and JZ). The funder provided support in the form of salaries for authors (SE and JZ), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.; Research reported in this publication was supported in part by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amico KR, 2016, AIDS BEHAV, DOI http://dx.doi.org/10.1007/s10461-016-1458-y; Andrei G, 2011, CELL HOST MICROBE, V10, P379, DOI 10.1016/j.chom.2011.08.015; Babusis D, 2013, MOL PHARMACEUT, V10, P459, DOI 10.1021/mp3002045; Baeten J, 2015, 2015 C RETR OPP INF; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten J.M., 2016, N ENGL J MED; Balimane PV, 1998, BIOCHEM BIOPH RES CO, V250, P246, DOI 10.1006/bbrc.1998.9298; Bam RA, 2014, ANTIVIR THER, V19, P669, DOI 10.3851/IMP2767; Baum MM, 2015, INT J PHARMACEUT, V495, P579, DOI 10.1016/j.ijpharm.2015.09.028; Baum MM, 2012, J PHARM SCI-US, V101, P2833, DOI 10.1002/jps.23208; Birkus G, 2008, MOL PHARMACOL, V74, P92, DOI 10.1124/mol.108.045526; Birx DL, 2014, DELIVERING AIDS FREE; Boonstra H, 2014, BJOG-INT J OBSTET GY, V121, P23, DOI 10.1111/1471-0528.12851; Boyd P, 2016, INT J PHARMACEUT, V511, P619, DOI 10.1016/j.ijpharm.2016.07.051; Brache V, 2010, CONTRACEPTION, V82, P418, DOI 10.1016/j.contraception.2010.04.012; Brady M, 2013, ANTIVIR RES, V100, pS25, DOI 10.1016/j.antiviral.2013.09.019; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Clark JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088509; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; De Clercq E, 2016, BIOCHEM PHARMACOL, V119, P1, DOI 10.1016/j.bcp.2016.04.015; Dobard C, 2012, J VIROL, V86, P718, DOI 10.1128/JVI.05842-11; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Freeman EE, 2007, SEX TRANSM INFECT, V83, pI17, DOI 10.1136/sti.2006.023549; Friend DR, 2016, EXPERT OPIN DRUG DEL, V13, P533, DOI 10.1517/17425247.2016.1134485; Friend DR, 2012, EXPERT OPIN DRUG DEL, V9, P417, DOI 10.1517/17425247.2012.668183; Friend DR, 2010, ANTIVIR RES, V88, pS47, DOI 10.1016/j.antiviral.2010.09.005; FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333; Ganapathy ME, 1998, BIOCHEM BIOPH RES CO, V246, P470, DOI 10.1006/bbrc.1998.8628; Gibson AK, 2016, ANN PHARMACOTHER, V50, P942, DOI 10.1177/1060028016660812; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gunawardana M, 2015, ANTIMICROB AGENTS CH; Gunawardana M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077340; Hendrix CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055013; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Keller MJ, 2012, J ANTIMICROB CHEMOTH, V67, P2005, DOI 10.1093/jac/dks151; KRUSE W, 1991, EUR J CLIN PHARMACOL, V41, P589, DOI 10.1007/BF00314990; Kutilek Victoria D., 2003, Current Drug Targets - Infectious Disorders, V3, P295, DOI 10.2174/1568005033481079; Lee WA, 2005, ANTIMICROB AGENTS CH, V49, P1898, DOI 10.1128/AAC.49.5.1898-1906.2005; Liu D., 2014, Patent US, Patent No. [8,754,065, 8754065]; Louissaint NA, 2013, AIDS RES HUM RETROV, V29, P1443, DOI [10.1089/aid.2013.0044, 10.1089/AID.2013.0044]; Casado JL, 2016, AIDS REV, V18, P59; Madden T, 2007, CLIN OBSTET GYNECOL, V50, P878, DOI 10.1097/GRF.0b013e318159c07e; Marcus JL, 2016, JAIDS-J ACQ IMM DEF, V71, P413, DOI 10.1097/QAI.0000000000000881; Margot NA, 2016, ANTIVIR RES, V132, P50, DOI 10.1016/j.antiviral.2016.05.012; Mbopi-Keou FX, 2000, J INFECT DIS, V182, P1090, DOI 10.1086/315836; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; McGowan I, 2015, FUTURE VIROL, V10, P1163, DOI 10.2217/fvl.15.83; Mesquita PMM, 2012, J ANTIMICROB CHEMOTH, V67, P1730, DOI 10.1093/jac/dks097; MILLER WH, 1980, J BIOL CHEM, V255, P7204; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Molina J-M, 2016, 2016 C RETR OPP INF; MORSE GD, 1993, CLIN PHARMACOKINET, V24, P101, DOI 10.2165/00003088-199324020-00002; Moss JA, 2016, ANTIMICROB AGENTS CH, V60, P3759, DOI 10.1128/AAC.00391-16; Moss JA, 2015, DRUG DELIVERY AND DEVELOPMENT OF ANTI-HIV MICROBICIDES, P221; Moss JA, 2014, ANTIMICROB AGENTS CH, V58, P5125, DOI 10.1128/AAC.02871-14; Moss JA, 2013, ANTIMICROB AGENTS CH, V57, P3994, DOI 10.1128/AAC.00547-13; Moss JA, 2012, ANTIMICROB AGENTS CH, V56, P5952, DOI 10.1128/AAC.01198-12; Moss JA, 2012, AIDS, V26, P707, DOI 10.1097/QAD.0b013e3283509abb; Moss JA, 2012, ANTIMICROB AGENTS CH, V56, P875, DOI 10.1128/AAC.05662-11; Nel A, 2016, NEW ENGL J MED, V375, P2133, DOI 10.1056/NEJMoa1602046; Nixon B, 2014, ANTIMICROB AGENTS CH, V58, P1153, DOI 10.1128/AAC.01818-13; Oddsson K, 2005, CONTRACEPTION, V71, P176, DOI 10.1016/j.contraception.2004.09.001; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Perry CM, 1996, DRUGS, V52, P754, DOI 10.2165/00003495-199652050-00009; Polis CB, 2016, AIDS, V30, P2665, DOI 10.1097/QAD.0000000000001228; Polis CB, 2016, AIDS, V30, P2571, DOI 10.1097/QAD.0000000000001229; Promadej-Lanier N, 2009, J MED PRIMATOL, V38, P263, DOI 10.1111/j.1600-0684.2009.00354.x; Quaife M, 2017, LANCET INFECT DIS, V17, P21, DOI 10.1016/S1473-3099(16)30550-3; Ray AS, 2016, ANTIVIR RES, V125, P63, DOI 10.1016/j.antiviral.2015.11.009; Renzi C, 2003, J INFECT DIS, V187, P19, DOI 10.1086/345867; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; Rollenhagen C, 2014, MUCOSAL IMMUNOL, V7, P1165, DOI 10.1038/mi.2014.3; Roumen F, 2002, EUR J CONTRACEP REPR, V7, P19; ROWE PJ, 1990, CONTRACEPTION, V41, P105, DOI 10.1016/0010-7824(90)90141-H; Sahota J, 1999, ADV CONTRACEPT, V15, P313, DOI 10.1023/A:1006748626008; Seidman D, 2016, SEMIN REPROD MED, V34, P159, DOI 10.1055/s-0036-1571436; Sershen S, 2002, ADV DRUG DELIVER REV, V54, P1225, DOI 10.1016/S0169-409X(02)00090-X; Smith JM, 2013, P NATL ACAD SCI USA, V110, P16145, DOI 10.1073/pnas.1311355110; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Srinivasan P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157061; Terris-Prestholt F, 2016, HEALTH ECON, V25, P116, DOI 10.1002/hec.3297; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Thurman Andrea Ries, 2011, Infect Dis Obstet Gynecol, V2011, P1, DOI 10.1155/2011/429403; Ugaonkar SR, 2015, J CONTROL RELEASE, V213, P57, DOI 10.1016/j.jconrel.2015.06.018; UNAIDS, 2016, PREV GAP REP; Ursell LK, 2014, ANTIVIR RES, V102, P87, DOI 10.1016/j.antiviral.2013.12.004; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; VANDYKE RB, 1982, AM J MED, V73, P172, DOI 10.1016/0002-9343(82)90085-7; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; WELLER S, 1993, CLIN PHARMACOL THER, V54, P595, DOI 10.1038/clpt.1993.196; Woodsong C, 2015, ADV DRUG DELIVER REV, V92, P146, DOI 10.1016/j.addr.2015.02.004; Yeaw J, 2009, J MANAGE CARE PHARM, V15, P728, DOI 10.18553/jmcp.2009.15.9.728	93	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185946	10.1371/journal.pone.0185946	http://dx.doi.org/10.1371/journal.pone.0185946			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982161	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300095
J	Issler, MVC; Mombach, JCM				Issler, Maria Vitoria C.; Mombach, Jose Carlos M.			MicroRNA-16 feedback loop with p53 and Wip1 can regulate cell fate determination between apoptosis and senescence in DNA damage response	PLOS ONE			English	Article							PHOSPHATASE; MIR-16; MECHANISM; ARREST; MDM2	Cell fate regulation is an open problem whose comprehension impacts several areas of the biosciences. DNA damage induces cell cycle checkpoints that activate the p53 pathway to regulate cell fate mechanisms such as apoptosis or senescence. Experiments with different cell types show that the p53 pathway regulates cell fate through a switch behavior in its dynamics. For low DNA damage the pathway presents an oscillatory pattern associated with intense DNA damage repair while for high damage there are no oscillations and either p53 concentration increases inducing apoptosis or the cell enters a senescence state. Apoptosis and senescence phenotypes seem to have compensatory functions in tissues and the microRNA 16-1 (miR-16) is involved in the regulation of the fate between both phenotypes in cancer cells. To investigate the regulation of cell fate we developed a logical model of the G1/S checkpoint in DNA damage response that takes into account different levels of damage and contemplates the influence of miR-16 through its positive feedback loop formed with p53 and Wip1. The model reproduces the observed cellular phenotypes in experiments: oscillatory (for low DNA damage) regulated by negative feedback loops involving mainly p53 and Mdm2 and apoptotic or senescent (for high DNA damage) regulated by the positive p53/Wip1/miR-16 feedback loop. We find good agreement between the level of DNA damage and the probability of the phenotype produced according to experiments. We also find that this positive feedback makes senescent and apoptotic phenotypes to be determined stochastically (bistable), however controlling the expression level of miR-16 allows the control of fate determination as observed experimentally.	[Issler, Maria Vitoria C.; Mombach, Jose Carlos M.] Univ Fed Santa Maria, Dept Phys, Santa Maria, RS, Brazil	Universidade Federal de Santa Maria (UFSM)	Mombach, JCM (corresponding author), Univ Fed Santa Maria, Dept Phys, Santa Maria, RS, Brazil.	jcmombach@ufsm.br	Mombach, Jose C. M./L-1484-2013	Mombach, Jose C. M./0000-0002-6602-3905				Abou-Jaoude W, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00094; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chen X, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-73; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; de Oliveira LR, 2015, MOL BIOSYST, V11, P2955, DOI 10.1039/c5mb00230c; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Flobak A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004426; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Gobbini E, 2013, DNA REPAIR, V12, P791, DOI 10.1016/j.dnarep.2013.07.009; Grieco L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003286; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Kitadate A, 2016, ONCOGENE, V35, P3692, DOI 10.1038/onc.2015.435; Kracikova M, 2013, CELL DEATH DIFFER, V20, P576, DOI 10.1038/cdd.2012.155; Le Novere N, 2015, NAT REV GENET, V16, P146, DOI 10.1038/nrg3885; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Lu X, 2007, CANCER CELL, V12, P1535; Medema RH, 2012, ONCOGENE, V31, P2601, DOI 10.1038/onc.2011.451; Mendes ND, 2014, QUANTIFICATION REACH; Mobarra N, 2012, IN VITRO CELL DEV, V51; Mombach JCM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125217; Mombach JCM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S7-S7; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Olivieri F, 2013, AGEING RES REV, V12, P1056, DOI 10.1016/j.arr.2013.05.001; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Sun T, 2005, FEBS LETT, V588, P815; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Thieffry D, 2007, BRIEF BIOINFORM, V8, P220, DOI 10.1093/bib/bbm028; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Yan F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043908; Zhang XN, 2010, CANCER RES, V70, P7176, DOI 10.1158/0008-5472.CAN-10-0697; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200	36	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185794	10.1371/journal.pone.0185794	http://dx.doi.org/10.1371/journal.pone.0185794			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968438	Green Submitted, gold, Green Published			2022-12-26	WOS:000412029600050
J	Lin, GL; Ting, HJ; Tseng, TC; Juang, V; Lo, YL				Lin, Guan-Liang; Ting, Huei-Ju; Tseng, Ta-Chien; Juang, Vivian; Lo, Yu-Li			Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells	PLOS ONE			English	Article							CYCLIN D1; C-MYC; ANTIMICROBIAL PEPTIDE; BETA-CATENIN; HELA-CELLS; ANTIGEN R; IN-VITRO; EXPRESSION; APOPTOSIS; GROWTH	HuR (ELAVL1), a RNA-binding protein, plays a key role in posttranscriptional regulation of multidrug resistance (MDR)-related genes. Among various HuR-regulated oncogenic transcripts, the activation of galectin-3/beta-catenin survival pathway is critical to induce transcription of cyclin D1, P-glycoprotein (P-gp) and/or multidrug resistance-associated proteins (MRPs). In this study, we aim to elucidate the HuR-regulating pathways related to epirubi-cin-mediated resistance in human colorectal carcinoma cells. The effects and mechanisms of epirubicin treatment on the expressions of upstream survival signals (e.g., beta-catenin) and downstream MDR transporters (e.g., P-gp) and anti-apoptotic pathways (e.g., Bcl-2) were assessed with or without HuR knockdown (siHuR) or overexpression (overHuR; ectopic HuR or pcDNA3/HA-HuR). Our results showed that siHuR decreased transcriptional expressions of galectin-3, beta-catenin, cyclin D1, Bcl-2, P-gp, MRP1, and MRP2 in epirubicintreated colon cancer cells. Consistently, the co-treatment of epirubicin and siHuR diminished the expressions of galectin-3, beta-catenin, c-Myc, P-gp and MRP1. HuR silencing enhanced the intracellular accumulation of epirubicin in colon cancer cells. On the other hand, overHuR abolished such effects. Furthermore, siHuR significantly intensified epirubicin-mediated apoptosis via increasing reactive oxygen species and thus promoted the cytotoxic effect of epirubicin. The combined treatments of siHuR and epirubicin significantly reduced the expression of Bcl-2, but increased the expression of Bax, as well as activity and expression levels of caspase-3 and -9. In contrast, overHuR abrogated these effects. Our findings provide insight into the mechanisms by which siHuR potentiated epirubicin-induced cytotoxicity via inhibiting galectin-3/beta-catenin signaling, suppressing MDR transporters and provoking apoptosis. To our best knowledge, this is an innovative investigation linking the post-transcriptional control by HuR silencing to survival signaling repression, efflux transporter reversal and apoptosis induction. Our study thus provides a powerful regimen for circumventing MDR in colon cancer cells.	[Lin, Guan-Liang; Ting, Huei-Ju] Natl Univ Tainan, Dept Biol Sci & Technol, Tainan, Taiwan; [Tseng, Ta-Chien] Natl Cheng Kung Univ, Inst Bioinformat & Biosignaling Transduct, Tainan, Taiwan; [Juang, Vivian; Lo, Yu-Li] Natl Yang Ming Univ, Dept & Inst Pharmacol, Taipei, Taiwan	National University Tainan; National Cheng Kung University; National Yang Ming Chiao Tung University	Lo, YL (corresponding author), Natl Yang Ming Univ, Dept & Inst Pharmacol, Taipei, Taiwan.	yuilio@ym.edu.tw	Tseng, Joseph Ta-Chien/I-2850-2018	Tseng, Joseph Ta-Chien/0000-0002-3304-6086; Ting, Huei-Ju/0000-0003-3709-5755; Juang, Vivian/0000-0002-3389-1829; Lo, Yu-Li/0000-0002-6548-3280	Ministry of Science and Technology of Taiwan [MOST 104-2320-B-010-004-MY2, MOST 106-2320-B-010-005]; Veterans General Hospitals; University System of Taiwan [VGHUST106-G7-7-3]; Ministry of Education; National Yang-Ming University [103AC-D112]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Veterans General Hospitals; University System of Taiwan; Ministry of Education; National Yang-Ming University	This project was financially supported by grants from Ministry of Science and Technology of Taiwan (MOST 104-2320-B-010-004-MY2; MOST 106-2320-B-010-005), Veterans General Hospitals and University System of Taiwan (VGHUST106-G7-7-3), the Ministry of Education (Aiming for the Top University Plan), and National Yang-Ming University (103AC-D112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was financially supported by grants from Ministry of Science and Technology of Taiwan (MOST 104-2320-B-010-004-MY2; MOST 106-2320-B-010-005), Veterans General Hospitals and University System of Taiwan (VGHUST106-G7-7-3), Ministry of Education of Taiwan (Aiming for the Top University Plan), and National Yang-Ming University (103AC-D112).	Aguado A, 2016, J HYPERTENS, V34, P253, DOI 10.1097/HJH.0000000000000801; Bai DN, 2015, BIOCHEM BIOPH RES CO, V463, P1273, DOI 10.1016/j.bbrc.2015.06.101; Biliran H, 2007, CLIN CANCER RES, V13, P2811, DOI 10.1158/1078-0432.CCR-06-1844; Briata P, 2003, MOL CELL, V12, P1201, DOI 10.1016/S1097-2765(03)00407-6; Cao CH, 2015, GASTROENTEROLOGY, V148, P415, DOI 10.1053/j.gastro.2014.10.012; Correa S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-303; de Silanes IL, 2003, ONCOGENE, V22, P7146, DOI 10.1038/sj.onc.1206862; Dharmapuri G, 2015, LEUKEMIA RES, V39, P696, DOI 10.1016/j.leukres.2015.02.013; Do SI, 2008, TUMORI, V94, P347; Filippova N, 2011, MOL CANCER RES, V9, P648, DOI 10.1158/1541-7786.MCR-10-0325; Hong SH, 2012, ONCOL REP, V27, P114, DOI 10.3892/or.2011.1451; Hostetter C, 2008, CANCER BIOL THER, V7, P1498, DOI 10.4161/cbt.7.9.6490; Huang YH, 2016, CANCER RES, V76, P1549, DOI 10.1158/0008-5472.CAN-15-2073; Hung TH, 2014, ONCOTARGET, V5, P12273, DOI 10.18632/oncotarget.2631; Juang V, 2016, INT J NANOMED, V11, P6047, DOI 10.2147/IJN.S117618; Kim I, 2012, NUCLEIC ACIDS RES, V40, P6863, DOI 10.1093/nar/gks331; Lage H, 2008, CELL MOL LIFE SCI, V65, P3145, DOI 10.1007/s00018-008-8111-5; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082478; Lo YL, 2015, CHEM-BIOL INTERACT, V242, P13, DOI 10.1016/j.cbi.2015.08.023; Lo YL, 2015, INT J MOL SCI, V16, P22711, DOI 10.3390/ijms160922711; Lo YL, 2013, CHEM-BIOL INTERACT, V205, P188, DOI 10.1016/j.cbi.2013.07.003; Lo YL, 2012, TOXICOLOGY, V302, P221, DOI 10.1016/j.tox.2012.08.003; Marbeuf-Gueye C, 2000, EUR J PHARMACOL, V391, P207, DOI 10.1016/S0014-2999(00)00047-9; Perrone EE, 2012, J SURG RES, V178, P155, DOI 10.1016/j.jss.2012.02.029; PLOSKER GL, 1993, DRUGS, V45, P788, DOI 10.2165/00003495-199345050-00011; Prislei S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-72; Raspaglio G, 2010, CANCER RES, V70, P5891, DOI 10.1158/0008-5472.CAN-09-4656; Romeo C, 2016, MOL CANCER RES, V14, P599, DOI 10.1158/1541-7786.MCR-15-0448; Serini S, 2011, J NUTR BIOCHEM, V22, P874, DOI 10.1016/j.jnutbio.2010.08.004; Song SM, 2009, CANCER RES, V69, P1343, DOI 10.1158/0008-5472.CAN-08-4153; Talwar S, 2011, J BIOL CHEM, V286, P32333, DOI 10.1074/jbc.M111.255927; Vanella L, 2013, ONCOL REP, V30, P2804, DOI 10.3892/or.2013.2757; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang J, 2013, INT J MOL SCI, V14, P10015, DOI 10.3390/ijms140510015; Yu C, 2014, MOL BIOL REP, V41, P1141, DOI 10.1007/s11033-013-2960-1; Yuan Z, 2011, ONCOL REP, V26, P237, DOI 10.3892/or.2011.1271; Zhang JJ, 2012, TOXICOL APPL PHARM, V263, P218, DOI 10.1016/j.taap.2012.06.012; Zhu XC, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0588-9; Zhu ZP, 2013, TUMOR BIOL, V34, P2299, DOI 10.1007/s13277-013-0774-3; Ziegeler G, 2010, J BIOL CHEM, V285, P15408, DOI 10.1074/jbc.M110.113365	40	26	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185625	10.1371/journal.pone.0185625	http://dx.doi.org/10.1371/journal.pone.0185625			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968471	gold, Green Published, Green Submitted			2022-12-26	WOS:000412029600031
J	Gharouni, A; Barbeau, MA; Chasse, J; Wang, L; Watmough, J				Gharouni, Ali; Barbeau, Myriam A.; Chasse, Joel; Wang, Lin; Watmough, James			Stochastic dispersal increases the rate of upstream spread: A case study with green crabs on the northwest Atlantic coast	PLOS ONE			English	Article							LARVAL DISPERSAL; ST-LAWRENCE; POPULATION PERSISTENCE; SENSITIVITY-ANALYSIS; BIOLOGICAL INVASION; VERTICAL MIGRATION; CARCINUS-MAENAS; CLIMATE-CHANGE; MARINE; GULF	Dispersal heterogeneity is an important process that can compensate for downstream advection, enabling aquatic organisms to persist or spread upstream. Our main focus was the effect of year-to-year variation in larval dispersal on invasion spread rate. We used the green crab, Carcinus maenas, as a case study. This species was first introduced over 200 years ago to the east coast of North America, and once established has maintained a relatively consistent spread rate against the dominant current. We used a stage-structured, integro- difference equation model that couples a demographic matrix for population growth and dispersal kernels for spread of individuals within a season. The kernel describing larval dispersal, the main dispersive stage, was mechanistically modeled to include both drift and settlement rate components. It was parameterized using a 3-dimensional hydrodynamic model of the Gulf of St Lawrence, which enabled us to incorporate larval behavior, namely vertical swimming. Dispersal heterogeneity was modeled at two temporal scales: within the larval period (months) and over the adult lifespan (years). The kernel models variation within the larval period. To model the variation among years, we allowed the kernel parameters to vary by year. Results indicated that when dispersal parameters vary with time, knowledge of the time-averaged dispersal process is insufficient for determining the upstream spread rate of the population. Rather upstream spread is possible over a number of years when incorporating the yearly variation, even when there are only a few "good years" featured by some upstream dispersal among many "bad years" featured by only downstream dispersal. Accounting for annual variations in dispersal in population models is important to enhance understanding of spatial dynamics and population spread rates. Our developed model also provides a good platform to link the modeling of larval behavior and demography to large-scale hydrodynamic models.	[Gharouni, Ali; Wang, Lin; Watmough, James] Univ New Brunswick, Dept Math & Stat, Fredericton, NB, Canada; [Barbeau, Myriam A.] Univ New Brunswick, Dept Biol, Fredericton, NB, Canada; [Chasse, Joel] Fisheries & Oceans Canada, Gulf Fisheries Ctr, Moncton, NB, Canada	University of New Brunswick; University of New Brunswick; Fisheries & Oceans Canada	Gharouni, A (corresponding author), Univ New Brunswick, Dept Math & Stat, Fredericton, NB, Canada.	a.gharouni@unb.ca	Wang, Lin/ABF-1622-2020	Watmough, James/0000-0002-0126-0504; Gharouni, Ali/0000-0003-4427-7688	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 238365-2012, RGPIN-2015-05686]; Atlantic Ecosystem Initiative from Environment and Climate Change Canada [GCXE17P009]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Atlantic Ecosystem Initiative from Environment and Climate Change Canada	The research was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC Discovery Grants to JW and LW; RGPIN 238365-2012, RGPIN-2015-05686), and an Atlantic Ecosystem Initiative grant from Environment and Climate Change Canada (Project Number: GCXE17P009). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, MATL VER R2012 7 14; ARONSON DG, 1978, ADV MATH, V30, P33, DOI 10.1016/0001-8708(78)90130-5; BERRILL M, 1982, Journal of Crustacean Biology, V2, P31, DOI 10.2307/1548108; Blakeslee AMH, 2010, DIVERS DISTRIB, V16, P879, DOI 10.1111/j.1472-4642.2010.00703.x; BONARDELLI JC, 1993, ATMOS OCEAN, V31, P541, DOI 10.1080/07055900.1993.9649485; Brickman D, 2014, MAR POLLUT BULL, V85, P235, DOI 10.1016/j.marpolbul.2014.05.034; Brickman D., 2012, CANADIAN TECHNICAL R, V278; Byers JE, 2006, MAR ECOL PROG SER, V313, P27, DOI 10.3354/meps313027; Caswell H, 2003, ECOLOGY, V84, P1968, DOI 10.1890/02-0100; Caswell H, 2011, THEOR ECOL-NETH, V4, P407, DOI 10.1007/s12080-010-0091-z; Chasse J, 2010, FISH OCEANOGR, V19, P319, DOI 10.1111/j.1365-2419.2010.00548.x; Chiswell SM, 2012, AQUAT BIOL, V16, P203, DOI 10.3354/ab00466; CONNELL JH, 1961, ECOL MONOGR, V31, P61, DOI 10.2307/1950746; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Daigle RM, 2016, PROG OCEANOGR, V144, P93, DOI 10.1016/j.pocean.2016.04.001; Ellner SP, 2012, THEOR POPUL BIOL, V82, P283, DOI 10.1016/j.tpb.2012.03.005; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; Gharouni A, 2015, MAR ECOL PROG SER, V541, P135, DOI 10.3354/meps11508; Grosholz ED, 2005, P NATL ACAD SCI USA, V102, P1088, DOI 10.1073/pnas.0308547102; Grosholz ED, 1996, BIOL CONSERV, V78, P59, DOI 10.1016/0006-3207(94)00018-2; Han GQ, 1999, J PHYS OCEANOGR, V29, P1279, DOI 10.1175/1520-0485(1999)029<1279:SMHACI>2.0.CO;2; Hardy, 1935, DISCOVERY REP, V11, P273; HAWKINS SJ, 1982, J EXP MAR BIOL ECOL, V62, P271, DOI 10.1016/0022-0981(82)90207-6; HOBBS RC, 1992, MAR BIOL, V112, P417, DOI 10.1007/BF00356287; Hrycik JM, 2013, ESTUAR COAST SHELF S, V133, P11, DOI 10.1016/j.ecss.2013.06.023; Jongejans E, 2011, ECOLOGY, V92, P86, DOI 10.1890/09-2226.1; Klassen G., 2007, CANADIAN REPOR UNPUB, V2818, P75, DOI DOI 10.1007/BF00348935; Largier JL, 2003, ECOL APPL, V13, pS71; LAUZIER LM, 1965, J FISH RES BOARD CAN, V22, P353, DOI 10.1139/f65-035; Lavoie D, 2016, ATMOS OCEAN, V54, P299, DOI 10.1080/07055900.2015.1082965; Long ZX, 2016, ATMOS OCEAN, V54, P337, DOI 10.1080/07055900.2015.1029869; Lutscher F, 2005, SIAM REV, V47, P749, DOI 10.1137/050636152; Madec G, 2012, NEMO OCEAN ENGINE; Maps F, 2015, LIMNOL OCEANOGR, V60, P1965, DOI 10.1002/lno.10145; Maps F, 2014, ICES J MAR SCI, V71, P282, DOI 10.1093/icesjms/fst021; Marculis NG, 2016, J BIOL DYNAM, V10, P140, DOI 10.1080/17513758.2015.1115563; MULLER K, 1982, OECOLOGIA, V52, P202, DOI 10.1007/BF00363837; Munday PL, 2009, CORAL REEFS, V28, P379, DOI 10.1007/s00338-008-0461-9; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; OKUBO A, 2001, DIFFUSION ECOLOGICAL; Ouellet P, 2013, CAN J FISH AQUAT SCI, V70, P1508, DOI 10.1139/cjfas-2013-0227; Pachepsky E, 2005, THEOR POPUL BIOL, V67, P61, DOI 10.1016/j.tpb.2004.09.001; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Pineda J, 2000, OCEANOGR E PAC, V1, P84; Pringle JM, 2009, MAR ECOL PROG SER, V377, P13, DOI 10.3354/meps07836; Pringle JM, 2011, P NATL ACAD SCI USA, V108, P15288, DOI 10.1073/pnas.1100473108; Queiroga H, 1997, MAR ECOL PROG SER, V149, P121, DOI 10.3354/meps149121; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Ruiz GM, 1997, AM ZOOL, V37, P621; Saucier FJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000686; Schreiber SJ, 2011, THEOR ECOL-NETH, V4, P423, DOI 10.1007/s12080-010-0098-5; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Snyder RE, 2014, AM NAT, V184, P523, DOI 10.1086/677925; Speirs DC, 2001, ECOLOGY, V82, P1219, DOI 10.2307/2679984; Stover JP, 2014, B MATH BIOL, V76, P2681, DOI 10.1007/s11538-014-0014-z; Therriault T.W., 2008, 2008042 CAN SCI ADV; Tuljapurkar S.D., 1990, POPULATION DYNAMICS; Watson JR, 2012, AM NAT, V180, P99, DOI 10.1086/665992; Williams PD, 2013, AM NAT, V182, P271, DOI 10.1086/671059; Yamamura K, 2002, POPUL ECOL, V44, P93, DOI 10.1007/s101440200011	61	6	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185671	10.1371/journal.pone.0185671	http://dx.doi.org/10.1371/journal.pone.0185671			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961269	gold, Green Published, Green Submitted			2022-12-26	WOS:000412027700032
J	Chen, L; Hatti-Kaul, R				Chen, Lu; Hatti-Kaul, Rajni			Exploring Lactobacillus reuteri DSM20016 as a biocatalyst for transformation of longer chain 1,2-diols: Limits with microcompartment	PLOS ONE			English	Article							B-12-DEPENDENT 1,2-PROPANEDIOL DEGRADATION; DEPENDENT DIOL DEHYDRATASE; SEROVAR TYPHIMURIUM LT2; KLEBSIELLA-PNEUMONIAE; 3-HYDROXYPROPIONIC ACID; GLYCEROL DEHYDRATASE; MICROBIAL-PRODUCTION; BACTERIAL MICROCOMPARTMENTS; CLOSTRIDIUM-BUTYRICUM; RESTING CELLS	Lactobacillus reuteri metabolises glycerol efficiently to form 3-hydroxypropionic acid (3-HP) and 1,3-propanediol (1,3PDO) by the same mechanism as that for 1,2-propanediol (1,2PDO) conversion to propionic acid and propanol via its propanediol utilization (pdu) pathway. Pdu enzymes are encoded by the pdu-operon, which also contain genes encoding the shell proteins of the microcompartment housing the metabolic pathway. In this work the selectivity and kinetics of the reactions catalysed by L. reuteri DSM20016 Pdu enzymes glycerol dehydratase (GDH), 1,3-propanediol oxidoreductase (PduQ) and coenzyme-A acylating propionaldehyde dehydrogenase (PduP), produced recombinantly, was investigated against corresponding substrates of different chain lengths. Glycerol dehydratase exhibited activity against C2-C4 polyols, with the highest activity against glycerol and 1,2-propanediol (1,2PDO). A double mutant of the pduC gene of GDH (PduC-S302A/Q337A) was constructed that displayed lowered activity against glycerol and 1,2PDO but extended the substrate range upto C6-diol. The best substrate for both PduQ and PduP was 3-hydroxypropanal (3HPA), although PduP exhibited nearly 10-fold higher specific activity. The enzymes also showed some activity against C3-C10 aliphatic aldehydes, with PduP having higher relative activity. Subsequently, transformation of polyols using whole cells of L. reuteri containing the wild type-and mutated GDH, respectively, confirmed the reduced activity of the mutant against glycerol and 1,2PDO, but its activity against longer substrates was negligible. In contrast, recombinant Escherichia coli BL21(DE3) cells harboring the GDH variant converted diols with up to C6 carbon chain length to their respective aldehydes, suggesting that the protein shell of the microcompartment in L. reuteri posed a barrier to the passage of longer chain substrate.	[Chen, Lu; Hatti-Kaul, Rajni] Lund Univ, Ctr Chem & Chem Engn, Div Biotechnol, Lund, Sweden	Lund University	Chen, L (corresponding author), Lund Univ, Ctr Chem & Chem Engn, Div Biotechnol, Lund, Sweden.	lu.chen@blotek.lu.se		CHEN, LU/0000-0001-8867-5851	Erasmus Mundus Action 2 programme	Erasmus Mundus Action 2 programme	This work was supported by the Erasmus Mundus Action 2 programme Lu Chen. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Erasmus Mundus Action 2 programme is acknowledged for financial support to Lu Chen.	Banat IM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00697; BIEBL H, 1991, APPL MICROBIOL BIOT, V35, P701; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Bobik TA, 1997, J BACTERIOL, V179, P6633, DOI 10.1128/jb.179.21.6633-6639.1997; Chen Hanmin, 2010, CEM ENG, V1, P3; Chen L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168107; Chen Z, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0625-8; Cheng SQ, 2011, J BACTERIOL, V193, P1385, DOI 10.1128/JB.01473-10; Chowdhury C, 2015, P NATL ACAD SCI USA, V112, P2990, DOI 10.1073/pnas.1423672112; Chowdhury C, 2014, MICROBIOL MOL BIOL R, V78, P438, DOI 10.1128/MMBR.00009-14; CIRCLE SJ, 1945, IND ENG CHEM, V17, P259, DOI 10.1021/i560140a021; Crowley CS, 2010, J BIOL CHEM, V285, P37838, DOI 10.1074/jbc.M110.160580; da Silva GP, 2009, BIOTECHNOL ADV, V27, P30, DOI 10.1016/j.biotechadv.2008.07.006; Dishisha T, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0388-0; Dishisha T, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-76; Doitomi K, 2014, B CHEM SOC JPN, V87, P950, DOI 10.1246/bcsj.20140115; Drozdzynska A, 2014, NEW BIOTECHNOL, V31, P402, DOI 10.1016/j.nbt.2014.04.002; Frank MS, PHARMACOTHERAPY, V1, P147; Gopi GR, 2015, FOOD TECHNOL BIOTECH, V53, P331; Kerfeld CA, 2015, TRENDS MICROBIOL, V23, P22, DOI 10.1016/j.tim.2014.10.003; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Kinney JN, 2011, PHOTOSYNTH RES, V109, P21, DOI 10.1007/s11120-011-9624-6; Leal NA, 2003, ARCH MICROBIOL, V180, P353, DOI 10.1007/s00203-003-0601-0; Li Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep26932; Maervoet VET, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0421-y; Makkar RS, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-5; Mori K, 1999, BIOCHEMISTRY-US, V38, P13170, DOI 10.1021/bi9911738; Morita H, 2008, DNA RES, V15, P151, DOI 10.1093/dnares/dsn009; O'Brien JR, 2004, BIOCHEMISTRY-US, V43, P4635, DOI 10.1021/bi035930k; Pang A, 2012, ACTA CRYSTALLOGR D, V68, P1642, DOI 10.1107/S0907444912039315; Przystalowska H, 2015, ACTA BIOCHIM POL, V62, P23, DOI 10.18388/abp.2014_885; Qi XH, 2006, CHINESE SCI BULL, V51, P2977, DOI 10.1007/s11434-006-2219-5; Ramakrishnan GG, 2015, CURR MICROBIOL, V71, P517, DOI 10.1007/s00284-015-0878-7; REID MF, 1994, CRIT REV MICROBIOL, V20, P13, DOI 10.3109/10408419409113545; Ricci MA, 2015, J MICROBIOL BIOTECHN, V25, P893, DOI 10.4014/jmb.1411.11078; Sabet-Azad R, 2013, ENZYME MICROB TECH, V53, P235, DOI 10.1016/j.enzmictec.2013.05.007; Sardari RRR, 2013, J BIOTECHNOL, V168, P534, DOI 10.1016/j.jbiotec.2013.09.009; SCHUTZ H, 1984, SYST APPL MICROBIOL, V5, P169, DOI 10.1016/S0723-2020(84)80018-1; Shibata N, 1999, STRUCTURE, V7, P997, DOI 10.1016/S0969-2126(99)80126-9; Sinha S, 2014, J MOL BIOL, V426, P2328, DOI 10.1016/j.jmb.2014.04.012; Sriramulu DD, 2008, J BACTERIOL, V190, P4559, DOI 10.1128/JB.01535-07; SUZUKI T, 1994, J FERMENT BIOENG, V78, P194, DOI 10.1016/0922-338X(94)90265-8; TALARICO TL, 1990, APPL ENVIRON MICROB, V56, P943, DOI 10.1128/AEM.56.4.943-948.1990; TALARICO TL, 1990, APPL ENVIRON MICROB, V56, P1195, DOI 10.1128/AEM.56.4.1195-1197.1990; Tokuyama K, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-64; TORAYA T, 1977, J BIOL CHEM, V252, P963; TORAYA T, 1979, J BACTERIOL, V139, P39, DOI 10.1128/JB.139.1.39-47.1979; Toraya T, 2016, BIOCHEMISTRY-US, V55, P69, DOI 10.1021/acs.biochem.5b01023; van Pijkeren JP, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S10; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; Wang JW, 2017, J ROBOT NETW ARTIF L, V4, P1, DOI 10.15226/2374-815X/4/2/00186; Yamanishi M, 2012, FEBS J, V279, P793, DOI 10.1111/j.1742-4658.2012.08470.x; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Zeng AP, 2011, CURR OPIN BIOTECH, V22, P749, DOI 10.1016/j.copbio.2011.05.005; ZENG AP, 1993, ENZYME MICROB TECH, V15, P770, DOI 10.1016/0141-0229(93)90008-P; Zhao L, 2009, BIOPROC BIOSYST ENG, V32, P313, DOI 10.1007/s00449-008-0250-4; Zhao YN, 2006, BIOCHEM ENG J, V32, P93, DOI 10.1016/j.bej.2006.09.007	57	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185734	10.1371/journal.pone.0185734	http://dx.doi.org/10.1371/journal.pone.0185734			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957423	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200112
J	Gkika, E; Vach, W; Adebahr, S; Schimeck-Jasch, T; Brenner, A; Brunner, TB; Kaier, K; Prasse, A; Muller-Quernheim, J; Grosu, AL; Zissel, G; Nestle, U				Gkika, Eleni; Vach, Werner; Adebahr, Sonja; Schimeck-Jasch, Tanja; Brenner, Anton; Brunner, Thomas Baptist; Kaier, Klaus; Prasse, Antje; Mueller-Quernheim, Joachim; Grosu, Anca-Ligia; Zissel, Gernot; Nestle, Ursula			Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; PULMONARY-FIBROSIS; CANCER PATIENTS; BREAST-CANCER; CCL18; PNEUMONITIS; THERAPY; RADIOTHERAPY; INDICATOR; CYTOKINES	The CC chemokine ligand 18 (CCL18) is produced by alveolar macrophages in patients with fibrosing lung disease and its concentration is increased in various fibrotic lung diseases. Furthermore CCL18 is elevated in several malignancies as it is produced by tumor associated macrophages. In this study we aimed to analyze the role of CCL18 as a prognostic biomarker for the development of early radiation induced lung toxicity (RILT), i.e. radiation pneumonitis after thoracic irradiation and its significance in the course of the disease. Sixty seven patients were enrolled prospectively in the study. Patients were treated with irradiation for several thoracic malignancies (lung cancer, esophageal cancer, thymoma), either with conventionally fractionated or hypo-fractionated radiotherapy. The CCL18 serum levels were quantified with ELISA (enzyme-linked immunosorbent assay) at predefined time points: before, during and at the end of treatment as well as in the first and second follow-up. Treatment parameters and functional tests were also correlated with the development of RILT. Fifty three patients were evaluable for this study. Twenty one patients (39%) developed radiologic signs of RILT Grade > 1 but only three of them (5.6%) developed clinical symptoms (Grade 2). We could not find any association between the different CCL18 concentrations and a higher incidence of RILT. Statistical significant factors were the planning target volume (odds ratio OR: 1.003, p = 0.010), the volume of the lung receiving > 20 Gy (OR: 1.132 p = 0.004) and age (OR: 0.917, p = 0.008). There was no association between serial CCL18 concentrations with tumor response and overall survival. In our study the dosimetric parameters remained the most potent predictors of RILT. Further studies are needed in order to estimate the role of CCL18 in the development of early RILT.	[Gkika, Eleni; Adebahr, Sonja; Schimeck-Jasch, Tanja; Brenner, Anton; Brunner, Thomas Baptist; Grosu, Anca-Ligia; Nestle, Ursula] Univ Hosp Freiburg, Med Ctr, Dept Radiat Oncol, Freiburg, Germany; [Vach, Werner; Kaier, Klaus] Univ Freiburg, Med Fac, Inst Med Biometry & Stat, Freiburg, Germany; [Vach, Werner; Kaier, Klaus] Univ Freiburg, Med Ctr, Freiburg, Germany; [Adebahr, Sonja; Brunner, Thomas Baptist; Grosu, Anca-Ligia; Nestle, Ursula] German Canc Consortium DKTK, Partner Site Freiburg, Heidelberg, Germany; [Adebahr, Sonja; Brunner, Thomas Baptist; Grosu, Anca-Ligia; Nestle, Ursula] German Canc Res Ctr, Heidelberg, Germany; [Brunner, Thomas Baptist; Grosu, Anca-Ligia; Nestle, Ursula] Univ Freiburg, Fac Med, Freiburg, Germany; [Prasse, Antje] Hannover Med Sch, Dept Pneumol, Hannover, Germany; [Mueller-Quernheim, Joachim; Zissel, Gernot] Univ Med Ctr Freiburg, Dept Pneumol, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; Hannover Medical School; University of Freiburg	Gkika, E (corresponding author), Univ Hosp Freiburg, Med Ctr, Dept Radiat Oncol, Freiburg, Germany.	eleni.gkika@uniklinik-freiburg.de	Prasse, Antje/AAM-7521-2021; Vach, Werner/F-2512-2011; Prasse, Antje/AAY-6279-2020; Kaier, Klaus/B-4227-2009; Nestle, Ursula/ABG-2339-2021; Zissel, Gernot/B-1208-2010	Prasse, Antje/0000-0002-7336-7458; Vach, Werner/0000-0003-1865-8399; Kaier, Klaus/0000-0003-0837-6945; Zissel, Gernot/0000-0001-8021-9798				Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Crohns M, 2010, CYTOKINE, V50, P30, DOI 10.1016/j.cyto.2009.11.017; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fleckenstein K, 2007, SEMIN RADIAT ONCOL, V17, P89, DOI 10.1016/j.semradonc.2006.11.004; Gao J, 2015, PATHOL BIOL, V63, P199, DOI 10.1016/j.patbio.2015.07.001; Hieshima K, 1997, J IMMUNOL, V159, P1140; Hou X, 2015, TUMOUR BIOL J INT SO; Khalil AA, 2015, ACTA ONCOL, V54, P1343, DOI 10.3109/0284186X.2015.1061216; Kong FM, 2005, SEMIN ONCOL, V32, pS42, DOI 10.1053/j.seminoncol.2005.03.009; Leung SY, 2004, GASTROENTEROLOGY, V127, P457, DOI 10.1053/j.gastro.2004.05.031; Lin L C Y, 2015, ONCOTARGET; Lota HK, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/121439; Mantovani A, 2004, EUR J CANCER, V40, P1660, DOI 10.1016/j.ejca.2004.03.016; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marks LB, 2010, INT J RADIAT ONCOL, V76, pS70, DOI 10.1016/j.ijrobp.2009.06.091; Mehta V, 2005, INT J RADIAT ONCOL, V63, P5, DOI 10.1016/j.ijrobp.2005.03.047; Palma DA, 2013, INT J RADIAT ONCOL, V85, P444, DOI 10.1016/j.ijrobp.2012.04.043; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Ploenes T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053068; Plones T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041746; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Prasse A, 2007, ARTHRITIS RHEUM-US, V56, P1685, DOI 10.1002/art.22559; Prasse A, 2009, RESPIROLOGY, V14, P788, DOI 10.1111/j.1440-1843.2009.01600.x; Prassel A, 2009, AM J RESP CRIT CARE, V179, P717, DOI 10.1164/rccm.200808-1201OC; Rube CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002898; Schmid S, 2016, ANTICANCER RES, V36, P4667, DOI 10.21873/anticanres.11018; Schupp JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116775; Schutyser E, 2005, J LEUKOCYTE BIOL, V78, P14, DOI 10.1189/jlb.1204712; Schutyser E, 2002, J BIOL CHEM, V277, P24584, DOI 10.1074/jbc.M112275200; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yuan RX, 2013, J SURG RES, V183, P163, DOI 10.1016/j.jss.2013.01.017	33	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185350	10.1371/journal.pone.0185350	http://dx.doi.org/10.1371/journal.pone.0185350			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957436	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200049
J	Kim, SY; Bang, W; Choi, HG				Kim, So Young; Bang, Woojin; Choi, Hyo Geun			Analysis of the prevalence of and factors associated with overactive bladder in adult Korean women	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; QUALITY-OF-LIFE; RISK-FACTORS; STRESS-INCONTINENCE; UNITED-STATES; IMPACT; SMOKING; BURDEN	Background Overactive bladder (OAB) is one of the most prevalent lower urinary tract conditions and has been suggested to be related to various factors. We assessed the prevalence of and factors associated with OAB in women based on a large cross-sectional, population-based study of adult Korean women. Methods The Korean community health survey (KCHS) of 2012 was reviewed, and 107,950 female participants aged 19 to 107 years were identified for inclusion in this study. The overactive bladder symptom score (OABSS) was used to define and classify OAB as mild, moderate, or severe. Numerous variables, including marital status; physical activity; education and income levels; type of occupation; body mass index (BMI); smoking; alcohol; sleep time; and medical history of hypertension, diabetes mellitus, hyperlipidemia, or cerebral stroke, were evaluated. The correlation of these variables with the prevalence of OAB was analyzed using simple and multiple logistic regression analyses with complex sampling. Results The results showed that 5.2% of adult women experienced OAB. Multiple regression analyses showed a significant correlation between the following variables and OAB: older age (adjusted odds ratio [AOR] = 1.44, 95% confidence interval [CI] = 1.39-1.50, P < 0.001 as 10 years older); married status (AOR = 0.83, 95%CI = 0.70-0.96, P = 0.016); lower level of income (AOR = 1.50, 95%CI = 1.34-1.68, P < 0.001); high BMI (AOR = 1.33, 95%CI = 1.23-1.44, P < 0.001); smoking (AOR = 1.24, 95%CI = 1.04-1.47, P < 0.001); long sleep time (AOR = 1.95, 95%CI = 1.69-2.26); and medical history of hypertension (AOR = 1.11, 95%CI = 1.03-1.21, P = 0.011), diabetes mellitus (AOR = 1.38, 95%CI = 1.25-1.53, P < 0.001), hyperlipidemia (AOR = 1.27, 95%CI = 1.16-1.39, P < 0.001), and cerebral stroke (AOR = 2.04, 95%CI = 1.73-2.41, P < 0.001). The level of stress showed a dose-dependent association with OAB (AOR [95%CI] = 3.28 [2.81-3.83] > 2.11 [1.91-2.33] >1.28 [1.16-1.41] for severe > moderate > some stress, respectively, P < 0.001). Conclusion The prevalence of OAB was approximately 5.2% among adult Korean women. Older age; high BMI; stress level; sleep duration; levels of income and education; marital status; smoking; and medical history of hypertension, diabetes mellitus, hyperlipidemia, and cerebral stroke were significantly related to OAB in women.	[Kim, So Young] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea; [Bang, Woojin] Hallym Univ, Coll Med, Dept Urol, Seoul, South Korea; [Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Pochon Cha University; Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	National Research Foundation (NRF) of Korea [NRF-2015-R1D1A1A01060860, 2017R1C1B1007696]; Hallym University Sacred Heart Hospital [HURF-2016-38]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Hallym University Sacred Heart Hospital	This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860 to HGC and 2017R1C1B1007696 to SYK) from the National Research Foundation (NRF) of Korea and a Research Grant funded by Hallym University Sacred Heart Hospital (HURF-2016-38) to HGC.; This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860 and 2017R1C1B1007696) from the National Research Foundation (NRF) of Korea and a Research Grant funded by Hallym University Sacred Heart Hospital (HURF-2016-38).	Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Antunes-Lopes T, 2011, ADV UROL, V2011, DOI 10.1155/2011/382431; Azadzoi KM, 1999, J UROLOGY, V162, P1768, DOI 10.1016/S0022-5347(05)68236-5; Bauer RM, 2013, WORLD J UROL, V31, P1081, DOI 10.1007/s00345-013-1132-1; Brubaker L, 2010, BJU INT, V105, P1283, DOI 10.1111/j.1464-410X.2009.09035.x; Coyne KS, 2012, UROLOGY, V80, P97, DOI 10.1016/j.urology.2012.03.039; Coyne KS, 2011, BJU INT, V108, P1459, DOI 10.1111/j.1464-410X.2010.10013.x; Dallosso HM, 2003, BJU INT, V92, P69, DOI 10.1046/j.1464-410X.2003.04271.x; de Boer TA, 2011, INT UROGYNECOL J, V22, P569, DOI 10.1007/s00192-010-1323-x; de Groat WC, 1997, UROLOGY, V50, P36, DOI 10.1016/S0090-4295(97)00587-6; Dmochowski RR, 2007, CURR MED RES OPIN, V23, P64, DOI 10.1185/030079907X159533; Eapen Renu S, 2016, Can J Urol, V23, P2; Findik RB, 2012, ADV CLIN EXP MED, V21, P207; Gold EB, 2001, AM J EPIDEMIOL, V153, P865, DOI 10.1093/aje/153.9.865; Handa VL, 2015, NEUROUROL URODYNAM, V34, P356, DOI 10.1002/nau.22583; Hill SR, 2008, NEUROUROL URODYNAM, V27, P362, DOI 10.1002/nau.20533; Hirayama A, 2012, UROLOGY, V80, P71, DOI 10.1016/j.urology.2012.04.019; Homma Y, 2006, UROLOGY, V68, P318, DOI 10.1016/j.urology.2006.02.042; Irwin DE, 2008, BJU INT, V101, P1381, DOI 10.1111/j.1464-410X.2008.07573.x; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Jeong Seong Jin, 2011, Int Neurourol J, V15, P135, DOI 10.5213/inj.2011.15.3.135; Kajioka Shunichi, 2010, Fukuoka Acta Medica, V101, P94; Kim HJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-195; Kim SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175641; Kim Y, 2016, UNINARY INCONTINENCE, P1; Kinsey D, 2016, J HEALTH PSYCHOL, V21, P69, DOI 10.1177/1359105314522084; Korea Centers for Disease Control and Prevention, COMM HLTH SURV 2013; Largo RH, 1999, EUR J PEDIATR, V158, P115; Madhu C, 2015, UROL INT, V95, P478, DOI 10.1159/000438928; Maserejian NN, 2012, J UROLOGY, V188, P490, DOI 10.1016/j.juro.2012.03.128; Masuda H, 2006, J UROLOGY, V176, P374, DOI 10.1016/S0022-5347(06)00581-7; Milsom I, 2001, BJU INT, V87, P760, DOI 10.1046/j.1464-410x.2001.02228.x; Milsom I, 2014, EUR UROL, V65, P79, DOI 10.1016/j.eururo.2013.08.031; Milsom I, 2012, UROLOGY, V80, P90, DOI 10.1016/j.urology.2012.04.004; Oh DH, 2013, J KOREAN MED SCI, V28, P128, DOI 10.3346/jkms.2013.28.1.128; Patra Phani B, 2013, Curr Urol, V6, P179, DOI 10.1159/000343536; Rim H, 2011, J KOREAN MED SCI, V26, P1409, DOI 10.3346/jkms.2011.26.11.1409; Savolainen S, 2005, MOL CELL ENDOCRINOL, V230, P17, DOI 10.1016/j.mce.2004.11.008; Sexton Chris C, 2009, Am J Manag Care, V15, pS98; Shen J, 2007, NEUROSCI LETT, V416, P193, DOI 10.1016/j.neulet.2007.02.003; Smith AL, 2016, INT UROGYNECOL J, V27, P1383, DOI 10.1007/s00192-016-2988-6; Stewart WF, 2002, WORLD J UROL, V20, P327, DOI 10.1007/s00345-002-0301-4; TAMPAKOUDIS P, 1995, EUR J OBSTET GYN R B, V63, P27, DOI 10.1016/0301-2115(95)02212-P; Taskforce IO, 2000, AS PAC PERSP RED OB; Uzun H, 2012, INT NEUROUROL J, V16, P181, DOI 10.5213/inj.2012.16.4.181; Valentino RJ, 2011, NAT REV UROL, V8, P19, DOI 10.1038/nrurol.2010.203; Wang R, 2015, FEMALE PELVIC MED RE, V21, P293, DOI 10.1097/SPV.0000000000000193; Wang YL, 2011, NEUROUROL URODYNAM, V30, P1448, DOI 10.1002/nau.21072; Wood SK, 2009, AM J PHYSIOL-REG I, V296, pR1671, DOI 10.1152/ajpregu.91013.2008	49	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185592	10.1371/journal.pone.0185592	http://dx.doi.org/10.1371/journal.pone.0185592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957446	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200089
J	Lee, S; Liu, P; Teinturier, R; Jakob, J; Tschaffon, M; Tasdogan, A; Wittig, R; Hoeller, S; Baumhoer, D; Frappart, L; Vettorazzi, S; Bertolino, P; Zhang, C; Tuckermann, J				Lee, S.; Liu, P.; Teinturier, R.; Jakob, J.; Tschaffon, M.; Tasdogan, A.; Wittig, R.; Hoeller, S.; Baumhoer, D.; Frappart, L.; Vettorazzi, S.; Bertolino, P.; Zhang, C.; Tuckermann, J.			Deletion of Menin in craniofacial osteogenic cells in mice elicits development of mandibular ossifying fibroma	ONCOGENE			English	Article							MESENCHYMAL STEM-CELLS; BENIGN FIBROOSSEOUS LESIONS; NEOPLASIA TYPE-1 MEN1; BONE; EXPRESSION; JAW; DIFFERENTIATION; SPECIFICATION; MAINTENANCE; PROGENITORS	Ossifying fibroma (OF) is a rare benign tumor of the craniofacial bones that can reach considerable and disfiguring dimensions if left untreated. Although the clinicopathological characteristics of OF are well established, the underlying etiology has remained largely unknown. Our work indicates that Men1-a tumor suppressor gene responsible of Multiple endocrine neoplasia type 1-is critical for OF formation and shows that mice with targeted disruption of Men1 in osteoblasts (Men1(Runx2Cre)) develop multifocal OF in the mandible with a 100% penetrance. Using lineage-tracing analysis, we demonstrate that loss of Men1 arrests stromal osteoprogenitors in OF at the osterix-positive pre-osteoblastic differentiation stage. Analysis of Men1-lacking stromal spindle cells isolated from OF (OF-derived MSCs (OFMSCs)) revealed a downregulation of the cyclin-dependent kinase (CDK) inhibitor Cdkn1a, consistent with an increased proliferation rate. Intriguingly, the re-expression of Men1 in Men1-deficient OFMSCs restored Cdkn1a expression and abrogated cellular proliferation supporting the tumor-suppressive role of Men1 in OF. Although our work presents the first evidence of Men1 in OF development, it further provides the first genetic mouse model of OF that can be used to better understand the molecular pathogenesis of these benign tumors and to potentially develop novel treatment strategies.	[Lee, S.; Liu, P.; Tschaffon, M.; Vettorazzi, S.; Tuckermann, J.] Univ Ulm, Inst Comparat Mol Endocrinol, Helmholtzstr 8-1, D-89081 Ulm, BW, Germany; [Teinturier, R.; Bertolino, P.; Zhang, C.] Univ Lyon 1, INSERM, Ctr Rech Cancerol Lyon, CNRS UMR5286,U1052, Lyon, France; [Jakob, J.; Frappart, L.] Leibniz Inst Aging, Fritz Lipmann Inst, Jena, Germany; [Tasdogan, A.] Univ Hosp Ulm, Inst Immunol, Ulm, Germany; [Wittig, R.] Ulm Univ, Inst Laser Technol Med & Metrol, Ulm, Germany; [Hoeller, S.; Baumhoer, D.] Univ Hosp, Bone Tumour Reference Ctr, Basel, Switzerland; [Hoeller, S.; Baumhoer, D.] Univ Hosp, DOESAK Registry, Inst Pathol, Basel, Switzerland; [Hoeller, S.; Baumhoer, D.] Univ Basel, Basel, Switzerland; [Frappart, L.] Univ Claude Bernard Lyon 1, INSERM, Oncogenese & Progress Tumorale, Lyon, France	Ulm University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Ulm University; Ulm University; University of Basel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Tuckermann, J (corresponding author), Univ Ulm, Inst Comparat Mol Endocrinol, Helmholtzstr 8-1, D-89081 Ulm, BW, Germany.	jan.tuckermann@uni-ulm.de	Wittig, Rainer/AAT-5361-2021; Bertolino, philippe/D-4072-2018; Bertolino, philippe/M-8977-2019; Tasdogan, Alpaslan/U-5133-2017; ZHANG, Chang Xian/G-2905-2013	Wittig, Rainer/0000-0002-3735-9370; Bertolino, philippe/0000-0001-8064-8269; Bertolino, philippe/0000-0001-8064-8269; Vettorazzi, Dr. Sabine/0000-0001-8667-9488; Zhang, Chang Xian/0000-0002-5443-8951; Lee, Sooyeon/0000-0001-6244-4975; Holler, Sylvia/0000-0001-9277-7076	Boehringer Ingelheim Foundation; Deutsche Forschungsgemeinschaft (DFG) [1468, Tu 220/6-1, Tu 220/6-2]; Deutsche Forschungsgemeinschaft (Collaborative Research Centre) [1149, C02/INST 40/492-1]; Deutsche Forschungsgemeinschaft (Trilateral Consortium) [Tu 220/12-1]; Leibniz Graduate School of Ageing from Fritz Lipmann Institute Jena	Boehringer Ingelheim Foundation(Boehringer Ingelheim); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (Collaborative Research Centre)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (Trilateral Consortium)(German Research Foundation (DFG)); Leibniz Graduate School of Ageing from Fritz Lipmann Institute Jena	We are grateful to the staff of the animal facilities of the University of Ulm, led by Dr Petra Kirsch and in particular to Tobias Rappold. We thank Professor Dr Volker Rasche from the Core Facility Animal MRI, Ulm University and Dr Markus Rojewsky from the Institut fur Transfusionsmedizin Universitatsklinikum Ulm. We thank Dr Merle Stein and Dr Giorgio Caratti for critical reading of the manuscript. This study was supported by the Boehringer Ingelheim Foundation (to JT), Deutsche Forschungsgemeinschaft (DFG, Priority Program Immunobone 1468, Tu 220/6-1, 6-2, Collaborative Research Centre 1149, C02/INST 40/492-1, Trilateral Consortium Tu 220/12-1 to JT) and the Leibniz Graduate School of Ageing from Fritz Lipmann Institute Jena (to SL).	Bertolino P, 2003, CANCER RES, V63, P4836; Bhasin M, 2013, CASE REP DENT, V2013, DOI 10.1155/2013/497234; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Chan CKF, 2015, CELL, V160, P285, DOI 10.1016/j.cell.2014.12.002; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Darling TN, 1997, ARCH DERMATOL, V133, P853, DOI 10.1001/archderm.133.7.853; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Engleka KA, 2007, DEV BIOL, V311, P524, DOI 10.1016/j.ydbio.2007.08.057; Eversole R, 2008, HEAD NECK PATHOL, V2, P177, DOI 10.1007/s12105-008-0057-2; Falchetti A, 2009, GENET MED, V11, P825, DOI 10.1097/GIM.0b013e3181be5c97; Fauquier T, 2014, DEVELOPMENT, V141, P166, DOI 10.1242/dev.103226; Gherardi S, 2017, BBA-GENE REGUL MECH, V1860, P427, DOI 10.1016/j.bbagrm.2017.02.003; Houlihan DD, 2012, NAT PROTOC, V7, P2103, DOI 10.1038/nprot.2012.125; Isakov O, 2013, GENET RES, V95, P114, DOI 10.1017/S0016672313000141; JACKSON CE, 1990, SURGERY, V108, P1006; Franco-Barrera MJ, 2016, ORAL MAXILLOFAC SURG, V20, P1, DOI 10.1007/s10006-015-0535-0; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kanazawa I, 2015, J BIOL CHEM, V290, P3910, DOI 10.1074/jbc.M114.629899; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; KASSEM M, 1994, CLIN ENDOCRINOL, V41, P415, DOI 10.1111/j.1365-2265.1994.tb02570.x; Kim YS, 1999, ONCOGENE, V18, P5936, DOI 10.1038/sj.onc.1203005; Kottemann MC, 2009, DNA REPAIR, V8, P944, DOI 10.1016/j.dnarep.2009.06.001; Lemmens I, 1997, HUM MOL GENET, V6, P1177, DOI 10.1093/hmg/6.7.1177; Liu P, 2017, CELL DEATH DIFFER, V24, P672, DOI 10.1038/cdd.2016.165; Liu Y, 2010, DENTOMAXILLOFAC RAD, V39, P57, DOI 10.1259/dmfr/96330046; Matkar S, 2013, TRENDS BIOCHEM SCI, V38, P394, DOI [10.1016/j.tibs.2013.0S.005, 10.1016/j.tibs.2013.05.005]; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Mizoguchi T, 2014, DEV CELL, V29, P340, DOI 10.1016/j.devcel.2014.03.013; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Ono N, 2014, NAT CELL BIOL, V16, P1157, DOI 10.1038/ncb3067; Papagerakis P., 2013, DEV STRUCTURE TEETH; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Qin HY, 2013, CELL STEM CELL, V13, P577, DOI 10.1016/j.stem.2013.08.010; Ramaesh T, 2003, J ANAT, V203, P213, DOI 10.1046/j.1469-7580.2003.00210.x; Rauch A, 2010, CELL METAB, V11, P517, DOI 10.1016/j.cmet.2010.05.005; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Schnepp RW, 2006, CANCER RES, V66, P5707, DOI 10.1158/0008-5472.CAN-05-4518; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shibata S, 2008, J ANAT, V213, P274, DOI 10.1111/j.1469-7580.2008.00934.x; Slootweg PJ, 2017, WHO CLASSIFICATION H, P251; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sung JH, 2008, TRANSPL P, V40, P2649, DOI 10.1016/j.transproceed.2008.08.009; Toyosawa S, 2007, MODERN PATHOL, V20, P389, DOI 10.1038/modpathol.3800753; Trijolet JP, 2011, EUR ANN OTORHINOLARY, V128, P30, DOI 10.1016/j.anorl.2010.06.005; WALDRON CA, 1973, ORAL SURG ORAL MED O, V35, P340, DOI 10.1016/0030-4220(73)90072-8; Woo SB, 2015, J ORAL MAXIL SURG, V73, pS87, DOI 10.1016/j.joms.2015.05.010; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042; Yadav R., 2009, J ORAL SCI, V51, P151, DOI [10.2334/josnusd.51.151, DOI 10.2334/JOSNUSD.51.151]; Yamaza T, 2011, J DENT RES, V90, P317, DOI 10.1177/0022034510387796; Yang YJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.98; Zhang H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/265380; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008	56	4	4	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 1	2018	37	5					616	626		10.1038/onc.2017.364	http://dx.doi.org/10.1038/onc.2017.364			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FU4GT	28991228				2022-12-26	WOS:000423812200007
J	Mori, Y; Asakura, S; Yamamoto, A; Odagiri, S; Yamada, D; Sekiguchi, M; Wada, K; Sato, M; Kurabayashi, A; Suzuki, H; Kanamoto, R; Ohinata, K				Mori, Yukiha; Asakura, Saho; Yamamoto, Akane; Odagiri, Saori; Yamada, Daisuke; Sekiguchi, Masayuki; Wada, Keiji; Sato, Masaru; Kurabayashi, Atsushi; Suzuki, Hideyuki; Kanamoto, Ryuhei; Ohinata, Kousaku			Characterization of soy-deprestatin, a novel orally active decapeptide that exerts antidepressant-like effects via gut-brain communication	FASEB JOURNAL			English	Article						vagus nerve; serotonin 5-HT1A; dopamine D-1; GABA(A)	ANXIOLYTIC-LIKE ACTIVITY; D1-D2 RECEPTOR COMPLEX; FORCED SWIMMING TEST; DOPAMINE D-1; FOOD-INTAKE; MAJOR DEPRESSION; BLOOD-PRESSURE; VAGUS NERVE; ARG-PHE; MICE	We found that the orally administered thermolysin digest of beta-conglycinin exhibits antidepressant-like effects in tail suspension and forced swim tests inmice. Acomprehensive peptide analysis of the digest using liquid chromatography/mass spectrometry was performed, and LSSTQAQQSY emerged as a candidate antidepressant-like peptide. Orally administered synthetic LSSTQAQQSY exhibited antidepressant-like effects at a dose of 0.3 mg/kg; therefore, we named the decapeptide soy-deprestatin. In contrast, intraperitoneally administered soy-deprestatin was ineffective. We then hypothesized that it acted on the gut, and its signal was transferred to the brain. Indeed, orally administered soy-deprestatin exhibited antidepressant-like activity in sham-treated, but not vagotomized, mice. Oral administration of soy-deprestatin also increased the c-Fos expression in the nucleus of the solitary tract, which receives inputs from the vagus nerve. These results suggested that the antidepressant-like effects were mediated by the vagus nerve. Thermolysin digest- and soy-deprestatin-induced antidepressant-like effects were also blocked by antagonists of serotonin 5-HT1A, dopamine D-1, or GABA(A) receptors. We also clarified the order of receptor activation as 5-HT1A, D-1, and GABA(A), using selective agonists and antagonists. Taken together, soy-deprestatin may exhibit antidepressant-like effects after oral administration via a novel pathway mediated by 5-HT1A, followed by D-1 and GABA(A) systems. This is the first orally active peptide demonstrating antidepressant-like effects via gut-brain communication.	[Mori, Yukiha; Asakura, Saho; Yamamoto, Akane; Kanamoto, Ryuhei; Ohinata, Kousaku] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6110011, Japan; [Odagiri, Saori; Yamada, Daisuke; Sekiguchi, Masayuki; Wada, Keiji] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Tokyo, Japan; [Sato, Masaru; Kurabayashi, Atsushi; Suzuki, Hideyuki] Kazusa DNA Res Inst, Dept Res & Dev, Kisarazu, Japan	Kyoto University; National Center for Neurology & Psychiatry - Japan; Kazusa DNA Research Institute	Ohinata, K (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6110011, Japan.	ohinata@kais.kyoto-u.ac.jp	Suzuki, Hideyuki/J-7571-2016; Wada, Keiji/AAV-1500-2021	Yamada, Daisuke/0000-0002-6989-6736	Japanese Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food industry; Grants-in-Aid for Scientific Research [15K06730] Funding Source: KAKEN	Japanese Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by the Japanese Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food industry. The authors declare no conflicts of interest.	Abbott CR, 2005, BRAIN RES, V1044, P127, DOI 10.1016/j.brainres.2005.03.011; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Dominguez-Lopez S, 2012, REV NEUROSCIENCE, V23, P429, DOI 10.1515/revneuro-2012-0044; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; EWART WR, 1983, AM J PHYSIOL, V244, pG613, DOI 10.1152/ajpgi.1983.244.6.G613; Ferres-Coy A, 2013, PSYCHOPHARMACOLOGY, V225, P61, DOI 10.1007/s00213-012-2795-9; Furmaga H, 2011, BIOL PSYCHIAT, V70, P937, DOI 10.1016/j.biopsych.2011.07.020; Hirata H, 2007, PEPTIDES, V28, P1998, DOI 10.1016/j.peptides.2007.07.024; Hou IC, 2011, J NEUROCHEM, V119, P785, DOI 10.1111/j.1471-4159.2011.07472.x; Kagebayashi T, 2012, MOL NUTR FOOD RES, V56, P1456, DOI 10.1002/mnfr.201200168; Kanegawa N, 2010, FEBS LETT, V584, P599, DOI 10.1016/j.febslet.2009.12.008; Kontani N, 2014, MOL NUTR FOOD RES, V58, P359, DOI 10.1002/mnfr.201300334; Mann JJ, 2014, DEPRESS ANXIETY, V31, P814, DOI 10.1002/da.22278; Maruyama Y, 2004, ACTA CRYSTALLOGR D, V60, P289, DOI 10.1107/S0907444903027367; Mizushige T, 2013, FASEB J, V27, P2911, DOI 10.1096/fj.12-225474; Mizushige T, 2013, NEUROSCI LETT, V543, P126, DOI 10.1016/j.neulet.2013.03.043; NIKULINA EM, 1991, PSYCHOPHARMACOLOGY, V105, P525, DOI 10.1007/BF02244374; Oda A, 2012, J NEUROCHEM, V122, P356, DOI 10.1111/j.1471-4159.2012.07777.x; Ohinata K, 2007, BIOSCI BIOTECH BIOCH, V71, P2618, DOI 10.1271/bbb.70516; Ota A, 2017, NEUROCHEM INT, V105, P51, DOI 10.1016/j.neuint.2016.12.020; Papakostas GI, 2009, J CLIN PSYCHIAT, V70, P16, DOI 10.4088/JCP.8133su1c.03; Pehrson AL, 2015, DRUG DES DEV THER, V9, P603, DOI 10.2147/DDDT.S62912; Pei L, 2010, NAT MED, V16, P1393, DOI 10.1038/nm.2263; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Richardson-Jones JW, 2011, J NEUROSCI, V31, P6008, DOI 10.1523/JNEUROSCI.5836-10.2011; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Strader AD, 2005, GASTROENTEROLOGY, V128, P175, DOI 10.1053/j.gastro.2004.10.043; Tanti A, 2010, BRIT J PHARMACOL, V159, P1187, DOI 10.1111/j.1476-5381.2009.00585.x; Thase ME, 2007, AM J PSYCHIAT, V164, P739, DOI 10.1176/appi.ajp.164.5.739; van der Kleij H, 2008, AM J PHYSIOL-REG I, V295, pD1131, DOI 10.1152/ajpregu.90434.2008; Wong AHC, 2012, CLIN PHARMACOL THER, V91, P298, DOI 10.1038/clpt.2011.311; Yamamoto Y, 2015, NEUROPEPTIDES, V51, P25, DOI 10.1016/j.npep.2015.04.002; Zeidan MP, 2007, EUR J PHARMACOL, V565, P125, DOI 10.1016/j.ejphar.2007.03.027; Zhao H, 2008, PEPTIDES, V29, P345, DOI 10.1016/j.peptides.2007.11.011	34	13	14	5	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					568	575		10.1096/fj.201700333RR	http://dx.doi.org/10.1096/fj.201700333RR			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28970253	Bronze			2022-12-26	WOS:000425146900004
J	Gelato, KA; Schockel, L; Klingbeil, O; Ruckert, T; Lesche, R; Toedling, J; Kalfon, E; Heroult, M; Lejeune, P; Monning, U; Fernandez-Montalvan, AE; Baurle, S; Siegel, S; Haendler, B				Gelato, K. A.; Schoeckel, L.; Klingbeil, O.; Rueckert, T.; Lesche, R.; Toedling, J.; Kalfon, E.; Heroult, M.; Lejeune, P.; Moenning, U.; Fernandez-Montalvan, A. E.; Baeurle, S.; Siegel, S.; Haendler, B.			Super-enhancers define a proliferative PGC-1 alpha-expressing melanoma subgroup sensitive to BET inhibition	ONCOGENE			English	Article							INTEGRATIVE GENOMICS VIEWER; TRANSCRIPTION FACTORS; SELECTIVE-INHIBITION; EXPRESSION PROFILES; BROMODOMAIN; SUPPRESSES; PGC1-ALPHA; APOPTOSIS; LYMPHOMA; I-BET151	Metabolic changes are linked to epigenetic reprogramming and play important roles in several tumor types. PGC-1 alpha is a transcriptional coactivator controlling mitochondrial biogenesis and is linked to oxidative phosphorylation. We provide evidence that melanoma models with elevated PGC-1 alpha levels are characteristic of the proliferative phenotype and are sensitive to bromodomain and extra-terminal domain (BET) inhibitor treatment. A super-enhancer region highly occupied by the BET family member BRD4was identified for the PGC-1 alpha gene. BET inhibitor treatment prevented this interaction, leading to a dramatic reduction of PGC-1 alpha expression. Accordingly, BET inhibition diminished respiration and mitochondrial function in cells. In vivo, melanoma models with high PGC-1 alpha expression strongly responded to BET inhibition by reduction of PGC-1 alpha and impaired tumor growth. Altogether, our findings identify epigenetic regulatory elements that define a subset of melanomas with high sensitivity to BET inhibition, which opens up the opportunity to define melanoma patients most likely to respond to this treatment, depending on their tumor characteristics.	[Gelato, K. A.; Schoeckel, L.; Klingbeil, O.; Rueckert, T.; Lesche, R.; Toedling, J.; Kalfon, E.; Lejeune, P.; Moenning, U.; Fernandez-Montalvan, A. E.; Baeurle, S.; Siegel, S.; Haendler, B.] Bayer AG, Drug Discovery, Mullerstr 178, D-13353 Berlin, Germany; [Rueckert, T.] Deutsch Rheuma Forschungszentrum, Innate Immun, Berlin, Germany; [Toedling, J.] Charite, Dept Pediat Oncol & Hematol, Berlin, Germany; [Heroult, M.] Bayer AG, Corp Res & Dev, Leverkusen, Germany; [Klingbeil, O.] Cold Spring Harbor Lab, Canc Ctr, Cold Spring Harbor, NY 11724 USA	Bayer AG; Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Bayer AG; Cold Spring Harbor Laboratory	Haendler, B (corresponding author), Bayer AG, Drug Discovery, Mullerstr 178, D-13353 Berlin, Germany.	bernard.haendler@bayer.com		Toedling, Joern/0000-0003-1471-1295; Klingbeil, Olaf/0000-0001-7248-7506; Fernandez-Montalvan, Amaury/0000-0001-9156-0000				Abildgaard C, 2015, TRENDS MOL MED, V21, P164, DOI 10.1016/j.molmed.2014.12.007; Amorim S, 2016, LANCET HAEMATOL, V3, pE196, DOI 10.1016/S2352-3026(16)00021-1; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bernasconi E, 2017, BRIT J HAEMATOL, V178, P936, DOI 10.1111/bjh.14803; Berthon C, 2016, LANCET HAEMATOL, V3, pE186, DOI 10.1016/S2352-3026(15)00247-1; Bhagwat AS, 2016, CELL REP, V15, P519, DOI 10.1016/j.celrep.2016.03.054; Caro P, 2012, CANCER CELL, V22, P547, DOI 10.1016/j.ccr.2012.08.014; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gallagher SJ, 2014, PIGM CELL MELANOMA R, V27, P1126, DOI 10.1111/pcmr.12282; Gallagher SJ, 2014, J INVEST DERMATOL, V134, P2795, DOI 10.1038/jid.2014.243; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gelato KA, 2016, EXPERT OPIN THER TAR, V20, P783, DOI 10.1517/14728222.2016.1134490; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Heinemann A, 2015, ONCOTARGET, V6, P21507, DOI 10.18632/oncotarget.4242; Ho JH, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-76; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Jung M, 2015, EPIGENOMICS-UK, V7, P487, DOI 10.2217/epi.14.91; Klingbeil O, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.271; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leiter Ulrike, 2014, Adv Exp Med Biol, V810, P120; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lo JA, 2014, SCIENCE, V346, P945, DOI 10.1126/science.1253735; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Luo C, 2016, NATURE, V537, P422, DOI 10.1038/nature19347; Mochizuki K, 2008, J BIOL CHEM, V283, P9040, DOI 10.1074/jbc.M707603200; Nagarajan S, 2014, CELL REP, V8, P459, DOI 10.1016/j.celrep.2014.06.016; Niezgoda A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/851387; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Salmon-Divon M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-415; Schockel L, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0138-0; Segura MF, 2013, CANCER RES, V73, P6264, DOI 10.1158/0008-5472.CAN-13-0122-T; Shakhova O, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004877; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Verfaillie A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7683; Villena JA, 2015, FEBS J, V282, P647, DOI 10.1111/febs.13175; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zhang WJ, 2015, CURR OPIN PHARMACOL, V23, P68, DOI 10.1016/j.coph.2015.05.015	45	22	23	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 25	2018	37	4					512	521		10.1038/onc.2017.325	http://dx.doi.org/10.1038/onc.2017.325			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT7KP	28991225	Green Published, hybrid			2022-12-26	WOS:000423331600009
J	Jiang, JY; Liu, Z; Ge, C; Chen, C; Zhao, FY; Li, H; Chen, TY; Yao, M; Li, JJ				Jiang, Jingyi; Liu, Zheng; Ge, Chao; Chen, Cong; Zhao, Fangyu; Li, Hong; Chen, Taoyang; Yao, Ming; Li, Jinjun			NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; FOXO; hepatocellular carcinoma; metastasis; tumor suppressor gene; NK3 Homeobox 1	BREAST-CANCER CELLS; PROSTATE-CANCER; TOPOISOMERASE-I; PROTEIN NKX3.1; DNA-DAMAGE; FOXO1; GENE; METASTASIS; CARCINOGENESIS; CONTRIBUTES	Hepatocellular carcinoma (HCC) is the leading cause of cancer-related mortality in China, and the molecular mechanism of uncontrolled HCC progression remains to be explored. NK3 homeobox 1 (NKX3.1), an androgen-regulated prostate-specific transcription factor, suppresses tumors in prostate cancer, but its role in HCC is unknown, especially in hepatocellular carcinoma. In the present study, the differential expression analyses in HCC tissues and matched adjacent noncancerous liver tissues revealed that NKX3.1 is frequently down-regulated in human primary HCC tissues compared with matched adjacent noncancerous liver tissues. We also noted that NKX3.1 significantly inhibits proliferation and mobility of HCC cells both in vitro and in vivo. Furthermore, NKX3.1 overexpression resulted in cell cycle arrest at the G(1)/S phase via direct binding to the promoter of forkhead box O1 (FOXO1) and up-regulation of expression. Of note, FOXO1 silencing in NKX3.1-overexpressing cells reversed the inhibitory effects of NKX3.1 on HCC cell proliferation and invasion. Consistently, both FOXO1 and NKX3.1 were down-regulated in human HCC tissues, and their expression was significantly and positively correlated with each other. These results suggest that NKX3.1 functions as a tumor suppressor in HCC cells through directly up-regulating FOXO1 expression.	[Jiang, Jingyi; Liu, Zheng] Fudan Univ, Shanghai Med Coll, Shanghai 200032, Peoples R China; [Jiang, Jingyi; Liu, Zheng; Ge, Chao; Chen, Cong; Zhao, Fangyu; Li, Hong; Yao, Ming; Li, Jinjun] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200032, Peoples R China; [Chen, Taoyang] Qi Dong Liver Canc Inst, Qi Dong 226200, Peoples R China	Fudan University; Shanghai Jiao Tong University	Li, JJ (corresponding author), 25 Ln 2200 Xietu Rd, Shanghai 200032, Peoples R China.	jjli@shsci.org		Li, Jinjun/0000-0002-6895-3508	National Natural Science Foundation of China [81472726]; National Key Sci-Tech Special Project of China [2013ZX10002-011]; SKLORG Research Foundation [91-15-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Special Project of China; SKLORG Research Foundation	This work was supported in part by National Natural Science Foundation of China Grant 81472726, National Key Sci-Tech Special Project of China Grant 2013ZX10002-011, and SKLORG Research Foundation Grant 91-15-03. The authors declare that they have no conflicts of interest with the contents of this article.	Abate-Shen C, 2003, CANCER RES, V63, P3886; Asatiani E, 2005, CANCER RES, V65, P1164, DOI 10.1158/0008-5472.CAN-04-2688; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bhatt S, 2016, ONCOGENE, V35, P5722, DOI 10.1038/onc.2016.105; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779, DOI 10.1074/jbc.271.50.31779; Bowen C, 2000, CANCER RES, V60, P6111; Bowen C, 2007, CANCER RES, V67, P455, DOI 10.1158/0008-5472.CAN-06-1591; Bowen C, 2015, CANCER RES, V75, P2686, DOI 10.1158/0008-5472.CAN-14-3387; Bowen C, 2010, CANCER RES, V70, P3089, DOI 10.1158/0008-5472.CAN-09-3138; Cai BW, 2013, CELL REP, V4, P516, DOI 10.1016/j.celrep.2013.06.039; Calvisi DF, 2009, GASTROENTEROLOGY, V137, P1816, DOI 10.1053/j.gastro.2009.08.005; Critelli RM, 2015, DIGEST DIS, V33, P635, DOI 10.1159/000438472; Debelec-Butuner B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109868; Dong TX, 2017, ONCOTARGET, V8, P1703, DOI [10.18632/oncotarget.13786, 10.18632/oncotarget.15954]; Dutta A, 2016, SCIENCE, V352, P1576, DOI 10.1126/science.aad9512; Fan CH, 2013, BIOMED PHARMACOTHER, V67, P521, DOI 10.1016/j.biopha.2013.04.014; Fendler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080807; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; He WW, 1997, GENOMICS, V43, P69, DOI 10.1006/geno.1997.4715; Jung HS, 2014, CELL SIGNAL, V26, P1456, DOI 10.1016/j.cellsig.2014.02.022; Kang J, 2015, EXP THER MED, V9, P345, DOI 10.3892/etm.2014.2123; Khalili M, 2010, AM J PATHOL, V176, P2259, DOI 10.2353/ajpath.2010.080747; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P2884, DOI 10.1073/pnas.042688999; Kim MJ, 2002, CANCER RES, V62, P2999; Kurimoto F, 2001, INT J MOL MED, V8, P89; Lee SY, 2013, CELL CYCLE, V12, P67, DOI 10.4161/cc.22962; Li CS, 2016, SAE INT J PASSENG CA, V9, P1, DOI 10.4271/2015-01-2846; Li H, 2011, HEPATOLOGY, V54, P910, DOI 10.1002/hep.24479; Markowski MC, 2008, CANCER RES, V68, P6896, DOI 10.1158/0008-5472.CAN-08-0578; Miyaguchi K, 2012, INT J ONCOL, V40, P1907, DOI 10.3892/ijo.2012.1373; Mosquera JM, 2009, CLIN CANCER RES, V15, P4706, DOI 10.1158/1078-0432.CCR-08-2927; Sciavolino PJ, 1997, DEV DYNAM, V209, P127, DOI 10.1002/(SICI)1097-0177(199705)209:1<127::AID-AJA12>3.0.CO;2-Z; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Song LN, 2015, MOL CANCER RES, V13, P913, DOI 10.1158/1541-7786.MCR-14-0680; Song LN, 2013, BIOCHEM J, V453, P125, DOI 10.1042/BJ20130012; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tikhanovich I, 2013, J GASTROEN HEPATOL, V28, P125, DOI 10.1111/jgh.12021; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Wallis CJD, 2015, J CANCER, V6, P1295, DOI 10.7150/jca.13176; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Xu D, 2013, ONCOL REP, V29, P653, DOI 10.3892/or.2012.2138; Yamaguchi F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-468; Yang XW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-909; Yu F, 2014, ONCOL REP, V31, P1459, DOI 10.3892/or.2013.2957; Zeng YB, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0328-z; Zhang HJ, 2011, CANCER RES, V71, P3257, DOI 10.1158/0008-5472.CAN-10-2603; Zhang YQ, 2011, CANCER BIOL THER, V12, P253, DOI 10.4161/cbt.12.4.15954	47	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19146	19159		10.1074/jbc.M117.793760	http://dx.doi.org/10.1074/jbc.M117.793760			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972178	Green Published, hybrid			2022-12-26	WOS:000416226700002
J	Sabra, H; Brunner, M; Mandati, V; Wehrle-Haller, B; Lallemand, D; Ribba, AS; Chevalier, G; Guardiola, P; Block, MR; Bouvard, D				Sabra, Hiba; Brunner, Molly; Mandati, Vinay; Wehrle-Haller, Bernhard; Lallemand, Dominique; Ribba, Anne-Sophie; Chevalier, Genevieve; Guardiola, Philippe; Block, Marc R.; Bouvard, Daniel			1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesion; cell proliferation; integrin; Rac (Rac GTPase); yes-associated protein (YAP)	RECEPTOR TYROSINE KINASES; SMALL-MOLECULE INHIBITOR; SMALL GTPASE RAC1; HIPPO PATHWAY; TUMOR-SUPPRESSOR; PLASMA-MEMBRANE; P21-ACTIVATED KINASE; OSTEOBLAST FUNCTION; CELL-PROLIFERATION; MATRIX ADHESION	Cell adhesion to the extracellular matrix or to surrounding cells plays a key role in cell proliferation and differentiation and is critical for proper tissue homeostasis. An important pathway in adhesion-dependent cell proliferation is the Hippo signaling cascade, which is coregulated by the transcription factors Yes-associated protein 1 (YAP1) and transcriptional coactivator with PDZ-binding motif (TAZ). However, how cells integrate extracellular information at the molecular level to regulate YAP1's nuclear localization is still puzzling. Herein, we investigated the role of 1 integrins in regulating this process. We found that 1 integrin-dependent cell adhesion is critical for supporting cell proliferation in mesenchymal cells both in vivo and in vitro. 1 integrin-dependent cell adhesion relied on the relocation of YAP1 to the nucleus after the down-regulation of its phosphorylated state mediated by large tumor suppressor gene 1 and 2 (LATS1/2). We also found that this phenotype relies on 1 integrin-dependent local activation of the small GTPase RAC1 at the plasma membrane to control the activity of P21 (RAC1)-activated kinase (PAK) of group 1. We further report that the regulatory protein merlin (neurofibromin 2, NF2) interacts with both YAP1 and LATS1/2 via its C-terminal moiety and FERM domain, respectively. PAK1-mediated merlin phosphorylation on Ser-518 reduced merlin's interactions with both LATS1/2 and YAP1, resulting in YAP1 dephosphorylation and nuclear shuttling. Our results highlight RAC/PAK1 as major players in YAP1 regulation triggered by cell adhesion.	[Sabra, Hiba; Brunner, Molly; Ribba, Anne-Sophie; Chevalier, Genevieve; Block, Marc R.; Bouvard, Daniel] Univ Grenoble Alpes, CNRS 5309, Inst Adv Biosci, INSERM 1209, F-38042 Grenoble, France; [Mandati, Vinay] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Wehrle-Haller, Bernhard] Univ Geneva, Dept Cell Physiol & Metab, Ctr Med Univ, CH-1211 Geneva, Switzerland; [Lallemand, Dominique] Ecole Polytech, CNRS 7654, Dept Biochem, F-91128 Palaiseau, France; [Guardiola, Philippe] Ctr Hosp Univ, F-49933 Angers, France; [Guardiola, Philippe] Univ Angers, Inst Biol Hlth Transcriptome & Epigen, Plateform, F-49933 Angers, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Scripps Research Institute; University of Geneva; Institut Polytechnique de Paris; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers	Bouvard, D (corresponding author), Univ Grenoble Alpes, Inst Adv Biosci, Site Sante,BP170, F-38042 Grenoble 9, France.	daniel.bouvard@univ-grenoble-alpes.fr	Mandati, Vinay/AAZ-1898-2020; Bouvard, Daniel/B-1260-2017; lallemand, dominique/O-7445-2017; Block, Marc R/M-2740-2013	Bouvard, Daniel/0000-0002-0845-6681; lallemand, dominique/0000-0002-0212-7342; Block, Marc R/0000-0003-2214-9706; Ribba, Anne-Sophie/0000-0001-5342-8455	"Ministere de la Recherche"; INCa (Institut National du Cancer); Societe Francaise de lutte contre les cancers de l'enfant (SFCE) grant	"Ministere de la Recherche"(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, FranceSpanish Government); INCa (Institut National du Cancer)(Institut National du Cancer (INCA) France); Societe Francaise de lutte contre les cancers de l'enfant (SFCE) grant	Supported by a fellowship from "Ministere de la Recherche," INCa (Institut National du Cancer), and Societe Francaise de lutte contre les cancers de l'enfant (SFCE) grant.	Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; Bentmann A, 2010, J BONE MINER RES, V25, P706, DOI 10.1359/jbmr.091011; Bouvard D, 2007, DEVELOPMENT, V134, P2615, DOI 10.1242/dev.000877; Bouvard D, 2013, NAT REV MOL CELL BIO, V14, P430, DOI 10.1038/nrm3599; Bouvier C, 2016, ONCOTARGET, V7, P64702, DOI 10.18632/oncotarget.11876; Brunner M, 2011, J CELL BIOL, V194, P307, DOI 10.1083/jcb.201007108; Chang FM, 2007, MOL BIOL CELL, V18, P253, DOI 10.1091/mbc.E06-03-0207; Choma DP, 2007, J INVEST DERMATOL, V127, P31, DOI 10.1038/sj.jid.5700505; Das S, 2015, P NATL ACAD SCI USA, V112, pE267, DOI 10.1073/pnas.1409667112; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Dib K, 2003, J BIOL CHEM, V278, P24181, DOI 10.1074/jbc.M302300200; Dise RS, 2008, AM J PHYSIOL-GASTR L, V294, pG276, DOI 10.1152/ajpgi.00340.2007; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Ehmer U, 2016, MOL CANCER RES, V14, P127, DOI 10.1158/1541-7786.MCR-15-0305; Elbediwy A, 2016, DEVELOPMENT, V143, P1674, DOI 10.1242/dev.133728; Faccio R, 2003, J CELL BIOL, V162, P499, DOI 10.1083/jcb.200212082; Feng HZ, 2011, J CLIN INVEST, V121, P4670, DOI 10.1172/JCI58559; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; GonzalezAgosti C, 1996, ONCOGENE, V13, P1239; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hirsch E, 2002, J CELL BIOL, V157, P481, DOI 10.1083/jcb.200111065; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Howe AK, 2000, NAT CELL BIOL, V2, P593, DOI 10.1038/35023536; Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kim M, 2013, EMBO J, V32, P1543, DOI 10.1038/emboj.2013.102; Kim NG, 2015, J CELL BIOL, V210, P503, DOI 10.1083/jcb.201501025; Li YJ, 2015, CELL RES, V25, P801, DOI 10.1038/cr.2015.69; Matsumoto S, 2014, EMBO J, V33, P702, DOI 10.1002/embj.201386942; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Okada T, 2005, J CELL BIOL, V171, P361, DOI 10.1083/jcb.200503165; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Parrini MC, 2009, J BIOL CHEM, V284, P24133, DOI 10.1074/jbc.M109.015271; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Reginensi A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003380; Robertson LK, 2011, J IMMUNOL, V187, P5824, DOI 10.4049/jimmunol.1003690; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Sero JE, 2017, CELL SYST, V4, P84, DOI 10.1016/j.cels.2016.11.015; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Weed SA, 1998, J CELL SCI, V111, P2433; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; ZHU XY, 1995, MOL BIOL CELL, V6, P273, DOI 10.1091/mbc.6.3.273	54	66	68	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19179	19197		10.1074/jbc.M117.808063	http://dx.doi.org/10.1074/jbc.M117.808063			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972170	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000416226700004
J	Brindle, E; Lillis, L; Barney, R; Hess, SY; Wessells, KR; Ouedraogo, CT; Stinca, S; Kalnoky, M; Peck, R; Tyler, A; Lyman, C; Boyle, DS				Brindle, Eleanor; Lillis, Lorraine; Barney, Rebecca; Hess, Sonja Y.; Wessells, K. Ryan; Ouedraogo, Cesaire T.; Stinca, Sara; Kalnoky, Michael; Peck, Roger; Tyler, Abby; Lyman, Christopher; Boyle, David S.			Simultaneous assessment of iodine, iron, vitamin A, malarial antigenemia, and inflammation status biomarkers via a multiplex immunoassay method on a population of pregnant women from Niger	PLOS ONE			English	Article							SOLUBLE TRANSFERRIN RECEPTOR; RETINOL-BINDING-PROTEIN; C-REACTIVE PROTEIN; ENZYME-IMMUNOASSAY; DEFICIENCY ANEMIA; FERRITIN INDEX; DIFFERENTIAL-DIAGNOSIS; CHILD UNDERNUTRITION; MICRONUTRIENT STATUS; PLASMA RETINOL	Deficiencies of vitamin A, iron, and iodine are major public health concerns in many low- and middle-income countries, but information on their status in populations is often lacking due to high costs and logistical challenges associated with assessing micronutrient status. Accurate, user-friendly, and low-cost analytical tools are needed to allow large-scale population surveys on micronutrient status. We present the expansion of a 7-plex protein microarray tool for the simultaneous measurement of up to seven biomarkers with relevance to the assessment of the key micronutrients iron, iodine, and vitamin A, and inflammation and malaria biomarkers: a-1-acid glycoprotein, C-reactive protein, ferritin, retinol binding protein 4, soluble transferrin receptor, thyroglobulin, and histidine-rich protein II. Assay performance was assessed using international reference standards and then verified by comparing the multiplexed and conventional immunoassay results on a training panel of plasma samples collected from US adults. These data were used to assign nominal concentrations to the calibrators of the assay to further improve performance which was then assessed by interrogating plasma samples from a cohort of pregnant women from Niger. The correlation between assays for each biomarker measured from this cohort was typically good, with the exception of thyroglobulin, and the sensitivity ranged from 74% to 93%, and specificity from 81% to 98%. The 7-Plex micronutrient assay has the potential for use as an affordable tool for population surveillance of vitamin A, iron, and iodine deficiencies as well as falciparum malarial parasitemia infectivity and inflammation. The assay is easy-to-use, requires minimal sample volume, and is scalable, rapid, and accurate-needing only a low-cost reader and basic equipment present in most reference laboratory settings and so may be employed by low and middle income countries for micronutrient surveillance to inform on status in keypopulations. Micronutrient deficiencies including iron, iodine, and vitamin A affect a significant portion of the world's population. Efforts to assess the prevalence of these deficiencies in vulnerable populations are challenging, partly due to measurement tools that are inadequate for assessing multiple micronutrients in large-scale population surveys. We have developed a 7-plex immunoassay for the simultaneous measurement of seven biomarkers relevant to assessing iodine, iron, and vitamin A status, inflammation and Plasmodium falciparum parasitemia by measuring levels of thyroglobulin, ferritin, soluble transferrin receptor, retinol binding protein 4, alpha-1-acid glycoprotein, C-reactive protein, and histidine-rich protein II. This 7-plex immunoassay technique has potential as a rapid and effective tool for use in large-scale surveys and assessments of nutrition intervention programs in low-and middle-income countries.	[Brindle, Eleanor] Univ Washington, Ctr Studies Demog & Ecol, Seattle, WA 98195 USA; [Lillis, Lorraine; Barney, Rebecca; Kalnoky, Michael; Peck, Roger; Boyle, David S.] PATH, Seattle, WA 98121 USA; [Hess, Sonja Y.; Wessells, K. Ryan; Ouedraogo, Cesaire T.] Univ Calif Davis, Dept Nutr, Program Int & Community Nutr, Davis, CA 95616 USA; [Ouedraogo, Cesaire T.] Helen Keller Int, Niamey, Niger; [Stinca, Sara] Swiss Fed Inst Technol, Lab Human Nutr, Zurich, Switzerland; [Tyler, Abby; Lyman, Christopher] Quansys Biosci, Logan, UT USA	University of Washington; University of Washington Seattle; University of California System; University of California Davis; Swiss Federal Institutes of Technology Domain; ETH Zurich	Boyle, DS (corresponding author), PATH, Seattle, WA 98121 USA.	dboyle@path.org	Brindle, Eleanor/AAK-5028-2021	Brindle, Eleanor/0000-0002-4272-0909; Hess, Sonja/0000-0002-4661-277X	Bill and Melinda Gates Foundation [OPP1110874, OPP1154343]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Support for this research came from the Bill and Melinda Gates Foundation (OPP1110874 and OPP1154343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson A, 1999, SCAND J CLIN LAB INV, V59, P77, DOI 10.1080/00365519950185788; Almekinder J, 2000, SCAND J CLIN LAB INV, V60, P199, DOI 10.1080/003655100750044848; BEADLE C, 1994, LANCET, V343, P564, DOI 10.1016/S0140-6736(94)91520-2; Beguin Y, 2003, CLIN CHIM ACTA, V329, P9, DOI 10.1016/S0009-8981(03)00005-6; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bresnahan KA, 2014, ADV NUTR, V5, P702, DOI 10.3945/an.114.006361; Brindle E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115164; Brindle E, 2010, J IMMUNOL METHODS, V362, P112, DOI 10.1016/j.jim.2010.09.014; Cermak J, 1998, EUR J HAEMATOL, V61, P210; Cook JD, 2005, BEST PRACT RES CL HA, V18, P319, DOI 10.1016/j.beha.2004.08.022; Cotton F, 2000, CLIN BIOCHEM, V33, P263, DOI 10.1016/S0009-9120(00)00071-0; Davies C., IMMUNOASSAY HDB ORY, P11; de Pee S, 2002, J NUTR, V132, p2895S, DOI 10.1093/jn/132.9.2895S; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; Ervasti M, 2004, CLIN LAB HAEMATOL, V26, P205, DOI 10.1111/j.1365-2257.2004.00600.x; Freedman LP, 2016, BIOTECHNIQUES, V61, P16, DOI 10.2144/000114431; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Hess S. Y., 2016, PUBLIC HEALTH NUTR, P1; Hikawa A, 1996, CLIN CHIM ACTA, V254, P159, DOI 10.1016/0009-8981(96)06375-9; Hix J, 2004, AM J CLIN NUTR, V79, P93; Horton R, 2008, LANCET, V371, P179, DOI 10.1016/S0140-6736(07)61869-8; ISHIKAWA K, 1982, CLIN CHIM ACTA, V123, P73, DOI 10.1016/0009-8981(82)90115-2; Larson L, 2017, AM J CLIN NUTR, V106, p390S; Ma ZF, 2014, THYROID, V24, P1195, DOI 10.1089/thy.2014.0052; Malope BI, 2001, BRIT J HAEMATOL, V115, P84, DOI 10.1046/j.1365-2141.2001.03063.x; Mei Z, 2017, AM J CLIN NUTR; Namaste SMI, 2017, AM J CLIN NUTR; NG RH, 1983, CLIN CHEM, V29, P1109; Rimon E, 2002, ARCH INTERN MED, V162, P445, DOI 10.1001/archinte.162.4.445; Rohner F, 2017, AM J CLIN NUTR; Rohner F, 2014, J NUTR, V144, p1322S, DOI 10.3945/jn.113.181974; Rosales FJ, 1996, J LIPID RES, V37, P962; Rosser CJ, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-24; Skikne BS, 2011, AM J HEMATOL, V86, P923, DOI 10.1002/ajh.22108; Stenman UH, 2001, CLIN CHEM, V47, P815; Stinca S, 2017, J CLIN ENDOCR METAB, V102, P23, DOI 10.1210/jc.2016-2829; Stinca S, 2015, THYROID, V25, P1297, DOI 10.1089/thy.2015.0428; Suchdev PS, 2016, ADV NUTR, V7, P349, DOI 10.3945/an.115.010215; Tanumihardjo SA, 2016, J NUTR, V146, P1816, DOI 10.3945/jn.115.229708; Thorpe SJ, 1997, CLIN CHEM, V43, P1582; Thorpe SJ, 2010, CLIN CHEM LAB MED, V48, P815, DOI 10.1515/CCLM.2010.167; Thurnham DI, 2014, P NUTR SOC, V73, P1, DOI 10.1017/S0029665113003662; Tuffrey V., 2016, BMC NUTR, V2, P1, DOI [10.1186/s40795-016-0054-x, DOI 10.1186/S40795-016-0054-X]; Tuffrey V, 2016, EMERG THEMES EPIDEMI, V13, DOI 10.1186/s12982-016-0045-z; Wessells KR, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050430; Wessells KR, 2014, J NUTR, V144, P2050, DOI 10.3945/jn.114.200345; WHO Centers for disease control and prevention, 2007, ASS IR STAT POP; Wians FH, 2001, CLIN CHIM ACTA, V303, P75, DOI 10.1016/S0009-8981(00)00376-4; Wilson DH, 2005, CLIN CHEM, V51, P684, DOI 10.1373/clinchem.2004.042358; Zimmermann MB, 2013, J CLIN ENDOCR METAB, V98, P1271, DOI 10.1210/jc.2012-3952	52	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185868	10.1371/journal.pone.0185868	http://dx.doi.org/10.1371/journal.pone.0185868			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982133	Green Submitted, Green Published, gold			2022-12-26	WOS:000412360300078
J	Cilek, EE; Ozturk, H; Dedeoglu, BG				Cilek, Emine Ezel; Ozturk, Hakime; Dedeoglu, Bala Gur			Construction of miRNA-miRNA networks revealing the complexity of miRNA-mediated mechanisms in trastuzumab treated breast cancer cell lines	PLOS ONE			English	Article							MICRORNA FUNCTION; METASTASIS; BIOGENESIS; WEBGESTALT; RESISTANCE; PATHWAY; DISEASE	Trastuzumab is a monoclonal antibody frequently used to prevent the progression of HER2+ breast cancers, which constitute approximately 20% of invasive breast cancers. microRNAs (miRNAs) are small, non-coding RNA molecules that are known to be involved in gene regulation. With their emerging roles in cancer, they are recently promoted as potential candidates to mediate therapeutic actions by targeting genes associated with drug response. In this study we explored miRNA-mediated regulation of trastuzumab mechanisms by identifying the important miRNAs responsible for the drug response via homogenous network analysis. Our network model enabled us to simplify the complexity of miRNA interactions by connecting them through their common pathways. We outlined the functionally relevant miRNAs by constructing pathway-based miRNA-miRNA networks in SKBR3 and BT474 cells, respectively. Identification of the most targeted genes revealed that trastuzumab responsive miRNAs favourably regulate the repression of targets with longer 3'UTR than average considered to be key elements, while the miRNA-miRNA networks highlighted central miRNAs such as hsa-miR-3976 and hsa-miR-3671 that showed strong interactions with the remaining members of the network. Furthermore, the clusters of the miRNA-miRNA networks showed that trastuzumab response was mostly established through cancer related and metabolic pathways. hsa-miR-216b was found to be the part of the most powerful interactions of metabolic pathways, which was defined in the largest clusters in both cell lines. The network based representation of miRNA-miRNA interactions through their shared pathways provided a better understanding of miRNA-mediated drug response and could be suggested for further characterization of miRNA functions.	[Cilek, Emine Ezel; Dedeoglu, Bala Gur] Ankara Univ, Biotechnol Inst, Ankara, Turkey; [Ozturk, Hakime] Bogazici Univ, Dept Comp Engn, Istanbul, Turkey	Ankara University; Bogazici University	Dedeoglu, BG (corresponding author), Ankara Univ, Biotechnol Inst, Ankara, Turkey.	bdedeoglu@ankara.edu.tr	Dedeoglu, Bala Gur/ABC-2436-2020; Öztürk, Hakime/J-6103-2018; Dedeoglu, Bala Gur/O-1604-2014	Dedeoglu, Bala Gur/0000-0002-4320-5685; Dedeoglu, Bala Gur/0000-0002-4320-5685; Ozturk, Hakime/0000-0002-2146-5638; Cilek, Emine Ezel/0000-0002-4829-4891	Ankara University BAP [14L0415001]; L'Oreal-UNESCO Women in Science Programme; TUBITAK [BIDEB 2211]	Ankara University BAP(Ankara University); L'Oreal-UNESCO Women in Science Programme; TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This study was funded by Ankara University BAP (Award no:14L0415001) (http://bap.ankara.edu.tr/); L'Oreal-UNESCO Women in Science Programme (http://www.forwomeninscience.com/en/) and it was supported by TUBITAK-BIDEB 2211 Scholarship Programme (https://www.tubitak.gov.tr/tr/burslar/).	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bracken CP, 2016, NAT REV GENET, V17, P719, DOI 10.1038/nrg.2016.134; Cao YZ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/724715; Cheng C, 2009, BMC GENOMICS, V10, P6; Chu HW, 2014, HUM MOL GENET, V23, P355, DOI 10.1093/hmg/ddt426; Creixell P, 2015, NAT METHODS, V12, P615, DOI [10.1038/nmeth.3440, 10.1038/NMETH.3440]; De Mattos-Arruda L, 2015, ONCOTARGET, P4; Gligorijevic V, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0571; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Ichikawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031422; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jauffret-Charafe E, 2004, GENE EXPRESSION PROF, P2273; Jung EJ, 2012, CANCER-AM CANCER SOC, V118, P2603, DOI 10.1002/cncr.26565; Kao J., 2009, MOL PROFILING BREAST; Kataoka Y, 2009, ASS GAIN OF FUNCTION, P255; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Le XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041170; Li J., 2016, ASIA COMMUN PHOTONIC, P1, DOI [10.1364/ACPC.2016.AF2A.157, DOI 10.1364/ACPC.2016.AF2A.157]; Lopez-Romero Pedro, 2010, BMC Res Notes, V3, P18, DOI 10.1186/1756-0500-3-18; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma T, 2015, ONCOL REP, V33, P1215, DOI 10.3892/or.2015.3713; Margeli M, 2014, LONG HER STUDY CLIN; Mari G, 2017, DRUG SCREENING GENOM; Min H, 2010, EXP MOL MED, V42, P233, DOI 10.3858/emm.2010.42.4.032; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Muller V, 2014, BREAST CANCER RES TR, V147, P61, DOI 10.1007/s10549-014-3079-3; Nahta Rita, 2012, ISRN Oncol, V2012, P428062, DOI 10.5402/2012/428062; Ozturk H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117874; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Parrella P, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-142; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Richards JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000768; Saxena R, 2011, ERBB FAMILY RECEPTOR, P166; Scaglione KM, 2013, UBIQUITIN CONJUGATIN, P18784; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Tirona MT, 2010, CANCER INVEST, V28, P743, DOI 10.3109/07357907.2010.494321; van Dongen S, 2012, METHODS MOL BIOL, V804, P281, DOI 10.1007/978-1-61779-361-5_15; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Witkos TM, 2011, CURR MOL MED, V11, P93; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Ye XM, 2014, BMB REP, V47, P268, DOI 10.5483/BMBRep.2014.47.5.165; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang JP, 2016, MOL BIOSYST, V12, P454, DOI 10.1039/c5mb00562k; Zhou JD, 2013, ONCOL REP, V30, P1275, DOI 10.3892/or.2013.2592	50	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185558	10.1371/journal.pone.0185558	http://dx.doi.org/10.1371/journal.pone.0185558			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981542	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300044
J	Concha-Marambio, L; Maldonado, P; Lagos, R; Monasterio, O; Montecinos-Franjola, F				Concha-Marambio, Luis; Maldonado, Paula; Lagos, Rosalba; Monasterio, Octavio; Montecinos-Franjola, Felipe			Thermal adaptation of mesophilic and thermophilic FtsZ assembly by modulation of the critical concentration	PLOS ONE			English	Article							DIVISION PROTEIN FTSZ; BACTERIAL-CELL DIVISION; ESCHERICHIA-COLI; GTPASE ACTIVITY; THERMODYNAMIC ANALYSIS; STRUCTURAL INSIGHTS; NUCLEOTIDE TURNOVER; LIGHT-SCATTERING; ANTARCTIC FISHES; IN-VITRO	Cytokinesis is the last stage in the cell cycle. In prokaryotes, the protein FtsZ guides cell constriction by assembling into a contractile ring-shaped structure termed the Z-ring. Constriction of the Z-ring is driven by the GTPase activity of FtsZ that overcomes the energetic barrier between two protein conformations having different propensities to assemble into polymers. FtsZ is found in psychrophilic, mesophilic and thermophilic organisms thereby functioning at temperatures ranging from subzero to >100 degrees C. To gain insight into the functional adaptations enabling assembly of FtsZ in distinct environmental conditions, we analyzed the energetics of FtsZ function from mesophilic Escherichia coli in comparison with FtsZ from thermophilic Methanocaldococcus jannaschii. Presumably, the assembly may be similarly modulated by temperature for both FtsZ orthologs. The temperature dependence of the first-order rates of nucleotide hydrolysis and of polymer disassembly, indicated an entropy-driven destabilization of the FtsZ-GTP intermediate. This destabilization was true for both mesophilic and thermophilic FtsZ, reflecting a conserved mechanism of disassembly. From the temperature dependence of the critical concentrations for polymerization, we detected a change of opposite sign in the heat capacity, that was partially explained by the specific changes in the solvent-accessible surface area between the free and polymerized states of FtsZ. At the physiological temperature, the assembly of both FtsZ orthologs was found to be driven by a small positive entropy. In contrast, the assembly occurred with a negative enthalpy for mesophilic FtsZ and with a positive enthalpy for thermophilic FtsZ. Notably, the assembly of both FtsZ orthologs is characterized by a critical concentration of similar value (1-2 mu M) at the environmental temperatures of their host organisms. These findings suggest a simple but robust mechanism of adaptation of FtsZ, previously shown for eukaryotic tubulin, by adjustment of the critical concentration for polymerization.	[Concha-Marambio, Luis; Maldonado, Paula; Lagos, Rosalba; Monasterio, Octavio; Montecinos-Franjola, Felipe] Univ Chile, Lab Biol Estruct & Mol, Dept Biol, Fac Ciencias, Santiago, Chile; [Concha-Marambio, Luis] Ampr Inc, 11175 Flintkote Ave, San Diego, CA 92121 USA; [Maldonado, Paula] Francis Crick Inst, Lymphocyte Biol Lab, 1 Midland Rd, London NW1 1AT, England; [Montecinos-Franjola, Felipe] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Unit Cytoskeletal Dynam, Div Basic & Translat Biophys, NIH, Bethesda, MD 20892 USA	Universidad de Chile; Francis Crick Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Monasterio, O; Montecinos-Franjola, F (corresponding author), Univ Chile, Lab Biol Estruct & Mol, Dept Biol, Fac Ciencias, Santiago, Chile.; Montecinos-Franjola, F (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Unit Cytoskeletal Dynam, Div Basic & Translat Biophys, NIH, Bethesda, MD 20892 USA.	monaster@uchile.cl; felipe.montecinos@nih.gov	Montecinos, Felipe/HHS-7232-2022; Franjola, Felipe A Montecinos/R-3907-2017; Concha-Marambio, Luis/V-3247-2019	Montecinos, Felipe/0000-0002-1823-103X; Franjola, Felipe A Montecinos/0000-0002-1823-103X; Concha-Marambio, Luis/0000-0002-9454-8389	Becas Chile and Programa de Mejoramiento de la Calidad y Equidad de la Educacion; Comision Nacional de Investigacion Cientifica y Tecnologica [24090139]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [1130711]	Becas Chile and Programa de Mejoramiento de la Calidad y Equidad de la Educacion; Comision Nacional de Investigacion Cientifica y Tecnologica; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	FMF received funding from Becas Chile and Programa de Mejoramiento de la Calidad y Equidad de la Educacion, and was supported by Comision Nacional de Investigacion Cientifica y Tecnologica grant 24090139. OM received financial support from Fondo Nacional de Desarrollo Cientifico y Tecnologico grant 1130711. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Andreu JM, 2002, J BIOL CHEM, V277, P43262, DOI 10.1074/jbc.M206723200; Bertrand S, 2005, J MOL BIOL, V346, P319, DOI 10.1016/j.jmb.2004.11.054; Busiek KK, 2011, MOL MICROBIOL, V82, P535, DOI 10.1111/j.1365-2958.2011.07833.x; Chen YD, 2017, J BIOL CHEM, V292, P5207, DOI 10.1074/jbc.M116.767715; Chen YD, 2011, BIOCHEMISTRY-US, V50, P4675, DOI 10.1021/bi200106d; CHOUDHURY GG, 1987, BIOCHEM CELL BIOL, V65, P558, DOI 10.1139/o87-072; Detrich HW, 1997, COMP BIOCHEM PHYS A, V118, P501, DOI 10.1016/S0300-9629(97)00012-1; Detrich HW, 2000, J BIOL CHEM, V275, P37038, DOI 10.1074/jbc.M005699200; Duggin IG, 2015, NATURE, V519, P362, DOI 10.1038/nature13983; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Erickson HP, 2009, P NATL ACAD SCI USA, V106, P9238, DOI 10.1073/pnas.0902258106; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; Huecas S, 2004, FEBS LETT, V569, P43, DOI 10.1016/j.febslet.2004.05.048; Huecas S, 2003, J BIOL CHEM, V278, P46146, DOI 10.1074/jbc.M307128200; Huecas S, 2008, BIOPHYS J, V94, P1796, DOI 10.1529/biophysj.107.115493; JOHNSON KA, 1979, J MOL BIOL, V133, P199, DOI 10.1016/0022-2836(79)90530-8; KASAI M, 1969, BIOCHIM BIOPHYS ACTA, V180, P399, DOI 10.1016/0005-2728(69)90124-8; LEE JC, 1977, BIOCHEMISTRY-US, V16, P1754, DOI 10.1021/bi00627a037; Lente G, 2005, NEW J CHEM, V29, P759, DOI 10.1039/b501687h; Lindas AC, 2013, NAT REV MICROBIOL, V11, P627, DOI 10.1038/nrmicro3077; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Martin-Galiano AJ, 2010, J BIOL CHEM, V285, P22554, DOI 10.1074/jbc.M110.117127; Mendieta J, 2009, J MOL BIOL, V390, P17, DOI 10.1016/j.jmb.2009.05.018; Mingorance J, 2001, MOL MICROBIOL, V41, P83, DOI 10.1046/j.1365-2958.2001.02498.x; Montecinos-Franjola F, 2014, BBA-PROTEINS PROTEOM, V1844, P1193, DOI 10.1016/j.bbapap.2014.03.012; Montecinos-Franjola F, 2012, BIOPHYS J, V102, P2176, DOI 10.1016/j.bpj.2012.03.064; Monterroso B, 2013, METHODS, V59, P349, DOI 10.1016/j.ymeth.2012.12.014; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Mukherjee A, 2001, J BACTERIOL, V183, P7190, DOI 10.1128/JB.183.24.7190-7197.2001; Ng KH, 2013, ARCHAEA, V2013, DOI 10.1155/2013/104147; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Nova E, 2007, ARCH BIOCHEM BIOPHYS, V465, P315, DOI 10.1016/j.abb.2007.06.032; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Oliva MA, 2003, J BIOL CHEM, V278, P33562, DOI 10.1074/jbc.M303798200; Oliva MA, 2014, ELS; Oliva MA, 2007, J MOL BIOL, V373, P1229, DOI 10.1016/j.jmb.2007.08.056; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Romberg L, 2004, BIOCHEMISTRY-US, V43, P282, DOI 10.1021/bi035465r; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Schmidt O, 2012, CURR BIOL, V22, pR116, DOI 10.1016/j.cub.2012.01.028; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; Sossong TM, 1999, BIOCHEMISTRY-US, V38, P14843, DOI 10.1021/bi990917e; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; SPOLAR RS, 1989, P NATL ACAD SCI USA, V86, P8382, DOI 10.1073/pnas.86.21.8382; Vaughan S, 2004, J MOL EVOL, V58, P19, DOI 10.1007/s00239-003-2523-5; Vulevic B, 1997, BIOPHYS J, V72, P1357, DOI 10.1016/S0006-3495(97)78782-4; WILLIAMS RC, 1985, BIOCHEMISTRY-US, V24, P2790, DOI 10.1021/bi00332a029	55	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185707	10.1371/journal.pone.0185707	http://dx.doi.org/10.1371/journal.pone.0185707			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982174	gold, Green Published, Green Submitted			2022-12-26	WOS:000412360300060
J	Latham, S; Hughes, E; Budged, B; Mechinaud, F; Crock, C; Ekert, H; Campbell, P; Morley, A				Latham, Sue; Hughes, Elizabeth; Budged, Bradley; Mechinaud, Francoise; Crock, Catherine; Ekert, Henry; Campbell, Peter; Morley, Alexander			Sources of error in measurement of minimal residual disease in childhood acute lymphoblastic leukemia	PLOS ONE			English	Article							PERIPHERAL-BLOOD; BONE-MARROW; CHILDREN; INDUCTION; THERAPY; SAMPLES	Introduction The level of minimal residual disease (MRD) in marrow predicts outcome and guides treatment in childhood acute lymphoblastic leukemia (ALL) but accurate prediction depends on accurate measurement. Methods Forty-one children with ALL were studied at the end of induction. Two samples were obtained from each iliac spine and each sample was assayed twice. Assay, sample and side-to-side variation were quantified by analysis of variance and presumptively incorrect decisions related to high-risk disease were determined using the result from each MRD assay, the mean MRD in the patient as the measure of the true value, and each of 3 different MRD cut-off levels which have been used for making decisions on treatment. Results Variation between assays, samples and sides each differed significantly from zero and the overall standard deviation for a single MRD estimation was 0.60 logs. Multifocal residual disease seemed to be at least partly responsible for the variation between samples. Decision errors occurred at a frequency of 13-14% when the mean patient MRD was between 10(-2) and 10(-5). Decision errors were observed only for an MRD result within 1 log of the cut-off value used for assessing high risk. Depending on the cut-off used, 31-40% of MRD results were within 1 log of the cut-off value and 21 -16% of such results would have resulted in a decision error. Conclusion When the result obtained for the level of MRD is within 1 log of the cut-off value used for making decisions, variation in the assay and/or sampling may result in a misleading assessment of the true level of marrow MRD. This may lead to an incorrect decision on treatment.	[Latham, Sue; Hughes, Elizabeth; Budged, Bradley; Morley, Alexander] Flinders Univ S Australia, Dept Haematol & Genet Pathol, Bedford Pk, SA, Australia; [Latham, Sue; Hughes, Elizabeth; Budged, Bradley; Morley, Alexander] Med Ctr, Bedford Pk, SA, Australia; [Mechinaud, Francoise; Ekert, Henry] Royal Childrens Hosp, Childrens Canc Ctr, Parkville, Vic, Australia; [Crock, Catherine] Royal Childrens Hosp, Clin Haematol Dept, Parkville, Vic, Australia; [Campbell, Peter] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England	Flinders University South Australia; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Wellcome Trust Sanger Institute	Morley, A (corresponding author), Flinders Univ S Australia, Dept Haematol & Genet Pathol, Bedford Pk, SA, Australia.; Morley, A (corresponding author), Med Ctr, Bedford Pk, SA, Australia.	alec.morley@flinders.edu.au		Budgen, Brad/0000-0001-9634-3996	Monoquant; Financial Markets for Children	Monoquant; Financial Markets for Children	The research support from Monoquant and the Financial Markets for Children involved grants to Flinders University. These grants provided support in the form of salaries for SL, EH and BB. AM, SL, EH and BB have equity in Monoquant. Neither of the funders had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baum C. F., 2006, INTRO MODERN ECONOME, p[136, 66]; Brisco MJ, 1997, BRIT J HAEMATOL, V99, P314, DOI 10.1046/j.1365-2141.1997.3723186.x; Brisco MJ, 2000, CANCER RES, V60, P5092; BRISCO MJ, 1994, LANCET, V343, P196, DOI 10.1016/S0140-6736(94)90988-1; Campbell PJ, 2003, BRIT J HAEMATOL, V122, P30, DOI 10.1046/j.1365-2141.2003.04356.x; Cave H, 1998, NEW ENGL J MED, V339, P591, DOI 10.1056/NEJM199808273390904; Coustan-Smith E, 2002, BLOOD, V100, P2399, DOI 10.1182/blood-2002-04-1130; Coustan-Smith E, 1998, LANCET, V351, P550, DOI 10.1016/S0140-6736(97)10295-1; GraphPad Software Inc, 2016, GRUBBS TEST DET OUTL; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Marchenko Y, 2006, STATA J, V6, P1; MATHE G, 1966, BMJ-BRIT MED J, V1, P640, DOI 10.1136/bmj.1.5488.640; Morley AA, 2009, J MOL DIAGN, V11, P201, DOI 10.2353/jmoldx.2009.080048; Pieters R, 2016, J CLIN ONCOL, V34, P2591, DOI 10.1200/JCO.2015.64.6364; StataCorp, 2016, STAT STAT SOFTW REL; Sykes PJ, 1998, BRIT J HAEMATOL, V103, P60; Tukey JW, 1977, EXPLORATORY DATA ANA; van der Velden VHJ, 2006, BRIT J HAEMATOL, V133, P382, DOI 10.1111/j.1365-2141.2006.06056.x; van der Velden VHJ, 2002, LEUKEMIA, V16, P1432, DOI 10.1038/sj.leu.2402636; van Dongen JJM, 1998, LANCET, V352, P1731, DOI 10.1016/S0140-6736(98)04058-6	20	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185556	10.1371/journal.pone.0185556	http://dx.doi.org/10.1371/journal.pone.0185556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973007	Green Published, gold			2022-12-26	WOS:000412131900025
J	Villalpando, DM; Rojas, MM; Garcia, HS; Ferrer, M				Villalpando, Diva M.; Rojas, Mibsam M.; Garcia, Hugo S.; Ferrer, Mercedes			Dietary docosahexaenoic acid supplementation prevents the formation of cholesterol oxidation products in arteries from orchidectomized rats	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE-C; CARDIOVASCULAR-DISEASES; MESENTERIC-ARTERY; HUMAN PLASMA; ORAL SUPPLEMENTATION; DIABETES-MELLITUS; ENDOTHELIAL-CELLS; SIGNALING PATHWAY	Testosterone deficiency has been correlated with increased cardiovascular diseases, which in turn has been associated with increased oxidative stress. Several studies have considered cholesterol oxidation products (COPs) as oxidative stress biomarkers, since some of them play pro-oxidant and pro-inflammatory roles. We have previously described the cardio-protective effects of a dosahexaenoic acid (DHA) supplemented diet on the aortic and mesenteric artery function of orchidectomized rats. The aim of this study was to investigate whether impaired gonadal function alters the formation of COPs, as well as the potential preventive role of a DHA-supplemented diet on that effect. For this purpose, aortic and mesenteric artery segments obtained from control and orchidectomized rats, fed with a standard or supplemented with DHA, were used. The content of the following COPs: 7 alpha-hydroxycholesterol, 7 beta-hydroxycholesterol, 7-ketocholesterol, 5,6 alpha-epoxycholesterol, 5,6 beta-epoxycholesterol, cholestanetriol and 25-hydroxycholesterol, were analyzed by gas chromatography. The results showed that orchidectomy increased the formation of COPs in arteries from orchidectomized rats, which may participate in the orchidectomy-induced structural and functional vascular alterations already reported. The fact that the DHA-supplemented diet prevented the orchidectomy-induced COPs increase confirms the cardiovascular protective actions of DHA, which could be of special relevance in mesenteric arterial bed, since it importantly controls the systemic vascular resistance.	[Villalpando, Diva M.; Ferrer, Mercedes] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain; [Rojas, Mibsam M.; Garcia, Hugo S.] Inst Tecnol Veracruz, Unidad Invest & Desarrollo Alimentos, Veracruz, Mexico	Autonomous University of Madrid	Ferrer, M (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain.; Garcia, HS (corresponding author), Inst Tecnol Veracruz, Unidad Invest & Desarrollo Alimentos, Veracruz, Mexico.	hugosgg@gmail.com; mercedes.ferrer@uam.es	Ferrer, Mercedes/E-3556-2018; Parra, Mercedes Ferrer/AAE-1746-2020; Villalpando, Diva/AAG-6337-2020	Parra, Mercedes Ferrer/0000-0002-4670-7146; 	CONACyT (Mexico); Comunidad de Madrid ("INSPIRA1-CM") [S2013/ABI 2783]; Fondo Europeo de Desarrollo Regional	CONACyT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Comunidad de Madrid ("INSPIRA1-CM")(Comunidad de Madrid); Fondo Europeo de Desarrollo Regional(European Commission)	This study was supported by fellowships (to DMV and to MMR) from the CONACyT (Mexico) and grants (to MF) from Comunidad de Madrid (S2013/ABI 2783, INSPIRA1-CM) and Fondo Europeo de Desarrollo Regional. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeywardena MY, 2001, CARDIOVASC RES, V52, P361, DOI 10.1016/S0008-6363(01)00406-0; Abo K, 2000, CLIN BIOCHEM, V33, P541, DOI 10.1016/S0009-9120(00)00167-3; Alba G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042195; Arca M, 2007, FREE RADICAL BIO MED, V42, P698, DOI 10.1016/j.freeradbiomed.2006.12.013; Ares MPS, 2000, ATHEROSCLEROSIS, V153, P23, DOI 10.1016/S0021-9150(00)00380-4; Blanco-Rivero J, 2006, J VASC RES, V43, P101, DOI 10.1159/000089791; Blanco-Rivero J, 2005, J VASC RES, V42, P526, DOI 10.1159/000088342; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Brown AJ, 2009, MOL ASPECTS MED, V30, P111, DOI 10.1016/j.mam.2009.02.005; Burban M, 2016, SHOCK, V46, P549, DOI 10.1097/SHK.0000000000000624; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Cao Jian, 2010, Chinese Medical Sciences Journal, V25, P44; de Medina P, 2010, P NATL ACAD SCI USA, V107, P13520, DOI 10.1073/pnas.1002922107; Debbabi M, 2017, CHEM PHYS LIPIDS; Deckert V, 2002, BRIT J PHARMACOL, V137, P655, DOI 10.1038/sj.bjp.0704920; del Campo L, 2008, J ENDOCRINOL, V197, P371, DOI 10.1677/JOE-07-0647; del Campo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102523; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frenoux JMR, 2001, J NUTR, V131, P39, DOI 10.1093/jn/131.1.39; Garcia-Cruset S, 2001, FREE RADICAL RES, V35, P31, DOI 10.1080/10715760100300571; Guardiola F, 1996, FOOD CHEM TOXICOL, V34, P193, DOI 10.1016/0278-6915(95)00094-1; Guardiola F, 2007, ANAL BIOANAL CHEM, V389, P277, DOI 10.1007/s00216-007-1413-x; Haider A, 2016, VASC HEALTH RISK MAN, V12, P251, DOI 10.2147/VHRM.S108947; Hernandez-Diaz G, 2010, PROSTAG LEUKOTR ESS, V82, P105, DOI 10.1016/j.plefa.2009.12.004; HIGLEY NA, 1984, FOOD CHEM TOXICOL, V22, P983, DOI 10.1016/0278-6915(84)90148-0; Hodis HN, 2000, HYPERTENSION, V36, P436, DOI 10.1161/01.HYP.36.3.436; Khatib S, 2014, BIOCHEM BIOPH RES CO, V446, P709, DOI 10.1016/j.bbrc.2013.12.116; Kiss L, 2006, INT J MOL MED, V18, P1113; Klapcinska B, 2008, J PHYSIOL SCI, V58, P173, DOI 10.2170/physiolsci.RP002208; Kulig W, 2016, CHEM PHYS LIPIDS, V199, P144, DOI 10.1016/j.chemphyslip.2016.03.001; Lemaire-Ewing S, 2009, CELL BIOL TOXICOL, V25, P127, DOI 10.1007/s10565-008-9063-0; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Lizard G, 1999, ARTERIOSCL THROM VAS, V19, P1190, DOI 10.1161/01.ATV.19.5.1190; Luchetti F, 2015, STEROIDS, V99, P204, DOI 10.1016/j.steroids.2015.02.008; Ma WW, 2015, NEUROCHEM RES, V40, P758, DOI 10.1007/s11064-015-1524-2; Martin MD, 2005, NITRIC OXIDE-BIOL CH, V12, P163, DOI 10.1016/j.niox.2005.02.003; Martorell A, 2008, CARDIOVASC RES, V77, P590, DOI 10.1093/cvr/cvm059; Menendez-Carreno M, 2008, LIPIDS, V43, P383, DOI 10.1007/s11745-008-3163-8; Menendez-Carreno M, 2012, ANAL BIOANAL CHEM, V402, P2023, DOI 10.1007/s00216-011-5432-2; Mitic T, 2013, BIOCHIMIE, V95, P548, DOI 10.1016/j.biochi.2012.08.007; Mol MJTM, 1997, ATHEROSCLEROSIS, V129, P169, DOI 10.1016/S0021-9150(96)06022-4; Molavi B, 2004, CURR OPIN CARDIOL, V19, P488, DOI 10.1097/01.hco.0000133657.77024.bd; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Negre-Salvayre A, 2010, FREE RADICAL RES, V44, P1125, DOI 10.3109/10715762.2010.498478; Nishio E, 1996, BIOCHEM BIOPH RES CO, V226, P928, DOI 10.1006/bbrc.1996.1452; Nury T, 2015, STEROIDS, V99, P194, DOI 10.1016/j.steroids.2015.02.003; Ou ZJ, 2016, AM J PHYSIOL-ENDOC M, V311, pE781, DOI 10.1152/ajpendo.00218.2016; Pedruzzi E, 2004, MOL CELL BIOL, V24, P10703, DOI 10.1128/MCB.24.24.10703-10717.2004; PENG SK, 1979, AM J CLIN NUTR, V32, P1033, DOI 10.1093/ajcn/32.5.1033; Plasen Duangporn, 2010, J Med Assoc Thai, V93 Suppl 2, pS59; Poli G, 2008, MED RES REV, V28, P569, DOI 10.1002/med.20117; ROSESALLIN C, 1995, J AGR FOOD CHEM, V43, P935, DOI 10.1021/jf00052a017; Ryan E, 2005, BRIT J NUTR, V94, P443, DOI 10.1079/BJN20051500; Sagredo A, 2011, JOINT M EUR SOC MICR; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; SEVANIAN A, 1986, FOOD CHEM TOXICOL, V24, P1103, DOI 10.1016/0278-6915(86)90295-4; Shibata N, 2010, CIRC J, V74, P2045, DOI 10.1253/circj.CJ-10-0860; Song EA, 2017, INT J BIOCHEM CELL B, V88, P60, DOI 10.1016/j.biocel.2017.05.011; Soto-Rodriguez I, 2008, J FOOD COMPOS ANAL, V21, P489, DOI 10.1016/j.jfca.2008.03.008; Soto-Rodriguez I, 2012, INFLAMMATION, V35, P1302, DOI 10.1007/s10753-012-9442-9; Soto-Rodriguez I, 2009, J APPL TOXICOL, V29, P715, DOI 10.1002/jat.1463; Sottero B, 2009, CURR MED CHEM, V16, P685, DOI 10.2174/092986709787458353; Steffen Y, 2012, NITRIC OXIDE-BIOL CH, V27, P176, DOI 10.1016/j.niox.2012.06.006; SWEELEY CC, 1963, J AM CHEM SOC, V85, P2497, DOI 10.1021/ja00899a032; Tesoriere L, 2015, BRIT J NUTR, V114, P368, DOI 10.1017/S0007114515002111; Testa G, 2016, REDOX BIOL, V10, P24, DOI 10.1016/j.redox.2016.09.001; Uemura M, 2002, EUR J PHARMACOL, V456, P29, DOI 10.1016/S0014-2999(02)02639-0; Upston JM, 2002, AM J PATHOL, V160, P701, DOI 10.1016/S0002-9440(10)64890-0; Vaya J, 2001, FREE RADICAL RES, V34, P485, DOI 10.1080/10715760100300431; Vericel E, 2015, THROMB HAEMOSTASIS, V114, P289, DOI 10.1160/TH14-12-1003; Villalpando DM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168841; Villalpando DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142039; Virginio VWM, 2015, FREE RADICAL RES, V49, P199, DOI 10.3109/10715762.2014.992894; Yogi A, 2011, HYPERTENSION, V57, P809, DOI 10.1161/HYPERTENSIONAHA.110.162719; Zarrouk A., 2017, CURR ALZHEIMER RES; Zarrouk A, 2015, STEROIDS, V99, P238, DOI 10.1016/j.steroids.2015.01.018; Zhang L, 2011, MOL MED REP, V4, P1183, DOI 10.3892/mmr.2011.539	79	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185805	10.1371/journal.pone.0185805	http://dx.doi.org/10.1371/journal.pone.0185805			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968462	Green Published, Green Submitted, gold			2022-12-26	WOS:000412029600051
J	Hodge-Hanson, KM; Downs, DM				Hodge-Hanson, Kelsey M.; Downs, Diana M.			Members of the Rid protein family have broad imine deaminase activity and can accelerate the Pseudomonas aeruginosa D-arginine dehydrogenase (DauA) reaction in vitro	PLOS ONE			English	Article							CONSERVED YJGF FAMILY; SALMONELLA-ENTERICA; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; YJGF/YER057C/UK114 FAMILY; SACCHAROMYCES-CEREVISIAE; ISOLEUCINE BIOSYNTHESIS; UK114; MAINTENANCE; MECHANISM	The Rid (YjgF/YER057c/UK114) protein family is a group of small, sequence diverse proteins that consists of eight subfamilies. The archetypal RidA subfamily is found in all domains, while the Rid1-7 subfamilies are present only in prokaryotes. Bacterial genomes often encode multiple members of the Rid superfamily. The best characterized member of this protein family, RidA from Salmonella enterica, is a deaminase that quenches the reactive metabolite 2-aminoacrylate generated by pyridoxal 5 '-phosphate-dependent enzymes and ultimately spares certain enzymes from damage. The accumulation of 2-aminoacrylate can damage enzymes and lead to growth defects in bacteria, plants, and yeast. While all subfamily members have been annotated as imine deaminases based on the RidA characterization, experimental evidence to support this annotation exists for a single protein outside the RidA subfamily. Here we report that six proteins, spanning Rid subfamilies 1-3, deaminate a variety of imine/enamine substrates with differing specific activities. Proteins from the Rid2 and Rid3 subfamilies, but not from the RidA and Rid1 subfamilies deaminated iminoarginine, generated in situ by the Pseudomonas aeruginosa D-arginine dehydrogenase DauA. These data biochemically distinguished the subfamilies and showed Rid proteins have activity on a metabolite that is physiologically relevant in Pseudomonas and other bacteria.	[Hodge-Hanson, Kelsey M.; Downs, Diana M.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Downs, DM (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	dmdowns@uga.edu			National Institute of General Medical Sciences [R01 GM095837]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095837] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (https.//www.nigms.nih.gov/Pages/default.aspx), grant R01 GM095837 to DMD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi R, 2004, YEAST, V21, P539, DOI 10.1002/yea.1121; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; Borchert AJ, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00140-17; Browne BA, 2006, J BACTERIOL, V188, P6786, DOI 10.1128/JB.00745-06; Burman JD, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-30; Bussolati G, 1997, INT J ONCOL, V10, P779; Ceciliani F, 1996, FEBS LETT, V393, P147, DOI 10.1016/0014-5793(96)00850-2; Chong CL, 2008, CANCER EPIDEM BIOMAR, V17, P535, DOI 10.1158/1055-9965.EPI-07-0506; Christopherson MR, 2008, J BACTERIOL, V190, P3057, DOI 10.1128/JB.01700-07; Deaconescu AM, 2002, PROTEINS, V48, P431, DOI 10.1002/prot.10151; Deriu D, 2003, ACTA CRYSTALLOGR D, V59, P1676, DOI 10.1107/S0907444903014306; Downs DM, 2015, MOL MICROBIOL, V96, P211, DOI 10.1111/mmi.12945; ElRamlawy KG, 2016, J BIOL CHEM, V291, P21607, DOI 10.1074/jbc.M116.728006; Enos-Berlage JL, 1998, J BACTERIOL, V180, P6519, DOI 10.1128/JB.180.24.6519-6528.1998; Ernst DC, 2016, MOL MICROBIOL, V101, P210, DOI 10.1111/mmi.13384; Ernst DC, 2016, J BACTERIOL, V198, P536, DOI 10.1128/JB.00804-15; Ernst DC, 2014, J BACTERIOL, V196, P3335, DOI 10.1128/JB.01960-14; Flynn JM, 2013, MOL MICROBIOL, V89, P751, DOI 10.1111/mmi.12313; Flynn JM, 2013, J BACTERIOL, V195, P3603, DOI 10.1128/JB.00463-13; Galloway NR, 2013, CRYST GROWTH DES, V13, P2833, DOI 10.1021/cg400171z; HAFNER EW, 1979, BIOCHEMISTRY-US, V18, P411, DOI 10.1021/bi00570a004; HILLEBRAND GG, 1979, BIOCHEMISTRY-US, V18, P1751, DOI 10.1021/bi00576a018; JANN A, 1988, J GEN MICROBIOL, V134, P1043; Kim JM, 2001, GENES CELLS, V6, P507, DOI 10.1046/j.1365-2443.2001.00443.x; Lambrecht JA, 2013, MBIO, V4, DOI 10.1128/mBio.00033-13; Lambrecht JA, 2012, J BIOL CHEM, V287, P3454, DOI 10.1074/jbc.M111.304477; Lambrecht JA, 2010, J BIOL CHEM, V285, P34401, DOI 10.1074/jbc.M110.160515; Leitner-Dagan Y, 2006, PLANTA, V225, P89, DOI 10.1007/s00425-006-0332-y; Li C, 2009, P NATL ACAD SCI USA, V106, P906, DOI 10.1073/pnas.0808269106; Manjasetty BA, 2004, PROTEINS, V54, P797, DOI 10.1002/prot.10619; Miyakawa T, 2005, ACTA CRYSTALLOGR F, V61, P828, DOI 10.1107/S1744309105023808; Niehaus TD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1584-3; Niehaus TD, 2014, PLANT CELL, V26, P3010, DOI 10.1105/tpc.114.126854; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Oxelmark E, 2000, MOL CELL BIOL, V20, P7784, DOI 10.1128/MCB.20.20.7784-7797.2000; Parsons L, 2003, BIOCHEMISTRY-US, V42, P80, DOI 10.1021/bi020541w; Racca S, 1997, VIRCHOWS ARCH, V431, P323, DOI 10.1007/s004280050106; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sinha S, 1999, P NATL ACAD SCI USA, V96, P13074, DOI 10.1073/pnas.96.23.13074; VanDrisse CM, 2016, PLASMID, V86, P1, DOI 10.1016/j.plasmid.2016.05.001; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Volz K, 1999, PROTEIN SCI, V8, P2428; WAY JC, 1984, GENE, V32, P369, DOI 10.1016/0378-1119(84)90012-X; Yuan HL, 2011, J AM CHEM SOC, V133, P18957, DOI 10.1021/ja2082729; Yuan H, 2010, BIOCHEMISTRY-US, V49, P9542, DOI 10.1021/bi101420w	45	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185544	10.1371/journal.pone.0185544	http://dx.doi.org/10.1371/journal.pone.0185544			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957411	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200082
J	Modi, HR; Wang, Q; Sahithi, GD; Sherman, D; Greenwald, E; Savonenko, AV; Geocadin, RG; Thakor, NV				Modi, Hiren R.; Wang, Qihong; Sahithi, G. D.; Sherman, David; Greenwald, Elliot; Savonenko, Alena V.; Geocadin, Romergryko G.; Thakor, Nitish V.			Intranasal post-cardiac arrest treatment with orexin-A facilitates arousal from coma and ameliorates neuroinflammation	PLOS ONE			English	Article							TARGETED TEMPERATURE MANAGEMENT; GLOBAL CEREBRAL-ISCHEMIA; THERAPEUTIC HYPOTHERMIA; INFLAMMATORY RESPONSE; QUANTITATIVE EEG; NEURONAL GLYCOCALYX; PARVALBUMIN NEURONS; BRAIN-INJURY; SLEEP-WAKE; TNF-ALPHA	Cardiac arrest (CA) entails significant risks of coma resulting in poor neurological and behavioral outcomes after resuscitation. Significant subsequent morbidity and mortality in post-CA patients are largely due to the cerebral and cardiac dysfunction that accompanies prolonged whole-body ischemia post-CA syndrome (PCAS). PCAS results in strong inflammatory responses including neuroinflammation response leading to poor outcome. Currently, there are no proven neuroprotective therapies to improve post-CA outcomes apart from therapeutic hypothermia. Furthermore, there are no acceptable approaches to promote cortical or cognitive arousal following successful return of spontaneous circulation (ROSC). Hypothalamic orexinergic pathway is responsible for arousal and it is negatively affected by neuroinflammation. However, whether activation of the orexinergic pathway can curtail neuroinflammation is unknown. We hypothesize that targeting the orexinergic pathway via intranasal orexin-A (ORXA) treatment will enhance arousal from coma and decrease the production of proinflammatory cytokines resulting in improved functional outcome after resuscitation. We used a highly validated CA rat model to determine the effects of intranasal ORXA treatment 30-minute post resuscitation. At 4hrs post-CA, the mRNA levels of proinflammatory markers (IL1 beta, iNOS, TNF-alpha, GFAP, CD11b) and orexin receptors (ORX1R and ORX2R) were examined in different brain regions. CA dramatically increased proinflammatory markers in all brain regions particularly in the prefrontal cortex, hippocampus and hypothalamus. Post-CA intranasal ORXA treatment significantly ameliorated the CA-induced neuroinflammatory markers in the hypothalamus. ORXA administration increased production of orexin receptors (ORX1R and ORX2R) particularly in hypothalamus. In addition, ORXA also resulted in early arousal as measured by quantitative electroencephalogram (EEG) markers, and recovery of the associated behavioral neurologic deficit scale score (NDS). Our results indicate that intranasal delivery of ORXA post-CA has an anti-inflammatory effect and accelerates cortical EEG and behavioral recovery. Beneficial outcomes from intranasal ORXA treatment lay the groundwork for therapeutic clinical approach to treating post-CA coma.	[Modi, Hiren R.; Wang, Qihong; Sahithi, G. D.; Sherman, David; Greenwald, Elliot; Thakor, Nitish V.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Savonenko, Alena V.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Savonenko, Alena V.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Geocadin, Romergryko G.] Johns Hopkins Univ, Sch Med, Neurol & Anesthesiol Crit Care Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Thakor, NV (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	nitish@jhu.edu	Thakor, Nitish V/A-5878-2008; Savonenko, Alena/AAT-2274-2021	Modi, Hiren/0000-0003-1731-7111	NHLBI, NIH [R01HL071568]	NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was sponsored by NHLBI, NIH grant R01HL071568, https://projectreponter.nit.gov/project_into_description.ctm?aid =90853718&icde=33528322&daparama=&ddavalue= &dasuba=&cr=1 &csn=detault&cs-ASC8ipball=.	Adrie Christophe, 2004, Curr Opin Crit Care, V10, P208, DOI 10.1097/01.ccx.0000126090.06275.fe; Akbari Y, 2012, CIRCULATION, V126, pA2; Bendel S, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/1471-2253-15-2; Benson DM, 2005, RESUSCITATION, V64, P209, DOI 10.1016/j.resuscitation.2003.03.001; Bro-Jeppesen J, 2015, CRIT CARE MED, V43, P1223, DOI 10.1097/CCM.0000000000000937; Bro-Jeppesen J, 2014, RESUSCITATION, V85, P1480, DOI 10.1016/j.resuscitation.2014.08.007; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Callaway CW, 2008, CRIT CARE MED, V36, P2607, DOI 10.1097/CCM.0b013e318184443b; Cantero JL, 2004, NEUROIMAGE, V22, P1271, DOI 10.1016/j.neuroimage.2004.03.014; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chaudhry H, 2013, IN VIVO, V27, P669; Claassen J, 2016, ANN NEUROL, V80, P541, DOI 10.1002/ana.24752; de la Tremblaye PB, 2017, PROG NEURO-PSYCHOPH, V79, P234, DOI 10.1016/j.pnpbp.2017.06.021; Deng RX, 2015, NEUROCRIT CARE, V23, P262, DOI 10.1007/s12028-015-0157-2; Deutschman CS, 2013, CRIT CARE MED, V41, pE368, DOI 10.1097/CCM.0b013e31828e9843; Drabek T, 2015, THER HYPOTHERMIA TEM, V5, P26, DOI 10.1089/ther.2014.0013; Duffy CM, 2015, NEUROSCI LETT, V606, P140, DOI 10.1016/j.neulet.2015.08.033; Espana RA, 2005, J COMP NEUROL, V481, P160, DOI 10.1002/cne.20369; Fries M, 2009, J CRIT CARE, V24, P453, DOI 10.1016/j.jcrc.2008.10.012; Gaieski DF, 2009, RESUSCITATION, V80, P418, DOI 10.1016/j.resuscitation.2008.12.015; Geocadin RG, 2000, CLIN NEUROPHYSIOL, V111, P1779, DOI 10.1016/S1388-2457(00)00379-5; Geocadin RG, 2000, MOVEMENT DISORD, V15, P14, DOI 10.1002/mds.870150704; Geocadin RG, 2008, NEUROL CLIN, V26, P487, DOI 10.1016/j.ncl.2008.03.015; Janata A, 2014, RESUSCITATION, V85, P694, DOI 10.1016/j.resuscitation.2014.01.033; Jia XF, 2008, RESUSCITATION, V78, P367, DOI 10.1016/j.resuscitation.2008.04.011; Jia XF, 2008, RESUSCITATION, V76, P431, DOI 10.1016/j.resuscitation.2007.08.014; Jia XF, 2006, BRAIN RES, V1111, P166, DOI 10.1016/j.brainres.2006.04.121; Jones BE, 2013, SLEEP, V36, P1769, DOI 10.5665/sleep.3188; Kang XX, 2009, IEEE T BIO-MED ENG, V56, P1023, DOI 10.1109/TBME.2008.2011917; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; Kim T, 2015, P NATL ACAD SCI USA, V112, P3535, DOI 10.1073/pnas.1413625112; Kim YJ, 2006, J NEUROSCI RES, V84, P1037, DOI 10.1002/jnr.21011; Koenig MA, 2009, BRAIN RES, V1255, P153, DOI 10.1016/j.brainres.2008.11.102; Kostin A, 2013, NEUROSCIENCE, V254, P275, DOI 10.1016/j.neuroscience.2013.09.022; Lambertsen KL, 2012, J CEREBR BLOOD F MET, V32, P1677, DOI 10.1038/jcbfm.2012.88; Linnartz B, 2013, GLIA, V61, P37, DOI 10.1002/glia.22359; Linnartz B, 2012, J NEUROSCI, V32, P946, DOI 10.1523/JNEUROSCI.3830-11.2012; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchant DJ, 2012, CIRC RES, V110, P126, DOI 10.1161/CIRCRESAHA.111.243170; Munk MHJ, 1996, SCIENCE, V272, P271, DOI 10.1126/science.272.5259.271; Murakami Y, 2005, J NEUROCHEM, V93, P1616, DOI 10.1111/j.1471-4159.2005.03163.x; Nagao K, 2012, CURR OPIN CRIT CARE, V18, P239, DOI 10.1097/MCC.0b013e3283523f4a; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Saito K, 1996, NEUROSCI LETT, V206, P149, DOI 10.1016/S0304-3940(96)12460-5; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Samborska-Sablik A, 2011, ARCH MED SCI, V7, P619, DOI 10.5114/aoms.2011.24131; Schmidt MR, 2013, CIRC RES, V113, P1278, DOI 10.1161/CIRCRESAHA.113.302942; Sherman DL, 1998, PROCEEDINGS OF THE IEEE-SP INTERNATIONAL SYMPOSIUM ON TIME-FREQUENCY AND TIME-SCALE ANALYSIS, P561, DOI 10.1109/TFSA.1998.721486; Sinton CM, 2011, SLEEP MED REV, V15, P197, DOI 10.1016/j.smrv.2010.12.003; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Wakselman S, 2008, J NEUROSCI, V28, P8138, DOI 10.1523/JNEUROSCI.1006-08.2008; Wang YF, 2016, CIRC RES, V119, P222, DOI 10.1161/CIRCRESAHA.116.308559; Xiang YX, 2016, BIOMED REP, V5, P11, DOI 10.3892/br.2016.677; Xiao F, 2013, NEUROPHARMACOLOGY, V67, P16, DOI 10.1016/j.neuropharm.2012.10.021; Xiong XX, 2013, STROKE, V44, P764, DOI 10.1161/STROKEAHA.112.681700; Yasuda Y, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-70; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e; Zuercher P, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0565-8	65	48	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0182707	10.1371/journal.pone.0182707	http://dx.doi.org/10.1371/journal.pone.0182707			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957432	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200005
J	Yeh, TN; Lin, MC				Yeh, Thao N.; Lin, Meng C.			Risk factors for severe Meibomian gland atrophy in a young adult population: A cross-sectional study	PLOS ONE			English	Article							NONCONTACT INFRARED MEIBOGRAPHY; FILM LIPID LAYER; CONTACT-LENS WEARERS; DRY EYE SYMPTOMS; TEAR FILM; GENE-EXPRESSION; INTERNATIONAL WORKSHOP; ORAL-CONTRACEPTIVES; LOGISTIC-REGRESSION; DYSFUNCTION REPORT	Purpose Assess potential risk factors for severe Meibomian gland atrophy (SMGA) in a young adult population. Methods Cross-sectional study using medical history and ocular surface examination to evaluate relationships with study outcomes: SMGA, tear lipid layer (TLL) thickness, non-invasive (NITBUT) and fluorescein (FTBUT) tear breakup times, and symptoms using the Standard Patient Evaluation of Eye Dryness (SPEED) questionnaire. Results One hundred one participants (101; 202 eyes; Age: mean +/- SD = 22.3 +/- 4.0 years) completed the study. Hormonal birth control (HBC) use was the only significant risk factor for SMGA (p = 0.028). Female HBC users had 4.8 times greater odds of having SMGA compared to female HBC non-users (p = 0.028), but the odds of having SMGA was similar between female HBC non-users and males (p = 0.885). Multivariable analysis suggested that the relationship between SMGA and TLL thickness was dependent on HBC use. Compared to female HBC non-users without SMGA, TLL thickness for HBC users was estimated to be 10 nm thinner if SMGA was absent (p = 0.007) and 21 nm thinner if SMGA was present (p<0.001). SMGA status had no significant impact on TLL thickness among female HBC non-users (p = 0.552). The effect of TLL thickness on FTBUT was small but significant (p = 0.026). TLL thickness was not significantly associated with NITBUT (p = 0.349). Neither FTBUT nor NITBUT was significantly associated with the SPEED score. Conclusion HBC use may be associated with SMGA, supporting the hypothesis that SMGA could lead to thinner TLL. However, less evidence was present to support that thin TLL could lead to clinically detectable tear film instability and subsequently to increased ocular dryness symptoms. Further investigation with a larger sample size is warranted to confirm these findings.	[Yeh, Thao N.; Lin, Meng C.] Univ Calif Berkeley, Sch Optometry, Clin Res Ctr, Berkeley, CA 94720 USA; [Yeh, Thao N.; Lin, Meng C.] Univ Calif Berkeley, Vis Sci Grad Grp, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Lin, MC (corresponding author), Univ Calif Berkeley, Sch Optometry, Clin Res Ctr, Berkeley, CA 94720 USA.; Lin, MC (corresponding author), Univ Calif Berkeley, Vis Sci Grad Grp, Berkeley, CA 94720 USA.	mlin@berkeley.edu			National Institute of Health/National Eye Institute [5K12EY017269-05]; Roberta Smith Research Fund; NATIONAL EYE INSTITUTE [K23EY026655] Funding Source: NIH RePORTER	National Institute of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Roberta Smith Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work received support from the National Institute of Health/National Eye Institute, 5K12EY017269-05, to TNY and the Roberta Smith Research Fund, to MCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghamdi WM, 2016, OPHTHAL PHYSL OPT, V36, P120, DOI 10.1111/opo.12278; Argiles M, 2015, INVEST OPHTH VIS SCI, V56, P6679, DOI 10.1167/iovs.15-16967; Arita R, 2008, OPHTHALMOLOGY, V115, P911, DOI 10.1016/j.ophtha.2007.06.031; Arita R, 2009, OPHTHALMOLOGY, V116, P379, DOI 10.1016/j.ophtha.2008.10.012; Asiedu K, 2016, CORNEA, V35, P175, DOI 10.1097/ICO.0000000000000712; Ban Y, 2013, OCUL SURF, V11, P47, DOI 10.1016/j.jtos.2012.09.005; BROWN SI, 1969, ARCH OPHTHALMOL-CHIC, V82, P537, DOI 10.1001/archopht.1969.00990020539019; Cardona G, 2011, CURR EYE RES, V36, P190, DOI 10.3109/02713683.2010.544442; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Eom Y, 2013, AM J OPHTHALMOL, V155, P1104, DOI 10.1016/j.ajo.2013.01.008; Finis D, 2015, CURR EYE RES, V40, P982, DOI 10.3109/02713683.2014.971929; Finis D, 2013, CORNEA, V32, P1549, DOI 10.1097/ICO.0b013e3182a7f3e1; Gipson IK, 2007, OCUL SURF, V5, P179; Greiner JV, 2012, CURR EYE RES, V37, P272, DOI 10.3109/02713683.2011.631721; Greiner JV, 2002, ADV EXP MED BIOL, V506, P507; Herok GH, 2009, CURR EYE RES, V34, P589, DOI 10.1080/02713680902972366; Himebaugh NL, 2009, OPTOMETRY VISION SCI, V86, P106, DOI 10.1097/OPX.0b013e318194e962; Hirota M, 2013, OPTOMETRY VISION SCI, V90, P650, DOI 10.1097/OPX.0b013e31829962ec; HOLLY FJ, 1973, EXP EYE RES, V15, P515, DOI 10.1016/0014-4835(73)90064-X; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Ji YW, 2017, CORNEA, V36, P176, DOI 10.1097/ICO.0000000000001101; Kawashima M, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-34; King-Smith PE, 2013, OCUL SURF, V11, P236, DOI 10.1016/j.jtos.2013.05.003; Knop E, 2011, INVEST OPHTH VIS SCI, V52, P1938, DOI 10.1167/iovs.10-6997c; Korb Donald R, 2005, Eye Contact Lens, V31, P2, DOI 10.1097/01.ICL.0000140910.03095.FA; Korb DR, 2010, CORNEA, V29, P377, DOI 10.1097/ICO.0b013e3181ba0cb2; Lin MC, 2016, INVESTIGATIVE OPHTHA, V57; Lin MC, 2014, AM AC OPT ANN C DENV; Machalinska A, 2015, CORNEA, V34, P1098, DOI 10.1097/ICO.0000000000000511; Matsumoto Y, 2008, MOL VIS, V14, P1263; Napoli PE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165558; Ousler GW, 2014, CLIN OPHTHALMOL, V8, P869, DOI 10.2147/OPTH.S56783; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pucker AD, 2015, OPTOMETRY VISION SCI, V92, pE206, DOI 10.1097/OPX.0000000000000650; Pult H, 2013, OPTOMETRY VISION SCI, V90, P1034, DOI 10.1097/OPX.0000000000000029; Pult H, 2012, OPTOMETRY VISION SCI, V89, pE310, DOI 10.1097/OPX.0b013e318244e487; Satjawatcharaphong P, 2015, OPTOMETRY VISION SCI, V92, pE334, DOI 10.1097/OPX.0000000000000670; Schaumberg DA, 2011, INVEST OPHTH VIS SCI, V52, P1994, DOI 10.1167/iovs.10-6997e; Schirra F, 2005, INVEST OPHTH VIS SCI, V46, P3666, DOI 10.1167/iovs.05-0426; Sullivan DA, 2002, ANN NY ACAD SCI, V966, P211, DOI 10.1111/j.1749-6632.2002.tb04217.x; Sullivan DA, 2009, MOL VIS, V15, P1553; Suzuki T, 2008, INVEST OPHTH VIS SCI, V49, P1797, DOI 10.1167/iovs.07-1458; TIFFANY JM, 1987, ADV LIPID RES, V22, P1; VANDERVANGE N, 1990, CONTRACEPTION, V41, P345, DOI 10.1016/0010-7824(90)90034-S; Wan T, 2015, CURR EYE RES, V19, P1; Whitcher JP, 2010, AM J OPHTHALMOL, V149, P405, DOI 10.1016/j.ajo.2009.09.013; Wiegratz I, 2003, CONTRACEPTION, V67, P25, DOI 10.1016/S0010-7824(02)00436-5; Yamaguchi M, 2006, AM J OPHTHALMOL, V141, P669, DOI 10.1016/j.ajo.2005.11.004; Yeh TN, 2015, OPTOMETRY VISION SCI, V92, pE264, DOI 10.1097/OPX.0000000000000649	49	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185603	10.1371/journal.pone.0185603	http://dx.doi.org/10.1371/journal.pone.0185603			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957399	Green Published, gold			2022-12-26	WOS:000411985200091
J	Jing, Y; Nguyen, MM; Wang, D; Pascal, LE; Guo, W; Xu, Y; Ai, J; Deng, FM; Masoodi, KZ; Yu, X; Zhang, J; Nelson, JB; Xia, S; Wang, Z				Jing, Y.; Nguyen, M. M.; Wang, D.; Pascal, L. E.; Guo, W.; Xu, Y.; Ai, J.; Deng, F-M; Masoodi, K. Z.; Yu, X.; Zhang, J.; Nelson, J. B.; Xia, S.; Wang, Z.			DHX15 promotes prostate cancer progression by stimulating Siah2-mediated ubiquitination of androgen receptor	ONCOGENE			English	Article							NUCLEAR EXPORT SIGNAL; BOX RNA HELICASE; TRANSCRIPTIONAL ACTIVITY; LIGASE SIAH2; TERMINAL SEQUENCES; SPLICING FACTORS; SPLICEOSOME; BINDING; STABILITY; RESPONSES	Androgen receptor (AR) activation is critical for prostate cancer (PCa) development and progression, including castration resistance. The nuclear export signal of AR (NESAR) has an important role in AR intracellular trafficking and proteasome-dependent degradation. Here, we identified the RNA helicase DHX15 as a novel AR co-activator using a yeast mutagenesis screen and revealed that DHX15 regulates AR activity by modulating E3 ligase Siah2-mediated AR ubiquitination independent of its ATPase activity. DHX15 and Siah2 form a complex with AR, through NESAR. DHX15 stabilized Siah2 and enhanced its E3 ubiquitin-ligase activity, resulting in AR activation. Importantly, DHX15 was upregulated in PCa specimens and its expression was correlated with Gleason scores and prostate-specific antigen recurrence. Furthermore, DHX15 immunostaining correlated with Siah2. Finally, DHX15 knockdown inhibited the growth of C4-2 prostate tumor xenografts in mice. Collectively, our data argue that DHX15 enhances AR transcriptional activity and contributes to PCa progression through Siah2.	[Jing, Y.; Xia, S.] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Urol, Sch Med, Shanghai, Peoples R China; [Jing, Y.; Nguyen, M. M.; Wang, D.; Pascal, L. E.; Guo, W.; Xu, Y.; Ai, J.; Masoodi, K. Z.; Nelson, J. B.; Wang, Z.] Univ Pittsburgh, Sch Med, Dept Urol, Inst Canc, Pittsburgh, PA 15232 USA; [Guo, W.] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Pathol, Sch Med, Shanghai, Peoples R China; [Xu, Y.] Cent S Univ, Xiangya Hosp 2, Dept Urol, Changsha, Hunan, Peoples R China; [Xu, Y.] Cent S Univ, Xiangya Hosp 3, Changsha, Hunan, Peoples R China; [Deng, F-M] NYU, Sch Med, Dept Pathol, New York, NY USA; [Masoodi, K. Z.] SKUAST K, Div Plant Biotechnol, Transcript Lab, Srinagar, Jammu & Kashmir, India; [Yu, X.] Guangzhou Gen Hosp Guangzhou Mil Command, Dept Geriatr, Guangzhou, Guangdong, Peoples R China; [Yu, X.] Guangdong Prov Key Lab Geriatr Infect & Organ Fun, Guangzhou, Guangdong, Peoples R China; [Yu, X.] Guangzhou Key Lab Geriatr Infect & Organ Funct Su, Guangzhou, Guangdong, Peoples R China; [Yu, X.] Southern Med Univ, Tradit Chinese Med Integrated Hosp, Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Zhang, J.] Guangxi Med Univ, Ctr Translat Med, Nanning, Guangxi, Peoples R China; [Zhang, J.] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA 15232 USA; [Nelson, J. B.; Wang, Z.] Univ Pittsburgh, Sch Med, Inst Canc, Dept Mol Pharmacol & Chem Biol, Pittsburgh, PA 15232 USA; [Wang, Z.] Univ Pittsburgh, Sch Med, Inst Canc, Dept Pathol, Pittsburgh, PA 15232 USA	Shanghai Jiao Tong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Shanghai Jiao Tong University; Central South University; Central South University; New York University; Sher-e-Kashmir University of Agricultural Sciences & Technology of Kashmir (SKUAST Kashmir); Southern Theater Command General Hospital; Southern Medical University - China; Guangxi Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xia, S; Wang, Z (corresponding author), Univ Pittsburgh, Sch Med, Inst Canc, Dept Pathol, Pittsburgh, PA 15232 USA.; Xia, S; Wang, Z (corresponding author), Univ Pittsburgh, Sch Med, Inst Canc, Dept Urol,Dept Mol Pharmacol & Chem Biol, Pittsburgh, PA 15232 USA.	xsjurologist@163.com; wangz2@upmc.edu	Masoodi, Khalid Z/F-1787-2015; Pascal, Laura E./AAH-5743-2019; Masoodi, KhalidZ./ABG-5492-2021	Masoodi, Khalid Z/0000-0002-4889-5558; Pascal, Laura E./0000-0003-3840-1662; Masoodi, KhalidZ./0000-0002-4889-5558	NIH [R01 CA186780, R01 CA108675, R50 CA211242-01]; ACS [PF-05-229-01-CSM]; Department of Defense Prostate Cancer Research Program Award [W81XWH-14-2-0182, W81XWH-14-2-0183, W81XWH-14-2-0185, W81XWH-14-2-0186, W81XWH-15-2-0062 PCBN]; National Nature Science Foundation of China [81402091]; National Natural Science Foundation of China [81130046, 2013GXNSFEA053004]; Urology Care Foundation of the American Urological Association; Mellam Family Fellowship; Tippens Scholarship; UPCI; Tissue and Research Pathology Services (TARPS) [NCI CCSG P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904, R01CA186780, R01CA108675, R50CA211242] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS(American Cancer Society); Department of Defense Prostate Cancer Research Program Award(United States Department of Defense); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Urology Care Foundation of the American Urological Association; Mellam Family Fellowship; Tippens Scholarship; UPCI; Tissue and Research Pathology Services (TARPS); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Aiyuan Zhang for technical support, Richard Gaber (Northwestern University) for advice on yeast screen, the PCBN for TMA with PCa specimens, Megan Lambert, Krystal Roskov and Robin Frederick for animal husbandry, and members of the Wang Lab for discussion. This work was supported in part by NIH R01 CA186780 (ZW), NIH R01 CA108675 (ZW), ACS #PF-05-229-01-CSM (MMN), the Department of Defense Prostate Cancer Research Program Award No W81XWH-14-2-0182, W81XWH-14-2-0183, W81XWH-14-2-0185, W81XWH-14-2-0186, and W81XWH-15-2-0062 PCBN, National Nature Science Foundation of China # 81402091 (YJ), and National Natural Science Foundation of China Key Project 81130046 (JZ) and 2013GXNSFEA053004 (JZ). This work was also supported by a post-doctoral fellowship from the Urology Care Foundation of the American Urological Association (DW), the Mellam Family Fellowship (DW and KZM), the Tippens Scholarship (LEP) and NIH R50 CA211242-01 (LEP). In addition, this research was supported by the UPCI Animal Facility, Vector Core and Tissue and Research Pathology Services (TARPS) funded through NCI CCSG P30CA047904.	Arenas JE, 1997, P NATL ACAD SCI USA, V94, P11798, DOI 10.1073/pnas.94.22.11798; BROWN JD, 1992, EMBO J, V11, P3721, DOI 10.1002/j.1460-2075.1992.tb05457.x; Chan Siu Chiu, 2014, Adv Pharmacol, V70, P327, DOI 10.1016/B978-0-12-417197-8.00011-0; Chymkowitch P, 2011, EMBO J, V30, P468, DOI 10.1038/emboj.2010.337; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Coffey K, 2012, J ENDOCRINOL, V215, P221, DOI 10.1530/JOE-12-0238; Combs DJ, 2006, MOL CELL BIOL, V26, P523, DOI 10.1128/MCB.26.2.523-534.2006; Dong XS, 2007, MOL CELL BIOL, V27, P4863, DOI 10.1128/MCB.02144-06; Ferraldeschi R, 2015, ONCOGENE, V34, P1745, DOI 10.1038/onc.2014.115; Fouraux MA, 2002, RNA, V8, P1428, DOI 10.1017/S1355838202021076; Fourmann JB, 2013, GENE DEV, V27, P413, DOI 10.1101/gad.207779.112; Freeman MR, 2013, ASIAN J ANDROL, V15, P447, DOI 10.1038/aja.2013.62; Fukuba H, 2008, NEUROSCI LETT, V433, P209, DOI 10.1016/j.neulet.2007.12.069; Gaughan L, 2005, NUCLEIC ACIDS RES, V33, P13, DOI 10.1093/nar/gki141; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Gong YQ, 2012, ENDOCRINOLOGY, V153, P5716, DOI 10.1210/en.2012-1841; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Haider AS, 2010, INTERN MED J, V40, P281, DOI 10.1111/j.1445-5994.2009.02041.x; Hellerstedt BA, 2002, CA-CANCER J CLIN, V52, P154, DOI 10.3322/canjclin.52.3.154; Hu G, 1999, MOL CELL BIOL, V19, P724; Kobayashi T, 2013, INT J MOL SCI, V14, P15615, DOI 10.3390/ijms140815615; Koodathingal P, 2010, MOL CELL, V39, P385, DOI 10.1016/j.molcel.2010.07.014; Li B., 2014, RECEPTORS CLIN INVES, V1, DOI 10.14800%14802Frci.14122; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Mosallanejad K, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004841; Nadeau RJ, 2007, J CELL BIOCHEM, V100, P151, DOI 10.1002/jcb.21040; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nakayama K, 2009, MOL CANCER RES, V7, P443, DOI 10.1158/1541-7786.MCR-08-0458; Nguyen MM, 2014, INT J CLIN EXP PATHO, V7, P2768; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; Poukka H, 2000, J CELL SCI, V113, P2991; Qi JF, 2013, CANCER CELL, V23, P332, DOI 10.1016/j.ccr.2013.02.016; Rajan P, 2008, J PATHOL, V215, P67, DOI 10.1002/path.2324; Reed JC, 2002, NAT STRUCT BIOL, V9, P8, DOI 10.1038/nsb0102-8; Saporita AJ, 2003, J BIOL CHEM, V278, P41998, DOI 10.1074/jbc.M302460200; Scortegagna M, 2011, J BIOL CHEM, V286, P27333, DOI 10.1074/jbc.M111.218214; Shafi AA, 2013, PHARMACOL THERAPEUT, V140, P223, DOI 10.1016/j.pharmthera.2013.07.003; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Tanaka N, 2007, GENE DEV, V21, P2312, DOI 10.1101/gad.1580507; Walbott H, 2010, EMBO J, V29, P2194, DOI 10.1038/emboj.2010.102; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021; Zhang JS, 1998, GENE DEV, V12, P1775, DOI 10.1101/gad.12.12.1775; Zhao HL, 2010, BIOCHEM BIOPH RES CO, V399, P623, DOI 10.1016/j.bbrc.2010.07.127; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115	46	33	34	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 1	2018	37	5					638	650		10.1038/onc.2017.371	http://dx.doi.org/10.1038/onc.2017.371			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FU4GT	28991234	Green Accepted			2022-12-26	WOS:000423812200009
J	Masola, V; Zaza, G; Bellin, G; Dall'Olmo, L; Granata, S; Vischini, G; Secchi, MF; Lupo, A; Gambaro, G; Onisto, M				Masola, Valentina; Zaza, Gianluigi; Bellin, Gloria; Dall'Olmo, Luigi; Granata, Simona; Vischini, Gisella; Secchi, Maria Francesca; Lupo, Antonio; Gambaro, Giovanni; Onisto, Maurizio			Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury	FASEB JOURNAL			English	Article						kidney; inflammation; cytokines; SST0001	ISCHEMIA-REPERFUSION INJURY; TOLL-LIKE RECEPTOR-4; ACUTE KIDNEY INJURY; GROUP BOX-1 PROTEIN; DENDRITIC CELLS; INFLAMMATION; ACTIVATION; EXPRESSION; MONOCYTES; CONTRIBUTE	Heparanase (HPSE) is part of the biologic network triggered by ischemia/reperfusion (I/R) injury, a complication of renal transplantation and acute kidney injury. During this period, the kidney or graft undergoes a process of macrophages recruitment and activation. HPSE may therefore control these biologic effects. We measured the ability of HPSE and its inhibitor, SST0001, to regulate macrophage polarization and the crosstalk between macrophages and HK-2 renal tubular cells during in vitro hypoxia/reoxygenation (H/R). Furthermore, we evaluated in vivo renal inflammation, macrophage polarization, and histologic changes in mice subjected to monolateral I/R and treated with SST0001 for 2 or 7 d. The in vitro experiments showed that HPSE sustained M1 macrophage polarization and modulated apoptosis, the release of damage associated molecular patterns in post-H/R tubular cells, the synthesis of proinflammatory cytokines, and the up-regulation of TLRs on both epithelial cells and macrophages. HPSE also regulated M1 polarization induced by H/R-injured tubular cells and the partial epithelial-mesenchymal transition of these epithelial cells by M1 macrophages. All these effects were prevented by inhibiting HPSE. Furthermore, the inhibition of HPSE in vivo reduced inflammation and M1 polarization in mice undergoing I/R injury, partially restored renal function and normal histology, and reduced apoptosis. These results show for the first time that HPSE regulates macrophage polarization as well as renal damage and repair after I/R. HPSE inhibitors could therefore provide a new pharmacologic approach to minimize acute kidney injury and to prevent the chronic profibrotic damages induced by I/R.	[Masola, Valentina; Zaza, Gianluigi; Bellin, Gloria; Granata, Simona; Lupo, Antonio] Univ Hosp Verona, Dept Med, Renal Unit, Piazzale A Stefani 1, I-37126 Verona, VR, Italy; [Dall'Olmo, Luigi] Osped San Giovanni & Paolo, Azienda Ulss Serenissima 3, Venice, Italy; [Vischini, Gisella; Gambaro, Giovanni] Univ Cattolica Sacro Cuore, Renal Unit, Rome, Italy; [Secchi, Maria Francesca; Onisto, Maurizio] Univ Padua, Dept Biomed Sci Padova, Padua, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; ULSS 3 Serenissima; Ospedale SS Giovanni Paolo Venezia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Padua	Zaza, G (corresponding author), Univ Hosp Verona, Dept Med, Renal Unit, Piazzale A Stefani 1, I-37126 Verona, VR, Italy.	gianluigi.zaza@univr.it	Onisto, Maurizio/K-5281-2014; Zaza, Gianluigi/K-3827-2018; Vischini, Gisella/N-9980-2019	Onisto, Maurizio/0000-0002-1191-7418; Vischini, Gisella/0000-0001-5829-4396; Gambaro, Giovanni/0000-0001-5733-2370; Masola, Valentina/0000-0003-2341-2481; Zaza, Gianluigi/0000-0002-6004-6196; dall'olmo, luigi/0000-0003-1564-2594	Leadiant Biosciences; University of Padova [CPDA144519/14]	Leadiant Biosciences; University of Padova	The authors thank A. Noseda (Leadiant Biosciences, Mendrisio, Switzerland) for continuous support. This work was supported by a grant from Leadiant Biosciences, and by a grant provided by the University of Padova (CPDA144519/14).	Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Bergler T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156900; Blich M, 2013, ARTERIOSCL THROM VAS, V33, pE56, DOI 10.1161/ATVBAHA.112.254961; Chadban SJ, 2010, SEMIN NEPHROL, V30, P278, DOI 10.1016/j.semnephrol.2010.03.009; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Garsen M, 2016, AM J PATHOL, V186, P805, DOI 10.1016/j.ajpath.2015.12.008; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goldberg R, 2014, DIABETES, V63, P4302, DOI 10.2337/db14-0001; Goldberg R, 2013, MATRIX BIOL, V32, P234, DOI 10.1016/j.matbio.2013.02.008; Goode KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109596; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gutter-Kapon L, 2016, P NATL ACAD SCI USA, V113, pE7808, DOI 10.1073/pnas.1611380113; HANCOCK WW, 1983, TRANSPLANTATION, V35, P458, DOI 10.1097/00007890-198305000-00013; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Jo SK, 2006, NEPHROL DIAL TRANSPL, V21, P1231, DOI 10.1093/ndt/gfk047; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Li L, 2010, SEMIN NEPHROL, V30, P268, DOI 10.1016/j.semnephrol.2010.03.005; Liu XJ, 2014, AM J NEPHROL, V39, P337, DOI 10.1159/000360549; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Masola V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175618; Masola V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160074; Masola V, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0538-5; Masola V, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-213; Masola V, 2011, BBA-MOL CELL RES, V1813, P1475, DOI 10.1016/j.bbamcr.2011.05.004; Matsuguchi T, 2000, J IMMUNOL, V165, P5767, DOI 10.4049/jimmunol.165.10.5767; Meirovitz A, 2013, FEBS J, V280, P2307, DOI 10.1111/febs.12184; Minafra L, 2011, LEUKEMIA RES, V35, P226, DOI 10.1016/j.leukres.2010.07.040; Naggi A, 2005, J BIOL CHEM, V280, P12103, DOI 10.1074/jbc.M414217200; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Pedregosa JF, 2011, INT IMMUNOPHARMACOL, V11, P1311, DOI 10.1016/j.intimp.2011.04.014; Ponticelli CE, 2015, KIDNEY INT, V87, P272, DOI 10.1038/ki.2014.359; Rabadi MM, 2012, AM J PHYSIOL-RENAL, V303, pF873, DOI 10.1152/ajprenal.00092.2012; Rabelink TJ, 2017, NAT REV NEPHROL, V13, P201, DOI 10.1038/nrneph.2017.6; Rivara S, 2016, FUTURE MED CHEM, V8, P647, DOI 10.4155/fmc-2016-0012; Sanchez-Nino MD, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/182958; Sedeek M, 2013, J AM SOC NEPHROL, V24, P1512, DOI 10.1681/ASN.2012111112; Taniguchi K, 2015, J CELL BIOCHEM, V116, P2840, DOI 10.1002/jcb.25230; Vesey DA, 2002, J LAB CLIN MED, V140, P342, DOI 10.1067/mlc.2002.128468; Vesey DA, 2002, KIDNEY INT, V62, P31, DOI 10.1046/j.1523-1755.2002.00401.x; Vlodaysky I, 2016, DRUG RESIST UPDATE, V29, P54, DOI 10.1016/j.drup.2016.10.001; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Wang YQ, 2015, KIDNEY INT, V88, P1274, DOI 10.1038/ki.2015.295; Wilson HM, 2004, CURR OPIN NEPHROL HY, V13, P285, DOI 10.1097/00041552-200405000-00004; Wolfs TGAM, 2002, J IMMUNOL, V168, P1286, DOI 10.4049/jimmunol.168.3.1286; Wyburn KR, 2005, TRANSPLANTATION, V80, P1641, DOI 10.1097/01.tp.0000173903.26886.20; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zaza G, 2015, J NEPHROL, V28, P431, DOI 10.1007/s40620-015-0216-y; Zaza G, 2014, EXP BIOL MED, V239, P52, DOI 10.1177/1535370213506678; Zhang J., 2016, MATH PROBL ENG, V2016, P1, DOI DOI 10.1042/BSR20160076; Zhang J, 2016, AM J TRANSL RES, V8, P4054; Zhang M, 2005, NEPHRON EXP NEPHROL, V99, P68, DOI 10.1159/000083414; Zhao HL, 2014, AM J PHYSIOL-RENAL, V306, pF801, DOI 10.1152/ajprenal.00469.2013; Zuk A, 2016, ANNU REV MED, V67, P293, DOI 10.1146/annurev-med-050214-013407	59	33	34	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					742	756		10.1096/fj.201700597R	http://dx.doi.org/10.1096/fj.201700597R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28970256	Bronze			2022-12-26	WOS:000425146900018
J	Zheng, W; Hu, RK; Cai, RQ; Hofmann, L; Hu, QL; Fatehi, M; Long, WT; Kong, T; Tang, JF; Light, P; Flockerzi, V; Cao, Y; Chen, XZ				Zheng, Wang; Hu, Ruikun; Cai, Ruiqi; Hofmann, Laura; Hu, Qiaolin; Fatehi, Mohammad; Long, Wentong; Kong, Tim; Tang, Jingfeng; Light, Peter; Flockerzi, Veit; Cao, Ying; Chen, Xing-Zhen			Identification and characterization of hydrophobic gate residues in TRP channels	FASEB JOURNAL			English	Article						electrophysiology; Xenopus oocyte; hydrophobicity; hydrophilicity	CRYSTAL-STRUCTURE; RECEPTOR; ACTIVATION; SELECTIVITY; PKD2L1	Transient receptor potential (TRP) channels, subdivided into 6 subfamilies in mammals, have essential roles in sensory physiology. They respond to remarkably diverse stimuli, comprising thermal, chemical, and mechanical modalities, through opening or closing of channel gates. In this study, we systematically substituted the hydrophobic residues within the distal fragment of pore-lining helix S6 with hydrophilic residues and, based on Xenopus oocyte and mammalian cell electrophysiology and a hydrophobic gate theory, identified hydrophobic gates in TRPV6/V5/V4/C4/M8. We found that channel activity drastically increased when TRPV6(Ala616) (or) (Met617) or TRPV5(Ala576) (or Met577), but not any of their adjacent residues, was substituted with hydrophilic residues. Channel activity strongly correlated with the hydrophilicity of the residues at those sites, suggesting that consecutive hydrophobic residues TRPV6(Ala616-Met617) and TRPV5(Ala576-Met577) form a double-residue gate in each channel. By the same strategy, we identified a hydrophobic single-residue gate in TRPV4(Iso715), TRPC4(Iso617), and TRPM8(Val976). In support of the hydrophobic gate theory, hydrophilic substitution at the gate site, which removes the hydrophobic gate seal, substantially increased the activity of TRP channels in low-activity states but had little effect on the function of activated channels. The double-residue gate channels were more sensitive to small changes in the gate's hydrophobicity or size than single-residue gate channels. The unconventional double-reside gating mechanism in TRP channels may have been evolved to respond especially to physiologic stimuli that trigger relatively small gate conformational changes.	[Zheng, Wang; Tang, Jingfeng] Hubei Univ Technol, Coll Bioengn, Inst Biomed & Pharmaceut Sci, Key Lab Fermentat Engn,Minist Educ, Wuhan, Hubei, Peoples R China; [Zheng, Wang; Cai, Ruiqi; Hu, Qiaolin; Kong, Tim; Chen, Xing-Zhen] Univ Alberta, Fac Med & Dent, Dept Physiol, Membrane Prot Dis Res Grp, Edmonton, AB, Canada; [Fatehi, Mohammad; Long, Wentong; Light, Peter] Univ Alberta, Fac Med & Dent, Dept Pharmacol, Edmonton, AB, Canada; [Hu, Ruikun; Cao, Ying] Tongji Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Hofmann, Laura; Flockerzi, Veit] Univ Saarland, Expt & Klin Pharmakol & Toxikol, Homburg, Germany	Hubei University of Technology; University of Alberta; University of Alberta; Tongji University; Saarland University	Tang, JF (corresponding author), Hubei Univ Technol, Wuhan, Hubei, Peoples R China.; Chen, XZ (corresponding author), Univ Alberta, Med Sci 7 29A, Edmonton, AB T6G 2H7, Canada.	jingfeng9930@163.com; xzchen@ualberta.ca		Tang, jingfeng/0000-0002-5524-4518; Long, Wentong/0000-0003-4650-8064; , Tim/0000-0002-3240-8989	Natural Sciences and Engineering Research Council of Canada (NSERC); National Natural Science Foundation of China [81570648, 81602448]; Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich/Transregio 152]; Alberta Innovates-Doctoral Graduate Student Scholarship; NSERC International Research Training Group (IRTG); DFG [IRTG 1830]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Alberta Innovates-Doctoral Graduate Student Scholarship; NSERC International Research Training Group (IRTG); DFG(German Research Foundation (DFG))	The authors are grateful to J. Y. Lapointe (University of Montreal, Montreal, QC, Canada) for valuable comments and X. Liu (University of Alberta) for important contributions to electrophysiology experiments. This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC; to X.-Z.C.), the National Natural Science Foundation of China (Grant 81570648, to X.-Z.C. and 81602448, to J. T.), and by the Deutsche Forschungsgemeinschaft (DFG;, Sonderforschungsbereich/Transregio 152, to V.F.). W.Z. was a recipient of the Alberta Innovates-Doctoral Graduate Student Scholarship. R.C. and Q.H. were recipients of the NSERC International Research Training Group (IRTG) Studentship. L.H. was a recipient of the IRTG 1830 Student Scholarship (DFG). The authors declare no conflicts of interest.	Akbulut Y, 2015, ANGEW CHEM INT EDIT, V54, P3787, DOI 10.1002/anie.201411511; Aryal P, 2015, J MOL BIOL, V427, P121, DOI 10.1016/j.jmb.2014.07.030; Aryal P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5377; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Beck A, 2013, J BIOL CHEM, V288, P19471, DOI 10.1074/jbc.M113.478305; Bharate SS, 2012, ACS CHEM NEUROSCI, V3, P248, DOI 10.1021/cn300006u; Brelidze TI, 2003, P NATL ACAD SCI USA, V100, P9017, DOI 10.1073/pnas.1532257100; Chen J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-3; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Courjaret R, 2013, J CELL PHYSIOL, V228, P2386, DOI 10.1002/jcp.24411; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; Eijkelkamp N, 2013, ANNU REV NEUROSCI, V36, P519, DOI 10.1146/annurev-neuro-062012-170412; Fecher-Trost C, 2013, J BIOL CHEM, V288, P16629, DOI 10.1074/jbc.M113.469726; Fernandez JA, 2011, J GEN PHYSIOL, V137, P173, DOI 10.1085/jgp.201010498; Freichel M, 2014, HANDB EXP PHARMACOL, V222, P85, DOI 10.1007/978-3-642-54215-2_5; Grieben M, 2017, NAT STRUCT MOL BIOL, V24, P114, DOI 10.1038/nsmb.3343; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Huynh KW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11130; Ishimaru Y, 2009, J DENT RES, V88, P212, DOI 10.1177/0022034508330212; Jeon JP, 2013, CELL CALCIUM, V54, P307, DOI 10.1016/j.ceca.2013.07.006; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kitaguchi T, 2004, J GEN PHYSIOL, V124, P319, DOI 10.1085/jgp.200409098; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu C, 2015, BIOCHEM BIOPH RES CO, V460, P22, DOI 10.1016/j.bbrc.2015.02.067; Loukin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019533; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Moran MM, 2011, NAT REV DRUG DISCOV, V10, P601, DOI 10.1038/nrd3456; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Nilius Bernd, 2005, Sci STKE, V2005, pre8, DOI 10.1126/stke.2952005re8; Oelstrom K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11608; Oelstrom K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4420; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Peng JB, 2011, ADV EXP MED BIOL, V704, P239, DOI 10.1007/978-94-007-0265-3_14; Salazar H, 2009, NAT STRUCT MOL BIOL, V16, P704, DOI 10.1038/nsmb.1633; Saotome K, 2016, NATURE, V534, P506, DOI 10.1038/nature17975; Shapovalov G, 2016, SEMIN IMMUNOPATHOL, V38, P357, DOI 10.1007/s00281-015-0525-1; Shen PS, 2016, CELL, V167, P763, DOI 10.1016/j.cell.2016.09.048; Sherkheli MA, 2008, PAK J PHARM SCI, V21, P370; Sukhareva M, 2003, J GEN PHYSIOL, V122, P541, DOI 10.1085/jgp.200308905; Teng JF, 2015, P NATL ACAD SCI USA, V112, P3386, DOI 10.1073/pnas.1502366112; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; Wilkes M, 2017, NAT STRUCT MOL BIOL, V24, P123, DOI 10.1038/nsmb.3357; Yang J, 2012, J BIOL CHEM, V287, P6551, DOI 10.1074/jbc.M111.305854; Yeh BI, 2005, EMBO J, V24, P3224, DOI 10.1038/sj.emboj.7600795; Zheng W, 2015, SCI REP-UK, V5, DOI 10.1038/srep09460; Zubcevic L, 2016, NAT STRUCT MOL BIOL, V23, P180, DOI 10.1038/nsmb.3159	50	22	23	2	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					639	653		10.1096/fj.201700599RR	http://dx.doi.org/10.1096/fj.201700599RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28970257	Bronze			2022-12-26	WOS:000425146900010
J	Liu, JZ; Duan, JC; Ni, M; Liu, Z; Qiu, WL; Whitham, SA; Qian, WJ				Liu, Jian-Zhong; Duan, Jicheng; Ni, Min; Liu, Zhen; Qiu, Wen-Li; Whitham, Steven A.; Qian, Wei-Jun			S-Nitrosylation inhibits the kinase activity of tomato phosphoinositide-dependent kinase 1 (PDK1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; nitric oxide; nitrosylation; phosphorylation; protein kinase; phosphoinositide-dependent kinase	APOPTOTIC CELL-DEATH; NITRIC-OXIDE; ASCORBATE PEROXIDASE; ARABIDOPSIS-THALIANA; PROTEIN; IDENTIFICATION; NITROSOTHIOLS; TOBACCO; COMPLEX; IMMUNITY	It is well known that the reactive oxygen species NO can trigger cell death in plants and other organisms, but the underlying molecular mechanisms are not well understood. Here we provide evidence that NO may trigger cell death in tomato (Solanum lycopersicum) by inhibiting the activity of phosphoinositide-dependent kinase 1 (SlPDK1), a conserved negative regulator of cell death in yeasts, mammals, and plants, via S-nitrosylation. Biotin-switch assays indicated that SlPDK1 is a target of S-nitrosylation. Moreover, the kinase activity of SlPDK1 was inhibited by S-nitrosoglutathione in a concentration-dependent manner, indicating that SlPDK1 activity is abrogated by S-nitrosylation. The S-nitrosoglutathione-induced inhibition was reversible in the presence of a reducing agent but additively enhanced by hydrogen peroxide (H2O2). Our LC-MS/MS analyses further indicated that SlPDK1 is primarily S-nitrosylated on a cysteine residue at position 128 (Cys(128)), and substitution of Cys(128) with serine completely abolished SlPDK1 kinase activity, suggesting that S-nitrosylation of Cys(128) is responsible for SlPDK1 inhibition. In summary, our results establish a potential link between NO-triggered cell death and inhibition of the kinase activity of tomato PDK1.	[Liu, Jian-Zhong; Ni, Min; Liu, Zhen] Zhejiang Normal Univ, Coll Chem & Life Sci, 688 Yingbin Rd, Jinhua 321004, Zhejiang, Peoples R China; [Duan, Jicheng; Qian, Wei-Jun] Pacific Northwest Natl Lab, Div Biol Sci, Integrat Om, Richland, WA 99352 USA; [Qiu, Wen-Li; Whitham, Steven A.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA 50011 USA	Zhejiang Normal University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Iowa State University	Liu, JZ (corresponding author), Zhejiang Normal Univ, Coll Chem & Life Sci, 688 Yingbin Rd, Jinhua 321004, Zhejiang, Peoples R China.	jzliu@zjnu.cn	Qian, Wei-Jun/C-6167-2011; QIAN, Wei-Jun/AAC-1907-2021	QIAN, Wei-Jun/0000-0002-5393-2827; Liu, Jianzhong/0000-0001-7826-7045	Department of Energy [DE-AC05-76RL0 1830]	Department of Energy(United States Department of Energy (DOE))	We thank Prof. Gregory Martin and Dr. Timothy P Devarenne for providing the MBP-SlPDK1, MBP-Adi3, and MBP-Adi3<SUP>K337Q</SUP> constructs. We also thank Prof. Meihao Sun for providing technical support with protein purification. The mass spectrometry analyses were performed in the Environmental Molecular Sciences Laboratory, a Department of Energy national scientific user facility located at Pacific Northwest National Laboratory that is operated by the Battelle Memorial Institute for the Department of Energy under Contract DE-AC05-76RL0 1830.	Albertos P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9669; Astier J, 2012, INT J MOL SCI, V13, P15193, DOI 10.3390/ijms131115193; Begara-Morales JC, 2014, J EXP BOT, V65, P527, DOI 10.1093/jxb/ert396; Belenghi B, 2007, J BIOL CHEM, V282, P1352, DOI 10.1074/jbc.M608931200; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; Chen RQ, 2009, CELL RES, V19, P1377, DOI 10.1038/cr.2009.117; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Choi BM, 2002, J BIOCHEM MOL BIOL, V35, P116; Choudhary G, 2003, J PROTEOME RES, V2, P59, DOI 10.1021/pr025557n; de Pinto MC, 2013, PLANT PHYSIOL, V163, P1766, DOI 10.1104/pp.113.222703; Deak M, 1999, FEBS LETT, V451, P220, DOI 10.1016/S0014-5793(99)00556-6; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Derakhshan B, 2007, NAT PROTOC, V2, P1685, DOI 10.1038/nprot.2007.210; Desai S, 2011, BBA-MOL CELL RES, V1813, P1190, DOI 10.1016/j.bbamcr.2011.03.007; Devarenne TP, 2006, EMBO J, V25, P255, DOI 10.1038/sj.emboj.7600910; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Duan JC, 2017, MOL BIOSYST, V13, P816, DOI 10.1039/c6mb00861e; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Feechan A, 2005, P NATL ACAD SCI USA, V102, P8054, DOI 10.1073/pnas.0501456102; Grennan AK, 2007, PLANT PHYSIOL, V144, P1237, DOI 10.1104/pp.104.900228; Han SJ, 2015, PLANT CELL, V27, P1316, DOI 10.1105/tpc.114.134692; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hu JL, 2015, PLANT PHYSIOL, V167, P1731, DOI 10.1104/pp.15.00026; Jaffrey S.R., 2001, SCI STKE, V2001, DOI [10.1126/stke.2001.86.pl1, DOI 10.1126/STKE.2001.86.PL1]; Jeon BW, 2002, J BIOCHEM, V131, P693, DOI 10.1093/oxfordjournals.jbchem.a003153; Keyster M, 2011, PLANT SIGNAL BEHAV, V6, P956, DOI 10.4161/psb.6.7.14879; Lee TY, 2012, BIOINFORMATICS, V28, P2293, DOI 10.1093/bioinformatics/bts436; Li HL, 2013, ACTA BIOCH BIOPH SIN, V45, P153, DOI 10.1093/abbs/gms103; Lin AH, 2012, PLANT PHYSIOL, V158, P451, DOI 10.1104/pp.111.184531; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Lindermayr C, 2010, PLANT CELL, V22, P2894, DOI 10.1105/tpc.109.066464; Liu JZ, 2005, PLANT PHYSIOL, V138, P1853, DOI 10.1104/pp.105.065722; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Liu MA, 2010, ANAL CHEM, V82, P7160, DOI 10.1021/ac100569d; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Lu XM, 2005, J MASS SPECTROM, V40, P1140, DOI 10.1002/jms.885; Mannick JB, 2007, AMINO ACIDS, V32, P523, DOI 10.1007/s00726-006-0427-6; Mengel A, 2017, PLANT PHYSIOL, V173, P1434, DOI 10.1104/pp.16.01734; Romero-Puertas MC, 2007, PLANT CELL, V19, P4120, DOI 10.1105/tpc.107.055061; Sell S, 2008, METHOD ENZYMOL, V440, P283, DOI 10.1016/S0076-6879(07)00818-X; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Swaney DL, 2010, J PROTEOME RES, V9, P1323, DOI 10.1021/pr900863u; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Terrile MC, 2012, PLANT J, V70, P492, DOI 10.1111/j.1365-313X.2011.04885.x; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Venigalla RKC, 2013, EMBO J, V32, P1008, DOI 10.1038/emboj.2013.40; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang PC, 2015, P NATL ACAD SCI USA, V112, P613, DOI 10.1073/pnas.1423481112; Wang YQ, 2009, J BIOL CHEM, V284, P2131, DOI 10.1074/jbc.M806782200; Yang HJ, 2015, PLANT PHYSIOL, V167, P1604, DOI 10.1104/pp.114.255216; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Yun BW, 2011, NATURE, V478, P264, DOI 10.1038/nature10427; Zaninotto F, 2006, PLANT PHYSIOL, V141, P379, DOI 10.1104/pp.106.078857; Zhang X, 2012, PROTEIN CELL, V3, P929, DOI 10.1007/s13238-012-2094-6; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016; Zhu JX, 2004, CANCER RES, V64, P4309, DOI 10.1158/0008-5472.CAN-03-4063	60	15	15	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19743	19751		10.1074/jbc.M117.803882	http://dx.doi.org/10.1074/jbc.M117.803882			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972151	hybrid, Green Published			2022-12-26	WOS:000416911300019
J	Todaro, DR; Augustus-Wallace, AC; Klein, JM; Haas, AL				Todaro, Dustin R.; Augustus-Wallace, Allison C.; Klein, Jennifer M.; Haas, Arthur L.			The mechanism of neural precursor cell expressed developmentally down-regulated 4-2 (Nedd4-2)/NEDD4L-catalyzed polyubiquitin chain assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; enzyme kinetics; enzyme mechanism; polyubiquitin chain; protein-protein interaction; ubiquitin; ubiquitylation (ubiquitination); linkage specificity; thiol exchange	UBIQUITIN-PROTEIN LIGASES; EPITHELIAL NA+ CHANNEL; C2 DOMAIN; CONJUGATING ENZYMES; BINDING DOMAINS; HECT DOMAIN; WW DOMAIN; NEDD4; DEGRADATION; SPECIFICITY	The mechanism of Nedd4-2 has been quantitatively explored for the first time using biochemically defined kinetic assays examining rates of I-125-polyubiquitin chain assembly as a functional readout. We demonstrate that Nedd4-2 exhibits broad specificity for E2 paralogs of the Ubc4/5 clade to assemble Lys(63)-linked polyubiquitin chains. Full-length Nedd4-2 catalyzes free I-125-polyubiquitin chain assembly by hyperbolic Michaelis-Menten kinetics with respect to Ubc5B approximate to ubiquitin thioester concentration (K-m = 44 +/- 6 nm; k(cat) = 0.020 +/- 0.007 s(-1)) and substrate inhibition above 0.5 m (K-i = 2.5 +/- 1.3 m) that tends to zero velocity, requiring ordered binding at two functionally distinct E2 approximate to ubiquitin-binding sites. The Ubc5BC85A product analog non-competitively inhibits Nedd4-2 (K-i = 2.0 +/- 0.5 m), consistent with the presence of the second E2-binding site. In contrast, the isosteric Ubc5BC85S-ubiquitin oxyester substrate analog exhibits competitive inhibition at the high-affinity Site 1 (K-i = 720 +/- 340 nm) and non-essential activation at the lower-affinity Site 2 (K-act = 750 +/- 260 nm). Additional studies utilizing Ubc5BF62A, defective in binding the canonical E2 site, demonstrate that the cryptic Site 1 is associated with thioester formation, whereas binding at the canonical site (Site 2) is associated with polyubiquitin chain elongation. Finally, previously described Ca2+-dependent C2 domain-mediated autoinhibition of Nedd4-2 is not observed under our reported experimental conditions. These studies collectively demonstrate that Nedd4-2 catalyzes polyubiquitin chain assembly by an ordered two-step mechanism requiring two dynamically linked E2 approximate to ubiquitin-binding sites analogous to that recently reported for E6AP, the founding member of the Hect ligase family.	[Todaro, Dustin R.; Augustus-Wallace, Allison C.; Klein, Jennifer M.; Haas, Arthur L.] Louisiana State Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Haas, Arthur L.] Louisiana State Univ, Sch Med, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University System	Haas, AL (corresponding author), LSU Hlth Sci Ctr, Dept Biochem & Mol Biol, 1901 Perdido St, New Orleans, LA 70112 USA.	ahaas@lsuhsc.edu			National Institutes of Health [GM034009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106392, R01GM034009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM034009 (to A. L. H.) and an appropriation from the Louisiana State University School of Medicine (New Orleans, LA). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Baboshina OV, 2001, J BIOL CHEM, V276, P39428, DOI 10.1074/jbc.M106967200; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; Debonneville C, 2004, MOL CELL BIOL, V24, P2397, DOI 10.1128/MCB.24.6.2397-2409.2004; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Edwards DJ, 2014, J BIOL CHEM, V289, P34114, DOI 10.1074/jbc.M114.609164; Eletr ZM, 2007, J MOL BIOL, V369, P419, DOI 10.1016/j.jmb.2007.03.026; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Erpapazoglou Zoi, 2014, Cells, V3, P1027, DOI 10.3390/cells3041027; Escobedo A, 2014, STRUCTURE, V22, P1446, DOI 10.1016/j.str.2014.08.016; Fotia AB, 2006, INT J BIOCHEM CELL B, V38, P472, DOI 10.1016/j.biocel.2005.11.006; Garrone NF, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-26; Goel P, 2015, GENE, V557, P1, DOI 10.1016/j.gene.2014.11.051; Gong W, 2015, ACTA CRYSTALLOGR F, V71, P1251, DOI 10.1107/S2053230X1501554X; HAAS AL, 1988, J BIOL CHEM, V263, P13258; Haas Arthur L., 2005, V301, P23; Harvey KF, 2001, J BIOL CHEM, V276, P8597, DOI 10.1074/jbc.C000906200; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kumar B, 2010, J BIOL CHEM, V285, P41300, DOI 10.1074/jbc.M110.169136; Lu KF, 2011, J BIOL CHEM, V286, P16861, DOI 10.1074/jbc.M110.211979; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Malakhova OA, 2008, J BIOL CHEM, V283, P8783, DOI 10.1074/jbc.C800030200; Mari S, 2014, STRUCTURE, V22, P1639, DOI 10.1016/j.str.2014.09.006; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Nuber U, 1999, J BIOL CHEM, V274, P7576, DOI 10.1074/jbc.274.11.7576; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Okumura A, 2008, P NATL ACAD SCI USA, V105, P3974, DOI 10.1073/pnas.0710629105; Perica T, 2010, CURR OPIN STRUC BIOL, V20, P367, DOI 10.1016/j.sbi.2010.03.007; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Ronchi VP, 2017, J BIOL CHEM, V292, P18006, DOI 10.1074/jbc.M117.813477; Ronchi VP, 2014, J BIOL CHEM, V289, P1033, DOI 10.1074/jbc.M113.517805; Ronchi VP, 2013, J BIOL CHEM, V288, P10349, DOI 10.1074/jbc.M113.458059; Ronchi VP, 2012, METHODS MOL BIOL, V832, P197, DOI 10.1007/978-1-61779-474-2_14; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Scheffner M, 2014, BBA-MOL CELL RES, V1843, P61, DOI 10.1016/j.bbamcr.2013.03.024; Schwarz SE, 1998, P NATL ACAD SCI USA, V95, P560, DOI 10.1073/pnas.95.2.560; SEGAL IH, 1975, ENZYME KINETICS; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Streich FC, 2013, J BIOL CHEM, V288, P8209, DOI 10.1074/jbc.M113.451567; Streich FC, 2010, SUBCELL BIOCHEM, V54, P1, DOI 10.1007/978-1-4419-6676-6_1; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	70	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19521	19536		10.1074/jbc.M117.817882	http://dx.doi.org/10.1074/jbc.M117.817882			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972136	Green Published, hybrid			2022-12-26	WOS:000416226700030
J	Guzman, RE; Bungert-Plumke, S; Franzen, A; Fahlke, C				Guzman, Raul E.; Bungert-Pluemke, Stefanie; Franzen, Arne; Fahlke, Christoph			Preferential association with ClC-3 permits sorting of ClC-4 into endosomal compartments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloride transport; protein sorting; protein-protein interaction; trafficking; transporter; ClC-3; ClC-4; chloride; proton exchanger; intracellular compartments; sorting signals	TRANSMEMBRANE CONDUCTANCE REGULATOR; MUSCLE CHLORIDE CHANNELS; ENDOPLASMIC-RETICULUM; FUNCTIONAL-CHARACTERIZATION; SUBUNIT STOICHIOMETRY; CYTOPLASMIC DOMAIN; LENTIVIRAL VECTORS; PLASMA-MEMBRANE; LIVING CELLS; PROTEIN	ClC-4 is an intracellular Cl-/H+ exchanger that is highly expressed in the brain and whose dysfunction has been linked to intellectual disability and epilepsy. Here we studied the subcellular localization of human ClC-4 in heterologous expression systems. ClC-4 is retained in the endoplasmic reticulum (ER) upon overexpression in HEK293T cells. Co-expression with distinct ClC-3 splice variants targets ClC-4 to late endosome/lysosomes (ClC-3a and ClC-3b) or recycling endosome (ClC-3c). When expressed in cultured astrocytes, ClC-4 sorted to endocytic compartments in WT cells but was retained in the ER in Clcn3(-/-) cells. To understand the virtual absence of ER-localized ClC-4 in WT astrocytes, we performed association studies by high-resolution clear native gel electrophoresis. Although other CLC channels and transporters form stable dimers, ClC-4 was mostly observed as monomer, with ClC-3-ClC-4 heterodimers being more stable than ClC-4 homodimers. We conclude that unique oligomerization properties of ClC-4 permit regulated targeting of ClC-4 to various endosomal compartment systems via expression of different ClC-3 splice variants.	[Guzman, Raul E.; Bungert-Pluemke, Stefanie; Franzen, Arne; Fahlke, Christoph] Forschungszentrum Julich, Inst Complex Syst, Zellulare Biophys ICS 4, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Guzman, RE; Fahlke, C (corresponding author), Forschungszentrum Julich, Inst Complex Syst, Zellulare Biophys ICS 4, D-52425 Julich, Germany.	r.guzman@fz-juelich.de; c.fahlke@fz-juelich.de	Fahlke, Christoph/G-3635-2013	Fahlke, Christoph/0000-0001-8602-9952; Franzen, Arne/0000-0002-8731-674X				Alekov AK, 2009, J GEN PHYSIOL, V133, P485, DOI 10.1085/jgp.200810155; Barde Isabelle, 2010, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0421s53; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chadda R, 2016, ELIFE, V5, DOI 10.7554/eLife.17438; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Detro-Dassen S, 2008, J BIOL CHEM, V283, P4177, DOI 10.1074/jbc.M704924200; Dickerson LW, 2002, BRAIN RES, V958, P227, DOI 10.1016/S0006-8993(02)03519-9; Eggermont J, 1997, BIOCHEM J, V325, P269, DOI 10.1042/bj3250269; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fahlke C, 1997, J GEN PHYSIOL, V109, P93, DOI 10.1085/jgp.109.1.93; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; Fallah G, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004697; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Follenzi A, 2002, HUM GENE THER, V13, P243, DOI 10.1089/10430340252769770; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Gentzsch M, 2003, J BIOL CHEM, V278, P6440, DOI 10.1074/jbc.M211050200; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Guzman RE, 2015, J BIOL CHEM, V290, P25851, DOI 10.1074/jbc.M115.668186; Guzman RE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00143; Guzman RE, 2013, ACS CHEM NEUROSCI, V4, P994, DOI 10.1021/cn400032z; Guzman RE, 2010, J NEUROSCI, V30, P10272, DOI 10.1523/JNEUROSCI.1551-10.2010; Hebeisen S, 2003, BIOPHYS J, V84, P2306, DOI 10.1016/S0006-3495(03)75036-X; Hu H, 2016, MOL PSYCHIATR, V21, P133, DOI 10.1038/mp.2014.193; Huang LQ, 2005, J BIOL CHEM, V280, P36150, DOI 10.1074/jbc.M507706200; KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Maritzen T, 2008, J NEUROSCI, V28, P10587, DOI 10.1523/JNEUROSCI.3750-08.2008; McMains E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017647; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Mohammad-Panah R, 2002, J BIOL CHEM, V277, P566, DOI 10.1074/jbc.M106968200; Nicke A, 1999, J RECEPT SIGNAL TR R, V19, P493, DOI 10.3109/10799899909036667; Nothmann D, 2011, J BIOL CHEM, V286, P3935, DOI 10.1074/jbc.M110.187492; Okkenhaug H, 2006, FASEB J, V20, P2390, DOI 10.1096/fj.05-5588fje; Palmer EE, 2018, MOL PSYCHIATR, V23, P222, DOI 10.1038/mp.2016.135; Parkerson KA, 2004, GLIA, V46, P419, DOI 10.1002/glia.10361; Robertson JL, 2010, NATURE, V468, P844, DOI 10.1038/nature09556; Ronstedt K, 2015, SCI REP-UK, V5, DOI 10.1038/srep15382; RUGARLI EI, 1995, NAT GENET, V10, P466, DOI 10.1038/ng0895-466; Schmieder S, 2001, BIOCHEM BIOPH RES CO, V286, P635, DOI 10.1006/bbrc.2001.5407; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Stauber T, 2013, ANNU REV PHYSIOL, V75, P453, DOI 10.1146/annurev-physiol-030212-183702; Stauber T, 2010, J BIOL CHEM, V285, P34537, DOI 10.1074/jbc.M110.162545; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Stolting G, 2015, J BIOL CHEM, V290, P30406, DOI 10.1074/jbc.M115.675827; Suzuki T, 2006, J CELL PHYSIOL, V206, P792, DOI 10.1002/jcp.20516; Vanoye CG, 2002, J PHYSIOL-LONDON, V539, P373, DOI 10.1113/jphysiol.2001.013115; VANSLEGTENHORST MA, 1994, HUM MOL GENET, V3, P547; Wang NS, 2001, J BIOL CHEM, V276, P44117, DOI 10.1074/jbc.M101958200; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Yoshikawa M, 2002, GENES CELLS, V7, P597, DOI 10.1046/j.1365-2443.2002.00539.x; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200; Zhao ZF, 2007, J BIOL CHEM, V282, P29022, DOI 10.1074/jbc.M703506200	57	14	14	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19055	19065		10.1074/jbc.M117.801951	http://dx.doi.org/10.1074/jbc.M117.801951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972156	hybrid, Green Published			2022-12-26	WOS:000415848000028
J	Bang, C; Vierbuchen, T; Gutsmann, T; Heine, H; Schmitz, RA				Bang, Corinna; Vierbuchen, Tim; Gutsmann, Thomas; Heine, Holger; Schmitz, Ruth A.			Immunogenic properties of the human gut-associated archaeon Methanomassiliicoccus luminyensis and its susceptibility to antimicrobial peptides	PLOS ONE			English	Article							7TH ORDER; METHANOGENIC ARCHAEON; RECOGNITION; DIVERSITY; GENOMICS; LIPIDS	The methanogenic archaeon Methanomassiliicoccus luminyensis strain B10(T) was isolated from human feces just a few years ago. Due to its remarkable metabolic properties, particularly the degradation of trimethylamines, this strain was supposed to be used as "Archaebiotic" during metabolic disorders of the human intestine. However, there is still no data published regarding adaptations to the natural habitat of M. luminyensis as it has been shown for the other two reported mucosa-associated methanoarchaea. This study aimed at unraveling susceptibility of M. luminyensis to antimicrobial peptides as well as its immunogenicity. By using the established microtiter plate assay adapted to the anaerobic growth requirements of methanogenic archaea, we demonstrated that M. luminyensis is highly sensitive against LL32, a derivative of human cathelicidin (MIC = 2 mu M). However, the strain was highly resistant against the porcine lysin NK-2 (MIC = 10 mu M) and the synthetic antilipopolysaccharide peptide (Lpep) (MIC>10 mu M) and overall differed from the two other methanoarchaea, Methanobrevibacter smithii and Methanosphaera stadtmanae in respect to AMP sensitivity. Moreover, only weak immunogenic potential of M. luminyensis was demonstrated using peripheral blood mononuclear cells (PBMCs) and monocyte-derived dendritic cells (moDCs) by determining release of pro-inflammatory cytokines. Overall, our findings clearly demonstrate that the archaeal gut inhabitant M. luminyensis is susceptible to the release of human-derived antimicrobial peptides and exhibits low immunogenicity towards human immune cells in vitro-revealing characteristics of a typical commensal gut microbe.	[Bang, Corinna; Schmitz, Ruth A.] Christian Albrechts Univ Kiel, Inst Gen Microbiol, Kiel, Germany; [Vierbuchen, Tim; Heine, Holger] German Ctr Lung Res DZL, Airway Res Ctr North, Res Ctr Borstel, Div Innate Immun, Borstel, Germany; [Gutsmann, Thomas] Res Ctr Borstel, Div Biophys, Borstel, Germany	University of Kiel; Forschungszentrum Borstel; Forschungszentrum Borstel	Schmitz, RA (corresponding author), Christian Albrechts Univ Kiel, Inst Gen Microbiol, Kiel, Germany.	rschmitz@ifam.uni-kiel.de	Vierbuchen, Tim/O-2525-2019; Heine, Holger/H-4552-2012	Vierbuchen, Tim/0000-0003-3110-4155; Heine, Holger/0000-0001-8128-5068; Bang, Corinna/0000-0001-6814-6151; Schmitz-Streit, Ruth Anne/0000-0002-6788-0829	German research foundation [SCHM1051/11-2, HH2758/4-1]	German research foundation(German Research Foundation (DFG))	CB and TV were funded by the German research foundation (www.dfg.de; SCHM1051/11-2, HH2758/4-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andra J, 2007, BIOCHEM J, V406, P297, DOI 10.1042/BJ20070279; Andra J, 2007, J BIOL CHEM, V282, P14719, DOI 10.1074/jbc.M608920200; Andra J, 2011, J BIOL CHEM, V286, P18692, DOI 10.1074/jbc.M111.226886; Bang C, 2012, ANTIMICROB AGENTS CH, V56, P4123, DOI 10.1128/AAC.00661-12; Bang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099411; Becker KW, 2016, APPL ENVIRON MICROB, V82, P4505, DOI 10.1128/AEM.00772-16; Blais-Lecours P, 2011, PLOS ONE, V6; Blais-Lecours P, 2014, PLOS ONE, V9; Borrel G, 2013, GENOME ANNOUNCEMENTS, V1; Borrel G, 2017, ISME J, V11, P2059, DOI 10.1038/ismej.2017.72; Borrel G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-679; Borrel G, 2012, J BACTERIOL, V194, P6944, DOI 10.1128/JB.01867-12; BOYUM A, 1964, NATURE, V204, P793, DOI 10.1038/204793a0; Brugere JF, 2014, GUT MICROBES, V5, P5, DOI 10.4161/gmic.26749; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Dridi B, 2012, CLIN MICROBIOL INFEC, V18, P825, DOI 10.1111/j.1469-0691.2012.03952.x; Dridi B, 2012, INT J SYST EVOL MICR, V62, P1902, DOI 10.1099/ijs.0.033712-0; Ehlers C, 2002, J BACTERIOL, V184, P1028, DOI 10.1128/jb.184.4.1028-1040.2002; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Gutsmann T, 2001, BIOPHYS J, V80, P2935, DOI 10.1016/S0006-3495(01)76259-5; Heinbockel L, 2013, ANTIMICROB AGENTS CH, V57, P1480, DOI 10.1128/AAC.02066-12; Konig H, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P1; KONIG H, 1988, CAN J MICROBIOL, V34, P395, DOI 10.1139/m88-071; Lotz M, 2007, INT J MED MICROBIOL, V297, P379, DOI 10.1016/j.ijmm.2007.03.010; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mackay Richard J, 2011, Clin Biochem Rev, V32, P33; MILLER TL, 1985, ARCH MICROBIOL, V141, P116, DOI 10.1007/BF00423270; MILLER TL, 1982, APPL ENVIRON MICROB, V43, P227, DOI 10.1128/AEM.43.1.227-232.1982; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Tang WHW, 2015, CIRC RES, V116, P448, DOI 10.1161/CIRCRESAHA.116.305360; Turpin J, 1986, J Clin Apher, V3, P111, DOI 10.1002/jca.2920030207; Ulrih NP, 2009, APPL MICROBIOL BIOT, V84, P249, DOI 10.1007/s00253-009-2102-9; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; ZASLOFF M, 1992, CURR OPIN IMMUNOL, V4, P3, DOI 10.1016/0952-7915(92)90115-U	35	14	15	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185919	10.1371/journal.pone.0185919	http://dx.doi.org/10.1371/journal.pone.0185919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982164	Green Submitted, Green Published, gold			2022-12-26	WOS:000412360300086
J	Mantovani, A; Rigolon, R; Pichiri, I; Bonapace, S; Morani, G; Zoppini, G; Bonora, E; Targher, G				Mantovani, Alessandro; Rigolon, Riccardo; Pichiri, Isabella; Bonapace, Stefano; Morani, Giovanni; Zoppini, Giacomo; Bonora, Enzo; Targher, Giovanni			Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus	PLOS ONE			English	Article							PROLONGED PR INTERVAL; CARDIOVASCULAR-DISEASE; PREVALENCE; DYSFUNCTION; OUTCOMES	Recent studies suggested that nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of cardiac tachyarrhythmias (mainly atrial fibrillation) in patients with and without type 2 diabetes mellitus. The aim of this study was to examine whether an association also exists between NAFLD and heart block. We have retrospectively evaluated a hospital-based cohort of 751 patients with type 2 diabetes discharged from our Division of Diabetes and Endocrinology during years 2007-2014. Standard electrocardiograms were performed on all patients. Diagnosis of NAFLD was based on ultrasonography, whereas the severity of advanced hepatic fibrosis was based on the fibrosis (FIB)-4 score and other non-invasive fibrosis markers. Overall, 524 (69.8%) patients had NAFLD and 202 (26.9%) had heart block (defined as at least one block among first-degree atrio-ventricular block, second-degree block, third-degree block, left bundle branch block, right bundle branch block, left anterior hemi-block or left posterior hemi-block) on electrocardiograms. Patients with NAFLD had a remarkably higher prevalence of any persistent heart block than those without NAFLD (31.3% vs. 16.7%, p<0.001); this prevalence was particularly increased among those with higher FIB-4 score. NAFLD was associated with a threefold increased risk of prevalent heart block (adjusted-odds ratio 3.04, 95% CI 1.81-5.10), independently of age, sex, hypertension, prior ischemic heart disease, hemoglobin A1c, microvascular complication status, use of medications and other potentially confounding factors. In conclusion, this is the largest cross-sectional study to show that NAFLD and its severity are independently associated with an increased risk of prevalent heart block in hospitalized patients with type 2 diabetes.	[Mantovani, Alessandro; Rigolon, Riccardo; Pichiri, Isabella; Zoppini, Giacomo; Bonora, Enzo; Targher, Giovanni] Univ Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy; [Mantovani, Alessandro; Rigolon, Riccardo; Pichiri, Isabella; Zoppini, Giacomo; Bonora, Enzo; Targher, Giovanni] Azienda Osped Univ Integrata Verona, Verona, Italy; [Bonapace, Stefano] Sacro Cuore Hosp, Div Cardiol, Verona, Italy; [Morani, Giovanni] Univ Verona, Dept Med, Sect Cardiol, Verona, Italy; [Morani, Giovanni] Azienda Osped Univ Integrata Verona, Verona, Italy	University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; IRCCS Sacro Cuore Don Calabria; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Targher, G (corresponding author), Univ Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy.; Targher, G (corresponding author), Azienda Osped Univ Integrata Verona, Verona, Italy.	giovanni.targher@univr.it	Bonora, Enzo/AAA-5300-2022; Mantovani, Alessandro/AAB-9015-2019; zoppini, giacomo/AAA-9000-2022; Targher, Giovanni/AAB-9008-2019; Morani, Giovanni/AAX-7857-2020	Mantovani, Alessandro/0000-0002-7271-6329; zoppini, giacomo/0000-0003-1085-554X; Targher, Giovanni/0000-0002-4325-3900; Bonapace, Stefano/0000-0001-9122-2642				Adams LA, 2017, GUT, V66, P1138, DOI 10.1136/gutjnl-2017-313884; Bonapace S, 2012, DIABETES CARE, V35, P389, DOI 10.2337/dc11-1820; Bussink BE, 2013, EUR HEART J, V34, P138, DOI 10.1093/eurheartj/ehs291; Byrne CD, 2016, GASTROENTEROLOGY, V150, P7, DOI 10.1053/j.gastro.2015.11.016; Castera L, 2013, NAT REV GASTRO HEPAT, V10, P666, DOI 10.1038/nrgastro.2013.175; Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888; Coumbe AG, 2013, HEART, V99, P334, DOI 10.1136/heartjnl-2012-302770; Hallsworth K, 2013, J HEPATOL, V58, P757, DOI 10.1016/j.jhep.2012.11.015; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Hung CS, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001820; Karajamaki AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142937; Kuehl M, 2012, NAT REV ENDOCRINOL, V8, P405, DOI 10.1038/nrendo.2012.21; Kwok CS, 2016, HEART, V102, P672, DOI 10.1136/heartjnl-2015-308956; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061803; Lonardo A, 2016, METABOLISM, V65, P1136, DOI 10.1016/j.metabol.2015.09.017; Lonardo A, 2015, DIGEST LIVER DIS, V47, P997, DOI 10.1016/j.dld.2015.08.004; Mangi MA, 2017, CUREUS, V9, DOI 10.7759/cureus.1107; Mantovani A, 2016, DIABETES CARE, V39, P1416, DOI 10.2337/dc16-0091; Mantovani A, 2016, DIGEST DIS SCI, V61, P1246, DOI 10.1007/s10620-016-4040-6; Mantovani A, 2015, METABOLISM, V64, P879, DOI 10.1016/j.metabol.2015.04.003; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; McPherson S, 2017, AM J GASTROENTEROL, V112, P740, DOI 10.1038/ajg.2016.453; Park CC, 2017, GASTROENTEROLOGY, V152, P598, DOI 10.1053/j.gastro.2016.10.026; Pokorney SD, 2016, AM HEART J, V171, P25, DOI 10.1016/j.ahj.2015.09.004; Prineas RJ, 2010, MINNESOTA CODE MANUA; Targher G, 2016, J HEPATOL, V65, P589, DOI 10.1016/j.jhep.2016.05.013; Targher G, 2014, NUTR METAB CARDIOVAS, V24, P663, DOI 10.1016/j.numecd.2014.01.005; Targher G, 2013, CLIN SCI, V125, P301, DOI 10.1042/CS20130036; Targher G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057183; Targher G, 2012, DIABETES CARE, V35, P2347, DOI 10.2337/dc12-0259; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; VanWagner LB, 2015, HEPATOLOGY, V62, P773, DOI 10.1002/hep.27869; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	34	29	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185459	10.1371/journal.pone.0185459	http://dx.doi.org/10.1371/journal.pone.0185459			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981521	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300040
J	Reber, LL; Starkl, P; Balbino, B; Sibilano, R; Gaudenzio, N; Rogalla, S; Sensarn, S; Kang, DM; Raghu, H; Sokolove, J; Robinson, WH; Contag, CH; Tsai, M; Galli, SJ				Reber, Laurent L.; Starkl, Philipp; Balbino, Bianca; Sibilano, Riccardo; Gaudenzio, Nicolas; Rogalla, Stephan; Sensarn, Steven; Kang, Dongmin; Raghu, Harini; Sokolove, Jeremy; Robinson, William H.; Contag, Christopher H.; Tsai, Mindy; Galli, Stephen J.			The tyrosine kinase inhibitor imatinib mesylate suppresses uric acid crystal-induced acute gouty arthritis in mice	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; RHEUMATOID-ARTHRITIS; IN-VIVO; MANAGEMENT; EFFICACY; STI571	Gouty arthritis is caused by the deposition of monosodium urate (MSU) crystals in joints. Despite many treatment options for gout, there is a substantial need for alternative treatments for patients unresponsive to current therapies. Tyrosine kinase inhibitors have demonstrated therapeutic benefit in experimental models of antibody-dependent arthritis and in rheumatoid arthritis in humans, but to date, the potential effects of such inhibitors on gouty arthritis has not been evaluated. Here we demonstrate that treatment with the tyrosine kinase inhibitor imatinib mesylate (imatinib) can suppress inflammation induced by injection of MSU crystals into subcutaneous air pouches or into the ankle joint of wild type mice. Moreover, imatinib treatment also largely abolished the lower levels of inflammation which developed in IL-1R1(-/-) or Kit(W-sh/W-sh) mice, indicating that this drug can inhibit IL-1-independent pathways, as well as mast cell-independent pathways, contributing to pathology in this model. Imatinib treatment not only prevented ankle swelling and synovial inflammation when administered before MSU crystals but also diminished these features when administrated after the injection of MSU crystals, a therapeutic protocol more closely mimicking the clinical situation in which treatment occurs after the development of an acute gout flare. Finally, we also assessed the efficiency of local intra-articular injections of imatinib-loaded poly(lactic-co-glycolic acid) (PLGA) nanoparticles in this model of acute gout. Treatment with low doses of this long-acting imatinib: PLGA formulation was able to reduce ankle swelling in a therapeutic protocol. Altogether, these results raise the possibility that tyrosine kinase inhibitors might have utility in the treatment of acute gout in humans.	[Reber, Laurent L.; Starkl, Philipp; Sibilano, Riccardo; Gaudenzio, Nicolas; Tsai, Mindy; Galli, Stephen J.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Reber, Laurent L.; Starkl, Philipp; Sibilano, Riccardo; Gaudenzio, Nicolas; Tsai, Mindy; Galli, Stephen J.] Stanford Univ, Sch Med, Sean N Parker Ctr Allergy Res, Stanford, CA 94305 USA; [Reber, Laurent L.; Balbino, Bianca] Inst Pasteur, Dept Immunol, Unit Antibodies Therapy & Pathol, Paris, France; [Reber, Laurent L.; Balbino, Bianca] INSERM, Paris, France; [Balbino, Bianca] Univ Paris 06, Paris, France; [Rogalla, Stephan; Sensarn, Steven; Kang, Dongmin; Contag, Christopher H.] Stanford Univ, Sch Med, Div Neonatol, Dept Bioengn, Stanford, CA 94305 USA; [Rogalla, Stephan; Sensarn, Steven; Kang, Dongmin; Contag, Christopher H.] Stanford Univ, Sch Med, Div Neonatol, Dept Radiol, Stanford, CA 94305 USA; [Rogalla, Stephan; Sensarn, Steven; Kang, Dongmin; Contag, Christopher H.] Stanford Univ, Sch Med, Div Neonatol, Dept Pediat, Stanford, CA 94305 USA; [Rogalla, Stephan; Sensarn, Steven; Kang, Dongmin; Contag, Christopher H.] Stanford, Mol Imaging Program, Stanford, CA USA; [Kang, Dongmin] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Raghu, Harini; Sokolove, Jeremy; Robinson, William H.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Raghu, Harini; Sokolove, Jeremy; Robinson, William H.] Vet Affairs Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA USA; [Contag, Christopher H.; Galli, Stephen J.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Starkl, Philipp] Austrian Acad Sci, Res Ctr Mol Med, CeMM, Vienna, Austria; [Starkl, Philipp] Med Univ Vienna, Dept Med 1, Res Lab Infect Biol, Vienna, Austria; [Gaudenzio, Nicolas] Univ Toulouse, INSERM, UDEAR, UMR 1056, Toulouse, France	Stanford University; Stanford University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Stanford University; Stanford University; Stanford University; Stanford University; Ewha Womans University; Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Reber, LL; Galli, SJ (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.; Reber, LL; Galli, SJ (corresponding author), Stanford Univ, Sch Med, Sean N Parker Ctr Allergy Res, Stanford, CA 94305 USA.; Reber, LL (corresponding author), Inst Pasteur, Dept Immunol, Unit Antibodies Therapy & Pathol, Paris, France.; Reber, LL (corresponding author), INSERM, Paris, France.; Galli, SJ (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	laurent.reber@pasteur.fr; sgalli@stanford.edu	Reber, Laurent L/K-4148-2014	Reber, Laurent L/0000-0003-3384-6769; Starkl, Philipp/0000-0001-7521-129X; Tsai, Mindy/0000-0002-8421-4721; Kang, Dongmin/0000-0001-5997-625X; Gaudenzio, Nicolas/0000-0002-5648-509X; Robinson, William/0000-0003-4385-704X; Contag, Christopher/0000-0002-1011-8278	Arthritis National Research Foundation (ANRF), National Institutes of Health [K99 AI110645]; European Commission [H2020-MSCA-IF-2014 656086]; Institut National de la Sante et de Ia Recherche Medicale (INSERM); Max Kade Fellowship of the Max Kade Foundation; Austrian Academy of Sciences; Schroedinger Fellowship of the Austrian Science Fund (FWF) [J3399-B21]; Pasteur - Paris University (PPU) International Ph.D. Program; Lucile Packard Foundation for Children's Health; Stanford NIH/NCRR CTSA award [UL1 RR025744]; French "Fondation pour la Recherche Medicale FRM"; George Will Foundation; Chambers Family Foundation Fund for Excellence in Pediatric Research; Child Health Research Institute at Stanford; National Institutes of Health [U19 AI104209, NS 080062, R01 AR067145]; Department of Pathology, Stanford University School of Medicine	Arthritis National Research Foundation (ANRF), National Institutes of Health; European Commission(European CommissionEuropean Commission Joint Research Centre); Institut National de la Sante et de Ia Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Max Kade Fellowship of the Max Kade Foundation; Austrian Academy of Sciences; Schroedinger Fellowship of the Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Pasteur - Paris University (PPU) International Ph.D. Program; Lucile Packard Foundation for Children's Health; Stanford NIH/NCRR CTSA award; French "Fondation pour la Recherche Medicale FRM"(Fondation pour la Recherche Medicale); George Will Foundation; Chambers Family Foundation Fund for Excellence in Pediatric Research; Child Health Research Institute at Stanford; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology, Stanford University School of Medicine	L.L.R. acknowledges support from the Arthritis National Research Foundation (ANRF), National Institutes of Health grant K99 AI110645, the European Commission (Marie Skfodowska-Curie Individual Fellowship H2020-MSCA-IF-2014 656086) and the Institut National de la Sante et de Ia Recherche Medicale (INSERM); P.S. was supported by a Max Kade Fellowship of the Max Kade Foundation and the Austrian Academy of Sciences and a Schroedinger Fellowship of the Austrian Science Fund (FWF): J3399-B21; B.B. was supported by a stipend from the Pasteur - Paris University (PPU) International Ph.D. Program; R.S. was supported by the Lucile Packard Foundation for Children's Health and the Stanford NIH/NCRR CTSA award number UL1 RR025744; N.G. was the recipient of a fellowship from the French "Fondation pour la Recherche Medicale FRM"; S.R. was supported in part by the George Will Foundation; C.H.C. acknowledges the Chambers Family Foundation Fund for Excellence in Pediatric Research, and the Child Health Research Institute at Stanford for their generous support; S.J.G. acknowledges support from National Institutes of Health grants U19 AI104209, NS 080062, and R01 AR067145 and the Department of Pathology, Stanford University School of Medicine.	Breccia M, 2013, LEUKEMIA RES, V37, P713, DOI 10.1016/j.leukres.2013.01.021; Colvin RA, 2010, NAT IMMUNOL, V11, P495, DOI 10.1038/ni.1878; Committee FA, 2011, SUMM MIN ARTHR ADV C, V21, P2011; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Eklund KK, 2003, ANN MED, V35, P362, DOI 10.1080/07853890310001339; Fels E, 2008, CURR OPIN RHEUMATOL, V20, P198, DOI 10.1097/BOR.0b013e3282f4eff5; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Higaki M, 2005, ANN RHEUM DIS, V64, P1132, DOI 10.1136/ard.2004.030759; Juurikivi A, 2005, ANN RHEUM DIS, V64, P1126, DOI 10.1136/ard.2004.029835; Kapoor DN, 2015, THER DELIV, V6, P41, DOI [10.4155/tde.14.91, 10.4155/TDE.14.91]; Kim WU, 2002, ARTHRITIS RHEUM-US, V46, P1109, DOI 10.1002/art.10198; Levitzki A, 2013, ANNU REV PHARMACOL, V53, P161, DOI 10.1146/annurev-pharmtox-011112-140341; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mitroulis I, 2013, SEMIN IMMUNOPATHOL, V35, P501, DOI 10.1007/s00281-013-0361-0; Miyachi K, 2003, CLIN RHEUMATOL, V22, P329, DOI 10.1007/s10067-003-0716-3; Paniagua RT, 2006, J CLIN INVEST, V116, P2633, DOI 10.1172/JCI28546; Reber LL, 2014, ARTHRITIS RHEUMATOL, V66, P2881, DOI 10.1002/art.38747; Schlesinger N, 2011, DRUGS, V71, P1413, DOI 10.2165/11592290-000000000-00000; SIMKIN PA, 1994, J RHEUMATOL, V21, P2320; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; Wolff NC, 2004, CLIN CANCER RES, V10, P3528, DOI 10.1158/1078-0432.CCR-0957-03; Zermati Y, 2003, ONCOGENE, V22, P660, DOI 10.1038/sj.onc.1206120; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	23	8	9	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185704	10.1371/journal.pone.0185704	http://dx.doi.org/10.1371/journal.pone.0185704			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982129	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300059
J	Hsu, AP; Tseng, CH; Barrat, J; Lee, SH; Shih, YH; Wasniewski, M; Mahl, P; Chang, CC; Lin, CT; Chen, RS; Tu, WJ; Cliquet, F; Tsai, HJ				Hsu, Ai-Ping; Tseng, Chun-Hsien; Barrat, Jacques; Lee, Shu-Hwae; Shih, Yu-Hua; Wasniewski, Marine; Mahl, Philippe; Chang, Chia-Chia; Lin, Chun-Ta; Chen, Re-Shang; Tu, Wen-Jane; Cliquet, Florence; Tsai, Hsiang-Jung			Safety, efficacy and immunogenicity evaluation of the SAG2 oral rabies vaccine in Formosan ferret badgers	PLOS ONE			English	Article							FOXES VULPES-VULPES; RED FOX; VIRUS; DOGS; IMMUNIZATION	Since 2013, rabies cases have been reported among Formosan ferret badgers in Taiwan, and they have been shown to be the major reservoirs for Taiwanese enzootics. To control and eradicate rabies, the authorities plan to implement a vaccination programme. Before distributing live vaccines in the field, this study assessed the safety, efficacy, and immunogenicity of SAG2 vaccine on ferret badgers by direct oral instillation. After application of 10(9) TCID50/dose, no virus was excreted into the oral cavity 1-7 days post-application, and safety was also satisfactorily verified over a 266-day period. Moreover, despite the low level of rabies virus neutralising antibodies induced after vaccination of a 10(8) TCID50/dose, the efficacy assessment revealed a 100% survival rate (15/15) of vaccinees and an 87.5% fatality rate (7/8) in control animals after a challenge on the 198th day post-vaccination. The immunisation and protection rates obtained more than 6 months after a single vaccination dose demonstrated that SAG2 is an ideal vaccine candidate to protect Formosan ferret badgers against rabies in Taiwan.	[Hsu, Ai-Ping; Tseng, Chun-Hsien; Shih, Yu-Hua; Chen, Re-Shang; Tu, Wen-Jane] Council Agr, Anim Hlth Res Inst, Div Biol, New Taipei, Taiwan; [Hsu, Ai-Ping; Shih, Yu-Hua; Tsai, Hsiang-Jung] Natl Taiwan Univ, Grad Inst Vet Med, Sch Vet Med, Taipei, Taiwan; [Barrat, Jacques; Wasniewski, Marine; Cliquet, Florence] French Agcy Food Environm & Occupat Hlth & Safety, Nancy OIE WHO EU Lab Rabies & Wildlife, Technopole Agr & Vet, Domaine De Pixerecourt, Malzeville, France; [Lee, Shu-Hwae; Chang, Chia-Chia; Lin, Chun-Ta] Council Agr, Anim Hlth Res Inst, Anim Drugs Inspect Branch, Gongguan Township, Miaoli County, Taiwan; [Mahl, Philippe] VIRBAC Labs, Carros, France; [Tsai, Hsiang-Jung] Natl Taiwan Univ, Sch Vet Med, Zoonoses Res Ctr, Taipei, Taiwan	National Taiwan University; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Technopole Agricole et Veterinaire; National Taiwan University	Tsai, HJ (corresponding author), Natl Taiwan Univ, Grad Inst Vet Med, Sch Vet Med, Taipei, Taiwan.; Cliquet, F (corresponding author), French Agcy Food Environm & Occupat Hlth & Safety, Nancy OIE WHO EU Lab Rabies & Wildlife, Technopole Agr & Vet, Domaine De Pixerecourt, Malzeville, France.; Tsai, HJ (corresponding author), Natl Taiwan Univ, Sch Vet Med, Zoonoses Res Ctr, Taipei, Taiwan.	florence.cliquet@anses.fr; tsaihj@ntu.edu.tw	WASNIEWSKI, Marine/AAX-8945-2020	CLIQUET, Florence/0000-0003-2237-1243	Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Taiwan;  [MOST 103-3114-Y-518-001];  [MOST 104-3114-Y518-002];  [1052101011001-10100562]	Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Taiwan; ; ; 	The grants for this study were provided by Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Taiwan (https://www.baphiq.gov.tw/en/). The authors received the grants were respectively HT (grant No. MOST 103-3114-Y-518-001), CT (grant No. MOST 104-3114-Y518-002 and grant No. 1052101011001-10100562). VIRBAC Laboratories provided support in the form of salaries for author [PM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the `author contributions' section.	Artois M, 1997, VET REC, V140, P57, DOI 10.1136/vr.140.3.57; Bingham J, 1999, VACCINE, V17, P551, DOI 10.1016/S0264-410X(98)00233-3; Bingham J, 1997, VACCINE, V15, P937, DOI 10.1016/S0264-410X(97)00009-1; Blancou Jean, 2009, P97, DOI 10.1007/978-4-431-77134-0_6; Bureau of Animal and Plant Health Inspection and Quarantine, 2016, TAIW RES RAB EPID SU; Cliquet F, 2008, DEV BIOLOGICALS, V131, P257; Cliquet F, 2007, VACCINE, V25, P3409, DOI 10.1016/j.vaccine.2006.12.054; Cliquet F, 2006, VACCINE, V24, P4386, DOI 10.1016/j.vaccine.2006.02.057; Cliquet F, 2000, VACCINE, V18, P3272, DOI 10.1016/S0264-410X(00)00127-4; Cliquet F, 2004, DEV BIOLOGICALS, V119, P185; Cliquet F, 1998, J IMMUNOL METHODS, V212, P79, DOI 10.1016/S0022-1759(97)00212-3; Cliquet F, 2014, EXPERT REV ANTI-INFE, V12, P905, DOI 10.1586/14787210.2014.921570; Dean D.J., 1996, LAB TECHNIQUES RABIE, P83; Dyer JL, 2014, JAVMA-J AM VET MED A, V245, P1111, DOI 10.2460/javma.245.10.1111; European Medicines Agency, 2004, RAB SAG2 EUR PUBL AS; Follmann EH, 2004, J WILDLIFE DIS, V40, P328, DOI 10.7589/0090-3558-40.2.328; Franka R, 2013, ANTIVIR RES, V100, P220, DOI 10.1016/j.antiviral.2013.07.004; Gong ZY, 2004, CHIN J VECTOR BIO CO, V15, P59; Hammami S, 1999, VET RES, V30, P353; Hanlon CA, 2002, J WILDLIFE DIS, V38, P420, DOI 10.7589/0090-3558-38.2.420; Hanlon CA, 1998, J WILDLIFE DIS, V34, P228, DOI 10.7589/0090-3558-34.2.228; Hsu Yung-Hsiang, 2006, Kaohsiung Journal of Medical Sciences, V22, P94, DOI 10.1016/S1607-551X(09)70227-X; Hu RL, 2008, EPIDEMIOL INFECT, V136, P1556, DOI 10.1017/S0950268807000131; Huang ASE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132160; LAFAY F, 1994, VACCINE, V12, P317, DOI 10.1016/0264-410X(94)90095-7; Lambot M, 2001, VACCINE, V19, P1827, DOI 10.1016/S0264-410X(00)00321-2; Mahl P, 2014, VET RES, V45, DOI 10.1186/s13567-014-0077-8; Menezes R, 2008, CAN MED ASSOC J, V178, P564, DOI 10.1503/cmaj.071488; Muller T, 2012, RABIES CONTROL SUSTA, P31; OIE (Office International des Epizooties/World Organization for Animal Health), 2004, MANUAL DIAGNOSTIC TE; Orciari LA, 2001, VACCINE, V19, P4511, DOI 10.1016/S0264-410X(01)00186-4; Robardet E, 2012, J WILDLIFE DIS, V48, P858, DOI 10.7589/2011-07-205; SCHUMACHER CL, 1993, ONDERSTEPOORT J VET, V60, P459; Vigilato MAN, 2013, EMERG INFECT DIS, V19, P678, DOI 10.3201/eid1904.121482; Webster W. A., 1996, P96; Weng HY, 2010, VET RES, V41, DOI 10.1051/vetres/2009059; WHO, 1992, WHO EXP COMM RAB 8 R; World Health Organization, 2013, WHO EXP CONS RAB 2 R; World Health Organization, 2005, WHO EXP CONS RAB 1 R; World Organization for Animal Health, 2013, HAB CHIN TAIP WEEKL; Yakobson B, 1999, 10 ANN RAB AM M SAN; Zhao JH, 2014, J WILDLIFE DIS, V50, P374, DOI 10.7589/2013-01-020	42	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0184831	10.1371/journal.pone.0184831	http://dx.doi.org/10.1371/journal.pone.0184831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977009	Green Submitted, Green Published, gold			2022-12-26	WOS:000412163100013
J	Liu, GS; Bratton, BP; Gital, Z; Shaevitz, JW				Liu, George S.; Bratton, Benjamin P.; Gital, Zemer; Shaevitz, Joshua W.			The effect of antibiotics on protein diffusion in the Escherichia coli cytoplasmic membrane	PLOS ONE			English	Article							PENICILLIN-BINDING-PROTEINS; IN-VIVO; MREB; TRANSPORT; MOBILITY	Accumulating evidence suggests that molecular motors contribute to the apparent diffusion of molecules in cells. However, current literature lacks evidence for an active process that drives diffusive-like motion in the bacterial membrane. One possible mechanism is cell wall synthesis, which involves the movement of protein complexes in the cell membrane circumferentially around the cell envelope and may generate currents in the lipid bilayer that advectively transport other transmembrane proteins. We test this hypothesis in Escherichia coli using drug treatments that slow cell wall synthesis and measure their effect on the diffusion of the transmembrane protein mannitol permease using fluorescence recovery after photobleaching. We found no clear decrease in diffusion in response to vancomycin and no decrease in response to mecillinam treatment. These results suggest that cell wall synthesis is not an active contributor to mobility in the cytoplasmic membrane.	[Liu, George S.; Shaevitz, Joshua W.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Bratton, Benjamin P.; Shaevitz, Joshua W.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Bratton, Benjamin P.; Gital, Zemer] Princeton Univ, Dept Mol Biol, Princeton, NJ USA; [Liu, George S.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Princeton University; Princeton University; Princeton University; Stanford University	Liu, GS; Shaevitz, JW (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.; Shaevitz, JW (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.; Liu, GS (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	gliu2@stanford.edu; shaevitz@princeton.edu	Bratton, Benjamin/AAB-9189-2021	Bratton, Benjamin/0000-0003-1128-2560; Liu, George/0000-0002-2066-5734	National Science Foundation, an NIH [CAREER PHY-844466, P50 GM071508]; Glenn Centers for Aging Research; Princeton University Department of Physics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP1AI124669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107384] Funding Source: NIH RePORTER	National Science Foundation, an NIH; Glenn Centers for Aging Research; Princeton University Department of Physics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Science Foundation (www.nsf.gov) CAREER PHY-844466 toJ WS (J.W.S.,B.P.B.), an NIH grant (P50 GM071508) (B.P.B.), the Glenn Centers for Aging Research (B.P.B.), and a Treiman Fellowship from the Princeton University Department of Physics (G.S.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean GJ, 2009, BIOCHEMISTRY-US, V48, P4852, DOI 10.1021/bi900014d; Brangwynne CP, 2009, TRENDS CELL BIOL, V19, P423, DOI 10.1016/j.tcb.2009.04.004; Brangwynne CP, 2008, J CELL BIOL, V183, P583, DOI 10.1083/jcb.200806149; Bratton BP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134616; Caspi A, 2000, PHYS REV LETT, V85, P5655, DOI 10.1103/PhysRevLett.85.5655; DELAROSA EJ, 1985, P NATL ACAD SCI USA, V82, P5632; DiezGonzalez F, 1997, FEMS MICROBIOL LETT, V151, P71, DOI 10.1111/j.1574-6968.1997.tb10396.x; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Elowitz MB, 1999, COLI J BACTERIOL, V181; Fakhri N, 2014, SCIENCE, V344, P1031, DOI 10.1126/science.1250170; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Guo M, 2014, CELL, V158, P822, DOI 10.1016/j.cell.2014.06.051; HATFIELD D, 1969, J BACTERIOL, V98, P559, DOI 10.1128/JB.98.2.559-567.1969; Javer A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4854; Jha DK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4965; KOCH AL, 1955, J BIOL CHEM, V217, P947; Konopka MC, 2006, J BACTERIOL, V188, P6115, DOI 10.1128/JB.01982-05; Konopka MC, 2009, J BACTERIOL, V191, P231, DOI 10.1128/JB.00536-08; Kumar M, 2010, BIOPHYS J, V98, P552, DOI 10.1016/j.bpj.2009.11.002; Lin CP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11814; Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404; NOGUCHI H, 1979, EUR J BIOCHEM, V100, P41, DOI 10.1111/j.1432-1033.1979.tb02031.x; Oswald F, 2016, BIOPHYS J, V110, P1139, DOI 10.1016/j.bpj.2016.01.010; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Parry BR, 2014, CELL, V156, P183, DOI 10.1016/j.cell.2013.11.028; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; SAMPSON BA, 1989, GENETICS, V122, P491; Schulmeister S, 2008, P NATL ACAD SCI USA, V105, P6403, DOI 10.1073/pnas.0710611105; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; van Teeffelen S, 2011, P NATL ACAD SCI USA, V108, P15822, DOI 10.1073/pnas.1108999108; Weber SC, 2012, P NATL ACAD SCI USA, V109, P7338, DOI 10.1073/pnas.1119505109; Weber SC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238102; YOUNG R, 1976, BIOCHEM J, V160, P185, DOI 10.1042/bj1600185	34	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185810	10.1371/journal.pone.0185810	http://dx.doi.org/10.1371/journal.pone.0185810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977034	Green Submitted, Green Published, gold			2022-12-26	WOS:000412163100047
J	Michael, B; Howard, M				Michael, Brendan; Howard, Matthew			Activity recognition with wearable sensors on loose clothing	PLOS ONE			English	Article							MOTION; GAIT	Observing human motion in natural everyday environments (such as the home), has evoked a growing interest in the development of on-body wearable sensing technology. However, wearable sensors suffer from motion artefacts introduced by the non-rigid attachment of sensors to the body, and the prevailing view is that it is necessary to eliminate these artefacts. This paper presents findings that suggest that these artefacts can, in fact, be used to distinguish between similar motions, by exploiting additional information provided by the fabric motion. An experimental study is presented whereby factors of both the motion and the properties of the fabric are analysed in the context of motion similarity. It is seen that while standard rigidly attached sensors have difficultly in distinguishing between similar motions, sensors mounted onto fabric exhibit significant differences (p < 0.01). An evaluation of the physical properties of the fabric shows that the stiffness of the material plays a role in this, with a trade-off between additional information and extraneous motion. This effect is evaluated in an online motion classification task, and the use of fabric-mounted sensors demonstrates an increase in prediction accuracy over rigidly attached sensors.	[Michael, Brendan; Howard, Matthew] Kings Coll London, Dept Informat, London, England	University of London; King's College London	Michael, B (corresponding author), Kings Coll London, Dept Informat, London, England.	brendan.michael@kcl.ac.uk		Michael, Brendan/0000-0002-5631-9913; Howard, Matthew/0000-0003-2534-4865	King's College London	King's College London	Open access for this article was funded by King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Open access for this article was funded by King's College London.	Alper SE, 2005, J MICROELECTROMECH S, V14, P707, DOI 10.1109/JMEMS.2005.845400; Andersen LL, 2010, PHYS THER, V90, P538, DOI 10.2522/ptj.20090167; Attal F, 2015, SENSORS-BASEL, V15, P31314, DOI 10.3390/s151229858; Banaee H, 2013, SENSORS-BASEL, V13, P17472, DOI 10.3390/s131217472; Bonmassar G, 2002, NEUROIMAGE, V16, P1127, DOI 10.1006/nimg.2002.1125; Chen F, 2016, TEXT RES J; Cooper S., 2016, STAGING DANCE; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cutti AG, 2010, MED BIOL ENG COMPUT, V48, P17, DOI 10.1007/s11517-009-0545-x; Deyle TJ, 2005, LOW COST INERTIAL ME; Dijkstra B, 2010, ARCH PHYS MED REHAB, V91, P1272, DOI 10.1016/j.apmr.2010.05.004; Galar M, 2011, PATTERN RECOGN, V44, P1761, DOI 10.1016/j.patcog.2011.01.017; Gillette R., 2015, P 14 ACM SIGGRAPHEUR, P17, DOI [10.1145/2786784.2786789, DOI 10.1145/2786784.2786789]; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Helmich RC, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0378-8; InvenSense, 2013, MPU 6500 PROD SPEC; James J., 2006, P 14 ACM INT C MULT, P470; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Kaldor JM, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1778765.1778842; Keerthi SS, 2003, NEURAL COMPUT, V15, P1667, DOI 10.1162/089976603321891855; Li L., 2009, TEXTILE RES J; Louis ED, 2010, MOVEMENT DISORD, V25, P534, DOI 10.1002/mds.22838; Mandel MI, 2005, P INT SOC MUS INF RE, V2005, P594; Michael B, 2015, NEURAL SYSTEMS REHAB, P1; Minton SC, 2007, HUMAN KINETICS; Moore ST, 2008, J NEUROSCI METH, V167, P340, DOI 10.1016/j.jneumeth.2007.08.023; Peng C., 2016, INTELL SYST TECHNOL, V8, P30, DOI [10.1145/2972957, DOI 10.1145/2972957]; Roetenberg Daniel, 2009, 1 XSENS MOT TECHN BV, V1, P1; Singh G, 2016, IEEE SENS J, V16, P2666, DOI 10.1109/JSEN.2015.2491225; Slyper R., 2008, P 2008 ACM SIGGRAPHE, P193, DOI DOI 10.2312/SCA/SCA08/193-199; Subasi A, 2013, COMPUT BIOL MED, V43, P576, DOI 10.1016/j.compbiomed.2013.01.020; Such O, 2007, P ANN INT IEEE EMBS, P1542, DOI 10.1109/IEMBS.2007.4352597; Tang M, 2016, COMPUT GRAPH FORUM, V35, P511, DOI 10.1111/cgf.12851; Watanabe K, 2009, IEEE SENS J, V9, P1847, DOI 10.1109/JSEN.2009.2030987; Wright JR, 2012, TEXT RES J, V82, P645, DOI 10.1177/0040517512436824; Yang CC, 2010, SENSORS-BASEL, V10, P7772, DOI 10.3390/s100807772	36	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0184642	10.1371/journal.pone.0184642	http://dx.doi.org/10.1371/journal.pone.0184642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976978	gold, Green Published, Green Submitted			2022-12-26	WOS:000412163100008
J	Casuso, RA; Plaza-Diaz, J; Ruiz-Ojeda, FJ; Aragon-Vela, J; Robles-Sanchez, C; Nordsborg, NB; Hebberecht, M; Salmeron, LM; Huertas, JR				Casuso, Rafael A.; Plaza-Diaz, Julio; Ruiz-Ojeda, Francisco J.; Aragon-Vela, Jeronimo; Robles-Sanchez, Candido; Nordsborg, Nikolai B.; Hebberecht, Marina; Salmeron, Luis M.; Huertas, Jesus R.			High-intensity high-volume swimming induces more robust signaling through PGC-1 alpha and AMPK activation than sprint interval swimming in m. triceps brachii	PLOS ONE			English	Article							OXIDATIVE STRESS; SKELETAL-MUSCLE; REACTIVE OXYGEN; EXERCISE; PHOSPHORYLATION; ADAPTATIONS; MECHANISMS; EXPRESSION; INCREASES; SIRT3	We aimed to test whether high-intensity high-volume training (HIHVT) swimming would induce more robust signaling than sprint interval training (SIT) swimming within the m. triceps brachii due to lower metabolic and oxidation. Nine well-trained swimmers performed the two training procedures on separate randomized days. Muscle biopsies from m. triceps brachii and blood samples were collected at three different time points: a) before the intervention (pre), b) immediately after the swimming procedures (post) and c) after 3 h of rest (3 h). Hydroperoxides, creatine kinase (CK), and lactate dehydrogenase (LDH) were quantified from blood samples, and peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and the AMPK (pTHR172)/AMPK ratio were quantified by Western blot analysis. PGC-1 alpha, sirtuin 3 (SIRT3), superoxide-dismutase 2 (SOD2), and vascular endothelial growth factor (VEGF) mRNA levels were also quantified. SIT induced a higher release of LDH (p < 0.01 at all time points) and CK (p < 0.01 at post) than HIHVT, but neither SIT nor HIHVT altered systemic hydroperoxides. Additionally, neither SIRT3 nor SOD2 mRNA levels increased, while PGC-1a transcription increased at 3 h after SIT (p < 0.01) and after HIHVT (p < 0.001). However, PGC-1a protein was higher after HIHVT than after SIT (p < 0.05). Moreover, the AMPK(pTHR172)/AMPK ratio increased at post after SIT (p < 0.05), whereas this effect was delayed after HIHVT as it increased after 3 h (p < 0.05). In addition, VEGF transcription was higher in response to HIHVT (p < 0.05). In conclusion, SIT induces higher muscular stress than HIHVT without increasing systemic oxidation. In addition, HIHVT may induce more robust oxidative adaptations through PGC-1 alpha and AMPK.	[Casuso, Rafael A.; Aragon-Vela, Jeronimo; Huertas, Jesus R.] Univ Granada, Sch Pharm, Dept Physiol, Granada, Spain; [Casuso, Rafael A.; Plaza-Diaz, Julio; Ruiz-Ojeda, Francisco J.; Aragon-Vela, Jeronimo; Robles-Sanchez, Candido; Huertas, Jesus R.] Univ Granada, Inst Nutr & Food Technol Jose Mataix, Biomed Res Ctr, Granada, Spain; [Plaza-Diaz, Julio; Ruiz-Ojeda, Francisco J.; Robles-Sanchez, Candido] Univ Granada, Sch Pharm, Dept Biochem & Mol Biol 2, Granada, Spain; [Nordsborg, Nikolai B.] Univ Copenhagen, Sect Human Physiol, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Hebberecht, Marina; Salmeron, Luis M.] San Cecilio Univ Hosp, Granada, Spain	University of Granada; University of Granada; University of Granada; University of Copenhagen; Hospital Universitario San Cecilio	Casuso, RA (corresponding author), Univ Granada, Sch Pharm, Dept Physiol, Granada, Spain.; Casuso, RA (corresponding author), Univ Granada, Inst Nutr & Food Technol Jose Mataix, Biomed Res Ctr, Granada, Spain.	casusopt@gmail.com	Plaza-Diaz, Julio/C-8094-2016; Huertas, Jesus Francisco Rodriguez/G-8188-2015; Aragón-Vela, Jerónimo/AAA-9889-2019; Casuso, Rafael/E-9617-2016; Ojeda, Francisco Javier Ruiz/D-1228-2016; Nordsborg, Nikolai/O-6173-2014	Plaza-Diaz, Julio/0000-0002-5171-9408; Huertas, Jesus Francisco Rodriguez/0000-0002-7446-0857; Aragón-Vela, Jerónimo/0000-0002-2550-6695; Casuso, Rafael/0000-0002-4482-3186; Ojeda, Francisco Javier Ruiz/0000-0002-4452-0855; Nordsborg, Nikolai/0000-0001-7077-9265				Anderson KA, 2011, CELL, V159, P956; Ansari A, 2017, AGING CELL, V16, P4, DOI 10.1111/acel.12538; Banfi G, 2012, ADV CLIN CHEM, V56, P1, DOI 10.1016/B978-0-12-394317-0.00015-7; Bartlett JD, 2012, J APPL PHYSIOL, V112, P1135, DOI 10.1152/japplphysiol.01040.2011; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; Brandauer J, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00085; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Casuso RA, 2017, HIGH ALT MED BIOL, V18, P46, DOI 10.1089/ham.2016.0046; Casuso RA, 2014, J SPORT SCI MED, V13, P958; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Combes A, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12462; Drake JC, 2016, FASEB J, V30, P13, DOI 10.1096/fj.15-276337; Edgett BA, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12879; Edgett BA, 2016, EXP PHYSIOL, V101, P1101, DOI 10.1113/EP085744; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Figueiredo P, 2013, APPL PHYSIOL NUTR ME, V38, P716, DOI 10.1139/apnm-2012-0263; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P3391, DOI 10.1113/jphysiol.2012.235127; Gibala MJ, 2009, J APPL PHYSIOL, V106, P929, DOI 10.1152/japplphysiol.90880.2008; Halson SL, 2014, SPORTS MED, V44, pS139, DOI 10.1007/s40279-014-0253-z; Henriquez-Olguin C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00282; Hoier B, 2014, MICROCIRCULATION, V21, P301, DOI 10.1111/micc.12117; Hood DA, 2016, BIOCHEM J, V473, P2295, DOI 10.1042/BCJ20160009; Jackson MJ, 2015, J APPL PHYSIOL, V119, P163, DOI 10.1152/japplphysiol.00760.2014; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Johnson ML, 2015, J GERONTOL A-BIOL, V70, P1386, DOI 10.1093/gerona/glu221; Kabasakalis A, 2011, J STRENGTH COND RES, V25, P805, DOI 10.1519/JSC.0b013e3181d0b109; Knab AM, 2013, INT J SPORT NUTR EXE, V23, P150, DOI 10.1123/ijsnem.23.2.150; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Koppo K, 2002, RESP PHYSIOL NEUROBI, V133, P241, DOI 10.1016/S1569-9048(02)00184-2; Kristensen DE, 2015, J PHYSIOL-LONDON, V593, P2053, DOI 10.1113/jphysiol.2014.283267; Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349; Larsen FJ, 2016, FASEB J, V30, P417, DOI 10.1096/fj.15-276857; Lu ZB, 2010, ANTIOXID REDOX SIGN, V13, P1011, DOI 10.1089/ars.2009.2940; Maglischo EW, 2003, SWIMMING FASTEST ESE; Morales-Alamo D, 2016, FREE RADICAL BIO MED, V98, P68, DOI 10.1016/j.freeradbiomed.2016.01.012; Morales-Alamo D, 2013, J APPL PHYSIOL, V114, P566, DOI 10.1152/japplphysiol.01246.2012; Mounier R, 2015, TRENDS ENDOCRIN MET, V26, P275, DOI 10.1016/j.tem.2015.02.009; Nordsborg NB, 2015, J APPL PHYSIOL, V119, P116, DOI 10.1152/japplphysiol.00101.2015; Powers SK, 2010, INT J SPORT NUTR EXE, V20, P2, DOI 10.1123/ijsnem.20.1.2; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Ramamoorthy TG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10210; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Robinson MM, 2017, CELL METAB, V25, P581, DOI 10.1016/j.cmet.2017.02.009; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Yoshida Y, 2013, J CLIN BIOCHEM NUTR, V52, P9, DOI 10.3164/jcbn.12-112; Zinner C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00426	50	12	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185494	10.1371/journal.pone.0185494	http://dx.doi.org/10.1371/journal.pone.0185494			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973039	gold, Green Published, Green Submitted			2022-12-26	WOS:000412131900020
J	Omodaka, K; Kikawa, T; Shiga, Y; Tsuda, S; Yokoyama, Y; Sato, H; Ohuchi, J; Matsumoto, A; Takahashi, H; Akiba, M; Nakazawa, T				Omodaka, Kazuko; Kikawa, Tsutomu; Shiga, Yukihiro; Tsuda, Satoru; Yokoyama, Yu; Sato, Haruka; Ohuchi, Junko; Matsumoto, Akiko; Takahashi, Hidetoshi; Akiba, Masahiro; Nakazawa, Toru			Usefulness of axonal tract-dependent OCT macular sectors for evaluating structural change in normal-tension glaucoma	PLOS ONE			English	Article							NERVE-FIBER LAYER; OPTICAL COHERENCE TOMOGRAPHY; RETINAL GANGLION-CELLS; OPEN-ANGLE GLAUCOMA; VISUAL-FIELD; DIAGNOSTIC-VALUE; DOMAIN OCT; THICKNESS; PROGRESSION; DAMAGE	Purpose To identify sectors of the optical coherence tomography (OCT) macular map that could be used to effectively assess structural progression in patients with normal-tension glaucoma (NTG). Methods This study examined 117 eyes of 117 NTG patients to establish axonal tract-dependent macular sectors, and also examined a separate group of 122 eyes of 81 NTG patients to evaluate the ability of these sectors to reveal glaucoma progression. Longitudinal data, including macular maps from at least 5 OCT examinations performed over at least 2 years, was available for all patients in this group. Circumpapillary retinal nerve fiber layer thickness (cpRNFLT), temporal clockwise sector scans (from 7 to 11 o'clock), macular retinal nerve fiber layer thickness (mRNFLT), and macular ganglion cell layer plus inner plexiform layer thickness (mGCIPLT) were measured with spectral-domain OCT (3D OCT-2000, TOP-CON). The axonal tract-dependent macular sectors were identified by calculating Spearman's rank correlation coefficient for each point on a grid overlaid on the macular map and cpRNFLT in each clockwise scan sector. Trend and event analyses for the slope of progression in each sector and macular map were performed. Visual field progression in the macula was defined by the presence of more than 2 progressive test points in the 16 central test points of the Humphrey field analyzer SITA standard 24-2 program, evaluated with Progressor software. Results The slope of progression in the entire macular area was -0.22 +/- 0.58 mu m/year for mRNFLT and -0.35 +/- 0.52 mu m/year for mGCIPLT. The fastest-progressing mRNFLT sector (-1.00 +/- 0.84 mu m/year, p < 0.001) and mGCIPLT sector (-1.16 +/- 0.63 mu m/year, p < 0.001) progressed significantly faster than the overall macula. Classifying patients according to visual field progression showed that baseline mRNFLT in the inferior hemifield, 7 and 8 o'clock sectors, as well as baseline mGCIPLT in the overall macular map, inferior hemifield, and 8 o'clock sector, were significantly lower in progressors (22 eyes) than non-progressors (100 eyes). There were significant differences in mRNFLT slope in 8 o'clock sector and in the fastest progressing sector in progressors and non-progressors, but mGCIPLT did not differ, even in the fastest-progressing sector. Event analysis showed that progression occurred most frequently in inferior mRNFLT and superior mGCIPLT in this study. Conclusion Axonal tract-dependent OCT macular sectors could effectively reveal structural change in patients with NTG. Furthermore, mRNFLT slope was consistent with visual field progression. This method promises to open new avenues for the OCT-based evaluation of glaucoma progression.	[Omodaka, Kazuko; Shiga, Yukihiro; Tsuda, Satoru; Yokoyama, Yu; Sato, Haruka; Ohuchi, Junko; Takahashi, Hidetoshi; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan; [Omodaka, Kazuko; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalm Imaging & Informat Analyt, Sendai, Miyagi, Japan; [Kikawa, Tsutomu; Matsumoto, Akiko; Akiba, Masahiro] Topcon Corp, Tokyo, Japan; [Takahashi, Hidetoshi] Tohoku Med & Pharmaceut Univ, Dept Med, Div Ophthalmol, Sendai, Miyagi, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Ophthalmol, Sendai, Miyagi, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Topcon Corporation; Tohoku Medical & Pharmaceutical University; Tohoku University; Tohoku University	Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalm Imaging & Informat Analyt, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Ophthalmol, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi, Japan.	ntoru@oph.med.tohoku.ac.jp			JST grant from JSPS KAKENHI [TN 17H04349, TN 16K15730]; JST Center for Revitalization Promotion; Topcon Corporation; KAKENHI [K0 17K16957]; Public Trust Suda Memorial Fund for Glaucoma Research	JST grant from JSPS KAKENHI; JST Center for Revitalization Promotion; Topcon Corporation; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Public Trust Suda Memorial Fund for Glaucoma Research	Topcon Corporation provided support in the form of salaries for authors TK, AM, and MA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This paper was supported in part by a JST grant from JSPS KAKENHI Grants-in-Aid for Scientific Research (B) (TN 17H04349) and for Exploratory Research (TN 16K15730), and by the JST Center for Revitalization Promotion and KAKENHI Grant-in Aid for young scientists (B) (K0 17K16957) and Public Trust Suda Memorial Fund for Glaucoma Research, and joint research project with Topcon Corporation.	Anraku A, 2014, GRAEF ARCH CLIN EXP, V252, P109, DOI 10.1007/s00417-013-2527-9; ARAIE M, 1995, JPN J OPHTHALMOL, V39, P60; De Moraes CGV, 2011, ARCH OPHTHALMOL-CHIC, V129, P562, DOI 10.1001/archophthalmol.2011.72; Ernest PJ, 2013, OPHTHALMOLOGY, V120, P512, DOI 10.1016/j.ophtha.2012.09.005; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Garway-Heath DF, 1998, BRIT J OPHTHALMOL, V82, P352, DOI 10.1136/bjo.82.4.352; Hood DC, 2017, PROG RETIN EYE RES, V57, P46, DOI 10.1016/j.preteyeres.2016.12.002; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jeong JH, 2014, ACTA OPHTHALMOL, V92, pE185, DOI 10.1111/aos.12277; Kanamori A, 2008, ARCH OPHTHALMOL-CHIC, V126, P1500, DOI 10.1001/archopht.126.11.1500; Kanamori A, 2013, INVEST OPHTH VIS SCI, V54, P6401, DOI 10.1167/iovs.13-12805; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; Kim HS, 2016, J GLAUCOMA, V25, P472, DOI 10.1097/IJG.0000000000000285; Kim NR, 2010, INVEST OPHTH VIS SCI, V51, P4646, DOI 10.1167/iovs.09-5053; Kim YK, 2017, J GLAUCOMA, V26, P126, DOI 10.1097/IJG.0000000000000576; Kim YK, 2015, OPHTHALMOLOGY, V122, P2252, DOI 10.1016/j.ophtha.2015.07.013; Lamparter J, 2013, INVEST OPHTH VIS SCI, V54, P6074, DOI 10.1167/iovs.13-11902; Lee EJ, 2011, INVEST OPHTH VIS SCI, V52, P1138, DOI 10.1167/iovs.10-5975; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Leung CKS, 2012, OPHTHALMOLOGY, V119, P731, DOI 10.1016/j.ophtha.2011.10.010; Liang YB, 2011, INVEST OPHTH VIS SCI, V52, P8250, DOI 10.1167/iovs.11-7472; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Lisboa R, 2013, INVEST OPHTH VIS SCI, V54, P3417, DOI 10.1167/iovs.13-11676; Mayama C, 2002, OPHTHALMOLOGY, V109, P2072, DOI 10.1016/S0161-6420(02)01175-2; Mayama C, 2015, INVEST OPHTH VIS SCI, V56, P5681, DOI 10.1167/iovs.15-17208; Medeiros FA, 2012, INVEST OPHTH VIS SCI, V53, P6939, DOI 10.1167/iovs.12-10345; Miki A, 2014, OPHTHALMOLOGY, V121, P1350, DOI 10.1016/j.ophtha.2014.01.017; Morooka S, 2012, INVEST OPHTH VIS SCI, V53, P4805, DOI 10.1167/iovs.12-9870; Niles PI, 2012, EYE, V26, P983, DOI 10.1038/eye.2012.76; Nitta K, 2011, J GLAUCOMA, V20, P189, DOI 10.1097/IJG.0b013e3181e0799c; Omodaka K, 2014, CLIN EXPT OPHTHALMOL, V43, P279; Omodaka K, 2015, CURR EYE RES, V40, P744, DOI 10.3109/02713683.2014.956371; Omodaka K, 2013, JPN J OPHTHALMOL, V57, P457, DOI 10.1007/s10384-013-0258-4; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; QUIGLEY HA, 1992, OPHTHALMOLOGY, V99, P19; Raza AS, 2014, INVEST OPHTH VIS SCI, V55, P612, DOI 10.1167/iovs.13-12351; Sehi M, 2013, AM J OPHTHALMOL, V155, P73, DOI 10.1016/j.ajo.2012.07.005; Seong M, 2010, INVEST OPHTH VIS SCI, V51, P1446, DOI 10.1167/iovs.09-4258; Sjostrand J, 1999, GRAEF ARCH CLIN EXP, V237, P1014, DOI 10.1007/s004170050338; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; SUZUKI Y, 1993, OPHTHALMOLOGY, V100, P69; Suzuki Y, 2001, J GLAUCOMA, V10, P121, DOI 10.1097/00061198-200104000-00009; Takada N, 2015, CLIN EXP OPHTHALMOL, V43, P291, DOI 10.1111/ceo.12429; Takahashi M, 2013, CURR EYE RES, V38, P1133, DOI 10.3109/02713683.2013.807932; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Yang Q, 2010, OPT EXPRESS, V18, P21293, DOI 10.1364/OE.18.021293	51	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185649	10.1371/journal.pone.0185649	http://dx.doi.org/10.1371/journal.pone.0185649			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973002	gold, Green Submitted, Green Published			2022-12-26	WOS:000412131900034
J	Park, TY; Chong, S; Jung, JW; Park, IW; Choi, BW; Lim, C; Lee, CU; Kim, YS; Choi, HW; Choi, JC				Park, Tae Yun; Chong, Semin; Jung, Jae-Woo; Park, In Won; Choi, Byoung Whui; Lim, Changwon; Lee, Chang Un; Kim, Yang Soo; Choi, Hye Won; Choi, Jae Chol			Natural course of the nodular bronchiectatic form of Mycobacterium Avium complex lung disease: Long-term radiologic change without treatment	PLOS ONE			English	Article							PULMONARY-DISEASE; INTRACELLULARE COMPLEX; CT FINDINGS; PREVALENCE; DIAGNOSIS; KOREA	Background/Purpose Although the incidence of Mycobacterium avium complex (MAC) lung disease is increasing, the long-term natural course of the nodular bronchiectatic form of MAC lung disease is not well described. The objective of our study is to evaluate long-term radiologic changes in untreated MAC lung disease by analyzing serial chest computed tomography (CT) scan findings. Methods Of 104 patients with MAC lung disease, we selected 40 untreated nodular bronchiectatic MAC patients who underwent serial chest CTs without treatment for at least four years (mean = 6.23 years). Majority of patients have minimal symptoms. Two chest radiologists retrospectively reviewed initial and final chest CT scans. Each chest CT scan was scored for presence and extent of bronchiectasis, cellular bronchiolitis, consolidation, cavity, and nodule (maximum score: 30). Results Of 40 patients, 39 (97.5%) experienced a significant increase in overall CT score (overall difference = 4.89, p<0.001). On repeated measure analysis of variance analysis, cavity yielded the largest increase compared with cellular bronchiolitis (p = 0.013), nodule (p< 0.001), and consolidation (p = 0.004). However, there was no significant difference in mean score change between cavity and bronchiectasis (p = 0.073). In analysis between radiologic parameters and the absolute number of involved segments, bronchiectasis showed most significant change compared with nodule (p< 0.001) and consolidation (p< 0.001). Conclusions Most untreated nodular bronchiectatic MAC lung disease cases showed radiologic deterioration over long-term observation periods when we compared serial chest CT scans. Careful monitoring of MAC lung disease with serial chest CT scan can be beneficial in these untreated patients.	[Park, Tae Yun; Jung, Jae-Woo; Park, In Won; Choi, Byoung Whui; Choi, Jae Chol] Chung Ang Univ, Chung Ang Univ Coll Med, Div Pulm Med, Dept Internal Med, Seoul, South Korea; [Chong, Semin; Lee, Chang Un; Kim, Yang Soo; Choi, Hye Won] Chung Ang Univ Hosp, Chung Ang Univ Coll Med, Dept Radiol, Seoul, South Korea; [Lim, Changwon] Chung Ang Univ, Dept Appl Stat, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital; Chung Ang University	Choi, JC (corresponding author), Chung Ang Univ, Chung Ang Univ Coll Med, Div Pulm Med, Dept Internal Med, Seoul, South Korea.	medics27@cau.ac.kr		Chong, Semin/0000-0002-7429-2566				Cole P., 1985, EUR J RESP DIS S, V147, P6; Daley CL, 2010, INT J TUBERC LUNG D, V14, P665; Fujita J, 2003, RESP MED, V97, P933, DOI 10.1016/S0954-6111(03)00120-3; Gochi M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008058; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hwang JA, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00537-2016; Ito Y, 2012, INT J TUBERC LUNG D, V16, P408, DOI 10.5588/ijtld.11.0148; Kim JS, 2005, CHEST, V128, P3863, DOI 10.1378/chest.128.6.3863; Kim SJ, 2014, INT J TUBERC LUNG D, V18, P730, DOI 10.5588/ijtld.13.0792; Kitada S, 2012, INT J TUBERC LUNG D, V16, P660, DOI 10.5588/ijtld.11.0534; Kobashi Y, 2007, RESP MED, V101, P130, DOI 10.1016/j.rmed.2006.04.002; Koh WJ, 2006, CHEST, V129, P341, DOI 10.1378/chest.129.2.341; Koh WJ, 2008, KOREAN J MED, V74, P120; Kuroishi S, 2008, EUR RESPIR J, V32, P147, DOI 10.1183/09031936.00074207; Lam PK, 2006, AM J RESP CRIT CARE, V173, P1283, DOI 10.1164/rccm.200509-1531OC; Lee G, 2013, AM J ROENTGENOL, V201, P764, DOI 10.2214/AJR.12.9897; Lee Geewon, 2013, Ann Am Thorac Soc, V10, P299, DOI 10.1513/AnnalsATS.201303-062OC; LEWIS AG, 1960, ANN INTERN MED, V53, P273, DOI 10.7326/0003-4819-53-2-273; Min J, 2015, INT J TUBERC LUNG D, V19, P1239, DOI 10.5588/ijtld.14.0139; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Park YS, 2010, INT J TUBERC LUNG D, V14, P1069; Prevots DR, 2010, AM J RESP CRIT CARE, V182, P970, DOI 10.1164/rccm.201002-0310OC; Ryu YJ, 2016, TUBERC RESPIR DIS, V79, P74, DOI 10.4046/trd.2016.79.2.74; Song JW, 2008, AM J ROENTGENOL, V191, pW160, DOI 10.2214/AJR.07.3505; Yoo JW, 2012, TUBERC RESPIR DIS, V72, P409, DOI 10.4046/trd.2012.72.5.409	26	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185774	10.1371/journal.pone.0185774	http://dx.doi.org/10.1371/journal.pone.0185774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968457	Green Published, Green Submitted, gold			2022-12-26	WOS:000412029600047
J	Wozniak, P; Kontek, B; Rozanski, W; Olas, B				Wozniak, Pawel; Kontek, Bogdan; Rozanski, Waldemar; Olas, Beata			Evaluation of hemostasis parameters and the role of the oxidative damage to plasma proteins in the modulation of hemostasis in patients with nephrolithiasis before and after extracorporeal shock wave lithotripsy	PLOS ONE			English	Article							PLATELET MEMBRANES; DISULFIDE GROUPS; STRESS; SULFHYDRYL; RAT	Purpose Extracorporeal shock wave lithotripsy (ESWL) is a commonly-used method in urology, which may modulate hemostasis and may induce lipid peroxidation in patients with nephrolithiasis. However, previous studies only examine changes occurring in patients 30-240 min after ESWL. The main aim of the present study was to determine whether oxidative stress may modulate the hemostatic activity of plasma in patients with nephrolithiasis before ESWL and the day after treatment ESWL. This will be performed by measuring selected parameters of hemostasis in these patients, both before ESWL and the following day, and assessing the level of oxidative damage to plasma proteins in these patients by measuring two biomarkers. Methods Twelve patients with nephrolithiasis and 10 healthy participants were included. The following parameters of hemostasis were measured: the activated partial thromboplastin time (APTT), prothrombin time (PT), and thrombin time (TT) of plasma, the level of fibrinogen, the level of D-dimer and blood platelet count. In addition, two selected biomarkers of oxidative stress were measured: protein carbonylation level and the number of protein thiol groups. Results No difference was observed between patients with nephrolithiasis before and after ESWL and healthy controls with regard to PT, TT or APTT. Fibrinogen concentration and blood platelet count were lower in the nephrolithiasis patients in the period after ESWL than before ESWL. The nephrolithiasis patients demonstrated elevated D-dimer concentration after ESWL. However, although oxidative damage was observed in the plasma proteins in the nephrolithiasis patients, this was not influenced by ESWL. Conclusion Oxidative stress may induce changes of hemostasis in patients with nephrolithiasis, both before and after ESWL. In addition, changes of hemostasis parameters such as fibrinogen, blood platelet count and D-dimer level can be observed in these patients, especially after ESWL, and this may suggest that ESWL modulates hemostasis. By having a better understanding of the influence of ESWL on hemostasis, this could lead to modifying patient care for those patients at increased risk of bleeding.	[Wozniak, Pawel; Rozanski, Waldemar] Med Univ Lodz, Dept Urol 2, Pabianicka 62, Lodz, Poland; [Kontek, Bogdan; Olas, Beata] Univ Lodz, Fac Biol & Environm Protect, Dept Gen Biochem, Pomorska 141-3, Lodz, Poland	Medical University Lodz; University of Lodz	Olas, B (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Gen Biochem, Pomorska 141-3, Lodz, Poland.	beata.olas@biol.uni.lodz.pl		Olas, Beata/0000-0002-7048-2952; Kontek, Bogdan/0000-0002-6098-2494	University of Lodz [506/1136]	University of Lodz	This work was supported by grant 506/1136 from the University of Lodz to BO.	ANDO Y, 1973, BIOCHIM BIOPHYS ACTA, V311, P26, DOI 10.1016/0005-2736(73)90251-4; ANDO Y, 1973, BIOCHIM BIOPHYS ACTA, V311, P38, DOI 10.1016/0005-2736(73)90252-6; Bartosz G., 2008, DRUGA TWARZ TLENU, V1.7, P99; Boonla C, 2007, UROL RES, V35, P185, DOI 10.1007/s00240-007-0098-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ceban E, 2016, J Med Life, V9, P259; Dedej T, 2013, G CHIR, V34, P202, DOI 10.11138/gchir/2013.34.7.202; Garca MF, 2014, TOXICOL IND HEALTH, V30, P454, DOI 10.1177/0748233712457452; Gecit I, 2012, CELL BIOCHEM FUNCT, V30, P303, DOI 10.1002/cbf.2802; Hughes SF, 2015, PLOS ONE, P1; Khan SR, 2013, MINERVA MED, V104, P23; Khan SR, 2014, TRANSL ANDROL UROL, V3, P256, DOI 10.3978/j.issn.2223-4683.2014.06.04; Khan SR, 2013, J UROLOGY, V189, P803, DOI 10.1016/j.juro.2012.05.078; Khan SR, 2012, UROL RES, V40, P95, DOI 10.1007/s00240-011-0448-9; Khan SR, 2005, UROL RES, V33, P349, DOI 10.1007/s00240-005-0492-4; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Ma M- C, 2014, UROLOGY, V8, P1; Moyes AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179599; Nowak Pawel, 2010, Postepy Biochem, V56, P239; SHACTER E, 1995, FREE RADICAL BIO MED, V18, P815, DOI 10.1016/0891-5849(95)93872-4; Shacter E, 1994, FREE RADIC BIOL MED, V36, P316; UMEKAWA T, 1993, UROL INT, V50, P159, DOI 10.1159/000282475	22	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185157	10.1371/journal.pone.0185157	http://dx.doi.org/10.1371/journal.pone.0185157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968428	Green Published, gold, Green Submitted			2022-12-26	WOS:000412029600015
J	Magliozzi, L; Almada, F; Robalo, J; Mollo, E; Polese, G; Goncalves, EJ; Felline, S; Terlizzi, A; D'Aniello, B				Magliozzi, Laura; Almada, Frederico; Robalo, Joana; Mollo, Ernesto; Polese, Gianluca; Goncalves, Emanuel J.; Felline, Serena; Terlizzi, Antonio; D'Aniello, Biagio			Cryptic effects of biological invasions: Reduction of the aggressive behaviour of a native fish under the influence of an "invasive" biomolecule	PLOS ONE			English	Article							RACEMOSA VAR. CYLINDRACEA; CAULERPA-RACEMOSA; MACROALGAL ASSEMBLAGES; MULTIVARIATE-ANALYSIS; MEDITERRANEAN SEA; PERMUTATION TESTS; MIRROR TESTS; DENSITY; GROWTH; LATERALIZATION	The invasive green alga Caulerpa cylindracea has become an important component of the diet of the Mediterranean white seabream Diplodus sargus. As a consequence of this "exotic diet", the algal bisindolic alkaloid caulerpin accumulates in the fish tissues. Although the compound shows structural similarity to endogenous indolamines that modulate animal behaviour, the potential impact of caulerpin on fish behaviour still remains unexplored. In this report, behavioural experiments both on groups and on single fish responding towards a mirror were performed under different doses of dietary caulerpin. Differences between treated and control groups for each behaviour and for the overall aggressive pattern during the different experimental phases showed that the aggressiveness of D. sargus decreased with the administration of caulerpin. These results call the attention to a still unexplored potential ability of bioactive metabolites from marine invasive species, to alter the behaviour on native species, with putative negative effects on patterns of fish growth and population dynamics.	[Magliozzi, Laura; Felline, Serena] Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, Lecce, Italy; [Magliozzi, Laura; Polese, Gianluca; D'Aniello, Biagio] Univ Napoli Federico II, Dipartimento Biol, Naples, Italy; [Almada, Frederico; Robalo, Joana; Goncalves, Emanuel J.] ISPA Inst Univ, MARE Marine & Environm Sci Ctr, Lisbon, Portugal; [Mollo, Ernesto] CNR, Ist Chim Biomol, Naples, Italy; [Terlizzi, Antonio] Univ Trieste, Dipartimento Sci Vita, CoNISMa, Trieste, Italy; [Terlizzi, Antonio] Staz Zool A Dohrn, Naples, Italy	University of Salento; University of Naples Federico II; Instituto Superior Psicologia Aplicada (ISPA); Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); CoNISMa; University of Trieste; Stazione Zoologica Anton Dohrn di Napoli	D'Aniello, B (corresponding author), Univ Napoli Federico II, Dipartimento Biol, Naples, Italy.	biagio.daniello@unina.it	Terlizzi, Antonio/B-6131-2015; Polese, Gianluca/P-4444-2019; Almada, Frederico/AAC-4340-2020; Mollo, Ernesto/F-7842-2013; Polese, Gianluca/F-3496-2013; Robalo, Joana Isabel/N-9960-2014; Robalo, Joana I./HIK-2365-2022; D'Aniello, Biagio/N-5287-2019	Terlizzi, Antonio/0000-0001-5968-4548; Polese, Gianluca/0000-0002-6322-7769; Almada, Frederico/0000-0002-1389-8951; Mollo, Ernesto/0000-0001-7379-1788; Polese, Gianluca/0000-0002-6322-7769; Robalo, Joana Isabel/0000-0002-7470-0574; Robalo, Joana I./0000-0002-7470-0574; D'Aniello, Biagio/0000-0002-1176-946X; Goncalves, Emanuel/0000-0002-3918-6215; Felline, Serena/0000-0003-1221-7306	Fundacao para a Ciencia e a Tecnologia - FCT; FEDER; MARE [UID/MAR/04292/2013]; MIUR (The Italian Ministry of Education, Universities and Research) (PRIN); EU; Unisalento BIOFORIU infrastructure; FCT [SFRH/BPD/63170/2009]; MARE/ISPA-IU project; Environmental Municipal Company of Cascais (EMAC, SA) [009.DMT.2016]	Fundacao para a Ciencia e a Tecnologia - FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER(European Commission); MARE; MIUR (The Italian Ministry of Education, Universities and Research) (PRIN)(Ministry of Education, Universities and Research (MIUR)); EU(European Commission); Unisalento BIOFORIU infrastructure; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); MARE/ISPA-IU project; Environmental Municipal Company of Cascais (EMAC, SA)	This study was funded by the Fundacao para a Ciencia e a Tecnologia - FCT (partially FEDER funded), now included in MARE (UID/MAR/04292/2013) (MARE/ISPA-IU), by MIUR (The Italian Ministry of Education, Universities and Research) (PRIN 2012, CAULERFISH project), and by the EU FP7 PERSEUS Project. L.M. PhD grant was supported by Unisalento BIOFORIU infrastructure. F.A. postdoctoral fellowship was supported by FCT (SFRH/BPD/63170/2009). This work was also supported by a MARE/ISPA-IU project aiming for the biological monitoring of the Marine Protected Area of Avencas, financed by the Environmental Municipal Company of Cascais (EMAC,SA)(http://www.cm-cascais.pt/empresa-municipal/cascais-ambtente), through direct invitation following public contract procedures (int. reference 009.DMT.2016). The funder or individuals employed or contracted by the funder played no role in the research.	Cavalcante-Silva LHA, 2013, MAR DRUGS, V11, P1553, DOI 10.3390/md11051553; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Ariyomo TO, 2013, ANIM BEHAV, V86, P617, DOI 10.1016/j.anbehav.2013.06.019; Balzarini V, 2014, BEHAV ECOL SOCIOBIOL, V68, P871, DOI 10.1007/s00265-014-1698-7; Box A, 2009, J EXP MAR BIOL ECOL, V380, P11, DOI 10.1016/j.jembe.2009.08.010; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; Desjardins JK, 2010, BIOL LETTERS, V6, P744, DOI 10.1098/rsbl.2010.0247; Deudero S, 2011, ESTUAR COAST SHELF S, V93, P106, DOI 10.1016/j.ecss.2011.03.017; Estabrook G.F., 2002, Acta Ethologica, V4, P73; Felline S, 2014, MAR BIOL, V161, P1275, DOI 10.1007/s00227-014-2417-7; Felline S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038763; Goncalves AR, 2015, ENVIRON BIOL FISH, V98, P1015, DOI 10.1007/s10641-014-0334-8; Gorbi S, 2014, MAR ENVIRON RES, V96, P2, DOI 10.1016/j.marenvres.2014.01.010; Gorley C.K., 2006, GETTING STARTED PRIM; HOLM JC, 1990, AQUACULTURE, V89, P225, DOI 10.1016/0044-8486(90)90128-A; Huntingford F, 2012, PHYSIOL BIOCHEM ZOOL, V85, P585, DOI 10.1086/668204; JORGENSEN EH, 1993, AQUACULTURE, V110, P191, DOI 10.1016/0044-8486(93)90272-Z; Killen SS, 2014, FUNCT ECOL, V28, P1367, DOI 10.1111/1365-2435.12296; Killen SS, 2013, TRENDS ECOL EVOL, V28, P651, DOI 10.1016/j.tree.2013.05.005; Klein J, 2008, MAR POLLUT BULL, V56, P205, DOI 10.1016/j.marpolbul.2007.09.043; Kochanowska-Karamyan AJ, 2010, CHEM REV, V110, P4489, DOI 10.1021/cr900211p; Madison BN, 2015, CAN J FISH AQUAT SCI, V72, P673, DOI 10.1139/cjfas-2014-0409; Maiti BC, 1978, J CHEM RES SYNOP, P126; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McCormick MI, 2012, P ROY SOC B-BIOL SCI, V279, P3899, DOI 10.1098/rspb.2012.0854; McCormick MI, 2010, MAR ECOL PROG SER, V407, P173, DOI 10.3354/meps08583; Mollo E, 2008, P NATL ACAD SCI USA, V105, P4582, DOI 10.1073/pnas.0709355105; Mollo E, 2015, BIOL INVASIONS, V17, P941, DOI 10.1007/s10530-014-0835-6; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Oliveira RF, 2005, NATURE, V437, P207, DOI 10.1038/437207a; Papoutsoglou SE, 2006, AQUAC RES, V37, P87, DOI 10.1111/j.1365-2109.2005.01401.x; Piazzi L, 2005, ESTUAR COAST SHELF S, V64, P467, DOI 10.1016/j.ecss.2005.03.010; Piazzi L, 2001, BOT MAR, V44, P509, DOI 10.1515/BOT.2001.057; Piazzi L, 2008, MAR ENVIRON RES, V65, P50, DOI 10.1016/j.marenvres.2007.07.002; Piazzi L, 2006, ESTUAR COAST SHELF S, V68, P455, DOI 10.1016/j.ecss.2006.02.011; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Raniello R, 2007, BIOL INVASIONS, V9, P361, DOI 10.1007/s10530-006-9044-2; Scherer U, 2016, J FISH BIOL, V89, P1866, DOI 10.1111/jfb.13069; Scott GR, 2004, AQUAT TOXICOL, V68, P369, DOI 10.1016/j.aquatox.2004.03.016; Terlizzi A, 2011, AQUAT BIOL, V12, P109, DOI 10.3354/ab00330; Vazquez-Luis M, 2009, ESTUAR COAST SHELF S, V84, P161, DOI 10.1016/j.ecss.2009.04.016; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Winberg S, 1996, BRAIN BEHAV EVOLUT, V48, P213, DOI 10.1159/000113199	48	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185620	10.1371/journal.pone.0185620	http://dx.doi.org/10.1371/journal.pone.0185620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961266	Green Published, Green Submitted, gold			2022-12-26	WOS:000412027700027
J	Vinod, N; Noh, HB; Oh, S; Ji, S; Park, HJ; Lee, KS; Kim, SC; Park, HO; Yang, JS; Choi, CW				Vinod, Nagarajan; Noh, Han Byul; Oh, Sung; Ji, Seongmi; Park, Hyun Jung; Lee, Ki-Sung; Kim, Sei Chang; Park, Han-Oh; Yang, Joo-Sung; Choi, Chang Won			A Salmonella typhimurium ghost vaccine induces cytokine expression in vitro and immune responses in vivo and protects rats against homologous and heterologous challenges	PLOS ONE			English	Article							EDWARDSIELLA-TARDA GHOSTS; NADPH PHAGOCYTE OXIDASE; DETOXIFIED LIPOPOLYSACCHARIDE; ANTIBIOTIC SUSCEPTIBILITY; VIRULENT CHALLENGE; DENDRITIC CELLS; DOSE-RESPONSE; LIVE; INFECTION; MACROPHAGES	Salmonella enteritidis and Salmonella typhimurium are important food-borne bacterial pathogens, which are responsible for diarrhea and gastroenteritis in humans and animals. In this study, S. typhimurium bacterial ghost (STG) was generated based on minimum inhibitory concentration (MIC) of sodium hydroxide (NaOH). Experimental studies performed using in vitro and in vivo experimental model systems to characterize effects of STG as a vaccine candidate. When compared with murine macrophages (RAW 264.7) exposed to PBS buffer (98.1%), the macrophages exposed to formalin-killed inactivated cells (FKC), live wild-type bacterial cells and NaOH-induced STG at 1 x 10(8) CFU/mL showed 85.6%, 66.5% and 84.6% cell viability, respectively. It suggests that STG significantly reduces the cytotoxic effect of wild-type bacterial cells. Furthermore, STG is an excellent inducer for mRNAs of pro-inflammatory cytokine (TNF-alpha, IL-1 beta) and factor (iNOS), anti-inflammatory cytokine (IL-10) and dual activities (IL-6) in the stimulated macrophage cells. In vivo, STG vaccine induced humoral and cellular immune responses and protection against homologous and heterologous challenges in rats. Furthermore, the immunogenicity and protective efficacy of STG vaccine were compared with those of FKC and non-vaccinated PBS control groups. The vaccinated rats from STG group exhibited higher levels of serum IgG antibody responses, serum bactericidal antibodies, and CD4(+) and CD8(+) T-cell populations than those of the FKC and PBS control groups. Most importantly, after challenge with homologous and heterologous strains, the bacterial loads in the STG group were markedly lower than the FKC and PBS control groups. In conclusion, these findings suggest that the STG vaccine induces protective immunity against homologous and heterologous challenges.	[Vinod, Nagarajan; Noh, Han Byul; Oh, Sung; Ji, Seongmi; Park, Hyun Jung; Lee, Ki-Sung; Kim, Sei Chang; Park, Han-Oh; Choi, Chang Won] Pai Chai Univ, Dept Biol & Med Sci, Daejeon, South Korea; [Park, Han-Oh; Yang, Joo-Sung] Bioneer Corp, New Drug R&D Ctr, Daejeon, South Korea	Pai Chai University	Choi, CW (corresponding author), Pai Chai Univ, Dept Biol & Med Sci, Daejeon, South Korea.	choicw@pcu.ac.kr		Nagarajan, Vinod/0000-0002-3765-8194; Choi, Chang Won/0000-0002-6175-2455	Human Resource Training Program for Regional Innovation and Creativity through the Ministry of Education and National Research Foundation of Korea [2015035949]	Human Resource Training Program for Regional Innovation and Creativity through the Ministry of Education and National Research Foundation of Korea(Ministry of Education (MOE), Republic of Korea)	This work was supported by the Human Resource Training Program for Regional Innovation and Creativity through the Ministry of Education and National Research Foundation of Korea (2015035949). As shown in the title of this government project, a final goal of the project is basically fostering graduate students to fit for industries and to have a job experience for a month with a partner company. Of course, graduate students should have performed R&D research to get salaries from the project. After graduation, some qualified graduate students can have a job in the company involved in the project. In this respect, the government requires principal investigators to include a commercial company in this project as a partner. The government and company support 90% and 10% of the fund, respectively. "The commercial funder provided support in the form of salaries for authors [HBN, SO, SJ, HJP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amara AA, 2013, THESCIENTIFICWORLDJO, V2013, P1; Amara AA, 2013, SAUDI PHARM J, V22, P273; BARROW PA, 1990, EPIDEMIOL INFECT, V104, P413, DOI 10.1017/S0950268800047439; Breuil J, 1996, MED MALADIES INFECT, V26, P420, DOI 10.1016/S0399-077X(96)80186-7; Casin I, 1996, MED MALADIES INFECT, V26, P426, DOI 10.1016/S0399-077X(96)80187-9; Chaudhari AA, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-44; CIZNAR I, 1970, Infection and Immunity, V2, P549; COOPER GL, 1992, VACCINE, V10, P247, DOI 10.1016/0264-410X(92)90160-L; DARODEN L, 1992, AM J VET RES, V53, P1895; Eko FO, 2000, J BIOTECHNOL, V83, P115, DOI 10.1016/S0168-1656(00)00315-1; HABASHA FG, 1985, AM J VET RES, V46, P1415; Harrison JA, 1997, IMMUNOLOGY, V90, P618, DOI 10.1046/j.1365-2567.1997.00158.x; HASSAN JO, 1994, INFECT IMMUN, V62, P5519, DOI 10.1128/IAI.62.12.5519-5527.1994; Havelaar AH, 2001, J APPL MICROBIOL, V91, P442, DOI 10.1046/j.1365-2672.2001.01399.x; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; HORMAECHE CE, 1991, MICROB PATHOGENESIS, V10, P149, DOI 10.1016/0882-4010(91)90075-L; Hormaeche CE, 1996, VACCINE, V14, P251, DOI 10.1016/0264-410X(95)00249-Z; Hossain M. M. M., 2012, Bangladesh Veterinarian, V29, P31, DOI 10.3329/bvet.v29i1.11889; HOUGEN HP, 1989, APMIS, V97, P825, DOI 10.1111/j.1699-0463.1989.tb00484.x; Hu MM, 2013, CLIN VACCINE IMMUNOL, V20, P795, DOI 10.1128/CVI.00676-12; Jawale CV, 2012, INFECT IMMUN, V80, P1502, DOI 10.1128/IAI.06264-11; Kwon SR, 2005, AQUACULTURE, V250, P16, DOI 10.1016/j.aquaculture.2005.02.052; Langemann Timo, 2010, Bioeng Bugs, V1, P326, DOI 10.4161/bbug.1.5.12540; Lillehoj Hyun, 2003, Journal of Poultry Science, V40, P151, DOI 10.2141/jpsa.40.151; Lubitz P, 2009, ADV EXP MED BIOL, V655, P159, DOI 10.1007/978-1-4419-1132-2_12; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Martel JL, 1996, MED MALADIES INFECT, V26, P415, DOI 10.1016/S0399-077X(96)80185-5; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; Mastroeni Pietro, 2002, Current Molecular Medicine (Hilversum), V2, P393, DOI 10.2174/1566524023362492; Mayr UB, 2012, MICROB BIOTECHNOL, V5, P283, DOI 10.1111/j.1751-7915.2011.00316.x; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; PALVA ET, 1978, J BACTERIOL, V136, P286, DOI 10.1128/JB.136.1.286-294.1978; PALVA ET, 1980, EUR J BIOCHEM, V107, P137, DOI 10.1111/j.1432-1033.1980.tb04634.x; Park H.J., 2016, INT J MOL SCI, V17; Peng W, 2011, IMMUNOBIOLOGY, V216, P558, DOI 10.1016/j.imbio.2010.10.001; Rabsch W, 2001, MICROBES INFECT, V3, P237, DOI 10.1016/S1286-4579(01)01375-2; REDMAN TK, 1995, INFECT IMMUN, V63, P2004, DOI 10.1128/IAI.63.5.2004-2011.1995; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Rosenberger CM, 2000, J IMMUNOL, V164, P5894, DOI 10.4049/jimmunol.164.11.5894; Salerno-Goncalves R, 2002, J IMMUNOL, V169, P2196, DOI 10.4049/jimmunol.169.4.2196; SCHAT KA, 1994, POULTRY SCI, V73, P1077, DOI 10.3382/ps.0731077; SEID RC, 1981, J BIOL CHEM, V256, P7305; SMITH BP, 1993, AM J VET RES, V54, P1249; STUBBS AD, 1994, J CLIN MICROBIOL, V32, P199, DOI 10.1128/JCM.32.1.199-201.1994; Svensson M, 2001, MICROB PATHOGENESIS, V31, P91, DOI 10.1006/mpat.2001.0448; Vazquez-Torres A, 2001, TRENDS MICROBIOL, V9, P29, DOI 10.1016/S0966-842X(00)01897-7; Vazquez-Torres A, 2001, P NATL ACAD SCI USA, V98, P2561, DOI 10.1073/pnas.041618998; VillarrealRamos B, 1998, VACCINE, V16, P45, DOI 10.1016/S0264-410X(97)00156-4; Vinod N, 2015, INFECT IMMUN, V83, P2957, DOI 10.1128/IAI.00009-15; Vinod N, 2014, VACCINE, V32, P3249, DOI 10.1016/j.vaccine.2014.03.090; VONESCHEN KB, 1976, J IMMUNOL, V116, P8; Wang XP, 2009, VACCINE, V27, P1571, DOI 10.1016/j.vaccine.2009.01.002; Yrlid U, 2001, MICROBES INFECT, V3, P1239, DOI 10.1016/S1286-4579(01)01484-8; Zhao CF, 2006, EUR J IMMUNOL, V36, P2939, DOI 10.1002/eji.200636179; Zhu WX, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/760730	57	17	18	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185488	10.1371/journal.pone.0185488	http://dx.doi.org/10.1371/journal.pone.0185488			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961267	Green Submitted, gold, Green Published			2022-12-26	WOS:000412027700021
J	Voxeur, A; Soubigou-Taconnat, L; Legee, F; Sakai, K; Antelme, S; Durand-Tardif, M; Lapierre, C; Sibout, R				Voxeur, Aline; Soubigou-Taconnat, Ludivine; Legee, Frederic; Sakai, Kaori; Antelme, Sebastien; Durand-Tardif, Mylene; Lapierre, Catherine; Sibout, Richard			Altered lignification in mur1-1 a mutant deficient in GDP-L-fucose synthesis with reduced RG-II cross linking	PLOS ONE			English	Article							POLYSACCHARIDE RHAMNOGALACTURONAN-II; PLANT-CELL; PECTIC POLYSACCHARIDE; ARABIDOPSIS-THALIANA; FUNCTIONAL GENOMICS; WALLS; BORON; JASMONATE; CELLULOSE; GROWTH	In the plant cell wall, boron links two pectic domain rhamnogalacturonan II (RG-II) chains together to form a dimer and thus contributes to the reinforcement of cell adhesion. We studied the mur1-1 mutant of Arabidopsis thaliana which has lost the ability to form GDP-fucose in the shoots and show that the extent of RG-II cross-linking is reduced in the lignified stem of this mutant. Surprisingly, MUR1 mutation induced an enrichment of resistant interunit bonds in lignin and triggered the overexpression of many genes involved in lignified tissue formation and in jasmonic acid signaling. The defect in GDP-fucose synthesis induced a loss of cell adhesion at the interface between stele and cortex, as well as between interfascicular fibers. This led to the formation of regenerative xylem, where tissue detachment occurred, and underlined a loss of resistance to mechanical forces. Similar observations were also made on bor1-3 mutant stems which are altered in boron xylem loading, leading us to suggest that diminished RG-II dimerization is responsible for regenerative xylem formation.	[Voxeur, Aline; Legee, Frederic; Sakai, Kaori; Antelme, Sebastien; Durand-Tardif, Mylene; Lapierre, Catherine; Sibout, Richard] Univ Paris Saclay, CNRS, Inst Jean Pierre Bourgin, AgroParisTech,INRA, Versailles, France; [Soubigou-Taconnat, Ludivine] Univ Paris Saclay, Univ Evry, Univ Paris Sud, Inst Plant Sci Paris Saclay IPS2,CNRS,INRA, Orsay, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay	Sibout, R (corresponding author), Univ Paris Saclay, CNRS, Inst Jean Pierre Bourgin, AgroParisTech,INRA, Versailles, France.	richard.sibout@inra.fr	Lapierre, Catherine/AAD-9209-2020; Voxeur, Aline/O-7149-2015	Voxeur, Aline/0000-0001-9452-6756; Mylene, Durand-Tardif/0000-0003-1568-6941; Kaori, SAKAI/0000-0001-9007-1192; Lapierre, Catherine/0000-0002-6757-1524	ANR Projects NoStressWall [ANR-12-ADAP-0011]; BFF project	ANR Projects NoStressWall(French National Research Agency (ANR)); BFF project	This work was supported in part by the ANR Projects NoStressWall (ANR-12-ADAP-0011) and by the BFF project.	ADLER E, 1977, WOOD SCI TECHNOL, V11, P169, DOI 10.1007/BF00365615; Ahn JW, 2006, J BIOL CHEM, V281, P13708, DOI 10.1074/jbc.M512403200; Asahina M, 2011, P NATL ACAD SCI USA, V108, P16128, DOI 10.1073/pnas.1110443108; BELL E, 1993, PLANT PHYSIOL, V103, P1133, DOI 10.1104/pp.103.4.1133; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Cabane A M, 2004, PLANT PHYSIOL, V134, P586; Caldelari D, 2011, PLANT MOL BIOL, V75, P25, DOI 10.1007/s11103-010-9701-9; Chormova D, 2014, PLANT J, V77, P534, DOI 10.1111/tpj.12403; clade L. A, 2010, PLANT MOL BIOL, V73, P605; Daher FB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00523; Delmas F, 2008, J EXP BOT, V59, P2639, DOI 10.1093/jxb/ern118; Dence CW, 1992, METHODS LIGNIN CHEM, P33, DOI DOI 10.1007/978-3-642-74065-7_3; Donaldson LA, 2001, PHYTOCHEMISTRY, V57, P859, DOI 10.1016/S0031-9422(01)00049-8; Dumont M, 2014, ANN BOT-LONDON, V114, P1177, DOI 10.1093/aob/mcu093; Flaishman MA, 2003, J PLANT GROWTH REGUL, V22, P253, DOI 10.1007/s00344-003-0030-y; Gagnot S, 2008, NUCLEIC ACIDS RES, V36, pD986, DOI 10.1093/nar/gkm757; Ge YC, 2003, TEST-SPAIN, V12, P1, DOI 10.1007/BF02595811; Glushka JN, 2003, CARBOHYD RES, V338, P341, DOI 10.1016/S0008-6215(02)00461-5; Harholt J, 2006, PLANT PHYSIOL, V140, P49, DOI 10.1104/pp.105.072744; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; JARVIS MC, 1984, PLANT CELL ENVIRON, V7, P153, DOI 10.1111/1365-3040.ep11614586; Ko JH, 2004, PLANT MOL BIOL, V55, P433, DOI 10.1007/s11103-004-1051-z; Lapierre C, 1999, PLANT PHYSIOL, V119, P153, DOI 10.1104/pp.119.1.153; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; Lerouxel O, 2002, PLANT PHYSIOL, V130, P1754, DOI 10.1104/pp.011965; LEWIS DH, 1980, NEW PHYTOL, V84, P209, DOI 10.1111/j.1469-8137.1980.tb04423.x; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Matoh T, 1998, PLANT CELL PHYSIOL, V39, P483, DOI 10.1093/oxfordjournals.pcp.a029395; Matsunaga T, 2004, PLANT PHYSIOL, V134, P339, DOI 10.1104/pp.103.030072; Melida H, 2015, J INTEGR PLANT BIOL, V57, P357, DOI 10.1111/jipb.12346; Miwa K, 2013, PLANT PHYSIOL, V163, P1699, DOI 10.1104/pp.113.225995; Nakamura A, 2001, BIOSCI BIOTECH BIOCH, V65, P2249, DOI 10.1271/bbb.65.2249; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Noguchi K, 1997, PLANT PHYSIOL, V115, P901, DOI 10.1104/pp.115.3.901; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; Obayashi T, 2010, J PLANT RES, V123, P311, DOI 10.1007/s10265-010-0333-6; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Pabst M, 2013, PLANT J, V76, P61, DOI 10.1111/tpj.12271; Popper ZA, 2008, CURR OPIN PLANT BIOL, V11, P286, DOI 10.1016/j.pbi.2008.02.012; RALPH J, 1991, J AGR FOOD CHEM, V39, P1426, DOI 10.1021/jf00008a014; Reid JB, 2011, P NATL ACAD SCI USA, V108, P17241, DOI 10.1073/pnas.1114432108; Reiter WD, 1997, PLANT J, V12, P335, DOI 10.1046/j.1365-313X.1997.12020335.x; REITER WD, 1993, SCIENCE, V261, P1032, DOI 10.1126/science.261.5124.1032; Reuhs BL, 2004, PLANTA, V219, P147, DOI 10.1007/s00425-004-1205-x; Rolando C., 1992, METHODS LIGNIN CHEM, P334, DOI DOI 10.1007/978-3-642-74065-7_23; Ryden P, 2003, PLANT PHYSIOL, V132, P1033, DOI 10.1104/pp.103.021873; Santino A, 2013, PLANT CELL REP, V32, P1085, DOI 10.1007/s00299-013-1441-2; Schaller F, 2000, PLANTA, V210, P979, DOI 10.1007/s004250050706; Takano J, 2002, NATURE, V420, P337, DOI 10.1038/nature01139; Taylor-Teeples M, 2015, NATURE, V517, P571, DOI 10.1038/nature14099; TERASHIMA N, 1993, FORAGE CELL WALL STRUCTURE AND DIGESTIBILITY, P247; Touzel JP, 2003, J AGR FOOD CHEM, V51, P981, DOI 10.1021/jf020200p; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Voxeur A, 2011, J BIOL CHEM, V286, P8014, DOI 10.1074/jbc.M110.198614; Wu YY, 2010, J BIOL CHEM, V285, P13638, DOI 10.1074/jbc.M110.102715	57	11	11	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0184820	10.1371/journal.pone.0184820	http://dx.doi.org/10.1371/journal.pone.0184820			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961242	Green Published, gold, Green Submitted			2022-12-26	WOS:000412027700010
J	Shan, S; She, J; Xue, ZQ; Su, CX; Ren, SX; Wu, FY				Shan, Shan; She, Jun; xue, Zhi-qiang; Su, Chun-xia; Ren, Shen-xiang; Wu, Feng-ying			Clinical characteristics and survival of lung cancer patients associated with multiple primary malignancies	PLOS ONE			English	Article							RISK; SINGLE; NEOPLASMS; AGE	Objectives To investigate the characteristics and survival of lung cancer patients with additional malignant primary cancers. Methods Records of lung cancer patients newly diagnosed in Shanghai Pulmonary Hospital between January 2000 and January 2010 were retrospectively reviewed. Patients with second primary lung cancer and those with lung cancer only were included for detailed analysis. Results Of 27642 newly diagnosed lung cancer patients, 283 patients (1.02%) suffered previous additional primary cancers. Compared with single primary lung cancer, patients with secondary lung cancer associated other primary cancers were more often women (female to male ratio 1:1.72 vs 1:2.58, P = 0.018), older (64.2 vs 60.5 years old, P<0.001), more squamous cell type (30.7% vs 20.5%, P = 0.004), less small cell (3.9% vs 15.5%, P<0.001) type, at earlier stages (17.7% vs 11.0% for stage I, P = 0.014), and more frequently with family history of cancers (7.8% vs 3.9%, P = 0.038). The most common previous primary cancers observed were colorectal (22.0%), breast (18.4%), gastric (14.4%) and larynx cancers (11.9%). Approximately 42.9% of patients were diagnosed with lung cancer 2 to 6 years after diagnosis of initial primary cancers. The survival of patients with secondary lung cancer associated other malignancies was not significantly different from those with single lung cancer (P = 0.491), while synchronous multiple primary malignancies showed worse prognosis compared with those with metachronous ones or single lung cancer (p = 0.012). Conclusion The possibility of second primary lung cancer should always be considered during the follow-up of related cancer types, especially those with family history of cancers. secondary lung cancer associated other primary malignancies have non-inferior survival than those with single lung cancer.	[Shan, Shan] Shanghai Jiao Tong Univ, Dept Respirol, Shanghai Peoples Hosp 6, Shanghai, Peoples R China; [She, Jun] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai, Peoples R China; [xue, Zhi-qiang] Peoples Liberat Army Gen Hosp, Dept Thorac Surg, Shanghai, Peoples R China; [Su, Chun-xia; Ren, Shen-xiang; Wu, Feng-ying] Tongji Univ, Shanghai Pulm Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Fudan University; Chinese People's Liberation Army General Hospital; Tongji University	Wu, FY (corresponding author), Tongji Univ, Shanghai Pulm Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R China.	fywu@163.com			National Natural Science Foundation of China [81402381]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China, Grant number:81402381 (http://www.nsfc.gov.cn/)to Fengying Wu. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-138; Amer MH, 2014, CANCER MANAG RES, V6, P119, DOI 10.2147/CMAR.S57378; Armstrong GT, 2011, J CLIN ONCOL, V29, P3056, DOI 10.1200/JCO.2011.34.6585; Chirila DN, 2013, CHIRURGIA-BUCHAREST, V108, P498; Geryk Edvard, 2010, Cas Lek Cesk, V149, P178; Hemminki K, 2005, EXP LUNG RES, V31, P205, DOI 10.1080/01902140490495606; Hsieh WC, 1997, JPN J CLIN ONCOL, V27, P63, DOI 10.1093/jjco/27.2.63; Irimie A, 2010, J GASTROINTEST LIVER, V19, P69; Koubkova L, 2014, Klin Onkol, V27, P11; Kricker A, 2013, JAMA DERMATOL, V149, P921, DOI 10.1001/jamadermatol.2013.4581; Kuligina E, 2010, EPIDEMIOLOGY, V21, P366, DOI 10.1097/EDE.0b013e3181cc8871; Lee JW, 2014, ANN COLOPROCTOL, V30, P18, DOI 10.3393/ac.2014.30.1.18; Liu LF, 2011, INT J CANCER, V128, P1659, DOI 10.1002/ijc.25480; Liu YY, 2002, LUNG CANCER, V35, P189, DOI 10.1016/S0169-5002(01)00408-1; Lortet-Tieulent J, 2014, LUNG CANCER, V84, P13, DOI 10.1016/j.lungcan.2014.01.009; LYNCH HT, 1977, CANCER, V40, P1849, DOI 10.1002/1097-0142(197710)40:4+<1849::AID-CNCR2820400813>3.0.CO;2-U; Milano MT, 2012, HEAD NECK-J SCI SPEC, V34, P1782, DOI 10.1002/hed.22006; Orlow I, 2008, J CLIN ONCOL, V26, P3560, DOI 10.1200/JCO.2007.13.2654; Pages PB, 2013, ANN THORAC SURG, V95, P1000, DOI 10.1016/j.athoracsur.2012.11.072; Rosso Stefano, 2009, Popul Health Metr, V7, P5, DOI 10.1186/1478-7954-7-5; Rosso S, 2009, EUR J CANCER, V45, P1080, DOI 10.1016/j.ejca.2008.11.030; She J, 2013, CHEST, V143, P1117, DOI 10.1378/chest.11-2948; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Soerjomataram Isabelle, 2009, V471, P85, DOI 10.1007/978-1-59745-416-2_5; Swerdlow AJ, 2000, J CLIN ONCOL, V18, P498, DOI 10.1200/JCO.2000.18.3.498; TUCKER MA, 1988, NEW ENGL J MED, V318, P76, DOI 10.1056/NEJM198801143180203; WATANABE S, 1984, J NATL CANCER I, V72, P1021	27	18	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185485	10.1371/journal.pone.0185485	http://dx.doi.org/10.1371/journal.pone.0185485			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957405	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200068
J	Wang, CH; Wang, PJ; Hsieh, YC; Lo, S; Lee, YC; Chen, YC; Tsai, CH; Chiu, WC; Hu, SCS; Lu, CW; Yang, YF; Chiu, CC; Ou-Yang, F; Wang, YM; Hou, MF; Yuan, SSF				Wang, C-H; Wang, P-J; Hsieh, Y-C; Lo, S.; Lee, Y-C; Chen, Y-C; Tsai, C-H; Chiu, W-C; Hu, S. Chu-Sung; Lu, C-W; Yang, Y-F; Chiu, C-C; Ou-Yang, F.; Wang, Y-M; Hou, M-F; Yuan, S-S F.			Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties	ONCOGENE			English	Article							ESTROGEN-RECEPTOR; 3T3-L1 ADIPOCYTES; EPITHELIAL-CELLS; REGULATED KINASE; GENE-EXPRESSION; INFLAMMATION; TRANSITION; PATHWAYS; BINDING; ALLIANCE	Growing evidence indicates that resistin-an obesity-related cytokine-is upregulated in breast cancer patients, yet its impact on breast cancer behavior remains to be ascertained. Similarly, Toll-like receptor 4 (TLR4) has been implicated in breast cancer progression, however, its clinically relevant endogenous ligand remains elusive. In this study, we observed that high serum resistin levels in breast cancer patients positively correlated with tumor stage, size and lymph node metastasis. These findings were replicated in animal models of breast cancer tumorigenesis and metastasis. Resistin was found to promote epithelial-mesenchymal transition and stemness in breast cancer cells-mechanisms critical to tumorigenesis and metastasis-through a TLR4/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B)/signal transducer and activator of transcription 3 (STAT3) signaling pathway and negated by TLR4-specific antibody and antagonist. These findings provide clear evidence that resistin is a clinically relevant endogenous ligand for TLR4, which promotes tumor progression via TLR4/NF-kappa B/STAT3 signaling, providing insights into a novel therapeutic target in breast cancer.	[Wang, C-H; Wang, P-J; Lo, S.; Lee, Y-C; Chen, Y-C; Tsai, C-H; Lu, C-W; Yang, Y-F; Yuan, S-S F.] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Translat Res Ctr, Kaohsiung 807, Taiwan; [Wang, C-H; Chen, Y-C; Yuan, S-S F.] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Wang, C-H; Chen, Y-C; Yuan, S-S F.] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Hsieh, Y-C] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Lo, S.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Lee, Y-C] Kaohsiung Med Univ, Sch Med, Dept Anat, Coll Med, Kaohsiung, Taiwan; [Tsai, C-H; Ou-Yang, F.] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Chiu, W-C] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Thorac Surg, Dept Surg, Kaohsiung, Taiwan; [Hu, S. Chu-Sung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Hu, S. Chu-Sung] Kaohsiung Med Univ, Dept Dermatol, Coll Med, Kaohsiung, Taiwan; [Chiu, C-C] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Ou-Yang, F.] Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung, Taiwan; [Wang, Y-M] Natl Chiao Tung Univ, Inst Mol Med & Bioengn, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Wang, Y-M] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Hou, M-F] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Canc Ctr, Kaohsiung, Taiwan; [Hou, M-F] Kaohsiung Municipal Shiao Kang Hosp, Dept Surg, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; University of Glasgow; University of Glasgow; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Yuan, SSF (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Translat Res Ctr, Kaohsiung 807, Taiwan.; Yuan, SSF (corresponding author), 100,Zihyou 1st Rd, Kaohsiung 80708, Taiwan.	yuanssf@kmu.edu.tw		Wang, Chie-Hong/0000-0003-0774-5323; Hou, Ming-Feng/0000-0001-6030-9702; Hu, Stephen Chu-Sung/0000-0002-1832-4471; yuan, shyng-shiou/0000-0002-4753-788X	Kaohsiung Medical University Hospital [KMUH102-2T07, KMUH103-3R28, KMUH104-4R29]; Kaohsiung Medical University (Aim for the Top Journals Grant) [KMU-DT105008, KMU-TP104D17]; National Health Research Institutes [NHRI-EX104-10212BI]; Ministry of Health and Welfare, Health and welfare surcharge of tobacco products of Taiwan [MOHW105-TDU-B-212-134007]	Kaohsiung Medical University Hospital; Kaohsiung Medical University (Aim for the Top Journals Grant); National Health Research Institutes(National Health Research Institutes, Japan); Ministry of Health and Welfare, Health and welfare surcharge of tobacco products of Taiwan	We thank Dr Tsung-Hsien Chuang and Dr Wen-Chun Hung from National Health Research Institutes, Taiwan, for providing plasmid. This work was supported by Kaohsiung Medical University Hospital (KMUH102-2T07, KMUH103-3R28, KMUH104-4R29); Kaohsiung Medical University (Aim for the Top Journals Grant, KMU-DT105008, KMU-TP104D17); National Health Research Institutes (NHRI-EX104-10212BI); and Ministry of Health and Welfare, Health and welfare surcharge of tobacco products (MOHW105-TDU-B-212-134007) of Taiwan.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Assiri AMA, 2015, DIS MARKERS, V2015, P1, DOI 10.1155/2015/253519; Bauer AK, 2005, J NATL CANCER I, V97, P1778, DOI 10.1093/jnci/dji403; Chen YH, 2006, ENDOCRINOLOGY, V147, P4496, DOI 10.1210/en.2005-1655; Chung SS, 2015, ANTICANCER RES, V35, P39; Codoner-Franch P, 2015, CLIN CHIM ACTA, V438, P46, DOI 10.1016/j.cca.2014.07.043; Conde J, 2011, BIOFACTORS, V37, P413, DOI 10.1002/biof.185; Drasin DJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3037; Ehsan N, 2013, TUMOR BIOL, V34, P1053, DOI 10.1007/s13277-013-0645-y; Franco HL, 2015, MOL CELL, V58, P21, DOI 10.1016/j.molcel.2015.02.001; Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Gonzalez-Reyes S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-665; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hsieh YY, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-59; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Iqbal J, 2013, J CLIN PATHOL, V66, P485, DOI 10.1136/jclinpath-2012-201304; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Jing YY, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-98; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Lee JO, 2016, SCI REP-UK, V6, DOI 10.1038/srep18923; Lee MJ, 2008, AM J PHYSIOL-CELL PH, V294, pC1542, DOI 10.1152/ajpcell.00403.2007; Lee YC, 2012, GYNECOL ONCOL, V125, P742, DOI 10.1016/j.ygyno.2012.02.032; Li L, 2013, OCHSNER J, V13, P109; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; May CD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2789; McTernan CL, 2002, LANCET, V359, P46, DOI 10.1016/S0140-6736(02)07281-1; Mehmeti M, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0640-x; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Oblak A, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/609579; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Pradhan M, 2010, J BIOL CHEM, V285, P31100, DOI 10.1074/jbc.M110.155309; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; Shostak K, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2886; Song JM, 2007, PLOS PATHOG, V3, P541, DOI 10.1371/journal.ppat.0030060; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Syed V, 2002, JNCI-J NATL CANCER I, V94, P617; Tarkowski A, 2010, J CELL MOL MED, V14, P1419, DOI 10.1111/j.1582-4934.2009.00899.x; Teng Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-453; Wang W, 2015, CURR MED CHEM, V22, P264; Wendt Michael K, 2014, JAKSTAT, V3, pe28975, DOI 10.4161/jkst.28975; Yang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109980; Yokota S, 2010, INFECT IMMUN, V78, P468, DOI 10.1128/IAI.00903-09; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zhang XJ, 2015, INT J ONCOL, V46, P1141, DOI 10.3892/ijo.2014.2809; Zhou CC, 2012, ORAL ONCOL, V48, P1068, DOI 10.1016/j.oraloncology.2012.06.005	50	72	73	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 1	2018	37	5					589	600		10.1038/onc.2017.357	http://dx.doi.org/10.1038/onc.2017.357			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FU4GT	28991224				2022-12-26	WOS:000423812200005
J	Byun, H; Park, J; Kim, SC; Ahn, JH				Byun, Hyunjong; Park, Jiyeon; Kim, Sun Chang; Ahn, Jung Hoon			A lower isoelectric point increases signal sequence-mediated secretion of recombinant proteins through a bacterial ABC transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; membrane transport; protein secretion; protein translocation; recombinant protein expression; isoelectric point; membrane potential	ESCHERICHIA-COLI; SWISS-MODEL; EVOLUTIONARY CONSERVATION; CHARGED RESIDUES; OUTER-MEMBRANE; TRANSLOCATION; MECHANISM; PEPTIDES; LIPASE; POLYPEPTIDE	Efficient protein production for industrial and academic purposes often involves engineering microorganisms to produce and secrete target proteins into the culture. Pseudomonas fluorescens has a TliDEF ATP-binding cassette transporter, a type I secretion system, which recognizes C-terminal LARD3 signal sequence of thermostable lipase TliA. Many proteins are secreted by TliDEF in vivo when recombined with LARD3, but there are still others that cannot be secreted by TliDEF even when LARD3 is attached. However, the factors that determine whether or not a recombinant protein can be secreted through TliDEF are still unknown. Here, we recombined LARD3 with several proteins and examined their secretion through TliDEF. We found that the proteins secreted via LARD3 are highly negatively charged with highly-acidic isoelectric points (pI) lower than 5.5. Attaching oligo-aspartate to lower the pI of negatively-charged recombinant proteins improved their secretion, and attaching oligo-arginine to negatively-charged proteins blocked their secretion by LARD3. In addition, negatively supercharged green fluorescent protein (GFP) showed improved secretion, whereas positively supercharged GFP did not secrete. These results disclosed that proteins' acidic pI and net negative charge are major factors that determine their secretion through TliDEF. Homology modeling for TliDEF revealed that TliD dimer forms evolutionarily-conserved positively-charged clusters in its pore and substrate entrance site, which also partially explains the pI dependence of the TliDEF-dependent secretions. In conclusion, lowering the isoelectric point improved LARD3-mediated protein secretion, both widening the range of protein targets for efficient production via secretion and signifying an important aspect of ABC transporter-mediated secretions.	[Byun, Hyunjong; Kim, Sun Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea; [Park, Jiyeon; Ahn, Jung Hoon] Korea Adv Inst Sci & Technol, Korea Sci Acad, Dept Biol & Chem, Busan 47162, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Ahn, JH (corresponding author), Korea Adv Inst Sci & Technol, Korea Sci Acad, Dept Biol & Chem, 403 Changjo Kwan,105-47 Baegyanggwanmun Ro, Busan 7162, South Korea.	hoony@kaist.ac.kr	Kim, Sun/GSN-4867-2022; Kim, Sun Chang/C-2026-2011	Byun, Hyunjong/0000-0003-1704-5013; Ahn, Jung Hoon/0000-0002-7779-4318	Intelligent Synthetic Biology Center of the Global Frontier Project; URP Program of the Korea Advanced Institute of Science and Technology; R&E Program of the Republic of Korea Ministry of Science, ICT and Future Planning	Intelligent Synthetic Biology Center of the Global Frontier Project; URP Program of the Korea Advanced Institute of Science and Technology; R&E Program of the Republic of Korea Ministry of Science, ICT and Future Planning	This work was supported by the Intelligent Synthetic Biology Center of the Global Frontier Project; URP Program of the Korea Advanced Institute of Science and Technology; and the R&E Program of the Republic of Korea Ministry of Science, ICT and Future Planning. The authors declare that they have no conflicts of interest with the contents of this article.	Ahn JH, 1999, J BACTERIOL, V181, P1847, DOI 10.1128/JB.181.6.1847-1852.1999; Anthony-Cahill S. J, 2013, BIOCHEMISTRY-US, P138; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; CAO GQ, 1995, EMBO J, V14, P866, DOI 10.1002/j.1460-2075.1995.tb07068.x; Chen R, 2012, BIOTECHNOL ADV, V30, P1102, DOI 10.1016/j.biotechadv.2011.09.013; Choi JH, 2004, APPL MICROBIOL BIOT, V64, P625, DOI 10.1007/s00253-004-1559-9; Cserzo M, 2002, PROTEIN ENG, V15, P745, DOI 10.1093/protein/15.9.745; DAMPER PD, 1981, ANTIMICROB AGENTS CH, V20, P803, DOI 10.1128/AAC.20.6.803; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; Demain AL, 2009, BIOTECHNOL ADV, V27, P297, DOI 10.1016/j.biotechadv.2009.01.008; Eom GT, 2016, PROCESS BIOCHEM, V51, P999, DOI 10.1016/j.procbio.2016.05.004; Galvez AF, 2001, CANCER RES, V61, P7473; GRAEVENITZ AV, 1971, YALE J BIOL MED, V44, P265; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Harley CA, 1996, J BIOL CHEM, V271, P24625, DOI 10.1074/jbc.271.40.24625; Higgins MK, 2004, J MOL BIOL, V342, P697, DOI 10.1016/j.jmb.2004.07.088; Hink MA, 2000, J BIOL CHEM, V275, P17556, DOI 10.1074/jbc.M001348200; Huang CJ, 2012, J IND MICROBIOL BIOT, V39, P383, DOI 10.1007/s10295-011-1082-9; Kang'ethe W, 2013, P NATL ACAD SCI USA, V110, pE4246, DOI 10.1073/pnas.1310345110; KENNEDY EP, 1982, P NATL ACAD SCI-BIOL, V79, P1092, DOI 10.1073/pnas.79.4.1092; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim D, 2006, EXP CELL RES, V312, P1277, DOI 10.1016/j.yexcr.2005.12.029; KOHARA A, 1991, J BIOL CHEM, V266, P20363; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Mishra S, 2014, ELIFE, V3, DOI 10.7554/eLife.02740; Morgan JLW, 2017, STRUCTURE, V25, P522, DOI 10.1016/j.str.2017.01.010; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Novo D, 1999, CYTOMETRY, V35, P55, DOI 10.1002/(SICI)1097-0320(19990101)35:1<55::AID-CYTO8>3.0.CO;2-2; ODANI S, 1987, J BIOL CHEM, V262, P10502; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Park Y, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-60; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ryu J, 2015, APPL ENVIRON MICROB, V81, P1735, DOI 10.1128/AEM.03514-14; Seidman C. E, 1987, CURRENT PROTOCOLS MO, V1; SEN K, 1988, J BIOL CHEM, V263, P1182; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Son M, 2012, APPL ENVIRON MICROB, V78, P8454, DOI 10.1128/AEM.02476-12; Squires C.H., 2004, BIOPROCESS INT, V2004, P54; Tran QH, 1998, EUR J BIOCHEM, V251, P538, DOI 10.1046/j.1432-1327.1998.2510538.x; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wilkins MR, 1999, METH MOL B, V112, P531; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; YAMANE K, 1988, J BIOL CHEM, V263, P19690; Yang KS, 2015, ACS CATAL, V5, P5016, DOI 10.1021/cs502079g	50	9	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19782	19791		10.1074/jbc.M117.786749	http://dx.doi.org/10.1074/jbc.M117.786749			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972172	hybrid, Green Published			2022-12-26	WOS:000416911300022
J	Nakanishi, A; Hatano, N; Fujiwara, Y; Sha'ri, A; Takabatake, S; Akano, H; Kanayama, N; Magari, M; Nozaki, N; Tokumitsu, H				Nakanishi, Akihiro; Hatano, Naoya; Fujiwara, Yuya; Sha'ri, Arian; Takabatake, Shota; Akano, Hiroki; Kanayama, Naoki; Magari, Masaki; Nozaki, Naohito; Tokumitsu, Hiroshi			AMP-activated protein kinase-mediated feedback phosphorylation controls the Ca2+/calmodulin (CaM) dependence of Ca2+/CaM-dependent protein kinase kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); Ca2+; calmodulin-dependent protein kinase (CaMK); calmodulin (CaM); phosphorylation; protein kinase	MOLECULAR-CLONING; REGULATORY MECHANISM; ESCHERICHIA-COLI; CALMODULIN; BETA; CASCADE; CALCIUM; IV; TRANSCRIPTION; EXPRESSION	The Ca2+/calmodulin-dependent protein kinase kinase (CaMKK)/5-AMP-activated protein kinase (AMPK) phosphorylation cascade affects various Ca2+-dependent metabolic pathways and cancer growth. Unlike recombinant CaMKK that exhibits higher basal activity (autonomous activity), activation of the CaMKK/AMPK signaling pathway requires increased intracellular Ca2+ concentrations. Moreover, the Ca2+/CaM dependence of CaMKK appears to arise from multiple phosphorylation events, including autophosphorylation and activities furnished by other protein kinases. However, the effects of proximal downstream kinases on CaMKK activity have not yet been evaluated. Here, we demonstrate feedback phosphorylation of CaMKK at multiple residues by CaMKK-activated AMPK in addition to autophosphorylation in vitro, leading to reduced autonomous, but not Ca2+/CaM-activated, CaMKK activity. MS analysis and site-directed mutagenesis of AMPK phosphorylation sites in CaMKK indicated that Thr(144) phosphorylation by activated AMPK converts CaMKK into a Ca2+/CaM-dependent enzyme as shown by completely Ca2+/CaM-dependent CaMKK activity of a phosphomimetic T144E CaMKK mutant. CaMKK mutant analysis indicated that the C-terminal domain (residues 471-587), including the autoinhibitory region, plays an important role in stabilizing an inactive conformation in a Thr(144) phosphorylation-dependent manner. Furthermore, immunoblot analysis with anti-phospho-Thr(144) antibody revealed phosphorylation of Thr(144) in CaMKK in transfected COS-7 cells that was further enhanced by exogenous expression of AMPK. These results indicate that AMPK-mediated feedback phosphorylation of CaMKK regulates the CaMKK/AMPK signaling cascade and may be physiologically important for intracellular maintenance of Ca2+-dependent AMPK activation by CaMKK.	[Nakanishi, Akihiro; Fujiwara, Yuya; Sha'ri, Arian; Takabatake, Shota; Akano, Hiroki; Kanayama, Naoki; Magari, Masaki; Tokumitsu, Hiroshi] Okayama Univ, Grad Sch Nat Sci & Technol, Div Med Bioengn, Okayama 7008530, Japan; [Hatano, Naoya] Kobe Univ, Integrated Ctr Mass Spectrometry, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Nozaki, Naohito] MAB Inst Inc, Iida, Nagano 3950157, Japan	Okayama University; Kobe University	Tokumitsu, H (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Div Med Bioengn, Kita Ku, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	tokumit@okayama-u.ac.jp	MAGARI, Masaki/B-2555-2011; Tokumitsu, Hiroshi/M-3978-2015; Kanayama, Naoki/G-1518-2010	Magari, Masaki/0000-0002-4624-0160; Tokumitsu, Hiroshi/0000-0002-2193-6794; Kanayama, Naoki/0000-0003-1778-2005	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26440056]; Grants-in-Aid for Scientific Research [15H04196] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-aid for Scientific Research 26440056 (to H. T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; COLBRAN RJ, 1992, NEUROCHEM INT, V21, P469, DOI 10.1016/0197-0186(92)90080-B; Davare MA, 2004, J BIOL CHEM, V279, P52191, DOI 10.1074/jbc.M409873200; ENSLEN H, 1995, BIOCHEM BIOPH RES CO, V207, P1038, DOI 10.1006/bbrc.1995.1289; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; Frigo DE, 2011, CANCER RES, V71, P528, DOI 10.1158/0008-5472.CAN-10-2581; Fujiwara Y, 2016, J BIOL CHEM, V291, P13802, DOI 10.1074/jbc.M116.727867; Fujiwara Y, 2015, BIOCHEMISTRY-US, V54, P3969, DOI 10.1021/acs.biochem.5b00149; FUKUNAGA K, 1989, J BIOL CHEM, V264, P21830; Ghislat G, 2012, J BIOL CHEM, V287, P38625, DOI 10.1074/jbc.M112.365767; Green MF, 2011, J BIOL CHEM, V286, P28066, DOI 10.1074/jbc.M111.251504; Hatano N, 2008, J PROTEOME RES, V7, P809, DOI 10.1021/pr700566d; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hayashi N, 1998, PROTEIN EXPRES PURIF, V12, P25, DOI 10.1006/prep.1997.0807; Horigane S, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0189-3; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Ichimura T, 2008, FEBS LETT, V582, P661, DOI 10.1016/j.febslet.2008.01.037; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Joseph JD, 2000, J BIOL CHEM, V275, P38230, DOI 10.1074/jbc.M006422200; KIMURA K, 1994, J BIOL CHEM, V269, P24523; Kimura Y, 2002, EMBO REP, V3, P962, DOI 10.1093/embo-reports/kvf191; Kitani T, 1997, J BIOCHEM-TOKYO, V122, P243; LEE JSC, 1994, J BIOL CHEM, V269, P2158; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Matsushita M, 1998, J BIOL CHEM, V273, P21473, DOI 10.1074/jbc.273.34.21473; Matsushita M, 1999, J BIOL CHEM, V274, P10086, DOI 10.1074/jbc.274.15.10086; Means AR, 2008, MOL ENDOCRINOL, V22, P2759, DOI 10.1210/me.2008-0312; MIRANTI CK, 1995, MOL CELL BIOL, V15, P3672; Nakamuta S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002011; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SELBERT MA, 1995, J BIOL CHEM, V270, P17616, DOI 10.1074/jbc.270.29.17616; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Tokumitsu H, 2000, J BIOL CHEM, V275, P20090, DOI 10.1074/jbc.M002193200; Tokumitsu H, 1996, J BIOL CHEM, V271, P5617, DOI 10.1074/jbc.271.10.5617; Tokumitsu H, 2004, J BIOL CHEM, V279, P40296, DOI 10.1074/jbc.M406534200; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Tokumitsu H, 2001, BIOCHEMISTRY-US, V40, P13925, DOI 10.1021/bi010863k; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; Tokumitsu H, 2011, BIOCHEMISTRY-US, V50, P8193, DOI 10.1021/bi201005g; Wayman GA, 1997, J BIOL CHEM, V272, P16073, DOI 10.1074/jbc.272.26.16073; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yamauchi M, 2008, MOL ENDOCRINOL, V22, P893, DOI 10.1210/me.2007-0249	51	29	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19804	19813		10.1074/jbc.M117.805085	http://dx.doi.org/10.1074/jbc.M117.805085			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28974582	Green Published, hybrid			2022-12-26	WOS:000416911300024
J	Hambrook, DA; Ilievski, M; Mosadeghzad, M; Tata, M				Hambrook, Dillon A.; Ilievski, Marko; Mosadeghzad, Mohamad; Tata, Matthew			A Bayesian computational basis for auditory selective attention using head rotation and the interaural time-difference cue	PLOS ONE			English	Article							BINAURAL SOUND LOCALIZATION; SPEECH SEGREGATION; MOVEMENTS; SYSTEM; DIRECTION; TRACKING; HEARING	The process of resolving mixtures of several sounds into their separate individual streams is known as auditory scene analysis and it remains a challenging task for computational systems. It is well-known that animals use binaural differences in arrival time and intensity at the two ears to find the arrival angle of sounds in the azimuthal plane, and this localization function has sometimes been considered sufficient to enable the un-mixing of complex scenes. However, the ability of such systems to resolve distinct sound sources in both space and frequency remains limited. The neural computations for detecting interaural time difference (ITD) have been well studied and have served as the inspiration for computational auditory scene analysis systems, however a crucial limitation of ITD models is that they produce ambiguous or "phantom" images in the scene. This has been thought to limit their usefulness at frequencies above about 1khz in humans. We present a simple Bayesian model and an implementation on a robot that uses ITD information recursively. The model makes use of head rotations to show that ITD information is sufficient to unambiguously resolve sound sources in both space and frequency. Contrary to commonly held assumptions about sound localization, we show that the ITD cue used with high-frequency sound can provide accurate and unambiguous localization and resolution of competing sounds. Our findings suggest that an "active hearing" approach could be useful in robotic systems that operate in natural, noisy settings. We also suggest that neurophysiological models of sound localization in animals could benefit from revision to include the influence of top-down memory and sensorimotor integration across head rotations.	[Hambrook, Dillon A.; Ilievski, Marko; Mosadeghzad, Mohamad; Tata, Matthew] Univ Lethbridge, Dept Neurosci, Lethbridge, AB, Canada	University of Lethbridge	Hambrook, DA (corresponding author), Univ Lethbridge, Dept Neurosci, Lethbridge, AB, Canada.	dillon.hambrook@uleth.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [G2463]; NSERC Colloborative Research and Training Experience program [Biological Information Processing: From Genome to Systems Level program]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Colloborative Research and Training Experience program [Biological Information Processing: From Genome to Systems Level program]	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) [Discovery grant number G2463]. Support for the authors was provided by the NSERC Colloborative Research and Training Experience program [Biological Information Processing: From Genome to Systems Level program]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2011, J NEUROSCI, V31, P10872, DOI 10.1523/JNEUROSCI.0622-11.2011; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Baumann C, 2015, J ACOUST SOC AM, V138, P635, DOI 10.1121/1.4923448; Blauert J., 1997, SPATIAL HEARING PSYC; Boersma Paul, 2002, GLOT INT, V5, P341; Bregman A.S., 1990, AUDITORY SCENE ANAL; Brimijoin WO, 2012, I-PERCEPTION, V3, P179, DOI 10.1068/i7173sas; Burger J., 1958, ACTA ACUST UNITED AC, V8, P301; CAIRD D, 1983, EXP BRAIN RES, V52, P385; CAIRD D, 1987, EXP BRAIN RES, V68, P379; Cao SY, 2011, J ACOUST SOC AM, V129, P2227, DOI 10.1121/1.3559707; CARR CE, 1990, J NEUROSCI, V10, P3227; Chi T, 2005, J ACOUST SOC AM, V118, P887, DOI 10.1121/1.1945807; DAYAN P, 1995, NEURAL COMPUT, V7, P889, DOI 10.1162/neco.1995.7.5.889; Dietz M, 2011, SPEECH COMMUN, V53, P592, DOI 10.1016/j.specom.2010.05.006; Even J, 2014, IEEE INT CONF ROBOT, P677, DOI 10.1109/ICRA.2014.6906927; Franken TP, 2015, NAT NEUROSCI, V18, P444, DOI 10.1038/nn.3948; GREGORY RL, 1980, PHILOS T ROY SOC B, V290, P181, DOI 10.1098/rstb.1980.0090; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; Hill PA, 2000, RESOLUTION FRONT D B; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Kallakuri N, 2013, IEEE INT CONF ROBOT, P2270, DOI 10.1109/ICRA.2013.6630884; Kleiner M, WHATS NEW PSYCHTOOLB; Krishnan L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003985; Kumon Makoto, 2010, Journal of Biomechanical Science and Engineering, V6, P26, DOI 10.1299/jbse.6.26; Lewald J, 2000, J NEUROPHYSIOL, P84; Li P, 2010, COMPUT SPEECH LANG, V24, P30, DOI 10.1016/j.csl.2008.05.005; LLINAS RR, 1991, NEUROSCIENCE, V44, P521, DOI 10.1016/0306-4522(91)90075-Y; Lyon R. F., 2010, 2010 IEEE International Symposium on Circuits and Systems. ISCAS 2010, P3809, DOI 10.1109/ISCAS.2010.5537724; Lyon R. F., 1983, Proceedings of ICASSP 83. IEEE International Conference on Acoustics, Speech and Signal Processing, P1148; Ma N, 2015, INT CONF ACOUST SPEE, P2699, DOI 10.1109/ICASSP.2015.7178461; Martinson E, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P1140; May T, 2015, INT CONF ACOUST SPEE, P2679, DOI 10.1109/ICASSP.2015.7178457; McAlpine D, 2005, J PHYSIOL-LONDON, V566, P21, DOI 10.1113/jphysiol.2005.083113; McCloy DR, 2013, THE PN NC CORPUS; Nakadai K, 2001, IROS 2001: PROCEEDINGS OF THE 2001 IEEE/RJS INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P1395, DOI 10.1109/IROS.2001.977176; Perrett S, 1997, J ACOUST SOC AM, V102, P2325, DOI 10.1121/1.419642; Roman N, 2004, INT CONF ACOUST SPEE, P373; Roman N, 2003, J ACOUST SOC AM, V114, P2236, DOI 10.1121/1.1610463; Roman N, 2008, IEEE T AUDIO SPEECH, V16, P728, DOI 10.1109/TASL.2008.918978; Shao Y, 2010, COMPUT SPEECH LANG, V24, P77, DOI 10.1016/j.csl.2008.03.004; THURLOW WR, 1967, J ACOUST SOC AM, V42, P480, DOI 10.1121/1.1910604; THURLOW WR, 1967, J ACOUST SOC AM, V42, P489, DOI 10.1121/1.1910605; Valin JM, 2007, ROBOT AUTON SYST, V55, P216, DOI 10.1016/j.robot.2006.08.004; Valin JM, 2004, IEEE INT CONF ROBOT, P1033, DOI 10.1109/ROBOT.2004.1307286; Van Veen B. D., 1988, IEEE ASSP Magazine, V5, P4, DOI 10.1109/53.665; Wallach H, 1939, J ACOUST SOC AM, V10, P270, DOI 10.1121/1.1915985; Wallach H, 1940, J EXP PSYCHOL, V27, P339, DOI 10.1037/h0054629; Wightman FL, 1999, J ACOUST SOC AM, V105, P2841, DOI 10.1121/1.426899; Wilber AA, 2014, J NEUROSCI, V34, P5431, DOI 10.1523/JNEUROSCI.0511-14.2014; YIN TCT, 1984, J ACOUST SOC AM, V76, P1401, DOI 10.1121/1.391457	52	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186104	10.1371/journal.pone.0186104	http://dx.doi.org/10.1371/journal.pone.0186104			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982139	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300123
J	Wang, XC; Jiang, HB; Wang, XM; Liu, HY; Zhou, L; Lu, XW				Wang, Xichen; Jiang, Hongbo; Wang, Xuemei; Liu, Hongyu; Zhou, Ling; Lu, Xiwei			ESMPE: A combined strategy for school tuberculosis prevention and control proposed by Dalian, China	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; STUDENTS; EXPERIENCES; OUTBREAK	Background Although China has paid more attention on the prevention and control of tuberculosis (TB) in schools, several unsolved questions in this field still threaten the progress of TB control. Therefore, there is an urgent need to develop a systematic and practical strategy for Chinese school TB prevention and control system. In this study, we aimed to assess the feasibility of a combined strategy named ESMPE (examination, screening, monitoring, prevention and education) that adhere to the basic principles of Chinese schools TB control strategy. Methods The ESMPE strategy included five sections, namely TB screening during physical examination for the school freshmen entrances, screening of close contacts, monitoring of high-risk schools, preventive treatment and TB education. The effectiveness of ESMPE strategy was evaluated from 2011 to 2016. The original data were provided by the Dalian Tuberculosis Hospital. Descriptive analysis and nonparametric tests were used for comparing statistical differences of results between different years. Results The detection rate of active pulmonary TB in school freshmen was decreased from 2011 to 2016 (chi(2) = 41.941, P = 6.0551E-8). 97.22% (17,043/17,530) of close contacts experienced close contacts screening, and the secondary attack rate (SAR) of TB in schools fell by 146.35/10 5 from 2011 to 2012, and finally reduced to 85.57/10 5 in 2016. There was a significant correlation between SAR of student TB and the rate of screened close contacts (r = -0.924, P = 0.009). TB incidence of five monitored schools had a substantial decline after receiving monitoring, and this declining trend continued in 2016. Due to the TB education and advanced screening methods, the mean of diagnostic delay time in students with TB was shortened (15.71 days), while still fewer latent TB infection students received preventive treatment (30.38%). Conclusions The ESMPE strategy has shown a favorable effect on TB prevention and control in Dalian schools. More systematic evidence is needed on the effect of this strategy in reducing the incidence of TB in schools from other settings prior to its further scaling-up in China.	[Wang, Xichen; Liu, Hongyu; Zhou, Ling] Dalian Med Univ, Sch Publ Hlth, Dalian, Liaoning, Peoples R China; [Jiang, Hongbo; Wang, Xuemei; Lu, Xiwei] Dalian TB Hosp, Off Epidem Surveillance, Dalian, Liaoning, Peoples R China	Dalian Medical University	Zhou, L (corresponding author), Dalian Med Univ, Sch Publ Hlth, Dalian, Liaoning, Peoples R China.; Lu, XW (corresponding author), Dalian TB Hosp, Off Epidem Surveillance, Dalian, Liaoning, Peoples R China.	zhouling0609@163.com; yiluxiwei@126.com	Wang, Xuemei/GXF-3702-2022					Chen Q, 2015, BIOMED ENVIRON SCI, V28, P611, DOI 10.3967/bes2015.085; Chen W, 2012, J INT MED RES, V40, P1830, DOI 10.1177/030006051204000521; Chen W, 2013, CHIN J ANTITUBERCULO, V35, P949; Dobler CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048900; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Garcia MJ, 2016, CLIN INFECT DIS, V62, P1401, DOI 10.1093/cid/ciw132; Huang~ Y, 2016, PEDIATRIA POLSKA, V91, P541, DOI [DOI 10.1016/J.PEPO.2016.09.005, 10.1016/j.pepo.2016.09.005, DOI 10.1016/j.pepo.2016.09.005]; López G., 2011, Rev. esp. sanid. penit., V13, P3, DOI 10.4321/s1575-06202011000100002; Ma MJ, 2015, INFECT GENET EVOL, V32, P148, DOI 10.1016/j.meegid.2015.03.001; Machiyama K, 2016, INT J PUBLIC HEALTH, V61, P603, DOI 10.1007/s00038-015-0768-6; Organization WH, 2016, GLOBAL TUBERCULOSIS; Pandit S, 2009, LUNG INDIA, V26, P109, DOI 10.4103/0970-2113.56343; Sendagire I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014459; Song SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100267; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Verhagen LM, 2010, INFECTION, V38, P443; Wei XL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-21; Zhang SR, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2077-y	18	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185646	10.1371/journal.pone.0185646	http://dx.doi.org/10.1371/journal.pone.0185646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973001	Green Published, Green Submitted, gold			2022-12-26	WOS:000412131900033
J	Aminov, A; Rogers, JM; Johnstone, SJ; Middleton, S; Wilson, PH				Aminov, Anna; Rogers, Jeffrey M.; Johnstone, Stuart J.; Middleton, Sandy; Wilson, Peter H.			Acute single channel EEG predictors of cognitive function after stroke	PLOS ONE			English	Article							FRONTAL-MIDLINE THETA; ISCHEMIC-STROKE; QUANTITATIVE EEG; DELTA/ALPHA RATIO; POWER; POSTSTROKE; RELIABILITY; IMPAIRMENT; PREVALENCE; DEPRESSION	Background Early and accurate identification of factors that predict post-stroke cognitive outcome is important to set realistic targets for rehabilitation and to guide patients and their families accordingly. However, behavioral measures of cognition are difficult to obtain in the acute phase of recovery due to clinical factors (e.g. fatigue) and functional barriers (e.g. language deficits). The aim of the current study was to test whether single channel wireless EEG data obtained acutely following stroke could predict longer-term cognitive function. Methods Resting state Relative Power (RP) of delta, theta, alpha, beta, delta/alpha ratio (DAR), and delta/ theta ratio (DTR) were obtained from a single electrode over FP1 in 24 participants within 72 hours of a first-ever stroke. The Montreal Cognitive Assessment (MoCA) was administered at 90-days post-stroke. Correlation and regression analyses were completed to identify relationships between 90-day cognitive function and electrophysiological data, neurological status, and demographic characteristics at admission. Results Four acute qEEG indices demonstrated moderate to high correlations with 90-day MoCA scores: DTR (r = -0.57, p = 0.01), RP theta (r = 0.50, p = 0.01), RP delta (r = -0.47, p = 0.02), and DAR (r = -0.45, p = 0.03). Acute DTR (b = -0.36, p < 0.05) and stroke severity on admission (b = -0.63, p < 0.01) were the best linear combination of predictors of MoCA scores 90days post-stroke, accounting for 75% of variance. Conclusions Data generated by a single pre-frontal electrode support the prognostic value of acute DAR, and identify DTR as a potential marker of post-stroke cognitive outcome. Use of single channel recording in an acute clinical setting may provide an efficient and valid predictor of cognitive function after stroke.	[Aminov, Anna] Australian Catholic Univ, Sch Psychol, Sydney, NSW, Australia; [Rogers, Jeffrey M.] South Eastern Sydney Local Hlth Dist, Sydney, NSW, Australia; [Johnstone, Stuart J.] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia; [Middleton, Sandy] St Vincents Hlth Australia, Nursing Res Inst, Sydney, NSW, Australia; [Middleton, Sandy] Australian Catholic Univ, Sydney, NSW, Australia; [Wilson, Peter H.] Australian Catholic Univ, Sch Psychol, Melbourne, Vic, Australia; [Wilson, Peter H.] Australian Catholic Univ, Ctr Disabil & Dev Res, Melbourne, Vic, Australia	Australian Catholic University; University of Wollongong; Australian Catholic University; Australian Catholic University; Australian Catholic University	Rogers, JM (corresponding author), South Eastern Sydney Local Hlth Dist, Sydney, NSW, Australia.	jeffrey.regers@health.nsw.gov.au	Middleton, Sandy/J-5526-2015; Wilson, Peter H./E-2881-2018	Middleton, Sandy/0000-0002-7201-4394; Wilson, Peter H./0000-0003-3747-0287; Rogers, Jeffrey M/0000-0002-0320-969X; Aminov, Anna/0000-0003-4805-5476	Australian Catholic University Faculty Research Grant; Australian Postgraduate Award	Australian Catholic University Faculty Research Grant; Australian Postgraduate Award(Australian Government)	This research was supported by an Australian Catholic University Faculty Research Grant provided to authors JR, SM, and SJ and an Australian Postgraduate Award provided to AA, https://research.acu.edu.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari MH, 2017, BRAIN, V140, P1068, DOI 10.1093/brain/awx021; Alcott D, 1997, DISABIL REHABIL, V19, P355, DOI 10.3109/09638289709166551; Andersen KK, 2009, STROKE, V40, P2068, DOI 10.1161/STROKEAHA.108.540112; Andreassi J. L., 2013, PSYCHOPHYSIOLOGY HUM, V4th; [Anonymous], CLIN NEUROPSYCHOLOGY; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Barker-Collo SL, 2007, ARCH CLIN NEUROPSYCH, V22, P519, DOI 10.1016/j.acn.2007.03.002; Bhalla A, 2013, STROKE, V44, P2174, DOI 10.1161/STROKEAHA.113.001263; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Carducci F, 2016, INT J PSYCHOPHYSIOL, V103, P110; Chi Yu Mike, 2010, IEEE Rev Biomed Eng, V3, P106, DOI 10.1109/RBME.2010.2084078; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crichton SL, 2016, J NEUROL NEUROSUR PS, V87, P1091, DOI 10.1136/jnnp-2016-313361; Cumming TB, 2013, ACTA NEUROL SCAND, V128, P122, DOI 10.1111/ane.12084; Cumming TB, 2011, STROKE, V42, P2642, DOI 10.1161/STROKEAHA.111.619486; Cumming TB, 2010, CEREBROVASC DIS, V30, P7, DOI 10.1159/000313438; Cummins TDR, 2008, INT J PSYCHOPHYSIOL, V70, P75, DOI 10.1016/j.ijpsycho.2008.06.002; Cummins TDR, 2007, INT J PSYCHOPHYSIOL, V66, P10, DOI 10.1016/j.ijpsycho.2007.05.008; Cuspineda E, 2007, CLIN EEG NEUROSCI, V38, P155, DOI 10.1177/155005940703800312; de Haan EH, 2006, CURR OPIN NEUROL, V19, P559, DOI 10.1097/01.wco.0000247612.21235.d9; Douiri A, 2013, STROKE, V44, P138, DOI 10.1161/STROKEAHA.112.670844; Ekandem JI, 2012, ERGONOMICS, V55, P592, DOI 10.1080/00140139.2012.662527; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Felberg R A, 2000, CNS Spectr, V5, P52; Finnigan S, 2016, CLIN NEUROPHYSIOL, V127, P1452, DOI 10.1016/j.clinph.2015.07.014; Finnigan S, 2013, CLIN NEUROPHYSIOL, V124, P10, DOI 10.1016/j.clinph.2012.07.003; Finnigan S, 2011, PSYCHOPHYSIOLOGY, V48, P1083, DOI 10.1111/j.1469-8986.2010.01173.x; Finnigan SP, 2007, CLIN NEUROPHYSIOL, V118, P2525, DOI 10.1016/j.clinph.2007.07.021; Fong KNK, 2001, BRAIN INJURY, V15, P443, DOI 10.1080/02699050010005940; Foreman B, 2012, CRIT CARE, V16, DOI 10.1186/cc11230; Gargiulo G, 2010, CLIN NEUROPHYSIOL, V121, P686, DOI 10.1016/j.clinph.2009.12.025; George S, 2017, UNDERGRAD RES J, P3; Hashimoto R, 2017, BRAIN STIMUL, V10, P426, DOI DOI 10.1016/J.BRS.2017.01.267; He W, 2017, BRAIN STIMUL, V10, P363; Hewetson R, 2017, APHASIOLOGY, P1; Hofgren C, 2007, ACTA NEUROL SCAND, V115, P73, DOI 10.1111/j.1600-0404.2006.00768.x; Hosking SG, 2000, AGING NEUROPSYCHOL C, V7, P205, DOI 10.1076/anec.7.4.205.798; Johnstone SJ, 2012, CLIN EEG NEUROSCI, V43, P112, DOI 10.1177/1550059411435857; Jokinen H, 2015, EUR J NEUROL, V22, P1288, DOI 10.1111/ene.12743; Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390; Kardos Z, 2014, NEUROSCIENCE, V273, P152, DOI 10.1016/j.neuroscience.2014.04.071; Kober SE, 2017, APPL PSYCHOPHYS BIOF, V42, P69, DOI 10.1007/s10484-017-9353-5; KOPRUNER V, 1984, PROG BRAIN RES, V62, P29; Le HH, 2017, BIOSYST BIOROBOT, V15, P369, DOI 10.1007/978-3-319-46669-9_62; Leon-Carrion J, 2009, CLIN NEUROPHYSIOL, V120, P1039, DOI 10.1016/j.clinph.2009.01.021; Lezak M, 2012, NEUROPSYCHOLOGICAL A; Li J, 2017, EXP THER MED, V13, P909, DOI 10.3892/etm.2017.4035; Lindow J, 2015, CLIN NEUROPHYSIOL, V126, pe93; Lithfous S, 2015, NEUROBIOL AGING, V36, P2821, DOI 10.1016/j.neurobiolaging.2015.07.007; Livingston-Thomas J, 2016, NEUROTHERAPEUTICS, V13, P395, DOI 10.1007/s13311-016-0423-9; Makedonov I, 2016, NEUROBIOL AGING, V37, P12, DOI 10.1016/j.neurobiolaging.2015.09.010; Mitchell DJ, 2008, PROG NEUROBIOL, V86, P156, DOI 10.1016/j.pneurobio.2008.09.005; Moriya M, 2016, ADV EXP MED BIOL, V923, P203, DOI 10.1007/978-3-319-38810-6_27; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Naunheim RS, 2010, BRAIN INJURY, V24, P1324, DOI 10.3109/02699052.2010.506862; Nesto R W, 1987, Am J Cardiol, V59, p23C; Ni L, 2017, SCI REP, P7; Nys GMS, 2007, CEREBROVASC DIS, V23, P408, DOI 10.1159/000101464; Planton M, 2012, EUR J NEUROL, V19, P212, DOI 10.1111/j.1468-1331.2011.03450.x; RANKIN J, 1957, Scott Med J, V2, P200; Renton T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177290; Rijsdijk M, 2008, NETH J CRIT CARE, V12, P157; Rogers JM, 2016, INT J PSYCHOPHYSIOL, V106, P87, DOI 10.1016/j.ijpsycho.2016.06.006; Rogers JM, 2015, NEUROREPORT, V26, P903, DOI 10.1097/WNR.0000000000000445; Scherg M, 1996, Electroencephalogr Clin Neurophysiol Suppl, V46, P127; Scheuer ML, 2002, EPILEPSIA, V43, P114, DOI 10.1046/j.1528-1157.43.s.3.7.x; Schleiger E, 2014, INT J PSYCHOPHYSIOL, V94, P19, DOI 10.1016/j.ijpsycho.2014.06.012; Strauss E., 2006, COMPENDIUM NEUROPSYC; Toth B, 2014, NEUROBIOL LEARN MEM, V114, P58, DOI 10.1016/j.nlm.2014.04.009; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; van Zandvoort MJE, 2005, CLIN NEUROL NEUROSUR, V107, P385, DOI 10.1016/j.clineuro.2004.10.012; Ward SA, 2017, INT J STROKE, V12, P108, DOI 10.1177/1747493016669848	74	28	30	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185841	10.1371/journal.pone.0185841	http://dx.doi.org/10.1371/journal.pone.0185841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968458	Green Published, gold			2022-12-26	WOS:000412029600058
J	Shemesh, N; Rosenberg, JT; Dumez, JN; Grant, SC; Frydman, L				Shemesh, Noam; Rosenberg, Jens T.; Dumez, Jean-Nicolas; Grant, Samuel C.; Frydman, Lucio			Distinguishing neuronal from astrocytic subcellular microstructures using in vivo Double Diffusion Encoded H-1 MRS at 21.1 T	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; N-ACETYL-ASPARTATE; LONGITUDINAL RELAXATION ENHANCEMENT; COMPARTMENT SHAPE ANISOTROPY; FIELD-GRADIENT NMR; RAT-BRAIN; H-1-NMR SPECTROSCOPY; WEIGHTED MR; INTRACELLULAR METABOLITES; TENSOR SPECTROSCOPY	Measuring cellular microstructures non-invasively and achieving specificity towards a celltype population within an interrogated in vivo tissue, remains an outstanding challenge in brain research. Magnetic Resonance Spectroscopy (MRS) provides an opportunity to achieve cellular specificity via the spectral resolution of metabolites such as N-Acetylaspartate (NAA) and myo-Inositol (mI), which are considered neuronal and astrocytic markers, respectively. Yet the information typically obtained with MRS describes metabolic concentrations, diffusion coefficients or relaxation rates rather than microstructures. Understanding how these metabolites are compartmentalized is a challenging but important goal, which so far has been mainly addressed using diffusion models. Here, we present direct in vivo evidence for the confinement of NAA and mI within sub-cellular components, namely, the randomly oriented process of neurons and astrocytes, respectively. Our approach applied Relaxation Enhanced MRS at ultrahigh (21.1 T) field, and used its high H-1 sensitivity to measure restricted diffusion correlations for NAA and mI using a Double Diffusion Encoding (DDE) filter. While very low macroscopic anisotropy was revealed by spatially localized Diffusion Tensor Spectroscopy, DDE displayed characteristic amplitude modulations reporting on confinements in otherwise randomly oriented anisotropic microstructures for both metabolites. This implies that for the chosen set of parameters, the DDE measurements had a biased sensitivity towards NAA and mI sited in the more confined environments of neurites and astrocytic branches, than in the cell somata. These measurements thus provide intrinsic diffusivities and compartment diameters, and revealed subcellular neuronal and astrocytic morphologies in normal in vivo rat brains. The relevance of these measurements towards human applications- which could in turn help understand CNS plasticity as well as diagnose brain diseases- is discussed.	[Shemesh, Noam] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal; [Rosenberg, Jens T.; Grant, Samuel C.; Frydman, Lucio] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Dumez, Jean-Nicolas] Inst Chim Subst Nat, CNRS UPR2301, Gif Sur Yvette, France; [Grant, Samuel C.] Florida State Univ, Chem & Biomed Engn, Tallahassee, FL 32306 USA; [Frydman, Lucio] Weizmann Inst Sci, Dept Chem Phys, Rehovot, Israel	Fundacao Champalimaud; State University System of Florida; Florida State University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); State University System of Florida; Florida State University; Weizmann Institute of Science	Shemesh, N (corresponding author), Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal.; Frydman, L (corresponding author), Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA.; Frydman, L (corresponding author), Weizmann Inst Sci, Dept Chem Phys, Rehovot, Israel.	Noam.Shemesh@neuro.fchampalimaud.org; Lucio.Frydman@weizmann.ac.il	Shemesh, Noam/GPK-7972-2022; Grant, Samuel Colles/D-8744-2013; Dumez, Jean-Nicolas/C-1080-2009	Grant, Samuel Colles/0000-0001-7738-168X; Dumez, Jean-Nicolas/0000-0002-5394-8001; Shemesh, Noam/0000-0001-6681-5876; Frydman, Lucio/0000-0001-8208-3521	NSF [DMR-1157490]; State of Florida; NHMFL User Collaboration Grants Program; Israel Science Foundation [795/13]; Minerva Foundation from the Federal German Ministry for Education and Research [712277]; Kimmel Institute for Magnetic Resonance; generosity of the Perlman Family Foundation; NHMFL [12456]	NSF(National Science Foundation (NSF)); State of Florida; NHMFL User Collaboration Grants Program; Israel Science Foundation(Israel Science Foundation); Minerva Foundation from the Federal German Ministry for Education and Research; Kimmel Institute for Magnetic Resonance; generosity of the Perlman Family Foundation; NHMFL	This work was performed at the National High Magnetic Field Laboratory (NHMFL), which is supported by NSF DMR-1157490 and the State of Florida. Funding was also provided by the NHMFL User Collaboration Grants Program (to SCG). The authors also thank the Israel Science Foundation (Grant 795/13), the Minerva Foundation (Grant No. 712277) from the Federal German Ministry for Education and Research, the Kimmel Institute for Magnetic Resonance and the generosity of the Perlman Family Foundation (to LF). NS gratefully acknowledges a Visiting Scientist Grant from NHMFL, Project Number 12456. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JJH, 2010, NMR BIOMED, V23, P725, DOI 10.1002/nbm.1530; Assaf Y, 1998, NMR BIOMED, V11, P67, DOI 10.1002/(SICI)1099-1492(199804)11:2<67::AID-NBM503>3.0.CO;2-5; Bar-Shir A, 2008, J MAGN RESON, V194, P230, DOI 10.1016/j.jmr.2008.07.009; Bernabeu A, 2009, NEUROIMAGE, V47, P1172, DOI 10.1016/j.neuroimage.2009.04.080; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Cheng Y, 1999, J AM CHEM SOC, V121, P7935, DOI 10.1021/ja9843324; Cusack CL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2910; de Graaf RA, 2006, MAGN RESON MED, V56, P386, DOI 10.1002/mrm.20946; de Graaf RA, 2014, NMR BIOMED, V27, P802, DOI 10.1002/nbm.3121; Demougeot C, 2001, J NEUROCHEM, V77, P408, DOI 10.1046/j.1471-4159.2001.00285.x; Dijkhuizen RM, 1999, J CEREBR BLOOD F MET, V19, P341, DOI 10.1097/00004647-199903000-00012; Dreher W, 2001, MAGN RESON MED, V45, P383, DOI 10.1002/1522-2594(200103)45:3<383::AID-MRM1050>3.0.CO;2-G; Drobnjak I, 2013, MICROPOR MESOPOR MAT, V178, P11, DOI 10.1016/j.micromeso.2013.03.004; Drobnjak I, 2010, J MAGN RESON, V206, P41, DOI 10.1016/j.jmr.2010.05.017; Duarte JMN, 2012, NEUROIMAGE, V61, P342, DOI 10.1016/j.neuroimage.2011.12.038; Eriksson S, 2013, J MAGN RESON, V226, P13, DOI 10.1016/j.jmr.2012.10.015; Finsterbusch J, 2008, J MAGN RESON, V195, P23, DOI 10.1016/j.jmr.2008.08.003; Finsterbusch J, 2010, ANNU REP NMR SPECTRO, V72, P225, DOI 10.1016/B978-0-12-385857-3.00006-2; Fisher SK, 2002, J NEUROCHEM, V82, P736, DOI 10.1046/j.1471-4159.2002.01041.x; Frullano L, 2011, J AM CHEM SOC, V133, P1611, DOI 10.1021/ja1040896; Fu R, 2005, J MAGN RESON, V177, P1, DOI 10.1016/j.jmr.2005.07.013; Garwood M, 2001, J MAGN RESON, V153, P155, DOI 10.1006/jmre.2001.2340; Grossman EJ, 2015, NEUROIMAGE, V118, P334, DOI 10.1016/j.neuroimage.2015.05.061; Harada M, 2002, NMR BIOMED, V15, P69, DOI 10.1002/nbm.759; Hattingen E, 2008, NMR BIOMED, V21, P233, DOI 10.1002/nbm.1186; Ianus A, 2013, J MAGN RESON, V227, P25, DOI 10.1016/j.jmr.2012.11.021; Jespersen SN, 2013, NMR BIOMED, V26, P1647, DOI 10.1002/nbm.2999; Jespersen SN, 2012, NMR BIOMED, V25, P813, DOI 10.1002/nbm.1808; Kandel E., 2000, PRINCIPLES NEURAL SC; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Kawai Y, 2010, NEUROIMAGE, V49, P3122, DOI 10.1016/j.neuroimage.2009.11.005; Kim H, 2004, MAGNET RESON MED, V51, P263, DOI 10.1002/mrm.10697; Koch MA, 2008, MAGN RESON MED, V60, P90, DOI 10.1002/mrm.21514; Koch MA, 2011, NMR BIOMED, V24, P1422, DOI 10.1002/nbm.1711; Koch MA, 2009, MAGN RESON MED, V62, P247, DOI 10.1002/mrm.21976; Lasic S, 2014, FRONT PHYS-LAUSANNE, V2, DOI 10.3389/fphy.2014.00011; Lawrenz M, 2015, NEUROIMAGE, V109, P283, DOI 10.1016/j.neuroimage.2015.01.025; Lawrenz M, 2015, MAGN RESON MED, V73, P773, DOI 10.1002/mrm.25140; Lawrenz M, 2011, MAGN RESON MED, V66, P1405, DOI 10.1002/mrm.22934; Le Belle JE, 2002, NMR BIOMED, V15, P37, DOI 10.1002/nbm.740; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Marchadour C, 2012, J CEREBR BLOOD F MET, V32, P2153, DOI 10.1038/jcbfm.2012.119; Markiewicz WD, 2015, IEEE T APPL SUPERCON, V25, DOI 10.1109/TASC.2014.2364540; Martins JPD, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.087601; McNab JA, 2013, NEUROIMAGE, V80, P234, DOI 10.1016/j.neuroimage.2013.05.074; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; MITRA PP, 1995, PHYS REV B, V51, P15074, DOI 10.1103/PhysRevB.51.15074; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Na HB, 2007, ANGEW CHEM INT EDIT, V46, P5397, DOI 10.1002/anie.200604775; Najac C, 2016, BRAIN STRUCT FUNCT, V221, P1245, DOI 10.1007/s00429-014-0968-5; Najac C, 2014, NEUROIMAGE, V90, P374, DOI 10.1016/j.neuroimage.2013.12.045; Nicolay K, 1995, NMR BIOMED, V8, P365, DOI 10.1002/nbm.1940080710; Nicolay K, 2001, NMR BIOMED, V14, P94, DOI 10.1002/nbm.686; Ozarslan E, 2009, J MAGN RESON, V199, P56, DOI 10.1016/j.jmr.2009.04.002; Palombo M, 2016, P NATL ACAD SCI USA, V113, P6671, DOI 10.1073/pnas.1504327113; Pervushin K, 2002, J AM CHEM SOC, V124, P12898, DOI 10.1021/ja027149q; Ronen I, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00013; Rosenberg JT, MAGN RESON MED; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Schanda P, 2009, PROG NUCL MAG RES SP, V55, P238, DOI 10.1016/j.pnmrs.2009.05.002; Serkova N, 1996, BBA-MOL CELL RES, V1314, P93, DOI 10.1016/S0167-4889(96)00081-X; Shemesh N, 2016, MAGN RESON MED, V75, P82, DOI 10.1002/mrm.25901; Shemesh N, 2014, J CEREBR BLOOD F MET, V34, P1810, DOI 10.1038/jcbfm.2014.149; Shemesh N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5958; Shemesh N, 2013, CHEM-EUR J, V19, P13002, DOI 10.1002/chem.201300955; Shemesh N, 2012, MAGN RESON MED, V68, P794, DOI 10.1002/mrm.23300; Shemesh N, 2012, NMR BIOMED, V25, P236, DOI 10.1002/nbm.1737; Shemesh N, 2011, J MAGN RESON, V212, P362, DOI 10.1016/j.jmr.2011.07.015; Shemesh N, 2011, J AM CHEM SOC, V133, P6028, DOI 10.1021/ja200303h; Shemesh N, 2011, MAGN RESON MED, V65, P1216, DOI 10.1002/mrm.22738; SIMMONS ML, 1991, NEUROSCIENCE, V45, P37, DOI 10.1016/0306-4522(91)90101-S; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Szczepankiewicz F, 2015, NEUROIMAGE, V104, P241, DOI 10.1016/j.neuroimage.2014.09.057; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tu C, 2009, ANGEW CHEM INT EDIT, V48, P6547, DOI 10.1002/anie.200900984; Upadhyay J, 2007, MAGN RESON MED, V58, P1045, DOI 10.1002/mrm.21372; Upadhyaya J, 2008, NEUROIMAGE, V39, P1, DOI 10.1016/j.neuroimage.2007.08.046; vanderToorn A, 1996, MAGN RESON MED, V36, P914, DOI 10.1002/mrm.1910360614; Westin CF, 2016, NEUROIMAGE, V135, P345, DOI 10.1016/j.neuroimage.2016.02.039; WICK M, 1995, STROKE, V26, P1930, DOI 10.1161/01.STR.26.10.1930; Wood ET, 2012, J NEUROSCI, V32, P6665, DOI 10.1523/JNEUROSCI.0044-12.2012; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zheng G, 2007, CONCEPT MAGN RESON A, V30A, P261, DOI 10.1002/cmr.a.20092	84	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185232	10.1371/journal.pone.0185232	http://dx.doi.org/10.1371/journal.pone.0185232			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968410	Green Submitted, Green Published, gold			2022-12-26	WOS:000412029600016
J	Wilson, RH; Martin-Avila, E; Conlan, C; Whitney, SM				Wilson, Robert H.; Martin-Avila, Elena; Conlan, Carly; Whitney, Spencer M.			An improved Escherichia coli screen for Rubisco identifies a protein-protein interface that can enhance CO2-fixation kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBAL FOOD; PHOTOSYNTHESIS; TOBACCO; GROWTH; CHLOROPLASTS; EXPRESSION; EFFICIENCY; ENZYME; PLANTS; CO2	An overarching goal of photosynthesis research is to identify how components of the process can be improved to benefit crop productivity, global food security, and renewable energy storage. Improving carbon fixation has mostly focused on enhancing the CO2 fixing enzyme ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco). This grand challenge has mostly proved ineffective because of catalytic mechanism constraints and required chaperone complementarity that hinder Rubisco biogenesis in alternative hosts. Here we refashion Escherichia coli metabolism by expressing a phosphoribulokinase-neomycin phosphotransferase fusion protein to produce a high-fidelity, high-throughput Rubisco-directed evolution (RDE2) screen that negates false-positive selection. Successive evolution rounds using the plant-like Te-Rubisco from the cyanobacterium Thermosynechococcus elongatus BP1 identified two large subunit and six small subunit mutations that improved carboxylation rate, efficiency, and specificity. Structural analysis revealed the amino acids clustered in an unexplored subunit interface of the holoenzyme. To study its effect on plant growth, the Te-Rubisco was transformed into tobacco by chloroplast transformation. As previously seen for Synechocccus PCC6301 Rubisco, the specialized folding and assembly requirements of Te-Rubisco hinder its heterologous expression in leaf chloroplasts. Our findings suggest that the ongoing efforts to improve crop photosynthesis by integrating components of a cyanobacteria CO2-concentrating mechanism will necessitate co-introduction of the ancillary molecular components required for Rubisco biogenesis.	[Wilson, Robert H.; Martin-Avila, Elena; Conlan, Carly; Whitney, Spencer M.] Australian Natl Univ, Res Sch Biol, Acton, ACT 2601, Australia	Australian National University	Whitney, SM (corresponding author), Australian Natl Univ, Res Sch Biol, Acton, ACT 2601, Australia.	spencer.whitney@anu.edu.au	Wilson, Robbie/AAP-7650-2020; Whitney, Spencer M/C-9266-2009; Wilson, Robert H/C-3593-2019	Wilson, Robbie/0000-0003-4168-2805; Whitney, Spencer M/0000-0003-2954-2359; Wilson, Robert H/0000-0003-4168-2805	Australian Research Council Centre of Excellence for Translational Photosynthesis Grant [CE140100015]	Australian Research Council Centre of Excellence for Translational Photosynthesis Grant(Australian Research Council)	This work was supported by Australian Research Council Centre of Excellence for Translational Photosynthesis Grant CE140100015 (to S. M. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Antonovsky N, 2017, CURR OPIN BIOTECH, V47, P83, DOI 10.1016/j.copbio.2017.06.006; Antonovsky N, 2016, CELL, V166, P115, DOI 10.1016/j.cell.2016.05.064; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Bracher A, 2017, ANNU REV PLANT BIOL, V68, P29, DOI 10.1146/annurev-arplant-043015-111633; Cai Z, 2014, PROTEIN CELL, V5, P552, DOI 10.1007/s13238-014-0072-x; Carmo-Silva E, 2015, PLANT CELL ENVIRON, V38, P1817, DOI 10.1111/pce.12425; Durao P, 2015, NAT CHEM BIOL, V11, P148, DOI [10.1038/NCHEMBIO.1715, 10.1038/nchembio.1715]; ELLIS RJ, 1979, TRENDS BIOCHEM SCI, V4, P241, DOI 10.1016/0968-0004(79)90212-3; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Greene DN, 2007, BIOCHEM J, V404, P517, DOI 10.1042/BJ20070071; Hanson MR, 2016, PLANT J, V87, P38, DOI 10.1111/tpj.13139; He ZL, 1997, PLANT PHYSIOL, V115, P1569, DOI 10.1104/pp.115.4.1569; Ishikawa C, 2011, PLANT PHYSIOL, V156, P1603, DOI 10.1104/pp.111.177030; KANE HJ, 1994, AUST J PLANT PHYSIOL, V21, P449, DOI 10.1071/PP9940449; Lin MT, 2014, NATURE, V513, P547, DOI 10.1038/nature13776; Long SP, 2015, CELL, V161, P56, DOI 10.1016/j.cell.2015.03.019; Mueller-Cajar O, 2008, BIOCHEM J, V414, P205, DOI 10.1042/BJ20080668; Mueller-Cajar O, 2007, BIOCHEMISTRY-US, V46, P14067, DOI 10.1021/bi700820a; Mueller-Cajar O, 2008, PHOTOSYNTH RES, V98, P667, DOI 10.1007/s11120-008-9324-z; Occhialini A, 2016, PLANT J, V85, P148, DOI 10.1111/tpj.13098; Ort DR, 2015, P NATL ACAD SCI USA, V112, P8529, DOI 10.1073/pnas.1424031112; Parry MAJ, 2013, J EXP BOT, V64, P717, DOI 10.1093/jxb/ers336; Price GD, 2014, NATURE, V513, P497, DOI 10.1038/nature13749; Sharwood RE, 2017, NEW PHYTOL, V213, P494, DOI 10.1111/nph.14351; Sharwood RE, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.186, 10.1038/nplants.2016.186]; Sharwood RE, 2008, PLANT PHYSIOL, V146, P83, DOI 10.1104/pp.107.109058; Tcherkez G, 2016, PLANT CELL ENVIRON, V39, P983, DOI 10.1111/pce.12629; Tsai YCC, 2012, J BIOL CHEM, V287, P20471, DOI 10.1074/jbc.M112.365411; Whitfield JH, 2015, PROTEIN SCI, V24, P1412, DOI 10.1002/pro.2721; Whitney SM, 2003, PLANT PHYSIOL, V133, P287, DOI 10.1104/pp.103.026146; Whitney SM, 2001, PLANT J, V26, P535, DOI 10.1046/j.1365-313x.2001.01056.x; Whitney SM, 2008, J EXP BOT, V59, P1909, DOI 10.1093/jxb/erm311; Whitney SM, 2015, P NATL ACAD SCI USA, V112, P3564, DOI 10.1073/pnas.1420536112; Whitney SM, 2011, PLANT PHYSIOL, V155, P27, DOI 10.1104/pp.110.164814; Wilson RH., 2017, DIRECTED ENZYME EVOL, P101, DOI [10.1007/978-3-319-50413-1_4, DOI 10.1007/978-3-319-50413-1_4]; Wilson RH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22284; Yin KQ, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.107	38	42	43	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					18	27		10.1074/jbc.M117.810861	http://dx.doi.org/10.1074/jbc.M117.810861			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	28986448	Green Published, hybrid			2022-12-26	WOS:000419453200002
J	Knittle, AM; Helkkula, M; Johnson, MS; Sundvall, M; Elenius, K				Knittle, Anna M.; Helkkula, Maria; Johnson, Mark S.; Sundvall, Maria; Elenius, Klaus			SUMOylation regulates nuclear accumulation and signaling activity of the soluble intracellular domain of the ErbB4 receptor tyrosine kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; nuclear transport; posttranslational modification (PTM); protein export; receptor tyrosine kinase; small ubiquitin-like modifier (SUMO); ErbB4; HER4; regulated intramembrane proteolysis (RIP); nuclear transport; RTK; breast cancer	GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; EXPORT SIGNALS; ESTROGEN-RECEPTOR; ACTIVATED STAT3; EGF RECEPTOR; IN-VIVO; PROTEIN; LOCALIZATION; EXPRESSION	Erb-B2 receptor tyrosine kinase 4 (ErbB4) is a kinase that can signal via a proteolytically released intracellular domain (ICD) in addition to classical receptor tyrosine kinase-activated signaling cascades. Previously, we have demonstrated that ErbB4 ICD is posttranslationally modified by the small ubiquitin-like modifier (SUMO) and functionally interacts with the PIAS3 SUMO E3 ligase. However, direct evidence of SUMO modification in ErbB4 signaling has remained elusive. Here, we report that the conserved lysine residue 714 in the ErbB4 ICD undergoes SUMO modification, which was reversed by sentrin-specific proteases (SENPs) 1, 2, and 5. Although ErbB4 kinase activity was not necessary for the SUMOylation, the SUMOylated ErbB4 ICD was tyrosine phosphorylated to a higher extent than unmodified ErbB4 ICD. Mutation of the SUMOylation site compromised neither ErbB4-induced phosphorylation of the canonical signaling pathway effectors Erk1/2, Akt, or STAT5 nor ErbB4 stability. In contrast, SUMOylation was required for nuclear accumulation of the ErbB4 ICD. We also found that Lys-714 was located within a leucine-rich stretch, which resembles a nuclear export signal, and could be inactivated by site-directed mutagenesis. Furthermore, SUMOylation modulated the interaction of ErbB4 with chromosomal region maintenance 1 (CRM1), the major nuclear export receptor for proteins. Finally, the SUMO acceptor lysine was functionally required for ErbB4 ICD-mediated inhibition of mammary epithelial cell differentiation in a three-dimensional cell culture model. Our findings indicate that a SUMOylation-mediated mechanism regulates nuclear localization and function of the ICD of ErbB4 receptor tyrosine kinase.	[Knittle, Anna M.; Helkkula, Maria; Sundvall, Maria; Elenius, Klaus] Univ Turku, Dept Med Biochem & Genet, FI-20520 Turku, Finland; [Knittle, Anna M.; Helkkula, Maria; Sundvall, Maria; Elenius, Klaus] Univ Turku, MediCity Res Lab, FI-20520 Turku, Finland; [Knittle, Anna M.] Univ Turku, Turku Doctoral Programmes Biomed Sci & Mol Med, FI-20014 Turku, Finland; [Johnson, Mark S.] Abo Akad Univ, Struct Bioinformat Lab, Biochem, Fac Sci & Engn, FI-20500 Turku, Finland; [Sundvall, Maria; Elenius, Klaus] Univ Turku, Dept Radiotherapy & Oncol, FI-20014 Turku, Finland; [Sundvall, Maria; Elenius, Klaus] Turku Univ Hosp, FI-20014 Turku, Finland	University of Turku; University of Turku; University of Turku; Abo Akademi University; University of Turku; University of Turku	Sundvall, M; Elenius, K (corresponding author), Kiinamyllynkatu 10, FIN-20520 Turku, Finland.	maria.sundvall@utu.fi; klaus.elenius@utu.fi	Elenius, Klaus/AAI-7594-2021	Elenius, Klaus/0000-0001-5700-0827; Sundvall, Maria H/0000-0002-0494-2965	Academy of Finland; Cancer Foundation of Finland; Cancer Society of Southwest Finland; Finnish Cultural Foundation; Foundation of Abo Akademi University; Ida Montin Foundation; Joe, Pentti, and Tor Borg Memorial Fund; Orion-Farmos Research Foundation; Sigrid Juselius Foundation; Turku Doctoral Programme of Biomedical Sciences; Turku University Central Hospital; Turku University Foundation; Cancer Foundation Finland sr [130077, 160067] Funding Source: researchfish	Academy of Finland(Academy of Finland); Cancer Foundation of Finland; Cancer Society of Southwest Finland; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Foundation of Abo Akademi University; Ida Montin Foundation; Joe, Pentti, and Tor Borg Memorial Fund; Orion-Farmos Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku Doctoral Programme of Biomedical Sciences; Turku University Central Hospital; Turku University Foundation; Cancer Foundation Finland sr	This work was financially supported by the Academy of Finland; the Cancer Foundation of Finland; the Cancer Society of Southwest Finland; the Finnish Cultural Foundation; the Foundation of Abo Akademi University; the Ida Montin Foundation; the Joe, Pentti, and Tor Borg Memorial Fund; the Orion-Farmos Research Foundation; the Sigrid Juselius Foundation; the Turku Doctoral Programme of Biomedical Sciences; Turku University Central Hospital; and the Turku University Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Bawa-Khalfe T, 2012, P NATL ACAD SCI USA, V109, P17466, DOI 10.1073/pnas.1209378109; de la Cruz-Herrera CF, 2015, ONCOGENE, V34, P1442, DOI 10.1038/onc.2014.48; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761; Elenius K, 1999, ONCOGENE, V18, P2607, DOI 10.1038/sj.onc.1202612; Engelsma D, 2004, EMBO J, V23, P3643, DOI 10.1038/sj.emboj.7600370; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gilmore-Hebert M, 2010, MOL CANCER RES, V8, P1388, DOI 10.1158/1541-7786.MCR-10-0042; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Hendriks IA, 2014, NAT STRUCT MOL BIOL, V21, P927, DOI 10.1038/nsmb.2890; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Impens F, 2014, P NATL ACAD SCI USA, V111, P12432, DOI 10.1073/pnas.1413825111; Jones FE, 2008, J MAMMARY GLAND BIOL, V13, P247, DOI 10.1007/s10911-008-9076-6; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Junttila TT, 2003, CLIN CANCER RES, V9, P5346; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kadare G, 2003, J BIOL CHEM, V278, P47434, DOI 10.1074/jbc.M308562200; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kurppa KJ, 2016, ONCOGENE, V35, P1283, DOI 10.1038/onc.2015.185; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lamoliatte F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6409; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Linggi B, 2006, ONCOGENE, V25, P160, DOI 10.1038/sj.onc.1209003; Linggi B, 2006, J BIOL CHEM, V281, P25373, DOI 10.1074/jbc.M603998200; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; McHale K, 2008, MODERN PATHOL, V21, P565, DOI 10.1038/modpathol.2008.7; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Muraoka-Cook RS, 2009, MOL CELL BIOL, V29, P4935, DOI 10.1128/MCB.01705-08; Naresh A, 2006, CANCER RES, V66, P6412, DOI 10.1158/0008-5472.CAN-05-2368; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Paatero I, 2012, J BIOL CHEM, V287, P9659, DOI 10.1074/jbc.M111.299537; Packham S, 2015, BIOCHEMISTRY-US, V54, P5157, DOI 10.1021/acs.biochem.5b00640; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Pichler Andrea, 2017, BioMolecular Concepts, V8, P13, DOI 10.1515/bmc-2016-0030; Pircher TJ, 1997, MOL CELL ENDOCRINOL, V133, P169, DOI 10.1016/S0303-7207(97)00164-0; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Rytinki MM, 2009, J BIOL CHEM, V284, P26184, DOI 10.1074/jbc.M109.038943; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Santiago A, 2013, MOL BIOL CELL, V24, P2739, DOI 10.1091/mbc.E12-10-0771; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Srinivasan R, 2000, CANCER RES, V60, P1483; Sundvall M, 2007, ONCOGENE, V26, P6905, DOI 10.1038/sj.onc.1210501; Sundvall M, 2008, J MAMMARY GLAND BIOL, V13, P259, DOI 10.1007/s10911-008-9079-3; Sundvall M, 2012, J BIOL CHEM, V287, P23216, DOI 10.1074/jbc.M111.335927; Sundvall M, 2010, MOL BIOL CELL, V21, P4275, DOI 10.1091/mbc.E10-04-0332; Tammsalu T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005146; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Tvorogov D, 2009, J BIOL CHEM, V284, P5582, DOI 10.1074/jbc.M805438200; Vidal GA, 2005, J BIOL CHEM, V280, P19777, DOI 10.1074/jbc.M412457200; Wang LM, 2004, ONCOL REP, V11, P1319; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Warsito D, 2012, EMBO REP, V13, P244, DOI 10.1038/embor.2011.251; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Wood ER, 2008, P NATL ACAD SCI USA, V105, P2773, DOI 10.1073/pnas.0708281105; Wood LD, 2003, P NATL ACAD SCI USA, V100, P3257, DOI 10.1073/pnas.0637114100; Yang SF, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2063-1; Yao Q, 2011, J BIOL CHEM, V286, P27342, DOI 10.1074/jbc.M111.220848; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Yun CW, 2008, J CELL BIOL, V183, P589, DOI 10.1083/jcb.200807185; Zhu Y, 2006, CANCER RES, V66, P7991, DOI 10.1158/0008-5472.CAN-05-4397	73	11	12	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19890	19904		10.1074/jbc.M117.794271	http://dx.doi.org/10.1074/jbc.M117.794271			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28974580	Green Published, hybrid			2022-12-26	WOS:000416911300031
J	Adebali, O; Sancar, A; Selby, CP				Adebali, Ogun; Sancar, Aziz; Selby, Christopher P.			Mfd translocase is necessary and sufficient for transcription-coupled repair in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; DNA sequencing; Escherichia coli (E; coli); genomics; nucleotide excision repair; Mfd; UvrD; lac operon; ppGpp; transcription-coupled repair	NUCLEOTIDE-EXCISION-REPAIR; STRAND-SPECIFIC REPAIR; DNA-POLYMERASE-I; LACTOSE OPERON; HELICASE-II; PROTEIN; VITRO; RESOLUTION; NUCLEASE; DOMAINS	Nucleotide excision repair in Escherichia coli is stimulated by transcription, specifically in the transcribed strand. Previously, it was shown that this transcription-coupled repair (TCR) is mediated by the Mfd translocase. Recently, it was proposed that in fact the majority of TCR in E. coli is catalyzed by a second pathway (backtracking-mediated TCR) that is dependent on the UvrD helicase and the guanosine pentaphosphate (ppGpp) alarmone/stringent response regulator. Recently, we reported that as measured by the excision repair-sequencing (XR-seq), UvrD plays no role in TCR genome-wide. Here, we tested the role of ppGpp and UvrD in TCR genome-wide and in the lacZ operon using the XR-seq method, which directly measures repair. We found that the mfd mutation abolishes TCR genome-wide and in the lacZ operon. In contrast, the relA(-)spoT(-) mutant deficient in ppGpp synthesis carries out normal TCR. We conclude that UvrD and ppGpp play no role in TCR in E. coli.	[Adebali, Ogun; Sancar, Aziz; Selby, Christopher P.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A; Selby, CP (corresponding author), 3070 Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu; cselby@med.unc.edu	Adebali, Ogun/N-4159-2016	Adebali, Ogun/0000-0001-9213-4070	National Institutes of Health [GM118102, ES027255]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES027255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM118102 and ES027255. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adebali O, 2017, P NATL ACAD SCI USA, V114, pE2116, DOI 10.1073/pnas.1700230114; Ahn B, 2000, MOL CELLS, V10, P592, DOI 10.1007/s100590000017; BOCKRATH RC, 1977, MOL GEN GENET, V156, P133, DOI 10.1007/BF00283485; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; Fan J, 2016, NATURE, V536, P234, DOI 10.1038/nature19080; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; HUSAIN I, 1985, P NATL ACAD SCI USA, V82, P6774, DOI 10.1073/pnas.82.20.6774; Kamarthapu V, 2016, SCIENCE, V352, P993, DOI 10.1126/science.aad6945; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; KUNALA S, 1995, J MOL BIOL, V246, P264, DOI 10.1006/jmbi.1994.0082; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Llorens-Rico V, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501363; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Manelyte L, 2010, MOL CELL, V40, P714, DOI 10.1016/j.molcel.2010.11.012; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Mellon I, 1996, P NATL ACAD SCI USA, V93, P1292, DOI 10.1073/pnas.93.3.1292; Miller JH, 1972, EXPT MOL GENETICS, P349; OLLER AR, 1992, P NATL ACAD SCI USA, V89, P11036, DOI 10.1073/pnas.89.22.11036; ORREN DK, 1992, J BIOL CHEM, V267, P780; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Sancar A, 2016, ANGEW CHEM INT EDIT, V55, P8502, DOI 10.1002/anie.201601524; Selby CP, 2017, PHOTOCHEM PHOTOBIOL, V93, P280, DOI 10.1111/php.12675; SELBY CP, 1991, P NATL ACAD SCI USA, V88, P8232, DOI 10.1073/pnas.88.18.8232; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1995, J BIOL CHEM, V270, P4890, DOI 10.1074/jbc.270.9.4890; SELBY CP, 1990, J BIOL CHEM, V265, P21330; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; SELBY CP, 1991, P NATL ACAD SCI USA, V88, P11574, DOI 10.1073/pnas.88.24.11574; Thomason MK, 2015, J BACTERIOL, V197, P18, DOI 10.1128/JB.02096-14; Vinella D, 2012, J BACTERIOL, V194, P261, DOI 10.1128/JB.06238-11; Wade JT, 2014, NAT REV MICROBIOL, V12, P647, DOI 10.1038/nrmicro3316; WITKIN EM, 1966, SCIENCE, V152, P1345, DOI 10.1126/science.152.3727.1345; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465	38	29	29	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18386	18391		10.1074/jbc.C117.818807	http://dx.doi.org/10.1074/jbc.C117.818807			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28986449	hybrid, Green Published			2022-12-26	WOS:000414958100001
J	Clark, DB; Clark, DA; Oberbauer, SF; Kellner, JR				Clark, David B.; Clark, Deborah A.; Oberbauer, Steven F.; Kellner, James R.			Multidecadal stability in tropical rain forest structure and dynamics across an old-growth landscape	PLOS ONE			English	Article							HABITAT ASSOCIATIONS; SCALE DISTRIBUTIONS; LA-SELVA; BIOMASS; CARBON; MORTALITY; FIELD; HETEROGENEITY; PRODUCTIVITY; LIMITATION	Have tropical rain forest landscapes changed directionally through recent decades? To answer this question requires tracking forest structure and dynamics through time and across within-forest environmental heterogeneity. While the impacts of major environmental gradients in soil nutrients, climate and topography on lowland tropical rain forest (TRF) structure and function have been extensively analyzed, the effects of the shorter environmental gradients typical of mesoscale TRF landscapes remain poorly understood. To evaluate multi-decadal performance of an old-growth TRF at the La Selva Biological Station, Costa Rica, we established 18 0.5-ha annually-censused forest inventory plots in a stratified-random design across major landscape edaphic gradients. Over the 17-year study period, there were moderate differences in stand dynamics and structure across these gradients but no detectable difference in woody productivity. We found large effects on forest structure and dynamics from the mega-Nino event at the outset of the study, with subdecadal recovery and subsequent stabilization. To extend the timeline to >40 years, we combined our findings with those from earlier studies at this site. While there were annual to multiannual variations in the structure and dynamics, particularly in relation to local disturbances and the mega-Nino event, at the longer temporal scale and broader spatial scale this landscape was remarkably stable. This stability contrasts notably with a current hypothesis of increasing biomass and dynamics of TRF, which we term the Bigger and Faster Hypothesis (B&FHo). We consider possible reasons for the contradiction and conclude that it is currently not possible to independently assess the vast majority of previously published B&FHo evidence due to restricted data access.	[Clark, David B.; Clark, Deborah A.] Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA; [Oberbauer, Steven F.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Kellner, James R.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI USA	University of Missouri System; University of Missouri Saint Louis; State University System of Florida; Florida International University; Brown University	Clark, DB (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	dbclark50@yahoo.com		Clark, Deborah/0000-0002-4000-4925	U.S. National Science Foundation of the CARBONO project, from NSF LTREB [NSF 1357177]; U.S. Department of Energy [DE-FG02-96ER62289]; Tropical Ecosystems Ecology and Monitoring Project of Conservation International; Direct For Biological Sciences [1544438, 1357112] Funding Source: National Science Foundation	U.S. National Science Foundation of the CARBONO project, from NSF LTREB; U.S. Department of Energy(United States Department of Energy (DOE)); Tropical Ecosystems Ecology and Monitoring Project of Conservation International; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the U.S. National Science Foundation (www.nsf.gov/) for long-term funding of the CARBONO project, most recently from NSF LTREB NSF 1357177 to David B. Clark, Deborah A. Clark and James Kellner. Additional funding was provided by the U.S. Department of Energy DE-FG02-96ER62289 (https://energy.gov/) and the Tropical Ecosystems Ecology and Monitoring Project of Conservation International (http://www.teamnetworkorg/).	Brienen RJW, 2015, NATURE, V519, P344, DOI 10.1038/nature14283; Brown S., 1997, 134 FAO, V134; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2008, PLOS BIOL, V6, P455, DOI 10.1371/journal.pbio.0060045; CLARK DA, 1995, ECOLOGY, V76, P2581, DOI 10.2307/2265829; Clark DB, 2012, J VEG SCI, V23, P1191, DOI 10.1111/j.1654-1103.2012.01471.x; Clark DB, 2010, GLOBAL CHANGE BIOL, V16, P747, DOI 10.1111/j.1365-2486.2009.02004.x; Clark DB, 1996, J TROP ECOL, V12, P735, DOI 10.1017/S0266467400009937; Clark DB, 1999, ECOLOGY, V80, P2662, DOI 10.1890/0012-9658(1999)080[2662:EFATLS]2.0.CO;2; Clark DB, 1998, J ECOL, V86, P101, DOI 10.1046/j.1365-2745.1998.00238.x; Clark DA, 2007, BIOTROPICA, V39, P4, DOI 10.1111/j.1744-7429.2006.00227.x; Clark DA, 2013, J GEOPHYS RES-BIOGEO, V118, P783, DOI 10.1002/jgrg.20067; Clark DA, 2011, BIOTROPICA, V43, P31, DOI 10.1111/j.1744-7429.2010.00654.x; Cleveland CC, 2011, ECOL LETT, V14, P939, DOI 10.1111/j.1461-0248.2011.01658.x; Dubayah RO, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG000933; Espeleta JF, 2007, ECOL MONOGR, V77, P377, DOI 10.1890/06-1257.1; Goll DS, 2012, BIOGEOSCIENCES, V9, P3547, DOI 10.5194/bg-9-3547-2012; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Hartshorn GS, 1988, TROPICAL RAINFORESTS, P281; Johnson MO, 2016, GLOBAL CHANGE BIOL, V22, P3996, DOI 10.1111/gcb.13315; Jones MM, 2007, J VEG SCI, V18, P13, DOI 10.1111/j.1654-1103.2007.tb02511.x; Jones MM, 2006, J ECOL, V94, P181, DOI 10.1111/j.1365-2745.2005.01071.x; Kellner JR, 2009, ECOL LETT, V12, P155, DOI 10.1111/j.1461-0248.2008.01274.x; Kennedy LM, 2008, BIOTROPICA, V40, P11, DOI 10.1111/j.1744-7429.2007.00334.x; Korner C, 2003, SCIENCE, V300, P1242, DOI 10.1126/science.1084460; Leigh EG, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P451; Lewis SL, 2009, ANNU REV ECOL EVOL S, V40, P529, DOI 10.1146/annurev.ecolsys.39.110707.173345; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; LIEBERMAN D, 1985, J ECOL, V73, P915, DOI 10.2307/2260157; LIEBERMAN D, 1987, J TROP ECOL, V3, P347, DOI 10.1017/S0266467400002327; Lieberman Milton, 1994, P106; Manokaran N, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P585; Marvin DC, 2014, P NATL ACAD SCI USA, V111, pE5224, DOI 10.1073/pnas.1412999111; McNutt M, 2016, SCIENCE, V351, P1024, DOI 10.1126/science.aad7048; Meyer V., 2013, Biogeosciences, V10, P5421, DOI 10.5194/bg-10-5421-2013; Muller-Landau H.C., 2014, FORESTS GLOBAL CHANG, P381, DOI DOI 10.1017/CBO9781107323506.018; Nakagawa M, 2000, J TROP ECOL, V16, P355, DOI 10.1017/S0266467400001450; Parker Geoffrey G., 1994, P54; Phillips OL, 2014, FORESTS GLOBAL CHANG, P77, DOI DOI 10.1017/CBO9781107323506.006; Phillips OL, 2016, ECOL STUD-ANAL SYNTH, V227, P191, DOI 10.1007/978-3-662-49902-3_10; Potts MD, 2003, J ECOL, V91, P467, DOI 10.1046/j.1365-2745.2003.00779.x; Quesada CA, 2012, BIOGEOSCIENCES, V9, P2203, DOI 10.5194/bg-9-2203-2012; Rolim SG, 2005, OECOLOGIA, V142, P238, DOI 10.1007/s00442-004-1717-x; Russo SE, 2008, J ECOL, V96, P192, DOI 10.1111/j.1365-2745.2007.01330.x; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; Sheil D, 1996, J ECOL, V84, P91, DOI 10.2307/2261703; Silva CE, 2013, GLOBAL CHANGE BIOL, V19, P3423, DOI 10.1111/gcb.12312; Townsend AR, 2008, TRENDS ECOL EVOL, V23, P424, DOI 10.1016/j.tree.2008.04.009	48	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0183819	10.1371/journal.pone.0183819	http://dx.doi.org/10.1371/journal.pone.0183819			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981502	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300006
J	Elliott, M; Maignel, J; Liu, SM; Favre-Guilmard, C; Mir, I; Farrow, P; Hornby, F; Marlin, S; Palan, S; Beard, M; Krupp, J				Elliott, Mark; Maignel, Jacquie; Liu, Sai Man; Favre-Guilmard, Christine; Mir, Imran; Farrow, Paul; Hornby, Fraser; Marlin, Sandra; Palan, Shilpa; Beard, Matthew; Krupp, Johannes			Augmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems	PLOS ONE			English	Article							SUBSTRATE RECOGNITION; SYNAPTOTAGMIN-II; NEUROTRANSMITTER RELEASE; STRUCTURAL-ANALYSIS; CERVICAL DYSTONIA; LIGHT-CHAIN; LOW PH; BINDING; TOXIN; TRANSLOCATION	Botulinum neurotoxins (BoNTs) are used extensively as therapeutic agents. Serotypes A and B are available as marketed products. Higher doses of BoNT/B are required to reach an efficacy similar to that of products containing BoNT/A. Advances in our understanding of BoNT/B mechanism of action have afforded the opportunity to make rational modifications to the toxin aimed at increasing its activity. Recently, a mutation in the light chain of BoNT/B (S201P) was described that increases the catalytic activity of the isolated BoNT/B light chain in biochemical assays. In this study, we have produced two full-length recombinant BoNT/B toxins in E. coli-one wild type (rBoNT/B1) and one incorporating the S201P mutation (rBoNT/B1((S201P))). We have compared the activity of these two molecules along with a native BoNT/B1 in biochemical cell-free assays and in several biological systems. In the cell-free assay, which measured light-chain activity alone, rBoNT/B1((S201P)) cleaved VAMP2 and VAMP-1 substrate with an activity 3-4-fold higher than rBoNT/B1. However, despite the enhanced catalytic activity of rBoNT/B1((S201P)), there was no significant difference in potency between the two molecules in any of the in vitro cell-based assays, using either rodent spinal cord neurons or cortical neurons. Similarly in ex vivo tissue preparations rBoNT/B1((S201P)) was not significantly more potent than rBoNT/B1 at inhibiting either diaphragm or detrusor (bladder) muscle activity in C57BL/6N and CD1 mice. Finally, no differences between rBoNT/B1 and rBoNT/B1((S201P)) were observed in an in vivo digit abduction score (DAS) assay in C57BL/6N mice, either in efficacy or safety parameters. The lack of translation from the enhanced BoNT/B1((S201P)) catalytic activity to potency in complex biological systems suggests that the catalytic step is not the rate-limiting factor for BoNT/B to reach maximum efficacy. In order to augment the efficacy of BoNT/B in humans, strategies other than enhancing light chain activity may need to be considered.	[Elliott, Mark; Liu, Sai Man; Mir, Imran; Farrow, Paul; Hornby, Fraser; Marlin, Sandra; Palan, Shilpa; Beard, Matthew] Ipsen Bioinnovat, 102 Pk Dr,Milton Pk, Abingdon, Oxon, England; [Maignel, Jacquie; Favre-Guilmard, Christine; Krupp, Johannes] Ipsen Innovat, Les Ulis, France	Ipsen	Elliott, M (corresponding author), Ipsen Bioinnovat, 102 Pk Dr,Milton Pk, Abingdon, Oxon, England.	mark.elliott@ipsen.com		Maignel, Jacquie/0000-0002-2512-5593	Ipsen	Ipsen(Ipsen)	This research was funded by Ipsen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2005, BIOCHEMISTRY-US, V44, P11758, DOI 10.1021/bi0510072; Ahmed SA, 2008, PROTEIN J, V27, P151, DOI 10.1007/s10930-007-9118-8; Aoki KR, 2001, TOXICON, V39, P1815, DOI 10.1016/S0041-0101(01)00101-5; Atassi MZ, 2014, PROTEIN J, V33, P278, DOI 10.1007/s10930-014-9557-y; Bentivoglio AR, 2015, TOXICON, V107, P77, DOI 10.1016/j.toxicon.2015.08.001; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Brin MF, 2008, MOVEMENT DISORD, V23, P1353, DOI 10.1002/mds.22157; Broide RS, 2013, TOXICON, V71, P18, DOI 10.1016/j.toxicon.2013.05.004; Chai Q, 2006, NATURE, V444, P1096, DOI 10.1038/nature05411; Chen S, 2006, J BIOL CHEM, V281, P10906, DOI 10.1074/jbc.M513032200; Chen S, 2008, J BIOL CHEM, V283, P21153, DOI 10.1074/jbc.M800611200; Chen S, 2007, J BIOL CHEM, V282, P9621, DOI 10.1074/jbc.M611211200; Chen S, 2012, TOXINS, V4, P913, DOI 10.3390/toxins4100913; Chen S, 2012, BIOCHEMISTRY-US, V51, P3941, DOI 10.1021/bi3000098; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Dressler D, 2005, J NEUROL, V252, P904, DOI 10.1007/s00415-005-0774-3; Fischer A, 2013, TOXICON, V75, P101, DOI 10.1016/j.toxicon.2013.01.007; Guo JB, 2013, TOXICON, V74, P158, DOI 10.1016/j.toxicon.2013.08.055; JANKOVIC J, 1995, NEUROLOGY, V45, P1743, DOI 10.1212/WNL.45.9.1743; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Lawrence GW, 2010, J PHARMACOL EXP THER, V334, P1080, DOI 10.1124/jpet.110.169342; Liu Y, 2011, J PHYSIOL-LONDON, V589, P1603, DOI 10.1113/jphysiol.2010.201939; Maignel-Ludop J, 2017, PHARMACOL RES PERSPE, V5, DOI 10.1002/prp2.289; Marques RE, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004315.pub3; Naumann M, 2013, J NEURAL TRANSM, V120, P275, DOI 10.1007/s00702-012-0893-9; Nishiki T, 1996, FEBS LETT, V378, P253, DOI 10.1016/0014-5793(95)01471-3; Palea S, 2012, EUR J PHARMACOL, V690, P202, DOI 10.1016/j.ejphar.2012.06.036; PAPINI E, 1993, J BIOL CHEM, V268, P1567; Peng LS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004177; Pirazzini M, 2016, BBA-BIOMEMBRANES, V1858, P467, DOI 10.1016/j.bbamem.2015.08.014; Pirazzini M, 2014, CELL REP, V8, P1870, DOI 10.1016/j.celrep.2014.08.017; Pirazzini M, 2013, FEBS LETT, V587, P3831, DOI 10.1016/j.febslet.2013.10.010; Rasetti-Escargueil C, 2011, TOXICON, V57, P1008, DOI 10.1016/j.toxicon.2011.04.003; Rossetto O, 2014, NAT REV MICROBIOL, V12, P535, DOI 10.1038/nrmicro3295; Rummel A, 2006, INVENTORTRANSPORT PR; Rummel A, 2007, P NATL ACAD SCI USA, V104, P359, DOI 10.1073/pnas.0609713104; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Sikorra S, 2008, J BIOL CHEM, V283, P21145, DOI 10.1074/jbc.M800610200; Sikorra S, 2016, J MOL BIOL, V428, P372, DOI 10.1016/j.jmb.2015.10.024; Sloop RR, 1997, NEUROLOGY, V49, P189, DOI 10.1212/WNL.49.1.189; Sun SH, 2012, BIOCHEMISTRY-US, V51, P5655, DOI 10.1021/bi3004928; Sun SH, 2011, CELL HOST MICROBE, V10, P237, DOI 10.1016/j.chom.2011.06.012; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Takahashi R, 2012, J UROLOGY, V188, P1993, DOI 10.1016/j.juro.2012.07.001; Tao L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00064-y; Yamamoto H, 2012, MICROBIOL IMMUNOL, V56, P245, DOI 10.1111/j.1348-0421.2012.00434.x	46	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185628	10.1371/journal.pone.0185628	http://dx.doi.org/10.1371/journal.pone.0185628			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982136	gold, Green Published, Green Submitted			2022-12-26	WOS:000412360300051
J	Li, HZ; Nykoluk, M; Li, L; Liu, LR; Omange, RW; Soule, G; Schroeder, LT; Toledo, N; Kashem, MA; Correia-Pinto, JF; Liang, BH; Schultz-Darken, N; Alonso, MJ; Whitney, JB; Plummer, FA; Luo, M				Li, Hongzhao; Nykoluk, Mikaela; Li, Lin; Liu, Lewis R.; Omange, Robert W.; Soule, Geoff; Schroeder, Lukas T.; Toledo, Nikki; Kashem, Mohammad Abul; Correia-Pinto, Jorge F.; Liang, Binhua; Schultz-Darken, Nancy; Alonso, Maria J.; Whitney, James B.; Plummer, Francis A.; Luo, Ma			Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaques	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; HUMAN ENDOGENOUS RETROVIRUSES; T-CELL RESPONSES; DNA VACCINE TRIAL; CLASS-I ALLELES; HIV-1 INFECTION; RHESUS MACAQUES; CATALYTIC ANTIBODIES; VIREMIA	Cynomolgus macaques are an increasingly important nonhuman primate model for HIV vaccine research. SIV-free animals without pre-existing anti-SIV immune responses are generally needed to evaluate the effect of vaccine-induced immune responses against the vaccine epitopes. Here, in order to select such animals for vaccine studies, we screened 108 naive female Mauritian cynomolgus macaques for natural (baseline) antibodies to SIV antigens using a Bio-Plex multiplex system. The antigens included twelve 20mer peptides overlapping the twelve SIV protease cleavage sites (-10/+10), respectively (PCS peptides), and three non-PCS Gag or Env peptides. Natural antibodies to SIV antigens were detected in subsets of monkeys. The antibody reactivity to SIV was further confirmed by Western blot using purified recombinant SIV Gag and Env proteins. As expected, the immunization of monkeys with PCS antigens elicited anti-PCS antibodies. However, unexpectedly, antibodies to non-PCS peptides were also induced, as shown by both Bio-Plex and Western blot analyses, while the non-PCS peptides do not share sequence homology with PCS peptides. The presence of natural and vaccine cross-inducible SIV antibodies in Mauritian cynomolgus macaques should be considered in animal selection, experimental design and result interpretation, for their best use in HIV vaccine research.	[Li, Hongzhao; Li, Lin; Liu, Lewis R.; Omange, Robert W.; Schroeder, Lukas T.; Toledo, Nikki; Kashem, Mohammad Abul; Plummer, Francis A.; Luo, Ma] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada; [Nykoluk, Mikaela; Soule, Geoff; Liang, Binhua; Plummer, Francis A.; Luo, Ma] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Correia-Pinto, Jorge F.; Alonso, Maria J.] Univ Santiago Compostela, CIMUS Res Inst, La Coruna, Spain; [Liang, Binhua] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Schultz-Darken, Nancy] Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Whitney, James B.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA USA; [Whitney, James B.] MIT & Harvard, Ragon Inst MGH, Cambridge, MA USA	University of Manitoba; Public Health Agency of Canada; Universidade de Santiago de Compostela; University of Manitoba; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Luo, M (corresponding author), Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada.; Luo, M (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	Ma.Luo@phac-aspc.gc.ca	Liang, Binhua/ABN-9806-2022; Alonso, Maria Jose/K-3893-2014; Correia-Pinto, Jorge/B-3344-2012; Omange, Were/F-1454-2016	Correia-Pinto, Jorge/0000-0002-9265-6896; Kashem, Mohammad/0000-0002-6472-3676; Omange, Were/0000-0002-0421-110X; Alonso, Maria Jose/0000-0001-7187-9567; liang, binhua/0000-0002-1108-6407	National Institute of Allergy and Infectious Diseases grant [R01AI111805]; Canadian Institutes of Health Research/Canadian HIV Vaccine Initiative Bridging grant; National Microbiology Laboratory of Canada; NIH [R01AI111805]; CIHR/CHVI bridging grant	National Institute of Allergy and Infectious Diseases grant; Canadian Institutes of Health Research/Canadian HIV Vaccine Initiative Bridging grant; National Microbiology Laboratory of Canada; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR/CHVI bridging grant	This study was supported by the following funding awarded to ML: a National Institute of Allergy and Infectious Diseases grant, with grant number: R01AI111805 and URL: https://www.niaid.nih.gov/; a Canadian Institutes of Health Research/Canadian HIV Vaccine Initiative Bridging grant (no grant number available), with URL: http://www.cihr-irsc.gc.ca/e/42458.html; and funding from National Microbiology Laboratory of Canada (no grant number available), with URL: https://www.nml-lnm.gc.ca/index-eng.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the VTS staff at Canadian Science Centre for Human and Animal Health, Christine De Graff, Julie Kubay, Michelle French, Stephanie Kucas, Kimberly Azaransky, Carissa EmburyHyatt and Valerie Smid, and the staff of the Mass Spectrometry and Proteomics Core Facility at the National Microbiology Laboratory, Dr. Garrett Westmacott, Dr. Christopher C. R. Grant, and Stuart McCorrister, for tremendous technical support. We would also like to thank Dr. Jon Warren and Dr. Nancy Miller, NIH Vaccine Research Program, for providing the SIVmac251 Desrosiers" 2010-Day 8 viral stock. We recognize Dr. Stuart Shapiro, NIH Vaccine Research Program, and Dr. Matthew Gilmour, National Microbiology Laboratory of Canada, for important support and discussion. This work was supported by an NIH grant (R01AI111805), a CIHR/CHVI bridging grant and funding from National Microbiology Laboratory of Canada.	Antony JM, 2015, VACCINE, V33, P3073, DOI 10.1016/j.vaccine.2014.12.004; Arimi M M, 2006, East Afr Med J, V83, P106; Budde ML, 2010, IMMUNOGENETICS, V62, P773, DOI 10.1007/s00251-010-0481-9; Burwitz BJ, 2009, J VIROL, V83, P6011, DOI 10.1128/JVI.00199-09; Carnathan DG, 2015, P NATL ACAD SCI USA, V112, P518, DOI 10.1073/pnas.1407466112; Chen YX, 2014, VACCINES, V2, P138, DOI 10.3390/vaccines2010138; Cho K, 2008, SHOCK, V30, P105, DOI 10.1097/SHK.0b013e31816a363f; Chowdhury A, 2015, J VIROL, V89, P8677, DOI 10.1128/JVI.00869-15; Contreras-Galindo R, 2007, AIDS RES HUM RETROV, V23, P116, DOI 10.1089/aid.2006.0117; Contreras-Galindo R, 2006, AIDS RES HUM RETROV, V22, P979, DOI 10.1089/aid.2006.22.979; Contreras-Galindo R, 2012, J VIROL, V86, P262, DOI 10.1128/JVI.00602-11; Craig L, 1998, J MOL BIOL, V281, P183, DOI 10.1006/jmbi.1998.1907; Cutts T, 2016, J INFECT DIS, V214, pS218, DOI 10.1093/infdis/jiw289; Dewannieux M, 2010, BIOLOGICALS, V38, P366, DOI 10.1016/j.biologicals.2010.01.006; Escalera-Zamudio M, 2016, APMIS, V124, P44, DOI 10.1111/apm.12489; Garrison KE, 2007, PLOS PATHOG, V3, P1617, DOI 10.1371/journal.ppat.0030165; Gonzalez-Hernandez MJ, 2012, J VIROL, V86, P7790, DOI 10.1128/JVI.07215-11; Greene JM, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0066-z; Grow EJ, 2015, NATURE, V522, P221, DOI 10.1038/nature14308; Jones RB, 2013, J VIROL, V87, P13307, DOI 10.1128/JVI.02257-13; Jones RB, 2012, J CLIN INVEST, V122, P4473, DOI 10.1172/JCI64560; Karl JA, 2017, IMMUNOGENETICS, V69, P211, DOI 10.1007/s00251-017-0969-7; Kassiotis G, 2016, NAT REV IMMUNOL, V16, P207, DOI 10.1038/nri.2016.27; Krebs KC, 2005, J IMMUNOL, V175, P5230, DOI 10.4049/jimmunol.175.8.5230; Laderoute MP, 2007, AIDS, V21, P2417, DOI 10.1097/QAD.0b013e3282f14d64; Langat DK, 1999, J REPROD IMMUNOL, V42, P41, DOI 10.1016/S0165-0378(98)00043-6; LAWLER SH, 1995, AM J PHYS ANTHROPOL, V96, P133, DOI 10.1002/ajpa.1330960203; Li HZ, 2017, J MED PRIMATOL, V46, P137, DOI 10.1111/jmp.12300; Lu S, 1996, J VIROL, V70, P3978, DOI 10.1128/JVI.70.6.3978-3991.1996; Lu S, 1997, VACCINE, V15, P920, DOI 10.1016/S0264-410X(96)00282-4; Lu S, 2010, CURR HIV RES, V8, P622, DOI 10.2174/157016210794088290; Luo M, 2013, VACCINE, V31, P3000, DOI 10.1016/j.vaccine.2013.04.057; Luo M, 2012, J VIROL, V86, P1166, DOI 10.1128/JVI.05721-11; O'Connor SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000524; Paces J, 2013, NEW BIOTECHNOL, V30, P314, DOI 10.1016/j.nbt.2012.11.009; Pal R, 2006, VIROLOGY, V348, P341, DOI 10.1016/j.virol.2005.12.029; Paul S, 2012, ADV EXP MED BIOL, V750, P56, DOI 10.1007/978-1-4614-3461-0_5; Planque S, 2008, AUTOIMMUN REV, V7, P473, DOI 10.1016/j.autrev.2008.04.002; Saadatian-Elahi M, 2016, VACCINE, V34, P3923, DOI 10.1016/j.vaccine.2016.06.020; Schlesinger S, 2015, MOL CELL BIOL, V35, P770, DOI 10.1128/MCB.01293-14; SenGupta D, 2011, J VIROL, V85, P6977, DOI 10.1128/JVI.00179-11; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Sui Y., 2013, CURR PROTOC IMMUNOL, V102, P12, DOI DOI 10.1002/0471142735.IM1214S102; Tandon R, 2011, J VIROL, V85, P11526, DOI 10.1128/JVI.05418-11; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-6; Whitney JB, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-96; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594; Whitney JB, 2009, AIDS, V23, P1453, DOI 10.1097/QAD.0b013e32832b43d9; Whitney JB, 2002, J VIROL, V76, P8958, DOI 10.1128/JVI.76.17.8958-8962.2002; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06; Wiseman RW, 2013, ILAR J, V54, P196, DOI 10.1093/ilar/ilt036; Yan GM, 2011, NAT BIOTECHNOL, V29, P1019, DOI 10.1038/nbt.1992; Yates NL, 2011, AIDS, V25, P2089, DOI 10.1097/QAD.0b013e32834b348e	54	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186079	10.1371/journal.pone.0186079	http://dx.doi.org/10.1371/journal.pone.0186079			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982126	Green Published, gold			2022-12-26	WOS:000412360300119
J	Serra-Casas, E; Manrique, P; Ding, XC; Carrasco-Escobar, G; Alava, F; Gave, A; Rodriguez, H; Contreras-Mancilla, J; Rosas-Aguirre, A; Speybroeck, N; Gonzalez, IJ; Rosanas-Urgell, A; Gamboa, D				Serra-Casas, Elisa; Manrique, Paulo; Ding, Xavier C.; Carrasco-Escobar, Gabriel; Alava, Freddy; Gave, Anthony; Rodriguez, Hugo; Contreras-Mancilla, Juan; Rosas-Aguirre, Angel; Speybroeck, Niko; Gonzalez, Iveth J.; Rosanas-Urgell, Anna; Gamboa, Dionicia			Loop-mediated isothermal DNA amplification for asymptomatic malaria detection in challenging field settings: Technical performance and pilot implementation in the Peruvian Amazon	PLOS ONE			English	Article							PLASMODIUM-VIVAX-MALARIA; ELIMINATION; FALCIPARUM; DIAGNOSIS; TRANSMISSION; INFECTIONS; LAMP; KIT; PCR	Background Loop-mediated isothermal DNA amplification (LAMP) methodology offers an opportunity for point-of-care (POC) molecular detection of asymptomatic malaria infections. However, there is still little evidence on the feasibility of implementing this technique for population screenings in isolated field settings. Methods Overall, we recruited 1167 individuals from terrestrial ('road') and hydric ('riverine') communities of the Peruvian Amazon for a cross-sectional survey to detect asymptomatic malaria infections. The technical performance of LAMP was evaluated in a subgroup of 503 samples, using real-time Polymerase Chain Reaction (qPCR) as reference standard. The operational feasibility of introducing LAMP testing in the mobile screening campaigns was assessed based on field-suitability parameters, along with a pilot POC-LAMP assay in a riverine community without laboratory infrastructure. Results LAMP had a sensitivity of 91.8% (87.7-94.9) and specificity of 91.9% (87.8-95.0), and the overall accuracy was significantly better among samples collected during road screenings than riverine communities (p <= 0.004). LAMP-based diagnostic strategy was successfully implemented within the field-team logistics and the POC-LAMP pilot in the riverine community allowed for a reduction in the turnaround time for case management, from 12-24 hours to less than 5 hours. Specimens with haemolytic appearance were regularly observed in riverine screenings and could help explaining the hindered performance/interpretation of the LAMP reaction in these communities. Conclusions LAMP-based molecular malaria diagnosis can be deployed outside of reference laboratories, providing similar performance as qPCR. However, scale-up in remote field settings such as riverine communities needs to consider a number of logistical challenges (e.g. environmental conditions, labour-intensiveness in large population screenings) that can influence its optimal implementation.	[Serra-Casas, Elisa; Rosanas-Urgell, Anna] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Manrique, Paulo; Carrasco-Escobar, Gabriel; Alava, Freddy; Gave, Anthony; Contreras-Mancilla, Juan; Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, LID, Lima, Peru; [Ding, Xavier C.; Gonzalez, Iveth J.] FIND, Geneva, Switzerland; [Alava, Freddy; Rodriguez, Hugo] Direcc Reg Salud DIRESA, Loreto, Peru; [Rosas-Aguirre, Angel; Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Rosas-Aguirre, Angel; Speybroeck, Niko] Catholic Univ Louvain, Res Inst Hlth & Soc IRSS, Brussels, Belgium; [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima, Peru	Institute of Tropical Medicine (ITM); Universidad Peruana Cayetano Heredia; Foundation For Innovative New Diagnostics; Universidad Peruana Cayetano Heredia; Universite Catholique Louvain; Universidad Peruana Cayetano Heredia	Rosanas-Urgell, A (corresponding author), Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.; Gamboa, D (corresponding author), Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, LID, Lima, Peru.; Gamboa, D (corresponding author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.; Gamboa, D (corresponding author), Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima, Peru.	arosanas@itg.be; dionigamboa@yahoo.com	Aguirre, Angel Rosas/A-5054-2016; Manrique, Paulo/ABF-6218-2020	Aguirre, Angel Rosas/0000-0002-3271-7028; Carrasco-Escobar, Gabriel/0000-0002-6945-0419; Gamboa, Dionicia/0000-0002-1420-7729; Speybroeck, Niko/0000-0003-3322-3502; ALAVA AREVALO, FREDDY FRANCO/0000-0002-1402-2556; Contreras Mancilla, Juan Jose/0000-0003-0447-0926	FIND through German Government (Kreditanstalt fur Wiederaufbau); Belgian Directorate-General for Development Cooperation (DGD); Peruvian National Council of Science Concytec [008-2014-FONDECYT]; Academie de Recherche et d'Enseignement Superieur Commission de la Cooperation au Developpement of Belgium (ARES-CCD); Fundacion Alfonso Martin Escudero grant	FIND through German Government (Kreditanstalt fur Wiederaufbau); Belgian Directorate-General for Development Cooperation (DGD); Peruvian National Council of Science Concytec; Academie de Recherche et d'Enseignement Superieur Commission de la Cooperation au Developpement of Belgium (ARES-CCD); Fundacion Alfonso Martin Escudero grant	This work was supported by FIND, through a grant from the German Government (Kreditanstalt fur Wiederaufbau) to Dr Iveth J Gonzalez. There was also a partial funding contribution to Dr Prof Anna Rosanas-Urgell from the Belgian Directorate-General for Development Cooperation (DGD) through the collaborative framework agreement 3 (FA3-DGD programme) between IMTAvH/UPCH (Peru) and ITM (Belgium), the Peruvian National Council of Science Concytec (008-2014-FONDECYT) to Prof Dionicia Gamboa - and the Academie de Recherche et d'Enseignement Superieur Commission de la Cooperation au Developpement of Belgium (ARES-CCD, PRD-Peru 2014-2019) to Prof Niko Speybroeck. ESC was supported by Fundacion Alfonso Martin Escudero grant. Funding sources had no direct involvement on the study design, analysis, report writing or decision to submit for publication.	Alexander N, 2012, TROP MED INT HEALTH, V17, P684, DOI 10.1111/j.1365-3156.2012.02987.x; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000396; [Anonymous], 2012, MAN STAND OP PROC MA; [Anonymous], 2013, 522013 SE MIN SALUD, P1088; Aydin-Schmidt B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169037; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; Cheng Q, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003413; Chuquiyauri R, 2012, ACTA TROP, V121, P292, DOI 10.1016/j.actatropica.2011.11.003; Cook J, 2015, J INFECT DIS, V211, P1476, DOI 10.1093/infdis/jiu655; Cook J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0573-y; Esposito A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003780; FIND, NEG PROD PRIC LOOPAM; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Guarda JA, 1999, EMERG INFECT DIS, V5, P209; Haanshuus CG, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-26; Hanscheid T, 2002, TRENDS PARASITOL, V18, P395, DOI 10.1016/S1471-4922(02)02348-6; Hayashida K, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1949-8; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Instituto Nacional de Estad o A stica e Informa A tica, 2014, AN EST AMB 2013; Lucchi NW, 2016, SCI REP-UK, V6, DOI 10.1038/srep36808; Maltha J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043094; Mangold KA, 2005, J CLIN MICROBIOL, V43, P2435, DOI 10.1128/JCM.43.5.2435-2440.2005; Marti H, 2015, TRAVEL MED INFECT DI, V13, P167, DOI 10.1016/j.tmaid.2014.12.016; McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x; Ministerio de Salud del Peru (MINSA), 2010, NORM TECN SALUD CONT; Moreno M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0804-2; Morris U, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0731-2; Njiru ZK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001572; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Olliaro PL, 2016, AM J TROP MED HYG, V95, P4, DOI 10.4269/ajtmh.16-0160; Perera RS, 2017, PLOS ONE, P12; Polley SD, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0558-x; Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183; Polley SD, 2010, J CLIN MICROBIOL, V48, P2866, DOI 10.1128/JCM.00355-10; Rosas-Aguirre A, 2016, AM J TROP MED HYG, V95, P133, DOI 10.4269/ajtmh.16-0268; Rosas-Aguirre A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0868-4; Rovira-Vallbona E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005674; Schneider P, 2007, AM J TROP MED HYG, V76, P470, DOI 10.4269/ajtmh.2007.76.470; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; Tegegne B, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1692-4; Tietje K, 2014, TRENDS PARASITOL, V30, P259, DOI 10.1016/j.pt.2014.03.003; VALLEJO AF, 2015, PLOS NEGLECT TROP D, V9; World Health Organization, 2016, MAL MICR QUAL ASS MA	45	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185742	10.1371/journal.pone.0185742	http://dx.doi.org/10.1371/journal.pone.0185742			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982155	Green Submitted, Green Published, gold			2022-12-26	WOS:000412360300063
J	Shin, MS; An, M; Kim, S; Shim, JL; Park, JK; Kim, J				Shin, Mi-Seung; An, Minjeong; Kim, Sunhwa; Shim, Jae Lan; Park, Jin-Kyu; Kim, JinShil			Concomitant diastolic dysfunction further interferes with cognitive performance in moderate to severe systolic heart failure	PLOS ONE			English	Article							LOW EJECTION FRACTION; SELF-CARE; IMPAIRMENT; DISEASE; ASSOCIATION; ECHOCARDIOGRAPHY; RECOMMENDATIONS; DETERMINANTS; DEFICITS; ADULTS	Background Studies of the relevance of cardiac functional markers to cognitive performance in heart failure (HF) have primarily focused on systolic markers. In this study, we examine whether concomitant diastolic dysfunction further interferes with cognitive performance in memory, attention, and executive function in patients with HF. Methods and results In this cross-sectional correlational study, 82 patients completed face-to-face interviews for neuropsychological testing for cognitive evaluation. Echocardiographic data were obtained from a review of medical records. Mild to moderate (ejection fraction [EF] >= 30%) and severe (EF < 30%) systolic dysfunction were present in 55 (67.1%) and 27 (32.9%) patients, respectively, while 21 (26.3%) had diastolic dysfunction (E/e' > 15). Those patients who had severe systolic dysfunction had significantly lower attention scores (Digit Span Test [DST] backward, t = 2.62, p = 0.011), while those with concomitant severe diastolic dysfunction had significantly lower verbal fluency (t = 2.84, p = 0.006) and executive function (Korean-Trail Making Test Part B) (t = -2.14, p = 0.036) scores than those without severe diastolic dysfunction. After controlling for age and education, systolic patients with HF with concomitant severe diastolic dysfunction had worse cognitive performance in verbal fluency than those without severe diastolic dysfunction (F = 4.33, p = 0.041, partial eta = 0.057). Concomitant moderate to severe systolic and severe diastolic dysfunction further reduced verbal fluency (F = 8.42, p = 0.005, partial eta = 0.106). Conclusions Cognitive performance, particularly executive function, was worse in patients with HF with systolic dysfunction when diastolic dysfunction was concomitantly present. Routine monitoring of and surveillance for diastolic dysfunction and cognitive screening are warranted in the management of patients with HF.	[Shin, Mi-Seung] Gachon Univ, Gil Med Ctr, Dept Internal Med, Incheon, South Korea; [An, Minjeong] Chonnam Natl Univ, Coll Nursing, Gwangju, South Korea; [Kim, Sunhwa; Shim, Jae Lan] Doowon Tech Univ, Dept Nursing, Seoul, South Korea; [Park, Jin-Kyu] Hanyang Univ, Med Ctr, Dept Internal Med, Seoul, South Korea; [Kim, JinShil] Gachon Univ, Coll Nursing, Incheon, South Korea	Gachon University; Chonnam National University; Hanyang University; Gachon University	Kim, J (corresponding author), Gachon Univ, Coll Nursing, Incheon, South Korea.	kimj317503@gmail.com		AN, MINJEONG/0000-0003-4318-8755	National Research Foundation of Korea [NRF-2014R1A1A2055948]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea, Grant number: NRF-2014R1A1A2055948 (URL: http://www.nrf.re. kr/index) to JSK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by a grant from the National Research Foundation of Korea (Grant #NRF-2014R1A1A2055948).	Almeida OP, 2012, EUR HEART J, V33, P1769, DOI 10.1093/eurheartj/ehr467; Angermann CE, 2012, EUR HEART J, V33, P1721, DOI 10.1093/eurheartj/ehs128; Ausili D, 2016, INT J NURS STUD, V63, P18, DOI 10.1016/j.ijnurstu.2016.08.006; Baynard T, 2008, OBESITY, V16, P1277, DOI 10.1038/oby.2008.212; Beer C, 2009, INTERN MED J, V39, P600, DOI 10.1111/j.1445-5994.2008.01790.x; Center for Continuing Education, 2014, DEF ET 2014; Cocchieri A, 2015, EUR J CARDIOVASC NUR, V14, P126, DOI 10.1177/1474515113518443; Davis KK, 2015, J CARDIOVASC NURS, V30, P152, DOI 10.1097/JCN.0000000000000130; de Roos A, 2017, CIRCULATION, V135, P2178, DOI 10.1161/CIRCULATIONAHA.116.021978; Eggermont LHP, 2012, HEART, V98, P1334, DOI 10.1136/heartjnl-2012-301682; Fenk S, 2015, INT HEART J, V56, P196, DOI 10.1536/ihj.14-261; Festa JR, 2011, ARCH NEUROL-CHICAGO, V68, P1021, DOI 10.1001/archneurol.2011.163; Gottesman RF, 2009, BEHAV NEUROL, V22, P63, DOI 10.3233/BEN-2009-0261; Gure TR, 2012, J AM GERIATR SOC, V60, P1724, DOI 10.1111/j.1532-5415.2012.04097.x; Hansen A, 2001, J AM COLL CARDIOL, V37, P1049, DOI 10.1016/S0735-1097(00)01211-0; Kang Y, 2012, PROFESSIONAL MANUAL; Kang Yeonwook, 2002, Korean Journal of Clinical Psychology, V21, P911; Koenig Julian, 2015, Biomed Sci Instrum, V51, P85; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Leto L, 2014, J GERIATR CARDIOL, V11, P316, DOI 10.11909/j.issn.1671-5411.2014.04.007; Lim SL, 2016, KOREAN J INTERN MED, V31, P1, DOI 10.3904/kjim.2016.31.1.1; Luers C, 2017, CLIN CARDIOL, P1; Nagueh SF, 2016, EUR HEART J-CARD IMG, V17, P1321, DOI 10.1093/ehjci/jew082; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; O'Donnell M, 2012, EUR HEART J, V33, P1777, DOI 10.1093/eurheartj/ehs053; Park Jaeseol, 2007, [Dementia and Neurocognitive Disorders, Dementia and Neurocognitive Disorders(대한치매학회지)], V6, P12; Pressler SJ, 2010, J CARD FAIL, V16, P750, DOI 10.1016/j.cardfail.2010.04.007; Pressler SJ, 2010, J CARDIOVASC NURS, V25, P189, DOI 10.1097/JCN.0b013e3181ca36fe; Pressler SJ, 2010, NURS RES, V59, P127, DOI 10.1097/NNR.0b013e3181d1a747; Riegel B, 2009, CIRCULATION, V120, P1141, DOI 10.1161/CIRCULATIONAHA.109.192628; Roy B, 2017, EUR J HEART IN PRESS; SPSS Statistics, 2016, SPSS STAT 23 0 WIND; van den Hurk K, 2011, EUR J HEART FAIL, V13, P1362, DOI 10.1093/eurjhf/hfr138; Wiegers SE, 2011, CIRC-CARDIOVASC IMAG, V4, P460, DOI 10.1161/CIRCIMAGING.111.968131; Yi H, 2007, DEMENT NEUROCOGNITIV, V6, P54	37	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0184981	10.1371/journal.pone.0184981	http://dx.doi.org/10.1371/journal.pone.0184981			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI7FU	28977012	Green Published, gold, Green Submitted			2022-12-26	WOS:000412163100015
J	Cai, XL; Akber, M; Spirov, A; Baumgartner, S				Cai, Xiaoli; Akber, Mira; Spirov, Alexander; Baumgartner, Stefan			Cortical movement of Bicoid in early Drosophila embryos is actin- and microtubule-dependent and disagrees with the SDD diffusion model	PLOS ONE			English	Article							MESSENGER-RNA; MORPHOGEN GRADIENT; HYPOXIA TOLERANCE; ANTERIOR PATTERN; F-ACTIN; ORGANIZATION; LOCALIZATION; NUCLEAR; PROTEIN; MELANOGASTER	The Bicoid (Bcd) protein gradient in Drosophila serves as a paradigm for gradient formation in textbooks. The SDD model (synthesis, diffusion, degradation) was proposed to explain the formation of the gradient. The SDD model states that the bcd mRNA is located at the anterior pole of the embryo at all times and serves a source for translation of the Bicoid protein, coupled with diffusion and uniform degradation throughout the embryo. Recently, the ARTS model (active RNA transport, synthesis) challenged the SDD model. In this model, the mRNA is transported at the cortex along microtubules to form a mRNA gradient which serves as template for the production of Bcd, hence little Bcd movement is involved. To test the validity of the SDD model, we developed a sensitive assay to monitor the movement of Bcd during early nuclear cycles. We observed that Bcd moved along the cortex and not in a broad front towards the posterior as the SDD model would have predicted. We subjected embryos to hypoxia where the mRNA remained strictly located at the tip at all times, while the protein was allowed to move freely, thus conforming to an ideal experimental setup to test the SDD model. Unexpectedly, Bcd still moved along the cortex. Moreover, cortical Bcd movement was sparse, even under longer hypoxic conditions. Hypoxic embryos treated with drugs compromising microtubule and actin function affected Bcd cortical movement and stability. Vinblastine treatment allowed the simulation of an ideal SDD model whereby the protein moved throughout the embryo in a broad front. In unfertilized embryos, the Bcd protein followed the mRNA which itself was transported into the interior of the embryo utilizing a hitherto undiscovered microtubular network. Our data suggest that the Bcd gradient formation is probably more complex than previously anticipated.	[Cai, Xiaoli; Akber, Mira; Baumgartner, Stefan] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Spirov, Alexander] SUNY Stony Brook, Dept Comp Sci, Stony Brook, NY 11794 USA; [Spirov, Alexander] Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg, Russia	Lund University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Baumgartner, S (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	Stefan.Baumgartner@med.lu.se	Spirov, Alexander V/G-4806-2010; Baumgartner, Stefan/A-5879-2011	Spirov, Alexander V/0000-0002-0509-6203; Baumgartner, Stefan/0000-0001-5320-8321	Swedish Research Council; RFBR [15-04-07800, 15-04-06480]	Swedish Research Council(Swedish Research CouncilEuropean Commission); RFBR(Russian Foundation for Basic Research (RFBR))	This work was supported by the Swedish Research Council (https://www.vr.se/) (Stefan Baumgartner: study design, data collection and analysis, decision to publish, or preparation of the manuscript); Eric Philipp Sorensen Stiftelse (Stefan Baumgartner: study design, data collection and analysis, decision to publish, or preparation of the manuscript); Byggmastare Olle Engkvist Stiftelse (Stefan Baumgartner: study design, data collection and analysis, decision to publish, or preparation of the manuscript); Russian Foundation for Basic Research (Alexander Spirov: study design, data collection and analysis). A.V.S. is partially supported by RFBR grants 15-04-07800 and 15-04-06480. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov T, 2008, J ELECTR COMPUT ENG, V2008, DOI 10.1155/2008/825758; Ali-Murthy Z, 2016, ELIFE, P5, DOI [10.7554/eLife.13222.441, DOI 10.7554/ELIFE.13222.441]; Allingham JS, 2006, CELL MOL LIFE SCI, V63, P2119, DOI 10.1007/s00018-006-6157-9; Azad P, 2012, G3-GENES GENOM GENET, V2, P1169, DOI 10.1534/g3.112.003681; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Callaini G, 1997, CELL MOTIL CYTOSKEL, V37, P300; Callaini G, 1996, DEV BIOL, V176, P199, DOI 10.1006/dbio.1996.0127; Douglas RM, 2001, AM J PHYSIOL-REG I, V280, pR1555, DOI 10.1152/ajpregu.2001.280.5.R1555; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Drocco JA, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/055004; Fahmy K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112053; Florian S, 2016, METHODS MOL BIOL, V1413, P403, DOI 10.1007/978-1-4939-3542-0_25; FOE VE, 1985, J CELL BIOL, V100, P1623, DOI 10.1083/jcb.100.5.1623; FOE VE, 1983, J CELL SCI, V61, P31; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; FRIGERIO G, 1986, CELL, V47, P735, DOI 10.1016/0092-8674(86)90516-7; FROHNHOFER HG, 1986, NATURE, V324, P120, DOI 10.1038/324120a0; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Gregor T, 2008, DEV BIOL, V316, P350, DOI 10.1016/j.ydbio.2008.01.039; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Grimm O, 2010, DEVELOPMENT, V137, P2857, DOI 10.1242/dev.052589; Grimm O, 2010, DEVELOPMENT, V137, P2253, DOI 10.1242/dev.032409; Haddad GG, 1997, P NATL ACAD SCI USA, V94, P10809, DOI 10.1073/pnas.94.20.10809; HATANAKA K, 1991, DEVELOPMENT, V111, P909; Heinrich EC, 2011, J EXP BIOL, V214, P1419, DOI 10.1242/jeb.051904; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; KARR TL, 1986, J CELL BIOL, V102, P1494, DOI 10.1083/jcb.102.4.1494; Lantz VA, 1999, MECH DEVELOP, V85, P111, DOI 10.1016/S0925-4773(99)00096-9; Lipshitz HD, 2009, NAT REV MOL CELL BIO, V10, P509, DOI 10.1038/nrm2730; Little SC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000596; Lucchetta EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003651; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Mavrakis M, 2009, DEV CELL, V16, P93, DOI 10.1016/j.devcel.2008.11.003; Namba R, 1997, DEVELOPMENT, V124, P1393; PAPASSIDERI I, 1991, TISSUE CELL, V23, P567, DOI 10.1016/0040-8166(91)90014-K; Parton RM, 2011, J CELL BIOL, V194, P121, DOI 10.1083/jcb.201103160; Petkova MD, 2014, CURR BIOL, V24, P1283, DOI 10.1016/j.cub.2014.04.028; Rand MD, 2014, JOVE-J VIS EXP, DOI 10.3791/51634; Rand MD, 2010, INSECT BIOCHEM MOLEC, V40, P792, DOI 10.1016/j.ibmb.2010.07.007; Riparbelli MG, 2007, DEV DYNAM, V236, P662, DOI 10.1002/dvdy.21062; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; SCHEJTER ED, 1993, ANNU REV CELL BIOL, V9, P67, DOI 10.1146/annurev.cellbio.9.1.67; Schulman VK, 2013, FLY, V7, P193, DOI 10.4161/fly.25438; Spector I, 1999, MICROSC RES TECHNIQ, V47, P18, DOI 10.1002/(SICI)1097-0029(19991001)47:1<18::AID-JEMT3>3.0.CO;2-E; Spirov A, 2009, DEVELOPMENT, V136, P605, DOI 10.1242/dev.031195; WARN RM, 1984, J CELL BIOL, V98, P156, DOI 10.1083/jcb.98.1.156; Weil TT, 2008, CURR BIOL, V18, P1055, DOI 10.1016/j.cub.2008.06.046; Weil TT, 2006, DEV CELL, V11, P251, DOI 10.1016/j.devcel.2006.06.006; Weil TT, 2010, DEVELOPMENT, V137, P169, DOI 10.1242/dev.044867; Zalokar M, 1976, J MICROSCOPIE BIOL C, V25; Zhao HW, 2011, PLACENTA, V32, pS104, DOI 10.1016/j.placenta.2010.11.017; Zhou D, 2013, ANNU REV GENOM HUM G, V14, P25, DOI 10.1146/annurev-genom-091212-153439	53	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185443	10.1371/journal.pone.0185443	http://dx.doi.org/10.1371/journal.pone.0185443			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973031	gold, Green Published, Green Submitted			2022-12-26	WOS:000412131900018
J	Franco, MEE; Lopez, SMY; Medina, R; Lucentini, CG; Troncozo, MI; Pastorino, GN; Saparrat, MCN; Balatti, PA				Ernesto Franco, Mario Emilio; Yanil Lopez, Silvina Marianela; Medina, Rocio; Gustavo Lucentini, Cesar; Ines Troncozo, Maria; Noemi Pastorino, Graciela; Nazareno Saparrat, Mario Carlos; Alberto Balatti, Pedro			The mitochondrial genome of the plant-pathogenic fungus Stemphylium lycopersici uncovers a dynamic structure due to repetitive and mobile elements	PLOS ONE			English	Article							OPEN READING FRAME; GROUP-I INTRON; CYTOCHROME-C-OXIDASE; HOMING ENDONUCLEASES; HORIZONTAL TRANSFER; COMPLETE SEQUENCE; GENE CONTENT; EVOLUTION; DNA; PHYLOGENY	Stemphylium lycopersici (Pleosporales) is a plant-pathogenic fungus that has been associated with a broad range of plant-hosts worldwide. It is one of the causative agents of gray leaf spot disease in tomato and pepper. The aim of this work was to characterize the mitochondrial genome of S. lycopersici CIDEFI-216, to use it to trace taxonomic relationships with other fungal taxa and to get insights into the evolutionary history of this phytopathogen. The complete mitochondrial genome was assembled into a circular double-stranded DNA molecule of 75,911 bp that harbors a set of 37 protein-coding genes, 2 rRNA genes (rns and rnl) and 28 tRNA genes, which are transcribed from both sense and antisense strands. Remarkably, its gene repertoire lacks both atp8 and atp9, contains a free-standing gene for the ribosomal protein S3 (rps3) and includes 13 genes with homing endonuclease domains that are mostly located within its 15 group I introns. Strikingly, subunits 1 and 2 of cytochrome oxidase are encoded by a single continuous open reading frame (ORF). A comparative mitogenomic analysis revealed the large extent of structural rearrangements among representatives of Pleosporales, showing the plasticity of their mitochondrial genomes. Finally, an exhaustive phylogenetic analysis of the subphylum Pezizomycotina based on mitochondrial data reconstructed their relationships in concordance with several studies based on nuclear data. This is the first report of a mitochondrial genome belonging to a representative of the family Pleosporaceae.	[Ernesto Franco, Mario Emilio; Yanil Lopez, Silvina Marianela; Medina, Rocio; Gustavo Lucentini, Cesar; Alberto Balatti, Pedro] Univ Nacl La Plata, Fac Ciencias Agr & Forestales, Ctr Invest Fitopatol, Comis Invest Cient Prov Buenos Aires, La Plata, Buenos Aires, Argentina; [Ines Troncozo, Maria; Noemi Pastorino, Graciela; Nazareno Saparrat, Mario Carlos; Alberto Balatti, Pedro] Univ Nacl La Plata, Fac Ciencias Agr & Forestales, Catedra Microbiol Agr, La Plata, Buenos Aires, Argentina; [Nazareno Saparrat, Mario Carlos] Univ Nacl La Plata, Fac Ciencias Nat & Museo, Inst Bot Carlos Spegazzini, La Plata, Buenos Aires, Argentina; [Nazareno Saparrat, Mario Carlos] Univ Nacl La Plata, Consejo Nacl Invest Cient & Tecn, Inst Fisiol Vegetal, Fac Ciencias Nat & Museo,Fac Ciencias Agr & Fores, La Plata, Buenos Aires, Argentina	Comision de Investigaciones Cientificas; National University of La Plata; National University of La Plata; National University of La Plata; Museo La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata	Balatti, PA (corresponding author), Univ Nacl La Plata, Fac Ciencias Agr & Forestales, Ctr Invest Fitopatol, Comis Invest Cient Prov Buenos Aires, La Plata, Buenos Aires, Argentina.; Balatti, PA (corresponding author), Univ Nacl La Plata, Fac Ciencias Agr & Forestales, Catedra Microbiol Agr, La Plata, Buenos Aires, Argentina.	pbalatti@gmail.com	Medina, Rocio/AAS-8532-2020; Balatti, Pedro/P-7598-2017	Lucentini, Cesar Gustavo/0000-0002-6278-5291; Medina, Rocio/0000-0001-5385-6441; Lopez, Silvina Marianela Yanil/0000-0001-6613-7243; Balatti, Pedro/0000-0002-5163-4084; Pastorino, Graciela/0000-0001-7517-8258; Franco, Mario Emilio Ernesto/0000-0002-4959-1257; Troncozo, Maria Ines/0000-0001-9553-3093	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) of the Ministro de Ciencia, Tecnologia e Innovacion Productiva [PICT 2012-2760]; PICT [2015-1620]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) of the Ministro de Ciencia, Tecnologia e Innovacion Productiva; PICT(ANPCyT)	This research was partially supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) of the Ministro de Ciencia, Tecnologia e Innovacion Productiva through the projects PICT 2012-2760 (PAB) and PICT 2015-1620 (MCNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2014, GENOME BIOL EVOL, V6, P451, DOI 10.1093/gbe/evu028; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2014, COMPENDIUM TOMATO DI; Basse CW, 2010, CURR OPIN MICROBIOL, V13, P712, DOI 10.1016/j.mib.2010.09.003; Berbee ML, 2001, PHYSIOL MOL PLANT P, V59, P165, DOI 10.1006/pmpp.2001.0355; Bonen L, 2001, TRENDS GENET, V17, P322, DOI 10.1016/S0168-9525(01)02324-1; Bowen Nathan J., 2002, Current Issues in Molecular Biology, V4, P65; Bullerwell CE, 2000, TRENDS BIOCHEM SCI, V25, P363, DOI 10.1016/S0968-0004(00)01612-1; Bullerwell CE, 2005, CURR OPIN MICROBIOL, V8, P362, DOI 10.1016/j.mib.2005.06.009; Bullerwell CE, 2003, NUCLEIC ACIDS RES, V31, P1614, DOI 10.1093/nar/gkg264; Bullerwell CE, 2003, NUCLEIC ACIDS RES, V31, P759, DOI 10.1093/nar/gkg134; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; BURGER G, 1995, J MOL BIOL, V245, P522, DOI 10.1006/jmbi.1994.0043; BURKE JM, 1982, CELL, V31, P509, DOI 10.1016/0092-8674(82)90307-5; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Camara MPS, 2002, MYCOLOGIA, V94, P660, DOI 10.2307/3761717; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Cho YR, 1999, MOL BIOL EVOL, V16, P1155, DOI 10.1093/oxfordjournals.molbev.a026206; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CUMMINGS DJ, 1990, CURR GENET, V17, P375, DOI 10.1007/BF00334517; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgell DR, 2009, CURR BIOL, V19, pR115, DOI 10.1016/j.cub.2008.12.019; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Farr DF, 2022, FUNGAL DATABASES; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferandon C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014048; Formey D, 2012, NEW PHYTOL, V196, P1217, DOI 10.1111/j.1469-8137.2012.04283.x; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; Franco MEE, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01069-15; Francois Monique E, 2017, Eur J Appl Physiol, V117, P1607, DOI 10.1007/s00421-017-3649-2; Freel KC, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov023; Goodwin SB, 2016, FUNGAL BIOL-UK, V120, P961, DOI 10.1016/j.funbio.2016.05.003; Gray MW, 1998, NUCLEIC ACIDS RES, V26, P865, DOI 10.1093/nar/26.4.865; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; GROOT GSP, 1979, MOL GEN GENET, V174, P339, DOI 10.1007/BF00267808; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haas Brian J, 2011, Mycology, V2, P118; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hane JK, 2007, PLANT CELL, V19, P3347, DOI 10.1105/tpc.107.052829; Joardar V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-698; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim BS, 2004, PLANT PATHOLOGY J, V20, P85, DOI DOI 10.5423/PPJ.2004.20.2.085; Kim YS, 2003, PHYTOPATHOLOGY, V93, P891, DOI 10.1094/PHYTO.2003.93.7.891; Kouvelis VN, 2008, MYCOL RES, V112, P829, DOI 10.1016/j.mycres.2008.01.016; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuberl A, 2011, J BIOTECHNOL, V154, P312, DOI 10.1016/j.jbiotec.2011.04.014; Lambowitz AM, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0050-2014; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Lang BF, 2014, MITOCHONDRIAL GENOME, P1; Li FW, 2017, CURR MICROBIOL, V74, P532, DOI 10.1007/s00284-017-1220-3; Liu Y, 2009, MOL BIOL EVOL, V26, P27, DOI 10.1093/molbev/msn221; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lonergan KM, 1996, J MOL BIOL, V257, P1019, DOI 10.1006/jmbi.1996.0220; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma L, 2013, FASEB J, V27, P1962, DOI 10.1096/fj.12-224444; Ma ZH, 2005, CROP PROT, V24, P853, DOI 10.1016/j.cropro.2005.01.011; Magnan C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162363; Nasehi A, 2014, EUR J PLANT PATHOL, V140, P261, DOI 10.1007/s10658-014-0460-3; Nasehi Abbas, 2014, Archives of Phytopathology and Plant Protection, V47, P1658, DOI 10.1080/03235408.2013.853905; Nishi N, 2009, J GEN PLANT PATHOL, V75, P80, DOI 10.1007/s10327-008-0133-1; Pantou MP, 2006, CURR GENET, V50, P125, DOI 10.1007/s00294-006-0079-9; Paquin B, 1997, CURR GENET, V31, P380, DOI 10.1007/s002940050220; Pellizzari R, 1997, BBA-BIOENERGETICS, V1320, P1, DOI 10.1016/S0005-2728(97)00010-8; Phadnis N, 2005, GENETICS, V171, P1549, DOI 10.1534/genetics.105.047092; Reeb V, 2004, MOL PHYLOGENET EVOL, V32, P1036, DOI 10.1016/j.ympev.2004.04.012; Repar J, 2017, GENETICS, V205, P1641, DOI 10.1534/genetics.116.199059; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sanchez-Puerta MV, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-277; Santamaria M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S15; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Sethuraman J, 2009, MOL BIOL EVOL, V26, P2299, DOI 10.1093/molbev/msp145; Sethuraman J, 2009, J MOL EVOL, V69, P372, DOI 10.1007/s00239-009-9291-9; Shen XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116466; Solieri L, 2010, TRENDS MICROBIOL, V18, P521, DOI 10.1016/j.tim.2010.08.001; Spatafora JW, 2006, MYCOLOGIA, V98, P1018, DOI 10.3852/mycologia.98.6.1018; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Talla E, 2005, FEBS LETT, V579, P30, DOI 10.1016/j.febslet.2004.10.106; Tomioka Keisuke, 1997, Annals of the Phytopathological Society of Japan, V63, P337, DOI 10.3186/jjphytopath.63.337; Torriani SFF, 2008, FUNGAL GENET BIOL, V45, P628, DOI 10.1016/j.fgb.2007.12.005; van de Sande WWJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038654; VAUGHN JC, 1995, J MOL EVOL, V41, P563, DOI 10.1007/BF00175814; Wu BJ, 2014, G3-GENES GENOM GENET, V4, P605, DOI 10.1534/g3.113.009910; Yao YR, 2016, MITOCHONDRIAL DNA A, V27, P3246, DOI 10.3109/19401736.2015.1007367; Zhang YJ, 2015, FUNGAL GENET BIOL, V77, P95, DOI 10.1016/j.fgb.2015.04.009	92	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185545	10.1371/journal.pone.0185545	http://dx.doi.org/10.1371/journal.pone.0185545			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972995	Green Published, gold			2022-12-26	WOS:000412131900023
J	Fusaro, L; Palma, A; Salvatori, E; Basile, A; Maresca, V; Karam, EA; Manes, F				Fusaro, Lina; Palma, Adriano; Salvatori, Elisabetta; Basile, Adriana; Maresca, Viviana; Karam, Elham Asadi; Manes, Fausto			Functional indicators of response mechanisms to nitrogen deposition, ozone, and their interaction in two Mediterranean tree species	PLOS ONE			English	Article							PHYSIOLOGICAL-RESPONSES; OXIDATIVE STRESS; QUERCUS-ILEX; PHOTOSYNTHETIC RESPONSES; CHLOROPHYLL FLUORESCENCE; STOMATAL UPTAKE; CLIMATE-CHANGE; AIR-POLLUTION; MATURE TREES; WATER-STRESS	The effects of nitrogen (N) deposition, tropospheric ozone (O-3) and their interaction were investigated in two Mediterranean tree species, Fraxinus ornus L. (deciduous) and Quercus ilex L. (evergreen), having different leaf habits and resource use strategies. An experiment was conducted under controlled condition to analyse how nitrogen deposition affects the ecophysiological and biochemical traits, and to explore how the nitrogen-induced changes influence the response to O-3. For both factors we selected realistic exposures (20 kg N ha(-1) yr(-1) and 80 ppb h for nitrogen and O-3, respectively), in order to elucidate the mechanisms implemented by the plants. Nitrogen addition resulted in higher nitrogen concentration at the leaf level in F. ornus, whereas a slight increase was detected in Q. ilex. Nitrogen enhanced the maximum rate of assimilation and ribulose 1,5-bisphosphate regeneration in both species, whereas it influenced the light harvesting complex only in the deciduous F. ornus that was also affected by O-3 (reduced assimilation rate and accelerated senescence-related processes). Conversely, Q. ilex developed an avoidance mechanism to cope with O-3, confirming a substantial O-3 tolerance of this species. Nitrogen seemed to ameliorate the harmful effects of O-3 in F. ornus: the hypothesized mechanism of action involved the production of nitrogen oxide as the first antioxidant barrier, followed by enzymatic antioxidant response. In Q. ilex, the interaction was not detected on gas exchange and photosystem functionality; however, in this species, nitrogen might stimulate an alternative antioxidant response such as the emission of volatile organic compounds. Antioxidant enzyme activity was lower in plants treated with both O-3 and nitrogen even though reactive oxygen species production did not differ between the treatments.	[Fusaro, Lina; Palma, Adriano; Salvatori, Elisabetta; Manes, Fausto] Sapienza Univ Rome, Dept Environm Biol, Rome, Italy; [Basile, Adriana; Maresca, Viviana] Univ Naples Federico II, Biol Dept, Naples, Italy; [Karam, Elham Asadi] Shahid Bahonar Univ Kerman, Biol Dept, Kerman, Iran	Sapienza University Rome; University of Naples Federico II; Shahid Bahonar University of Kerman (SBUK)	Fusaro, L (corresponding author), Sapienza Univ Rome, Dept Environm Biol, Rome, Italy.	lina.fusaro@uniroma1.it	BASILE, Adriana/ABC-8500-2021; Fusaro, Lina/Q-4369-2017; Salvatori, Elisabetta/F-8931-2010; Palma, Adriano/AAL-6622-2020; Maresca, Viviana/AEP-6443-2022; Maresca, Viviana/AAW-9990-2021	BASILE, Adriana/0000-0002-2001-8959; Fusaro, Lina/0000-0003-3316-707X; Maresca, Viviana/0000-0002-4656-320X; Palma, Adriano/0000-0002-8100-2977; MANES, Fausto/0000-0002-4563-4272; SALVATORI, ELISABETTA/0000-0002-5603-5064	MIUR, Rome, Project PRIN TreeCity [20109E8F95]; Avvio alla Ricerca, Sapienza Research Project [C26N15CHHN]; Sapienza Ateneo Research Project [RM116154C90A4EAD, RM116154C9CFDE3B]; Accademia Nazionale delle Scienze detta dei XL	MIUR, Rome, Project PRIN TreeCity(Ministry of Education, Universities and Research (MIUR)); Avvio alla Ricerca, Sapienza Research Project; Sapienza Ateneo Research Project; Accademia Nazionale delle Scienze detta dei XL	This research has been supported by the following grants: MIUR, Rome, Project PRIN 2010-2011 TreeCity (Prot. no. 20109E8F95); Avvio alla Ricerca, Sapienza Research Project 2015 (Prot.No. C26N15CHHN) to Lina Fusaro; Sapienza Ateneo Research Project 2016 (Prot.No. RM116154C90A4EAD) to Fausto Manes; Sapienza Ateneo Research Project 2016 (RM116154C9CFDE3B); Accademia Nazionale delle Scienze detta dei XL (2012 Grants) to Fausto Manes. We thank Dr. Antonietta Siciliano for providing support for antioxidant analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amponsah IG, 2004, TREE PHYSIOL, V24, P1099, DOI 10.1093/treephys/24.10.1099; [Anonymous], MAN METH CRIT MOD MA; Aranda I, 2004, ACTA OECOL, V25, P187, DOI 10.1016/j.actao.2004.01.003; Azuchi F, 2014, ENVIRON POLLUT, V184, P481, DOI 10.1016/j.envpol.2013.09.025; Bassin S, 2013, ECOSYSTEMS, V16, P1105, DOI 10.1007/s10021-013-9670-3; Beligni MV, 1999, PLANTA, V208, P337, DOI 10.1007/s004250050567; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Borghetti M, 2017, TREE PHYSIOL, V37, P4, DOI 10.1093/treephys/tpw087; Bussotti F, 2008, GLOBAL CHANGE BIOL, V14, P2727, DOI 10.1111/j.1365-2486.2008.01677.x; Bussotti F, 2011, ENVIRON EXP BOT, V73, P116, DOI 10.1016/j.envexpbot.2010.10.023; Bytnerowicz A, 2007, ENVIRON POLLUT, V147, P438, DOI 10.1016/j.envpol.2006.08.028; Calatayud V, 2007, WATER AIR SOIL POLL, V185, P239, DOI 10.1007/s11270-007-9446-5; Calatayud V, 2011, ENVIRON POLLUT, V159, P55, DOI 10.1016/j.envpol.2010.09.024; Calvete-Sogo H, 2016, OECOLOGIA, V181, P1055, DOI 10.1007/s00442-016-3628-z; Catovsky S, 2002, ECOL APPL, V12, P1056, DOI 10.1890/1051-0761(2002)012[1056:NAIROT]2.0.CO;2; Cotrozzi L, 2016, PHYSIOL PLANTARUM, V157, P69, DOI 10.1111/ppl.12402; Crous KY, 2017, NEW PHYTOL, V215, P992, DOI 10.1111/nph.14591; Das P, 2015, FRONT ENV SCI, P2; de la Riva EG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148788; de Pinto MC, 1999, PROTOPLASMA, V209, P90, DOI 10.1007/BF01415704; de Vries W, 2014, PLANT SOIL, V380, P1, DOI 10.1007/s11104-014-2056-2; Dezi S, 2010, GLOBAL CHANGE BIOL, V16, P1470, DOI 10.1111/j.1365-2486.2009.02102.x; Dirnbock T, 2014, GLOBAL CHANGE BIOL, V20, P429, DOI 10.1111/gcb.12440; Edwards EJ, 2014, J ECOL, V102, P328, DOI 10.1111/1365-2745.12209; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fares S, 2008, PLANT BIOLOGY, V10, P44, DOI 10.1055/s-2007-965257; Fares S, 2013, ENVIRON SCI TECHNOL, V47, P11073, DOI 10.1021/es4022156; Feng YL, 2007, OECOLOGIA, V153, P501, DOI 10.1007/s00442-007-0759-2; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Fenn ME, 2010, J ENVIRON MANAGE, V91, P2404, DOI 10.1016/j.jenvman.2010.07.034; Ferretti M, 2014, GLOBAL CHANGE BIOL, V20, P3423, DOI 10.1111/gcb.12552; Fleischer K, 2013, GLOBAL BIOGEOCHEM CY, V27, P187, DOI 10.1002/gbc.20026; Fusaro L, 2016, PLANT BIOLOGY, V18, P13, DOI 10.1111/plb.12383; Garcia-Gomez H, 2014, SCI TOTAL ENVIRON, V485, P450, DOI 10.1016/j.scitotenv.2014.03.112; Guidi L, 2008, TREE PHYSIOL, V28, P873, DOI 10.1093/treephys/28.6.873; Guidi L, 2010, ENVIRON POLLUT, V158, P3164, DOI 10.1016/j.envpol.2010.06.037; Hikosaka K, 2001, OECOLOGIA, V126, P174, DOI 10.1007/s004420000517; Camarero J, 2017, TREE PHYSIOL, V37, P1, DOI 10.1093/treephys/tpw111; Karnosky DF, 2007, ENVIRON POLLUT, V147, P489, DOI 10.1016/j.envpol.2006.08.043; Li P, 2016, TREE PHYSIOL, V36, P1105, DOI 10.1093/treephys/tpw042; Long SP, 2003, J EXP BOT, V54, P2393, DOI 10.1093/jxb/erg262; Loreto F, 2004, TREE PHYSIOL, V24, P361, DOI 10.1093/treephys/24.4.361; Loustau D, 1999, TREE PHYSIOL, V19, P707; Manes F, 2003, SCI TOTAL ENVIRON, V308, P133, DOI 10.1016/S0048-9697(02)00633-2; Manes F, 2001, PHYSIOL PLANTARUM, V113, P249, DOI 10.1034/j.1399-3054.2001.1130213.x; Manes F, 2007, ENVIRON EXP BOT, V59, P235, DOI 10.1016/j.envexpbot.2005.12.001; Marzuoli R, 2016, TREES-STRUCT FUNCT, V30, P1995, DOI 10.1007/s00468-016-1427-0; Mata CG, 2001, PLANT PHYSIOL, V126, P1196, DOI 10.1104/pp.126.3.1196; Mills G, 2016, ENVIRON POLLUT, V208, P898, DOI 10.1016/j.envpol.2015.09.038; Mills G, 2009, GLOBAL CHANGE BIOL, V15, P1522, DOI 10.1111/j.1365-2486.2008.01798.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nali C, 2004, ATMOS ENVIRON, V38, P2247, DOI 10.1016/j.atmosenv.2003.11.043; Neill SJ, 2003, NEW PHYTOL, V159, P11, DOI 10.1046/j.1469-8137.2003.00804.x; Niinemets U, 2014, TREE PHYSIOL, V34, P1301, DOI 10.1093/treephys/tpu099; Ochoa-Hueso R, 2017, ENVIRON POLLUT, V227, P194, DOI 10.1016/j.envpol.2017.04.062; Palmroth S, 2014, OECOLOGIA, V175, P457, DOI 10.1007/s00442-014-2923-9; Paoletti E, 2009, SCI TOTAL ENVIRON, V407, P1631, DOI 10.1016/j.scitotenv.2008.11.061; Pardo LH, 2011, ECOL APPL, V21, P3049, DOI 10.1890/10-2341.1; Pivovaroff AL, 2016, OECOLOGIA, V181, P721, DOI 10.1007/s00442-016-3609-2; Ribas A, 2005, ATMOS ENVIRON, V39, P685, DOI 10.1016/j.atmosenv.2004.10.022; Ribas A, 2005, ENVIRON POLLUT, V134, P291, DOI 10.1016/j.envpol.2004.07.026; Salvatori E, 2015, PLANT PHYSIOL BIOCH, V97, P368, DOI 10.1016/j.plaphy.2015.10.027; Salvatori E, 2014, PLANT PHYSIOL BIOCH, V85, P105, DOI 10.1016/j.plaphy.2014.11.002; Santurtun A, 2015, ATMOS ENVIRON, V101, P10, DOI 10.1016/j.atmosenv.2014.11.005; Scalet M, 1995, ENVIRON EXP BOT, V35, P417, DOI 10.1016/0098-8472(95)00001-3; Scholz FG, 2007, REMOVAL NUTR LIMITAT; Sharkey TD, 2007, PLANT CELL ENVIRON, V30, P1035, DOI 10.1111/j.1365-3040.2007.01710.x; Strasser RJ, 2010, BBA-BIOENERGETICS, V1797, P1313, DOI 10.1016/j.bbabio.2010.03.008; Takashima T, 2004, PLANT CELL ENVIRON, V27, P1047, DOI 10.1111/j.1365-3040.2004.01209.x; Thomas VFD, 2005, ENVIRON POLLUT, V137, P507, DOI 10.1016/j.envpol.2005.02.002; TRETIACH M, 1993, ACTA OECOL, V14, P341; Tulloss EM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156685; Uscola M, 2014, EUR J FOREST RES, V133, P235, DOI 10.1007/s10342-013-0749-3; Vainonen JP, 2015, PLANT CELL ENVIRON, V38, P240, DOI 10.1111/pce.12273; Valladares F, 2000, NEW PHYTOL, V148, P79, DOI 10.1046/j.1469-8137.2000.00737.x; Velikova V, 2008, PLANT CELL ENVIRON, V31, P1882, DOI 10.1111/j.1365-3040.2008.01893.x; Volk M, 2016, BIOGEOSCIENCES, V13, P3807, DOI 10.5194/bg-13-3807-2016; Wildt J, 1997, J GEOPHYS RES-ATMOS, V102, P5919, DOI 10.1029/96JD02968; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yamaguchi M, 2007, TREES-STRUCT FUNCT, V21, P707, DOI 10.1007/s00468-007-0163-x; Yamaguchi Masahiro, 2011, Asian Journal of Atmospheric Environment, V5, P65; Yao XQ, 2006, PLANT GROWTH REGUL, V50, P165, DOI 10.1007/s10725-006-9116-4; Zhang WW, 2012, ENVIRON POLLUT, V163, P149, DOI 10.1016/j.envpol.2011.12.035	84	13	13	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185836	10.1371/journal.pone.0185836	http://dx.doi.org/10.1371/journal.pone.0185836			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973038	Green Submitted, Green Published, gold			2022-12-26	WOS:000412131900059
J	Queller, PS; Murphy, TG				Queller, Philip S.; Murphy, Troy G.			Seasonal variation in the utility of a status signaling system: Plumage ornament predicts foraging success only during periods of high competition	PLOS ONE			English	Article							SEXUAL SELECTION; SOCIAL COMPETITION; FOOD ABUNDANCE; SIZE; TESTOSTERONE; EVOLUTION; DOMINANCE; TERRITORIALITY; AGGRESSION; COLORATION	Status signals allow competitors to assess each other's resource holding potential and reduce the occurrence of physical fights. Because status signals function to mediate competition over resources, a change in the strength of competition may affect the utility of a status signaling system. Status signals alter competitor behavior during periods of high competition, and thus determine access to resources; however, when competition is reduced, we expect these signals to become disassociated from access to resources. We investigated seasonal changes in status signaling of the male black-crested titmouse (Baeolophus atricristatus), a species that experiences substantial changes in population density and competition for food over the annual cycle. We compared the size of the prominent head-crest to foraging success at community-used feeding stations; we tested this relationship when competition was seasonally high, and when competition was seasonally low. We then experimentally decreased the number of feeders to increase competition (during the season of low-competition), and again tested whether male crest size predicted access to feeders. When competition was seasonally high, males with longer crests had greater access to feeders, but this pattern was not apparent when competition was seasonally low. When competition was experimentally increased, males with longer crests were again more successful at maintaining access to feeders. These findings provide evidence of a contextdependent status signaling system, where the status signal only mediates access to resources during periods of high competition. We discuss possible hypotheses for why the signaling system may not be functional, or detectable, during periods of low competition, including that competitors may interact less frequently and so have reduced opportunity for signaling, or that status signals are disregarded by receivers during periods of low competition because signalers are unlikely to escalate a contest into a fight. In any case, these results indicate that resource availability affects a status signaling system, and that the potential for status signaling persists in this system between seasons, even though such signaling may not be overtly present or detectable during periods of low competition.	[Queller, Philip S.; Murphy, Troy G.] Trinity Univ, Dept Biol, San Antonio, TX 78212 USA; [Queller, Philip S.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	Trinity University; University of Texas System; University of Texas Austin	Murphy, TG (corresponding author), Trinity Univ, Dept Biol, San Antonio, TX 78212 USA.	troy.murphy@trinity.edu	Murphy, Troy/A-7092-2008	Murphy, Troy/0000-0001-7239-2160	Trinity University; Texas Ecolab	Trinity University; Texas Ecolab	PSQ was supported by the Biology Summer Undergraduate Research Fellowship and the Mach Fellowship provided by Trinity University. TGM was supported by a grant from Texas Ecolab, and by a Faculty Development Grant from Trinity University.	Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; [Anonymous], 2004, BIOPHOT INT, V11, P36; Arnott G, 2009, ANIM BEHAV, V77, P991, DOI 10.1016/j.anbehav.2009.02.010; Bonter DN, 2011, J FIELD ORNITHOL, V82, P1, DOI 10.1111/j.1557-9263.2010.00302.x; Bridge ES, 2011, J FIELD ORNITHOL, V82, P52, DOI 10.1111/j.1557-9263.2010.00307.x; Briffa M, 2005, ANIM BEHAV, V70, P119, DOI 10.1016/j.anbehav.2004.10.013; Briffa M, 2004, P ROY SOC B-BIOL SCI, V271, P373, DOI 10.1098/rspb.2003.2633; Brown J. L., 1964, Wilson Bulletin, V76, P160; CARPENTER FL, 1987, AM ZOOL, V27, P387; Chaine AS, 2008, SCIENCE, V319, P459, DOI 10.1126/science.1149167; Chaine AS, 2011, ANIM BEHAV, V81, P447, DOI 10.1016/j.anbehav.2010.11.016; Crowhurst CJ, 2012, ETHOLOGY, V118, P63, DOI 10.1111/j.1439-0310.2011.01986.x; Dearborn DC, 1998, BIOTROPICA, V30, P306, DOI 10.1111/j.1744-7429.1998.tb00064.x; Dey CJ, 2013, P R SOC B, V281; DOLMAN PM, 1995, OECOLOGIA, V102, P511, DOI 10.1007/BF00341364; Emaresi G, 2014, AM NAT, V183, P269, DOI 10.1086/674444; ENQUIST M, 1987, J THEOR BIOL, V127, P187, DOI 10.1016/S0022-5193(87)80130-3; EVANS MR, 1992, BEHAV ECOL SOCIOBIOL, V29, P413; FINCK P, 1990, OECOLOGIA, V83, P68, DOI 10.1007/BF00324636; GILL FB, 1975, ECOLOGY, V56, P333, DOI 10.2307/1934964; Golabek KA, 2012, ANIM BEHAV, V83, P613, DOI 10.1016/j.anbehav.2011.11.034; Grant JWA, 2002, ANIM BEHAV, V63, P323, DOI 10.1006/anbe.2001.1891; HANSEN AJ, 1986, ANIM BEHAV, V34, P69, DOI 10.1016/0003-3472(86)90007-2; HENDERSON IG, 1995, J AVIAN BIOL, V26, P217, DOI 10.2307/3677322; LEMEL J, 1993, ANIM BEHAV, V45, P549, DOI 10.1006/anbe.1993.1065; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; LIGON JD, 1990, ANIM BEHAV, V40, P367, DOI 10.1016/S0003-3472(05)80932-7; Ligon RA, 2014, BEHAV ECOL SOCIOBIOL, V68, P1007, DOI 10.1007/s00265-014-1713-z; Lyon BE, 2012, PHILOS T R SOC B, V367, P2266, DOI 10.1098/rstb.2012.0012; Maynard Smith J., 1982, pi; McGraw KJ, 2000, P ROY SOC B-BIOL SCI, V267, P1525, DOI 10.1098/rspb.2000.1174; Miyai CA, 2011, ZOOLOGY, V114, P335, DOI 10.1016/j.zool.2011.07.001; MOLLER AP, 1987, ANIM BEHAV, V35, P1637, DOI 10.1016/S0003-3472(87)80056-8; MOLLER AP, 1992, BEHAV ECOL SOCIOBIOL, V31, P271; Moses SP, 2000, KENTUCKY WARBLER, V76, P48; Murphy TG, 2009, BEHAV ECOL, V20, P1348, DOI 10.1093/beheco/arp140; Murphy TG, 2009, BEHAV ECOL, V20, P1000, DOI 10.1093/beheco/arp089; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Patten MA, 2008, BLACK CRESTED TITMOU; Piault R, 2009, AM NAT, V174, P548, DOI 10.1086/605374; Pryke SR, 2003, ANIM BEHAV, V66, P217, DOI 10.1006/anbe.2003.2193; Pryke SR, 2003, BEHAV ECOL SOCIOBIOL, V53, P393, DOI 10.1007/s00265-003-0587-2; Quinn MA, 2000, THESIS; ROHWER S, 1975, EVOLUTION, V29, P593, DOI 10.1111/j.1558-5646.1975.tb00853.x; ROHWER S, 1978, ANIM BEHAV, V26, P1012, DOI 10.1016/0003-3472(78)90090-8; ROHWER S, 1982, AM ZOOL, V22, P531; Rylander RJ, 2015, THESIS; Searcy WA, 2006, EVOLUTION ANIMAL COM, V31, P794; Senar JC, 1998, P ROY SOC B-BIOL SCI, V265, P1515, DOI 10.1098/rspb.1998.0466; Senar Juan Carlos, 2006, P87; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; SMITH JM, 1988, PHILOS T ROY SOC B, V319, P557, DOI 10.1098/rstb.1988.0065; Tarvin KA, 2016, FRONTIERS IN ECOLOGY; Taylor PW, 2001, BEHAV ECOL SOCIOBIOL, V50, P403, DOI 10.1007/s002650100390; Tibbetts EA, 2014, INETGR COMP BIOL, P1, DOI [10.1093/icb/icu083Society, DOI 10.1093/ICB/ICU083SOCIETY]; Tibbetts EA, 2008, P ROY SOC B-BIOL SCI, V275, P2201, DOI 10.1098/rspb.2008.0477; Vedder O, 2010, FUNCT ECOL, V24, P417, DOI 10.1111/j.1365-2435.2009.01660.x; Vergara P, 2012, HORM BEHAV, V62, P407, DOI 10.1016/j.yhbeh.2012.07.007; WESTEBERHARD MJ, 1979, P AM PHILOS SOC, V123, P222; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Wingfield JC, 2001, BRAIN BEHAV EVOLUT, V57, P239, DOI 10.1159/000047243; Yasukawa K, 2009, ANIM BEHAV, V77, P531, DOI 10.1016/j.anbehav.2008.11.013	62	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185584	10.1371/journal.pone.0185584	http://dx.doi.org/10.1371/journal.pone.0185584			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973029	Green Published, gold, Green Submitted			2022-12-26	WOS:000412131900027
J	Richards, C; Otani, S; Mikaelyan, A; Poulsen, M				Richards, Callum; Otani, Saria; Mikaelyan, Aram; Poulsen, Michael			Pycnoscelus surinamensis cockroach gut microbiota respond consistently to a fungal diet without mirroring those of fungus-farming termites	PLOS ONE			English	Article							BACTERIAL COMMUNITY STRUCTURE; PROFILES; DIVERSITY; ANTS; WOOD	The gut microbiotas of cockroaches and termites play important roles in the symbiotic digestion of dietary components, such as lignocellulose. Diet has been proposed as a primary determinant of community structure within the gut, acting as a selection force to shape the diversity observed within this "bioreactor", and as a key factor for the divergence of the termite gut microbiota from the omnivorous cockroach ancestor. The gut microbiota in most termites supports primarily the breakdown of lignocellulose, but the fungus-farming subfamily of higher termites has become similar in gut microbiota to the ancestral omnivorous cockroaches. To assess the importance of a fungus diet as a driver of community structure, we compare community compositions in the guts of experimentally manipulated Pycnoscelus surinamensis cockroaches fed on fungus cultivated by fungus-farming termites. MiSeq amplicon analysis of gut microbiotas from 49 gut samples showed a step-wise gradient pattern in community similarity that correlated with an increase in the proportion of fungal material provided to the cockroaches. Comparison of the taxonomic composition of manipulated communities to that of gut communities of a fungus-feeding termite species showed that although some bacteria OTUs shared by P. surinamensis and the farming termites increased in the guts of cockroaches on a fungal diet, cockroach communities remained distinct from those of termites. These results demonstrate that a fungal diet can play a role in structuring gut community composition, but at the same time exemplifies how original community compositions constrain the magnitude of such change.	[Richards, Callum; Otani, Saria; Poulsen, Michael] Univ Copenhagen, Dept Biol, Sect Ecol & Evolut, Ctr Social Evolut, Copenhagen East, Denmark; [Mikaelyan, Aram] Vanderbilt Univ, Dept Biol Sci, VU Stn B, Nashville, TN 37235 USA; [Mikaelyan, Aram] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, VU Stn B, Nashville, TN 37235 USA; [Richards, Callum] Imperial Coll London, Dept Life Sci, London, England	University of Copenhagen; Vanderbilt University; Vanderbilt University; Imperial College London	Poulsen, M (corresponding author), Univ Copenhagen, Dept Biol, Sect Ecol & Evolut, Ctr Social Evolut, Copenhagen East, Denmark.	MPoulsen@bio.ku.dk	Poulsen, Michael/C-6276-2012; Mikaelyan, Aram/I-6071-2015	Poulsen, Michael/0000-0002-2839-1715; Mikaelyan, Aram/0000-0002-7276-0194	Erasmus student exchange program, as part of Imperial College London's Biology; Research Abroad degree; Department of Biology, University of Copenhagen; Danish National Research Foundation Centre of Excellence Centre for Social Evolution [DNRF57]; Villum Kann Rasmussen Young Investigator Fellowship [VKR10101]; Villum Fonden [00010101] Funding Source: researchfish	Erasmus student exchange program, as part of Imperial College London's Biology; Research Abroad degree; Department of Biology, University of Copenhagen; Danish National Research Foundation Centre of Excellence Centre for Social Evolution; Villum Kann Rasmussen Young Investigator Fellowship; Villum Fonden(Villum Fonden)	The work was funded by an Erasmus student exchange program, as part of Imperial College London's Biology with Research Abroad degree to CR; a PhD stipend to SO funded by the Department of Biology, University of Copenhagen, and the Danish National Research Foundation Centre of Excellence Centre for Social Evolution (DNRF57) to Jacobus J. Boomsma, and a Villum Kann Rasmussen Young Investigator Fellowship (VKR10101) to MP.; We thank Harriette Carrington from the Microbial Systems molecular biology lab at the University of Michigan Medical School for laboratory assistance with MiSeq library, and Sylvia Mathiasen and Panagiotis Sapountzis for laboratory assistance. The work was funded by an Erasmus student exchange program, as part of Imperial College London's Biology with a Research Abroad degree to CR, for which we thank course coordinator Prof. Dave Hartley for guidance throughout the project, and Victoria L. Challinor, Rafael R. da Costa, and Dave Hartley for comments on a draft of this manuscript; a PhD stipend to SO funded by the Department of Biology, University of Copenhagen, and the Danish National Research Foundation Centre of Excellence Centre for Social Evolution (DNRF57) to Jacobus J. Boomsma, and a Villum Kann Rasmussen Young Investigator Fellowship (VKR10101) to MP.	Blum JE, 2013, MBIO, V4, DOI 10.1128/mBio.00860-13; Bourguignon T, 2015, MOL BIOL EVOL, V32, P406, DOI 10.1093/molbev/msu308; Brune A, 2015, ANNU REV MICROBIOL, V69, P145, DOI 10.1146/annurev-micro-092412-155715; BUXTON RD, 1981, OECOLOGIA, V51, P379, DOI 10.1007/BF00540909; Carrasco P, 2014, INT MICROBIOL, V17, P99, DOI 10.2436/20.1501.01.212; Dietrich C, 2014, APPL ENVIRON MICROB, V80, P2261, DOI 10.1128/AEM.04206-13; Douglas AE, 2015, ANNU REV ENTOMOL, P6017; Perez-Cobas AE, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv022; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Gade B, 1997, J EVOLUTION BIOL, V10, P479, DOI 10.1007/s000360050037; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hongoh Y, 2006, MOL ECOL, V15, P505, DOI 10.1111/j.1365-294X.2005.02795.x; Hongoh Y, 2007, APPL ENVIRON MICROB, V73, P6270, DOI 10.1128/AEM.00750-07; Hongoh Y, 2011, CELL MOL LIFE SCI, V68, P1311, DOI 10.1007/s00018-011-0648-z; Inward D, 2007, BIOL LETTERS, V3, P331, DOI 10.1098/rsbl.2007.0102; Ji R, 2005, SOIL BIOL BIOCHEM, V37, P1648, DOI 10.1016/j.soilbio.2005.01.026; Ji R, 2001, BIOL FERT SOILS, V33, P166, DOI 10.1007/s003740000310; Kohler T, 2008, ENVIRON MICROBIOL, V10, P1260, DOI 10.1111/j.1462-2920.2007.01540.x; Kohler T, 2012, APPL ENVIRON MICROB, V78, P4691, DOI 10.1128/AEM.00683-12; Komatsu N, 2015, TROP BIOMED, V32, P98; Korb J, 2012, J INSECT PHYSIOL, V58, P376, DOI 10.1016/j.jinsphys.2011.12.016; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lanan MC, 2016, ISME J, V10, P1866, DOI 10.1038/ismej.2015.264; LEUTHOLD RH, 1989, INSECT SOC, V36, P328, DOI 10.1007/BF02224884; Li HJ, 2012, J INSECT PHYSIOL, V58, P1368, DOI 10.1016/j.jinsphys.2012.07.012; McFall-Ngai M, 2007, NATURE, V445, P153, DOI 10.1038/445153a; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Mikaelyan A, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fiw210; Mikaelyan A, 2016, APPL ENVIRON MICROB, V82, P1256, DOI 10.1128/AEM.03700-15; Mikaelyan A, 2015, SYST APPL MICROBIOL, V38, P472, DOI 10.1016/j.syapm.2015.07.004; Mikaelyan A, 2015, MOL ECOL, V24, P5284, DOI 10.1111/mec.13376; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Ohkuma M, 2008, TRENDS MICROBIOL, V16, P345, DOI 10.1016/j.tim.2008.04.004; Oksanen J., **DATA OBJECT**; Otani S, 2016, MICROB ECOL, V71, P207, DOI 10.1007/s00248-015-0692-6; Otani S, 2014, MOL ECOL, V23, P4631, DOI 10.1111/mec.12874; Poulsen M, 2015, ENVIRON MICROBIOL, V17, P2562, DOI 10.1111/1462-2920.12765; R Core Team, 2021, R LANGUAGE ENV STAT; R Core Team, R LANG ENV STAT COMP; Rahman NA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0067-8; ROTH LM, 1974, ANN ENTOMOL SOC AM, V67, P215, DOI 10.1093/aesa/67.2.215; Sachs JL, 2011, P NATL ACAD SCI USA, V108, P10800, DOI 10.1073/pnas.1100304108; Sanders JG, 2014, MOL ECOL, V23, P1268, DOI 10.1111/mec.12611; Sapountzis P, 2015, APPL ENVIRON MICROB, V81, P5527, DOI 10.1128/AEM.00961-15; Schauer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085861; Schauer C, 2012, APPL ENVIRON MICROB, V78, P2758, DOI 10.1128/AEM.07788-11; Scheuring I, 2012, ECOL LETT, V15, P1300, DOI 10.1111/j.1461-0248.2012.01853.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmitt-Wagner D, 1999, APPL ENVIRON MICROB, V65, P4490; Staubach F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070749; Su SW, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iev152	51	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185745	10.1371/journal.pone.0185745	http://dx.doi.org/10.1371/journal.pone.0185745			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973021	Green Published, gold, Green Submitted			2022-12-26	WOS:000412131900044
J	Visone, V; Han, WY; Perugino, G; del Monaco, G; She, QX; Rossi, M; Valenti, A; Ciaramella, M				Visone, Valeria; Han, Wenyuan; Perugino, Giuseppe; del Monaco, Giovanni; She, Qunxin; Rossi, Mose; Valenti, Anna; Ciaramella, Maria			In vivo and in vitro protein imaging in thermophilic archaea by exploiting a novel protein tag	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; DNA-ALKYLATION-DAMAGE; REVERSE GYRASE; SULFOLOBUS-SOLFATARICUS; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; DIRECTED EVOLUTION; FUSION PROTEINS; TOPOISOMERASE; EXPRESSION; METHYLTRANSFERASE	Protein imaging, allowing a wide variety of biological studies both in vitro and in vivo, is of great importance in modern biology. Protein and peptide tags fused to proteins of interest provide the opportunity to elucidate protein location and functions, detect protein-protein interactions, and measure protein activity and kinetics in living cells. Whereas several tags are suitable for protein imaging in mesophilic organisms, the application of this approach to microorganisms living at high temperature has lagged behind. Archaea provide an excellent and unique model for understanding basic cell biology mechanisms. Here, we present the development of a toolkit for protein imaging in the hyperthermophilic archaeon Sulfolobus islandicus. The system relies on a thermostable protein tag (H5) constructed by engineering the alkylguanine-DNA-alkyl-transferase protein of Sulfolobus solfataricus, which can be covalently labeled using a wide range of small molecules. As a suitable host, we constructed, by CRISPR-based genome-editing technology, a S. islandicus mutant strain deleted for the alkylguanine-DNA-alkyl-transferase gene (triangle ogt). Introduction of a plasmidborne H5 gene in this strain led to production of a functional H5 protein, which was successfully labeled with appropriate fluorescent molecules and visualized in cell extracts as well as in.ogt live cells. H5 was fused to reverse gyrase, a peculiar thermophile-specific DNA topoisomerase endowed with positive supercoiling activity, and allowed visualization of the enzyme in living cells. To the best of our knowledge, this is the first report of in vivo imaging of any protein of a thermophilic archaeon, filling an important gap in available tools for cell biology studies in these organisms.	[Visone, Valeria; Perugino, Giuseppe; del Monaco, Giovanni; Rossi, Mose; Valenti, Anna; Ciaramella, Maria] Natl Res Council Italy, Inst Biosci & Bioresources, Naples, Italy; [Han, Wenyuan; She, Qunxin] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); University of Copenhagen	Valenti, A; Ciaramella, M (corresponding author), Natl Res Council Italy, Inst Biosci & Bioresources, Naples, Italy.	anna.valenti@ibbr.cnr.it; maria.ciaramella@ibbr.cnr.it	She, Qunxin/E-4311-2012; Perugino, Giuseppe/P-8147-2016; Han, Wenyuan/AAE-1995-2021; Ciaramella, Maria/O-1152-2015	She, Qunxin/0000-0002-4448-6669; DEL MONACO, Giovanni/0000-0003-0332-9306; Ciaramella, Maria/0000-0003-1583-1694; Perugino, Giuseppe/0000-0003-3266-4744	Italian Ministry of Education and Research, Firb-Futuro in Ricerca, Nematic; Research Fund Denmark [DFF-0602-02196]	Italian Ministry of Education and Research, Firb-Futuro in Ricerca, Nematic; Research Fund Denmark	This work was supported by a) Italian Ministry of Education and Research, Firb-Futuro in Ricerca, Nematic to AV; b) Research Fund Denmark, DFF-0602-02196 to QS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliye N, 2015, APPL MICROBIOL BIOT, V99, P1205, DOI 10.1007/s00253-014-5975-1; Atomi H, 2004, J BACTERIOL, V186, P4829, DOI 10.1128/JB.186.14.4829-4833.2004; Brochier-Armanet Celine, 2007, Archaea, V2, P83; Cava F, 2008, ENVIRON MICROBIOL, V10, P605, DOI 10.1111/j.1462-2920.2007.01482.x; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Contursi P, 2006, EXTREMOPHILES, V10, P615, DOI 10.1007/s00792-006-0017-2; Deng L, 2009, EXTREMOPHILES, V13, P735, DOI 10.1007/s00792-009-0254-2; Forterre P, 2002, TRENDS GENET, V18, P236, DOI 10.1016/S0168-9525(02)02650-1; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Grogan DW, 2009, BIOCHEM SOC T, V37, P88, DOI 10.1042/BST0370088; Gronemeyer T, 2006, PROTEIN ENG DES SEL, V19, P309, DOI 10.1093/protein/gzl014; Guo L, 2011, J BACTERIOL, V193, P1672, DOI 10.1128/JB.01487-10; Han WY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071340; Hinner MJ, 2010, CURR OPIN BIOTECH, V21, P766, DOI 10.1016/j.copbio.2010.09.011; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Hsieh TS, 2006, J BIOL CHEM, V281, P5640, DOI 10.1074/jbc.M513252200; Jamroze A, 2014, J BIOL CHEM, V289, P3231, DOI 10.1074/jbc.M113.517649; Johnsson N, 2003, CHEMBIOCHEM, V4, P803, DOI 10.1002/cbic.200200603; Juillerat A, 2003, CHEM BIOL, V10, P313, DOI 10.1016/S1074-5521(03)00068-1; Li YJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1044; Lipscomb GL, 2017, EXTREMOPHILES, V21, P603, DOI 10.1007/s00792-017-0929-z; Lulchev P, 2014, NUCLEIC ACIDS RES, V42, P8200, DOI 10.1093/nar/gku589; Miggiano R, 2013, J BACTERIOL, V195, P2728, DOI 10.1128/JB.02298-12; Morita R, 2008, J BIOCHEM, V144, P267, DOI 10.1093/jb/mvn065; NADAL M, 1994, J BIOL CHEM, V269, P5255; Napoli A, 2005, NUCLEIC ACIDS RES, V33, P564, DOI 10.1093/nar/gki202; Napoli A, 2004, J BIOL CHEM, V279, P33192, DOI 10.1074/jbc.M402619200; Napoli A, 2002, NUCLEIC ACIDS RES, V30, P2656, DOI 10.1093/nar/gkf377; Peng N, 2017, SCI CHINA LIFE SCI, V60, P370, DOI 10.1007/s11427-016-0355-8; Peng N, 2012, APPL ENVIRON MICROB, V78, P5630, DOI 10.1128/AEM.00855-12; Peng WF, 2015, NUCLEIC ACIDS RES, V43, P406, DOI 10.1093/nar/gku1302; Perugino G, 2015, NUCLEIC ACIDS RES, V43, P8801, DOI 10.1093/nar/gkv774; Perugino G, 2012, J BIOL CHEM, V287, P4222, DOI 10.1074/jbc.M111.308320; Perugino G, 2009, BIOCHEM SOC T, V37, P69, DOI 10.1042/BST0370069; Schneider AFL, 2017, CURR OPIN BIOTECH, V48, P61, DOI 10.1016/j.copbio.2017.03.012; Valenti A, 2008, NUCLEIC ACIDS RES, V36, P4587, DOI 10.1093/nar/gkn418; Valenti A, 2006, NUCLEIC ACIDS RES, V34, P2098, DOI 10.1093/nar/gkl115; Valenti A, 2010, J BIOL CHEM, V285, P36532, DOI 10.1074/jbc.M110.169029; Valenti A, 2009, NUCLEIC ACIDS RES, V37, P4287, DOI 10.1093/nar/gkp386; Vettone A, 2016, EXTREMOPHILES, V20, P1, DOI 10.1007/s00792-015-0791-9; Visone V, 2014, INT J MOL SCI, V15, P17162, DOI 10.3390/ijms150917162; Zhang CY, 2013, BIOCHEM SOC T, V41, P405, DOI 10.1042/BST20120285	42	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185791	10.1371/journal.pone.0185791	http://dx.doi.org/10.1371/journal.pone.0185791			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973046	Green Submitted, Green Published, gold			2022-12-26	WOS:000412131900051
J	Farahmand, S; Foroughmand-Araabi, MH; Goliaei, S; Razaghi-Moghadam, Z				Farahmand, S.; Foroughmand-Araabi, M. H.; Goliaei, S.; Razaghi-Moghadam, Z.			CytoGTA: A cytoscape plugin for identifying discriminative subnetwork markers using a game theoretic approach	PLOS ONE			English	Article							BREAST-CANCER; HUMAN-DISEASE; NETWORKS	In recent years, analyzing genome-wide expression profiles to find genetic markers has received much attention as a challenging field of research aiming at unveiling biological mechanisms behind complex disorders. The identification of reliable and reproducible markers has lately been achieved by integrating genome-scale functional relationships and transcriptome datasets, and a number of algorithms have been developed to support this strategy. In this paper, we present a promising and easily applicable tool to accomplish this goal, namely CytoGTA, which is a Cytoscape plug-in that relies on an optimistic game theoretic approach (GTA) for identifying subnetwork markers. Given transcriptomic data of two phenotype classes and interactome data, this plug-in offers discriminative markers for the two classes. The high performance of CytoGTA would not have been achieved if the strategy of GTA was not implemented in Cytoscape. This plug-in provides a simple-to-use platform, convenient for biological researchers to interactively work with and visualize the structure of subnetwork markers. CytoGTA is one of the few available Cytoscape plug-ins for marker identification, which shows superior performance to existing methods.	[Farahmand, S.; Razaghi-Moghadam, Z.] Univ Tehran, Fac New Sci & Technol, Tehran, Iran; [Farahmand, S.] Univ Massachusetts Boston, Coll Sci & Math, Boston, MA USA; [Foroughmand-Araabi, M. H.] Sharif Univ Technol, Dept Math Sci, Tehran, Iran; [Goliaei, S.] Univ Tehran, Tehran, Iran	University of Tehran; University of Massachusetts System; University of Massachusetts Boston; Sharif University of Technology; University of Tehran	Razaghi-Moghadam, Z (corresponding author), Univ Tehran, Fac New Sci & Technol, Tehran, Iran.	razzaghi@ut.ac.ir	farahmand, saman/K-8759-2019	farahmand, saman/0000-0001-8999-2322				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; [Anonymous], 2017, APACHE COMMONS MATH; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Dao P, 2010, BIOINFORMATICS, V26, pi625, DOI 10.1093/bioinformatics/btq393; Farahmand S, 2016, MOL BIOSYST, V12, P818, DOI 10.1039/c5mb00684h; Guo Z, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-58; Holt CA, 2004, P NATL ACAD SCI USA, V101, P3999, DOI 10.1073/pnas.0308738101; Hwang T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-128; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jahid MJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S6-S8; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mitra K, 2013, NAT REV GENET, V14, P719, DOI 10.1038/nrg3552; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Qiu YQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-26; RDC T, 2004, R LANG ENV STAT; Sadikovic B, 2008, CURR GENOMICS, V9, P394, DOI 10.2174/138920208785699580; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Su JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008161; Tomfohr J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-225; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Yao C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-151	26	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185016	10.1371/journal.pone.0185016	http://dx.doi.org/10.1371/journal.pone.0185016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968407	Green Submitted, Green Published, gold			2022-12-26	WOS:000412029600012
J	Ye, JW; Li, J; Li, ZG; Han, SC				Ye, Jingwen; Li, Jun; Li, Zhigang; Han, Shichou			Rearing of Mallada basalis (Neuroptera: Chrysopidae) on modified artificial diets	PLOS ONE			English	Article							REPRODUCTION	Mallada basalis (Walker) has the potential to be a valuable biological control agent because of its predatory abilities, strong reproductive capacity, and broad prey range. This study aimed to improve on a previously used artificial diet for M. basalis, to achieve a longer oviposition period and greater survival rate and fecundity. We analyzed the development, survival, longevity, and reproduction of M. basalis (F1 and F2 generations) fed two artificial diets (AD1 and AD2). Both diets contained chicken egg yolk, beer yeast powder, honey, trehalose, seawater spirulina, and potassium sorbate. AD1 also contained sucrose and vitamin C. The duration of F1 1st larvae, F1 2nd larvae, F1 pupae, F2 egg, and F2 2nd larvae reared on AD1 were significantly shorter than those reared on AD2. F1 adult longevity and F2 oviposition period for AD1 (45.40 d and 31.00 d) were significantly longer than for AD2 (30.74 d and 20.80 d). All the following were significantly greater for AD1 compared with AD2: F1 female proportion, F1 daily oviposition, F1 female oviposition, F2 daily oviposition, F2 female oviposition, F1 emergence rate, F2 pupation rate, and F3 egg hatching rate. Moreover, for M. basalis fed AD2, the duration of F2 2nd and 3rd larvae (9.00 d and 8.64 d) were significantly longer than for F1 (4.70 d and 4.92 d). The F1 oviposition period (31.57 d) was significantly longer than F2 (20.80 d). The F2 female oviposition (189.20 egg/female) was significantly less than F1 (307.14 egg/female). We found that the oviposition period and female longevity of F1 reared on AD1 was longer than that reared on the artificial diet in a previous study. The daily oviposition and female oviposition of F1 from AD1 was larger, while the F2 egg hatching rate was greater compared with that from the previous diet. However, the offspring of M. basalis fed AD2 were less thrifty. We found diet AD1 supported development and reproduction better than AD2 and the diets in our previous study. These findings may contribute to the mass rearing of this economically important predatory green lacewing.	[Ye, Jingwen; Li, Jun; Li, Zhigang; Han, Shichou] Guangdong Inst Appl Biol Resources, Dept Invas Biol Control, Guangzhou, Guangdong, Peoples R China; [Ye, Jingwen; Li, Jun; Li, Zhigang; Han, Shichou] Guangdong Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Guangdong, Peoples R China; [Ye, Jingwen; Li, Jun; Li, Zhigang; Han, Shichou] Guangdong Key Lab Anim Conservat & Resource Utili, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Han, SC (corresponding author), Guangdong Inst Appl Biol Resources, Dept Invas Biol Control, Guangzhou, Guangdong, Peoples R China.; Han, SC (corresponding author), Guangdong Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Guangdong, Peoples R China.; Han, SC (corresponding author), Guangdong Key Lab Anim Conservat & Resource Utili, Guangzhou, Guangdong, Peoples R China.	hansc@gdei.gd.cn			National Key Research & Development Program of China [2016YFC1201100]; Science & Technology Planning Project of Guangdong [2015A030302059, 2013B050800024]; Funds for Environment Construction & Capacity Building of GDAS' Research Platform [2016GDASPT-0305]; GDAS Special Project of Science and Technology Development [2017GDASCX-0107]	National Key Research & Development Program of China; Science & Technology Planning Project of Guangdong; Funds for Environment Construction & Capacity Building of GDAS' Research Platform; GDAS Special Project of Science and Technology Development	This study was supported by National Key Research & Development Program of China (2016YFC1201100), Science & Technology Planning Project of Guangdong (2015A030302059, 2013B050800024), Funds for Environment Construction & Capacity Building of GDAS' Research Platform (2016GDASPT-0305), and GDAS Special Project of Science and Technology Development (2017GDASCX-0107).	Albuquerque GS, 1997, J ANIM ECOL, P7; Boo KS, 1998, J CHEM ECOL, V24, P631, DOI 10.1023/A:1022386001722; Chen Chien-Chung, 2014, Journal of Taiwan Agricultural Research, V63, P91; Cheng LL, 2010, BIOL CONTROL, V53, P267, DOI 10.1016/j.biocontrol.2010.02.006; Cohen AC, 1998, BIOL CONTROL, V13, P49, DOI 10.1006/bcon.1998.0636; De Clercq P, 2005, BIOCONTROL SCI TECHN, V15, P467, DOI 10.1080/09583150500086706; De Clercq P. T. A., 2014, MASS PRODUCTION BENE, P57, DOI DOI 10.1016/B978-0-12-391453; Grenier S, 2003, QUALITY CONTROL AND PRODUCTION OF BIOLOGICAL CONTROL AGENTS: THEORY AND TESTING PROCEDURES, P115, DOI 10.1079/9780851996882.0115; Grenier S, 2009, B INSECTOL, V62, P1; Hou RF, 1994, ENTOMOLOGIA EXPT APP, V35, P49; Jiang L, 2013, FOREST PESTS DIS, V32, p[23, 13]; LAMUNYON CW, 1987, ANN ENTOMOL SOC AM, V80, P804, DOI 10.1093/aesa/80.6.804; Lee W. T, 2003, Plant Protection Bulletin (Taichung), V45, P45; Li Zhi-Gang, 2011, Huanjing Kunchong Xuebao, V33, P209; Liu F, 2013, BIOCONTROL, V58, P789, DOI 10.1007/s10526-013-9529-8; Lo N.C., 2002, FORMOSAN ENTOMOL SPE, V3, P1; Lo PKC, 2002, ACTA HORTIC, P201, DOI 10.17660/ActaHortic.2002.578.24; Lu ChiuTung, 2006, Journal of Taiwan Agricultural Research, V55, P111; Nguyen DT, 2015, J APPL ENTOMOL, V139, P1; Riddick EW, 2009, BIOCONTROL, V54, P325, DOI 10.1007/s10526-008-9171-z; Tauber Maurice J., 2000, American Entomologist, V46, P26; Tzeng C. C., 1996, Plant Protection Bulletin (Taichung), V38, P203; Wu TzeKann, 1995, Chinese Journal of Entomology, V15, P113; Ye Jing-Wen, 2013, Huanjing Kunchong Xuebao, V35, P67; Ye JW, 2015, FLA ENTOMOL, V98, P1072; Ye Jingwen, 2012, Chinese Journal of Biological Control, V28, P289; Ye Z. C., 1986, Chinese Journal of Biological Control, V2, P132	27	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185223	10.1371/journal.pone.0185223	http://dx.doi.org/10.1371/journal.pone.0185223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961246	Green Published, gold, Green Submitted			2022-12-26	WOS:000412027700016
J	Su, DD; Hu, XX; Wang, DS; Cui, T; Yao, RY; Sun, HB				Su, Dandan; Hu, Xingxue; Wang, Dashan; Cui, Ting; Yao, Ruyong; Sun, Huibin			Semiconductor laser irradiation improves root canal sealing during routine root canal therapy	PLOS ONE			English	Article							KILL ENTEROCOCCUS-FAECALIS; POWER DIODE-LASER; SMEAR LAYER; IN-VITRO; APICAL PERIODONTITIS; ENDODONTIC TREATMENT; DENTINAL TUBULES; IRRIGATION; BACTERIA; DISINFECTION	Objective To evaluate the effect of semiconductor laser irradiation on root canal sealing after routine root canal therapy (RCT). Methods Sixty freshly extracted single-rooted human teeth were randomly divided into six groups (n = 10). The anatomic crowns were sectioned at the cementoenamel junction and the remaining roots were prepared endodontically with conventional RCT methods. Groups A and B were irradiated with semiconductor laser at 1W for 20 seconds; Groups C and D were ultrasonically rinsed for 60 seconds as positive control groups; Groups E and F without treatment of root canal prior to RCT as negative control groups. Root canal sealing of Groups A, C and E were evaluated by measurements of apical microleakage. The teeth from Groups B, D and F were sectioned, and the micro-structures were examined with scanning electron microscopy (SEM). One way ANOVA and LSD- t test were used for statistical analysis (alpha =.05). Results The apical sealing of both the laser irradiated group and the ultrasonic irrigated group were significantly different from the control group (p 0.5). There was no significant difference between the laser irradiated group and the ultrasonic irrigated group (p>0.5). SEM observation showed that most of the dentinal tubules in the laser irradiation group melted, narrowed or closed, while most of the dentinal tubules in the ultrasonic irrigation group were filled with tooth paste. Conclusion The application of semiconductor laser prior to root canal obturation increases the apical sealing of the roots treated.	[Su, Dandan; Wang, Dashan; Cui, Ting; Sun, Huibin] Qingdao Univ, Dept Stomatol, Affiliated Hosp, Qingdao, Peoples R China; [Hu, Xingxue] Ohio State Univ, Div Gen Practice & Mat Sci, Coll Dent, Columbus, OH 43210 USA; [Yao, Ruyong] Qingdao Univ, Cent Lab, Affiliated Hosp, Qingdao, Peoples R China	Qingdao University; University System of Ohio; Ohio State University; Qingdao University	Sun, HB (corresponding author), Qingdao Univ, Dept Stomatol, Affiliated Hosp, Qingdao, Peoples R China.	shb353.qindao@163.com	su, dan/GYJ-1940-2022					Alfredo E, 2008, J DENT, V36, P529, DOI 10.1016/j.jdent.2008.03.009; Bawazir OA, 2007, J DENT CHILD, V74, P46; BECKER SA, 1989, J ENDODONT, V15, P246, DOI 10.1016/S0099-2399(89)80217-1; Berutti E, 1997, J ENDODONT, V23, P725, DOI 10.1016/S0099-2399(97)80342-1; de Souza EB, 2008, ORAL SURG ORAL MED O, V106, pE68, DOI 10.1016/j.tripleo.2008.02.032; Eldeniz AU, 2007, INT ENDOD J, V40, P329, DOI 10.1111/j.1365-2591.2007.01211.x; Fan Mingwen, 2012, ENDODONTICS, P260; Fan Mingwen, 2012, ENDODONTICS, P317; Fleming CH, 2010, J ENDODONT, V36, P414, DOI 10.1016/j.joen.2009.11.013; Gutknecht N, 2004, J CLIN LASER MED SUR, V22, P9, DOI 10.1089/104454704773660912; Hui Zhao, 2015, SHANDONG MED J, V55, P86; Kuah HG, 2009, J ENDODONT, V35, P393, DOI 10.1016/j.joen.2008.12.007; Lee SJ, 2004, INT ENDOD J, V37, P672, DOI 10.1111/j.1365-2591.2004.00848.x; Li Wanghong, 2001, ZHEJIANG MED J, V23, P726; Li Yuliang, 2011, J PRACTICAL MED TECH, V18, P1153; [刘畅 Liu Chang], 2010, [实用口腔医学杂志, Journal of Practical Stomatology], V26, P650; Lottanti S, 2009, INT ENDOD J, V42, P335, DOI 10.1111/j.1365-2591.2008.01514.x; Meire MA, 2009, INT ENDOD J, V42, P351, DOI 10.1111/j.1365-2591.2008.01532.x; MOR C, 1995, ENDOD DENT TRAUMATOL, V11, P169; Moritz A, 2000, LASER SURG MED, V26, P250, DOI 10.1002/(SICI)1096-9101(2000)26:3<250::AID-LSM2>3.0.CO;2-H; Nair PNR, 2005, ORAL SURG ORAL MED O, V99, P231, DOI 10.1016/j.tripleo.2004.10.005; Niu W, 2002, INT ENDOD J, V35, P934, DOI 10.1046/j.1365-2591.2002.00594.x; Ozata F, 1999, J ENDODONT, V25, P603, DOI 10.1016/S0099-2399(99)80317-3; Peters LB, 2001, J ENDODONT, V27, P76, DOI 10.1097/00004770-200102000-00002; Peters OA, 2001, INT ENDOD J, V34, P221, DOI 10.1046/j.1365-2591.2001.00373.x; Pirnat S, 2011, LASER MED SCI, V26, P755, DOI 10.1007/s10103-010-0808-7; Preethee Thomas, 2012, J Conserv Dent, V15, P46, DOI 10.4103/0972-0707.92606; Radaelli CM, 2003, INT CONGR SER, V1248, P273, DOI 10.1016/S0531-5131(02)01308-0; Rohde TR, 1996, J ENDODONT, V22, P365, DOI 10.1016/S0099-2399(96)80220-2; Romeo U, 2015, AUST ENDOD J, V41, P17, DOI 10.1111/aej.12057; Schoop U, 2004, LASER SURG MED, V35, P111, DOI 10.1002/lsm.20026; Siqueira JF, 2000, J ENDODONT, V26, P331, DOI 10.1097/00004770-200006000-00006; SJOGREN U, 1990, J ENDODONT, V16, P498; Stabholz Adam, 2008, Alpha Omegan, V101, P195, DOI 10.1016/j.aodf.2008.07.029; Townsend C, 2009, J ENDODONT, V35, P1040, DOI 10.1016/j.joen.2009.04.007; Upadya MH, 2010, INT ENDOD J, V43, P978, DOI 10.1111/j.1365-2591.2010.01717.x; Violich DR, 2010, INT ENDOD J, V43, P2, DOI 10.1111/j.1365-2591.2009.01627.x; Wu Xiaozhen, 2014, J CLIN STOMATOLOGY, V30, P294; [张晓 Zhang Xiao], 2013, [实用口腔医学杂志, Journal of Practical Stomatology], V29, P101	39	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185512	10.1371/journal.pone.0185512	http://dx.doi.org/10.1371/journal.pone.0185512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957407	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200072
J	Winsvold, BS; Bettella, F; Witoelar, A; Anttila, V; Gormley, P; Kurth, T; Terwindt, GM; Freilinger, TM; Frei, O; Shadrin, A; Wang, YP; Dale, AM; van den Maagdenberg, AMJM; Chasman, DI; Nyholt, DR; Palotie, A; Andreassen, OA; Zwart, JA				Winsvold, Bendik S.; Bettella, Francesco; Witoelar, Aree; Anttila, Verneri; Gormley, Padhraig; Kurth, Tobias; Terwindt, Gisela M.; Freilinger, Tobias M.; Frei, Oleksander; Shadrin, Alexey; Wang, Yunpeng; Dale, Anders M.; van den Maagdenberg, Am M. J. M.; Chasman, Daniel I.; Nyholt, Dale R.; Palotie, Aarno; Andreassen, Ole A.; Zwart, John-Anker		Int Headache Genetics Consortium	Shared genetic risk between migraine and coronary artery disease: A genome-wide analysis of common variants	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; PROSTATE-CANCER; ASSOCIATION; METAANALYSIS; SCHIZOPHRENIA; PLEIOTROPY; CHANNELS; GENOTYPE; PROTEIN; CELLS	Migraine is a recurrent pain condition traditionally viewed as a neurovascular disorder, but little is known of its vascular basis. In epidemiological studies migraine is associated with an increased risk of cardiovascular disease, including coronary artery disease (CAD), suggesting shared pathogenic mechanisms. This study aimed to determine the genetic overlap between migraine and CAD, and to identify shared genetic risk loci, utilizing a conditional false discovery rate approach and data from two large-scale genome-wide association studies (GWAS) of CAD (C4D, 15,420 cases, 15,062 controls; CARDIoGRAM, 22,233 cases, 64,762 controls) and one of migraine (22,120 cases, 91,284 controls). We found significant enrichment of genetic variants associated with CAD as a function of their association with migraine, which was replicated across two independent CAD GWAS studies. One shared risk locus in the PHACTR1 gene (conjunctional false discovery rate for index SNP rs9349379 < 3.90 x 10(-5)), which was also identified in previous studies, explained much of the enrichment. Two further loci (in KCNK5 and AS3MT) showed evidence for shared risk (conjunctional false discovery rate < 0.05). The index SNPs at two of the three loci had opposite effect directions in migraine and CAD. Our results confirm previous reports that migraine and CAD share genetic risk loci in excess of what would be expected by chance, and highlight one shared risk locus in PHACTR1. Understanding the biological mechanisms underpinning this shared risk is likely to improve our understanding of both disorders.	[Winsvold, Bendik S.; Zwart, John-Anker] Oslo Univ Hosp, FORMI, Oslo, Norway; [Winsvold, Bendik S.; Zwart, John-Anker] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Winsvold, Bendik S.; Bettella, Francesco; Witoelar, Aree; Frei, Oleksander; Shadrin, Alexey; Wang, Yunpeng; Andreassen, Ole A.; Zwart, John-Anker] Univ Oslo, Inst Clin Med, Oslo, Norway; [Bettella, Francesco; Witoelar, Aree; Frei, Oleksander; Shadrin, Alexey; Wang, Yunpeng; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, NORMENT KG Jebsen Ctr, Oslo, Norway; [Anttila, Verneri] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Anttila, Verneri; Chasman, Daniel I.] Harvard Med Sch, Boston, MA USA; [Anttila, Verneri; Gormley, Padhraig; Palotie, Aarno] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Anttila, Verneri; Gormley, Padhraig; Palotie, Aarno] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Gormley, Padhraig; Palotie, Aarno] Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Kurth, Tobias] Charite Univ Med Berlin, Inst Publ Hlth, Berlin, Germany; [Kurth, Tobias; Chasman, Daniel I.] Harvard Med Sch, Brigham & Womens Hosp, Div Prevent Med, Boston, MA USA; [Terwindt, Gisela M.; van den Maagdenberg, Am M. J. M.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Freilinger, Tobias M.] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Tubingen, Germany; [Freilinger, Tobias M.] Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Dale, Anders M.] Univ Calif San Diego, Ctr Multimodal Imaging & Genet, La Jolla, CA 92093 USA; [van den Maagdenberg, Am M. J. M.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Nyholt, Dale R.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Stat & Genom Epidemiol Lab, Kelvin Grove, Australia; [Int Headache Genetics Consortium] Int Headache Genet Consortium, Helsinki, Finland	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; University of California System; University of California San Diego; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Queensland University of Technology (QUT)	Winsvold, BS (corresponding author), Oslo Univ Hosp, FORMI, Oslo, Norway.; Winsvold, BS (corresponding author), Oslo Univ Hosp, Dept Neurol, Oslo, Norway.; Winsvold, BS (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	bendik.s.winsvold@gmail.com	Kurth, Tobias/A-9243-2012; Andreassen, Ole A./AAY-7531-2020; Belin, Andrea Carmine/AAV-9933-2021; Winsvold, Bendik/ABF-7839-2021; Nyholt, Dale Robert/J-3174-2017; van den Maagdenberg, Arn M.J.M./AAE-9052-2019; Gormley, Padhraig/L-1949-2018; Wang, Yunpeng/W-8871-2018; Hansen, Thomas Folkmann/O-5965-2014	Kurth, Tobias/0000-0001-7169-2620; Belin, Andrea Carmine/0000-0001-6668-3172; Winsvold, Bendik/0000-0003-4171-8919; Nyholt, Dale Robert/0000-0001-7159-3040; Gormley, Padhraig/0000-0002-8908-6968; Wang, Yunpeng/0000-0001-9831-1090; Hansen, Thomas Folkmann/0000-0001-6703-7762; vila-pueyo, marta/0000-0003-0652-2988; Palotie, Aarno/0000-0002-2527-5874	Research Council of Norway [231187/F20, 248778, 223273]; KG Jebsen Stiftelsen; EU [6026337]; 23AMP;Me Inc. (Mountain View, USA); Decode genetics Inc. (Reykjavik, Iceland); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS092963] Funding Source: NIH RePORTER; Medical Research Council [MR/N01104X/2, MR/N01104X/1, G1001799] Funding Source: researchfish; MRC [G1001799, MR/N01104X/2, MR/N01104X/1] Funding Source: UKRI	Research Council of Norway(Research Council of Norway); KG Jebsen Stiftelsen; EU(European Commission); 23AMP;Me Inc. (Mountain View, USA); Decode genetics Inc. (Reykjavik, Iceland); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Research Council of Norway (grant # 231187/F20 to BSW, grant # 248778, # 223273 to OAA), KG Jebsen Stiftelsen (OAA) and EU-funded FP7 "EUROHEADPAIN" grant (nr. 6026337 to AMvdM & AP). Data on coronary artery disease have been contributed by CARDloGRAMplusC4D investigators and have been downloaded from www.CARDIOGRAMPLUSG4D.ORG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 23&Me Inc. (Mountain View, USA) provided support in the form of salaries for authors NF, NL, CN (see Acknowledgments), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Decode genetics Inc. (Reykjavik, Iceland) provided support in the form of salaries for authors Al, KS, HS and SS (see Acknowledgments), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain B, 2012, CELL SIGNAL, V24, P214, DOI 10.1016/j.cellsig.2011.09.003; Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andreassen OA, 2015, MOL PSYCHIATR, V20, P207, DOI 10.1038/mp.2013.195; Andreassen OA, 2014, INT J EPIDEMIOL, V43, P1205, DOI 10.1093/ije/dyu090; Andreassen OA, 2014, HYPERTENSION, V63, P819, DOI 10.1161/HYPERTENSIONAHA.113.02077; Andreassen OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003455; Andreassen OA, 2013, AM J HUM GENET, V92, P197, DOI 10.1016/j.ajhg.2013.01.001; Anttila V, 2013, NAT GENET, V45, P912, DOI 10.1038/ng.2676; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Cazals Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9780; Debette S, 2015, NAT GENET, V47, P78, DOI 10.1038/ng.3154; Debette S, 2009, LANCET NEUROL, V8, P668, DOI 10.1016/S1474-4422(09)70084-5; Desikan RS, 2015, CIRCULATION, V131, P2061, DOI 10.1161/CIRCULATIONAHA.115.015489; Freilinger T, 2012, NAT GENET, V44, P777, DOI 10.1038/ng.2307; Gestreau C, 2010, P NATL ACAD SCI USA, V107, P2325, DOI 10.1073/pnas.0910059107; Gonczi M, 2006, BRIT J PHARMACOL, V147, P496, DOI 10.1038/sj.bjp.0706649; Gormley P, 2016, NAT GENET, V48, P856, DOI 10.1038/ng.3598; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Kurth T, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2610; Lehner B, 2013, NAT REV GENET, V14, P168, DOI 10.1038/nrg3404; Li M, 2016, NAT MED, V22, P649, DOI 10.1038/nm.4096; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; MACHIELA MJ, 2015, BIOINFORMATICS, V31, P3555, DOI DOI 10.1093/BI0INF0RMATICS/BTV402; Malik R, 2015, NEUROLOGY, V84, P2132, DOI 10.1212/WNL.0000000000001606; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Patel RS, 2012, AM J HYPERTENS, V25, P797, DOI 10.1038/ajh.2012.41; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Pietrobon D, 2013, ANNU REV PHYSIOL, V75, P365, DOI 10.1146/annurev-physiol-030212-183717; Polderman TJC, 2015, NAT GENET, V47, P702, DOI 10.1038/ng.3285; Rodriguez-Osorio X, 2012, NEUROLOGY, V79, P474, DOI 10.1212/WNL.0b013e31826170ce; Sacco S, 2015, EUR J NEUROL, V22, P1001, DOI 10.1111/ene.12701; Schork AJ, 2016, CURR OPIN NEUROBIOL, V36, P89, DOI 10.1016/j.conb.2015.10.008; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Spector JT, 2010, AM J MED, V123, P612, DOI 10.1016/j.amjmed.2009.12.021; Tajti J, 2011, J NEURAL TRANSM, V118, P511, DOI 10.1007/s00702-010-0515-3; Tietjen GE, 2009, CEPHALALGIA, V29, P989, DOI 10.1111/j.1468-2982.2009.01937.x; Verhaaren BFJ, 2015, CIRC-CARDIOVASC GENE, V8, P398, DOI 10.1161/CIRCGENETICS.114.000858; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Winsvold BS, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000010; Winsvold BS, 2013, PAIN, V154, P1305, DOI 10.1016/j.pain.2013.04.007; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563	51	29	30	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185663	10.1371/journal.pone.0185663	http://dx.doi.org/10.1371/journal.pone.0185663			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957430	gold, Green Published, Green Submitted			2022-12-26	WOS:000411985200103
J	Di Ruocco, F; Basso, V; Rivoire, M; Mehlen, P; Ambati, J; De Falco, S; Tarallo, V				Di Ruocco, F.; Basso, V.; Rivoire, M.; Mehlen, P.; Ambati, J.; De Falco, S.; Tarallo, V.			Alu RNA accumulation induces epithelial-to-mesenchymal transition by modulating miR-566 and is associated with cancer progression	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; DOWN-REGULATION; POOR-PROGNOSIS; NONCODING RNAS; 7SL RNA; EXPRESSION; DICER; METASTASIS; INITIATION; ELEMENTS	Alu sequences are the most abundant short interspersed repeated elements in the human genome. Here we show that in a cell culture model of colorectal cancer (CRC) progression, we observe accumulation of Alu RNA that is associated with reduced DICER1 levels. Alu RNA induces epithelial-to-mesenchymal transition (EMT) by acting as a molecular sponge of miR-566. Moreover, Alu RNA accumulates as consequence of DICER1 deficit in colorectal, ovarian, renal and breast cancer cell lines. Interestingly, Alu RNA knockdown prevents DICER1 depletion-induced EMT despite global microRNA (miRNA) downregulation. Alu RNA expression is also induced by transforming growth factor-beta 1, a major driver of EMT. Corroborating this data, we found that non-coding Alu RNA significantly correlates with tumor progression in human CRC patients. Together, these findings reveal an unexpected DICER1-dependent, miRNA-independent role of Alu RNA in cancer progression that could bring mobile element transcripts in the fields of cancer therapeutic and prognosis.	[Di Ruocco, F.; De Falco, S.; Tarallo, V.] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, Angiogenesis Lab, 111 Pietro Castellino St, I-80131 Naples, Italy; [Basso, V.; Mehlen, P.] Univ Lyon, CNRS UMR5286, Equipe Labellisee La Ligue,Ctr Leon Berard,INSERM, LabEx DEVweCAN,Ctr Rech Cancerol Lyon,Apoptosis C, Lyon, France; [Rivoire, M.] Ctr Leon Berard, Surg Dept, Lyon, France; [Ambati, J.] Univ Virginia, Sch Med, Ctr Adv Vis Sci, Dept Ophthalmol, Charlottesville, VA 22908 USA; [Ambati, J.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA; [Ambati, J.] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard; University of Virginia; University of Virginia; University of Virginia	Tarallo, V (corresponding author), CNR, Inst Genet & Biophys Adriano Buzzati Traverso, Angiogenesis Lab, 111 Pietro Castellino St, I-80131 Naples, Italy.	valeria.tarallo@igb.cnr.it		De Falco, Sandro/0000-0002-6501-1697; Tarallo, Valeria/0000-0002-6920-4402	Marie Curie Action [FP7-PEOPLE-2013-CIG 631311 CanAlu]; Italian Ministry of Scientific Research [PON 01_01434 REACT]; EU Horizon (TRANSCAN-2, project BeFIT); Nuovo-Soldati Cancer Research Foundation	Marie Curie Action(European Commission); Italian Ministry of Scientific Research(Ministry of Education, Universities and Research (MIUR)); EU Horizon (TRANSCAN-2, project BeFIT); Nuovo-Soldati Cancer Research Foundation	We thank the IGB integrated microscopy and FACS facilities and Grazia Mercadante for technical assistance, and Ivana Apicella, Valeria Cicatiello, Nagaraj Kerur and Monica Autiero for discussions. This work was supported by Marie Curie Action (FP7-PEOPLE-2013-CIG 631311 CanAlu) to VT, Italian Ministry of Scientific Research (PON 01_01434 REACT) and EU Horizon2020 (TRANSCAN-2, project BeFIT) to SDF, and Nuovo-Soldati Cancer Research Foundation to VB.	Alsaleh G, 2016, ARTHRITIS RHEUMATOL, V68, P1839, DOI 10.1002/art.39641; Baryakin DN, 2013, ACTA NATURAE, V5, P83, DOI 10.32607/20758251-2013-5-4-83-93; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Cho NY, 2007, J PATHOL, V211, P269, DOI 10.1002/path.2106; Cordaux R, 2010, METHODS MOL BIOL, V628, P137, DOI 10.1007/978-1-60327-367-1_8; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Daskalos A, 2009, INT J CANCER, V124, P81, DOI 10.1002/ijc.23849; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Deininger P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-236; Drusco A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096670; Faggad A, 2012, HISTOPATHOLOGY, V61, P552, DOI 10.1111/j.1365-2559.2011.04110.x; Gomez I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018023; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; Hasler J, 2007, CELL MOL LIFE SCI, V64, P1793, DOI 10.1007/s00018-007-7084-0; Hewitt RE, 2000, J PATHOL, V192, P446; Hung T, 2015, SCIENCE, V350, P455, DOI 10.1126/science.aac7442; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kitagawa N, 2013, CANCER SCI, V104, P543, DOI 10.1111/cas.12126; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Leonova KI, 2013, P NATL ACAD SCI USA, V110, pE89, DOI 10.1073/pnas.1216922110; Liu CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep33947; Ma X., 2014, UROL ONCOL, V32, P46; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Pandey R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r117; PANNING B, 1994, VIROLOGY, V202, P408, DOI 10.1006/viro.1994.1357; Rupaimoole R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6202; SAKAMOTO K, 1991, J BIOL CHEM, V266, P3031; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shaikh TH, 1997, J MOL BIOL, V271, P222, DOI 10.1006/jmbi.1997.1161; Shibue T, 2013, CANCER CELL, V24, P481, DOI 10.1016/j.ccr.2013.08.012; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Tang RB, 2005, MOL CARCINOGEN, V42, P93, DOI 10.1002/mc.20057; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Tsushima H, 2001, CLIN CANCER RES, V7, P1258; van den Beucken T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6203; Wang W, 2016, MOL CELL ENDOCRINOL, V426, P91, DOI 10.1016/j.mce.2016.02.008; Xiang SY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-44; Zhang KL, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-63	41	28	28	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 1	2018	37	5					627	637		10.1038/onc.2017.369	http://dx.doi.org/10.1038/onc.2017.369			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FU4GT	28991230	Green Published, hybrid			2022-12-26	WOS:000423812200008
J	Sehgal, P; Szalai, P; Olesen, C; Praetorius, HA; Nissen, P; Christensen, SB; Engedal, N; Moller, JV				Sehgal, Pankaj; Szalai, Paula; Olesen, Claus; Praetorius, Helle A.; Nissen, Poul; Christensen, Soren Brogger; Engedal, Nikolai; Moller, Jesper V.			Inhibition of the sarco/endoplasmic reticulum (ER) Ca2+-ATPase by thapsigargin analogs induces cell death via ER Ca2+ depletion and the unfolded protein response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; calcium; endoplasmic reticulum (ER); stromal interaction molecule 1 (STIM1); unfolded protein response (UPR)	PROSTATE-SPECIFIC ANTIGEN; SARCOPLASMIC-RETICULUM; CALCIUM-PUMP; CANCER CELLS; INTRACELLULAR CALCIUM; APOPTOSIS; CALPAIN; PRODRUG; STRESS; INACTIVATION	Calcium (Ca2+) is a fundamental regulator of cell signaling and function. Thapsigargin (Tg) blocks the sarco/endoplasmic reticulum (ER) Ca2+-ATPase (SERCA), disrupts Ca2+ homeostasis, and causes cell death. However, the exact mechanisms whereby SERCA inhibition induces cell death are incompletely understood. Here, we report that low (0.1 m) concentrations of Tg and Tg analogs with various long-chain substitutions at the O-8 position extensively inhibit SERCA1a-mediated Ca2+ transport. We also found that, in both prostate and breast cancer cells, exposure to Tg or Tg analogs for 1 day caused extensive drainage of the ER Ca2+ stores. This Ca2+ depletion was followed by markedly reduced cell proliferation rates and morphological changes that developed over 2-4 days and culminated in cell death. Interestingly, these changes were not accompanied by bulk increases in cytosolic Ca2+ levels. Moreover, knockdown of two key store-operated Ca2+ entry (SOCE) components, Orai1 and STIM1, did not reduce Tg cytotoxicity, indicating that SOCE and Ca2+ entry are not critical for Tg-induced cell death. However, we observed a correlation between the abilities of Tg and Tg analogs to deplete ER Ca2+ stores and their detrimental effects on cell viability. Furthermore, caspase activation and cell death were associated with a sustained unfolded protein response. We conclude that ER Ca2+ drainage and sustained unfolded protein response activation are key for initiation of apoptosis at low concentrations of Tg and Tg analogs, whereas high cytosolic Ca2+ levels and SOCE are not required.	[Sehgal, Pankaj; Olesen, Claus; Praetorius, Helle A.; Moller, Jesper V.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; [Sehgal, Pankaj] Univ Toronto, Sunnybrook Res Inst, Biol Platform, Toronto, ON M4N 3M5, Canada; [Sehgal, Pankaj] Univ Toronto, Dept Biochem, Toronto, ON M4N 3M5, Canada; [Sehgal, Pankaj; Olesen, Claus; Nissen, Poul; Moller, Jesper V.] Danish Res Fdn, Ctr Membrane Pumps Cells & Dis Pumpkin, DK-8000 Aarhus, Denmark; [Szalai, Paula; Engedal, Nikolai] Univ Oslo, Ctr Mol Med Norway NCMM, Nord European Mol Biol Lab EMBL Partnership Mol M, POB 1137 Blindern, N-0318 Oslo, Norway; [Nissen, Poul] Danish Res Inst Translat Neurosci DANDRITE, Dept Mol Biol & Genet, Nord EMBL Partnership Mol Med, DK-8000 Aarhus, Denmark; [Christensen, Soren Brogger] Univ Copenhagen, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark	Aarhus University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Oslo; University of Copenhagen	Moller, JV (corresponding author), Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark.; Engedal, N (corresponding author), Univ Oslo, Ctr Mol Med Norway NCMM, Nord European Mol Biol Lab EMBL Partnership Mol M, POB 1137 Blindern, N-0318 Oslo, Norway.	k.n.engedal@ncmm.uio.no; jvm@biomed.au.dk	Engedal, Nikolai/AAJ-8951-2020; Christensen, Søren Brøgger/H-4526-2019; Lindner, Paula/S-6929-2019	Engedal, Nikolai/0000-0003-3718-3464; Christensen, Søren Brøgger/0000-0002-5773-6874; Lindner, Paula/0000-0003-0734-6429; Olesen, Claus/0000-0002-0462-1686; Praetorius, Helle/0000-0002-0970-5061; Nissen, Poul/0000-0003-0948-6628	Danish Council for Strategic Research (SPOT-Light); Danish National Research Foundation (DNRF); Canadian Institutes of Health Foundation; DNRF; Lundbeck Foundation; Karen Elise Jensen Foundation; Lundbeck Foundation [R191-2015-1512] Funding Source: researchfish	Danish Council for Strategic Research (SPOT-Light); Danish National Research Foundation (DNRF)(Danmarks Grundforskningsfond); Canadian Institutes of Health Foundation(Canadian Institutes of Health Research (CIHR)); DNRF; Lundbeck Foundation(Lundbeckfonden); Karen Elise Jensen Foundation; Lundbeck Foundation(Lundbeckfonden)	This work was supported by The Danish Council for Strategic Research (SPOT-Light) and from The Danish National Research Foundation (DNRF) to the Centre for Membrane Pumps in Cells and Disease (PUMPkin). The experiments performed at Sunnybrook Research Institute were supported by grants from the Canadian Institutes of Health Foundation (to David W. Andrews). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by DNRF and grants from The Lundbeck Foundation (to J. V. M.) and the Karen Elise Jensen Foundation (to C. O.).	Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; CHRISTENSEN SB, 1982, J ORG CHEM, V47, P649; Chua BT, 2000, J BIOL CHEM, V275, P5131, DOI 10.1074/jbc.275.7.5131; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; Denmeade SR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003886; Denmeade SR, 1997, CANCER RES, V57, P4924; Denmeade SR, 2005, CANCER BIOL THER, V4, P14; Denmeade SR, 2003, J NATL CANCER I, V95, P990, DOI 10.1093/jnci/95.13.990; Dubois C, 2013, FEBS J, V280, P5430, DOI 10.1111/febs.12475; Engedal N, 2013, AUTOPHAGY, V9, P1475, DOI 10.4161/auto.25900; Flourakis M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.52; Fortea MI, 2001, J BIOL CHEM, V276, P37266, DOI 10.1074/jbc.M103949200; GERDES U, 1983, BIOCHIM BIOPHYS ACTA, V734, P191, DOI 10.1016/0005-2736(83)90117-7; Griend DJV, 2009, MOL CANCER THER, V8, P1340, DOI 10.1158/1535-7163.MCT-08-1136; Jakobsen CM, 2001, J MED CHEM, V44, P4696, DOI 10.1021/jm010985a; Kroemer G, 2015, J CLIN INVEST, V125, P1, DOI 10.1172/JCI78652; Lankiewicz S, 2000, J BIOL CHEM, V275, P17064, DOI 10.1074/jbc.275.22.17064; Lee AG, 2001, BIOCHEM J, V356, P665, DOI 10.1042/0264-6021:3560665; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; LEVY D, 1990, J BIOL CHEM, V265, P19524; Levy O, 2016, BIOMATERIALS, V91, P140, DOI 10.1016/j.biomaterials.2016.03.023; Lotem J, 1998, P NATL ACAD SCI USA, V95, P4601, DOI 10.1073/pnas.95.8.4601; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Mahalingam D, 2016, BRIT J CANCER, V114, P986, DOI 10.1038/bjc.2016.72; Moller JV, 2016, METHODS MOL BIOL, V1377, P11, DOI 10.1007/978-1-4939-3179-8_3; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Muruganandan S, 2006, TOXICOL SCI, V94, P118, DOI 10.1093/toxsci/kfl084; Musgaard M, 2012, BIOPHYS J, V102, P268, DOI 10.1016/j.bpj.2011.12.009; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Papp B, 2012, BIOMOLECULES, V2, P165, DOI 10.3390/biom2010165; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; SAGARA Y, 1992, J BIOL CHEM, V267, P1286; Schwarze SR, 2008, PROSTATE, V68, P1615, DOI 10.1002/pros.20828; Sohoel H, 2006, BIOORGAN MED CHEM, V14, P2810, DOI 10.1016/j.bmc.2005.12.001; Tombal B, 2000, PROSTATE, V43, P303; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; WICTOME M, 1992, FEBS LETT, V304, P109, DOI 10.1016/0014-5793(92)80599-C; Winther AML, 2010, J BIOL CHEM, V285, P28883, DOI 10.1074/jbc.M110.136242; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200	43	92	94	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19656	19673		10.1074/jbc.M117.796920	http://dx.doi.org/10.1074/jbc.M117.796920			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972171	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000416911300013
J	Garg, H; Loughlin, PC; Willows, RD; Chen, M				Garg, Harsh; Loughlin, Patrick C.; Willows, Robert D.; Chen, Min			The C2(1)-formyl group in chlorophyll f originates from molecular oxygen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosynthesis; chlorophyll; cyanobacteria; isotopic tracer; mass spectrometry (MS); photosynthetic pigment; chlorophyll f; deuterated molecules	RHODOBACTER-SPHAEROIDES; DEUTERIUM; DEGRADATION; DERIVATION; WATER; BACTERIOCHLOROPHYLL; CYANOBACTERIUM; METABOLISM; CONVERSION; O-18(2)	Chlorophylls (Chls) are the most important cofactors for capturing solar energy to drive photosynthetic reactions. Five spectral types of Chls have been identified to date, with Chl f having the most red-shifted absorption maximum because of a C2(1)-formyl group substitution of Chl f. However, the biochemical provenance of this formyl group is unknown. Here, we used a stable isotope labeling technique (O-18 and H-2) to determine the origin of the C2(1)-formyl group of Chl f and to verify whether Chl f is synthesized from Chl a in the cyanobacterial species Halomicronema hongdechloris. In the presence of either (H2O)-O-18 or O-18(2), the origin of oxygen atoms in the newly synthesized chlorophylls was investigated. The pigments were isolated with HPLC, followed by MS analysis. We found that the oxygen atom of the C2(1)-formyl group originates from molecular oxygen and not from H2O. Moreover, we examined the kinetics of the labeling of Chl a and Chl f from H. hongdechloris grown in 50% D2O-seawater medium under different light conditions. When cells were shifted from white light D2O-seawater medium to far-red light H2O-seawater medium, the observed deuteration in Chl f indicated that Chl(ide) a is the precursor of Chl f. Taken together, our results advance our understanding of the biosynthesis pathway of the chlorophylls and the formation of the formyl group in Chl f.	[Garg, Harsh; Loughlin, Patrick C.; Chen, Min] Univ Sydney, Australian Res Council Ctr Excellence Translat Ph, Sydney, NSW 2006, Australia; [Garg, Harsh; Loughlin, Patrick C.; Chen, Min] Univ Sydney, Sch Life & Environm Sci, A12 Macleay Bldg, Sydney, NSW 2006, Australia; [Willows, Robert D.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia	University of Sydney; University of Sydney; Macquarie University	Chen, M (corresponding author), Univ Sydney, Sch Life & Environm Sci, A12 Macleay Bldg, Sydney, NSW 2006, Australia.	min.chen@sydney.edu.au	Willows, Robert/C-1537-2010	Willows, Robert/0000-0002-0731-2950; Chen, Min/0000-0001-8070-3248	Australian Research Council [CE140100015]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council Grant CE140100015. The authors declare that they have no conflicts of interest with the contents of this article.	Akutsu S., 2011, PHOTOMED PHOTOBIOL, V33, P35; Berry D, 2015, P NATL ACAD SCI USA, V112, pE194, DOI 10.1073/pnas.1420406112; Busch R, 2006, BBA-GEN SUBJECTS, V1760, P730, DOI 10.1016/j.bbagen.2005.12.023; Chen M, 2014, ANNU REV BIOCHEM, V83, P317, DOI 10.1146/annurev-biochem-072711-162943; Chen M, 2012, FEBS LETT, V586, P3249, DOI 10.1016/j.febslet.2012.06.045; Chen M, 2011, TRENDS PLANT SCI, V16, P427, DOI 10.1016/j.tplants.2011.03.011; Chen M, 2010, SCIENCE, V329, P1318, DOI 10.1126/science.1191127; CHORNEY W, 1960, BIOCHIM BIOPHYS ACTA, V37, P280, DOI 10.1016/0006-3002(60)90235-3; Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/NCHEMBIO.1555, 10.1038/nchembio.1555]; Egorova-Zachernyuk T, 2008, MAGN RESON CHEM, V46, P1074, DOI 10.1002/mrc.2295; Folly P, 1999, J BIOL CHEM, V274, P21811, DOI 10.1074/jbc.274.31.21811; Garvey CJ, 2013, INT J MOL SCI, V14, P8148, DOI 10.3390/ijms14048148; GRANICK S., 1965, P67; Ho MY, 2016, SCIENCE, V353, DOI 10.1126/science.aaf9178; Hochuli M, 2000, J BIOMOL NMR, V17, P33, DOI 10.1023/A:1008329124672; Hollingshead S, 2017, BIOCHEM J, V474, P667, DOI 10.1042/BCJ20161002; Ito H, 1996, J BIOL CHEM, V271, P1475, DOI 10.1074/jbc.271.3.1475; Kasumov T., 2015, RECENT ADV PROTEOMIC; KATZ JJ, 1964, J AM CHEM SOC, V86, P4220, DOI 10.1021/ja01073a080; KELLER MD, 1987, J PHYCOL, V23, P633; Krautler B, 2011, ANGEW CHEM INT EDIT, V50, P2439, DOI 10.1002/anie.201007339; LESTER W, 1960, ANN NY ACAD SCI, V84, P667, DOI 10.1111/j.1749-6632.1960.tb39099.x; Li YQ, 2016, BBA-BIOENERGETICS, V1857, P107, DOI 10.1016/j.bbabio.2015.10.009; Li YQ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00067; Loughlin PC, 2014, SCI REP-UK, V4, DOI 10.1038/srep06069; Lu M., 2013, AFR J MICROBIOL RES, V7, P604; Mosin O., 2015, J HLTH MED NURSING, V11, P2422; Mosin O. V., 2014, EUR J MOL BIOTECHNOL, V3, P11; Mosin OV, 2012, WATER CHEM ECOLOGY, V3, P83; PENGELLY WL, 1983, PLANT PHYSIOL, V73, P445, DOI 10.1104/pp.73.2.445; PORRA RJ, 1994, EUR J BIOCHEM, V219, P671, DOI 10.1111/j.1432-1033.1994.tb19983.x; Porra RJ, 2000, PHOTOSYNTH RES, V66, P159, DOI 10.1023/A:1010631505071; PORRA RJ, 1995, FEBS LETT, V371, P21, DOI 10.1016/0014-5793(95)00854-3; Porra RJ, 1996, EUR J BIOCHEM, V239, P85, DOI 10.1111/j.1432-1033.1996.0085u.x; Schliep M, 2010, J BIOL CHEM, V285, P28450, DOI 10.1074/jbc.M110.146753; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; Tcherkez G, 2009, PLANT PHYSIOL, V151, P620, DOI 10.1104/pp.109.142976; Vavilin D, 2005, BBA-BIOENERGETICS, V1708, P91, DOI 10.1016/j.bbabio.2004.12.011; WILLOWS RD, 1994, AUST J PLANT PHYSIOL, V21, P327, DOI 10.1071/PP9940327; Willows RD, 2013, ORG LETT, V15, P1588, DOI 10.1021/ol400327j	41	14	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19279	19289		10.1074/jbc.M117.814756	http://dx.doi.org/10.1074/jbc.M117.814756			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972142	Green Published, hybrid			2022-12-26	WOS:000416226700011
J	de Gouveia, NM; Rodrigues, WF; de Sousa, RMF; Calabria, LK; Mundim, AV; Miguel, CB; Oliveira, CJF; Lazo-Chica, JE; de Oliveira, A; Lago, JHG; dos Santos, VB; do Lago, CL; Espindola, FS				de Gouveia, Neire M.; Rodrigues, Wellington F.; de Sousa, Raquel M. F.; Calabria, Luciana K.; Mundim, Antonio V.; Miguel, Camila B.; Oliveira, Carlo J. F.; Lazo-Chica, Javier E.; de Oliveira, Alberto; Lago, Joao H. G.; dos Santos, Vagner B.; do Lago, Claudimir L.; Espindola, Foued S.			Phytochemical characterization of the Vochysia rufa (Vochysiaceae) extract and its effects on oxidative stress in the pancreata of streptozotocin-induced diabetic rats	PLOS ONE			English	Article							GLUTATHIONE-PEROXIDASE; ANTIOXIDANT ACTIVITIES; LIPID-PEROXIDATION; BETA-CELL; IN-VIVO; POLYSACCHARIDES; MICE; GLUCOSE; LIVER; ACID	Aqueous extract of macerated Vochysia rufa stem bark has been commonly used in the treatment of diabetes. Therefore, we evaluated the antihyperglycemic and antioxidant effects of an extract of V. rufa on the pancreata of streptozotocin (STZ)-induced diabetic rats. Animals received one of the following treatments daily by oral gavage: water (diabetic- control), V. rufa extract (diabetic- V. rufa), or glibenclamide (diabetic- GBD). Total antioxidant capacity; levels of thiobarbituric acid reactive substances, reduced glutathione, and sulfhydryls; and superoxide dismutase, catalase, and glutathione peroxidase (GPx) activities were measured in the pancreas. Biochemical analysis of serum total cholesterol and fractions, triglycerides, creatinine, urea, acid uric, ALP,gamma-GT, AST, and ALT was performed, and pancreatic beta-cells positive for insulin were evaluated by immunohistochemistry. Rats treated with extract exhibited a decrease in fasting blood glucose compared with levels in diabetic control rats. GPx activity and sulfhydryl levels were significantly lower in diabetic-V. rufa rats compared with those of diabetic- control rats. V. rufa extract acted to normalize the biochemical alterations found in diabetic rats (diabetic- controls), as demonstrated by increases in urea, HDL, ALP, AST, and ALT. Reduction in blood glucose was independent of an increase in insulin. The V. rufa extract was found to be composed of free sugars (inositol, galactose, glucose, mannose, sucrose, arabinose, and ribose) as the main metabolites. Thus, aqueous extract of the stem bark of V. rufa is capable of reducing blood glucose, resulting in an antioxidant effect on the pancreatic tissue of STZ-diabetic rats.	[de Gouveia, Neire M.; Rodrigues, Wellington F.; Calabria, Luciana K.; Espindola, Foued S.] Univ Fed Uberlandia, Inst Genet & Bioquim, Uberlandia, MG, Brazil; [de Gouveia, Neire M.] Fac Morgana Potrich, Dept Ciencias Biofuncionais, Goiania, Go, Brazil; [Rodrigues, Wellington F.; Miguel, Camila B.; Lazo-Chica, Javier E.] Univ Fed Triangulo Mineiro, Curso Posgrad Ciencias Saude, Uberaba, MG, Brazil; [de Sousa, Raquel M. F.; de Oliveira, Alberto] Univ Fed Uberlandia, Inst Quin, Uberlandia, MG, Brazil; [Calabria, Luciana K.] Univ Fed Uberlandia, Fac Ciencias Integradas Pontal, Ituiutaba, MG, Brazil; [Mundim, Antonio V.] Univ Fed Uberlandia, Fac Med Vet, Uberlandia, MG, Brazil; [Miguel, Camila B.] Ctr Univ Mineiros, UNIFIMES, Lab Morfofunc, Goiania, Go, Brazil; [Oliveira, Carlo J. F.; Lazo-Chica, Javier E.] Univ Fed Triangulo Mineiro, Inst Ciencias Biol & Nat, Uberaba, MG, Brazil; [Lago, Joao H. G.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil; [dos Santos, Vagner B.; do Lago, Claudimir L.] Univ Sao Paulo, Inst Quim, Sao Paulo, SP, Brazil	Universidade Federal de Uberlandia; Universidade Federal do Triangulo Mineiro; Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Universidade Federal do Triangulo Mineiro; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo	Espindola, FS (corresponding author), Univ Fed Uberlandia, Inst Genet & Bioquim, Uberlandia, MG, Brazil.	foued@ufu.br	Botelho Miguel, Camila/GNP-5269-2022; Sousa, Raquel M. F./W-9238-2019; Espindola, Foued Salmen/C-5324-2013; santos, vagner B/D-3443-2013; Lago, Joao/W-5238-2019; Rodrigues, Wellington/AEW-3823-2022; Oliveira, Carlo Jose Freire/AAY-8751-2020; de Oliveira, Alberto/P-9884-2019; dos santos, Vagner Bezerra/GQQ-5338-2022; do Lago, Claudimir Lucio/A-1852-2008	Sousa, Raquel M. F./0000-0003-1509-2721; Espindola, Foued Salmen/0000-0002-6937-1411; santos, vagner B/0000-0002-9426-6197; Lago, Joao/0000-0002-1193-8374; Rodrigues, Wellington/0000-0002-3426-2186; de Oliveira, Alberto/0000-0002-7210-164X; dos santos, Vagner Bezerra/0000-0002-9426-6197; do Lago, Claudimir Lucio/0000-0003-1542-4343; Lazo Chica, Javier Emilio/0000-0003-1950-1895; Mundim, Antonio/0000-0003-1081-0544	Foundation for Research Support of Minas Gerais State [FAPEMIG-APQ-01271-10/APQ-01856-14]; CAPES/PNPD [007277/2011-01]; National Postdoctoral Program of Coordination for the Improvement of Higher Education Personnel (Social Demand/PNPD/CAPES); CNPq [308965/2015-9]	Foundation for Research Support of Minas Gerais State; CAPES/PNPD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Postdoctoral Program of Coordination for the Improvement of Higher Education Personnel (Social Demand/PNPD/CAPES); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by a Foundation for Research Support of the Minas Gerais State (FAPEMIG-APQ-01271-10/APQ-01856-14), CAPES/PNPD (007277/2011-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. WFR receives, and NMG, LKC received, post-doctoral fellowships from National Postdoctoral Program of the Coordination for the Improvement of Higher Education Personnel (Social Demand/PNPD/CAPES). FSE is grant recipient of CNPq (308965/2015-9).; The authors gratefully acknowledge the Pro-Rectory of Research and Graduate Studies and the technical assistance of Felipe Cezar Gonsalves, Helen Lara Machado, Alice Vieira da Costa, Izabela Barbosa Moraes, Camilla Manzan Martins, Douglas Carvalho Caixeta, Aline Borges Rodovalho and Alexandre Azenha Alves de Rezende, of Federal University of Uberlandia. WFR receives, and NMG, LKC received, post-doctoral fellowships form National Postdoctoral Program of the Coordination for the Improvement of Higher Education Personnel (Social Demand/PNPD/CAPES). FSE is grant recipient of CNPq (308965/2015-9).	AEBI H, 1968, BIOCHEM GENET, V2, P245, DOI 10.1007/BF01474764; ALMDAL TP, 1988, DIABETOLOGIA, V31, P114, DOI 10.1007/BF00395558; Ardestani A, 2008, J MED FOOD, V11, P525, DOI 10.1089/jmf.2006.0230; Benzie IFF, 1999, METHOD ENZYMOL, V299, P15; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calabria LK, 2013, ISRN NEUROSCI, V2013, P1; Chen XM, 2013, CARBOHYD POLYM, V94, P378, DOI 10.1016/j.carbpol.2013.01.037; CHRISTOPHERSEN BO, 1968, BIOCHIM BIOPHYS ACTA, V164, P35, DOI 10.1016/0005-2760(68)90068-4; Christophersen BO, 1969, BIOCHIM BIOPHYS ACTA, V176, P4463; Cumaoglu A, 2011, EUR J PHARMACOL, V654, P80, DOI 10.1016/j.ejphar.2010.11.035; da Silva MAB, 2010, REV BRAS FARMACOGN, V20, P549, DOI 10.1590/S0102-695X2010000400014; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; de Gouveia NM, 2014, J MED FOOD, V17, P915, DOI 10.1089/jmf.2013.0044; DOBRINA A, 1986, J CLIN INVEST, V78, P462, DOI 10.1172/JCI112598; Erejuwa OO, 2010, ANN ENDOCRINOL-PARIS, V71, P291, DOI 10.1016/j.ando.2010.03.003; Faure P., 1995, P237; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; FORTSON WC, 1985, J CLIN GASTROENTEROL, V7, P502, DOI 10.1097/00004836-198512000-00012; Gomes RD, 2009, J ETHNOPHARMACOL, V121, P466, DOI 10.1016/j.jep.2008.11.013; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HERMESLIMA M, 1995, FREE RADICAL BIO MED, V19, P271, DOI 10.1016/0891-5849(95)00020-X; HESS SC, 1995, J ETHNOPHARMACOL, V47, P97, DOI 10.1016/0378-8741(95)01260-K; HULTCRANTZ R, 1986, SCAND J GASTROENTERO, V21, P109, DOI 10.3109/00365528609034632; HUNT JV, 1990, DIABETES, V39, P1420, DOI 10.2337/diabetes.39.11.1420; Ilhan N, 2001, CELL BIOCHEM FUNCT, V19, P207, DOI 10.1002/cbf.912; Jia J, 2009, FOOD CHEM, V115, P32, DOI 10.1016/j.foodchem.2008.11.043; Jiang S, 2013, INT J BIOL MACROMOL, V55, P118, DOI 10.1016/j.ijbiomac.2012.12.035; KAKKAR R, 1995, MOL CELL BIOCHEM, V151, P113, DOI 10.1007/BF01322333; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Li XM, 2007, INT J BIOL MACROMOL, V40, P461, DOI 10.1016/j.ijbiomac.2006.11.002; Liu YT, 2013, FOOD CHEM TOXICOL, V57, P39, DOI 10.1016/j.fct.2013.03.001; Loomis TA, 1996, ESSENTIALS TOXICOLOG; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Moraes I. B., 2015, EVID-BASED COMPL ALT, V2015, P8; Pandikumar P, 2009, J ETHNOPHARMACOL, V124, P111, DOI 10.1016/j.jep.2009.04.001; Robertson RP, 2007, FEBS LETT, V581, P3743, DOI 10.1016/j.febslet.2007.03.087; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; SAXENA AK, 1993, BIOCHEM PHARMACOL, V45, P539, DOI 10.1016/0006-2952(93)90124-F; Schultes R. E., 1990, HEALING FOREST MED T; Weniger B, 2005, PHYTOTHER RES, V19, P75, DOI 10.1002/ptr.1613; Wu CM, 2011, PHYTOMEDICINE, V18, P292, DOI 10.1016/j.phymed.2010.07.005; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Xue SX, 2009, CARBOHYD POLYM, V75, P415, DOI 10.1016/j.carbpol.2008.08.003; Yazdanparast R, 2007, J ETHNOPHARMACOL, V112, P13, DOI 10.1016/j.jep.2007.01.030; Zhang D, 2012, INT J BIOL MACROMOL, V50, P720, DOI 10.1016/j.ijbiomac.2011.12.020; Zhao LY, 2011, PHYTOMEDICINE, V18, P661, DOI 10.1016/j.phymed.2011.01.001; Zou S, 2010, CARBOHYD POLYM, V80, P1161, DOI 10.1016/j.carbpol.2010.01.038; Zucaro YL, 2000, J BRAZIL CHEM SOC, V11, P241, DOI 10.1590/S0103-50532000000300007	49	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184807	10.1371/journal.pone.0184807	http://dx.doi.org/10.1371/journal.pone.0184807			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981518	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300018
J	Lee, MR; Canales-Aguirre, CB; Nunez, D; Perez, K; Hernandez, CE; Brante, A				Lee, Matthew R.; Canales-Aguirre, Cristian B.; Nunez, Daniela; Perez, Karla; Hernandez, Crisitan E.; Brante, Antonio			The identification of sympatric cryptic free-living nematode species in the Antarctic intertidal	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; MARINA COMPLEX NEMATODA; DNA-SEQUENCES; SSU RDNA; DIVERSITY; EVOLUTION; DISTINCT; BIODIVERSITY; DELIMITATION; COMMUNITIES	The diversity of free-living nematodes in the beaches of two Antarctic islands, King George and Deception islands was investigated. We used morphological and molecular (LSU, and two fragments of SSU sequences) approaches to evaluate 236 nematodes. Specimens were assigned to at least genera using morphology and were assessed for the presence of cryptic speciation. The following genera were identified: Halomonhystera, Litoditis, Enoploides, Chromadorita, Theristus, Oncholaimus, Viscosia, Gammanema, Bathylaimus, Choanolaimus, and Paracanthonchus; along with specimens from the families Anticomidae and Linhomoeidae. Cryptic speciation was identified within the genera Halomonhystera and Litoditis. All of the cryptic species identified live sympatrically. The two cryptic species of Halomonhystera exhibited no significant morphological differences. However, Litoditis species 2 was significantly larger than Litoditis species 1. The utility of molecular data in confirming the identifications of some of the morphologically more challenging families of nematodes was demonstrated. In terms of which molecular sequences to use for the identification of free-living nematodes, the SSU sequences were more variable than the LSU sequences, and thus provided more resolution in the identification of cryptic speciation. Finally, despite the considerable amount of time and effort required to put together genetic and morphological data, the resulting advance in our understanding of diversity and ecology of free-living marine nematodes, makes that effort worthwhile.	[Lee, Matthew R.; Canales-Aguirre, Cristian B.; Nunez, Daniela] Univ Lagos, Ctr I Mar, Puerto Montt, Chile; [Perez, Karla; Brante, Antonio] Univ Catolica Santisima Concepcion, Dept Ecol, Concepcion, Chile; [Hernandez, Crisitan E.] Univ Concepcion, Fac Ciencias Nat & Oceanog, Dept Zool, Lab Ecol Evolut & Filoinformat, Concepcion, Chile; [Brante, Antonio] Univ Catolica Santisima Concepcion, CIBAS, Concepcion, Chile	Universidad de Los Lagos; Universidad Catolica de la Santisima Concepcion; Universidad de Concepcion; Universidad Catolica de la Santisima Concepcion	Lee, MR (corresponding author), Univ Lagos, Ctr I Mar, Puerto Montt, Chile.	matthew.lee@ulagos.cl	Lee, Matthew/B-6360-2008; Hernández, Cristián E./AAS-1286-2020; Hernández, Cristián E./GLS-1111-2022	Lee, Matthew/0000-0001-9675-9908; Hernández, Cristián E./0000-0002-9811-2881; Hernández, Cristián E./0000-0002-9811-2881; Perez-Araneda, karla/0000-0002-5073-5975; Nunez Rivera, Daniela Alejandra/0000-0002-8056-9461; Brante, Antonio/0000-0002-2699-9700	Instituto Antartico Chileno (INACH) Project [T_13-10]; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1140692, 3150456]; INACh Project [T_13-10]; FONDECYT [1140692, 3150456]	Instituto Antartico Chileno (INACH) Project; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); INACh Project; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This project was funded by Instituto Antartico Chileno (INACH) Project T_13-10, to M. R.L, C.E.H. and A.B. C.E.H. and C.B.C.A. are grateful for funding from Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) grants 1140692 and 3150456 respectiviely. The Institute Antartico Chileno provided logistical support in Antarctica. Fondo Nacional de Desarrollo Cientifico y Tecnologico had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to Marcela Riveros and Jorge Avaria-Llautureo for help in the field. Thanks to the Instituto Nacional de Antartica Chilena (INACh) staff, both in Punta Arenas and in Antarctica for their logistical support. Thanks to the Comandante and Crew of the Chilean Navy Ice-breaker AP-46 "Almirante Oscar Viel". This project was funded by INACh Project T_13-10. C.E.H. is grateful for funding from FONDECYT grant 1140692, C.B.C.A. was funded by FONDECYT grant 3150456.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrassy Istvan, 2006, Meiofauna Marina, V15, P11; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Ardila-Garcia AM, 2012, EUKARYOT CELL, V11, P1544, DOI 10.1128/EC.00228-12; Arikan M., 2016, PLANT OMICS TRENDS A, P109, DOI DOI 10.1007/978-3-319-31703-8_5; Armenteros M, 2014, NEMATOLOGY, V16, P979, DOI 10.1163/15685411-00002824; Armenteros M, 2014, ZOOL J LINN SOC-LOND, V171, P1, DOI 10.1111/zoj12126; Bhadury P, 2008, MAR BIOL, V154, P509, DOI 10.1007/s00227-008-0945-8; Bhadury P, 2006, MAR ECOL PROG SER, V320, P1, DOI 10.3354/meps320001; Blaxter M, 1998, SCIENCE, V282, P2041, DOI 10.1126/science.282.5396.2041; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Boufahja F, 2015, J NEMATOL, V47, P198; Canales-Aguirre CB, 2011, REV BIOL MAR OCEANOG, V46, P89, DOI 10.4067/S0718-19572011000100014; Carugati L, 2015, MAR GENOM, V24, P11, DOI 10.1016/j.margen.2015.04.010; Coomans A, 2002, NEMATOLOGY, V4, P573, DOI 10.1163/15685410260438836; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; De Meester N, 2016, OECOLOGIA, V182, P559, DOI 10.1007/s00442-016-3677-3; De Meester N, 2015, J EXP MAR BIOL ECOL, V472, P54, DOI 10.1016/j.jembe.2015.07.002; De Meester N, 2015, OIKOS, V124, P561, DOI 10.1111/oik.01779; de Oliveira DAS, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0908-0; Dell'Anno A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144928; Deprez T, 2005, NEMYS; Derycke S, 2007, MAR BIOL, V151, P1799, DOI 10.1007/s00227-007-0609-0; Derycke S, 2006, GENETICA, V128, P307, DOI 10.1007/s10709-006-6944-0; Derycke S, 2016, MOL ECOL, V25, P2093, DOI 10.1111/mec.13597; Derycke S, 2010, ZOOL SCR, V39, P276, DOI 10.1111/j.1463-6409.2009.00420.x; Dorris M, 1999, PARASITOL TODAY, V15, P188, DOI 10.1016/S0169-4758(99)01439-8; Ferri E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-1; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Gallucci F, 2005, MAR ECOL PROG SER, V304, P167, DOI 10.3354/meps304167; GERLACH SA, 1971, MAR BIOL, V9, P274, DOI 10.1007/BF00351390; Grosemans T, 2016, ECOL EVOL, V6, P1854, DOI 10.1002/ece3.1975; Gutzmann E, 2004, DEEP-SEA RES PT II, V51, P1617, DOI 10.1016/j.dsr2.2004.06.026; Hauquier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022240; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hentschel U, 1999, MAR ECOL PROG SER, V183, P149, DOI 10.3354/meps183149; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Hut RA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0433; Ingels J, 2006, POLAR BIOL, V29, P936, DOI 10.1007/s00300-006-0135-4; JENSEN P, 1995, MAR BIOL, V123, P131, DOI 10.1007/BF00350331; Pereira TJ, 2010, MAR BIOL, V157, P1665, DOI 10.1007/s00227-010-1439-z; Kim J, 2017, MOL PHYLOGENET EVOL, V107, P90, DOI 10.1016/j.ympev.2016.10.010; Krehenwinkel H, 2017, METHODS ECOL EVOL, V8, P126, DOI 10.1111/2041-210X.12647; Kuklinski P, 2014, J SEA RES, V85, P542, DOI 10.1016/j.seares.2013.09.002; Kwong S, 2012, CLADISTICS, V28, P639, DOI 10.1111/j.1096-0031.2012.00408.x; Markmann M, 2005, PHILOS T R SOC B, V360, P1917, DOI 10.1098/rstb.2005.1723; McSorley R, 2003, FLA ENTOMOL, V86, P138, DOI 10.1653/0015-4040(2003)086[0138:AONTEE]2.0.CO;2; Meyer-Wachsmuth I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107688; Moens T, 1999, MAR BIOL, V134, P585, DOI 10.1007/s002270050573; Moens T, 2005, J MAR BIOL ASSOC UK, V85, P1401, DOI 10.1017/S0025315405012580; Moens T, 1997, J MAR BIOL ASSOC UK, V77, P211, DOI 10.1017/S0025315400033889; Moens T, 2006, FEEDING ECOLOGY FREE; Moens T, 2014, HBK ZOOL, P109; Mullin PG, 2003, NEMATOLOGY, V5, P699, DOI 10.1163/156854103322746878; Muthumbi AW, 1998, HYDROBIOLOGIA, V364, P155; Nunn G.B., 1992, NEMATODE MOL EVOLUTI; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Pagel M, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P121; Pagel M, 2008, PHILOS T R SOC B, V363, P3955, DOI 10.1098/rstb.2008.0178; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Perez-Portela R, 2013, SCI REP-UK, V3, DOI 10.1038/srep03197; Pfannkuche O, 1988, INTRO STUDY MEIOFAUN; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Powers T, 2004, ANNU REV PHYTOPATHOL, V42, P367, DOI 10.1146/annurev.phyto.42.040803.140348; R Core Team, 2021, R LANGUAGE ENV STAT; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rusin LY, 2001, MOL BIOL+, V35, P778, DOI 10.1023/A:1012394808661; Schander C, 2005, MAR BIOL RES, V1, P79, DOI 10.1080/17451000510018962; Seesao Y, 2016, J MICROBIOLOGICAL ME, V102, P69; Sinniger F, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00092; Smith KL, 2003, DEEP-SEA RES PT II, V50, P1595, DOI 10.1016/S0967-0645(03)00081-X; TAJIMA F, 1983, GENETICS, V105, P437; Tchesunov AV, 2015, HELGOLAND MAR RES, V69, P57, DOI 10.1007/s10152-014-0416-1; Toprak Z, 2016, MOL PHYLOGENET EVOL, V102, P1, DOI 10.1016/j.ympev.2016.05.024; Urban-Malinga B, 2009, POLAR BIOL, V32, P243, DOI 10.1007/s00300-008-0525-x; Valderrama-Aravena N, 2014, REV BIOL MAR OCEANOG, V49, P147, DOI 10.4067/S0718-19572014000100017; Van Campenhout J, 2014, J ZOOL SYST EVOL RES, V52, P203, DOI [10.1111/jzs.12054, DOI 10.1111/JZS.12054]; Van Campenhout J, 2016, GENOME BIOL EVOL, V8, P51, DOI 10.1093/gbe/evv242; Van Campenhout J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111889; Van Gaever S, 2009, DEEP-SEA RES PT I, V56, P772, DOI 10.1016/j.dsr.2008.12.015; vanVoorhies WA, 1996, EVOLUTION, V50, P1259, DOI 10.2307/2410666; Velasco-Castrillon A, 2014, SOIL BIOL BIOCHEM, V70, P272, DOI 10.1016/j.soilbio.2013.12.016; Vermeeren H, 2004, DEEP-SEA RES PT II, V51, P1643, DOI 10.1016/j.dsr2.2004.06.028; Viltrop T, 2010, ANAL BIOCHEM, V398, P260, DOI 10.1016/j.ab.2009.11.026; Wang NF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01188; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Warwick R, 1998, SYNOPSES BRIT FAUNA, V53, P1; WARWICK RM, 1979, ESTUAR COAST MAR SCI, V9, P257, DOI 10.1016/0302-3524(79)90039-2; WIESER W., 1953, ARKIV ZOOL, V4, P439; Yoder M, 2006, NEMATOLOGY, V8, P367, DOI 10.1163/156854106778493448; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	93	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186140	10.1371/journal.pone.0186140	http://dx.doi.org/10.1371/journal.pone.0186140			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982192	Green Submitted, gold, Green Published			2022-12-26	WOS:000412360300128
J	Risselada, M; Linder, KE; Griffith, E; Roberts, BV; Davidson, G; Zamboni, WC; Messenger, KM				Risselada, Marije; Linder, Keith E.; Griffith, Emily; Roberts, Brittney V.; Davidson, Gigi; Zamboni, William C.; Messenger, Kristen M.			Pharmacokinetics and toxicity of subcutaneous administration of carboplatin in poloxamer 407 in a rodent model pilot study	PLOS ONE			English	Article							IN-VITRO; ANAL SAC; CLINICAL PHARMACOKINETICS; ADJUVANT CARBOPLATIN; DOGS; CHEMOTHERAPY; TUMORS; ADENOCARCINOMA; PLATINUM; RELEASE	The objectives of this study were to assess the pharmacokinetics and safety of subcutaneously delivered carboplatin in poloxamer 407 in rats. Carboplatin (5mg/rat) in 0.5ml poloxamer 407 (1.0 ml total volume) was administered subcutaneously in a right subcutaneous perineal incision in all 12 treatment rats. Three control rats received 1.0 ml of poloxamer 407. Total platinum was measured in plasma q24hrs from 0 to 168hrs. Protein-unbound platinum was measured in plasma at 168hrs. After sacrifice on day 7, total platinum was determined in wound bed muscle. Platinum concentrations in all samples were measured by ICP-MS. Wounds were visually assessed daily for 7 days. Perineal tissues (full wound bed including muscle, subcutis, skin) were assessed histologically and scored. Total platinum was detectable in plasma from 24 to 168 hrs. Total plasma platinum AUC and C-max were 9,165.3 ng/mL.h and 129.4 ng/mL. Day 7 total platinum concentration in muscle was approximately 10-fold higher than total plasma platinum concentration. No unbound platinum was detected in plasma samples at 168 hours. No wound healing complications were detected at any time point, nor was tissue necrosis observed histologically. The results of this study suggest that subcutaneous carboplatin in poloxamer 407 can be used in vivo providing direct tissue exposure to carboplatin without significant local effects or systemic absorption and without wound healing complications.	[Risselada, Marije; Griffith, Emily] North Carolina State Univ, Coll Vet Med, Dept Clin Sci, 4700 Hillsborough St, Raleigh, NC 27695 USA; [Risselada, Marije] Purdue Univ, Coll Vet Med, Dept Vet Clin Sci, W Lafayette, IN 47907 USA; [Linder, Keith E.] North Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC USA; [Griffith, Emily] North Carolina State Univ, Coll Agr & Life Sci, Dept Stat, Raleigh, NC 27695 USA; [Roberts, Brittney V.; Zamboni, William C.] Univ North Carolina Chapel Hill, UNC Lineberger Comprehens Canc Ctr, UNC Eshelman Sch Pharm, Chapel Hill, NC USA; [Davidson, Gigi] North Carolina State Univ, Coll Vet Med, CPS, Raleigh, NC USA; [Messenger, Kristen M.] North Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC USA	University of North Carolina; North Carolina State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Risselada, M (corresponding author), North Carolina State Univ, Coll Vet Med, Dept Clin Sci, 4700 Hillsborough St, Raleigh, NC 27695 USA.; Risselada, M (corresponding author), Purdue Univ, Coll Vet Med, Dept Vet Clin Sci, W Lafayette, IN 47907 USA.	mrissela@purdue.edu		Davidson, Gigi/0000-0002-0322-9607	NCSU, CVM intramural grant competition	NCSU, CVM intramural grant competition	Funding for this study was through the 2014 NCSU, CVM intramural grant competition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JJ, 2008, VET RADIOL ULTRASOUN, V49, P85, DOI 10.1111/j.1740-8261.2007.00322.x; Bennett PE, 2002, J VET INTERN MED, V16, P100, DOI 10.1892/0891-6640(2002)016&lt;0100:CASACP&gt;2.3.CO;2; Chun R., 2007, WITHROW MACEWENS SMA, P163; Emms SG, 2005, AUST VET J, V83, P340, DOI 10.1111/j.1751-0813.2005.tb15626.x; Exner AA, 2005, J CONTROL RELEASE, V106, P188, DOI 10.1016/j.jconrel.2005.04.015; Gabrielsson J. L., 2006, PHARMACOKINETIC PHAE; Gibaldi M, 1982, PHARMACOKINETICS; Holmes KE, 2015, VET COMP ONCOL, V13, P166, DOI 10.1111/vco.12031; Hsu YH, 2014, INT J NANOMED, V9, P4347, DOI 10.2147/IJN.S66526; Johansen Mary J, 2002, J Exp Ther Oncol, V2, P163, DOI 10.1046/j.1359-4117.2002.01019.x; Kim ST, 2014, RES J BIOTECHNOL, V9, P1; Kozicki AR, 2015, VET COMP ONCOL, V13, P229, DOI 10.1111/vco.12040; Mathews KG, 2009, AM J VET RES, V70, P640, DOI 10.2460/ajvr.70.5.640; Morrison JG, 2000, J PHARMACEUT BIOMED, V24, P1, DOI 10.1016/S0731-7085(00)00377-0; NIH NCIatFrederick [Internet], EQ SURF AR DOS CONV; OGURI S, 1988, J CLIN PHARMACOL, V28, P208, DOI 10.1002/j.1552-4604.1988.tb03134.x; Risselada M, 2016, AM J VET RES, V77, P1381, DOI 10.2460/ajvr.77.12.1381; ROSS JT, 1991, J AM ANIM HOSP ASSOC, V27, P349; Saam DE, 2011, JAVMA-J AM VET MED A, V238, P195, DOI 10.2460/javma.238.2.195; Selmic LE, 2014, J VET INTERN MED, V28, P554, DOI 10.1111/jvim.12313; Simcock JO, 2012, JAVMA-J AM VET MED A, V241, P608, DOI 10.2460/javma.241.5.608; Simon D, 2001, AM J VET RES, V62, P1825, DOI 10.2460/ajvr.2001.62.1825; Skorupski KA, 2016, VET COMP ONCOL, V14, P81, DOI 10.1111/vco.12069; Sonoda A, 2010, CARDIOVASC INTER RAD, V33, P135, DOI 10.1007/s00270-009-9741-1; VANDERVIJGH WJF, 1991, CLIN PHARMACOKINET, V21, P242, DOI 10.2165/00003088-199121040-00002; Wouda RM, 2016, VET COMP ONCOL, V14, P67, DOI 10.1111/vco.12068; Yu CH, 2012, EUR SPINE J, V21, P971, DOI 10.1007/s00586-011-2098-6; Zamboni WC, 2002, CLIN CANCER RES, V8, P2992; Zhang K, 2015, DRUG DELIV, V22, P375, DOI 10.3109/10717544.2014.891272	29	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186018	10.1371/journal.pone.0186018	http://dx.doi.org/10.1371/journal.pone.0186018			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982137	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300110
J	Somanath, P; Klein, RH; Knoepfler, PS				Somanath, Priyanka; Klein, Rachel Herndon; Knoepfler, Paul S.			CRISPR-mediated HDAC2 disruption identifies two distinct classes of target genes in human cells	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; HISTONE DEACETYLASE INHIBITORS; CANCER; NURD; PLURIPOTENCY; COMPLEX; MEMORY	The transcriptional functions of the class I histone deacetylases (HDACs) HDAC1 and HDAC2 are mainly viewed as both repressive and redundant based on murine knockout studies, but they may have additional independent roles and their physiological functions in human cells are not as clearly defined. To address the individual epigenomic functions of HDAC2, here we utilized CRISPR-Cas9 to disrupt HDAC2 in human cells. We find that while HDAC2 null cells exhibited signs of cross-regulation between HDAC1 and HDAC2, specific epigenomic phenotypes were still apparent using RNA-seq and ChIP assays. We identified specific targets of HDAC2 repression, and defined a novel class of genes that are actively expressed in a partially HDAC2-dependent manner. While HDAC2 was required for the recruitment of HDAC1 to repressed HDAC2-gene targets, HDAC2 was dispensable for HDAC1 binding to HDAC2-activated targets, supporting the notion of distinct classes of targets. Both active and repressed classes of gene targets demonstrated enhanced histone acetylation and methylation in HDAC2-null cells. Binding of the HDAC1/2-associated SIN3A corepressor was altered at most HDAC2-targets, but without a clear pattern. Overall, our study defines two classes of HDAC2 targets in human cells, with a dependence of HDAC1 on HDAC2 at one class of targets, and distinguishes unique functions for HDAC2.	[Somanath, Priyanka; Klein, Rachel Herndon; Knoepfler, Paul S.] Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA; [Somanath, Priyanka; Klein, Rachel Herndon; Knoepfler, Paul S.] Shriners Hosp Children Northern Calif, Inst Pediat Regenerat Med, Sacramento, CA USA	University of California System; University of California Davis	Knoepfler, PS (corresponding author), Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA.; Knoepfler, PS (corresponding author), Shriners Hosp Children Northern Calif, Inst Pediat Regenerat Med, Sacramento, CA USA.	knoepfler@ucdavis.edu		Knoepfler, Paul/0000-0001-5444-334X	National Institute of General Medical Sciences [5R01GM100782-05, 1R01GM116919-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100782, R01GM116919] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences, grants 5R01GM100782-05 to PSK, and 1R01GM116919-01 to PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Brunmeir R, 2009, INT J DEV BIOL, V53, P275, DOI 10.1387/ijdb.082649rb; Bush KM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-7; Cotterman R, 2008, CANCER RES, V68, P9654, DOI 10.1158/0008-5472.CAN-08-1961; Czermin B, 2001, EMBO REP, V2, P915, DOI 10.1093/embo-reports/kve210; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Haberland M, 2009, P NATL ACAD SCI USA, V106, P7751, DOI 10.1073/pnas.0903139106; Kelly RDW, 2013, BIOCHEM SOC T, V41, P741, DOI 10.1042/BST20130010; Kidder BL, 2012, NUCLEIC ACIDS RES, V40, P2925, DOI 10.1093/nar/gkr1151; Kim JK, 2013, MOL CANCER RES, V11, P62, DOI 10.1158/1541-7786.MCR-12-0332; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Noh JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028103; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Penney J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa0069; Phelps MP, 2016, P NATL ACAD SCI USA; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saunders A, 2017, CELL REP, V18, P1713, DOI 10.1016/j.celrep.2017.01.055; Senese S, 2007, MOL CELL BIOL, V27, P4784, DOI 10.1128/MCB.00494-07; Seto E, 2014, COLD SPRING HARB PER, V6; Smith KT, 2009, INT J BIOCHEM CELL B, V41, P21, DOI 10.1016/j.biocel.2008.09.008; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tung PY, 2013, STEM CELLS, V31, P2330, DOI 10.1002/stem.1526; Varlakhanova N, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-20; Wagner FF, 2015, CHEM SCI, V6, P804, DOI 10.1039/c4sc02130d; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang MH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16923; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wei T, 2015, NUCLEIC ACIDS RES, P1; Weichert W, 2008, BRIT J CANCER, V98, P604, DOI 10.1038/sj.bjc.6604199; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Wilting RH, 2010, EMBO J, V29, P2586, DOI 10.1038/emboj.2010.136; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yamaguchi T, 2010, GENE DEV, V24, P455, DOI 10.1101/gad.552310; Yang L, 2003, BIOCHEM J, V369, P651, DOI 10.1042/BJ20020854; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	49	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185627	10.1371/journal.pone.0185627	http://dx.doi.org/10.1371/journal.pone.0185627			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982113	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300050
J	Travassos, AG; Netto, E; Xavier-Souza, E; Nobrega, I; Adami, K; Timbo, M; Abbehusen, K; Fernandes, S; Duran, C; Haguihara, T; Ferreira, F; Brites, C				Travassos, Ana Gabriela; Netto, Eduardo; Xavier-Souza, Eveline; Nobrega, Isabella; Adami, Karina; Timbo, Maiara; Abbehusen, Karen; Fernandes, Sheyla; Duran, Camila; Haguihara, Tatiana; Ferreira, Fabio; Brites, Carlos			Predictors of HPV incidence and clearance in a cohort of Brazilian HIV-infected women	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; RISK HUMAN-PAPILLOMAVIRUS; RIO-DE-JANEIRO; ANTIRETROVIRAL THERAPY; VIRAL SUPPRESSION; CERVICAL-CANCER; PERSISTENCE; INTEGRATION; PREVALENCE; RESPONSES	Persistent infection with high-risk human papillomavirus (HR-HPV) is necessary for the development of precursor lesions and cervical cancer. HPV infection among women living with HIV/AIDS (WLHA) occurs more frequently, presents a higher rate of persistent infections and an earlier progression to cancer. We aimed to evaluate HR-HPV prevalence, incidence and clearance, and its association with HIV viral suppression, immunological response and other risk factors among WLHA followed at an STD/HIV reference center. This was a cohort study conducted at a reference center for STD/AIDS in Northeastern Brazil from September 2013 to September 2015. Follow-up visits were conducted at 6 and 12 months after enrolment, where socio-epidemiological data were obtained. Cervical samples were collected for conventional cytology and HPV DNA research (PCR COBAS (R) Roche) in addition to blood samples for CD4+ T lymphocyte count and HIV viral load. We prospectively evaluated 333 women. HR-HPV DNA prevalence was 33.3% at baseline. HPV-16 was present in 5.1%, HPV-18 in 3.9% and 29.4% WLHA had other HR-HPV (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68). The HR-HPV incidence during the follow-up was 10.8%, at the 6-month visit was 7.7% and at the 12-month visit was 3.7%. Variables associated with HRHPV incidence were: nulliparity, combined oral contraceptive use and detectable HIV viral load. The HR-HPV clearance rate was 41.7% and was associated with age > 30 years and lymphocyte T CD4 count >500 cells/mm3 at enrolment. These findings contribute to the knowledge about a group of women that need more careful HPV screening and describe the association between an efficient immunological response and HIV viral suppression with lower incidence and increased clearance of HR-HPV.	[Travassos, Ana Gabriela; Nobrega, Isabella; Adami, Karina; Abbehusen, Karen; Fernandes, Sheyla; Haguihara, Tatiana] Secretaria Saude Estado Bahia, CEDAP, Salvador, BA, Brazil; [Travassos, Ana Gabriela] Univ Estadual Bahia, Colegiado Med, Dept Ciencias Vida, Salvador, BA, Brazil; [Netto, Eduardo; Xavier-Souza, Eveline; Timbo, Maiara; Brites, Carlos] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil; [Duran, Camila] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil; [Ferreira, Fabio] Lab Cent Saude Publ Prof Goncalo Moniz, Salvador, BA, Brazil	Universidade Federal da Bahia; Escola Bahiana de Medicina e Saude Publica	Travassos, AG (corresponding author), Secretaria Saude Estado Bahia, CEDAP, Salvador, BA, Brazil.; Travassos, AG (corresponding author), Univ Estadual Bahia, Colegiado Med, Dept Ciencias Vida, Salvador, BA, Brazil.	atravassos@uneb.br	Travassos, Ana Gabriela A/E-6809-2016; Brites, Carlos/D-1353-2013; Travassos, Ana Gabriela/AGE-0622-2022; Netto, Eduardo/D-1432-2013	Travassos, Ana Gabriela A/0000-0001-9242-828X; Brites, Carlos/0000-0002-4673-6991; Travassos, Ana Gabriela/0000-0001-9242-828X; Netto, Eduardo/0000-0003-1691-6761; de Sa Adami Goncalves Brandao, Karina/0000-0003-3928-7507				ACOG, 2014, AM COLL OBSTET GYNEC, V123, P1118; Adler DH, 2010, CURR HIV RES, V8, P493, DOI 10.2174/157016210793499240; [Anonymous], 2014, MANUAL TECNICO DIAGN; Blitz S, 2013, J INFECT DIS, V208, P454, DOI 10.1093/infdis/jit181; Bornstein J, 2012, OBSTET GYNECOL, V120, P166, DOI 10.1097/AOG.0b013e318254f90c; Branca M, 2003, INT J STD AIDS, V14, P417, DOI 10.1258/095646203765371321; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de DST Aids e Hepatites Virais., 2015, PROT CLIN DIR TER AT, P120; Brickman C, 2015, CURR HIV-AIDS REP, V12, P6, DOI 10.1007/s11904-014-0254-4; Cambou MC, 2015, INT J INFECT DIS, V41, P17, DOI 10.1016/j.ijid.2015.10.017; Castellsague A X, 2003, J NATL CANC I MONOGR, P20; Castilho JL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1486-4; Centers for Disease Control and Prevention (CDC), 1993, MMWR REC REP MORB MO; da Silva L, 2015, BRAZ J INFECT DIS, V19, P557, DOI 10.1016/j.bjid.2015.07.001; de Abreu ALP, 2016, AM J CANCER RES, V6, P1371; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Geraets DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080382; Heard I, 2009, CURR OPIN HIV AIDS, V4, P68, DOI 10.1097/COH.0b013e328319bcbe; Instituto Nacional de ca A ncer (INCA), 2011, DIR RASTR CANC COL U; Jaisamrarn U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079260; Keller MJ, 2015, CLIN INFECT DIS, V61, P1573, DOI 10.1093/cid/civ569; Kitchener HC, 2006, VACCINE, V24, P63, DOI 10.1016/j.vaccine.2006.05.113; Konopnicki D, 2013, J INFECT DIS, V207, P1723, DOI 10.1093/infdis/jit090; Ministry of Land Infrastructure transport and tourism and Ministry of economy trade and industry of Japan, 2006, IN LAT CAR DES SOST, P1; Minkoff H, 2010, J INFECT DIS, V201, P681, DOI 10.1086/650467; Money DM, 2016, VACCINE, V34, P4799, DOI 10.1016/j.vaccine.2016.08.016; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Nayar Ritu, 2004, Cytojournal, V1, P4, DOI 10.1186/1742-6413-1-4; Palefsky JM, 2016, CURR OPIN HIV AIDS, V1; Palefsky J, 2009, CURR OPIN HIV AIDS, V4, P52, DOI 10.1097/COH.0b013e32831a7246; Ramanakumar AV, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011371; Rosa MI, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.033; Rositch AF, 2013, INT J CANCER, V133, P1271, DOI 10.1002/ijc.27828; Roura E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147029; Secretaria de Vigilancia em Saude, 2013, PROT CLIN DIR TER MA; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Shrestha S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-295; Martins AES, 2014, MEM I OSWALDO CRUZ, V109, P738, DOI 10.1590/0074-0276140070; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Strickler HD, 2003, JNCI-J NATL CANCER I, V95, P1062, DOI 10.1093/jnci/95.14.1062; Sudenga SL, 2013, INT J INFECT DIS, V17, pE216, DOI 10.1016/j.ijid.2012.12.027; Thorsteinsson K, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2881-1; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; Vaccarella S, 2008, INT J EPIDEMIOL, V37, P536, DOI 10.1093/ije/dyn033; Ceccato BPV, 2015, REV BRAS GINECOL OBS, V37, P178, DOI 10.1590/SO100-720320150005184; vonKarsa L, 2015, EUROPEAN GUIDELINES; Vriend HJ, 2015, CANCER MED-US, V4, P1589, DOI 10.1002/cam4.496; WHO, 2012, WHOHIV201212, V1; Williams VM, 2011, FUTURE VIROL, V6, P45, DOI 10.2217/FVL.10.73; Wongworawat YC, 2016, AM J CANCER RES, V6, P764; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; Zhu HY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003077	51	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185423	10.1371/journal.pone.0185423	http://dx.doi.org/10.1371/journal.pone.0185423			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981551	Green Submitted, Green Published, gold			2022-12-26	WOS:000412360300038
J	Aoun, SM; Rumbold, B; Howting, D; Bolleter, A; Breen, LJ				Aoun, Samar M.; Rumbold, Bruce; Howting, Denise; Bolleter, Amanda; Breen, Lauren J.			Bereavement support for family caregivers: The gap between guidelines and practice in palliative care	PLOS ONE			English	Article							ADVANCE DIRECTIVES; WESTERN-AUSTRALIA; NEEDS-ASSESSMENT; INTERVENTION; PREDICTORS; NETWORK; PEOPLE	Background Standards for bereavement care propose that support should be matched to risk and need. However, studies in many countries demonstrate that palliative care services continue to adopt a generic approach in offering support to bereaved families. Objective To identify patterns of bereavement support in palliative care services based upon the experience of bereaved people from a population based survey and in relation to clinical practice guidelines. Design An anonymous postal survey collected information from clients of six funeral providers in four Australian states (2014-15), 6 to 24 months after the death of their family member or friend, with 1,139 responding. Responses from 506 bereaved relatives of people who had terminal illnesses were analysed. Of these, 298 had used palliative care services and 208 had not. Results More people with cancer (64%) had received palliative care in comparison to other illnesses such as heart disease, dementia and organ failure (4-10%). The support for family caregivers before and after their relative's death was not considered optimal. Only 39.4% of the bereaved reported being specifically asked about their emotional/psychological distress pre-bereavement, and just half of the bereaved perceived they had enough support from palliative care services. Half of the bereaved had a follow up contact from the service at 3-6 weeks, and a quarter had a follow-up at 6 months. Their qualitative feedback underlined the limited helpfulness of the blanket approach to bereavement support, which was often described as "not personal" or "generic", or "just standard practice". Conclusions Timeliness and consistency of relationship is crucial to building rapport and trust in the service's ability to help at post-bereavement as well as a focus on the specific rather than the generic needs of the bereaved. In light of these limitations, palliative care services might do better investing their efforts principally in assessing and supporting family caregivers during the pre-bereavement period and developing community capacity and referral pathways for bereavement care. Our findings suggest that bereavement support in Australian palliative care services has only a tenuous relationship with guidelines and assessment tools, a conclusion also drawn in studies from other countries, emphasizing the international implications of our study.	[Aoun, Samar M.; Howting, Denise] Curtin Univ, Fac Hlth Sci, Sch Nursing Midwifery & Paramed, Perth, WA, Australia; [Rumbold, Bruce] La Trobe Univ, Palliat Care Unit, Dept Publ Hlth, Melbourne, Vic, Australia; [Bolleter, Amanda] Hlth Dept WA, WA Canc & Palliat Care Network, Perth, WA, Australia; [Breen, Lauren J.] Curtin Univ, Sch Psychol & Speech Pathol, Fac Hlth Sci, Perth, WA, Australia	Curtin University; La Trobe University; Curtin University	Aoun, SM (corresponding author), Curtin Univ, Fac Hlth Sci, Sch Nursing Midwifery & Paramed, Perth, WA, Australia.	s.aoun@curtin.edu.au	Rumbold, Bruce/AAJ-5261-2020; Breen, Lauren J/B-8746-2013; Howting, Denise Ann/GWU-5045-2022	Rumbold, Bruce/0000-0001-6733-6201; Breen, Lauren J/0000-0002-0463-0363; Howting, Denise Ann/0000-0001-8753-5849; Aoun, Samar/0000-0002-4073-4805	WA Cancer and Palliative Care Network, Health Department of Western Australia	WA Cancer and Palliative Care Network, Health Department of Western Australia	The authors acknowledge the financial support of the WA Cancer and Palliative Care Network, Health Department of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors acknowledge the financial support of the WA Cancer and Palliative Care Network, Health Department of Western Australia, the cooperation of funeral providers who assisted with the recruitment of participants, and the bereaved families who agreed to complete the survey and contributed to our understanding in this field.	Abbott J, 2008, AUST J CANC NURS, V9, P12; Agnew A, 2010, PALLIATIVE MED, V24, P46, DOI 10.1177/0269216309107013; Aoun S, 2015, PLOS ONE, P10; Aoun S, 2010, J PALLIAT MED, V13, P653, DOI 10.1089/jpm.2009.0318; Aoun SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121101; Aoun SM, 2014, AUST NZ J PUBL HEAL, V38, P473, DOI 10.1111/1753-6405.12177; Aoun SM, 2012, AUST NZ J PUBL HEAL, V36, P14, DOI 10.1111/j.1753-6405.2012.00825.x; Auerbach AD, 2008, J HOSP MED, V3, P437, DOI 10.1002/jhm.369; Australian Bureau of Statistics, 2015, 33030 AUSTR BUR STAT; Australian Institute for Health and Welfare, 2016, PALL CAR OUTC; Bergman EJ, 2009, J PALLIAT MED, V12, P170, DOI 10.1089/jpm.2008.0237; Breen LJ, 2017, AM J HOSP PALLIAT ME, V34, P275, DOI 10.1177/1049909115615568; Breen LJ, 2014, DEATH STUD, V38, P54, DOI 10.1080/07481187.2012.725451; Burns CM, 2013, PALLIATIVE MED, V27, P608, DOI 10.1177/0269216313483664; Calanzani N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146134; Foliart DE, 2001, DEATH STUD, V25, P461, DOI 10.1080/074811801750257545; Ghesquiere A, 2016, AM J HOSP PALLIAT ME, V33, P124, DOI 10.1177/1049909114555155; Grande GE, 2017, BMJ SUPPORT PALLIAT, V7, P326, DOI 10.1136/bmjspcare-2014-000829; Guldin M., 2015, EUR J PALLIAT CARE, V22, P185; Hall C., 2012, BEREAVEMENT SUPPORT; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hudson P., 2010, CLIN PRACTICE GUIDEL; Hunt KJ, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-3; Lewis E, 2016, PALLIATIVE MED, V30, P807, DOI 10.1177/0269216316637239; Mather MA, 2008, MED J AUSTRALIA, V188, P228, DOI 10.5694/j.1326-5377.2008.tb01590.x; McNamara B, 2006, J PAIN SYMPTOM MANAG, V32, P5, DOI 10.1016/j.jpainsymman.2005.12.018; National Hospice and Palliative Care Organization, 2008, GUID BER CAR HOSP; Nielsen MK, 2017, J PAIN SYMPTOM MANAG, V53, P540, DOI 10.1016/j.jpainsymman.2016.09.013; Office for National Statistics (UK), 2012, NAT BER SURV VOICES; Onwuteaka-Philipsen BD, 2012, PALLIATIVE MED, V26, P656; Palliative Care Australia, 2005, STAND PROV QUAL PALL; Pautex S, 2008, PALLIATIVE MED, V22, P835, DOI 10.1177/0269216308094336; Pidgeon TM, 2017, PALLIAT SUPPORT CARE, P1; Rosenwax LK, 2006, PALLIATIVE MED, V20, P439, DOI 10.1191/0269216306pm1146oa; Rumbold B, 2015, BEREAVE CARE, V34, P99, DOI 10.1080/02682621.2015.1115185; Rumbold B, 2014, PROG PALLIAT CARE, V22, P131, DOI 10.1179/1743291X13Y.0000000079; Schut H, 2001, HDB BEREAVEMENT RES, P705, DOI DOI 10.1037/10436-029; Sealey M, 2015, BMC PALLIAT CARE, V14, DOI 10.1186/s12904-015-0046-7; Stroebe M, 2015, PALLIATIVE MED, V29, P574, DOI 10.1177/0269216315585952; Toye C, 2016, INT J NURS STUD, V64, P32, DOI 10.1016/j.ijnurstu.2016.09.012; Walter T., 1999, BEREAVEMENT CULTURE; White B, 2014, INTERN MED J, V44, P975, DOI 10.1111/imj.12549; Williams BR, 2008, DEATH STUD, V32, P197, DOI 10.1080/07481180701881297; World Health Organization, 2007, WHO GUID EFF PROGR P	44	66	68	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0184750	10.1371/journal.pone.0184750	http://dx.doi.org/10.1371/journal.pone.0184750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI7FU	28977013	Green Published, gold, Green Submitted			2022-12-26	WOS:000412163100011
J	Wasielica-Poslednik, J; Schmeisser, J; Hoffmann, EM; Weyer-Elberich, V; Bell, K; Lorenz, K; Pfeiffer, N				Wasielica-Poslednik, Joanna; Schmeisser, Julian; Hoffmann, Esther M.; Weyer-Elberich, Veronika; Bell, Katharina; Lorenz, Katrin; Pfeiffer, Norbert			Fluctuation of intraocular pressure in glaucoma patients before and after trabeculectomy with mitomycin C	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; VISUAL-FIELD PROGRESSION; INDEPENDENT RISK-FACTOR; INTERVENTION; TRIAL; EYES	Purpose Intraocular pressure (IOP) fluctuation is considered as a risk factor for glaucoma progression. We investigated IOP values and IOP fluctuation before and after trabeculectomy (TE) with mitomycin C (MMC) measured by 48-hour diurnal-nocturnal-IOP-profiles (DNP). Methods Pre-and postoperative DNPs of 92 eyes undergoing primary TE with MMC were analysed. Each 48-hour IOP-profile involved 10 IOP measurements (8:00 a.m., 2:00 p.m., 6:00 p.m., and 9:00 p.m. in sitting and at 00: 00 in supine position). The "preoperative DNP" was performed a few weeks before TE. The "postoperative DNP" was performed at least six months (range: 6 months-2 years) after TE. Mean IOP values and IOP fluctuations were calculated. Results After TE with MMC mean IOP was reduced from 16.94 +/- 3.83 to 11.26 +/- 3.77 mmHg at daytime and from 18.17 +/- 4.26 to 11.76 +/- 3.90 mmHg at night. At daytime mean IOP-fluctuation decreased from 8.61 +/- 4.19 to 4.92 +/- 2.52 mmHg, at night from 3.15 +/- 2.95 to 1.99 +/- 1.82 mmHg. Mean IOP was lower on the second day of the preoperative DNP. This effect was not present in the postoperative DNP. Preoperatively, IOP was controlled in all eyes with a mean of 3.22 +/- 0.94 antiglaucomatous agents. Postoperatively, IOP <= 15 mmHg was achieved in 71.7%, IO <= 18 mmHg in 77.1% and a decrease in IOP of >30% in 47.8% without antiglaucomatous therapy. Postoperatively, pseudophakia was associated by a higher mean IOP-fluctuation compared to the phakic eyes. Conclusions TE with MMC significantly reduces both mean IOP-values and IOP-fluctuations at day and night at least 6 months postoperatively. The effect of TE on the IOP fluctuation was less pronounced in pseudophakic eyes.	[Wasielica-Poslednik, Joanna; Schmeisser, Julian; Hoffmann, Esther M.; Bell, Katharina; Lorenz, Katrin; Pfeiffer, Norbert] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Mainz, Germany; [Weyer-Elberich, Veronika] Johannes Gutenberg Univ Mainz, Univ Med Ctr, IMBEI, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Wasielica-Poslednik, J (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Mainz, Germany.	joanna.wasielica-poslednik@unimedizin-mainz.de	Hoffmann, Esther/AAY-3575-2020; Hoffmann, Esther/AAO-5968-2021; Weyer-Elberich, Veronika/AAB-8993-2020; Bell, Katharina/T-5802-2019; Pfeiffer, Norbert/AAO-7586-2020	Hoffmann, Esther/0000-0002-0949-4268; 				Asrani S, 2000, J GLAUCOMA, V9, P134; Bengtsson B, 2005, GRAEF ARCH CLIN EXP, V243, P513, DOI 10.1007/s00417-004-1103-8; Bengtsson B, 2007, OPHTHALMOLOGY, V114, P205, DOI 10.1016/j.ophtha.2006.07.060; Bergea B, 1999, OPHTHALMOLOGY, V106, P997, DOI 10.1016/S0161-6420(99)00523-0; Caprioli J, 2008, OPHTHALMOLOGY, V115, P1123, DOI 10.1016/j.ophtha.2007.10.031; Clement CI, 2014, SURV OPHTHALMOL, V59, P615, DOI 10.1016/j.survophthal.2014.04.001; Coleman AL, 2008, SURV OPHTHALMOL, V53, pS3, DOI 10.1016/j.survophthal.2008.08.006; Daugeliene L, 1999, GRAEF ARCH CLIN EXP, V237, P105, DOI 10.1007/s004170050203; European Glaucoma Society, 2021, GUIDELINESEUROPEAN G, P97; Fischer N, 2013, OPHTHALMOLOGE, V110, P755, DOI 10.1007/s00347-012-2774-x; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Klink T, 2012, OPHTHALMOLOGICA, V227, P160, DOI 10.1159/000333099; Konstas AGP, 2016, ADV THER, V33, P481, DOI 10.1007/s12325-016-0302-0; Liu JHK, 2003, INVEST OPHTH VIS SCI, V44, P4439, DOI 10.1167/iovs.03-0349; Liu JHK, 2003, INVEST OPHTH VIS SCI, V44, P1586, DOI 10.1167/iovs.02-0666; Mosaed Sameh, 2009, Trans Am Ophthalmol Soc, V107, P127; Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017; PFEIFFER N, 1992, INT OPHTHALMOL, V16, P391, DOI 10.1007/BF00917998; Pfeiffer N., 2005, GLAUKOM OKULAERE HYP; SAIZ A, 1990, OPHTHALMIC SURG LAS, V21, P799; Takihara Y, 2014, JAMA OPHTHALMOL, V132, P69, DOI 10.1001/jamaophthalmol.2013.5605; Wilensky J T, 1994, Trans Am Ophthalmol Soc, V92, P377	22	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185246	10.1371/journal.pone.0185246	http://dx.doi.org/10.1371/journal.pone.0185246			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977004	Green Published, Green Submitted, gold			2022-12-26	WOS:000412163100018
J	Zhang, B; Zhao, JS; Chen, X; Wu, JH				Zhang, Bo; Zhao, Jiasheng; Chen, Xiao; Wu, Jianhuang			ECG data compression using a neural network model based on multi-objective optimization	PLOS ONE			English	Article							CLASSIFICATION; METHODOLOGY; PROGRAM; SIGNALS	Electrocardiogram (ECG) data analysis is of great significance to the diagnosis of cardiovascular disease. ECG compression should be processed in real time, and the data should be based on lossless compression and have high predictability. In terms of the real time aspect, short-time Fourier transformation is applied to the processing of signal wave for reducing computational time. For the lossless compression requirement, wavelet-transformation that is a coding algorithm can be used to avoid loss of data. In practice, compression is required to avoid storing redundant recording data that are not useful in the diagnosis platform. The obtained data can be preprocessed to remove noise by using wavelet transform, and then a multi-objective optimize neural network model is used to extract feature information. Compared with the existing traditional methods such as direct data processing method and transform method, our proposed compression model has self-learning ability to achieve high data compression ratio at 1: 19 without losing important ECG information and compromising quality. Upon testing, we demonstrated that the proposed ECG data compression method based on multi-objective optimization neural network is effective and efficient in clinical practice.	[Zhang, Bo] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Ultrasound Med, Shanghai, Peoples R China; [Zhao, Jiasheng; Wu, Jianhuang] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Chen, Xiao] Univ Technol Sydney, Sch Comp & Commun, Fac Engn & Informat Technol, Sydney, NSW, Australia	Tongji University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; University of Technology Sydney	Zhang, B (corresponding author), Tongji Univ, Sch Med, Shanghai East Hosp, Dept Ultrasound Med, Shanghai, Peoples R China.; Wu, JH (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China.	zhangbodongfang@qq.com; jh.wu@siat.ac.cn		Zhang, Bo/0000-0002-6085-111X	National Natural Science Foundation of China [61672510, 81571693, 81401428]; Guangdong Natural Science Foundation [2014A030313690]; Shenzhen Science and Technology Program [SGG20150602143414338, JCYJ20160331191401141]; Guangdong Science and Technology Program [2016A020220016]; Pudong New Area Committee of Science and Technology [PKJ2015-Y17]; Academic Leaders Training Program of Pudong Health Bureau of Shanghai [PWRd2013-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Shenzhen Science and Technology Program; Guangdong Science and Technology Program; Pudong New Area Committee of Science and Technology; Academic Leaders Training Program of Pudong Health Bureau of Shanghai	This work was supported in part by National Natural Science Foundation of China (No.61672510, 81571693, 81401428), Guangdong Natural Science Foundation (No. 2014A030313690), Shenzhen Science and Technology Program (No. SGG20150602143414338, No. JCYJ20160331191401141), Guangdong Science and Technology Program (No.2016A020220016), Pudong New Area Committee of Science and Technology (No.PKJ2015-Y17), and the Academic Leaders Training Program of Pudong Health Bureau of Shanghai (grant No. PWRd2013-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmeda SM, 2001, MED ENG PHYS, V23, P117, DOI 10.1016/S1350-4533(01)00026-1; Belciug S, 2015, J BIOMED INFORM, V53, P261, DOI 10.1016/j.jbi.2014.11.010; Bin G, 2016, IEEE T NEUR NET LEAR, DOI [DOI 10.1109/TNNLS.2016.2527796, 10.1109/TNNLS.2016.2527796]; Braojos R, 2014, SENSORS-BASEL, V14, P22532, DOI 10.3390/s141222532; BROHET CR, 1990, METHOD INFORM MED, V29, P403; Cadieu CF, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003963; Chaturvedi A, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/5/056023; Cichy RM, 2016, SCI REP-UK, V6, DOI 10.1038/srep27755; Clifford GD, 2012, PHYSIOL MEAS, V33, P1419, DOI 10.1088/0967-3334/33/9/1419; Cohen AR, 2010, NAT METHODS, V7, P213, DOI [10.1038/NMETH.1424, 10.1038/nmeth.1424]; DASSEN WRM, 1993, J ELECTROCARDIOL, V26, P61; Devoe LD, 2011, CLIN OBSTET GYNECOL, V54, P56, DOI 10.1097/GRF.0b013e31820a0ee7; Ditzler G, 2015, IEEE T NANOBIOSCI, V14, P608, DOI 10.1109/TNB.2015.2461219; Dranca L, 2009, PHYSIOL MEAS, V30, P983, DOI 10.1088/0967-3334/30/9/009; Dubra A, 2004, APPL OPTICS, V43, P1108, DOI 10.1364/AO.43.001108; Ertosun Mehmet Gunhan, 2015, AMIA Annu Symp Proc, V2015, P1899; Fearon WF, 2000, J AM COLL CARDIOL, V35, P1206, DOI 10.1016/S0735-1097(00)00518-0; Fira CM, 2008, IEEE T BIO-MED ENG, V55, P1319, DOI 10.1109/TBME.2008.918465; Gu B, 2017, IEEE T NEUR NET LEAR, V28, P1646, DOI 10.1109/TNNLS.2016.2544779; Heaton LLM, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021905; IWATA A, 1990, IEEE ENG MED BIOL, V9, P53, DOI 10.1109/51.59214; KORS JA, 1992, J ELECTROCARDIOL, V25, P263, DOI 10.1016/0022-0736(92)90031-T; KORS JA, 1992, AM J CARDIOL, V70, P96, DOI 10.1016/0002-9149(92)91397-M; Ledezma CA, 2014, IEEE ENG MED BIO, P2738, DOI 10.1109/EMBC.2014.6944189; Li RJ, 2014, LECT NOTES COMPUT SC, V8675, P305, DOI 10.1007/978-3-319-10443-0_39; Li X, 2010, IEEE T SYST MAN CY B, V40, P125, DOI 10.1109/TSMCB.2009.2021573; Manor R, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00146; MARCUS M, 1987, J ELECTROCARDIOL, V20, P91; PARK J, 2015, IEEE ENG MED BIO, P5191; RAUTAHARJU PM, 1990, METHOD INFORM MED, V29, P362; Sharma LN, 2012, IEEE T INF TECHNOL B, V16, P730, DOI 10.1109/TITB.2012.2195322; VANBEMMEL JH, 1990, METHOD INFORM MED, V29, P317, DOI 10.1055/s-0038-1634807; Xue Y, 2018, SOFT COMPUT, V22, P2935, DOI 10.1007/s00500-017-2547-1; Zhang WL, 2015, NEUROIMAGE, V108, P214, DOI 10.1016/j.neuroimage.2014.12.061	34	6	7	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0182500	10.1371/journal.pone.0182500	http://dx.doi.org/10.1371/journal.pone.0182500			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972986	Green Published, Green Submitted, gold			2022-12-26	WOS:000412131900002
J	Hack, NL; Iyengar, VK				Hack, Nicole L.; Iyengar, Vikram K.			Big wigs and small wigs: Time, sex, size and shelter affect cohabitation in the maritime earwig (Anisolabis maritima)	PLOS ONE			English	Article							EUROPEAN EARWIG; AGGREGATION BEHAVIOR; FORFICULA-AURICULARIA; DERMAPTERA; PHEROMONE; SUCCESS	Animal aggregations can occur for a variety of abiotic factors, such as resource limitation, or biotic factors, including group foraging and protection from predators. In our study, we examined whether time, sex, body size or shelter availability affected aggregation behavior of the maritime earwig, Anisolabis maritima (Order Dermaptera), an insect found globally at high densities under driftwood. Specifically, we monitored the distribution of two individuals in arenas with either two shelters (no habitat limitation) or one shelter (habitat limitation) to determine their propensity for cohabitation at times of peak activity and times of quiescence. Females, whose high levels of aggression are often associated with maternal care, were particularly averse to cohabitation, whereas males were generally more tolerant of other earwigs. Females initially preferred not to cohabitate when placed with a male, but were more tolerant of cohabitation later, regardless of the number of shelters. Same-sex pairs, on the other hand, were less likely to cohabitate with only one shelter present, but males were again more tolerant of conspecifics than females regardless of habitat limitation. When competition for one shelter did not lead to cohabitation, the lone occupant was more likely to be the larger individual in same-sex trials and females in mixed-sex trials. Understanding the tolerance for close proximity under these varying conditions may provide insight into aggregative behavior and spatial distribution patterns in the maritime earwig.	[Hack, Nicole L.] Calif Polytech State Univ San Luis Obispo, Dept Biol Sci, San Luis Obispo, CA USA; [Iyengar, Vikram K.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA	California State University System; California Polytechnic State University San Luis Obispo; Villanova University	Iyengar, VK (corresponding author), Villanova Univ, Dept Biol, Villanova, PA 19085 USA.	vikram.iyengar@villanova.edu			Villanova University; National Science Foundation [DBI 1262239]; Direct For Biological Sciences [1262239] Funding Source: National Science Foundation	Villanova University; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by grants from Villanova University (to VKI) and the National Science Foundation (DBI 1262239; https://www.nsf.gov/; to VKI and NLH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist Goran, 2005, pUnpaginated; Bennett C., 1904, PSYCHE, V11, P47; Briceuo R.D., 1995, SMITHSON CONTRIB ZOO, V555, P1, DOI DOI 10.5479/SI.00810282.555; Earley Ryan L., 2010, P285; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; Evans KA, 1996, 2 INT C INS PESTS UR, P163; Hehar G, 2008, CAN ENTOMOL, V140, P674, DOI [10.4039/n08-026, 10.4039/N08-026]; Hincks W. D., 1947, ANN MAG NAT HIST, V11, P517, DOI [10.1080/00222934708654662, DOI 10.1080/00222934708654662]; HOGLUND J, 1990, BEHAV ECOL SOCIOBIOL, V26, P173; Kaseda Y, 1996, APPL ANIM BEHAV SCI, V47, P163, DOI 10.1016/0168-1591(95)00675-3; Kendall-Bar JM, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-016-2233-9; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; LANGSTON RL, 1974, PAN-PAC ENTOMOL, V50, P28; Lordan J, 2014, CROP PROT, V65, P71, DOI 10.1016/j.cropro.2014.07.005; Miller JS, 2012, ANIM BEHAV, V83, P1387, DOI 10.1016/j.anbehav.2012.03.006; Miller JS, 2011, BEHAV ECOL SOCIOBIOL, V65, P1873, DOI 10.1007/s00265-011-1196-0; Moerkens R, 2009, ENTOMOL EXP APPL, V130, P198, DOI 10.1111/j.1570-7458.2008.00808.x; Munoz NE, 2012, ETHOLOGY, V118, P943, DOI 10.1111/j.1439-0310.2012.02086.x; ORING LW, 1978, IBIS, V120, P348; Raveh S, 2014, ETHOLOGY, V120, P776, DOI 10.1111/eth.12249; SAUPHANOR B, 1992, ENTOMOL EXP APPL, V62, P285, DOI 10.1007/BF00353448; SAUPHANOR B, 1993, OECOLOGIA, V96, P360, DOI 10.1007/BF00317506; Scudder S. H., 1876, B US GEOLOGICAL SURV, V2, P249, DOI [10.3133/70159432, DOI 10.3133/70159432]; SHUSTER SM, 2003, MG BEH ECOL, pR7; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; Torney CJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002194; van Lieshout E, 2009, BEHAV ECOL, V20, P258, DOI 10.1093/beheco/arp013; VANCASSEL M, 1984, ADV STUD BEHAV, V14, P51, DOI 10.1016/S0065-3454(08)60299-5; WALKER KA, 1993, J CHEM ECOL, V19, P2029, DOI 10.1007/BF00983805; Wiley HR, 1971, COOPERATIVE ROLES MI, V88, P881; ZIMMERFAUST RK, 1987, J EXP MAR BIOL ECOL, V105, P57, DOI 10.1016/S0022-0981(87)80029-1	31	3	3	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185754	10.1371/journal.pone.0185754	http://dx.doi.org/10.1371/journal.pone.0185754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968460	Green Published, gold, Green Submitted			2022-12-26	WOS:000412029600042
J	Hajek, A; Bock, JO; Konig, HH				Hajek, Andre; Bock, Jens-Oliver; Koenig, Hans-Helmut			Psychosocial correlates of unintentional weight loss in the second half of life in the German general population	PLOS ONE			English	Article							NUTRITIONAL RISK; ELDERLY-PEOPLE; OLDER-ADULTS; SATISFACTION; MORTALITY; FRAILTY; HOME	Background Unintentional weight loss (UWL) is common in older age and associated with adverse outcomes including mortality. The aim of the present study was to determine psychosocial correlates of UWL. Methods Data were derived from a large, nationally representative study of community-dwelling individuals in the second half of life (40 years and over) in Germany in 2014 (n = 7,933). Data on UWL were assessed in face-to-face interviews as unintentional loss of more than 5kg (11 pounds) in weight in the past 12 months, and data on psychosocial factors were recorded in self-administered questionnaires. Results Multiple logistic regressions revealed that UWL was positively associated with depressive symptoms and positive affect, whereas it was negatively associated with self-esteem. Individuals with UWL were more likely to feel lonely and perceive themselves as socially excluded. Conclusion The findings of important psychosocial correlates of UWL may help to identify individuals at risk for UWL in older age. This is in particular important since interventions to treat this phenomenon in older age are available that reduce adverse consequences resulting from UWL.	[Hajek, Andre; Bock, Jens-Oliver; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg Ctr Hlth Econ, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Hajek, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg Ctr Hlth Econ, Hamburg, Germany.	a.hajek@uke.de	König, Hans-Helmut/P-1211-2018	König, Hans-Helmut/0000-0001-5711-6862; Hajek, Andre/0000-0002-6886-2745				Alibhai SMH, 2005, CAN MED ASSOC J, V172, P773, DOI 10.1503/cmaj.1031527; Bailey TC, 2007, J POSIT PSYCHOL, V2, P168, DOI [10.1080/17439760701409546, DOI 10.1080/17439760701409546]; Bude H, 2006, KOLNER Z SOZIOL SOZ, V58, P233, DOI 10.1007/s11575-006-0054-1; Callen BL, 2005, PUBLIC HEALTH NURS, V22, P138, DOI 10.1111/j.0737-1209.2005.220207.x; Carmel S, 2013, PSYCHOL AGING, V28, P1115, DOI 10.1037/a0034649; Gierveld JD, 2006, RES AGING, V28, P582, DOI 10.1177/0164027506289723; Engstler H, 2015, DTSCH ALTERSSURVEY D; Engstler H, 2017, GERMAN AGEING SURVEY; Ernsberger P, 1999, J SOC ISSUES, V55, P221, DOI 10.1111/0022-4537.00114; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Harrington M, 2009, NUTR RES REV, V22, P93, DOI 10.1017/S0954422409990035; Hernandez JL, 2003, AM J MED, V114, P631, DOI 10.1016/S0002-9343(03)00115-3; Kanapuru B, 2009, AM J MED, V122, P605, DOI 10.1016/j.amjmed.2009.01.030; Klaus D, 2016, ALTERN WANDEL, P25, DOI DOI 10.1007/978-3-658-12502-8_2; Klaus Daniela, 2017, Int J Epidemiol, V46, P1105, DOI 10.1093/ije/dyw326; Kvamme JM, 2011, QUAL LIFE RES, V20, P575, DOI 10.1007/s11136-010-9788-0; Langkamp DL, 2010, ACAD PEDIATR, V10, P205, DOI 10.1016/j.acap.2010.01.005; Lankisch PG, 2001, J INTERN MED, V249, P41, DOI 10.1046/j.1365-2796.2001.00771.x; Martin CT, 2006, J GERONTOL A-BIOL, V61, P927, DOI 10.1093/gerona/61.9.927; MARTON KI, 1981, ANN INTERN MED, V95, P568, DOI 10.7326/0003-4819-95-5-568; McMinn J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1732; MELTZER AA, 1995, AM J EPIDEMIOL, V142, P1039, DOI 10.1093/oxfordjournals.aje.a117557; Metalidis C, 2008, EUR J INTERN MED, V19, P345, DOI 10.1016/j.ejim.2007.09.019; MORLEY JE, 1994, J AM GERIATR SOC, V42, P583, DOI 10.1111/j.1532-5415.1994.tb06853.x; Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; RABINOVITZ M, 1986, ARCH INTERN MED, V146, P186, DOI 10.1001/archinte.146.1.186; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Schiel S., 2015, METHODENBERICHT DURC; Schilp J, 2011, BRIT J NUTR, V106, P708, DOI 10.1017/S0007114511000717; Skovlund E, 2001, J CLIN EPIDEMIOL, V54, P86, DOI 10.1016/S0895-4356(00)00264-X; Smith K, 2007, GERIATR AGING, V10, P91; Sorbye LW, 2008, J NUTR HEALTH AGING, V12, P10, DOI 10.1007/BF02982158; Stajkovic S, 2011, CAN MED ASSOC J, V183, P443, DOI 10.1503/cmaj.101471; Stenholm S, 2013, J GERONTOL A-BIOL; THOMPSON MP, 1991, J AM GERIATR SOC, V39, P497, DOI 10.1111/j.1532-5415.1991.tb02496.x; Wallace JI, 2002, INT J CARDIOL, V85, P15, DOI 10.1016/S0167-5273(02)00246-2; Wallis DJ, 2009, APPETITE, V52, P355, DOI 10.1016/j.appet.2008.11.007; Wannamethee SG, 2005, ARCH INTERN MED, V165, P1035, DOI 10.1001/archinte.165.9.1035; Wanous JP, 1997, J APPL PSYCHOL, V82, P247, DOI 10.1037/0021-9010.82.2.247; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wikby K, 2004, SCAND J CARING SCI, V18, P120, DOI 10.1111/j.1471-6712.2004.00259.x	42	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185749	10.1371/journal.pone.0185749	http://dx.doi.org/10.1371/journal.pone.0185749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MY	28968437	gold, Green Published, Green Submitted			2022-12-26	WOS:000412029600041
J	Koga, M; Toyomaki, A; Miyazaki, A; Nakai, Y; Yamaguchi, A; Kubo, C; Suzuki, J; Ohkubo, I; Shimizu, M; Musashi, M; Kiso, Y; Kusumi, I				Koga, Minori; Toyomaki, Atsuhito; Miyazaki, Akane; Nakai, Yukiei; Yamaguchi, Atsuko; Kubo, Chizuru; Suzuki, Junko; Ohkubo, Iwao; Shimizu, Mari; Musashi, Manabu; Kiso, Yoshinobu; Kusumi, Ichiro			Mediators of the effects of rice intake on health in individuals consuming a traditional Japanese diet centered on rice	PLOS ONE			English	Article							VERSION; VALIDITY; LIFE; NUTRIENTS; MICE; FOOD	Although the Japanese diet is believed to be balanced and healthy, its benefits have been poorly investigated, especially in terms of effects on mental health. We investigated dietary patterns and physical and mental health in the Japanese population using an epidemiological survey to determine the health benefits of the traditional Japanese diet. Questionnaires to assess dietary habits, quality of life, sleep quality, impulsivity, and depression severity were distributed to 550 randomly selected middle-aged and elderly individuals. Participants with any physical or mental disease were excluded. Two-hundred and seventy-eight participants were selected for the final statistical analysis. We determined rice to be one of the most traditional foods in Japanese cuisine. Scores for each questionnaire were computed, and the correlations between rice intake and health indices were assessed. When analyzing the direct correlations between rice intake and health indices, we found only two correlations, namely those with quality of life (vitality) and sleep quality. Path analysis using structural equation modeling was performed to investigate the association between rice intake and health, with indirect effects included in the model. Additional associations between rice intake and health were explained using this model when compared to those using direct correlation analysis. Path analysis was used to identify mediators of the rice-health association. These mediators were miso (soybean paste) soup, green tea, and natto (fermented soybean) intake. Interestingly, these mediators have been major components of the Japanese diet since 1975, which has been considered one of the healthiest diets since the 1960s. Our results indicate that the combination of rice with other healthy foods, which is representative of the traditional Japanese diet, may contribute to improvements in physical and mental health.	[Koga, Minori; Toyomaki, Atsuhito; Miyazaki, Akane; Nakai, Yukiei; Kusumi, Ichiro] Hokkaido Univ, Dept Psychiat, Grad Sch Med, Sapporo, Hokkaido, Japan; [Yamaguchi, Atsuko; Kubo, Chizuru; Suzuki, Junko; Ohkubo, Iwao; Shimizu, Mari; Musashi, Manabu] Tenshi Coll, Dept Nutr, Sapporo, Hokkaido, Japan; [Kiso, Yoshinobu] Hokkaido Univ, Inst Promot Business Reg Collaborat, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Koga, M (corresponding author), Hokkaido Univ, Dept Psychiat, Grad Sch Med, Sapporo, Hokkaido, Japan.	mkoga@med.hokudai.ac.jp	Kiso, Yoshinobu/D-5424-2012		Integration Research for Agriculture and Interdisciplinary Fields [14538872]; Ministry of Agriculture, Forestry and Fisheries	Integration Research for Agriculture and Interdisciplinary Fields; Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by Integration Research for Agriculture and Interdisciplinary Fields (Grant 14538872), the Ministry of Agriculture, Forestry and Fisheries (IK); https://www.s.affrc.go.jp/docs/kibonkeikaku/pdf/h27plan_en pdf.	Bolla KN, 2015, INT J SCI TECHNOL RE, V4, P50; Doi Y, 2000, PSYCHIAT RES, V97, P165, DOI 10.1016/S0165-1781(00)00232-8; Drouin A, 2011, AM J PHYSIOL-HEART C, V300, pH1032, DOI 10.1152/ajpheart.00410.2010; Ganmaa D, 2003, MED HYPOTHESES, V60, P724, DOI 10.1016/S0306-9877(03)00047-1; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Iso H, 2008, CIRCULATION, V118, P2725, DOI 10.1161/CIRCULATIONAHA.107.750117; Isshiki K., 2007, FOODS FOOD INGREDIEN, V212; Kakutani Y, 2015, J NUTR SCI VITAMINOL, V61, P55, DOI 10.3177/jnsv.61.55; Kohara Y, 2015, PHYSIOL BEHAV, V140, P15, DOI 10.1016/j.physbeh.2014.12.005; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Matsuyama T, 2008, OBESITY, V16, P1338, DOI 10.1038/oby.2008.60; Muramatsu K, 2007, PSYCHOL REP, V101, P952, DOI 10.2466/pr0.101.3.952-960; Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505; Nakaji S, 2002, EUR J NUTR, V41, P244, DOI 10.1007/s00394-002-0380-4; Sasaki S, 1998, J Epidemiol, V8, P203; Shiwaku K, 2004, LANCET, V363, P1737, DOI 10.1016/S0140-6736(04)16274-0; Someya T, 2001, PSYCHIAT CLIN NEUROS, V55, P111, DOI 10.1046/j.1440-1819.2001.00796.x; Tokuda Y, 2009, VALUE HEALTH, V12, P568, DOI 10.1111/j.1524-4733.2008.00449.x; Tomata Y, 2016, J GERONTOLOGY A; Yamamoto K, 2016, NUTRITION, V32, P122, DOI 10.1016/j.nut.2015.07.002; Yamamura K., 1987, POLITICAL EC JAPAN; Yoneyama S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105198; Yoshiike N, 2007, NUTR REV, V65, P149, DOI 10.1301/nr.2007.apr.149-154	23	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185816	10.1371/journal.pone.0185816	http://dx.doi.org/10.1371/journal.pone.0185816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968452	Green Published, Green Submitted, gold			2022-12-26	WOS:000412029600053
J	Becker, AD; Grenfell, BT				Becker, Alexander D.; Grenfell, Bryan T.			tsiR: An R package for time-series Susceptible-Infected-Recovered models of epidemics	PLOS ONE			English	Article							MEASLES EPIDEMICS; DYNAMICAL-SYSTEMS; INFERENCE	tsiR is an open source software package implemented in the R programming language designed to analyze infectious disease time-series data. The software extends a well-studied and widely-applied algorithm, the time-series Susceptible-Infected-Recovered (TSIR) model, to infer parameters from incidence data, such as contact seasonality, and to forward simulate the underlying mechanistic model. The tsiR package aggregates a number of different fitting features previously described in the literature in a user-friendly way, providing support for their broader adoption in infectious disease research. Also included in tsiR are a number of diagnostic tools to assess the fit of the TSIR model. This package should be useful for researchers analyzing incidence data for fully-immunizing infectious diseases.	[Becker, Alexander D.; Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Grenfell, Bryan T.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA	Princeton University; Princeton University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Becker, AD (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	adbecker@princeton.edu			National Science Foundation Graduate Research Fellowship; Center for Health and Wellbeing at Princeton University; Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; Bill and Melinda Gates Foundation; U.S. Centers for Disease Control and Prevention; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Center for Health and Wellbeing at Princeton University(Princeton University); Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	A.D.B. was supported by a National Science Foundation Graduate Research Fellowship and the Center for Health and Wellbeing at Princeton University. B.T.G. was supported by the Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security, the Fogarty International Center, National Institutes of Health, the Bill and Melinda Gates Foundation, and the U.S. Centers for Disease Control and Prevention.	Anderson RM, 1992, INFECT DIS HUMANS DY, V15; [Anonymous], 2016, BAYESIAN GRAPHICAL M; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Breto C, 2009, ANN APPL STAT, V3, P319, DOI 10.1214/08-AOAS201; Caudron Q, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1125; Dalziel BD, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004655; Ferrari MJ, 2008, NATURE, V451, P679, DOI 10.1038/nature06509; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Freckleton R., 1999, J APPL ECOL, V36, P842; Glass K, 2003, J THEOR BIOL, V223, P19, DOI 10.1016/S0022-5193(03)00031-6; Grenfell BT, 2002, ECOL MONOGR, V72, P185, DOI 10.1890/0012-9615(2002)072[0185:DOMESN]2.0.CO;2; Groendyke C, 2012, BIOMETRICS, V68, P755, DOI 10.1111/j.1541-0420.2012.01748.x; Hadley W., 2009, ELEGANT GRAPHICS DAT; He DH, 2011, THEOR ECOL-NETH, V4, P283, DOI 10.1007/s12080-011-0123-3; He DH, 2010, J R SOC INTERFACE, V7, P271, DOI 10.1098/rsif.2009.0151; HOLLAND PW, 1981, J AM STAT ASSOC, V76, P33, DOI 10.2307/2287037; Ionides EL, 2006, P NATL ACAD SCI USA, V103, P18438, DOI 10.1073/pnas.0603181103; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; King AA, 2015, POMP STAT INFERENCE; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Metcalf CJE, 2009, P ROYAL SOC LONDON B, V276; Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414; Takahashi S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001958; Wallinga J, 2001, EPIDEMIOL INFECT, V127, P281, DOI 10.1017/S095026880100601X; Wickham H., 2007, RESHAPING DATA RESHA; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341	27	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185528	10.1371/journal.pone.0185528	http://dx.doi.org/10.1371/journal.pone.0185528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957408	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200077
J	Kim, SH; Oh, D; Jung, KS; Lee, JE; Kim, H; Kim, HJ; Kim, BS; Park, HC; Lee, BK; Choi, HY				Kim, Seok-hyung; Oh, Donghwan; Jung, Kwon Soo; Lee, Jung Eun; Kim, Hyunwook; Kim, Hyung Jong; Kim, Beom Seok; Park, Hyeong Cheon; Lee, Byoung Kwon; Choi, Hoon Young			The association between the apolipoprotein B/A-I ratio and coronary calcification may differ depending on kidney function in a healthy population	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; ARTERY CALCIUM SCORE; MILD RENAL-INSUFFICIENCY; HEART-DISEASE EVENTS; CARDIOVASCULAR-DISEASE; A-I; MYOCARDIAL-INFARCTION; COMPUTED-TOMOGRAPHY; STATIN TREATMENT; RISK	Background The apolipoprotein B/A-1 ratio has been reported to be one of the strongest risk predictors of cardiovascular events. However, its prognostic value for cardiovascular disease is still uncertain, especially in patients with chronic kidney disease. This study aimed to investigate whether the association between the apolipoprotein B/A-I ratio and coronary artery calcification differed according to kidney function in a healthy population. Methods Of the data from 7,780 participants from the medical records database in Gangnam Severance Hospital from 2005 through 2016, a cross-sectional analysis included participants with an estimated glomerular filtration rate (eGFR) >= 60 mL/min/1.73 m(2) determined based on the Chronic Kidney Disease-Epidemiology Collaboration equation (n = 1,800). Mild renal insufficiency was defined as an eGFR of 60-90 mL/min/1.73 m(2). Coronary artery calcification measured with computed tomography was defined as an above-zero score. Logistic regression analyses were used to determine the association between coronary calcification and the apolipoprotein B/A-I ratio according to eGFR by adjusting for the influence of confounders. Results The mean apolipoprotein B/A-I level was significantly higher in the participants with coronary artery calcification than in the participants without coronary artery calcification. The apolipoprotein B/A-I ratio was significantly different according to coronary artery calcification in the participants with normal kidney function, but in the participants with mild renal insufficiency, it was not different. After adjusting for age, male sex, systolic blood pressure, body mass index, current smoking status, and fasting plasma glucose, the apolipoprotein B/A-I ratio was significantly associated with an increased risk of coronary artery calcification in participants with normal kidney function (odds ratio = 2.411, p = 0.011), while in the participants with mild renal insufficiency, the apolipoprotein B/A-I ratio was not associated with coronary artery calcification. Conclusion Our study showed that the predictive value of apolipoprotein B/A-I ratio for coronary artery calcification may differ according to kidney function.	[Kim, Seok-hyung; Oh, Donghwan; Jung, Kwon Soo; Kim, Hyunwook; Park, Hyeong Cheon; Lee, Byoung Kwon; Choi, Hoon Young] Yonsei Univ, Coll Med, Dept Internal Med, Gangnam Severance Hosp, Seoul, South Korea; [Lee, Jung Eun] Yonsei Univ, Coll Med, Dept Internal Med, Yongin Severance Hosp, Seoul, South Korea; [Kim, Hyung Jong] CHA Univ, Dept Internal Med, CHA Bundang Med Ctr, Seongnam, South Korea; [Kim, Beom Seok] Yonsei Univ, Coll Med, Dept Internal Med, Severance Hosp, Seoul, South Korea; [Park, Hyeong Cheon; Choi, Hoon Young] Yonsei Univ, Severance Inst Vasc & Metab Res, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Pochon Cha University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Choi, HY (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Gangnam Severance Hosp, Seoul, South Korea.; Choi, HY (corresponding author), Yonsei Univ, Severance Inst Vasc & Metab Res, Coll Med, Seoul, South Korea.	hychoi.dr@gmail.com		Kim, Beom Seok/0000-0002-5732-2583; Lee, Byoung Kwon/0000-0001-9259-2776; Kim, Hyunwook/0000-0002-4274-7562; CHOI, HOON YOUNG/0000-0002-4245-0339; Jung, Kwon Soo/0000-0003-3238-5139; Park, Hyeong-Cheon/0000-0002-1550-0812; LEE, JUNG EUN/0000-0003-0917-2872				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Bashir A, 2015, AM J KIDNEY DIS, V65, P937, DOI 10.1053/j.ajkd.2015.01.012; Carl A, 2006, BRUNS TIETZ TXB CLIN; Chou YC, 2015, ENDOCRINE, V49, P404, DOI 10.1007/s12020-014-0447-z; Demer LL, 2014, ARTERIOSCL THROM VAS, V34, P715, DOI 10.1161/ATVBAHA.113.302070; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Faergeman O, 2006, J INTERN MED, V259, P434, DOI 10.1111/j.1365-2796.2006.01650.x; Florens N, 2016, TOXINS, V8, DOI 10.3390/toxins8120376; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goek ON, 2012, NEPHROL DIAL TRANSPL, V27, P2839, DOI 10.1093/ndt/gfr795; Goupil R, 2016, CENTRAL BLOOD PRESSU; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Henry RMA, 2002, KIDNEY INT, V62, P1402, DOI 10.1046/j.1523-1755.2002.00571.x; Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; Joosen IA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047267; Jung CH, 2013, J KOREAN MED SCI, V28, P709, DOI 10.3346/jkms.2013.28.5.709; Kastelein JJP, 2008, CIRCULATION, V117, P3002, DOI 10.1161/CIRCULATIONAHA.107.713438; LaMonte MJ, 2005, AM J EPIDEMIOL, V162, P421, DOI 10.1093/aje/kwi228; Lamprea-Montealegre JA, 2014, ATHEROSCLEROSIS, V234, P42, DOI 10.1016/j.atherosclerosis.2014.02.006; Lamprea-Montealegre JA, 2013, ARTERIOSCL THROM VAS, V33, P652, DOI 10.1161/ATVBAHA.112.300624; Levey AS, 2014, AM J KIDNEY DIS, V63, P820, DOI 10.1053/j.ajkd.2013.12.006; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114397; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Moody WE, 2013, HEART, V99, P365, DOI 10.1136/heartjnl-2012-302818; Nakamura S, 2009, CLIN J AM SOC NEPHRO, V4, P1892, DOI 10.2215/CJN.04320709; Nakazato Ryo, 2009, J Cardiovasc Comput Tomogr, V3, P394, DOI 10.1016/j.jcct.2009.10.002; Peng Y, 2017, J RENAL NUTR, V27, P187, DOI 10.1053/j.jrn.2017.01.018; Pletcher MJ, 2004, ARCH INTERN MED, V164, P1285, DOI 10.1001/archinte.164.12.1285; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; SAMUELSSON O, 1994, NEPHROL DIAL TRANSPL, V9, P1580; Schianca GPC, 2011, NUTR METAB CARDIOVAS, V21, P406, DOI 10.1016/j.numecd.2009.11.002; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Shareghi S, 2007, YOUNG, V1, P155, DOI [DOI 10.1016/j.jcct.2007.10.001, DOI 10.1016/J.JCCT.2007.10.001]; Sniderman AD, 2005, CIRCULATION, V112, P3366, DOI 10.1161/CIRCULATIONAHA.105.583336; Sniderman AD, 2003, LANCET, V361, P777, DOI 10.1016/S0140-6736(03)12663-3; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Thompson A, 2006, J INTERN MED, V259, P481, DOI 10.1111/j.1365-2796.2006.01644.x; Vaziri ND, 2014, CLIN EXP NEPHROL, V18, P265, DOI 10.1007/s10157-013-0847-z; Walldius G, 2006, J INTERN MED, V259, P493, DOI 10.1111/j.1365-2796.2006.01643.x; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Wilkins JT, 2016, J AM COLL CARDIOL, V67, P193, DOI 10.1016/j.jacc.2015.10.055; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	45	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185522	10.1371/journal.pone.0185522	http://dx.doi.org/10.1371/journal.pone.0185522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957410	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200075
J	Poli, A; Ratti, S; Finelli, C; Mongiorgi, S; Clissa, C; Lonetti, A; Cappellini, A; Catozzi, A; Barraco, M; Suh, PG; Manzoli, L; McCubrey, JA; Cocco, L; Follo, MY				Poli, Alessandro; Ratti, Stefano; Finelli, Carlo; Mongiorgi, Sara; Clissa, Cristina; Lonetti, Annalisa; Cappellini, Alessandra; Catozzi, Alessia; Barraco, Marilena; Suh, Pann-Ghill; Manzoli, Lucia; McCubrey, James A.; Cocco, Lucio; Follo, Matilde Y.			Nuclear translocation of PKC-alpha is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs)	FASEB JOURNAL			English	Article						nucleus; erythropoiesis; lenalidomide; chromosome 5q deletion	ACUTE LYMPHOBLASTIC-LEUKEMIA; PHOSPHOLIPASE-C; RISK MDS; SIGNALING PATHWAYS; K562 CELLS; LENALIDOMIDE; PI-PLC-BETA-1; AZACITIDINE; INVOLVEMENT; ACTIVATION	PI-PLC beta 1 is involved in cell proliferation, differentiation, and myelodysplastic syndrome (MDS) pathogenesis. Moreover, the increased activity of PI-PLC beta 1 reduces the expression of PKC-alpha, which, in turn, delays the cell proliferation and is linked to erythropoiesis. Lenalidomide is currently used in low-risk patients with MDS and del(5q), where it can suppress the del(5q) clone and restore normal erythropoiesis. In this study, we analyzed the effect of lenalidomide on 16 patients with low-risk del(5q) MDS, as well as del(5q) and non-del(5q) hematopoietic cell lines, mainly focusing on erythropoiesis, cell cycle, and PI-PLC beta 1/PKC-alpha signaling. Overall, 11 patients were evaluated clinically, and 10 (90%) had favorable responses; the remaining case had a stable disease. At a molecular level, both responder patients and del(5q) cells showed a specific induction of erythropoiesis, with a reduced gamma/beta-globin ratio, an increase in glycophorin A, and a nuclear translocation of PKC-alpha. Moreover, lenalidomide could induce a selective G(0)/G(1) arrest of the cell cycle in del(5q) cells, slowing down the rate proliferation in those cells. Altogether, our results could not only better explain the role of PI-PLC beta 1/PKC-alpha signaling in erythropoiesis but also lead to a better comprehension of the lenalidomide effect on del(5q) MDS and pave the way to innovative, targeted therapies.	[Poli, Alessandro; Ratti, Stefano; Mongiorgi, Sara; Lonetti, Annalisa; Catozzi, Alessia; Manzoli, Lucia; Cocco, Lucio; Follo, Matilde Y.] Univ Bologna, Policlin St Orsola Malpighi Hosp, Dipartimento Sci Biomed & NeuroMotorie, Inst Human Anat,Cellular Signalling Lab, Bologna, Italy; [Finelli, Carlo; Clissa, Cristina; Barraco, Marilena] Univ Bologna, Policlin St Orsola Malpighi Hosp, L & E Seragnoli Inst Hematol, Bologna, Italy; [Lonetti, Annalisa] Univ Bologna, Policlin St Orsola Malpighi Hosp, Lalla Seragnoli Dept Pediat, Bologna, Italy; [Poli, Alessandro] Fdn Romeo & Enrica Invernizzi, Ist Nazl Genet Mol, Milan, Italy; [Clissa, Cristina] San Salvatore Hosp, Hematol & Stem Cell Transplant Ctr, Pesaro, Italy; [Cappellini, Alessandra] Univ Cassino, Dept Human Social Sci & Hlth, Cassino, Italy; [Suh, Pann-Ghill] Ulsan Natl Inst Sci & Technol, Sch Life Sci, Ulsan, South Korea; [McCubrey, James A.] East Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC USA	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Cassino; Ulsan National Institute of Science & Technology (UNIST); University of North Carolina; East Carolina University	Cocco, L; Follo, MY (corresponding author), Univ Bologna, Cellular Signalling Lab, Inst Human Anat, Dipartimento Sci Biomed & NeuroMotorie, Via Irnerio 48, I-40126 Bologna, Italy.	lucio.cocco@unibo.it; matilde.follo@unibo.it	ratti, stefano/AAC-8714-2022; Cocco, Lucio/AAI-2206-2020; Lonetti, Annalisa/AAB-3647-2019; Suh, Pann-Ghill/F-3610-2010	Cocco, Lucio/0000-0002-9206-8277; Lonetti, Annalisa/0000-0002-3944-3090; RATTI, STEFANO/0000-0002-6258-5345; Catozzi, Alessia/0000-0002-7263-5203; Poli, Alessandro/0000-0001-5808-820X	Italian Ministero dell'Istruzione dell'Universita e della Ricerca-Progetti di Ricerca di Interesse Nazionale; Intesa S. Paolo	Italian Ministero dell'Istruzione dell'Universita e della Ricerca-Progetti di Ricerca di Interesse Nazionale; Intesa S. Paolo	This work was supported by grants from the Italian Ministero dell'Istruzione dell'Universita e della Ricerca-Progetti di Ricerca di Interesse Nazionale and Intesa S. Paolo. The authors declare no conflicts of interest.	Bae Yoe-Sik, 2017, Advances in Biological Regulation, V63, P92, DOI 10.1016/j.jbior.2016.09.006; Basiorka AA, 2016, CANCER RES, V76, P3531, DOI 10.1158/0008-5472.CAN-15-1756; Bavelloni A, 2014, ONCOTARGET, V5, P4222, DOI 10.18632/oncotarget.1972; Blalock WL, 2011, LEUKEMIA, V25, P236, DOI 10.1038/leu.2010.264; Buontempo F, 2012, CELL CYCLE, V11, P2467, DOI 10.4161/cc.20859; Cheson BD, 2006, BLOOD, V108, P419, DOI 10.1182/blood-2005-10-4149; Cocco Lucio, 2015, Advances in Biological Regulation, V60, P1, DOI 10.1016/j.jbior.2015.10.008; Cocco L, 2015, J LEUKOCYTE BIOL, V98, P769, DOI 10.1189/jlb.2MA1114-541R; Cocco L, 2015, J LIPID RES, V56, P1853, DOI 10.1194/jlr.R057984; Cocco L, 2010, ADV ENZYME REGUL, V50, P2, DOI 10.1016/j.advenzreg.2009.10.007; Faenza I, 2005, ANTICANCER RES, V25, P2039; Follo MY, 2012, LEUKEMIA, V26, P2474, DOI 10.1038/leu.2012.133; Follo MY, 2012, LEUKEMIA, V26, P943, DOI 10.1038/leu.2011.300; Follo MY, 2011, LEUKEMIA, V25, P271, DOI 10.1038/leu.2010.266; Follo Matilde Y, 2015, Adv Biol Regul, V57, P10, DOI 10.1016/j.jbior.2014.10.004; Follo Matilde Y., 2014, Advances in Biological Regulation, V54, P2, DOI 10.1016/j.jbior.2013.11.003; Follo Matilde Y., 2013, Advances in Biological Regulation, V53, P2, DOI 10.1016/j.jbior.2012.09.009; Follo MY, 2012, CURR PHARM DESIGN, V18, P1751; Follo MY, 2010, J CELL BIOCHEM, V109, P1065, DOI 10.1002/jcb.22483; Follo MY, 2009, P NATL ACAD SCI USA, V106, P16811, DOI 10.1073/pnas.0907109106; Gandhi AK, 2006, LEUKEMIA RES, V30, P849, DOI 10.1016/j.leukres.2006.01.010; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Lonetti A, 2014, LEUKEMIA, V28, P1196, DOI 10.1038/leu.2013.369; Manzoli L, 2014, MINI-REV MED CHEM, V14, P873, DOI 10.2174/1389557514666141013125936; Martelli AM, 2005, HISTOL HISTOPATHOL, V20, P1251, DOI 10.14670/HH-20.1251; Mongiorgi S, 2016, EXPERT OPIN THER TAR, V20, P677, DOI 10.1517/14728222.2016.1125885; Mongiorgi S, 2016, CURR PHARM DESIGN, V22, P2345, DOI 10.2174/1381612822666160226132338; Mongiorgi S, 2012, CURR TOP MICROBIOL, V362, P235, DOI 10.1007/978-94-007-5025-8_11; Myklebust JH, 2002, EXP HEMATOL, V30, P990, DOI 10.1016/S0301-472X(02)00868-8; Narla A, 2011, BLOOD, V118, P2296, DOI 10.1182/blood-2010-11-318543; Poli A, 2017, J CELL PHYSIOL, V232, P2550, DOI 10.1002/jcp.25642; Poli A, 2016, J CELL PHYSIOL, V231, P1645, DOI 10.1002/jcp.25273; Poli A, 2014, ONCOTARGET, V5, P11526, DOI 10.18632/oncotarget.2578; Poli A, 2014, BIOCHEM SOC T, V42, P1471, DOI 10.1042/BST20140128; Poli A, 2013, CELL CYCLE, V12, P1713, DOI 10.4161/cc.24806; Ramazzotti Giulia, 2017, Advances in Biological Regulation, V63, P1, DOI 10.1016/j.jbior.2016.10.005; Ramazzotti G, 2011, CRIT REV EUKAR GENE, V21, P291, DOI 10.1615/CritRevEukarGeneExpr.v21.i3.50; Ramazzotti G, 2011, J CELL PHYSIOL, V226, P14, DOI 10.1002/jcp.22334; Ratti S, 2017, J CELL BIOCHEM, V118, P1969, DOI 10.1002/jcb.25894; Stahl M, 2017, CANCER-AM CANCER SOC, V123, P1703, DOI 10.1002/cncr.30585; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262	41	16	20	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					681	692		10.1096/fj.201700690R	http://dx.doi.org/10.1096/fj.201700690R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28970249	Green Submitted			2022-12-26	WOS:000425146900013
J	Yu, XL; Chen, H; Zuo, C; Jin, X; Yin, YB; Wang, H; Jin, M; Ozato, K; Xu, SX				Yu, Xiaoli; Chen, Hui; Zuo, Chen; Jin, Xi; Yin, Yibing; Wang, Hong; Jin, Mei; Ozato, Keiko; Xu, Songxiao			Chromatin remodeling: demethylating H3K4me3 of type I IFNs gene by Rbp2 through interacting with Piasy for transcriptional attenuation	FASEB JOURNAL			English	Article						histone modification; RNA expression regulation; protein-protein interaction	NF-KAPPA-B; PROTEIN INHIBITOR; GASTRIC-CANCER; HISTONE; ACTIVATION; RECEPTOR; REPRESSION; TRANSACTIVATION; METHYLATION; RECRUITMENT	Type I IFNs (IFNIs) are involved in the course of antiviral and antimicrobial activities; however, robust inductions of these can lead to host immunopathology. We have reported that the Pias (protein inhibitor of activated signal transducer and activator of transcription) family member, Piasy, possesses the ability to suppress IFNI transcriptions in mouse embryonic fibroblasts (MEFs), yet the specific molecular mechanism by which it acts remains elusive. Here, we identify that the H3K4me3 levels, one activation mark of genes, in MEFs that were stimulated by poly(I:C) were impaired by Piasy in the IFN-beta gene. Piasy bound to the promoter region of the IFN-beta gene in MEFs. Meanwhile, retinoblastoma binding protein 2 (Rbp2) was proven to be the only known and novel H3K4me3 demethylase that interacted with Piasy. Overexpression of Rbp2, but not its enzymatically inactive mutant Rbp2(H483G/E485Q), retarded the transcription activities of IFNI, whereas small interfering RNA-mediated or short hairpin RNA-mediated knockdown of Rbp2 enhanced IFNI promoter responses. Above all, coexpression of Piasy and Rbp2 led to statistically less IFNI induction than overexpression of either Piasy or Rbp2 alone. Mechanistically, Piasy bound to the Jmjc domain (451-503 aa) of Rbp2 via its PINIT domain (101-218 aa), which is consistent with the domain required for their attenuation of transcription and H3K4me3 levels of IFNI genes. Our study demonstrates that Piasy may prevent exaggerated transcription of IFNI by Rbp2-mediated demethylation of H3K4me3 of IFNI, avoiding excessive immune responses.	[Yu, Xiaoli; Chen, Hui; Jin, Xi; Jin, Mei; Xu, Songxiao] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Pathol, 3 East Qingchun Rd, Hangzhou 310016, Zhejiang, Peoples R China; [Zuo, Chen; Yin, Yibing; Wang, Hong] Chongqing Med Univ, Minist Educ, Key Lab Diagnost Med Designated, Dept Lab Med, Chongqing, Peoples R China; [Ozato, Keiko] NICHHD, NIH, Bethesda, MD 20892 USA	Zhejiang University; Chongqing Medical University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Xu, SX (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Pathol, 3 East Qingchun Rd, Hangzhou 310016, Zhejiang, Peoples R China.	xusx1979@hotmail.com	Xu, Songxiao/L-5737-2019	Jin, Xi/0000-0002-2981-8581	National Natural Science Foundation of China [81273315]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001310, ZIAHD008815] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Grant 81273315 from the National Natural Science Foundation of China. The authors thank Prof. Shuai Ke (University of California, Los Angeles, Los Angeles, CA, USA) for the generous gifts of Pias1<SUP>-/-</SUP>, Pias1<SUP>+/+</SUP>, Pias1<SUP>-/-</SUP>, and Pias1<SUP>+/+</SUP> MEFs. The authors also thank Shu Qiao (Dauntsey's School, West Lavington, United Kingdom) for assistance with English language editing. The authors declare no conflicts of interest.	Ballestar E, 2011, ADV EXP MED BIOL, V711, P1; Black JC, 2011, EPIGENETICS-US, V6, P13, DOI 10.4161/epi.6.1.13331; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Chang TH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000493; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Facompre ND, 2016, CANCER RES, V76, P5538, DOI 10.1158/0008-5472.CAN-15-3377; Fang MM, 2016, BBA-GENE REGUL MECH, V1859, P294, DOI 10.1016/j.bbagrm.2015.11.010; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Ge Z, 2010, FASEB J, V24, P579, DOI 10.1096/fj.09-140087; Gross M, 2004, ONCOGENE, V23, P3059, DOI 10.1038/sj.onc.1207443; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Huo HR, 2010, CANCER RES, V70, P8726, DOI 10.1158/0008-5472.CAN-10-0755; Kim H, 2009, J BIOL CHEM, V284, P19867, DOI 10.1074/jbc.M109.021485; Kimura H, 2013, J HUM GENET, V58, P439, DOI 10.1038/jhg.2013.66; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kubota T, 2011, J BIOL CHEM, V286, P8165, DOI 10.1074/jbc.M110.195255; Kurihara I, 2005, J BIOL CHEM, V280, P6721, DOI 10.1074/jbc.M411820200; Kurt-Jones EA, 2004, J ENDOTOXIN RES, V10, P419, DOI 10.1179/096805104225006516; Lao MX, 2016, J IMMUNOL, V196, P596, DOI 10.4049/jimmunol.1403254; Lee JM, 2003, FEBS LETT, V555, P322, DOI 10.1016/S0014-5793(03)01268-7; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li PF, 2012, INFLAMMATION, V35, P1611, DOI 10.1007/s10753-012-9476-z; Liang XM, 2015, ONCOTARGET, V6, P17661, DOI 10.18632/oncotarget.3756; Liberatore RA, 2011, P NATL ACAD SCI USA, V108, P18097, DOI 10.1073/pnas.1113694108; Lloret-Llinares M, 2012, NUCLEIC ACIDS RES, V40, P9493, DOI 10.1093/nar/gks773; Mattei F, 2010, CYTOKINE GROWTH F R, V21, P227, DOI 10.1016/j.cytogfr.2010.05.002; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Naidu SR, 2012, CELL CYCLE, V11, P2717, DOI 10.4161/cc.21091; Nelson V, 2001, APOPTOSIS, V6, P221, DOI 10.1023/A:1011392811628; Nishibuchi G, 2014, J BIOL CHEM, V289, P28956, DOI 10.1074/jbc.M114.573725; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Patsialou A, 2005, NUCLEIC ACIDS RES, V33, P66, DOI 10.1093/nar/gki145; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sadakierska-Chudy A, 2015, NEUROTOX RES, V27, P172, DOI 10.1007/s12640-014-9508-6; Salifou K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10174; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Sharrocks AD, 2006, GENE DEV, V20, P754, DOI 10.1101/gad.1421006; Shuai K, 2006, CELL RES, V16, P196, DOI 10.1038/sj.cr.7310027; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Tahk S, 2007, P NATL ACAD SCI USA, V104, P11643, DOI 10.1073/pnas.0701877104; Torikoshi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041186; Tu SJ, 2008, NAT STRUCT MOL BIOL, V15, P419, DOI 10.1038/nsmb.1400; Xia M, 2013, IMMUNITY, V39, P470, DOI 10.1016/j.immuni.2013.08.016; Yoo YS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8910; Zeng JP, 2010, GASTROENTEROLOGY, V138, P981, DOI 10.1053/j.gastro.2009.10.004; Zhang J, 2004, FEBS LETT, V570, P97, DOI 10.1016/j.febslet.2004.05.081; Zhao DZ, 2016, CELL REP, V15, P288, DOI 10.1016/j.celrep.2016.03.035; Zhao D, 2016, ADVANCES IN ENERGY, ENVIRONMENT AND MATERIALS SCIENCE, P29; Zhou MR, 2015, ONCOTARGET, V6, P1249, DOI 10.18632/oncotarget.2859; Zhou S, 2008, J BIOL CHEM, V283, P20137, DOI 10.1074/jbc.M801307200	52	3	3	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					552	567		10.1096/fj.201700088RR	http://dx.doi.org/10.1096/fj.201700088RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28970247	Bronze, Green Published			2022-12-26	WOS:000425146900003
J	Oda, K; Oda, T; Matoba, Y; Sato, M; Irie, T; Sakaguchi, T				Oda, Kosuke; Oda, Takashi; Matoba, Yasuyuki; Sato, Mamoru; Irie, Takashi; Sakaguchi, Takemasa			Structural analysis of the STAT1:STAT2 heterodimer revealed the mechanism of Sendai virus C protein-mediated blockade of type 1 interferon signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; interferon; negative-strand RNA virus; signal transduction; small-angle X-ray scattering (SAXS); surface plasmon resonance (SPR); paramyxovirus	V PROTEIN; VIRAL PATHOGENESIS; PLASMA-MEMBRANE; ACTIVATION; PARAMYXOVIRUS; BINDING; RNA; INHIBITION; SCATTERING; PARTICLES	Sendai virus (SeV), which causes respiratory diseases in rodents, possesses the C protein that blocks the signal transduction of interferon (IFN), thereby escaping from host innate immunity. We previously demonstrated by using protein crystallography that two molecules of Y3 (the C-terminal half of the C protein) can bind to the homodimer of the N-terminal domain of STAT1 (STAT1ND), elucidating the mechanism of inhibition of IFN- signal transduction. SeV C protein also blocks the signal transduction of IFN-/ by inhibiting the phosphorylation of STAT1 and STAT2, although the mechanism for the inhibition is unclear. Therefore, we sought to elucidate the mechanism of inhibition of the IFN signal transduction via STAT1 and STAT2. Small angle X-ray scattering analysis indicated that STAT1ND associates with the N-terminal domain of STAT2 (STAT2ND) with the help of a Gly-rich linker. We generated a linker-less recombinant protein possessing a STAT1ND:STAT2ND heterodimeric structure via an artificial disulfide bond. Analytical size-exclusion chromatography and surface plasmon resonance revealed that one molecule of Y3 can associate with a linker-less recombinant protein. We propose that one molecule of C protein associates with the STAT1:STAT2 heterodimer, inducing a conformational change to an antiparallel form, which is easily dephosphorylated. This suggests that association of C protein with the STAT1ND:STAT2ND heterodimer is an important factor to block the IFN-/ signal transduction.	[Oda, Kosuke; Irie, Takashi; Sakaguchi, Takemasa] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Virol, Hiroshima 7348551, Japan; [Matoba, Yasuyuki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Microbiol, Hiroshima 7348551, Japan; [Oda, Takashi; Sato, Mamoru] Yokohama City Univ, Grad Sch Med Life Sci, Struct Biol Lab, Yokohama, Kanagawa 2300045, Japan	Hiroshima University; Hiroshima University; Yokohama City University	Sakaguchi, T (corresponding author), Kasumi 1-2-3,Minami Ku, Hiroshima 7348551, Japan.	tsaka@hiroshima-u.ac.jp	Sakaguchi, Takemasa/H-1488-2019; ODA, KOSUKE/ABD-2610-2021	Sakaguchi, Takemasa/0000-0002-3754-1252; 	INAMORI Foundation; GlaxoSmithKline Japan; Takeda Science Foundation; Japan Society for the Promotion of Science [15K151430, 16H051975]; Japan Agency for Medical Research and Development	INAMORI Foundation; GlaxoSmithKline Japan(GlaxoSmithKline); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by grants from the INAMORI Foundation (to K. O.), GlaxoSmithKline Japan (to K. O.), the Takeda Science Foundation (to K. O.), Japan Society for the Promotion of Science Grants 15K151430 and 16H051975 (to T. S. and K. O.), and the Japan Agency for Medical Research and Development (to T. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Begitt A, 2014, NAT IMMUNOL, V15, P168, DOI 10.1038/ni.2794; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Chichili VPR, 2013, PROTEIN SCI, V22, P153, DOI 10.1002/pro.2206; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Domoszlai T, 2014, J CELL SCI, V127, P1899, DOI 10.1242/jcs.137422; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Garcin D, 1999, J VIROL, V73, P6559, DOI 10.1128/JVI.73.8.6559-6565.1999; Glatter O., 1982, SMALL ANGLE X RAY SC; Gotoh B, 2004, FEBS LETT, V567, P291, DOI 10.1016/j.febslet.2004.05.001; Gotoh B, 2003, J VIROL, V77, P3360, DOI 10.1128/JVI.77.6.3360-3370.2003; Gotoh B, 1999, FEBS LETT, V459, P205, DOI 10.1016/S0014-5793(99)01241-7; Gotoh G, 2003, VIROLOGY, V316, P29, DOI 10.1016/S0042-6822(03)00590-7; Ho J, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000117; Huang C, 2000, J VIROL, V74, P7834, DOI 10.1128/JVI.74.17.7834-7841.2000; Irie T, 2008, VIROLOGY, V374, P495, DOI 10.1016/j.virol.2008.01.004; Irie T, 2008, VIROLOGY, V371, P108, DOI 10.1016/j.virol.2007.09.020; Irie T, 2007, J VIROL, V81, P2263, DOI 10.1128/JVI.02218-06; Irie T, 2014, J VIROL, V88, P690, DOI 10.1128/JVI.02798-13; Irie T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073740; Irie T, 2012, J VIROL, V86, P7136, DOI 10.1128/JVI.06705-11; Irie T, 2010, VIROLOGY, V405, P334, DOI 10.1016/j.virol.2010.06.031; Irie T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010719; Kato A, 2004, J VIROL, V78, P7443, DOI 10.1128/JVI.78.14.7443-7454.2004; Kato A, 1996, GENES CELLS, V1, P569, DOI 10.1046/j.1365-2443.1996.d01-261.x; Kato A, 1997, J VIROL, V71, P7266, DOI 10.1128/JVI.71.10.7266-7272.1997; Kato A, 1997, EMBO J, V16, P578, DOI 10.1093/emboj/16.3.578; Kato A, 2007, J VIROL, V81, P3264, DOI 10.1128/JVI.02590-06; Kingston RL, 2004, P NATL ACAD SCI USA, V101, P8301, DOI 10.1073/pnas.0402690101; KIYOTANI K, 1990, VIROLOGY, V177, P65, DOI 10.1016/0042-6822(90)90460-9; Komatsu T, 2004, VIROLOGY, V325, P137, DOI 10.1016/j.virol.2004.04.025; Komatsu T, 2000, J VIROL, V74, P2477, DOI 10.1128/JVI.74.5.2477-2480.2000; Komatsu T, 2002, FEBS LETT, V511, P139, DOI 10.1016/S0014-5793(01)03301-4; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lim CP, 2006, MOL BIOSYST, V2, P536, DOI 10.1039/b606246f; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Marq JB, 2007, J VIROL, V81, P3187, DOI 10.1128/JVI.02465-06; Mertens C, 2006, GENE DEV, V20, P3372, DOI 10.1101/gad.1485406; Nagai Y, 2011, BIOLOGY OF PARAMYXOVIRUSES, P115; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; O'Sullivan LA, 2007, MOL IMMUNOL, V44, P2497, DOI 10.1016/j.molimm.2006.11.025; Oda K, 2015, J VIROL, V89, P11487, DOI 10.1128/JVI.01887-15; Ota N, 2004, NAT IMMUNOL, V5, P208, DOI 10.1038/ni1032; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Roberts A.R.G.D.P., 2013, FIELDS VIROLOGY, V6th, P957; Saijo M, 2002, J CLIN MICROBIOL, V40, P372, DOI 10.1128/JCM.40.2.372-375.2002; Sakaguchi T, 2005, J VIROL, V79, P8933, DOI 10.1128/JVI.79.14.8933-8941.2005; Sakaguchi T, 2011, MICROBIOL IMMUNOL, V55, P760, DOI 10.1111/j.1348-0421.2011.00379.x; Shimizu N, 2016, AIP CONF PROC, V1741, DOI 10.1063/1.4952937; Sugahara F, 2004, VIROLOGY, V325, P1, DOI 10.1016/j.virol.2004.04.019; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takeuchi K, 2001, GENES CELLS, V6, P545, DOI 10.1046/j.1365-2443.2001.00442.x; Takeuchi K, 2008, J VIROL, V82, P10102, DOI 10.1128/JVI.00599-08; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wenta N, 2008, P NATL ACAD SCI USA, V105, P9238, DOI 10.1073/pnas.0802130105; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102	58	7	7	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19752	19766		10.1074/jbc.M117.786285	http://dx.doi.org/10.1074/jbc.M117.786285			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28978648	Green Published, hybrid			2022-12-26	WOS:000416911300020
J	Kitai, Y; Iwakami, M; Saitoh, K; Togi, S; Isayama, S; Sekine, Y; Muromoto, R; Kashiwakura, J; Yoshimura, A; Oritani, K; Matsuda, T				Kitai, Yuichi; Iwakami, Masashi; Saitoh, Kodai; Togi, Sumihito; Isayama, Serina; Sekine, Yuichi; Muromoto, Ryuta; Kashiwakura, Jun-ichi; Yoshimura, Akihiko; Oritani, Kenji; Matsuda, Tadashi			STAP-2 protein promotes prostate cancer growth by enhancing epidermal growth factor receptor stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; prostate cancer; protein degradation; signal transduction; STAT3; c-CBL	TRANSDUCING ADAPTER PROTEIN-2; STAT3 ACTIVATION; EGF RECEPTOR; PHASE-II; CELLS; DEGRADATION; GEFITINIB; ENDOCYTOSIS; RESPONSES; KINASE	Signal-transducing adaptor family member-2 (STAP-2) is an adaptor protein that regulates various intracellular signaling pathways and promotes tumorigenesis in melanoma and breast cancer cells. However, the contribution of STAP-2 to the behavior of other types of cancer cells is unclear. Here, we show that STAP-2 promotes tumorigenesis of prostate cancer cells through up-regulation of EGF receptor (EGFR) signaling. Tumor growth of a prostate cancer cell line, DU145, was strongly decreased by STAP-2 knockdown. EGF-induced gene expression and phosphorylation of AKT, ERK, and STAT3 were significantly decreased in STAP-2-knockdown DU145 cells. Mechanistically, we found that STAP-2 interacted with EGFR and enhanced its stability by inhibiting c-CBL-mediated EGFR ubiquitination. Our results indicate that STAP-2 promotes prostate cancer progression via facilitating EGFR activation.	[Kitai, Yuichi; Iwakami, Masashi; Saitoh, Kodai; Togi, Sumihito; Isayama, Serina; Sekine, Yuichi; Muromoto, Ryuta; Kashiwakura, Jun-ichi; Matsuda, Tadashi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan; [Yoshimura, Akihiko] Keio Univ, Dept Microbiol & Immunol, Sch Med, Tokyo 1608582, Japan; [Oritani, Kenji] Int Univ Hlth & Welf, Dept Hematol, 4-3 Kouzunomori, Chiba 2868686, Japan	Hokkaido University; Keio University; International University of Health & Welfare	Matsuda, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.	tmatsuda@pharm.hokudai.ac.jp	Sekine, Yuichi/S-8813-2019; Muromoto, Ryuta/E-4203-2012; Togi, Sumihito/ABH-6734-2020; Matsuda, Tadashi/A-3835-2012; Yoshimura, Akihiko/K-5515-2013	Sekine, Yuichi/0000-0002-2861-603X; Muromoto, Ryuta/0000-0002-7474-493X; Matsuda, Tadashi/0000-0002-3089-3757; Togi, Sumihito/0000-0002-3189-8111	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Canil CM, 2005, J CLIN ONCOL, V23, P455, DOI 10.1200/JCO.2005.02.129; Carrion-Salip D, 2012, INT J ONCOL, V41, P1128, DOI 10.3892/ijo.2012.1509; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Grovdal LM, 2004, EXP CELL RES, V300, P388, DOI 10.1016/j.yexcr.2004.07.003; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Ikeda O, 2011, CANCER SCI, V102, P756, DOI 10.1111/j.1349-7006.2010.01842.x; Ikeda O, 2010, J BIOL CHEM, V285, P38093, DOI 10.1074/jbc.M110.162388; Ikeda O, 2009, BIOCHEM BIOPH RES CO, V384, P71, DOI 10.1016/j.bbrc.2009.04.076; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kitai Y, 2015, J BIOL CHEM, V290, P1269, DOI 10.1074/jbc.M114.611053; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Li X, 2012, ONCOGENE, V31, P4372, DOI 10.1038/onc.2011.608; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Matsuda Tadashi, 2015, World J Biol Chem, V6, P324, DOI 10.4331/wjbc.v6.i4.324; Mellinghoff IK, 2002, CANCER RES, V62, P5254; Minoguchi M, 2003, J BIOL CHEM, V278, P11182, DOI 10.1074/jbc.M211230200; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; Nishimura M, 2009, MOL CELL BIOL, V29, P5529, DOI 10.1128/MCB.00375-09; Sekine Y, 2006, J IMMUNOL, V176, P380, DOI 10.4049/jimmunol.176.1.380; Sekine Y, 2005, J BIOL CHEM, V280, P8188, DOI 10.1074/jbc.M411692200; Sekine Y, 2012, ONCOGENE, V31, P4384, DOI 10.1038/onc.2011.604; Sekine Y, 2007, J IMMUNOL, V179, P2397, DOI 10.4049/jimmunol.179.4.2397; Sekine Y, 2015, J BIOL CHEM, V290, P17462, DOI 10.1074/jbc.M115.658575; Sekine Y, 2014, J IMMUNOL, V192, P3488, DOI 10.4049/jimmunol.1300886; Sekine Y, 2012, J IMMUNOL, V188, P6194, DOI 10.4049/jimmunol.1103467; Sekine Y, 2009, BIOCHEM BIOPH RES CO, V384, P187, DOI 10.1016/j.bbrc.2009.04.109; Small EJ, 2007, BJU INT, V100, P765, DOI 10.1111/j.1464-410X.2007.07121.x; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290	31	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19392	19399		10.1074/jbc.M117.802884	http://dx.doi.org/10.1074/jbc.M117.802884			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28986450	Green Published, hybrid			2022-12-26	WOS:000416226700020
J	Zaidi, H; Hoffman, EA; Shetty, SJ; Bekiranov, S; Auble, DT				Zaidi, Hussain; Hoffman, Elizabeth A.; Shetty, Savera J.; Bekiranov, Stefan; Auble, David T.			Second-generation method for analysis of chromatin binding with formaldehyde-cross-linking kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin immunoprecipitation (ChiP); chromatin structure; nucleic acid chemistry; protein cross-linking; protein dynamic; transcription factor; formaldehyde chemistry	RNA-POLYMERASE-II; GENERAL INITIATION-FACTORS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; HUMAN GENOME; AMINO-ACIDS; DNA; PROTEIN; DYNAMICS; IDENTIFICATION	Formaldehyde-cross-linking underpins many of the most commonly used experimental approaches in the chromatin field, especially in capturing site-specific protein-DNA interactions. Extending such assays to assess the stability and binding kinetics of protein-DNA interactions is more challenging, requiring absolute measurements with a relatively high degree of physical precision. We previously described an experimental framework called the cross-linking kinetics (CLK) assay, which uses time-dependent formaldehyde-cross-linking data to extract kinetic parameters of chromatin binding. Many aspects of formaldehyde behavior in cells are unknown or undocumented, however, and could potentially affect CLK data analyses. Here, we report biochemical results that better define the properties of formaldehyde-cross-linking in budding yeast cells. These results have the potential to inform interpretations of standard chromatin assays, including chromatin immunoprecipitation. Moreover, the chemical complexity we uncovered resulted in the development of an improved method for measuring binding kinetics with the CLK approach. Optimum conditions included an increased formaldehyde concentration and more robust glycine-quench conditions. Notably, we observed that formaldehyde-cross-linking rates can vary dramatically for different protein-DNA interactions in vivo. Some interactions were cross-linked much faster than the in vivo macromolecular interactions, making them suitable for kinetic analysis. For other interactions, we found the cross-linking reaction occurred on the same time scale or slower than binding dynamics; for these interactions, it was sometimes possible to compute the in vivo equilibrium-binding constant but not binding on- and off-rates. This improved method yields more accurate in vivo binding kinetics estimates on the minute time scale.	[Zaidi, Hussain] Univ Virginia, Sch Med Res Comp, Charlottesville, VA 22908 USA; [Hoffman, Elizabeth A.; Shetty, Savera J.; Bekiranov, Stefan; Auble, David T.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Bekiranov, S; Auble, DT (corresponding author), Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	sb3de@virginia.edu; auble@virginia.edu			National Institutes of Health [R01 GM55763, R21 GM110380]; NCI Cancer Training Grant [T32 CA009109-38]; Wagner Fellowship; NATIONAL CANCER INSTITUTE [T32CA009109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055763, R21GM110380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Training Grant; Wagner Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM55763 (to D. T. A.), Grant R21 GM110380 (to S. B. and D. T. A.), and NCI Cancer Training Grant T32 CA009109-38 and a Wagner Fellowship (to E. A. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aparicio Oscar, 2005, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2103s69; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; Coulon A, 2013, NAT REV GENET, V14, P572, DOI 10.1038/nrg3484; Cramer P, 2014, CELL, V159, P985, DOI 10.1016/j.cell.2014.10.047; DAMMANN R, 1993, NUCLEIC ACIDS RES, V21, P2331, DOI 10.1093/nar/21.10.2331; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gavrilov A, 2015, BRIEF FUNCT GENOMICS, V14, P163, DOI 10.1093/bfgp/elu037; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Hoffman EA, 2015, J BIOL CHEM, V290, P26404, DOI 10.1074/jbc.R115.651679; Horn AE, 2016, NUCLEIC ACIDS RES, V44, P7132, DOI 10.1093/nar/gkw321; Kaplan T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001290; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; Karpova TS, 2004, EMBO REP, V5, P1064, DOI 10.1038/sj.embor.7400281; Kawashima Y, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-4; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Larson DR, 2009, TRENDS CELL BIOL, V19, P630, DOI 10.1016/j.tcb.2009.08.008; Lu K, 2010, J AM CHEM SOC, V132, P3388, DOI 10.1021/ja908282f; Luse DS, 2014, TRANSCR-AUSTIN, V5, DOI 10.4161/trns.27050; MCGHEE JD, 1975, BIOCHEMISTRY-US, V14, P1281, DOI 10.1021/bi00677a029; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Morisaki T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5456; Mueller F, 2013, CRIT REV BIOCHEM MOL, V48, P492, DOI 10.3109/10409238.2013.833891; Poorey K, 2013, SCIENCE, V342, P369, DOI 10.1126/science.1242369; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Ravarani CNJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10417; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Shi SR, 2013, PROTEOM CLIN APPL, V7, P264, DOI 10.1002/prca.201200031; SIKORSKI RS, 1989, GENETICS, V122, P19; SIOMIN YA, 1973, BIOCHIM BIOPHYS ACTA, V331, P27, DOI 10.1016/0005-2787(73)90415-2; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; Stewart-Ornstein J, 2012, MOL CELL, V45, P483, DOI 10.1016/j.molcel.2011.11.035; Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Toews J, 2008, ANAL CHIM ACTA, V618, P168, DOI 10.1016/j.aca.2008.04.049; Toth J, 2000, Nucleic Acids Res, V28, pe4, DOI 10.1093/nar/28.2.e4; Viswanathan R, 2014, METHODS, V70, P97, DOI 10.1016/j.ymeth.2014.10.029; Wal M, 2012, METHOD ENZYMOL, V513, P233, DOI 10.1016/B978-0-12-391938-0.00010-0; Wolfram Research Inc, 2016, MATH VERS 10 6; Wu CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026217; Zaidi HA, 2017, SCI REP-UK, V7, DOI 10.1038/srep39631; ZAWEL L, 1992, Current Opinion in Cell Biology, V4, P488, DOI 10.1016/0955-0674(92)90016-6	48	6	6	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19338	19355		10.1074/jbc.M117.796441	http://dx.doi.org/10.1074/jbc.M117.796441			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972159	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000416226700016
J	Liu, Y; Stojadinovic, S; Hrycushko, B; Wardak, Z; Lau, S; Lu, WG; Yan, YL; Jiang, SB; Zhen, X; Timmerman, R; Nedzi, L; Gu, XJ				Liu, Yan; Stojadinovic, Strahinja; Hrycushko, Brian; Wardak, Zabi; Lau, Steven; Lu, Weiguo; Yan, Yulong; Jiang, Steve B.; Zhen, Xin; Timmerman, Robert; Nedzi, Lucien; Gu, Xuejun			A deep convolutional neural network-based automatic delineation strategy for multiple brain metastases stereotactic radiosurgery	PLOS ONE			English	Article							SUPPORT-VECTOR-MACHINES; TUMOR SEGMENTATION; IMAGES; MRI; CLASSIFICATION; IDENTIFICATION; LESIONS	Accurate and automatic brain metastases target delineation is a key step for efficient and effective stereotactic radiosurgery (SRS) treatment planning. In this work, we developed a deep learning convolutional neural network (CNN) algorithm for segmenting brain metastases on contrast-enhanced T1-weighted magnetic resonance imaging (MRI) datasets. We integrated the CNN-based algorithm into an automatic brain metastases segmentation workflow and validated on both Multimodal Brain Tumor Image Segmentation challenge (BRATS) data and clinical patients' data. Validation on BRATS data yielded average DICE coefficients (DCs) of 0.75 +/- 0.07 in the tumor core and 0.81 +/- 0.04 in the enhancing tumor, which outperformed most techniques in the 2015 BRATS challenge. Segmentation results of patient cases showed an average of DCs 0.67 +/- 0.03 and achieved an area under the receiver operating characteristic curve of 0.98 +/- 0.01. The developed automatic segmentation strategy surpasses current benchmark levels and offers a promising tool for SRS treatment planning for multiple brain metastases.	[Liu, Yan] Sichuan Univ, Sch Elect Engn & Informat, Chengdu, Sichuan, Peoples R China; [Liu, Yan; Stojadinovic, Strahinja; Hrycushko, Brian; Wardak, Zabi; Lau, Steven; Lu, Weiguo; Yan, Yulong; Jiang, Steve B.; Zhen, Xin; Timmerman, Robert; Nedzi, Lucien; Gu, Xuejun] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Zhen, Xin] Southern Med Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China	Sichuan University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Southern Medical University - China	Gu, XJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.	xuejun.gu@utsouthwestern.edu	Stojadinovic, Strahinja/R-3818-2019; Jiang, Steve/GRO-3951-2022; Lu, Wei/AAE-2921-2022	Stojadinovic, Strahinja/0000-0002-6840-5747; Lu, Wei/0000-0002-4150-8674; Lau, Steven/0000-0002-6433-8735	China Scholarship Council [201406245043]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024982] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work is supported by China Scholarship Council, Grant No.201406245043. http://en.csc.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agn Mikael, 2015, P MULT BRAIN TUM IM, P1; Assaf Hoogi AL, 2015, MICCAI BRATS 2015, P34; Bakas S., 2015, P MULT BRAIN TUM IM, P5; Bauer S, 2013, PHYS MED BIOL, V58, pR97, DOI 10.1088/0031-9155/58/13/R97; Bauer S, 2011, LECT NOTES COMPUT SC, V6893, P354, DOI 10.1007/978-3-642-23626-6_44; Bergner N, 2013, ANALYST, V138, P3983, DOI 10.1039/c3an00326d; Bleau A, 2000, COMPUT VIS IMAGE UND, V77, P317, DOI 10.1006/cviu.2000.0822; Christ P.F., 2017, ARXIV E PRINTS; Dera D, 2016, B MATH BIOL, V78, P1450, DOI 10.1007/s11538-016-0190-0; Dusch E, 2016, P 7 INT S OPTR DEF S; Glotsos D, 2005, INT J NEURAL SYST, V15, P1, DOI 10.1142/S0129065705000013; Gordillo N, 2013, MAGN RESON IMAGING, V31, P1426, DOI 10.1016/j.mri.2013.05.002; Gurney K., 2018, INTRO NEURAL NETWORK; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Hinton G. E., 2012, COMPUT SCI, DOI DOI 10.9774/GLEAF.978-1-909493-38-4_2; Iglesias JE, 2011, IEEE T MED IMAGING, V30, P1617, DOI 10.1109/TMI.2011.2138152; Ilunga-Mbuyamba E, 2016, EXPERT SYST APPL, V56, P59, DOI 10.1016/j.eswa.2016.02.048; Kamnitsas K, 2016, ARXIV E PRINTS; LaMontagne P, 2014, NEURO-ONCOLOGY, V16, DOI 10.1093/neuonc/nou264.48; LeCun Y, 1998, LECT NOTES COMPUT SC, V1524, P9, DOI 10.1007/3-540-49430-8_2; Liu Y, 2016, PHYS MED BIOL, V61, P8440, DOI 10.1088/0031-9155/61/24/8440; Malmi E., 2015, P MICCAI BRAIN TUM S, P42; Meier R., 2015, P MULT BRAIN TUM IM, P48; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; OZKAN M, 1993, IEEE T MED IMAGING, V12, P534, DOI 10.1109/42.241881; Pereira S., 2015, P MICCAI WORKSH MULT, P52; Sachdeva J, 2016, APPL SOFT COMPUT, V47, P151, DOI 10.1016/j.asoc.2016.05.020; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Subudhi BN, 2016, MAGN RESON IMAGING, V34, P1292, DOI 10.1016/j.mri.2016.07.002; Tsao MN, 2012, PRACT RADIAT ONCOL, V2, P210, DOI 10.1016/j.prro.2011.12.004; Vaidhya K., 2015, P MULT BRAIN TUM IM, P60; Wadell H, 1935, J GEOL, V43, P250, DOI 10.1086/624298; Wardak Z, 2016, J NEURO-ONCOL, V128, P251, DOI 10.1007/s11060-016-2103-3; Zhang N, 2011, COMPUT VIS IMAGE UND, V115, P256, DOI 10.1016/j.cviu.2010.09.007	34	81	87	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0185844	10.1371/journal.pone.0185844	http://dx.doi.org/10.1371/journal.pone.0185844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ1QR	28985229	Green Published, gold			2022-12-26	WOS:000412493000011
J	Sabra, S; Malmqvist, E; Saborit, A; Gratacos, E; Roig, MDG				Sabra, Sally; Malmqvist, Ebba; Saborit, Alicia; Gratacos, Eduard; Gomez Roig, Maria Dolores			Heavy metals exposure levels and their correlation with different clinical forms of fetal growth restriction	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; BIRTH-WEIGHT; ARSENIC EXPOSURE; GESTATIONAL-AGE; LEAD-EXPOSURE; ENVIRONMENTAL EXPOSURE; PLACENTAL-TRANSFER; DNA METHYLATION; PREGNANT-WOMEN; TRACE-ELEMENTS	Background Prenatal heavy metals exposure has shown a negative impact on birth weight. However, their influence on different clinical forms of fetal smallness was never assessed. Objectives To investigate whether there is a differential association between heavy metals exposure and fetal smallness subclassification into intrauterine growth restriction (IUGR) and small-for-gestational age (SGA). Method In this prospective case-control study, we included 178 mother-infant pairs; 96 of appropriate for gestational age (AGA) and 82 of small fetuses diagnosed in third trimester. The small ones were further subclassified into IUGR, n = 49 and SGA, n = 33. Cadmium (Cd), mercury (Hg), lead (Pb), arsenic (As) and zinc (Zn) levels were measured in the maternal and cord serum, and in the placentas of the three groups. Results Maternal serum level of Cd (p < 0.001) was higher in the small fetuses compared to AGA. Fetal serum level of Cd (p < 0.001) was increased in the small fetuses compared to AGA. Fetal serum level of Hg (p < 0.05) showed an increase in SGA compared to both IUGR and AGA. Fetal serum level of Zn was increased in the AGA (p < 0.001) compared to each of the small fetuses groups. Only differences in the levels between the small fetuses' subgroups were detected in the fetal serum levels of Cd and Hg. Fetal birth weight was negatively correlated with the fetal serum level of Cd (p < 0.001). No differences in the placental heavy metal levels were observed among the groups. Conclusion Fetal serum levels of Cd showed differential correlation between small fetuses' clinical subclassification, which together with the increased Cd levels in both maternal and fetal serum of the small fetuses reinforce the negative influence of heavy metals on birth weight. These findings provide more opportunities to verify the role of heavy metals exposure in relation to small fetuses' subclassification.	[Sabra, Sally; Saborit, Alicia; Gratacos, Eduard; Gomez Roig, Maria Dolores] Univ Barcelona, Barcelona Ctr Maternal Fetal & Neonatal Med, Hosp St Joan Deu, BCNatal, Barcelona, Spain; [Sabra, Sally; Saborit, Alicia; Gratacos, Eduard; Gomez Roig, Maria Dolores] Univ Barcelona, Hosp Clin, Barcelona, Spain; [Malmqvist, Ebba] Lund Univ, Occupat & Environm Med, Lund, Sweden; [Gratacos, Eduard] Univ Barcelona, IDIBAPS, Barcelona, Spain; [Gratacos, Eduard] Ctr Biomed Res Rare Dis, Barcelona, Spain; [Gomez Roig, Maria Dolores] Spanish Minist Econ & Competitiveness, Hlth Res Inst Carlos III, Spanish Maternal & Child Hlth & Dev Network Ret R, Madrid, Spain; [Gomez Roig, Maria Dolores] Inst Recerca St Joan Deu, Santa Rosa 39-57, Esplugas de Llobregat, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Lund University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Spanish Ministry of Economy & Competitiveness	Roig, MDG (corresponding author), Univ Barcelona, Barcelona Ctr Maternal Fetal & Neonatal Med, Hosp St Joan Deu, BCNatal, Barcelona, Spain.; Roig, MDG (corresponding author), Univ Barcelona, Hosp Clin, Barcelona, Spain.; Roig, MDG (corresponding author), Spanish Minist Econ & Competitiveness, Hlth Res Inst Carlos III, Spanish Maternal & Child Hlth & Dev Network Ret R, Madrid, Spain.; Roig, MDG (corresponding author), Inst Recerca St Joan Deu, Santa Rosa 39-57, Esplugas de Llobregat, Spain.	lgomezroig@sjdhospitalbarcelona.org	Gratacos, Eduard/AAR-4939-2020; Roig, Maria Dolores Gómez/F-4345-2016	Gratacos, Eduard/0000-0002-7405-7224; Roig, Maria Dolores Gómez/0000-0003-2329-1851; Malmqvist, Ebba/0000-0002-5043-9789	Erasmus Programme of the European Union [2013-0040]	Erasmus Programme of the European Union	This work has been funded with support of the Erasmus Programme of the European Union (frame work agreement number: 2013-0040).	Al-Saleh I, 2014, INT J HYG ENVIR HEAL, V217, P205, DOI 10.1016/j.ijheh.2013.04.009; Al-Saleh I, 2011, INT J HYG ENVIR HEAL, V214, P79, DOI 10.1016/j.ijheh.2010.10.001; Angeli JK, 2013, FREE RADICAL BIO MED, V65, P838, DOI 10.1016/j.freeradbiomed.2013.08.167; Bamfo JEAK, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/640715; BARKER DJP, 1989, LANCET, V2, P577; Bernstein IM, 2000, AM J OBSTET GYNECOL, V182, P198, DOI 10.1016/S0002-9378(00)70513-8; Bjerregaard P, 2000, SCI TOTAL ENVIRON, V245, P195, DOI 10.1016/S0048-9697(99)00444-1; Bjerregaard P, 1996, Arctic Med Res, V55, P156; Bose-O'Reilly S, 2010, CURR PROB PEDIATR AD, V40, P186, DOI 10.1016/j.cppeds.2010.07.002; Broberg K, 2014, J DEV ORIG HLTH DIS, V5, P288, DOI 10.1017/S2040174414000221; Brodsky Dara, 2004, J Intensive Care Med, V19, P307, DOI 10.1177/0885066604269663; Burton GJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0066; Butt K, 2014, J OBSTET GYNAECOL CA, V36, P171, DOI 10.1016/S1701-2163(15)30664-2; Caserta D, 2013, EUR REV MED PHARMACO, V17, P2198; CASEY CE, 1978, BRIT J NUTR, V39, P639, DOI 10.1079/BJN19780079; Chen Z, 2014, J EXPO SCI ENV EPID, V24, P537, DOI 10.1038/jes.2014.26; CLARKSON TW, 1985, SCAND J WORK ENV HEA, V11, P145, DOI 10.5271/sjweh.2239; Cornelis R, 1996, J TRACE ELEM MED BIO, V10, P103, DOI 10.1016/S0946-672X(96)80018-6; Cosmi E, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/364381; Fiala J, 1998, Cent Eur J Public Health, V6, P241; Figueras F, 2008, EUR J OBSTET GYN R B, V136, P20, DOI 10.1016/j.ejogrb.2006.12.015; Figueras F, 2014, FETAL DIAGN THER, V36, P86, DOI 10.1159/000357592; FRERY N, 1993, TOXICOLOGY, V79, P109, DOI 10.1016/0300-483X(93)90124-B; Grandjean P, 2001, INT J EPIDEMIOL, V30, P1272, DOI 10.1093/ije/30.6.1272; Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3; Gundacker C, 2012, WIEN MED WOCHENSCHR, V162, P201, DOI 10.1007/s10354-012-0074-3; Guo YY, 2010, SCI TOTAL ENVIRON, V408, P3113, DOI 10.1016/j.scitotenv.2010.04.018; Hanna CW, 2012, HUM REPROD, V27, P1401, DOI 10.1093/humrep/des038; HARADA M, 1995, CRIT REV TOXICOL, V25, P1, DOI 10.3109/10408449509089885; Harville EW, 2005, OCCUP ENVIRON MED, V62, P263, DOI 10.1136/oem.2003.012492; He WJ, 2007, TOXICOL SCI, V99, P244, DOI 10.1093/toxsci/kfm162; Hong Young-Seoub, 2014, J Prev Med Public Health, V47, P245, DOI 10.3961/jpmph.14.035; Hunt CE, 2007, ARCH DIS CHILD-FETAL, V92, P428, DOI 10.1136/adc.2006.112243; Hur J, 2013, J NUTR, V143, P67, DOI 10.3945/jn.112.161638; Ismail H, 2012, J MED ULTRASOUND, V20, P191, DOI 10.1016/j.jmu.2012.10.005; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Jiang CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109984; Jin YP, 2006, ENVIRON RES, V101, P349, DOI 10.1016/j.envres.2005.11.006; Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012; Karagas MR, 2012, ENVIRON HEALTH PERSP, V120, P799, DOI 10.1289/ehp.1104494; Kim BM, 2009, EUR J EPIDEMIOL, V24, P573, DOI 10.1007/s10654-009-9370-7; Kim YM, 2015, INT J ENV RES PUB HE, V12, P13482, DOI 10.3390/ijerph121013482; Kippler M, 2010, TOXICOL LETT, V192, P162, DOI 10.1016/j.toxlet.2009.10.018; KOPP SJ, 1982, SCIENCE, V217, P837, DOI 10.1126/science.6213041; Kuhnert PM, 1982, AM J OBSTET GYNECOL, P142; Lafuente A, 2000, FOOD CHEM TOXICOL, V38, P913, DOI 10.1016/S0278-6915(00)00077-6; Lagerkvist BJ, 1996, ARCH ENVIRON HEALTH, V51, P389, DOI 10.1080/00039896.1996.9934427; Latkoczy C, 2002, J ANAL ATOM SPECTROM, V17, P1264, DOI 10.1039/b204532j; Lederman SA, 2008, ENVIRON HEALTH PERSP, V116, P1085, DOI 10.1289/ehp.10831; Lee BE, 2010, ENVIRON HEALTH PERSP, V118, P437, DOI 10.1289/ehp.0900731; Lin CM, 2011, OCCUP ENVIRON MED, V68, P641, DOI 10.1136/oem.2010.059758; Llanos MN, 2009, REPROD TOXICOL, V27, P88, DOI 10.1016/j.reprotox.2008.11.057; Longo S, 2013, J MATERN-FETAL NEO M, V26, P222, DOI 10.3109/14767058.2012.715006; Lucas M, 2004, LIPIDS, V39, P617, DOI 10.1007/s11745-004-1274-7; Markel TA, 2014, J CLIN NEONATOL, V3, P1, DOI 10.4103/2249-4847.128717; Needham LL, 2011, ENVIRON SCI TECHNOL, V45, P1121, DOI 10.1021/es1019614; Osman K, 2000, CLIN BIOCHEM, V33, P131, DOI 10.1016/S0009-9120(00)00052-7; PEEREBOOMSTEGEMAN JHJC, 1983, ECOTOX ENVIRON SAFE, V7, P79; Piasek M, 2001, REPROD TOXICOL, V15, P673, DOI 10.1016/S0890-6238(01)00174-5; Rahbar MH, 2015, INT J ENV RES PUB HE, V12, P4481, DOI 10.3390/ijerph120504481; Rahman A, 2010, EPIDEMIOLOGY, V21, P797, DOI 10.1097/EDE.0b013e3181f56a0d; Rahman A, 2009, AM J EPIDEMIOL, V169, P304, DOI 10.1093/aje/kwn332; Rauh Virginia A, 2010, Neoreviews, V11, P363; Rentschler G, 2014, METALLOMICS, V6, P885, DOI 10.1039/c3mt00365e; Renzetti S, 2017, ENVIRON RES, V152, P226, DOI 10.1016/j.envres.2016.10.014; Rice Kevin M, 2014, J Prev Med Public Health, V47, P74, DOI 10.3961/jpmph.2014.47.2.74; ROELS H, 1978, ENVIRON RES, V16, P236, DOI 10.1016/0013-9351(78)90159-7; SALTMAN P, 1983, ANN INTERN MED, V98, P823, DOI 10.7326/0003-4819-98-5-823; Sanders Talia, 2009, Reviews on Environmental Health, V24, P15; SCHROEDER HA, 1965, J CHRON DIS, V18, P647, DOI 10.1016/0021-9681(65)90066-4; Singh R, 2011, INDIAN J PHARMACOL, V43, P246, DOI 10.4103/0253-7613.81505; Taylor Caroline M, 2016, BMC Res Notes, V9, P291, DOI 10.1186/s13104-016-2092-5; Tchounwou P. B., 1999, Reviews on Environmental Health, V14, P211; Tchounwou P.B., 2012, EXP S, V101, P133, DOI [10.1007/978-3-7643-8340-4_6, 10.1007/978-3-7643-8340-4, DOI 10.1007/978-3-7643-8340-4_6]; Tekin D, 2012, INT ARCH OCC ENV HEA, V85, P631, DOI 10.1007/s00420-011-0711-y; Thomas S, 2015, ENVIRON RES, V140, P430, DOI 10.1016/j.envres.2015.04.018; TRUSKA P, 1989, Journal of Hygiene Epidemiology Microbiology and Immunology (Prague), V33, P141; Uriu-Adams JY, 2010, BIRTH DEFECTS RES B, V89, P313, DOI 10.1002/bdrb.20264; Vejrup K, 2014, PUBLIC HEALTH NUTR, V17, P2071, DOI 10.1017/S1368980013002619; Walker JB, 2006, ENVIRON RES, V100, P295, DOI 10.1016/j.envres.2005.05.006; WIER PJ, 1990, TOXICOL APPL PHARM, V105, P156, DOI 10.1016/0041-008X(90)90367-4; Wuana Raymond A, ISRN ECOLOGY, V2011; Xie X, 2013, ENVIRON POLLUT, V175, P30, DOI 10.1016/j.envpol.2012.12.013; Zhang YL, 2004, J ENVIRON SCI HEAL A, V39, P2507, DOI [10.1081/ESE-200026331, 10.1081/lesa-200026331]	84	47	49	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0185645	10.1371/journal.pone.0185645	http://dx.doi.org/10.1371/journal.pone.0185645			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ1QR	28985223	gold, Green Published, Green Submitted			2022-12-26	WOS:000412493000007
J	Brothers, TD; Kirkland, S; Theou, O; Zona, S; Malagoli, A; Wallace, LMK; Stentarelli, C; Mussini, C; Falutz, J; Guaraldi, G; Rockwood, K				Brothers, Thomas D.; Kirkland, Susan; Theou, Olga; Zona, Stefano; Malagoli, Andrea; Wallace, Lindsay M. K.; Stentarelli, Chiara; Mussini, Cristina; Falutz, Julian; Guaraldi, Giovanni; Rockwood, Kenneth			Predictors of transitions in frailty severity and mortality among people aging with HIV	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG-TERM MORTALITY; INJECTION-DRUG USE; DEFICIT ACCUMULATION; OLDER-ADULTS; INFECTED PERSONS; CLINICAL FRAILTY; ELDERLY SUBJECTS; AGE; DISEASE	Background People aging with HIV show variable health trajectories. Our objective was to identify longitudinal predictors of frailty severity and mortality among a group aging with HIV. Methods Exploratory analyses employing a multistate transition model, with data from the prospective Modena HIV Metabolic Clinic Cohort Study, based in Northern Italy, begun in 2004. Participants were followed over four years from their first available visit. We included all 963 participants (mean age 46.8 +/- 7.1; 29% female; 89% undetectable HIV viral load; median current CD4 count 549, IQR 405-720; nadir CD4 count 180, 81-280) with four-year data. Frailty was quantified using a 31-item frailty index. Outcomes were frailty index score or mortality at four-year follow-up. Candidate predictor variables were baseline frailty index score, demographic (age, sex), HIV-disease related (undetectable HIV viral load, current CD4+ T-cell count, nadir CD4 count, duration of HIV infection, and duration of antiretroviral therapy [ ARV] exposure), and behavioral factors (smoking, injection drug use (IDU), and hepatitis C virus co-infection). Results Four-year mortality was 3.0% (n = 29). In multivariable analyses, independent predictors of frailty index at follow-up were baseline frailty index (RR 1.06, 95% CI 1.05-1.07), female sex (RR 0.93, 95% CI 0.87-0.98), nadir CD4 cell count (RR 0.96, 95% CI 0.93-0.99), duration of HIV infection (RR 1.06, 95% CI 1.01-1.12), duration of ARV exposure (RR 1.08, 95% CI 1.02-1.14), and smoking pack-years (1.03, 1.01-1.05). Independent predictors of mortality were baseline frailty index (OR 1.19, 1.02-1.38), current CD4 count (0.34, 0.20-0.60), and IDU (2.89, 1.30-6.42). Conclusions Demographic, HIV-disease related, and social and behavioral factors appear to confer risk for changes in frailty severity and mortality among people aging with HIV.	[Brothers, Thomas D.] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Kirkland, Susan] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Theou, Olga; Wallace, Lindsay M. K.; Rockwood, Kenneth] Dalhousie Univ, Dept Med, Div Geriatr Med, Halifax, NS, Canada; [Zona, Stefano; Malagoli, Andrea; Stentarelli, Chiara; Mussini, Cristina; Guaraldi, Giovanni] Univ Modena & Reggio Emilia, Dept Med & Surg Sci Adults & Children, Clin Infect Dis, Modena, Emilia Romagna, Italy; [Falutz, Julian] McGill Univ, Hosp Ctr, Montreal, PQ, Canada; [Rockwood, Kenneth] Nova Scotia Hlth Author, Ctr Hlth Care Elderly, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University; Universita di Modena e Reggio Emilia; McGill University	Rockwood, K (corresponding author), Dalhousie Univ, Dept Med, Div Geriatr Med, Halifax, NS, Canada.; Rockwood, K (corresponding author), Nova Scotia Hlth Author, Ctr Hlth Care Elderly, Halifax, NS, Canada.	kenneth.rockwood@dal.ca	Rockwood, Kenneth/AAD-8951-2019; Mussini, Cristina/K-8672-2016; Theou, Olga/AAS-9923-2020; Brothers, Thomas/ABH-5700-2020; Guaraldi, Giovanni/J-9467-2018; Malagoli, Andrea/I-7744-2015	Mussini, Cristina/0000-0002-6615-4198; Theou, Olga/0000-0001-6460-782X; Brothers, Thomas/0000-0002-5570-5556; Zona, Stefano/0000-0003-3451-2744; Malagoli, Andrea/0000-0001-7857-4133; Kirkland, Susan/0000-0002-8182-2369	Canadian Institutes of Health Research; Dalhousie University Internal Medicine Research Foundation; Co-morbidity in relation to AIDS [305522]; European Union; Dalhousie Medical Research Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Dalhousie University Internal Medicine Research Foundation; Co-morbidity in relation to AIDS; European Union(European Commission); Dalhousie Medical Research Foundation	TDB was supported by a Canadian Institutes of Health Research Summer Research Studentship and an award from the Dalhousie University Internal Medicine Research Foundation. GG was partially supported by 'Co-morbidity in relation to AIDS' grant agreement (305522), European Union Seventh Framework. KR is supported by the Dalhousie Medical Research Foundation through the Kathryn Allen Weldon Chain in Alzheimer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; TDB was supported by a Canadian Institutes of Health Research Summer Research Studentship and an award from the Dalhousie University Internal Medicine Research Foundation. GG was partially supported by 'Co-morbidity in relation to AIDS' grant agreement (305522), European Union Seventh Framework. KR is supported by the Dalhousie Medical Research Foundation through the Kathryn Allen Weldon Chair in Alzheimer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2014, J GERONTOL A-BIOL, V69, P189, DOI 10.1093/gerona/glt148; Brothers TD, 2014, J INFECT DIS, V210, P1170, DOI 10.1093/infdis/jiu258; Brothers TD, 2014, CURR OPIN HIV AIDS, V9, P412, DOI 10.1097/COH.0000000000000070; Cacciatore F, 2013, ACTA DIABETOL, V50, P251, DOI 10.1007/s00592-012-0413-2; Clegg A, 2016, AGE AGEING, V45, P353, DOI 10.1093/ageing/afw039; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Desquilbet L, 2011, J GERONTOL A-BIOL, V66, P1030, DOI 10.1093/gerona/glr097; Desquilbet L, 2009, JAIDS-J ACQ IMM DEF, V50, P299, DOI 10.1097/QAI.0b013e3181945eb0; Erlandson KM, 2014, CURR HIV-AIDS REP, V11, P279, DOI 10.1007/s11904-014-0215-y; Escota GV, 2015, AIDS RES HUM RETROV, V31, P313, DOI [10.1089/aid.2014.0225, 10.1089/AID.2014.0225]; Galizia G, 2011, AGING CLIN EXP RES, V23, P118, DOI 10.1007/BF03351076; Gill TM, 2006, ARCH INTERN MED, V166, P418, DOI 10.1001/.418; Guaraldi G., 2017, HIV MED; Guaraldi G, 2006, HIV CLIN TRIALS, V7, P97, DOI 10.1310/EYWJ-8B5K-X7VQ-9CPE; Guaraldi G, 2015, AIDS, V29, P1633, DOI 10.1097/QAD.0000000000000753; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hessol NA, 2017, AIDS BEHAV, P1; Levett T, 2017, SEX TRANSM INFECT; Levett TJ, 2016, J AM GERIATR SOC, V64, P1006, DOI 10.1111/jgs.14101; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mazzella F, 2010, ARCH GERONTOL GERIAT, V51, P323, DOI 10.1016/j.archger.2010.01.011; Mitnitski A, 2006, MECH AGEING DEV, V127, P490, DOI 10.1016/j.mad.2006.01.007; Mitnitski A B, 2001, ScientificWorldJournal, V1, P323; Mitnitski AB, 2017, BIOGERONTOLOGY, V2, P1; Mitnitski A, 2017, J GERONTOL A-BIOL, V72, P877, DOI 10.1093/gerona/glw089; Mitnitski A, 2015, INTERD T GERONT GERI, V40, P85, DOI 10.1159/000364933; Mitnitski A, 2014, J GERONTOL A-BIOL, V69, P295, DOI 10.1093/gerona/glt137; Mitnitski A, 2013, BIOGERONTOLOGY, V14, P709, DOI 10.1007/s10522-013-9446-3; Mitnitski AB, 2014, STAT METHODS MED RES, V23, P244, DOI 10.1177/0962280211406470; Molsberry SA, 2015, AIDS, V29, P713, DOI 10.1097/QAD.0000000000000561; Pajewski NM, 2016, J GERONTOL A-BIOL, V71, P649, DOI 10.1093/gerona/glv228; Palella FJ, 2004, CLIN INFECT DIS, V38, P903, DOI 10.1086/381684; Pathai S, 2014, J GERONTOL A-BIOL, V69, P833, DOI 10.1093/gerona/glt168; Piggott DA, 2017, J GERONTOL A-BIOL, V72, P389, DOI 10.1093/gerona/glw142; Piggott DA, 2016, CURR HIV-AIDS REP, V13, P340, DOI 10.1007/s11904-016-0334-8; Piggott DA, 2015, J GERONTOL A-BIOL, V70, P1542, DOI 10.1093/gerona/glv107; Rasmussen LD, 2015, LANCET HIV, V2, pE288, DOI 10.1016/S2352-3018(15)00077-6; Richert L, 2014, AIDS, V28, P1441, DOI 10.1097/QAD.0000000000000246; Rockwood K, 2011, CAN MED ASSOC J, V183, pE487, DOI 10.1503/cmaj.101271; Rockwood K, 2011, CLIN GERIATR MED, V27, P17, DOI 10.1016/j.cger.2010.08.008; Rodriguez-Manas L, 2015, LANCET, V385, pE7, DOI 10.1016/S0140-6736(14)61595-6; Sangarlangkarn A, 2016, J AM GERIATR SOC, V64, P2322, DOI 10.1111/jgs.14584; Saum KU, 2014, EUR J EPIDEMIOL, V29, P171, DOI 10.1007/s10654-014-9891-6; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Smit E, 2015, J FRALITY AGING, V4, P191, DOI 10.14283/jfa.2015.50; Steinsaltz D, 2012, EXP GERONTOL, V47, P792, DOI 10.1016/j.exger.2012.06.007; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Theou O, 2014, J AM GERIATR SOC, V62, P901, DOI 10.1111/jgs.12773; Theou O, 2013, J AM GERIATR SOC, V61, P1537, DOI 10.1111/jgs.12420; Wallace LMK, 2017, AIDS RES HUM RETROV, V33, P157, DOI [10.1089/aid.2016.0189, 10.1089/AID.2016.0189]; Wang CX, 2014, J AM GERIATR SOC, V62, P821, DOI 10.1111/jgs.12792; Zhang W, 2015, J GERONTOL A-BIOL	53	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185352	10.1371/journal.pone.0185352	http://dx.doi.org/10.1371/journal.pone.0185352			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28981535	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300035
J	Coccia, E; Calleja-Yague, I; Planells-Ferrer, L; Sanuy, B; Sanz, B; Lopez-Soriano, J; Moubarak, RS; Munell, F; Barneda-Zahonero, B; Comella, JX; Perez-Garcia, MJ				Coccia, Elena; Calleja-Yague, Isabel; Planells-Ferrer, Laura; Sanuy, Blanca; Sanz, Belen; Lopez-Soriano, Joaquin; Moubarak, Rana S.; Munell, Francina; Barneda-Zahonero, Bruna; Comella, Joan X.; Jose Perez-Garcia, M.			Identification and characterization of new isoforms of human fas apoptotic inhibitory molecule (FAIM)	PLOS ONE			English	Article							OPEN READING FRAMES; NERVOUS-SYSTEM; CELL-DEATH; LONG FORM; EXPRESSION; PROTEIN; NEUROGENESIS; PREDICTION; MECHANISM; DISEASE	Fas Apoptosis Inhibitory Molecule (FAIM) is an evolutionarily highly conserved death receptor antagonist, widely expressed and known to participate in physiological and pathological processes. Two FAIM transcript variants have been characterized to date, namely FAIM short (FAIM-S) and FAIM long (FAIM-L). FAIM-S is ubiquitously expressed and serves as an anti-apoptotic protein in the immune system. Furthermore, in neurons, this isoform promotes NGF-induced neurite outgrowth through NF-kappa B and ERK signaling. In contrast FAIM-L is found only in neurons, where it exerts anti-apoptotic activity against several stimuli. In addition to these two variants, in silico studies point to the existence of two additional isoforms, neither of which have been characterized to date. In this regard, here we confirm the presence of these two additional FAIM isoforms in human fetal brain, fetal and adult testes, and placenta tissues. We named them FAIM-S_2a and FAIM-L_2a since they have the same sequence as FAIM-S and FAIM-L, but include exon 2a. PCR and western blot revealed that FAIM-S_2a shows ubiquitous expression in all the tissues and cellular models tested, while FAIM-L_2a is expressed exclusively in tissues of the nervous system. In addition, we found that, when overexpressed in non-neuronal cells, the splicing factor nSR100 induces the expression of the neuronal isoforms, thus identifying it as responsible for the generation of FAIM-L and FAIM-L_2a. Functionally, FAIM-S_2a and FAIM-L_2a increased neurite outgrowth in response to NGF stimulation in a neuronal model. This observation thus, supports the notion that these two isoforms are involved in neuronal differentiation. Furthermore, subcellular fractionation experiments revealed that, in contrast to FAIM-S and FAIM-L, FAIM-S_2a and FAIM-L_2a are able to localize to the nucleus, where they may have additional functions. In summary, here we report on two novel FAIM isoforms that may have relevant roles in the physiology and pathology of the nervous system.	[Coccia, Elena; Calleja-Yague, Isabel; Planells-Ferrer, Laura; Sanuy, Blanca; Sanz, Belen; Lopez-Soriano, Joaquin; Moubarak, Rana S.; Barneda-Zahonero, Bruna; Comella, Joan X.; Jose Perez-Garcia, M.] VHIR, Cell Signaling & Apoptosis Grp, Barcelona, Spain; [Coccia, Elena; Calleja-Yague, Isabel; Planells-Ferrer, Laura; Sanuy, Blanca; Sanz, Belen; Lopez-Soriano, Joaquin; Moubarak, Rana S.; Barneda-Zahonero, Bruna; Comella, Joan X.; Jose Perez-Garcia, M.] ISCIII, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Coccia, Elena; Calleja-Yague, Isabel; Planells-Ferrer, Laura; Sanuy, Blanca; Sanz, Belen; Lopez-Soriano, Joaquin; Moubarak, Rana S.; Barneda-Zahonero, Bruna; Comella, Joan X.; Jose Perez-Garcia, M.] Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Inst Neurosci, Bellaterra, Spain; [Munell, Francina] VHIR, Pediat Neurol Grp, Barcelona, Spain; [Sanz, Belen] Spanish Natl Canc Res Ctr CNIO, Cell Div, Madrid, Spain; [Sanz, Belen] Spanish Natl Canc Res Ctr CNIO, Canc Grp, Madrid, Spain; [Moubarak, Rana S.] NYU, Langone Med Ctr, Dept Pathol, New York, NY USA	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBERNED; Instituto de Salud Carlos III; Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); New York University; NYU Langone Medical Center	Comella, JX; Perez-Garcia, MJ (corresponding author), VHIR, Cell Signaling & Apoptosis Grp, Barcelona, Spain.; Comella, JX; Perez-Garcia, MJ (corresponding author), ISCIII, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.; Comella, JX; Perez-Garcia, MJ (corresponding author), Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Inst Neurosci, Bellaterra, Spain.	joan.comella@vhir.org; maria.perez@vhir.org	Lopez-Soriano, Joaquin/AAB-7459-2019; Comella, Joan X/D-7333-2012; Comella, Joan/GQA-4279-2022	Comella, Joan X/0000-0002-6218-0786; Coccia, Elena/0000-0002-9849-2423; Barneda Zahonero, Bruna/0000-0002-6557-5222; Lopez-Soriano, Joaquin/0000-0002-5374-2222; Munell Casadesus, Francina/0000-0001-8580-2819; Moubarak, Rana/0000-0003-2096-1258	Spanish Government "Ministerio de Economia y Competitividad" [SAF2013-47989-R, SAF2016-80236-R, CIBERNED CB06/05/1104, PIE13/00027]; Generalitat de Catalunya [2014SGR1609]; Fundacio La Marato de TV3 [201414-30]; Spanish "Ministerio de Economia y Competitividad" [SAF2013-47989-R, SAF2016-80236-R, CIBERNED CB06/05/1104, PIE13/00027];  [BES-2014-069550]	Spanish Government "Ministerio de Economia y Competitividad"(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Fundacio La Marato de TV3; Spanish "Ministerio de Economia y Competitividad"(Spanish Government); 	This work was funded by the Spanish Government "Ministerio de Economia y Competitividad" (SAF2013-47989-R, SAF2016-80236-R, CIBERNED CB06/05/1104 and PIE13/00027), Generalitat de Catalunya (2014SGR1609), and Fundacio La Marato de TV3 (201414-30) to JXC. Fellowship BES-2014-069550 to IC-Y.; This work was funded by grants awarded to JXC from the Spanish "Ministerio de Economia y Competitividad" (SAF2013-47989-R, SAF2016-80236-R, CIBERNED CB06/05/1104 and PIE13/00027), the "Generalitat de Catalunya" (2014SGR1609), and the "Fundacio La Marato de TV3" (201414-30). IC-Y is a recipient of fellowship BES-2014-069550	Anko ML, 2014, SEMIN CELL DEV BIOL, V32, P11, DOI 10.1016/j.semcdb.2014.03.011; Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Carriba P, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.6; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Evin G, 2016, BIODRUGS, V30, P173, DOI 10.1007/s40259-016-0168-3; Gruber AR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-122; Guigo R, 2006, MOL CELL, V23, P150, DOI 10.1016/j.molcel.2006.07.003; Hu L, 2009, APOPTOSIS, V14, P1255, DOI 10.1007/s10495-009-0402-2; Huo J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.12; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jacobs SBR, 2007, CELL DEATH DIFFER, V14, P1374, DOI 10.1038/sj.cdd.4402128; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kim WR, 2011, DEV GROWTH DIFFER, V53, P225, DOI 10.1111/j.1440-169X.2010.01226.x; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Li Q, 2014, ELIFE, V3, DOI 10.7554/eLife.01201; Martinez-Marmol R, 2016, SCI REP-UK, V6, DOI 10.1038/srep35775; Moubarak RS, 2013, J NEUROSCI, V33, P19262, DOI 10.1523/JNEUROSCI.2479-13.2013; Planells-Ferrer L, 2016, J NEUROCHEM, V139, P11, DOI 10.1111/jnc.13729; Raj B, 2015, NEURON, V87, P14, DOI 10.1016/j.neuron.2015.05.004; Raj B, 2014, MOL CELL, V56, P90, DOI 10.1016/j.molcel.2014.08.011; Raj B, 2011, MOL CELL, V43, P843, DOI 10.1016/j.molcel.2011.08.014; Schneider TJ, 1999, J EXP MED, V189, P949, DOI 10.1084/jem.189.6.949; Segura MF, 2007, J NEUROSCI, V27, P11228, DOI 10.1523/JNEUROSCI.3462-07.2007; Sole C, 2004, J CELL BIOL, V167, P479, DOI 10.1083/jcb.200403093; Somers J, 2013, INT J BIOCHEM CELL B, V45, P1690, DOI 10.1016/j.biocel.2013.04.020; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Urresti J, 2016, J BIOL CHEM, V291, P1221, DOI 10.1074/jbc.M115.677682; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wethmar K, 2014, WIRES RNA, V5, P765, DOI 10.1002/wrna.1245; Wethmar K, 2014, NUCLEIC ACIDS RES, V42, pD60, DOI 10.1093/nar/gkt952; Zhong XM, 2001, MOL IMMUNOL, V38, P65, DOI 10.1016/S0161-5890(01)00035-9; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	36	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185327	10.1371/journal.pone.0185327	http://dx.doi.org/10.1371/journal.pone.0185327			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981531	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300033
J	Li, H; Chen, LP; Wang, T; Wang, SG; Liu, JH				Li, Hao; Chen, Liping; Wang, Tao; Wang, Shaogang; Liu, Jihong			The effect of cavernous nerve traction on erectile function in rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MAJOR PELVIC GANGLION; RADICAL PROSTATECTOMY; CORPUS CAVERNOSUM; GROWTH-FACTOR; NEUROTROPHIC FACTOR; DIABETIC-RATS; SMOOTH-MUSCLE; STEM-CELLS; DYSFUNCTION	We performed this study to evaluate the effect of cavernous nerve (CN) traction on erectile function in rats. Thirty-two 8-week-old Sprague-Dawley rats were divided into four groups: control, 1-minute CN traction, 2-minute CN traction, and 2-minute CN crush. CN traction was performed using a glass hook with a tensile force of 0.2 Newton. One month later, the mean arterial pressure (MAP) and intracavernosal pressure (ICP) in response to CN stimulation were measured to assess erectile function. The penis and major pelvic ganglion (MPG) were harvested to explore the expression of neuronal nitric oxide synthase (nNOS) and neurofilament, fibrosis and apoptosis. The ICP/MAP ratio was reduced in the 2-minute CN traction group compared with the control group (P < 0.05). The ICP/MAP ratio in the CN crush group was lower than in the other three groups (P < 0.05, for each). Expression of nNOS in both MPG and dorsal penile nerve was lower in the CN traction group than in the control group, but was higher than in the CN crush group (P < 0.05). Nerve fiber number in the dorsal penile nerve was reduced by 2-minute CN traction (P < 0.05). The ratios of collagen to smooth muscle content and the apoptosis were both increased the in 2-minute CN traction group compared with the control group (P < 0.05). The findings indicate that CN traction is an effective CN injury model and the injury it caused is relatively mild compared with the CN crush model.	[Li, Hao; Wang, Tao; Wang, Shaogang; Liu, Jihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan, Hubei, Peoples R China; [Li, Hao; Wang, Tao; Wang, Shaogang; Liu, Jihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Urol, Wuhan, Hubei, Peoples R China; [Chen, Liping] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Gastroenterol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liu, JH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan, Hubei, Peoples R China.; Liu, JH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Urol, Wuhan, Hubei, Peoples R China.	jhliu@tjh.tjmu.edu.cn	Wang, Shaogang/AGO-4944-2022	Wang, Shaogang/0000-0002-3206-1495	National Natural Science Foundation of China [81471451]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (grant number:81471451,URL:http://www.nsfc.gov.cn/) to JL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atilgan D, 2014, SCI WORLD J, V2014, DOI DOI 10.1155/2014/970363; Burnett AL, 2007, J UROLOGY, V178, P597, DOI 10.1016/j.juro.2007.03.140; Canguven O, 2008, J SEX MED, V5, P1776, DOI 10.1111/j.1743-6109.2008.00955.x; Chen Y, 2012, ASIAN J ANDROL, V14, P616, DOI 10.1038/aja.2012.22; Cho MC, 2015, J UROLOGY, V193, P1716, DOI 10.1016/j.juro.2014.10.099; DING YQ, 1993, NEUROSCI LETT, V164, P187, DOI 10.1016/0304-3940(93)90888-R; El-Sakka AI, 1998, J UROLOGY, V160, P2245, DOI 10.1016/S0022-5347(01)62304-8; Ferrini MG, 2006, UROLOGY, V68, P429, DOI 10.1016/j.urology.2006.05.011; GIULIANO FA, 1995, UROL CLIN N AM, V22, P747; Gokce A, 2015, J SEX MED, V12, P1533, DOI 10.1111/jsm.12916; Gonzalez-Cadavid NF, 2000, BIOL REPROD, V63, P704, DOI 10.1095/biolreprod63.3.704; Haglind E, 2015, EUR UROL, V68, P216, DOI 10.1016/j.eururo.2015.02.029; Hannan JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29416; Hisasue SI, 2008, INT J UROL, V15, P82, DOI 10.1111/j.1442-2042.2007.01917.x; Hsieh PS, 2003, BJU INT, V92, P470, DOI 10.1046/j.1464-410X.2003.04373.x; Hu WL, 2004, BJU INT, V94, P424, DOI 10.1111/j.1464-410X.2004.04969.x; Hu WL, 2004, ASIAN J ANDROL, V6, P111; Jin HR, 2010, J SEX MED, V7, P3351, DOI 10.1111/j.1743-6109.2010.01942.x; Jung GW, 1999, INT J IMPOT RES, V11, P227, DOI 10.1038/sj.ijir.3900426; Katz EG, 2016, UROLOGY, V89, P76, DOI 10.1016/j.urology.2015.12.021; Leungwattanakij S, 2003, J ANDROL, V24, P239; Li HX, 2016, J SEX MED, V13, P22, DOI 10.1016/j.jsxm.2015.11.008; Liao CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep33040; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Moran PS, 2013, INT J UROL, V20, P312, DOI 10.1111/iju.12070; Mullerad M, 2006, J SEX MED, V3, P77, DOI 10.1111/j.1743-6109.2005.00158.x; REDDY KB, 1993, J CELL PHYSIOL, V156, P48, DOI 10.1002/jcp.1041560108; Ruan YJ, 2016, J SEX MED, V13, P778, DOI 10.1016/j.jsxm.2016.02.164; Shimizu T, 2005, INT J UROL, V12, P552, DOI 10.1111/j.1442-2042.2005.01088.x; User HM, 2003, J UROLOGY, V169, P1175, DOI 10.1097/01.ju.0000048974.47461.50; WALSH PC, 1983, PROSTATE, V4, P473, DOI 10.1002/pros.2990040506; Wang T, 2013, J UROLOGY, V190, P790, DOI 10.1016/j.juro.2013.03.043; Watabe T, 2003, J CELL BIOL, V163, P1303, DOI 10.1083/jcb.200305147; Yamashita S, 2009, INT J UROL, V16, P905, DOI 10.1111/j.1442-2042.2009.02382.x; You D, 2013, PROSTATE, V73, P278, DOI 10.1002/pros.22567; Zhang X H, 1999, Asian J Androl, V1, P135; Zhang Y, 2016, ONCOTARGET, V7, P39302, DOI 10.18632/oncotarget.9909	37	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186077	10.1371/journal.pone.0186077	http://dx.doi.org/10.1371/journal.pone.0186077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982169	Green Submitted, gold, Green Published			2022-12-26	WOS:000412360300118
J	Mekonnen, E; Bekele, E				Mekonnen, Ephrem; Bekele, Endashaw			An ancestral human genetic variant linked to an ancient disease: A novel association of FMO2 polymorphisms with tuberculosis (TB) in Ethiopian populations provides new insight into the differential ethno-geographic distribution of FMO2*1	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; MYCOBACTERIUM-TUBERCULOSIS; OXYGENATION; ETHIONAMIDE; FREQUENCY; EVOLUTION; PATTERN; MOUSE	The human FMO2 (flavin-containing monooxygenase 2) gene has been shown to be involved in innate immunity against microbial infections, including tuberculosis (TB), via the modulation of oxidative stress levels. It has also been found to possess a curious loss-of-function mutation (FMO2*1/FMO2*2) that demonstrates a distinctive differentiation in expression, function and ethno-geographic distribution. However, despite evidences of ethnic-specific genetic associations in the inflammatory profile of TB, no studies were done to investigate whether these patterns of variations correlate with evidences for the involvement of FMO2 in antimicrobial immune responses and ethnic differences in the distribution of FMO2 polymorphisms except for some pharmacogenetic data that suggest a potentially deleterious role for the functional variant (FMO2* 1). This genetic epidemiological study was designed to investigate whether there is an association between FMO2 polymorphisms and TB, an ancient malady that remains a modern global health concern, in a sub-Saharan Africa setting where there is not only a relatively high co-prevalence of the disease and the ancestral FMO2* 1 variant but also where both Mycobcaterium and Homo sapiens are considered to have originated and co-evolved. Blood samples and TB related clinical data were collected from ascertained TB cases and unrelated household controls (n = 292) from 3 different ethnic groups in Ethiopia. Latent Mtb infection was determined using Quantiferon to develop reliable TB progression phenotypes. We sequenced exonic regions of FMO2. We identified for the first time an association between FMO2 and TB both at the SNP and haplotype level. Two novel SNPs achieved a study-wide significance [chr1:171181877(A), p = 3.15E-07, OR = 4.644 and chr1:171165749(T), p = 3.32E-06, OR = 6.825] while multiple SNPs (22) showed nominal signals. The pattern of association suggested a protective effect of FMO2 against both active and latent TB with distinct genetic variants underlying the TB-progression pathway. The results were robust for population stratification. Haplotype-based tests confirmed the SNP-based results with a single haplotype bearing the ancestral-and-functional FMO2*1 ("c") under bar allele ("AGCTCTACAATCCCCTCGTTGCGC") explaining the overall association (haplotype-specific-p = 0.000103). Strikingly, not only was FMO2*1 nominally associated with reduced risk to "Active TB" (p = 0.0118, OR = 0.496) but it also does not co-segregate with the 5'-3' flanking top high-TB-risk alleles. The study provides an evidence for the existence of an evolutionary adaptation to an ancient disease based on an ancestral genetic variant acting in a haplotypic framework in Ethiopian populations.	[Mekonnen, Ephrem; Bekele, Endashaw] Addis Ababa Univ, Dept Microbial Cellular Mol Biol, Addis Ababa, Ethiopia; [Mekonnen, Ephrem] Addis Ababa Univ, Inst Biotechnol, Dept Hlth Biotechnol, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University	Mekonnen, E (corresponding author), Addis Ababa Univ, Dept Microbial Cellular Mol Biol, Addis Ababa, Ethiopia.; Mekonnen, E (corresponding author), Addis Ababa Univ, Inst Biotechnol, Dept Hlth Biotechnol, Addis Ababa, Ethiopia.	ephrememuti@gmail.com		Mekonnen, Ephrem/0000-0003-0416-649X	C.S. (National Institutes of Health) [R01HL096811]	C.S. (National Institutes of Health)	This study was in part funded by C.S. (grant # R01HL096811, National Institutes of Health).	Abate D, 2014, INT J TUBERC LUNG D, V18, P946, DOI 10.5588/ijtld.13.0926; Agonafir M, 2010, INT J TUBERC LUNG D, V14, P1259; Akiibinu M. O., 2011, European Journal of General Medicine, V8, P213; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Beall CM, 2002, P NATL ACAD SCI USA, V99, P17215, DOI 10.1073/pnas.252649199; Brites D, 2015, IMMUNOL REV, V264, P6, DOI 10.1111/imr.12264; Comas I, 2015, CURR BIOL, V25, P3260, DOI 10.1016/j.cub.2015.10.061; Coussens AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003468; Delgado JC, 2002, J INFECT DIS, P186; Dolphin CT, 1998, J BIOL CHEM, V273, P30599, DOI 10.1074/jbc.273.46.30599; Francois AA, 2009, DRUG METAB DISPOS, V37, P178, DOI 10.1124/dmd.108.024158; Gagneux S., 2012, PHIL T R SOC B, P367; Gebretsadik G, 2015, J TUBERCULOSIS RES, V3, P63, DOI DOI 10.4236/JTR.2015.33010; Hao D, 2009, GENETICA, V137, P173, DOI 10.1007/s10709-009-9382-y; Hao DC, 2011, CHINESE SCI BULL, V56, P1246, DOI 10.1007/s11434-011-4380-8; Henderson MC, 2008, TOXICOL APPL PHARM, V233, P420, DOI 10.1016/j.taap.2008.09.017; Henderson MC, 2004, CHEM RES TOXICOL, V17, P633, DOI 10.1021/tx034253s; Hernandez D, 2004, PHARMACOGENETICS, V14, P117, DOI 10.1097/00008571-200402000-00006; I Verma, 2014, STUDIES RESP DISORDE, P101, DOI [10.1007/978-1-4939-0497-6_6., DOI 10.1007/978-1-4939-0497-6_6]; Kreuger SK, 2005, PHARMACOL THERAPEUT, V106, P3; Krueger Sharon K, 2005, Pharmacogenet Genomics, V15, P245, DOI 10.1097/01213011-200504000-00008; Krueger SK, 2004, DRUG METAB DISPOS, V32, P1337, DOI 10.1124/dmd.104.001099; Liu N, 2008, ADV GENETICS, V60; Moses A. O., 2008, European Journal of General Medicine, V5, P208; Oyedeji SO, 2013, GREENER J MED SCI, V3, P228; Palmer AL, 2012, PHARMACEUTICALS, V5, P1147, DOI 10.3390/ph5111147; Pawar BD, 2011, BIOMED RES-INDIA, V22, P455; Purcell S, 2005, DOCUMENTATION TOOLSE; Ramachandran G, 2012, PHARMACOGN PERS MED, V5, P89, DOI 10.2147/PGPM.S15454; Scheinfeldt LB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r1; Siddens LK, 2014, BIOCHEM PHARMACOL, V89, P141, DOI 10.1016/j.bcp.2014.02.006; Sirugo G, 2008, HUM GENET, V123, P557, DOI 10.1007/s00439-008-0511-y; Veeramah KR, 2008, PHARMACOGENET GENOM, V18, P877, DOI 10.1097/FPC.0b013e3283097311; Whetstine JR, 2000, TOXICOL APPL PHARM, V168, P216, DOI 10.1006/taap.2000.9050; Zhang J, 2006, DRUG METAB DISPOS, V34, P19, DOI 10.1124/dmd.105.006171	35	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184931	10.1371/journal.pone.0184931	http://dx.doi.org/10.1371/journal.pone.0184931			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981537	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300024
J	Merchant, M; Moffat, J; Schaefer, G; Chan, J; Wang, X; Orr, C; Cheng, J; Hunsaker, T; Shao, L; Wang, SJ; Wagle, MC; Lin, E; Haverty, PM; Shahidi-Latham, S; Ngu, H; Solon, M; Eastham-Anderson, J; Koeppen, H; Huang, SMA; Schwarz, J; Belvin, M; Kirouac, D; Junttila, MR				Merchant, Mark; Moffat, John; Schaefer, Gabriele; Chan, Jocelyn; Wang, Xi; Orr, Christine; Cheng, Jason; Hunsaker, Thomas; Shao, Lily; Wang, Stephanie J.; Wagle, Marie-Claire; Lin, Eva; Haverty, Peter M.; Shahidi-Latham, Sheerin; Ngu, Hai; Solon, Margaret; Eastham-Anderson, Jeffrey; Koeppen, Hartmut; Huang, Shih-Min A.; Schwarz, Jacob; Belvin, Marcia; Kirouac, Daniel; Junttila, Melissa R.			Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors	PLOS ONE			English	Article							NEGATIVE-FEEDBACK; PHOSPHORYLATION SITES; KINASE CASCADE; MAPK PATHWAY; RESISTANCE; BRAF; CANCER; KRAS; ACTIVATION; IDENTIFICATION	Mitogen-activated protein kinase (MAPK) pathway dysregulation is implicated in >30% of all cancers, rationalizing the development of RAF, MEK and ERK inhibitors. While BRAF and MEK inhibitors improve BRAF mutant melanoma patient outcomes, these inhibitors had limited success in other MAPK dysregulated tumors, with insufficient pathway suppression and likely pathway reactivation. In this study we show that inhibition of either MEK or ERK alone only transiently inhibits the MAPK pathway due to feedback reactivation. Simultaneous targeting of both MEK and ERK nodes results in deeper and more durable suppression of MAPK signaling that is not achievable with any dose of single agent, in tumors where feedback reactivation occurs. Strikingly, combined MEK and ERK inhibition is synergistic in RAS mutant models but only additive in BRAF mutant models where the RAF complex is dissociated from RAS and thus feedback productivity is disabled. We discovered that pathway reactivation in RAS mutant models occurs at the level of CRAF with combination treatment resulting in a markedly more active pool of CRAF. However, distinct from single node targeting, combining MEK and ERK inhibitor treatment effectively blocks the downstream signaling as assessed by transcriptional signatures and phospho-p90RSK. Importantly, these data reveal that MAPK pathway inhibitors whose activity is attenuated due to feedback reactivation can be rescued with sufficient inhibition by using a combination of MEK and ERK inhibitors. The MEK and ERK combination significantly suppresses MAPK pathway output and tumor growth in vivo to a greater extent than the maximum tolerated doses of single agents, and results in improved anti-tumor activity in multiple xenografts as well as in two Kras mutant genetically engineered mouse (GEM) models. Collectively, these data demonstrate that combined MEK and ERK inhibition is functionally unique, yielding greater than additive anti-tumor effects and elucidates a highly effective combination strategy in MAPK-dependent cancer, such as KRAS mutant tumors.	[Merchant, Mark; Schaefer, Gabriele; Chan, Jocelyn; Wang, Xi; Orr, Christine; Cheng, Jason; Hunsaker, Thomas; Shao, Lily; Junttila, Melissa R.] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Moffat, John] Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Wang, Stephanie J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Wagle, Marie-Claire; Huang, Shih-Min A.] Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA; [Lin, Eva] Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA; [Haverty, Peter M.] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Shahidi-Latham, Sheerin] Genentech Inc, Dept Drug Metab & Pharmacokinet, San Francisco, CA 94080 USA; [Ngu, Hai; Eastham-Anderson, Jeffrey; Koeppen, Hartmut] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Solon, Margaret; Schwarz, Jacob] Genentech Inc, Dept Discovery Chem, San Francisco, CA 94080 USA; [Belvin, Marcia] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA; [Kirouac, Daniel] Genentech Inc, Dept Preclin & Translat Pharmacokinet, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Massachusetts Institute of Technology (MIT); Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Junttila, MR (corresponding author), Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA.	junttila.melissa@gene.com		wagle, Marie-Claire/0000-0002-8657-1538; /0000-0002-7789-2049; Schaefer, Gabriele/0000-0001-9727-3555	Genentech	Genentech(Roche HoldingGenentech)	Genentech provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Andersson CR, HIGH THROUGHPUT SCRE, P37; Balan V, 2006, MOL BIOL CELL, V17, P1141, DOI 10.1091/mbc.E04-12-1123; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Blake JF, 2016, J MED CHEM, V59, P5650, DOI 10.1021/acs.jmedchem.6b00389; Blake JF, PREPARATION AMINOPYR; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Brummer T, 2003, ONCOGENE, V22, P8823, DOI 10.1038/sj.onc.1207185; Chan GKY, 2016, JALA-J LAB AUTOM, V21, P125, DOI 10.1177/2211068215593759; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Fremin C, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-8; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; GRECO WR, 1995, PHARMACOL REV, V47, P331; Hatzivassiliou G, 2013, NATURE, V501, P232, DOI 10.1038/nature12441; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hoeflich KP, 2012, CANCER RES, V72, P210, DOI 10.1158/0008-5472.CAN-11-1515; Junttila MR, 2015, MOL CANCER THER, V14, P40, DOI 10.1158/1535-7163.MCT-14-0030; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kitai H, 2016, CANCER DISCOV, V6, P754, DOI 10.1158/2159-8290.CD-15-1377; Kolch W, 2015, NAT REV CANCER, V15, P515, DOI 10.1038/nrc3983; LANGLOIS WJ, 1995, J BIOL CHEM, V270, P25320, DOI 10.1074/jbc.270.43.25320; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Lito P, 2014, CANCER CELL, V25, P697, DOI 10.1016/j.ccr.2014.03.011; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Manchado E, 2016, NATURE, V534, P647, DOI 10.1038/nature18600; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Neuzillet C, 2014, PHARMACOL THERAPEUT, V141, P160, DOI 10.1016/j.pharmthera.2013.10.001; Phan VT, 2013, P NATL ACAD SCI USA, V110, P6079, DOI 10.1073/pnas.1303302110; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rebecca VW, 2014, PIGM CELL MELANOMA R, V27, P1154, DOI 10.1111/pcmr.12303; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Sever R, 2015, COLD SPRING HARB PER, V5, P5; Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319; Singh M, 2010, NAT BIOTECHNOL, V28, P585, DOI 10.1038/nbt.1640; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sturm OE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001212; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Veta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070221; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Weekes CD, AACR ANN M 2017 WASH; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249	49	51	51	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185862	10.1371/journal.pone.0185862	http://dx.doi.org/10.1371/journal.pone.0185862			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982154	Green Submitted, Green Published, gold			2022-12-26	WOS:000412360300076
J	Na, KI; Jeoung, JW; Lee, WJ; Kim, YK; Kim, CY; Park, KH				Na, Kyeong Ik; Jeoung, Jin Wook; Lee, Won June; Kim, Young Kook; Kim, Chan Yun; Park, Ki Ho		Korean Ophthalmologic Soc	Prevalence of retinal nerve fiber layer defects: The Korea National Health and Nutrition Examination Survey 2008-2012	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; NORMAL-TENSION GLAUCOMA; OPTIC DISC HEMORRHAGE; VISUAL-FIELD DEFECTS; RISK-FACTORS; DIABETIC-RETINOPATHY; PANRETINAL PHOTOCOAGULATION; COHERENCE TOMOGRAPHY; INSULIN-RESISTANCE; VEIN OCCLUSION	Purpose To investigate the prevalence and associated factors of retinal nerve fiber layer defects (RNFLDs) in a Korean population. Methods The Korea National Health and Nutrition Examination Survey (KNHANES) is a population-based study using a complex, stratified, multistage, probability-cluster survey. We performed a review of 2008-2012 data from the KNHANES. Two masked ophthalmologists evaluated fundus photography to detect RNFLDs. All participants underwent ocular and systemic evaluations. Results A total of 28,637 subjects aged >= 19 years with at least one evaluable fundus photograph were enrolled. The estimated prevalence of RNFLDs in this Korean population was 4.8% (95% confidence interval, 4.4%-5.3%). The estimated percentages of glaucomatous RNFLD and non-glaucomatous RNFLD subjects were 34.4% and 65.6%, respectively. In a multivariate analysis, the prevalence of RNFLDs was significantly associated with older age (P < 0.001), male gender (P = 0.047), glycosylated hemoglobin (P = 0.048), disc hemorrhage (P = 0.016), ISNT rule (P < 0.001), and vertical cup to disc ratio (P < 0.001). Conclusions The prevalence of RNFLDs in a large Korean population-based sample with a minimum age of 19 years was 4.8%. RNFLD prevalence was associated with old age, male gender, glycosylated hemoglobin, disc hemorrhage, and glaucomatous optic disc.	[Na, Kyeong Ik] Hallym Univ, Coll Med, Kangdong Sacred Heart Hosp, Dept Ophthalmol, Seoul, South Korea; [Jeoung, Jin Wook; Lee, Won June; Kim, Young Kook; Park, Ki Ho] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul, South Korea; [Kim, Chan Yun] Yonsei Univ, Coll Med, Inst Vis Res, Dept Ophthalmol, Seoul, South Korea	Hallym University; Seoul National University (SNU); Seoul National University Hospital; Yonsei University; Yonsei University Health System	Jeoung, JW; Park, KH (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul, South Korea.	neuroprotect@gmail.com; kihopark@snu.ac.kr	Lee, Won June/Y-8207-2018	Lee, Won June/0000-0002-3506-7139; Kim, Young Kook/0000-0002-6037-8449; Na, Kyeong Ik/0000-0002-0951-9162				AIRAKSINEN PJ, 1981, ACTA OPHTHALMOL, V59, P627, DOI 10.1111/j.1755-3768.1981.tb08728.x; Alencar Luciana M, 2007, Semin Ophthalmol, V22, P103, DOI 10.1080/08820530701420058; Chaum E, 2001, J NEURO-OPHTHALMOL, V21, P276, DOI 10.1097/00041327-200112000-00010; CHIHARA E, 1991, GRAEF ARCH CLIN EXP, V229, P13, DOI 10.1007/BF00172255; CHIHARA E, 1993, OPHTHALMOLOGY, V100, P1147; Cho HK, 2012, AM J OPHTHALMOL, V154, P958, DOI 10.1016/j.ajo.2012.05.025; Demir MN, 2009, EUR J OPHTHALMOL, V19, P1034, DOI 10.1177/112067210901900621; GUPTA P, 2016, INVEST OPHTH VIS SCI, V57, P2577; HEIJL A, 1984, ACTA OPHTHALMOL, V62, P658; HOYT WF, 1972, BRIT J OPHTHALMOL, V56, P577, DOI 10.1136/bjo.56.8.577; Hu XX, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0322-1; Hwang JM, 2006, J GLAUCOMA, V15, P223, DOI 10.1097/01.ijg.0000212218.96932.f7; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jeon SJ, 2016, INVEST OPHTH VIS SCI, V57, P4008, DOI 10.1167/iovs.16-19525; Jiang XJ, 2012, OPHTHALMOLOGY, V119, P2245, DOI 10.1016/j.ophtha.2012.05.030; JONAS JB, 1992, INVEST OPHTH VIS SCI, V33, P2012; JONAS JB, 1994, BRIT J OPHTHALMOL, V78, P285, DOI 10.1136/bjo.78.4.285; JONAS JB, 1994, GRAEF ARCH CLIN EXP, V232, P759, DOI 10.1007/BF00184280; Katz BJ, 2006, AM J OPHTHALMOL, V141, P248, DOI 10.1016/j.ajo.2005.09.029; Kim J, 2012, RETINA-J RET VIT DIS, V32, P2052, DOI 10.1097/IAE.0b013e3182562000; Kim KE, 2016, OPHTHALMOLOGY, V123, P532, DOI 10.1016/j.ophtha.2015.11.004; Kim M, 2011, INVEST OPHTH VIS SCI, V52, P6882, DOI 10.1167/iovs.11-7276; Kim SH, 2006, OPHTHALMOLOGY, V113, P598, DOI 10.1016/j.ophtha.2005.12.018; Lee SB, 2013, RETINA-J RET VIT DIS, V33, P188, DOI 10.1097/IAE.0b013e318261a710; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Liang YB, 2011, INVEST OPHTH VIS SCI, V52, P8250, DOI 10.1167/iovs.11-7472; LOCKWOOD A, 1992, LANCET, V340, P1100, DOI 10.1016/0140-6736(92)93123-5; Lucy M, 2002, OPHTHALMOLOGY, V109, P2232, DOI 10.1016/S0161-6420(02)01248-4; Ma Jin, 2013, Zhonghua Yan Ke Za Zhi, V49, P514; de Alencar LPM, 2007, CLINICS, V62, P197, DOI 10.1590/S1807-59322007000200016; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Nukada M, 2011, OPHTHALMOLOGY, V118, P1038, DOI 10.1016/j.ophtha.2010.10.025; Oray M, 2015, AM J OPHTHALMOL, V159, P475, DOI 10.1016/j.ajo.2014.11.029; PandaJonas S, 1996, AM J OPHTHALMOL, V121, P181, DOI 10.1016/S0002-9394(14)70583-5; PandaJonas S, 1995, OPHTHALMOLOGY, V102, P1853, DOI 10.1016/S0161-6420(95)30784-1; QUIGLEY HA, 1993, OPHTHALMOLOGY, V100, P1800; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; Stewart RMK, 2008, AM J OPHTHALMOL, V145, P394, DOI 10.1016/j.ajo.2007.11.005; Sugiyama K, 1997, OPHTHALMOLOGY, V104, P1926, DOI 10.1016/S0161-6420(97)30005-0; Suh MH, 2011, CLIN EXP OPHTHALMOL, V39, P513, DOI 10.1111/j.1442-9071.2010.02482.x; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Takis A, 2014, CLIN OPHTHALMOL, V8, P455, DOI 10.2147/OPTH.S47762; Vijaya L, 2008, OPHTHALMOLOGY, V115, P648, DOI 10.1016/j.ophtha.2007.04.062; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Ye C, 2011, OPHTHALMOLOGY, V118, P2196, DOI 10.1016/j.ophtha.2011.03.035; Zhang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062022; Zhao L, 2013, ABSTR APPL ANAL, V2013, P8, DOI [DOI 10.1371/J0URNAL.P0NE.0063928, DOI 10.1155/2013/812143]; Zheng YF, 2010, INVEST OPHTH VIS SCI, V51, P2998, DOI 10.1167/iovs.09-4470	50	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186032	10.1371/journal.pone.0186032	http://dx.doi.org/10.1371/journal.pone.0186032			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982124	Green Submitted, Green Published, gold			2022-12-26	WOS:000412360300113
J	Paul-Victor, C; Vacche, SD; Sordo, F; Fink, S; Speck, T; Michaud, V; Speck, O				Paul-Victor, Cloe; Vacche, Sara Dalle; Sordo, Federica; Fink, Siegfried; Speck, Thomas; Michaud, Veronique; Speck, Olga			Effect of mechanical damage and wound healing on the viscoelastic properties of stems of flax cultivars (Linum usitatissimum L. cv. Eden and cv. Drakkar)	PLOS ONE			English	Article							WALL-ASSOCIATED PEROXIDASES; FIBERS; HISTOCHEMISTRY; DEPOSITION; BEHAVIOR; LIGNIN; GROWTH	As plant fibres are increasingly used in technical textiles and their composites, underlying principles of wound healing in living plant fibres are relevant to product quality, and provide inspiration for biomimetic healing in synthetic materials. In this work, two Linum usitatissimum cultivars differing in their stem mechanical properties, cv. Eden (stems resistant to lodging) and cv. Drakkar (with more flexible stems), were grown without wound or with stems previously wounded with a cut parallel or transversal to the stem. To investigate wound healing efficiency, growth traits, stem biomechanics with Dynamic Mechanical Analysis and anatomy were analysed after 25-day recovery. Longitudinal incisions formed open wounds while transversal incisions generated stem growth restoring the whole cross-section but not the original stem organisation. In the case of transversal wound healing, all the bast fibre bundles in the perturbed area became lignified and pulled apart by parenchyma cells growth. Both Linum cultivars showed a healing efficiency from 79% to 95% with higher scores for transversal healing. Morphological and anatomical modifications of Linum were related to mechanical properties and healing ability. Alongside with an increased understanding of wound healing in plants, our results highlight their possible impact on textile quality and fibre yield.	[Paul-Victor, Cloe; Speck, Thomas; Speck, Olga] Univ Freiburg, Plant Biomech Grp & Bot Garden, Freiburg, Germany; [Paul-Victor, Cloe; Speck, Thomas; Speck, Olga] Freiburg Mat Res Ctr FMF, Freiburg, Germany; [Vacche, Sara Dalle; Sordo, Federica; Michaud, Veronique] Ecole Polytech Fed Lausanne, Inst Mat, LPAC, Lausanne, Switzerland; [Fink, Siegfried] Univ Freiburg, Inst Forest Bot, Freiburg, Germany; [Speck, Thomas; Speck, Olga] Competence Network Biomimet, Freiburg, Germany	University of Freiburg; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Freiburg	Speck, O (corresponding author), Univ Freiburg, Plant Biomech Grp & Bot Garden, Freiburg, Germany.; Speck, O (corresponding author), Freiburg Mat Res Ctr FMF, Freiburg, Germany.; Speck, O (corresponding author), Competence Network Biomimet, Freiburg, Germany.	olga.speck@biologie.uni-freiburg.de	Dalle Vacche, Sara/M-3330-2017; Dalle Vacche, Sara/AAB-9820-2020; Michaud, Veronique/A-6390-2009	Dalle Vacche, Sara/0000-0001-5459-5714; Dalle Vacche, Sara/0000-0001-5459-5714; Michaud, Veronique/0000-0001-5699-740X; Paul-Victor, Cloe/0000-0001-5413-8046	European Union [290308]; German Research Foundation (DFG); University of Freiburg	European Union(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	Funding from the European Union Seventh Framework Program (FP7/2007-2013) under grant agreement no. 290308 (Marie Curie ITN SHeMat 'Self-Healing Materials: from Concepts to Market') is gratefully acknowledged. We thank "Terre de Lin" for providing Linum usitatissimum seeds. We thank Heidi Petarus and her team of the Botanic Garden of the University of Freiburg (Germany) for assistance in plant growing. We thank Sabine Diener, Susanne Roske and Nardo Streit (Institute for Forest Botany, University of Freiburg, Germany) for technical assistance in the anatomical sample preparation. The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing.	Alix S, 2008, COMPOS PART A-APPL S, V39, P1793, DOI 10.1016/j.compositesa.2008.08.008; [Anonymous], 2014, R LANG ENV STAT COMP; Bates D.M., 2010, LME4 MIXED EFFECTS M; Bauer G, 2012, ANN BOT-LONDON, V109, P807, DOI 10.1093/aob/mcr307; BIGGS AR, 1985, PHYTOPATHOLOGY, V75, P1191, DOI 10.1094/Phyto-75-1191; Blaiszik BJ, 2010, ANNU REV MATER RES, V40, P179, DOI 10.1146/annurev-matsci-070909-104532; Busch S, 2010, P ROY SOC B-BIOL SCI, V277, P2113, DOI 10.1098/rspb.2010.0075; Charlet K, 2007, COMPOS PART A-APPL S, V38, P1912, DOI 10.1016/j.compositesa.2007.03.006; Charlet K, 2009, PROCEDIA ENGINEER, V1, P233, DOI 10.1016/j.proeng.2009.06.055; Duc F., 2014, THESIS; Duc F, 2014, J REINF PLAST COMP, V33, P1625, DOI 10.1177/0731684414539779; Esau K, 1943, AM J BOT, V30, P579, DOI 10.2307/2437468; Evert RF., 2006, ESAUS PLANT ANATOMY, DOI [10.1002/0470047380, DOI 10.1002/0470047380]; Faraway JJ., 2006, TEXTS STAT SCI, DOI [DOI 10.1111/J.1541-0420.2006.00596, 10.1111/11541-0420.2006.00596_I2.x]; Fink S, 1999, PATHOLOGICAL REGENER; Gorshkova TA, 2000, ANN BOT-LONDON, V85, P477, DOI 10.1006/anbo.1999.1091; Harrington MJ, 2016, ADV POLYM SCI, V273, P307, DOI 10.1007/12_2015_334; Hawkins S, 1996, PROTOPLASMA, V191, P96, DOI 10.1007/BF01280829; Hughes M, 2012, J MATER SCI, V47, P599, DOI 10.1007/s10853-011-6025-3; Ibrahim L, 2001, ANN BOT-LONDON, V88, P313, DOI 10.1006/anbo.2001.1461; Kalia S, 2011, INT J POLYM SCI, V2011, DOI 10.1155/2011/837875; Konrad W, 2013, J THEOR BIOL, V336, P96, DOI 10.1016/j.jtbi.2013.07.013; Lamb RJ, 2008, CAN ENTOMOL, V140, P600, DOI 10.4039/N08-014; MCDOUGALL GJ, 1993, J PLANT PHYSIOL, V142, P651, DOI 10.1016/S0176-1617(11)80897-7; MCDOUGALL GJ, 1993, J SCI FOOD AGR, V62, P1, DOI 10.1002/jsfa.2740620102; MCDOUGALL GJ, 1991, J PLANT PHYSIOL, V139, P182, DOI 10.1016/S0176-1617(11)80605-X; Morvan C, 2003, PLANT PHYSIOL BIOCH, V41, P935, DOI 10.1016/j.plaphy.2003.07.001; Romhany G, 2003, J APPL POLYM SCI, V90, P3638, DOI 10.1002/app.13110; Satyanarayana KG, 2009, PROG POLYM SCI, V34, P982, DOI 10.1016/j.progpolymsci.2008.12.002; Schreiber L, 2005, PLANTA, V220, P520, DOI 10.1007/s00425-004-1364-9; Speck T, 2013, RSC SMART MATER, P359, DOI 10.1039/9781849737555-00359; Speck T, 2013, SELF-HEALING POLYMERS: FROM PRINCIPLES TO APPLICATIONS, P61; Stamboulis A, 2001, COMPOS PART A-APPL S, V32, P1105, DOI 10.1016/S1359-835X(01)00032-X; Stobbe H, 2002, ANN BOT-LONDON, V89, P773, DOI 10.1093/aob/mcf137; Trask RS, 2007, BIOINSPIR BIOMIM, V2, pP1, DOI 10.1088/1748-3182/2/1/P01; Trask RS, 2010, J R SOC INTERFACE, V7, P921, DOI 10.1098/rsif.2009.0420; Vallet C, 1996, ANN BOT-LONDON, V78, P625, DOI 10.1006/anbo.1996.0170; van der Zwaag S, 2014, MATER SCI TECH-LOND, V30, P1633, DOI 10.1179/1743284714Y.0000000624; Quirien Elfrida van Oirschot QEA, 2006, POSTHARVEST BIOL TEC, V42, P65, DOI 10.1016/j.postharvbio.2006.05.013; Williams HR, 2007, SMART MATER STRUCT, V16, P1198, DOI 10.1088/0964-1726/16/4/031; Wrobel-Kwiatkowska M, 2007, J BIOTECHNOL, V128, P919, DOI 10.1016/j.jbiotec.2006.12.030; Zhu JC, 2013, MATERIALS, V6, P5171, DOI 10.3390/ma6115171	42	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185958	10.1371/journal.pone.0185958	http://dx.doi.org/10.1371/journal.pone.0185958			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982196	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300098
J	Geary, B; Longest, SM; Ottewell, K; Lantz, SM; Walter, ST; Karubian, J; Leberg, PL				Geary, Brock; Longest, Susan M.; Ottewell, Kym; Lantz, Samantha M.; Walter, Scott T.; Karubian, Jordan; Leberg, Paul L.			Genetic structure of brown pelicans (Pelecanus occidentalis) in the northern Gulf of Mexico in the context of human management and disturbance	PLOS ONE			English	Article							DEEP-WATER-HORIZON; EFFECTIVE POPULATION-SIZE; SALMON SALMO-SALAR; OIL-SPILL; MICROSATELLITE LOCI; MOVEMENT PATTERNS; COMPUTER-PROGRAM; TEMPORAL-CHANGES; HIGHLY MOBILE; F-STATISTICS	Environmental disturbances, both natural and anthropogenic, have the capacity to substantially impact animal behavior and abundance, which can in turn influence patterns of genetic diversity and gene flow. However, little empirical information is available on the nature and degree of such changes due to the relative rarity of longitudinal genetic sampling of wild populations at appropriate intervals. Addressing this knowledge gap is therefore of interest to evolutionary biologists, policy makers, and managers. In the past half century, populations of the brown pelican (Pelecanus occidentalis) in the southeastern United States have been exposed to regional extirpations, translocations, colony losses, and oil spills, but potential impacts on genetic diversity and population structure remain unknown. To investigate the cumulative impacts of recent disturbances and management actions, we analyzed seven microsatellite loci using genetic samples collected from 540 nestlings across twelve pelican colonies from two time periods, corresponding to before (n = 305) and after (n = 235) the 2010 Deepwater Horizon oil spill. Pre-2010 populations in Texas were significantly differentiated from Louisiana, Alabama, and Florida populations to the east, with reintroduced populations in southeastern Louisiana having less genetic diversity than sites in Texas, consistent with a recent bottleneck. In contrast, there was no evidence of a geographic component to genetic structure among colonies sampled after the spill, consistent with increased dispersal among sites following the event. This pattern may be associated with reduced philopatry in response to colony abandonment in the areas most heavily impacted by the Deepwater Horizon event, though other factors (e.g., rehabilitation and translocation of oiled birds or colony loss due to erosion and tropical storms) were likely also involved. Future monitoring is necessary to determine if bottlenecks and loss of genetic variation are associated with the oil spill over time, and is recommended for other systems in which disturbance effects may be inferred via repeated genetic sampling.	[Geary, Brock; Longest, Susan M.; Ottewell, Kym; Lantz, Samantha M.; Walter, Scott T.; Karubian, Jordan] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Leberg, Paul L.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Longest, Susan M.] Colorado Mesa Univ, Biol Sci Dept, Grand Junction, CO USA; [Ottewell, Kym] Dept Pk & Wildlife, Sci & Conservat Div, Perth, WA, Australia; [Walter, Scott T.] Texas State Univ, Dept Biol, San Marcos, TX USA	Tulane University; University of Louisiana Lafayette; Texas State University System; Texas State University San Marcos	Geary, B (corresponding author), Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA.	brock.j.geary@gmail.com	Kym, Ottewell/I-9875-2019	Kym, Ottewell/0000-0002-4273-3224; Geary, Brock/0000-0002-6032-0052	National Science Foundation [1139962]; Louisiana Department of Wildlife and Fisheries; NSF [1139962]; LDWF	National Science Foundation(National Science Foundation (NSF)); Louisiana Department of Wildlife and Fisheries; NSF(National Science Foundation (NSF)); LDWF	This work was supported by National Science Foundation #1139962 to JK and PLL: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1139962& and Louisiana Department of Wildlife and Fisheries to PLL: http:/www.gcjv.org/working.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the US Fish and Wildlife Service, Florida Fish and Wildlife Commission, Texas Parks & Wildlife and Louisiana Department of Wildlife & Fisheries (LDWF) for permits and sampling site access. We thank Iliana Pena, Jim Rodgers, John Himes, John Dindo, Chester Smith, Winnie Burkett, Richard Zane, the Dauphin Island Sea Lab for field assistance and/or access to sampling sites, and the Karubian lab for comments and discussions to improve this manuscript. This project was funded by an NSF award #1139962 to JK and PLL, and an LDWF contract to PLL.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; Aeppli C, 2012, ENVIRON SCI TECHNOL, V46, P8799, DOI 10.1021/es3015138; Almeda R, 2013, PLOS ONE, V8, P20; [Anonymous], 2021, LANG ENV STAT COMP; Apodaca JJ, 2013, AM NAT, V181, P254, DOI 10.1086/668831; Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Athrey G, 2012, EVOL APPL, V5, P540, DOI 10.1111/j.1752-4571.2011.00233.x; Barlow EJ, 2011, IBIS, V153, P768, DOI 10.1111/j.1474-919X.2011.01159.x; Bartlett M, 2016, CONSERV GENET, V17, P703, DOI 10.1007/s10592-016-0816-7; Becker PH, 2008, OIKOS, V117, P60, DOI 10.1111/j.2007.0030-1299.16287.x; Briskie JV, 2004, P NATL ACAD SCI USA, V101, P558, DOI 10.1073/pnas.0305103101; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Cornwall W, 2015, SCIENCE, V348, P22, DOI 10.1126/science.348.6230.22; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Doligez B, 2003, ANIM BEHAV, V66, P973, DOI 10.1006/anbe.2002.2270; Drabeck DH, 2014, J HERPETOL, V48, P125, DOI 10.1670/12-186; DURAND E, 2009, TESS VERSION 2 3 REF; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Echols BS, 2016, CHEMOSPHERE, V144, P1893, DOI 10.1016/j.chemosphere.2015.10.082; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fisher CR, 2016, OCEANOGRAPHY, V29, P182, DOI 10.5670/oceanog.2016.82; Friesen VL, 2007, MOL ECOL, V16, P1765, DOI 10.1111/j.1365-294X.2006.03197.x; Genovart M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070711; Goodbody-Gringley G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045574; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Haney JC, 2014, MAR ECOL PROG SER, V513, P239, DOI 10.3354/meps10839; HARRIS MP, 1973, IBIS, V115, P484; Hauser L, 2002, P NATL ACAD SCI USA, V99, P11742, DOI 10.1073/pnas.172242899; Hickman CR, 2008, MOL ECOL RESOUR, V8, P1439, DOI 10.1111/j.1755-0998.2008.02191.x; Holm GO, 2003, WILSON BULL, V115, P431, DOI 10.1676/03-019; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jamieson IG, 2011, CONSERV BIOL, V25, P115, DOI 10.1111/j.1523-1739.2010.01574.x; Janes JK, 2017, MOL ECOL, V26, P3594, DOI 10.1111/mec.14187; Kekkonen J, 2016, PROBLEMATIC WILDLIFE, P269; Kekkonen J, 2011, BIOL CONSERV, V144, P2931, DOI 10.1016/j.biocon.2011.08.012; King DT, 2013, WATERBIRDS, V36, P494, DOI 10.1675/063.036.0406; Klomp N. I., 1992, Ringing and Migration, V13, P73; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Lane SM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1944; Latch EK, 2005, CONSERV GENET, V6, P981, DOI 10.1007/s10592-005-9089-2; LESSA EP, 1990, SYST ZOOL, V39, P242, DOI 10.2307/2992184; Levin II, 2012, ECOL EVOL, V2, P2775, DOI 10.1002/ece3.386; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Machado MD, 2009, CONSERV GENET, V10, P1033, DOI 10.1007/s10592-008-9681-3; MANTEL N, 1967, CANCER RES, V27, P209; McNease L., 1984, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V38, P165; McNease Larry, 1992, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V46, P223; Milot E, 2008, MOL ECOL, V17, P1658, DOI 10.1111/j.1365-294X.2008.03700.x; Milot E, 2007, P ROY SOC B-BIOL SCI, V274, P779, DOI 10.1098/rspb.2006.0221; Moum T, 2001, MOL ECOL, V10, P2463, DOI 10.1046/j.0962-1083.2001.01375.x; NEI M, 1981, GENETICS, V98, P625; NESBITT SA, 1978, WILSON BULL, V90, P443; Nielsen EE, 1997, MOL ECOL, V6, P487, DOI 10.1046/j.1365-294X.1997.00204.x; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Owen TM, 2013, WATERBIRDS, V36, P342, DOI 10.1675/063.036.0311; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; PRINCE PA, 1994, IBIS, V136, P50, DOI 10.1111/j.1474-919X.1994.tb08131.x; Pritchard JK, 2000, GENETICS, V155, P945; Quintana-Rizzo E, 2015, MAR POLLUT BULL, V94, P241, DOI 10.1016/j.marpolbul.2015.02.002; Rabalais NN, 2016, OCEANOGRAPHY, V29, P150, DOI 10.5670/oceanog.2016.79; Raynor EJ, 2013, WATERBIRDS, V36, P88, DOI 10.1675/063.036.0113; Raynor EJ, 2012, AUK, V129, P763, DOI 10.1525/auk.2012.11181; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richards C, 1996, CONSERV BIOL, V10, P832, DOI 10.1046/j.1523-1739.1996.10030832.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Selman W, 2016, WATERBIRDS, V39, P45, DOI 10.1675/063.039.0106; Selman W, 2012, SOUTHEAST NAT, V11, pG1, DOI 10.1656/058.011.0117; Shields M, 2014, PELECANUS OCCIDENTAL; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; Smith TB, 2008, MOL ECOL, V17, P1, DOI 10.1111/j.1365-294X.2007.03607.x; Snyder MR, 2017, MOL ECOL, V26, P1075, DOI 10.1111/mec.13997; SOULE ME, 1991, J AM PLANN ASSOC, V57, P313, DOI 10.1080/01944369108975502; Spear SF, 2012, ECOL APPL, V22, P856, DOI 10.1890/11-0627.1; Spencer CC, 2000, MOL ECOL, V9, P1517, DOI 10.1046/j.1365-294x.2000.01031.x; Sullivan TJ, 2014, J GREAT LAKES RES, V40, P101, DOI 10.1016/j.jglr.2012.12.004; SWENNEN C, 1991, J ORNITHOL, V132, P427, DOI 10.1007/BF01640382; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Taylor SS, 2008, MOL ECOL, V17, P545, DOI 10.1111/j.1365-294X.2007.03591.x; Tessier N, 1999, MOL ECOL, V8, P169, DOI 10.1046/j.1365-294X.1999.00547.x; Tracy LN, 2011, CONSERV GENET, V12, P517, DOI 10.1007/s10592-010-0158-9; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vandewoestijne S, 1999, MOL ECOL, V8, P1539, DOI 10.1046/j.1365-294x.1999.00725.x; Venables WN., 2002, MODERN APPL STAT S 4; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; Walter ST, 2014, CAN J ZOOL, V92, P885, DOI 10.1139/cjz-2014-0051; Walter ST, 2014, J FIELD ORNITHOL, V85, P421, DOI 10.1111/jofo.12081; Walter ST, 2013, CONDOR, V115, P788, DOI 10.1525/cond.2013.110195; Walter ST, 2013, J COASTAL RES, V29, P187, DOI 10.2112/JCOASTRES-D-13-00018.1; Walter ST, 2013, WATERBIRDS, V36, P53, DOI 10.1675/063.036.0109; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WAPLES RS, 1989, GENETICS, V121, P379; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Welch AJ, 2012, HEREDITY, V109, P19, DOI 10.1038/hdy.2012.7; WILKINSON PM, 1994, WILDLIFE SOC B, V22, P420; Wilson AS, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-8; Wisely SM, 2002, J HERED, V93, P231, DOI 10.1093/jhered/93.4.231; Zengel S, 2016, ENVIRON SCI TECHNOL, V50, P643, DOI 10.1021/acs.est.5b04371	105	1	1	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185309	10.1371/journal.pone.0185309	http://dx.doi.org/10.1371/journal.pone.0185309			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977003	Green Published, gold, Green Submitted			2022-12-26	WOS:000412163100020
J	Caduff, M; Bauer, A; Jagannathan, V; Leeb, T				Caduff, Madleina; Bauer, Anina; Jagannathan, Vidhya; Leeb, Tosso			OCA2 splice site variant in German Spitz dogs with oculocutaneous albinism	PLOS ONE			English	Article							PINK-EYED-DILUTION; COAT-COLOR MUTANTS; GENE; MELANINS; GENOME	We investigated a German Spitz family where the mating of a black male to a white female had yielded three puppies with an unexpected light brown coat color, lightly pigmented lips and noses, and blue eyes. Combined linkage and homozygosity analysis based on a fully penetrant monogenic autosomal recessive mode of inheritance identified a critical interval of 15 Mb on chromosome 3. We obtained whole genome sequence data from one affected dog, three wolves, and 188 control dogs. Filtering for private variants revealed a single variant with predicted high impact in the critical interval in LOC100855460 (XM_005618224.1: c.377+2T>GLT844587.1:c.-45+2T>G). The variant perfectly co-segregated with the phenotype in the family. We genotyped 181 control dogs with normal pigmentation from diverse breeds including 22 unrelated German Spitz dogs, which were all homozygous wildtype. Comparative sequence analyses revealed that LOC100855460 actually represents the 5'-end of the canine OCA2 gene. The CanFam 3.1 reference genome assembly is incorrect and separates the first two exons from the remaining exons of the OCA2 gene. We amplified a canine OCA2 cDNA fragment by RT-PCR and determined the correct full-length mRNA sequence (LT844587.1). Variants in the OCA2 gene cause oculocutaneous albinism type 2 (OCA2) in humans, pink-eyed dilution in mice, and similar phenotypes in corn snakes, medaka and Mexican cave tetra fish. We therefore conclude that the observed oculocutaneous albinism in German Spitz is most likely caused by the identified variant in the 5'-splice site of the first intron of the canine OCA2 gene.	[Caduff, Madleina; Bauer, Anina; Jagannathan, Vidhya; Leeb, Tosso] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Caduff, Madleina; Bauer, Anina; Jagannathan, Vidhya; Leeb, Tosso] Univ Bern, DermFocus, Bern, Switzerland	University of Bern; University of Bern	Leeb, T (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland.; Leeb, T (corresponding author), Univ Bern, DermFocus, Bern, Switzerland.	Tosso.Leeb@vetsuisse.unibe.ch	Leeb, Tosso/G-3187-2014; Jagannathan, Vidhya/P-1055-2019	Leeb, Tosso/0000-0003-0553-4880; Jagannathan, Vidhya/0000-0002-8155-0041; Bauer, Anina/0000-0002-6765-4012	Swiss National Science Foundation [CRSII3_160738]; Albert-Heim Foundation [105]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Albert-Heim Foundation	This study was supported by grants from the Swiss National Science Foundation (CRSII3_160738; http://www.snf.ch) and the Albert-Heim Foundation (no. 105; http://www.albert-heim-stiftung.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Bauer A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006651; Brilliant MH, 2001, PIGM CELL RES, V14, P86, DOI 10.1034/j.1600-0749.2001.140203.x; Burset M, 2001, NUCLEIC ACIDS RES, V29, P255, DOI 10.1093/nar/29.1.255; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Fukamachi S, 2004, GENETICS, V168, P1519, DOI 10.1534/genetics.104.030494; Gronskov K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-43; Hirobe T, 2011, PIGM CELL MELANOMA R, V24, P462, DOI 10.1111/j.1755-148X.2011.00845.x; KING RA, 1980, CLIN GENET, V17, P259; LEE ST, 1994, NEW ENGL J MED, V330, P529, DOI 10.1056/NEJM199402243300803; Manga Prashiela, 1999, Journal of Dermatology (Tokyo), V26, P738; Martinez-Garcia M, 2013, J DERMATOL, V40, P319, DOI 10.1111/1346-8138.12170; Montoliu L, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12167; OZEKI H, 1995, J INVEST DERMATOL, V105, P361, DOI 10.1111/1523-1747.ep12320792; PROTA G, 1995, PIGM CELL RES, V8, P153, DOI 10.1111/j.1600-0749.1995.tb00657.x; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; ROSEMBLAT S, 1994, P NATL ACAD SCI USA, V91, P12071, DOI 10.1073/pnas.91.25.12071; RUSSELL ES, 1949, GENETICS, V34, P146; Saenko SV, 2015, SCI REP-UK, V5, DOI 10.1038/srep17118	21	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185944	10.1371/journal.pone.0185944	http://dx.doi.org/10.1371/journal.pone.0185944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973042	Green Submitted, Green Published, gold			2022-12-26	WOS:000412131900068
J	Jahandideh, F; Chakrabarti, S; Davidge, ST; Wu, JP				Jahandideh, Forough; Chakrabarti, Subhadeep; Davidge, Sandra T.; Wu, Jianping			Egg white hydrolysate shows insulin mimetic and sensitizing effects in 3T3-F442A pre-adipocytes	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITION; RENIN-ANGIOTENSIN SYSTEM; ACTIVATED RECEPTOR PPAR; METABOLIC SYNDROME; ADIPOSE-TISSUE; BLOOD-PRESSURE; COX-2 EXPRESSION; TNF-ALPHA; ARTERIAL-HYPERTENSION; BIOACTIVE PEPTIDES	Insulin resistance and inflammation in adipose tissue is a key mechanism underlying metabolic syndrome, a growing health problem characterized by diabetes, obesity and hypertension. Previous work from our research group has demonstrated the potential of egg white ovotransferrin derived bioactive peptides against hypertension, oxidative stress and inflammation in vitro and in vivo. Egg white hydrolysate (EWH) has also shown anti-hypertensive effects in spontaneously hypertensive rats. Given the interplay among hypertension, inflammation, oxidative stress and metabolic syndrome, the objective of the study was to test the EWH on differentiation, insulin signaling and inflammatory responses in 3T3-F442A pre-adipocytes. Our study suggested that EWH could promote adipocyte differentiation as shown by increased lipid accumulation, increased release of adiponectin and upregulation of peroxisome proliferator associated receptor gamma (PPAR.) and CCAAT/enhancer binding protein alpha (C/EBP-a). In addition to enhanced insulin effects on the upregulation of protein kinase B/Akt phosphorylation, EWH treatment increased extracellular signal regulated kinase 1/2 (ERK1/2) phosphorylation to a level similar to that of insulin, indicating insulin sensitizing and mimetic properties of the EWH. EWH further attenuated cytokine induced inflammatory marker; cyclooxygenase -2 (COX-2) by 48.78%, possibly through the AP-1 pathway by down regulating c-Jun phosphorylation in adipocytes. Given the critical role of adipose in the pathogenesis of insulin resistance and metabolic syndrome, EWH may have potential applications in the prevention and management of metabolic syndrome and its complications.	[Jahandideh, Forough; Chakrabarti, Subhadeep; Wu, Jianping] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Jahandideh, Forough; Chakrabarti, Subhadeep; Davidge, Sandra T.; Wu, Jianping] Univ Alberta, Cardiovasc Res Ctr, Edmonton, AB, Canada; [Davidge, Sandra T.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Davidge, Sandra T.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Davidge, Sandra T.] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Wu, JP (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.; Wu, JP (corresponding author), Univ Alberta, Cardiovasc Res Ctr, Edmonton, AB, Canada.	jwu3@ualberta.ca	Jahandideh, Forough/M-4648-2019; Wu, Jian/AAU-5221-2020; Chakrabarti, Subhadeep/AAD-1078-2022; Wu, Jian/AAU-5221-2020	Jahandideh, Forough/0000-0001-9731-0854; Wu, Jian/0000-0001-9933-7364; Davidge, Sandra/0000-0002-5559-4905; Wu, Jian/0000-0002-3394-1507	Alberta Livestock and Meat Agency (ALMA); Egg Farmers of Canada; Natural Sciences and Engineering Research Council (NSERC)	Alberta Livestock and Meat Agency (ALMA); Egg Farmers of Canada; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from Alberta Livestock and Meat Agency (ALMA), Egg Farmers of Canada, Egg Farmers of Alberta, and the Natural Sciences and Engineering Research Council (NSERC) to JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beh JE, 2013, J ETHNOPHARMACOL, V150, P339, DOI 10.1016/j.jep.2013.09.001; Bell D S, 2000, Endocr Pract, V6, P272; Bou M, 2014, GEN COMP ENDOCR, V205, P218, DOI 10.1016/j.ygcen.2014.05.005; Braga MFB, 2009, AM J CARDIOL, V104, P835, DOI 10.1016/j.amjcard.2009.05.015; Chakrabarti S, 2009, J STEROID BIOCH MOL; Chakrabarti S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117492; Chakrabarti S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/608979; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Christensen KB, 2009, PHYTOTHER RES, V23, P1316, DOI 10.1002/ptr.2782; Coppack S, 2005, CARDIOVASCULAR DISEASE: DIET, NUTRITION AND EMERGING RISK FACTORS, P22; de Kloet AD, 2009, ENDOCRINOLOGY, V150, P4114, DOI 10.1210/en.2009-0065; de Souza CJ, 2001, DIABETES, V50, P1863, DOI 10.2337/diabetes.50.8.1863; Doyen A, 2014, FOOD CHEM, V145, P66, DOI 10.1016/j.foodchem.2013.07.108; Eduardsen K, 2011, CELL PHYSIOL BIOCHEM, V28, P1231, DOI 10.1159/000335855; Erdmann K, 2008, J NUTR BIOCHEM, V19, P643, DOI 10.1016/j.jnutbio.2007.11.010; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Guo W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040958; Hamm JK, 1999, ANN NY ACAD SCI, V892, P134, DOI 10.1111/j.1749-6632.1999.tb07792.x; Harwood HJ, 2012, NEUROPHARMACOLOGY, V63, P57, DOI 10.1016/j.neuropharm.2011.12.010; Havel PJ, 2002, CURR OPIN LIPIDOL, V13, P51, DOI 10.1097/00041433-200202000-00008; Henriksen EJ, 2007, AM J PHYSIOL-REG I, V293, pR974, DOI 10.1152/ajpregu.00147.2007; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hsu CK, 2015, J CELL PHYSIOL, V230, P702, DOI 10.1002/jcp.24795; Huang WY, 2012, FOOD CHEM, V135, P1600, DOI 10.1016/j.foodchem.2012.05.093; Huang WY, 2010, J AGR FOOD CHEM, V58, P10840, DOI 10.1021/jf102120c; Jahandideh F, 2016, J FUNCT FOODS; Jahandideh F, 2016, J FUNCT FOODS, V27, P667, DOI 10.1016/j.jff.2016.10.019; Jahandideh F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115006; Jandeleit-Dahm KAM, 2005, J HYPERTENS, V23, P463, DOI 10.1097/01.hjh.0000160198.05416.72; Kadowaki T, 2003, EXP BIOL MED, V228, P1111, DOI 10.1177/153537020322801003; Kadowaki T, 2002, J DIABETES COMPLICAT, V16, P41, DOI 10.1016/S1056-8727(01)00206-9; Khan HMS, 2012, AFR J PHARM PHARMACO, V6, P1805, DOI 10.5897/AJPP12.684; Kleiman E, 2009, BIOCHEM BIOPH RES CO, V388, P554, DOI 10.1016/j.bbrc.2009.08.063; Laviola Luigi, 2006, Archives of Physiology and Biochemistry, V112, P82, DOI 10.1080/13813450600736174; Lee MH, 2008, KIDNEY INT, V74, P890, DOI 10.1038/ki.2008.313; Lu HL, 2006, WORLD J GASTROENTERO, V12, P1747, DOI 10.3748/wjg.v12.i11.1747; MACDOUGALD OA, 1995, J BIOL CHEM, V270, P647, DOI 10.1074/jbc.270.2.647; Majumder K, 2009, J AGR FOOD CHEM, V57, P471, DOI 10.1021/jf8028557; Majumder K, 2015, J FUNCT FOODS, V13, P50, DOI 10.1016/j.jff.2014.12.028; Majumder K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082829; Majumder K, 2013, J FUNCT FOODS, V5, P187, DOI 10.1016/j.jff.2012.10.004; Mathai ML, 2008, INT J OBESITY, V32, P1576, DOI 10.1038/ijo.2008.126; Medvedev IN, 2007, RUSS J CARDIOL, P97; Moon SH, 2013, POULTRY SCI, V92, P424, DOI 10.3382/ps.2012-02680; Muller-Wieland D, 1998, BASIC RES CARDIOL, V93, P131; Murasaki KM, 2006, CIRCULATION, V114, P71; Park SA, 2007, ANN NY ACAD SCI, V1095, P545, DOI 10.1196/annals.1397.059; Pershadsingh HA, 2004, DIABETES CARE, V27, P1015, DOI 10.2337/diacare.27.4.1015; Potenza MV, 2009, NUTR CLIN PRACT, V24, P560, DOI 10.1177/0884533609342436; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Rekovets O, 2010, J HYPERTENS, V28, pE569, DOI 10.1097/01.hjh.0000379936.92800.4d; Renna NF, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/513251; Rikimaru K, 2012, BIOORGAN MED CHEM, V20, P714, DOI 10.1016/j.bmc.2011.12.008; Rodrigues CEM, 2012, CLIN EXP RHEUMATOL, V30, P871; Roncal CA, 2009, AM J NEPHROL, V30, P399, DOI 10.1159/000235731; Ruan H, 2003, CYTOKINE GROWTH F R, V14, P447, DOI 10.1016/S1359-6101(03)00052-2; Salazar MR, 2013, J INTERN MED, V273, P595, DOI 10.1111/joim.12036; Salazard B, 2004, CELL BIOL TOXICOL, V20, P375, DOI 10.1007/s10565-004-1471-1; Sawada Y, 2015, MOL NUTR FOOD RES, V59, P2502, DOI 10.1002/mnfr.201500324; Shahidi F, 2008, J AOAC INT, V91, P914; Smorlesi A, 2012, OBES REV, V13, P83, DOI 10.1111/j.1467-789X.2012.01039.x; Sonnenberg GE, 2004, OBES RES, V12, P180, DOI 10.1038/oby.2004.24; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Strowski MZ, 2004, ENDOCRINOLOGY, V145, P5259, DOI 10.1210/en.2004-0610; Sumner DA, 2011, POULTRY SCI, V90, P241, DOI 10.3382/ps.2010-00822; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Udenigwe CC, 2012, FOOD CHEM, V132, P468, DOI 10.1016/j.foodchem.2011.11.024; Valverde AM, 1999, DIABETES, V48, P2122, DOI 10.2337/diabetes.48.11.2122; Velloso LA, 1995, FEBS LETT, V377, P353, DOI 10.1016/0014-5793(95)01370-9; Weisinger RS, 2009, PHYSIOL BEHAV, V98, P192, DOI 10.1016/j.physbeh.2009.05.009; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Winkler G, 2003, EUR J ENDOCRINOL, V149, P129, DOI 10.1530/eje.0.1490129; Wong ND, 2007, AM J CARDIOVASC DRUG, V7, P259, DOI 10.2165/00129784-200707040-00004; Yusuf S, 2001, JAMA-J AM MED ASSOC, V286, P1882, DOI 10.1001/jama.286.15.1882; Yvan-Charvet L, 2011, KIDNEY INT, V79, P162, DOI 10.1038/ki.2010.391; Zarich Stuart W, 2005, Rev Cardiovasc Med, V6, P194; Zhang DY, 2008, MOL CANCER RES, V6, P165, DOI 10.1158/1541-7786.MCR-07-0181; Zhang J, 2013, J BIOL CHEM, V288, P20692, DOI 10.1074/jbc.M113.485730; Zolotnik IA, 2012, LIFE SCI, V91, P816, DOI 10.1016/j.lfs.2012.08.038	80	29	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185653	10.1371/journal.pone.0185653	http://dx.doi.org/10.1371/journal.pone.0185653			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972997	Green Submitted, Green Published, gold			2022-12-26	WOS:000412131900035
J	Paskevicius, S; Starkevic, U; Misiunas, A; Vitkauskiene, A; Gleba, Y; Razanskiene, A				Paskevicius, Sarunas; Starkevic, Urte; Misiunas, Audrius; Vitkauskiene, Astra; Gleba, Yuri; Razanskiene, Ausra			Plant-expressed pyocins for control of Pseudomonas aeruginosa	PLOS ONE			English	Article							TRANSPOSON MUTANT LIBRARY; HIGH-YIELD PRODUCTION; COLICIN M; PROTEIN ANTIBIOTICS; VIRAL VECTORS; BACTERIOCINS; EFFICACY; DISEASE	The emergence, persistence and spread of antibiotic-resistant human pathogenic bacteria heralds a growing global health crisis. Drug-resistant strains of gram-negative bacteria, such as Pseudomonas aeruginosa, are especially dangerous and the medical and economic burden they impose underscore the critical need for finding new antimicrobials. Recent studies have demonstrated that plant-expressed bacteriocins of the colicins family can be efficient antibacterials against all major enteropathogenic strains of E. coli. We extended our studies of colicin-like bacteriocins to pyocins, which are produced by strains of P. aeruginosa for ecological advantage against other strains of the same species. Using a plant-based transient expression system, we expressed six different pyocins, namely S5, PaeM, L1, L2, L3 and one new pyocin, PaeM4, and purified them to homogeneity. Among these pyocins, PaeM4 demonstrated the broadest spectrum of activity by controlling 53 of 100 tested clinical isolates of P. aeruginosa. The activity of plant-made pyocins was confirmed in the agar drop, liquid culture susceptibility and biofilm assays, and in the Galleria mellonella animal infection model.	[Paskevicius, Sarunas; Starkevic, Urte; Misiunas, Audrius; Razanskiene, Ausra] Nomads UAB, Gelezinio Vilko 29A, Vilnius, Lithuania; [Paskevicius, Sarunas; Starkevic, Urte] Vilnius Univ, Inst Biotechnol, Sauletekio Al 7, Vilnius, Lithuania; [Vitkauskiene, Astra] Lithuanian Univ Hlth Sci, A Mickeviciaus G 9, Kaunas, Lithuania; [Gleba, Yuri] Nomad Biosci GmbH, Biozentrum Halle, Weinbergweg 22, Halle, Saale, Germany	Vilnius University; Lithuanian University of Health Sciences	Razanskiene, A (corresponding author), Nomads UAB, Gelezinio Vilko 29A, Vilnius, Lithuania.	ausra@nomadsbio.lt	Paškevičius, Šarūnas/GPK-7815-2022	Gleba, Yuri/0000-0003-4675-7474; Paskevicius, Sarunas/0000-0001-6421-5842; Razanskiene, Ausra/0000-0002-0839-1224	LVPA (Lietuvos verslo paramos agentura, a Lithuanian Business Support Agency) [J05-LVPA-K-01-0035]	LVPA (Lietuvos verslo paramos agentura, a Lithuanian Business Support Agency)	LVPA (Lietuvos verslo paramos agentura, a Lithuanian Business Support Agency) provided funding for the study (grant J05-LVPA-K-01-0035, http://lvpa.lt/). Nomads UAB and its parent company Nomad Bioscience GmbH provided support in the form of salaries for authors SP, US, AM, YG, and AR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "Author Contributions" section.	Barreteau H, 2012, J BIOL CHEM, V287, P37395, DOI 10.1074/jbc.M112.406439; Barreteau H, 2010, J BIOL CHEM, V285, P12378, DOI 10.1074/jbc.M109.093583; Barreteau H, 2009, J BACTERIOL, V191, P3657, DOI 10.1128/JB.01824-08; Bassetti M, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-22; Bendandi M, 2010, ANN ONCOL, V21, P2420, DOI 10.1093/annonc/mdq256; Brown CL, 2012, BIOCHEM SOC T, V40, P1549, DOI 10.1042/BST20120241; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; DIAZ E, 1994, MOL MICROBIOL, V13, P855, DOI 10.1111/j.1365-2958.1994.tb00477.x; Elfarash A, 2014, MICROBIOL-SGM, V160, P261, DOI 10.1099/mic.0.070672-0; Ghequire MGK, 2017, MBIO, V8, DOI 10.1128/mBio.01961-16; Ghequire MGK, 2015, SCI REP-UK, V5, DOI 10.1038/srep17368; Ghequire MGK, 2014, FEMS MICROBIOL REV, V38, P523, DOI 10.1111/1574-6976.12079; Gleba Y, 2007, CURR OPIN BIOTECH, V18, P134, DOI 10.1016/j.copbio.2007.03.002; Gleba YY, 2014, CURR TOP MICROBIOL, V375, P155, DOI 10.1007/82_2013_352; Grinter R, 2013, FEMS MICROBIOL LETT, V338, P1, DOI 10.1111/1574-6968.12011; Grinter R, 2012, J BIOL CHEM, V287, P38876, DOI 10.1074/jbc.M112.400150; Hahn S, 2015, PLANT BIOTECHNOL J, V13, P708, DOI 10.1111/pbi.12299; Held K, 2012, J BACTERIOL, V194, P6387, DOI 10.1128/JB.01479-12; Hoiby N, 2011, INT J ORAL SCI, V3, P55, DOI 10.4248/IJOS11026; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Mah TF, 2003, LETT NAT, V426, P1, DOI DOI 10.1038/; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; McCaughey LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30201; Medina C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023055; Michel-Briand Y, 2002, BIOCHIMIE, V84, P499, DOI 10.1016/S0300-9084(02)01422-0; Moskowitz SM, 2004, J CLIN MICROBIOL, V42, P1915, DOI 10.1128/JCM.42.5.1915-1922.2004; Oey M, 2009, P NATL ACAD SCI USA, V106, P6579, DOI 10.1073/pnas.0813146106; Oey M, 2009, PLANT J, V57, P436, DOI 10.1111/j.1365-313X.2008.03702.x; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Scholl D, 2008, ANTIMICROB AGENTS CH, V52, P1647, DOI 10.1128/AAC.01479-07; Schulz S, 2015, P NATL ACAD SCI USA, V112, pE5454, DOI 10.1073/pnas.1513311112; Smith K, 2012, ANTIMICROB AGENTS CH, V56, P1599, DOI 10.1128/AAC.05714-11; Starkevic U, 2015, J BIOTECHNOL, V200, P10, DOI 10.1016/j.jbiotec.2015.02.028; Tommasi R, 2015, NAT REV DRUG DISCOV, V14, P529, DOI 10.1038/nrd4572; Tuse D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/648143; Wiens JR, 2014, MBIO, V5, DOI 10.1128/mBio.01010-13	38	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185782	10.1371/journal.pone.0185782	http://dx.doi.org/10.1371/journal.pone.0185782			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973027	gold, Green Submitted, Green Published			2022-12-26	WOS:000412131900049
J	Ashrafzadeh, S; Leung, DWM				Ashrafzadeh, Seyedardalan; Leung, David W. M.			Novel potato plants with enhanced cadmium resistance and antioxidative defence generated after in vitro cell line selection	PLOS ONE			English	Article							OXIDATIVE STRESS; LIPID-PEROXIDATION; PROLINE CONTENT; CULTIVARS; ACCUMULATION; TOLERANT; RESPONSES; ENZYMES; GROWTH; PB	It is of interest to apply plant tissue culture to generate plants resistant to toxic effects of cadmium (Cd) on plant growth. Callus cultures were initiated from leaf explants of micropropagated potato plantlets (Solanum tuberosum L., cv. Iwa) for in vitro selection comprising 18 different Cd treatments varying in Cd exposure timing and duration. Plantlets regenerated from two different lines of Cd-selected calli, L9 and L11, were found to exhibit enhanced resistance to 218 mu M Cd compared to control (source plantlets for leaf explants used to initiate callus cultures for Cd resistance). In response to 218 mu M Cd, L11 plantlets had lower levels of lipid peroxidation and hydrogen peroxide than control and L9 plantlets. In addition, antioxidative enzyme activities in L11 were generally higher than control. L11 also had a higher level of proline than control.	[Ashrafzadeh, Seyedardalan; Leung, David W. M.] Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch, New Zealand	University of Canterbury	Leung, DWM (corresponding author), Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch, New Zealand.	david.leung@canterbuy.ac.nz		Leung, David/0000-0002-9572-2465				Albiski Fahed, 2012, Physiology and Molecular Biology of Plants, V18, P315, DOI 10.1007/s12298-012-0127-5; Ashrafadeh S, 2015, BIOLOGIA, V70, P581, DOI 10.1515/biolog-2015-0067; Ashrafzadeh S, 2017, J FOOD COMPOS ANAL, V59, P55, DOI 10.1016/j.jfca.2017.02.008; Ashrafzadeh S, 2016, J CROP IMPROV, V30, P107, DOI 10.1080/15427528.2015.1134743; Ashrafzadeh S, 2015, HORTIC ENVIRON BIOTE, V56, P131, DOI 10.1007/s13580-015-0128-8; Atwell BJ, 1999, PLANTS ACTION ADAPTA; Baisakhi B, 2003, ACTA PHYSIOL PLANT, V25, P357, DOI 10.1007/s11738-003-0017-0; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Charfeddine M, 2017, PLANT CELL TISS ORG, V128, P521, DOI 10.1007/s11240-016-1130-2; Clemens S, 2001, PLANTA, V212, P475, DOI 10.1007/s004250000458; Cuypers A, 2010, BIOMETALS, V23, P927, DOI 10.1007/s10534-010-9329-x; Demiral T, 2005, ENVIRON EXP BOT, V53, P247, DOI 10.1016/j.envexpbot.2004.03.017; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Grant CA, 2008, SCI TOTAL ENVIRON, V390, P301, DOI 10.1016/j.scitotenv.2007.10.038; Hayat S, 2012, PLANT SIGNAL BEHAV, V7, P1456, DOI 10.4161/psb.21949; Hell R., 2003, J PLANT PHYSL, V160, P706; Joseph P, 2009, TOXICOL APPL PHARM, V238, P272, DOI 10.1016/j.taap.2009.01.011; Koca H, 2007, ENVIRON EXP BOT, V60, P344, DOI 10.1016/j.envexpbot.2006.12.005; Lachman J, 2009, FOOD CHEM, V114, P836, DOI 10.1016/j.foodchem.2008.10.029; MADAN S, 1995, ANN BOT-LONDON, V76, P51, DOI 10.1006/anbo.1995.1077; Martins LL, 2014, ACTA PHYSIOL PLANT, V36, P755, DOI 10.1007/s11738-013-1453-0; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nadgorska-Socha A, 2013, ECOTOXICOLOGY, V22, P1422, DOI 10.1007/s10646-013-1129-y; Nehnevajova E, 2007, PLANT CELL REP, V26, P429, DOI 10.1007/s00299-006-0264-9; Phang IC, 2011, PLANT GROWTH REGUL, V64, P17, DOI 10.1007/s10725-010-9527-0; Predieri S, 2001, PLANT CELL TISS ORG, V64, P185, DOI 10.1023/A:1010623203554; Rai MK, 2011, ENVIRON EXP BOT, V71, P89, DOI 10.1016/j.envexpbot.2010.10.021; Ranieri A, 1997, ENVIRON EXP BOT, V37, P125, DOI 10.1016/S0098-8472(96)01040-4; Sharma P, 2004, PLANT SCI, V167, P541, DOI 10.1016/j.plantsci.2004.04.028; Singh N, 2006, PLANT SCI, V170, P274, DOI 10.1016/j.plantsci.2005.08.013; Sun JY, 2013, ARCH ENVIRON CON TOX, V64, P243, DOI 10.1007/s00244-012-9824-x; van der Vyver C, 2013, IN VITRO CELL DEV-PL, V49, P198, DOI 10.1007/s11627-013-9493-0; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Wilson CR, 2010, PHYTOPATHOLOGY, V100, P460, DOI 10.1094/PHYTO-100-5-0460; Yoon KS, 2004, ACTA PHYSIOL PLANT, V26, P47, DOI 10.1007/s11738-004-0043-6; Zhang YL, 1997, POTATO RES, V40, P285, DOI 10.1007/BF02358010; Zhu Y, 2007, J AGR FOOD CHEM, V55, P1045, DOI 10.1021/jf062971p	37	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185621	10.1371/journal.pone.0185621	http://dx.doi.org/10.1371/journal.pone.0185621			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968406	Green Published, gold, Green Submitted			2022-12-26	WOS:000412029600030
J	Brazier, L; Elguero, E; Koumavor, CK; Renaud, N; Prugnolle, F; Thomas, F; Ategbo, S; Engoba, M; Obengui; Leroy, EM; Durand, P; Renaud, F; Becquart, P				Brazier, Lionel; Elguero, Eric; Koumavor, Claudine Kombila; Renaud, Nicolas; Prugnolle, Franck; Thomas, Frederic; Ategbo, Simon; Engoba, Moyen; Obengui; Leroy, Eric M.; Durand, Patrick; Renaud, Francois; Becquart, Pierre			Evolution in fecal bacterial/viral composition in infants of two central African countries (Gabon and Republic of the Congo) during their first month of life	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; HUMAN GUT MICROBIOME; 5 YEARS OLD; MOLECULAR EPIDEMIOLOGY; CAUSATIVE AGENTS; ENTERIC VIRUSES; BODY HABITATS; ROTAVIRUS; CHILDREN; ADENOVIRUS	Few studies have analyzed the gut microbiota of child in unindustrialized countries, but none during the first month of life. Stool samples were collected from healthy newborns in hospitals of Gabon (n = 6) and Republic of the Congo (n = 9) at different time points during the first month of life: meconium, day 2 (D02), day 7 (D07) and day 28 (D28). In addition, one fecal sample was collected from each mother after delivery. Metagenomic sequencing was performed to determine the bacterial communities, and multiplex real-time PCR was used to detect the presence of seven enteric viruses (rotavirus a, adenovirus, norovirus I and II, sapovirus, astrovirus, enterovirus) in these samples. Bacterial diversity was high in the first days of life, and was dominated by the genus Prevotella. Then, it rapidly decreased and remained low up to D28 when the gut flora was composed almost exclusively of strictly anaerobic bacteria. Each infant's fecal bacterial microbiota composition was significantly closer to that of their mother than to that of any other woman in the mothers' group, suggesting an intrauterine, placental or amniotic fluid origin of such bacteria. Moreover, bacterial communities differed according to the delivery mode. Overall, the bacterial microbiota communities displayed a similar diversification and expansion in newborns within and between countries during the first four weeks of life. Moreover, six of the fifteen infants of this study harbored enteric viruses (rotavirus, enterovirus and adenovirus) in fecal samples, but never in the meconium. A maternal source for the viruses detected at D02 and D07 can be excluded because none of them was found also in the child's mother. These findings improve our knowledge on the gut bacterial and viral communities of infants from two Sub-Saharan countries during their first month of life.	[Brazier, Lionel; Elguero, Eric; Prugnolle, Franck; Thomas, Frederic; Leroy, Eric M.; Durand, Patrick; Renaud, Francois; Becquart, Pierre] IRD, UMR MIVEGEC 5290, Montpellier, France; [Koumavor, Claudine Kombila; Leroy, Eric M.] Ctr Int Rech Med Franceville, Franceville, Gabon; [Renaud, Nicolas] Labco Midi, Montpellier, France; [Ategbo, Simon] Ctr Hosp Univ Angondje, Libreville, Gabon; [Engoba, Moyen] Ctr Hosp Univ Brazzaville, Brazzaville, Rep Congo	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Brazier, L (corresponding author), IRD, UMR MIVEGEC 5290, Montpellier, France.	lionel.brazier@ird.fr	LEROY, Eric M/I-4347-2016; Becquart, Pierre/GLT-0845-2022	LEROY, Eric M/0000-0003-0022-0890; Prugnolle, Franck/0000-0001-8519-1253; Becquart, Pierre/0000-0002-0980-1678; THOMAS, Frederic/0000-0003-2238-1978	Centre National de la Recherche Scientifique (CNRS); Centre International de Recherche Medicales de Franceville (CIRMF); Institut de Recherche pour le Developpement (IRD); Laboratoire mixte international (LMI) ZOFAC (IRD)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Centre International de Recherche Medicales de Franceville (CIRMF); Institut de Recherche pour le Developpement (IRD); Laboratoire mixte international (LMI) ZOFAC (IRD)	The authors thank Centre National de la Recherche Scientifique (CNRS), Centre International de Recherche Medicales de Franceville (CIRMF) and Institut de Recherche pour le Developpement (IRD) for general support. This work was supported by the Laboratoire mixte international (LMI) ZOFAC (IRD) to Eric Leroy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Allard A, 2001, J CLIN MICROBIOL, V39, P498, DOI 10.1128/JCM.39.2.498-505.2001; Anderson EJ, 2010, EXPERT REV ANTI-INFE, V8, P205, DOI [10.1586/eri.10.1, 10.1586/ERI.10.1]; Ardissone AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090784; Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BETTELHEIM KA, 1974, J HYG-CAMBRIDGE, V72, P67, DOI 10.1017/S0022172400023226; Breitbart M, 2008, RES MICROBIOL, V159, P367, DOI 10.1016/j.resmic.2008.04.006; Collado MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23129; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Chu DKW, 2008, J VIROL, V82, P9107, DOI 10.1128/JVI.00857-08; Chu DM, 2017, NATURE MED; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Coppa GV, 2004, J CLIN GASTROENTEROL, V38, pS80, DOI 10.1097/01.mcg.0000128926.14285.25; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; De Palma G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-63; Dehingia M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18563; Dey RS, 2011, J CLIN MICROBIOL, V49, P500, DOI 10.1128/JCM.01834-10; Dinan TG, 2015, CURR OPIN CLIN NUTR, V18, P552, DOI 10.1097/MCO.0000000000000221; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gomez A, 2016, CELL REP, V14, P2142, DOI 10.1016/j.celrep.2016.02.013; Gosalbes MJ, 2013, CLIN EXP ALLERGY, V43, P198, DOI 10.1111/cea.12063; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Han YPW, 2006, J CLIN MICROBIOL, V44, P1475, DOI 10.1128/JCM.44.4.1475-1483.2006; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Hoehne M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-69; Hu JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078257; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Janda J.M., 2006, THE ENTEROBACTERIA, P115; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Kanungo S, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2016.e00223; Kapusinszky B, 2012, J CLIN MICROBIOL, V50, P3427, DOI 10.1128/JCM.01589-12; Koleva PT, 2015, BIRTH DEFECTS RES C, V105, P265, DOI 10.1002/bdrc.21117; Lekana-Douki SE, 2015, INT J INFECT DIS, V34, P90, DOI 10.1016/j.ijid.2015.03.009; LENNOX-KING S M J, 1976, Infection, V4, P139, DOI 10.1007/BF01638940; Lin AY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063550; Logan C, 2007, J VIROL METHODS, V146, P36, DOI 10.1016/j.jviromet.2007.05.031; Logan C, 2006, J CLIN MICROBIOL, V44, P3189, DOI 10.1128/JCM.00915-06; Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007; Martinez I, 2015, CELL REP, V11, P527, DOI 10.1016/j.celrep.2015.03.049; Mayindou G, 2016, J MED VIROL, V88, P596, DOI 10.1002/jmv.24382; Milani C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068739; Morton ER, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005658; Nagpal R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01997; Nasri D, 2007, J CLIN MICROBIOL, V45, P2370, DOI 10.1128/JCM.00093-07; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Pereira E, 2007, J MED MICROBIOL, V56, P313, DOI 10.1099/jmm.0.46685-0; Perez-Munoz ME, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0268-4; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; Ramani S, 2009, CURR OPIN INFECT DIS, V22, P477, DOI 10.1097/QCO.0b013e328330662f; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Richardson S, 1998, LANCET, V351, P1844, DOI 10.1016/S0140-6736(97)11257-0; Rutayisire E, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0498-0; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schnorr S. L., 2014, NAT COMMUN, V15, P5; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; SHINOZAKI T, 1991, SCAND J INFECT DIS, V23, P543, DOI 10.3109/00365549109105175; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Tissier H., 1900, RECHERCHES FLORE INT; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WILDE J, 1991, LANCET, V337, P323, DOI 10.1016/0140-6736(91)90945-L; Wold WSM, 2007, ADENOVIRUSES; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05001	80	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185569	10.1371/journal.pone.0185569	http://dx.doi.org/10.1371/journal.pone.0185569			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968427	gold, Green Published, Green Submitted			2022-12-26	WOS:000412029600025
J	Giusti, A; Armani, A; Sotelo, CG				Giusti, Alice; Armani, Andrea; Sotelo, Carmen G.			Advances in the analysis of complex food matrices: Species identification in surimi-based products using Next Generation Sequencing technologies	PLOS ONE			English	Article							AQUACULTURE; COD	The Next Generation Sequencing (NGS) technologies represent a turning point in the food inspection field, particularly for species identification in matrices composed of a blend of two or more species. In this study NGS technologies were applied by testing the usefulness of the Ion Torrent Personal Genome Machine (PGM) in seafood traceability. Sixteen commercial surimi samples produced both in EU and non-EU countries were analysed. Libraries were prepared using a universal primer pair able to amplify a short 16SrRNA fragment from a wide range of fish and cephalopod species. The mislabelling rate of the samples was also evaluated. Overall, DNA from 13 families, 19 genera and 16 species of fish, and from 3 families, 3 genera and 3 species of cephalopods was found with the analysis. Samples produced in non-EU countries exhibited a higher variability in their composition. 37.5% of the surimi products were found to be mislabelled. Among them, 25% voluntary declared a species different from those identified and 25% (all produced in non-EU countries) did not report the presence of molluscs on the label, posing a potential health threat for allergic consumers. The use of vulnerable species was also proved. Although the protocol should be further optimized, PGM platform proved to be a useful tool for the analysis of complex, highly processed products.	[Giusti, Alice; Armani, Andrea] Univ Pisa, Dept Vet Sci, FishLab, Pisa, Italy; [Sotelo, Carmen G.] CSIC, IIM, Vigo, Spain	University of Pisa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Armani, A (corresponding author), Univ Pisa, Dept Vet Sci, FishLab, Pisa, Italy.; Sotelo, CG (corresponding author), CSIC, IIM, Vigo, Spain.	andrea.armani@unipi.it; carmen@iim.csic.es	Sotelo, Carmen Gonzalez/L-3696-2014; Giusti, Alice/AAB-9688-2022	Sotelo, Carmen Gonzalez/0000-0002-0726-4370; Armani, Andrea/0000-0002-9614-2032; Palhares, Rafael/0000-0003-2512-8273; Giusti, Alice/0000-0001-9693-5721	Atlantic Area Programme (INTERREG IVB) [2011-1/163 REF 1070134]	Atlantic Area Programme (INTERREG IVB)	LABELFISH. ATLANTIC NETWORK ON GENETIC CONTROL OF FISH AND SEAFOOD LABELLING AND TRACEABILITY, funded by Atlantic Area Programme (INTERREG IVB) 2011-1/163 REF 1070134; URL: http://www.atlanticarea.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3894; Andrea A, 2014, FOOD ANAL METHOD, V7, P946, DOI 10.1007/s12161-014-9792-z; Bertolini F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121701; Brennan MA, 2013, INT J FOOD SCI TECH, V48, P893, DOI 10.1111/ijfs.12055; Carvalho DC, 2017, FOOD CONTROL, V80, P183, DOI 10.1016/j.foodcont.2017.04.049; Chapela MJ, 2002, J FOOD SCI, V67, P1672, DOI 10.1111/j.1365-2621.2002.tb08703.x; D'Amico P, 2016, MAR POLICY, V71, P147, DOI 10.1016/j.marpol.2016.05.026; D'Amico P, 2014, FOOD CONTROL, V35, P7, DOI 10.1016/j.foodcont.2013.06.029; Ehara T, 2004, FISHERIES SCI, V70, P306, DOI 10.1111/j.1444-2906.2003.00805.x; Galal-Khallaf A, 2016, FOOD CONTROL, V61, P62, DOI 10.1016/j.foodcont.2015.09.027; Giusti A, 2017, J AGR FOOD CHEM, V65, P2902, DOI 10.1021/acs.jafc.6b05802; Kappel K, 2017, FOOD CHEM, V234, P212, DOI 10.1016/j.foodchem.2017.04.178; Keskin E, 2012, J APPL ICHTHYOL, V28, P811, DOI 10.1111/j.1439-0426.2012.02031.x; Lopata AL, 2009, CURR OPIN ALLERGY CL, V9, P270, DOI 10.1097/ACI.0b013e32832b3e6f; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Munoz-Colmenero M, 2017, FOOD CHEM, V214, P631, DOI 10.1016/j.foodchem.2016.07.121; Musmand JJ, 1996, J ALLERGY CLIN IMMUN, V98, P697, DOI 10.1016/S0091-6749(96)70104-5; Park JY, 2012, BIOCHIP J, V6, P354, DOI 10.1007/s13206-012-6407-x; Park JW, 2012, J FOOD ENG, V108, P557; Pedrosa M, 2015, CLIN REV ALLERG IMMU, V49, P203, DOI 10.1007/s12016-014-8429-8; Pepe T, 2007, J AGR FOOD CHEM, V55, P3681, DOI 10.1021/jf063321o; Suarez Daniela Mariel, 2014, Braz. J. Food Technol., V17, P8, DOI 10.1590/bjft.2014.003; Swoboda I, 2002, J IMMUNOL, V168, P4576, DOI 10.4049/jimmunol.168.9.4576; Tillmar AO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083761; Vidal-Giraud B., 2007, GLOBEFISH RES PROGRA, V89; Xiong X, 2016, MAR POLICY, V68, P123, DOI 10.1016/j.marpol.2016.02.024; Zaiko A, 2015, MAR ENVIRON RES, V112, P64, DOI 10.1016/j.marenvres.2015.07.002	27	32	33	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185586	10.1371/journal.pone.0185586	http://dx.doi.org/10.1371/journal.pone.0185586			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968423	Green Published, Green Submitted, gold			2022-12-26	WOS:000412029600027
J	De Rechter, S; Kringen, J; Janssens, P; Liebau, MC; Devriendt, K; Levtchenko, E; Bergmann, C; Jouret, F; Bammens, B; Borry, P; Schaefer, F; Mekahli, D				De Rechter, Stephanie; Kringen, Jonathan; Janssens, Peter; Liebau, Max Christoph; Devriendt, Koenraad; Levtchenko, Elena; Bergmann, Carsten; Jouret, Francois; Bammens, Bert; Borry, Pascal; Schaefer, Franz; Mekahli, Djalila			Clinicians' attitude towards family planning and timing of diagnosis in autosomal dominant polycystic kidney disease	PLOS ONE			English	Article							RENAL-DISEASE; CHILDREN; VOLUME; RISK; INDIVIDUALS; MINORS; ADPKD	Several ethical aspects in the management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) are still controversial, including family planning and testing for disease presence in at-risk individuals. We performed an online survey aiming to assess the opinion and current clinical practice of European pediatric and adult nephrologists, as well as geneticists. A total of 410 clinicians (53% male, mean (SD) age of 48 (10) years) responded, including 216 pediatric nephrologists, 151 adult nephrologists, and 43 clinical geneticists. While the 3 groups agreed to encourage clinical testing in asymptomatic ADPKD minors and adults, only geneticists would recommend genetic testing in asymptomatic at-risk adults (P<0.001). Statistically significant disagreement between disciplines was observed regarding the ethical justification of prenatal genetic diagnosis, termination of pregnancy and pre-implantation genetic diagnosis (PGD) for ADPKD. Particularly, PGD is ethically justified according to geneticists (4.48 (1.63)), whereas pediatric (3.08 (1.78); P<0.001) and adult nephrologists (3.66(1.88); P<0.05) appeared to be less convinced. Our survey suggests that most clinicians support clinical testing of at-risk minors and adults in ADPKD families. However, there is no agreement for genetic testing in asymptomatic offspring and for family planning, including PGD. The present data highlight the need for a consensus among clinicians, to avoid that ADPKD families are being given conflicting information.	[De Rechter, Stephanie; Levtchenko, Elena; Mekahli, Djalila] Univ Hosp Leuven, Dept Pediat Nephrol, Leuven, Belgium; [De Rechter, Stephanie; Janssens, Peter; Levtchenko, Elena; Mekahli, Djalila] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Kringen, Jonathan] Univ New Haven, New Haven, CT USA; [Janssens, Peter] Univ Hosp Brussels, Dept Nephrol, Brussels, Belgium; [Liebau, Max Christoph] Univ Hosp Cologne, Dept Pediat, Cologne, Germany; [Liebau, Max Christoph] Univ Hosp Cologne, Ctr Mol Med, Cologne, Germany; [Devriendt, Koenraad] Katholieke Univ Leuven, Dept Genet, Univ Hosp Leuven, Leuven, Belgium; [Bergmann, Carsten] Bioscientia, Ctr Human Genet, Ingelheim, Germany; [Bergmann, Carsten] Univ Hosp Freiburg, Dept Med, Freiburg, Germany; [Jouret, Francois] Univ Liege Hosp ULg CHU, Div Nephrol, Liege, Belgium; [Jouret, Francois] Univ Liege, GIGA, Cardiovasc Sci, Liege, Belgium; [Bammens, Bert] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Bammens, Bert] Univ Hosp Leuven, Dept Nephrol Dialysis & Renal Transplantat, Leuven, Belgium; [Borry, Pascal] Univ Leuven, Dept Publ Hlth & Primary Care, Ctr Biomed Eth & Law, Leuven, Belgium; [Schaefer, Franz] Heidelberg Univ, Div Pediat Nephrol, Ctr Pediat & Adolescent Med, Med Ctr, Heidelberg, Germany	KU Leuven; University Hospital Leuven; KU Leuven; University New Haven; University Hospital Brussels; University of Cologne; University of Cologne; KU Leuven; University Hospital Leuven; University of Freiburg; University of Liege; University of Liege; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; Ruprecht Karls University Heidelberg	De Rechter, S (corresponding author), Univ Hosp Leuven, Dept Pediat Nephrol, Leuven, Belgium.; De Rechter, S (corresponding author), Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium.	stephanie.derechter@uzleuven.be	Levtchenko, Elena/AAO-7125-2020; Janssens, Peter/ABD-3251-2020; Liebau, Max Christoph/K-3470-2019; Bammens, Bert/D-4659-2018; Borry, Pascal/B-5836-2012	Liebau, Max Christoph/0000-0003-0494-9080; Bammens, Bert/0000-0002-2477-2633; Janssens, Peter/0000-0002-0981-8621; Mekahli, Djalila/0000-0003-0954-6088; Borry, Pascal/0000-0002-4931-9560	German Research Fund (DFG Collaborative Research Centre (SFB)) [KIDGEM 1140]; Federal Ministry of Education and Research (BMBF) [01GM1515C]; UZ Leuven; Fund for Scientific Research (FWO) [GOB1313N]; European Society for Pediatric Nephrology; Fund for Scientific Research, Flanders (FWO) [ZKC5782, 11M5214N]; European Commission (EU 7th Framework ProgramFme) [2012-305608]; German Federal Ministry of Education and Research (NEOCYST) [FKZ 01GM1515]	German Research Fund (DFG Collaborative Research Centre (SFB)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); UZ Leuven(KU Leuven); Fund for Scientific Research (FWO)(FWO); European Society for Pediatric Nephrology; Fund for Scientific Research, Flanders (FWO)(FWO); European Commission (EU 7th Framework ProgramFme); German Federal Ministry of Education and Research (NEOCYST)	CB receives support from the German Research Fund (DFG Collaborative Research Centre (SFB) KIDGEM 1140) and the Federal Ministry of Education and Research (BMBF, 01GM1515C). DM is supported by the Clinical Research Fund of UZ Leuven and by the Fund for Scientific Research (FWO) GOB1313N. DM and MCL are supported by a research grant from the European Society for Pediatric Nephrology. EL is supported by the Fund for Scientific Research, Flanders (FWO) ZKC5782. FJ is a Fellow of the Belgian Fonds National de la Recherche Scientifique (FNRS). FS receives support by the European Commission (EU 7th Framework ProgramFme grant no. 2012-305608 (EURenOmics)). MCL, CB and FS receive funding from the German Federal Ministry of Education and Research (NEOCYST consortium FKZ 01GM1515). SDR is supported by the Fund for Scientific Research, Flanders (FWO) 11M5214N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, EUR J HUM GENET, V17, P720; Bellone E, 1991, Boll Soc Ital Biol Sper, V67, P915; Benohr-Laqueur Susanne, 2011, Poiesis Prax, V8, P3; Bergmann C, 2011, J AM SOC NEPHROL, V22, P2047, DOI 10.1681/ASN.2010101080; Borry P, 2008, MT SINAI J MED, V75, P287, DOI 10.1002/msj.20038; Borry P, 2008, AM J MED GENET C, V148C, P78, DOI 10.1002/ajmg.c.30165; Brun M, 2004, ULTRASOUND OBST GYN, V24, P55, DOI 10.1002/uog.1098; Cadnapaphornchai MA, 2014, CLIN J AM SOC NEPHRO, V9, P889, DOI 10.2215/CJN.08350813; Cadnapaphornchai MA, 2011, CLIN J AM SOC NEPHRO, V6, P369, DOI 10.2215/CJN.03780410; Chapman AB, 2015, KIDNEY INT, V88, P17, DOI 10.1038/ki.2015.59; Chapman AB, 2011, SEMIN NEPHROL, V31, P237, DOI 10.1016/j.semnephrol.2011.05.003; Chebib FT, 2016, AM J KIDNEY DIS, V67, P792, DOI 10.1053/j.ajkd.2015.07.037; Cornec- Le Gall E, 2015, J AM SOC NEPHROLOGY; DALGAARD O Z, 1957, Acta Med Scand Suppl, V328, P1; De Rycke M, 2005, MOL HUM REPROD, V11, P65, DOI 10.1093/molehr/gah128; Division UNS, 2016, COMP MACR CONT REG G; Eisenberger T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116680; Fick-Brosnahan G, 1999, AM J KIDNEY DIS, V34, P639, DOI 10.1016/S0272-6386(99)70387-2; Flahault A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153176; Forum EA, 2015, TRANSLATING SCI POLI; Gabow PA, 1997, J AM SOC NEPHROL, V8, P105; GABOW PA, 1992, KIDNEY INT, V41, P1311, DOI 10.1038/ki.1992.195; Gansevoort RT, 2016, NEPHROL DIAL TRANSPL, V31, P337, DOI 10.1093/ndt/gfv456; Gentechnikgesetz GTG, 5101994 GTG BGBI; German Society of Human Genetics, 2013, STAT GEN DIAGN CHILD; Golin CO, 1996, AM J KIDNEY DIS, V27, P220, DOI 10.1016/S0272-6386(96)90544-2; Grantham JJ, 2008, NEW ENGL J MED, V359, P1477, DOI 10.1056/NEJMcp0804458; Grantham JJ, 2015, PEDIATR NEPHROL, V30, P1053, DOI 10.1007/s00467-014-2882-8; Grantham JJ, 2010, CLIN J AM SOC NEPHRO, V5, P889, DOI 10.2215/CJN.00550110; Harper J, 2014, HUM REPROD, V29, P1603, DOI 10.1093/humrep/deu130; Marsick R, 1998, AM J KIDNEY DIS, V32, P934, DOI 10.1016/S0272-6386(98)70087-3; Nys H DI, GENETIC TESTING PATI; Pei Y, 2015, J AM SOC NEPHROL, V26, P746, DOI 10.1681/ASN.2014030297; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Perrone RD, 2005, AM J KIDNEY DIS, V46, P557, DOI 10.1053/j.ajkd.2005.07.016; Reddy BV, 2017, PEDIATR NEPHROL, V32, P31, DOI 10.1007/s00467-016-3364-y; Reed B, 2010, AM J KIDNEY DIS, V56, P50, DOI 10.1053/j.ajkd.2010.02.349; Rule AD, 2006, J AM SOC NEPHROL, V17, P854, DOI 10.1681/ASN.2005070697; Sans L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005595; Seeman T, 2003, BLOOD PRESS MONIT, V8, P107, DOI 10.1097/00126097-200306000-00003; Soini S, 2012, J COMMUN GENET, V3, P143, DOI 10.1007/s12687-012-0078-0; SUJANSKY E, 1990, AM J MED GENET, V35, P510, DOI 10.1002/ajmg.1320350413; Swift O, 2016, GENETIC TESTING MOL; Torres VE, 2017, KIDNEY INT, V91, P493, DOI 10.1016/j.kint.2016.10.018; Tuffs Annette, 2011, BMJ, V343, pd4425, DOI 10.1136/bmj.d4425; TURCO A, 1992, PRENATAL DIAG, V12, P513, DOI 10.1002/pd.1970120606; Turillazzi E, 2015, MED SCI LAW, V55, P194, DOI 10.1177/0025802414532245; Wuthrich RP, 2015, POLYCYSTIC KIDNEY DISEASE, P95; Zidovska J, 1994, Cas Lek Cesk, V133, P184	49	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185779	10.1371/journal.pone.0185779	http://dx.doi.org/10.1371/journal.pone.0185779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961265	Green Published, Green Submitted, gold			2022-12-26	WOS:000412027700038
J	Mani, U; Sankareswaran, SA; Goutham, RNA; Mohan, SS				Mani, Udayakumar; Sankareswaran, Alagu S.; Goutham, Arun R. N.; Mohan, Suma S.			SWI/SNF Infobase-An exclusive information portal for SWI/SNF remodeling complex subunits	PLOS ONE			English	Article							CHROMATIN; YEAST; DATABASE; GENE	Chromatin remodeling complexes facilitate the access of condensed genomic DNA during transcription, replication, and repair, by altering the histone-DNA contacts in the nucleosome structures. SWI/SNF (SWItch/Sucrose Non-Fermentable) family of ATP dependent chromatin remodeling complexes have been documented for their tumour suppressor function. Recent studies have reported the high frequency of cancer causing mutations in this protein family. There exist multiple subunits for this complex and can form context-dependent sub-complexes. The cataloguing of individual subunits of this complex is essential for understanding their specific functions and their mechanism of action during chromatin remodeling. This would also facilitate further studies to characterize cancer causing mutations in SWI/SNF subunits. In the current study, a database containing information on the subunits of SWI/SNF-alpha (BRG1/BRM-Associated Factors (BAF)) and SWI/SNF-beta (Poly-bromo-Associated BAF (PBAF)) sub classes of SWI/SNF family has been curated and catalogued. The database hosts information on 27 distinct SWI/SNF subunits from 20 organisms spanning a wide evolutionary range of eukaryotes. A non-redundant set of 522 genes coding for SWI/SNF subunits have been documented in the database. A detailed annotation on each subunit, including basic protein/gene information, protein sequence, functional domains, homologs and missense mutations of human proteins have been provided with a user-friendly graphical interface. The SWI/SNF Infobase presented here, would be a first of its kind exclusive information portal on SWI/SNF complex subunits and would be a valuable resource for the research community working on chromatin remodeling.	[Mani, Udayakumar; Sankareswaran, Alagu S.; Goutham, Arun R. N.; Mohan, Suma S.] SASTRA Univ, Sch Chem & Biotechnol, Tirumalaisamudram, Thanjavur, India	Shanmugha Arts, Science, Technology & Research Academy (SASTRA)	Mohan, SS (corresponding author), SASTRA Univ, Sch Chem & Biotechnol, Tirumalaisamudram, Thanjavur, India.	sumamohan@scbt.sastra.edu	Mohan S, Suma/GNW-4180-2022; Upper, Outstanding/V-9652-2018	Mohan S, Suma/0000-0001-7692-163X; Upper, Outstanding/0000-0003-3774-2158	Department of Science & Technology, Science Engineering Research Board(DST-SERB), Government of India [YSS/2015/000016]	Department of Science & Technology, Science Engineering Research Board(DST-SERB), Government of India	This work was funded by the grant from Department of Science & Technology, Science Engineering Research Board(DST-SERB), Government of India (YSS/2015/000016). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; Bruno M, 2003, MOL CELL, V12, P1599, DOI 10.1016/S1097-2765(03)00499-4; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Goljanek-Whysall K, 2014, DEVELOPMENT, V141, P3378, DOI 10.1242/dev.108787; HIRSCHHORN JN, 1992, GENE DEV, V6, P2288, DOI 10.1101/gad.6.12a.2288; Hota SK, 2016, DEVELOPMENT, V143, P2882, DOI 10.1242/dev.128892; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lorch Y, 1999, CELL, V96, P389, DOI 10.1016/S0092-8674(00)80551-6; Medvedeva YA, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav067; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Mohrmann L, 2004, MOL CELL BIOL, V24, P3077, DOI 10.1128/MCB.24.8.3077-3088.2004; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Sarnowska E, 2016, TRENDS PLANT SCI, V21, P594, DOI 10.1016/j.tplants.2016.01.017; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Shipra A, 2006, BIOINFORMATICS, V22, P2940, DOI 10.1093/bioinformatics/btl509; Simone C, 2006, J CELL PHYSIOL, V207, P309, DOI 10.1002/jcp.20514; STERN M, 1984, J MOL BIOL, V178, P853, DOI 10.1016/0022-2836(84)90315-2; Tando T, 2010, J BIOL CHEM, V285, P21951, DOI 10.1074/jbc.M109.087783; Wang XF, 2014, CLIN CANCER RES, V20, P21, DOI 10.1158/1078-0432.CCR-13-0280; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; WINSTON F, 1992, TRENDS GENET, V8, P387, DOI 10.1016/0168-9525(92)90167-3; Xue YT, 2000, P NATL ACAD SCI USA, V97, P13015, DOI 10.1073/pnas.240208597; Yan L, 2017, J MOL BIOL, V429, P1650, DOI 10.1016/j.jmb.2017.04.008	28	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0184445	10.1371/journal.pone.0184445	http://dx.doi.org/10.1371/journal.pone.0184445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961249	Green Submitted, Green Published, gold			2022-12-26	WOS:000412027700006
J	Padala, C; Tupurani, MA; Puranam, K; Gantala, S; Shyamala, N; Kondapalli, MS; Gundapaneni, KK; Mudigonda, S; Galimudi, RK; Kupsal, K; Nancharil, SR; Chavan, U; Chinta, SK; Mukta, S; Satti, V; Hanumanth, SR				Padala, Chiranjeevi; Tupurani, Mohini Aiyengar; Puranam, Kaushik; Gantala, Srilatha; Shyamala, Nivas; Kondapalli, Mrudula Spurthi; Gundapaneni, Kishore Kumar; Mudigonda, Saraswati; Galimudi, Rajesh Kumar; Kupsal, Keerthi; Nancharil, Santoshi Rani; Chavan, Uday; Chinta, Sanjeeva Kumari; Mukta, Srinivasulu; Satti, Vishnupriya; Hanumanth, Surekha Rani			Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-1 PROMOTER; SINGLE NUCLEOTIDE POLYMORPHISM; 5A/6A POLYMORPHISM; RISK; LUNG; ASSOCIATION; PROGRESSION; EXPRESSION; REGIONS	Background Extracellular matrix degradation by matrix metalloproteinases (MMPs) is an important mechanism involved in tumor invasion and metastasis. Genetic variations of MMPs have shown association with multiple cancers. The present study is focused to elucidate the association of MMP-1, 3 and 9 genetic variants with respect to epidemiological and clinicopathological variables by haplotype, LD, MDR, survival in silico analyses among South Indian women. Material and methods MMP3-1171 5A/6A and MMP9-1562 C/T SNPs were genotyped by Allele specific polymerase chain reaction and MMP1-1607 1G/2G polymorphism by restriction fragment length polymorphism assays respectively, in 300 BC patients and age-matched 300 healthy controls. Statistical analysis was performed using the SNPStats and SPSS software. Linkage disequilibrium and gene-gene interactions were performed using Haploview and MDR software respectively. Further, transcription factor binding sites in the promoter regions of SNPs under study were carried out using AliBaba2.1 software. Results We have observed an increased frequency of 2G-allele of MMP1, 6A-allele of MMP3 and Tallele of MMP9 (p<0.05) respectively in BC subjects. The 2G-6A haplotype (minor alleles of MMP-1 and MMP-3 respectively) has shown an increased susceptibility to BC. Further, MMP polymorphisms were associated with the clinical characteristics of BC patients such as steroid hormone receptor status, lymph node involvement and metastasis. SNP combinations were in perfect LD in controls. MDR analysis revealed a positive interaction between the SNPs. 5-years survival rate and cox-regression analysis showed a significant association with clinicopathological variables. Conclusion Our results suggest that MMP1-1607 1G/2G, MMP3-1171 5A/6A and MMP9-1562 C/T gene polymorphisms have synergistic effect on breast cancer. The interactions of MMPs clinical risk factors such as lymph node involvement has shown a strong correlation and might influence the 5-years survival rate, suggesting their potential role in the breast carcinogenesis.	[Padala, Chiranjeevi; Tupurani, Mohini Aiyengar; Puranam, Kaushik; Gantala, Srilatha; Shyamala, Nivas; Kondapalli, Mrudula Spurthi; Gundapaneni, Kishore Kumar; Mudigonda, Saraswati; Galimudi, Rajesh Kumar; Kupsal, Keerthi; Nancharil, Santoshi Rani; Satti, Vishnupriya; Hanumanth, Surekha Rani] Osmania Univ, Dept Genet, Hyderabad, Telangana State, India; [Chavan, Uday; Chinta, Sanjeeva Kumari; Mukta, Srinivasulu] MNJ Inst Oncol & Reg Canc Ctr, Red Hills, Hyderabad, Telangana State, India	Osmania University	Hanumanth, SR (corresponding author), Osmania Univ, Dept Genet, Hyderabad, Telangana State, India.	surekharanih@gmail.com	Hanumanth, SUREKHA/Z-5518-2019; G.Kumar, Dr.Rajesh/ABD-1925-2021	G.Kumar, Dr.Rajesh/0000-0003-3042-5141; Padala, Chiranjeevi/0000-0003-0662-7800; Shyamala, Nivas/0000-0003-3586-6050				Back M, 2010, PROG CARDIOVASC DIS, V52, P410, DOI 10.1016/j.pcad.2009.12.002; Bayram S, 2015, FAM CANCER, V14, P561, DOI 10.1007/s10689-015-9813-0; Beeghly-Fadiel A, 2009, CANCER EPIDEM BIOMAR, V18, P1925, DOI 10.1158/1055-9965.EPI-09-0244; Brinckerhoff CE, 2000, CLIN CANCER RES, V6, P4823; Buttici G, 1998, CANCER RES, P5321; Chaudhary AK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-369; Che YL, 2015, CANCER LETT, V359, P241, DOI 10.1016/j.canlet.2015.01.019; Chiranjeevi P, 2014, TUMOR BIOL, V35, P1351, DOI 10.1007/s13277-013-1181-5; Decock J, 2008, CLIN GENET, V73, P197, DOI 10.1111/j.1399-0004.2007.00946.x; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Ding C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11667; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fang SM, 2005, CARCINOGENESIS, V26, P481, DOI 10.1093/carcin/bgh327; Ghilardi G, 2002, CLIN CANCER RES, V8, P3820; Gonzalez-Villasana V, 2015, CLIN CANCER RES, V21, P2127, DOI 10.1158/1078-0432.CCR-14-2279; Hirata H, 2003, INT J CANCER, V106, P372, DOI 10.1002/ijc.11229; Hughes S, 2007, CLIN CANCER RES, V13, P6673, DOI 10.1158/1078-0432.CCR-07-0884; Ishimaru H, 2002, ACTA ONCOL, V41, P289, DOI 10.1080/02841860260088845; Ivkovic I, 2006, J NEUROIMMUNOL, V39, P630; Johansson N, 1997, DEV DYNAM, V208, P387, DOI 10.1002/(SICI)1097-0177(199703)208:3<387::AID-AJA9>3.0.CO;2-E; Key TJ, 2011, BRIT J CANCER, V105, P709, DOI 10.1038/bjc.2011.254; Kishore Kumar G, 2016, POLYMORPHISMS EXTRIN, V21, P558; Krippl P, 2004, CLIN CANCER RES, V10, P3518, DOI 10.1158/1078-0432.CCR-04-0010; Lei HX, 2007, BREAST CANCER RES TR, V103, P61, DOI 10.1007/s10549-006-9345-2; Li HX, 2015, SCI REP-UK, V5, DOI 10.1038/srep10056; Liu L, 2011, CANCER-AM CANCER SOC, V117, P5172, DOI 10.1002/cncr.26154; Maller O, 2010, J MAMMARY GLAND BIOL, V15, P301, DOI 10.1007/s10911-010-9189-6; Morosova EB, 2012, GENET TEST MOL BIOMA, V16, P1032, DOI 10.1089/gtmb.2011.0376; Murray GI, 1996, NAT MED, V2, P461, DOI 10.1038/nm0496461; Nishioka Y, 2003, CANCER LETT, V200, P49, DOI 10.1016/S0304-3835(03)00411-7; Peng B, 2010, MUTAGENESIS, V25, P41, DOI 10.1093/mutage/gep041; Price SJ, 2001, J BIOL CHEM, V276, P7549, DOI 10.1074/jbc.M010242200; Przybylowska K, 2006, BREAST CANCER RES TR, V95, P65, DOI 10.1007/s10549-005-9042-6; Przybylowska K, 2004, J EXP CLIN CANC RES, V23, P121; Roeb E, 2004, INT J COLORECTAL DIS, V19, P518, DOI 10.1007/s00384-004-0592-6; Sinn HP, 2013, BREAST CARE, V8, P149, DOI 10.1159/000350774; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Sparano JA, 2015, NEW ENGL J MED, V373, P2005, DOI 10.1056/NEJMoa1510764; Srivastava P, 2010, DIS MARKERS, V29, P37, DOI [10.3233/DMA-2010-0724, 10.1155/2010/149651]; Wieczorek E, 2013, BJU INT, V112, P1207, DOI 10.1111/bju.12230; Woo M, 2007, J GASTROEN HEPATOL, V22, P1064, DOI 10.1111/j.1440-1746.2006.04424.x; Yang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087562; Ye S, 1996, J BIOL CHEM, V271, P13055, DOI 10.1074/jbc.271.22.13055; Zhu Y, 2001, CANCER RES, V61, P7825	44	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0184448	10.1371/journal.pone.0184448	http://dx.doi.org/10.1371/journal.pone.0184448			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961241	gold, Green Submitted, Green Published			2022-12-26	WOS:000412027700007
J	Kethiri, AR; Basu, S; Shukla, S; Sangwan, VS; Singh, V				Kethiri, Abhinav Reddy; Basu, Sayan; Shukla, Sachin; Sangwan, Virender Singh; Singh, Vivek			Optimizing the role of limbal explant size and source in determining the outcomes of limbal transplantation: An in vitro study	PLOS ONE			English	Article							EPITHELIAL PROGENITOR CELLS; AMNIOTIC MEMBRANE; NICHE; CULTURE	Purpose Simple limbal epithelial transplantation (SLET) and cultivated limbal epithelial transplantation (CLET) are proven clinical techniques for treating limbal stem cell deficiency (LSCD). However, the ideal size and number of the limbal explants required for transplantation has not been clearly elucidated. This in vitro study aimed to determine the optimal limbal explant size required for complete corneal epithelialization by characterizing the cell expansion. Methods Limbal explants obtained from both live and cadaveric biopsies were cultured on the denuded amniotic membrane. Explant size and the explant cell outgrowth (expansion) were measured using ImageJ software with respect to days. Cultures were characterized by assessing the rate of proliferation of cells with 5-bromo-2'-deoxyuridine (BrdU) assay along with the expression of different stem cell markers (ABCG2, p63 alpha), corneal epithelial (CK3+12) and adherens junction molecules (E-Cadherin) by immunofluorescence. Results Explants from live biopsies had 80% growth potential in vitro whereas 40% of the cadaveric tissue failed to grow. Minimum explant sizes of 0.3 mm(2) for live and >= 0.5 mm(2) for cadaveric tissue had a mean expansion areas of 182.39 +/- 17.06 mm(2) and 217.59 +/- 16.91 mm(2) respectively suggesting adequate growth potential of the explants. Mean total percentage of proliferative cells was 31.80 +/- 3.81 in live and 33.49 +/- 4.25 in cadaveric tissue expansion. The expression was noted to be similar in cells cultured from cadaveric compared to cells cultured from live limbal tissue with respect to ABCG2, p63 alpha, CK(3+12) and E-cadherin. Conclusion Our findings show that a minimal amount of 0.3 mm(2) live tissue would be sufficient for ample limbal cell expansion in vitro. Cadaveric explants <0.5 mm(2) had poor growth potential. However, larger explants (>= 0.5 mm(2)) had growth rate and proliferative potential similar to the live tissue. These findings could prove to be critical for clinical success especially while attempting cadaveric limbal transplantation. This study provides a novel clinical strategy for enhancing efficacy of the limbal transplantation surgery and opens the probability of even using the cadaveric tissue by considering the size of explant.	[Kethiri, Abhinav Reddy; Basu, Sayan; Shukla, Sachin; Sangwan, Virender Singh; Singh, Vivek] LV Prasad Eye Inst, SSR Stem Cell Biol Lab, Hyderabad, Telangana, India; [Kethiri, Abhinav Reddy; Basu, Sayan; Shukla, Sachin; Sangwan, Virender Singh; Singh, Vivek] LV Prasad Eye Inst, Ctr Ocular Regenerat, Hyderabad, Telangana, India; [Kethiri, Abhinav Reddy; Basu, Sayan; Shukla, Sachin; Sangwan, Virender Singh; Singh, Vivek] LV Prasad Eye Inst, Tej Kohli Cornea Inst, Hyderabad, Telangana, India; [Kethiri, Abhinav Reddy] Manipal Univ, Manipal, Karnataka, India	L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; Manipal Academy of Higher Education (MAHE)	Singh, V (corresponding author), LV Prasad Eye Inst, SSR Stem Cell Biol Lab, Hyderabad, Telangana, India.; Singh, V (corresponding author), LV Prasad Eye Inst, Ctr Ocular Regenerat, Hyderabad, Telangana, India.; Singh, V (corresponding author), LV Prasad Eye Inst, Tej Kohli Cornea Inst, Hyderabad, Telangana, India.	viveksingh@lvpei.org	Singh, Vivek/C-4574-2013; Sangwan, Virender Singh/AAA-1091-2022; Basu, Sayan/R-9454-2019; SHUKLA, SACHIN/N-1274-2017	Singh, Vivek/0000-0003-3958-5635; Sangwan, Virender Singh/0000-0002-8229-4158; SHUKLA, SACHIN/0000-0003-2113-6073; Basu, Sayan/0000-0001-5030-5003; Kethiri, Abhinav Reddy/0000-0001-9286-4591	Science and Engineering Research Board [SB/YS/LS-263/2013]; Center for Ocular Regeneration, L V Prasad Eye Institute, Hyderabad, Telangana, India	Science and Engineering Research Board; Center for Ocular Regeneration, L V Prasad Eye Institute, Hyderabad, Telangana, India	This work was supported by 1. Science and Engineering Research Board SB/YS/LS-263/2013, Dr. Vivek Singh; 2. Center for Ocular Regeneration, L V Prasad Eye Institute, Hyderabad, Telangana, India.	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Basu S, 2016, OPHTHALMOLOGY, V123, P1000, DOI 10.1016/j.ophtha.2015.12.042; Chen SY, 2015, STEM CELLS, V33, P3341, DOI 10.1002/stem.2091; Choudhary P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130379; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Fatima A, 2006, J POSTGRAD MED, V52, P257; Ghoubay-Benallaoua D, 2011, MOL VIS, V17, P341; Grieve K, 2015, EXP EYE RES, V140, P75, DOI 10.1016/j.exer.2015.08.003; Haagdorens M, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/9798374; Han ES, 2007, GRAEF ARCH CLIN EXP, V245, P745, DOI 10.1007/s00417-006-0453-9; KINOSHITA S, 1982, INVEST OPHTH VIS SCI, V23, P73; Kolli S, 2008, REGEN MED, V3, P329, DOI 10.2217/17460751.3.3.329; KWOK LS, 1984, J THEOR BIOL, V108, P295, DOI 10.1016/S0022-5193(84)80072-7; Lal I, 2013, BMJ CASE REPORTS, V2013; Li De-Quan, 2014, J Stem Cells, V9, P79; Li W, 2007, CELL RES, V17, P26, DOI 10.1038/sj.cr.7310137; Li W, 2007, INVEST OPHTH VIS SCI, V48, P605, DOI 10.1167/iovs.06-0514; Mariappan I, 2014, STEM CELL TRANSL MED, V3, P1331, DOI 10.5966/sctm.2014-0120; Mariappan I, 2010, NAT PROTOC, V5, P1470, DOI 10.1038/nprot.2010.115; Miri A, 2011, OPHTHALMOLOGY, V118, P1265, DOI 10.1016/j.ophtha.2010.11.030; Mittal V, 2015, CORNEA, V34, P1227, DOI 10.1097/ICO.0000000000000573; Notara M, 2010, STEM CELL RES, V5, P188, DOI 10.1016/j.scr.2010.07.002; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Rufer F, 2005, CORNEA, V24, P259; Sangwan Virender S., 2006, Indian Journal of Ophthalmology, V54, P29; Sangwan VS, 2014, INDIAN J OPHTHALMOL, V62, P29, DOI 10.4103/0301-4738.126173; Sangwan VS, 2012, BRIT J OPHTHALMOL, V96, P931, DOI 10.1136/bjophthalmol-2011-301164; Sejpal K, 2013, JAMA OPHTHALMOL, V131, P731, DOI 10.1001/jamaophthalmol.2013.2308; Singh V, 2015, INT REV CEL MOL BIO, V319, P45, DOI 10.1016/bs.ircmb.2015.07.001; Singh V, 2013, EXP EYE RES, V115, P27, DOI 10.1016/j.exer.2013.06.006; Tan EK, 2011, INVEST OPHTH VIS SCI, V52, P4534, DOI 10.1167/iovs.10-6376; THOFT RA, 1983, INVEST OPHTH VIS SCI, V24, P1442; Vazirani J, 2016, BRIT J OPHTHALMOL, V100, P1416, DOI 10.1136/bjophthalmol-2015-307348; Vemuganti Geeta K., 2004, Indian Journal of Ophthalmology, V52, P113	35	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185623	10.1371/journal.pone.0185623	http://dx.doi.org/10.1371/journal.pone.0185623			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957444	gold, Green Published, Green Submitted			2022-12-26	WOS:000411985200095
J	Wang, T; Moon, JY; Wu, YQ; Amos, CI; Hung, RJ; Tardon, A; Andrew, A; Chen, C; Christiani, DC; Albanes, D; van der Heijdendr, EHFM; Duell, E; Rennert, G; Goodman, G; Liu, G; Mckay, JD; Yuan, JM; Field, JK; Manjer, J; Grankvist, K; Kiemeney, LA; Le Marchand, L; Teare, MD; Schabath, MB; Johansson, M; Aldrich, MC; Davies, M; Johansson, M; Tsao, MS; Caporaso, N; Lazarus, P; Lam, S; Bojesen, SE; Arnold, S; Wu, XF; Zong, XC; Hong, YC; Ho, GYF				Wang, Tao; Moon, Jee-Young; Wu, Yiqun; Amos, Christopher I.; Hung, Rayjean J.; Tardon, Adonina; Andrew, Angeline; Chen, Chu; Christiani, David C.; Albanes, Demetrios; van der Heijdendr, Erik H. F. M.; Duell, Eric; Rennert, Gadi; Goodman, Gary; Liu, Geoffrey; Mckay, James D.; Yuan, Jian-Min; Field, John K.; Manjer, Jonas; Grankvist, Kjell; Kiemeney, Lambertus A.; Le Marchand, Loic; Teare, M. Dawn; Schabath, Matthew B.; Johansson, Mattias; Aldrich, Melinda C.; Davies, Michael; Johansson, Mikael; Tsao, Ming-Sound; Caporaso, Neil; Lazarus, Philip; Lam, Stephen; Bojesen, Stig E.; Arnold, Susanne; Wu, Xifeng; Zong, Xuchen; Hong, Yun-Chul; Ho, Gloria Y. F.			Pleiotropy of genetic variants on obesity and smoking phenotypes: Results from the Oncoarray Project of The International Lung Cancer Consortium	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; NEUROTROPHIC FACTOR BDNF; CELL-ADHESION MOLECULES; SYNAPTIC PLASTICITY; CIGARETTE-SMOKING; SEQUENCE VARIANTS; TOBACCO SMOKING; COMMON SNPS; BRAIN	Obesity and cigarette smoking are correlated through complex relationships. Common genetic causes may contribute to these correlations. In this study, we selected 241 loci potentially associated with body mass index (BMI) based on the Genetic Investigation of ANthropometric Traits (GIANT) consortium data and calculated a BMI genetic risk score (BMI-GRS) for 17,037 individuals of European descent from the Oncoarray Project of the International Lung Cancer Consortium (ILCCO). Smokers had a significantly higher BMI-GRS than never-smokers (p = 0.016 and 0.010 before and after adjustment for BMI, respectively). The BMI-GRS was also positively correlated with pack-years of smoking (p<0.001) in smokers. Based on causal network inference analyses, seven and five of 241 SNPs were classified to pleiotropic models for BMI/smoking status and BMI/pack-years, respectively. Among them, three and four SNPs associated with smoking status and pack-years (p<0.05), respectively, were followed up in the ever-smoking data of the Tobacco, Alcohol and Genetics (TAG) consortium. Among these seven candidate SNPs, one SNP (rs11030104, BDNF) achieved statistical significance after Bonferroni correction for multiple testing, and three suggestive SNPs (rs13021737, TMEM18; rs11583200, ELAVL4; and rs6990042, SGCZ) achieved a nominal statistical significance. Our results suggest that there is a common genetic component between BMI and smoking, and pleiotropy analysis can be useful to identify novel genetic loci of complex phenotypes.	[Wang, Tao; Moon, Jee-Young; Wu, Yiqun] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Wu, Yiqun] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China; [Amos, Christopher I.] Dartmouth Coll, Community & Family Med, Geisel Sch Med, Hanover, NH 03755 USA; [Hung, Rayjean J.; Liu, Geoffrey; Zong, Xuchen] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Hung, Rayjean J.; Liu, Geoffrey; Zong, Xuchen] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Tardon, Adonina] Univ Oviedo, IUOPA, Oviedo, Spain; [Tardon, Adonina] CIBERESP, Oviedo, Spain; [Andrew, Angeline] Norris Cotton Canc Ctr, Hanover, NH USA; [Chen, Chu; Goodman, Gary] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Christiani, David C.] Harvard Sch Publ Hlth, Boston, MA USA; [Albanes, Demetrios; Caporaso, Neil] NCI, Bethesda, MD USA; [van der Heijdendr, Erik H. F. M.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands; [Duell, Eric] Catalan Inst Oncol ICO, Barcelona, Spain; [Rennert, Gadi] Carmel Hosp, Haifa, Israel; [Mckay, James D.; Johansson, Mattias] Int Agcy Res Canc, Lyon, France; [Yuan, Jian-Min] Univ Pittsburgh, Canc Inst, Pittsburgh, PA USA; [Field, John K.; Davies, Michael] Univ Liverpool, Dept Mol & Clin Canc Med, Roy Castle Lung Canc Res Programme, Liverpool, Merseyside, England; [Manjer, Jonas] Lund Univ, Unit Breast Surg, Dept Surg, Malmo, Sweden; [Manjer, Jonas] Skane Univ Hosp Malmo, Malmo, Sweden; [Grankvist, Kjell; Johansson, Mikael] Umea Univ, Dept Med Biosci, Umea, Sweden; [Le Marchand, Loic] Univ Hawaii, Canc Ctr, Honolulu, HI USA; [Teare, M. Dawn] Univ Sheffield, Sheffield, S Yorkshire, England; [Schabath, Matthew B.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA; [Aldrich, Melinda C.] Vanderbilt Univ, Med Ctr, Div Epidemiol, Dept Thorac Surg, Nashville, TN USA; [Tsao, Ming-Sound] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Lazarus, Philip] Washington State Univ, Coll Pharm, Washington, DC USA; [Lam, Stephen] British Columbia Canc Agcy, Vancouver, BC, Canada; [Bojesen, Stig E.] Herlev & Gentofte Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark; [Bojesen, Stig E.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Bojesen, Stig E.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Arnold, Susanne] Markey Canc Ctr, Lexington, KY USA; [Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Hong, Yun-Chul] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Ho, Gloria Y. F.] Feinstein Inst Med Res, Merinoff Ctr Patient Oriented Res, New York, NY USA; [Ho, Gloria Y. F.] Northwell Hlth, Epidemiol & Res, New York, NY USA; [Ho, Gloria Y. F.] Hofstra Northwell Sch Med, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Peking University; Dartmouth College; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Oviedo; Instituto Universitario de Oncologia de Asturias; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Norris Cotton Cancer Center; Fred Hutchinson Cancer Center; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Radboud University Nijmegen; Catalan Institute of Oncology; Clalit Health Services; Carmel Medical Center; World Health Organization; International Agency for Research on Cancer (IARC); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Liverpool; Lund University; Lund University; Skane University Hospital; Umea University; Cancer Research Center of Hawaii; University of Hawaii System; University of Sheffield; H Lee Moffitt Cancer Center & Research Institute; Vanderbilt University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Washington State University; British Columbia Cancer Agency; University of Copenhagen; University of Copenhagen; University of Texas System; UTMD Anderson Cancer Center; Seoul National University (SNU); Northwell Health; Northwell Health; Northwell Health	Wang, T (corresponding author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA.; Ho, GYF (corresponding author), Feinstein Inst Med Res, Merinoff Ctr Patient Oriented Res, New York, NY USA.; Ho, GYF (corresponding author), Northwell Hlth, Epidemiol & Res, New York, NY USA.; Ho, GYF (corresponding author), Hofstra Northwell Sch Med, New York, NY USA.	tao.wang@einstein.yu.edu; gho1@northwell.edu	van der Heijden, Erik H.F.M/D-3774-2009; Hong, Yun-Chul/J-5725-2012; Tsao, Ming Sound/AFQ-7332-2022; Johansson, Mikael/AAI-7688-2020; Johansson, Mattias/ABF-3365-2020; Tsao, Ming-Sound/M-3503-2017; Davies, Michael/GWV-2527-2022; Schabath, Matthew B./J-3763-2016; TARDON, ADONINA/B-6563-2014; Kiemeney, Lambertus A./D-3357-2009; Hung, Rayjean J/A-7439-2013; Field, John K./AAD-5674-2020	van der Heijden, Erik H.F.M/0000-0003-3596-518X; Tsao, Ming Sound/0000-0002-9160-5405; Schabath, Matthew B./0000-0003-3241-3216; TARDON, ADONINA/0000-0001-5150-1209; Kiemeney, Lambertus A./0000-0002-2368-1326; Field, John K./0000-0003-3951-6365; Bojesen, Stig/0000-0002-4061-4133; Arnold, Susanne/0000-0001-6542-9551; Liu, Geoffrey/0000-0002-2603-7296; Rennert, Gad/0000-0002-8512-068X; Grankvist, Kjell/0000-0003-4289-2097; Hung, Rayjean/0000-0002-4486-7496; Johansson, Mattias/0000-0002-3116-5081; Davies, Michael Peter Alan/0000-0002-7609-4977; Wu, Yiqun/0000-0002-5554-1678	National Cancer Institution [R21 CA202529]; R21 grant [CA202529]; NATIONAL CANCER INSTITUTE [UM1CA167462, K07CA172294, P30CA023108, R21CA202529, R35CA197449, ZIACP010195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541] Funding Source: NIH RePORTER	National Cancer Institution; R21 grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by National Cancer Institution (https://www.cancer.gov, R21 CA202529, TWG YFH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by an R21 grant (CA202529, Wang/Ho).	Amos CI, 2017, CANCER EPIDEM BIOMAR, V26, P126, DOI 10.1158/1055-9965.EPI-16-0106; Aubin HJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4439; Audrain-McGovern J, 2011, CLIN PHARMACOL THER, V90, P164, DOI 10.1038/clpt.2011.105; Bamia C, 2004, INT J OBESITY, V28, P1091, DOI 10.1038/sj.ijo.0802697; Benson DL, 2000, TRENDS CELL BIOL, V10, P473, DOI 10.1016/S0962-8924(00)01838-9; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Chiolero A, 2007, OBESITY, V15, P1311, DOI 10.1038/oby.2007.153; Conner JM, 1997, J NEUROSCI, V17, P2295; David SP, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.41; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gandini S, 2008, INT J CANCER, V122, P155, DOI 10.1002/ijc.23033; Gearhardt AN, 2011, ADDICTION, V106, P1208, DOI 10.1111/j.1360-0443.2010.03301.x; Gratacos M, 2007, BIOL PSYCHIAT, V61, P911, DOI 10.1016/j.biopsych.2006.08.025; Grimm JW, 2003, J NEUROSCI, V23, P742; Guillin O, 2001, NATURE, V411, P86, DOI 10.1038/35075076; Gunstad J, 2006, NEUROPSYCHOBIOLOGY, V53, P153, DOI 10.1159/000093341; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC MONOGR EVAL CAR, V100, P1; Janhunen S, 2007, NEUROSCI BIOBEHAV R, V31, P287, DOI 10.1016/j.neubiorev.2006.09.008; Justice AE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14977; KatohSemba R, 1997, J NEUROCHEM, V69, P34; Kenny PJ, 2000, J NEUROCHEM, V75, P2409, DOI 10.1046/j.1471-4159.2000.0752409.x; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Liu QR, 2006, AM J MED GENET B, V141B, P918, DOI 10.1002/ajmg.b.30436; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; McKay JD, 2017, NAT GENET, V49, P1126, DOI 10.1038/ng.3892; McMichael AJ, 2008, PUBLIC HEALTH NUTR, V11, P762, DOI 10.1017/S1368980008002358; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; Mossner R, 2000, NEUROCHEM INT, V36, P197, DOI 10.1016/S0197-0186(99)00122-9; Nicklas BJ, 1999, METABOLISM, V48, P804, DOI 10.1016/S0026-0495(99)90183-X; Noureddine MA, 2005, HUM GENET, V117, P27, DOI 10.1007/s00439-005-1259-2; Qiu SF, 2006, NEUROBIOL LEARN MEM, V85, P16, DOI 10.1016/j.nlm.2005.08.009; Renehan AG, 2015, NAT REV CANCER, V15, P484, DOI 10.1038/nrc3967; SAMET JM, 1990, AM REV RESPIR DIS, V142, P993, DOI 10.1164/ajrccm/142.5.993; Seth P, 2002, PHARMACOL BIOCHEM BE, V71, P795, DOI 10.1016/S0091-3057(01)00715-8; Song MY, 2016, J CLIN ONCOL, V34, P3237, DOI 10.1200/JCO.2016.67.6916; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Thorgeirsson TE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.81; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Uhl GR, 2004, NEUROPHARMACOLOGY, V47, P140, DOI 10.1016/j.neuropharm.2004.07.029; Vink JM, 2009, AM J HUM GENET, V84, P367, DOI 10.1016/j.ajhg.2009.02.001; Volkow ND, 2008, PHILOS T R SOC B, V363, P3191, DOI 10.1098/rstb.2008.0107; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Welzl H, 2003, NEWS PHYSIOL SCI, V18, P147, DOI 10.1152/nips.01422.2002; Yang J, 2016, MOL PSYCHIATR, V21, P992, DOI 10.1038/mp.2016.67; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yoon D, 2012, HUM GENET, V131, P1009, DOI 10.1007/s00439-011-1102-x; Zhao W, 2012, OBESITY, V20, P2431, DOI 10.1038/oby.2012.162; Zheng WH, 2002, J NEUROCHEM, V80, P1049, DOI 10.1046/j.0022-3042.2002.00783.x; Zhu WW, 2004, MOL BRAIN RES, V126, P45, DOI 10.1016/j.molbrainres.2004.03.019; Ziauddeen H, 2013, EUR NEUROPSYCHOPHARM, V23, pS156, DOI 10.1016/S0924-977X(13)70233-5	59	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185660	10.1371/journal.pone.0185660	http://dx.doi.org/10.1371/journal.pone.0185660			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957450	Green Published, gold, Green Accepted			2022-12-26	WOS:000411985200101
J	Lee, IW; Jo, YJ; Jung, SM; Wang, HY; Kim, NH; Namgoong, S				Lee, In-Won; Jo, Yu-Jin; Jung, Seung-Min; Wang, Hai-Yang; Kim, Nam-Hyung; Namgoong, Suk			Distinct roles of Cep192 and Cep152 in acentriolar MTOCs and spindle formation during mouse oocyte maturation	FASEB JOURNAL			English	Article						PLK4; PCM; CDK1; meiosis	MICROTUBULE-ORGANIZING CENTERS; CHROMOSOME SEGREGATION; GAMMA-TUBULIN; PERICENTRIOLAR MATERIAL; CENTRIOLE BIOGENESIS; CENTROSOME FUNCTION; MAMMALIAN OOCYTES; PROMOTING FACTOR; MEIOSIS-I; PLK4	Mammalian oocytes lack a centriole that acts as a microtubule organization center (MTOC) in most somatic cells. During oocyte maturation, MTOCs undergo remodeling processes, including decondensation, fragmentation, and self-organization. However, the underlying mechanisms of MTOC remodeling in mouse oocytes are not well understood. We showed that two pericentriolar proteins, Cep192 and Cep152, play crucial roles during MTOC remodeling in mouse oocytes. Cep192 is present in MTOCs at all stages of oocyte maturation, and its depletion induces ablation of MTOCs, delay in spindle formation, and abnormal chromosomal alignment in spindles. In the case of Cep152, its localization on MTOCs is limited at the germinal vesicle stage and then disappears from the MTOCs after the germinal vesicle breakdown stage. Cep152 exclusion from MTOCs is involved in the fragmentation of MTOCs, and it is regulated by cyclin-dependent kinase 1 activity. Our results demonstrate the different roles of Cep192 and Cep152 in MTOC remodeling and a novel regulatory mechanism during meiotic spindle formation in mouse oocytes.	[Lee, In-Won; Jo, Yu-Jin; Jung, Seung-Min; Wang, Hai-Yang; Kim, Nam-Hyung; Namgoong, Suk] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea	Chungbuk National University	Kim, NH; Namgoong, S (corresponding author), Chungbuk Natl Univ, Chungdae Ro 1, Cheongju 28644, Chungbuk, South Korea.	nhkim@chungbuk.ac.kr; suknamgoong@chungbuk.ac.kr		WANG, HAIYANG/0000-0002-6362-6022; Lee, In-won/0000-0003-4336-5897	Next Generation Biogreen 21 Program from South Korean Rural Developmental Administration [PJ011206, PJ011126]	Next Generation Biogreen 21 Program from South Korean Rural Developmental Administration	This study was supported by Next Generation Biogreen 21 Program Grants PJ011206 (to S.M.) and PJ011126 (to N.-H. K.) from South Korean Rural Developmental Administration. The authors declare no conflicts of interest.	Adhikari D, 2014, MOL CELL ENDOCRINOL, V382, P480, DOI 10.1016/j.mce.2013.07.027; Baumann C, 2017, J CELL SCI, V130, P1251, DOI 10.1242/jcs.196188; Bennabi I, 2016, J CELL BIOL, V215, P611, DOI 10.1083/jcb.201607062; CALARCOGILLAM PD, 1983, CELL, V35, P621, DOI 10.1016/0092-8674(83)90094-6; Carabatsos MJ, 2000, MICROSC RES TECHNIQ, V49, P435, DOI 10.1002/(SICI)1097-0029(20000601)49:5<435::AID-JEMT5>3.0.CO;2-H; CHOI T, 1991, DEVELOPMENT, V113, P789; Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107; Clift D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8217; Clift D, 2013, NAT REV MOL CELL BIO, V14, P549, DOI 10.1038/nrm3643; Coelho PA, 2013, DEV CELL, V27, P586, DOI 10.1016/j.devcel.2013.09.029; Conduit PT, 2015, NAT REV MOL CELL BIO, V16, P611, DOI 10.1038/nrm4062; Courtois A, 2012, J CELL BIOL, V198, P357, DOI 10.1083/jcb.201202135; Davydenko O, 2013, J CELL BIOL, V202, P221, DOI 10.1083/jcb.201303019; Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059; Dumont J, 2007, J CELL BIOL, V176, P295, DOI 10.1083/jcb.200605199; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Firat-Karalar EN, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0460; Gomez-Ferreria MA, 2007, CURR BIOL, V17, P1960, DOI 10.1016/j.cub.2007.10.019; GUETHHALLONET C, 1993, J CELL SCI, V105, P157; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Holubcova Z, 2015, SCIENCE, V348, P1143, DOI 10.1126/science.aaa9529; Joukov V, 2014, MOL CELL, V55, P578, DOI 10.1016/j.molcel.2014.06.016; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kim TS, 2013, P NATL ACAD SCI USA, V110, pE4849, DOI 10.1073/pnas.1319656110; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Lee J, 2000, BIOL REPROD, V62, P1184, DOI 10.1095/biolreprod62.5.1184; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Ma W, 2010, DEV BIOL, V339, P439, DOI 10.1016/j.ydbio.2010.01.009; MARO B, 1985, J CELL BIOL, V101, P1665, DOI 10.1083/jcb.101.5.1665; Meng L, 2015, MOL CELL BIOL, V35, P2626, DOI 10.1128/MCB.00068-15; Park SY, 2014, NAT STRUCT MOL BIOL, V21, P696, DOI 10.1038/nsmb.2846; Sanchez-Huertas C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12187; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Sonnen KF, 2013, J CELL SCI, V126, P3223, DOI 10.1242/jcs.129502; SZOLLOSI D, 1972, J CELL SCI, V11, P521; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wong YL, 2015, SCIENCE, V348, P1155, DOI 10.1126/science.aaa5111; Woodruff JB, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0459	42	9	9	5	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					625	638		10.1096/fj.201700559RR	http://dx.doi.org/10.1096/fj.201700559RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28970258				2022-12-26	WOS:000425146900009
J	Wang, LF; Liu, YS; Yang, B; Li, P; Cheng, XS; Xiao, CX; Liu, JJ; Li, S; Ren, JL; Guleng, B				Wang, L-F; Liu, Y-S; Yang, B.; Li, P.; Cheng, X-S; Xiao, C-X; Liu, J-J; Li, S.; Ren, J-L; Guleng, B.			The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation	ONCOGENE			English	Article							PATTERN-RECOGNITION MOLECULE; TRANSCRIPTION FACTOR EGR-1; THYROID-HORMONE; BREAST-CANCER; CELLS; EXPRESSION; GROWTH; SPONDIN-2; INJURY; IDENTIFICATION	Mindin, a secreted, highly conserved extracellular matrix (ECM) protein, exerts a broad spectrum of effects on the innate immune system. However, its function in colorectal cancer (CRC) progression is not well established, and its upstream regulation mechanisms remain unclear. Contrary to previous reports, this study used two different enzyme-linked immunosorbent assay (ELISA) kits to show that the serum level of mindin was significantly decreased in CRC patients and that this decreased level is more significantly associated with the early stages of the disease. To explore the regulation of mindin, we used a bioinformatics approach to predict potential transcription factors and determined that early growth response factor (Egr)-1 directly regulates mindin expression at the transcriptional level using dual luciferase, chromatin immunoprecipitation (ChIP) DNA and electrophoretic mobility shift assay (EMSA) methods. Egr-1 regulates mindin mRNA and protein expression in CRC cells, and the protein expression of both Egr-1 and mindin was significantly decreased in tumor lesions of patients compared with adjacent control tissues. Mindin is essential for Egr-1-mediated inhibition of endothelial cell tube formation, and mindin inhibits endotheliocyte proliferation, migration and angiogenic sprouts in vitro. Overexpression of mindin suppressed xenograft tumor growth by blocking angiogenesis instead of directly suppressing CRC cell proliferation. Mechanically, mindin inhibits the hypoxia-induced HIF-1a and VEGFA protein expression in CRC cells and the phosphorylation of VEGFR-2 in endothelial cells. The results suggest that the serum level of mindin can be used as a novel biomarker for early detection of CRC and that the Egr-1/mindin axis is a potential therapeutic target for the inhibition of angiogenesis in CRC development.	[Wang, L-F; Liu, Y-S; Yang, B.; Li, P.; Cheng, X-S; Xiao, C-X; Liu, J-J; Ren, J-L; Guleng, B.] Xiamen Univ, Dept Gastroenterol, Zhongshan Hosp, 201 Hubin South Rd, Xiamen 361004, Fujian, Peoples R China; [Li, P.] Zhejiang Univ, Childrens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Li, S.] Tsinghua Univ, MOE Key Lab Bioinformat, Beijing, Peoples R China; [Guleng, B.] Xiamen Univ, Fac Clin Med, Med Coll, 168 Univ Rd, Xiamen 361005, Fujian, Peoples R China; [Guleng, B.] Xiamen Univ, State Key Lab Cellular Stress Biol, 168 Univ Rd, Xiamen 361005, Fujian, Peoples R China	Xiamen University; Zhejiang University; Tsinghua University; Xiamen University; Xiamen University	Guleng, B (corresponding author), Xiamen Univ, Dept Gastroenterol, Zhongshan Hosp, 201 Hubin South Rd, Xiamen 361004, Fujian, Peoples R China.; Guleng, B (corresponding author), Xiamen Univ, Fac Clin Med, Med Coll, 168 Univ Rd, Xiamen 361005, Fujian, Peoples R China.; Guleng, B (corresponding author), Xiamen Univ, State Key Lab Cellular Stress Biol, 168 Univ Rd, Xiamen 361005, Fujian, Peoples R China.	bayasi@xmu.edu.cn	Li, Shao/GPX-5473-2022	Guleng, Bayasi/0000-0003-1106-5304; Li, Shao/0000-0002-8709-9167	National Natural Science Foundation of China [81570496, 81370505, 81370591, 91229201]; 973 programs in China [2015CB553800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 programs in China(National Basic Research Program of China)	The National Natural Science Foundation of China (No. 81570496, 81370505, 81370591 and 91229201) and 973 programs (2015CB553800) in China supported this study.	Adams JC, 2000, DEV DYNAM, V218, P280; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Bergers G, 1998, INT J DEV BIOL, V42, P995; Bouck N, 1996, ADV CANCER RES, V69, P135, DOI 10.1016/S0065-230X(08)60862-3; Cai H, 2017, ONCOGENE, V36, P318, DOI 10.1038/onc.2016.212; Chen WQ, 2017, CANCER LETT, V401, P63, DOI 10.1016/j.canlet.2017.04.024; Chen WQ, 2015, CHINESE J CANCER RES, V27, P2, DOI 10.3978/j.issn.1000-9604.2015.01.06; Duclot F, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00035; Feinstein Y, 2004, INT J BIOCHEM CELL B, V36, P975, DOI 10.1016/j.biocel.2004.01.002; Ferraro B, 2005, J CLIN ONCOL, V23, P1921, DOI 10.1200/JCO.2005.08.127; Folkman J, 2000, ACAD RADIOL, V7, P783, DOI 10.1016/S1076-6332(00)80625-X; Folkman J, 1997, NAT BIOTECHNOL, V15, P510, DOI 10.1038/nbt0697-510; Fontao L, 1999, EXP CELL RES, V250, P298, DOI 10.1006/excr.1999.4549; Fournier ML, 2010, MOL CELL PROTEOMICS, V9, P271, DOI 10.1074/mcp.M900415-MCP200; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Guleng B, 2010, WORLD J GASTROENTERO, V16, P1070, DOI 10.3748/wjg.v16.i9.1070; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He YW, 2004, NAT IMMUNOL, V5, P88, DOI 10.1038/ni1021; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jia W, 2005, BLOOD, V106, P3854, DOI 10.1182/blood-2005-04-1658; Jia W, 2008, J IMMUNOL, V180, P6255, DOI 10.4049/jimmunol.180.9.6255; Jing FY, 2014, TUMOR BIOL, V35, P9233, DOI 10.1007/s13277-014-2197-1; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Li DP, 2013, ONCOTARGET, V4, P1373, DOI 10.18632/oncotarget.1165; Liao CH, 2010, ENDOCR-RELAT CANCER, V17, P99, DOI 10.1677/ERC-09-0050; Liu Jingbo, 2007, Cancer Genomics & Proteomics, V4, P377; Liu MJ, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-14; Liu Y, 2007, VISION RES, V47, P2314, DOI 10.1016/j.visres.2007.04.023; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Munkley J, 2016, ONCOTARGET, V7, P35478, DOI 10.18632/oncotarget.8155; Murakoshi M, 2011, NEPHROL DIAL TRANSPL, V26, P2153, DOI 10.1093/ndt/gfq708; MUTHUKKUMAR S, 1995, MOL CELL BIOL, V15, P6262; NGUYEN HQ, 1993, CELL, V72, P197, DOI 10.1016/0092-8674(93)90660-I; Nie L, 2014, SMALL, V10, P1441; Parry R, 2005, CANCER RES, V65, P8397, DOI 10.1158/0008-5472.CAN-05-1203; Pusztai L, 2004, CYTOKINE, V25, P94, DOI 10.1016/j.cyto.2003.10.004; Qian XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037225; Qin M, 2015, INT J COLORECTAL DIS, V30, P353, DOI 10.1007/s00384-014-2090-9; Quante M, 2013, GASTROENTEROLOGY, V145, P63, DOI 10.1053/j.gastro.2013.03.052; Romanuik TL, 2009, AM J PATHOL, V175, P2264, DOI 10.2353/ajpath.2009.080868; Santiago FS, 1999, AM J PATHOL, V155, P897, DOI 10.1016/S0002-9440(10)65189-9; Scharnhorst V, 2000, ONCOGENE, V19, P791, DOI 10.1038/sj.onc.1203390; Schmid F, 2016, ONCOGENE, V35, P5942, DOI 10.1038/onc.2015.451; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; Simon I, 2007, GYNECOL ONCOL, V106, P112, DOI 10.1016/j.ygyno.2007.03.007; Sobolewski C, 2015, BIOMOLECULES, V5, P2035, DOI 10.3390/biom5032035; Tan K, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-22; Villani F, 2008, TUMORI J, V94, P803; Wirth M, 2014, NUCLEIC ACIDS RES, V42, P10433, DOI 10.1093/nar/gku763; Zhang M, 2014, WORLD J GASTROENTERO, V20, P5082, DOI 10.3748/wjg.v20.i17.5082; Zhang Q, 2015, ONCOTARGET, V6, P15095, DOI 10.18632/oncotarget.3822; Zhu LH, 2015, CLIN SCI, V129, P129, DOI 10.1042/CS20140679; Zhu LH, 2014, J HEPATOL, V60, P1046, DOI 10.1016/j.jhep.2014.01.011; Zwang Y, 2012, CANCER RES, V72, P1051, DOI 10.1158/0008-5472.CAN-11-3382	56	34	35	3	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 1	2018	37	5					601	615		10.1038/onc.2017.359	http://dx.doi.org/10.1038/onc.2017.359			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FU4GT	28991232				2022-12-26	WOS:000423812200006
J	Loderer, C; Jonna, VR; Crona, M; Grinberg, IR; Sahlin, M; Hofer, A; Lundin, D; Sjoberg, BM				Loderer, Christoph; Jonna, Venkateswara Rao; Crona, Mikael; Grinberg, Inna Rozman; Sahlin, Margareta; Hofer, Anders; Lundin, Daniel; Sjoeberg, Britt-Marie			A unique cysteine-rich zinc finger domain present in a majority of class II ribonucleotide reductases mediates catalytic turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metal ion-protein interaction; oligomerization; oxidation-reduction (redox); phylogenetics; ribonucleotide reductase; thioredoxin	ESCHERICHIA-COLI; SWISS-MODEL; CRYSTAL-STRUCTURE; REDUCTION; SITE; ENZYME; GLUTAREDOXIN; SPECIFICITY; EXPRESSION; MECHANISM	Ribonucleotide reductases (RNRs) catalyze the reduction of ribonucleotides to the corresponding deoxyribonucleotides, used in DNA synthesis and repair. Two different mechanisms help deliver the required electrons to the RNR active site. Formate can be used as reductant directly in the active site, or glutaredoxins or thioredoxins reduce a C-terminal cysteine pair, which then delivers the electrons to the active site. Here, we characterized a novel cysteine-rich C-terminal domain (CRD), which is present in most class II RNRs found in microbes. The NrdJd-type RNR from the bacterium Stackebrandtia nassauensis was used as a model enzyme. We show that the CRD is involved in both higher oligomeric state formation and electron transfer to the active site. The CRD-dependent formation of high oligomers, such as tetramers and hexamers, was induced by addition of dATP or dGTP, but not of dTTP or dCTP. The electron transfer was mediated by an array of six cysteine residues at the very C-terminal end, which also coordinated a zinc atom. The electron transfer can also occur between subunits, depending on the enzyme's oligomeric state. An investigation of the native reductant of the system revealed no interaction with glutaredoxins or thioredoxins, indicating that this class II RNR uses a different electron source. Our results indicate that the CRD has a crucial role in catalytic turnover and a potentially new terminal reduction mechanism and suggest that the CRD is important for the activities of many class II RNRs.	[Loderer, Christoph; Crona, Mikael; Grinberg, Inna Rozman; Sahlin, Margareta; Lundin, Daniel; Sjoeberg, Britt-Marie] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [Jonna, Venkateswara Rao; Hofer, Anders] Umea Univ, Dept Med Biochem, SE-90187 Umea, Sweden; [Crona, Mikael] Swedish Orphan Biovitrum AB, SE-11276 Solna, Sweden	Stockholm University; Umea University; Swedish Orphan Biovitrum	Lundin, D; Sjoberg, BM (corresponding author), Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	daniel.lundin@dbb.su.se; britt-marie.sjoberg@dbb.su.se		Lundin, Daniel/0000-0002-8779-6464; Hofer, Anders/0000-0003-2890-2957	Swedish Research Council [2016-01920]; Swedish Cancer Society [CAN 2016/670]; Wenner-Gren Foundations; Carl Trygger's Foundation; Kempe Foundations	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Wenner-Gren Foundations; Carl Trygger's Foundation; Kempe Foundations	This work was supported by Swedish Research Council Grant 2016-01920 and Swedish Cancer Society Grant CAN 2016/670 and by the Wenner-Gren Foundations, Carl Trygger's Foundation, and Kempe Foundations. The authors declare that they have no conflicts of interest with the contents of this article.	ABERG A, 1989, J BIOL CHEM, V264, P12249; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; AVERETT DR, 1983, J BIOL CHEM, V258, P9831; Berardi MJ, 1999, J MOL BIOL, V292, P151, DOI 10.1006/jmbi.1999.3067; BERTINI I, 1985, J CHEM EDUC, V62, P924, DOI 10.1021/ed062p924; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BOOKER S, 1994, BIOCHEMISTRY-US, V33, P12676, DOI 10.1021/bi00208a019; Borovok I, 2002, MICROBIOL-SGM, V148, P391, DOI 10.1099/00221287-148-2-391; BRACEY MH, 1994, BIOCHEMISTRY-US, V33, P13126, DOI 10.1021/bi00248a023; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Crona M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134293; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Domkin V, 2014, SCI REP-UK, V4, DOI 10.1038/srep05539; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eliasson R, 1999, J BIOL CHEM, V274, P7182, DOI 10.1074/jbc.274.11.7182; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Larsson KM, 2004, NAT STRUCT MOL BIOL, V11, P1142, DOI 10.1038/nsmb838; Lawrence CC, 1998, CURR OPIN CHEM BIOL, V2, P650, DOI 10.1016/S1367-5931(98)80097-5; Li FH, 2015, ANGEW CHEM INT EDIT, V54, P4597, DOI 10.1002/anie.201410433; Logan DT, 2003, P NATL ACAD SCI USA, V100, P3826, DOI 10.1073/pnas.0736456100; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; Lundin Daniel, 2015, Life-Basel, V5, P604, DOI 10.3390/life5010604; Luttringer F, 2009, J BIOL INORG CHEM, V14, P923, DOI 10.1007/s00775-009-0505-9; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9752, DOI 10.1021/bi00155a031; MULLIEZ E, 1995, P NATL ACAD SCI USA, V92, P8759, DOI 10.1073/pnas.92.19.8759; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Pace NJ, 2014, BIOMOLECULES, V4, P419, DOI 10.3390/biom4020419; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Torrents E, 2005, J BIOL CHEM, V280, P16571, DOI 10.1074/jbc.M501322200; Torrents E, 2000, J BIOL CHEM, V275, P2463, DOI 10.1074/jbc.275.4.2463; VlamisGardikas A, 1997, J BIOL CHEM, V272, P11236; Wei YF, 2015, BIOCHEMISTRY-US, V54, P7019, DOI 10.1021/acs.biochem.5b01092; Wheeler TJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-7; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P2217, DOI 10.1073/pnas.0611095104; Zhou ZHS, 1999, BIOCHEMISTRY-US, V38, P15915, DOI 10.1021/bi992062b	41	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19044	19054		10.1074/jbc.M117.806331	http://dx.doi.org/10.1074/jbc.M117.806331			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972190	Green Published, hybrid			2022-12-26	WOS:000415848000027
J	DaSilva, JK; Husain, E; Lei, YL; Mann, GL; Morrison, AR; Tejani-Butt, S				DaSilva, Jamie K.; Husain, Eram; Lei, Yanlin; Mann, Graziella L.; Morrison, Adrian R.; Tejani-Butt, Shanaz			Social partnering alters sleep in fear-conditioned Wistar rats	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SHORT-TERM HOMEOSTASIS; REM-SLEEP; DEPRIVATION; ENVIRONMENT; SUPPORT; BRAIN; IMMOBILIZATION; DISTURBANCES; ARCHITECTURE	Social support, when provided following a traumatic experience, is associated with a lower incidence of stress-related psychiatric disorders. Our hypothesis was that providing a social interaction period with a naive conspecific would improve sleep architecture in response to cued fear conditioning in Wistar rats. Rats were randomly assigned to either the socially isolated or socially partnered groups. Rats assigned to the socially isolated group were individually housed following electrode implantation and fear conditioning. Rats assigned to the socially partnered group were initially paired-housed, and then one rat from each pair was randomly chosen for sleep electrode implantation and fear conditioning. Rats from both groups were habituated to a recording chamber, and baseline sleep was recorded over 22 hours. One day later (Training Day), they were fear-conditioned to 10 presentations of a tone (800 Hz, 90 dB, 5 sec) co-terminating with a mild electric foot shock (1.0 mA, 0.5 sec), at 30-sec intervals. While rats in the socially isolated group were left undisturbed in their home cage for 30-min, socially partnered rats interacted for 30 minutes with their non-stressed rat partner immediately after fear conditioning and while the auditory tones were presented on Days 1 and 14. The results indicated that social interaction increased sleep efficiency in partnered rats compared to isolated rats following the fear conditioning procedure. This was due to an increase in the amount of rapid eye movement sleep (REMS) during the light phase. Evaluation of REMS microarchitecture revealed that the increase in REMS was due to an increase in the number of single REMS episodes (siREMS), which represented a more consolidated REMS pattern. A surprising finding was that partnered rats had a greater number of sequential REMS episodes (seqREMS) at Baseline, on the Training Day and on Day 1 when compared to isolated rats. The greater number of seqREMS episodes in partnered rats may be due to the partnering procedure and not fear conditioning, as the effect was also seen at Baseline. Thus it appears that while the partnering procedure may have given rise to a fragmented REMS pattern, social partnering promoted a greater consolidation of REMS in response to the fear conditioning procedure.	[DaSilva, Jamie K.; Husain, Eram; Lei, Yanlin; Tejani-Butt, Shanaz] Univ Sci, Dept Pharmaceut Sci, Philadelphia, PA 19104 USA; [Mann, Graziella L.; Morrison, Adrian R.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [DaSilva, Jamie K.] Pfizer Inc, Drug Safety Res & Dev, Groton, CT USA; [Husain, Eram] Univ Tabuk, Fac Appl Med Sci, Dept Med Lab Technol, Tabuk, Saudi Arabia	University of Pennsylvania; Pfizer; University of Tabuk	Tejani-Butt, S (corresponding author), Univ Sci, Dept Pharmaceut Sci, Philadelphia, PA 19104 USA.	s.tejani@usciences.edu		DaSilva, Jamie/0000-0003-2820-5377	United States Public Health Service [MH072897, MH090541]	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was funded by United States Public Health Service grants MH072897 to Adrian R. Morrison and MH090541 to Shanaz Tejani-Butt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1992, PHYSIOL BEHAV, V51, P345, DOI 10.1016/0031-9384(92)90151-Q; Adolphs R, 2002, NAT NEUROSCI, V5, P192, DOI 10.1038/nn0302-192; AMICI R, 1994, J SLEEP RES, V3, P250, DOI 10.1111/j.1365-2869.1994.tb00139.x; ARMARIO A, 1983, BEHAV NEURAL BIOL, V37, P332, DOI 10.1016/S0163-1047(83)91425-5; ARMARIO A, 1983, EXPERIENTIA, V39, P1316, DOI 10.1007/BF01990391; Beattie L, 2015, SLEEP MED REV, V24, P83, DOI 10.1016/j.smrv.2014.12.005; BROWNELL A, 1984, J SOC ISSUES, V40, P1, DOI 10.1111/j.1540-4560.1984.tb01104.x; Cacioppo JT, 2014, SOC PERSONAL PSYCHOL, V8, P58, DOI 10.1111/spc3.12087; Cacioppo JT, 2002, PSYCHOL SCI, V13, P384, DOI 10.1111/j.0956-7976.2002.00469.x; CESPUGLIO R, 1995, ADV NEUROIMMUNOL, V5, P145, DOI 10.1016/0960-5428(95)00005-M; Charuvastra A, 2008, ANNU REV PSYCHOL, V59, P301, DOI 10.1146/annurev.psych.58.110405.085650; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; Dasilva JK, 2011, NEUROSCIENCE, V199, P193, DOI 10.1016/j.neuroscience.2011.09.066; DaSilva JK, 2011, PROG NEURO-PSYCHOPH, V35, P67, DOI 10.1016/j.pnpbp.2010.08.023; Descamps A, 2010, BRAIN RES, V1335, P14, DOI 10.1016/j.brainres.2010.03.087; DeVries AC, 2002, HORM BEHAV, V41, P405, DOI 10.1006/hbeh.2002.1780; Fanselow M.S., 1988, P185; Febinger HY, 2014, J AM ASSOC LAB ANIM, V53, P29; Friedman EM, 2005, P NATL ACAD SCI USA, V102, P18757, DOI 10.1073/pnas.0509281102; HATCH AM, 1965, TOXICOL APPL PHARM, V7, P737, DOI 10.1016/0041-008X(65)90132-8; Iversen AC, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-68; Jha SK, 2005, EUR J NEUROSCI, V21, P1077, DOI 10.1111/j.1460-9568.2005.03920.x; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim-Cohen J, 2004, CHILD DEV, V75, P651, DOI 10.1111/j.1467-8624.2004.00699.x; Kiyokawa Y, 2007, EUR J NEUROSCI, V26, P3606, DOI 10.1111/j.1460-9568.2007.05969.x; Lincoln KD, 2000, SOC SERV REV, V74, P231, DOI 10.1086/514478; Madan V, 2008, SLEEP, V31, P497, DOI 10.1093/sleep/31.4.497; Marinesco S, 1999, NEUROSCIENCE, V92, P921, DOI 10.1016/S0306-4522(99)00045-7; Mellman TA, 2002, AM J PSYCHIAT, V159, P1696, DOI 10.1176/appi.ajp.159.10.1696; Nelson EE, 1998, NEUROSCI BIOBEHAV R, V22, P437, DOI 10.1016/S0149-7634(97)00052-3; Ocampo-Garces A, 2002, J SLEEP RES, V11, P81, DOI 10.1046/j.1365-2869.2002.00281.x; Ozbay Fatih, 2007, Psychiatry (Edgmont), V4, P35; Pawlyk AC, 2008, NEUROSCI BIOBEHAV R, V32, P99, DOI 10.1016/j.neubiorev.2007.06.001; Pawlyk AC, 2005, BIOL PSYCHIAT, V57, P268, DOI 10.1016/j.biopsych.2004.11.008; Philbert J, 2011, BEHAV BRAIN RES, V221, P149, DOI 10.1016/j.bbr.2011.02.039; Pietrzak RH, 2010, J PSYCHOSOM RES, V69, P441, DOI 10.1016/j.jpsychores.2010.07.002; Pietrzak RH, 2010, J AFFECT DISORDERS, V120, P188, DOI 10.1016/j.jad.2009.04.015; Pietrzak RH, 2009, DEPRESS ANXIETY, V26, P745, DOI 10.1002/da.20558; Platt J, 2013, COMP PSYCH, V54, pe33; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; RAMPIN C, 1991, NEUROSCI LETT, V126, P113, DOI 10.1016/0304-3940(91)90532-X; Rosen JB, 2006, BEHAV NEUROSCI, V120, P290, DOI 10.1037/0735-7044.120.2.290; Sanford LD, 2003, BEHAV GENET, V33, P43, DOI 10.1023/A:1021051516829; Seeman TE, 1996, PSYCHOSOM MED, V58, P459, DOI 10.1097/00006842-199609000-00008; Southwick SM, 2005, ANNU REV CLIN PSYCHO, V1, P255, DOI 10.1146/annurev.clinpsy.1.102803.143948; Suchecki D., 2009, SLEEP, V2, P151; VIVALDI EA, 1994, J NEUROPHYSIOL, V72, P1745; Walker MP, 2009, PSYCHOL BULL, V135, P731, DOI 10.1037/a0016570; Wellman LL, 2008, SLEEP, V31, P1035	50	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186017	10.1371/journal.pone.0186017	http://dx.doi.org/10.1371/journal.pone.0186017			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982125	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300109
J	Martins, MT; Sardenberg, F; Bendo, CB; Abreu, MH; Vale, MP; Paiva, SM; Pordeus, IA				Martins, Milene T.; Sardenberg, Fernanda; Bendo, Cristiane B.; Abreu, Mauro Henrique; Vale, Miriam P.; Paiva, Saul M.; Pordeus, Isabela A.			Dental caries remains as the main oral condition with the greatest impact on children's quality of life	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; SOUTHERN BRAZIL; ADOLESCENTS; INEQUALITIES; MALOCCLUSION	Purpose The objective of this study was to assess the negative impact of dental caries on the OHRQoL of 8- to 10-year-old Brazilian children. Methods This population-based case-control study involved 546 children (8-10 years old), 182 cases with a high negative impact on OHRQoL and 364 controls with a low negative impact on OHRQoL. Children's OHRQOL was measured using the Child Perceptions Questionnaire (CPQ8-10). Cases and controls (1x2 ratio) were individually matched by school and gender. Dental caries experience, malocclusion, and traumatic dental injuries were used as independent variables. Dental examinations were carried out at school during daytime hours by two calibrated examiners (Kappa = 0.93-interexaminer and 0.95-intraexaminer). The data were analyzed by descriptive statistics, conditional bivariate and multiple logistic regression, with the significance level set at 5%. Results There was no significant difference in traumatic dental injuries and malocclusion between the case and control groups (p>0.05). Children with DMFT/dmft >= 3 had a 2.06-fold (95% CI = 1.28-3.31, p = 0.003) greater chance of experiencing a high negative impact on OHRQoL than those with DMFT/dmft = 0 Conclusion Children with high dental caries experience are more likely to present a high negative impact on OHRQoL than those with no dental caries experience.	[Martins, Milene T.; Sardenberg, Fernanda; Bendo, Cristiane B.; Vale, Miriam P.; Paiva, Saul M.; Pordeus, Isabela A.] Univ Fed Minas Gerais, Sch Dent, Dept Pediat Dent & Orthodont, Belo Horizonte, MG, Brazil; [Martins, Milene T.] Estadual Univ Montes Claros, Sch Dent, Dept Pediat Dent, Montes Claros, Brazil; [Abreu, Mauro Henrique] Univ Fed Minas Gerais, Fac Dent, Dept Social & Prevent Dent, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Martins, MT (corresponding author), Univ Fed Minas Gerais, Sch Dent, Dept Pediat Dent & Orthodont, Belo Horizonte, MG, Brazil.; Martins, MT (corresponding author), Estadual Univ Montes Claros, Sch Dent, Dept Pediat Dent, Montes Claros, Brazil.	mileneelaura@yahoo.com.br	Paiva, Saul Martins/H-5757-2012; Bendo, Cristiane Baccin/H-5835-2012; Abreu, Mauro Henrique/G-6502-2012; PORDEUS, ISABELA A/B-1570-2013	Paiva, Saul Martins/0000-0002-3968-1638; Bendo, Cristiane Baccin/0000-0003-4849-8779; Abreu, Mauro Henrique/0000-0001-8794-5725; PORDEUS, ISABELA A/0000-0002-5902-7481	National Council for Scientific and Technological Development (CNPq); Ministry of Science and Technology, Brazil [161325/2015-7]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Science and Technology, Brazil	This study was supported by the National Council for Scientific and Technological Development (CNPq), by the Ministry of Science and Technology, Brazil (161325/2015-7). MTM received a scholarship for 17 months. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen JO, 2007, TXB COLOR ATLAS TRAU, V4th; Barbosa TD, 2016, ORAL HLTH PREV DENT, V14, P137, DOI 10.3290/j.ohpd.a35301; Barbosa TD, 2013, ARCH ORAL BIOL, V58, P1070, DOI 10.1016/j.archoralbio.2013.01.012; Barretto EDR, 2004, PEDIATR DENT, V26, P485; Bendo CB, 2014, INT J PAEDIATR DENT, V24, P387, DOI 10.1111/ipd.12083; Bendo CB, 2014, COMMUNITY DENT ORAL, V42, P216, DOI 10.1111/cdoe.12078; Bonanato K, 2010, ORAL HLTH PREV DENT, V8, P125; Cons NC., 1986, DAI THE DENT AESTHET; Costa SD, 2013, CIENC SAUDE COLETIVA, V18, P461, DOI 10.1590/S1413-81232013000200017; Peres SHDS, 2008, CIENC SAUDE COLETIVA, V13, P2155, DOI 10.1590/S1413-81232008000900020; Edelstein BL, 2006, BMC ORAL HLTH, V15; Firmino RT, 2016, INT J PAEDIATR DENT, V26, P242, DOI 10.1111/ipd.12182; Freire-Maia FB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135369; Kassebaum NJ, 2015, J DENT RES, V94, P650, DOI 10.1177/0022034515573272; Kramer PF, 2015, INT J PAEDIATR DENT, V25, P383, DOI 10.1111/ipd.12140; Leal SC, 2012, CARIES RES, V46, P102, DOI 10.1159/000336387; Levin Kate Ann, 2006, Evid Based Dent, V7, P83, DOI 10.1038/sj.ebd.6400436; Marques LS, 2006, AM J ORTHOD DENTOFAC, V129, P424, DOI 10.1016/j.ajodo.2005.11.003; Martins MT, 2009, EUR J PAEDIATR DENT, V10, P135; Martins MT, 2014, COMMUNITY DENT ORAL, V42, P289, DOI 10.1111/cdoe.12087; Martins MT, 2015, BRAZ ORAL RES, V29, DOI 10.1590/1807-3107BOR-2015.vol29.0133; Martins-Junior P A, 2012, Pediatr Dent, V34, P49; Moura-Leite FR, 2011, EUR ARCH PAEDIATR DE, V12, P293, DOI 10.1007/BF03262826; Narvai PC, 2006, REV PANAM SALUD PUBL, V19, P385, DOI 10.1590/S1020-49892006000600004; Norusis MJ, 2008, SPSS STAT 17 0 ADV S; Oliveira DC, 2015, ORAL HLTH PREV DENT, V13, P417, DOI 10.3290/j.ohpd.a33922; Ramos-Jorge ML, 2007, DENT TRAUMATOL, V23, P114, DOI 10.1111/j.1600-9657.2005.00409.x; Roncalli AG, 2015, COMMUNITY DENT ORAL, V43, P317, DOI 10.1111/cdoe.12156; Melo RR, 2013, EUR J PAEDIATR DENT, V14, P8; Sardenberg F, 2013, ANGLE ORTHOD, V83, P83, DOI 10.2319/010912-20.1; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; World Health Organization, 2013, ORAL HLTH SURVEYS BA, V5th edn, p., P19	32	28	28	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185365	10.1371/journal.pone.0185365	http://dx.doi.org/10.1371/journal.pone.0185365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981545	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300036
J	Robles-Fernandez, I; Martinez-Gonzalez, LJ; Pascual-Geler, M; Cozar, JM; Puche-Sanz, I; Serrano, MJ; Lorente, JA; Alvarez-Cubero, MJ				Robles-Fernandez, Inmaculada; Javier Martinez-Gonzalez, Luis; Pascual-Geler, Manrique; Manuel Cozar, Jose; Puche-Sanz, Ignacio; Jose Serrano, Maria; Antonio Lorente, Jose; Jesus Alvarez-Cubero, Maria			Association between polymorphisms in sex hormones synthesis and metabolism and prostate cancer aggressiveness	PLOS ONE			English	Article							BIOCHEMICAL RECURRENCE; GENETIC POLYMORPHISMS; CELL-PROLIFERATION; RISK; CYP17A1; PATHWAY; SINGLE	Novel biomarkers for prostate cancer (PCa) diagnosis and prognosis are necessary to improve the accuracy of current ones employed in clinic. We performed a retrospective study between the association of several polymorphisms in the main genes involved in the synthesis and metabolism of sex hormones and PCa risk and aggressiveness. A total of 311 Caucasian men (155 controls and 156 patients) were genotyped for 9 SNPs in AR, CYP17A1, LHCGR, ESR1 and ESR2 genes. Diagnostic PSA serum levels, Gleason score, tumor stage, D A Amico risk and data of clinical progression were obtained for patients at the moment of the diagnosis and after 54 months of follow-up. Chi-squared test were used for comparisons between clinical variables groups, logistic regression for clinical variables associations between SNPs; and Kaplan-Meier for the association between SNPs and time to biochemical progression. We found 5 variants (CYP17A1) rs743572, rs6162, rs6163; (LHCGR) rs2293275 and (ESR2) rs1256049 that were statistically significant according to clinical variables (PSA, D A Amico risk and T stage) on a case-case analysis. Moreover, the presence of A and G alleles in rs743572 and rs6162 respectively, increase the risk of higher PSA levels (>10 ng/mu l). With respect to D A Amico risk rs743572 (AG-GG), rs6162 (AG-AA) and rs6163 (AC-AA) were associated with an increased risk; and last, AC and AA genotypes for rs6163 were associated with a shorter biochemical recurrence free survival (BRFS) in patients with radical prostatectomy. In multigene analysis, several variants in SNPs rs2293275, rs6152, rs1062577, rs6162, rs6163, rs1256049 and rs1004467 were described to be associated with a more aggressiveness in patients. However, none of the selected SNPs show significant values between patients and controls. In conclusion, this study identified inherited variants in genes CYP17A1, LHCGR and ESR2 related to more aggressiveness and/or a poor progression of the disease. According to this study, new promise PCa biomarkers for clinical management could be included in these previous SNPs.	[Robles-Fernandez, Inmaculada; Javier Martinez-Gonzalez, Luis; Jose Serrano, Maria; Antonio Lorente, Jose; Jesus Alvarez-Cubero, Maria] Univ Granada, Andalusian Reg Govt, Pfizer, GENYO,Ctr Genom & Oncol Res, Granada, Spain; [Javier Martinez-Gonzalez, Luis; Pascual-Geler, Manrique; Manuel Cozar, Jose; Puche-Sanz, Ignacio] Univ Hosp Virgen de las Nieves, Urol Dept, Granada, Spain; [Jose Serrano, Maria] Clin Univ Hospital, Integral Oncol Div, Granada, Spain; [Antonio Lorente, Jose] Univ Granada, Fac Med, Dept Legal Med, Lab Genet Identificat, Granada, Spain; [Jesus Alvarez-Cubero, Maria] Univ Granada, Fac Sci, Cell Biol Dept, Granada, Spain	Pfizer; University of Granada; Hospital Universitario Virgen de las Nieves; University of Granada; University of Granada	Alvarez-Cubero, MJ (corresponding author), Univ Granada, Andalusian Reg Govt, Pfizer, GENYO,Ctr Genom & Oncol Res, Granada, Spain.; Alvarez-Cubero, MJ (corresponding author), Univ Granada, Fac Sci, Cell Biol Dept, Granada, Spain.	mjesusac@ugr.es	Cubero, Maria Jesus Alvarez/M-2892-2015; Robles-Fernandez, Inmaculada/L-3531-2017; Martinez-Gonzalez, Luis Javier/L-6136-2014; LORENTE, JOSE A./B-8372-2008; Puche-Sanz, Ignacio/J-3086-2013	Cubero, Maria Jesus Alvarez/0000-0002-5492-9355; Robles-Fernandez, Inmaculada/0000-0002-3107-9474; Martinez-Gonzalez, Luis Javier/0000-0003-2202-0662; LORENTE, JOSE A./0000-0002-9892-7386; Puche-Sanz, Ignacio/0000-0003-4121-0162				Alukal JP, 2016, UROL CLIN N AM, V43, P203, DOI 10.1016/j.ucl.2016.01.013; [Anonymous], INF NCFB; Audet-Walsh E, 2012, EUR UROL, V62, P88, DOI 10.1016/j.eururo.2011.12.021; Audet-Walsh E, 2011, EUR UROL, V60, P1226, DOI 10.1016/j.eururo.2011.06.020; Barbieri CE, 2013, EUR UROL, V64, P567, DOI 10.1016/j.eururo.2013.05.029; Beuten J, 2009, CANCER EPIDEM BIOMAR, V18, P1869, DOI 10.1158/1055-9965.EPI-09-0076; Brureau L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153609; Colicchia M, 2017, EXPERT REV MOL DIAGN, V17, P367, DOI 10.1080/14737159.2017.1302332; Dai ZJ, 2014, INT J CLIN EXP MED, V7, P5031; Disciglio V, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-016-0115-1; El Ezzi Asmahan A, 2017, Asian Pac J Cancer Prev, V18, P93; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fu CY, 2014, TUMOR BIOL, V35, P8319, DOI 10.1007/s13277-014-2086-7; Fujimoto N, 2017, CLIN GENITOURIN CANC, V15, P337, DOI 10.1016/j.clgc.2017.01.006; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Hart SN, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010332; Hayes VM, 2005, CANCER EPIDEM BIOMAR, V14, P993, DOI 10.1158/1055-9965.EPI-04-0778; Helfand BT, 2015, CURR OPIN UROL, V25, P53, DOI 10.1097/MOU.0000000000000130; Hua X, 2016, AM J CANCER RES, V6, P1650; Ingles SA, 2013, INT J MOL EPIDEMIOL, V4, P228; Irshad S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006408; Alvarez-Cubero MJ, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2016.05.018; Lalonde E, 2014, LANCET ONCOL, V15, P1521, DOI 10.1016/S1470-2045(14)71021-6; Lau KM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091434; Levesque E, 2013, CLIN CANCER RES, V19, P699, DOI 10.1158/1078-0432.CCR-12-2812; Maia S, 2016, FAM CANCER, V15, P111, DOI 10.1007/s10689-015-9832-x; Narita S, 2015, INT J UROL, V22, P1029, DOI 10.1111/iju.12898; Oh JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104146; Poniah P, 2015, INT J CLIN EXP MED, V8, P19232; Ramos-Montoya A, 2014, EMBO MOL MED, V6, P651, DOI 10.1002/emmm.201303581; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Stelloo S, 2015, EMBO MOL MED, V7, P1450, DOI 10.15252/emmm.201505424; Tao S, 2016, AM J TRANSL RES, V8, P1659; Udhane SS, 2016, BIOCHEM BIOPH RES CO, V477, P1005, DOI 10.1016/j.bbrc.2016.07.019; Van den Broeck T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/627510; Wang Y, QUANTITATIVE ASSESSM; Weng H, 2017, SCI REP-UK, V7, DOI 10.1038/srep40554; Wright JL, 2010, PROSTATE, V70, P1094, DOI 10.1002/pros.21143; Xu J, 2017, METHODS COMPOSITIONS; Xu JF, 2010, P NATL ACAD SCI USA, V107, P2136, DOI 10.1073/pnas.0914061107; Yamada T, 2013, INT J CLIN ONCOL, V18, P711, DOI 10.1007/s10147-012-0430-8	42	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185447	10.1371/journal.pone.0185447	http://dx.doi.org/10.1371/journal.pone.0185447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981526	gold, Green Published, Green Submitted			2022-12-26	WOS:000412360300039
J	Simak, M; Yeang, CH; Lu, HHS				Simak, Maria; Yeang, Chen-Hsiang; Lu, Henry Horng-Shing			Exploring candidate biological functions by Boolean Function Networks for Saccharomyces cerevisiae	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; MARKOV BLANKET INDUCTION; TIME-SERIES DATA; EXPRESSION PROGRAMS; FEATURE-SELECTION; CAUSAL DISCOVERY; STEADY-STATE; LOCAL CAUSAL; RECONSTRUCTION; MODEL	The great amount of gene expression data has brought a big challenge for the discovery of Gene Regulatory Network (GRN). For network reconstruction and the investigation of regulatory relations, it is desirable to ensure directness of links between genes on a map, infer their directionality and explore candidate biological functions from high-throughput transcriptomic data. To address these problems, we introduce a Boolean Function Network (BFN) model based on techniques of hidden Markov model (HMM), likelihood ratio test and Boolean logic functions. BFN consists of two consecutive tests to establish links between pairs of genes and check their directness. We evaluate the performance of BFN through the application to S. cerevisiae time course data. BFN produces regulatory relations which show consistency with succession of cell cycle phases. Furthermore, it also improves sensitivity and specificity when compared with alternative methods of genetic network reverse engineering. Moreover, we demonstrate that BFN can provide proper resolution for GO enrichment of gene sets. Finally, the Boolean functions discovered by BFN can provide useful insights for the identification of control mechanisms of regulatory processes, which is the special advantage of the proposed approach. In combination with low computational complexity, BFN can serve as an efficient screening tool to reconstruct genes relations on the whole genome level. In addition, the BFN approach is also feasible to a wide range of time course datasets.	[Simak, Maria] Acad Sinica, Inst Informat Sci, Taiwan Int Grad Program, Bioinformat Program, Taipei, Taiwan; [Simak, Maria; Lu, Henry Horng-Shing] Natl Chiao Tung Univ, Inst Stat, Hsinchu, Taiwan; [Yeang, Chen-Hsiang] Acad Sinica, Inst Stat Sci, Taipei, Taiwan; [Lu, Henry Horng-Shing] Natl Chiao Tung Univ, Big Data Res Ctr, Hsinchu, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University	Lu, HHS (corresponding author), Natl Chiao Tung Univ, Inst Stat, Hsinchu, Taiwan.; Lu, HHS (corresponding author), Natl Chiao Tung Univ, Big Data Res Ctr, Hsinchu, Taiwan.	hslu@stat.nctu.edu.tw	Yeang, Chen-Hsiang/AAP-2962-2021		Ministry of Science and Technology [105-2118-M-009-003-MY2]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study is supported by the research grant from Ministry of Science and Technology, No. 105-2118-M-009-003-MY2 to Henry Horng-Shing Lu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi EM, 2016, MOL BIOL CELL, V27, P1383, DOI 10.1091/mbc.E14-05-1013; Aliferis CF, 2010, J MACH LEARN RES, V11, P171; Aliferis CF, 2010, J MACH LEARN RES, V11, P235; Butte A J, 2000, Pac Symp Biocomput, P418; De Caluwe J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00074; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gene Expression Omnibus [GEO], GENE EXPRESSION OMNI; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kauffman S.A., 1993, ORIGINS ORDER; KEGG, KYOTO ENCY GENES GEN; Lahdesmaki H, 2003, MACH LEARN, V52, P147, DOI 10.1023/A:1023905711304; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lebre S., 2013, G1DBN PACKAGE PERFOR; Liang S, 1998, Pac Symp Biocomput, P18; Ma S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106479; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Meyer PE, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/79879; Mussel C, 2010, BIOINFORMATICS, V26, P1378, DOI 10.1093/bioinformatics/btq124; Narendra V, 2011, GENOMICS, V97, P7, DOI 10.1016/j.ygeno.2010.10.003; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Perrin BE, 2003, BIOINFORMATICS, V19, pII138, DOI 10.1093/bioinformatics/btg1071; RNA, RNA SEQ ATLAS REFERE; Shmulevich I, 2003, COMP FUNCT GENOM, V4, P601, DOI 10.1002/cfg.342; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Sima C, 2009, CURR GENOMICS, V10, P416, DOI 10.2174/138920209789177610; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Vijesh N, 2013, J BIOMED SCI ENG, V6, P223, DOI DOI 10.4236/JBISE.2013.62A027; Villaverde Alejandro F, 2013, Cells, V2, P306, DOI 10.3390/cells2020306; Xiao YF, 2009, CURR GENOMICS, V10, P511, DOI 10.2174/138920209789208237; Yeung KY, 2011, P NATL ACAD SCI USA, V108, P19436, DOI 10.1073/pnas.1116442108	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185475	10.1371/journal.pone.0185475	http://dx.doi.org/10.1371/journal.pone.0185475			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981547	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300041
J	Bhogal, M; Lwin, CN; Seah, XY; Murugan, E; Adnan, K; Lin, SJ; Peh, G; Mehta, JS				Bhogal, Maninder; Lwin, Chan N.; Seah, Xin-Yi; Murugan, Elavazhagan; Adnan, Khadijah; Lin, Shu-Jun; Peh, Gary; Mehta, Jodhbir S.			Real-time assessment of corneal endothelial cell damage following graft preparation and donor insertion for DMEK	PLOS ONE			English	Article							IN-VITRO; KERATOPLASTY; TISSUE; TRANSPLANTATION; LAMELLAR; MODEL; EYE; NEURODEGENERATION; VIABILITY; APOPTOSIS	Purpose To establish a method for assessing graft viability, in-vivo, following corneal transplantation. Methods Optimization of calcein AM fluorescence and toxicity assessment was performed in cultured human corneal endothelial cells and ex-vivo corneal tissue. Descemet membrane endothelial keratoplasty grafts were incubated with calcein AM and imaged pre and post preparation, and in-situ after insertion and unfolding in a pig eye model. Global, macroscopic images of the entire graft and individual cell resolution could be attained by altering the magnification of a clinical confocal scanning laser microscope. Patterns of cell loss observed in situ were compared to those seen using standard ex-vivo techniques. Results Calcein AM showed a positive dose-fluorescence relationship. A dose of 2.67 mu mol was sufficient to allow clear discrimination between viable and non-viable areas (sensitivity of 96.6% with a specificity of 96.1%) and was not toxic to cultured endothelial cells or ex-vivo corneal tissue. Patterns of cell loss seen in-situ closely matched those seen on ex-vivo assessment with fluorescence viability imaging, trypan blue/alizarin red staining or scanning electron microscopy. Iatrogenic graft damage from preparation and insertion varied between 7-35% and incarceration of the graft tissue within surgical wounds was identified as a significant cause of endothelial damage. Conclusions In-situ graft viability assessment using clinical imaging devices provides comparable information to ex-vivo methods. This method shows high sensitivity and specificity, is non-toxic and can be used to evaluate immediate cell viability in new grafting techniques in-vivo.	[Bhogal, Maninder; Lwin, Chan N.; Seah, Xin-Yi; Murugan, Elavazhagan; Adnan, Khadijah; Lin, Shu-Jun; Peh, Gary; Mehta, Jodhbir S.] Singapore Eye Res Inst, Singapore, Singapore; [Bhogal, Maninder; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Bhogal, Maninder] UCL, Inst Ophthalmol, London, England; [Peh, Gary; Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; University of London; University College London; National University of Singapore	Bhogal, M; Mehta, JS (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.; Bhogal, M; Mehta, JS (corresponding author), Singapore Natl Eye Ctr, Singapore, Singapore.; Bhogal, M (corresponding author), UCL, Inst Ophthalmol, London, England.; Mehta, JS (corresponding author), Duke NUS Grad Med Sch, Singapore, Singapore.	manibhogal@aol.com; jodmehta@gmail.com	Peh, Gary/A-8327-2010	Peh, Gary/0000-0002-5387-4209	National Research Foundation Translational and Clinical Research (TCR) Programme [NMRC/TCR/008-SERI/2013]	National Research Foundation Translational and Clinical Research (TCR) Programme	We gratefully acknowledge funding support by a program grant from the National Research Foundation Translational and Clinical Research (TCR) Programme (NMRC/TCR/008-SERI/2013). The funding bodies had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Albon J, 2000, INVEST OPHTH VIS SCI, V41, P2887; Amann J, 2003, AM J OPHTHALMOL, V135, P584, DOI 10.1016/S0002-9394(02)02237-7; [Anonymous], 2015 EYE BANK STAT R; Bhogal M, 2016, BR J OPHTHALMOL, V56; Bhogal M, 2015, J CATARACT REFR SURG, V41, P2022, DOI 10.1016/j.jcrs.2015.08.005; BOURNE WM, 1976, ARCH OPHTHALMOL-CHIC, V94, P1730; Bourne WM, 1997, INVEST OPHTH VIS SCI, V38, P779; Bourne WM, 2001, CORNEA, V20, P560, DOI 10.1097/00003226-200108000-00002; Cordeiro MF, 2004, P NATL ACAD SCI USA, V101, P13352, DOI 10.1073/pnas.0405479101; Coster DJ, 2014, OPHTHALMOLOGY, V121, P979, DOI 10.1016/j.ophtha.2013.12.017; Dapena I, 2011, ARCH OPHTHALMOL-CHIC, V129, P88, DOI 10.1001/archophthalmol.2010.334; Dirisamer M, 2011, ARCH OPHTHALMOL-CHIC, V129, P1435, DOI 10.1001/archophthalmol.2011.195; Doughman D J, 1980, Trans Am Ophthalmol Soc, V78, P567; Droutsas K, 2014, ACTA OPHTHALMOL, V92, pE362, DOI 10.1111/aos.12371; Fuest M, 2016, REGEN MED, V11, P601, DOI 10.2217/rme-2016-0054; Gain P, 2002, BRIT J OPHTHALMOL, V86, P306, DOI 10.1136/bjo.86.3.306; Gauthier AS, 2016, BR J OPHTHALMOL; Genicio N, 2015, INVEST OPHTH VIS SCI, V56, P3051, DOI 10.1167/iovs.14-15973; George AJT, 2004, AM J TRANSPLANT, V4, P678, DOI 10.1111/j.1600-6143.2004.00417.x; Hsiung PL, 2008, NAT MED, V14, P454, DOI 10.1038/nm1692; Ide T, 2008, CORNEA, V27, P754, DOI 10.1097/ICO.0b013e31816a6266; Ide T, 2007, CORNEA, V26, P1079, DOI 10.1097/ICO.0b013e318142bdde; Koizumi N, 2012, EXP EYE RES, V95, P60, DOI 10.1016/j.exer.2011.10.014; Kuo AN, 2008, AM J OPHTHALMOL, V145, P91, DOI 10.1016/j.ajo.2007.08.036; Levis HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050993; MADDEN PW, 1987, CURR EYE RES, V6, P1441, DOI 10.3109/02713688709044508; Meek KM, 2015, PROG RETIN EYE RES, V49, P1, DOI 10.1016/j.preteyeres.2015.07.001; Mehta JS, 2008, ARCH OPHTHALMOL-CHIC, V126, P1383, DOI 10.1001/archopht.126.10.1383; MollerPedersen T, 1997, CORNEA, V16, P333; Normando EM, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0346-z; Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310; Pipparelli A, 2011, INVEST OPHTH VIS SCI, V52, P6018, DOI 10.1167/iovs.10-6641; Price MO, 2008, OPHTHALMOLOGY, V115, P857, DOI 10.1016/j.ophtha.2007.06.033; Rose L, 2008, OPHTHALMOLOGY, V115, P279, DOI 10.1016/j.ophtha.2007.04.020; Saad HA, 2008, CORNEA, V27, P818, DOI 10.1097/ICO.0b013e3181705ca2; SCHIMMELPFENNIG BH, 1984, INVEST OPHTH VIS SCI, V25, P223; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; Terry MA, 2009, CORNEA, V28, P1149, DOI 10.1097/ICO.0b013e3181a87a28; Terry MA, 2009, CORNEA, V28, P24, DOI 10.1097/ICO.0b013e318182a4d3	39	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0184824	10.1371/journal.pone.0184824	http://dx.doi.org/10.1371/journal.pone.0184824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977017	Green Published, gold, Green Submitted			2022-12-26	WOS:000412163100012
J	Howe, GA; Kazda, K; Addison, CL				Howe, Grant A.; Kazda, Kayla; Addison, Christina L.			MicroRNA-30b controls endothelial cell capillary morphogenesis through regulation of transforming growth factor beta 2	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; UP-REGULATION; MESENCHYMAL TRANSITION; TUMOR ANGIOGENESIS; SIGNALING PATHWAY; FACTOR EXPRESSION; TARGETING VEGFA; IN-VITRO; CANCER; ATF-2	The importance of microRNA (miRNA) to vascular biology is becoming increasingly evident; however, the function of a significant number of miRNA remains to be determined. In particular, the effect of growth factor regulation of miRNAs on endothelial cell morphogenesis is incomplete. Thus, we aimed to identify miRNAs regulated by pro-angiogenic vascular endothelial growth factor (VEGF) and determine the effects of VEGF-regulated miRNAs and their targets on processes important for angiogenesis. Human umbilical vein endothelial cells (HUVECs) were thus stimulated with VEGF and miRNA levels assessed using microarrays. We found that VEGF altered expression of many miRNA, and for this study focused on one of the most significantly down-regulated miRNA in HUVECs following VEGF treatment, miR-30b. Using specific miRNA mimics, we found that overexpression of miR-30b inhibited capillary morphogenesis in vitro, while depletion of endogenous miR-30b resulted in increased capillary morphogenesis indicating the potential significance of down-regulation of miR-30b as a pro-angiogenic response to VEGF stimulation. MiR-30b overexpression in HUVEC regulated transforming growth factor beta 2 (TGF beta 2) production, which led to increased phosphorylation of Smad2, indicating activation of an autocrine TGF beta signaling pathway. Up-regulation of TGF beta 2 by miR-30b overexpression was found to be dependent on ATF2 activation, a transcription factor known to regulate TGF beta 2 expression, as miR-30b overexpressing cells exhibited increased levels of phosphorylated ATF2 and depletion of ATF2 inhibited miR-30b-induced TGF beta 2 expression. However, miR-30b effects on ATF2 were indirect and found to be via targeting of the known ATF2 repressor protein JDP2 whose mRNA levels were indirectly correlated with miR-30b levels. Increased secretion of TGF beta 2 from HUVEC was shown to mediate the inhibitory effects of miR-30b on capillary morphogenesis as treatment with a neutralizing antibody to TGF beta 2 restored capillary morphogenesis to normal levels in miR-30b overexpressing cells. These results support that the regulation of miR-30b by VEGF in HUVEC is important for capillary morphogenesis, as increased miR-30b expression inhibits capillary morphogenesis through enhanced expression of TGF beta 2.	[Howe, Grant A.; Kazda, Kayla; Addison, Christina L.] Ottawa Hosp Res Inst, Canc Therapeut Program, Ottawa, ON, Canada; [Howe, Grant A.; Addison, Christina L.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Addison, Christina L.] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Addison, CL (corresponding author), Ottawa Hosp Res Inst, Canc Therapeut Program, Ottawa, ON, Canada.; Addison, CL (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.; Addison, CL (corresponding author), Univ Ottawa, Dept Med, Ottawa, ON, Canada.	caddison@ohri.ca			Canadian Institute of Health Research [MOP83383]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by a grant from the Canadian Institute of Health Research (MOP83383) awarded to CLA.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaiti MA, 2012, J CELL MOL MED, V16, P2413, DOI 10.1111/j.1582-4934.2012.01557.x; Baker AB, 2008, CIRC RES, V103, P289, DOI 10.1161/CIRCRESAHA.108.179465; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bridge G, 2012, BLOOD, V120, P5063, DOI 10.1182/blood-2012-04-423004; Chamorro-Jorganes A, 2011, ARTERIOSCL THROM VAS, V31, P2595, DOI 10.1161/ATVBAHA.111.236521; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; DiMaio TA, 2014, J VIROL, V88, P14301, DOI 10.1128/JVI.01696-14; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Doerr M, 2016, MICROVASC RES, V108, P48, DOI 10.1016/j.mvr.2016.08.001; Eguchi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058796; Fang S, 2016, STEM CELL TRANSL MED, V5, P1425, DOI 10.5966/sctm.2015-0367; Filkova M, 2012, BIODRUGS, V26, P131, DOI 10.2165/11631480-000000000-00000; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Gong M, 2017, ONCOTARGET, V8, P45200, DOI 10.18632/oncotarget.16778; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Guess MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118229; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hassel D, 2012, CIRC RES, V111, P1421, DOI 10.1161/CIRCRESAHA.112.279711; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Honeywell DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070515; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jiang Q, 2013, HYPERTENSION, V62, P592, DOI 10.1161/HYPERTENSIONAHA.113.01767; Jin CY, 2001, FEBS LETT, V489, P34, DOI 10.1016/S0014-5793(00)02387-5; KIM SJ, 1992, NATURE, V358, P331, DOI 10.1038/358331a0; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Lau E, 2012, J CELL SCI, V125, P2815, DOI 10.1242/jcs.095000; Leng RB, 2014, FEBS LETT, V588, P2078, DOI 10.1016/j.febslet.2014.04.040; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu B, 2009, LUNG CANCER, V66, P169, DOI 10.1016/j.lungcan.2009.01.010; Liu F, 2012, KIDNEY BLOOD PRESS R, V35, P182, DOI 10.1159/000331054; Liu LX, 2000, BLOOD, V96, P1772, DOI 10.1182/blood.V96.5.1772.h8001772_1772_1781; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Maroni D, 2011, J CELL SCI, V124, P2501, DOI 10.1242/jcs.084558; McCall MN, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-78; Mechtcheriakova D, 1999, BLOOD, V93, P3811, DOI 10.1182/blood.V93.11.3811.411k40_3811_3823; Mechtcheriakova D, 2001, FASEB J, V15, P230, DOI 10.1096/fj.00-0247com; Medici D, 2011, BIOCHEM J, V437, P515, DOI 10.1042/BJ20101500; Nicoli S, 2012, DEV CELL, V22, P418, DOI 10.1016/j.devcel.2012.01.008; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Nikitina E. G., 2012, Experimental Oncology, V34, P2; Ocak S, 2012, CANCER-AM CANCER SOC, V118, P1293, DOI 10.1002/cncr.26382; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Papageorgiou N, 2012, CURR MED CHEM, V19, P2605, DOI 10.2174/092986712800493048; PEPPER MS, 1991, J CELL PHYSIOL, V146, P170, DOI 10.1002/jcp.1041460122; Pereira DM, 2013, DRUG DISCOV TODAY, V18, P282, DOI 10.1016/j.drudis.2012.10.002; Pin AL, 2012, ANGIOGENESIS, V15, P593, DOI 10.1007/s10456-012-9283-z; Plummer PN, 2013, CANCER RES, V73, P341, DOI 10.1158/0008-5472.CAN-12-0271; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Roitbak T, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-25; Sabatel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016979; Shen XK, 2011, J BIOL CHEM, V286, P26616, DOI 10.1074/jbc.M111.224212; Smits M, 2012, FASEB J, V26, P2639, DOI 10.1096/fj.11-202820; Sodhi A, 2000, CANCER RES, V60, P4873; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Urbich C, 2012, BLOOD, V119, P1607, DOI 10.1182/blood-2011-08-373886; Wang R, 2014, FEBS LETT, V588, P4438, DOI 10.1016/j.febslet.2014.09.045; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; Wu TT, 2012, J BIOL CHEM, V287, P7503, DOI 10.1074/jbc.M111.292722; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Zhou BS, 2013, CANCER LETT, V333, P159, DOI 10.1016/j.canlet.2013.01.028; Zhu T, 2000, J BIOL CHEM, V275, P2103, DOI 10.1074/jbc.275.3.2103; Zhu XY, 2013, CELL PHYSIOL BIOCHEM, V32, P64, DOI 10.1159/000350125	66	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185619	10.1371/journal.pone.0185619	http://dx.doi.org/10.1371/journal.pone.0185619			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977001	Green Published, Green Submitted, gold			2022-12-26	WOS:000412163100033
J	Liu, DY; Hu, Y; Guo, Y; Zhu, Z; Lu, BZ; Wang, XL; Huang, YJ				Liu, Danyang; Hu, Yang; Guo, Ying; Zhu, Zhu; Lu, Bingzheng; Wang, Xuelan; Huang, Yijun			Mycoplasma-associated multidrug resistance of hepatocarcinoma cells requires the interaction of P37 and Annexin A2	PLOS ONE			English	Article							GASTRIC-CANCER; MEMBRANE GLYCOPROTEIN; HYORHINIS INFECTION; LIPOPROTEIN P37; GUT MICROBIOTA; INVASIVENESS; TRANSPORT; TUMORIGENESIS; PNEUMONIAE; GENITALIUM	Mycoplasma infection has been reported to be associated with cancer migration, invasion, epithelial-mesenchymal transition as well as the resistance to nucleoside analogues chemotherapeutic drugs. In this study, we found that the sensitivity of hepatocarcinoma cells to Cisplatin, Gemcitabine and Mitoxantrone was increased by mycoplasma elimination. Similar to the effect of anti-mycoplasma agent, interrupting the interaction between Mycoplasma hyorhinis membrane protein P37 and Annexin A2 of host cells using the N-terminal of ANXA2 polypeptide enhanced the sensitivity of HCC97L cells to Gemcitabine and Mitoxantrone. Meanwhile, we did not observe any changes in expression or distribution of multidrug resistance associated transporters, ATP-Binding Cassette protein B1, C1 and G2, on the removal of mycoplasma. These results suggest that mycoplasma induces a resistance to multiple drugs in hepatocarcinoma cells which required the interaction of P37 and Annexin A2. The pathway downstream this interaction needs to be explored.	[Liu, Danyang; Hu, Yang; Zhu, Zhu; Lu, Bingzheng; Wang, Xuelan; Huang, Yijun] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China; [Guo, Ying] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Wang, XL; Huang, YJ (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China.	mdswxl@mail.sysu.edu.cn; huangyj@mail.sysu.edu.cn						Brenner C, 2006, ONCOGENE, V25, P4744, DOI 10.1038/sj.onc.1209609; Bronckaers A, 2008, BIOCHEM PHARMACOL, V76, P188, DOI 10.1016/j.bcp.2008.04.019; Chaudhry R, 2016, INDIAN J MED MICROBI, V34, P7, DOI 10.4103/0255-0857.174112; Chen CY, 2015, ONCOTARGET, V6, P26946, DOI 10.18632/oncotarget.4521; Choi HS, 2014, BIOCHEM BIOPH RES CO, V446, P620, DOI 10.1016/j.bbrc.2014.03.024; Dean M, 2001, J LIPID RES, V42, P1007; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Duan HY, 2014, CANCER RES, V74, P5782, DOI 10.1158/0008-5472.CAN-14-0650; Duan HY, 2014, CANCER LETT, V354, P447, DOI 10.1016/j.canlet.2014.08.018; DUDLER R, 1988, EMBO J, V7, P3963, DOI 10.1002/j.1460-2075.1988.tb03283.x; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; Gong MM, 2008, MOL CANCER THER, V7, P530, DOI 10.1158/1535-7163.MCT-07-2191; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Joyce H, 2015, EXPERT OPIN DRUG MET, V11, P795, DOI 10.1517/17425255.2015.1028356; Ketcham CM, 2005, MOL CANCER THER, V4, P1031, DOI 10.1158/1535-7163.MCT-05-0040; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Li J, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0222-x; Liekens S, 2009, LANCET ONCOL, V10, P628, DOI 10.1016/S1470-2045(09)70037-3; Manhart LE, 2015, CLIN INFECT DIS, V61, pS802, DOI 10.1093/cid/civ785; Manhart LE, 2013, INFECT DIS CLIN N AM, V27, P779, DOI 10.1016/j.idc.2013.08.003; Medjo B, 2014, ITAL J PEDIATR, V40, DOI 10.1186/s13052-014-0104-4; MURPHY WH, 1967, ANN NY ACAD SCI, V143, P544, DOI 10.1111/j.1749-6632.1967.tb27701.x; Raherison S, 2005, ANTIMICROB AGENTS CH, V49, P421, DOI 10.1128/AAC.49.1.421-424.2005; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rosenbaum M, 2015, TRENDS ENDOCRIN MET, V26, P493, DOI 10.1016/j.tem.2015.07.002; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Sippel KH, 2009, J BACTERIOL, V191, P2585, DOI 10.1128/JB.01680-08; Sodani K, 2014, BIOCHEM PHARMACOL, V89, P52, DOI 10.1016/j.bcp.2014.02.012; STEINEMANN C, 1984, INT J CANCER, V34, P407, DOI 10.1002/ijc.2910340319; STEINEMANN C, 1984, P NATL ACAD SCI-BIOL, V81, P3747, DOI 10.1073/pnas.81.12.3747; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Vande Voorde J, 2014, NUCLEOS NUCLEOT NUCL, V33, P394, DOI 10.1080/15257770.2013.851394; Vande Voorde J, 2014, J BIOL CHEM, V289, P13054, DOI 10.1074/jbc.M114.558924; Vande Voorde J, 2013, MOL PHARMACOL, V84, P865, DOI 10.1124/mol.113.088625; Voorde JV, 2015, FEBS OPEN BIO, V5, P634, DOI 10.1016/j.fob.2015.07.007; Voorde JV, 2014, EXCLI J, V13, P300; WAISMAN DM, 1995, MOL CELL BIOCHEM, V149, P301, DOI 10.1007/BF01076592; Wang CY, 2014, DIS MARKERS, V2014, P1, DOI 10.1155/2014/231736; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wu J, 2016, MICROBIOL RES, V192, P253, DOI 10.1016/j.micres.2016.08.003; Yuan S, 2016, PLOS ONE, V11; Zhang ZD, 2014, NEOPLASMA, V61, P627, DOI 10.4149/neo_2014_078	45	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0184578	10.1371/journal.pone.0184578	http://dx.doi.org/10.1371/journal.pone.0184578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976984	gold, Green Published, Green Submitted			2022-12-26	WOS:000412163100007
J	Muldoon, KM; Armstrong-Heimsoth, A; Thomas, J				Muldoon, Kathleen M.; Armstrong-Heimsoth, Amy; Thomas, Jodi			Knowledge of congenital cytomegalovirus (cCMV) among physical and occupational therapists in the United States	PLOS ONE			English	Article							CEREBRAL-PALSY; DAY-CARE; NEUROTROPIC VIRUSES; MECHANICAL TURK; INFECTION; CHILDREN; PREVENTION; TRANSMISSION; RISK; PREVALENCE	Congenital cytomegalovirus (cCMV) infections cause more children to have permanent disabilities than Down Syndrome, Fetal Alcohol Syndrome, Spina Bifida, and pediatric HIV/AIDS combined. The risk of infection during pregnancy can be significantly decreased using universal precautions, such as thorough handwashing and cleansing of surfaces and objects that have come into contact with infected body fluids. Children under 3 years of age are commonly asymptomatic excretors of CMV, with the highest viral loads present in saliva. Pediatric therapists have regular close contact with young children, and are thus likely at elevated occupational risk of acquiring CMV. Our objective was to evaluate therapist knowledge of cCMV and its transmission. We recruited American Occupational Therapy Association (AOTA) and American Physical Therapy Association (APTA) members via electronic newsletters and printed flyers from April to September 2015. Participants completed an online, anonymous 24-question survey using Survey Monkey. We compared responses between groups and previously published CMV awareness data using binomial tests of difference of proportions and multiple logistic regression. Our study identified both a low level of therapist awareness and poor demonstrated understanding of cCMV. Self-reported cCMV awareness amongst therapists was greater than awareness in the general population, and equivalent to awareness amongst health care professionals. Whereas 52% of participants self-reported awareness of cCMV, only 18% demonstrated understanding of the behavioral modes of CMV transmission. Fewer therapists reported awareness of cCMV than other, less prevalent conditions. Higher levels of health risk knowledge were associated with greater contact with children. Most participants reported learning about cCMV from the workplace. The knowledge gaps between self-reported awareness of cCMV and demonstrated understanding of modes of transmission described by our results emphasize the need for additional training of therapists. cCMV is preventable, and accurate knowledge of modes of transmission is crucial for the health of practitioners and clients.	[Muldoon, Kathleen M.] Midwestern Univ, Dept Anat, Arizona Coll Osteopath Med, Glendale, AZ 85308 USA; [Armstrong-Heimsoth, Amy] No Arizona Univ, Dept Occupat Therapy, Phoenix, AZ USA; [Thomas, Jodi] Midwestern Univ, Dept Phys Therapy, Glendale, AZ USA	Midwestern University; Northern Arizona University; Midwestern University	Muldoon, KM (corresponding author), Midwestern Univ, Dept Anat, Arizona Coll Osteopath Med, Glendale, AZ 85308 USA.	kmuldo@midwestern.edu		Thomas, Jodi/0000-0002-6602-9442	Midwestern University	Midwestern University	Funding was provided by Midwestern University to KMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accreditation Council for Occupational Therapy, 2017, ACCR MAN; ADLER SP, 1989, NEW ENGL J MED, V321, P1290, DOI 10.1056/NEJM198911093211903; Adler SP, 2013, CLIN INFECT DIS, V57, pS189, DOI 10.1093/cid/cit585; Alberman E, 2006, BMJ-BRIT MED J, V332, P63, DOI 10.1136/bmj.332.7533.63; American Academy of Pediatrics, 2015, RED BOOK 2015 REP CO; American Occupational Therapy Association, 2015, SAL WORKF SURV EX SU; [Anonymous], 2013, SPSS STAT WIND VERS; [Anonymous], 2013, PHYS THER MEMB DEM P; Atkinson NL, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1035; Baer HR, 2014, J CLIN VIROL, V60, P222, DOI 10.1016/j.jcv.2014.03.023; Bale JF, 1999, ARCH PEDIAT ADOL MED, V153, P75; BALFOUR CL, 1986, JAMA-J AM MED ASSOC, V256, P1909, DOI 10.1001/jama.256.14.1909; Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Binda S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1861-z; Boppana SB, 1999, PEDIATRICS, V104, P55, DOI 10.1542/peds.104.1.55; Boppana SB, 2013, CLIN INFECT DIS, V57, pS178, DOI 10.1093/cid/cit629; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cannon MJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0569-1; Cannon MJ, 2011, REV MED VIROL, V21, P240, DOI 10.1002/rmv.695; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Cannon MJ, 2009, J CLIN VIROL, V46, pS6, DOI 10.1016/j.jcv.2009.09.002; Cannon MJ, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-70; Celikel E, 2015, EUR J PEDIATR, V174, P1101, DOI 10.1007/s00431-015-2513-9; Centers for Disease Control and Prevention, 2007, MMWR-MORBID MORTAL W, V57, P65; Centers for Disease Control and Prevention, 2013, CONG CMV INF TRENDS; Chandler J, 2014, AMONG AMAZON MECH TU; Chandler J, 2016, ANNU REV CLIN PSYCHO, V12, P53, DOI 10.1146/annurev-clinpsy-021815-093623; Chin TL, 2014, J HOSP INFECT, V87, P11, DOI 10.1016/j.jhin.2013.12.011; Commission on Accreditation in Physical Therapy Education, 2016, STAND REQ EL ACCR PH; Cordier AG, 2012, J CLIN VIROL, V55, P158, DOI 10.1016/j.jcv.2012.06.022; Cordier AG, 2012, J CLIN VIROL, V53, P332, DOI 10.1016/j.jcv.2011.12.031; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; Dakovic I, 2014, EUR J PAEDIATR NEURO, V18, P618, DOI 10.1016/j.ejpn.2014.04.007; De Kegel A, 2016, RES DEV DISABIL, V48, P253, DOI 10.1016/j.ridd.2015.11.014; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Doutre SM, 2016, J EARLY HEAR DETECT, V1, P39, DOI DOI 10.15142/T32G62; Duval M, 2014, CURR OPIN OTOLARYNGO, V22, P495, DOI 10.1097/MOO.0000000000000104; DWORSKY ME, 1983, NEW ENGL J MED, V309, P950, DOI 10.1056/NEJM198310203091604; Flacker J., 1995, THESIS; FordJones EL, 1996, PEDIATR INFECT DIS J, V15, P507, DOI 10.1097/00006454-199606000-00007; Fowler KB, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2128; Gantt S, 2016, JAMA PEDIATR, V170, P1173, DOI 10.1001/jamapediatrics.2016.2016; Ghekiere S, 2012, J PEDIAT OPHTH STRAB, V49, P274, DOI 10.3928/01913913-20120710-03; Gibson CS, 2006, BRIT MED J, V332, P76, DOI 10.1136/bmj.38668.616806.3A; Hamprecht K, 2001, LANCET, V357, P513, DOI 10.1016/S0140-6736(00)04043-5; Harrison GJ, 2015, PEDIATR ANN, V44, pE115, DOI 10.3928/00904481-20150512-11; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; Jeon J, 2006, INFECT DIS OBSTET GY, V2006, DOI [10.1155/IDOG/2006/80383, DOI 10.1155/IDOG/2006/80383]; Jones Cheryl A, 2003, Curr Probl Pediatr Adolesc Health Care, V33, P70, DOI 10.1016/S1538-5442(03)90007-1; Joseph Serene A, 2006, Paediatr Child Health, V11, P401; Kiss P, 2002, INT J OCCUP ENV HEAL, V8, P79; Korver AMH, 2009, J CLIN VIROL, V46, pS11, DOI 10.1016/j.jcv.2009.09.006; Lepage N, 2011, EUR J CLIN MICROBIOL, V30, P65, DOI 10.1007/s10096-010-1054-4; Lynch L, 2015, CURR OPIN INFECT DIS, V28, P362, DOI 10.1097/QCO.0000000000000180; Majima Y, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00378; MARCIL WM, 1993, AM J OCCUP THER, V47, P523, DOI 10.5014/ajot.47.6.523; Marshall BC, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.037; Mason W., 2010, SIGKDD EXPLORATIONS, V11, P100, DOI [DOI 10.1145/1809400.1809422, 10.1145/1600150.1600175]; Mechling J., 2006, ESOMAR WORLD RES C P; Mestas E, 2016, ADV NEONAT CARE, V16, P60, DOI 10.1097/ANC.0000000000000242; MURPH JR, 1991, JAMA-J AM MED ASSOC, V265, P603, DOI 10.1001/jama.265.5.603; MURPH JR, 1988, AM J DIS CHILD, V142, P843, DOI 10.1001/archpedi.1988.02150080049020; Myrhaug HT, 2014, BMC PEDIATR, V14, DOI 10.1186/s12887-014-0292-5; Novak I, 2013, DEV MED CHILD NEUROL, V55, P885, DOI 10.1111/dmcn.12246; ORNE MT, 1962, AM PSYCHOL, V17, P776, DOI 10.1037/h0043424; PASS RF, 1990, PEDIATR INFECT DIS J, V9, P465, DOI 10.1097/00006454-199007000-00003; Pereboom MTR, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-98; Remington JS, 2001, INFECT DIS FETUS NEW, P389; Revello MG, 2015, EBIOMEDICINE, V2, P1205, DOI 10.1016/j.ebiom.2015.08.003; Rosenthal LS, 2009, PEDIATR INFECT DIS J, V28, P515, DOI 10.1097/INF.0b013e318198c724; Ross DS, 2008, J WOMENS HEALTH, V17, P849, DOI 10.1089/jwh.2007.0523; Schleiss MR, 2006, CURR OPIN PEDIATR, V18, P48; Shapiro DN, 2013, CLIN PSYCHOL SCI, V1, P213, DOI 10.1177/2167702612469015; Smithers-Sheedy H, 2015, J PAEDIATR CHILD H, V51, P901, DOI 10.1111/jpc.12896; Smithers-Sheedy H, 2014, DEV MED CHILD NEUROL, V56, P846, DOI 10.1111/dmcn.12467; Sobaszek A, 2000, J OCCUP ENVIRON MED, V42, P1109, DOI 10.1097/00043764-200011000-00015; Stowell JD, 2014, APPL ENVIRON MICROB, V80, P455, DOI 10.1128/AEM.03262-13; Stowell JD, 2012, J INFECT DIS, V205, P211, DOI 10.1093/infdis/jir722; Sumartojo E, 2000, AIDS, V14, pS3, DOI 10.1097/00002030-200006001-00002; Swanson EC, 2013, PEDIATR CLIN N AM, V60, P335, DOI 10.1016/j.pcl.2012.12.008; Thackeray R, CHILD CARE PROVIDER, V45, P301; Thackeray R, 2014, MATERN CHILD HLTH J, V18, P584, DOI 10.1007/s10995-013-1275-0; Townsend CL, 2013, CLIN INFECT DIS, V56, P1232, DOI 10.1093/cid/cit018; Vauloup-Fellous C, 2009, J CLIN VIROL, V46, pS49, DOI 10.1016/j.jcv.2009.09.003; World Confederation for Physical Therapy, 2011, WORLD CONF PHYS THER, V5; Ziviani J, 2010, AUST OCCUP THER J, V57, P210, DOI 10.1111/j.1440-1630.2010.00850.x	87	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185635	10.1371/journal.pone.0185635	http://dx.doi.org/10.1371/journal.pone.0185635			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI7FU	28976995	Green Published, gold, Green Submitted			2022-12-26	WOS:000412163100035
J	Song, G; Li, XR; Hui, R				Song, Guang; Li, Xinrong; Hui, Rong			Effect of biological soil crusts on seed germination and growth of an exotic and two native plant species in an arid ecosystem	PLOS ONE			English	Article							ALTERS NITROGEN DYNAMICS; BROMUS-TECTORUM INVASION; TENGGER-DESERT; NORTHERN CHINA; SAND DUNES; ECOLOGICAL RESTORATION; MICROBIOTIC CRUSTS; REVEGETATED AREA; VASCULAR PLANTS; COMMUNITIES	Biological soil crusts (BSCs) can improve the stability and health of native plant communities in arid ecosystems. However, it is unknown whether BSCs can also inhibit invasions of exotic vascular plants on stabilized reclaimed sand dunes. To answer this question, we conducted a greenhouse experiment to test the effects of cyanobacteria-dominated BSCs on 1) seed germination and biomass of an exotic grass (Stipa glareosa P. Smirn.), and 2) individual biomass of the exotic S. glareosa growing with two native plants, Eragrostis poaeoides Beauv. and Artemisia capillaris Thunb. Our experiment included three BSC treatments (intact crust, disturbed crust, and bare soil) and five species trials (native E. poaeoides alone, E. poaeoides mixed with exotic S. glareosa, native A. capillaris alone, A. capillaris mixed with exotic S. glareosa, and S. glareosa alone). The results showed that cyanobacteria-dominated crusts can significantly reduce the cumulative percent germination of the exotic grass (P < 0.001) and native plants (P < 0.001). Maximum cumulative percent germinations of the exotic grass and two native plants were found in bare soil, and minimum in intact crusts. The interaction of crust treatment x species trials on shoot biomass of the two native plants was significant (P < 0.05). These results indicate that the presence of BSCs on stabilized sand dunes may reduce the germination of the exotic and two native plants. The effect of reducing exotic and native plant seeds germination would maintain more diverse plant communities and contribute to the formation of clumped vegetation patterns. We conclude that BSCs act as a natural regulator for vegetation patterns and thus promote ecosystem stability and sustainability.	[Song, Guang; Li, Xinrong] Chinese Acad Sci, Shapotou Desert Res & Expt Stn, Northwest Inst Ecoenvironm & Resources, Lanzhou, Gansu, Peoples R China; [Song, Guang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, XR (corresponding author), Chinese Acad Sci, Shapotou Desert Res & Expt Stn, Northwest Inst Ecoenvironm & Resources, Lanzhou, Gansu, Peoples R China.	Lxinrong@lzb.ac.cn	Li, Xinrong/GNW-6025-2022		National Natural Science Foundation of China [41621001, 41530746, 41701104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China, 41621001 (prof Xinrong Li); National Natural Science Foundation of China, 41530746 (prof Xinrong Li); and National Natural Science Foundation of China, 41701104 (prof Rong Hui).	Adeel Z, 2008, Future of Drylands, P677; Alba C, 2015, J VEG SCI, V26, P102, DOI 10.1111/jvs.12212; ANDERSON DC, 1982, J RANGE MANAGE, V35, P180, DOI 10.2307/3898386; Assouline S, 2015, J GEOPHYS RES-BIOGEO, V120, P2108, DOI 10.1002/2015JG003185; Balch JK, 2013, GLOBAL CHANGE BIOL, V19, P173, DOI 10.1111/gcb.12046; Bashkin M, 2003, APPL SOIL ECOL, V22, P67, DOI 10.1016/S0929-1393(02)00108-7; Belnap J, 2006, APPL SOIL ECOL, V32, P63, DOI 10.1016/j.apsoil.2004.12.010; Belnap J, 2002, BIOL FERT SOILS, V35, P128, DOI 10.1007/s00374-002-0452-x; BELNAP J, 2001, BIOL SOIL CRUSTS STR, V150, P281; Belnap J., 2003, BIOL SOIL CRUSTS STR, DOI 10.1007/978-3-642-56475-8_21; Belnap J, 2006, HYDROL PROCESS, V20, P3159, DOI 10.1002/hyp.6325; Benvenuti S, 2007, SEED SCI RES, V17, P211, DOI 10.1017/S0960258507782752; BEYMER RJ, 1991, ARID SOIL RES REHAB, V5, P187, DOI 10.1080/15324989109381279; Bowker MA, 2008, CONSERV BIOL, V22, P1533, DOI 10.1111/j.1523-1739.2008.01036.x; Briggs AL, 2011, PLANT ECOL, V212, P91, DOI 10.1007/s11258-010-9806-x; Brooks ML, 2011, RANGELAND ECOL MANAG, V64, P431, DOI 10.2111/REM-D-09-00165.1; Chacon N, 2009, BIOL FERT SOILS, V45, P321, DOI 10.1007/s00374-008-0342-y; Chambers JC, 2016, SPRINGER SER ENV MAN, P275, DOI 10.1007/978-3-319-24930-8_10; Corbin JD, 2010, PLANT ECOL, V209, P71, DOI 10.1007/s11258-010-9722-0; Crisp MD, 1975, RANGELAND J, V1, P78; DeCorte A., 2011, THESIS; deRivera CE, 2005, ECOLOGY, V86, P3364, DOI 10.1890/05-0479; ELDRIDGE DJ, 1994, AUST J SOIL RES, V32, P389, DOI 10.1071/SR9940389; Eldridge DJ, 2000, CATENA, V40, P323, DOI 10.1016/S0341-8162(00)00082-5; Evans RD, 2001, ECOL APPL, V11, P1301, DOI 10.1890/1051-0761(2001)011[1301:EPIAND]2.0.CO;2; Fagan WF, 2000, AM NAT, V155, P238, DOI 10.1086/303320; Flory SL, 2010, OECOLOGIA, V164, P1029, DOI 10.1007/s00442-010-1697-y; Flory SL, 2010, BIOL INVASIONS, V12, P1285, DOI 10.1007/s10530-009-9546-9; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Ghermandi L, 1995, ACTA OECOL, V16, P719; Godinez-Alvarez H, 2012, PLANT BIOLOGY, V14, P157, DOI 10.1111/j.1438-8677.2011.00495.x; Hawkes CV, 2004, PLANT ECOL, V170, P121, DOI 10.1023/B:VEGE.0000019035.56245.91; Hernandez RR, 2011, PLANT ECOL, V212, P1709, DOI 10.1007/s11258-011-9943-x; Jimenez MA, 2011, ECOL LETT, V14, P1227, DOI 10.1111/j.1461-0248.2011.01693.x; Knochel DG, 2010, BIOL INVASIONS, V12, P3771, DOI 10.1007/s10530-010-9769-9; Langhans TM, 2009, FLORA, V204, P157, DOI 10.1016/j.flora.2008.01.001; Larsen K. D., 1995, THESIS; Li XJ, 2008, GEOMORPHOLOGY, V96, P221, DOI 10.1016/j.geomorph.2007.08.006; Li XR, 2012, CATENA, V97, P119, DOI 10.1016/j.catena.2012.05.009; Li XR, 2010, HYDROL PROCESS, V24, P3621, DOI 10.1002/hyp.7791; Li XR, 2010, EARTH SURF PROC LAND, V35, P932, DOI 10.1002/esp.1963; Li XR, 2014, SCI CHINA LIFE SCI, V57, P539, DOI 10.1007/s11427-014-4633-2; Li XR, 2005, PLANT SOIL, V277, P375, DOI 10.1007/s11104-005-8162-4; Li XR, 2002, BIOL FERT SOILS, V35, P147, DOI 10.1007/s00374-002-0453-9; Li XR, 2004, RESTOR ECOL, V12, P376, DOI 10.1111/j.1061-2971.2004.00313.x; Li XR, 2004, J ARID ENVIRON, V57, P1, DOI 10.1016/S0140-1963(03)00089-2; Liu HL, 2013, CONSERV BIOL, V27, P1011, DOI 10.1111/cobi.12084; Liu LC, 2006, J HYDROL, V328, P331, DOI 10.1016/j.jhydrol.2005.12.004; Liu LC, 2007, AUST J SOIL RES, V45, P422, DOI 10.1071/SR06175; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Luzuriaga AL, 2015, J VEG SCI, V26, P866, DOI 10.1111/jvs.12285; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Maestre FT, 2012, J ECOL, V100, P317, DOI 10.1111/j.1365-2745.2011.01918.x; Maier S, 2014, BIODIVERS CONSERV, V23, P1735, DOI 10.1007/s10531-014-0719-1; Marshall VM, 2012, J ARID ENVIRON, V78, P1, DOI 10.1016/j.jaridenv.2011.11.005; McLean R.J.C., 1990, MICROBIAL MINERAL RE, P231; Mendoza-Aguilar DO, 2014, PLANT SOIL, V375, P267, DOI 10.1007/s11104-013-1958-8; Miller G, 2010, RANGELAND J, V32, P353, DOI 10.1071/RJ09076; Milton SJ, 2010, BIOL INVASIONS, V12, P3935, DOI 10.1007/s10530-010-9820-x; Orrock JL, 2015, ECOLOGY, V96, P1052, DOI 10.1890/14-0732.1; Pan YX, 2010, J HYDROL, V387, P265, DOI 10.1016/j.jhydrol.2010.04.016; Patrick E, 2002, PROG PHYS GEOG, V26, P442, DOI 10.1191/0309133302pp338pr; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pointing SB, 2012, NAT REV MICROBIOL, V10, P551, DOI 10.1038/nrmicro2831; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Rieder JP, 2010, BIOL INVASIONS, V12, P2429, DOI 10.1007/s10530-009-9653-7; Ronnenberg K, 2007, J ARID ENVIRON, V71, P404, DOI 10.1016/j.jaridenv.2007.04.012; Ronnenberg K, 2008, PLANT ECOL, V196, P269, DOI 10.1007/s11258-007-9351-4; Schaeffer SM, 2012, BIOGEOCHEMISTRY, V111, P427, DOI 10.1007/s10533-011-9668-x; Schoning C, 2004, J ARID ENVIRON, V56, P43, DOI 10.1016/S0140-1963(03)00024-7; Sedia EG, 2003, OIKOS, V100, P447, DOI 10.1034/j.1600-0706.2003.12058.x; Serpe MD, 2006, PLANT ECOL, V185, P163, DOI 10.1007/s11258-005-9092-1; Shapotou Desert Research and Experiment Station Chinese Academy of Sciences, 1991, STUD SHITT SAND CONT; Shinneman DJ, 2008, J ARID ENVIRON, V72, P207, DOI 10.1016/j.jaridenv.2007.06.002; Soltani A, 2002, SEED SCI TECHNOL, V30, P51; Sperry LJ, 2006, ECOLOGY, V87, P603, DOI 10.1890/05-0836; Stohlgren Thomas J., 2001, Biological Invasions, V3, P37, DOI 10.1023/A:1011451417418; Su JQ, 2013, ECOL RES, V28, P21, DOI 10.1007/s11284-012-0994-9; Thiet RK, 2014, PLANT SOIL, V377, P235, DOI 10.1007/s11104-013-2002-8; Tsoar H, 2005, PHYSICA A, V357, P50, DOI 10.1016/j.physa.2005.05.067; Walker L.R., 1997, ASSESSMENT MANAGEMEN, P69, DOI [10.1007/978-1-4612-1926-2_7, DOI 10.1007/978-1-4612-1926-2_7]; Warren SD, 2003, BIOL SOIL CRUSTS STR, P401, DOI DOI 10.1007/978-3-642-56475-8_29; West N. E., 1990, Advances in Ecological Research, V20, P179, DOI 10.1016/S0065-2504(08)60055-0; WILLIAMS JD, 1993, P 46 ANN M SOC RANG; Wu JS, 2013, J MT SCI-ENGL, V10, P1097, DOI 10.1007/s11629-013-2435-9; Zhang Y., 2016, BIOL SOIL CRUSTS ORG, V226, DOI [10.1007/978-3-319-30214-0_19, DOI 10.1007/978-3-319-30214-0_19]; Zhang Yuan-Ming, 2011, Chinese Journal of Plant Ecology, V35, P380, DOI 10.3724/SP.J.1258.2011.00380; Zhang YM, 2015, ECOL RES, V30, P1037, DOI 10.1007/s11284-015-1305-z; Zhang YM, 2010, J ARID LAND, V2, P180, DOI 10.3724/SP.J.1227.2010.00180; Zhang ZS, 2008, J ARID ENVIRON, V72, P964, DOI 10.1016/j.jaridenv.2007.11.010	90	20	26	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185839	10.1371/journal.pone.0185839	http://dx.doi.org/10.1371/journal.pone.0185839			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977018	Green Published, Green Submitted, gold			2022-12-26	WOS:000412163100049
J	Mittal, N; Minasyan, A; Romaneschi, N; Hakimian, JK; Gonzalez-Fernandez, G; Albert, R; Desai, N; Mendez, IA; Schallert, T; Ostlund, SB; Welwyn, W				Mittal, Nitish; Minasyan, Ani; Romaneschi, Nicole; Hakimian, Joshua K.; Gonzalez-Fernandez, Gabriel; Albert, Ralph; Desai, Nina; Mendez, Ian A.; Schallert, Timothy; Ostlund, Sean B.; Welwyn, Wendy			Beta-arrestin 1 regulation of rewardmotivated behaviors and glutamatergic function	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS SHELL; PROTEASE-ACTIVATED RECEPTOR-2; MEDIATED ACTIN DYNAMICS; LONG-TERM DEPRESSION; SYNAPTIC PLASTICITY; AMPA RECEPTOR; IN-VIVO; COCAINE; COFILIN; MICE	The two highly homologous non-visual arrestins, beta-arrestin 1 and 2, are ubiquitously expressed in the central nervous system, yet knowledge of their disparate roles is limited. While beta-arrestin 2 (beta arr2) has been implicated in several aspects of reward-related learning and behavior, very little is known about the behavioral function of beta-arrestin 1 (beta arr1). Using mice lacking beta arr1, we focused on the role of this scaffolding and signal transduction protein in reward-motivated behaviors and in striatal glutamatergic function. We found that beta arr1 KO mice were both slower in acquiring cocaine self-administration and in extinguishing this behavior. They also showed deficits in learning tasks supported by a natural food reward, suggesting a general alteration in reward processing. We then examined glutamatergic synaptic strength in WT and KO medium spiny neurons (MSNs) of the Nucleus Accumbens (NAc) shell in naive animals, and from those that underwent cocaine selfadministration. An increase in the AMPA/NMDA (A/N) ratio and a relative lack of GluN2Benriched NMDARs was found in naive KO vs WT MSNs. Applying Lim Domain Kinase (LIMK1), the kinase that phosphorylates and inactivates cofilin, to these cells, showed that both beta arr1 and LIMK regulate the A/N ratio and GluN2B-NMDARs. Cocaine self-administration increased the A/N ratio and GluN2B-NMDARs in WT MSNs and, although the A/N ratio also increased in KO MSNs, this was accompanied by fewer GluN2B-NMDARs and an appearance of calcium-permeable AMPARs. Finally, to examine the consequences of reduced basal GluN2B-NMDARs in reward-processing seen in KO mice, we chronically infused ifenprodil, a GluN2B antagonist, into the NAc shell of WT mice. This intervention substantially reduced food-motivated behavior. Together these findings identify a previously unknown role of beta arr1 in regulating specific reward-motivated behaviors and glutamatergic function.	[Mittal, Nitish; Minasyan, Ani; Romaneschi, Nicole; Hakimian, Joshua K.; Gonzalez-Fernandez, Gabriel; Albert, Ralph; Desai, Nina; Mendez, Ian A.; Welwyn, Wendy] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Semel Inst, Los Angeles, CA 90095 USA; [Mittal, Nitish; Schallert, Timothy] Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78712 USA; [Ostlund, Sean B.] Univ Calif Irvine, Sch Biol Sci, Dept Anesthesiol & Perioperat Care, Sch Med,UCI Ctr Addict Neurosci, Irvine, CA 92717 USA; [Welwyn, Wendy] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Texas System; University of Texas Austin; University of California System; University of California Irvine; University of California System; University of California Los Angeles	Welwyn, W (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Semel Inst, Los Angeles, CA 90095 USA.; Welwyn, W (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA.	wwalwyn@g.ucla.edu	Mendez, Ian/L-9592-2019	Walwyn, Wendy/0000-0001-8101-2844; Mittal, Nitish/0000-0002-4934-3157; Mendez, Ian/0000-0001-8381-4592; Hakimian, Joshua/0000-0003-2712-6204	National Institutes of Health [AG045380, DK098709, DA029035]; Sean B Ostlund; National Institute of Neurological Disorders and Stroke [5R01NS081063-04]; Bill and Melinda Gates Foundation, a GMSP Fellowship, which funded Nitish Mittal; Shirley and Stefan Hatos Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sean B Ostlund; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Bill and Melinda Gates Foundation, a GMSP Fellowship, which funded Nitish Mittal; Shirley and Stefan Hatos Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study is supported by the National Institutes of Health (AG045380, DK098709 and DA029035), which funded Sean B Ostlund; National Institute of Neurological Disorders and Stroke (5R01NS081063-04), which funded Timothy Schallert; Bill and Melinda Gates Foundation, a GMSP Fellowship, which funded Nitish Mittal; Shirley and Stefan Hatos Foundation, which funded NM, AM, NR, JH, GGF, RA, ND, IAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertran-Gonzalez J, 2013, J NEUROSCI, V33, P16060, DOI 10.1523/JNEUROSCI.1927-13.2013; Bjork K, 2013, PSYCHOPHARMACOLOGY, V230, P439, DOI 10.1007/s00213-013-3166-x; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Briand LA, 2014, NEUROPSYCHOPHARMACOL, V39, P759, DOI 10.1038/npp.2013.265; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Conner DA, 1997, CIRC RES, V81, P1021; Cooper S, 2017, NEUROTHERAPEUTICS; Corbit LH, 2001, J NEUROSCI, V21, P3251, DOI 10.1523/JNEUROSCI.21-09-03251.2001; Dalton GL, 2012, NEUROPHARMACOLOGY, V62, P797, DOI 10.1016/j.neuropharm.2011.09.001; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Green JA, 2016, MOL CELL BIOL, V36, P223, DOI 10.1128/MCB.00765-15; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Hall BJ, 2007, J NEUROSCI, V27, P13446, DOI 10.1523/JNEUROSCI.3793-07.2007; Hanley JG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00381; Huang YHH, 2009, NEURON, V63, P40, DOI 10.1016/j.neuron.2009.06.007; Ibanez I, 2016, NEUROPHARMACOLOGY, V107, P376, DOI 10.1016/j.neuropharm.2016.03.042; James AS, 2013, BEHAV BRAIN RES, P1; Jedynak J, 2016, NEUROPSYCHOPHARMACOL, V41, P464, DOI 10.1038/npp.2015.168; Johnson AW, 2007, BEHAV NEUROSCI, V121, P1192, DOI 10.1037/0735-7044.121.6.1192; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kelley AE, 1997, P NATL ACAD SCI USA, V94, P12174, DOI 10.1073/pnas.94.22.12174; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Kermath BA, 2013, J NEUROENDOCRINOL, V25, P887, DOI 10.1111/jne.12087; Kiraly DD, 2013, MOL PHARMACOL, V84, P582, DOI 10.1124/mol.113.087106; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Laurent V, 2014, J NEUROSCI, V34, P1358, DOI 10.1523/JNEUROSCI.4592-13.2014; Lee BR, 2011, NEUROPHARMACOLOGY, V61, P1060, DOI 10.1016/j.neuropharm.2010.12.033; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; McCutcheon JE, 2011, J NEUROSCI, V31, P5737, DOI 10.1523/JNEUROSCI.0350-11.2011; McGovern Kathryn W, 2014, Handb Exp Pharmacol, V219, P341, DOI 10.1007/978-3-642-41199-1_17; Min JA, 2011, MOL PHARMACOL, V80, P760, DOI 10.1124/mol.111.072470; Mittal N, 2013, CELL REP, V5, P1010, DOI 10.1016/j.celrep.2013.10.015; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Opazo P, 2011, MOL CELL NEUROSCI, V46, P1, DOI 10.1016/j.mcn.2010.08.014; Ortinski PI, 2012, NEUROPSYCHOPHARMACOL, V37, P1671, DOI 10.1038/npp.2012.12; Ostlund SB, 2007, J NEUROSCI, V27, P4819, DOI 10.1523/JNEUROSCI.5443-06.2007; Ostlund SB, 2017, EUR J NEUROSCI, V45, P358, DOI 10.1111/ejn.13462; Ostlund SB, 2012, NEUROPSYCHOPHARMACOL, V37, P508, DOI 10.1038/npp.2011.217; Peterson SM, 2015, P NATL ACAD SCI USA, V112; Pierce RC, 2013, COLD SPRING HARB PER, V3, P1; Pontrello CG, 2012, P NATL ACAD SCI USA, V109, pE442, DOI 10.1073/pnas.1118803109; Porter-Stransky KA, 2017, J PHARMACOL EXP THER, V361, P341, DOI 10.1124/jpet.117.240622; Rodd-Henricks ZA, 2002, J PHARMACOL EXP THER, V303, P1216, DOI 10.1124/jpet.102.038950; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Shieh BH, 2014, J BIOL CHEM, V289, P18526, DOI 10.1074/jbc.M114.571224; Standley S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039585; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249; Takei Y, 2015, J NEUROSCI, V35, P15539, DOI 10.1523/JNEUROSCI.2671-15.2015; Wang Y, 2013, J NEUROSCI, V33, P6423, DOI 10.1523/JNEUROSCI.5107-12.2013; Wolf ME, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00072; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Yin HH, 2006, NEUROBIOL LEARN MEM, V85, P283, DOI 10.1016/j.nlm.2005.12.001; Yin XL, 2012, J NEUROSCI, V32, P5486, DOI 10.1523/JNEUROSCI.0718-12.2012; Yin Xu-Ming, 2013, Shengli Xuebao, V65, P178; Yuen EY, 2010, J PHYSIOL-LONDON, V588, P2361, DOI 10.1113/jphysiol.2009.186353; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200; Zoudilova M, 2010, J BIOL CHEM, V285, P14318, DOI 10.1074/jbc.M109.055806	59	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185796	10.1371/journal.pone.0185796	http://dx.doi.org/10.1371/journal.pone.0185796			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973019	gold, Green Published			2022-12-26	WOS:000412131900053
J	Rudebusch, J; Benkner, A; Poesch, A; Dorr, M; Volker, U; Grube, K; Hammer, E; Felix, SB				Ruedebusch, Julia; Benkner, Alexander; Poesch, Axel; Doerr, Marcus; Voelker, Uwe; Grube, Karina; Hammer, Elke; Felix, Stephan B.			Dynamic adaptation of myocardial proteome during heart failure development	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; ASSOCIATION; METABOLISM; PROTEINS; MATRIX; HSPB7; LOCI	Heart failure (HF) development is characterized by huge structural changes that are crucial for disease progression. Analysis of time dependent global proteomic adaptations during HF progression offers the potential to gain deeper insights in the disease development and identify new biomarker candidates. Therefore, hearts of TAC (transverse aortic constriction) and sham mice were examined by cardiac MRI on either day 4, 14, 21, 28, 42, and 56 after surgery (n = 6 per group/time point). At each time point, proteomes of the left (LV) and right ventricles (RV) of TAC and sham mice were analyzed by mass spectrometry (MS). In TAC mice, systolic LV heart function worsened from day 4 to day 14, remained on a stable level from day 14 to day 42, and showed a further pronounced decline at day 56. MS analysis identified in the LV 330 and in RV 246 proteins with altered abundance over time (TAC vs. sham, fc >=+/- 2). Functional categorization of proteins disclosed the time-dependent alteration of different pathways. Heat shock protein beta-7 (HSPB7) displayed differences in abundance in tissue and serum at an early stage of HF. This study not only provides an overview of the time dependent molecular alterations during transition to HF, but also identified HSPB7 as a novel blood biomarker candidate for the onset of cardiac remodeling.	[Ruedebusch, Julia; Benkner, Alexander; Poesch, Axel; Doerr, Marcus; Grube, Karina; Felix, Stephan B.] Univ Med Greifswald, Dept Internal Med B, Greifswald, Germany; [Ruedebusch, Julia; Benkner, Alexander; Doerr, Marcus; Voelker, Uwe; Grube, Karina; Hammer, Elke; Felix, Stephan B.] German Ctr Cardiovasc Res, DZHK, Partner Site Greifswald, Greifswald, Germany; [Benkner, Alexander; Voelker, Uwe; Hammer, Elke] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany	Greifswald Medical School; German Centre for Cardiovascular Research; Greifswald Medical School	Felix, SB (corresponding author), Univ Med Greifswald, Dept Internal Med B, Greifswald, Germany.; Hammer, E; Felix, SB (corresponding author), German Ctr Cardiovasc Res, DZHK, Partner Site Greifswald, Greifswald, Germany.; Hammer, E (corresponding author), Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany.	hammer@uni-greifswald.de; felix@uni-greifswald.de	Dörr, Marcus/F-1919-2010	Dörr, Marcus/0000-0001-7471-475X; Volker, Uwe/0000-0002-5689-3448; Benkner, Alexander/0000-0002-3415-0512; Rudebusch, Julia/0000-0002-8556-6665; Hammer, Elke/0000-0002-1507-0402	Greifswald Approach to Individualized Medicine (GANI_MED); Federal Ministry of Education and Research; Ministry of Cultural Affairs of the Federal State of Mecklenburg, West Pomerania [03IS2061A]	Greifswald Approach to Individualized Medicine (GANI_MED); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs of the Federal State of Mecklenburg, West Pomerania	This study was partly supported by the research project Greifswald Approach to Individualized Medicine (GANI_MED). The GANI_MED consortium was funded by the Federal Ministry of Education and Research and the Ministry of Cultural Affairs of the Federal State of Mecklenburg, West Pomerania (03IS2061A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Cappola TP, 2010, CIRC-CARDIOVASC GENE, V3, P147, DOI 10.1161/CIRCGENETICS.109.898395; Chen YW, 2011, AM J PHYSIOL-HEART C, V300, pH2251, DOI 10.1152/ajpheart.01104.2010; Chiu TF, 2012, CIRC J, V76, P2226, DOI 10.1253/circj.CJ-12-0238; Dadson K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121049; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Garnier S, 2015, INT J CARDIOL, V189, P105, DOI 10.1016/j.ijcard.2015.04.003; Hammer E, 2011, J PROTEOME RES, V10, P2161, DOI 10.1021/pr1008042; Hammer E, 2010, PROTEOMICS, V10, P1802, DOI 10.1002/pmic.200900734; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Kampourakis T, 2016, P NATL ACAD SCI USA, V113, pE3039, DOI 10.1073/pnas.1602776113; Ke L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020395; Krief S, 1999, J BIOL CHEM, V274, P36592, DOI 10.1074/jbc.274.51.36592; Lam L, 2010, J MOL CELL CARDIOL, V48, P1014, DOI 10.1016/j.yjmcc.2009.08.015; Lau E, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.15; Li C, 2014, MOL BIOSYST, V10, P505, DOI 10.1039/c3mb70422j; Mohamed BA, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0898-5; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Nagoshi T, 2011, CURR PHARM DESIGN, V17, P3846, DOI 10.2174/138161211798357773; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; RUZICKA M, 1994, CIRCULATION, V90, P1989, DOI 10.1161/01.CIR.90.4.1989; Spinale FG, 2013, CIRC RES, V112, P195, DOI 10.1161/CIRCRESAHA.112.266882; Tanonaka K, 2001, BIOCHEM BIOPH RES CO, V283, P520, DOI 10.1006/bbrc.2001.4801; Turer AT, 2010, CURR OPIN CLIN NUTR, V13, P458, DOI 10.1097/MCO.0b013e32833a55a5; Villard E, 2011, EUR HEART J, V32, P1065, DOI 10.1093/eurheartj/ehr105	27	13	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185915	10.1371/journal.pone.0185915	http://dx.doi.org/10.1371/journal.pone.0185915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973020	Green Submitted, gold, Green Published			2022-12-26	WOS:000412131900066
J	Scholz, M; Reske, T; Bohmer, F; Hornung, A; Grabow, N; Lang, H				Scholz, Malte; Reske, Thomas; Boehmer, Femke; Hornung, Anne; Grabow, Niels; Lang, Hermann			In vitro chlorhexidine release from alginate based microbeads for periodontal therapy	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; DRUG-DELIVERY-SYSTEM; VIVO; MICROSPHERES; BEADS; ACID	Periodontitis is one of the most common infectious diseases globally that, if untreated, leads to destruction of the tooth supporting tissues and finally results in tooth loss. Evidence shows that standard procedures as mechanical root cleaning could be supported by further treatment options such as locally applied substances. Due to gingival crevicular fluid flow, substances are commonly washed out off the periodontal pockets. The evaluation of administration techniques and the development of local drug releasing devices is thus an important aspect in periodontal research. This study describes the development and examination of a new alginate based, biodegradable and easily applicable drug delivery system for chlorhexidine (CHX). Different micro beads were produced and loaded with CHX and the release profiles were investigated by high performance liquid chromatography (HPLC). The in vitrodemonstrated release of CHX from alginate based beads shows comparable releasing characteristics as clinically approved systems. Yet many characteristics of this new delivery system show to be favourable for periodontal therapy. Easy application by injection, low production costs and multifunctional adaptions to patient related specifics may improve the usage in routine care.	[Scholz, Malte; Lang, Hermann] Rostock Univ, Med Ctr, Dept Operat Dent & Periodontol, Rostock, Germany; [Reske, Thomas; Grabow, Niels] Univ Rostock, Inst Biomed Engn, Rostock, Germany; [Boehmer, Femke] Rostock Univ, Med Ctr, Inst Gen Practice, Rostock, Germany; [Hornung, Anne] Rostock Univ, Med Ctr, Inst Biostat & Informat Med & Ageing Res, Rostock, Germany	University of Rostock; University of Rostock; University of Rostock; University of Rostock	Scholz, M (corresponding author), Rostock Univ, Med Ctr, Dept Operat Dent & Periodontol, Rostock, Germany.	malte.scholz@uni-rostock.de						Abruzzo A, 2013, CARBOHYD POLYM, V91, P651, DOI 10.1016/j.carbpol.2012.08.074; Ampawong S, 2017, J BIOMATER SCI POLYM, P1; Bazban-Shotorbani S, 2016, LANGMUIR, V32, P4996, DOI 10.1021/acs.langmuir.5b04645; Bidoret A, 2017, METHODS MOL BIOL, V1479, P43, DOI 10.1007/978-1-4939-6364-5_3; Chen FM, 2012, BIOMATERIALS, V33, P6320, DOI 10.1016/j.biomaterials.2012.05.048; Chitsazi Mohammad Taghi, 2013, J Dent Res Dent Clin Dent Prospects, V7, P95, DOI 10.5681/joddd.2013.017; Da Rocha Huberth Alexandre Junior, 2015, J Int Acad Periodontol, V17, P82; Eickholz P., 2006, GLOSSAR GRUNDBEGRIFF, V17, P271; Eke PI, 2015, J PERIODONTOL, P1; Gadad AP, 2009, J APPL POLYM SCI, V114, P1921, DOI 10.1002/app.30617; Garner S, 2015, ORAL DIS, V21, P641, DOI 10.1111/odi.12328; Gonzalez-Fernandez T, 2016, TISSUE ENG PT A, V22, P776, DOI [10.1089/ten.tea.2015.0576, 10.1089/ten.TEA.2015.0576]; Goodson JM, 2003, PERIODONTOL 2000, V31, P43, DOI 10.1034/j.1600-0757.2003.03104.x; Greenstein G, 2000, J Periodontol, V71, P125; Griffiths GS, 2003, PERIODONTOL, V31, P32; He QY, 2015, NAT BIOTECHNOL, V33, P395, DOI 10.1038/nbt.3121; Jiang B, 2013, ACTA BIOMATER, V9, P4976, DOI 10.1016/j.actbio.2012.10.005; Jones CG, 1997, PERIODONTOL 2000, V15, P55, DOI 10.1111/j.1600-0757.1997.tb00105.x; Jordan R. A., 2016, F NFTE DTSCH MUNDGES; Kalsi Rupali, 2011, J Indian Soc Periodontol, V15, P304, DOI 10.4103/0972-124X.92559; Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Liu K, 2006, LANGMUIR, V22, P9453, DOI 10.1021/la061729+; Madhumathi K, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035002; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Mandal S, 2017, METHODS MOL BIOL, V1479, P273, DOI 10.1007/978-1-4939-6364-5_22; Mandlik VB, 2007, ELSEVIER, V63, P368; Matricardi P, 2008, RECENT ADV PERSPECTI, P417; Merchant AT, 2016, J DENT RES, V95, P408, DOI 10.1177/0022034515622197; Murphy Kevin G, 2003, Ann Periodontol, V8, P266, DOI 10.1902/annals.2003.8.1.266; Petersen PE, 2005, J PERIODONTOL, V76, P2187, DOI 10.1902/jop.2005.76.12.2187; Poncelet D, 2001, ANN NY ACAD SCI, V944, P74; Ribeiro CC, 2004, BIOMATERIALS, V25, P4363, DOI 10.1016/j.biomaterials.2003.11.028; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; SCHIOTT C R, 1970, Journal of Periodontal Research, V5, P84; Scholz M, 2013, CED IADR ABSTR B, V1, P40; Silva MD, 2017, MAT SCI ENG C-MATER, V71, P498, DOI 10.1016/j.msec.2016.10.032; Smiley CJ, 2015, J AM DENT ASSOC, V146, P508, DOI 10.1016/j.adaj.2015.01.028; Soriano-Souza CA, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5505-4; Soskolne WA, 1998, J CLIN PERIODONTOL, V25, P1017, DOI 10.1111/j.1600-051X.1998.tb02407.x; Soskolne WA, 2003, J PERIODONTOL, V74, P420, DOI 10.1902/jop.2003.74.4.420; STANLEY A, 1989, J CLIN PERIODONTOL, V16, P259, DOI 10.1111/j.1600-051X.1989.tb01651.x; Sundararaj SC, 2013, BIOMATERIALS, V34, P8835, DOI 10.1016/j.biomaterials.2013.07.093; Taylor JJ, 2016, PERIODONTOL 2000, V70, P7, DOI 10.1111/prd.12118; Tripodo G, 2015, EUR J PHARM BIOPHARM, V97, P400, DOI 10.1016/j.ejpb.2015.03.032; Wasiak J., 2015, BMJ CLIN EVID; Zhou XD, 2015, ARCH ORAL BIOL, V60, P667, DOI 10.1016/j.archoralbio.2014.11.008	47	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185562	10.1371/journal.pone.0185562	http://dx.doi.org/10.1371/journal.pone.0185562			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973028	Green Published, gold, Green Submitted			2022-12-26	WOS:000412131900026
J	Valianatos, G; Valcikova, B; Growkova, K; Verlande, A; Mlcochova, J; Radova, L; Stetkova, M; Vyhnakova, M; Slaby, O; Uldrijan, S				Valianatos, Georgios; Valcikova, Barbora; Growkova, Katerina; Verlande, Amandine; Mlcochova, Jitka; Radova, Lenka; Stetkova, Monika; Vyhnakova, Michaela; Slaby, Ondrej; Uldrijan, Stjepan			A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein	PLOS ONE			English	Article							THERAPEUTIC TARGET; MICRORNAS; MELANOMA; EXPRESSION; CIPROFLOXACIN; PREDICTION; INHIBITOR; BIOMARKER; SURVIVAL; MUTATION	MdmX overexpression contributes to the development of cancer by inhibiting tumor suppressor p53. A switch in the alternative splicing of MdmX transcript, leading to the inclusion of exon 6, has been identified as the primary mechanism responsible for increased MdmX protein levels in human cancers, including melanoma. However, there are no approved drugs, which could translate these new findings into clinical applications. We analyzed the anti-melanoma activity of enoxacin, a fluoroquinolone antibiotic inhibiting the growth of some human cancers in vitro and in vivo by promoting miRNA maturation. We found that enoxacin inhibited the growth and viability of human melanoma cell lines much stronger than a structurally related fluoroquinolone ofloxacin, which only weakly modulates miRNA processing. A microarray analysis identified a set of miRNAs significantly dysregulated in enoxacin-treated A375 melanoma cells. They had the potential to target multiple signaling pathways required for cancer cell growth, among them the RNA splicing. Recent studies showed that interfering with cellular splicing machinery can result in MdmX downregulation in cancer cells. We, therefore, hypothesized that enoxacin could, by modulating miRNAs targeting splicing machinery, activate p53 in melanoma cells overexpressing MdmX. We found that enoxacin and ciprofloxacin, a related fluoroquinolone capable of promoting microRNA processing, but not ofloxacin, strongly activated wild type p53-dependent transcription in A375 melanoma without causing significant DNA damage. On the molecular level, the drugs promoted MdmX exon 6 skipping, leading to a dose-dependent downregulation of MdmX. Not only in melanoma, but also in MCF7 breast carcinoma and A2780 ovarian carcinoma cells overexpressing MdmX. Together, our results suggest that some clinically approved fluoroquinolones could potentially be repurposed as activators of p53 tumor suppressor in cancers overexpressing MdmX oncoprotein and that p53 activation might contribute to the previously reported activity of enoxacin towards human cancer cells.	[Valianatos, Georgios; Valcikova, Barbora; Growkova, Katerina; Verlande, Amandine; Stetkova, Monika; Vyhnakova, Michaela; Uldrijan, Stjepan] Masaryk Univ, Dept Biol, Fac Med, Brno, Czech Republic; [Valianatos, Georgios; Verlande, Amandine; Uldrijan, Stjepan] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic; [Mlcochova, Jitka; Radova, Lenka; Slaby, Ondrej] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic	Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno	Uldrijan, S (corresponding author), Masaryk Univ, Dept Biol, Fac Med, Brno, Czech Republic.; Uldrijan, S (corresponding author), St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic.	uldrijan@med.muni.cz	Uldrijan, Stjepan/N-1664-2016; Vallianatos, George/AAF-2973-2019	Uldrijan, Stjepan/0000-0001-8316-2539; Radova, Lenka/0000-0001-8103-148X; Valcikova, Barbora/0000-0002-1830-8084	Czech Science Foundation (GACR) [GA14-12166S]; Ministry of Education, Youth and Sports of the Czech Republic [CZ.1.07/2.3.00/30.0009]; Specific University Research Grant [MUNI/A/0810/2016]; National Program of Sustainability II project [LQ1605]; Seventh Framework Programme of the European Union (ICRC-ERA-Human Bridge) [316345]	Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Specific University Research Grant; National Program of Sustainability II project; Seventh Framework Programme of the European Union (ICRC-ERA-Human Bridge)	This work was supported by the Czech Science Foundation (GACR; Grant No. GA14-12166S), the Ministry of Education, Youth and Sports of the Czech Republic (Project POSTDOC I, grant No. CZ.1.07/2.3.00/30.0009, Specific University Research Grant No. MUNI/A/0810/2016, and the National Program of Sustainability II project No. LQ1605), and the Seventh Framework Programme of the European Union (ICRC-ERA-Human Bridge, Grant No. 316345).	Adams BD, 2014, CURR BIOL, V24, pR762, DOI 10.1016/j.cub.2014.06.043; Allende-Vega N, 2013, ONCOGENE, V32, P1, DOI 10.1038/onc.2012.38; Almalki ZS, 2016, PHARMACOEPIDEM DR S, V25, P1042, DOI 10.1002/pds.4021; Bartel F, 2005, INT J CANCER, V117, P469, DOI 10.1002/ijc.21206; Blandino G, 2014, FEBS LETT, V588, P2639, DOI 10.1016/j.febslet.2014.03.033; Bourgeois T, 2016, REGUL TOXICOL PHARM, V74, P161, DOI 10.1016/j.yrtph.2015.11.002; Caramuta S, 2010, J INVEST DERMATOL, V130, P2062, DOI 10.1038/jid.2010.63; Carr MI, 2016, TRANSL CANCER RES, V5, P707, DOI 10.21037/tcr.2016.11.75; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chandler DS, 2006, CANCER RES, V66, P9502, DOI 10.1158/0008-5472.CAN-05-4271; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Dal Bo M, 2010, BRIT J HAEMATOL, V150, P237, DOI 10.1111/j.1365-2141.2010.08185.x; Dewaele M, 2016, J CLIN INVEST, V126, P68, DOI 10.1172/JCI82534; Dutertre M, 2010, NAT STRUCT MOL BIOL, V17, P1358, DOI 10.1038/nsmb.1912; Enright AJ, 2004, GENOME BIOL, V5; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gembarska A, 2012, NAT MED, V18, P1239, DOI 10.1038/nm.2863; Grawenda AM, 2015, CANCER RES, V75, P698, DOI 10.1158/0008-5472.CAN-14-2637; Hammerova J, 2011, J DERMATOL SCI, V62, P22, DOI 10.1016/j.jdermsci.2011.01.006; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Herbold BA, 2001, MUTAT RES-GEN TOX EN, V498, P193, DOI 10.1016/S1383-5718(01)00275-3; Hoffman Y, 2014, J MOL CELL BIOL, V6, P192, DOI 10.1093/jmcb/mju020; Itoh T, 2006, MUTAT RES-GEN TOX EN, V603, P135, DOI 10.1016/j.mrgentox.2005.11.003; Jacob AG, 2014, PLOS ONE, V9; Kotala V, 2001, CELL MOL LIFE SCI, V58, P1333, DOI 10.1007/PL00000944; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Lam S, 2010, ONCOGENE, V29, P2415, DOI 10.1038/onc.2009.522; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Lenos K, 2012, CANCER RES, V72, P4074, DOI 10.1158/0008-5472.CAN-12-0215; Liu L, 2012, CANCER SCI, V103, P2056, DOI 10.1111/cas.12008; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maragkakis M, 2011, NUCLEIC ACIDS RES, V39, pW145, DOI 10.1093/nar/gkr294; McEvoy J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042739; Pajak M, 2015, R PACKAGE; Patel K, 2016, J CLIN PHARMACOL, V56, P1060, DOI 10.1002/jcph.715; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shan G, 2008, NAT BIOTECHNOL, V26, P933, DOI 10.1038/nbt.1481; Smalheiser NR, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00006; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Sousa EJ, 2013, EPIGENETICS-US, V8, P548, DOI 10.4161/epi.24519; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Voller D, 2013, BRIT J CANCER, V109, P3116, DOI 10.1038/bjc.2013.646; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Yu Q, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-71	50	13	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185801	10.1371/journal.pone.0185801	http://dx.doi.org/10.1371/journal.pone.0185801			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973015	Green Submitted, gold, Green Published			2022-12-26	WOS:000412131900055
J	Li, YY; Chen, W; Wang, YS; Luo, K; Li, Y; Bai, LY; Luo, F				Li, Yingying; Chen, Wu; Wang, Yunsheng; Luo, Kun; Li, Yue; Bai, Lianyang; Luo, Feng			Identifying and sequencing a Mycobacterium sp. strain F4 as a potential bioremediation agent for quinclorac	PLOS ONE			English	Article							HERBICIDE QUINCLORAC; SOIL; IDENTIFICATION; DEGRADATION; SYSTEMS; ESTER	Quinclorac is a widely used herbicide in rice filed. Unfortunately, quinclorac residues are phytotoxic to many crops/vegetables. The degradation of quinclorac in nature is very slow. On the other hand, degradation of quinclorac using bacteria can be an effective and efficient method to reduce its contamination. In this study, we isolated a quinclorac bioremediation bacterium strain F4 from quinclorac contaminated soils. Based on morphological characteristics and 16S rRNA gene sequence analysis, we identified strain F4 as Mycobacterium sp. We investigated the effects of temperature, pH, inoculation size and initial quinclorac concentration on growth and degrading efficiency of F4 and determined the optimal quinclorac degrading condition of F4. Under optimal degrading conditions, F4 degraded 97.38% of quinclorac from an initial concentration of 50 mg/L in seven days. Our indoor pot experiment demonstrated that the degradation products were non-phytotoxic to tobacco. After analyzing the quinclorac degradation products of F4, we proposed that F4 could employ two pathways to degrade quinclorac: one is through methylation, the other is through dechlorination. Furthermore, we reconstructed the whole genome of F4 through single molecular sequencing and de novo assembly. We identified 77 methyltransferases and eight dehalogenases in the F4 genome to support our hypothesized degradation path.	[Li, Yingying; Chen, Wu; Wang, Yunsheng; Luo, Kun; Li, Yue; Luo, Feng] Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China; [Wang, Yunsheng; Luo, Feng] Clemson Univ, Sch Comp, Clemson, SC USA; [Bai, Lianyang] Hunan Acad Agr Sci, Changsha, Hunan, Peoples R China	Hunan Agricultural University; Clemson University; Hunan Academy of Agricultural Sciences	Luo, F (corresponding author), Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China.; Luo, F (corresponding author), Clemson Univ, Sch Comp, Clemson, SC USA.; Bai, LY (corresponding author), Hunan Acad Agr Sci, Changsha, Hunan, Peoples R China.	bailianyang2005@aliyun.com; luofeng@clemson.edu			National Natural Science Foundation of China [31471789]; fund from Hunan Agricultural University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); fund from Hunan Agricultural University	This work was supported by the National Natural Science Foundation of China No. 31471789 and fund from Hunan Agricultural University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China No. 31471789 and funds from Hunan Agricultural University.	Chalut C, 2016, TUBERCULOSIS, V100, P32, DOI 10.1016/j.tube.2016.06.004; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Delcher AL, 2003, CURRENT PROTOCOLS BI, DOI DOI 10.13.11-10.13.18; Fan J, 2013, CHINESE J PESTIC SCI, V15, P316; Fan Jun, 2013, Chinese Journal of Biological Control, V29, P431; GROSSMANN K, 1995, PLANT GROWTH REGUL, V16, P183, DOI 10.1007/BF00029539; Grossmann K, 1998, WEED SCI, V46, P707, DOI 10.1017/S004317450008975X; Harris RS, 2007, IMPROVED PAIRWISE AL, DOI DOI 10.1093/molbev/msx116; Hill BD, 1998, CAN J PLANT SCI, V78, P697, DOI 10.4141/P97-119; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108012; Lu ZM, 2006, J ENVIRON SCI HEAL B, V41, P821, DOI 10.1080/03601230600805873; Lu ZM, 2003, J ENVIRON SCI HEAL B, V38, P771, DOI 10.1081/PFC-120025560; Lu ZM, 2008, PEDOSPHERE, V18, P554, DOI 10.1016/S1002-0160(08)60049-1; Pan HY, 2009, J ENVIRON SCI, V21, P307, DOI 10.1016/S1001-0742(08)62269-X; Pareja L, 2012, CHEMOSPHERE, V87, P838, DOI 10.1016/j.chemosphere.2012.01.016; Pinna MV, 2012, CHEMOSPHERE, V86, P655, DOI 10.1016/j.chemosphere.2011.11.016; Rusness DG, 1998, PESTIC BIOCHEM PHYS, V61, P115, DOI 10.1006/pest.1998.2357; Singh DK, 2008, INDIAN J MICROBIOL, V48, P35, DOI 10.1007/s12088-008-0004-7; Tatusova T., 2016, NUCLEIC ACIDS RES; Tittlemier SA, 2016, FOOD ADDIT CONTAM A, V33, P1003, DOI 10.1080/19440049.2016.1179133; Viljoen A, 2017, MOL MICROBIOLOGY; XU S-x, 2012, J SAFETY ENV, V2	23	5	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185721	10.1371/journal.pone.0185721	http://dx.doi.org/10.1371/journal.pone.0185721			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968436	gold, Green Submitted, Green Published			2022-12-26	WOS:000412029600039
J	de Michele, M; Ergintav, S; Aochi, H; Raucoules, D				de Michele, Marcello; Ergintav, Semih; Aochi, Hideo; Raucoules, Daniel			An L-band interferometric synthetic aperture radar study on the Ganos section of the north Anatolian fault zone between 2007 and 2011: Evidence for along strike segmentation and creep in a shallow fault patch	PLOS ONE			English	Article							SAN-ANDREAS FAULT; STRAIN ACCUMULATION; WESTERN TURKEY; SURFACE CREEP; EARTHQUAKE; INSAR; EVOLUTION; MARMARA; REGION; SAROS	We utilize L-band interferometric synthetic aperture radar (InSAR) data in this study to retrieve a ground velocity map for the near field of the Ganos section of the north Anatolian fault (NAF) zone. The segmentation and creep distribution of this section, which last ruptured in 1912 to generate a moment magnitude (Mw) 7.3 earthquake, remains incompletely understood. Because InSAR processing removes the mean orbital plane, we do not investigate large scale displacements due to regional tectonics in this study as these can be determined using global positioning system (GPS) data, instead concentrating on the close-tothe- fault displacement field. Our aim is to determine whether, or not, it is possible to retrieve robust near field velocity maps from stacking L-band interferograms, combining both single and dual polarization SAR data. In addition, we discuss whether a crustal velocity map can be used to complement GPS observations in an attempt to discriminate the present-day surface displacement of the Ganos fault (GF) across multiple segments. Finally, we characterize the spatial distribution of creep on shallow patches along multiple along-strike segments at shallow depths. Our results suggest the presence of fault segmentation along strike as well as creep on the shallow part of the fault (i.e. the existence of a shallow creeping patch) or the presence of a smoother section on the fault plane. Data imply a heterogeneous fault plane with more complex mechanics than previously thought. Because this study improves our knowledge of the mechanisms underlying the GF, our results have implications for local seismic hazard assessment.	[de Michele, Marcello; Aochi, Hideo; Raucoules, Daniel] French Geol Survey BRGM, Nat Risks Dept, Orleans, France; [Ergintav, Semih] Bogazici Univ, Dept Geodesy, Kandilli Observ, Istanbul, Turkey; [Ergintav, Semih] Earthquake Res Inst, Istanbul, Turkey	Bureau de Recherches Geologiques et Minieres (BRGM); Bogazici University; Bogazici University	de Michele, M (corresponding author), French Geol Survey BRGM, Nat Risks Dept, Orleans, France.	m.demichele@brgm.fr	ergintav, semih/P-9315-2015; Aochi, Hideo/A-3281-2011; Raucoules, Daniel/G-6366-2010	ergintav, semih/0000-0001-7080-183X; Aochi, Hideo/0000-0001-9405-9596; Raucoules, Daniel/0000-0003-1715-3743	EU [308417]	EU(European Commission)	This study was conducted within the context of the EU 7th framework program project MARSite: New Directions in Seismic Hazard assessment through Focused Earth Observation in the Marmara Supersite (Grant agreement no: 308417).; This study was conducted within the context of the EU 7 th framework program project 'MARSite: New Directions in Seismic Hazard assessment through Focused Earth Observation in the Marmara Supersite' (Grant agreement no: 308417). ALOS PALSAR radar data are available from the Japanese Aerospace Exploration Agency (JAXA). We are thankful to JAXA for providing ALOS PALSAR data. Original ALOS radar data are copyright JAXA and were provided under Marmara Supersite Grant agreement no: 308417. We made raw interferograms available to the public on the MARsite.eu/publications website.	Aksoy ME, 2010, GEOLOGY, V38, P991, DOI 10.1130/G31447.1; AMBRASEYS NN, 1987, EARTHQUAKE ENG STRUC, V15, P189, DOI 10.1002/eqe.4290150204; Armijo R, 1999, GEOLOGY, V27, P267, DOI 10.1130/0091-7613(1999)027<0267:WPOTNA>2.3.CO;2; Barbot S, 2013, J GEOPHYS RES-SOL EA, V118, P6311, DOI 10.1002/2013JB010442; BARKA AA, 1988, TECTONICS, V7, P663, DOI 10.1029/TC007i003p00663; Barka AA, 1992, ANN TECTONICAE, P164; Bilham R, 2016, J GEOPHYS RES-SOL EA, V121, P7409, DOI 10.1002/2016JB013394; Cakir Z, 2005, EARTH PLANET SC LETT, V238, P225, DOI 10.1016/j.epsl.2005.06.044; Costantini M., 1999, IEEE 1999 International Geoscience and Remote Sensing Symposium. IGARSS'99 (Cat. No.99CH36293), P267, DOI 10.1109/IGARSS.1999.773467; de Michele M, 2011, EARTH PLANET SC LETT, V308, P141, DOI 10.1016/j.epsl.2011.05.049; De Michele M, 2013, REMOTE SENS LETT, V4, P863, DOI 10.1080/2150704X.2013.808777; Doin MP, 2009, J APPL GEOPHYS, V69, P35, DOI 10.1016/j.jappgeo.2009.03.010; Ergintav S, 2014, GEOPHYS RES LETT, V41, P5783, DOI 10.1002/2014GL060985; Farr T.G., 2000, EOS T AM GEOPHYS UN, V81, P583, DOI [DOI 10.1029/EO081I048P00583, 10.1029/EO081i048p00583]; Hussain E, 2016, J GEOPHYS RES-SOL EA, V121, P9000, DOI 10.1002/2016JB013108; Janssen C, 2009, J STRUCT GEOL, V31, P9, DOI 10.1016/j.jsg.2008.09.010; Le Mouelic S, 2005, PHOTOGRAMM ENG REM S, V71, P197, DOI 10.14358/PERS.71.2.197; Massonnet D, 1998, REV GEOPHYS, V36, P441, DOI 10.1029/97RG03139; Meghraoui M, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003960; Meyer FJ, 2013, IEEE T GEOSCI REMOTE, V51, P4961, DOI 10.1109/TGRS.2013.2252469; Motagh M, 2007, EARTH PLANET SC LETT, V255, P432, DOI 10.1016/j.epsl.2007.01.003; Okay AI, 2004, TECTONOPHYSICS, V391, P259, DOI 10.1016/j.tecto.2004.07.016; Puyssegur B, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004352; Reilinger RE, 2000, SCIENCE, V289, P1519, DOI 10.1126/science.289.5484.1519; Rousset B, 2016, GEOPHYS RES LETT, V43, P3254, DOI 10.1002/2016GL068250; Smith-Konter BR, 2011, J GEOPHYS RES-SOL EA, V116, DOI [10.1029/2010JB00S117, 10.1029/2010JB008117]; Stein RS, 1997, GEOPHYS J INT, V128, P594, DOI 10.1111/j.1365-246X.1997.tb05321.x; Tuysuz O, 1998, TECTONOPHYSICS, V293, P105, DOI 10.1016/S0040-1951(98)00085-7; Wegmuuller U., 2009, P ALOS PI S 2009 NOV; Werner C. L., 2002, P EUSAR C JUN 4 6 CO; Yaltirak C, 2002, MAR GEOL, V190, P351, DOI 10.1016/S0025-3227(02)00354-7; Zebker HA, 1997, J GEOPHYS RES-SOL EA, V102, P7547, DOI 10.1029/96JB03804	32	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185422	10.1371/journal.pone.0185422	http://dx.doi.org/10.1371/journal.pone.0185422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961264	Green Published, gold, Green Submitted			2022-12-26	WOS:000412027700018
J	Panayi, E; Peters, GW; Kyriakides, G				Panayi, Efstathios; Peters, Gareth W.; Kyriakides, George			Statistical modelling for precision agriculture: A case study in optimal environmental schedules for Agaricus Bisporus production via variable domain functional regression	PLOS ONE			English	Article							FOOD-INDUSTRY; MUSHROOM; CULTIVATION; SUBSTRATE; TIME	Quantifying the effects of environmental factors over the duration of the growing process on Agaricus Bisporus (button mushroom) yields has been difficult, as common functional data analysis approaches require fixed length functional data. The data available from commercial growers, however, is of variable duration, due to commercial considerations. We employ a recently proposed regression technique termed Variable-Domain Functional Regression in order to be able to accommodate these irregular-length datasets. In this way, we are able to quantify the contribution of covariates such as temperature, humidity and water spraying volumes across the growing process, and for different lengths of growing processes. Our results indicate that optimal oxygen and temperature levels vary across the growing cycle and we propose environmental schedules for these covariates to optimise overall yields.	[Panayi, Efstathios; Peters, Gareth W.; Kyriakides, George] UCL, Dept Stat Sci, London, England; [Kyriakides, George] Kyiakides Mushrooms Ltd, Larnaka, Cyprus	University of London; University College London	Peters, GW (corresponding author), UCL, Dept Stat Sci, London, England.	gareth.peters@ucl.ac.uk		Peters, Gareth/0000-0003-2768-8979	Kyiakides Mushrooms Ltd.	Kyiakides Mushrooms Ltd.	The author(s) received no specific funding for this work. Kyiakides Mushrooms Ltd. provided support in the form of salaries for author GK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the `author contributions' section.	[Anonymous], 1993, NONPARAMETRIC REGRES; [Anonymous], 2004, MUSHROOMS CULTIVATIO; Aqeel-ur-Rehman, 2014, COMPUT STAND INTER, V36, P263, DOI 10.1016/j.csi.2011.03.004; ATKEY PT, 1983, J APPL BACTERIOL, V55, P293, DOI 10.1111/j.1365-2672.1983.tb01326.x; Braaksma A, 1999, POSTHARVEST BIOL TEC, V16, P195, DOI 10.1016/S0925-5214(99)00019-8; CAREY A T, 1991, P673; Chang ST, 1978, BIOL CULTIVATION EDI; Chaudhary D.D., 2011, INT J WIRELESS MOBIL, V3, P140, DOI [DOI 10.5121/IJWMN.2011.3113, 10.5121/ijwmn.2011.3113140]; Coffey N, 2011, HUM MOVEMENT SCI, V30, P1144, DOI 10.1016/j.humov.2010.11.005; de Boor C, 2001, MATH MOD METH APPL S, V11, P33, DOI 10.1142/S0218202501000726; Duchon J, 1977, CONSTRUCTIVE THEORY, P85, DOI DOI 10.1007/BFB0086566; FLEGG PB, 1956, J SOIL SCI, V7, P168, DOI 10.1111/j.1365-2389.1956.tb00872.x; Gao ZK, 2017, CHAOS, V27, DOI 10.1063/1.4977950; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35622; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gellar JE, 2014, J AM STAT ASSOC, V109, P1425, DOI 10.1080/01621459.2014.940044; GERRITS J. P. G., 1967, Mushroom Science, V6, P225; Gulser CK, 2003, BIORESOURCE TECHNOL, V88, P153, DOI 10.1016/S0960-8524(02)00279-1; James GM, 2002, J ROY STAT SOC B, V64, P411, DOI 10.1111/1467-9868.00342; Lin FC, 2000, SCIENCE AND CULTIVATION OF EDIBLE FUNGI, VOLS 1 AND 2, P955; Morris JS, 2015, ANNU REV STAT APPL, V2, P321, DOI 10.1146/annurev-statistics-010814-020413; Muller HG, 2005, ANN STAT, V33, P774, DOI 10.1214/009053604000001156; NOBLE R, 1991, SCI HORTIC-AMSTERDAM, V46, P177, DOI 10.1016/0304-4238(91)90040-6; Panayi E, 2015, LIQUIDITY C IN PRESS; Peyvast G, 2007, BIOSCIENCES BIOTECHN, V4; Ramsay J. O, 2006, FUNCTIONAL DATA ANAL; RAMSAY JO, 1991, J ROY STAT SOC B MET, V53, P539; Ramsay JO, 2002, APPL FUNCTIONAL DATA, V77; RICE JA, 1991, J ROY STAT SOC B MET, V53, P233; Royse D. J., 2014, Proceedings of 8th International Conference on Mushroom Biology and Mushroom Products (ICMBMP8), New Delhi, India, 19-22 November 2014. Volume I & II, P1; Ruiz-Garcia L, 2009, SENSORS-BASEL, V9, P4728, DOI 10.3390/s90604728; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Sassine Y., 2005, J APPL SCI RES, V1, P277; Sharma HS, 2000, CAN J MICROBIOL, V46, P515, DOI 10.1139/cjm-46-6-515; Singh P, 2010, J SCI FOOD AGR, V90, P1393, DOI 10.1002/jsfa.3971; STAMETS P., 1983, MUSHROOM CULTIVATOR; Taherzadeh L., 2013, International Journal of Agriculture and Crop Sciences (IJACS), V5, P656; Tuhy L, 2015, ECOL ENG, V84, P370, DOI 10.1016/j.ecoleng.2015.09.032; Vedder P.J.C., 1978, MODERN MUSHROOM GROW; Vellidis G, 2008, COMPUT ELECTRON AGR, V61, P44, DOI 10.1016/j.compag.2007.05.009; Visscher H.R., 1988, CULTIVATION MUSHROOM, P29; Wang N, 2006, COMPUT ELECTRON AGR, V50, P1, DOI 10.1016/j.compag.2005.09.003; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood S.N., 2001, R R NEWS, V1, P20; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374; Wuest P.J., 1996, MUSHROOM NEWS, V44, P16; Zhang YQ, 2014, SUSTAINABILITY-BASEL, V6, P2961, DOI 10.3390/su6052961	47	3	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0181921	10.1371/journal.pone.0181921	http://dx.doi.org/10.1371/journal.pone.0181921			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961254	Green Published, Green Submitted, gold			2022-12-26	WOS:000412027700002
J	Nguyen, MQ; Wu, YM; Bonilla, LS; von Buchholtz, LJ; Ryba, NJP				Nguyen, Minh Q.; Wu, Youmei; Bonilla, Lauren S.; von Buchholtz, Lars J.; Ryba, Nicholas J. P.			Diversity amongst trigeminal neurons revealed by high throughput single cell sequencing	PLOS ONE			English	Article							TRPM8-EXPRESSING SENSORY NEURONS; RNA-SEQ; TRANSCRIPTOME ANALYSIS; MOLECULAR SIGNATURES; TRP CHANNELS; PAIN; COLD; RECEPTOR; TOUCH; THERMOSENSATION	The trigeminal ganglion contains somatosensory neurons that detect a range of thermal, mechanical and chemical cues and innervate unique sensory compartments in the head and neck including the eyes, nose, mouth, meninges and vibrissae. We used single-cell sequencing and in situ hybridization to examine the cellular diversity of the trigeminal ganglion in mice, defining thirteen clusters of neurons. We show that clusters are well conserved in dorsal root ganglia suggesting they represent distinct functional classes of somatosensory neurons and not specialization associated with their sensory targets. Notably, functionally important genes (e.g. the mechanosensory channel Piezo2 and the capsaicin gated ion channel Trpv1) segregate into multiple clusters and often are expressed in subsets of cells within a cluster. Therefore, the 13 genetically-defined classes are likely to be physiologically heterogeneous rather than highly parallel (i.e., redundant) lines of sensory input. Our analysis harnesses the power of single-cell sequencing to provide a unique platform for in silico expression profiling that complements other approaches linking gene-expression with function and exposes unexpected diversity in the somatosensory system.	[Nguyen, Minh Q.; Wu, Youmei; Bonilla, Lauren S.; von Buchholtz, Lars J.; Ryba, Nicholas J. P.] Natl Inst Dent & Craniofacial Res, Taste & Smell Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Ryba, NJP (corresponding author), Natl Inst Dent & Craniofacial Res, Taste & Smell Sect, NIH, Bethesda, MD 20892 USA.	nick.ryba@nih.gov		Ryba, Nicholas/0000-0002-2060-8393; Bonilla, Lauren/0000-0002-9151-9603	National Institutes of Health, National Institute of Dental and Craniofacial Research [ZIA-DE000561]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Intramural program of the National Institutes of Health, National Institute of Dental and Craniofacial Research (N.J.P.R.) ZIA-DE000561. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Cao J, 2017, BIORXIV; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Chiu IM, 2014, ELIFE, V3, DOI 10.7554/eLife.04660; Coste B, 2010, SCIENCE NEW YORK NY, V330; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; Euler T, 2014, NAT REV NEUROSCI, V15, P507, DOI 10.1038/nrn3783; Goswami SC, 2014, J PAIN, V15, P1338, DOI 10.1016/j.jpain.2014.09.010; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Knowlton WM, 2013, J NEUROSCI, V33, P2837, DOI 10.1523/JNEUROSCI.1943-12.2013; Lacar B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11022; Li CL, 2016, CELL RES, V26, P83, DOI 10.1038/cr.2015.149; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; McGlone F, 2014, NEURON, V82, P737, DOI 10.1016/j.neuron.2014.05.001; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Osteen JD, 2016, NATURE, V534, P494, DOI 10.1038/nature17976; Pogorzala LA, 2013, J NEUROSCI, V33, P5533, DOI 10.1523/JNEUROSCI.5788-12.2013; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Viana F, 2011, ACS CHEM NEUROSCI, V2, P38, DOI 10.1021/cn100102c; Waltman L, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40829-0; Weng HJ, 2015, NEURON, V85, P833, DOI 10.1016/j.neuron.2014.12.065; Xing H, 2006, J NEUROPHYSIOL, V95, P1221, DOI 10.1152/jn.01035.2005; Yarmolinsky DA, 2016, NEURON, V92, P1079, DOI 10.1016/j.neuron.2016.10.021	39	83	82	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185543	10.1371/journal.pone.0185543	http://dx.doi.org/10.1371/journal.pone.0185543			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957441	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200081
J	Stepanova, EV; Kondrashin, AV; Sergiev, VP; Morozova, LF; Turbabina, NA; Maksimova, MS; Brazhnikov, AI; Shevchenko, SB; Morozov, EN				Stepanova, Ekaterina V.; Kondrashin, Anatoly V.; Sergiev, Vladimir P.; Morozova, Lola F.; Turbabina, Natalia A.; Maksimova, Maria S.; Brazhnikov, Alexey I.; Shevchenko, Sergei B.; Morozov, Evgeny N.			Significance of chronic toxoplasmosis in epidemiology of road traffic accidents in Russian Federation	PLOS ONE			English	Article							LATENT TOXOPLASMOSIS; HUMAN PERSONALITY; GONDII; BEHAVIOR; PARASITE; HUMANS; RISK	Studies carried out in Moscow residents have revealed that the prevalence of chronic toxoplasmosis is very close to those in countries of Eastern and Central Europe. Our findings also demonstrated a statistically significant relationship between the rate of traffic accidents and the seroprevalence of chronic toxoplasmosis in drivers who were held responsible for accidents. The latter was 2.37 times higher in drivers who were involved in road accidents compared with control groups. These results suggest that the consequences of chronic toxoplasmosis (particularly a slower reaction time and decreased concentration) might contribute to the peculiarities of the epidemiology of road traffic accidents in the Russian Federation and might interfere with the successful implementation of the Federal Programme named "Increase road traffic safety" . Suggestions for how to address overcome this problem are discussed in this paper.	[Stepanova, Ekaterina V.; Kondrashin, Anatoly V.; Turbabina, Natalia A.; Maksimova, Maria S.; Shevchenko, Sergei B.] IM Sechenov First Moscow State Med Univ, Martsinovsky Inst Med Parasitol Trop & Vector Bor, Moscow, Russia; [Sergiev, Vladimir P.; Morozova, Lola F.; Morozov, Evgeny N.] IM Sechenov First Moscow State Med Univ, Dept Trop Med & Parasit Dis, Moscow, Russia; [Brazhnikov, Alexey I.] IM Sechenov First Moscow State Med Univ, Dept Epidemiol & Evidence Based Med, Moscow, Russia; [Morozov, Evgeny N.] Russian Med Acad Continuous Profess Educ, Dept Trop Parasit Dis & Disinfectol, Moscow, Russia	Sechenov First Moscow State Medical University; Sechenov First Moscow State Medical University; Sechenov First Moscow State Medical University	Morozov, EN (corresponding author), IM Sechenov First Moscow State Med Univ, Dept Trop Med & Parasit Dis, Moscow, Russia.; Morozov, EN (corresponding author), Russian Med Acad Continuous Profess Educ, Dept Trop Parasit Dis & Disinfectol, Moscow, Russia.	emorozov@mail.ru	Morozova, Lola/C-7721-2014; Stepanova, Ekaterina/U-5837-2017; Morozova, Lola/M-4181-2019; Sergiev, Vladimir P./U-5520-2017; Morozov, Evgeny N./B-8483-2016; Turbabina, Natalia/T-9713-2017; Maria, Maksimova/T-9339-2017; Brazhnikov, Alexey I./U-9620-2017	Morozova, Lola/0000-0003-3033-1401; Stepanova, Ekaterina/0000-0002-5893-5517; Morozova, Lola/0000-0003-3033-1401; Morozov, Evgeny N./0000-0002-1324-9142; Turbabina, Natalia/0000-0002-7834-7560; Maria, Maksimova/0000-0002-9182-5184; Brazhnikov, Alexey I./0000-0002-5587-8860; Sergiev, Vladimir/0000-0002-1163-8419				Galvan-Ramirez MD, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-294; Dolgikh T. I., 2008, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P19; Flegr J, 1996, PARASITOLOGY, V113, P49, DOI 10.1017/S0031182000066269; Flegr J, 2003, BIOL PSYCHOL, V63, P253, DOI 10.1016/S0301-0511(03)00075-9; Flegr J, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-11; FLEGR J, 1994, FOLIA PARASIT, V41, P122; Flegr J, 2008, PARASITOLOGY, V135, P427, DOI 10.1017/S0031182007004064; Flegr J, 1999, FOLIA PARASIT, V46, P22; Flegr J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090203; Flegr J, 2013, J EXP BIOL, V216, P127, DOI 10.1242/jeb.073635; Flegr J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-72; Havlicek J, 2001, PARASITOLOGY, V122, P515, DOI 10.1017/S0031182001007624; Kocazeybek B, 2009, FORENSIC SCI INT, V187, P103, DOI 10.1016/j.forsciint.2009.03.007; Lafferty KD, 2006, P ROY SOC B-BIOL SCI, V273, P2749, DOI 10.1098/rspb.2006.3641; Novotna M, 2008, PARASITOLOGY, V135, P1253, DOI 10.1017/S003118200800485X; Rasouli MR, 2008, CHIN J TRAUMATOL, V11, P131, DOI 10.1016/S1008-1275(08)60028-0; Russian Federation Programme, INCR SAF ROADS; Sergiev V, 2010, MED PARASITOL, V3, P48; Sergiev V, 2008, PARASITIC DIS MAN PR; Sergiev V, 2010, J MICROB EPIDEM IMMU, V3, P108; Sergiev V, 2010, MAN HIS PARASITES CO; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Webster JP, 2010, FOLIA PARASIT, V57, P95, DOI 10.14411/fp.2010.012; WEBSTER JP, 1994, PARASITOLOGY, V109, P37, DOI 10.1017/S003118200007774X; WHO, 2013, WHO ROAD SAF EST ROA; Yereli K, 2006, FORENSIC SCI INT, V163, P34, DOI 10.1016/j.forsciint.2005.11.002	27	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184930	10.1371/journal.pone.0184930	http://dx.doi.org/10.1371/journal.pone.0184930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957427	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200022
J	Venkatesan, N; Wong, JF; Tan, KP; Chung, HH; Yau, YH; Cukuroglu, E; Allahverdi, A; Nordenskiold, L; Goke, J; Geifman-Shochat, S; Lin, VCL; Madhusudhan, MS; Su, IH				Venkatesan, N.; Wong, J. F.; Tan, K. P.; Chung, H. H.; Yau, Y. H.; Cukuroglu, E.; Allahverdi, A.; Nordenskiold, L.; Goke, J.; Geifman-Shochat, S.; Lin, V. C. L.; Madhusudhan, M. S.; Su, I-h			EZH2 promotes neoplastic transformation through VAV interaction-dependent extranuclear mechanisms	ONCOGENE			English	Article							GROUP PROTEIN EZH2; C-MYC PROMOTER; ACUTE LYMPHOBLASTIC-LEUKEMIA; EMBRYONIC STEM-CELLS; POLYCOMB GROUP GENE; PROSTATE-CANCER; TYROSINE PHOSPHORYLATION; BREAST-CANCER; H3K27 METHYLATION; E-CADHERIN	Recently, we reported that the histone methyltransferase, EZH2, controls leukocyte migration through interaction with the cytoskeleton remodeling effector, VAV, and direct methylation of the cytoskeletal regulatory protein, Talin. However, it is unclear whether this extranuclear, epigenetic-independent function of EZH2 has a profound impact on the initiation of cellular transformation and metastasis. Here, we show that EZH2 increases Talin1 methylation and cleavage, thereby enhancing adhesion turnover and promoting accelerated tumorigenesis. This transforming capacity is abolished by targeted disruption of EZH2 interaction with VAV. Furthermore, our studies demonstrate that EZH2 in the cytoplasm is closely associated with cancer stem cell properties, and that overexpression of EZH2, a mutant EZH2 lacking its nuclear localization signal (EZH2 Delta NLS), or a methylmimicking Talin1 mutant substantially promotes JAK2-dependent STAT3 activation and cellular transformation. Taken together, our results suggest a critical role for the VAV interaction-dependent, extranuclear action of EZH2 in neoplastic transformation.	[Venkatesan, N.; Wong, J. F.; Chung, H. H.; Yau, Y. H.; Allahverdi, A.; Nordenskiold, L.; Geifman-Shochat, S.; Lin, V. C. L.; Su, I-h] Nanyang Technol Univ, Coll Sci, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore; [Tan, K. P.; Madhusudhan, M. S.] Agcy Sci Technol & Res, Biopolis, Bioinformat Inst, Singapore, Singapore; [Tan, K. P.] Nanyang Technol Univ, Sch Comp Engn, Singapore, Singapore; [Cukuroglu, E.; Goke, J.] Agcy Sci Technol & Res, Biopolis, Genome Inst Singapore, Singapore, Singapore; [Goke, J.] Natl Canc Ctr Singapore, Singapore, Singapore; [Madhusudhan, M. S.] Indian Inst Sci Educ & Res, Pune, Maharashtra, India; [Madhusudhan, M. S.] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National Cancer Centre Singapore (NCCS); Indian Institute of Science Education & Research (IISER) Pune; National University of Singapore	Su, IH (corresponding author), Nanyang Technol Univ, Coll Sci, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	ihsu@ntu.edu.sg	Allahverdi, Abdollah/AAE-1244-2022; Chun Ling, Valerie Lin/A-2188-2011; NORDENSKIÖLD, LARS/ABD-4725-2020; Su, I-hsin/A-2207-2011; Hoe, YAU Yin/A-2817-2011	NORDENSKIÖLD, LARS/0000-0002-3681-209X; Su, I-hsin/0000-0002-5894-9580; Hoe, YAU Yin/0000-0001-8136-2393; Goke, Jonathan/0000-0002-0825-4991; Wong, Jong Fu/0000-0001-6539-5865	Singapore Agency for Science Technology and Research (A*STAR) through a Biomedical Research Council (BMRC) grant [10/1/22/19/666]; Singapore Ministry of Education [MOE2009-T21-034, MOE2013-T2-2-038]; Ministry of Health, National Medical Research Council [NMRC-CBRG/0057/201]	Singapore Agency for Science Technology and Research (A*STAR) through a Biomedical Research Council (BMRC) grant(Agency for Science Technology & Research (A*STAR)); Singapore Ministry of Education(Ministry of Education, Singapore); Ministry of Health, National Medical Research Council	We thank S Stromblad for critical reading, discussions and comments on the manuscript; Y Zhang (Harvard University) for the EZH2, SUZ12 and EED baculovirus expression vectors; we thank Y Or for providing BALB/c mice and technical support, LY Lu for advice on statistical analysis and A Sullivan from Obrizus Communications for editing the manuscript. This work was supported by the Singapore Agency for Science Technology and Research (A*STAR) through a Biomedical Research Council (BMRC) grant (10/1/22/19/666) to LN, Singapore Ministry of Education (MOE2009-T21-034 and MOE2013-T2-2-038) and Ministry of Health, National Medical Research Council (NMRC-CBRG/0057/201)to I-hS.	Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Boddicker RL, 2016, BLOOD, V128, P1234, DOI 10.1182/blood-2016-03-707141; Campbell JD, 2016, NAT GENET, V48, P607, DOI 10.1038/ng.3564; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4127; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Chang KH, 2012, BLOOD, V120, P800, DOI 10.1182/blood-2011-06-361709; Chen YH, 2012, AM J TRANSL RES, V4, P364; Chen YT, 2016, CANCER CHEMOTH PHARM, V77, P757, DOI 10.1007/s00280-016-2990-1; Chou RH, 2011, AM J TRANSL RES, V3, P243; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Citterio C, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002962; Dasgupta M, 2015, P NATL ACAD SCI USA, V112, P3985, DOI 10.1073/pnas.1503152112; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; de Vries NA, 2015, CELL REP, V10, P383, DOI 10.1016/j.celrep.2014.12.028; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gonzalez ME, 2014, P NATL ACAD SCI USA, V111, P3098, DOI 10.1073/pnas.1308953111; Groysman M, 1998, ONCOGENE, V17, P1597, DOI 10.1038/sj.onc.1202074; Gunawan M, 2015, NAT IMMUNOL, V16, P505, DOI 10.1038/ni.3125; HARRINGTON EA, 1994, CURR OPIN GENET DEV, V4, P120, DOI 10.1016/0959-437X(94)90100-7; He AB, 2012, GENE DEV, V26, P37, DOI 10.1101/gad.173930.111; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Hobert O, 1996, MOL CELL BIOL, V16, P3066; Hobert O, 1996, MECH DEVELOP, V55, P171, DOI 10.1016/0925-4773(96)00499-6; Hock H, 2012, GENE DEV, V26, P751, DOI 10.1101/gad.191163.112; Hsieh FC, 2005, BIOCHEM BIOPH RES CO, V335, P292, DOI 10.1016/j.bbrc.2005.07.075; Huq MDM, 2007, MOL CELL PROTEOMICS, V6, P677, DOI 10.1074/mcp.M600223-MCP200; Jain N, 2013, P NATL ACAD SCI USA, V110, P11349, DOI 10.1073/pnas.1300801110; Jiao LY, 2015, SCIENCE, V350, DOI 10.1126/science.aac4383; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kataoka K, 2015, NAT GENET, V47, P1304, DOI 10.1038/ng.3415; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Lee JM, 2012, MOL CELL, V48, P572, DOI 10.1016/j.molcel.2012.09.004; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Lee TC, 1999, J BIOL CHEM, V274, P595, DOI 10.1074/jbc.274.2.595; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lock JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090593; Masuda H, 2012, BREAST CANCER RES TR, V136, P331, DOI 10.1007/s10549-012-2289-9; MATSUGUCHI T, 1995, EMBO J, V14, P257, DOI 10.1002/j.1460-2075.1995.tb06999.x; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Menacho-Marquez M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001615; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nagano Makoto, 2012, Int J Cell Biol, V2012, P310616, DOI 10.1155/2012/310616; Natsume A, 2013, CANCER RES, V73, P4559, DOI 10.1158/0008-5472.CAN-13-0109; Nicolaidou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039871; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Rangel LBA, 2003, CLIN CANCER RES, V9, P2567; Ren G, 2012, CANCER RES, V72, P3091, DOI 10.1158/0008-5472.CAN-11-3546; Rodriguez JL, 2006, BIOCHEM J, V398, P431, DOI 10.1042/BJ20060380; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Su I, 2006, CURR OPIN IMMUNOL, V18, P152, DOI 10.1016/j.coi.2006.01.012; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tanos B, 2008, ONCOGENE, V27, P6939, DOI 10.1038/onc.2008.345; Thalappilly S, 2010, ONCOGENE, V29, P2528, DOI 10.1038/onc.2010.1; Toh TB, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0596-9; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vergani L, 2004, INT J BIOCHEM CELL B, V36, P1447, DOI 10.1016/j.biocel.2003.11.015; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wassef M, 2015, GENE DEV, V29, P2547, DOI 10.1101/gad.269522.115; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107; Yoo KH, 2012, INT J BIOL SCI, V8, P59, DOI 10.7150/ijbs.8.59; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang Y, 2011, J BIOL CHEM, V286, P42414, DOI 10.1074/jbc.M111.271064; Zhao ED, 2016, NAT IMMUNOL, V17, P95, DOI 10.1038/ni.3313; Zhu PP, 2016, NAT STRUCT MOL BIOL, V23, P631, DOI 10.1038/nsmb.3235	81	10	10	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 25	2018	37	4					461	477		10.1038/onc.2017.309	http://dx.doi.org/10.1038/onc.2017.309			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT7KP	28967906	Green Accepted			2022-12-26	WOS:000423331600005
J	Arbez, N; Ratovitski, T; Roby, E; Chighladze, E; Stewart, JC; Ren, M; Wang, XF; Lavery, DJ; Ross, CA				Arbez, Nicolas; Ratovitski, Tamara; Roby, Elaine; Chighladze, Ekaterine; Stewart, Jacqueline C.; Ren, Mark; Wang, Xiaofang; Lavery, Daniel J.; Ross, Christopher A.			Post-translational modifications clustering within proteolytic domains decrease mutant huntingtin toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Huntington disease; neurodegeneration; neuron; phosphorylation; toxicity	QUANTITATIVE PROTEOMIC ANALYSIS; MITOCHONDRIAL DYNAMICS; N-17 DOMAIN; DISEASE; PHOSPHORYLATION; FRAGMENTS; CASPASE-6; PROTEIN; MICE; HD	Huntington's disease (HD) is caused in large part by a polyglutamine expansion within the huntingtin (Htt) protein. Post-translational modifications (PTMs) control and regulate many protein functions and cellular pathways, and PTMs of mutant Htt are likely important modulators of HD pathogenesis. Alterations of selected numbers of PTMs of Htt fragments have been shown to modulate Htt cellular localization and toxicity. In this study, we systematically introduced site-directed alterations in individual phosphorylation and acetylation sites in full-length Htt constructs. The effects of each of these PTM alteration constructs were tested on cell toxicity using our nuclear condensation assay and on mitochondrial viability by measuring mitochondrial potential and size. Using these functional assays in primary neurons, we identified several PTMs whose alteration can block neuronal toxicity and prevent potential loss and swelling of the mitochondria caused by mutant Htt. These PTMs included previously described sites such as serine 116 and newly found sites such as serine 2652 throughout the protein. We found that these functionally relevant sites are clustered in protease-sensitive domains throughout full-length Htt. These findings advance our understanding of the Htt PTM code and its role in HD pathogenesis. Because PTMs are catalyzed by enzymes, the toxicity-modulating Htt PTMs identified here may be promising therapeutic targets for managing HD.	[Arbez, Nicolas; Ratovitski, Tamara; Roby, Elaine; Chighladze, Ekaterine; Stewart, Jacqueline C.; Wang, Xiaofang; Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Neurobiol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; [Ren, Mark] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Lavery, Daniel J.] CHDI Management Inc, CHDI Fdn, Princeton, NJ 08540 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Cornell University	Arbez, N; Ross, CA (corresponding author), CMSC 8-121,600 N Wolfe St, Baltimore, MD 21287 USA.	narbez1@jhmi.edu; caross@jhu.edu		Ren, Mark/0000-0003-0179-3471; Lavery, Daniel J./0000-0002-4218-0527	CHDI Foundation, Inc.; National Institutes of Health [R01 NS086452]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086452] Funding Source: NIH RePORTER	CHDI Foundation, Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the CHDI Foundation, Inc. and by National Institutes of Health Grant R01 NS086452. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aharony I, 2015, HUM MOL GENET, V24, P2604, DOI 10.1093/hmg/ddv023; Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Anne SL, 2007, J NEUROSCI, V27, P7318, DOI 10.1523/JNEUROSCI.1831-07.2007; Aronin N, 2014, MOVEMENT DISORD, V29, P1455, DOI 10.1002/mds.26020; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Colin E, 2005, EUR J NEUROSCI, V21, P1478, DOI 10.1111/j.1460-9568.2005.03985.x; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Dickey AS, 2016, NAT MED, V22, P37, DOI 10.1038/nm.4003; DiGiovanni LF, 2016, HUM MOL GENET, V25, P3937, DOI 10.1093/hmg/ddw234; Dong GF, 2012, PROTEOMICS, V12, P2060, DOI 10.1002/pmic.201100380; Duan WZ, 2014, MOVEMENT DISORD, V29, P1366, DOI 10.1002/mds.25992; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Ehrnhoefer DE, 2011, NEUROSCIENTIST, V17, P475, DOI 10.1177/1073858410390378; Ehrnhoefer DE, 2009, DIS MODEL MECH, V2, P123, DOI 10.1242/dmm.002451; El-Daher MT, 2015, EMBO J, V34, P2255, DOI 10.15252/embj.201490808; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Halliday GM, 1998, EXP NEUROL, V154, P663, DOI 10.1006/exnr.1998.6919; Hasegawa M, 2011, J MOL NEUROSCI, V45, P480, DOI 10.1007/s12031-011-9571-x; Huang B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121055; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jin J, 2016, NEUROMOL MED, V18, P581, DOI 10.1007/s12017-016-8412-z; Kasahara A, 2014, TRENDS CELL BIOL, V24, P761, DOI 10.1016/j.tcb.2014.08.005; Kratter IH, 2016, J CLIN INVEST, V126, P3585, DOI 10.1172/JCI80339; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maiuri T, 2013, HUM MOL GENET, V22, P1383, DOI 10.1093/hmg/dds554; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; Nucifora LG, 2012, J BIOL CHEM, V287, P16017, DOI 10.1074/jbc.M111.252577; Orr AL, 2008, J NEUROSCI, V28, P2783, DOI 10.1523/JNEUROSCI.0106-08.2008; Ratovitski T, 2017, J PROTEOME RES, V16, P2692, DOI 10.1021/acs.jproteome.6b00991; Ratovitski T, 2016, J PROTEOME RES, V15, P3266, DOI 10.1021/acs.jproteome.6b00448; Ratovitski T, 2012, CELL CYCLE, V11, P2006, DOI 10.4161/cc.20423; Ratovitski T, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.185348; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Saudou F, 2016, NEURON, V89, P910, DOI 10.1016/j.neuron.2016.02.003; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Seong IS, 2010, HUM MOL GENET, V19, P573, DOI 10.1093/hmg/ddp524; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tebbenkamp ATN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050750; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Vijayvargia R, 2016, ELIFE, V5, DOI 10.7554/eLife.11184; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P55, DOI 10.1007/s00401-007-0306-6; Warby SC, 2008, HUM MOL GENET, V17, P2390, DOI 10.1093/hmg/ddn139; Watkin EE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088284; Xu Y, 2015, J NEUROCHEM, V135, P4, DOI 10.1111/jnc.13234; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702	54	32	32	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19238	19249		10.1074/jbc.M117.782300	http://dx.doi.org/10.1074/jbc.M117.782300			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972180	Green Published, hybrid			2022-12-26	WOS:000416226700008
J	Tsai, WC; Reineke, LC; Jain, A; Jung, SY; Lloyd, RE				Tsai, Wei-Chih; Reineke, Lucas C.; Jain, Antrix; Jung, Sung Yun; Lloyd, Richard E.			Histone arginine demethylase JMJD6 is linked to stress granule assembly through demethylation of the stress granule-nucleating protein G3BP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						post-translational modification (PTM); protein methylation; RNA-binding protein; stress granule; stress response; demethylase	DOMAIN-CONTAINING PROTEIN; RNA-BINDING PROTEINS; CELL-FREE FORMATION; MESSENGER-RNA; TRANSLATION INITIATION; PHOSPHATIDYLSERINE RECEPTOR; EIF2-ALPHA PHOSPHORYLATION; PHASE-SEPARATION; METHYLATION; COMPLEXES	Stress granules (SG) are membrane-less organelles that are condensates of stalled translation initiation complexes and mRNAs. SG formation is a cytoprotective response to environmental stress and results from protein interactions involving regions of low amino acid complexity and poorly defined post-translational modifications of SG components. Many RNA-binding proteins are methylated, and we previously demonstrated that the potent SG-nucleating protein G3BP1 is methylated by protein arginine methyltransferase 1 and 5 (PRMT1 and PRMT5). G3BP1 methylation represses SG formation and is reversible. Here we functionally link JMJD6 (Jumonji C domain-containing protein 6) to G3BP1 demethylation. Our findings reveal that JMJD6 is a novel SG component that interacts with G3BP1 complexes, and its expression reduces G3BP1 monomethylation and asymmetric dimethylation at three Arg residues. Knockdown of JMJD6 repressed SG formation and G3BP1 demethylation, but SG formation and G3BP1 demethylation were rescued with catalytically active but not mutant JMJD6. These results suggest that JMJD6 functions directly or indirectly as an arginine demethylase of G3BP1 that promotes SG formation.	[Tsai, Wei-Chih; Reineke, Lucas C.; Lloyd, Richard E.] Baylor Coll Med, Dept Mol Virol & Microbiol, 1 Baylor Plaza, Houston, TX 77030 USA; [Reineke, Lucas C.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Jain, Antrix; Jung, Sung Yun] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lloyd, RE (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, 1 Baylor Plaza, Houston, TX 77030 USA.	rlloyd@bcm.edu	Jain, Antrix/AEB-7319-2022	Jain, Antrix/0000-0002-2815-3645; Jung, Sung Yun/0000-0003-1521-7977	National Institutes of Health [HD007495, DK56338, CA125123]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD007495, T32HD007495] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027914, R56AI050237, R01AI050237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Mark Bedford for fruitful discussions and support. The Integrated Microscopy Core at Baylor College of Medicine with funded through National Institutes of Health Grants HD007495, DK56338, and CA125123.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Aulas A, 2015, J CELL BIOL, V209, P73, DOI 10.1083/jcb.201408092; Aulas A, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-54; Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Brown JAL, 2011, MOL CELL BIOL, V31, P4417, DOI 10.1128/MCB.05987-11; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chen CF, 2014, SCI REP-UK, V4, DOI 10.1038/srep06359; Courchet J, 2008, J BIOL CHEM, V283, P32131, DOI 10.1074/jbc.M802927200; De Leeuw F, 2007, EXP CELL RES, V313, P4130, DOI 10.1016/j.yexcr.2007.09.017; Eisinger-Mathason TSK, 2008, MOL CELL, V31, P722, DOI 10.1016/j.molcel.2008.06.025; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Emara MM, 2012, BIOCHEM BIOPH RES CO, V423, P763, DOI 10.1016/j.bbrc.2012.06.033; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Gao WW, 2015, P NATL ACAD SCI USA, V112, pE3327, DOI 10.1073/pnas.1509658112; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Goulet I, 2008, HUM MOL GENET, V17, P3055, DOI 10.1093/hmg/ddn203; Hahn P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013769; Han G, 2012, J CELL BIOCHEM, V113, P1663, DOI 10.1002/jcb.24035; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Heim A, 2014, NUCLEIC ACIDS RES, V42, P7833, DOI 10.1093/nar/gku488; Hong X, 2010, P NATL ACAD SCI USA, V107, P14568, DOI 10.1073/pnas.1008832107; Hu YJ, 2015, NUCLEIC ACIDS RES, V43, P7790, DOI 10.1093/nar/gkv645; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2016, J CELL BIOL, V212, P845, DOI 10.1083/jcb.201508028; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Kobayashi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035820; Kunisaki Y, 2004, BLOOD, V103, P3362, DOI 10.1182/blood-2003-09-3245; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lawrence P, 2014, VIROLOGY, V452, P1, DOI 10.1016/j.virol.2013.12.040; Lee YF, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3200; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Lloyd RE, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040093; Lyons SM, 2016, NUCLEIC ACIDS RES, V44, P6949, DOI 10.1093/nar/gkw418; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Mokas S, 2009, MOL BIOL CELL, V20, P2673, DOI 10.1091/mbc.E08-10-1061; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Oh SW, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005444; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Panas MD, 2016, J CELL BIOL, V215, P313, DOI 10.1083/jcb.201609081; Poulard C, 2016, ONCOTARGET, V7, P67532, DOI 10.18632/oncotarget.11376; Poulard C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126181; Poulard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087982; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Rai DK, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0452-8; Reineke LC, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00596-16; Reineke LC, 2015, MBIO, V6, DOI 10.1128/mBio.02486-14; Reineke LC, 2013, VIROLOGY, V436, P255, DOI 10.1016/j.virol.2012.11.017; Reineke LC, 2012, MOL BIOL CELL, V23, P3499, DOI 10.1091/mbc.E12-05-0385; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Su C, 2017, BBA-MOL CELL RES, V1864, P562, DOI 10.1016/j.bbamcr.2016.12.018; Suzuki T, 2011, J MED CHEM, V54, P8236, DOI 10.1021/jm201048w; Takahashi M, 2013, MOL CELL BIOL, V33, P815, DOI 10.1128/MCB.00763-12; Tikhanovich I, 2015, J BIOL CHEM, V290, P22236, DOI 10.1074/jbc.M115.653543; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tsai WC, 2016, J BIOL CHEM, V291, P22671, DOI 10.1074/jbc.M116.739573; Unoki M, 2013, J BIOL CHEM, V288, P6053, DOI 10.1074/jbc.M112.433284; Wang F, 2014, CHIN J POPUL RESOUR, V12, P6, DOI 10.1080/10042857.2014.886802; White JP, 2007, CELL HOST MICROBE, V2, P295, DOI 10.1016/j.chom.2007.08.006; Wu TF, 2015, J BIOL CHEM, V290, P20556, DOI 10.1074/jbc.M114.607713; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Zhang J, 2013, TUMOR BIOL, V34, P2397, DOI 10.1007/s13277-013-0789-9	75	40	40	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18886	18896		10.1074/jbc.M117.800706	http://dx.doi.org/10.1074/jbc.M117.800706			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972166	Green Published, hybrid			2022-12-26	WOS:000415848000014
J	Marquez-Rodas, I; Pollan, M; Escudero, MJ; Ruiz, A; Martin, M; Santaballa, A; del Prado, PM; Batista, N; Andres, R; Anton, A; Llombart, A; Aramburu, AF; Adrover, E; Gonzalez, S; Segui, MA; Calvo, L; Lizon, J; Lescure, AR; Cajal, TRY; Llort, G; Jara, C; Carrasco, E; Lopez-Tarruella, S				Marquez-Rodas, Ivan; Pollan, Marina; Jose Escudero, Maria; Ruiz, Amparo; Martin, Miguel; Santaballa, Ana; Martinez del Prado, Purificacion; Batista, Norberto; Andres, Raquel; Anton, Antonio; Llombart, Antonio; Fernandez Aramburu, Antonio; Adrover, Encarnacion; Gonzalez, Sonia; Angel Segui, Miguel; Calvo, Lourdes; Lizon, Jose; Rodriguez Lescure, Alvaro; Ramon y Cajal, Teresa; Llort, Gemma; Jara, Carlos; Carrasco, Eva; Lopez-Tarruella, Sara			Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "ElA Alamo III" retrospective study	PLOS ONE			English	Article							FAMILY-HISTORY; GERMLINE MUTATIONS; MORTALITY; PATTERNS; GUIDELINES; METAANALYSIS; ASSOCIATION; MAMMOGRAPHY; CONSORTIUM; SUBTYPES	Purpose To determine the frequency of breast cancer (BC) patients with hereditary risk features in a wide retrospective cohort of patients in Spain. Methods a retrospective analysis was conducted from 10,638 BC patients diagnosed between 1998 and 2001 in the GEICAM registry "ElA A lamo III", dividing them into four groups according to modified ESMO and SEOM hereditary cancer risk criteria: Sporadic breast cancer group (R0); Individual risk group (IR); Familial risk group (FR); Individual and familial risk group (IFR) with both individual and familial risk criteria. Results 7,641 patients were evaluable. Of them, 2,252 patients (29.5%) had at least one hereditary risk criteria, being subclassified in: FR 1.105 (14.5%), IR 970 (12.7%), IFR 177 (2.3%). There was a higher frequency of newly diagnosed metastatic patients in the IR group (5.1% vs 3.2%, p = 0.02). In contrast, in RO were lower proportion of big tumors (> T2) (43.8% vs 47.4%, p = 0.023), nodal involvement (43.4% vs 48.1%, p = 0.004) and lower histological grades (20.9% G3 for the R0 vs 29.8%) when compared to patients with any risk criteria. Conclusions Almost three out of ten BC patients have at least one hereditary risk cancer feature that would warrant further genetic counseling. Patients with hereditary cancer risk seems to be diagnosed with worse prognosis factors.	[Marquez-Rodas, Ivan; Martin, Miguel; Lopez-Tarruella, Sara] Hosp Gen Univ Gregorio Maranon, Serv Oncol Med, Madrid, Spain; [Marquez-Rodas, Ivan; Pollan, Marina; Jose Escudero, Maria; Ruiz, Amparo; Martin, Miguel; Santaballa, Ana; Martinez del Prado, Purificacion; Batista, Norberto; Andres, Raquel; Anton, Antonio; Llombart, Antonio; Fernandez Aramburu, Antonio; Adrover, Encarnacion; Gonzalez, Sonia; Angel Segui, Miguel; Calvo, Lourdes; Lizon, Jose; Rodriguez Lescure, Alvaro; Ramon y Cajal, Teresa; Llort, Gemma; Jara, Carlos; Carrasco, Eva; Lopez-Tarruella, Sara] Spanish Breast Canc Res Grp GEICAM, San Sebastian Reyes, Spain; [Pollan, Marina] Inst Salud Carlos III, Madrid, Spain; [Ruiz, Amparo] Inst Valenciano Oncol, Serv Oncol Med, Valencia, Spain; [Santaballa, Ana] Hosp Univ & Politecn La Fe, Serv Oncol Med, Valencia, Spain; [Martinez del Prado, Purificacion] Hosp Basurto Osakidetza, Serv Oncol Med, Bilbao, Spain; [Batista, Norberto] Hosp Univ Canarias, Serv Oncol Med, Santa Cruz De Tenerife, Spain; [Andres, Raquel] Hosp Lozano Blesa, Serv Oncol Med, Zaragoza, Spain; [Anton, Antonio] Hosp Univ Miguel Servet, Serv Oncol Med, Zaragoza, Spain; [Llombart, Antonio] Hosp Arnau Vilanova, Serv Oncol Med, Valencia, Spain; [Fernandez Aramburu, Antonio; Adrover, Encarnacion] Complejo Univ Albacete, Secc Oncol Med, Albacete, Spain; [Gonzalez, Sonia] Hosp Mutua Terrassa, Serv Oncol Med, Barcelona, Spain; [Angel Segui, Miguel] Hosp Sabadell Consorcio Sanitario Parc Taul Sabad, Serv Oncol Med, Barcelona, Spain; [Calvo, Lourdes] Complejo Hosp Univ A Coruna, Serv Oncol Med, La Coruna, Spain; [Lizon, Jose] Hosp Univ St Joan, Serv Oncol Med, Alicante, Spain; [Rodriguez Lescure, Alvaro] Hosp Gen Univ Elche, Serv Oncol Med, Elche, Spain; [Ramon y Cajal, Teresa] Hosp Santa Creu & Sant Pau, Serv Oncol Med, Barcelona, Spain; [Llort, Gemma] Inst Oncol Valles, Unitat Consell Genet, Terrassa, Spain; [Jara, Carlos] Hosp Univ Fdn Alcorco, Unidad Oncol, Madrid, Spain	General University Gregorio Maranon Hospital; GEICAM; Instituto de Salud Carlos III; Instituto Valenciano De Oncologia; Hospital Universitari i Politecnic La Fe; Basurto Hospital; Universidad de la Laguna; Lozano Blesa University Clinical Hospital; Miguel Servet University Hospital; Hospital Universitario Mutua Terrassa; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Hospital of Santa Creu i Sant Pau; Alcorcon Foundation University Hospital	Marquez-Rodas, I (corresponding author), Hosp Gen Univ Gregorio Maranon, Serv Oncol Med, Madrid, Spain.; Marquez-Rodas, I (corresponding author), Spanish Breast Canc Res Grp GEICAM, San Sebastian Reyes, Spain.	ivanpantic@hotmail.com	Anton, Antonio/AAP-6563-2020; Marquez-Rodas, Ivan/ABD-5532-2021; CALVO, LOURDES/F-2329-2015; Martin, Miguel/AAJ-9242-2020; Pollan, Marina/M-3259-2014	Marquez-Rodas, Ivan/0000-0002-2476-668X; CALVO, LOURDES/0000-0001-8314-0241; Martin, Miguel/0000-0001-9237-3231; Pollan, Marina/0000-0002-4328-1565; Santaballa, Ana/0000-0001-7763-320X; Llombart Cussac, Antonio/0000-0003-4515-8293; Lopez-Tarruella, Sara/0000-0002-2606-9538; SEGUI PALMER, MIQUEL ANGEL/0000-0002-5103-6746; Fernandez Aramburo, Antonio/0000-0003-3897-2262				Andres R, 2014, CLIN TRANSL ONCOL, V16, P280, DOI 10.1007/s12094-013-1070-9; Baretta Z, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004975; Bethea TN, 2016, CANCER EPIDEM BIOMAR, V25, P366, DOI 10.1158/1055-9965.EPI-15-1068; Castellvi-Bel S, 2012, MUTAGENESIS, V27, P153, DOI 10.1093/mutage/ger047; de Sanjose S, 2003, INT J CANCER, V106, P588, DOI 10.1002/ijc.11271; Depypere H, 2014, MATURITAS, V79, P481, DOI 10.1016/j.maturitas.2014.09.002; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gonzalez-Rivera M, 2016, BREAST CANCER RES TR, V156, P507, DOI 10.1007/s10549-016-3792-1; Jara-Sanchez C., 2006, J CLIN ONCOL S, V28; Lee EH, 2010, BREAST CANCER RES TR, V122, P11, DOI 10.1007/s10549-010-0859-2; Llort G, 2015, CLIN TRANSL ONCOL, V17, P956, DOI 10.1007/s12094-015-1435-3; Loman N, 2001, JNCI-J NATL CANCER I, V93, P1215, DOI 10.1093/jnci/93.16.1215; Lopez-Abente G, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-535; Marquez-Rodas I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124239; Martin M, 2006, Clin Transl Oncol, V8, P508, DOI 10.1007/s12094-006-0051-7; Melvin JC, 2016, CANCER MED-US, V5, P942, DOI 10.1002/cam4.648; Mocci E, 2015, EUR J CANC OXF ENGL, V51, P1911; Paluch-Shimon S, 2016, ANN ONCOL, V27, pv103, DOI 10.1093/annonc/mdw327; Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003; Shao J, 2015, J HUAZHONG U SCI-MED, V35, P629, DOI 10.1007/s11596-015-1481-7; Sonnenblick A, 2015, NAT REV CLIN ONCOL, V12, P27, DOI 10.1038/nrclinonc.2014.163; Stuckey A, 2016, AM J CLIN ONCOL-CANC, V39, P363, DOI 10.1097/COC.0000000000000073; Yang XR, 2011, JNCI-J NATL CANCER I, V103, P250, DOI 10.1093/jnci/djq526; Zhou WB, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-248; Zugazagoitia J, 2014, BREAST CANCER RES TR, V148, P415, DOI 10.1007/s10549-014-3167-4	26	0	0	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0184181	10.1371/journal.pone.0184181	http://dx.doi.org/10.1371/journal.pone.0184181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ1QR	28985233	Green Published, gold, Green Submitted			2022-12-26	WOS:000412493000001
J	Rehker, J; Rodhe, J; Nesbitt, RR; Boyle, EA; Martin, BK; Lord, J; Karaca, I; Naj, A; Jessen, F; Helisalmi, S; Soininen, H; Hiltunen, M; Ramirez, A; Scherer, M; Farrer, LA; Haines, JL; Pericak-Vance, MA; Raskind, WH; Cruchaga, C; Schellenberg, GD; Joseph, B; Brkanac, Z				Rehker, Jan; Rodhe, Johanna; Nesbitt, Ryan R.; Boyle, Evan A.; Martin, Beth K.; Lord, Jenny; Karaca, Ilker; Naj, Adam; Jessen, Frank; Helisalmi, Seppo; Soininen, Hilkka; Hiltunen, Mikko; Ramirez, Alfredo; Scherer, Martin; Farrer, Lindsay A.; Haines, Jonathan L.; Pericak-Vance, Margaret A.; Raskind, Wendy H.; Cruchaga, Carlos; Schellenberg, Gerard D.; Joseph, Bertrand; Brkanac, Zoran			Caspase-8, association with Alzheimer's Disease and functional analysis of rare variants	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; NON-APOPTOTIC ROLES; CELL-DEATH; NEURONAL APOPTOSIS; MISSENSE MUTATIONS; TREM2 DEFICIENCY; CODING VARIANTS; MOUSE MODELS; BETA; GENE	The accumulation of amyloid beta (A beta) peptide (Amyloid cascade hypothesis), an APP protein cleavage product, is a leading hypothesis in the etiology of Alzheimer's disease (AD). In order to identify additional AD risk genes, we performed targeted sequencing and rare variant burden association study for nine candidate genes involved in the amyloid metabolism in 1886 AD cases and 1700 controls. We identified a significant variant burden association for the gene encoding caspase-8, CASP8 (p = 8.6x10(-5)). For two CASP8 variants, p.K148R and p.I298V, the association remained significant in a combined sample of 10,820 cases and 8,881 controls. For both variants we performed bioinformatics structural, expression and enzymatic activity studies and obtained evidence for loss of function effects. In addition to their role in amyloid processing, caspase-8 and its downstream effector caspase-3 are involved in synaptic plasticity, learning, memory and control of microglia pro-inflammatory activation and associated neurotoxicity, indicating additional mechanisms that might contribute to AD. As caspase inhibition has been proposed as a mechanism for AD treatment, our finding that AD-associated CASP8 variants reduce caspase function calls for caution and is an impetus for further studies on the role of caspases in AD and other neurodegenerative diseases.	[Rehker, Jan; Nesbitt, Ryan R.; Raskind, Wendy H.; Brkanac, Zoran] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Rodhe, Johanna; Joseph, Bertrand] Karolinska Inst, Canc Centrum Karolinska, Dept Oncol Pathol, Stockholm, Sweden; [Boyle, Evan A.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Martin, Beth K.] Univ Washington, Dept Genome Sci, Seattle, WA USA; [Lord, Jenny; Cruchaga, Carlos] Washington Univ, Dept Psychiat, St Louis, MO USA; [Karaca, Ilker; Jessen, Frank; Ramirez, Alfredo] Univ Bonn, Dept Psychiat & Psychotherapy, Bonn, Germany; [Naj, Adam] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Jessen, Frank; Ramirez, Alfredo] Univ Cologne, Dept Psychiat & Psychotherapy, Cologne, Germany; [Jessen, Frank] German Ctr Neurodegenerat Dis, Bonn, Germany; [Helisalmi, Seppo; Soininen, Hilkka] Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland; [Soininen, Hilkka; Hiltunen, Mikko] Kuopio Univ Hosp, Dept Neurol, Kuopio, Finland; [Hiltunen, Mikko] Univ Eastern Finland, Inst Biomed, Kuopio, Finland; [Ramirez, Alfredo] Univ Bonn, Inst Human Genet, Bonn, Germany; [Scherer, Martin] Univ Med Ctr Hamburg Eppendorf, Dept Primary Med Care, Hamburg, Germany; [Farrer, Lindsay A.] Boston Univ, Dept Med Biomed Genet, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Dept Neurol, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Dept Ophthalmol, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Dept Epidemiol, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Dept Biostat, Boston, MA USA; [Haines, Jonathan L.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Haines, Jonathan L.] Case Western Reserve Univ, Inst Computat Biol, Cleveland, OH 44106 USA; [Pericak-Vance, Margaret A.] Univ Miami, John P Hussman Inst Human Gen, Miami, FL USA; [Pericak-Vance, Margaret A.] Univ Miami, Dept Human Genet, John T Macdonald Fdn, Miami, FL USA; [Raskind, Wendy H.] Univ Washington, Dept Med, Seattle, WA USA; [Schellenberg, Gerard D.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA	University of Washington; University of Washington Seattle; Karolinska Institutet; Stanford University; University of Washington; University of Washington Seattle; Washington University (WUSTL); University of Bonn; University of Pennsylvania; Pennsylvania Medicine; University of Cologne; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; Boston University; Boston University; Boston University; Boston University; Boston University; Case Western Reserve University; Case Western Reserve University; University of Miami; University of Miami; University of Washington; University of Washington Seattle; University of Pennsylvania; Pennsylvania Medicine	Brkanac, Z (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	zbrkanac@uw.edu	Lord, Jenny/AAR-5643-2021; Cruchaga, Carlos/ABF-4065-2020; Florica, Camelia F./C-8929-2014; Jessen, Frank/AAK-6170-2020; Haines, Jonathan/C-3374-2012; Ramirez, Alfredo/S-5126-2019; Lord, Jenny/GYJ-1039-2022; Farrer, Lindsay/AAS-1035-2020; Enculescu, Monica/C-2091-2011	Lord, Jenny/0000-0002-0539-9343; Cruchaga, Carlos/0000-0002-0276-2899; Florica, Camelia F./0000-0003-0666-6543; Haines, Jonathan/0000-0002-4351-4728; Ramirez, Alfredo/0000-0003-4991-763X; Enculescu, Monica/0000-0002-4476-5545; Joseph, Bertrand/0000-0001-5655-9979; Farrer, Lindsay/0000-0001-5533-4225	National Institute on Aging [1R01AG039700]; Swedish Research Council; Swedish Brain Foundation; Parkinson Foundation in Sweden; Karolinska Institutet Foundations; NATIONAL INSTITUTE ON AGING [P01AG003991, U01AG016976, P50AG005681, U01AG032984, U24AG021886] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Parkinson Foundation in Sweden; Karolinska Institutet Foundations(Karolinska Institutet); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by National Institute on Aging grant 1R01AG039700 to ZB and the Swedish Research Council, the Swedish Brain Foundation, the Parkinson Foundation in Sweden, and the Karolinska Institutet Foundations for BJ.	Aplin AE, 1996, J NEUROCHEM, V67, P699; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bird T.D, 1993, ALZHEIMER DIS OVERVI; Boyle EA, 2014, BIOINFORMATICS, V30, P2670, DOI 10.1093/bioinformatics/btu353; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Campion D, 1999, AM J HUM GENET, V65, P664, DOI 10.1086/302553; Caron N.S., 1993, GENEREVIEWS; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; Dickens LS, 2012, MOL CELL, V47, P291, DOI 10.1016/j.molcel.2012.05.004; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hall AM, 2012, BRAIN RES BULL, V88, P3, DOI 10.1016/j.brainresbull.2011.11.017; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hyman BT, 2012, NAT REV NEUROSCI, V13, P395, DOI 10.1038/nrn3228; Ivins KJ, 1999, NEUROBIOL DIS, V6, P440, DOI 10.1006/nbdi.1999.0268; Jay TR, 2017, J NEUROSCI, V37, P637, DOI [10.1523/JNEUROSCI.2110-16.2017, 10.1523/JNEUROSCI.2110-16.2016]; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jin SC, 2014, HUM MOL GENET, V23, P5838, DOI 10.1093/hmg/ddu277; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karch CM, 2015, BIOL PSYCHIAT, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kudryashova I V, 2009, Neurosci Behav Physiol, V39, P13, DOI 10.1007/s11055-008-9089-z; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lee Jung-Eun, 2013, Exp Neurobiol, V22, P84, DOI 10.5607/en.2013.22.2.84; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Lu YJ, 2015, NEUROL SCI, V36, P1881, DOI 10.1007/s10072-015-2274-2; Ma C, 2013, GENET EPIDEMIOL, V37, P539, DOI 10.1002/gepi.21742; Marchetti B, 2005, TRENDS PHARMACOL SCI, V26, P517, DOI 10.1016/j.tips.2005.08.007; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Montgomery SL, 2012, J NEUROIMMUNE PHARM, V7, P42, DOI 10.1007/s11481-011-9287-2; Mukherjee A, 2017, CELL DEATH DIFFER, V24, P1411, DOI 10.1038/cdd.2017.64; Nicotera P, 2000, IUBMB LIFE, V49, P421, DOI 10.1080/152165400410272; Nicotera P, 2000, BRAIN PATHOL, V10, P276, DOI 10.1111/j.1750-3639.2000.tb00261.x; Pellegrini L, 1999, J BIOL CHEM, V274, P21011, DOI 10.1074/jbc.274.30.21011; Reitz C, 2012, INT J ALZHEIMERS DIS; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rohn TT, 2010, APOPTOSIS, V15, P1403, DOI 10.1007/s10495-010-0463-2; Rohn TT, 2001, NEUROBIOL DIS, V8, P1006, DOI 10.1006/nbdi.2001.0449; Roth KA, 2001, J NEUROPATH EXP NEUR, V60, P829, DOI 10.1093/jnen/60.9.829; Sassi C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150079; Schleich K, 2012, MOL CELL, V47, P306, DOI 10.1016/j.molcel.2012.05.006; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shimohama S, 1999, BIOCHEM BIOPH RES CO, V256, P381, DOI 10.1006/bbrc.1999.0344; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Southam KA, 2016, J ALZHEIMERS DIS, V51, P657, DOI 10.3233/JAD-151075; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Su JH, 2001, BRAIN RES, V898, P350, DOI 10.1016/S0006-8993(01)02018-2; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Troy CM, 2015, NEUROTHERAPEUTICS, V12, P42, DOI 10.1007/s13311-014-0307-9; Ulrich JD, 2017, NEURON, V94, P237, DOI 10.1016/j.neuron.2017.02.042; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Venero JL, 2011, CELL DEATH DIFFER, V18, P1679, DOI 10.1038/cdd.2011.107; Wang YM, 2016, J EXP MED, V213, P667, DOI 10.1084/jem.20151948; Weuve J, 2015, EPIDEMIOLOGY, V26, pE4, DOI 10.1097/EDE.0000000000000199; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003	69	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0185777	10.1371/journal.pone.0185777	http://dx.doi.org/10.1371/journal.pone.0185777			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ1QR	28985224	gold, Green Published, Green Submitted			2022-12-26	WOS:000412493000010
J	Dymarska, M; Grzeszczuk, J; Urbaniak, M; Janeczko, T; Plaskowska, E; Stepien, L; Kostrzewa-Suslow, E				Dymarska, Monika; Grzeszczuk, Jakub; Urbaniak, Monika; Janeczko, Tomasz; Plaskowska, Elzbieta; Stepien, Lukasz; Kostrzewa-Suslow, Edyta			Glycosylation of 6-methylflavone by the strain Isaria fumosorosea KCH J2	PLOS ONE			English	Article							MICROBIAL TRANSFORMATIONS; ASPERGILLUS-NIGER; DIAPHORINA-CITRI; PROMISCUITY; FUNGUS; BRAIN	Entomopathogenic fungi are known for their ability to carry out glycosylation of flavonoids, which usually results in the improvement of their stability and bioavailability. In this study we used a newly isolated strain of the entomopathogenic filamentous fungus Isaria fumosorosea KCH J2 as a biocatalyst. Our aim was to evaluate its ability to carry out the biotransformation of flavonoids and to obtain new flavonoid derivatives. The fungus was isolated from a spider's carcass and molecularly identified using analysis of the ITS1-ITS2 rDNA sequence. As a result of biotransformation of 6-methylflavone two new products were obtained: 6-methylflavone 8-O-beta-D-(4"-O-methyl)-glucopyranoside and 6-methylflavone 4'-O-beta-D-(4"-O-methyl)-glucopyranoside. Chemical structures of the products were determined based on spectroscopic methods (H-1 NMR, C-13 NMR, COSY, HMBC, HSQC). Our research allowed us to discover a new species of filamentous fungus capable of carrying out glycosylation reactions and proved that I. fumosorosea KCH J2 is an effective biocatalyst for glycosylation of flavonoid compounds. For the first time we describe biotransformations of 6-methylflavone and the attachment of the sugar unit to the flavonoid substrate having no hydroxyl group. The possibility of using flavonoid aglycones is often limited by their low bioavailability due to poor solubility in water. The incorporation of a sugar unit improves the physical properties of tested compounds and thus increases the chance of using them as pharmaceuticals.	[Dymarska, Monika; Janeczko, Tomasz; Kostrzewa-Suslow, Edyta] Wroclaw Univ Environm & Life Sci, Fac Biotechnol & Food Sci, Dept Chem, Wroclaw, Poland; [Grzeszczuk, Jakub; Plaskowska, Elzbieta] Wroclaw Univ Environm & Life Sci, Fac Life Sci & Technol, Dept Plant Protect, Plant Pathol & Mycol Div, Wroclaw, Poland; [Urbaniak, Monika; Stepien, Lukasz] Polish Acad Sci, Inst Plant Genet, Dept Pathogen Genet & Plant Resistance, Plant Microorganism Interact Team, Poznan, Poland	Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences; Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences	Dymarska, M (corresponding author), Wroclaw Univ Environm & Life Sci, Fac Biotechnol & Food Sci, Dept Chem, Wroclaw, Poland.	monika.dymarska@gmail.com	Urbaniak, Monika/J-8174-2017; Plaskowska, Elzbieta/ABA-8210-2020; Dymarska, Monika/A-6125-2017; Janeczko, Tomasz/AAL-3121-2020; Stepien, Lukasz/G-2322-2012; Grzeszczuk, Jakub/O-4659-2014	Urbaniak, Monika/0000-0002-1735-4556; Plaskowska, Elzbieta/0000-0002-8643-9318; Dymarska, Monika/0000-0002-2688-8883; Janeczko, Tomasz/0000-0002-9757-6684; Stepien, Lukasz/0000-0001-9740-9520; Grzeszczuk, Jakub/0000-0002-8083-6363; Kostrzewa-Suslow, Edyta/0000-0002-9259-0161	Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW); Wroclaw Centre of Biotechnology, The Leading National Research Centre (KNOW) program	Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW); Wroclaw Centre of Biotechnology, The Leading National Research Centre (KNOW) program	Publication is supported by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018, http://know.wroc.pl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Publication supported by Wroclaw Centre of Biotechnology, The Leading National Research Centre (KNOW) program for the years 2014-2018.	Ai JL, 1997, DRUG DEVELOP RES, V41, P99, DOI 10.1002/(SICI)1098-2299(199706)41:2<99::AID-DDR7>3.3.CO;2-9; Bartmanska A, 2012, BIOORG MED CHEM LETT, V22, P6451, DOI 10.1016/j.bmcl.2012.08.060; Bravo L, 2008, FUNCT FOOD NUTRA SER, P147; Gallou A, 2016, FUNGAL BIOL-UK, V120, P414, DOI 10.1016/j.funbio.2015.11.009; Gurung RB, 2013, MOL CELLS, V36, P355, DOI 10.1007/s10059-013-0164-0; Hall BJ, 2004, EUR J PHARMACOL, V491, P1, DOI 10.1016/j.ejphar.2004.03.014; Hussein HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152399; Ko JH, 2006, FEMS MICROBIOL LETT, V258, P263, DOI 10.1111/j.1574-6968.2006.00226.x; Kostrzewa-Suslow E, 2006, J MOL CATAL B-ENZYM, V39, P18, DOI 10.1016/j.molcatb.2006.01.020; Kostrzewa-suslow E, 2015, SCI WORLD J, V2012, P1; Kostrzewa-Suslow E, 2014, J MOL CATAL B-ENZYM, V102, P59, DOI 10.1016/j.molcatb.2014.01.013; Kostrzewa-Suslow E, 2014, POL J MICROBIOL, V63, P111; Kostrzewa-Suslow E, 2012, Z NATURFORSCH C, V67, P411; Kren V, 1997, CHEM SOC REV, V26, P463, DOI 10.1039/cs9972600463; Liu LX, 2015, FUNGAL GENET BIOL, V81, P191, DOI 10.1016/j.fgb.2015.03.009; Markham KR, FLAVONOIDS, DOI 10.1016/0022-2860(71)87109-0; Matias I, 2016, NEUROCHEM INT, V95, P85, DOI 10.1016/j.neuint.2016.01.009; Pandey RP, 2014, CARBOHYD RES, V393, P26, DOI 10.1016/j.carres.2014.03.011; Patt JM, 2015, BIOL CONTROL, V88, P37, DOI 10.1016/j.biocontrol.2015.04.014; Schocken MJ, 1997, J AGR FOOD CHEM, V45, P3647, DOI 10.1021/jf970298l; Sordon S, 2016, POL J MICROBIOL, V65, P137, DOI 10.5604/17331331.1204473; Spencer JPE, 2009, GENES NUTR, V4, P243, DOI 10.1007/s12263-009-0136-3; Stepien L, 2013, WORLD MYCOTOXIN J, V6, P399, DOI 10.3920/WMJ2012.1464; Tronina T, 2013, BIOORG MED CHEM LETT, V23, P1957, DOI 10.1016/j.bmcl.2013.02.031; Vavrikova E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060899; Vogiatzoglou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128132; Wang L, 2013, CARBOHYD RES, V368, P73, DOI 10.1016/j.carres.2012.12.012; Wang XQ, 2009, FEBS LETT, V583, P3303, DOI 10.1016/j.febslet.2009.09.042; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Xiao JB, 2014, BIOTECHNOL ADV, V32, P1145, DOI 10.1016/j.biotechadv.2014.04.006; Youdim KA, 2004, FREE RADICAL BIO MED, V36, P592, DOI 10.1016/j.freeradbiomed.2003.11.023; Yuan W, 2010, BIOCATAL BIOTRANSFOR, V28, P117, DOI 10.3109/10242420903497354	32	25	26	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184885	10.1371/journal.pone.0184885	http://dx.doi.org/10.1371/journal.pone.0184885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981527	Green Submitted, Green Published, gold			2022-12-26	WOS:000412360300023
J	Gonzales-Gustavson, E; Timoneda, N; Fernandez-Cassi, X; Caballero, A; Abril, JF; Buti, M; Rodriguez-Frias, F; Girones, R				Gonzales-Gustavson, Eloy; Timoneda, N.; Fernandez-Cassi, X.; Caballero, A.; Abril, J. F.; Buti, M.; Rodriguez-Frias, F.; Girones, R.			Identification of sapovirus GV.2, astrovirus VA3 and novel anelloviruses in serum from patients with acute hepatitis of unknown aetiology	PLOS ONE			English	Article							ACUTE VIRAL-HEPATITIS; E VIRUS; TT VIRUS; MLB-CLADE; METAGENOMICS; PREVALENCE; INFECTION; SEQUENCES; GENOTYPE; HISTORY	Hepatitis is a general term meaning inflammation of the liver, which can be caused by a variety of viruses. However, a substantial number of cases remain with unknown aetiology. We analysed the serum of patients with clinical signs of hepatitis using a metagenomics approach to characterize their viral species composition. Four pools of patients with hepatitis without identified aetiological agents were evaluated. Additionally, one pool of patients with hepatitis E (HEV) and pools of healthy volunteers were included as controls. A high diversity of anelloviruses, including novel sequences, was found in pools from patients with hepatitis of unknown aetiology. Moreover, viruses recently associated with gastroenteritis as sapovirus GV.2 and astrovirus VA3 were also detected only in those pools. Besides, most of the HEV genome was recovered from the HEV pool. Finally, GB virus C and human endogenous retrovirus were found in the HEV and healthy pools. Our study provides an overview of the virome in serum from hepatitis patients suggesting a potential role of these viruses not previously described in cases of hepatitis. However, further epidemiologic studies are necessary to confirm their contribution to the development of hepatitis.	[Gonzales-Gustavson, Eloy; Timoneda, N.; Fernandez-Cassi, X.; Girones, R.] Univ Barcelona, Fac Biol, Dept Genet Microbiol & Stat, Lab Virus Contaminants Water & Food, Barcelona, Catalonia, Spain; [Timoneda, N.; Abril, J. F.] Univ Barcelona, Fac Biol, Dept Genet Microbiol & Stat, Computat Genom Lab, Barcelona, Catalonia, Spain; [Timoneda, N.; Abril, J. F.] Univ Barcelona, Inst Biomed, Barcelona, Catalonia, Spain; [Caballero, A.; Buti, M.; Rodriguez-Frias, F.] Hosp Univ Vall dHebron, Barcelona, Catalonia, Spain; [Caballero, A.; Buti, M.; Rodriguez-Frias, F.] Inst Carlos III, CIBEREHD, Barcelona, Catalonia, Spain	University of Barcelona; University of Barcelona; University of Barcelona; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Girones, R (corresponding author), Univ Barcelona, Fac Biol, Dept Genet Microbiol & Stat, Lab Virus Contaminants Water & Food, Barcelona, Catalonia, Spain.	rgirones@ub.edu	Ferrando, Josep F Abril/B-3877-2014; Girones, Rosina/B-2975-2009; Rodriguez-Frias, Francisco/AAC-3507-2020; Fernandez Cassi, Xavier/B-9088-2019; Timoneda, Natalia/I-7831-2014	Ferrando, Josep F Abril/0000-0001-7793-589X; Girones, Rosina/0000-0002-1097-6395; Fernandez Cassi, Xavier/0000-0003-2314-9126; CABALLERO, ANDREA/0000-0003-2891-6347; rodriguez-frias, francisco/0000-0002-9128-7013; Timoneda, Natalia/0000-0001-9955-0712; Gonzales-Gustavson, Eloy/0000-0001-7328-2983; Buti Ferret, Maria/0000-0002-0732-3078	Programa RecerCaixa [ACUP-00300]; Spanish MINECO [AGL2011-30461-C02-01/ALI, AGL2014-55081-R]; Catalan Government [2014SRG914]; JPI Water project METAWATER [4193-00001B]; Institut de Recerca de l'Aigua (IdRA)	Programa RecerCaixa; Spanish MINECO(Spanish Government); Catalan Government; JPI Water project METAWATER; Institut de Recerca de l'Aigua (IdRA)	The study reported here was partially funded by the Programa RecerCaixa 2012 (ACUP-00300), AGL2011-30461-C02-01/ALI and AGL2014-55081-R from Spanish MINECO. This study was partially funded by a grant from the Catalan Government to Consolidated Research Group VirBaP (2014SRG914), the JPI Water project METAWATER (4193-00001B) and with the collaboration of the Institut de Recerca de l'Aigua (IdRA). During the development of this study, Eloy Gonzales-Gustayson is a fellow of the Peruvian Government; Natalia Timoneda is a fellow of the Spanish Ministry of Science and Xavier FernandezCassi was a fellow of the Catalan Government "AGAUR" (FI-DGR).	Alter MJ, 1997, NEW ENGL J MED, V336, P741, DOI 10.1056/NEJM199703133361101; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Banks M, 2004, EMERG INFECT DIS, V10, P953, DOI 10.3201/eid1005.030908; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Biagini P, 2012, VIRUS TAXONOMY, P331; Bihari Chhagan, 2013, Hepat Res Treat, V2013, P472027, DOI 10.1155/2013/472027; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bostan N., 2013, J VACCINES VACCIN, P1; Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207; Bzhalava D, 2016, INT J CANCER, V138, P2212, DOI 10.1002/ijc.29666; Cacopardo B, 2000, Eur Rev Med Pharmacol Sci, V4, P117; Canuti M, 2015, PSYCHIAT RES, V229, P678, DOI 10.1016/j.psychres.2015.08.025; Chivero ET, 2015, J GEN VIROL, V96, P1521, DOI 10.1099/vir.0.000086; Chu C, 2011, MOL MED, V17, P1; Chu C-M, 2001, J MED VIROL J MED VI, V65; Chu CM, 1999, J MED VIROL, V58, P154, DOI 10.1002/(SICI)1096-9071(199906)58:2&lt;154::AID-JMV9&gt;3.0.CO;2-E; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; CLC Bio, 2008, CLC GEN WORKB; Colson P, 2013, J CLIN VIROL, V57, P191, DOI 10.1016/j.jcv.2013.03.018; Conrad ME, 2014, JAMA-J AM MED ASSOC, V312, P654, DOI 10.1001/jama.2013.279664; Delic D, 2010, VOJNOSANIT PREGL, V67, P903, DOI 10.2298/VSP1011903D; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Mateos ME, 2012, J PEDIAT HEMATOL ONC, V34, pE298, DOI 10.1097/MPH.0b013e318266ba72; Finkbeiner SR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-161; Hannon G.J., 2015, FASTX TOOLKIT; Hansman GS, 2007, EMERG INFECT DIS, V13, P133, DOI 10.3201/eid1301.061047; Hofer U, 2014, NAT REV MICROBIOL, V12, DOI 10.1038/nrmicro3192; Hsiao KL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149901; Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a; Jiang HB, 2013, VIROLOGY, V436, P8, DOI 10.1016/j.virol.2012.09.040; Kakkola L, 2008, VIROLOGY, V382, P182, DOI 10.1016/j.virol.2008.09.012; Kaufman B, 1997, CLIN INFECT DIS, V24, P334, DOI 10.1093/clinids/24.3.334; Kawashima Nozomu, 2015, J Infect Chemother, V21, P857, DOI 10.1016/j.jiac.2015.08.018; Leary TP, 2004, VIRAL HEPATITIS DIAG, P223; Legrand-Abravanel F, 2009, EMERG INFECT DIS, V15, P110, DOI 10.3201/eid1501.080296; Li LL, 2013, J VIROL, V87, P10912, DOI 10.1128/JVI.01839-13; Liu N, 2014, VET MICROBIOL, V170, P39, DOI 10.1016/j.vetmic.2014.01.026; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luo KX, 2002, J MED VIROL, V67, P118, DOI 10.1002/jmv.2200; Manka P, 2016, VISC MED, V32, P80, DOI 10.1159/000444915; Medici MC, 2012, J MED VIROL, V84, P643, DOI 10.1002/jmv.23231; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Meyer CT, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0299-z; Mi Zhiqiang, 2014, Virologica Sinica, V29, P112, DOI 10.1007/s12250-014-3424-z; NCBI, 2016, ASS GEN; Ninomiya M, 2007, ARCH VIROL, V152, P1961, DOI 10.1007/s00705-007-1046-6; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; Ogilvie LA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00918; Ohbayashi H, 2001, J GASTROEN HEPATOL, V16, P424, DOI 10.1046/j.1440-1746.2001.02460.x; Oka T, 2015, CLIN MICROBIOL REV, V28, P32, DOI 10.1128/CMR.00011-14; Okamoto H, 2004, PERSP MED V, V10, P241; Okamoto H, 2009, CURR TOP MICROBIOL, V331, P1, DOI 10.1007/978-3-540-70972-5_1; Olarte-Castillo XA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163548; Previsani N, 2004, PERSP MED V, V10, P1; Riveiro-Barciela M, 2015, J CLIN GASTROENTEROL, V49, P165, DOI 10.1097/MCG.0000000000000113; Rivero-Juarez A, 2017, ZOONOSES PUBLIC HLTH, V64, pe60, DOI 10.1111/zph.12347; Rosseel T, 2015, J VIROL METHODS, V222, P72, DOI 10.1016/j.jviromet.2015.05.010; Sano D, 2011, APPL ENVIRON MICROB, V77, P1111, DOI 10.1128/AEM.01721-10; Shibata S, 2015, GENOME ANNOUNCEMENTS, V3, P2, DOI DOI 10.1128/GEN0MEA.01553-14; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Smith DB, 2016, J GEN VIROL, V97, P537, DOI 10.1099/jgv.0.000393; Somasekar S, 2017, CLIN INFECT DIS; Spandole S, 2015, ARCH VIROL, V160, P893, DOI 10.1007/s00705-015-2363-9; Tassopoulos NC, 2008, J GASTROEN HEPATOL, V23, P1208, DOI 10.1111/j.1440-1746.2008.05454.x; Touinssi M, 2001, J CLIN VIROL, V21, P135, DOI 10.1016/S1386-6532(01)00157-3; van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-6; Van Thiel D H, 1994, J Okla State Med Assoc, V87, P364; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Xiao JP, 2011, ARCH VIROL, V156, P1415, DOI 10.1007/s00705-011-1011-2; Yeh CT, 2006, J INFECT DIS, V193, P1089, DOI 10.1086/501474; Yokoyama CC, 2012, J VIROL, V86, P12262, DOI 10.1128/JVI.02018-12; ZHANG Y, 2016, SCI REP-UK, V6, DOI DOI 10.1038/SREP26	74	8	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185911	10.1371/journal.pone.0185911	http://dx.doi.org/10.1371/journal.pone.0185911			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982120	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300085
J	Thakuria, D; Shahi, N; Singh, AK; Khangembam, VC; Singh, AK; Kumar, S				Thakuria, Dimpal; Shahi, Neetu; Singh, Atul Kumar; Khangembam, Victoria Chanu; Singh, Arvind Kumar; Kumar, Satish			Conformational analysis of a synthetic fish kisspeptin 1 peptide in membrane mimicking environments	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; CIRCULAR-DICHROISM; HORMONE NEURONS; GPR54 AGONISTS; IN-VIVO; GONADOTROPIN; ACTIVATION; METASTIN; PUBERTY; ANALOGS	Kisspeptin 1 is a neuropeptide hormone of the RFamide family, which act as an upstream regulator of brain-pituitary-gonad (BPG) axis in most vertebrates including teleosts. In the present study, a 16 amino acid long putative mature bioactive peptide (kiss 1) from preprokis-speptin 1 of golden mahseer, Tor putitora (Hamilton, 1822), was synthesized and characterized using an integrated (experimental and in silico) approach. The far-UV circular dichroism (CD) spectrum of this peptide was evaluated both in aqueous and membrane mimicking solvents (TFE, HFIP and Dioxane). The results indicate that kiss 1 peptide adopted helical, turn and beta conformations in membrane like environments. The near-UV CD spectroscopy was also carried out to examine the tertiary packing around aromatic residues of kiss 1 peptide and the peptide-membrane complex. The kiss 1 peptide exhibited little signal in water, but a prominent negative band was observed at around 275 nm when membrane mimetic solution was added. The observed ordered conformations of kiss 1 peptide in the different solvents indicated its potential biological activity which could enhance the secretion of gonadotrop-inreleasing hormone (GnRH) at BPG axis. The conformational information generated from the present study reinforces the application prospects of bioactive synthetic peptide analogs of kisspeptin 1 in improving the reproductive performances of important cultivable fish species.	[Thakuria, Dimpal; Shahi, Neetu; Singh, Atul Kumar; Khangembam, Victoria Chanu] ICAR Directorate Coldwater Fisheries Res, Naini Tal, Uttarakhand, India; [Singh, Arvind Kumar; Kumar, Satish] Indian Vet Res Inst, ICAR, Bareilly, Uttar Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Directorate of Coldwater Fisheries Research; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute	Thakuria, D (corresponding author), ICAR Directorate Coldwater Fisheries Res, Naini Tal, Uttarakhand, India.	drdimpal@gmail.com		Khangembam, Victoria Chanu/0000-0003-1153-4182; Singh, Arvind Kumar/0000-0001-8711-9191; Thakuria, Dimpal/0000-0002-4434-0483	ICAR-Directorate of Coldwater Fisheries Research, Bhimtal, Uttarakhand, India	ICAR-Directorate of Coldwater Fisheries Research, Bhimtal, Uttarakhand, India	The project was funded by institutional research fund of ICAR-Directorate of Coldwater Fisheries Research, Bhimtal, Uttarakhand, India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asami T, 2013, J MED CHEM, V56, P8298, DOI 10.1021/jm401056w; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; CARPINO LA, 1972, J ORG CHEM, V37, P3404, DOI 10.1021/jo00795a005; Curtis AE, 2010, AM J PHYSIOL-ENDOC M, V298, pE296, DOI 10.1152/ajpendo.00426.2009; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Ebenhan T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/867381; Elizur A, 2009, PEPTIDES, V30, P164, DOI 10.1016/j.peptides.2008.08.018; Fadhil I, 2004, J BIOL CHEM, V279, P21069, DOI 10.1074/jbc.M311468200; Felip A, 2015, REPRODUCTION, V150, P227, DOI 10.1530/REP-15-0204; Felip A, 2009, MOL CELL ENDOCRINOL, V312, P61, DOI 10.1016/j.mce.2008.11.017; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Gutierrez-Pascual E, 2009, MOL PHARMACOL, V76, P58, DOI 10.1124/mol.108.053751; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Kanda S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062776; Kinoshita M, 2005, ENDOCRINOLOGY, V146, P4431, DOI 10.1210/en.2005-0195; Le Marec O, 2011, J MED CHEM, V54, P4806, DOI 10.1021/jm200418c; Lee JY, 2009, ARCH BIOCHEM BIOPHYS, V485, P109, DOI 10.1016/j.abb.2009.03.002; Lee YR, 2009, ENDOCRINOLOGY, V150, P2837, DOI 10.1210/en.2008-1679; Li SS, 2009, J ENDOCRINOL, V201, P407, DOI 10.1677/JOE-09-0016; Matsui H, 2014, EUR J PHARMACOL, V735, P77, DOI 10.1016/j.ejphar.2014.03.058; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Mylonas CC, 2010, GEN COMP ENDOCR, V165, P516, DOI 10.1016/j.ygcen.2009.03.007; Nagahama Y, 2008, DEV GROWTH DIFFER, V50, pS195, DOI 10.1111/j.1440-169X.2008.01019.x; Niida A, 2006, BIOORG MED CHEM LETT, V16, P134, DOI 10.1016/j.bmcl.2005.09.054; Nocillado JN, 2013, GEN COMP ENDOCR, V191, P168, DOI 10.1016/j.ygcen.2013.06.005; Ohga H, 2013, GEN COMP ENDOCR, V193, P130, DOI 10.1016/j.ygcen.2013.07.016; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Orsini MJ, 2007, J MED CHEM, V50, P462, DOI 10.1021/jm0609824; Parhar IS, 2004, ENDOCRINOLOGY, V145, P3613, DOI 10.1210/en.2004-0395; Prabhu VV, 2013, ASIAN PAC J CANCER P, V14, P6215, DOI 10.7314/APJCP.2013.14.11.6215; Roseweir AK, 2009, J NEUROSCI, V29, P3920, DOI 10.1523/JNEUROSCI.5740-08.2009; Saxena VK, 2015, INDIAN J EXP BIOL, V53, P676; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shahab M, 2005, P NATL ACAD SCI USA, V102, P2129, DOI 10.1073/pnas.0409822102; Siano A, 2014, J NAT PROD, V77, P831, DOI 10.1021/np4009317; Tena-Sempere M, 2012, GEN COMP ENDOCR, V175, P234, DOI 10.1016/j.ygcen.2011.11.015; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; Thundimadathil J, 2006, BIOPOLYMERS, V84, P317, DOI 10.1002/bip.20470; Tomita K, 2008, BIOPOLYMERS, V90, P503, DOI 10.1002/bip.20968; Tomita K, 2007, BIOPOLYMERS, V88, P272, DOI 10.1002/bip.20676; Tomita K, 2007, J MED CHEM, V50, P3222, DOI 10.1021/jm070064l; Tomita K, 2006, BIOORGAN MED CHEM, V14, P7595, DOI 10.1016/j.bmc.2006.07.009; WALTER B, 1977, BIOPOLYMERS, V16, P17, DOI 10.1002/bip.1977.360160103; Zhao YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104330; Zmora N, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097667; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	48	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185892	10.1371/journal.pone.0185892	http://dx.doi.org/10.1371/journal.pone.0185892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977030	Green Submitted, Green Published, gold			2022-12-26	WOS:000412163100051
J	Moran, JL; Santamaria, J				Moran, John L.; Santamaria, John			Reconsidering lactate as a sepsis risk biomarker	PLOS ONE			English	Article							NET RECLASSIFICATION IMPROVEMENT; GOAL-DIRECTED RESUSCITATION; PREDICTION MODELS; CLINICAL-CRITERIA; INCREMENTAL VALUE; IDENTIFY PATIENTS; SEPTIC SHOCK; GRAPHICAL ASSESSMENT; HOSPITAL MORTALITY; COULD LACTATE	Objectives There has been renewed interest in lactate as a risk biomarker in sepsis and septic shock. However, the ability of the odds ratio (OR) and change in the area under the receiver operator characteristic curve (AUC-ROC) to assess biomarker added-value has been questioned. Design, setting and participants A sepsis cohort was identified from the ICU database of an Australian tertiary referral hospital using APACHE III diagnostic codes. Demographic information, APACHE III scores, 24-hour post-admission patient lactate levels, and hospital mortality were accessed. Measurements and main results Hospital mortality was modelled using a base predictive logistic regression model and sequential addition of admission lactate, lactate clearance ([lactate(admission)-lactate(final)]/lactate(admission)), and area under the lactate-time curve (LTC). Added-value was assessed using lactate index OR; AUC-ROC difference (base-model versus lactate index addition); net (mortality) reclassification index (NRI; range -2 to +2); and net benefit (NB), the number of true positives per patient adjusted for the number of false positives. The data set comprised 717 patients with mean(SD) age and APACHE III score 61.1(16.5) years and 68.3 (28.2) respectively; 59.2% were male. Admission lactate was 2.3(2.5) mmol/l; with lactate of >= 4 mmol/L (37% hospital mortality) in 17% and patients with lactate <4 mmol/L having 18% hospital mortality. The admission base-model had an AUC-ROC = 0.81 with admission lactate OR = 1.127 (95% CI: 1.038, 1.224), AUC-ROC difference of 0.0032 (-0.0037, 0.01615; P = 0.61), and NRI 0.240(0.030, 0.464). The over-time model had an AUC-ROC = 0.86 with (i) clearance OR = 0.771, 95% CI: 0.578, 1.030; P = 0.08; AUC-ROC difference 0.001 (-0.003, 0.014; P = 0.78), and NRI 0.109(-0.193, 0.425) and (ii) LTC OR = 0.997, 95% CI: 0.989, 1.005, P = 0.49; AUC-ROC difference 0.004 (-0.002, 0.004; P = 0.34), and NRI 0.111(-0.222, 0.403). NB was not incremented by any lactate index. Conclusions Lactate added-value assessment is dependent upon the performance of the underlying predictive model and should incorporate risk reclassification and net benefit measures.	[Moran, John L.] Queen Elizabeth Hosp, Dept Intens Care Med, Woodville, SA, Australia; [Santamaria, John] St Vincents Hosp Melbourne, Dept Crit Care Med, Fitzroy, Vic, Australia	St Vincent's Hospital Melbourne	Moran, JL (corresponding author), Queen Elizabeth Hosp, Dept Intens Care Med, Woodville, SA, Australia.	John.moran@adelaide.edu.au	Santamaria, John/M-9581-2019					ANZICS-CORE, 2017, APD DATA DICTIONARY; Austin PC, 2013, STAT MED, V32, P661, DOI 10.1002/sim.5598; Baker SG, 2014, STAT MED, V33, P3946, DOI 10.1002/sim.6195; Ballman KV, 2015, J CLIN ONCOL, V33, P3968, DOI 10.1200/JCO.2015.63.3651; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Bartlett JW, 2015, AM J EPIDEMIOL, V182, P730, DOI 10.1093/aje/kwv114; Bilger M., 2015, STAT SOFT COMP; Bilger M, 2015, HEALTH ECON, V24, P75, DOI 10.1002/hec.3003; Casserly B, 2016, CRIT CARE MED, V44, pE178, DOI [10.1097/CCM.0000000000001533, 10.1097/CCM.0000000000001455]; Casserly B, 2015, CRIT CARE MED, V43, P567, DOI 10.1097/CCM.0000000000000742; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4181; Gerdin M, 2016, JAMA-J AM MED ASSOC, V316, P453, DOI 10.1001/jama.2016.6410; Harrell FE, 2016, SHOULD CHANGE BE MEA; Harrell FE, 2015, SPRINGER SER STAT, P63, DOI 10.1007/978-3-319-19425-7_4; Hilden J, 2014, STAT MED, V33, P3405, DOI 10.1002/sim.5804; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Houwink API, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1243-3; Hutcheon JA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2289; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jaki T, 2011, PHARM STAT, V10, P284, DOI 10.1002/pst.449; Jansen TC, 2010, AM J RESP CRIT CARE, V182, P752, DOI 10.1164/rccm.200912-1918OC; JENCKS SF, 1988, JAMA-J AM MED ASSOC, V260, P2240, DOI 10.1001/jama.260.15.2240; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Junhasavasdikul D, 2016, J CRIT CARE, V33, P71, DOI 10.1016/j.jcrc.2016.01.019; KAISER L, 1989, STAT MED, V8, P1183, DOI 10.1002/sim.4780081002; Kerr KF, 2016, J CLIN ONCOL, V34, P2534, DOI 10.1200/JCO.2015.65.5654; Kerr KF, 2011, AM J EPIDEMIOL, V174, P364, DOI 10.1093/aje/kwr086; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Kuha J, 2004, SOCIOL METHOD RES, V33, P188, DOI 10.1177/0049124103262065; Lee SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145181; Leening MJG, 2014, ANN INTERN MED, V160, P122, DOI 10.7326/M13-1522; Liu ZJ, 2016, CRIT CARE MED, V44, pE178, DOI 10.1097/CCM.0000000000001455; Longton G, 2011, INCRISK INCREMENTAL; Madigan D, 2013, AM J EPIDEMIOL, V178, P645, DOI 10.1093/aje/kwt010; Makam AN, 2016, JAMA-J AM MED ASSOC, V316, P453, DOI 10.1001/jama.2016.6407; Martens FK, 2016, J CLIN EPIDEMIOL, V79, P159, DOI 10.1016/j.jclinepi.2016.07.002; Midi H, 2010, J INTERDISCIP MATH, V13, P253, DOI 10.1080/09720502.2010.10700699; Moons KGM, 2012, CLIN CHEM, V58, P1408, DOI 10.1373/clinchem.2012.182550; Moran J L, 2002, Crit Care Resusc, V4, P93; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Muhlenbruch K, 2013, EUR J EPIDEMIOL, V28, P25, DOI 10.1007/s10654-012-9744-0; Nattino G, 2016, STAT MED, V35, P709, DOI 10.1002/sim.6744; Nattino G, 2014, STAT MED, V33, P2696, DOI 10.1002/sim.6126; Nguyen HB, 2013, CHEST, V143, P1521, DOI 10.1378/chest.13-0006; Nguyen HB, 2004, CRIT CARE MED, V32, P1637, DOI 10.1097/01.CCM.0000132904.35713.A7; Nichol A, 2011, CRIT CARE, V15, DOI 10.1186/cc10497; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Pencina KM, 2014, STAT MED, V33, P4975, DOI 10.1002/sim.6286; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Pepe MS, 2015, STAT BIOSCI, V7, P282, DOI 10.1007/s12561-014-9118-0; Pepe MS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju041; Pepe MS, 2013, STAT MED, V32, P1467, DOI 10.1002/sim.5727; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Puskarich MA, 2013, CHEST, V143, P1548, DOI 10.1378/chest.12-0878; Reineck LA, 2014, CRIT CARE MED, V42, P1055, DOI 10.1097/CCM.0000000000000132; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Royston P, 2016, STATA J, V16, P72, DOI 10.1177/1536867X1601600109; Seymour CW, 2016, JAMA-J AM MED ASSOC, V316, P454, DOI 10.1001/jama.2016.6413; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Shlipak MG, 2013, NAT REV NEPHROL, V9, P478, DOI 10.1038/nrneph.2013.108; STACPOOLE PW, 1992, NEW ENGL J MED, V327, P1564, DOI 10.1056/NEJM199211263272204; Steichen TJ, 1999, STATA TECHNICAL B RE, V8, P137; Steyerberg EW, 2015, BIOMETRICAL J, V57, P556, DOI 10.1002/bimj.201300260; Steyerberg EW, 2012, EUR J CLIN INVEST, V42, P216, DOI 10.1111/j.1365-2362.2011.02562.x; Stow PJ, 2006, J CRIT CARE, V21, P133, DOI 10.1016/j.jcrc.2005.11.010; Tang Y, 2015, QJM-INT J MED, V108, P279, DOI 10.1093/qjmed/hcu186; Thomas-Rueddel DO, 2015, J CRIT CARE, V30, P439, DOI 10.1016/j.jcrc.2014.10.027; Trzeciak S, 2004, CRIT CARE MED, V32, P1785, DOI 10.1097/01.CCM.0000134837.18530.14; Tzoulaki I, 2009, JAMA-J AM MED ASSOC, V302, P2345, DOI 10.1001/jama.2009.1757; Van Calster B, 2015, MED DECIS MAKING, V35, P162, DOI 10.1177/0272989X14547233; Van Calster B, 2013, MED DECIS MAKING, V33, P490, DOI 10.1177/0272989X12470757; Vasilevskis EE, 2009, MED CARE, V47, P803, DOI 10.1097/MLR.0b013e3181a39454; Vickers AJ, 2014, DECISION CURVE ANAL; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vickers AJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-13; Vickers AJ, 2010, SEMIN ONCOL, V37, P31, DOI 10.1053/j.seminoncol.2009.12.004; Vincent JL, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1403-5; Wacharasint P, 2012, SHOCK, V38, P4, DOI 10.1097/SHK.0b013e318254d41a; WEIL MH, 1970, CIRCULATION, V41, P989, DOI 10.1161/01.CIR.41.6.989; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602; Zhang ZH, 2014, CRIT CARE MED, V42, P2118, DOI 10.1097/CCM.0000000000000405	84	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185320	10.1371/journal.pone.0185320	http://dx.doi.org/10.1371/journal.pone.0185320			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972976	gold, Green Submitted, Green Published			2022-12-26	WOS:000412131900015
J	Narayan, N; Mandhair, H; Smyth, E; Dakin, SG; Kiriakidis, S; Wells, L; Owen, D; Sabokbar, A; Taylor, P				Narayan, Nehal; Mandhair, Harpreet; Smyth, Erica; Dakin, Stephanie Georgina; Kiriakidis, Serafim; Wells, Lisa; Owen, David; Sabokbar, Afsie; Taylor, Peter			The macrophage marker translocator protein (TSPO) is down-regulated on pro-inflammatory 'M1' human macrophages	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PERIPHERAL BENZODIAZEPINE-RECEPTOR; COUNTER-FLOW ELUTRIATION; RHEUMATOID-ARTHRITIS; CENTRIFUGAL ELUTRIATION; MULTIPLE-SCLEROSIS; CHOLESTEROL EFFLUX; HUMAN MONOCYTE; ACTIVATION; PET	The translocator protein (TSPO) is a mitochondrial membrane protein, of as yet uncertain function. Its purported high expression on activated macrophages, has lent utility to TSPO targeted molecular imaging in the form of positron emission tomography (PET), as a means to detect and quantify inflammation in vivo. However, existing literature regarding TSPO expression on human activated macrophages is lacking, mostly deriving from brain tissue studies, including studies of brain malignancy, and inflammatory diseases such as multiple sclerosis. Here, we utilized three human sources of monocyte derived macrophages (MDM), from THP-1 monocytes, healthy peripheral blood monocytes and synovial fluid monocytes from patients with rheumatoid arthritis, to undertake a detailed investigation of TSPO expression in activated macrophages. In this work, we demonstrate a consistent down-regulation of TSPO mRNA and protein in macrophages activated to a pro-inflammatory, or 'M1' phenotype. Conversely, stimulation of macrophages to an M2 phenotype with IL-4, dexamethasone or TGF-beta 1 did not alter TSPO expression, regardless of MDM source. The reasons for this are uncertain, but our study findings add some supporting evidence for recent investigations concluding that TSPO may be involved in negative regulation of inflammatory responses in macrophages.	[Narayan, Nehal; Mandhair, Harpreet; Dakin, Stephanie Georgina; Kiriakidis, Serafim; Sabokbar, Afsie; Taylor, Peter] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Oxford, England; [Smyth, Erica; Wells, Lisa] Imanova Ctr Imaging Sci, London, England; [Owen, David] Imperial Coll, Div Brain Sci, London, England	University of Oxford; Imperial College London	Narayan, N (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Oxford, England.	nehal.narayan@ndorms.ox.ac.uk		Owen, David/0000-0002-1198-7563; Smyth, Erica/0000-0002-8715-674X; Dakin, Stephanie Georgina/0000-0003-2470-1031	NIHR BRC at the University of Oxford through an unrestricted [OXF141232]; Medical Research Council [MR/N008219/1] Funding Source: researchfish; MRC [MR/N008219/1] Funding Source: UKRI	NIHR BRC at the University of Oxford through an unrestricted; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	NN was supported by the NIHR BRC at the University of Oxford through an unrestricted grant (OXF141232).	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Allen AM, 2013, CLIN SCI, V124, P509, DOI 10.1042/CS20120358; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Bae KR, 2014, J NEUROIMMUNE PHARM, V9, P424, DOI 10.1007/s11481-014-9540-6; Banfalvi G, 2008, NAT PROTOC, V3, P663, DOI 10.1038/nprot.2008.34; Banks WA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0434-1; Batarseh A, 2010, MOL CELL ENDOCRINOL, V327, P1, DOI 10.1016/j.mce.2010.06.013; Berger TG, 2005, J IMMUNOL METHODS, V298, P61, DOI 10.1016/j.jim.2005.01.005; Bernards N, 2015, MOL IMAGING BIOL, V17, P67, DOI 10.1007/s11307-014-0765-9; Bonsack F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0619-2; CANAT X, 1993, LIFE SCI, V52, P107, DOI 10.1016/0024-3205(93)90293-C; Chauveau F, 2008, EUR J NUCL MED MOL I, V35, P2304, DOI 10.1007/s00259-008-0908-9; Ching ASC, 2012, INSIGHTS IMAGING, V3, P111, DOI 10.1007/s13244-011-0128-x; Chowdhury SM, 2015, MOL CELL PROTEOMICS, V14, P1859, DOI 10.1074/mcp.M114.045179; Dakin SG, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4269; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Garcia-Cabezas MA, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00107; Gent YYJ, 2014, J RHEUMATOL, V41, P2145, DOI 10.3899/jrheum.140059; Gent YYJ, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4509; Gent YYJ, 2012, ARTHRITIS RHEUM-US, V64, P62, DOI 10.1002/art.30655; Han JH, 2000, J BIOL CHEM, V275, P1241, DOI 10.1074/jbc.275.2.1241; Hume DA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00370; Kennedy A, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00052; Koning N, 2010, J INNATE IMMUN, V2, P195, DOI 10.1159/000252803; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Lamare F, 2011, J NUCL MED, V52, P33, DOI 10.2967/jnumed.110.079038; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Liu HT, 2008, IMMUNOL LETT, V117, P70, DOI 10.1016/j.imlet.2007.12.012; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO., 2012, CURR PROTOC IMMUNOL, V28, P1; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Morin D, 2016, BIOCHEM PHARMACOL, V105, P1, DOI 10.1016/j.bcp.2015.12.003; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mulherin D, 1996, ARTHRITIS RHEUM, V39, P115, DOI 10.1002/art.1780390116; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Nair A, 2016, EJNMMI RES, V6, DOI 10.1186/s13550-016-0226-3; Navegantes KC, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1141-8; Niyonzima N, 2015, J IMMUNOL, V195, P257, DOI 10.4049/jimmunol.1403044; Oh U, 2011, J NEUROIMMUNE PHARM, V6, P354, DOI 10.1007/s11481-010-9243-6; Owen DR, 2012, J CEREBR BLOOD F MET, V32, P1, DOI 10.1038/jcbfm.2011.147; Owen DR, 2010, J CEREBR BLOOD F MET, V30, P1608, DOI 10.1038/jcbfm.2010.63; Papadopoulos V, 2006, NEUROSCIENCE, V138, P749, DOI 10.1016/j.neuroscience.2005.05.063; Park E, 2015, EUR J NUCL MED MOL I, V42, P1081, DOI 10.1007/s00259-015-3043-4; Raes G, 2005, J IMMUNOL, V174, P6561, DOI 10.4049/jimmunol.174.11.6561; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Sandiego CM, 2015, P NATL ACAD SCI USA, V112, P12468, DOI 10.1073/pnas.1511003112; Scarf AM, 2011, J NUCL MED, V52, P667, DOI 10.2967/jnumed.110.086629; Schneemann M, 2002, NAT IMMUNOL, V3, P102, DOI 10.1038/ni0202-102a; Schneemann M, 2007, J LEUKOCYTE BIOL, V81, P579, DOI 10.1189/jlb.1106702; Schwanke U, 2006, J CLIN APHERESIS, V21, P153, DOI 10.1002/jca.20077; Schweitzer PJ, 2010, DRUG DISCOV TODAY, V15, P933, DOI 10.1016/j.drudis.2010.08.012; Shao X, 2013, NUCL MED BIOL, V40, P906, DOI 10.1016/j.nucmedbio.2013.06.008; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Stroncek DF, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0241-y; Taylor JMW, 2014, CLIN SCI, V127, P603, DOI 10.1042/CS20140047; Taylor SC, 2013, MOL BIOTECHNOL, V55, P217, DOI 10.1007/s12033-013-9672-6; Thomas AC, 2014, FRONT IMMUNOL, V5, DOI [10.3389/fimmu.2014.00479, 10.3389/fimmu.2014.00478]; van der Laken CJ, 2008, ARTHRITIS RHEUM, V58, P3350, DOI 10.1002/art.23955; Vowinckel E, 1997, J NEUROSCI RES, V50, P345, DOI 10.1002/(SICI)1097-4547(19971015)50:2<345::AID-JNR22>3.0.CO;2-5; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; YASAKA T, 1981, J IMMUNOL, V127, P1515	67	44	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185767	10.1371/journal.pone.0185767	http://dx.doi.org/10.1371/journal.pone.0185767			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968465	Green Published, gold, Green Submitted			2022-12-26	WOS:000412029600046
J	Nosaka, T; Naito, T; Hiramatsu, K; Ohtani, M; Nemoto, T; Marusawa, H; Mai, N; Hiraku, Y; Kawanishi, S; Yamashita, T; Kaneko, S; Nakamoto, Y				Nosaka, Takuto; Naito, Tatsushi; Hiramatsu, Katsushi; Ohtani, Masahiro; Nemoto, Tomoyuki; Marusawa, Hiroyuki; Mai, Ning; Hiraku, Yusuke; Kawanishi, Shosuke; Yamashita, Taro; Kaneko, Shuichi; Nakamoto, Yasunari			Gene expression profiling of hepatocarcinogenesis in a mouse model of chronic hepatitis B	PLOS ONE			English	Article							VIRUS TRANSGENIC MICE; INDUCED HEPATOCELLULAR-CARCINOMA; LIVER-CANCER; T-CELLS; GROWTH-FACTOR; THERAPY; PATHOGENESIS; PROGNOSIS; MECHANISMS; INJURY	Background Hepatocellular carcinoma (HCC) is a common complication of chronic viral hepatitis. In support of this notion, we have reported that hepatitis B surface antigen (HBsAg)-specific CD8 + T lymphocytes critically contribute to inducing chronic liver cell injury that exerts high carcinogenic potential in a hepatitis B virus (HBV) transgenic mouse model. The dynamics of the molecular signatures responsible for hepatocellular carcinogenesis are not fully understood. The current study was designed to determine the serial changes in gene expression profiles in a model of chronic immune-mediated hepatitis. Methods Three-month-old HBV transgenic mice were immunologically reconstituted with bone marrow cells and splenocytes from syngeneic nontransgenic donors. Liver tissues were obtained every three months until 18 months at which time all mice developed multiple liver tumors. Nitrative DNA lesions and hepatocyte turnover were assessed immunohistochemically. Gene expression profiles were generated by extracting total RNA from the tissues and analyzing by microarray. Results The nitrative DNA lesions and the regenerative proliferation of hepatocytes were increased during the progression of chronic liver disease. In a gene expression profile analysis of liver samples, the chemokine-and T cell receptor (TCR)-mediated pathways were enhanced during chronic hepatitis, and the EGF-and VEGF-mediated pathways were induced in HCC. Among these molecules, the protein levels of STAT3 were greatly enhanced in all hepatocyte nuclei and further elevated in the cytoplasm in HCC tissue samples at 18 months, and the levels of phosphorylated TP53 (p-p53-Ser 6 and -Ser 15) were increased in liver tissues. Conclusions HBV-specific immune responses caused unique molecular signatures in the liver tissues of chronic hepatitis and triggered subsequent carcinogenic gene expression profiles in a mouse model. The results suggest a plausible molecular basis responsible for HBV-induced immune pathogenesis of HCC.	[Nosaka, Takuto; Naito, Tatsushi; Hiramatsu, Katsushi; Ohtani, Masahiro; Nemoto, Tomoyuki; Nakamoto, Yasunari] Univ Fukui, Fac Med Sci, Dept Internal Med 2, Fukui, Japan; [Marusawa, Hiroyuki] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto, Japan; [Mai, Ning] Suzuka Univ Med Sci, Fac Nursing Sci, Suzuka, Mie, Japan; [Hiraku, Yusuke] Mie Univ, Grad Sch Med, Dept Environm & Mol Med, Tsu, Mie, Japan; [Kawanishi, Shosuke] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie, Japan; [Yamashita, Taro; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med Sci, Dept Gastroenterol, Kanazawa, Ishikawa, Japan	University of Fukui; Kyoto University; Mie University; Kanazawa University	Nakamoto, Y (corresponding author), Univ Fukui, Fac Med Sci, Dept Internal Med 2, Fukui, Japan.	nakamoto_med2@med.u-fukui.ac.jp	Nosaka, Takuto/ABB-5695-2021	Ma, Ning/0000-0001-7315-8835; Marusawa, Hiroyuki/0000-0002-4286-2712; Naito, Tatsushi/0000-0001-5472-8193	JSPS KAKENHI [JP 25293171]; Research Programs on the Innovative Development; Application of New Drugs for Hepatitis B [16fk0310509h0005, 17fk0310116h0001]; Chubu Regional Consortium for Advanced Medicine; C-CAM from Japan Agency for Medical Research and development [17lm0203005j0001]; AMED; Grants-in-Aid for Scientific Research [26253046] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Programs on the Innovative Development; Application of New Drugs for Hepatitis B; Chubu Regional Consortium for Advanced Medicine; C-CAM from Japan Agency for Medical Research and development; AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was partially supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (B) (JP 25293171) and the Research Programs on the Innovative Development and the Application of New Drugs for Hepatitis B (16fk0310509h0005 and 17fk0310116h0001) and on the Chubu Regional Consortium for Advanced Medicine, C-CAM (17lm0203005j0001) from Japan Agency for Medical Research and development, AMED, to Yasunari Nakamoto. Authors have no commercial or other associations that might pose a conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO K, 1993, J EXP MED, V178, P1541, DOI 10.1084/jem.178.5.1541; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; CHISARI FV, 1989, CELL, V59, P1145, DOI 10.1016/0092-8674(89)90770-8; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; CHISARI FV, 1986, J VIROL, V60, P880, DOI 10.1128/JVI.60.3.880-887.1986; DiBisceglie AM, 1997, HEPATOLOGY, V26, pS34, DOI 10.1002/hep.510260706; Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802; Ferrari C, 2015, LIVER INT, V35, P121, DOI 10.1111/liv.12749; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Franco A, 1997, J IMMUNOL, V159, P2001; Giordano S, 2013, HEPATOLOGY, V57, P840, DOI 10.1002/hep.26095; Guidotti LG, 2015, CURR OPIN IMMUNOL, V36, P61, DOI 10.1016/j.coi.2015.06.016; Guidotti LG, 2015, CELL, V161, P486, DOI 10.1016/j.cell.2015.03.005; Halama N, 2016, CANCER CELL, V29, P587, DOI 10.1016/j.ccell.2016.03.005; Hiraku Y, 2007, CANC SCI, V98; Inoue K, 2012, CLIN CANCER RES, V18, P3924, DOI 10.1158/1078-0432.CCR-11-2041; Kang HJ, 2017, ONCOTARGET, V8, P27263, DOI 10.18632/oncotarget.15930; Levrero M, 2016, J HEPATOL, V64, pS84, DOI 10.1016/j.jhep.2016.02.021; Llovet JM, 2012, CLIN CANCER RES, V18, P2290, DOI 10.1158/1078-0432.CCR-11-2175; Loughery J, 2014, NUCLEIC ACIDS RES, V42, P7664, DOI 10.1093/nar/gku501; Ma N, 2006, NITRIC OXIDE-BIOL CH, V14, P137, DOI 10.1016/j.niox.2005.09.012; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; MORIYAMA T, 1990, SCIENCE, V248, P361, DOI 10.1126/science.1691527; Nakamoto Y, 1998, J EXP MED, V188, P341, DOI 10.1084/jem.188.2.341; Nakamoto Y, 2004, CANCER RES, V64, P3326, DOI 10.1158/0008-5472.CAN-03-3817; Nakamoto Y, 2003, CURR MOL MED, V3, P537, DOI 10.2174/1566524033479591; Nakamoto Y, 2002, J EXP MED, V196, P1105, DOI 10.1084/jem.20020633; Nakamoto Y, 2017, HEPATOL RES, V47, P251, DOI 10.1111/hepr.12795; Ozturk M, 2009, CANCER LETT, V286, P103, DOI 10.1016/j.canlet.2008.10.048; Pencik J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8736; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Safa M, 2010, APOPTOSIS, V15, P196, DOI 10.1007/s10495-009-0417-8; Scheffel MJ, 2016, CANCER RES, V76, P6006, DOI 10.1158/0008-5472.CAN-16-0587; Sia D, 2017, GASTROENTEROLOGY, V152, P745, DOI 10.1053/j.gastro.2016.11.048; Sitia G, 2012, P NATL ACAD SCI USA, V109, pE2165, DOI 10.1073/pnas.1209182109; Tang S, 2016, CANCER LETT, V376, P137, DOI 10.1016/j.canlet.2016.03.034; Tsuruya K, 2003, DNA REPAIR, V2, P211, DOI 10.1016/S1568-7864(02)00214-8; Ueda S, 2006, CANCER RES, V66, P5346, DOI 10.1158/0008-5472.CAN-05-3684; White DL, 2017, GASTROENTEROLOGY, V152, P812, DOI 10.1053/j.gastro.2016.11.020; WIRTH S, 1995, J IMMUNOL, V154, P2504; Xu C, 2014, CANCER LETT, V345, P216, DOI 10.1016/j.canlet.2013.08.035; Yamaguchi R, 1998, HEPATOLOGY, V28, P68, DOI 10.1002/hep.510280111; Yamashita T, 2009, J HEPATOL, V50, P100, DOI 10.1016/j.jhep.2008.07.036; Yu HY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6218; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zucman-Rossi J, 2015, GASTROENTEROLOGY, V149, P1226, DOI 10.1053/j.gastro.2015.05.061	46	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185442	10.1371/journal.pone.0185442	http://dx.doi.org/10.1371/journal.pone.0185442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968425	Green Submitted, Green Published, gold			2022-12-26	WOS:000412029600021
J	Otoshi, T; Kataoka, Y; Ikegaki, S; Saito, E; Matsumoto, H; Kaku, S; Shimada, M; Hirabayashi, M				Otoshi, Takehiro; Kataoka, Yuki; Ikegaki, Shunkichi; Saito, Emiko; Matsumoto, Hirotaka; Kaku, Sawako; Shimada, Masatoshi; Hirabayashi, Masataka			Pleural effusion biomarkers and computed tomography findings in diagnosing malignant pleural mesothelioma: A retrospective study in a single center	PLOS ONE			English	Article							SOLUBLE MESOTHELIN; HYALURONIC-ACID; MARKER; FLUID; SERUM; PEPTIDE; RATIO; TOOL	In this study, we aimed to examine the clinical value of the pleural effusion (PE) biomarkers, soluble mesothelin-related peptide (SMRP), cytokeratin 19 fragment (CYFRA 21-1) and carcinoembryonic antigen (CEA), and the utility of combining chest computed tomography (CT) findings with these biomarkers, in diagnosing malignant pleural mesothelioma (MPM). We conducted a retrospective cohort study in a single center. Consecutive patients with undiagnosed pleural effusions who underwent PE analysis between September 2014 and August 2016 were reviewed. This study included 240 patients (32 with MPM and 208 non-MPM). SMRP and the CYFRA 21-1/CEA ratio had a sensitivity and specificity for diagnosing MPM of 56.3% and 86.5%, and 87.5% and 74.0%, respectively. Using receiver operating characteristics (ROC) curve analysis of the ability of these markers to distinguish MPM from all other PE causes, the area under the ROC curve (AUC) for SMRP and the CYFRA 21-1/CEA ratio was 0.804 and 0.874, respectively. The sensitivity and specificity of SMRP combined with the CYFRA 21-1/CEA ratio were 93.8% and 64.9%, respectively. The sensitivity of the combination of SMRP, the CYFRA 21-1/CEA ratio, and the presence of Leung's criteria (a chest CT finding that is suggestive of malignant pleural disease) was 93.8%. In conclusion, the combined PE biomarkers had a high sensitivity for diagnosing MPM, although the addition of chest CT findings did not improve the sensitivity of SMRP combined with the CYFRA 21-1/CEA ratio. Combination of these biomarkers helped to rule out MPM effectively among patients at high risk of suffering MPM and would be valuable especially for old frail patients who have difficulty in undergoing invasive procedures such as thoracoscopy.	[Otoshi, Takehiro; Kataoka, Yuki; Ikegaki, Shunkichi; Saito, Emiko; Matsumoto, Hirotaka; Kaku, Sawako; Shimada, Masatoshi; Hirabayashi, Masataka] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Resp Med, Amagasaki, Hyogo, Japan		Otoshi, T (corresponding author), Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Resp Med, Amagasaki, Hyogo, Japan.	takehiro-otoshi19850902@gmail.com		Kataoka, Yuki/0000-0001-7982-5213				Aleman C, 2009, MED CLIN-BARCELONA, V133, P449, DOI 10.1016/j.medcli.2008.11.047; Burgess LJ, 1996, CHEST, V109, P414, DOI 10.1378/chest.109.2.414; Canessa PA, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0649-x; Canessa PA, 2013, CANCER INVEST, V31, P48, DOI 10.3109/07357907.2012.749265; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Creaney J, 2007, THORAX, V62, P569, DOI 10.1136/thx.2006.068114; Creaney J, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/413946; Damhuis RA, 2015, LUNG CANCER, V89, P212, DOI 10.1016/j.lungcan.2015.05.014; Davies HE, 2009, AM J RESP CRIT CARE, V180, P437, DOI 10.1164/rccm.200811-1729OC; Ferro P, 2013, ANTICANCER RES, V33, P2707; Filiberti R, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0543-6; Franceschini MC, 2014, ANTICANCER RES, V34, P7425; Fujimoto N, 2013, RESPIR INVESTIG, V51, P92, DOI 10.1016/j.resinv.2013.02.002; Fujimoto N, 2010, EXP THER MED, V1, P313, DOI 10.3892/etm_00000048; Fujimoto N, 2010, J CANCER RES CLIN, V136, P1755, DOI 10.1007/s00432-010-0834-7; Hooper C, 2010, THORAX, V65, P4, DOI 10.1136/thx.2010.136978; Hooper CE, 2013, EUR RESPIR J, V41, P18, DOI 10.1183/09031936.00148211; Kurumatani N, 2008, AM J RESP CRIT CARE, V178, P624, DOI 10.1164/rccm.200801-063OC; LEUNG AN, 1990, AM J ROENTGENOL, V154, P487, DOI 10.2214/ajr.154.3.2106209; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Metintas M, 2002, EUR J RADIOL, V41, P1, DOI 10.1016/S0720-048X(01)00426-0; Nakamachi M, 2011, IGAKU TO YAKUGAKU, V65, P261; Paganuzzi M, 2001, CHEST, V119, P1138, DOI 10.1378/chest.119.4.1138; Parodi S, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S9-S3; Pass HI, 2008, ANN THORAC SURG, V85, P265, DOI 10.1016/j.athoracsur.2007.07.042; PETTERSSON T, 1988, CHEST, V94, P1037, DOI 10.1378/chest.94.5.1037; Scherpereel A, 2006, AM J RESP CRIT CARE, V173, P1155, DOI 10.1164/rccm.200511-1789OC; Suzuki H, 2010, ANTICANCER RES, V30, P4343; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yamada S, 2011, CLIN CHEM LAB MED, V49, P1721, DOI 10.1515/CCLM.2011.242; Yilmaz U M, 1998, Respirology, V3, P33, DOI 10.1046/j.1440-1843.1998.00069.x	31	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185850	10.1371/journal.pone.0185850	http://dx.doi.org/10.1371/journal.pone.0185850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968445	Green Submitted, Green Published, gold			2022-12-26	WOS:000412029600060
J	Csoka, B; Nemeth, ZH; Duerr, CU; Fritz, JH; Pacher, P; Hasko, G				Csoka, Balazs; Nemeth, Zoltan H.; Duerr, Claudia U.; Fritz, Jorg H.; Pacher, Pal; Hasko, Gyorgy			Adenosine receptors differentially regulate type 2 cytokine production by IL-33-activated bone marrow cells, ILC2s, and macrophages	FASEB JOURNAL			English	Article						A(2A)AR; A(2B)AR; ILC2s; helminth infection; allergic inflammation	INNATE LYMPHOID-CELLS; PULMONARY INFLAMMATION; TNF-ALPHA; T-CELLS; ACTIVATION; A(2A); EXPRESSION; IL-10; MICE	Group 2 innate lymphoid cells (ILC2s) represent a rapid source of type 2 cytokines, such as IL-5 and IL-13, and play an important role in orchestrating type 2 immune response. Adenosine is an endogenous purine nucleoside, a catabolite of ATP that binds and activates >= 1 of 4 transmembrane G protein-coupled cell-surface adenosine receptors (ARs)-A(1), A(2A), A(2B), and A(3). Here, we studied the role of ARs in the regulation of cytokine production by ILC2s. We found that A(2B)ARs suppress the production of both IL-5 and IL-13 by ILC2s, whereas A(2A)ARs augment IL-5 production and fail to affect IL-13 release. Combined stimulation of all ARs led to the suppression of both IL-5 and IL-13 production, which indicated that A(2B)ARs dominate A(2A)ARs. Both pre-and post-transcriptional processes may be involved in the AR modulation of ILC2 IL-5 and IL-13 production. Thus, we identify adenosine as a novel negative regulator of ILC2 activation.	[Csoka, Balazs; Nemeth, Zoltan H.; Hasko, Gyorgy] Rutgers New Jersey Med Sch, Dept Surg, Newark, NJ USA; [Csoka, Balazs; Nemeth, Zoltan H.; Hasko, Gyorgy] Rutgers New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ USA; [Nemeth, Zoltan H.] Morristown Mem Med Ctr, Dept Surg, Morristown, NJ USA; [Duerr, Claudia U.; Fritz, Jorg H.] McGill Univ, Res Ctr Complex Traits, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Pacher, Pal] NIAAA, NIH, Bethesda, MD USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; McGill University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Hasko, G (corresponding author), UMDNJ Rutgers New Jersey Med Sch, Dept Surg, Ctr Immun & Inflammat, MSB, 185 South Orange Ave,G-586, Newark, NJ 07103 USA.	haskoge@njms.rutgers.edu	Pacher, Pal/B-6378-2008	Pacher, Pal/0000-0001-7036-8108	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grant [R01-GM066189]; NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant [R01-DK113790]; Intramural Research Program of the NIH National Institute on Alcohol Abuse and Alcoholism; Canadian Institutes of Health Research (CIHR); Leaders Opportunity Fund infrastructure grant from the Canadian Foundation of Innovation; CIHR New Investigator Award; Fonds de Recherche du Quebec-Sante (FRQS); CIHR; German National Academy of Sciences Leopoldina; American Association of Immunologists Careers in Immunology Fellowship Program; NIH [1S10-RR027022]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000375] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grant; NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant; Intramural Research Program of the NIH National Institute on Alcohol Abuse and Alcoholism; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Leaders Opportunity Fund infrastructure grant from the Canadian Foundation of Innovation; CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante (FRQS); CIHR(Canadian Institutes of Health Research (CIHR)); German National Academy of Sciences Leopoldina; American Association of Immunologists Careers in Immunology Fellowship Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The authors thank Dr. Joana Vindeirinho and Gabor Toro (both from Rutgers New Jersey Medical School) for technical assistance with the experiments. This work was supported by U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grant R01-GM066189 (to G.H.), NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK113790 (to G.H.), and the Intramural Research Program of the NIH National Institute on Alcohol Abuse and Alcoholism (to P.P.). Work in the laboratory of J.H.F. is supported by a foundation grant from the Canadian Institutes of Health Research (CIHR), and a Leaders Opportunity Fund infrastructure grant from the Canadian Foundation of Innovation. J.H.F. is supported by a CIHR New Investigator Award, and by a Junior 1 and 2 Investigator Award by the Fonds de Recherche du Quebec-Sante (FRQS). C.U.D. is supported by a fellowship of CIHR and the German National Academy of Sciences Leopoldina. J.H.F. and C.U.D. are supported through the American Association of Immunologists Careers in Immunology Fellowship Program. Sorting was performed on the BDFACSAria II, which was obtained through NIH Shared Instrument Grant 1S10-RR027022. The authors declare no conflicts of interest.	Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Belikoff BG, 2012, J IMMUNOL, V189, P3707, DOI 10.4049/jimmunol.1201207; Brickshawana A, 2011, J IMMUNOL, V187, P5795, DOI 10.4049/jimmunol.1102242; Csoka B, 2008, FASEB J, V22, P3491, DOI 10.1096/fj.08-107458; Csoka B, 2014, DIABETES, V63, P850, DOI 10.2337/db13-0573; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Duerr CU, 2016, NAT IMMUNOL, V17, P65, DOI 10.1038/ni.3308; Ernst PB, 2010, J IMMUNOL, V185, P1993, DOI 10.4049/jimmunol.1000108; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 1996, J IMMUNOL, V157, P4634; Hasko G, 2000, FASEB J, V14, P2065, DOI 10.1096/fj.99-0508com; Hasko G, 2009, TRENDS IMMUNOL, V30, P263, DOI 10.1016/j.it.2009.04.001; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Huang S, 1997, BLOOD, V90, P1600, DOI 10.1182/blood.V90.4.1600.1600_1600_1610; Koscso B, 2013, J LEUKOCYTE BIOL, V94, P1309, DOI 10.1189/jlb.0113043; Koshiba M, 1997, J BIOL CHEM, V272, P25881, DOI 10.1074/jbc.272.41.25881; Krishnamoorthy N, 2015, J IMMUNOL, V194, P863, DOI 10.4049/jimmunol.1402534; Laffont S, 2017, J EXP MED, V214, P1581, DOI 10.1084/jem.20161807; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Maazi H, 2018, J ALLERGY CLIN IMMUN, V141, P893, DOI 10.1016/j.jaci.2017.04.043; Mchedlidze T, 2016, MUCOSAL IMMUNOL, V9, P1384, DOI 10.1038/mi.2016.20; Meylan F, 2014, MUCOSAL IMMUNOL, V7, P958, DOI 10.1038/mi.2013.114; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Nemeth ZH, 2005, J IMMUNOL, V175, P8260, DOI 10.4049/jimmunol.175.12.8260; Novitskiy SV, 2008, BLOOD, V112, P1822, DOI 10.1182/blood-2008-02-136325; Paclik D, 2015, EUR J IMMUNOL, V45, P2766, DOI 10.1002/eji.201545635; Panther E, 2003, BLOOD, V101, P3985, DOI 10.1182/blood-2002-07-2113; Patel N, 2014, CELL HOST MICROBE, V15, P339, DOI 10.1016/j.chom.2014.02.001; Raskovalova T, 2005, J IMMUNOL, V175, P4383, DOI 10.4049/jimmunol.175.7.4383; Ryzhov S, 2004, J IMMUNOL, V172, P7726, DOI 10.4049/jimmunol.172.12.7726; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2009, TRENDS IMMUNOL, V30, P102, DOI 10.1016/j.it.2008.12.002; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Taylor S, 2017, J EXP MED, V214, P1663, DOI 10.1084/jem.20161653; von Moltke J, 2017, J EXP MED, V214, P27, DOI 10.1084/jem.20161274; Walford HH, 2014, CLIN IMMUNOL, V155, P126, DOI 10.1016/j.clim.2014.09.007; Wallace KL, 2010, BLOOD, V116, P5010, DOI 10.1182/blood-2010-06-290643; Wilson JM, 2011, J IMMUNOL, V186, P6746, DOI 10.4049/jimmunol.1100117; Wojno EDT, 2015, MUCOSAL IMMUNOL, V8, P1313, DOI 10.1038/mi.2015.21; Yang ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068433; Yu X, 2014, MUCOSAL IMMUNOL, V7, P730, DOI 10.1038/mi.2013.92; Zhou Y, 2009, J IMMUNOL, V182, P8037, DOI 10.4049/jimmunol.0900515	46	25	26	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					829	837		10.1096/fj.201700770R	http://dx.doi.org/10.1096/fj.201700770R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28982732	Green Published, Bronze			2022-12-26	WOS:000425146900025
J	Zheng, X; Chi, J; Zhi, J; Zhang, H; Yue, D; Zhao, J; Li, D; Li, Y; Gao, M; Guo, J				Zheng, X.; Chi, J.; Zhi, J.; Zhang, H.; Yue, D.; Zhao, J.; Li, D.; Li, Y.; Gao, M.; Guo, J.			Aurora-A-mediated phosphorylation of LKB1 compromises LKB1/AMPK signaling axis to facilitate NSCLC growth and migration	ONCOGENE			English	Article							TUMOR-SUPPRESSOR LKB1; EML4-ALK FUSION GENE; CELL LUNG-CANCER; KINASE INHIBITOR; PROSTATE-CANCER; POOR-PROGNOSIS; AMPK ACTIVITY; SURVIVAL; MLN8237; AURKA	Deletion or loss-of-function mutation of LKB1, frequently occurring in non-small cell lung cancers (NSCLCs), is a predominant caution of NSCLC initiation and progression. However, the upstream signaling pathways governing LKB1 activation are largely unknown. Here, we report that LKB1 undergoes Aurora kinase A (AURKA)-mediated phosphorylation, which largely compromises the LKB1/AMPK signaling axis, in turn leading to the elevation of NSCLC cell proliferation, invasion and migration. Mechanically, AURKA-mediated phosphorylation of LKB1 impairs LKB1 interaction with and phosphorylation of its downstream target AMPKa, which has critical roles in governing cancer cell energy metabolic homeostasis and tumorigenesis. Clinically, AURKA displays high levels in NSCLC patients, and correlates with poor outcome of patients with lung adenocarcinoma. Pathologically, the amplification or activation of AURKA-induced impairment of the LKB1/AMPK signaling pathway contributes to NSCLC initiation and progression, highlighting AURKA as a potential therapeutic target for combatting hyperactive AURKA-driven NSCLCs.	[Zheng, X.; Chi, J.; Zhi, J.; Zhao, J.; Li, D.; Li, Y.; Gao, M.] Tianjin Med Univ, Dept Thyroid & Neck Tumor, Canc Inst & Hosp, Oncol Key Lab Canc Prevent & Therapy,Natl Clin Res, Tianjin, Peoples R China; [Zhang, H.] Tianjin Med Univ, Canc Prevent Ctr, Canc Inst & Hosp, Oncol Key Lab Canc Prevent & Therapy,Natl Clin Res, Tianjin, Peoples R China; [Yue, D.] Tianjin Med Univ, Dept Lung Tumor, Canc Inst & Hosp, Oncol Key Lab Canc Prevent & Therapy,Natl Clin Res, Tianjin, Peoples R China; [Guo, J.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, E CLS 628,3 Blackfan Circle, Boston, MA 02115 USA	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Gao, M; Guo, J (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, E CLS 628,3 Blackfan Circle, Boston, MA 02115 USA.	gaoming68@aliyun.com; Jguo3@bidmc.harvard.edu			National Natural Science Foundation of China [81402392, 81472580, 81502322, 81501983]; Tianjin Municipal Science and technology project [15JCQNJC12800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and technology project	This work was partially supported by grants from National Natural Science Foundation of China (Grant No. 81402392, 81472580, 81502322 and 81501983) and Tianjin Municipal Science and technology project (Grant No. 15JCQNJC12800).	Al-Khafaji ASK, 2017, ONCOL LETT, V13, P4463, DOI 10.3892/ol.2017.6012; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; Brose MS, 2002, CANCER RES, V62, P6997; Carretero J, 2007, ONCOGENE, V26, P1616, DOI 10.1038/sj.onc.1209951; Cheng J, 2016, BBA-REV CANCER, V1866, P232, DOI 10.1016/j.bbcan.2016.09.006; Dees EC, 2012, CLIN CANCER RES, V18, P4775, DOI 10.1158/1078-0432.CCR-12-0589; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goos JACM, 2013, BRIT J CANCER, V109, P2445, DOI 10.1038/bjc.2013.608; Guo J, 2013, ONCOGENE, V32, P151, DOI 10.1038/onc.2012.39; Guo JP, 2009, AM J PATHOL, V175, P324, DOI 10.2353/ajpath.2009.080767; Guo JP, 2016, SCIENCE, V353, P929, DOI 10.1126/science.aad5755; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Katayama H, 2010, BBA-GENE REGUL MECH, V1799, P829, DOI 10.1016/j.bbagrm.2010.09.004; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Lee SW, 2015, MOL CELL, V57, P1022, DOI 10.1016/j.molcel.2015.01.015; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Liu X, 2016, ONCOTARGET, V7, P33152, DOI 10.18632/oncotarget.8888; Lo Iacono M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-100; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Mahadevan D, 2012, CLIN CANCER RES, V18, P2210, DOI 10.1158/1078-0432.CCR-11-2413; Marcus AI, 2010, J THORAC ONCOL, V5, P1883, DOI 10.1097/JTO.0b013e3181fbc28a; Matulonis UA, 2012, GYNECOL ONCOL, V127, P63, DOI 10.1016/j.ygyno.2012.06.040; Nikonova AS, 2013, CELL MOL LIFE SCI, V70, P661, DOI 10.1007/s00018-012-1073-7; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Patel AV, 2012, CLIN CANCER RES, V18, P5020, DOI 10.1158/1078-0432.CCR-12-1072; Pirker R, 2009, LANCET, V373, P1525, DOI 10.1016/S0140-6736(09)60569-9; Pollard JR, 2009, J MED CHEM, V52, P2629, DOI 10.1021/jm8012129; Reiter R, 2006, CLIN CANCER RES, V12, P5136, DOI 10.1158/1078-0432.CCR-05-1650; Ritho J, 2015, CELL REP, V12, P734, DOI 10.1016/j.celrep.2015.07.002; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Staff S, 2010, ONCOL REP, V23, P307, DOI 10.3892/or_00000637; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zhang LL, 2017, CANCER LETT, V390, P11, DOI 10.1016/j.canlet.2017.01.003; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026; Zheng XQ, 2014, ONCOGENE, V33, P4985, DOI 10.1038/onc.2013.444	47	24	25	1	19	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 25	2018	37	4					502	511		10.1038/onc.2017.354	http://dx.doi.org/10.1038/onc.2017.354			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT7KP	28967900				2022-12-26	WOS:000423331600008
J	Soysa, HSM; Schulte, A; Suginta, W				Soysa, H. Sasimali M.; Schulte, Albert; Suginta, Wipa			Functional analysis of an unusual porin-like channel that imports chitin for alternative carbon metabolism in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL OUTER-MEMBRANE; SUGAR TRANSLOCATION; CHITOOLIGOSACCHARIDE-BINDING; MALTOPORIN CHANNELS; CURRENT NOISE; PROTEIN; TRANSPORT; CHITOPORIN; MOLECULES; PATHWAY	Escherichia coli have the genetic potential to use chitin as a carbon source in the absence of glucose, importing it via the chitin-uptake channel EcChiP for processing by the glucosamine catabolic pathway. The chip gene is usually not expressed when E. coli are grown on glucose-enriched nutrients, providing a general regulatory mechanism for the pathway. EcChiP is unusual in that it is homologous to porins and monomeric instead of trimeric, the typical form of sugar-specific channels, making it unclear how this channel operates. We recently reported that EcChiP could form a stable channel in lipid membranes and that the channel is specific for chitooligosaccharides. This report describes the biophysical nature of sugar-channel interactions and the kinetics of sugar association and dissociation. Titrating EcChiP with chitohexaose resulted in protein fluorescence enhancement in a concentration-dependent manner, yielding a binding constant of 2.9 x 10(5) m(-1), consistent with the value of 2.5 x 10(5) m(-1) obtained from isothermal titration microcalorimetry. Analysis of the integrated heat change suggested that the binding process was endothermic and driven by entropy. Single-channel recordings confirmed the voltage dependence of the penetration of chitohexaose molecules into and their release from EcChiP. Once inside the pore, the sugar release rate (k(off)) from the affinity site increased with elevated voltage, regardless of the side of sugar addition. Our findings revealed distinct thermodynamic and kinetic features of the activity of sugar-specific EcChiP and advance our knowledge of the physiological possibility of chitin utilization by non-chitinolytic bacteria.	[Soysa, H. Sasimali M.; Suginta, Wipa] Suranaree Univ Technol, Biochem Electrochem Res Unit, Inst Sci, Nakhon Ratchasima 30000, Thailand; [Suginta, Wipa] Suranaree Univ Technol, Ctr Excellence Adv Funct Mat, Nakhon Ratchasima 30000, Thailand; [Schulte, Albert] Vidyasirimedhi Inst Sci & Technol, Sch Biomol Sci & Engn, Rayong 21210, Thailand	Suranaree University of Technology; Suranaree University of Technology; Vidyasirimedhi Institute of Science & Technology	Suginta, W (corresponding author), Suranaree Univ Technol, Ctr Excellence Adv Funct Mat, Nakhon Ratchasima 30000, Thailand.	wipa@sut.ac.th		M. Soysa, H. Sasimali/0000-0003-3244-8670	Suranaree University of Technology; Office of the Higher Education Commission under the National Research University (NRU) project of Thailand; Suranaree University of Technology through a Suranaree University of Technology-One Research One Grant (SUT-OROG) grant; Deutscher Akademischer Austausch Dienst; Thailand Research Fund; Suranaree University of Technology through Basic Research Grant [BRG578001]; Suranaree University of Technology Grant [SUT1-102-60-36-13]	Suranaree University of Technology; Office of the Higher Education Commission under the National Research University (NRU) project of Thailand; Suranaree University of Technology through a Suranaree University of Technology-One Research One Grant (SUT-OROG) grant; Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Thailand Research Fund(Thailand Research Fund (TRF)); Suranaree University of Technology through Basic Research Grant; Suranaree University of Technology Grant	This work was supported by Suranaree University of Technology and the Office of the Higher Education Commission under the National Research University (NRU) project of Thailand. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Suranaree University of Technology through a Suranaree University of Technology-One Research One Grant (SUT-OROG) grant and the Deutscher Akademischer Austausch Dienst.; Supported by the Thailand Research Fund and Suranaree University of Technology through Basic Research Grant BRG578001 and Suranaree University of Technology Grant SUT1-102-60-36-13. To whom correspondence should be addressed. E-mail: wipa@sut.ac.th.	Abraham T, 2005, BIOCHEMISTRY-US, V44, P11279, DOI 10.1021/bi050898a; Anbazhagan V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025993; Andersen C, 1998, J MEMBRANE BIOL, V164, P263, DOI 10.1007/s002329900411; ANDERSEN C, 1995, J GEN PHYSIOL, V105, P385, DOI 10.1085/jgp.105.3.385; Bajaj H, 2017, ACS NANO, V11, P5465, DOI 10.1021/acsnano.6b08613; Bezrukov SM, 2000, FEBS LETT, V476, P224, DOI 10.1016/S0014-5793(00)01753-1; Bhamidimarri SP, 2016, BIOPHYS J, V110, P600, DOI 10.1016/j.bpj.2015.12.027; Biswas S, 2007, NAT STRUCT MOL BIOL, V14, P1108, DOI 10.1038/nsmb1304; Danelon C, 2003, J BIOL CHEM, V278, P35542, DOI 10.1074/jbc.M305434200; Dutzler R, 1996, STRUCTURE, V4, P127, DOI 10.1016/S0969-2126(96)00016-0; Eftink MR, 1997, METHOD ENZYMOL, V278, P221; Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609; Forst D, 1998, NAT STRUCT BIOL, V5, P37, DOI 10.1038/nsb0198-37; Francetic O, 2000, MOL MICROBIOL, V35, P1506, DOI 10.1046/j.1365-2958.2000.01817.x; Francetic O, 2000, EMBO J, V19, P6697, DOI 10.1093/emboj/19.24.6697; Ghisaidoobe ABT, 2014, INT J MOL SCI, V15, P22518, DOI 10.3390/ijms151222518; Hilty C, 2001, PHYS REV LETT, V86, P5624, DOI 10.1103/PhysRevLett.86.5624; Keyhani NO, 2000, J BIOL CHEM, V275, P33068, DOI 10.1074/jbc.M001041200; Kim BH, 2008, BACTERIAL PHYSIOLOGY AND METABOLISM, P1; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; PERI KG, 1990, BIOCHEM CELL BIOL, V68, P123, DOI 10.1139/o90-017; Piguet F, 2014, J PHYS CHEM LETT, V5, P4362, DOI 10.1021/jz502360c; Plumbridge J, 2014, MOL MICROBIOL, V92, P648, DOI 10.1111/mmi.12573; Ranok A, 2015, J BIOL CHEM, V290, P2617, DOI 10.1074/jbc.M114.588905; Rasmussen AA, 2009, MOL MICROBIOL, V72, P566, DOI 10.1111/j.1365-2958.2009.06688.x; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schimpl M, 2012, BIOCHEM J, V446, P149, DOI 10.1042/BJ20120377; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; Schwarz G, 2003, BIOPHYS J, V84, P2990, DOI 10.1016/S0006-3495(03)70025-3; Singh PR, 2012, ACS NANO, V6, P10699, DOI 10.1021/nn303900y; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Soysa HSM, 2016, J BIOL CHEM, V291, P13622, DOI 10.1074/jbc.M116.728881; Srivastava DB, 2006, J STRUCT BIOL, V156, P505, DOI 10.1016/j.jsb.2006.05.008; Suginta W, 2016, BBA-BIOMEMBRANES, V1858, P3032, DOI 10.1016/j.bbamem.2016.09.007; Suginta W, 2013, J BIOL CHEM, V288, P11038, DOI 10.1074/jbc.M113.454108; Suginta W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055126; Takanao S, 2014, BIOSCI BIOTECH BIOCH, V78, P524, DOI 10.1080/09168451.2014.882755; Valentin-Hansen P, 2007, CURR OPIN MICROBIOL, V10, P152, DOI 10.1016/j.mib.2007.03.001; Van Gelder P, 2002, J BACTERIOL, V184, P2994, DOI 10.1128/JB.184.11.2994-2999.2002; Vazquez-Ibar JL, 2003, P NATL ACAD SCI USA, V100, P12706, DOI 10.1073/pnas.1835645100; Verma SC, 2012, J BACTERIOL, V194, P4959, DOI 10.1128/JB.00533-12; Vogel J, 2006, CURR OPIN MICROBIOL, V9, P605, DOI 10.1016/j.mib.2006.10.006; Yang C, 2006, J BIOL CHEM, V281, P29872, DOI 10.1074/jbc.M605052200	43	4	4	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19328	19337		10.1074/jbc.M117.812321	http://dx.doi.org/10.1074/jbc.M117.812321			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972167	Green Published, hybrid			2022-12-26	WOS:000416226700015
J	Zabek, A; Paslawski, R; Paslawska, U; Wojtowicz, W; Drozdz, K; Polakof, S; Podhorska, M; Dziegiel, P; Mlynarz, P; Szuba, A				Zabek, Adam; Paslawski, Robert; Paslawska, Urszula; Wojtowicz, Wojciech; Drozdz, Katarzyna; Polakof, Sergio; Podhorska, Marzena; Dziegiel, Piotr; Mlynarz, Piotr; Szuba, Andrzej			The influence of different diets on metabolism and atherosclerosis processes-A porcine model: Blood serum, urine and tissues H-1 NMR metabolomics targeted analysis	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; BRANCHED-CHAIN; INOSINE MONOPHOSPHATE; INSULIN-RESISTANCE; MUSCLE; OBESE; PIGS; SPECTROSCOPY; HOMOCYSTEINE; DISEASE	The global epidemic of cardiovascular diseases leads to increased morbidity and mortality caused mainly by myocardial infarction and stroke. Atherosclerosis is the major pathological process behind this epidemic. We designed a novel model of atherosclerosis in swine. Briefly, the first group (11 pigs) received normal pig feed (balanced diet group D BDG) for 12 months, the second group (9 pigs) was fed a Western high-calorie diet (unbalanced diet group D UDG) for 12 months, the third group (8 pigs) received a Western type high-calorie diet for 9 months later replaced by a normal diet for 3 months (regression group D RG). Clinical measurements included zoometric data, arterial blood pressure, heart rate and ultrasonographic evaluation of femoral arteries. Then, the animals were sacrificed and the blood serum, urine and skeletal muscle tissue were collected and 1 H NMR based metabolomics studies with the application of fingerprinting PLS-DA and univariate analysis were done. Our results have shown that the molecular disturbances might overlap with other diseases such as onset of diabetes, sleep apnea and other obesity accompanied diseases. Moreover, we revealed that once initiated, molecular changes did not return to homeostatic equilibrium, at least for the duration of this experiment.	[Zabek, Adam; Wojtowicz, Wojciech; Mlynarz, Piotr] Wroclaw Univ Technol, Dept Chem, Bioorgan Chem Grp, Wroclaw, Poland; [Paslawski, Robert; Paslawska, Urszula; Drozdz, Katarzyna; Szuba, Andrzej] WROVASC Reg Specialist Hosp Wroclaw, Res & Dev Ctr, Wroclaw, Poland; [Paslawski, Robert] Wroclaw Med Univ, Dept & Clin Internal & Occupat Dis & Hypertens, Wroclaw, Poland; [Paslawska, Urszula] Wroclaw Univ Environm & Life Sci, Dept Internal Dis Clin Horses Dogs & Cats, Fac Vet Med, Wroclaw, Poland; [Drozdz, Katarzyna; Szuba, Andrzej] Wroclaw Med Univ, Div Angiol, Wroclaw, Poland; [Drozdz, Katarzyna; Szuba, Andrzej] 4th Mil Hosp Wroclaw, Wroclaw, Poland; [Polakof, Sergio] Univ Auvergne, Clermont Univ, Unite Nutr Humaine, BP 10448, Clermont Ferrand, France; [Polakof, Sergio] CRNH Auvergne, UNH, UMR 1019, INRA, Clermont Ferrand, France; [Podhorska, Marzena; Dziegiel, Piotr] Wroclaw Med Univ, Dept Histol & Embriol, Wroclaw, Poland	Wroclaw University of Science & Technology; Wroclaw Medical University; Wroclaw University of Environmental & Life Sciences; Wroclaw Medical University; Universite Clermont Auvergne (UCA); INRAE; Wroclaw Medical University	Mlynarz, P (corresponding author), Wroclaw Univ Technol, Dept Chem, Bioorgan Chem Grp, Wroclaw, Poland.	piotr.mlynarz@pwr.wroc.pl	Polakof, Sergio/V-1132-2017; Szuba, Andrzej/AAY-1162-2020; Paslawski, Robert/S-7743-2016	Polakof, Sergio/0000-0002-0976-8732; Podhorska-Okolow, Marzenna/0000-0003-2215-5997; Dziegiel, Piotr/0000-0002-8292-1385; Paslawski, Robert/0000-0002-9607-2919; Drozdz, Katarzyna/0000-0002-9484-7418; Mlynarz, Piotr/0000-0002-8502-4022; Szuba, Andrzej/0000-0002-7555-6201; Wojtowicz, Wojciech/0000-0001-6906-3120	KNOW project; European Regional Development Fund as part of Innovative Economy Operational Program; Wroclaw University of Science and Technology [S0401/0247/16]; WCB KNOW	KNOW project; European Regional Development Fund as part of Innovative Economy Operational Program; Wroclaw University of Science and Technology; WCB KNOW	This work was supported by KNOW project 2014-2018.; This publication is part of the project "WROVASC D Integrated Cardiovascular Centre" co-financed by the European Regional Development Fund as part of Innovative Economy Operational Program 2007-2013 implemented in the Regional Specialist Hospital, Research and Development Centre in Wroclaw. Additionally this study was partly financed by an internal project of the Wroclaw University of Science and Technology S0401/0247/16 and WCB KNOW 2014-2018.	Arriaran S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119572; Badoud F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134613; Bentzon JF, 2016, J PATHOL, V238, P257; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Calvani R, 2010, INT J OBESITY, V34, P1095, DOI 10.1038/ijo.2010.44; de Almeida AM, 2012, J PROTEOMICS, V75, P4296, DOI 10.1016/j.jprot.2012.04.010; Djekic D, 2015, IJC METAB ENDOCR, V8, P26, DOI 10.1016/j.ijcme.2014.11.004; Doi M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1683, DOI 10.1152/ajpendo.00609.2006; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; FELIG P, 1974, J CLIN INVEST, V53, P582, DOI 10.1172/JCI107593; Fenning RS, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001477; Ganguly P, 2015, NUTR J, V14, DOI 10.1186/1475-2891-14-6; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Guo W, 2016, J PROTEOME RES, V15, P3500, DOI 10.1021/acs.jproteome.6b00179; Harris K, 2012, J OBES, V2012, DOI 10.1155/2012/879151; He QH, 2012, J NUTR BIOCHEM, V23, P133, DOI 10.1016/j.jnutbio.2010.11.007; Holecek M, 2001, NUTRITION, V17, P70, DOI 10.1016/S0899-9007(00)00483-4; Holmes E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/j.tim.2011.05.006; Hruby A, 2014, PHARMACOECONOMICS, P1, DOI DOI 10.1007/S40273-013-0118-6; James EL, 2015, CURR OPIN CLIN NUTR, V18, P478, DOI 10.1097/MCO.0000000000000200; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Koopmans SJ, 2015, EUR J PHARMACOL, V759, P231, DOI 10.1016/j.ejphar.2015.03.044; Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009; Lynch CJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE621, DOI 10.1152/ajpendo.00462.2005; Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; McConell GK, 2005, MED SCI SPORT EXER, V37, P2054, DOI 10.1249/01.mss.0000179096.03129.a4; McCormack SE, 2013, PEDIATR OBES, V8, P52, DOI 10.1111/j.2047-6310.2012.00087.x; Mesangeau D, 2000, CARDIOVASC RES, V45, P889, DOI 10.1016/S0008-6363(99)00406-X; MILLER ER, 1987, ANNU REV NUTR, V7, P361, DOI 10.1146/annurev.nu.07.070187.002045; Nakamura H, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.32; Newgard CB, 2009, CELL METABOLISM, V9; Nielsen KL, 2014, AM J CLIN NUTR, V99, P941, DOI 10.3945/ajcn.113.074724; Obeid R, 2013, NUTRIENTS, V5, P3481, DOI 10.3390/nu5093481; Pasoawski R, 2011, ADV CLIN EXP MED, V20, P211; Plaisance EP, 2011, J CLIN ENDOCR METAB, V96, pE836, DOI 10.1210/jc.2010-2493; Rauschert S, 2014, ANN NUTR METAB, V64, P314, DOI 10.1159/000365040; Reichard GA, 1979, J CLIN INIVEST, P63619; SAHLIN K, 1989, ACTA PHYSIOL SCAND, V136, P199, DOI 10.1111/j.1748-1716.1989.tb08653.x; Shockcor JP, 1996, ANAL CHEM, V68, P4431, DOI 10.1021/ac9606463; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Teerlink T, 2005, VASC MED, V10, pS73, DOI 10.1191/1358863x05vm597oa; Waldram A, 2009, J PROTEOME RES, V8, P2361, DOI 10.1021/pr8009885; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wurtz P, 2013, DIABETES CARE, V36, P648, DOI 10.2337/dc12-0895; Xu X, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0141-z; YOUNG VR, 1973, METABOLISM, V22, P1429, DOI 10.1016/0026-0495(73)90257-6; ZHANG AQ, 1993, BIOCHEM PHARMACOL, V45, P2185, DOI 10.1016/0006-2952(93)90187-2	50	12	13	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0184798	10.1371/journal.pone.0184798	http://dx.doi.org/10.1371/journal.pone.0184798			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	28991897	Green Published, Green Submitted, gold			2022-12-26	WOS:000412601800009
J	Kim, JS; Yang, HK; Hwang, JM				Kim, Jin-Soo; Yang, Hee Kyung; Hwang, Jeong-Min			Long-term outcomes of augmented unilateral recess-resect procedure in children with intermittent exotropia	PLOS ONE			English	Article							LATERAL RECTUS RECESSION; SURGICAL OUTCOMES; SURVIVAL ANALYSIS; SURGERY	Background Initial overcorrection after exotropia surgery has been considered as a desirable result. Recently, there had been several studies that reported better surgical results of augmented bilateral lateral rectus muscle recession procedure over the conventional procedure. Objectives To compare the long-term results of augmented unilateral lateral rectus recession-medial rectus resection procedure (RR) with the original surgery in exotropic children. Data extraction A retrospective cohort study was performed on a total of 121 children with exotropia who underwent RR from February 2005 to December 2012 and were followed-up for at least 24 months. In 64 patients, RR was performed based on the original surgical table (original RR group). In 57 patients, the amount of medial rectus muscle resection was increased by 1 mm (augmented RR group). Results In the original RR group, 47 of 64 patients (73.4%) had a successful outcome, 13 patients (20.3%) had recurrence, and 4 patients (6.3%) had overcorrection at 2 years after surgery. In the augmented RR group, 45 of 57 patients (79.0%) were successful, 4 patients (7.0%) had recurrence and 8 patients (14.0%) had overcorrection at 2 years after surgery. The recurrence rate was significantly lower in the augmented RR group than the original RR group, whereas the overcorrection rate was not significantly different between two groups at 2 years after surgery (P = 0.036 and P = 0.153, respectively). The cumulative probability of recurrence was lower in the augmented group at 36 months after surgery (P = 0.046, log rank test). Conclusions The long-term success rate of augmented RR in exotropic children was 79.0% and the recurrence rate was significantly lower than original RR with comparable overcorrection rates. Augmented RR can be considered as an alternative procedure in children with basic and convergence insufficiency type exotropia.	[Kim, Jin-Soo; Yang, Hee Kyung; Hwang, Jeong-Min] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea	Seoul National University (SNU)	Hwang, JM (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea.	hjm@snu.ac.kr	Kim, Jin-Soo/AAF-3359-2019	Kim, Jin-Soo/0000-0003-2393-5346				Adams WE, 2009, OPHTHALMOLOGY, V116, P281, DOI 10.1016/j.ophtha.2008.09.012; Chia A, 2006, J AAPOS, V10, P206, DOI 10.1016/j.jaapos.2005.11.015; Choi J, 2012, AM J OPHTHALMOL, V153, P343, DOI 10.1016/j.ajo.2011.06.024; Choi J, 2011, J AAPOS, V15, P224, DOI 10.1016/j.jaapos.2010.12.019; Edelman PM, 1988, AM ORTHOPT J, V38, P111, DOI [10.1080/0065955X.1988.11981779, DOI 10.1080/0065955X.1988.11981779]; Heo H, 2013, JPN J OPHTHALMOL, V57, P475, DOI 10.1007/s10384-013-0260-x; Jeoung JW, 2006, AM J OPHTHALMOL, V141, P683, DOI 10.1016/j.ajo.2005.11.021; Kim C, 2005, EYE, V19, P637, DOI 10.1038/sj.eye.6701604; Kim H, 2016, AM J OPHTHALMOL, V163, P11, DOI 10.1016/j.ajo.2015.12.003; Kushner BJ, 1998, ARCH OPHTHALMOL-CHIC, V116, P324, DOI 10.1001/archopht.116.3.324; Lee EK, 2013, OPHTHALMOLOGY, V120, P504, DOI 10.1016/j.ophtha.2012.08.026; Lee JY, 2014, INT J OPHTHALMOL-CHI, V7, P528, DOI 10.3980/j.issn.2222-3959.2014.03.26; Lee SY, 2007, J AAPOS, V11, P266, DOI 10.1016/j.jaapos.2007.02.014; Leow PL, 2010, J PEDIAT OPHTH STRAB, V47, P12, DOI 10.3928/01913913-20100106-04; Lim SH, 2011, EYE, V25, P449, DOI 10.1038/eye.2011.12; Maruo T, 2001, Binocul Vis Strabismus Q, V16, P265; Oh JY, 2006, EYE, V20, P1268, DOI 10.1038/sj.eye.6702091; RICHARD JM, 1983, OPHTHALMOLOGY, V90, P1172; Suh SY, 2015, J AAPOS, V19, P507, DOI 10.1016/j.jaapos.2015.08.011; Wang B, 2014, BRIT J OPHTHALMOL, V98, P1409, DOI 10.1136/bjophthalmol-2013-304442; Wright K, 2014, COLOR ATLAS STRABISM, V2000, P3959; Yang HK, 2011, OPHTHALMOLOGY, V118, P1512, DOI 10.1016/j.ophtha.2011.01.004; Yang M, 2016, MEDICINE, V95, P1, DOI 10.1097/MD.0000000000002590; Yang X, 2014, INT J OPHTHALMOL-CHI, V7, P1043, DOI 10.3980/j.issn.2222-3959.2014.06.25	24	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0184863	10.1371/journal.pone.0184863	http://dx.doi.org/10.1371/journal.pone.0184863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ1QR	28985221	gold, Green Submitted, Green Published			2022-12-26	WOS:000412493000002
J	Ferreira, TB; Hoffer, KJ; Ribeiro, F; Ribeiro, P; O'Neill, JG				Ferreira, Tiago B.; Hoffer, Kenneth J.; Ribeiro, Filomena; Ribeiro, Paulo; O'Neill, Joao G.			Ocular biometric measurements in cataract surgery candidates in Portugal	PLOS ONE			English	Article							AXIAL LENGTH; REFRACTIVE ERROR; POPULATION; PARAMETERS; SINGAPORE; AGE; ASTIGMATISM; COMPONENTS	Objective Describe the ocular biometric parameters and their associations in a population of cataract surgery candidates. Methods A cross-sectional study of 13,012 eyes of 6,506 patients was performed. Biometric parameters of the eyes were measured by optical low-coherence reflectometry. The axial length (AL), mean keratometry (K) and astigmatism, anterior chamber depth (ACD) (epithelium to lens), lens thickness (LT), and Corneal Diameter (CD) were evaluated. Results The mean age was 69 +/- 10 years (44-99 years). Mean AL, Km, and ACD were 23.87 +/- 1.55 mm (19.8-31.92 mm), 43.91 +/- 1.71 D (40.61-51.14 D), and 3.25 +/- 0.44 mm (2.04-5.28 mm), respectively. The mean LT was 4.32 +/- 0.49 mm (2.73-5.77 mm) and the mean CD was 12.02 +/- 0.46 mm (10.50-14.15 mm). The mean corneal astigmatism was 1.08 +/- 0.84 D (0.00-7.58 D) and 43.5% of eyes had astigmatism >= 1.00 D. Male patients had longer AL and ACDs (p <.001) and flatter corneas (p <.001). In regression models considering age, gender, Km, ACD, LT, and CD, a longer AL was associated with being male and having higher ACD, LT and CD. Conclusions These data represent normative biometric values for the Portuguese population. The greatest predictor of ocular biometrics was gender. There was no significant correlation between age and AL, ACD, or Km. These results may be relevant in the evaluation of refractive error and in the calculation of intraocular lens power.	[Ferreira, Tiago B.; Ribeiro, Filomena] Hosp Luz, Dept Refract Surg, Lisbon, Portugal; [Ferreira, Tiago B.; O'Neill, Joao G.] NOVA Med Sch, Lisbon, Portugal; [Hoffer, Kenneth J.] Univ Calif Los Angeles, Stein Eye Inst, Los Angeles, CA USA; [Hoffer, Kenneth J.] St Marys Eye Ctr, Santa Monica, CA USA; [Ribeiro, Paulo] Fac Ciencias & Tecnol, Lisbon, Portugal	University of California System; University of California Los Angeles	Ferreira, TB (corresponding author), Hosp Luz, Dept Refract Surg, Lisbon, Portugal.; Ferreira, TB (corresponding author), NOVA Med Sch, Lisbon, Portugal.	tiagoferreira@netcabo.pt	Hoffer, Kenneth J/P-6431-2019; Ribeiro, Paulo/GYA-1014-2022; Ribeiro, Paulo/G-8563-2013	Ferreira, Tiago/0000-0001-9962-2579; Ribeiro, Filomena/0000-0002-6790-443X; Ribeiro, Paulo/0000-0001-9665-7610	Portuguese research Grant through FCT-MEC [PEst-OE/FIS/UI0068/2011, UID/FIS/00068/2013]; Fundacao para a Ciencia e Tecnologia, Portugal; Sociedade Portuguesa de Oftalmologia PhD Grant; Fundacao para a Ciencia e a Tecnologia [PEst-OE/FIS/UI0068/2011, UID/FIS/00068/2013]; Sociedade Portuguesa de Oftalmologia	Portuguese research Grant through FCT-MEC; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Sociedade Portuguesa de Oftalmologia PhD Grant; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Sociedade Portuguesa de Oftalmologia	This work was supported by Portuguese research Grant numbers PEst-OE/FIS/UI0068/2011 and UID/FIS/00068/2013 through the FCT-MEC, the "Plurianual" financial contribution of "Fundacao para a Ciencia e Tecnologia", Portugal and Sociedade Portuguesa de Oftalmologia PhD Grant.; Fundacao para a Ciencia e a Tecnologia-PEst-OE/FIS/UI0068/2011 and UID/FIS/00068/2013 - Prof Paulo Ribeiro.; Sociedade Portuguesa de Oftalmologia-N/A-Dr Tiago Ferreira.; Portuguese research Grant numbers PEst-OE/FIS/UI0068/2011 and UID/FIS/00068/2013 through the FCT-MEC, the "Plurianual" financial contribution of "Fundacao para a Ciencia e Tecnologia", Portugal and Sociedade Portuguesa de Oftalmologia PhD Grant.	ANSTICE J, 1971, AMER J OPT ARCH AM A, V48, P1001; Cao XG, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/171564; Cartwright NEK, 2010, EYE, V24, P894, DOI 10.1038/eye.2009.196; Ferrer-Blasco T, 2009, J CATARACT REFR SURG, V35, P70, DOI 10.1016/j.jcrs.2008.09.027; Fotedar R, 2010, OPHTHALMOLOGY, V117, P417, DOI 10.1016/j.ophtha.2009.07.028; GROSVENOR T, 1987, AM J OPTOM PHYS OPT, V64, P657; Hoffer KJ, 2010, J CATARACT REFR SURG, V36, P644, DOI 10.1016/j.jcrs.2009.11.007; HOFFER KJ, 1980, AM J OPHTHALMOL, V90, P360, DOI 10.1016/S0002-9394(14)74917-7; HOFFER KJ, 1993, ARCH OPHTHALMOL-CHIC, V111, P914, DOI 10.1001/archopht.1993.01090070032014; Ip JM, 2007, INVEST OPHTH VIS SCI, V48, P4846, DOI 10.1167/iovs.07-0101; Jivrajka R, 2008, J CATARACT REFR SURG, V34, P289, DOI 10.1016/j.jcrs.2007.10.015; Laursen JVN, 2016, INT OPHTHALMOL, V36, P17, DOI 10.1007/s10792-015-0069-3; Lee KE, 2009, ARCH OPHTHALMOL-CHIC, V127, P88, DOI 10.1001/archophthalmol.2008.521; Lege BAM, 2004, GRAEF ARCH CLIN EXP, V242, P8, DOI 10.1007/s00417-003-0672-2; Lim LS, 2010, INVEST OPHTH VIS SCI, V51, P103, DOI 10.1167/iovs.09-3553; Olsen T, 2007, ACTA OPHTHALMOL SCAN, V85, P84, DOI 10.1111/j.1600-0420.2006.00774.x; Olsen T, 2007, ACTA OPHTHALMOL SCAN, V85, P361, DOI 10.1111/j.1600-0420.2006.00847.x; Ribeiro F, 2013, J REFRACT SURG, V29, P206, DOI 10.3928/1081597X-20130129-07; Santodomingo-Rubido J, 2002, BRIT J OPHTHALMOL, V86, P458, DOI 10.1136/bjo.86.4.458; Saw SM, 2002, INVEST OPHTH VIS SCI, V43, P1408; Shufelt C, 2005, INVEST OPHTH VIS SCI, V46, P4450, DOI 10.1167/iovs.05-0435; Siahmed K, 2001, J FR OPHTALMOL, V24, P922; Wong TY, 2001, INVEST OPHTH VIS SCI, V42, P73	23	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184837	10.1371/journal.pone.0184837	http://dx.doi.org/10.1371/journal.pone.0184837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982150	Green Submitted, gold, Green Published			2022-12-26	WOS:000412360300020
J	Hernandez-Orts, JS; Brandao, M; Georgieva, S; Raga, JA; Crespo, EA; Luque, JL; Aznar, FJ				Hernandez-Orts, Jesus Servando; Brandao, Martha; Georgieva, Simona; Antonio Raga, Juan; Alberto Crespo, Enrique; Luque, Jose Luis; Javier Aznar, Francisco			From mammals back to birds: Host-switch of the acanthocephalan Corynosoma australe from pinnipeds to the Magellanic penguin Spheniscus magellanicus	PLOS ONE			English	Article							MITOCHONDRIAL GENE-SEQUENCES; PARASITE COMMUNITY STRUCTURE; AMERICAN SEA LION; PHYLOGENETIC-RELATIONSHIPS; ARCTOCEPHALUS-AUSTRALIS; POLYMORPHIDAE ACANTHOCEPHALA; ECOLOGICAL SPECIALIZATION; EVOLUTIONARY ECOLOGY; SYSTEMATIC POSITION; HELMINTH-PARASITES	Trophically-transmitted parasites are regularly exposed to potential new hosts through food web interactions. Successful colonization, or switching, to novel hosts, occur readily when 'donor' and 'target' hosts are phylogenetically related, whereas switching between distantly related hosts is rare and may result from stochastic factors (i.e. rare favourable mutations). This study investigates a host-switching event between a marine acanthocephalan specific to pinnipeds that is apparently able to reproduce in Magellanic penguins Spheniscus magellanicus from Brazil. Detailed analysis of morphological and morphometrical data from acanthocephalans from penguins indicates that they belong to Corynosoma australe Johnston, 1937. Partial fragments of the 28S rRNA and mitochondrial cox1 genes were amplified from isolates from penguins and two pinniped species (i.e. South American sea lion Otaria flavescens and South American fur seal Arctocephalus australis) to confirm this identification. Infection parameters clearly differ between penguins and the two pinniped species, which were significantly lower in S. magellanicus. The sex ratio of C. australe also differed between penguins and pinnipeds; in S. magellanicus was strongly biased against males, while in pinnipeds it was close to 1:1. Females of C. australe from O. flavescens were smaller than those from S. magellanicus and A. australis. However, fecundity (i.e. the proportion of fully developed eggs) was lower and more variable in females collected from S. magellanicus. At first glance, the occurrence of reproductive individuals of C. australe in Magellanic penguins could be interpreted as an adaptive colonization of a novel avian host through favourable mutations. However, it could also be considered, perhaps more likely, as an example of ecological fitting through the use of a plesimorphic (host) resource, since the ancestors of Corynosoma infected aquatic birds.	[Hernandez-Orts, Jesus Servando] Univ Nacl Comahue, Ctr Invest Aplicada & Transferencia Tecnol Recurs, CONICET, CIMAS,CCT,CENPAT, San Antonio Oeste, Rio Negro, Argentina; [Hernandez-Orts, Jesus Servando] Univ Nacl Comahue, Escuela Super Ciencias Marinas ESCiMar, San Antonio Oeste, Rio Negro, Argentina; [Brandao, Martha; Luque, Jose Luis] Univ Fed Rural Rio de Janeiro, Dept Parasitol Anim, Seropedica, RJ, Brazil; [Georgieva, Simona] Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic; [Antonio Raga, Juan; Javier Aznar, Francisco] Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, Parque Cient, Valencia, Spain; [Alberto Crespo, Enrique] Consejo Nacl Invest Cient & Tecn, CENPAT, Ctr Estudio Sistemas Marinos CESIMAR, Puerto Madryn, Chubut, Argentina; [Alberto Crespo, Enrique] Univ Nacl Patagonia San Juan Bosco UNPSJB, Puerto Madryn, Chubut, Argentina	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Universidad Nacional del Comahue; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Valencia; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de la Patagonia San Juan Bosco	Hernandez-Orts, JS (corresponding author), Univ Nacl Comahue, Ctr Invest Aplicada & Transferencia Tecnol Recurs, CONICET, CIMAS,CCT,CENPAT, San Antonio Oeste, Rio Negro, Argentina.; Hernandez-Orts, JS (corresponding author), Univ Nacl Comahue, Escuela Super Ciencias Marinas ESCiMar, San Antonio Oeste, Rio Negro, Argentina.	jesus.hernandez.orts@gmail.com	Hernandez Orts, Jesus Servando/GRF-4394-2022; Georgieva, Simona/I-3852-2018; Luque, Jose L/C-9767-2014; Georgieva, Simona/N-5193-2015; Aznar, Francisco Javier/S-3427-2018; Raga, Juan Antonio/L-7669-2014	Hernandez Orts, Jesus Servando/0000-0002-8177-7959; Georgieva, Simona/0000-0003-1721-5035; Georgieva, Simona/0000-0001-8887-472X; Aznar, Francisco Javier/0000-0002-1316-1175; Raga, Juan Antonio/0000-0003-2687-2539; Luque, Jose/0000-0003-3515-1127	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil; Ministry of Economy and Competitiveness of Spain [CGL2012-39545]; Generalitat Valenciana [PROMETEO/2011/040]; Czech Academy of Sciences	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Economy and Competitiveness of Spain(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Czech Academy of Sciences(Czech Academy of Sciences)	This study was partially supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (http://cnpq.br/) of Brazil to MB and JLL, the Ministry of Economy and Competitiveness (http://www.mineco.gob.es/portal/site/mineco/) of Spain through the project CGL2012-39545 to FJA, the Generalitat Valenciana (http//www.ceice.gva.es/web/ciencia) thought the project PROMETEO/2011/040 to JAR, and by Czech Academy of Sciences (http://www.avcr.cz/en/) postdoctoral fellowship to SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta SJ, 2008, ECOL LETT, V11, P1123, DOI 10.1111/j.1461-0248.2008.01237.x; Agosta SJ, 2006, OIKOS, V114, P556, DOI 10.1111/j.2006.0030-1299.15025.x; Agosta SJ, 2010, ZOOLOGIA-CURITIBA, V27, P151, DOI 10.1590/S1984-46702010000200001; Alonso MK, 2000, FISH B-NOAA, V98, P250; Amin OM, 2013, FOLIA PARASIT, V60, P273, DOI 10.14411/fp.2013.031; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Aznar FJ, 2012, J HELMINTHOL, V86, P156, DOI 10.1017/S0022149X11000149; Aznar FJ, 2006, J PARASITOL, V92, P548, DOI 10.1645/GE-715R.1; Aznar FJ, 2004, CAN J ZOOL, V82, P726, DOI [10.1139/z04-044, 10.1139/Z04-044]; Aznar FJ, 2001, J PARASITOL, V87, P536, DOI 10.1645/0022-3395(2001)087[0536:CCITSO]2.0.CO;2; BOERO J J, 1972, Analecta Veterinaria, V4, P17; Brandao Martha L., 2014, Check List, V10, P562; Bray RA, 2009, ACTA PARASITOL, V54, P310, DOI 10.2478/s11686-009-0045-z; Brooks Daniel R., 2008, Evolution Education and Outreach, V1, P2; Brooks DR, 2006, ECOLOGY, V87, pS76, DOI 10.1890/0012-9658(2006)87[76:EFAADO]2.0.CO;2; Brooks Daniel R., 2013, P215; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Carballo MC, 2012, J FISH BIOL, V80, P15, DOI 10.1111/j.1095-8649.2011.03125.x; COMBES C, 1991, AM NAT, V138, P866, DOI 10.1086/285257; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Crompton D.W.T., 1985, P213; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Diaz JI, 2010, COMP PARASITOL, V77, P172, DOI 10.1654/4441.1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fraija-Fernandez N, 2015, INT J PARASITOL, V45, P167, DOI 10.1016/j.ijpara.2014.10.004; Frere E., 1996, Ornitologia Neotropical, V7, P35; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Garcia-Borboroglu P, 2010, MAR POLLUT BULL, V60, P1652, DOI 10.1016/j.marpolbul.2010.07.006; Garcia-Varela M, 2005, J PARASITOL, V91, P1401, DOI 10.1645/GE-523R.1; Garcia-Varela M, 2008, J PARASITOL, V94, P212, DOI 10.1645/GE-1257.1; Garcia-Varela M, 2006, MOL PHYLOGENET EVOL, V40, P61, DOI 10.1016/j.ympev.2006.02.010; Garcia-Varela M, 2013, MOL PHYLOGENET EVOL, V68, P176, DOI 10.1016/j.ympev.2013.03.029; Garcia-Varela M, 2009, J PARASITOL, V95, P178, DOI 10.1645/GE-1538.1; Gemmill AW, 2000, PARASITOLOGY, V120, P429, DOI 10.1017/S0031182099005478; Georgieva S, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-64; Gonzalez AF, 2003, FISH RES, V60, P177, DOI 10.1016/S0165-7836(02)00059-0; Gregori M, 2012, DIS AQUAT ORGAN, V99, P37, DOI 10.3354/dao02457; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HELLE E, 1980, CAN J ZOOL, V58, P298, DOI 10.1139/z80-035; Hernandez-Orts JS, 2013, J HELMINTHOL, V87, P336, DOI 10.1017/S0022149X12000454; Hernandez-Orts J. S, 2013, THESIS; Hernandez-Orts JS, 2017, PARASITOL INT, V66, P905, DOI 10.1016/j.parint.2016.10.007; Hernandez-Orts JS, 2012, PARASITOLOGY, V139, P945, DOI 10.1017/S0031182012000078; Hoberg E.P., 2000, Bulletin of the Scandinavian Society for Parasitology, V10, P19; HOBERG EP, 1986, ANN PARASIT HUM COMP, V61, P199; HOBERG EP, 1992, J PARASITOL, V78, P601, DOI 10.2307/3283535; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Janz N, 1998, EVOLUTION, V52, P486, DOI [10.2307/2411084, 10.1111/j.1558-5646.1998.tb01648.x]; JANZEN DH, 1985, OIKOS, V45, P308, DOI 10.2307/3565565; Johnston T. H., 1937, Proceedings of the Linnean Society of New South Wales, V62, P9; JOHNSTON T. H., 1941, Records of the South Australian Museum, V6, P429; JOHNSTON T. HARVEY, 1953, REC DOMINION MUS, V2, P55; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Knoff M, 2001, MEM I OSWALDO CRUZ, V96, P1095, DOI 10.1590/S0074-02762001000800012; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Laskowski Zdzislaw, 2005, Polish Polar Research, V26, P315; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Luque JL, 2004, ACTA PARASITOL, V49, P353; MACHADO D A, 1970, Revista Brasileira de Biologia, V30, P377; Margolis L, 1997, J HELMINTHOL SOC W, V64, P161; Mateu P, 2011, J HELMINTHOL, V85, P12, DOI 10.1017/S0022149X10000180; Mattiucci S, 2008, ADV PARASIT, V66, P47, DOI 10.1016/S0065-308X(08)00202-9; McQuaid CF, 2013, B MATH BIOL, V75, P2196, DOI 10.1007/s11538-013-9887-5; Miller M.A., 2010, P GAT COMP ENV WORKS; Morini EG, 1959, ACTA TRAB C SUDAM ZO, P229; Nadler SA, 2000, PARASITOLOGY, V121, P455, DOI 10.1017/S0031182099006423; Nadler SA, 2006, SYST PARASITOL, V63, P161, DOI 10.1007/s11230-005-9009-3; Naya DE, 2002, MAR MAMMAL SCI, V18, P734, DOI 10.1111/j.1748-7692.2002.tb01070.x; Nickol BB, 2002, J PARASITOL, V88, P1222, DOI 10.1645/0022-3395(2002)088[1222:CMIGSF]2.0.CO;2; Noronha D., 1988, Arquivos Fluminenses de Medicina Veterinaria, V3, P119; Petrochenko VI, 1958, ACANTHOCEPHALA DOMES; Putz K, 2007, MAR BIOL, V152, P1227, DOI 10.1007/s00227-007-0770-5; Raga JA, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P821; Rambaut A, 2009, TRACER; Rambaut A, 2012, FIGTREE V 1 4 MOL EV; Reiczigel J, 2003, STAT MED, V22, P611, DOI 10.1002/sim.1320; Reiczigel J, 2013, QUANTITATIVE PARASIT; Richardson DJ, 1997, J PARASITOL, V83, P540, DOI 10.2307/3284428; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Sardella NH, 2005, SYST PARASITOL, V61, P143, DOI 10.1007/s11230-005-3131-0; Schiavini Adrián, 2005, Hornero, V20, P5; SCHMIDT GD, 1971, J PARASITOL, V57, P582, DOI 10.2307/3277920; Scolaro J.A., 1986, Cormorant, V13, P91; Scolaro JA, 1999, WATERBIRDS, V22, P104, DOI 10.2307/1521999; Silva Renato Z., 2014, Journal of Parasitic Diseases, V38, P410, DOI 10.1007/s12639-013-0250-4; Silva RZ, 2013, ESTUD BIOL, V35, P121, DOI DOI 10.7213/estud.biol.35.085.AO03; SMALES LR, 1986, SYST PARASITOL, V8, P91, DOI 10.1007/BF00009865; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stryukov A. A., 2004, Vestnik Zoologii, V38, P23; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Telford MJ, 2000, P NATL ACAD SCI USA, V97, P11359, DOI 10.1073/pnas.97.21.11359; Timi JT, 2003, INT J PARASITOL, V33, P1353, DOI 10.1016/S0020-7519(03)00203-0; Tkach V, 1999, ACTA PARASITOL, V44, P170; VALTONEN E T, 1983, Aquilo Ser Zoologica, V22, P1; VALTONEN ET, 1982, PARASITOLOGY, V85, P9, DOI 10.1017/S0031182000054093; VANCLEAVE HJ, 1953, J PARASITOL, V39, P1, DOI 10.2307/3274052; Via S, 2002, AM NAT, V159, pS76, DOI 10.1086/338374; Ward SA, 1998, J ANIM ECOL, V67, P763, DOI 10.1046/j.1365-2656.1998.00238.x; Yamaguti S, 1963, SYSTEMA HELMINTHUM, VV; ZDZITOWIECKI K, 1986, Polish Polar Research, V7, P79; Zdzitowiecki K, 1984, ACTA PARASITOL POL, V29, P359; Zdzitowiecki Krzysztof, 2001, Polish Polar Research, V22, P205	103	22	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0183809	10.1371/journal.pone.0183809	http://dx.doi.org/10.1371/journal.pone.0183809			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981550	Green Submitted, Green Published, gold			2022-12-26	WOS:000412360300005
J	Lu, P; Li, HH; Li, N; Singh, RN; Bishop, CE; Chen, XX; Lu, BS				Lu, Pin; Li, Huanhuan; Li, Ning; Singh, Ravi N.; Bishop, Colin E.; Chen, Xiangxian; Lu, Baisong			MEX3C interacts with adaptor-related protein complex 2 and involves in miR-451a exosomal sorting	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; MUTATION REDUCES ADIPOSITY; I MESSENGER-RNA; COATED VESICLES; BINDING; ENDOSOMES; UBIQUITIN; TRAFFICKING; BIOGENESIS; TRANSPORT	Some RNA species, especially microRNAs, are non-randomly sorted into exosomes, but how selectivity of RNA exosomal sorting is achieved is unknown. We found that all three variants of RNA-binding ubiquitin E3 ligase (MEX3C)-MEX3C-1, MEX3C-2, and MEX3C-3-interact with adaptor-related protein complex 2 (AP-2), a cargo adaptor in clathrin-mediated endocytosis. MEX3C's C-terminal RING finger domain and the hnRNP K homology (KH) domain shared by the three MEX3C variants are both necessary for MEX3C/AP-2 interaction. MEX3C associates with the endolysosomal compartment through an endocytosis-like process. siRNA-mediated inhibition of the MEX3C or AP-2 complex substantially decreased exosomal but not cellular microRNA miR-451a expression. Exosomal sorting is ceramide-dependent but not ESCRT-dependent in microRNA miR-451a. That RNA-binding protein associates with membrane trafficking machinery, and that its involvement in exosomal microRNA expression, suggest the existence of a mechanism for specific recruiting of RNA molecules to endosomes for subsequent exosomal sorting.	[Lu, Pin; Chen, Xiangxian] Anhui Normal Univ, Wuhu, Peoples R China; [Lu, Pin; Li, Huanhuan; Li, Ning; Bishop, Colin E.; Chen, Xiangxian; Lu, Baisong] Wake Forest Univ Hlth Sci, Inst Regenerat Med, Winston Salem, NC 27157 USA; [Singh, Ravi N.] Wake Forest Univ Hlth Sci, Dept Canc Biol, Winston Salem, NC USA	Anhui Normal University; Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine	Chen, XX (corresponding author), Anhui Normal Univ, Wuhu, Peoples R China.; Chen, XX; Lu, BS (corresponding author), Wake Forest Univ Hlth Sci, Inst Regenerat Med, Winston Salem, NC 27157 USA.	Jhchxxlu@mail.ahnu.edu.cn; blu@wakehealth.edu	Lu, Baisong/B-5837-2013; Singh, Ravi N/A-5740-2011	Lu, Baisong/0000-0001-9240-558X; Singh, Ravi N/0000-0003-0750-1804; lyu, pin/0000-0001-6841-1373				Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Batagov AO, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S18; Baumann S, 2014, EMBO REP, V15, P94, DOI 10.1002/embr.201338037; Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111; Benmerah A, 1995, J CELL BIOL, V131, P1831, DOI 10.1083/jcb.131.6.1831; Bolukbasi MF, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2011.2; Buchet-Poyau K, 2007, NUCLEIC ACIDS RES, V35, P1289, DOI 10.1093/nar/gkm016; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Cano F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9670; Cano F, 2012, EMBO J, V31, P3596, DOI 10.1038/emboj.2012.218; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Colombo M, 2013, J CELL SCI, V126, P5553, DOI 10.1242/jcs.128868; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dollar G, 2002, DEVELOPMENT, V129, P517; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Guduric-Fuchs J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-357; Guzman B, 2006, HYPERTENSION, V48, P883, DOI 10.1161/01.HYP.0000244085.52918.a0; Han CJ, 2014, J ENDOCRINOL, V221, P457, DOI 10.1530/JOE-14-0071; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Irion U, 2007, NATURE, V445, P554, DOI 10.1038/nature05503; Jiao Y, 2012, MOL CELL BIOL, V32, P4350, DOI 10.1128/MCB.00452-12; Jiao Y, 2012, MOL BIOL CELL, V23, P1404, DOI 10.1091/mbc.E11-11-0960; KEEN JH, 1987, J CELL BIOL, V105, P1989, DOI 10.1083/jcb.105.5.1989; Konig J, 2009, EMBO J, V28, P1855, DOI 10.1038/emboj.2009.145; Konopacki FA, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150218; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kuniyoshi K, 2014, P NATL ACAD SCI USA, V111, P5646, DOI 10.1073/pnas.1401674111; Lau AW, 2008, J CELL SCI, V121, P4008, DOI 10.1242/jcs.033522; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Li X, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136630; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; PEARSE BMF, 1984, EMBO J, V3, P1951, DOI 10.1002/j.1460-2075.1984.tb02075.x; Pohlmann T, 2015, ELIFE, V4, DOI 10.7554/eLife.06041; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Santangelo L, 2016, CELL REP, V17, P799, DOI 10.1016/j.celrep.2016.09.031; SEAMAN MNJ, 1993, J CELL BIOL, V123, P1093, DOI 10.1083/jcb.123.5.1093; Shurtleff MJ, 2016, ELIFE, V5, DOI 10.7554/eLife.19276; Smith VL, 2015, J IMMUNOL, V195, P2722, DOI 10.4049/jimmunol.1403186; Sorkina T, 1999, J CELL SCI, V112, P317; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Traub LM, 1996, J CELL BIOL, V135, P1801, DOI 10.1083/jcb.135.6.1801; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2011, DEV CELL, V21, P708, DOI 10.1016/j.devcel.2011.08.019; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107	54	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185992	10.1371/journal.pone.0185992	http://dx.doi.org/10.1371/journal.pone.0185992			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982131	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300103
J	Min, YW; Song, BG; Kim, HS; Kim, K; Lee, H; Min, BH; Lee, JH; Son, HJ; Rhee, PL; Kim, JJ				Min, Yang Won; Song, Byeong Geun; Kim, Hye Seung; Kim, Kyunga; Lee, Hyuk; Min, Byung-Hoon; Lee, Jun Haeng; Son, Hee Jung; Rhee, Poong-Lyul; Kim, Jae J.			Associations between reflux esophagitis and the progression of coronary artery calcification: A cohort study	PLOS ONE			English	Article							METABOLIC SYNDROME; GASTROESOPHAGEAL-REFLUX; HEART-DISEASE; EROSIVE ESOPHAGITIS; COMPUTED-TOMOGRAPHY; RISK-FACTORS; OBESITY; CALCIUM; MORTALITY; ATHEROSCLEROSIS	Background Reflux esophagitis (RE) and coronary heart disease (CHD) have common risk factors, including obesity and metabolic syndrome. This study aimed to evaluate the associations between RE and the future CHD risk. Methods This retrospective cohort study included 8,221 participants who were >= 20 years old, and who underwent esophagogastroduodenoscopy and coronary computed tomography (CT) scans during the same visit and subsequent CT scans between 2003 and 2013. RE was defined as the presence of at least Los Angeles classification grade A mucosal break. CT scan was used to determine the coronary artery calcium (CAC) scores. CAC progression was defined as an increase in the CAC score on a subsequent CT scan. Results RE was present in 984 (12.0%) participants. RE at baseline was associated with CAC progression (odds ratio [OR], 1.253; 95% confidence interval [CI], 1.088-1.444; P = 0.002), and this association persisted after adjusting the model for age, sex, smoking status, and alcohol consumption (OR, 1.175; 95% CI, 1.001-1.378; P = 0.048). This association disappeared when the model was further adjusted for body mass index, diastolic blood pressure, the presence of hypertension, glycated hemoglobin, low-density lipoprotein cholesterol, and triglycerides (OR, 1.088; 95% CI, 0.924-1.281; P = 0.311) which were selected using a step-wise selection procedure from several metabolic variables. Conclusions Our results suggest that the presence of RE is closely associated with CHD, even though RE is not a direct risk factor for CHD. Metabolic factors may play roles in CAC progression in individuals with RE.	[Min, Yang Won; Song, Byeong Geun; Lee, Hyuk; Min, Byung-Hoon; Lee, Jun Haeng; Son, Hee Jung; Rhee, Poong-Lyul; Kim, Jae J.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Kim, Hye Seung; Kim, Kyunga] Samsung Med Ctr, Biostat & Clin Epidemiol Ctr, Seoul, South Korea; [Son, Hee Jung] Samsung Med Ctr, Ctr Hlth Promot, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Rhee, PL (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea.	plrhee@skku.edu		Rhee, Poong-Lyul/0000-0003-0495-5296				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Budoff MJ, 2013, J AM COLL CARDIOL, V61, P1231, DOI 10.1016/j.jacc.2012.12.035; Budoff MJ, 2010, JACC-CARDIOVASC IMAG, V3, P1229, DOI 10.1016/j.jcmg.2010.08.018; Chen CH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004089; Chua CS, 2009, J GASTROEN HEPATOL, V24, P1375, DOI 10.1111/j.1440-1746.2009.05858.x; Chung SJ, 2008, GUT, V57, P1360, DOI 10.1136/gut.2007.147090; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; Derakhshan MH, 2012, GUT, V61, P337, DOI 10.1136/gutjnl-2011-300633; Dunbar KB, 2016, JAMA-J AM MED ASSOC, V315, P2104, DOI 10.1001/jama.2016.5657; El-Serag HB, 2007, GUT, V56, P749, DOI 10.1136/gut.2006.100263; El-Serag HB, 2014, GUT, V63, P871, DOI 10.1136/gutjnl-2012-304269; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P1243, DOI 10.1111/j.1572-0241.2005.41703.x; Fan JY, 2013, INT J CARDIOL, V168, P4761, DOI 10.1016/j.ijcard.2013.07.230; Fisher BL, 1999, DIGEST DIS SCI, V44, P2290, DOI 10.1023/A:1026617106755; Flint AJ, 2010, OBES RES CLIN PRACT, V4, pE171, DOI 10.1016/j.orcp.2010.01.001; Flint AJ, 2010, OBESITY, V18, P377, DOI 10.1038/oby.2009.223; Friedenberg FK, 2008, AM J GASTROENTEROL, V103, P2111, DOI 10.1111/j.1572-0241.2008.01946.x; Katzmarzyk PT, 2006, DIABETES CARE, V29, P404, DOI 10.2337/diacare.29.02.06.dc05-1636; Katzmarzyk PT, 2005, DIABETES CARE, V28, P391, DOI 10.2337/diacare.28.2.391; Kim LK, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0404-7; Kip KE, 2004, CIRCULATION, V109, P706, DOI 10.1161/01.CIR.0000115514.44135.A8; Lanas F, 2016, J CLIN EPIDEMIOL; Loke SS, 2013, WORLD J GASTROENTERO, V19, P5883, DOI 10.3748/wjg.v19.i35.5883; Niigaki M, 2013, J GASTROENTEROL, V48, P463, DOI 10.1007/s00535-012-0671-3; Osawa K, 2016, GLOB HEART, V11, P287, DOI 10.1016/j.gheart.2016.08.001; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Ryu J, 2013, INT J CARDIOVAS IMAG, V29, P101, DOI 10.1007/s10554-013-0319-2; Shah NH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124653; Singh S, 2013, CLIN GASTROENTEROL H, V11, P1399, DOI 10.1016/j.cgh.2013.05.009; St-Pierre AC, 2005, CAN MED ASSOC J, V172, P1301, DOI 10.1503/cmaj.1040834; Watanabe S, 2007, J GASTROENTEROL, V42, P267, DOI 10.1007/s00535-007-2033-0; Wong RKM, 2009, J GASTROEN HEPATOL, V24, P103, DOI 10.1111/j.1440-1746.2008.05680.x	32	3	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184996	10.1371/journal.pone.0184996	http://dx.doi.org/10.1371/journal.pone.0184996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981523	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300025
J	Bastin, F; Savarit, F; Lafon, G; Sandoz, JC				Bastin, Florian; Savarit, Fabrice; Lafon, Gregory; Sandoz, Jean-Christophe			Age-specific olfactory attraction between Western honey bee drones (Apis mellifera) and its chemical basis	PLOS ONE			English	Article							CONGREGATION AREAS; PHEROMONE COMMUNICATION; QUEEN PHEROMONE; HYMENOPTERA; EVOLUTION; WORKERS; RADAR; ODOR; PERCEPTION; COMPONENTS	During the mating season, drones (males) of the Western honey bee (Apis mellifera) form congregations numbering thousands high in the air. Virgin queens arrive at these congregations after they have formed and mate on the fly with 15-20 drones. To explain the formation of drone congregations, a drone-produced aggregation pheromone has been proposed many years ago but due to the low accessibility of natural mating sites in bees, its study has progressed slowly. Recently, we used a walking simulator in controlled laboratory conditions to show that drones are indeed attracted by groups of other drones. Since these previous experiments were carried out with drones captured when flying out of the hive, it is currently unclear if this olfactory attraction behaviour is related to the drones' sexual maturity (usually reached between 9 and 12 days) and may thus be indicative of a possible role in congregation formation, or if it is observed at any age and may represent in-hive aggregation. We thus assessed here the dependency of drone olfactory attraction on their age. First, we performed behavioural experiments in the walking simulator to measure olfactory preferences of drones in three age groups from 2-3 to 12-15 days. Then, we performed chemical analyses in the same age groups to evaluate whether chemical substances produced by the drones may explain age differences in olfactory attraction. We show that honey bee drones are attracted by conspecifics of the same age when they are sexually mature (12-15 days old) but not when they are younger (2-3 and 7-8 days old). In parallel, our data show that drones' chemical profile changes with age, including its most volatile fraction. These results are discussed in the context of drone mutual attraction both within the hive and at drone congregations.	[Bastin, Florian; Lafon, Gregory; Sandoz, Jean-Christophe] Univ Paris Saclay, Evolut Genomes Behav & Ecol, CNRS, UMR 9191,Univ Paris Sud,IRD, Gif Sur Yvette, France; [Savarit, Fabrice] Univ Paris 13, Lab Ethol Expt & Comparee, Sorbonne Paris Cite, Villetaneuse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; Universite Paris 13	Sandoz, JC (corresponding author), Univ Paris Saclay, Evolut Genomes Behav & Ecol, CNRS, UMR 9191,Univ Paris Sud,IRD, Gif Sur Yvette, France.	sandoz@egce.cnrs-gif.fr	; SANDOZ, Jean-Christophe/A-6085-2012	Lafon, Gregory/0000-0002-1825-5269; SANDOZ, Jean-Christophe/0000-0002-5423-9645; Bastin, Florian/0000-0002-2883-7860	Agence Nationale de la Recherche (FR), Paris, France [Project EVOLBEE] [2010-BLAN-1712-01]; Agence Nationale de la Recherche (FR), Paris, France [Project Bee-o-CHOC]; Agence Nationale de la Recherche (ANR), Paris, France [Project EVOLBEE] [2010-BLAN-1712-01]; Agence Nationale de la Recherche (ANR), Paris, France [Project Bee-o-CHOC]	Agence Nationale de la Recherche (FR), Paris, France [Project EVOLBEE](French National Research Agency (ANR)); Agence Nationale de la Recherche (FR), Paris, France [Project Bee-o-CHOC](French National Research Agency (ANR)); Agence Nationale de la Recherche (ANR), Paris, France [Project EVOLBEE](French National Research Agency (ANR)); Agence Nationale de la Recherche (ANR), Paris, France [Project Bee-o-CHOC](French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche (FR) (http://www.agence-nationale-recherche.fr/), Paris, France [Projects EVOLBEE, 2010-BLAN-1712-01 and Bee-o-CHOC, 2017 to J.C.S]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to Lionel Garnery and Damien Delalande for beekeeping support. We thank Andreas Brandstaetter for the development of the walking simulator. This work was supported by the Agence Nationale de la Recherche (ANR), Paris, France [Projects EVOLBEE, 2010-BLAN-1712-01 and Bee-o-CHOC, 2017 to J.C.S]. G. L thanks the ENS Cachan and Universite A Paris-Saclay.	ALLAN SA, 1987, J INSECT PHYSIOL, V33, P917, DOI 10.1016/0022-1910(87)90003-5; [Anonymous], 1974, SOCIAL BEHAV BEES; ARNOLD G, 1985, CELL TISSUE RES, V242, P593, DOI 10.1007/BF00225425; Baer B, 2005, APIDOLOGIE, V36, P187, DOI 10.1051/apido:2005013; Bartlett JE, 2000, INFORM TECHNOLOGY LE, V19, P43, DOI DOI 10.1109/LPT.2009.2020494; Bastin F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06241-9; Baudry E, 1998, P ROY SOC B-BIOL SCI, V265, P2009, DOI 10.1098/rspb.1998.0533; Boucher M, 2009, ANIM BEHAV, V78, P247, DOI 10.1016/j.anbehav.2009.04.019; Brandstaetter AS, 2014, J EXP BIOL, V217, P1278, DOI 10.1242/jeb.094292; Brockmann A, 1998, NATURWISSENSCHAFTEN, V85, P283, DOI 10.1007/s001140050500; Brockmann A, 2001, NATURWISSENSCHAFTEN, V88, P78, DOI 10.1007/s001140000199; Brockmann A, 2006, J CHEM ECOL, V32, P657, DOI 10.1007/s10886-005-9027-2; Buter C. G., 1964, Journal of Apicultural Research London, V3, P65; Butler C., 1609, FEMININE MONARCHIE O; Crailsheim K, 1998, APIDOLOGIE, V29, P97, DOI 10.1051/apido:19980106; DRESCHER W, 1969, Z BIENENFORSCH, V9, P390; ESSLEN J, 1976, ZOOMORPHOLOGIE, V83, P227, DOI 10.1007/BF00993511; Farine JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040396; Free J. B., 1957, British Journal of Animal Behaviour, V5, P7, DOI 10.1016/S0950-5601(57)80038-0; Free J. B., 1987, PHEROMONES SOCIAL BE; FREE JB, 1975, ANIM BEHAV, V23, P650, DOI 10.1016/0003-3472(75)90143-8; GARY NE, 1962, SCIENCE, V136, P773, DOI 10.1126/science.136.3518.773; GERIG L, 1972, Zeitschrift fuer Angewandte Entomologie, V70, P286; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Gries M, 1996, J COMP PHYSIOL A, V179, P539, DOI 10.1007/BF00192319; HARRISON JM, 1987, J EXP BIOL, V129, P53; HOWELL D. E., 1933, ANN ENT SOC AMERICA, V26, P239; Jarriault D, 2012, APIDOLOGIE, V43, P292, DOI 10.1007/s13592-011-0117-6; JAYCOX ELBERT R., 1961, ANN ENT SOC AMER, V54, P519; Jean-Prost P., 1957, ACAD SCI, V245, P2107; Jensen AB, 2005, CONSERV GENET, V6, P527, DOI 10.1007/s10592-005-9007-7; KAISSLIN.KE, 1968, Z VERGL PHYSIOL, V59, P357, DOI 10.1007/BF00365967; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Klein Alexandra-Maria, 2009, P195; KOENIGER G, 1990, APIDOLOGIE, V21, P185, DOI 10.1051/apido:19900303; KOENIGER G, 1979, BEE WORLD, V60, P53, DOI 10.1080/0005772X.1979.11097736; Koeniger G., 2014, PAARUNGSBIOLOGIE PAA; Koeniger N., 2004, Tropical Agricultural Research and Extension, V7, P13; Koeniger N, 2005, APIDOLOGIE, V36, P211, DOI 10.1051/apido:2005011; Kovac H, 2009, APIDOLOGIE, V40, P82, DOI 10.1051/apido/2008069; Kurennoi NM, 1954, PCHELOVODSTO, V30, P28; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; LENSKY Y, 1985, J INSECT PHYSIOL, V31, P265, DOI 10.1016/0022-1910(85)90002-2; LOPER GM, 1987, APIDOLOGIE, V18, P163, DOI 10.1051/apido:19870206; LOPER GM, 1992, J KANSAS ENTOMOL SOC, V65, P223; LOPER GM, 1993, J CHEM ECOL, V19, P1929, DOI 10.1007/BF00983797; MASSON C, 1984, J INSECT PHYSIOL, V30, P7, DOI 10.1016/0022-1910(84)90104-5; MASSON C, 1993, APIDOLOGIE, V24, P169, DOI 10.1051/apido:19930302; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Menzel R, 2012, NAT REV NEUROSCI, V13, P758, DOI 10.1038/nrn3357; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Morse R. A., 1967, J ECON ENTOMOL, V60, P1192; Nishino H, 2009, J COMP NEUROL, V515, P161, DOI 10.1002/cne.22064; OERTEL E., 1956, ANN ENT SOC AMER, V49, P497; OHTANI T, 1974, Journal of the Faculty of Science Hokkaido University Series VI Zoology, V19, P706; OMHOLT SW, 1988, J THEOR BIOL, V134, P309, DOI 10.1016/S0022-5193(88)80061-4; PAIN J, 1963, CR HEBD ACAD SCI, V256, P512; PAIN JANINE, 1966, ANN ABEILLE [PARIS], V9, P71, DOI 10.1051/apido:19660106; Palmer KA, 2000, APIDOLOGIE, V31, P235, DOI 10.1051/apido:2000119; ROBINSON GE, 1987, J COMP PHYSIOL A, V160, P613, DOI 10.1007/BF00611934; Ruttner, 1966, Z BIENENFORSCH, V8, P332; RUTTNER F, 1985, FORTS ZOOL, V31, P225; Ruttner F., 1968, Annales de l'Abeille, V11, P243, DOI 10.1051/apido:19680402; RUTTNER F, 1957, Z VERGL PHYSIOL, V39, P577, DOI 10.1007/BF00348457; RUTTNER F, 1965, Z BIENENFORSCHUNG, V8, P1; Ruttner F., 1988, BIOGEOGRAPHY TAXONOM, DOI [10.1007/978-3-642-72649-1, DOI 10.1007/978-3-642-72649-1]; RUTTNER H, 1972, Apidologie, V3, P203, DOI 10.1051/apido:19720301; Sandoz JC, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00098; Sandoz JC, 2006, J EXP BIOL, V209, P3587, DOI 10.1242/jeb.02423; Sandoz JC, 2007, FRONT BEHAV NEUROSCI, V1, DOI 10.3389/neuro.08.005.2007; Schluns H, 2005, ANIM BEHAV, V70, P125, DOI 10.1016/j.anbehav.2004.11.005; Seeley T., 1995, WISDOM HIVE SOCIAL P; Skirkevicius, 1994, PHEROMONES, V4, P83; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; SLESSOR KN, 1988, NATURE, V332, P354, DOI 10.1038/332354a0; Sokal RR, 1995, BIOMETRY; Stout TL, 2011, ETHOLOGY, V117, P459, DOI 10.1111/j.1439-0310.2011.01895.x; Tofilski Adam, 1996, Pszczelnicze Zeszyty Naukowe, V40, P55; Vareschi E., 1971, J COMP PHYSIOL A, V75, P143; Vetter RS, 1997, J CHEM ECOL, V23, P1867, DOI 10.1023/B:JOEC.0000006456.90528.94; Villar G, 2015, J COMP PHYSIOL A, V201, P731, DOI 10.1007/s00359-015-1006-7; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wakonigg G, 2000, J APICULT RES, V39, P137, DOI 10.1080/00218839.2000.11101033; Wanner KW, 2007, P NATL ACAD SCI USA, V104, P14383, DOI 10.1073/pnas.0705459104; WATANABE ME, 1994, SCIENCE, V265, P1170, DOI 10.1126/science.265.5176.1170; WILLIAMS JL, 1987, J ECON ENTOMOL, V80, P532, DOI 10.1093/jee/80.2.532; Winston M.L., 1991, BIOL HONEY BEE; WOYKE J, 1978, APIDOLOGIE, V9, P203, DOI 10.1051/apido:19780304	88	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185949	10.1371/journal.pone.0185949	http://dx.doi.org/10.1371/journal.pone.0185949			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977020	gold, Green Submitted, Green Published			2022-12-26	WOS:000412163100054
J	Boireau, C; Dufour, B; Praud, A				Boireau, Clemence; Dufour, Barbara; Praud, Anne			The importance of communication in promoting voluntary participation in an experimental trial: A qualitative study based on the assessment of the gamma-interferon test for the diagnosis of bovine tuberculosis in France	PLOS ONE			English	Article							FARMERS PERCEPTIONS; VETERINARY SERVICES; PIG FARMERS; CATTLE; INTERVIEWS; RESISTANCE; KNOWLEDGE; ATTITUDES; HEALTH	Understanding the factors leading each stakeholder to participate in an experimental trial is a key element for improving trial set-up and for identifying selection bias in statistical analyses. An experimental protocol, validated by the European Commission, was developed in France to assess the ability of the gamma-interferon test in terms of accuracy to replace the second intradermal skin test in cases of suspected bovine tuberculosis. Implemented between 2013 and 2015, this experimental trial was based on voluntary participation. To determine and understand the motivation or reluctance of farmers to take part in this trial, we carried out a sociological survey in France. Our study was based on semi-structured interviews with the farmers and other stakeholders involved. The analysis of findings demonstrated that shortening the lock-up period during tuberculosis suspicion, following the use of a gamma-interferon test, was an important aim and a genuine challenge for the animal health stakeholders. However, some farmers did not wish to continue the trial because it could potentially have drastic consequences for them. Moreover, misunderstandings and confusion concerning the objectives and consequences of the trial led stakeholders to reject it forcefully. Based on our results, we offer some recommendations: clear and appropriate communication tools should be prepared to explain the protocol and its aims. In addition, these types of animal health trials should be designed with the stakeholders' interests in mind. This study provides a better understanding of farmer motivations and stakeholder influences on trial participation and outcomes. The findings can be used to help design trials so that they promote participation by farmers and by all animal health stakeholders in general.	[Boireau, Clemence] VetagroSup, Ecole Natl Serv Vet, Marcy Letoile, France; [Boireau, Clemence] Univ Lyon, French Agcy Food Environm & Occupat Hlth & Safety, Lab Lyon, Unite Epidemiol, Lyon, France; [Dufour, Barbara; Praud, Anne] Paris Est Univ, Ecole Natl Vet Alfort, Epidemiol Anim Infect Dis Unit, French Agcy Food Environm & Occupat Hlth & Safety, Maisons Alfort, France	VetAgro Sup; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Lyon; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Boireau, C (corresponding author), VetagroSup, Ecole Natl Serv Vet, Marcy Letoile, France.; Boireau, C (corresponding author), Univ Lyon, French Agcy Food Environm & Occupat Hlth & Safety, Lab Lyon, Unite Epidemiol, Lyon, France.	clemence.boireau@gmail.com			French Ministry of Agriculture	French Ministry of Agriculture	This work was partly supported by the French Ministry of Agriculture (http://agriculture.gouv.fr). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Busaidi Zakiya Q, 2008, Sultan Qaboos Univ Med J, V8, P11; Alarcon P, 2014, PREV VET MED, V116, P223, DOI 10.1016/j.prevetmed.2013.08.004; Alders RG, 2007, WORLD POULTRY SCI J, V63, P139, DOI 10.1017/S0043933907001365; [Anonymous], 2014, DGAUSDSPAN2014864; [Anonymous], 2013, DGAUSDSPAN20138162; Autissier D, 2013, METHODE CONDUITE CHA; Azhar M, 2010, AVIAN DIS, V54, P749, DOI 10.1637/8713-031809-Reg.1; Bardin L., 2013, LANALYSE CONTENU; Beaud S., 2003, GUIDE ENQUETE TERRAI; Becker H.S., 2002, COMMENT CONDUIRE SA; Bernoux P, 2002, RELAT IND-IND RELAT, V57, P77, DOI 10.7202/006711ar; Bernoux P, 2010, POINTS; Blanchet Alain, 2010, ENTRETIEN ENQUETE SE; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Braun V, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.26152; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; Catley A, 2001, PREV VET MED, V49, P95, DOI 10.1016/S0167-5877(01)00171-4; Catley A, 2012, VET J, V191, P151, DOI 10.1016/j.tvjl.2011.03.010; Christley RM, 2010, EQUINE VET J, V42, P285, DOI 10.1111/j.2042-3306.2010.00074.x; Coch L, 1948, HUM RELAT, V1, P512, DOI 10.1177/001872674800100408; Collingridge DS, 2008, AM J MED QUAL, V23, P389, DOI 10.1177/1062860608320646; Crozier M, 2014, POINTS; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; de Olivier Sardan J-PO, 2008, RIGUEUR QUALITATIF L; Dean W. R., 2011, International Journal of Sociology of Agriculture and Food, V18, P104; Decaudin J-M, 2013, COMMUNICATION INTERN; DiCicco-Bloom B, 2006, MED EDUC, V40, P314, DOI 10.1111/j.1365-2929.2006.02418.x; Domingo M, 2014, RES VET SCI, V97, pS20, DOI 10.1016/j.rvsc.2014.03.017; Dorn ML, 2005, WILDLIFE SOC B, V33, P539, DOI 10.2193/0091-7648(2005)33[539:BTIMSA]2.0.CO;2; Enticott G, 2012, T I BRIT GEOGR, V37, P75, DOI 10.1111/j.1475-5661.2011.00452.x; Ferreol G., 2011, DICT SOCIOLOGIE; Garforth C, 2015, ZOONOSES PUBLIC HLTH, V62, P29, DOI 10.1111/zph.12189; Ghiglione R, 1998, ENQUETES SOCIOLOGIQU; Given L, 2006, LIBR HI TECH, V24, P376, DOI 10.1108/07378830610692145; Goldberg, 1999, J APPL BEHAV SCI, V35, P25, DOI [DOI 10.1177/0021886399351003, 10.1177/0021886399351003]; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Guta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104383; Henning J, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-726; Humblet MF, 2011, RES VET SCI, V91, P199, DOI 10.1016/j.rvsc.2010.12.004; Jones B, 2002, PARTICIP LEARN ACTIO, V45, P5; Kaufmann Jean-Claude, 2011, ENTRETIEN COMPREHENS; KOTTER JP, 1995, HARVARD BUS REV, V73, P59; Lam TJGM, 2011, NEW ZEAL VET J, V59, P8, DOI 10.1080/00480169.2011.547163; LAWRENCE PR, 1969, HARVARD BUS REV, V47, P4; LoBue PA, 2010, INT J TUBERC LUNG D, V14, P1075; Lucand C., 2015, PINARD POILUS HIST V; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Mathevet P, 2005, GTV RECUEIL JOURNEES, P73; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Meskell P, 2013, VET REC, V173, DOI 10.1136/vr.101676; More SJ, 2006, VET MICROBIOL, V112, P239, DOI 10.1016/j.vetmic.2005.11.022; Mucchielli R., 2006, ANAL CONTENU DOCUMEN; Mukamurera J., 2006, RECHERCHES QUALITATI, V26, P110, DOI [10.7202/1085400ar, DOI 10.7202/1085400AR]; Nantima N, 2016, TROP ANIM HEALTH PRO, V48, P727, DOI 10.1007/s11250-016-1015-8; O'Rourke D, 2014, VET REC, V174, DOI 10.1136/vr.g2231; Onwuegbuzie AJ, 2007, QUAL QUANT, V41, P105, DOI 10.1007/s11135-005-1098-1; Paine P, 2003, LAHARMATTAN; Palmer Mitchell V, 2011, Vet Med Int, V2011, P816345, DOI 10.4061/2011/816345; Praud A, 2016, Vet Rec, V179, P174, DOI 10.1136/vr.103803; Praud A, 2014, EPIDEMIOL INFECT, P1; PRETTY JN, 1995, WORLD DEV, V23, P1247, DOI 10.1016/0305-750X(95)00046-F; Richens IF, 2015, VET REC, V177, P465, DOI 10.1136/vr.103415; Ryan TJ, 2000, RES VET SCI, V69, P57, DOI 10.1053/rvsc.2000.0386; Sungirai M, 2016, TICKS TICK-BORNE DIS, V7, P1, DOI 10.1016/j.ttbdis.2015.07.015; Tracy SJ, 2010, QUAL INQ, V16, P837, DOI 10.1177/1077800410383121; Van Campenhoudt L., 2011, MANUEL RECHERCHE SCI; van Dijk L, 2016, PARTICIPATORY POLICY	68	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185799	10.1371/journal.pone.0185799	http://dx.doi.org/10.1371/journal.pone.0185799			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI6UJ	28973018	Green Submitted, Green Published, gold			2022-12-26	WOS:000412131900054
J	Pratt, H; Hassanin, K; Troughton, LD; Czanner, G; Zheng, YL; McCormick, AG; Hamill, KJ				Pratt, Harry; Hassanin, Kareem; Troughton, Lee D.; Czanner, Gabriela; Zheng, Yalin; McCormick, Austin G.; Hamill, Kevin J.			UV imaging reveals facial areas that are prone to skin cancer are disproportionately missed during sunscreen application	PLOS ONE			English	Article							BASAL-CELL-CARCINOMA; PITUITARY-ADRENAL AXIS; VITAMIN-D DEFICIENCY; SUN PROTECTION; ULTRAVIOLET-RADIATION; RISK-FACTORS; INTERVENTION; MELANOMA; EXPOSURE; COHORT	Application of sunscreen is a widely used mechanism for protecting skin from the harmful effects of UV light. However, protection can only be achieved through effective application, and areas that are routinely missed are likely at increased risk of UV damage. Here we sought to determine if specific areas of the face are missed during routine sunscreen application, and whether provision of public health information is sufficient to improve coverage. To investigate this, 57 participants were imaged with a UV sensitive camera before and after sunscreen application: first visit; minimal pre-instruction, second visit; provided with a public health information statement. Images were scored using a custom automated image analysis process designed to identify areas of high UV reflectance, i. e. missed during sunscreen application, and analysed for 5% significance. Analyses revealed eyelid and periorbital regions to be disproportionately missed during routine sunscreen application (median 14% missed in eyelid region vs 7% in rest of face, p<0.01). Provision of health information caused a significant improvement in coverage to eyelid areas in general however, the medial canthal area was still frequently missed. These data reveal that a public health announcement- type intervention could be effective at improving coverage of high risk areas of the face, however high risk areas are likely to remain unprotected therefore other mechanisms of sun protection should be widely promoted such as UV blocking sunglasses.	[Pratt, Harry; Hassanin, Kareem; Troughton, Lee D.; Czanner, Gabriela; Zheng, Yalin; Hamill, Kevin J.] Univ Liverpool, Inst Ageing & Chron Dis, Dept Eye & Vis Sci, Liverpool, Merseyside, England; [Czanner, Gabriela] Univ Liverpool, Inst Translat Med, Dept Biostat, Liverpool, Merseyside, England; [McCormick, Austin G.] Aintree Univ, Teaching Hosp, Dept Opthalmol, Liverpool, Merseyside, England	University of Liverpool; University of Liverpool	Hamill, KJ (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Dept Eye & Vis Sci, Liverpool, Merseyside, England.	khamill@liverpool.ac.uk	Czanner, Gabriela/ABC-7569-2021; Hamill, Kevin/ABF-9727-2020	Czanner, Gabriela/0000-0002-1157-2093; Hamill, Kevin/0000-0002-7852-1944	University of Liverpool Mastersin Research Course	University of Liverpool Mastersin Research Course	This work was supported by bench fees raised from a University of Liverpool Mastersin Research Course.	ABRAHAM JC, 1973, AM J SURG, V126, P492, DOI 10.1016/S0002-9610(73)80036-4; Arnold J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b541; Bauer A, 2011, BRIT J DERMATOL, V165, P612, DOI 10.1111/j.1365-2133.2011.10425.x; Buller DB, 2017, PREV MED, V99, P29, DOI 10.1016/j.ypmed.2017.01.014; Carter KD, 1999, OPHTHALMIC PLAST REC, V15, P83, DOI 10.1097/00002341-199903000-00004; Cherbuin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005265; Cook BE, 1999, OPHTHALMOLOGY, V106, P746, DOI 10.1016/S0161-6420(99)90161-6; Cook BE, 2001, OPHTHALMOLOGY, V108, P2088, DOI 10.1016/S0161-6420(01)00796-5; de Blacam C, 2017, SURG-J R COLL SURG E, V15, P12, DOI 10.1016/j.surge.2015.07.001; Gamble RG, 2012, J AM ACAD DERMATOL, V67, P587, DOI 10.1016/j.jaad.2011.11.922; Ganesan P, 2014, 2014 INTERNATIONAL CONFERENCE ON CONTROL, INSTRUMENTATION, COMMUNICATION AND COMPUTATIONAL TECHNOLOGIES (ICCICCT), P101, DOI 10.1109/ICCICCT.2014.6992938; Garland CF, 2006, AM J PUBLIC HEALTH, V96, P252, DOI 10.2105/AJPH.2004.045260; Gibbons FX, 2005, HEALTH PSYCHOL, V24, P358, DOI 10.1037/0278-6133.24.4.358; Glanz K, 2015, CANCER EPIDEM BIOMAR, V24, P415, DOI 10.1158/1055-9965.EPI-14-0926; Gorham ED, 2007, ANN EPIDEMIOL, V17, P956, DOI 10.1016/j.annepidem.2007.06.008; Grant WB, 2009, DERM-ENDOCRINOL, V1, P207, DOI 10.4161/derm.1.4.9841; Grencis P W, 1999, J Audiov Media Med, V22, P171; HADDAD RA, 1991, IEEE T SIGNAL PROCES, V39, P723, DOI 10.1109/78.80892; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Isedeh P, 2013, PHOTODERMATOL PHOTO, V29, P55, DOI 10.1111/phpp.12017; Iuliano A, 2012, AM J OPHTHALMOL, V153, P238, DOI 10.1016/j.ajo.2011.08.004; Jackson KM, 2006, HEALTH PSYCHOL, V25, P34, DOI 10.1037/0278-6133.25.1.34; Jeanmougin M, 2014, PHOTODERMATOL PHOTO, V30, P323, DOI 10.1111/phpp.12138; Kalra S, 2015, J PAK MED ASSOC, V65, P569; Kirchberger MC, 2016, PHOTODERMATOLOGY PHO; Kiviniemi MT, 2014, J BEHAV MED, V37, P1069, DOI 10.1007/s10865-013-9538-1; Koch S., 2016, J CANC ED; Lademann J, 2004, J Cosmet Dermatol, V3, P62, DOI 10.1111/j.1473-2130.2004.00107.x; Liou JC, 2015, MOL VIS, V21; LOESCH H, 1994, ARCH DERMATOL, V130, P665, DOI 10.1001/archderm.130.5.665; Mahler HIM, 2003, HEALTH PSYCHOL, V22, P199, DOI 10.1037/0278-6133.22.2.199; Manson JE, 2000, EPIDEMIOLOGY, V11, P728, DOI 10.1097/00001648-200011000-00021; MARGO CE, 1993, SURV OPHTHALMOL, V38, P169, DOI 10.1016/0039-6257(93)90100-L; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Petersen B, 2014, PHOTODERMATOL PHOTO, V30, P96, DOI 10.1111/phpp.12099; Ransohoff KJ, 2016, CANCER CAUSE CONTROL, V27, P817, DOI 10.1007/s10552-016-0730-9; Roberts JE, 2011, EYE CONTACT LENS, V37, P246, DOI 10.1097/ICL.0b013e31821cbcc9; Saleh GM, 2017, BRIT J OPHTHALMOL, V101, P209, DOI 10.1136/bjophthalmol-2015-308261; Samanek AJ, 2006, MED J AUSTRALIA, V184, P338, DOI 10.5694/j.1326-5377.2006.tb00267.x; Sattler U, 2014, BRIT J DERMATOL, V170, P1327, DOI 10.1111/bjd.12966; Schuz N, 2013, J BEHAV MED, V36, P508, DOI 10.1007/s10865-012-9445-x; Skobowiat C, 2017, PHOTOCHEM PHOTOBIOL, V93, P1008, DOI 10.1111/php.12642; Skobowiat C, 2016, EXP DERMATOL, V25, P120, DOI 10.1111/exd.12890; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Surdu Simona, 2014, Reviews on Environmental Health, V29, P255, DOI 10.1515/reveh-2014-0040; TRAHANIAS PE, 1992, 11TH IAPR INTERNATIONAL CONFERENCE ON PATTERN RECOGNITION, PROCEEDINGS, VOL III, P545, DOI 10.1109/ICPR.1992.202045; Trakatelli M, 2016, J EUR ACAD DERMATOL, V30, P5, DOI 10.1111/jdv.13603; Walther U, 2004, BRIT J DERMATOL, V151, P170, DOI 10.1111/j.1365-2133.2004.06030.x; Wang SQ, 2016, PHOTODERMATOL PHOTO, V32, P55, DOI 10.1111/phpp.12211; Yan XS, 2008, CUTAN OCUL TOXICOL, V27, P231, DOI 10.1080/15569520802251072; Young AR, 2017, J AM ACAD DERMATOL, V76, pS100, DOI 10.1016/j.jaad.2016.09.038; Zgaga L, 2011, J NUTR, V141, P1535, DOI 10.3945/jn.111.140012	55	16	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185297	10.1371/journal.pone.0185297	http://dx.doi.org/10.1371/journal.pone.0185297			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MY	28968413	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000412029600017
J	Chuchuen, O; Maher, JR; Henderson, MH; Desoto, M; Rohan, LC; Wax, A; Katz, DF				Chuchuen, Oranat; Maher, Jason R.; Henderson, Marcus H.; Desoto, Michael; Rohan, Lisa C.; Wax, Adam; Katz, David F.			Label-free analysis of tenofovir delivery to vaginal tissue using co-registered confocal Raman spectroscopy and optical coherence tomography	PLOS ONE			English	Article							BIOLOGICAL TISSUES; MICROBICIDE GEL; EX-VIVO; SKIN; PERMEATION; MICROSPECTROSCOPY; SCATTERING; MUCOSA; WOMEN; MODEL	Vaginally applied microbicide products offer a female-controlled strategy for preventing sexual transmission of HIV. Microbicide transport processes are central to their functioning, and there is a clear need for a better understanding of them. To contribute to that end, we developed an assay to analyze mass transport rates of microbicide molecules within the epithelial and stromal layers of polarized vaginal mucosal tissue during contact with a gel vehicle. The assay utilizes a new diffusion chamber mounted in a custom instrument that combines con-focal Raman spectroscopy and optical coherence tomography. This measures depth-resolved microbicide concentration distributions within epithelium and stroma. Data for a tenofovir gel were fitted with a compartmental diffusion model to obtain fundamental transport properties: the molecular diffusion and partition coefficients in different compartments. Diffusion coefficients in epithelium and stroma were computed to be 6.10 +/- 2.12 x 10(-8) and 4.52 +/- 1.86 x 10(-7) cm(2) /sec, respectively. The partition coefficients between epithelium and gel and between stroma and epithelium were found to be 0.53 +/- 0.15 and 1.17 +/- 0.16, respectively. These drug transport parameters are salient in governing the drug delivery performance of different drug and gel vehicle systems. They can be used to contrast drugs and vehicles during product design, development and screening. They are critical inputs to deterministic transport models that predict the gels' pharmacokinetic performance, which can guide improved design of products and optimization of their dosing regimens.	[Chuchuen, Oranat] Khon Kaen Univ, Fac Technol, Dept Biotechnol, Khon Kaen, Thailand; [Chuchuen, Oranat; Maher, Jason R.; Henderson, Marcus H.; Desoto, Michael; Wax, Adam; Katz, David F.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Rohan, Lisa C.] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Rohan, Lisa C.] Magee Womens Res Inst, Pittsburgh, PA USA; [Katz, David F.] Duke Univ, Dept Obstet & Gynecol, Durham, NC 27708 USA	Khon Kaen University; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Duke University	Katz, DF (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.; Katz, DF (corresponding author), Duke Univ, Dept Obstet & Gynecol, Durham, NC 27708 USA.	dkatz@duke.edu	Chuchuen, Oranat/GQA-4250-2022	Chuchuen, Oranat/0000-0002-4152-683X	National Institute of Health [RO1 HD 072702, U19 Al 113127]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072702] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study is funded by National Institute of Health grants RO1 HD 072702 and U19 Al 113127. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, 20 C RETR OPP INF AT, DOI DOI 10.1056/NEJM0A1402269; Baeten JM, 2016, NEW ENGLAND J MED; Belsey NA, 2014, J CONTROL RELEASE, V174, P37, DOI 10.1016/j.jconrel.2013.11.002; Berger AJ, 1997, APPL SPECTROSC, V51, P725, DOI 10.1366/0003702971940882; Camp CH, 2015, NAT PHOTONICS, V9, P295, DOI 10.1038/NPHOTON.2015.60; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Chuchuen O, 2017, J PHARM SCI-US, V106, P639, DOI 10.1016/j.xphs.2016.09.030; Chuchuen O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085124; Davis CC, 2014, TOXICOL APPL PHARM, V274, P240, DOI 10.1016/j.taap.2013.11.021; Dezzutti CS, 2012, J ANTIMICROB CHEMOTH, V67, P2139, DOI 10.1093/jac/dks173; Everall NJ, 2010, ANALYST, V135, P2512, DOI 10.1039/c0an00371a; Franz TJ, 1975, J INVEST DERMATOL, V64, P190; FUJIMOTO JG, 1995, NAT MED, V1, P970, DOI 10.1038/nm0995-970; Gao Y, 2015, PREGNANCY HYPERTENS, V5, P94, DOI DOI 10.1007/S13346-015-0227-1; Gao YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167696; Gao YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074404; HAALAND DM, 1988, ANAL CHEM, V60, P1193, DOI 10.1021/ac00162a020; Hendrix CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055013; IZATT JA, 1997, OPT PHOTONICS NEWS, V8, P41; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Katz DF, 2015, ADV DRUG DELIVER REV, V92, P2, DOI 10.1016/j.addr.2015.04.017; Lai BE, 2010, ANTIVIR RES, V88, P143, DOI 10.1016/j.antiviral.2010.08.006; Mahalingam A, 2011, ANTIMICROB AGENTS CH, V55, P1650, DOI 10.1128/AAC.01368-10; Maher JR, 2015, BIOMED OPT EXPRESS, V6, P2022, DOI 10.1364/BOE.6.002022; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Mcgowan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060147; Nel AM, 2010, AIDS RES HUM RETROV, V26, P1181, DOI 10.1089/aid.2009.0227; Neves JD, 2014, DRUG DELIVERY DEV AN; Nguyen TT, 2012, SPECTROSC-INT J, V27, P421, DOI 10.1155/2012/686183; Rees H, 2015, C RETR OPP INF SEATT, p26LB; Rohan LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009310; Roy K, 1995, INT SOC OPTICS PHOTO; Schmitt JM, 1999, IEEE J SEL TOP QUANT, V5, P1205, DOI 10.1109/2944.796348; Severcan F, 2012, ADV BIOMED SPECTROSC, V6, P1; Shrivastava A., 2011, CHRONICLES YOUNG SCI, V2, P21, DOI [DOI 10.4103/2229-5186.79345, 10.4103/2229-5186.79345]; Squier CA, 2008, J PHARM SCI-US, V97, P9, DOI 10.1002/jps.21077; Tfayli A, 2007, EUR BIOPHYS J BIOPHY, V36, P1049, DOI 10.1007/s00249-007-0191-x; Truskey G. A., 2004, TRANSPORT PHENOMENA; ur Rehman I., 2012, VIBRATIONAL SPECTROS; USAID, FACTS 001 TRIAL QUES; Van der Bijl P., 1998, EFFECT FREEZING PERM; Vargas G, 2009, J INFECT DIS, V199, P1546, DOI 10.1086/598221; Wood BR, 1996, BIOSPECTROSCOPY, V2, P143, DOI 10.1002/(SICI)1520-6343(1996)2:3<143::AID-BSPY1>3.0.CO;2-9; Xiao CH, 2005, J INVEST DERMATOL, V124, P622, DOI 10.1111/j.0022-202X.2004.23608.x; Zidan AS, 2014, J PHARM SCI-US, V103, P952, DOI 10.1002/jps.23867	46	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185633	10.1371/journal.pone.0185633	http://dx.doi.org/10.1371/journal.pone.0185633			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961280	Green Published, Green Submitted, gold			2022-12-26	WOS:000412027700028
J	Liu, YJ; Wei, JH; Yuen, SMWK; Sun, B; Tang, YJ; Wang, RW; Van Petegem, F; Chen, SRW				Liu, Yingjie; Wei, Jinhong; Yuen, Siobhan M. Wong King; Sun, Bo; Tang, Yijun; Wang, Ruiwu; Van Petegem, Filip; Chen, S. R. Wayne			CPVT-associated cardiac ryanodine receptor mutation G357S with reduced penetrance impairs Ca2+ release termination and diminishes protein expression	PLOS ONE			English	Article							POLYMORPHIC VENTRICULAR-TACHYCARDIA; SUDDEN-DEATH; MOLECULAR CHARACTERIZATION; CHANNEL; REGION; ACTIVATION; AFTERDEPOLARIZATIONS; ARRHYTHMIAS; THRESHOLD; DIAGNOSIS	Catecholaminergic polymorphic ventricular tachycardia (CPVT) is one of the most lethal inherited cardiac arrhythmias mostly linked to cardiac ryanodine receptor (RyR2) mutations with high disease penetrance. Interestingly, a novel RyR2 mutation G357S discovered in a large family of more than 1400 individuals has reduced penetrance. The molecular basis for the incomplete disease penetrance in this family is unknown. To gain insights into the variable disease expression in this family, we determined the impact of the G357S mutation on RyR2 function and expression. We assessed spontaneous Ca2+ release in HEK293 cells expressing RyR2 wildtype and the G357S mutant during store Ca2+ overload, also known as store overload induced Ca2+ release (SOICR). We found that the G357S mutation reduced the percentage of RyR2-expressing cells that showed SOICR. However, in cells that displayed SOICR, G357S reduced the thresholds for the activation and termination of SOICR. Furthermore, G357S decreased the thermal stability of the N-terminal domain of RyR2, and markedly reduced the protein expression of the full-length RyR2. On the other hand, the G357S mutation did not alter the Ca2+ activation of [H-3] ryanodine binding or the Ca2+ induced release of Ca2+ from the intracellular stores in HEK293 cells. These data indicate that the CPVT-associated G357S mutation enhances the arrhythmogenic SOICR and reduces RyR2 protein expression, which may be attributable to the incomplete penetrance of CPVT in this family.	[Liu, Yingjie; Wei, Jinhong; Sun, Bo; Tang, Yijun; Wang, Ruiwu; Chen, S. R. Wayne] Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Yuen, Siobhan M. Wong King; Van Petegem, Filip] Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC, Canada; [Tang, Yijun] Hubei Univ Med, Taihe Hosp, Affiliated Hosp, Wuhan, Hubei, Peoples R China	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of British Columbia; Hubei University of Medicine	Chen, SRW (corresponding author), Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Physiol & Pharmacol, Calgary, AB, Canada.	swchen@ucalgary.ca	Wei, Jinhong/GWV-0561-2022; Van petegem, Filip/M-6061-2016	Wei, Jinhong/0000-0002-5251-9192; Van petegem, Filip/0000-0003-2728-8537	Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Canada Foundation for Innovation; Heart and Stroke Foundation Chair in Cardiovascular Research; Alberta Innovates-Health Solutions (AIHS) Studentship Award; Libin Cardiovascular Institute of Alberta and Cumming School of Medicine Postdoctoral Fellowship Award; Heart and Stroke Foundation of Canada Junior Fellowship Award; AIHS Fellowship Award; Alberta Innovates [201400104] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Heart and Stroke Foundation Chair in Cardiovascular Research; Alberta Innovates-Health Solutions (AIHS) Studentship Award; Libin Cardiovascular Institute of Alberta and Cumming School of Medicine Postdoctoral Fellowship Award; Heart and Stroke Foundation of Canada Junior Fellowship Award; AIHS Fellowship Award; Alberta Innovates	This work was supported by research grants from the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Canada, the Canada Foundation for Innovation, and the Heart and Stroke Foundation Chair in Cardiovascular Research (to S.R.W.C.). YL is a recipient of the Alberta Innovates-Health Solutions (AIHS) Studentship Award. JW is a recipient of the Libin Cardiovascular Institute of Alberta and Cumming School of Medicine Postdoctoral Fellowship Award. BS is a recipient of the Heart and Stroke Foundation of Canada Junior Fellowship Award and the AIHS Fellowship Award. SRWC is an AIHS Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador FJ, 2009, P NATL ACAD SCI USA, V106, P11040, DOI 10.1073/pnas.0905186106; Bai XC, 2016, CELL RES, V26, P995, DOI 10.1038/cr.2016.89; BASSANI JWM, 1995, AM J PHYSIOL-CELL PH, V268, pC1313, DOI 10.1152/ajpcell.1995.268.5.C1313; Bauce B, 2002, J AM COLL CARDIOL, V40, P341, DOI 10.1016/S0735-1097(02)01946-0; Diaz ME, 1997, J PHYSIOL-LONDON, V501, P3, DOI 10.1111/j.1469-7793.1997.003bo.x; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Haugaa KH, 2010, EUROPACE, V12, P417, DOI 10.1093/europace/eup448; Hayashi M, 2009, CIRCULATION, V119, P2426, DOI 10.1161/CIRCULATIONAHA.108.829267; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jones PP, 2008, BIOCHEM J, V412, P171, DOI 10.1042/BJ20071287; Kannankeril PJ, 2006, P NATL ACAD SCI USA, V103, P12179, DOI 10.1073/pnas.0600268103; Kimlicka L, 2013, STRUCTURE, V21, P1440, DOI 10.1016/j.str.2013.06.012; Kimlicka L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2501; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lahat H, 2001, AM J HUM GENET, V69, P1378, DOI 10.1086/324565; Laitinen PJ, 2001, CIRCULATION, V103, P485, DOI 10.1161/01.CIR.103.4.485; LAKATTA EG, 1992, CARDIOVASC RES, V26, P193, DOI 10.1093/cvr/26.3.193; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Liu N, 2006, CIRC RES, V99, P292, DOI 10.1161/01.RES.0000235869.50747.e1; Liu YJ, 2015, J BIOL CHEM, V290, P7736, DOI 10.1074/jbc.M114.618827; Lobo PA, 2009, STRUCTURE, V17, P1505, DOI 10.1016/j.str.2009.08.016; MARBAN E, 1986, J CLIN INVEST, V78, P1185, DOI 10.1172/JCI112701; Medeiros-Domingo A, 2009, J AM COLL CARDIOL, V54, P2065, DOI 10.1016/j.jacc.2009.08.022; Napolitano C, 2007, HEART RHYTHM, V4, P675, DOI 10.1016/j.hrthm.2006.12.048; Nyegaard M, 2012, AM J HUM GENET, V91, P703, DOI 10.1016/j.ajhg.2012.08.015; ORCHARD CH, 1983, NATURE, V304, P735, DOI 10.1038/304735a0; Paavola J, 2007, EUR HEART J, V28, P1135, DOI 10.1093/eurheartj/ehl543; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Peng W, 2016, SCIENCE, V354, DOI 10.1126/science.aah5324; Postma AV, 2002, CIRC RES, V91, pE21, DOI 10.1161/01.RES.0000038886.18992.6B; Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8; Priori SG, 2001, CIRCULATION, V103, P196; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Roston TM, 2015, CIRC-ARRHYTHMIA ELEC, V8, P633, DOI 10.1161/CIRCEP.114.002217; Roux-Buisson N, 2012, HUM MOL GENET, V21, P2759, DOI 10.1093/hmg/dds104; Sedej S., 2010, CARDIOVASCULAR RES; Shannon TR, 2003, CIRC RES, V93, P592, DOI 10.1161/01.RES.0000093399.11734.B3; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; Tester DJ, 2004, MAYO CLIN PROC, V79, P1380, DOI 10.4065/79.11.1380; Tian XX, 2013, J BIOL CHEM, V288, P4066, DOI 10.1074/jbc.M112.427864; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; van der Werf C, 2012, CIRC-ARRHYTHMIA ELEC, V5, P748, DOI 10.1161/CIRCEP.112.970517; Wanguemert F, 2015, HEART RHYTHM, V12, P1636, DOI 10.1016/j.hrthm.2015.03.033; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971	48	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0184177	10.1371/journal.pone.0184177	http://dx.doi.org/10.1371/journal.pone.0184177			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961276	Green Published, gold, Green Submitted			2022-12-26	WOS:000412027700004
J	Sammallahti, S; Kajantie, E; Matinolli, HM; Pyhala, R; Lahti, J; Heinonen, K; Lahti, M; Pesonen, AK; Eriksson, JG; Hovi, P; Jarvenpaa, AL; Andersson, S; Raikkonen, K				Sammallahti, Sara; Kajantie, Eero; Matinolli, Hanna-Maria; Pyhala, Riikka; Lahti, Jari; Heinonen, Kati; Lahti, Marius; Pesonen, Anu-Katriina; Eriksson, Johan G.; Hovi, Petteri; Jarvenpaa, Anna-Liisa; Andersson, Sture; Raikkonen, Katri			Nutrition after preterm birth and adult neurocognitive outcomes	PLOS ONE			English	Article							HUMAN-MILK PROTEIN; YOUNG-ADULTS; BREAST-MILK; DEVELOPMENTAL OUTCOMES; INFANT GROWTH; WEIGHT; SUPPLEMENTATION; ABILITIES; FORMULA; TRIAL	Background Preterm birth (<37 gestational weeks) poses a risk of poorer neurocognitive functioning. Faster growth after preterm birth predicts better cognitive abilities and can be promoted through adequate nutrition, but it remains unknown whether variations in nutrient intakes translate into long-term benefits for neurodevelopment. Methods In 86 participants of the Helsinki Study of Very Low Birth Weight Adults (birthweight < 1500g), we examined if higher intakes of energy, macronutrients, and human milk during the first nine weeks after preterm birth predict performance in tests of cognitive ability at 25.1 years of age (SD = 2.1). Results 10 kcal/kg/day higher total energy intake at 3 to 6 weeks of age was associated with 0.21 SD higher adult IQ (95% Confidence Interval [CI] 0.07-0.35). Higher carbohydrate and fat intake at 3-6 weeks, and higher energy intake from human milk at 3-6 and at 6-9 weeks were also associated with higher adult IQ: these effect sizes ranged from 0.09 SD (95% CI 0.01-0.18) to 0.34 SD (0.14-0.54) higher IQ, per one gram/kg/day more carbohydrate and fat, and per 10 kcal/kg/day more energy from human milk. Adjustment for neonatal complications attenuated the associations: intraventricular hemorrhage, in particular, was associated with both poorer nutrition and poorer IQ. Conclusion In preterm neonates with very low birth weight, higher energy and human milk intake predict better neurocognitive abilities in adulthood. To understand the determinants of these infants' neurocognitive outcome, it seems important to take into account the role of postnatal nutrition, not just as an isolated exposure, but as a potential mediator between neonatal illness and long-term neurodevelopment.	[Sammallahti, Sara; Pyhala, Riikka; Lahti, Jari; Heinonen, Kati; Lahti, Marius; Pesonen, Anu-Katriina; Raikkonen, Katri] Univ Helsinki, Dept Psychol & Logoped, Helsinki, Finland; [Sammallahti, Sara; Kajantie, Eero; Hovi, Petteri; Jarvenpaa, Anna-Liisa; Andersson, Sture] Helsinki Univ Hosp, Childrens Hosp, Helsinki, Finland; [Sammallahti, Sara; Kajantie, Eero; Hovi, Petteri; Jarvenpaa, Anna-Liisa; Andersson, Sture] Univ Helsinki, Helsinki, Finland; [Sammallahti, Sara; Kajantie, Eero; Matinolli, Hanna-Maria; Eriksson, Johan G.; Hovi, Petteri] Natl Inst Hlth & Welf, Helsinki, Finland; [Kajantie, Eero] Oulu Univ Hosp, PEDEGO Res Unit, MRC Oulu, Oulu, Finland; [Kajantie, Eero] Univ Oulu, Oulu, Finland; [Lahti, Jari] Helsinki Coll Adv Studies, Helsinki, Finland; [Lahti, Marius] Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Helsinki Univ Hosp, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Helsinki; University of Edinburgh; Folkhalsan Research Center; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Sammallahti, S (corresponding author), Univ Helsinki, Dept Psychol & Logoped, Helsinki, Finland.; Sammallahti, S (corresponding author), Helsinki Univ Hosp, Childrens Hosp, Helsinki, Finland.; Sammallahti, S (corresponding author), Univ Helsinki, Helsinki, Finland.; Sammallahti, S (corresponding author), Natl Inst Hlth & Welf, Helsinki, Finland.	sara.sammallahti@helsinki.fi	Lahti, Jari/P-2283-2019; Pyhälä, Riikka/AAG-1947-2021; Lahti, Jari/P-7987-2018; Matinolli, Hanna-Maria/P-9477-2019; Lahti-Pulkkinen, Marius/Q-2472-2017	Lahti, Jari/0000-0002-4310-5297; Lahti, Jari/0000-0002-4310-5297; Heinonen, Kati/0000-0002-1262-5599; Pesonen, Anu-Katriina/0000-0002-0662-6261; Lahti-Pulkkinen, Marius/0000-0002-5244-5525; Matinolli, Hanna-Maria/0000-0001-8281-6801; Sammallahti, Sara/0000-0001-8928-000X; Raikkonen, Katri/0000-0003-3124-3470	Academy of Finland; University of Helsinki Research Foundation; Finnish Medical Society Duodecim; Finska Lakaresallskapet; Foundation for Pediatric Research in Finland; Finnish Special Governmental Subsidy for Health Sciences; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Emil Aaltonen Foundation; Novo Nordisk Foundation; Paivikki and Sakari Sohlberg Foundation; Signe and Ane Gyllenberg Foundation; Orion-Pharma Foundation; Sigrid Juselius Foundation; Finnish National Graduate School of Clinical Investigation; Hope and Optimism Initiative; Wilhelm and Else Stockmann Foundation; Pediatric Graduate School, University of Helsinki; Novo Nordisk Fonden [NNF15OC0016362] Funding Source: researchfish	Academy of Finland(Academy of Finland); University of Helsinki Research Foundation; Finnish Medical Society Duodecim; Finska Lakaresallskapet; Foundation for Pediatric Research in Finland; Finnish Special Governmental Subsidy for Health Sciences; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Emil Aaltonen Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Paivikki and Sakari Sohlberg Foundation; Signe and Ane Gyllenberg Foundation; Orion-Pharma Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish National Graduate School of Clinical Investigation; Hope and Optimism Initiative; Wilhelm and Else Stockmann Foundation; Pediatric Graduate School, University of Helsinki; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was part of the Helsinki Study of Very Low Birth Weight Adults funded by the Academy of Finland (http://www.aka.fi/), University of Helsinki Research Foundation (https://www.helsinki.fi/en/university/university-of-helsink-research-foundation), the Finnish Medical Society Duodecim (http://www.duodecim.fi/english/), Finska Lakaresallskapet (htlp://www.fls.fi/), the Foundation for Pediatric Research in Finland (http://www.lastentautientutkimussaatio.fi/), the Finnish Special Governmental Subsidy for Health Sciences, the Jalmari and Rauha Ahokas Foundation (http://www.ahokkaansaatio.org/), the Juho Vainio Foundation (http://www.juhovainionsaatio.fi), the Emil Aaltonen Foundation (http://www.emilaaltonen.fi/), the Novo Nordisk Foundation (http://www.novonordisk.com/about-novo-nordisk/corporate-govemance/foundation.html), the Paivikki and Sakari Sohlberg Foundation (http://www.pss-saatio.fi/), the Signe and Ane Gyllenberg Foundation (http://gyllenbergs.fi/), the Yrjo Jahnsson Foundation (http://www.yis.fi/), the Orion-Pharma Foundation (http://www.orion.fi/tutkimus/orionin-tutkimussaatio/),the Sigrid Juselius Foundation (http://sigridjuselius.fi/), the Finnish National Graduate School of Clinical Investigation (http://www.vktk.fi/), Hope and Optimism Initiative (http://hopeoptimism.com/), the Wilhelm and Else Stockmann Foundation, and the Pediatric Graduate School, University of Helsinki (http://www.kll.helsinki.fi/tutkimus/Inktko.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0; ANDERSON DM, 1983, AM J CLIN NUTR, V37, P810, DOI 10.1093/ajcn/37.5.810; Belfort MB, 2016, J PEDIATR-US, V177, P133, DOI 10.1016/j.jpeds.2016.06.045; Bellagamba MP, 2016, J PEDIATR GASTR NUTR, V62, P879, DOI 10.1097/MPG.0000000000000989; Bohnen N, 1992, Clin Neuropsychol, V6, P178, DOI 10.1080/13854049208401854; Brandt I, 2003, J PEDIATR-US, V142, P463, DOI 10.1067/mpd.2003.149; Breeman LD, 2015, PEDIATRICS, V136, P415, DOI 10.1542/peds.2015-0608; Brown JVE, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000343.pub3; Collins CT, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007314; Conners C.K., 2004, CONNERS CONTINUOUS P; Ehrenkranz RA, 2011, PEDIATR RES, V69, P522, DOI 10.1203/PDR.0b013e318217f4f1; Fenton TR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003959.pub3; Furman L, 2004, J DEV BEHAV PEDIATR, V25, P247, DOI 10.1097/00004703-200408000-00004; Gibertoni D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116552; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Gutierrez E, 2015, ACTA PAEDIATR, V104, P974, DOI DOI 10.1111/APA.13128; Heinonen K, 2013, PEDIATRICS, V131, pE243, DOI 10.1542/peds.2012-0839; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Isaacs EB, 2008, PEDIATR RES, V63, P308, DOI 10.1203/PDR.0b013e318163a271; Isaacs EB, 2010, PEDIATR RES, V67, P357, DOI 10.1203/PDR.0b013e3181d026da; Isaacs EB, 2009, J PEDIATR-US, V155, P229, DOI 10.1016/j.jpeds.2009.02.030; Jarvenpaa A L, 1987, Duodecim, V103, P1238; Johnson S, 2011, DEV NEUROPSYCHOL, V36, P74, DOI 10.1080/87565641.2011.540541; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lohaugen GCC, 2010, DEV MED CHILD NEUROL, V52, P1133, DOI 10.1111/j.1469-8749.2010.03743.x; LUCAS A, 1994, ARCH DIS CHILD-FETAL, V70, pF141, DOI 10.1136/fn.70.2.F141; Lucas A, 1998, BRIT MED J, V317, P1481, DOI 10.1136/bmj.317.7171.1481; Matinolli HM, 2015, J NUTR, V145, P2084, DOI 10.3945/jn.115.212415; Moe-Byrne T, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001457.pub6; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; O'Connor DL, 2003, J PEDIATR GASTR NUTR, V37, P437, DOI 10.1097/00005176-200310000-00008; Patel RM, 2015, NEW ENGL J MED, V372, P331, DOI 10.1056/NEJMoa1403489; Pihkala J, 1989, Duodecim, V105, P1540; Pyhala R, 2011, NEUROLOGY, V77, P2052, DOI 10.1212/WNL.0b013e31823b473e; Pyhala R, 2014, PEDIATRICS, V134, P1075, DOI 10.1542/peds.2014-1097; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; RONNHOLM KAR, 1984, PEDIATRICS, V74, P792; RONNHOLM KAR, 1982, J PEDIATR-US, V101, P243, DOI 10.1016/S0022-3476(82)80133-9; Roze JC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000834; Sammallahti S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137092; Sammallahti S, 2014, J PEDIATR-US, V165, P1109, DOI 10.1016/j.jpeds.2014.08.028; Schulzke SM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000375.pub4; Smith MM, 2003, AM J EPIDEMIOL, V158, P1075, DOI 10.1093/aje/kwg257; Stephens BE, 2009, PEDIATRICS, V123, P1337, DOI 10.1542/peds.2008-0211; Tan M, 2008, ARCH DIS CHILD-FETAL, V93, pF342, DOI 10.1136/adc.2007.124255; Trolli SED, 2012, EARLY HUM DEV, V88, pS25, DOI 10.1016/j.earlhumdev.2011.12.024; Vohr BR, 2007, PEDIATRICS, V120, pe953, DOI 10.1542/peds.2006-3227; Wechsler D., 2005, WECHSLER ADULT INTEL	51	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185632	10.1371/journal.pone.0185632	http://dx.doi.org/10.1371/journal.pone.0185632			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957424	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200097
J	Stockli, J; Fisher-Wellman, KH; Chaudhuri, R; Zeng, XY; Fazakerley, DJ; Meoli, CC; Thomas, KC; Hoffman, NJ; Mangiafico, SP; Xirouchaki, CE; Yang, CH; Ilkayeva, O; Wong, K; Cooney, GJ; Andrikopoulos, S; Muoio, DM; James, DE				Stockli, Jacqueline; Fisher-Wellman, Kelsey H.; Chaudhuri, Rima; Zeng, Xiao-Yi; Fazakerley, Daniel J.; Meoli, Christopher C.; Thomas, Kristen C.; Hoffman, Nolan J.; Mangiafico, Salvatore P.; Xirouchaki, Chrysovalantou E.; Yang, Chieh-Hsin; Ilkayeva, Olga; Wong, Kari; Cooney, Gregory J.; Andrikopoulos, Sofianos; Muoio, Deborah M.; James, David E.			Metabolomic analysis of insulin resistance across different mouse strains and diets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ceramide; glucose metabolism; insulin resistance; metabolomics; skeletal muscle metabolism; genetic diversity; metabolite signature; strain differences	GENE-NUTRIENT INTERACTIONS; FATTY-ACID OXIDATION; ENERGY-EXPENDITURE; MEDIUM-CHAIN; OBESITY; MUSCLE; MICE; POLYMORPHISM; SENSITIVITY; ELOVL3	Insulin resistance is a major risk factor for many diseases. However, its underlying mechanism remains unclear in part because it is triggered by a complex relationship between multiple factors, including genes and the environment. Here, we used metabolomics combined with computational methods to identify factors that classified insulin resistance across individual mice derived from three different mouse strains fed two different diets. Three inbred ILSXISS strains were fed high-fat or chow diets and subjected to metabolic phenotyping and metabolomics analysis of skeletal muscle. There was significant metabolic heterogeneity between strains, diets, and individual animals. Distinct metabolites were changed with insulin resistance, diet, and between strains. Computational analysis revealed 113 metabolites that were correlated with metabolic phenotypes. Using these 113 metabolites, combined with machine learning to segregate mice based on insulin sensitivity, we identified C22:1-CoA, C2-carnitine, and C16-ceramide as the best classifiers. Strikingly, when these three metabolites were combined into one signature, they classified mice based on insulin sensitivity more accurately than each metabolite on its own or other published metabolic signatures. Furthermore, C22:1-CoA was 2.3-fold higher in insulin-resistant mice and correlated significantly with insulin resistance. We have identified a metabolomic signature composed of three functionally unrelated metabolites that accurately predicts whole-body insulin sensitivity across three mouse strains. These data indicate the power of simultaneous analysis of individual, genetic, and environmental variance in mice for identifying novel factors that accurately predict metabolic phenotypes like whole-body insulin sensitivity.	[Stockli, Jacqueline; Chaudhuri, Rima; Zeng, Xiao-Yi; Fazakerley, Daniel J.; Thomas, Kristen C.; Hoffman, Nolan J.; James, David E.] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Fisher-Wellman, Kelsey H.; Meoli, Christopher C.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Fisher-Wellman, Kelsey H.; Ilkayeva, Olga; Wong, Kari; Muoio, Deborah M.] Duke Univ, Duke Mol Physiol Inst, Durham, NC 27708 USA; [Mangiafico, Salvatore P.; Xirouchaki, Chrysovalantou E.; Yang, Chieh-Hsin; Andrikopoulos, Sofianos] Univ Melbourne, Dept Med, Melbourne, Vic 3010, Australia; [Cooney, Gregory J.; James, David E.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Hoffman, Nolan J.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Ctr Exercise & Nutr, Melbourne, Vic 3000, Australia	University of Sydney; Garvan Institute of Medical Research; Duke University; University of Melbourne; University of Sydney; Australian Catholic University	James, DE (corresponding author), Univ Sydney, Charles Perkins Ctr, Sch Life & Environm Sci, Sydney Med Sch, Sydney, NSW 2006, Australia.	david.james@sydney.edu.au	Fisher-Wellman, Kelsey/O-8209-2019; Fazakerley, Daniel/J-2652-2019; Stoeckli, Jacqueline/D-7053-2016; Stoeckli, Jacqueline/Z-4443-2019; Muoio, Debbie Marie/E-1147-2012	Fisher-Wellman, Kelsey/0000-0002-0300-829X; Fazakerley, Daniel/0000-0001-8241-2903; Stoeckli, Jacqueline/0000-0002-6446-7350; Stoeckli, Jacqueline/0000-0002-6446-7350; Muoio, Deborah/0000-0003-3760-9277; Cooke, Kristen/0000-0002-3534-1660; Xirouchaki, Chrysovalantou Eleni/0000-0002-8153-8958; Hoffman, Nolan/0000-0001-5168-7082; James, David/0000-0001-5946-5257; Yang, Chieh-Hsin (Jessie)/0000-0003-4360-670X	National Health and Medical Research Council (NHMRC) [GNT1061122, GNT1086851, GNT1086850]; National Institutes of Health [2R01DK089312, 2P01-DK058398]; National Institutes of Health F32 Fellowship [1F32DK105665-01A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089312, P01DK058398] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health F32 Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Health and Medical Research Council (NHMRC) Project Grants GNT1061122, GNT1086851, and GNT1086850 (to D. E. J.) and National Institutes of Health Grants 2R01DK089312 and 2P01-DK058398 (to D. M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or NHMRC.; Supported by National Institutes of Health F32 Fellowship 1F32DK105665-01A1.	Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Andrikopoulos S, 2005, J ENDOCRINOL, V187, P45, DOI 10.1677/joe.1.06333; Bennett B, 2006, J PHARMACOL EXP THER, V319, P299, DOI 10.1124/jpet.106.103572; Bergman BC, 2016, DIABETOLOGIA, V59, P785, DOI 10.1007/s00125-015-3850-y; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BREMER J, 1982, J LIPID RES, V23, P243; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Chaudhuri R, 2015, NPJ SYST BIOL APPL, V1, DOI 10.1038/npjsba.2015.10; Chavez JA, 2014, J BIOL CHEM, V289, P723, DOI 10.1074/jbc.M113.522847; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; CHRISTIANSEN RZ, 1977, BIOCHIM BIOPHYS ACTA, V487, P28, DOI 10.1016/0005-2760(77)90041-8; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Gallou-Kabani C, 2007, OBESITY, V15, P1996, DOI 10.1038/oby.2007.238; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Hoehn KL, 2010, CELL METAB, V11, P70, DOI 10.1016/j.cmet.2009.11.008; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Imamura M, 2011, ENDOCR J, V58, P723, DOI 10.1507/endocrj.EJ11-0113; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Kasumov T, 2015, OBESITY, V23, P1414, DOI 10.1002/oby.21117; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Kuhn M, 2021, CARET CLASSIFICATION, DOI DOI 10.1887/0750303123/B365C43; Kusunoki Masataka, 2007, J Med Invest, V54, P243, DOI 10.2152/jmi.54.243; Lee BC, 2014, BBA-MOL BASIS DIS, V1842, P446, DOI 10.1016/j.bbadis.2013.05.017; Li QL, 2015, J BIOL CHEM, V290, P8121, DOI 10.1074/jbc.M114.631549; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Lotta LA, 2017, NAT GENET, V49, P17, DOI 10.1038/ng.3714; Magkos F, 2013, DIABETES, V62, P2757, DOI 10.2337/db13-0185; Magnes C, 2005, ANAL CHEM, V77, P2889, DOI 10.1021/ac048314i; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Minkler PE, 2008, ANAL BIOCHEM, V376, P275, DOI 10.1016/j.ab.2008.02.022; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Muoio DM, 2012, CELL METAB, V15, P595, DOI 10.1016/j.cmet.2012.04.010; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Palmer ND, 2015, J CLIN ENDOCR METAB, V100, pE463, DOI 10.1210/jc.2014-2357; Parks BW, 2015, CELL METAB, V21, P334, DOI 10.1016/j.cmet.2015.01.002; Phillips CM, 2013, NUTRIENTS, V5, P32, DOI 10.3390/nu5010032; Phillips CM, 2011, ATHEROSCLEROSIS, V214, P408, DOI 10.1016/j.atherosclerosis.2010.10.029; Phillips CM, 2010, J LIPID RES, V51, P3500, DOI 10.1194/jlr.M008474; Phillips CM, 2010, J LIPID RES, V51, P1793, DOI 10.1194/jlr.M003046; R Core Team, 2021, R LANGUAGE ENV STAT; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; REUBSAET FAG, 1989, LIPIDS, V24, P945, DOI 10.1007/BF02544539; Robitaille J, 2007, INT J OBESITY, V31, P411, DOI 10.1038/sj.ijo.0803450; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Scacchi R, 2007, NUTR METAB CARDIOVAS, V17, P632, DOI 10.1016/j.numecd.2006.12.007; Seiler SE, 2014, J LIPID RES, V55, P635, DOI 10.1194/jlr.M043448; Shen J, 2008, J LIPID RES, V49, P1839, DOI 10.1194/jlr.P700033-JLR200; Straczkowski M, 2004, DIABETES, V53, P1215, DOI 10.2337/diabetes.53.5.1215; Tan SX, 2015, J BIOL CHEM, V290, P11337, DOI 10.1074/jbc.M114.623686; Thalacker-Mercer AE, 2014, DIABETES, V63, P791, DOI 10.2337/db13-0396; Torgo L., 2010, DATA MINING R LEARNI; Tucci S, 2015, FEBS J, V282, P4242, DOI 10.1111/febs.13418; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; Tvrdik P, 1997, J BIOL CHEM, V272, P31738, DOI 10.1074/jbc.272.50.31738; Wang XS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10464; Weindruch R, 1996, TOXICOL PATHOL, V24, P742, DOI 10.1177/019262339602400618; Westerberg R, 2006, J BIOL CHEM, V281, P4958, DOI 10.1074/jbc.M511588200; Westerberg R, 2004, J BIOL CHEM, V279, P5621, DOI 10.1074/jbc.M310529200; Williams RW, 2004, MAMM GENOME, V15, P637, DOI 10.1007/s00335-004-2380-6; Wu JY, 2004, J CLIN INVEST, V113, P434, DOI 10.1172/JCI200419574; Wurtz P, 2012, DIABETES, V61, P1372, DOI 10.2337/db11-1355; Zadravec D, 2010, FASEB J, V24, P4366, DOI 10.1096/fj.09-152298	71	24	26	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19135	19145		10.1074/jbc.M117.818351	http://dx.doi.org/10.1074/jbc.M117.818351			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28982973	hybrid, Green Published			2022-12-26	WOS:000416226700001
J	Njuma, OJ; Davis, I; Ndontsa, EN; Krewall, JR; Liu, AM; Goodwin, DC				Njuma, Olive J.; Davis, Ian; Ndontsa, Elizabeth N.; Krewall, Jessica R.; Liu, Aimin; Goodwin, Douglas C.			Mutual synergy between catalase and peroxidase activities of the bifunctional enzyme KatG is facilitated by electron hole-hopping within the enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electron paramagnetic resonance (EPR); electron transfer; enzyme inactivation; free radicals; heme; hydrogen peroxide; tryptophan	CYTOCHROME-C PEROXIDASE; MYCOBACTERIUM-TUBERCULOSIS KATG; SITE-DIRECTED MUTAGENESIS; TRP CROSS-LINK; BURKHOLDERIA-PSEUDOMALLEI; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ISONIAZID RESISTANCE; DELETION MUTAGENESIS	KatG is a bifunctional, heme-dependent enzyme in the front-line defense of numerous bacterial and fungal pathogens against H2O2-induced oxidative damage from host immune responses. Contrary to the expectation that catalase and peroxidase activities should be mutually antagonistic, peroxidatic electron donors (PxEDs) enhance KatG catalase activity. Here, we establish the mechanism of synergistic cooperation between these activities. We show that at low pH values KatG can fully convert H2O2 to O-2 and H2O only if a PxED is present in the reaction mixture. Stopped-flow spectroscopy results indicated rapid initial rates of H2O2 disproportionation slowing concomitantly with the accumulation of ferryl-like heme states. These states very slowly returned to resting (i.e. ferric) enzyme, indicating that they represented catalase-inactive intermediates. We also show that an active-site tryptophan, Trp-321, participates in off-pathway electron transfer. A W321F variant in which the proximal tryptophan was replaced with a non-oxidizable phenylalanine exhibited higher catalase activity and less accumulation of off-pathway heme intermediates. Finally, rapid freeze-quench EPR experiments indicated that both WT and W321F KatG produce the same methionine-tyrosine-tryptophan (MYW) cofactor radical intermediate at the earliest reaction time points and that Trp-321 is the preferred site of off-catalase protein oxidation in the native enzyme. Of note, PxEDs did not affect the formation of the MYW cofactor radical but could reduce non-productive protein-based radical species that accumulate during reaction with H2O2. Our results suggest that catalase-inactive intermediates accumulate because of off-mechanism oxidation, primarily of Trp-321, and PxEDs stimulate KatG catalase activity by preventing the accumulation of inactive intermediates.	[Njuma, Olive J.; Ndontsa, Elizabeth N.; Krewall, Jessica R.; Goodwin, Douglas C.] Auburn Univ, Dept Chem & Biochem, 179 Chem Bldg, Auburn, AL 36849 USA; [Davis, Ian; Liu, Aimin] Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA; [Davis, Ian] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Njuma, Olive J.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Ndontsa, Elizabeth N.] Aduro Biotech Inc, 740 Heinz Ave, Berkeley, CA 94710 USA	Auburn University System; Auburn University; University of Texas System; University of Texas at San Antonio (UTSA); University System of Georgia; Georgia State University; Vanderbilt University	Goodwin, DC (corresponding author), Auburn Univ, Dept Chem & Biochem, 179 Chem Bldg, Auburn, AL 36849 USA.	goodwdc@auburn.edu	Liu, Aimin/C-1572-2017	Liu, Aimin/0000-0002-4182-8176; Goodwin, Douglas/0000-0002-7869-7704; Davis, Ian/0000-0002-1566-4972	National Science Foundation [MCB 1616059, MCB 0641614]; National Institutes of Health Grant [GM108988]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108988] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grants MCB 1616059 and MCB 0641614 from the National Science Foundation (to D. C. G.) and National Institutes of Health Grant GM108988 (to A. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bertrand T, 2004, J BIOL CHEM, V279, P38991, DOI 10.1074/jbc.M402382200; Cade CE, 2010, PROTEIN SCI, V19, P458, DOI 10.1002/pro.324; Carpena X, 2006, BIOCHEMISTRY-US, V45, P5171, DOI 10.1021/bi060017f; Carpena X, 2005, EMBO REP, V6, P1156, DOI 10.1038/sj.embor.7400550; Carpena X, 2003, J MOL BIOL, V327, P475, DOI 10.1016/S0022-2836(03)00122-0; CLAIBORNE A, 1979, J BIOL CHEM, V254, P4245; Colin J, 2009, J AM CHEM SOC, V131, P8557, DOI 10.1021/ja901402v; DeLano W. L., 2013, MACPYMOL MOL GRAPHIC; Donald LJ, 2003, J BIOL CHEM, V278, P35687, DOI 10.1074/jbc.M304053200; Dunford H. B., 1999, HEME PEROXIDASES, P58; Falk J. E., 1964, PORPHYRINS METALLOPO, P804; FINZEL BC, 1984, J BIOL CHEM, V259, P3027; Fita I, 2015, HEME PEROXIDASES, P133; Gasselhuber B., 2015, HEME PEROXIDASES, P156; Gasselhuber B, 2016, BIOCHEMISTRY-US, V55, P3528, DOI 10.1021/acs.biochem.6b00436; Ghiladi RA, 2005, BIOCHEMISTRY-US, V44, P15093, DOI 10.1021/bi051463q; Ghiladi RA, 2005, J AM CHEM SOC, V127, P13428, DOI 10.1021/ja054366t; Ghiladi RA, 2005, J BIOL CHEM, V280, P22651, DOI 10.1074/jbc.M502486200; GOODWIN DC, 1995, ANAL BIOCHEM, V231, P333, DOI 10.1006/abio.1995.0059; Goodwin DC, 2003, ARCH BIOCHEM BIOPHYS, V417, P18, DOI 10.1016/S0003-9861(03)00321-7; Gray HB, 2015, P NATL ACAD SCI USA, V112, P10920, DOI 10.1073/pnas.1512704112; Guo HL, 2006, J MED MICROBIOL, V55, P1527, DOI 10.1099/jmm.0.46718-0; Hillar A, 2000, BIOCHEMISTRY-US, V39, P5868, DOI 10.1021/bi0000059; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Ivancich A, 2001, J AM CHEM SOC, V123, P5050, DOI 10.1021/ja0036514; Ivancich A, 2013, BIOCHEMISTRY-US, V52, P7271, DOI 10.1021/bi400963j; Jakopitsch C, 2005, J BIOL CHEM, V280, P42411, DOI 10.1074/jbc.M508009200; Jakopitsch C, 2003, FEBS LETT, V552, P135, DOI 10.1016/S0014-5793(03)00901-3; Jakopitsch C, 2004, J BIOL CHEM, V279, P46082, DOI 10.1074/jbc.M408399200; Jakopitsch C, 2003, J BIOL CHEM, V278, P20185, DOI 10.1074/jbc.M211625200; Jakopitsch C, 2007, BIOCHEMISTRY-US, V46, P1183, DOI 10.1021/bi062266+; Jakopitsch C, 2006, J INORG BIOCHEM, V100, P1091, DOI 10.1016/j.jinorgbio.2006.02.009; Kathiresan M, 2017, CHEM SCI, V8, P1152, DOI 10.1039/c6sc03125k; Kruft BI, 2015, J PHYS CHEM A, V119, P6850, DOI 10.1021/jp511358p; Kudalkar SN, 2015, BIOCHEMISTRY-US, V54, P1648, DOI 10.1021/bi501221a; Kudalkar SN, 2012, J INORG BIOCHEM, V116, P106, DOI 10.1016/j.jinorgbio.2012.08.002; Liu A, 1998, BIOCHEMISTRY-US, V37, P16369, DOI 10.1021/bi981471p; Loewen PC, 2014, J AM CHEM SOC, V136, P7249, DOI 10.1021/ja502794e; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Moore RL, 2008, BBA-PROTEINS PROTEOM, V1784, P900, DOI 10.1016/j.bbapap.2008.03.008; Moore S., 2016, ROUND THE HORN SITE; Ndontsa EN, 2012, ARCH BIOCHEM BIOPHYS, V525, P215, DOI 10.1016/j.abb.2012.06.003; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Njuma OJ, 2014, ARCH BIOCHEM BIOPHYS, V544, P27, DOI 10.1016/j.abb.2013.11.007; Passardi F, 2007, GENE, V397, P101, DOI 10.1016/j.gene.2007.04.016; PATTERSON WR, 1995, BIOCHEMISTRY-US, V34, P4331, DOI 10.1021/bi00013a023; Ranguelova K, 2008, BIOCHEMISTRY-US, V47, P11377, DOI 10.1021/bi800952b; Regelsberger G, 2001, BIOCHEM SOC T, V29, P99; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; SCOTT SL, 1993, J PHYS CHEM-US, V97, P6710, DOI 10.1021/j100127a022; Singh R, 2008, ARCH BIOCHEM BIOPHYS, V471, P207, DOI 10.1016/j.abb.2007.12.008; Singh R, 2007, J AM CHEM SOC, V129, P15954, DOI 10.1021/ja075108u; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; Suarez J, 2009, J BIOL CHEM, V284, P7017, DOI 10.1074/jbc.M808106200; Suarez J, 2009, J BIOL CHEM, V284, P16146, DOI 10.1074/jbc.M109.005546; Tanabe S, 2011, MOL PLANT MICROBE IN, V24, P163, DOI 10.1094/MPMI-07-10-0175; Uhlich GA, 2012, MICROBIOL-SGM, V158, P2225, DOI 10.1099/mic.0.059535-0; Uhlich GA, 2009, MICROBIOL-SGM, V155, P3589, DOI 10.1099/mic.0.031435-0; Varnado CL, 2004, PROTEIN EXPRES PURIF, V35, P76, DOI 10.1016/j.pep.2003.12.001; Vidossich P, 2007, J AM CHEM SOC, V129, P13436, DOI 10.1021/ja072245i; Vlasits J, 2010, ARCH BIOCHEM BIOPHYS, V500, P74, DOI 10.1016/j.abb.2010.04.018; Welinder KG, 1992, CURR OPIN STRUC BIOL, V2, P388, DOI [DOI 10.1016/0959-440X(92)90230-5, 10.1016/0959-440x(92)90230-5]; Wiseman B, 2010, J BIOL CHEM, V285, P26662, DOI 10.1074/jbc.M110.139428; Wiseman B, 2009, J BIOL INORG CHEM, V14, P801, DOI 10.1007/s00775-009-0493-9; Yamada Y, 2002, NAT STRUCT BIOL, V9, P691, DOI 10.1038/nsb834; Yu SW, 2002, PROTEIN SCI, V11, P58, DOI 10.1110/ps.ps.09902; Yu SW, 2003, J BIOL CHEM, V278, P44121, DOI 10.1074/jbc.M304757200; Yukl ET, 2013, BIOCHEMISTRY-US, V52, P9447, DOI 10.1021/bi401441h; Zamocky M, 2001, FEBS LETT, V492, P177, DOI 10.1016/S0014-5793(01)02237-2; Zamocky M, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P7, DOI 10.1007/978-3-642-12627-7_2; Zamocky M, 2010, ARCH BIOCHEM BIOPHYS, V500, P45, DOI 10.1016/j.abb.2010.03.024; Zhang Y, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P115; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zhao XB, 2006, BIOCHEMISTRY-US, V45, P4131, DOI 10.1021/bi051967o; Zhao XB, 2004, J BIOL CHEM, V279, P7606, DOI 10.1074/jbc.M311884200; Zhao XB, 2012, J BIOL CHEM, V287, P37057, DOI 10.1074/jbc.M112.401208; Zhao XB, 2010, J AM CHEM SOC, V132, P8268, DOI 10.1021/ja103311e; Zhao XB, 2009, J BIOL CHEM, V284, P7030, DOI 10.1074/jbc.M808107200	78	10	10	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18408	18421		10.1074/jbc.M117.791202	http://dx.doi.org/10.1074/jbc.M117.791202			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28972181	Green Published, hybrid			2022-12-26	WOS:000414958100003
J	Blagoev, KB; Wilkerson, J; Burotto, M; Kim, C; Espinal-Dominguez, E; Garcia-Alfonso, P; Alimchandani, M; Miettinen, M; Blanco-Codesido, M; Fojo, T				Blagoev, Krastan B.; Wilkerson, Julia; Burotto, Mauricio; Kim, Chul; Espinal-Dominguez, Edward; Garcia-Alfonso, Pilar; Alimchandani, Meghna; Miettinen, Markku; Blanco-Codesido, Montserrat; Fojo, Tito			Neutral evolution of drug resistant colorectal cancer cell populations is independent of their KRAS status	PLOS ONE			English	Article							RESTING ENERGY-EXPENDITURE; WILD-TYPE KRAS; ACQUIRED-RESISTANCE; CLINICAL RESISTANCE; POTENTIAL MECHANISM; RAS MUTATIONS; LUNG-CANCER; CETUXIMAB; SURVIVAL; CHEMOTHERAPY	Emergence of tumor resistance to an anti-cancer therapy directed against a putative target raises several questions including: (1) do mutations in the target/pathway confer resistance? (2) Are these mutations pre-existing? (3) What is the relative fitness of cells with/without the mutation? We addressed these questions in patients with metastatic colorectal cancer (mCRC). We conducted an exhaustive review of published data to establish a median doubling time for CRCs and stained a cohort of CRCs to document mitotic indices. We analyzed published data and our own data to calculate rates of growth (g) and regression (d, decay) of tumors in patients with CRC correlating these results with the detection of circulating MT-KRAS DNA. Additionally we estimated mathematically the caloric burden of such tumors using data on mitotic and apoptotic indices. We conclude outgrowth of cells harboring intrinsic or acquired MT-KRAS cannot explain resistance to anti-EGFR (epidermal growth factor receptor) antibodies. Rates of tumor growth with panitumumab are unaffected by presence/absence of MT-KRAS. While MT-KRAS cells may be resistant to anti-EGFR antibodies, WT-KRAS cells also rapidly bypass this blockade suggesting inherent resistance mechanisms are responsible and a neutral evolution model is most appropriate. Using the above clinical data on tumor doubling times and mitotic and apoptotic indices we estimated the caloric intake required to support tumor growth and suggest it may explain in part cancer-associated cachexia.	[Blagoev, Krastan B.] Natl Sci Fdn, Phys Living Syst, 4201 Wilson Blvd, Arlington, VA 22230 USA; [Blagoev, Krastan B.] Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21218 USA; [Wilkerson, Julia] NCI, Med Oncol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Burotto, Mauricio] Clin Alemana Santiago, Dept Oncol, Santiago, Chile; [Espinal-Dominguez, Edward; Garcia-Alfonso, Pilar; Blanco-Codesido, Montserrat] Gregorio Maranon Univ Hosp, Dept Oncol Med, Madrid, Spain; [Alimchandani, Meghna] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Miettinen, Markku] NCI, Lab Pathol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Fojo, Tito] Columbia Univ, New York & James J Peters VA Med Ctr, Dept Med, Div Hematol & Oncol, Bronx, NY USA	National Science Foundation (NSF); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Clinica Alemana; General University Gregorio Maranon Hospital; US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Columbia University	Blagoev, KB (corresponding author), Natl Sci Fdn, Phys Living Syst, 4201 Wilson Blvd, Arlington, VA 22230 USA.; Blagoev, KB (corresponding author), Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21218 USA.	krastanb@gmail.com			National Science Foundation; National Cancer Institute; National Institutes of Health; Gregorio Maranon University Hospital	National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gregorio Maranon University Hospital	The National Science Foundation supported the work of K. B. Blagoev. Mauricio Burotto, Julia Wilkerson, Chul Kim, Meghna Alimchandani, Markku Miettinen, and Tito Fojo all were supported by the intramural programs of the National Cancer Institute and the National Institutes of Health. Edward Espinal-Dominguez, Pilar Garcia-Alfonso and Montserrat Blanco-Codesido received support from Gregorio Maranon University Hospital.; K. B. Blagoev would like to thank Herbert Levine for valuable discussions. The National Science Foundation supported the work of K. B. Blagoev. Mauricio Burotto, Julia Wilkerson, Chul Kim, Meghna Alimchandani, Markku Miettinen, and Tito Fojo all were supported by the intramural programs of the National Cancer Institute and the National Institutes of Health. Edward Espinal-Dominguez, Pilar Garcia-Alfonso and Montserrat Blanco-Codesido received support from Gregorio Maranon University Hospital. The National Science Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views presented here are not those of the National Science Foundation and represent solely the views of the authors.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; [Anonymous], 2014, ATLAS CLIN NUCL MED; [Anonymous], 2014, MOL BIOL CELL; Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Bosaeus I, 2002, J NUTR, V132, p3465S, DOI 10.1093/jn/132.11.3465S; Buczek M, 2014, BBA-REV CANCER, V1845, P31, DOI 10.1016/j.bbcan.2013.10.001; Cao DX, 2010, CLIN NUTR, V29, P72, DOI 10.1016/j.clnu.2009.07.001; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; EVANS WK, 1985, CANCER RES, V45, P3347; FALCONER JS, 1994, ANN SURG, V219, P325, DOI 10.1097/00000658-199404000-00001; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FREDRIX EWHM, 1991, CANCER, V68, P1616, DOI 10.1002/1097-0142(19911001)68:7<1616::AID-CNCR2820680725>3.0.CO;2-3; Fredrix EWHM, 1997, CANCER, V79, P717, DOI 10.1002/(SICI)1097-0142(19970215)79:4<717::AID-CNCR8>3.0.CO;2-A; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hegedus C, 2009, BRIT J PHARMACOL, V158, P1153, DOI 10.1111/j.1476-5381.2009.00383.x; Ignac Fogelman, 2014, ATLAS CLIN NUCL MED; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lieffers JR, 2009, AM J CLIN NUTR, V89, P1173, DOI 10.3945/ajcn.2008.27273; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Liu J, 2016, ADV CANCER RES, V130, P1, DOI 10.1016/bs.acr.2016.01.005; Maughan TS, 2011, LANCET, V377, P2103, DOI 10.1016/S0140-6736(11)60613-2; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schwartzberg LS, 2014, J CLIN ONCOL, V32, P2240, DOI 10.1200/JCO.2013.53.2473; Sinicrope FA, 1999, CLIN CANCER RES, V5, P1793; Soini Y, 1998, AM J PATHOL, V153, P1041, DOI 10.1016/S0002-9440(10)65649-0; Stein WD, 2008, ONCOLOGIST, V13, P1046, DOI 10.1634/theoncologist.2008-0075; Stein WD, 2008, ONCOLOGIST, V13, P1055, DOI 10.1634/theoncologist.2008-0016; Stein WD, 2012, CLIN CANCER RES, V18, P2374, DOI 10.1158/1078-0432.CCR-11-2275; Stein WD, 2011, CLIN CANCER RES, V17, P907, DOI 10.1158/1078-0432.CCR-10-1762; Takezawa K, 2012, CANCER DISCOV, V2, P922, DOI 10.1158/2159-8290.CD-12-0108; Tejpar S, 2012, J CLIN ONCOL, V30, P3570, DOI 10.1200/JCO.2012.42.2592; Valverde A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131363; VANDENBREKEL AJS, 1995, J CLIN ONCOL, V13, P2600, DOI 10.1200/JCO.1995.13.10.2600; von Bubnoff N, 2002, LANCET, V359, P487, DOI 10.1016/S0140-6736(02)07679-1; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047	42	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0175484	10.1371/journal.pone.0175484	http://dx.doi.org/10.1371/journal.pone.0175484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981524	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300001
J	Gluge, J; Steinlin, C; Schalles, S; Wegmann, L; Tremp, J; Breivik, K; Hungerbuhler, K; Bogdal, C				Gluge, Juliane; Steinlin, Christine; Schalles, Simone; Wegmann, Lukas; Tremp, Josef; Breivik, Knut; Hungerbuhler, Konrad; Bogdal, Christian			Import, use, and emissions of PCBs in Switzerland from 1930 to 2100	PLOS ONE			English	Article							POLYCHLORINATED-BIPHENYLS PCBS; TOXIC EQUIVALENCY FACTORS; JOINT SEALANTS; MODEL; INVENTORY; AIR; UNCERTAINTY; PROPAGATION; VARIABILITY; ENVIRONMENT	Polychlorinated biphenyls (PCBs) are persistent organic compounds that are ubiquitously found in the environment. Their use and manufacture were restricted or banned in many countries in the 1970-1980s, however, they still persist in the antroposphere, the environment and in biota worldwide today. Conventions like the Convention on Long-range Transboundary Air Pollution encourage or bind the member parties to annually submit emission inventories of regulated air pollutants. Unfortunately, several member states have not yet reported PCB emissions. The identification and quantification of stocks and emissions sources is, however, an important precondition to handle and remove the remaining reservoirs of PCBs and, thus, to be able to reduce emissions and subsequently environmental exposure. Here, we estimate past, present, and future emissions of PCBs to air in Switzerland and provide emission factors for all relevant emission categories. Switzerland hereby represents a typical developed industrial country, and most of the assumptions and parameters presented here can be used to calculate PCB emission also for other countries. PCB emissions to air are calculated using a dynamic mass flow and emissions model for Switzerland, which is run for the years 1930-2100. The results point out the importance of the use of PCBs in open applications, which have largely been previously overlooked. Additionally, we show that PCBs will persist in applications during the coming decades with ongoing emissions. Especially the use of PCBs in open applications will cause Swiss emissions to remain above 100 kg PCB per year, even after the year 2030. Our developed model is available in Excel/VBA and can be downloaded with this article.	[Gluge, Juliane; Steinlin, Christine; Schalles, Simone; Hungerbuhler, Konrad; Bogdal, Christian] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Chem & Bioengn, Zurich, Switzerland; [Wegmann, Lukas] Off Environm Protect & Energy Canton Basel Countr, Liestal, Switzerland; [Tremp, Josef] Fed Off Environm, Ind Chem Sect, Bern, Switzerland; [Breivik, Knut] NILU Norwegian Inst Air Res, Kjeller, Norway; [Breivik, Knut] Univ Oslo, Dept Chem, Oslo, Norway; [Steinlin, Christine] EBP Schweiz AG, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Norwegian Institute for Air Research; University of Oslo	Gluge, J; Bogdal, C (corresponding author), Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Chem & Bioengn, Zurich, Switzerland.	juliane.gluege@chem.ethz.ch; christian.bogdal@chem.ethz.ch	Breivik, Knut/D-2311-2011	Breivik, Knut/0000-0003-1112-1900	Research Council of Norway [244298]; Carbotech AG;  [00.0009.PZ / P121-2329]	Research Council of Norway(Research Council of Norway); Carbotech AG; 	The BAFU is acknowledged for the project funding (Grant 00.0009.PZ / P121-2329). KB was supported by the Research Council of Norway (244298).; We thank Sabine Schenker, Andre Hauser, Andreas M. Buser, Christiane Wermeille (BAFU), Roland Weber (POPs Environmental Consulting), and Carbotech AG for supporting this work with helpful comments. We also thank Justin M. Boucher (ETH Zurich) for proof-reading the manuscript, Markus Zennegg (Empa Dubendorf) for providing the sewage sludge data, and Pascal S. Diefenbacher (previously ETH Zurich, currently Arcadis Switzerland) for the initial support of this project.	Abbasi G, 2015, ENVIRON SCI TECHNOL, V49, P1521, DOI 10.1021/es504007v; [Anonymous], 1988, SCHRIFT UMW; Arnet R, 2011, KONDENSATOREN VERZEI; Barghoorn M, 1988, ABSCHLUSSBERICHT FOR; Bogdal C, 2017, ENVIRON POLLUT, V220, P891, DOI 10.1016/j.envpol.2016.10.073; Bogdal C, 2014, ENVIRON SCI TECHNOL, V48, P482, DOI 10.1021/es4044352; Bogdal C, 2010, ENVIRON SCI TECHNOL, V44, P4063, DOI 10.1021/es903007h; Breivik K, 2002, SCI TOTAL ENVIRON, V290, P199, DOI 10.1016/S0048-9697(01)01076-2; BREIVIK K, 2002, EMISSIONS SCI TOTAL, V290, P296, DOI DOI 10.1016/S0048-9697(01)01075-0; Breivik K, 2007, SCI TOTAL ENVIRON, V377, P296, DOI 10.1016/j.scitotenv.2007.02.026; BUWAL, 1994, DIFF QUELL PCB SCHWE; BUWAL, 1984, SCHRIFT UMW; BUWAL, 2003, RICHTL PCB HALT FUG; BUWAL, 2000, PRAX PCB EM BEIM KOR; Cui S, 2015, SCI TOTAL ENVIRON, V533, P247, DOI 10.1016/j.scitotenv.2015.06.144; Davis J, 2007, RESOUR CONSERV RECY, V51, P118, DOI 10.1016/j.resconrec.2006.08.007; de Voogt P., 1989, PRODUCTION PROPERTIE; Diefenbacher PS, 2016, ENVIRON SCI TECHNOL, V50, P232, DOI 10.1021/acs.est.5b04626; Diefenbacher PS, 2015, ENVIRON SCI TECHNOL, V49, P2199, DOI 10.1021/es505242d; EEA, 2016, EMEP EEA AIR POLL EM, P19; Erickson MD, 2011, ENVIRON SCI POLLUT R, V18, P135, DOI 10.1007/s11356-010-0392-1; Flisak M, 2005, J ENV SCI HEAL A, V40, P43; FOEN, 2016, PAINTS VARN; FOEN, 2015, SWITZ INF INV REP 20; Frame GM, 1996, HRC-J HIGH RES CHROM, V19, P657; Gluge J, 2016, SCI TOTAL ENVIRON, V550, P1152, DOI 10.1016/j.scitotenv.2016.01.097; Grontmij, 2013, SURV PCB MAT IND AIR; Halse AK, 2011, ATMOS CHEM PHYS, V11, P1549, DOI 10.5194/acp-11-1549-2011; HARRAD SJ, 1994, ENVIRON POLLUT, V85, P131, DOI 10.1016/0269-7491(94)90079-5; Hauser A., 2014, THESENPAPIER ENTSORG; Helton JC, 2003, RELIAB ENG SYST SAFE, V81, P23, DOI 10.1016/S0951-8320(03)00058-9; Hu DF, 2010, ENVIRON SCI TECHNOL, V44, P2822, DOI 10.1021/es902413k; Ifeu, 1998, 98115 UBAFB IFEU; Jepson PD, 2016, SCIENCE, V352, P1388, DOI 10.1126/science.aaf9075; Jepson PD, 2016, SCI REP-UK, V6, DOI 10.1038/srep18573; Kohler M, 2005, ENVIRON SCI TECHNOL, V39, P1967, DOI 10.1021/es048632z; Kuhn E, 1998, PCB VORSCHALTGERATEN; Li YF, 2010, ENVIRON SCI TECHNOL, V44, P2784, DOI 10.1021/es901871e; LRTAP, 1979, CONV LONG RANG TRANS; Mackay D., 2006, HDB PHYS PROP ENV FA; Macleod M, 2005, ENVIRON SCI TECHNOL, V39, P6749, DOI 10.1021/es048426r; MacLeod M, 2002, ENVIRON TOXICOL CHEM, V21, P700, DOI 10.1002/etc.5620210403; SRF, 2013, LETZT COR; Steinlin C, 2015, ENVIRON SCI TECHNOL, V49, P14092, DOI 10.1021/acs.est.5b03304; Steinlin C, 2014, ENVIRON SCI TECHNOL, V48, P7849, DOI 10.1021/es501793h; Takasuga T., 1996, ORGANOHALOGEN COMPOU, V27, P391; Tremp J, 2001, ARBEITSEXEMPLAR SCHR; Ubl S, 2012, ATMOS ENVIRON, V62, P391, DOI 10.1016/j.atmosenv.2012.07.061; UNECE, 2009, 1998 PROT PERS ORG P; UNECE, 2009, ECEEBAIR97 UNECE; UNECE, 2015, REP EM PROJ DAT CONV; UNECE, 1998, PROT 1979 CONV LONG; Van den Berg M, 1998, ENVIRON HEALTH PERSP, V106, P775, DOI 10.1289/ehp.98106775; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Wermeille C., 2016, COMMUNICATION, V2016; Wohrnschimmel H, 2016, ENVIRON POLLUT, V217, P149, DOI 10.1016/j.envpol.2016.01.090	56	11	11	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0183768	10.1371/journal.pone.0183768	http://dx.doi.org/10.1371/journal.pone.0183768			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981534	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300004
J	Oueslati, A; Salhi-Hannachi, A; Luro, F; Vignes, H; Mournet, P; Ollitrault, P				Oueslati, Amel; Salhi-Hannachi, Amel; Luro, Francois; Vignes, Helene; Mournet, Pierre; Ollitrault, Patrick			Genotyping by sequencing reveals the interspecific C. maxima / C. reticulata admixture along the genomes of modern citrus varieties of mandarins, tangors, tangelos, orangelos and grapefruits	PLOS ONE			English	Article							CHEMICAL VARIABILITY; CULTIVATED CITRUS; GENETIC DIVERSITY; ORIGIN; NUCLEAR; DENSITY; HISTORY; DOMESTICATION; TOLERANCE; DISCOVERY	The mandarin horticultural group is an important component of world citrus production for the fresh fruit market. This group formerly classified as C. reticulata is highly polymorphic and recent molecular studies have suggested that numerous cultivated mandarins were introgressed by C. maxima (the pummelos). C. maxima and C. reticulata are also the ancestors of sweet and sour oranges, grapefruit, and therefore of all the "small citrus" modern varieties (mandarins, tangors, tangelos) derived from sexual hybridization between these horticultural groups. Recently, NGS technologies have greatly modified how plant evolution and genomic structure are analyzed, moving from phylogenetics to phylogenomics. The objective of this work was to develop a workflow for phylogenomic inference from Genotyping By Sequencing (GBS) data and to analyze the interspecific admixture along the nine citrus chromosomes for horticultural groups and recent varieties resulting from the combination of the C. reticulata and C. maxima gene pools. A GBS library was established from 55 citrus varieties, using the ApekI restriction enzyme and selective PCR to improve the read depth. Diagnostic polymorphisms (DPs) of C. reticulata/C. maxima differentiation were identified and used to decipher the phylogenomic structure of the 55 varieties. The GBS approach was powerful and revealed 30,289 SNPs and 8,794 Indels with 12.6% of missing data. 11,133 DPs were selected covering the nine chromosomes with a higher density in genic regions. GBS combined with the detection of DPs was powerful for deciphering the "phylogenomic karyotypes" of cultivars derived from admixture of the two ancestral species after a limited number of interspecific recombinations. All the mandarins, mandarin hybrids, tangelos and tangors analyzed displayed introgression of C. maxima in different parts of the genome. C. reticulata/C. maxima admixture should be a major component of the high phenotypic variability of this germplasm opening up the way for association studies based on phylogenomics.	[Oueslati, Amel; Salhi-Hannachi, Amel] Univ Tunis El Manar, FST, Lab Genet Mol Immunol & Biotechnol, Tunis, Tunisia; [Oueslati, Amel; Ollitrault, Patrick] Ctr Cooperat Int Rech Agronom Dev Petit Bourg, AGAP Res Unit, Petit Bourg, Guadeloupe, France; [Luro, Francois] Inst Natl Rech Agronom, AGAPRes Unit, San Giuliano, France; [Vignes, Helene; Mournet, Pierre] Ctr Cooperat Int Rech Agronom Dev, AGAP Res Unit, Montpellier, France	Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); INRAE; CIRAD	Ollitrault, P (corresponding author), Ctr Cooperat Int Rech Agronom Dev Petit Bourg, AGAP Res Unit, Petit Bourg, Guadeloupe, France.	patrick.ollitrault@cirad.fr		Mournet, Pierre/0000-0001-8011-8647; SALHI HANNACHI, Amel/0000-0003-1874-4713; Ollitrault, Patrick/0000-0002-9456-5517	CIRAD; Tunisian Ministry for Higher Education and Scientific Research; ED STVST of El Manar University in Tunis, Tunisia	CIRAD; Tunisian Ministry for Higher Education and Scientific Research; ED STVST of El Manar University in Tunis, Tunisia	This work was supported by CIRAD and a grant from the Tunisian Ministry for Higher Education and Scientific Research and ED STVST of El Manar University in Tunis, Tunisia atributed to Dr AO for an international visit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert Wu G, 2017, W146 P PLANT AN GEN, P1; Aleza P, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0464-y; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barkley NA, 2006, THEOR APPL GENET, V112, P1519, DOI 10.1007/s00122-006-0255-9; Barrett H. C., 1976, Systematic Botany, V1, P105, DOI 10.2307/2418763; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Beissinger TM, 2013, GENETICS, V193, P1073, DOI 10.1534/genetics.112.147710; Ben Yahmed J, 2015, SCI HORTIC-AMSTERDAM, V191, P90, DOI 10.1016/j.scienta.2015.05.005; Bernet GP, 2010, MOL BREEDING, V25, P659, DOI 10.1007/s11032-009-9363-y; Cornille A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002703; Curk F., 2014, THESIS; Curk F, 2016, ANN BOT-LONDON, V117, P565, DOI 10.1093/aob/mcw005; Curk F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125628; Curk F, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0152-1; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Davey JW, 2011, BRIEF FUNCT GENOMICS, V10, P108, DOI 10.1093/bfgp/elr007; de Moraes AP, 2007, CHROMOSOME RES, V15, P115, DOI 10.1007/s10577-006-1101-2; Dugrand-Judek A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142757; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fanciullino AL, 2006, FLAVOUR FRAG J, V21, P359, DOI 10.1002/ffj.1658; Fanciullino AL, 2006, J AGR FOOD CHEM, V54, P4397, DOI 10.1021/jf0526644; Fujii H, 2016, BREEDING SCI, V66, P683, DOI 10.1270/jsbbs.16060; Fujii H, 2013, TREE GENET GENOMES, V9, P145, DOI 10.1007/s11295-012-0542-3; Garcia-Lor A, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0951-1; Garcia-Lor A, 2013, ANN BOT-LONDON, V111, P1, DOI 10.1093/aob/mcs227; Garcia-Lor A, 2012, MOL GENET GENOMICS, V287, P77, DOI 10.1007/s00438-011-0658-4; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Ipek A, 2016, BIOCHEM GENET, V54, P313, DOI 10.1007/s10528-016-9721-5; Koehler-Santos P, 2003, PESQUI AGROPECU BRAS, V38, P797, DOI 10.1590/S0100-204X2003000700003; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lota ML, 2000, BIOCHEM SYST ECOL, V28, P61, DOI 10.1016/S0305-1978(99)00036-8; Ma XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033821; Mabberley D. J., 1997, Telopea, V7, P167; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Montero-Pau J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3439-y; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nicolosi E, 2000, THEOR APPL GENET, V100, P1155, DOI 10.1007/s001220051419; Ollitrault P, 2016, INT CITR C 2016 SEP, P126; Ollitrault Patrick, 2003, P193; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-593; Ollitrault P, 2012, HANDB PLANT BREED, V8, P623, DOI 10.1007/978-1-4419-0763-9_16; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-13; Perrier X., 2006, DARWIN SOFTWARE; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Petr D, 2011, BIOINFORMATICS; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Ramadugu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068410; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schilling MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095292; SCORA RW, 1975, B TORREY BOT CLUB, V102, P369, DOI 10.2307/2484763; Shimizu T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166969; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Stover E, 2015, ACTA HORTIC, V1065, P899; Swingle W T, 1967, CITRUS IND, P190; Tanaka T, 1954, SPECIES PROBLEM CITR, P152; Terol J., 2012, 12 INT CITR C VAL SP, V61; Wang JP, 2016, G3-GENES GENOM GENET, V6, P1417, DOI 10.1534/g3.116.026971; Ward JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-2; Webber H.J., 1967, CITRUS IND, V1, P1; Webber HJ, 1943, CITRUS IND, V1, P475; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Yamamoto M, 2003, EUPHYTICA, V129, P267, DOI 10.1023/A:1022284908424	66	32	32	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185618	10.1371/journal.pone.0185618	http://dx.doi.org/10.1371/journal.pone.0185618			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982157	gold, Green Published, Green Submitted			2022-12-26	WOS:000412360300048
J	Revuz, S; Decullier, E; Ginon, I; Lamblin, N; Hatron, PY; Kaminsky, P; Carette, MF; Lacombe, P; Simon, AC; Riviere, S; Harle, JR; Fraisse, A; Lavigne, C; Leguy-Seguin, V; Chaouat, A; Khouatra, C; Dupuis-Girod, S; Hachulla, E				Revuz, Sabine; Decullier, Evelyne; Ginon, Isabelle; Lamblin, Nicolas; Hatron, Pierre-Yves; Kaminsky, Pierre; Carette, Marie-France; Lacombe, Pascal; Simon, Anne-Claire; Riviere, Sophie; Harle, Jean-Robert; Fraisse, Alain; Lavigne, Christian; Leguy-Seguin, Vanessa; Chaouat, Ari; Khouatra, Chahera; Dupuis-Girod, Sophie; Hachulla, Eric			Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probability	PLOS ONE			English	Article							HEPATIC VASCULAR MALFORMATIONS; SICKLE-CELL-DISEASE; ARTERIAL-HYPERTENSION; SYSTOLIC PRESSURE; MUTATIONS; PATIENT; MANIFESTATIONS; PREVALENCE; ENDOGLIN; THERAPY	Background Different pulmonary hypertension (PH) mechanisms are associated with hereditary haemorrhagic telangiectasia (HHT). Methods and results We conducted a retrospective study of all suspected cases of PH (echocardiographically estimated systolic pulmonary artery pressure [sPAP] >= 40 mmHg) in patients with definite HHT recorded in the French National Reference Centre for HHT database. When right heart catheterization (RHC) was performed, PH cases were confirmed and classified among the PH groups according to the European guidelines. Among 2,598 patients in the database, 110 (4.2%) had suspected PH. Forty-seven of these 110 patients had RHC: 38/47 (81%) had a confirmed diagnosis of PH. The majority of these had isolated post-capillary PH (n = 20). We identified for the first time other haemodynamic profiles: pre-capillary pulmonary arterial hypertension (PAH) cases (n = 3) with slightly raised pulmonary vascular resistances (PVR), and combined post- and pre-capillary PH cases (n = 4). Compared to controls, survival probability was lower in patients with PAH. Conclusion This study revealed the diversity of PH mechanisms in HHT. The description of combined post- and pre-capillary PH with/or without high cardiac output (CO) suggests either a continuum between the pre- and post-capillary haemodynamic profiles or a different course in response to high CO.	[Revuz, Sabine; Hatron, Pierre-Yves] CHU Brabois, Dept Med Interne, Vandoeuvre Les Nancy, France; [Revuz, Sabine; Hatron, Pierre-Yves] CHU Brabois, Immunol Clin, Vandoeuvre Les Nancy, France; [Decullier, Evelyne] Hosp Civils Lyon, Pole IMER, Lyon, France; [Ginon, Isabelle] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Serv Explorat Cardiol, Lyon, France; [Lamblin, Nicolas] Univ Lille, CHRU Lille, Serv Cardiol, Lille, France; [Hatron, Pierre-Yves; Hachulla, Eric] Univ Lille, CHRU Lille, Serv Med Interne, Lille, France; [Carette, Marie-France] Hop Tenon, AP HP, Serv Radiol, Paris, France; [Lacombe, Pascal] Hop Ambroise Pare, AP HP, Serv Imagerie Diagnost & Intervent, Boulogne, France; [Simon, Anne-Claire] CHU Poitiers, Serv Pneumol, Poitiers, France; [Riviere, Sophie] CHU Montpellier, Serv Med interne, Montpellier, France; [Harle, Jean-Robert] CHU Marseille, Hop Concept, Serv Med Interne, Marseille, France; [Fraisse, Alain] Royal Brompton & Harefield Hosp Trust, Paediat Cardiol Serv, London, England; [Lavigne, Christian] CHU Angers, Serv Med Interne & Malad Vasc, Angers, France; [Leguy-Seguin, Vanessa] CHU Dijon, Serv Med Interne, Dijon, France; [Leguy-Seguin, Vanessa] CHU Dijon, Immunol Clin, Dijon, France; [Chaouat, Ari] CHU Brabois, Dept Pneumol, Vandoeuvre Les Nancy, France; [Khouatra, Chahera] Hosp Civils Lyon, Hop Louis Pradel, Serv Pneumol, Bron, France; [Dupuis-Girod, Sophie] Hosp Civils Lyon, Hop Louis Pradel, Serv Genet, Bron, France; [Dupuis-Girod, Sophie] Hosp Civils Lyon, Hop Louis Pradel, Ctr Reference Maladie Rendu Osler, Bron, France	CHU de Nancy; CHU de Nancy; CHU Lyon; CHU Lyon; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; CHU Poitiers; Universite de Poitiers; Universite de Montpellier; CHU de Montpellier; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU de Nancy; CHU Lyon; CHU Lyon; CHU Lyon	Revuz, S (corresponding author), CHU Brabois, Dept Med Interne, Vandoeuvre Les Nancy, France.; Revuz, S (corresponding author), CHU Brabois, Immunol Clin, Vandoeuvre Les Nancy, France.	s.revuz@chru-nancy.fr	Chaouat, Ari/AAP-9249-2021; Chaouat, Ari/AAP-6784-2021; Dupuis-Girod, Sophie/D-6268-2014; HACHULLA, ERIC/R-8488-2018; decullier, evelyne/AAL-5861-2021	Chaouat, Ari/0000-0001-6056-202X; HACHULLA, ERIC/0000-0001-7432-847X; LAMBLIN, NICOLAS/0000-0003-3754-1241; Revuz, Sabine/0000-0001-8421-912X				Abdalla SA, 2006, J MED GENET, V43, P97, DOI 10.1136/jmg.2005.030833; Abdalla SA, 2004, EUR RESPIR J, V23, P373, DOI 10.1183/09031936.04.00085504; Armstrong DWJ, 2010, CAN J CARDIOL, V26, pE35, DOI 10.1016/S0828-282X(10)70004-0; Ayala E, 2012, CHEST, V141, P1598, DOI 10.1378/chest.11-1402; Bayrak-Toydemir P, 2006, AM J MED GENET A, V140A, P463, DOI 10.1002/ajmg.a.31101; Bhuachalla CFN, 2010, RESP MED, V104, P1218, DOI 10.1016/j.rmed.2010.03.003; Bonderman D, 2006, EUR J CLIN INVEST, V36, P71, DOI 10.1111/j.1365-2362.2006.01683.x; Buscarini E, 2004, ULTRASCHALL MED, V25, P348, DOI 10.1055/s-2004-813549; Chakinala M, 2010, PATHLIGHT        WIN, P20; Chang SA, 2011, HEART VESSELS, V26, P231, DOI 10.1007/s00380-010-0079-z; Chaouat A, 2004, THORAX, V59, P446, DOI 10.1136/thx.2003.11890; Chen YJ, 2013, EUR J CLIN INVEST, V43, P1016, DOI 10.1111/eci.12138; Coghlan JG, 2014, ANN RHEUM DIS, V73, P1340, DOI 10.1136/annrheumdis-2013-203301; Cottin V, 2007, RESPIRATION, V74, P361, DOI 10.1159/000103205; Dupuis-Girod S, 2012, JAMA-J AM MED ASSOC, V307, P948, DOI 10.1001/jama.2012.250; Dupuis-Girod S, 2010, LIVER TRANSPLANT, V16, P340, DOI 10.1002/lt.21990; Faughnan ME, 2011, J MED GENET, V48, P73, DOI 10.1136/jmg.2009.069013; Faughnan ME, 2009, EUR RESPIR J, V33, P1186, DOI 10.1183/09031936.00061308; Garcia-Tsao G, 2000, NEW ENGL J MED, V343, P931, DOI 10.1056/NEJM200009283431305; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; Gincul R, 2008, HEPATOLOGY, V48, P1570, DOI 10.1002/hep.22514; Ginon I, 2013, EUR J INTERN MED, V24, pE35, DOI 10.1016/j.ejim.2012.12.013; Girerd B, 2010, AM J RESP CRIT CARE, V181, P851, DOI 10.1164/rccm.200908-1284OC; Harrison RE, 2005, CIRCULATION, V111, P435, DOI 10.1161/01.CIR.0000153798.78540.87; Harrison RE, 2003, J MED GENET, V40, P865, DOI 10.1136/jmg.40.12.865; Hayes Margaret M, 2014, Ann Am Thorac Soc, V11, P1488, DOI 10.1513/AnnalsATS.201408-405CME; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Humbert N, 2015, EUR RESPIR J; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kovacs G, 2009, EUR RESPIR J, V34, P888, DOI 10.1183/09031936.00145608; Lyle MA, 2016, CHEST, V149, P362, DOI 10.1378/chest.15-0535; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Olivieri C, 2006, GENET MED, V8, P183, DOI 10.1097/01.gim.0000204463.77319.1c; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565; PLAUCHU H, 1989, AM J MED GENET, V32, P291, DOI 10.1002/ajmg.1320320302; Pousada G, 2015, MED CLIN-BARCELONA, V144, P261, DOI 10.1016/j.medcli.2014.09.024; Rozenberg D, 2015, RESP MED, V109, P768, DOI 10.1016/j.rmed.2015.04.003; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Shovlin CL, 2014, AM J RESP CRIT CARE, V190, P1217, DOI 10.1164/rccm.201407-1254CI; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; Sitbon O, 2008, AM J RESP CRIT CARE, V177, P108, DOI 10.1164/rccm.200704-541OC; Sopena B, 2013, EUR J INTERN MED, V24, pE30, DOI 10.1016/j.ejim.2012.11.012; Trembath RC, 2001, NEW ENGL J MED, V345, P325, DOI 10.1056/NEJM200108023450503; Vorselaars VMM, 2015, WORLD J CARDIOL, V7, P230, DOI 10.4330/wjc.v7.i5.230	44	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184227	10.1371/journal.pone.0184227	http://dx.doi.org/10.1371/journal.pone.0184227			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981519	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300010
J	Teimoury, E; Jabbarzadeh, A; Babaei, M				Teimoury, Ebrahim; Jabbarzadeh, Armin; Babaei, Mohammadhosein			Integrating strategic and tactical decisions in livestock supply chain using bi-level programming, case study: Iran poultry supply chain	PLOS ONE			English	Article							PERISHABLE PRODUCTS; INVENTORY; OPTIONS; MODELS	Inventory management has frequently been targeted by researchers as one of the most pivotal problems in supply chain management. With the expansion of research studies on inventory management in supply chains, perishable inventory has been introduced and its fundamental differences from non-perishable inventory have been emphasized. This article presents livestock as a type of inventory that has been less studied in the literature. Differences between different inventory types, affect various levels of strategic, tactical and operational decision-making. In most articles, different levels of decision-making are discussed independently and sequentially. In this paper, not only is the livestock inventory introduced, but also a model has been developed to integrate decisions across different levels of decision-making using bi-level programming. Computational results indicate that the proposed bi-level approach is more efficient than the sequential decision-making approach.	[Teimoury, Ebrahim; Jabbarzadeh, Armin; Babaei, Mohammadhosein] Univ Sci & Technol, Dept Ind Engn, Tehran, Iran		Teimoury, E (corresponding author), Univ Sci & Technol, Dept Ind Engn, Tehran, Iran.	teimoury@iust.ac.ir	jabbarzadeh, armin/S-8809-2018; Teimoury, Ebrahim/S-8806-2018	Teimoury, Ebrahim/0000-0003-3083-1609				Baky IA, 2010, APPL MATH MODEL, V34, P2377, DOI 10.1016/j.apm.2009.11.004; Barge P, 2013, CANADIAN J ANIMAL SC, V93; Blackburn J, 2009, PROD OPER MANAG, V18, P129, DOI 10.1111/j.1937-5956.2009.01016.x; Cho G-S, 2013, INT J IND ENG, V20; Colson B., 2005, 4OR-Q J OPER RES, V3, P87, DOI DOI 10.1007/S10288-005-0071-0; Dreyer HC, 2016, PRODUCTION PLANNING, P1; Goliomytis M, 2003, POULTRY SCI, V82, P1061, DOI 10.1093/ps/82.7.1061; Heft-Neal S., 2008, SUPPLY CHAIN AUDITIN; Ifft J., 2008, POULTRY SUPPLY CHAIN; Kim H, 2014, SCI WORLD J, DOI 10.1155/2014/683045; Lapar ML, 2003, FOOD POLICY, V28, P187, DOI 10.1016/S0306-9192(03)00017-4; Liang WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139558; Manning L., 2004, British Food Journal, V106, P819, DOI 10.1108/00070700410561414; Meindl S.C., 2013, SUPPLY CHAIN MANAGEM; Mohamed Z, 2013, INT C SOC RES; Mohan Usha, 2009, International Journal of Logistics Systems and Management, V5, P89, DOI 10.1504/IJLSM.2009.021646; Napel Jt, 2011, LIVEST SCI, V139, P150; Pan FB, 2016, J INTERDISCIP MATH, V19, P111, DOI 10.1080/09720502.2015.1113676; Rabbani M., 2016, UNCERTAIN SUPPLY CHA, V4, P171, DOI [10.5267/j.uscm.2016.3.001, DOI 10.5267/J.USCM.2016.3.001]; Rebolledo B, 2013, ATMOS ENVIRON, V64, P125, DOI 10.1016/j.atmosenv.2012.10.005; Roghanian E, 2007, APPL MATH COMPUT, V188, P786, DOI 10.1016/j.amc.2006.10.032; Sana SS, 2012, ECON MODEL, V29, P1024, DOI 10.1016/j.econmod.2012.03.010; Sarker BR, 2000, COMPUT OPER RES, V27, P59, DOI 10.1016/S0305-0548(99)00008-8; Sauian MS, 2012, INT C STAT SCI BUS E; Shamsuddoha M., 2009, INTEGRATING FORWARD; Shamsuddoha M., 2013, ECOFORUM J, V2, P7; Shoushtari KD, 2011, 55 ANN M ISSS; Song BD, 2016, J FOOD ENG, V169, P61, DOI 10.1016/j.jfoodeng.2015.08.027; Soysal M, 2014, INT J PROD ECON, V152, P57, DOI 10.1016/j.ijpe.2013.12.012; Stehfest E, 2013, AGR SYST, V114, P38, DOI 10.1016/j.agsy.2012.07.002; Tsao Y-C, 2016, INT J PROD RES, P1	31	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185743	10.1371/journal.pone.0185743	http://dx.doi.org/10.1371/journal.pone.0185743			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982180	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300064
J	Wang, JY; Kollarik, M; Ru, F; Sun, H; McNeil, B; Dong, XZ; Stephens, G; Korolevich, S; Brohawn, P; Kolbeck, R; Undem, B				Wang, Jingya; Kollarik, Marian; Ru, Fei; Sun, Hui; McNeil, Benjamin; Dong, Xinzhong; Stephens, Geoffrey; Korolevich, Susana; Brohawn, Philip; Kolbeck, Roland; Undem, Bradley			Distinct and common expression of receptors for inflammatory mediators in vagal nodose versus jugular capsaicin-sensitive/TRPV1-positive neurons detected by low input RNA sequencing	PLOS ONE			English	Article							BRONCHOPULMONARY C-FIBERS; SENSORY NEURONS; AFFERENT INNERVATION; NEURAL CREST; VAGUS NERVE; BRAIN-STEM; GANGLIA; SUBTYPES; LUNG; MODULATION	Capsaicin-sensitive sensory C-fibers derived from vagal ganglia innervate the visceral organs, and respond to inflammatory mediators and noxious stimuli. These neurons play an important role in maintenance of visceral homeostasis, and contribute to the symptoms of visceral inflammatory diseases. Vagal sensory neurons are located in two ganglia, the jugular ganglia (derived from the neural crest), and the nodose ganglia (from the epibranchial placodes). The functional difference, especially in response to immune mediators, between jugular and nodose neurons is not fully understood. In this study, we microscopically isolated murine nodose and jugular capsaicin-sensitive/Trpv1-expressing C-fiber neurons and performed transcriptome profiling using ultra-low input RNA sequencing. RNAseq detected genes with significantly differential expression in jugular and nodose neurons, which were mostly involved in neural functions. Transcriptional regulators, including Cited1, Hoxb5 and Prdm12 showed distinct expression patterns in the two C-fiber neuronal populations. Common and specific expression of immune receptor proteins was characterized in each neuronal type. The expression of immune receptors that have received little or no attention from vagal sensory biologists is highlighted including receptors for certain chemokines (CXCLs), interleukins (IL-4) and interferons (IFN alpha, IFN gamma). Stimulation of immune receptors with their cognate ligands led to activation of the C-fibers in isolated functional assays.	[Wang, Jingya; Stephens, Geoffrey; Kolbeck, Roland] MedImmune LLC, Dept Resp Inflammatory & Autoimmun, Gaithersburg, MD USA; [Kollarik, Marian; Ru, Fei; Sun, Hui; Undem, Bradley] Johns Hopkins Univ, Sch Med, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD 21205 USA; [Kollarik, Marian] Comenius Univ, Jessenius Fac Med, Biomed Ctr Martin, Dept Pathophysiol, Martin, Slovakia; [McNeil, Benjamin; Dong, Xinzhong] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD USA; [Korolevich, Susana; Brohawn, Philip] MedImmune LLC, Dept Translat Med, Gaithersburg, MD USA	AstraZeneca; Medimmune; Johns Hopkins University; Comenius University Bratislava; Johns Hopkins University; Johns Hopkins Medicine; AstraZeneca; Medimmune	Undem, B (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD 21205 USA.	bundem@jhmi.edu			Johns Hopkins University [90057138]; NIH [HL137807, HL122228]; VEGA [1/0226/15];  [APVV-15-0163]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL137807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054791] Funding Source: NIH RePORTER	Johns Hopkins University(Johns Hopkins University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)European Commission); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the following: 1. BU received funding from Johns Hopkins University-Medimmune CollaborativeAgreement, # 90057138, (http://releases.jhu.edu/2013/12/11/medimmune/); 2. BU received funding from NIH HL137807 and HL122228, (www.nih.gov); 3. MK was partially supported by APVV-15-0163 and VEGA 1/0226/15 (Department of Education, Slovakia) (http://www apvv.sk/?lang=en, https://www.minedu.sk/vedecka-grantova-agentura-msvvas-sr-asav-vega/); 4. JW, SK, PB and RK are full time employees and shareholders of Medlmmune, LLC (https://www.medimmune.com/). GS has been a full time employee and shareholder of Medlmmune until recently. His current affiliation is Cellcion, LLC (http://cellcion.com/). Funding bodies did not have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the "author contributions" section.	ALTSCHULER SM, 1989, J COMP NEUROL, V283, P248, DOI 10.1002/cne.902830207; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aoyama M, 2005, CANCER RES, V65, P4587, DOI 10.1158/0008-5472.CAN-04-4630; Baker CVH, 2005, EMBRYOLOGY VAGAL SEN; BROWN L, 1992, P NATL ACAD SCI USA, V89, P8492, DOI 10.1073/pnas.89.18.8492; Canning BJ, 2004, J PHYSIOL-LONDON, V557, P543, DOI 10.1113/jphysiol.2003.057885; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; Chang RB, 2015, CELL, V161, P622, DOI 10.1016/j.cell.2015.03.022; Chen JY, 2016, NATURE, V530, P223, DOI 10.1038/nature16943; Chen YC, 2015, NAT GENET, V47, P803, DOI 10.1038/ng.3308; Chou YL, 2008, AM J PHYSIOL-REG I, V295, pR1572, DOI 10.1152/ajpregu.90382.2008; Christianson JA, 2009, BRAIN RES REV, V60, P171, DOI 10.1016/j.brainresrev.2008.12.004; Chuaychoo B, 2005, PULM PHARMACOL THER, V18, P269, DOI 10.1016/j.pupt.2004.12.010; Czaja K, 2008, NEUROSCIENCE, V154, P621, DOI 10.1016/j.neuroscience.2008.03.055; Dittmer S, 2011, J CELL SCI, V124, P252, DOI 10.1242/jcs.068759; Driessen AK, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00378; Esmailpour T, 2012, STEM CELLS, V30, P2152, DOI 10.1002/stem.1187; Foreman RD, 1999, ANNU REV PHYSIOL, V61, P143, DOI 10.1146/annurev.physiol.61.1.143; Grimm MC, 1996, GUT, V38, P90, DOI 10.1136/gut.38.1.90; Gudmundsson G, 1999, EXP LUNG RES, V25, P217; HAMILTON RB, 1987, J AUTONOM NERV SYST, V19, P153, DOI 10.1016/0165-1838(87)90008-7; Harrison TA, 1996, PEDIATR RES, V39, P90, DOI 10.1203/00006450-199601000-00013; Hayakawa T, 2011, J CHEM NEUROANAT, V41, P55, DOI 10.1016/j.jchemneu.2010.11.003; Isogai E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019297; Joshi S K, 2000, Curr Rev Pain, V4, P499; KHURANA RK, 1991, AM J ANAT, V192, P293, DOI 10.1002/aja.1001920309; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim YS, 2014, NEURON, V81, P873, DOI 10.1016/j.neuron.2013.12.011; Kollarik M, 2003, J PHYSIOL-LONDON, V551, P869, DOI 10.1113/jphysiol.2003.042028; Kollarik M, 2010, AUTON NEUROSCI-BASIC, V153, P12, DOI 10.1016/j.autneu.2009.08.001; KUMMER W, 1992, NEUROSCIENCE, V49, P715, DOI 10.1016/0306-4522(92)90239-X; Kwong K, 2008, AM J PHYSIOL-LUNG C, V295, pL858, DOI 10.1152/ajplung.90360.2008; Kwong K, 2010, J PHYSIOL-LONDON, V588, P1171, DOI 10.1113/jphysiol.2009.181669; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee LY, 2014, COMPR PHYSIOL, V4, P287, DOI 10.1002/cphy.c130020; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; LUCIER GE, 1986, BRAIN RES BULL, V16, P713, DOI 10.1016/0361-9230(86)90143-7; Maher SA, 2015, EUR RESPIR J, V45, P1108, DOI 10.1183/09031936.00061614; Mazzone SB, 2016, PHYSIOL REV, V96, P975, DOI 10.1152/physrev.00039.2015; McGovern AE, 2015, J NEUROSCI, V35, P7041, DOI 10.1523/JNEUROSCI.5128-14.2015; Miyazaki JJ, 1999, OTOLARYNG HEAD NECK, V120, P905, DOI 10.1016/S0194-5998(99)70335-9; Nassenstein C, 2010, J PHYSIOL-LONDON, V588, P4769, DOI 10.1113/jphysiol.2010.195339; Neumann H, 1997, J EXP MED, V186, P2023, DOI 10.1084/jem.186.12.2023; Peeters PJ, 2006, PHYSIOL GENOMICS, V24, P252, DOI 10.1152/physiolgenomics.00169.2005; Potenzieri C, 2012, J PHYSIOL-LONDON, V590, P5449, DOI 10.1113/jphysiol.2012.237115; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; RANDICH A, 1992, BRAIN RES REV, V17, P77, DOI 10.1016/0165-0173(92)90009-B; ROBERTS AM, 1985, J APPL PHYSIOL, V58, P1823, DOI 10.1152/jappl.1985.58.6.1823; Ru F, 2011, AM J PHYSIOL-GASTR L, V300, pG485, DOI 10.1152/ajpgi.00361.2010; SATODA T, 1995, NEUROSCI RES, V22, P381, DOI 10.1016/0168-0102(95)00918-J; Sherrington, 1906, INTEGRATIVE ACTION N; SPRINGALL DR, 1987, J AUTONOM NERV SYST, V20, P155, DOI 10.1016/0165-1838(87)90113-5; Surdenikova L, 2012, NEUROGASTROENT MOTIL, V24, pe517, DOI 10.1111/nmo.12002; Talbot S, 2015, NEURON, V87, P341, DOI 10.1016/j.neuron.2015.06.007; Trankner D, 2014, P NATL ACAD SCI USA, V111, P11515, DOI 10.1073/pnas.1411032111; Undem BJ, 2004, J PHYSIOL-LONDON, V556, P905, DOI 10.1113/jphysiol.2003.060079; UNDEM BJ, 1993, J AUTONOM NERV SYST, V44, P17, DOI 10.1016/0165-1838(93)90375-5; Wank M, 2001, J COMP NEUROL, V435, P41, DOI 10.1002/cne.1192; WEINREICH D, 1995, J PHYSIOL-LONDON, V483, P735, DOI 10.1113/jphysiol.1995.sp020618; Yang CM, 2013, CELL STRUCT FUNCT, V38, P195, DOI 10.1247/csf.13010; Yu SY, 2005, J PHYSIOL-LONDON, V563, P831, DOI 10.1113/jphysiol.2004.079574	61	36	36	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185985	10.1371/journal.pone.0185985	http://dx.doi.org/10.1371/journal.pone.0185985			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982197	Green Published, Green Submitted, gold			2022-12-26	WOS:000412360300102
J	de Farias-Martins, F; Sperber, CF; Albeny-Simoes, D; Breaux, JA; Fianco, M; Szinwelski, N				de Farias-Martins, Fernando; Sperber, Carlos Frankl; Albeny-Simoes, Daniel; Breaux, Jennifer Ann; Fianco, Marcos; Szinwelski, Neucir			Forest litter crickets prefer higher substrate moisture for oviposition: Evidence from field and lab experiments	PLOS ONE			English	Article							BODY-SIZE; PHENOTYPIC PLASTICITY; SOIL-MOISTURE; ACHETA-DOMESTICUS; BOTTOM-UP; EGG-SHELL; TRADE-OFF; TOP-DOWN; ORTHOPTERA; BEHAVIOR	For insects, choosing a favorable oviposition site is a type of parental care, as far as it increases the fitness of its offspring. Niche theory predicts that crickets should show a bellshaped oviposition response to substrate moisture. However, lab experiments with mole crickets showed a linear oviposition response to substrate moisture. Studies with the house cricket Acheta domesticus also showed a linear juvenile body growth response to water availability, thus adult ovipositing females should respond positively to substrate moisture. We used a field experiment to evaluate the relationship between oviposition preference and substrate moisture in forest litter-dwelling cricket species. We also evaluated oviposition responses to substrate moisture level in Ubiquepuella telytokous, the most abundant litter cricket species in our study area, using a laboratory study. We offered cotton substrate for oviposition which varied in substrate moisture level from zero (i.e., dry) to maximum water absorption capacity. We used two complementary metrics to evaluate oviposition preference: (i) presence or absence of eggs in each sampling unit as binary response variable, and (ii) number of eggs oviposited per sampling unit as count response variable. To test for non-linear responses, we adjusted generalized additive models (GAMM) with mixed effects. We found that both cricket oviposition probability and effort (i. e., number of eggs laid) increased linearly with substrate moisture in the field experiment, and for U. telytokous in the lab experiment. We discarded any non-linear responses. Our results demonstrate the importance of substrate moisture as an ecological niche dimension for litter crickets. This work bolsters knowledge of litter cricket life history association with moisture, and suggests that litter crickets may be particularly threatened by changes in climate that favor habitat drying.	[de Farias-Martins, Fernando; Szinwelski, Neucir] Univ Estadual Oeste Parana, Lab Orthoptera, Cascavel, Parana, Brazil; [de Farias-Martins, Fernando] Univ Estadual Oeste Parana, Programa Posgrad Conservacao & Manejo Recursos Na, Cascavel, Parana, Brazil; [Sperber, Carlos Frankl] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil; [Albeny-Simoes, Daniel; Breaux, Jennifer Ann] Univ Comunitaria Regiao Chapeco, Programa Posgrad Ciencias Ambientais, Chapeco, SC, Brazil; [Fianco, Marcos] Univ Fed Integracao Latinoamer, Inst Latinoamer Ciencias Vida & Nat, Foz Do Iguacu, Parana, Brazil	Universidade Estadual do Oeste do Parana; Universidade Estadual do Oeste do Parana; Universidade Federal de Vicosa; Universidade Comunitaria Regional de Chapeco; Universidade Federal da Integracao Latino-Americana	de Farias-Martins, F (corresponding author), Univ Estadual Oeste Parana, Lab Orthoptera, Cascavel, Parana, Brazil.; de Farias-Martins, F (corresponding author), Univ Estadual Oeste Parana, Programa Posgrad Conservacao & Manejo Recursos Na, Cascavel, Parana, Brazil.	fernandof_martins@hotmal.com	Sperber, Carlos Frankl/AAH-4443-2021; Sperber, Carlos Frankl/F-9298-2012; Breaux, Jennifer/ABG-6997-2020; Simoes, Daniel A/E-5086-2016; Szinwelski, Neucir/I-2523-2012; Fianco, Marcos/AAV-5338-2021	Sperber, Carlos Frankl/0000-0002-0334-7216; Szinwelski, Neucir/0000-0003-4049-3121; Fianco, Marcos/0000-0001-6662-6311	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [CRA-APQ-01478-11, BPD-00196-12]; CCBS UNIOESTE [11/2017]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BR); Sistema Nacional de Pesquisa em Biodiversidade (SISBIOTA-BR, CNPQ) [5653360/2010-0]; Sistema Nacional de Pesquisa em Biodiversidade (SISBIOTA-BR-FAPEMIG) [CRA-APQ-0003-11]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR) [310032/2015-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [Portaria 367/VICE-EPE/2014]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CCBS UNIOESTE; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BR); Sistema Nacional de Pesquisa em Biodiversidade (SISBIOTA-BR, CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Sistema Nacional de Pesquisa em Biodiversidade (SISBIOTA-BR-FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by the following grants: Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (CRA-APQ-01478-11; received by Dr Carlos Frankl Sperber); CCBS UNIOESTE (11/2017; received by Dr Neucir Szinwelski); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BR) (received by Fernando de Farias-Martins); Sistema Nacional de Pesquisa em Biodiversidade (SISBIOTA-BR, CNPQ) (5653360/2010-0); Sistema Nacional de Pesquisa em Biodiversidade (SISBIOTA-BR-FAPEMIG) (CRA-APQ-0003-11); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR) (310032/2015-6; received by Dr Carlos Frankl Sperber); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (BPD-00196-12; received by Dr Neucir Szinwelski); and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Portaria 367/VICE-EPE/2014; received by Dr Jennifer Ann Breaux). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KR, 2016, ANIM BEHAV, V121, P53, DOI 10.1016/j.anbehav.2016.08.012; ADAMO SA, 1995, J INSECT PHYSIOL, V41, P269, DOI 10.1016/0022-1910(94)00095-X; AE A, 2003, CAD SAUDE PUBLICA, V19, P1107; ALEXANDE.RD, 1968, Q REV BIOL, V43, P1, DOI 10.1086/405628; Alexander RD, 1957, OHIO J SCI, V57, P101; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bahia State, 2006, AN AC BRAS CIENC, V78, P59; Bang HS, 2011, J ASIA-PAC ENTOMOL, V14, P373, DOI 10.1016/j.aspen.2011.04.007; BELL PD, 1980, CAN J ZOOL, V58, P1861, DOI 10.1139/z80-254; Biron DG, 2005, P ROY SOC B-BIOL SCI, V272, P2117, DOI 10.1098/rspb.2005.3213; BLANK RH, 1988, NEW ZEAL J AGR RES, V31, P211; Boychuk EC, 2015, J INSECT PHYSIOL, V81, P157, DOI 10.1016/j.jinsphys.2015.07.015; BRADFORD MJ, 1993, OECOLOGIA, V93, P263, DOI 10.1007/BF00317680; Branson David H., 2008, Journal of Orthoptera Research, V17, P259, DOI 10.1665/1082-6467-17.2.259; Brouwers NC, 2009, J INSECT CONSERV, V13, P529, DOI 10.1007/s10841-008-9199-5; Bruggisser OT, 2012, BASIC APPL ECOL, V13, P706, DOI 10.1016/j.baae.2012.10.001; Caglar SS, 2014, INSECT SCI, V21, P213, DOI 10.1111/1744-7917.12027; Chown SL, 2011, J INSECT PHYSIOL, V57, P1070, DOI 10.1016/j.jinsphys.2011.05.004; Crawley MJ, 2013, R BOOK, P557; DESTEPHANO DB, 1982, ANN ENTOMOL SOC AM, V75, P111, DOI 10.1093/aesa/75.2.111; Desutter-Grandcolas L., 1992, BIOL ECOLOGIE ANIMAL, V14, P93; Donoughe S, 2016, DEV BIOL, V411, P140, DOI 10.1016/j.ydbio.2015.04.009; Federle W, 2002, INTEGR COMP BIOL, V42, P1100, DOI 10.1093/icb/42.6.1100; Fernandes ML, 2015, ZOOTAXA, V4032, P407, DOI 10.11646/zootaxa.4032.4.5; Filin Ido, 2008, Journal of Orthoptera Research, V17, P283, DOI 10.1665/1082-6467-17.2.283; FORREST TG, 1991, BEHAV ECOL, V2, P327, DOI 10.1093/beheco/2.4.327; FURNEAUX PJ, 1969, J CELL SCI, V5, P227; Fusco G, 2010, PHILOS T R SOC B, V365, P547, DOI 10.1098/rstb.2009.0267; Gehrken U, 1996, J INSECT PHYSIOL, V42, P483, DOI 10.1016/0022-1910(95)00128-X; Gelman A., 2007, DATA ANAL USING REGR; GHOURI A. S. K., 1958, CANADIAN ENT, V90, P158; Girard C, 2015, GLOBAL ENVIRON CHANG, V34, P132, DOI 10.1016/j.gloenvcha.2015.07.002; Gray DA, 2001, FLA ENTOMOL, V84, P314, DOI 10.2307/3496190; Green K, 2009, ANIM BEHAV, V77, P887, DOI 10.1016/j.anbehav.2008.12.017; Griffiths AJ, 2000, INTRO GENETIC ANAL, V7th; Groll M, 2016, ECOL INDIC, V61, P219, DOI 10.1016/j.ecolind.2015.09.019; Guarneri AA, 2002, PHYSIOL ENTOMOL, V27, P142, DOI 10.1046/j.1365-3032.2002.00279.x; Gwynne DT, 2001, KATYDID BUSH CRICKET; Hertl PT, 2001, ENVIRON ENTOMOL, V30, P466, DOI 10.1603/0046-225X-30.3.466; Hilker M, 2011, PHYTOCHEMISTRY, V72, P1612, DOI 10.1016/j.phytochem.2011.02.018; Hinton HE, 1981, BIOL INSECT EGGS; Hodek I, 2003, EUR J ENTOMOL, V100, P223, DOI 10.14411/eje.2003.037; Hopper KR, 1999, ANNU REV ENTOMOL, V44, P535, DOI 10.1146/annurev.ento.44.1.535; Huber F., 1989, CRICKET BEHAV NEUROB; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Ingrisch S, 1996, TROP ZOOL, V9, P431, DOI 10.1080/03946975.1996.10539321; Karagkouni M, 2016, J ZOOL SYST EVOL RES, V54, P182, DOI 10.1111/jzs.12125; Key KHL, 1979, INSECTS AUSTR, P321; Martin CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014395; McCluney KE, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3201; MCFARLAN.JE, 1970, COMP BIOCHEM PHYSIOL, V37, P133, DOI 10.1016/0010-406X(70)90540-2; Miyoshi AR, 2007, IHERINGIA SER ZOOL, V97, P461, DOI 10.1590/S0073-47212007000400016; Moriyama M, 2006, J INSECT PHYSIOL, V52, P1219, DOI 10.1016/j.jinsphys.2006.09.005; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Neto EMC, 2006, ANAIS ACAD BRASILEIR; Neto SS, MANUAL ECOLOGIA INSE; Norhisham AR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-9; Ogawa H, 2011, J INSECT PHYSIOL, V57, P326, DOI 10.1016/j.jinsphys.2010.11.021; Olalla-Tarraga MA, 2009, ECOGRAPHY, V32, P581, DOI 10.1111/j.1600-0587.2008.05632.x; Olofsson H, 2009, P ROY SOC B-BIOL SCI, V276, P2963, DOI 10.1098/rspb.2009.0500; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; PHILIPPI T, 1989, TRENDS ECOL EVOL, V4, P41, DOI 10.1016/0169-5347(89)90138-9; Pigliucci M, 2006, J EXP BIOL, V209, P2362, DOI 10.1242/jeb.02070; PLATT SA, 1988, J COMP PSYCHOL, V102, P254, DOI 10.1037/0735-7036.102.3.254; POTTER DA, 1983, ENVIRON ENTOMOL, V12, P1223, DOI 10.1093/ee/12.4.1223; Prakrash M., 2008, INSECT ECOLOGY; Qi XL, 2007, PHYSIOL ENTOMOL, V32, P219, DOI 10.1111/j.1365-3032.2007.00564.x; Randall D, 2011, ECKERT FISIOLOGIA AN, P531; Reale D, 2002, ANIM BEHAV, V64, P397, DOI 10.1006/anbe.2002.3084; Refsnider JM, 2010, ANNU REV ECOL EVOL S, V41, P39, DOI 10.1146/annurev-ecolsys-102209-144712; Reitz M, 2015, ANAL CHIM ACTA, V854, P47, DOI 10.1016/j.aca.2014.10.056; Ribas CR, 2005, ACTA OECOL, V27, P31, DOI 10.1016/j.actao.2004.08.008; Ross CL, 2006, OIKOS, V115, P53, DOI 10.1111/j.2006.0030-1299.15054.x; Seger J., 1987, Oxford Surveys in Evolutionary Biology, V4, P182; Srygley RB, 2014, J INSECT PHYSIOL, V65, P57, DOI 10.1016/j.jinsphys.2014.05.005; Stahlschmidt ZR, 2015, FUNCT ECOL, V29, P88, DOI 10.1111/1365-2435.12287; Stahlschmidt ZR, 2013, ANIM BEHAV, V86, P553, DOI 10.1016/j.anbehav.2013.06.009; Stahlschmidt ZR, 2013, FUNCT ECOL, V27, P800, DOI 10.1111/1365-2435.12071; Subramanian KA, 2005, CURR SCI INDIA, V89, P976; Sugano Yoshikazu C., 2008, Journal of Orthoptera Research, V17, P243, DOI 10.1665/1082-6467-17.2.243; Szinwelski N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139669; Szinwelski Neucir, 2012, International Journal of Zoology, P1; Szinwelski N, 2012, ZOOKEYS, P11, DOI 10.3897/zookeys.196.3130; TALLAMY DW, 1984, BIOSCIENCE, V34, P20, DOI 10.2307/1309421; Tauber MJ, 1998, ENVIRON ENTOMOL, V27, P523, DOI 10.1093/ee/27.3.523; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Whitman Douglas W., 2008, Journal of Orthoptera Research, V17, P117, DOI 10.1665/1082-6467-17.2.117; WILCOX BA, 1985, AM NAT, V125, P879, DOI 10.1086/284386; Zefa E, 2008, IHERINGIA SER ZOOL, V98, P325, DOI 10.1590/S0073-47212008000300006; Zuur AF, 2012, BEGINNERS GUIDE GENE; Zuur Alain F., 2009, P1	91	0	0	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185800	10.1371/journal.pone.0185800	http://dx.doi.org/10.1371/journal.pone.0185800			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977023	gold, Green Published, Green Submitted			2022-12-26	WOS:000412163100046
J	McElroy, T; McReynolds, CN; Gulledge, A; Knight, KR; Smith, WE; Albrecht, EA				McElroy, Thomas; McReynolds, C. Neal; Gulledge, Alyssa; Knight, Kelci R.; Smith, Whitney E.; Albrecht, Eric A.			Differential toxicity and venom gland gene expression in Centruroides vittatus	PLOS ONE			English	Article							INTRAGUILD PREDATION; SCORPION; PEPTIDES; DIET; TIME; VARIABILITY; TOXINS; PREY; COMPONENTS; EVOLUTION	Variation in venom toxicity and composition exists in many species. In this study, venom potency and venom gland gene expression was evaluated in Centruroides vittatus, size class I-II (immature) and size class IV (adults/penultimate instars) size classes. Venom toxicity was evaluated by probit analysis and returned ED50 values of 50.1 mu g/g for class IV compared to 134.2 mu g/g for class I-II 24 hours post injection, suggesting size class IV was 2.7 fold more potent. Next generation sequencing (NGS and qPCR were used to characterize venom gland gene expression. NGS data was assembled into 36,795 contigs, and annotated using BLASTx with UNIPROT. EdgeR analysis of the sequences showed statistically significant differential expression in transcripts associated with sodium and potassium channel modulation. Sodium channel modulator expression generally favored size class IV; in contrast, potassium channel modulators were favored in size class I-II expression. Real-time quantitative PCR of 14 venom toxin transcripts detected relative expression ratios that paralleled NGS data and identified potential family members or splice variants for several sodium channel modulators. Our data suggests ontogenetic differences in venom potency and venom related genes expression exist between size classes I-II and IV.	[McElroy, Thomas; Gulledge, Alyssa] Kennesaw State Univ, Dept Ecol Evolut & Organismal Biol, Kennesaw, GA USA; [McReynolds, C. Neal] Texas A&M Int Univ, Dept Biol & Chem, Laredo, TX USA; [Knight, Kelci R.; Smith, Whitney E.; Albrecht, Eric A.] Kennesaw State Univ, Dept Mol & Cellular Biol, Kennesaw, GA 30144 USA	University System of Georgia; Kennesaw State University; Texas A&M University System; Texas A&M International University; University System of Georgia; Kennesaw State University	Albrecht, EA (corresponding author), Kennesaw State Univ, Dept Mol & Cellular Biol, Kennesaw, GA 30144 USA.	ealbrec1@kennesaw.edu		Albrecht, Eric/0000-0001-8949-2758	Kennesaw State University College Mentor Protege [432081]; Kennesaw State University Creative Activities and Research Experiences for Teams	Kennesaw State University College Mentor Protege; Kennesaw State University Creative Activities and Research Experiences for Teams	This work was supported by Kennesaw State University College Mentor Protege, grant# 432081, http://csm.kennesaw.edu/research/mentor-protege.php, EAA; and Kennesaw State University Creative Activities and Research Experiences for Teams, http://research.kennesaw.edu/our/funding/faculty.php, EAA and TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman M., 2014, VENOM GENOMICS PROTE, P1; Abdel-Rahman MA, 2009, TOXICON, V53, P349, DOI 10.1016/j.toxicon.2008.12.007; Almaaytah A, 2014, PEPTIDES, V51, P35, DOI 10.1016/j.peptides.2013.10.021; Baelde HJ, 2001, J CLIN PATHOL, V54, P778, DOI 10.1136/jcp.54.10.778; Barlow A, 2009, P ROY SOC B-BIOL SCI, V276, P2443, DOI 10.1098/rspb.2009.0048; BOEVE JL, 1995, TOXICON, V33, P1347, DOI 10.1016/0041-0101(95)00066-U; Casewell NR, 2014, P NATL ACAD SCI USA, V111, P9205, DOI 10.1073/pnas.1405484111; Casewell NR, 2013, TRENDS ECOL EVOL, V28, P219, DOI 10.1016/j.tree.2012.10.020; Chang D, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0592-5; Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; de Oliveira UC, 2015, TOXICON, V95, P52, DOI 10.1016/j.toxicon.2014.12.013; Durban J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-234; Dyason K, 2002, RAPID COMMUN MASS SP, V16, P768, DOI 10.1002/rcm.637; Edmunds MC, 2010, J ARACHNOL, V38, P123, DOI 10.1636/Hi09-38.1; El Hafny B, 2002, TOXICON, V40, P1609, DOI 10.1016/S0041-0101(02)00178-2; Finney D.J., 1952, PROBIT ANAL; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haney RA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-366; Jackman J.A., 1998, INSECTS; Kalapothakis E, 1997, TOXICON, V35, P1523, DOI 10.1016/S0041-0101(97)00017-2; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lima L, 2017, ALGORITHM MOL BIOL, V12, DOI 10.1186/s13015-017-0091-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luna-Ramirez K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127883; MACKESSY SP, 1988, COPEIA, P92, DOI 10.2307/1445927; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McCormick S.J., 1990, P294; McReynolds C. Neal, 2012, Euscorpius, V144, P1; McReynolds C. Neal, 2004, Euscorpius, V12-17, P35; McReynolds CN, 2008, J ARACHNOL, V36, P557, DOI 10.1636/T07-07.1; Nisani Z, 2012, TOXICON, V60, P315, DOI 10.1016/j.toxicon.2012.04.343; Olamendi-Portugal T, 2016, TOXICON, V115, P1, DOI 10.1016/j.toxicon.2016.02.017; Ozkan O, 2010, J VENOM ANIM TOXINS, V16, P505, DOI 10.1590/S1678-91992010000300017; PAPPONE PA, 1988, J GEN PHYSIOL, V91, P817, DOI 10.1085/jgp.91.6.817; Phuong MA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2755-6; Pimenta AMC, 2003, RAPID COMMUN MASS SP, V17, P413, DOI 10.1002/rcm.934; Polis G., 2001, SCORPION BIOL RES; POLIS GA, 1987, ECOLOGY, V68, P332, DOI 10.2307/1939264; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Polis GA, 1990, BIOL SCORPIONS; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Pucca MB, 2014, TOXICON, V90, P326, DOI 10.1016/j.toxicon.2014.08.064; Quintero-Hernandez V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117188; Richards DP, 2012, TOXICON, V59, P110, DOI 10.1016/j.toxicon.2011.10.015; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Sanchez-Pinero F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161747; Schiavon E, 2012, TOXICON, V59, P283, DOI 10.1016/j.toxicon.2011.12.003; SHELLEY RM, 1995, J ARACHNOL, V23, P100; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Starkov VG, 2007, TOXICON, V49, P995, DOI 10.1016/j.toxicon.2007.01.010; Sunagar K, 2016, J PROTEOMICS, V135, P62, DOI 10.1016/j.jprot.2015.09.015; Swartz KJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00873; Valdez-Cruz NA, 2004, BIOCHIMIE, V86, P387, DOI 10.1016/j.biochi.2004.05.005; YAHELNIV A, 1979, TOXICON, V17, P435, DOI 10.1016/0041-0101(79)90277-0; Zeng XC, 2005, IUBMB LIFE, V57, P13, DOI 10.1080/15216540500058899; Zhang L, 2015, J PROTEOMICS, V128, P231, DOI 10.1016/j.jprot.2015.07.030; Zhao RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-452	59	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0184695	10.1371/journal.pone.0184695	http://dx.doi.org/10.1371/journal.pone.0184695			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976980	Green Published, gold, Green Submitted			2022-12-26	WOS:000412163100009
J	Mohammed, RH; Anderton, H; Brameld, JM; Sweetman, D				Mohammed, Rabeea Hazim; Anderton, Helen; Brameld, John Michael; Sweetman, Dylan			Effects of insulin like growth factors on early embryonic chick limb myogenesis	PLOS ONE			English	Article							MUSCLE PROGENITOR CELLS; SKELETAL-MUSCLE; SONIC HEDGEHOG; RETINOIC ACID; SOMITE; DIFFERENTIATION; EXPRESSION; SF/HGF; ORIGIN; CXCR4	Limb muscles derive from pax3 expressing precursor cells that migrate from the hypaxial somite into the developing limb bud. Once there they begin to differentiate and express muscle determination genes such as MyoD. This process is regulated by a combination of inductive or inhibitory signals including Fgf18, retinoic acid, HGF, Notch and IGFs. IGFs are well known to affect late stages of muscle development and to promote both proliferation and differentiation. We examined their roles in early stage limb bud myogenesis using chicken embryos as an experimental model. Grafting beads soaked in purified recombinant IGF-I, IGF-II or small molecule inhibitors of specific signaling pathways into developing chick embryo limbs showed that both IGF-I and IGF-II induce expression of the early stage myogenic markers pax3 and MyoD as well as myogenin. Their effects on pax3 and MyoD expression were blocked by inhibitors of both the IGF type I receptor (picropodophyllotoxin, PPP) and MEK (U0126). The PI3K inhibitor LY294002 blocked IGF-II, but not IGF-I, induction of pax3 mRNA as well as the IGF-I, but not IGF-II, induction of MyoD mRNA. In addition SU5402, an FGFR/.VEGFR inhibitor, blocked the induction of MyoD by both IGFs but had no effect on pax3 induction, suggesting a role for FGF or VEGF signaling in their induction of MyoD. This was confirmed by in situ hybridization showing that FGF18, a known regulator of MyoD in limb myoblasts, was induced by IGF-I. In addition to their well-known effects on later stages of myogenesis via their induction of myogenin expression, both IGF-I and IGF-II induced pax3 and MyoD expression in developing chick embryos, indicating that they also regulate early stages of myogenesis. The data suggests that the IGFs may have slightly different effects on IGF1R signal transduction via PI3K and that their stimulatory effects on MyoD expression may be indirect, possibly via induction of FGF18 expression.	[Mohammed, Rabeea Hazim; Anderton, Helen; Brameld, John Michael; Sweetman, Dylan] Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England; [Mohammed, Rabeea Hazim] Univ Mosul, Coll Educ, Dept Biol, Mosul, Iraq; [Sweetman, Dylan] Livestock Wellness & Performance, Zoetis VMRD GTR, Kalamazoo, MI USA	University of Nottingham; University of Mosul; Zoetis	Brameld, JM (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England.	john.brameld@nottingham.ac.uk	Mohammed, Rabeea Hazim/GYJ-3387-2022; Brameld, John/AAB-1745-2021	Brameld, John/0000-0003-4942-080X; Mohammed, Dr.Rabeea/0000-0002-7757-8068	Higher Committee for Education Development (HCED), Iraq and HA - a BBSRC Doctoral Training Programme PhD studentship	Higher Committee for Education Development (HCED), Iraq and HA - a BBSRC Doctoral Training Programme PhD studentship	RHM was funded by a PhD studentship from the Higher Committee for Education Development (HCED), Iraq and HA was funded by a BBSRC Doctoral Training Programme PhD studentship. The funders had no role in the design, collection of samples, data analysis, interpretation of data or writing of this manuscript.	Abu-Elmagd M, 2010, DEV BIOL, V337, P211, DOI 10.1016/j.ydbio.2009.10.023; Agrogiannis GD, 2014, MOL MED REP, V10, P579, DOI 10.3892/mmr.2014.2258; Allan GJ, 2003, ANAT EMBRYOL, V207, P73, DOI 10.1007/s00429-003-0321-x; Amthor H, 1998, CURR BIOL, V8, P642, DOI 10.1016/S0960-9822(98)70251-9; Berti F, 2015, J ANAT, V227, P361, DOI 10.1111/joa.12353; BrandSaberi B, 1996, DEV BIOL, V179, P303, DOI 10.1006/dbio.1996.0260; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Buckingham M, 2007, CR BIOL, V330, P530, DOI 10.1016/j.crvi.2007.03.015; Carter EJ, 2009, J CELL SCI, V122, P3104, DOI 10.1242/jcs.045757; CHEVALLIER A, 1977, J EMBRYOL EXP MORPH, V41, P245; Christ B, 2002, INT J DEV BIOL, V46, P905; Davey MG, 2007, CYTOGENET GENOME RES, V117, P231, DOI 10.1159/000103184; Dietrich S, 1999, DEVELOPMENT, V126, P1621; Duan CM, 2010, GEN COMP ENDOCR, V167, P344, DOI 10.1016/j.ygcen.2010.04.009; Duprez D, 1998, DEVELOPMENT, V125, P495; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Kocamis H, 1998, POULTRY SCI, V77, P1913, DOI 10.1093/ps/77.12.1913; LANCEJONES C, 1988, DEV BIOL, V126, P394, DOI 10.1016/0012-1606(88)90149-2; Maki RG, 2010, J CLIN ONCOL, V28, P4985, DOI 10.1200/JCO.2009.27.5040; Marics I, 2002, DEVELOPMENT, V129, P4559; Mayeuf-Louchart A, 2014, P NATL ACAD SCI USA, V111, P8844, DOI 10.1073/pnas.1407606111; McQueeney K, 2001, GROWTH HORM IGF RES, V11, P346, DOI 10.1054/ghir.2001.0250; Mitchell PJ, 2002, DEV DYNAM, V223, P12, DOI 10.1002/dvdy.1227; Mohammed RH, 2016, JOVE-J VIS EXP, DOI 10.3791/53342; Mok GF, 2015, J ANAT, V227, P352, DOI 10.1111/joa.12340; Mok GF, 2014, DEV BIOL, V396, P214, DOI 10.1016/j.ydbio.2014.10.004; Mok GF, 2011, REPRODUCTION, V141, P301, DOI 10.1530/REP-10-0394; Moumne S., 2016, CAN J SCH PSYCHOL, V1, P1; Murphy M, 2011, CURR TOP DEV BIOL, V96, P1, DOI 10.1016/B978-0-12-385940-2.00001-2; Otto A, 2010, EXP CELL RES, V316, P3059, DOI 10.1016/j.yexcr.2010.04.009; Philippou A., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P208; Reijntjes S, 2010, INT J DEV BIOL, V54, P125, DOI 10.1387/ijdb.082783sr; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Scaal M, 1999, DEVELOPMENT, V126, P4885; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Tickle C, 2004, MECH DEVELOP, V121, P1019, DOI 10.1016/j.mod.2004.05.015; Vasyutina E, 2005, GENE DEV, V19, P2187, DOI 10.1101/gad.346205; Vigneri R, 2016, J ENDOCRINOL INVEST, V39, P1365, DOI 10.1007/s40618-016-0508-7; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200; Yusuf F, 2006, DEV DYNAM, V235, P3007, DOI 10.1002/dvdy.20951	41	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185775	10.1371/journal.pone.0185775	http://dx.doi.org/10.1371/journal.pone.0185775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972999	Green Submitted, Green Published, gold			2022-12-26	WOS:000412131900047
J	Zainuddin, M; Farhum, A; Safruddin, S; Selamat, MB; Sudirman, S; Nurdin, N; Syamsuddin, M; Ridwan, M; Saitoh, S				Zainuddin, Mukti; Farhum, Aisjah; Safruddin, Safruddin; Selamat, Muhammad Banda; Sudirman, Sudirman; Nurdin, Nurjannah; Syamsuddin, Mega; Ridwan, Muhammad; Saitoh, Seiichi			Detection of pelagic habitat hotspots for skipjack tuna in the Gulf of Bone-Flores Sea, southwestern Coral Triangle tuna, Indonesia	PLOS ONE			English	Article							ALBACORE THUNNUS-ALALUNGA; WESTERN NORTH PACIFIC; KATSUWONUS-PELAMIS; SURFACE TEMPERATURE; HOT-SPOTS; OCEAN; FISHERIES; ECOSYSTEM; BEHAVIOR; FEATURES	Using remote sensing of sea surface temperature (SST), sea surface height anomaly (SSHA) and chlorophyll-a (Chl-a) together with catch data, we investigated the detection and persistence of important pelagic habitat hotspots for skipjack tuna in the Gulf of BoneFlores Sea, Indonesia. We analyzed the data for the period between the northwest and southeast monsoon 2007-2011. A pelagic hotspot index was constructed from a model of multi-spectrum satellite-based oceanographic data in relation to skipjack fishing performance. Results showed that skipjack catch per unit efforts (CPUEs) increased significantly in areas of highest pelagic hotspot indices. The distribution and dynamics of habitat hotspots were detected by the synoptic measurements of SST, SSHA and Chl-a ranging from 29.5 degrees to 31.5 degrees C, from 2.5 to 12.5 cm and from 0.15 to 0.35 mg m(-3), respectively. Total area of hotspots consistently peaked in May. Validation of skipjack CPUE predicted by our model against observed data from 2012 was highly significant. The key pelagic habitat corresponded with the Chl-a front, which could be related to the areas of relatively high prey abundance (enhanced feeding opportunity) for skipjack. We found that the area and persistence of the potential skipjack habitat hotspots for the 5 years were clearly identified by the 0.2 mg m(-3) Chl-a isopleth, suggesting that the Chl-a front provides a key oceanographic indicator for global understanding on skipjack tuna habitat hotspots in the western tropical Pacific Ocean, especially within Coral Triangle tuna.	[Zainuddin, Mukti; Farhum, Aisjah; Safruddin, Safruddin; Selamat, Muhammad Banda; Sudirman, Sudirman] Hasanuddin Univ, Fac Marine Sci & Fisheries, Makassar, Indonesia; [Nurdin, Nurjannah] Hasanuddin Univ, Ctr Reg Spatial Planning & Informat, Makassar, Indonesia; [Syamsuddin, Mega] Padjadjaran State Univ, Fac Fisheries & Marine Sci, Bandung, Indonesia; [Ridwan, Muhammad] Natl Agr Polytech, Fisheries Agribusiness Dept, Pangkep, Indonesia; [Saitoh, Seiichi] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido, Japan	Universitas Hasanuddin; Universitas Hasanuddin; Universitas Padjadjaran; Hokkaido University	Zainuddin, M (corresponding author), Hasanuddin Univ, Fac Marine Sci & Fisheries, Makassar, Indonesia.	mukti_fishocean@yahoo.co.id	Safruddin, Safruddin/ABA-4389-2021; Zainuddin, Mukti/O-9272-2019; Zainuddin, Mukti/U-2357-2017; Nurdin, Nurjannah/AAD-8307-2021	Safruddin, Safruddin/0000-0003-3877-6333; Zainuddin, Mukti/0000-0003-2018-7143; Zainuddin, Mukti/0000-0002-1600-4191; 	National Competitive Research Grant (Hibah Kompetensi) [019/SP2H/LT/DPRM/II/2016]; National Competitive Research Grant (PTUPT) Ministry of Research, Technology and Higher Education of the Republic of Indonesia [005/SP2H/LT/DPRM/IV/2017]; National Competitive Research Grant (PTUPT), Ministry of Research, Technology and Higher Education of the Republic of Indonesia; National Competitive Research Grant (Hibah Kompetensi)	National Competitive Research Grant (Hibah Kompetensi); National Competitive Research Grant (PTUPT) Ministry of Research, Technology and Higher Education of the Republic of Indonesia; National Competitive Research Grant (PTUPT), Ministry of Research, Technology and Higher Education of the Republic of Indonesia; National Competitive Research Grant (Hibah Kompetensi)	This work was partly supported by the National Competitive Research Grant (Hibah Kompetensi 2016 No. 019/SP2H/LT/DPRM/II/2016 and PTUPT 2017 No. 005/SP2H/LT/DPRM/IV/2017) Ministry of Research, Technology and Higher Education of the Republic of Indonesia, to MZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge to Prof. Susan Williams, Dr. Joanne Wilson and Dr. Laurence McCook for reading and improving English of this manuscript. We also appreciate the use of TERRA-MODIS SST and Chl-a datasets, downloaded from the ocean color portal (http://oceancolor.gsfc.nasa.gov) and SSHA (AVISO-altimetry). This work was partly supported to MZ by the National Competitive Research Grant (Hibah Kompetensi 2016 and PTUPT 2017), Ministry of Research, Technology and Higher Education of the Republic of Indonesia.	ADB, 2014, EC FISH AQ COR TRIAN, P1; Alabia ID, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142885; Andrade HA, 2003, FISH OCEANOGR, V12, P10, DOI 10.1046/j.1365-2419.2003.00220.x; Andrade HA, 1999, FISH OCEANOGR, V8, P245, DOI 10.1046/j.1365-2419.1999.00107.x; Arai T, 2005, J MAR BIOL ASSOC UK, V85, P1211, DOI 10.1017/S0025315405012336; Atmadipoera A S, 2015, JURNAL ILMU DAN TEKN, V6, P355; Azwir A, 2004, JURNAL NATURAL, V4, P20; Bailey M, 2012, OCEAN COAST MANAGE, V63, P30, DOI 10.1016/j.ocecoaman.2012.03.010; BARKLEY RA, 1978, FISH B-NOAA, V76, P653; Bergmann M, 2004, FISH RES, V66, P373, DOI 10.1016/j.fishres.2003.07.007; Bertignac M, 1998, FISH OCEANOGR, V7, P326, DOI 10.1046/j.1365-2419.1998.00065.x; Bertrand A, 2002, CAN J FISH AQUAT SCI, V59, P1002, DOI 10.1139/F02-073; Brill Richard W., 1994, Fisheries Oceanography, V3, P204, DOI 10.1111/j.1365-2419.1994.tb00098.x; Druon JN, 2016, IOTC P; Etnoyer Peter, 2004, Oceanography, V17, P90; Gordon A.L, 2005, OCEANOGRAPHY, V18, P15, DOI [10.5670/oceanog.2005.01, DOI 10.5670/OCEANOG.2005.01]; Harsono G., 2014, Asian Journal of Scientific Research, V7, P571, DOI 10.3923/ajsr.2014.571.580; Hendiarti Nani, 2005, Oceanography, V18, P112; IOTC. The Scientific Committee of The Indian Ocean Tuna Commission, 2015, IR HAR EK NUGR BUD W, P1; ISSF, 2015, 201503 ISSF; Kirby DS, 2000, FISH OCEANOGR, V9, P328, DOI 10.1046/j.1365-2419.2000.00144.x; Kitagawa T, 2007, FISHERIES SCI, V73, P98, DOI 10.1111/j.1444-2906.2007.01307.x; Lehodey P, 1998, FISH OCEANOGR, V7, P317, DOI 10.1046/j.1365-2419.1998.00063.x; Lehodey P, 2008, PROG OCEANOGR, V78, P304, DOI 10.1016/j.pocean.2008.06.004; Malakoff D, 2004, SCIENCE, V304, P1104, DOI 10.1126/science.304.5674.1104; Matsumoto T, 2016, FISH OCEANOGR, V25, P565, DOI 10.1111/fog.12173; Morato T, 2016, FISH FISH, V17, P1227, DOI 10.1111/faf.12126; Mugo R, 2010, FISH OCEANOGR, V19, P382, DOI 10.1111/j.1365-2419.2010.00552.x; Muhling BA, 2015, J MARINE SYST, V148, P1, DOI 10.1016/j.jmarsys.2015.01.010; Nuzula F, 2017, IOP C SER EARTH ENV, V54, DOI 10.1088/1755-1315/54/1/012079; Olson D., 1994, OCEANOGRAPHY, V7, P52, DOI DOI 10.5670/OCEANOG.1994.03; Palacios DM, 2006, DEEP-SEA RES PT II, V53, P250, DOI 10.1016/j.dsr2.2006.03.004; Pedraza M.J., 2006, ADV GEOSCI, V6, P155, DOI 10.5194/adgeo-6-155-2006; Polovina JJ, 2005, ICES J MAR SCI, V62, P319, DOI 10.1016/j.icesjms.2004.07.031; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; Qu T., 2005, OCEANOGRAPHY, V18, P50, DOI [DOI 10.5670/OCEANOG.2005.05, 10.5670/oceanog.2005.05]; Ramos AG, 1996, INT J REMOTE SENS, V17, P749, DOI 10.1080/01431169608949042; REBERT JP, 1985, J GEOPHYS RES-OCEANS, V90, P1719, DOI 10.1029/JC090iC06p11719; Roger Claude, 1994, Fisheries Oceanography, V3, P133, DOI 10.1111/j.1365-2419.1994.tb00055.x; Royer F, 2004, MAR ECOL PROG SER, V269, P249, DOI 10.3354/meps269249; Setiawati MD, 2015, ADV SPACE RES, V55, P732, DOI 10.1016/j.asr.2014.10.007; Sprintall J., 2005, OCEANOGRAPHY, V18, P88, DOI [DOI 10.5670/0CEAN, 10.5670/oceanog.2005.09, DOI 10.5670/OCEANOG.2005.09]; STRETTA JM, 1991, INT J REMOTE SENS, V12, P771, DOI 10.1080/01431169108929693; Sund P.N., 1981, Oceanography and Marine Biology an Annual Review, V19, P443; Syamsuddin M, 2016, INT J REMOTE SENS, V37, P1, DOI DOI 10.1016/S1001-6058(06)60144-3; Sydeman WJ, 2006, DEEP-SEA RES PT II, V53, P247, DOI 10.1016/j.dsr2.2006.03.001; Uda M, 1973, J FAC MAR SCI TECHNO, V7, P245; Wilson C., 2008, REPORTS INT OCEAN CO; Wyrtki K., 1961, PHYS OCEANOGRAPHY SE, V2, P1; Yoder JA, 2010, OCEANOGRAPHY, V23, P104, DOI 10.5670/oceanog.2010.09; Zainuddin M., 2011, J ILMU TEKNOL KELAUT, V3, P82, DOI [10.29244/jitkt.v3i1.7837, DOI 10.29244/JITKT.V3I1.7837]; Zainuddin M, 2008, FISH OCEANOGR, V17, P61, DOI 10.1111/j.1365-2419.2008.00461.x; Zainuddin M, 2006, DEEP-SEA RES PT II, V53, P419, DOI 10.1016/j.dsr2.2006.01.007	53	22	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185601	10.1371/journal.pone.0185601	http://dx.doi.org/10.1371/journal.pone.0185601			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968405	Green Published, gold, Green Submitted			2022-12-26	WOS:000412029600028
J	Sung, PL; Wen, KC; Chen, YJ; Chao, TC; Tsai, YF; Tseng, LM; Qiu, JTT; Chao, KC; Wu, HH; Chuang, CM; Wang, PH; Huang, CYF				Sung, Pi-Lin; Wen, Kuo-Chang; Chen, Yi-Jen; Chao, Ta-Chung; Tsai, Yi-Fang; Tseng, Ling-Ming; Qiu, Jian-Tai Timothy; Chao, Kuan-Chong; Wu, Hua-Hsi; Chuang, Chi-Mu; Wang, Peng-Hui; Huang, Chi-Ying F.			The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1/2 to multi-gene panels	PLOS ONE			English	Article							FAMILIAL BREAST; RISK-ASSESSMENT; SUSCEPTIBILITY GENES; EARLY-ONSET; MAINTENANCE THERAPY; INHERITED MUTATIONS; GERMLINE MUTATIONS; GENOMIC CAPTURE; POLISH BREAST; MULTIPLE	An important role of genetic factors in the development of breast cancer (BC) or ovarian cancer (OC) in Taiwanese (ethnic Chinese) patients has been suggested. However, other than germline BRCA1 or BRCA2 mutations, which are related to hereditary breast-ovarian cancer (HBOC), cancer-predisposition genes have not been well studied in this population. The aim of the present study was to more accurately summarize the prevalence of genetic mutations in HBOC patients using various gene panels ranging in size from BRCA1/2 alone to multi-gene panels. Among 272 HBOC patients analyzed, the prevalence of BRCA1, BRCA2 and non-BRCA1/2 pathogenic mutations was 7.7% (21/272), 6.8% (16/236) and 8.2% (13/ 159), respectively. The total mutation rate was 18.4% (50/272). Although no founder mutations were identified in this study, two recurrent mutations, BRCA1 (c.3607C>T) and BRCA2 (c.5164_5165 delAG), were found. The main pathogenic/likely pathogenic mutations in nonBRCA1/2 genes included ATM, BRIP1, FANCI, MSH2, MUYTH, RAD50, RAD51C and TP53. The prevalence rate of gene mutations in HBOC patients did not differ with respect to whether BC or OC was the first diagnosis or they presented a family history of the disease or their age at diagnosis. HBOC patients with both BC and OC exhibited a higher prevalence rate of mutations (50.0%) than patients with OC (25.0%) or BC (8.6%) alone. In conclusion, evaluation of hereditary cancer risk in Taiwan HBOC patients, particularly individuals with double cancer, is strongly encouraged. Panel testing can yield additional genomic information, and widespread and well-designed panel testing will help in assessing more accurate mutational prevalence of risk genes.	[Sung, Pi-Lin; Wen, Kuo-Chang; Chen, Yi-Jen; Chuang, Chi-Mu; Wang, Peng-Hui; Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Sung, Pi-Lin; Wen, Kuo-Chang; Chen, Yi-Jen; Chao, Kuan-Chong; Wu, Hua-Hsi; Chuang, Chi-Mu; Wang, Peng-Hui] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Sung, Pi-Lin; Wen, Kuo-Chang; Chen, Yi-Jen; Chao, Kuan-Chong; Wu, Hua-Hsi; Chuang, Chi-Mu; Wang, Peng-Hui] Natl Yang Ming Univ, Dept Obstet & Gynecol, Taipei, Taiwan; [Chao, Ta-Chung] Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan; [Tsai, Yi-Fang; Tseng, Ling-Ming] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Qiu, Jian-Tai Timothy] Chang Gung Univ, Dept Biomed Sci, New Taipei, Taiwan; [Qiu, Jian-Tai Timothy] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taoyuan, Taiwan; [Wang, Peng-Hui] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Yang Ming Chiao Tung University	Wang, PH; Huang, CYF (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.; Wang, PH (corresponding author), Taipei Vet Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan.; Wang, PH (corresponding author), Natl Yang Ming Univ, Dept Obstet & Gynecol, Taipei, Taiwan.; Wang, PH (corresponding author), China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.; Huang, CYF (corresponding author), Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei, Taiwan.	phwang@vghtpe.gov.tw; cyhuang5@ym.edu.tw	Huang, Chi-Ying/AAG-7672-2022; Huang, Chi-Ying/AFL-7729-2022	Huang, Chi-Ying/0000-0003-4898-4937; Huang, Chi-Ying/0000-0003-4898-4937; Meir, Yaa-Jyuhn/0000-0001-6084-3446; Qiu, JT/0000-0001-7090-6906; Chen, CJ/0000-0003-3766-4612	YEN TJING LING MEDICAL FOUNDATION [CI-100-34]; Taipei Veterans General Hospital [V105B-006]; Ministry of Science and Technology, Taiwan, ROC [105-2314-B-075-039-]; Ministry of Science and Technology [104-2627-B-010-001-]	YEN TJING LING MEDICAL FOUNDATION; Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	Funded by YEN TJING LING MEDICAL FOUNDATION (CI-100-34), Taipei Veterans General Hospital (V105B-006), Ministry of Science and Technology, Taiwan, ROC (105-2314-B-075-039-) to PL Sung and by a grant from the Ministry of Science and Technology (104-2627-B-010-001-) to CY Huang.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ang P, 2007, CANCER EPIDEM BIOMAR, V16, P2276, DOI 10.1158/1055-9965.EPI-07-0403; [Anonymous], 2009, Obstet Gynecol, V113, P957, DOI 10.1097/AOG.0b013e3181a106d4; [Anonymous], 2009, GYNECOL ONCOL, V113, P6, DOI 10.1016/j.ygyno.2009.02.017; [Anonymous], 2015, LANCET ONCOLOGY, V16, pe158; Banerjee S, 2010, NAT REV CLIN ONCOL, V7, P508, DOI 10.1038/nrclinonc.2010.116; Berg AO, 2005, ANN INTERN MED, V143, P355, DOI 10.7326/0003-4819-143-5-200509060-00011; Beroud C, 2016, HUM MUTAT, V37, P1318, DOI 10.1002/humu.23113; Brozek I, 2012, FAM CANCER, V11, P351, DOI 10.1007/s10689-012-9519-5; Castera L, 2014, EUR J HUM GENET, V22, P1305, DOI 10.1038/ejhg.2014.16; Chao A, 2016, ONCOTARGET, V7, P85529, DOI 10.18632/oncotarget.13456; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Chen ST, 2003, BREAST CANCER RES TR, V77, P133, DOI 10.1023/A:1021386026051; Chiang CJ, 2016, J FORMOS MED ASSOC, V115, P1076, DOI 10.1016/j.jfma.2015.10.011; Desmond A, 2015, JAMA ONCOL, V1, P943, DOI 10.1001/jamaoncol.2015.2690; Gorski B, 2004, INT J CANCER, V110, P683, DOI 10.1002/ijc.20162; Guan YF, 2015, FAM CANCER, V14, P9, DOI 10.1007/s10689-014-9749-9; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; Harries M, 2002, LANCET ONCOL, V3, P529, DOI 10.1016/S1470-2045(02)00846-X; Hemminki K, 2003, BREAST CANCER RES TR, V82, P17, DOI 10.1023/B:BREA.0000003871.38587.8b; Kang E, 2015, BREAST CANCER RES TR, V151, P157, DOI 10.1007/s10549-015-3377-4; Kapoor NS, 2015, ANN SURG ONCOL, V22, P3282, DOI 10.1245/s10434-015-4754-2; Kim YC, 2016, ONCOTARGET, V7, P9601, DOI 10.18632/oncotarget.7144; Kraus C, 2017, INT J CANCER, V140, P95, DOI 10.1002/ijc.30428; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kuo WH, 2012, J HUM GENET, V57, P130, DOI 10.1038/jhg.2011.142; Kurian AW, 2014, J CLIN ONCOL, V32, P2001, DOI 10.1200/JCO.2013.53.6607; Kwong A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043994; LaDuca H, 2014, GENET MED, V16, P830, DOI 10.1038/gim.2014.40; Ledermann J, 2014, LANCET ONCOL, V15, P852, DOI 10.1016/S1470-2045(14)70228-1; Li SSL, 1999, HUM GENET, V104, P201, DOI 10.1007/s004390050936; Lin PH, 2016, ONCOTARGET, V7, P8310, DOI 10.18632/oncotarget.7027; Liu C, 2007, GASTROENTEROLOGY, V132, P119, DOI 10.1053/j.gastro.2006.10.034; Llort G, 2015, CLIN TRANSL ONCOL, V17, P956, DOI 10.1007/s12094-015-1435-3; Minion LE, 2015, GYNECOL ONCOL, V137, P86, DOI 10.1016/j.ygyno.2015.01.537; Mirza MR, 2016, NEW ENGL J MED, V375, P2154, DOI 10.1056/NEJMoa1611310; Moyer VA, 2014, ANN INTERN MED, V160, P271, DOI 10.7326/M13-2747; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Ng PS, 2016, CLIN GENET, V90, P315, DOI 10.1111/cge.12735; Nilprabhassorn P, 1976, J Med Assoc Thai, V59, P162; Rahman B, 2017, BJOG-INT J OBSTET GY, V124, P855, DOI 10.1111/1471-0528.14603; Rajkumar Thangarajan, 2015, Asian Pac J Cancer Prev, V16, P5211; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ripperger T, 2009, EUR J HUM GENET, V17, P722, DOI 10.1038/ejhg.2008.212; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Schroeder C, 2010, BREAST CANCER RES TR, V122, P287, DOI 10.1007/s10549-009-0639-z; Serova OM, 1997, AM J HUM GENET, V60, P486; Shih HA, 2002, J CLIN ONCOL, V20, P994, DOI 10.1200/JCO.20.4.994; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Stadler ZK, 2012, CANCER-AM CANCER SOC, V118, P493, DOI 10.1002/cncr.26191; Szabo CI, 1997, AM J HUM GENET, V60, P1013; Tedaldi G, 2017, ONCOTARGET; Tung N, 2016, J CLIN ONCOL, V34, P1460, DOI 10.1200/JCO.2015.65.0747; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Wang PH, 2000, JPN J CLIN ONCOL, V30, P343, DOI 10.1093/jjco/hyd092; Weaver JMJ, 2011, GENOME MED, V3, DOI 10.1186/gm274; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Wong ESY, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2015.3; Wong ESY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134408	60	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185615	10.1371/journal.pone.0185615	http://dx.doi.org/10.1371/journal.pone.0185615			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961279	gold, Green Published, Green Submitted			2022-12-26	WOS:000412027700026
J	Wang, YB; Ding, YJ; Guo, F; Wei, LY; Tang, JJ				Wang, Yubo; Ding, Yijie; Guo, Fei; Wei, Leyi; Tang, Jijun			Improved detection of DNA-binding proteins via compression technology on PSSM information	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; RIBOSOMAL-RNA-BINDING; WEB SERVER; PREDICTION; IDENTIFICATION; CLASSIFICATION; GENERATION; SELECTION; SITES	Since the importance of DNA-binding proteins in multiple biomolecular functions has been recognized, an increasing number of researchers are attempting to identify DNA-binding proteins. In recent years, the machine learning methods have become more and more compelling in the case of protein sequence data soaring, because of their favorable speed and accuracy. In this paper, we extract three features from the protein sequence, namely NMBAC (Normalized Moreau-Broto Autocorrelation), PSSM-DWT (Position-specific scoring matrix-D Discrete Wavelet Transform), and PSSM-DCT (Position-specific scoring matrix-D Discrete Cosine Transform). We also employ feature selection algorithm on these feature vectors. Then, these features are fed into the training SVM (support vector machine) model as classifier to predict DNA-binding proteins. Our method applys three datasets, namely PDB1075, PDB594 and PDB186, to evaluate the performance of our approach. The PDB1075 and PDB594 datasets are employed for Jackknife test and the PDB186 dataset is used for the independent test. Our method achieves the best accuracy in the Jacknife test, from 79.20% to 86.23% and 80.5% to 86.20% on PDB1075 and PDB594 datasets, respectively. In the independent test, the accuracy of our method comes to 76.3%. The performance of independent test also shows that our method has a certain ability to be effectively used for DNA-binding protein prediction.	[Wang, Yubo; Ding, Yijie; Guo, Fei; Wei, Leyi; Tang, Jijun] Tianjin Univ, Sch Comp Sci & Technol, Tianjin 300350, Peoples R China; [Tang, Jijun] Univ South Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA; [Wang, Yubo; Ding, Yijie; Guo, Fei; Wei, Leyi; Tang, Jijun] Tianjin Univ, Inst Computat Biol, Tianjin 300350, Peoples R China	Tianjin University; University of South Carolina System; University of South Carolina Columbia; Tianjin University	Guo, F; Tang, JJ (corresponding author), Tianjin Univ, Sch Comp Sci & Technol, Tianjin 300350, Peoples R China.; Tang, JJ (corresponding author), Univ South Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA.; Guo, F; Tang, JJ (corresponding author), Tianjin Univ, Inst Computat Biol, Tianjin 300350, Peoples R China.	fguo@tju.edu.cn; tangjijun@tju.edu.cn	Tang, Jijun/ABH-6528-2020; Wei, Leyi/Q-5699-2018	Wei, Leyi/0000-0003-1444-190X	National Science Foundation of China [NSFC 61772362, 61402326]; Peiyang Scholar Program of Tianjin University [2016XRG-0009]; Tianjin Research Program of Application Foundation and Advanced Technology [16JCQNJC00200]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peiyang Scholar Program of Tianjin University; Tianjin Research Program of Application Foundation and Advanced Technology	This work is supported by a grant from the National Science Foundation of China (NSFC 61772362 and 61402326 to FG), Peiyang Scholar Program of Tianjin University (no. 2016XRG-0009 to FG), and the Tianjin Research Program of Application Foundation and Advanced Technology (16JCQNJC00200 to FG).	Ahmad S, 2004, J MOL BIOL, V341, P65, DOI 10.1016/j.jmb.2004.05.058; AHMED N, 1974, IEEE T COMPUT, VC 23, P90, DOI 10.1109/T-C.1974.223784; Alhamdoosh M, BIORXIV2016061978; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bhardwaj N, 2005, NUCLEIC ACIDS RES, V33, P6486, DOI 10.1093/nar/gki949; Bhardwaj N, 2007, FEBS LETT, V581, P1058, DOI 10.1016/j.febslet.2007.01.086; Cai YD, 2003, BBA-PROTEINS PROTEOM, V1648, P127, DOI 10.1016/S1570-9639(03)00112-2; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dong QW, 2015, IEEE INT C BIOINFORM, P470, DOI 10.1109/BIBM.2015.7359730; Fang Y, 2008, AMINO ACIDS, V34, P103, DOI 10.1007/s00726-007-0568-2; Feng ZP, 2000, J PROTEIN CHEM, V19, P269, DOI 10.1023/A:1007091128394; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Gao M, 2008, NUCLEIC ACIDS RES, V36, P3978, DOI 10.1093/nar/gkn332; Gao M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000567; Guo YZ, 2008, NUCLEIC ACIDS RES, V36, P3025, DOI 10.1093/nar/gkn159; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hajisharifi Z, 2014, J THEOR BIOL, V341, P34, DOI 10.1016/j.jtbi.2013.08.037; Ho SY, 2007, BIOSYSTEMS, V90, P234, DOI 10.1016/j.biosystems.2006.08.007; Kumar KK, 2009, J BIOMOL STRUCT DYN, V26, P679, DOI 10.1080/07391102.2009.10507281; Kumar M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-463; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; LIU B, 2015, SCI REP UK, V5; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2015, MOL INFORM, V34, P8, DOI 10.1002/minf.201400025; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691; Lou WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086703; Ma X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167345; Martin S, 2005, BIOINFORMATICS, V21, P218, DOI 10.1093/bioinformatics/bth483; Motion GB, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv805; Mundra PA, 2010, IEEE T NANOBIOSCI, V9, P31, DOI 10.1109/TNB.2009.2035284; Nanni L, 2008, AMINO ACIDS, V34, P635, DOI 10.1007/s00726-007-0016-3; Nanni L, 2014, SCI WORLD J, DOI 10.1155/2014/236717; Nanni L, 2012, AMINO ACIDS, V43, P657, DOI 10.1007/s00726-011-1114-9; Nanni L, 2009, AMINO ACIDS, V36, P167, DOI 10.1007/s00726-008-0044-7; Nimrod G, 2010, BIOINFORMATICS, V26, P692, DOI 10.1093/bioinformatics/btq019; Pan G, 2017, SCI REP, V7; Patel A K, 2009, DIG J NANOMAT BIOSTR, V4; Roy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007813; Shao XJ, 2009, J THEOR BIOL, V258, P289, DOI 10.1016/j.jtbi.2009.01.024; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Song L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-298; Stawiski EW, 2003, J MOL BIOL, V326, P1065, DOI 10.1016/S0022-2836(03)00031-7; Szaboova A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S3; Szilagyi A, 2006, J MOL BIOL, V358, P922, DOI 10.1016/j.jmb.2006.02.053; Tolosi L, 2011, BIOINFORMATICS, V27, P1986, DOI 10.1093/bioinformatics/btr300; Wang D, BIORXIV2016058800; Waris M, 2016, NEUROCOMPUTING, V199, P154, DOI 10.1016/j.neucom.2016.03.025; Wei LY, 2017, INFORM SCIENCES, V384, P135, DOI 10.1016/j.ins.2016.06.026; Xu RF, 2015, J BIOMOL STRUCT DYN, V33, P1720, DOI 10.1080/07391102.2014.968624; Xu RF, 2015, BMC SYST BIOL, V9, DOI 10.1186/1752-0509-9-S1-S10; Xu RF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/294279; Yan K, 2015, SENSOR ACTUAT B-CHEM, V212, P353, DOI 10.1016/j.snb.2015.02.025; Yang L, 2010, PROTEIN PEPTIDE LETT, V17, P1085, DOI 10.2174/092986610791760306; Yu XJ, 2006, J THEOR BIOL, V240, P175, DOI 10.1016/j.jtbi.2005.09.018; Zhao HY, 2010, BIOINFORMATICS, V26, P1857, DOI 10.1093/bioinformatics/btq295; Zhou WQ, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S1; Zhou YZ, 2011, COMM COM INF SC, V202, P254; Zou CX, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-90	62	45	45	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185587	10.1371/journal.pone.0185587	http://dx.doi.org/10.1371/journal.pone.0185587			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961273	Green Submitted, Green Published, gold			2022-12-26	WOS:000412027700025
J	Zhang, M; Zhao, HT; Cai, J; Li, HH; Wu, Q; Qiao, T; Li, KY				Zhang, Meng; Zhao, Hongting; Cai, Jing; Li, Huihui; Wu, Qi; Qiao, Tong; Li, Kuanyu			Chronic administration of mitochondrion-targeted peptide SS-31 prevents atherosclerotic development in ApoE knockout mice fed Western diet	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; OXIDATIVE STRESS; APOLIPOPROTEIN-E; DEFICIENT MICE; RECEPTOR; CELLS; MACROPHAGES; INHIBITION; ATHEROGENESIS; INFLAMMATION	Background Oxidative stress and inflammatory factors are deeply involved in progression of atherosclerosis. Mitochondrion-targeted peptide SS-31, selectively targeting to mitochondrial inner membrane reacting with cardiolipin, has been reported to inhibit ROS generation and mitigate inflammation. The present study was designed to investigate whether SS-31 could suppress the development of atherosclerosis in vivo. Methods Male ApoE(-/-) mice (8 weeks old) fed with Western diet were treated with normal saline or SS-31 (1 mg/kg/d or 3 mg/kg/d) through subcutaneous injection for 12 weeks. Oil Red O staining was performed to evaluate area and sizes of the plaques. DHE staining and immunohistochemical staining of 8-OHDG was performed to assess the oxidative stress. The aorta ATP contents were assessed by the ATP bioluminescence assay kit. Immunohistochemical staining of CD68 and alpha-SMA and Masson's trichrome staining were performed to evaluate the composition of atherosclerotic plaque. Biochemical assays were performed to determine the protein level and activity of superoxide dismutase (SOD). The levels of CD36, LOX-1 and ABCA1 were immunohistochemically and biochemically determined to evaluate the cholesterol transport in aorta and peritoneal macrophages. Inflammatory factors, including ICAM-1, MCP-1, IL-6 and CRP in serum, were detected through ELISA. Results SS-31 administration reduced the area and sizes of western diet-induced atherosclerotic plaques and changed the composition of the plaques in ApoE(-/-) mice. Oxidative stress was suppressed, as evidenced by the reduced DHE stain, down-regulated 8-OHDG expression, and increased SOD activity after chronic SS-31 administration. Moreover, systemic inflammation was ameliorated as seen by decreasing serum ICAM-1, MCP-1, and IL-6 levels. Most importantly, SS-31 administration inhibited cholesterol influx by down-regulating expression of CD36 and LOX-1 to prevent lipid accumulation to further suppress the foam cell formation and atherosclerotic progression. Conclusion Administration of SS-31 prevents against atherosclerotic formation in ApoE(-/-) mice suggesting that SS-31 might be considered to be a potential drug to prevent atherosclerotic progression.	[Zhang, Meng; Qiao, Tong] Nanjing Med Univ, Dept Vasc Surg, Drum Tower Clin Med Coll, Nanjing, Jiangsu, Peoples R China; [Zhao, Hongting; Li, Huihui; Wu, Qi; Li, Kuanyu] Nanjing Univ, Jiangsu Key Lab Mol Med, Med Sch, Nanjing, Jiangsu, Peoples R China; [Cai, Jing; Qiao, Tong] Nanjing Univ, Dept Vasc Surg, Med Sch, Affiliated Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing University; Nanjing University	Qiao, T (corresponding author), Nanjing Med Univ, Dept Vasc Surg, Drum Tower Clin Med Coll, Nanjing, Jiangsu, Peoples R China.; Li, KY (corresponding author), Nanjing Univ, Jiangsu Key Lab Mol Med, Med Sch, Nanjing, Jiangsu, Peoples R China.; Qiao, T (corresponding author), Nanjing Univ, Dept Vasc Surg, Med Sch, Affiliated Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China.	giaotongmail@aliyun.com; likuanyu@nju.edu.cn	Li, Kuanyu/AAL-2051-2020	Li, Kuanyu/0000-0001-9738-049X	National Natural Science Foundation of China [31571218, 81370387]; National Basic Research Program of China ("973" program) [2015C6856300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China ("973" program)(National Basic Research Program of China)	The financial assistance given by the National Natural Science Foundation of China (No. 31571218 and 81370387) and National Basic Research Program of China ("973" program, No. 2015C6856300) is gratefully acknowledged.; The financial assistance given by the National Basic Research Program of China ("973" program, No. 2015CB856300) and National Natural Science Foundation of China (No. 31571218 and 81370387) is gratefully acknowledged.	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Barter PJ, 2016, PHARMACOL REV, V68, P458, DOI 10.1124/pr.115.012203; Birk AV, 2013, J AM SOC NEPHROL, V24, P1250, DOI 10.1681/ASN.2012121216; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Bourdillon MC, 2000, ARTERIOSCL THROM VAS, V20, P2630, DOI 10.1161/01.ATV.20.12.2630; Dai DF, 2011, J AM COLL CARDIOL, V58, P73, DOI 10.1016/j.jacc.2010.12.044; Degoma EM, 2008, J AM COLL CARDIOL, V51, P2199, DOI 10.1016/j.jacc.2008.03.016; Fuhrman B, 2002, ATHEROSCLEROSIS, V161, P307, DOI 10.1016/S0021-9150(01)00646-3; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Goncalves JL, 2012, EUR J NUTR, V51, P927, DOI 10.1007/s00394-011-0270-8; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Hao SY, 2015, MOLECULES, V20, P21287, DOI 10.3390/molecules201219764; Higashi Y, 2016, CIRCULATION, V133, P2263, DOI 10.1161/CIRCULATIONAHA.116.021805; Jaipersad AS, 2014, J AM COLL CARDIOL, V63, P1, DOI 10.1016/j.jacc.2013.09.019; Joyce CW, 2006, J BIOL CHEM, V281, P33053, DOI 10.1074/jbc.M604526200; Koh KK, 2002, CARDIOVASC RES, V55, P714, DOI 10.1016/S0008-6363(02)00487-X; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Meurs I, 2012, ATHEROSCLEROSIS, V221, P41, DOI 10.1016/j.atherosclerosis.2011.11.024; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; NAGEL T, 1994, J CLIN INVEST, V94, P885, DOI 10.1172/JCI117410; Nickel AG, 2015, CELL METAB, V22, P472, DOI 10.1016/j.cmet.2015.07.008; Protogerou AD, 2011, ATHEROSCLEROSIS, V219, P734, DOI 10.1016/j.atherosclerosis.2011.09.015; Rios-Navarro C, 2015, EUR J PHARMACOL, V765, P355, DOI 10.1016/j.ejphar.2015.08.054; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; Szeto HH, 2014, BRIT J PHARMACOL, V171, P2029, DOI 10.1111/bph.12461; Szeto HH, 2011, J AM SOC NEPHROL, V22, P1041, DOI 10.1681/ASN.2010080808; Terasaki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070933; Topper JN, 1996, P NATL ACAD SCI USA, V93, P10417, DOI 10.1073/pnas.93.19.10417; Tousoulis D, 2016, EUR HEART J, V37, P1723, DOI 10.1093/eurheartj/ehv759; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Yang LC, 2009, ANTIOXID REDOX SIGN, V11, P2095, DOI [10.1089/ars.2009.2445, 10.1089/ARS.2009.2445]; Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271; Yu EP, 2016, FREE RADICAL BIOL ME; Yu XH, 2013, CLIN CHIM ACTA, V424, P245, DOI 10.1016/j.cca.2013.06.006	37	24	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185688	10.1371/journal.pone.0185688	http://dx.doi.org/10.1371/journal.pone.0185688			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961281	Green Published, Green Submitted, gold			2022-12-26	WOS:000412027700033
J	Faburay, B; McGill, J; Jongejan, F				Faburay, Bonto; McGill, Jodi; Jongejan, Frans			A glycosylated recombinant subunit candidate vaccine consisting of Ehrlichia ruminantium major antigenic protein1 induces specific humoral and Th1 type cell responses in sheep	PLOS ONE			English	Article							INACTIVATED COWDRIA-RUMINANTIUM; IN-VITRO; MYCOBACTERIUM-TUBERCULOSIS; EXPERIMENTAL TRANSMISSION; ELEMENTARY BODIES; GENETIC DIVERSITY; CROSS-IMMUNITY; HEARTWATER; IMMUNIZATION; PROTECTION	Heartwater, or cowdriosis, is a tick-borne disease of domestic and wild ruminants that is endemic in the Caribbean and sub-Saharan Africa. The disease is caused by an intracellular pathogen, Ehrlichia ruminantium and may be fatal within days of the onset of clinical signs with mortality rates of up to 90% in susceptible hosts. Due to the presence of competent tick vectors in North America, there is substantial risk of introduction of heartwater with potentially devastating consequences to the domestic livestock industry. There is currently no reliable or safe vaccine for use globally. To develop a protective DIVA (differentiate infected from vaccinated animals) subunit vaccine for heartwater, we targeted the E. ruminantium immunodominant major antigenic protein1 (MAP1) with the hypothesis that MAP1 is a glycosylated protein and glycans contained in the antigenic protein are important epitope determinants. Using a eukaryotic recombinant baculovirus expression system, we expressed and characterized, for the first time, a glycoform profile of MAP1 of two Caribbean E. ruminantium isolates, Antigua and Gardel. We have shown that the 37-38 kDa protein corresponded to a glycosylated form of the MAP1 protein, whereas the 31-32 kDa molecular weight band represented the non-glycosylated form of the protein frequently reported in scientific literature. Three groups of sheep (n = 3-6) were vaccinated with increasing doses of a bivalent (Antigua and Gardel MAP1) rMAP1 vaccine cocktail formulation with montanide ISA25 as an adjuvant. The glycosylated recombinant subunit vaccine induced E. ruminantium-specific humoral and Th1 type T cell responses, which are critical for controlling intracellular pathogens, including E. ruminantium, in infected hosts. These results provide an important basis for development of a subunit vaccine as a novel strategy to protect susceptible livestock against heartwater in non-endemic and endemic areas.	[Faburay, Bonto; McGill, Jodi] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Jongejan, Frans] Univ Utrecht, Utrecht Ctr Tick Borne Dis, FAO Reference Ctr Ticks & Tick Borne Dis, Fac Vet Med, Yalelaan 1, Utrecht, Netherlands; [Jongejan, Frans] Univ Pretoria, Dept Vet Trop Dis, Fac Vet Sci, Private Bag X04, Onderstepoort, South Africa	Kansas State University; Utrecht University; University of Pretoria	Faburay, B (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.	bfaburay@vet.k-state.edu			Science and Technology Directorate of the United States Department of Homeland Security (DHS) [D15PC0027]	Science and Technology Directorate of the United States Department of Homeland Security (DHS)(United States Department of Homeland Security (DHS))	This project is the result of funding provided by the Science and Technology Directorate of the United States Department of Homeland Security (DHS) under Award Instrument Number: D15PC0027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adakal H, 2010, VACCINE, V28, P4573, DOI 10.1016/j.vaccine.2010.04.087; Allsopp BA, 2009, ONDERSTEPOORT J VET, V76, P81; Allsopp MTEP, 2001, J CLIN MICROBIOL, V39, P4200, DOI 10.1128/JCM.39.11.4200-4203.2001; BIRNIE EF, 1985, VET REC, V116, P121, DOI 10.1136/vr.116.5.121; Brayton KA, 1998, ANN NY ACAD SCI, V849, P247, DOI 10.1111/j.1749-6632.1998.tb11055.x; BRETSCHER PA, 1994, IMMUNOBIOLOGY, V191, P548, DOI 10.1016/S0171-2985(11)80461-4; BRETSCHER PA, 1992, SCIENCE, V257, P539, DOI 10.1126/science.1636090; Burridge MJ, 1985, PARASITOL TODAY, V1, P1; Collins N. E., 2003, VVolume 114, P121; Doyle CK, 2006, INFECT IMMUN, V74, P711, DOI 10.1128/IAI.74.1.711-720.2006; Faburay B, 2007, THESIS; Faburay B, 2007, VACCINE, V25, P7939, DOI 10.1016/j.vaccine.2007.09.002; Faburay B, 2014, VECTOR-BORNE ZOONOT, V14, P746, DOI 10.1089/vbz.2014.1650; Faburay B, 2013, VECTOR-BORNE ZOONOT, V13, P619, DOI 10.1089/vbz.2012.1285; FLESCH I, 1987, J IMMUNOL, V138, P4408; Gerrard SR, 2007, VIROLOGY, V357, P124, DOI 10.1016/j.virol.2006.08.002; Gerrard SR, 2002, J VIROL, V76, P12200, DOI 10.1128/JVI.76.23.12200-12210.2002; JONGEJAN F, 1991, RES VET SCI, V51, P24, DOI 10.1016/0034-5288(91)90025-J; JONGEJAN F, 1991, INFECT IMMUN, V59, P729, DOI 10.1128/IAI.59.2.729-731.1991; JONGEJAN F, 1992, EXP APPL ACAROL, V15, P117, DOI 10.1007/BF01275522; JONGEJAN F, 1991, VET MICROBIOL, V28, P199, DOI 10.1016/0378-1135(91)90093-U; Louw E, 2002, ANN NY ACAD SCI, V969, P147, DOI 10.1111/j.1749-6632.2002.tb04367.x; MAHAN SM, 1995, RES VET SCI, V58, P46, DOI 10.1016/0034-5288(95)90087-X; Mahan SM, 1998, VACCINE, V16, P1203, DOI 10.1016/S0264-410X(98)80120-5; Mahan SM, 2001, VET PARASITOL, V97, P295, DOI 10.1016/S0304-4017(01)00437-X; MARTINEZ D, 1994, VET IMMUNOL IMMUNOP, V41, P153, DOI 10.1016/0165-2427(94)90064-7; Martinez D, 1996, VET PARASITOL, V67, P175, DOI 10.1016/S0304-4017(96)01043-6; McBride JW, 2000, INFECT IMMUN, V68, P13, DOI 10.1128/IAI.68.1.13-18.2000; McGill JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151083; McGill JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148229; Nyika A, 2002, VACCINE, V20, P1215, DOI 10.1016/S0264-410X(01)00430-3; Nyika A, 1998, PARASITE IMMUNOL, V20, P111, DOI 10.1046/j.1365-3024.1998.00120.x; ORME IM, 1993, J IMMUNOL, V151, P518; Postigo M, 2008, VET MICROBIOL, V128, P136, DOI 10.1016/j.vetmic.2007.09.023; Pretorius A, 2007, VACCINE, V25, P2316, DOI 10.1016/j.vaccine.2006.11.061; Rogers PR, 2000, J IMMUNOL, V164, P2338, DOI 10.4049/jimmunol.164.5.2338; ROMAGNANI S, 1992, INT ARCH ALLERGY IMM, V98, P279, DOI 10.1159/000236199; Singu V, 2006, CELL MICROBIOL, V8, P1475, DOI 10.1111/j.1462-5822.2006.00727.x; Specht CA, 2007, J INFECT DIS, V196, P796, DOI 10.1086/520536; Totte P, 1997, INFECT IMMUN, V65, P236; Totte P, 1999, PARASITOL TODAY, V15, P286, DOI 10.1016/S0169-4758(99)01467-2; UILENBERG G, 1983, ADV VET SCI COMP MED, V27, P427; UILENBERG G, 1982, AM J VET RES, V43, P1279; UILENBERG G, 1983, RES VET SCI, V35, P200, DOI 10.1016/S0034-5288(18)32179-9; Vachiery N, 2008, ANN NY ACAD SCI, V1149, P191, DOI 10.1196/annals.1428.081; Vachiery N, 2006, VACCINE, V24, P4747, DOI 10.1016/j.vaccine.2006.03.031; Zweygarth E, 2005, VACCINE, V23, P1695, DOI 10.1016/j.vaccine.2004.09.030	48	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185495	10.1371/journal.pone.0185495	http://dx.doi.org/10.1371/journal.pone.0185495			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957443	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200069
J	Markussen, LK; Isidor, MS; Breining, P; Andersen, ES; Rasmussen, NE; Petersen, LI; Pedersen, SB; Richelsen, B; Hansen, JB				Markussen, Lasse K.; Isidor, Marie S.; Breining, Peter; Andersen, Elise S.; Rasmussen, Nanna E.; Petersen, Louise I.; Pedersen, Steen B.; Richelsen, Bjorn; Hansen, Jacob B.			Characterization of immortalized human brown and white pre-adipocyte cell models from a single donor	PLOS ONE			English	Article							ADIPOSE-TISSUE MITOCHONDRIA; GENE-EXPRESSION; FUNCTIONAL-CHARACTERIZATION; ENERGY-EXPENDITURE; MESSENGER-RNA; HIGH-CAPACITY; ACTIVATION; DISTINCT; MOUSE; POPULATION	Brown adipose tissue with its constituent brown adipocytes is a promising therapeutic target in metabolic disorders due to its ability to dissipate energy and improve systemic insulin sensitivity and glucose homeostasis. The molecular control of brown adipocyte differentiation and function has been extensively studied in mice, but relatively little is known about such regulatory mechanisms in humans, which in part is due to lack of human brown adipose tissue derived cell models. Here, we used retrovirus-mediated overexpression to stably integrate human telomerase reverse transcriptase (TERT) into stromal-vascular cell fractions from deep and superficial human neck adipose tissue biopsies from the same donor. The brown and white pre-adipocyte cell models (TERT-hBA and TERT-hWA, respectively) displayed a stable proliferation rate and differentiation until at least passage 20. Mature TERT-hBA adipocytes expressed higher levels of thermogenic marker genes and displayed a higher maximal respiratory capacity than mature TERT-hWA adipocytes. TERT-hBA adipocytes were UCP1-positive and responded to beta-adrenergic stimulation by activating the PKAMKK3/6-p38 MAPK signaling module and increasing thermogenic gene expression and oxygen consumption. Mature TERT-hWA adipocytes underwent efficient rosiglitazone-induced 'browning', as demonstrated by strongly increased expression of UCP1 and other brown adipocyte-enriched genes. In summary, the TERT-hBA and TERT-hWA cell models represent useful tools to obtain a better understanding of the molecular control of human brown and white adipocyte differentiation and function as well as of browning of human white adipocytes.	[Markussen, Lasse K.; Isidor, Marie S.; Andersen, Elise S.; Rasmussen, Nanna E.; Petersen, Louise I.; Hansen, Jacob B.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Breining, Peter; Pedersen, Steen B.; Richelsen, Bjorn] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Breining, Peter; Pedersen, Steen B.; Richelsen, Bjorn] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark	University of Copenhagen; Aarhus University; Aarhus University	Hansen, JB (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	jacob.hansen@bio.ku.dk	Hansen, Jacob B/F-3775-2010; Pedersen, Steen B./AAB-3331-2019	Hansen, Jacob B/0000-0001-5249-2586; Pedersen, Steen B./0000-0002-7838-8063; Isidor, Marie Sophie Lykke/0000-0003-3396-5389; Richelsen, Bjoern/0000-0001-8886-9736; Markussen, Lasse K./0000-0002-8655-3719	EU DIABAT [HEALTH-F2-2011-278373]; Novo Nordisk Foundation; Siemens Foundation; Novo Nordisk Fonden [NNF13OC0006651, NNF15OC0017634] Funding Source: researchfish	EU DIABAT; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Siemens Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants to JBH from the EU FP7 project DIABAT (HEALTH-F2-2011-278373) and The Novo Nordisk Foundation, and a grant to LKM from the Siemens Foundation.; We thank Reuven Agami (The Netherlands Cancer Institute, the Netherlands), Karsten Kristiansen (University of Copenhagen, Denmark), Christian Dani (University Nice Sophia Antipolis, France), Martin Wabitch (University of Ulm, Germany) for the kind gift of materials. This work was supported by grants to JBH from the EU FP7 project DIABAT (HEALTH-F2-2011-278373) and The Novo Nordisk Foundation, and a grant to LKM from the Siemens Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Breining P, 2016, MOL CELLULAR ENDOCRI; Collins S, 1997, ENDOCRINOLOGY, V138, P405, DOI 10.1210/en.138.1.405; COUSIN B, 1992, J CELL SCI, V103, P931; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Darimont C, 2003, CELL DEATH DIFFER, V10, P1025, DOI 10.1038/sj.cdd.4401273; Digby JE, 1998, DIABETES, V47, P138, DOI 10.2337/diabetes.47.1.138; Elabd C, 2009, STEM CELLS, V27, P2753, DOI 10.1002/stem.200; Fjeldborg K, 2014, J MOL ENDOCRINOL, V53, P227, DOI 10.1530/JME-14-0089; Hansen JB, 1999, J BIOL CHEM, V274, P2386, DOI 10.1074/jbc.274.4.2386; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hugo ER, 2006, ENDOCRINOLOGY, V147, P306, DOI 10.1210/en.2005-0989; Isidor MS, 2016, ADIPOCYTE, V5, P175, DOI 10.1080/21623945.2015.1111972; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; KERN PA, 1988, J LIPID RES, V29, P909; Kiwaki K, 2003, J COMP PHYSIOL B, V173, P675, DOI 10.1007/s00360-003-0377-1; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Liu DX, 2016, J CLIN INVEST, V126, P1704, DOI 10.1172/JCI83532; Loft A, 2015, GENE DEV, V29, P7, DOI 10.1101/gad.250829.114; Murholm M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-41; Murholm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008458; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Petruzzelli M, 2014, CELL METAB, V20, P433, DOI 10.1016/j.cmet.2014.06.011; Pisani Didier F, 2011, Front Endocrinol (Lausanne), V2, P87, DOI 10.3389/fendo.2011.00087; Porter C, 2016, CELL METAB, V24, P246, DOI 10.1016/j.cmet.2016.07.004; Ramage LE, 2016, CELL METAB, V24, P130, DOI 10.1016/j.cmet.2016.06.011; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wabitsch M, 2000, INT J CANCER, V88, P889, DOI 10.1002/1097-0215(20001215)88:6<889::AID-IJC8>3.0.CO;2-N; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue RD, 2015, NAT MED, V21, P760, DOI 10.1038/nm.3881	41	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185624	10.1371/journal.pone.0185624	http://dx.doi.org/10.1371/journal.pone.0185624			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957413	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200096
J	Xu, JJ; Zhang, JH; Zhuo, JM; Li, Y; Tian, YQ; Tan, HR				Xu, Jingjing; Zhang, Jihui; Zhuo, Jiming; Li, Yue; Tian, Yuqing; Tan, Huarong			Activation and mechanism of a cryptic oviedomycin gene cluster via the disruption of a global regulatory gene, adpA, in Streptomyces ansochromogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; metabolism; natural product biosynthesis; polyketide; transcriptional coactivator; AdpA; Streptomyces ansochromogenes; cryptic gene clusters; global regulators; oviedomycin	A-FACTOR; ANTIBIOTIC BIOSYNTHESIS; COELICOLOR A3(2); TRANSCRIPTIONAL REGULATORS; HETEROLOGOUS EXPRESSION; NIKKOMYCIN BIOSYNTHESIS; SECONDARY METABOLITES; MOLECULAR REGULATION; POLYKETIDE SYNTHASE; END-PRODUCT	Genome sequencing analysis has revealed at least 35 clusters of likely biosynthetic genes for secondary metabolites in Streptomyces ansochromogenes. Disruption of adpA encoding a global regulator (AdpA) resulted in the failure of nikkomycin production, whereas other antibacterial activities against Staphylococcus aureus, Bacillus cereus, and Bacillus subtilis were observed with the fermentation broth of adpA but not with that of the wild-type strain. Transcriptional analysis showed that a cryptic gene cluster (pks7), which shows high identity with an oviedomycin biosynthetic gene cluster (ovm), was activated in adpA. The corresponding product of pks7 was characterized as oviedomycin by MS and NMR spectroscopy. To understand the molecular mechanism of ovm activation, the roles of six regulatory genes situated in the ovm cluster were investigated. Among them, proteins encoded by co-transcribed genes ovmZ and ovmW are positive regulators of ovm. AdpA directly represses the transcription of ovmZ and ovmW. Co-overexpression of ovmZ and ovmW can relieve the repression of AdpA on ovm transcription and effectively activate oviedomycin biosynthesis. The promoter of ovmOI-ovmH is identified as the direct target of OvmZ and OvmW. This is the first report that AdpA can simultaneously activate nikkomycin biosynthesis but repress oviedomycin biosynthesis in one strain. Our findings provide an effective strategy that is able to activate cryptic secondary metabolite gene clusters by genetic manipulation of global regulatory genes.	[Xu, Jingjing; Zhang, Jihui; Zhuo, Jiming; Li, Yue; Tian, Yuqing; Tan, Huarong] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China; [Xu, Jingjing; Zhuo, Jiming; Tian, Yuqing; Tan, Huarong] Univ Chinese Acad Sci, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Tian, YQ; Tan, HR (corresponding author), Chinese Acad Sci, Inst Microbiol, Beijing 100101, Peoples R China.	tianyq@im.ac.cn; tanhr@im.ac.cn	xu, jing/GRR-8698-2022		Ministry of Science and Technology of China [2015CB150600, 2013CB734001]; National Natural Science Foundation of China [31370097, 31571281]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grants 2015CB150600 and 2013CB734001 and National Natural Science Foundation of China Grants 31370097 and 31571281. The authors declare that they have no conflicts of interest with the contents of this article.	Akanuma G, 2009, MOL MICROBIOL, V73, P898, DOI 10.1111/j.1365-2958.2009.06814.x; Anand S, 2010, NUCLEIC ACIDS RES, V38, pW487, DOI 10.1093/nar/gkq340; Baltz RH, 2006, J IND MICROBIOL BIOT, V33, P507, DOI 10.1007/s10295-005-0077-9; Bate N, 2006, MOL MICROBIOL, V62, P148, DOI 10.1111/j.1365-2958.2006.05338.x; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Du D, 2013, APPL MICROBIOL BIOT, V97, P6383, DOI 10.1007/s00253-013-4836-7; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gomez-Escribano JP, 2011, MICROB BIOTECHNOL, V4, P207, DOI 10.1111/j.1751-7915.2010.00219.x; Guo F, 2015, METAB ENG, V28, P134, DOI 10.1016/j.ymben.2014.12.006; Guyet A, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-81; Heine D, 2014, J NAT PROD, V77, P1083, DOI 10.1021/np400915p; Higashi T, 2007, J BACTERIOL, V189, P3515, DOI 10.1128/JB.00055-07; Ichinose K, 2003, MICROBIOL-SGM, V149, P1633, DOI 10.1099/mic.0.26310-0; Kalan L, 2013, CHEM BIOL, V20, P1214, DOI 10.1016/j.chembiol.2013.09.006; Kato J, 2002, J BACTERIOL, V184, P6016, DOI 10.1128/JB.184.21.6016-6025.2002; Kealey C, 2017, BIOTECHNOL LETT, V39, P805, DOI 10.1007/s10529-017-2311-8; Kharel MK, 2012, NAT PROD REP, V29, P264, DOI 10.1039/c1np00068c; Kieser T., 2000, PRACTICAL STREPTOMYC, P406; Laureti L, 2011, P NATL ACAD SCI USA, V108, P6258, DOI 10.1073/pnas.1019077108; Li Y, 2017, SCI CHINA LIFE SCI, V60, P935, DOI 10.1007/s11427-017-9115-x; Li Y, 2016, J BIOL CHEM, V291, P5406, DOI 10.1074/jbc.M115.695874; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Lombo F, 2004, CHEMBIOCHEM, V5, P1181, DOI 10.1002/cbic.200400073; Lombo F, 2009, CHEMBIOCHEM, V10, P296, DOI 10.1002/cbic.200800425; Lu C, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0359-5; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Mendez C, 2002, J NAT PROD, V65, P779, DOI 10.1021/np010555n; Metsa-Ketela M, 2004, J ANTIBIOT, V57, P502, DOI 10.7164/antibiotics.57.502; Myronovskyi M, 2011, APPL ENVIRON MICROB, V77, P5370, DOI 10.1128/AEM.00434-11; Nazari B, 2013, APPL ENVIRON MICROB, V79, P707, DOI 10.1128/AEM.02217-12; Niu GQ, 2016, FEMS MICROBIOL REV, V40, P554, DOI 10.1093/femsre/fuw012; Novakova R, 2002, GENE, V297, P197, DOI 10.1016/S0378-1119(02)00889-2; Ohnishi Y, 1999, MOL MICROBIOL, V34, P102, DOI 10.1046/j.1365-2958.1999.01579.x; Olano C, 2014, MICROB BIOTECHNOL, V7, P242, DOI 10.1111/1751-7915.12116; Paget MSB, 1999, J BACTERIOL, V181, P204, DOI 10.1128/JB.181.1.204-211.1999; Pan YY, 2009, MOL MICROBIOL, V72, P710, DOI 10.1111/j.1365-2958.2009.06681.x; Pullan ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-175; Sambrook J., 2001, MOL CLONING LAB MANU; Sherwood EJ, 2013, P NATL ACAD SCI USA, V110, pE2500, DOI 10.1073/pnas.1305392110; Starcevic A, 2008, NUCLEIC ACIDS RES, V36, P6882, DOI 10.1093/nar/gkn685; Tobes R, 2002, NUCLEIC ACIDS RES, V30, P318, DOI 10.1093/nar/30.1.318; van Wezel GP, 2009, METHOD ENZYMOL, V458, P117, DOI 10.1016/S0076-6879(09)04805-8; Wang LQ, 2009, P NATL ACAD SCI USA, V106, P8617, DOI 10.1073/pnas.0900592106; Weber T, 2009, J BIOTECHNOL, V140, P13, DOI 10.1016/j.jbiotec.2009.01.007; Xu GM, 2010, J BIOL CHEM, V285, P27440, DOI 10.1074/jbc.M110.143081; Yamazaki H, 2004, MOL MICROBIOL, V53, P555, DOI 10.1111/j.1365-2958.2004.04153.x; Yamazaki H, 2000, J BACTERIOL, V182, P4596, DOI 10.1128/JB.182.16.4596-4605.2000; Yamazaki H, 2003, J BACTERIOL, V185, P1273, DOI 10.1128/JB.185.4.1273-1283.2003; Zeng HM, 2002, CURR MICROBIOL, V45, P175, DOI 10.1007/s00284-001-0115-4; Zhong XY, 2013, SCI CHINA LIFE SCI, V56, P609, DOI 10.1007/s11427-013-4506-0; Zhou ZX, 2015, CHEMBIOCHEM, V16, P496, DOI 10.1002/cbic.201402577; Zou ZZ, 2014, MOL MICROBIOL, V94, P490, DOI 10.1111/mmi.12752	54	45	46	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19708	19720		10.1074/jbc.M117.809145	http://dx.doi.org/10.1074/jbc.M117.809145			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972184	hybrid, Green Published			2022-12-26	WOS:000416911300016
J	Bookwalter, CS; Tay, CL; McCrorie, R; Previs, MJ; Lu, HL; Krementsova, EB; Fagnant, PM; Baum, J; Trybus, KM				Bookwalter, Carol S.; Tay, Chwen L.; McCrorie, Rama; Previs, Michael J.; Lu, Hailong; Krementsova, Elena B.; Fagnant, Patricia M.; Baum, Jake; Trybus, Kathleen M.			Reconstitution of the core of the malaria parasite glideosome with recombinant Plasmodium class XIV myosin A and Plasmodium actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; chaperone; malaria; myosin; parasite; Plasmodium falciparum; myosin XIV; glideosome; malaria; myosin light chain; MTIP; UCS family chaperone	SKELETAL-MUSCLE MYOSIN; LIGHT-CHAIN; ESCHERICHIA-COLI; CELL INVASION; COMPLEX; MOTILITY; MOTOR; CHAPERONE; PHOSPHORYLATION; REQUIRES	Motility of the apicomplexan malaria parasite Plasmodium falciparum is enabled by a multiprotein glideosome complex, whose core is the class XIV myosin motor, PfMyoA, and a divergent Plasmodium actin (PfAct1). Parasite motility is necessary for host-cell invasion and virulence, but studying its molecular basis has been hampered by unavailability of sufficient amounts of PfMyoA. Here, we expressed milligram quantities of functional full-length PfMyoA with the baculovirus/Sf9 cell expression system, which required a UCS (UNC-45/CRO1/She4p) family myosin chaperone from Plasmodium spp. In addition to the known light chain myosin tail interacting protein (MTIP), we identified an essential light chain (PfELC) that co-purified with PfMyoA isolated from parasite lysates. The speed at which PfMyoA moved actin was fastest with both light chains bound, consistent with the light chain-binding domain acting as a lever arm to amplify nucleotide-dependent motions in the motor domain. Surprisingly, PfELC binding to the heavy chain required that MTIP also be bound to the heavy chain, unlike MTIP that bound the heavy chain independently of PfELC. Neither the presence of calcium nor deletion of the MTIP N-terminal extension changed the speed of actin movement. Of note, PfMyoA moved filaments formed from Sf9 cell-expressed PfAct1 at the same speed as skeletal muscle actin. Duty ratio estimates suggested that as few as nine motors can power actin movement at maximal speed, a feature that may be necessitated by the dynamic nature of Plasmodium actin filaments in the parasite. In summary, we have reconstituted the essential core of the glideosome, enabling drug targeting of both of its core components to inhibit parasite invasion.	[Bookwalter, Carol S.; Previs, Michael J.; Lu, Hailong; Krementsova, Elena B.; Fagnant, Patricia M.; Trybus, Kathleen M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Tay, Chwen L.; McCrorie, Rama; Baum, Jake] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England; [Tay, Chwen L.] NHSBT, Bristol BS34 7QH, Avon, England	University of Vermont; Imperial College London	Trybus, KM (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Hlth Sci Res Facil 132, Burlington, VT 05405 USA.	kathleen.trybus@uvm.edu	lu, hailong/C-7754-2009	Baum, Jake/0000-0002-0275-352X	National Institutes of Health [AI117476, AI132378, HL124041]; Wellcome Trust Investigator Award [100993/Z/13/Z]; Human Frontier Science Organization Young Investigator Program [RGY0066/2016]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL124041, K99HL124041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117476, R01AI132378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Investigator Award(Wellcome Trust); Human Frontier Science Organization Young Investigator Program(Human Frontier Science Program); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants AI117476 and AI132378 (to K. M. T.) and HL124041 (to M. J. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Wellcome Trust Investigator Award 100993/Z/13/Z and Human Frontier Science Organization Young Investigator Program Award RGY0066/2016.	Baca AM, 2000, INT J PARASITOL, V30, P113, DOI 10.1016/S0020-7519(00)00019-9; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; BEMENT WM, 1995, CELL MOTIL CYTOSKEL, V31, P87, DOI 10.1002/cm.970310202; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Bird JE, 2014, P NATL ACAD SCI USA, V111, P12390, DOI 10.1073/pnas.1409459111; Bookwalter CS, 2014, J BIOL CHEM, V289, P30832, DOI 10.1074/jbc.M114.572453; Bosch J, 2006, P NATL ACAD SCI USA, V103, P4852, DOI 10.1073/pnas.0510907103; Bosch J, 2007, J MOL BIOL, V372, P77, DOI 10.1016/j.jmb.2007.06.016; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Frenal K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15710; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Green JL, 2006, J MOL BIOL, V355, P933, DOI 10.1016/j.jmb.2005.11.027; Hellerschmied D, 2014, CURR OPIN STRUC BIOL, V25, P9, DOI 10.1016/j.sbi.2013.11.002; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Kinose F, 1996, J CELL BIOL, V134, P895, DOI 10.1083/jcb.134.4.895; Koldewey P, 2017, J BIOL CHEM, V292, P12010, DOI 10.1074/jbc.R117.796862; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LI SJ, 1993, J BACTERIOL, V175, P332, DOI 10.1128/JB.175.2.332-340.1993; LOWEY S, 1993, J BIOL CHEM, V268, P20414; Lu H, 2015, P NATL ACAD SCI USA, V112, pE4168, DOI 10.1073/pnas.1507587112; Nebl T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002222; Olshina MA, 2016, FASEB J, V30, P405, DOI 10.1096/fj.15-276618; Periz J, 2017, ELIFE, V6, DOI [10.7554/eLife.24119, 10.7554/elife.24119]; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Previs MJ, 2008, ANAL CHEM, V80, P5864, DOI 10.1021/ac800337v; Rohrbach P, 2005, J BIOL CHEM, V280, P27960, DOI 10.1074/jbc.M500777200; Srikakulam R, 2004, J CELL SCI, V117, P641, DOI 10.1242/jcs.00899; Tardieux I, 2016, J CELL BIOL, V214, P507, DOI 10.1083/jcb.201605100; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trybus KM, 2000, METHODS, V22, P327, DOI 10.1006/meth.2000.1085; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Vahokoski J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004091; Warshaw DM, 2000, J BIOL CHEM, V275, P37167, DOI 10.1074/jbc.M006438200; Warshaw DM, 2004, J MUSCLE RES CELL M, V25, P467, DOI 10.1007/s10974-004-1767-z; Weith A, 2012, J MOL CELL CARDIOL, V52, P219, DOI 10.1016/j.yjmcc.2011.09.019; Williams MJ, 2015, MBIO, V6, DOI 10.1128/mBio.00845-15; World Health Organization, 2016, 2014 WORLD MAL REP; Wright MH, 2014, NAT CHEM, V6, P112, DOI [10.1038/NCHEM.1830, 10.1038/nchem.1830]	43	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19290	19303		10.1074/jbc.M117.813972	http://dx.doi.org/10.1074/jbc.M117.813972			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28978649	Green Published, hybrid			2022-12-26	WOS:000416226700012
J	Chu, YD; Tu, T; Penttinen, L; Xue, XL; Wang, XY; Yi, ZL; Gong, L; Rouvinen, J; Luo, HY; Hakulinen, N; Yao, B; Su, XY				Chu, Yindi; Tu, Tao; Penttinen, Leena; Xue, Xianli; Wang, Xiaoyu; Yi, Zhuolin; Gong, Li; Rouvinen, Juha; Luo, Huiying; Hakulinen, Nina; Yao, Bin; Su, Xiaoyun			Insights into the roles of non-catalytic residues in the active site of a GH10 xylanase with activity on cellulose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellulase; crystal structure; glycoside hydrolase; molecular docking; mutagenesis; bifunctional; biofuels; GH10; xylanase	BACTERIUM CALDICELLULOSIRUPTOR-BESCII; HYDROLASE FAMILY 10; ANAEROCELLUM-THERMOPHILUM; SACCHAROMYCES-CEREVISIAE; MOLECULAR-DYNAMICS; CATALYTIC DOMAINS; ESCHERICHIA-COLI; PLANT BIOMASS; FORCE-FIELD; DSM 6725	Bifunctional glycoside hydrolases have potential for cost-savings in enzymatic decomposition of plant cell wall polysaccharides for biofuels and bio-based chemicals. The N-terminal GH10 domain of a bifunctional multimodular enzyme CbXyn10C/Cel48B from Caldicellulosiruptor bescii is an enzyme able to degrade xylan and cellulose simultaneously. However, the molecular mechanism underlying its substrate promiscuity has not been elucidated. Herein, we discovered that the binding cleft of CbXyn10C would have at least six sugar-binding subsites by using isothermal titration calorimetry analysis of the inactive E140Q/E248Q mutant with xylo- and cello-oligosaccharides. This was confirmed by determining the catalytic efficiency of the wild-type enzyme on these oligosaccharides. The free form and complex structures of CbXyn10C with xylose- or glucose-configured oligosaccharide ligands were further obtained by crystallographic analysis and molecular modeling and docking. CbXyn10C was found to have a typical (/)(8)-TIM barrel fold and salad-bowl shape of GH10 enzymes. In complex structures with xylo-oligosaccharides, seven sugar-binding subsites were found, and many residues responsible for substrate interactions were identified. Site-directed mutagenesis indicated that 6 and 10 amino acid residues were key residues for xylan and cellulose hydrolysis, respectively. The most important residues are centered on subsites -2 and -1 near the cleavage site, whereas residues playing moderate roles could be located at more distal regions of the binding cleft. Manipulating the residues interacting with substrates in the distal regions directly or indirectly improved the activity of CbXyn10C on xylan and cellulose. Most of the key residues for cellulase activity are conserved across GH10 xylanases. Revisiting randomly selected GH10 enzymes revealed unreported cellulase activity, indicating that the dual function may be a more common phenomenon than has been expected.	[Chu, Yindi; Tu, Tao; Xue, Xianli; Wang, Xiaoyu; Gong, Li; Luo, Huiying; Yao, Bin; Su, Xiaoyun] Chinese Acad Agr Sci, Feed Res Inst, Key Lab Feed Biotechnol, Minist Agr, Beijing 100081, Peoples R China; [Penttinen, Leena; Rouvinen, Juha; Hakulinen, Nina] Univ Eastern Finland, Dept Chem, Joensuu Campus, FIN-80101 Joensuu, Finland; [Yi, Zhuolin] Chinese Acad Sci, Chengdu Inst Biol, Chengdu 610041, Sichuan, Peoples R China; [Gong, Li] Zhejiang Univ, Coll Anim Sci, Key Lab Mol Anim Nutr & Feed Sci, Hangzhou 310058, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; University of Eastern Finland; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Zhejiang University	Hakulinen, N (corresponding author), Univ Eastern Finland, POB 111,Yliopistokatu 7, FIN-80101 Joensuu, Finland.; Yao, B; Su, XY (corresponding author), Feed Res Inst, 12 S Zhongguancun St, Beijing 100081, Peoples R China.	nina.hakulinen@uef.fi; binyao@caas.cn; suxiaoyun@caas.cn		Hakulinen, Nina/0000-0003-4471-7188; Penttinen, Leena/0000-0002-7847-1676; Rouvinen, Juha/0000-0003-1843-5718	National Natural Science Foundation of China [31672458]; National Key Research and Development Program of China [2016YFD0501409-02]; China Modern Agriculture Research System [CARS-42]; Elite Youth Program of Chinese Academy of Agricultural Sciences; Academy of Finland [287241, 292705]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; China Modern Agriculture Research System; Elite Youth Program of Chinese Academy of Agricultural Sciences; Academy of Finland(Academy of Finland)	This work was supported by National Natural Science Foundation of China Grant 31672458, National Key Research and Development Program of China Grant 2016YFD0501409-02, China Modern Agriculture Research System Grant CARS-42, and the Elite Youth Program of Chinese Academy of Agricultural Sciences. The work at University of Eastern Finland was conducted with financial support from the Academy of Finland (grant decisions 287241 and 292705). The authors declare that they have no conflicts of interest with the contents of this article.	Andrews SR, 2000, J BIOL CHEM, V275, P23027, DOI 10.1074/jbc.M000128200; BIELY P, 1981, EUR J BIOCHEM, V119, P559, DOI 10.1111/j.1432-1033.1981.tb05644.x; Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273; Charnock SJ, 1998, J BIOL CHEM, V273, P32187, DOI 10.1074/jbc.273.48.32187; Dam P, 2011, NUCLEIC ACIDS RES, V39, P3240, DOI 10.1093/nar/gkq1281; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Groot J, 2017, BIOTECHNOL BIOENG, V114, P885, DOI 10.1002/bit.26217; Ha SJ, 2011, P NATL ACAD SCI USA, V108, P504, DOI 10.1073/pnas.1010456108; Han YJ, 2010, J BACTERIOL, V192, P4111, DOI 10.1128/JB.00257-10; Hong SY, 2006, BIOTECHNOL LETT, V28, P1857, DOI 10.1007/s10529-006-9166-8; Ichinose H, 2012, PROCESS BIOCHEM, V47, P358, DOI 10.1016/j.procbio.2011.06.002; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kataeva I, 2013, ENERG ENVIRON SCI, V6, P2186, DOI 10.1039/c3ee40932e; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Lochner A, 2011, APPL ENVIRON MICROB, V77, P4042, DOI 10.1128/AEM.02811-10; MATSUI I, 1991, J BIOCHEM-TOKYO, V109, P566, DOI 10.1093/oxfordjournals.jbchem.a123420; Mckee LS, 2012, P NATL ACAD SCI USA, V109, P6537, DOI 10.1073/pnas.1117686109; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Nakazawa H, 2008, APPL MICROBIOL BIOT, V81, P681, DOI 10.1007/s00253-008-1667-z; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Solomon V, 2007, ACTA CRYSTALLOGR D, V63, P845, DOI 10.1107/S0907444907024845; Speciale G, 2014, CURR OPIN STRUC BIOL, V28, P1, DOI 10.1016/j.sbi.2014.06.003; Su XY, 2013, APPL ENVIRON MICROB, V79, P1481, DOI 10.1128/AEM.03265-12; Su XY, 2012, APPL ENVIRON MICROB, V78, P2230, DOI 10.1128/AEM.06814-11; Sun HH, 2016, ANGEW CHEM INT EDIT, V55, P14275, DOI 10.1002/anie.201606722; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wickstrom L, 2009, BIOPHYS J, V97, P853, DOI 10.1016/j.bpj.2009.04.063; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Xue XL, 2015, APPL ENVIRON MICROB, V81, P3823, DOI 10.1128/AEM.00432-15; Yang SJ, 2010, INT J SYST EVOL MICR, V60, P2011, DOI 10.1099/ijs.0.017731-0; Yang SJ, 2009, APPL ENVIRON MICROB, V75, P4762, DOI 10.1128/AEM.00236-09; Ye LB, 2012, APPL ENVIRON MICROB, V78, P7048, DOI 10.1128/AEM.02009-12; Yi ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084172; Zhao L, 2013, PROCESS BIOCHEM, V48, P1879, DOI 10.1016/j.procbio.2013.08.020; Zhou JP, 2009, APPL MICROBIOL BIOT, V85, P323, DOI 10.1007/s00253-009-2081-x; Zolotnitsky G, 2004, P NATL ACAD SCI USA, V101, P11275, DOI 10.1073/pnas.0404311101; Zverlov V, 1998, MICROBIOL-SGM, V144, P457, DOI 10.1099/00221287-144-2-457	41	26	27	2	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19315	19327		10.1074/jbc.M117.807768	http://dx.doi.org/10.1074/jbc.M117.807768			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28974575	Green Published, hybrid			2022-12-26	WOS:000416226700014
J	Nogal, B; Bowman, CA; Ward, AB				Nogal, Bartek; Bowman, Charles A.; Ward, Andrew B.			Time-course, negative-stain electron microscopy-based analysis for investigating protein-protein interactions at the single-molecule level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electron microscopy (EM); glycoprotein; human immunodeficiency virus (HIV); kinetics; protein-protein interaction; broadly neutralizing antibodies; single-particle analysis	BROADLY NEUTRALIZING ANTIBODIES; HIV-1 ENVELOPE GLYCOPROTEIN; CRYO-EM STRUCTURE; TREATMENT INTERRUPTION; CD4 BINDING; TRIMER; 3BNC117; SYSTEM; IMAGES; VRC01	Several biophysical approaches are available to study protein-protein interactions. Most approaches are conducted in bulk solution, and are therefore limited to an average measurement of the ensemble of molecular interactions. Here, we show how single-particle EM can enrich our understanding of protein-protein interactions at the single-molecule level and potentially capture states that are unobservable with ensemble methods because they are below the limit of detection or not conducted on an appropriate time scale. Using the HIV-1 envelope glycoprotein (Env) and its interaction with receptor CD4-binding site neutralizing antibodies as a model system, we both corroborate ensemble kinetics-derived parameters and demonstrate how time-course EM can further dissect stoichiometric states of complexes that are not readily observable with other methods. Visualization of the kinetics and stoichiometry of Env-antibody complexes demonstrated the applicability of our approach to qualitatively and semi-quantitatively differentiate two highly similar neutralizing antibodies. Furthermore, implementation of machine-learning techniques for sorting class averages of these complexes into discrete subclasses of particles helped reduce human bias. Our data provide proof of concept that single-particle EM can be used to generate a visual kinetic profile that should be amenable to studying many other protein-protein interactions, is relatively simple and complementary to well-established biophysical approaches. Moreover, our method provides critical insights into broadly neutralizing antibody recognition of Env, which may inform vaccine immunogen design and immunotherapeutic development.	[Nogal, Bartek; Bowman, Charles A.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Ward, AB (corresponding author), 10550 North Torrey Pines Rd,Mail Code TRY-21, La Jolla, CA 92037 USA.	andrew@scripps.edu	Ward, Andrew/ABD-7728-2021; Ward, Andrew B/F-9203-2014	Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769	Bill and Melinda Gates Foundation [OPP1115782]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by Bill and Melinda Gates Foundation Grant OPP1115782. The authors declare that they have no conflicts of interest with the contents of this article.	Balla-Jhagjhoorsingh SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068863; Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243; Behrens AJ, 2016, CELL REP, V14, P2695, DOI 10.1016/j.celrep.2016.02.058; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chen B, 2015, STRUCTURE, V23, P1097, DOI 10.1016/j.str.2015.04.007; Ciompi F, 2015, IEEE T MED IMAGING, V34, P962, DOI 10.1109/TMI.2014.2371821; Derking R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004767; Gray GE, 2016, CURR OPIN VIROL, V17, P104, DOI 10.1016/j.coviro.2016.02.010; Gristick HB, 2016, NAT STRUCT MOL BIOL, V23, P906, DOI 10.1038/nsmb.3291; Julien JP, 2015, P NATL ACAD SCI USA, V112, P11947, DOI 10.1073/pnas.1507793112; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kong L, 2016, IMMUNITY, V44, P939, DOI 10.1016/j.immuni.2016.03.006; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lee J.S., 2015, NAT COMMUN, V6; Lu CL, 2016, SCIENCE, V352, P1001, DOI 10.1126/science.aaf1279; Lynch RM, 2015, J VIROL, V89, P4201, DOI 10.1128/JVI.03608-14; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; McCoy LE, 2016, CELL REP, V16, P2327, DOI 10.1016/j.celrep.2016.07.074; Mulder AM, 2010, SCIENCE, V330, P673, DOI 10.1126/science.1193220; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Rich R. L., 2011, LABEL FREE TECHNOLOG; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schoofs T, 2016, SCIENCE, V352, P997, DOI 10.1126/science.aaf0972; Shammas SL, 2016, J BIOL CHEM, V291, P6689, DOI 10.1074/jbc.R115.692715; Stephenson KE, 2016, CURR HIV-AIDS REP, V13, P31, DOI 10.1007/s11904-016-0299-7; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wang WB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-14; Ward AB, 2017, IMMUNOL REV, V275, P21, DOI 10.1111/imr.12507; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	40	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19400	19410		10.1074/jbc.M117.808352	http://dx.doi.org/10.1074/jbc.M117.808352			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972148	hybrid, Green Published			2022-12-26	WOS:000416226700021
J	Rasouli, S; Abdolvahabi, A; Croom, CM; Plewman, DL; Shi, YH; Ayers, JI; Shaw, BF				Rasouli, Sanaz; Abdolvahabi, Alireza; Croom, Corbin M.; Plewman, Devon L.; Shi, Yunhua; Ayers, Jacob I.; Shaw, Bryan F.			Lysine acylation in superoxide dismutase-1 electrostatically inhibits formation of fibrils with prion-like seeding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); fibril; oligomer; protein aggregation; lysine acetylation; motor neuron disease; succinylation	AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN CHARGE LADDERS; WILD-TYPE SOD1; CAPILLARY-ELECTROPHORESIS; TRANSGENIC MICE; ALPHA-SYNUCLEIN; SPORADIC ALS; LINKED SOD1; NET CHARGE; AGGREGATION	The acylation of lysine residues in superoxide dismutase-1 (SOD1) has been previously shown to decrease its rate of nucleation and elongation into amyloid-like fibrils linked to amyotrophic lateral sclerosis. The chemical mechanism underlying this effect is unclear, i.e. hydrophobic/steric effects versus electrostatic effects. Moreover, the degree to which the acylation might alter the prion-like seeding of SOD1 in vivo has not been addressed. Here, we acylated a fraction of lysine residues in SOD1 with groups of variable hydrophobicity, charge, and conformational entropy. The effect of each acyl group on the rate of SOD1 fibril nucleation and elongation were quantified in vitro with thioflavin-T (ThT) fluorescence, and we performed 594 iterate aggregation assays to obtain statistically significant rates. The effect of the lysine acylation on the prion-like seeding of SOD1 was assayed in spinal cord extracts of transgenic mice expressing a G85R SOD1-yellow fluorescent protein construct. Acyl groups with >2 carboxylic acids diminished self-assembly into ThT-positive fibrils and instead promoted the self-assembly of ThT-negative fibrils and amorphous complexes. The addition of ThT-negative, acylated SOD1 fibrils to organotypic spinal cord failed to produce the SOD1 inclusion pathology that typically results from the addition of ThT-positive SOD1 fibrils. These results suggest that chemically increasing the net negative surface charge of SOD1 via acylation can block the prion-like propagation of oligomeric SOD1 in spinal cord.	[Rasouli, Sanaz; Abdolvahabi, Alireza; Croom, Corbin M.; Plewman, Devon L.; Shi, Yunhua; Shaw, Bryan F.] Baylor Univ, Dept Chem & Biochem, Waco, TX 76706 USA; [Rasouli, Sanaz] Baylor Univ, Inst Biomed Studies, Waco, TX 76706 USA; [Ayers, Jacob I.] Univ Florida, Dept Neurosci, Gainesville, FL 32611 USA	Baylor University; Baylor University; State University System of Florida; University of Florida	Shaw, BF (corresponding author), Baylor Univ, Dept Chem & Biochem, Waco, TX 76706 USA.	bryan_shaw@baylor.edu	Ayers, Jacob/AAQ-7158-2021	Ayers, Jacob/0000-0003-4544-2366	National Science Foundation [CHE 1352122]; Welch Foundation [AA-1854]; NINDS, National Institutes of Health [1R01NA092788-01]; Division Of Chemistry [1352122] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Science Foundation Grant CHE 1352122 (to B. F. S.), Welch Foundation Grant AA-1854 (to B. F. S.), and NINDS, National Institutes of Health Grant 1R01NA092788-01 (to J. I. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdolvahabi A, 2017, ACS CHEM NEUROSCI, V8, P1378, DOI 10.1021/acschemneuro.7b00029; Abdolvahabi A, 2016, ACS CHEM NEUROSCI, V7, P799, DOI 10.1021/acschemneuro.6b00048; Abdolvahabi A, 2015, BIOPHYS J, V108, P1199, DOI 10.1016/j.bpj.2015.01.014; Alfonso LF, 2009, MOL MED REP, V2, P533, DOI 10.3892/mmr_00000132; Antinone SE, 2013, J BIOL CHEM, V288, P21606, DOI 10.1074/jbc.M113.487231; Ayers JI, 2016, ACTA NEUROPATHOL, V132, P827, DOI 10.1007/s00401-016-1623-4; Ayyadevara S., 2017, ANTIOXID RE IN PRESS; Banks CJ, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00354-17; Bateman LA, 2013, J AM CHEM SOC, V135, P14568, DOI 10.1021/ja408322b; Carbeck JD, 1998, ACCOUNTS CHEM RES, V31, P343, DOI 10.1021/ar970255q; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Cohen TJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6845; Cook C, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt259; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Eisele YS, 2015, NAT REV DRUG DISCOV, V14, P759, DOI 10.1038/nrd4593; Felder CE, 2007, NUCLEIC ACIDS RES, V35, pW512, DOI 10.1093/nar/gkm307; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Frutiger K, 2008, AMYOTROPH LATERAL SC, V9, P184, DOI 10.1080/17482960801984358; Fukada K, 2001, EUR J NEUROSCI, V14, P2032, DOI 10.1046/j.0953-816x.2001.01828.x; Furukawa Y, 2016, J BIOL CHEM, V291, P4144, DOI 10.1074/jbc.M115.683763; Gitlin I, 2003, J PHYS CHEM B, V107, P1466, DOI 10.1021/jp027066w; Gitlin I, 2006, ANGEW CHEM INT EDIT, V45, P3022, DOI 10.1002/anie.200502530; Ivanova MI, 2014, P NATL ACAD SCI USA, V111, P197, DOI 10.1073/pnas.1320786110; Iyer A, 2016, J BIOL CHEM, V291, P21110, DOI 10.1074/jbc.M116.726612; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kruger NJ, 2009, SPRINGER PROTOC HAND, P17, DOI 10.1007/978-1-59745-198-7_4; Kundu B, 1999, PROTEINS, V37, P321, DOI 10.1002/(SICI)1097-0134(19991115)37:3<321::AID-PROT1>3.0.CO;2-L; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; de Lavor MSL, 2015, INT J CLIN EXP PATHO, V8, P9941; Menon MK, 2000, ANAL CHEM, V72, P5714, DOI 10.1021/ac000752b; Mompean M, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002447; Nagy M, 2016, P NATL ACAD SCI USA, V113, P5424, DOI 10.1073/pnas.1604885113; Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9; Profit AA, 2017, BIOCONJUGATE CHEM, V28, P666, DOI 10.1021/acs.bioconjchem.6b00732; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Rich JT, 2010, OTOLARYNG HEAD NECK, V143, P331, DOI 10.1016/j.otohns.2010.05.007; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; Rotunno MS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00253; Sangwan S, 2017, P NATL ACAD SCI USA, V114, P8770, DOI 10.1073/pnas.1705091114; Schmitt ND, 2017, J MASS SPECTROM, V52, P480, DOI 10.1002/jms.3953; Shaw BF, 2008, PROTEIN SCI, V17, P1446, DOI 10.1110/ps.035154.108; Shaw BF, 2010, J AM CHEM SOC, V132, P17411, DOI 10.1021/ja9067035; Shi YH, 2015, ACS CHEM NEUROSCI, V6, P1696, DOI 10.1021/acschemneuro.5b00146; Shi Y, 2014, PROTEIN SCI, V23, P1417, DOI 10.1002/pro.2526; Shi YH, 2013, J MOL BIOL, V425, P4388, DOI 10.1016/j.jmb.2013.07.018; Shi YH, 2013, J AM CHEM SOC, V135, P15897, DOI 10.1021/ja407801x; Tanaka M, 2015, NAT CHEM BIOL, V11, P373, DOI 10.1038/nchembio.1818; Tatham MH, 2017, MOL CELL PROTEOMICS, V16, P310, DOI 10.1074/mcp.O116.065219; Taylor JD, 2016, SCI REP-UK, V6, DOI 10.1038/srep24656; Walker JM, 2009, SPRINGER PROTOC HAND, P11, DOI 10.1007/978-1-59745-198-7_3; Wang J, 2009, P NATL ACAD SCI USA, V106, P1392, DOI 10.1073/pnas.0813045106; Wang LJ, 2009, HUM MOL GENET, V18, P1642, DOI 10.1093/hmg/ddp085; Xu GL, 2015, HUM MOL GENET, V24, P1019, DOI 10.1093/hmg/ddu517; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109; Younan ND, 2015, BIOCHEMISTRY-US, V54, P4297, DOI 10.1021/acs.biochem.5b00309	58	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19366	19380		10.1074/jbc.M117.805283	http://dx.doi.org/10.1074/jbc.M117.805283			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28974578	Green Published, hybrid			2022-12-26	WOS:000416226700018
J	de Beaufort, HWL; Coda, M; Conti, M; van Bakel, TMJ; Nauta, FJH; Lanzarone, E; Moll, FL; van Herwaarden, JA; Auricchio, F; Trimarchi, S				de Beaufort, Hector W. L.; Coda, Margherita; Conti, Michele; van Bakel, Theodorus M. J.; Nauta, Foeke J. H.; Lanzarone, Ettore; Moll, Frans L.; van Herwaarden, Joost A.; Auricchio, Ferdinando; Trimarchi, Santi			Changes in aortic pulse wave velocity of four thoracic aortic stent grafts in an ex vivo porcine model	PLOS ONE			English	Article							ASCENDING AORTA; ARTERIAL STIFFNESS; WALL; DISSECTION; ENDOGRAFTS; MECHANICS; ANEURYSMS; TISSUES; DEVICE; VALVES	Objectives Thoracic endovascular aortic repair (TEVAR) has been shown to lead to increased aortic stiffness. The aim of this study was to investigate the effect of stent graft type and stent graft length on aortic stiffness in a controlled, experimental setting. Methods Twenty porcine thoracic aortas were connected to a pulsatile mock loop system. Intraluminal pressure was recorded at two sites in order to measure pulse wave velocity (PWV) for each aorta: before stent graft deployment (t(1)); after deployment of a 100-mm long stent graft (t(2)); and after distal extension through deployment of a second 100-mm long stent graft (t(3)). Four different types of stent grafts (Conformable Gore (R) TAG (R) Device, Bolton Relay (R) Device, Cook Zenith Alpha (TM), and Medtronic Valiant (R)) were evaluated. Results For the total cohort of 20 aortas, PWV increased by a mean 0.6 m/s or 8.9% of baseline PWV after deployment of a 100-mm proximal stent graft (P<0.001), and by a mean 1.4 m/s or 23.0% of baseline PWV after distal extension of the stent graft (P<0.001). Univariable regression analysis showed a significant correlation between aortic PWV and extent of stent graft coverage, (P<0.001), but no significant effect of baseline aortic length, baseline aortic PWV, or stent graft type on the percentual increase in PWV at t(2) or at t(3). Conclusions In this experimental set-up, aortic stiffness increased significantly after stent graft deployment with each of the four types of stent graft, with the increase in aortic stiffness depending on the extent of stent graft coverage.	[de Beaufort, Hector W. L.; van Bakel, Theodorus M. J.; Nauta, Foeke J. H.; Trimarchi, Santi] Univ Milan, Policlin San Donato IRCCS, Thorac Aort Res Ctr, San Donato Milanese, Italy; [Coda, Margherita; Conti, Michele; Auricchio, Ferdinando] Univ Pavia, Dept Civil Engn & Architecture, Pavia, Italy; [Lanzarone, Ettore] Natl Res Council Italy CNR, IMATI, Milan, Italy; [Moll, Frans L.; van Herwaarden, Joost A.] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands	IRCCS Policlinico San Donato; University of Milan; University of Pavia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Matematica Applicata e Tecnologie Informatiche "Enrico Magenes" (IMATI-CNR); Utrecht University; Utrecht University Medical Center	Trimarchi, S (corresponding author), Univ Milan, Policlin San Donato IRCCS, Thorac Aort Res Ctr, San Donato Milanese, Italy.	santi.trimarchi@grupposandonato.it	Stefanadis, Christodoulos/ABH-2232-2020; Conti, Michele/J-3580-2014; van Bakel, Theodorus/K-4994-2019; Auricchio, Ferdinando/B-9405-2009; Lanzarone, Ettore/G-1560-2011	Stefanadis, Christodoulos/0000-0001-5974-6454; Conti, Michele/0000-0003-1275-0653; van Bakel, Theodorus/0000-0001-5317-3026; Auricchio, Ferdinando/0000-0002-3735-2400; van Herwaarden, Joost/0000-0003-1165-5179; Lanzarone, Ettore/0000-0001-8816-9086	ERC [259229]; Ministero dell'Istruzione, dell'Universita e della Ricerca [2010BFXRHS]; iCardioCloud project by Cariplo Foundation [2013-1779]; Lombardy Region [42938382, 46554874]; European Society of Vascular Surgery	ERC(European Research Council (ERC)European Commission); Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); iCardioCloud project by Cariplo Foundation; Lombardy Region(Regione Lombardia); European Society of Vascular Surgery	This work was supported by: ERC Starting Grant through the Project ISOBIO: Isogeometric Methods for Biomechanics [No. 259229]; Ministero dell'Istruzione, dell'Universita e della Ricerca [Project no. 2010BFXRHS], iCardioCloud project by Cariplo Foundation [no. 2013-1779] and Lombardy Region [No. 42938382; No. 46554874]. Material support was provided by Medtronic Inc, W.L. Gore & Associates, Bolton Medical, and Cook Medical. W.L. Gore & Associates have had insight into the manuscript before submitting it for publication, and have asked for correct mentioning of the name of their product in the final version of the manuscript. Hector de Beaufort gratefully acknowledges support from the European Society of Vascular Surgery by way of an Educational Travel Grant. But not W.L. Gore nor any of the other funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Beaufort HWL, 2017, ANN VASC SURG; Deplano V, 2016, J BIOMECH, V49, P2031, DOI 10.1016/j.jbiomech.2016.05.005; Eggebrecht H, 2009, CIRCULATION, V120, pS276, DOI 10.1161/CIRCULATIONAHA.108.835926; Erbel R, 2014, EUR HEART J, V35, P2873, DOI 10.1093/eurheartj/ehu281; HANNON JP, 1990, LAB ANIM SCI, V40, P293; Juraszek A, 2014, EUR J CARDIO-THORAC, V46, P349, DOI 10.1093/ejcts/ezu055; Kleinstreuer C, 2008, J BIOMECH, V41, P2370, DOI 10.1016/j.jbiomech.2008.05.032; Lanzarone E, 2009, ARTIF ORGANS, V33, P1048, DOI 10.1111/j.1525-1594.2009.00812.x; Li WC, 2008, XENOTRANSPLANTATION, V15, P384, DOI 10.1111/j.1399-3089.2008.00498.x; Liu X, 2011, J BIOMECH, V44, P1123, DOI 10.1016/j.jbiomech.2011.01.024; Liu Y, 2007, AM J PHYSIOL-HEART C, V293, pH3290, DOI 10.1152/ajpheart.00666.2007; Martin C, 2011, EUR J CARDIO-THORAC, V40, P28, DOI 10.1016/j.ejcts.2010.08.056; Morris L, 2016, EUR J VASC ENDOVASC, V51, P44, DOI 10.1016/j.ejvs.2015.07.041; Moulakakis KG, 2016, ANN VASC SURG, V1327; Nauta FJ, 2016, EUR J CARDIOTHORAC S; Nauta FJH, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012270; Nichols WW, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P1; Polzer S, 2015, ACTA BIOMATER, V14, P133, DOI 10.1016/j.actbio.2014.11.043; Qing KX, 2012, EUR J VASC ENDOVASC, V44, P399, DOI 10.1016/j.ejvs.2012.06.004; Roccabianca S, 2014, J MECH BEHAV BIOMED, V29, P618, DOI 10.1016/j.jmbbm.2013.01.026; Sugita S., 2011, CARDIOVASCULAR ENG T, V3, DOI [10.1007/s13239-011-0067-1, DOI 10.1007/S13239-011-0067-1]; Townsend RR, 2015, HYPERTENSION, V66, P698, DOI 10.1161/HYP.0000000000000033; Tzilalis VD, 2012, ANN VASC SURG, V26, P462, DOI 10.1016/j.avsg.2011.06.021; van Herwaarden JA, 2006, J ENDOVASC THER, V13, P406, DOI 10.1583/06-1848.1; van Prehn J, 2009, ANN VASC SURG, V23, P291, DOI 10.1016/j.avsg.2008.08.007; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061	26	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186080	10.1371/journal.pone.0186080	http://dx.doi.org/10.1371/journal.pone.0186080			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982135	gold, Green Published, Green Submitted			2022-12-26	WOS:000412360300120
J	de la Pena, P; Wadley, L				de la Pena, Paloma; Wadley, Lyn			Technological variability at Sibudu Cave: The end of Howiesons Poort and reduced mobility strategies after 62,000 years ago	PLOS ONE			English	Article							MIDDLE-STONE-AGE; DIEPKLOOF ROCK SHELTER; SOUTH-AFRICA; KLIPDRIFT SHELTER; BONE TECHNOLOGY; WESTERN-CAPE; OCHRE; PATTERNS; CONTINUITY; ADHESIVES	We evaluate the cultural variation between the youngest Howiesons Poort layer (GR) and the oldest post-Howiesons Poort layers (RB-YA) of Sibudu Cave (KwaZulu-Natal, South Africa). We first conducted a technological analysis, secondly we performed a cladistic study with all the technological traits and, finally, we compare the technological variability with other data from Sibudu (ochre, micromorphology, fauna and plant remains). The synapomorphies of the cladistical analysis show numerous lithic technological changes between the youngest Howiesons Poort and the oldest post-Howiesons Poort layers as previously concluded. However, some technological strategies that are present, yet uncommon, in the Howiesons Poort become abundant in the overlying layers, whereas others that were fundamental to the Howiesons Poort continue, but are poorly represented in the overlying layers. We further show that lithic technological strategies appear and disappear as pulses in the post-Howiesons Poort layers studied. Among the most notable changes in the post-Howiesons Poort layers is the importance of flake production from discoidal knapping methods, the unstandardized retouched pieces and their infrequent representation, and the higher than usual frequency of grindstones. We evaluate various hypotheses to explain the transformation of a Howiesons Poort formal industry to a more 'expedient' assemblage. Since no marked environmental changes are contemporary with the technological transformation, a change in residential mobility patterns seems a plausible explanation. This hypothesis is supported by the changes observed in stratigraphy, lithic technology, site management, ochre and firewood collection.	[de la Pena, Paloma; Wadley, Lyn] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [de la Pena, Paloma] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand	de la Pena, P (corresponding author), Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa.; de la Pena, P (corresponding author), Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa.	paloma.delapenya@gmail.com	Wadley, Lyn/AAC-6577-2022; de la Peña, Paloma/ABB-3086-2021; de la Peña, Paloma/AAA-6605-2021	de la Peña, Paloma/0000-0001-9731-7001; 	DST-National Research Foundation of South Africa Centre of Excellence in Paleosciences (CoE-Pal); DST-National Research Foundation of South Africa Centre of Excellence in Paleosciences	DST-National Research Foundation of South Africa Centre of Excellence in Paleosciences (CoE-Pal); DST-National Research Foundation of South Africa Centre of Excellence in Paleosciences	Fernando Abdala, Karim Sadr, Julien Benoit, Jerome Reynard and Aurore Val generously read the manuscript and helped us with the cladistics and discussion. The support of the DST-National Research Foundation of South Africa Centre of Excellence in Paleosciences (CoE-Pal) towards this research is hereby acknowledged. The opinions expressed in this paper are not necessarily held by the funding body.; PP has a Post-doctoral grant from DST-National Research Foundation of South Africa Centre of Excellence in Paleosciences.	Allott L.F., 2006, S AFR HUMANIT, V18, P173; Ambrose SH, EMERGENCE MODERN HUM, P3; ARCHER F M, 1990, Mitteilungen aus dem Institut fuer Allgemeine Botanik Hamburg, V23, P959; Backwell L, 2008, J ARCHAEOL SCI, V35, P1566, DOI 10.1016/j.jas.2007.11.006; Beaumont P.B., 1978, BORDER CAVE; Bentsen S. E., 2014, THESIS; Bruch AA, 2012, QUATERNARY SCI REV, V45, P7, DOI 10.1016/j.quascirev.2012.04.005; Clark JL, 2017, J HUM EVOL, V107, P49, DOI 10.1016/j.jhevol.2017.03.002; Clark JL, 2010, J ARCHAEOL SCI, V37, P2650, DOI 10.1016/j.jas.2010.06.001; Clark JL, 2008, J HUMAN EVOLUTION, V54; Clarke B.M., 2007, GEOLOGY VERULAM AREA; Cochrane G.W.G., 2006, SOUTH AFR HUMANIT, V18, P69; Cochrane G.W.G., 2008, S AFRICAN ARCHAEOLOG, V10, P157; Conard NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130001; Conard NJ, 2012, S AFR ARCHAEOL BULL, V67, P180; d'Errico F, 2007, J HUM EVOL, V52, P142, DOI 10.1016/j.jhevol.2006.08.003; d'Errico F, 2012, J ARCHAEOL SCI, V39, P2479, DOI 10.1016/j.jas.2012.01.040; de la Pen~a P., 2013, S AFR ARCHAEOL BULL, V68, P119; de la Pena P, 2015, CURR ANTHROPOL, V56, P911, DOI 10.1086/684071; DEACON HJ, 1989, HUMAN REVOLUTION, P547; Dusseldorp GL, 2014, AZANIA, V49, P317, DOI 10.1080/0067270X.2014.937080; Glenny W., 2006, SOUTH AFR HUMANIT, V18, P279; Goldberg P, 2006, PRACTICAL THEORETICA; Goldberg P, 2009, ARCHAEOL ANTHROP SCI, V1, P95, DOI 10.1007/s12520-009-0008-1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; GOULD RA, 1971, AM ANTIQUITY, V36, P149, DOI 10.2307/278668; Haidle MN, 2006, THESIS; Harper PTH, 1997, THESIS; Harper PTN, 1997, S AFR J SCI, V93, P470; HAYDEN B, 1979, PALEOLITHIC REFLECTI; Henshilwood CS, 2014, J ARCHAEOL SCI, V45, P284, DOI 10.1016/j.jas.2014.01.033; Herries, 2006, SOUTH AFR HUMANIT, V18, P131; Hodgskiss T, 2013, J AFR ARCHAEOL, V11, P75, DOI 10.3213/2191-5784-10232; Hodgskiss T, 2012, SOUTH AFR HUMANIT, V24, P99; Igreja M, 2013, J ARCHAEOLOGICAL SCI, V40; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Jacobs Z, 2008, J ARCHAEOL SCI, V35, P1790, DOI 10.1016/j.jas.2007.11.028; Lennox S, 2016, THESIS; Lombard M, 2012, S AFRICAN ARCHAEOLOG, V67; Lombard M., 2007, THESIS; Lombard M, 2008, J ARCHAEOL SCI, V35, P26, DOI 10.1016/j.jas.2007.02.021; Lombard M, 2007, J HUM EVOL, V53, P406, DOI 10.1016/j.jhevol.2007.05.004; Lombard M, 2011, ANTIQUITY, V85, P1433, DOI 10.1017/S0003598X00062153; Lombard M, 2010, ANTIQUITY, V84, P635, DOI 10.1017/S0003598X00100134; Lourandos Harry, 1985, ARCHAEOL OCEAN, V20, P37; Lycett SJ, 2011, J EVOLUTIONARY PSYCH, V9, P143, DOI [DOI 10.1016/J.JAA.2007.07.003, DOI 10.1556/JEP.9.2011.23.1]; Lycett SJ, 2015, J ARCHAEOL SCI, V56, P21, DOI 10.1016/j.jas.2015.01.004; MacCalman NR, 1965, CIMBEBASIA, V13, P1; Mackay A, 2014, J HUMAN EVOLUTION, V72; Mackay A, 2008, J ARCHAEOL SCI, V35, P1521, DOI 10.1016/j.jas.2007.10.015; Mackay A, 2011, J ARCHAEOL SCI, V38, P1430, DOI 10.1016/j.jas.2011.02.006; MADDISON W.P., 2001, MESQUITE MODULAR SYS; Marean CW, 2014, FYNBOS: ECOLOGY, EVOLUTION, AND CONSERVATION OF A MEGADIVERSE REGION, P164; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McCall GS, 2007, J ARCHAEOL SCI, V34, P1738, DOI 10.1016/j.jas.2006.12.015; McCall GS, 2012, AFR ARCHAEOL REV, V29, P7, DOI 10.1007/s10437-012-9107-y; MILLER TO, 1979, LITHIC USE WEAR ANAL, P401; Mitchell P., 2008, S AFRICAN ARCHAEOLOG, V10, P52; Oswalt W. H, 1976, ANTHR ANAL FOOD GETT; Parry WJ., 1987, ORG CORE TECHNOLOGY, P285; Perreault C, 2013, CURR ANTHROPOL, V54, pS397, DOI 10.1086/673264; Porraz G, 2013, J ARCHAEOL SCI, V40, P3376, DOI 10.1016/j.jas.2013.02.012; Rautenbach I. L., 1982, MAMMALS TRANSVAAL; Renaut R., 2006, SOUTH AFR HUMANIT, V18, P235; Reynard JP, 2016, PALAEOGEOGR PALAEOCL, V449, P349, DOI 10.1016/j.palaeo.2016.02.035; Roberts P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157408; Schiegl S, 2004, S AFR J SCI, V100, P185; Schiegl S., 2006, SOUTH AFR HUMANIT, V18, P149; Sievers C., 2006, SOUTH AFR HUMANIT, V18, P203; Singer R., 1982, MIDDLE STONE AGE KLA; Soriano S, 2007, J ARCHAEOL SCI, V34, P681, DOI 10.1016/j.jas.2006.06.017; STERN N, 1994, J HUM EVOL, V27, P89, DOI 10.1006/jhev.1994.1037; Texier PJ, 2010, P NATL ACAD SCI USA, V107, P6180, DOI 10.1073/pnas.0913047107; THACKERAY AI, 1992, J WORLD PREHIST, V6, P385, DOI 10.1007/BF00975633; Torrence R., 1989, TIME ENERGY STONE TO; Torrence Robin., 1983, HUNTER GATHERER EC P, P11, DOI DOI 10.1073/PNAS.0913047107; Val A, 2016, QUATERN INT, V421, P173, DOI 10.1016/j.quaint.2014.11.068; van der Ryst M, 2013, AZANIA, V48, P403, DOI 10.1080/0067270X.2013.785238; Villa P, 2010, J ARCHAEOL SCI, V37, P630, DOI 10.1016/j.jas.2009.10.028; Villa P, 2012, P NATL ACAD SCI USA, V109, P13208, DOI 10.1073/pnas.1202629109; Volman T.P., 1984, P169; Wadley L, 2006, SOUTH AFR HUMANIT, V18, P1; Wadley L, QUARTZ KNAPPING STRA; Wadley L, 2008, J ARCHAEOL SCI, V35, P2594, DOI 10.1016/j.jas.2008.04.017; Wadley L, 2015, AZANIA, V50, P155, DOI 10.1080/0067270X.2015.1039236; Wadley L, 2011, SCIENCE, V334, P1388, DOI 10.1126/science.1213317; Wadley L, 2010, J HUM EVOL, V58, P179, DOI 10.1016/j.jhevol.2009.10.004; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Wallace IJ, 2006, J ARCHAEOL SCI, V33, P1293, DOI 10.1016/j.jas.2006.01.005; Wilkins J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174051; Will M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098359; Williams MJ, 2016, AREA, V48, P513, DOI 10.1111/area.12278; Williamson BS, 2000, THESIS; Wurz S., 2000, MIDDLE STONE AGE KLA; Wurz S., 2013, CURRENT ANTHR, V54	95	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185845	10.1371/journal.pone.0185845	http://dx.doi.org/10.1371/journal.pone.0185845			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FI9WM	28982148	Green Submitted, Green Published, gold			2022-12-26	WOS:000412360300075
J	Mendy, AL; Agbla, SC; Odutola, AA; Antonio, M; Greenwood, BM; Sutherland, JS; Ota, MOC				Mendy, Awa L.; Agbla, Schadrac C.; Odutola, Aderonke A.; Antonio, Martin; Greenwood, Brian M.; Sutherland, Jayne S.; Ota, Martin O. C.			Kinetics of antibodies against pneumococcal proteins and their relationship to nasopharyngeal carriage in the first two months of life	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; COLONIZATION; IMMUNOGENICITY; IMMUNIZATION; RESPONSES; ANTIGENS; DENSITY; MEASLES; SERUM	Introduction The currently used Streptococcus pneumoniae vaccines have had a significant impact on the pneumococcal diseases caused by the serotypes they cover. Their limitations have stimulated a search for alternate vaccines that will cover all serotypes, be affordable and effective in young children. Pneumococcal protein antigens are potential vaccine candidates that may meet some of the shortfalls of the current vaccines. Thus, this study aimed to determine the relationship between antibodies against pneumococcal protein antigens and nasopharyngeal carriage in infants. Methods One hundred and twenty mother-infant pairs were enrolled into the study. They had nasopharyngeal swabs(NPS) taken at birth and every two weeks for the first eight weeks after delivery, and blood samples were obtained at birth and every four weeks for the first eight weeks after delivery. Nasopharyngeal carriage of S. pneumoniae was determined from the NPS and antibodies against the pneumococcal proteins CbpA, PspA and rPly were measured in the blood samples. Results The S. pneumoniae carriage rate in infants increased to that of mothers by eight weeks of age. The odds of carriage in infants was 6.2 times (95% CI: 2.0-18.9) higher when their mothers were also carriers. Bacterial density in infants was lower at birth compared to their mothers (p = 0.004), but increased with age and became higher than that of their mothers at weeks 4 (p = 0.009), 6 (p = 0.002) and 8 (p<0.0001). At birth, the infants' antibodies against CbpA, and rPly pneumococcal protein antigens were similar, but that of PspA was lower (p<0.0001), compared to their mothers. Higher antibody concentrations to CbpA [OR (95% CI): 0.49 (0.26-0.92, p = 0.03)], but not PspA and rPly, were associated with protection against carriage in the infants. Conclusion Naturally induced antibodies against the three pneumococcal protein antigens were transferred from mother to child. The proportion of infants with nasopharyngeal carriage and the bacterial density of S. pneumoniae increased with age within the first eight weeks of life. Higher concentrations of antibodies against CbpA, but not PspA and rPly, were associated with reduced risk of nasopharyngeal carriage of S. pneumoniae in infants.	[Mendy, Awa L.; Agbla, Schadrac C.; Odutola, Aderonke A.; Antonio, Martin; Sutherland, Jayne S.; Ota, Martin O. C.] MRC Unit, Vaccines & Immun Theme, Fajara, Gambia; [Agbla, Schadrac C.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Antonio, Martin; Greenwood, Brian M.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Antonio, Martin] Univ Warwick, Warwick Med Sch, Div Microbiol & Immun, Coventry, W Midlands, England; [Ota, Martin O. C.] WHO Reg Off Africa, Hlth Informat & Knowledge Management, Hlth Syst & Serv Cluster, Brazzaville, Rep Congo	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Warwick; World Health Organization	Ota, MOC (corresponding author), MRC Unit, Vaccines & Immun Theme, Fajara, Gambia.; Ota, MOC (corresponding author), WHO Reg Off Africa, Hlth Informat & Knowledge Management, Hlth Syst & Serv Cluster, Brazzaville, Rep Congo.	otama@who.int		Agbla, Schadrac/0000-0002-0648-3336; Sutherland, Jayne/0000-0002-7083-4997	Pfizer Prize; MRC UK; Royal Society of London; Pfizer	Pfizer Prize(Pfizer); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society of London(Royal Society of London); Pfizer(Pfizer)	Primary funding was from Pfizer Prize awarded to MOCO. The MRC UK supported funding ALM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Archibald Worwui for managing the database, all field workers and nurses involved in this study, and the staff and management of Fajikunda and Brikama Health Centres. They also thank Joseph Okeibunor (WHO AFRO) and Brenda Kwambana Adams (MRC) for helpful discussions, and James Paton (Australia) for his kind gift of the pneumococcal protein antigens. Special thanks to the Royal Society of London for selecting MOCO for the Pfizer Exceptional Merit Award, and to Pfizer for funding this study. The authors declare no competing interest both to the Royal Society of London and Pfizer.	ALBRECHT P, 1977, J PEDIATR-US, V91, P715, DOI 10.1016/S0022-3476(77)81021-4; Azarian T, 2017, J INFECT DIS, V215, P713, DOI 10.1093/infdis/jiw628; Baggett HC, 2017, CLIN INFECT DIS, V64, pS317, DOI 10.1093/cid/cix100; Berglund J, 2014, CLIN VACCINE IMMUNOL, V21, P56, DOI 10.1128/CVI.00430-13; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; BOOY R, 1992, LANCET, V339, P507, DOI 10.1016/0140-6736(92)90336-2; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Davis SM, 2013, VACCINE, V32, P133, DOI 10.1016/j.vaccine.2013.05.005; Egere U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049143; Francis JP, 2009, CLIN VACCINE IMMUNOL, V16, P1633, DOI 10.1128/CVI.00247-09; Friedel V, 2014, EPIDEMIOL INFECT, V142, P2186, DOI 10.1017/S0950268813003178; Gans H, 2001, J INFECT DIS, V184, P817, DOI 10.1086/323346; Garcia P, 1999, MOL MICROBIOL, V33, P128, DOI 10.1046/j.1365-2958.1999.01455.x; Garcia-Suarez MD, 2004, INFECT IMMUN, V72, P4534, DOI 10.1128/IAI.72.8.4534-4540.2004; Givon-Lavi N, 2010, PEDIATR INFECT DIS J, V29, P756, DOI 10.1097/INF.0b013e3181d99345; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Gupta A, 2014, VACCINE, V32, P1466, DOI 10.1016/j.vaccine.2014.01.033; Hermand P, 2017, HUM VACC IMMUNOTHER, V13, P220, DOI 10.1080/21645515.2016.1234553; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Khan MN, 2014, HUM VACC IMMUNOTHER, V10, P3688, DOI 10.4161/21645515.2014.979631; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; McCool TL, 2003, INFECT IMMUN, V71, P5724, DOI 10.1128/IAI.71.10.5724-5732.2003; McCool TL, 2002, J EXP MED, V195, P359, DOI 10.1084/jem.20011576; Mina MJ, 2013, J INFECT DIS, V208, P1281, DOI 10.1093/infdis/jit317; Moral-Benito, 2016, XTDPDML LINEAR DYNAM; Mureithi MW, 2009, J INFECT DIS, V200, P783, DOI 10.1086/605023; Nabors GS, 2000, VACCINE, V18, P1743, DOI 10.1016/S0264-410X(99)00530-7; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Odutola A, 2015, HUM VACCIN IMMUNOTHE; Odutola A, 2017, VACCINE, Vi; Odutola A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075558; Okoko BJ, 2001, J HEALTH POPUL NUTR, V19, P59; Ota MO, 2011, VACCINE, V29, P2999, DOI 10.1016/j.vaccine.2011.01.098; Pichichero ME, 2016, HUM VACC IMMUNOTHER, V12, P194, DOI 10.1080/21645515.2015.1052198; Richards L, 2010, IMMUNOBIOLOGY, V215, P251, DOI 10.1016/j.imbio.2009.12.004; Roca A, 2012, CLIN INFECT DIS, V55, P816, DOI 10.1093/cid/cis554; Roca A, 2015, VACCINE, V33, P7144, DOI 10.1016/j.vaccine.2015.11.012; Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107; Russell FM, 2010, CLIN VACCINE IMMUNOL, V17, P1970, DOI 10.1128/CVI.00117-10; SHAHID NS, 1995, LANCET, V346, P1252, DOI 10.1016/S0140-6736(95)91861-2; Skrondal A, 2014, J R STAT SOC C-APPL, V63, P211, DOI 10.1111/rssc.12023; Spellerberg B, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P412; Turner P, 2013, CLIN MICROBIOL INFEC, V19, pE551, DOI [10.1111/1469-0691.12286, 10.1111/1469-0691.12431]; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; Zhang QB, 2006, EUR J IMMUNOL, V36, P46, DOI 10.1002/eji.200535101	46	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185824	10.1371/journal.pone.0185824	http://dx.doi.org/10.1371/journal.pone.0185824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982123	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000412360300071
J	Minchom, A; Thavasu, P; Ahmad, Z; Stewart, A; Georgiou, A; O'Brien, MER; Popat, S; Bhosle, J; Yap, TA; de Bono, J; Banerji, U				Minchom, Anna; Thavasu, Parames; Ahmad, Zai; Stewart, Adam; Georgiou, Alexandros; O'Brien, Mary E. R.; Popat, Sanjay; Bhosle, Jaishree; Yap, Timothy A.; de Bono, Johann; Banerji, Udai			A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments	PLOS ONE			English	Article							EGFR MUTATIONS; IMMUNE ESCAPE; UP-REGULATION; GEFITINIB; CHEMOTHERAPY; ASSOCIATION; DOWNSTREAM; ACTIVATION; DOCETAXEL; PATHWAYS	We investigated PD-L1 changes in response to MEK and AKT inhibitors in KRAS mutant lung adenocarcinoma (adeno-NSCLC). PD-L1 expression was quantified using immunofluorescence and co-culture with a jurkat cell-line transfected with NFAT-luciferase was used to study if changes in PD-L1 expression in cancer cell lines were functionally relevant. Five KRAS mutant cell lines with high PD-L1 expression (H441, H2291, H23, H2030 and A549) were exposed to GI(50) inhibitor concentrations of a MEK inhibitor (trametinib) and an AKT inhibitor (AZD5363) for 3 weeks. Only 3/5 (H23, H2030 and A549) and 2/5 cell lines (H441 and H23) showed functionally significant increases in PD-L1 expression when exposed to trametinib or AZD5363 respectively. PD-L1 overexpression is not consistent and is unlikely to be an early mechanism of resistance to KRAS mutant adeno-NSCLC treated with MEK or AKT inhibitors.	[Minchom, Anna; O'Brien, Mary E. R.; Bhosle, Jaishree] Royal Marsden, Dept Med, Lung Unit, Sutton, Surrey, England; [Thavasu, Parames; Ahmad, Zai; Stewart, Adam; Georgiou, Alexandros; Yap, Timothy A.; de Bono, Johann; Banerji, Udai] Inst Canc Res, Drug Dev Unit, London, England; [Thavasu, Parames; Ahmad, Zai; Stewart, Adam; Georgiou, Alexandros; Yap, Timothy A.; de Bono, Johann; Banerji, Udai] Royal Marsden, London, England; [Popat, Sanjay] Royal Marsden, Lung Unit, London, England	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust	Banerji, U (corresponding author), Inst Canc Res, Drug Dev Unit, London, England.; Banerji, U (corresponding author), Royal Marsden, London, England.	udai.banerji@icr.ac.uk	Yap, Timothy/AAV-3573-2020; Popat, Sanjay/AAO-1634-2021	Popat, Sanjay/0000-0003-2087-4963; de Bono, Johann S/0000-0002-2034-595X; Minchom, Anna/0000-0002-9339-7101; Banerji, Udai/0000-0003-1503-3123	National Institute for Health Research Biomedical Research Centre; CRUK (Cancer Research UK); ECMC (Experimental Cancer Medicine Centre initiative); Cancer Research UK [11566] Funding Source: researchfish	National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); CRUK (Cancer Research UK)(Cancer Research UK); ECMC (Experimental Cancer Medicine Centre initiative); Cancer Research UK(Cancer Research UK)	Funding was received from National Institute for Health Research Biomedical Research Centre, CRUK (Cancer Research UK) and ECMC (Experimental Cancer Medicine Centre initiative).	Azuma K, 2014, ANN ONCOL, V25, P1935, DOI 10.1093/annonc/mdu242; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Carden CP, 2012, MOL CANCER THER, V11, P1609, DOI 10.1158/1535-7163.MCT-11-0996; Chen N, 2017, CANCER IMMUNOL IMMUN, V66, P1175, DOI 10.1007/s00262-017-2005-z; Chen N, 2015, J THORAC ONCOL, V10, P910, DOI 10.1097/JTO.0000000000000500; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Hirsch FR, 2017, J THORAC ONCOL, V12, P208, DOI 10.1016/j.jtho.2016.11.2228; Horn L, 2014, J CLIN ONCOL, V32; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Janne PA, 2016, EUR SOC MED ONC ANN; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Lastwika KJ, 2016, CANCER RES, V76, P227, DOI 10.1158/0008-5472.CAN-14-3362; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Ota K, 2015, CLIN CANCER RES, V21, P4014, DOI 10.1158/1078-0432.CCR-15-0016; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Park K, 2016, LANCET ONCOL, V17, P577, DOI 10.1016/S1470-2045(16)30033-X; Puglisi M, 2016, ONCOLOGY-BASEL, V90, P280, DOI 10.1159/000444928; Reck M, 2016, NEW ENG J MED; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Tolcher AW, 2015, CLIN CANCER RES, V21, P739, DOI 10.1158/1078-0432.CCR-14-1901; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Zhu ZH, 2014, PHARMACOGENOMICS, V15, P1507, DOI [10.2217/PGS.14.108, 10.2217/pgs.14.108]	26	13	15	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186106	10.1371/journal.pone.0186106	http://dx.doi.org/10.1371/journal.pone.0186106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982179	Green Published, gold, Green Submitted			2022-12-26	WOS:000412360300124
J	Parajuli, N; Shrum, S; Tobacyk, J; Herb, A; Arthur, JM; MacMillan-Crow, LA				Parajuli, Nirmala; Shrum, Stephen; Tobacyk, Julia; Herb, Alex; Arthur, John M.; MacMillan-Crow, Lee Ann			Renal cold storage followed by transplantation impairs expression of key mitochondrial fission and fusion proteins	PLOS ONE			English	Article							DELAYED GRAFT FUNCTION; POLYETHYLENE-GLYCOL; UNITED-STATES; OMA1; ISCHEMIA; CELLS; YME1L; FRAGMENTATION; ACTIVATION; APOPTOSIS	Background The majority of transplanted kidneys are procured from deceased donors which all require exposure to cold storage (CS) for successful transplantation. Unfortunately, this CS leads to renal and mitochondrial damage but, specific mitochondrial targets affected by CS remain largely unknown. The goal of this study is to determine whether pathways involved with mitochondrial fusion or fission, are disrupted during renal CS. Methods Male Lewis rat kidneys were exposed to cold storage (CS) alone or cold storage combined with transplantation (CS/Tx). To compare effects induced by CS, kidney transplantation without CS exposure (autotransplantation; ATx) was also used. Mitochondrial function was assessed using high resolution respirometry. Expression of mitochondrial fusion and fission proteins were monitored using Western blot analysis. Results CS alone (no Tx) reduced respiratory complex I and II activities along with reduced expression of the primary mitochondrial fission protein, dynamin related protein (DRP1), induced loss of the long form of Optic Atrophy Protein (OPA1), and altered the mitochondrial protease, OMA1, which regulates OPA1 processing. CS followed by Tx (CS/Tx) reduced complex I, II, and III activities, and induced a profound loss of the long and short forms of OPA1, mitofusin 1 (MFN1), and mitofusin 2 (MFN2) which all control mitochondrial fusion. In addition, expression of DRP1, along with its primary receptor protein, mitochondrial fission factor (MFF), were also reduced after CS/Tx. Interestingly, CS/Tx lead to aberrant higher molecular weight OMA1 aggregate expression. Conclusions Our results suggest that CS appears to involve activation of the OMA1, which could be a key player in proteolysis of the fusion and fission protein machinery following transplantation. These findings raise the possibility that impaired mitochondrial fission and fusion may be unrecognized contributors to CS induced mitochondrial injury and compromised renal graft function after transplantation.	[Parajuli, Nirmala; Shrum, Stephen; Tobacyk, Julia; Herb, Alex; MacMillan-Crow, Lee Ann] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Arthur, John M.] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	MacMillan-Crow, LA (corresponding author), Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA.	lmcrow@uams.edu	Parajuli, Nirmala/V-9901-2019	Arthur, John/0000-0003-4342-4762; Parajuli, Nirmala/0000-0003-3994-5338	American Heart Association [16SDG276000026, 16PRE30830010]; National Institutes of Health-General Medicine [T32GM106999]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM106999] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health-General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the American Heart Association 16SDG276000026 (NP) and 16PRE30830010 (SS) and the National Institutes of Health-General Medicine T32GM106999 (SS and JT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand R, 2014, J CELL BIOL, V204, P919, DOI 10.1083/jcb.201308006; Baker MJ, 2014, EMBO J, V33, P578, DOI 10.1002/embj.201386474; Bohovych I, 2014, J BIOL CHEM, V289, P13259, DOI 10.1074/jbc.M113.542910; Cecka J M, 1993, Clin Transpl, P1; Debout A, 2015, KIDNEY INT, V87, P343, DOI 10.1038/ki.2014.304; Doucet C, 2004, BBA-GEN SUBJECTS, V1673, P105, DOI 10.1016/j.bbagen.2004.03.018; Dutheil D, 2006, AM J TRANSPLANT, V6, P1529, DOI 10.1111/j.1600-6143.2006.01343.x; Fan XY, 2010, FREE RADICAL BIO MED, V49, P1646, DOI 10.1016/j.freeradbiomed.2010.08.024; Faure JP, 2002, J PHARMACOL EXP THER, V302, P861, DOI 10.1124/jpet.102.033688; Funk JA, 2012, AM J PHYSIOL-RENAL, V302, pF853, DOI 10.1152/ajprenal.00035.2011; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Hauet T, 2001, J PHARMACOL EXP THER, V297, P946; Healy DA, 2006, J AM SOC NEPHROL, V17, P805, DOI 10.1681/ASN.2005090980; Jani A, 2004, AM J TRANSPLANT, V4, P1246, DOI 10.1111/j.1600-6143.2004.00498.x; Jendrach M, 2008, MITOCHONDRION, V8, P293, DOI 10.1016/j.mito.2008.06.001; Khalimonchuk O, 2012, J BIOL CHEM, V287, P7289, DOI 10.1074/jbc.M111.313148; Leonard AP, 2015, BBA-MOL CELL RES, V1853, P348, DOI 10.1016/j.bbamcr.2014.11.002; Mitchell T, 2011, J PHARMACOL EXP THER, V336, P682, DOI 10.1124/jpet.110.176743; Mitchell T, 2010, FREE RADICAL BIO MED, V49, P1273, DOI 10.1016/j.freeradbiomed.2010.07.012; Ojo AO, 1997, TRANSPLANTATION, V63, P968, DOI 10.1097/00007890-199704150-00011; Parajuli N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048590; Patil NK, 2014, AM J PHYSIOL-RENAL, V306, pF734, DOI 10.1152/ajprenal.00643.2013; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Port FK, 2005, AM J TRANSPLANT, V5, P843, DOI 10.1111/j.1600-6135.2005.00831.x; Rainbolt TK, 2016, CELL REP, V14, P2041, DOI 10.1016/j.celrep.2016.02.011; Rainbolt TK, 2015, EMBO REP, V16, P97, DOI 10.15252/embr.201438976; Saba H, 2008, RENAL FAILURE, V30, P125, DOI 10.1080/08860220701813327; Saita S, 2016, GENES CELLS, V21, P408, DOI 10.1111/gtc.12351; Salahudeen AK, 2004, AM J PHYSIOL-RENAL, V287, pF181, DOI 10.1152/ajprenal.00098.2004; Salahudeen AK, 2004, KIDNEY INT, V65, P713, DOI 10.1111/j.1523-1755.2004.00416.x; Salahudeen AK, 2003, AM J TRANSPLANT, V3, P273, DOI 10.1034/j.1600-6143.2003.00042.x; Salahudeen AK, 2001, TRANSPLANTATION, V72, P798, DOI 10.1097/00007890-200109150-00010; Salahudeen AK, 2000, TRANSPLANTATION, V70, P1424, DOI 10.1097/00007890-200011270-00005; Shoskes DA, 1998, TRANSPLANTATION, V66, P1697, DOI 10.1097/00007890-199812270-00022; Shrum S., 2016, AM J KIDNEY DIS, V2, P114; SOUTHARD JH, 1983, CRYOBIOLOGY, V20, P395, DOI 10.1016/0011-2240(83)90029-9; SOUTHARD JH, 1980, CRYOBIOLOGY, V17, P148, DOI 10.1016/0011-2240(80)90019-X; SOUTHARD JH, 1984, CRYOBIOLOGY, V21, P13, DOI 10.1016/0011-2240(84)90017-8; Stiburek L, 2012, MOL BIOL CELL, V23, P1010, DOI 10.1091/mbc.E11-08-0674; Watanabe T, 2014, EXP CELL RES, V323, P314, DOI 10.1016/j.yexcr.2014.02.027; Xiao X., 2014, J CHEM, V2014, P1; Xiao X, 2014, AM J PHYSIOL-RENAL, V306, pF1318, DOI 10.1152/ajprenal.00036.2014; Yin M, 2002, RENAL FAILURE, V24, P147, DOI 10.1081/JDI-120004092; Zhang K, 2014, EMBO REP, V15, P576, DOI 10.1002/embr.201338240; Zolezzi JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064019	45	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185542	10.1371/journal.pone.0185542	http://dx.doi.org/10.1371/journal.pone.0185542			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977005	Green Submitted, Green Published, gold			2022-12-26	WOS:000412163100027
J	Leder, K; Grobusch, MP; Gautret, P; Chen, LH; Kuhn, S; Lim, PL; Yates, J; McCarthy, AE; Rothe, C; Kato, Y; Bottieau, E; Huber, K; Schwartz, E; Stauffer, W; Malvy, D; Shaw, MTM; Rapp, C; Blumberg, L; Jensenius, M; van Genderen, PJJ; Hamer, DH				Leder, Karin; Grobusch, Martin P.; Gautret, Philippe; Chen, Lin H.; Kuhn, Susan; Lim, Poh Lian; Yates, Johnnie; McCarthy, Anne E.; Rothe, Camilla; Kato, Yasuyuki; Bottieau, Emmanuel; Huber, Kristina; Schwartz, Eli; Stauffer, William; Malvy, Denis; Shaw, Marc T. M.; Rapp, Christophe; Blumberg, Lucille; Jensenius, Mogens; van Genderen, Perry J. J.; Hamer, Davidson H.		GeoSentinel Surveillance Network	Zika beyond the Americas: Travelers as sentinels of Zika virus transmission. A GeoSentinel analysis, 2012 to 2016	PLOS ONE			English	Article							SEXUAL TRANSMISSION; UNITED-STATES; DISEASE; SPECIFICITY; INFECTION; INDONESIA; PACIFIC	Background Zika virus (ZIKV) was first isolated in Africa; decades later, caused large outbreaks in the Pacific, and is considered endemic in Asia. We aim to describe ZIKV disease epidemiology outside the Americas, the importance of travelers as sentinels of disease transmission, and discrepancies in travel advisories from major international health organizations. Methods and findings This descriptive analysis using GeoSentinel Surveillance Network records involves sixty-four travel and tropical medicine clinics in 29 countries. Ill returned travelers with a confirmed or probable diagnosis of ZIKV disease acquired in Africa, Asia and the Pacific seen between 1 January 2012 and 31 December 2016 are included, and the frequencies of demographic, trip, and diagnostic characteristics described. ZIKV was acquired in Asia (18), the Pacific (10) and Africa (1). For five countries (Indonesia, Philippines, Thailand, Vietnam, Cameroon), GeoSentinel patients were sentinel markers of recent Zika activity. Additionally, the first confirmed ZIKV infection acquired in Kiribati was reported to GeoSentinel (2015), and a probable case was reported from Timor Leste (April 2016), representing the only case known to date. Review of Zika situation updates from major international health authorities for country risk classifications shows heterogeneity in ZIKV country travel advisories. Conclusions Travelers are integral to the global spread of ZIKV, serving as sentinel markers of disease activity. Although GeoSentinel data are collected by specialized clinics and do not capture all imported cases, we show that surveillance of imported infections by returned travelers augments local surveillance system data regarding ZIKV epidemiology and can assist with risk categorization by international authorities. However, travel advisories are variable due to risk uncertainties.	[Leder, Karin] Monash Univ, Sch Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Leder, Karin] Royal Melbourne Hosp, Doherty Inst Infect & Immun, Victorian Infect Dis Serv, Melbourne, Vic, Australia; [Grobusch, Martin P.] Univ Amsterdam, Ctr Trop Med & Travel Med, Dept Infect Dis, Div Internal Med,Acad Med Ctr, Amsterdam, Netherlands; [Gautret, Philippe] Aix Marseille Univ, CNRS 7278, IRD 198, UM63,INSERM 1095,IHU Mediterranee Infect, Marseillle, France; [Chen, Lin H.] Mt Auburn Hosp, Travel Med Ctr, Cambridge, MA USA; [Chen, Lin H.] Harvard Med Sch, Boston, MA USA; [Kuhn, Susan] Univ Calgary, Calgary, AB, Canada; [Lim, Poh Lian] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore; [Lim, Poh Lian] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Yates, Johnnie] Hawaii Permenente Med Grp, Honolulu, HI USA; [McCarthy, Anne E.] Ottawa Hosp, Dept Med, Ottawa, ON, Canada; [McCarthy, Anne E.] Univ Ottawa, Ottawa, ON, Canada; [Rothe, Camilla] Univ Hamburg, Div Trop Med & Infect Dis, Hamburg, Germany; [Kato, Yasuyuki] Natl Ctr Global Hlth & Med, Div Preparedness & Emerging Infect, Dis Control & Prevent Ctr, Tokyo, Japan; [Bottieau, Emmanuel] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Huber, Kristina] Univ Munich LMU, Div Infect Dis & Trop Med, Med Ctr, Munich, Germany; [Schwartz, Eli] Chaim Sheba Med Ctr, Ctr Geog Med & Trop Dis, Tel Hashomer, Tel Aviv, Israel; [Schwartz, Eli] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Stauffer, William] Univ Minnesota, Dept Med & Pediat Infect Dis & Internal Med, Minneapolis, MN USA; [Malvy, Denis] Univ Bordeaux, Univ Hosp Ctr, Bordeaux, France; [Malvy, Denis] Univ Bordeaux, Inserm 1219, Bordeaux, France; [Shaw, Marc T. M.] James Cook Univ, Townsville, Qld, Australia; [Rapp, Christophe] Begin Mil Hosp, Dept Infect & Trop Dis, CMETE Travel Clin Paris, St Mande, France; [Blumberg, Lucille] Natl Inst Communicable Dis, Johannesburg, South Africa; [Jensenius, Mogens] Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway; [van Genderen, Perry J. J.] Harbour Hosp, Inst Trop Dis, Rotterdam, Netherlands; [Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA USA; [Hamer, Davidson H.] Boston Univ, Sch Med, Sect Infect Dis, Dept Med, Boston, MA USA	Monash University; Royal Melbourne Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Harvard University; Mount Auburn Hospital; Harvard University; Harvard Medical School; University of Calgary; Tan Tock Seng Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Hamburg; National Center for Global Health & Medicine - Japan; Institute of Tropical Medicine (ITM); University of Munich; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Minnesota System; University of Minnesota Twin Cities; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; James Cook University; National Institute for Communicable Diseases (NICD); University of Oslo; Boston University; Boston University; Boston University	Leder, K (corresponding author), Monash Univ, Sch Epidemiol & Prevent Med, Melbourne, Vic, Australia.; Leder, K (corresponding author), Royal Melbourne Hosp, Doherty Inst Infect & Immun, Victorian Infect Dis Serv, Melbourne, Vic, Australia.	karin.leder@monash.edu	Gautret, Philippe/AAY-5126-2021; MALVY, Denis/T-7930-2019; Chen, Lin/ADS-6751-2022; Hamer, Davidson Howes/J-2020-2019; Leder, Karin/AAD-2388-2019	Gautret, Philippe/0000-0002-1664-958X; Hamer, Davidson Howes/0000-0002-4700-1495; Leder, Karin/0000-0003-1368-1039; Chen, Lin/0000-0002-5684-8436	Centers for Disease Control and Prevention [U50CK00189]; ISTM; Public Health Agency of Canada; CENTERS FOR DISEASE CONTROL AND PREVENTION [U50CK000189] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); ISTM; Public Health Agency of Canada; CENTERS FOR DISEASE CONTROL AND PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This project was supported by a cooperative agreement (U50CK00189) between the Centers for Disease Control and Prevention (https://www.cdc.gov/ncezid/dgmq/) to the International Society of Travel Medicine (ISTM) and funding from the ISTM (http://www.istm.org/) and the Public Health Agency of Canada (http://www.phac-aspc.gc.ca/index-engphp). The funding agencies supported the collection of GeoSentinel data, but had no role in the writing or content of this manuscript, or in the decision to submit the paper for publication.	Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617; Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/msphere.00292-17, 10.1128/mSphere.00292-17]; Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6; Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5; Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2; Center for Disease Control, ZIK TRAV INF; Centers for Diseases Control and Prevention (CDC), ZIK VIR SE AS; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; ECDC, ZIK VIR SIT REP; ECDC, PLAC INF IMP CAS EU; ECDC, 2017, ZIK VIR DIS EP; Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636; Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Goorhuis A, 2016, LANCET INFECT DIS, V16, P1204, DOI 10.1016/S1473-3099(16)30316-4; Hamer DH, 2016, ANN INTERNAL MED; HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323; Harvey K, 2013, MMWR SURVEILL SUMM, V62, P1; Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442; Hennessey MJ, 2016, AM J TROP MED HYG, V95, P212, DOI 10.4269/ajtmh.16-0049; Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182; Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9; Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082; Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029; Lobigs M, 2009, J VIROL, V83, P2436, DOI 10.1128/JVI.02273-08; MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411; Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480; NaTHNaC, ZIK VIR COUNTR SPEC; Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314; Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720; OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687; Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7; Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011; SMITHBURN KC, 1954, J IMMUNOL, V72, P248; SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630; Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9; Van Esbroeck M, 2016, EUROSURVEILLANCE, V21, P32, DOI 10.2807/1560-7917.ES.2016.21.21.30237; Veasna D, 2016, INT J INFECT DIS IJI; Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302; WHO, ZIK VIR COUNTR CLASS; Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X; World Health Organization, 2016, ZIK VIR DIS INT CAS; World Health Organization, ZIK VIR SIT REP; World Health Organization Fifth Meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH	46	31	32	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185689	10.1371/journal.pone.0185689	http://dx.doi.org/10.1371/journal.pone.0185689			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973011	Green Published, Green Accepted, gold			2022-12-26	WOS:000412131900036
J	Makarov, EM; Shtam, TA; Kovalev, RA; Pantina, RA; Varfolomeeva, EY; Filatov, MV				Makarov, Evgeny M.; Shtam, Tatyana A.; Kovalev, Roman A.; Pantina, Rimma A.; Varfolomeeva, Elena Yu; Filatov, Michael V.			The rare nonsense mutation in p53 triggers alternative splicing to produce a protein capable of inducing apoptosis	PLOS ONE			English	Article							BLADDER-CARCINOMA ONCOGENE; CANCER CELL-LINES; MUTANT P53; MEDIATED DECAY; RNA SURVEILLANCE; RESTORATION; GENE; REACTIVATION; EXPRESSION; DATABASE	P53 protein is more frequently mutated in human tumours compared with the other proteins. While the majority of the p53 mutations, especially within its DNA-binding domain, lead to the loss of the wild-type function, there are accumulating data demonstrating that the p53 mutants gain tumour promoting activities; the latter triggers a revitalised interest in functional analysis of the p53 mutants. A systematic screening for p53 mutations in surgical materials from patients with glioma revealed a 378C>G mutation that creates a stop codon at the position of amino acid residue 126. The mutation eliminates the recognition site for the restriction endonuclease Sca I that allowed us to carry out RFLP analysis of DNA extracted from the clinical samples and suggests that this mutation is more frequent than is documented in the p53 databases. Both the ECV-304 and EJ cell lines, that probably originate from the bladder carcinoma T24 cell line, were confirmed to contain the homozygous 378C>G mutation but were shown to produce the p53 protein of expected full-length size detected by Western blotting. We provide evidence that the 378C>G mutation generates an alternative 3' splice site (ss) which is more often used instead of the authentic upstream 3' ss, driving the production of mRNA encoding the protein with the single amino acid deletion (p53.Y126). Using endogenous expression, we demonstrated that the p53.Y126 protein is nearly as active as the wild type protein in inducing the p21/Waf1 expression and apoptosis.	[Makarov, Evgeny M.] Brunel Univ London, Coll Hlth & Life Sci, Div Biosci, Uxbridge, Middx, England; [Shtam, Tatyana A.; Kovalev, Roman A.; Pantina, Rimma A.; Varfolomeeva, Elena Yu; Filatov, Michael V.] Natl Res Ctr, Kurchatov Inst, BP Konstantinov Petersburg Nucl Phys Inst, Gatchina, Russia; [Shtam, Tatyana A.] Peter Great St Petersburg Polytech Univ, St Petersburg, Russia; [Shtam, Tatyana A.] Petrov Inst Oncol, St Petersburg, Russia	Brunel University; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; Peter the Great St. Petersburg Polytechnic University; N.N. Petrov Research Institute of Oncology	Filatov, MV (corresponding author), Natl Res Ctr, Kurchatov Inst, BP Konstantinov Petersburg Nucl Phys Inst, Gatchina, Russia.	fil53ster@gmail.com	Varfolomeeva, Elena Yu/G-1008-2015; Shtam, Tatyana A/B-1274-2014; Filatov, Michael/D-5004-2014	Varfolomeeva, Elena Yu/0000-0003-3287-4709; Shtam, Tatyana A/0000-0003-0651-4785; Makarov, Evgeny/0000-0003-2543-9637; Filatov, Michael/0000-0003-3908-3061				Akerman M, 2006, NUCLEIC ACIDS RES, V34, P23, DOI 10.1093/nar/gkj408; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BELLOC F, 1994, CYTOMETRY, V17, P59, DOI 10.1002/cyto.990170108; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Bridger JM, 2004, EXP GERONTOL, V39, P717, DOI 10.1016/j.exger.2004.02.002; BURNS JE, 1993, BRIT J CANCER, V67, P1274, DOI 10.1038/bjc.1993.238; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Bykov VJN, 2014, FEBS LETT, V588, P2622, DOI 10.1016/j.febslet.2014.04.017; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Dou YM, 2006, RNA, V12, P2047, DOI 10.1261/rna.151106; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; GRIMM MO, 1995, UROL RES, V23, P293, DOI 10.1007/BF00300017; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232; Hiller M, 2004, NAT GENET, V36, P1255, DOI 10.1038/ng1469; Hinow P, 2006, BIOPHYS J, V91, P330, DOI 10.1529/biophysj.105.078303; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Joerger AC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000919; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Keeling KM, 2014, ANNU REV GENOM HUM G, V15, P81; Leroy B, 2014, HUM MUTAT, V35, P672, DOI 10.1002/humu.22552; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liu XR, 2013, NUCLEIC ACIDS RES, V41, P6034, DOI 10.1093/nar/gkt305; Liu Y, 2006, P NATL ACAD SCI USA, V103, P976, DOI 10.1073/pnas.0510146103; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Maxwell SA, 2000, P NATL ACAD SCI USA, V97, P13009, DOI 10.1073/pnas.230445997; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; PARADA LF, 1982, NATURE, V297, P474, DOI 10.1038/297474a0; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Pospelova TV, 2009, CELL CYCLE, V8, P4112, DOI 10.4161/cc.8.24.10215; RIEGER KM, 1995, BRIT J CANCER, V72, P683, DOI 10.1038/bjc.1995.394; SANTOS E, 1982, NATURE, V298, P343, DOI 10.1038/298343a0; SHARMA S, 1993, CELL GROWTH DIFFER, V4, P861; TAKAHASHI K, 1990, IN VITRO CELL DEV B, V26, P265; Tate WP, 1995, BIOCHEM CELL BIOL, V73, P1095, DOI 10.1139/o95-118; Ulus-Senguloglu G, 2012, BRIT J CANCER, V107, P1506, DOI 10.1038/bjc.2012.443; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wiman KG, 2010, ONCOGENE, V29, P4245, DOI 10.1038/onc.2010.188; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yu M, 2015, NATURE, V520, P307, DOI 10.1038/nature14397	46	4	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185126	10.1371/journal.pone.0185126	http://dx.doi.org/10.1371/journal.pone.0185126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961258	Green Submitted, gold, Green Published			2022-12-26	WOS:000412027700015
J	Moreau, JM; Cen, S; Berger, A; Furlonger, C; Paige, CJ				Moreau, Joshua M.; Cen, Selena; Berger, Alexandra; Furlonger, Caren; Paige, Christopher J.			Bone marrow basophils provide survival signals to immature B cells in vitro but are dispensable in vivo	PLOS ONE			English	Article							NEGATIVE SELECTION; ANTIGEN; DIFFERENTIATION; LYMPHOCYTES; TOLERANCE; ROLES; BLOOD; MICE	Immature B cells are the first B cell progenitors to express a fully formed B cell receptor and are therefore subject to extensive selection processes that act to mitigate the emergence of autoreactive clones. While it is well appreciated that most B cell generation in the bone marrow is highly dependent on access to molecules present in the local milieu, the existence of extrinsically provided factors that modulate immature B cell biology is ambiguous. Nonetheless, a population of CD49b(+)CD90 lo cells has demonstrated in vitro potential to promote immature B cell survival. Using a mouse basophil reporter strain we confirmed the identity of these CD49b(+)CD90 lo supportive cells as basophils. However, analysis of bone marrow B cell populations following lineage specific basophil depletion demonstrates that basophils do not have a significant role in vivo in modulating immature B cell biology during steady-state conditions.	[Moreau, Joshua M.; Cen, Selena; Berger, Alexandra; Furlonger, Caren; Paige, Christopher J.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Paige, Christopher J.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Paige, Christopher J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto	Moreau, JM (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.	josh.moreau@mail.utoronto.ca		Moreau, Joshua/0000-0002-1227-1508	Princess Margaret Cancer Centre; Toronto General/Toronto Western Foundation	Princess Margaret Cancer Centre(University of Toronto); Toronto General/Toronto Western Foundation	This study was supported through Princess Margaret Cancer Centre and Toronto General/Toronto Western Foundation operating grants held by CJP.; This study was supported through Princess Margaret Cancer Centre and Toronto General/Toronto Western Foundation operating grants held by CJP. JMM conceived the study, designed and performed experiments, and wrote the paper; SC, AB, and CF performed experiments; CJP provided study oversight, funding, and wrote the paper.	Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; BATTEN SJ, 1984, J IMMUNOL METHODS, V72, P381, DOI 10.1016/0022-1759(84)90007-3; Cariappa A, 2005, IMMUNITY, V23, P397, DOI 10.1016/j.immuni.2005.09.004; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; CHERVENICK PA, 1968, AM J PHYSIOL, V215, P353, DOI 10.1152/ajplegacy.1968.215.2.353; Corfe SA, 2012, SEMIN IMMUNOL, V24, P198, DOI 10.1016/j.smim.2012.02.001; Donovan EE, 2010, EUR J IMMUNOL, V40, P688, DOI 10.1002/eji.200939858; Gomez MR, 2010, J IMMUNOL, V185, P7180, DOI 10.4049/jimmunol.1002319; Granato A, 2014, J IMMUNOL, V192, P5761, DOI 10.4049/jimmunol.1300749; Halverson R, 2004, NAT IMMUNOL, V5, P645, DOI 10.1038/ni1076; Hideto N, 2011, J IMMUNOL, V186, P5766; Karasuyama H, 2009, NAT REV IMMUNOL, V9, P9, DOI 10.1038/nri2458; King LB, 2000, IMMUNOL REV, V176, P86; Lim VY, 2017, ADV IMMUNOL, V134, P47, DOI 10.1016/bs.ai.2017.02.001; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Merluzzi S, 2015, MOL IMMUNOL, V63, P94, DOI 10.1016/j.molimm.2014.02.016; Metcalf D, 2013, P NATL ACAD SCI USA, V110, P17029, DOI 10.1073/pnas.1317055110; Moreau JM, 2015, BLOOD, V126, P1184, DOI 10.1182/blood-2015-03-635805; Nemazee D, 2017, NAT REV IMMUNOL, V17, P281, DOI 10.1038/nri.2017.19; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Pelanda R, 2012, CENTRAL B CELL TOLER, V4; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Rowland SL, 2013, IMMUNOL RES, V55, P231, DOI 10.1007/s12026-012-8366-7; Rowland SL, 2010, J IMMUNOL, V185, P4570, DOI 10.4049/jimmunol.1001708; Sandel PC, 1999, IMMUNITY, V10, P289, DOI 10.1016/S1074-7613(00)80029-1; Sandel PC, 2001, J IMMUNOL, V166, P5935, DOI 10.4049/jimmunol.166.10.5935; Sapoznikov A, 2008, NAT IMMUNOL, V9, P388, DOI 10.1038/ni1571; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; URBINA C, 1981, INT ARCH ALLER A IMM, V66, P158, DOI 10.1159/000232814; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680	30	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185509	10.1371/journal.pone.0185509	http://dx.doi.org/10.1371/journal.pone.0185509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957409	Green Published, Green Submitted, gold			2022-12-26	WOS:000411985200071
J	Mtui, DT; Lepczyk, CA; Chen, Q; Miura, T; Cox, LJ				Mtui, Devolent T.; Lepczyk, Christopher A.; Chen, Qi; Miura, Tomoaki; Cox, Linda J.			Assessing multi-decadal land-cover - land-use change in two wildlife protected areas in Tanzania using Landsat imagery	PLOS ONE			English	Article							NATIONAL-PARK; SAVANNA VEGETATION; WESTERN TANZANIA; AFRICAN SAVANNAS; MIOMBO WOODLAND; RUKWA ECOSYSTEM; SOUTH-AFRICA; MARA REGION; EAST-AFRICA; WOODY COVER	Landscape change in and around protected areas is of concern worldwide given the potential impacts of such change on biodiversity. Given such impacts, we sought to understand the extent of changes in different land-cover types at two protected areas, Tarangire and Katavi National Parks in Tanzania, over the past 27 years. Using Maximum Likelihood classification procedures we derived eight land-cover classes from Landsat TM and ETM+ images, including: woody savannah, savannah, grassland, open and closed shrubland, swamp and water, and bare land. We determined the extent and direction of changes for all land-cover classes using a post-classification comparison technique. The results show declines in woody savannah and increases in barren land and swamps inside and outside Tarangire National Park and increases in woody savannah and savannah, and declines of shrubland and grassland inside and outside Katavi National Park. The decrease of woody savannah was partially due to its conversion into grassland and barren land, possibly caused by human encroachment by cultivation and livestock. Based upon these changes, we recommend management actions to prevent detrimental effects on wildlife populations.	[Mtui, Devolent T.; Lepczyk, Christopher A.; Miura, Tomoaki; Cox, Linda J.] Univ Hawaii Manoa, Dept Nat Resources & Environm Management, Honolulu, HI 96822 USA; [Chen, Qi] Univ Hawaii Manoa, Dept Geog, Honolulu, HI 96822 USA; [Mtui, Devolent T.] Tanzania Wildlife Res Inst, Arusha, Tanzania; [Lepczyk, Christopher A.] Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Auburn University System; Auburn University	Mtui, DT (corresponding author), Tanzania Wildlife Res Inst, Arusha, Tanzania.	deovolentem@gmail.com			International Ford Foundation Fellowship-Tanzania; East West Center-Honolulu; International Ford Foundation Fellowships Program	International Ford Foundation Fellowship-Tanzania; East West Center-Honolulu; International Ford Foundation Fellowships Program	Funded by International Ford Foundation Fellowship-Tanzania (2009-2012), East West Center-Honolulu (2013).; We wish to thank Tanzania National Parks Headquarters for granting a research permit, the Tarangire and Katavi National Parks management teams and ecology departments of these parks particularly James Wakibara, Abel Mtui, Houston Njamasi and Davis Mushi, for logistical support and information. Assistance by Joseph Mhina, Richard Ndaskoi, Yusuf, Luc Leblanc, and Travis Idol during the field study and data analysis is greatly appreciated. We would also like to thank two anonymous reviewers that provided feedback on the draft manuscript. The USGS Earth Resources Observation and Science Centre has provided the Landsat satellite images. Tanzania Wildlife Research Institute's Conservation and Monitoring Unit, particularly Simon Mduma, Honori Maliti, Machoke Mwita and Hadia Haji have kindly provided data on human activities. This study was financially supported by the International Ford Foundation Fellowships Program to Devolent Mtui.	Banda T, 2008, FOREST ECOL MANAG, V255, P3382, DOI 10.1016/j.foreco.2008.01.079; Banda T, 2006, FOREST ECOL MANAG, V230, P179, DOI 10.1016/j.foreco.2006.04.032; BARNES RFW, 1983, BIOL CONSERV, V26, P127, DOI 10.1016/0006-3207(83)90062-9; Bhola N, 2012, J ANIM ECOL, V81, P1268, DOI 10.1111/j.1365-2656.2012.02000.x; Birkett A, 2005, AFR J ECOL, V43, P123, DOI 10.1111/j.1365-2028.2005.00555.x; Brenneman RA, 2009, AFR J ECOL, V47, P711, DOI 10.1111/j.1365-2028.2008.01029.x; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Byamungu M, 2016, LIVEST RES RURAL DEV, V28; Caro TM, 1999, J APPL ECOL, V36, P205, DOI 10.1046/j.1365-2664.1999.00392.x; Coppin P, 2004, INT J REMOTE SENS, V25, P1565, DOI 10.1080/0143116031000101675; Cumming DHM, 1997, S AFR J SCI, V93, P231; Elisa Manase, 2010, Ecohydrology & Hydrobiology, V10, P153, DOI 10.2478/v10104-011-0001-z; Fisher B, 2007, ECOL ECON, V62, P93, DOI 10.1016/j.ecolecon.2006.05.020; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Govender N, 2006, J APPL ECOL, V43, P748, DOI 10.1111/j.1365-2664.2006.01184.x; Greenwald KR, 2009, BIOL CONSERV, V142, P2493, DOI 10.1016/j.biocon.2009.05.021; Guldemond R, 2008, J WILDLIFE MANAGE, V72, P892, DOI 10.2193/2007-072; Haberl H, 2009, ECOL ECON, V68, P1797, DOI 10.1016/j.ecolecon.2008.11.013; Higgins SI, 2000, J ECOL, V88, P213, DOI 10.1046/j.1365-2745.2000.00435.x; Holdo RM, 2006, J VEG SCI, V17, P509, DOI 10.1111/j.1654-1103.2006.tb02472.x; Holdo RM, 2009, ECOL APPL, V19, P95, DOI 10.1890/07-1954.1; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Ishengoma DRS, 2008, CONSERV GENET, V9, P247, DOI 10.1007/s10592-007-9332-0; Jensen JR, 2007, REMOTE SENSING ENV E; Jensen TE, 2005, INTRO DIGITAL IMAGE; Kiffner C, 2015, AFR J ECOL, V53, P156, DOI 10.1111/aje.12160; KIKULA IS, 1986, OIKOS, V46, P317, DOI 10.2307/3565829; Kioko J, 2013, S AFR J WILDL RES, V43, P44, DOI 10.3957/056.043.0109; LAWTON RM, 1978, J ECOL, V66, P175, DOI 10.2307/2259187; Loarie SR, 2009, BIOL CONSERV, V142, P3099, DOI 10.1016/j.biocon.2009.08.021; Lu D, 2004, INT J REMOTE SENS, V25, P2365, DOI 10.1080/0143116031000139863; Mapaure IN, 2002, AFR J ECOL, V40, P212, DOI 10.1046/j.1365-2028.2002.00355.x; Mfunda Iddi M., 2010, International Journal of Biodiversity and Conservation, V2, P263; MNRT (Ministry of Natural Resources and Tourism), 2007, WILDL POL TANZ; Msoffe FU, 2011, J LAND USE SCI, V6, P261, DOI 10.1080/1747423X.2010.511682; Mundia CN, 2009, REMOTE SENS-BASEL, V1, P952, DOI 10.3390/rs1040952; Munyati C, 2000, INT J REMOTE SENS, V21, P1787, DOI 10.1080/014311600209742; MWALYOSI RBB, 1992, ENVIRON CONSERV, V19, P145, DOI 10.1017/S0376892900030629; Ogutu JO, 2011, J ZOOL, V285, P99, DOI 10.1111/j.1469-7998.2011.00818.x; Ottichilo WK, 2001, BIOL CONSERV, V97, P271, DOI 10.1016/S0006-3207(00)00090-2; Owen-Smith N, 2006, S AFR J SCI, V102, P389; Owen-Smith N.R., 1988, MEGAHERBIVORES INFLU; Pelkey NW, 2003, INT J REMOTE SENS, V24, P2533, DOI 10.1080/01431160210155929; Peter Frost, 1996, MIOMBO TRANSITION WO; PRINS HHT, 1987, BIOL CONSERV, V40, P141, DOI 10.1016/0006-3207(87)90064-4; Reed DN, 2009, J BIOGEOGR, V36, P770, DOI 10.1111/j.1365-2699.2008.02017.x; Richards J. A., 2006, REMOTE SENSING DIGIT; Sanchez-Azofeifa GA, 2003, BIOL CONSERV, V109, P123, DOI 10.1016/S0006-3207(02)00145-3; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Sankaran M, 2008, GLOBAL ECOL BIOGEOGR, V17, P236, DOI 10.1111/j.1466-8238.2007.00360.x; SAS Institute, 2010, SAS SYST WIND VERS 9; Scanlon TM, 2002, REMOTE SENS ENVIRON, V82, P376, DOI 10.1016/S0034-4257(02)00054-8; Sinclair ARE, 2007, CONSERV BIOL, V21, P580, DOI 10.1111/j.1523-1739.2007.00699.x; SINGH A, 1989, INT J REMOTE SENS, V10, P989, DOI 10.1080/01431168908903939; Skarpe C, 2004, AMBIO, V33, P276, DOI 10.1639/0044-7447(2004)033[0276:TROTGE]2.0.CO;2; SKARPE C, 1991, AMBIO, V20, P351; Swain P. H, EMOTE SENSING QUANTI; Van de Vijver CADM, 1999, J TROP ECOL, V15, P545, DOI 10.1017/S0266467499001017; van Langevelde F, 2003, ECOLOGY, V84, P337, DOI 10.1890/0012-9658(2003)084[0337:EOFAHO]2.0.CO;2; Vanclay JK, 2001, SCIENCE, V293, P1007, DOI 10.1126/science.293.5532.1007a; Verbyla DL, 2000, INT J REMOTE SENS, V21, P3553, DOI 10.1080/014311600750037570; Wessels KJ, 2007, J ARID ENVIRON, V68, P271, DOI 10.1016/j.jaridenv.2006.05.015; Western D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006140	64	10	10	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185468	10.1371/journal.pone.0185468	http://dx.doi.org/10.1371/journal.pone.0185468			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957397	Green Published, gold, Green Submitted			2022-12-26	WOS:000411985200065
J	Zheng, W; Wen, MJ; Zhao, ZY; Liu, J; Wang, ZH; Zhai, BN; Li, ZY				Zheng, Wei; Wen, Meijuan; Zhao, Zhiyuan; Liu, Jie; Wang, Zhaohui; Zhai, Bingnian; Li, Ziyan			Black plastic mulch combined with summer cover crop increases the yield and water use efficiency of apple tree on the rainfed Loess Plateau	PLOS ONE			English	Article							BELOW-GROUND INTERACTIONS; ORCHARD FLOOR MANAGEMENT; SOIL-MANAGEMENT; INTERCROPPING SYSTEM; ORGANIC MANURE; GRASS COVER; GROWTH; TEMPERATURE; COMPETITION; INFILTRATION	Water deficit significantly limits dryland rainfed fruit production, so increasing water conservation is crucial for improving fruit productivity in arid and semiarid areas. In this study, we tested two treatments in an apple orchard: 1) PC treatment comprising black plastic mulch (BPM) (in-row) with weed control (inter-row); 2) and PGC treatment comprising BPM (in-row) combined with a summer cover crop (inter-row) of rape (Brassica campestris L.), which was sown in mid-June and was living from July to September. Under PGC, the inter-row soil water storage increased by 17.9% and 11.5% compared with PC after the harvest in 2013 and 2014, respectively, but there was no significant increase in 2015. The evapotranspiration (ET) from the inter-row areas during the cover crop period was lower under PGC than PC in 2013 (19.6%), 2014 (11.3%), and 2015 (13.3%). However, the differences in the total ET from the inter-row areas between the two treatments were not obvious, and the total ET from in-row areas was higher under PGC than PC due to the increased water uptake by apple trees under PGC. The apple yield, water use efficiency during the cover crop period (WUEg) and total water use efficiency (WUE) fluctuated during the experimental years. Compared with PC, the apple yield increased by 14.1%, 18.8%, and 26.7% under PGC in 2013, 2014, and 2015, respectively. In addition, the WUEg was 26.4%, 24.7%, and 32.7% higher under PGC compared with PC in 2013, 2014, and 2015, respectively. Thus, the WUE under PGC was 13.8% and 11.7% higher than that under PC in 2013 and 2014, respectively, but the difference was not significant in 2015 (p = 0.0527). Thus, BPM combined with a summer cover crop is recommended for decreasing the summer ET and promoting apple production in rainfed dryland areas where the rainy season is usually the hot season.	[Zheng, Wei; Wen, Meijuan; Zhao, Zhiyuan; Liu, Jie; Wang, Zhaohui; Zhai, Bingnian; Li, Ziyan] Northwest A&F Univ, Coll Resources & Environm, Yangling, Peoples R China; [Zheng, Wei; Wen, Meijuan; Zhao, Zhiyuan; Liu, Jie; Wang, Zhaohui; Zhai, Bingnian; Li, Ziyan] Minist Agr, Key Lab Plant Nutr & Agrienvironm Northwest China, Yangling, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs	Zhai, BN; Li, ZY (corresponding author), Northwest A&F Univ, Coll Resources & Environm, Yangling, Peoples R China.; Zhai, BN; Li, ZY (corresponding author), Minist Agr, Key Lab Plant Nutr & Agrienvironm Northwest China, Yangling, Peoples R China.	bingnianzhaitg@126.com; liziyan0161@126.com		Zheng, Wei/0000-0002-5034-4712	Special Fund for Agro-scientific Research in the Public Interest of China [201303104, 201103005-9]; Agriculture Science Technology Achievement Transformation Fund of Shaanxi (NYKJ); Science and Technology Innovation Project of Shaanxi Province [2011KTZB02-02-05]; Project of Promoting Agricultural Science and Technology Demonstration of Yangling [2015-TS-18]; Scientific and Technological Achievements Promotion Project of Northwest AF University [TGZX2014-16]	Special Fund for Agro-scientific Research in the Public Interest of China; Agriculture Science Technology Achievement Transformation Fund of Shaanxi (NYKJ); Science and Technology Innovation Project of Shaanxi Province; Project of Promoting Agricultural Science and Technology Demonstration of Yangling; Scientific and Technological Achievements Promotion Project of Northwest AF University	Funded by Special Fund for Agro-scientific Research in the Public Interest of China (201303104, 201103005-9), Agriculture Science Technology Achievement Transformation Fund of Shaanxi (NYKJ-2015-17), the Science and Technology Innovation Project of Shaanxi Province (2011KTZB02-02-05), the Project of Promoting Agricultural Science and Technology Demonstration of Yangling (2015-TS-18), the Scientific and Technological Achievements Promotion Project of Northwest A&F University (TGZX2014-16) to Bingnian Zhai.	Bhardwaj R. L., 2013, Agricultural Reviews, V34, P188, DOI 10.5958/j.0976-0741.34.3.003; CARDINA J, 1986, WEED SCI, V34, P338, DOI 10.1017/S0043174500066959; Celette F, 2005, PLANT SOIL, V276, P205, DOI 10.1007/s11104-005-4415-5; Celette F, 2009, EUR J AGRON, V30, P41, DOI 10.1016/j.eja.2008.07.003; Celette F, 2008, EUR J AGRON, V29, P153, DOI 10.1016/j.eja.2008.04.007; Chen YX, 2014, SCI HORTIC-AMSTERDAM, V172, P248, DOI 10.1016/j.scienta.2014.04.010; Cook HF, 2006, SOIL TILL RES, V91, P227, DOI 10.1016/j.still.2005.12.007; Du SN, 2015, PLANT SOIL, V390, P431, DOI 10.1007/s11104-014-2363-7; DUNCAN RA, 1992, J NEMATOL, V24, P681; Fetene M, 2003, J ARID ENVIRON, V55, P441, DOI 10.1016/S0140-1963(03)00052-1; FOLORUNSO OA, 1992, SOIL TECHNOL, V5, P189, DOI 10.1016/0933-3630(92)90021-R; Giese G, 2014, SCI HORTIC-AMSTERDAM, V170, P256, DOI 10.1016/j.scienta.2014.03.011; GLENN DM, 1989, J AM SOC HORTIC SCI, V114, P10; GULICK SH, 1994, SOIL SCI SOC AM J, V58, P1539, DOI 10.2136/sssaj1994.03615995005800050038x; HAM JM, 1993, J AM SOC HORTIC SCI, V118, P188, DOI 10.21273/JASHS.118.2.188; Hammermeister AM, 2016, SCI HORTIC-AMSTERDAM, V208, P28, DOI 10.1016/j.scienta.2016.02.004; Hanninen K, 1999, PLANT SOIL, V216, P129, DOI 10.1023/A:1004731009386; HAYNES RJ, 1980, AGRO-ECOSYSTEMS, V6, P3, DOI 10.1016/0304-3746(80)90003-7; JARVIS BDW, 1983, CURR MICROBIOL, V8, P153, DOI 10.1007/BF01568849; King AP, 2005, AGR ECOSYST ENVIRON, V109, P262, DOI 10.1016/j.agee.2005.03.002; Klodd AE, 2016, PLANT SOIL, V400, P391, DOI 10.1007/s11104-015-2748-2; Lehmann J, 1998, FOREST ECOL MANAG, V111, P157, DOI 10.1016/S0378-1127(98)00322-3; LIAKATAS A, 1986, AGR FOREST METEOROL, V36, P227, DOI 10.1016/0168-1923(86)90037-7; Liu CA, 2013, AGR WATER MANAGE, V117, P123, DOI 10.1016/j.agwat.2012.11.002; Liu QF, 2016, SOIL TILL RES, V157, P1, DOI 10.1016/j.still.2015.11.003; Lopes CM, 2011, SCI HORTIC-AMSTERDAM, V129, P603, DOI 10.1016/j.scienta.2011.04.033; MERWIN IA, 1994, J AM SOC HORTIC SCI, V119, P209, DOI 10.21273/JASHS.119.2.209; NEILSEN GH, 1986, CAN J SOIL SCI, V66, P701, DOI 10.4141/cjss86-069; Parker ML, 1996, HORTSCIENCE, V31, P330, DOI 10.21273/HORTSCI.31.3.330; Poeplau C, 2015, AGR ECOSYST ENVIRON, V200, P33, DOI 10.1016/j.agee.2014.10.024; Pradel E., 2000, Australian Journal of Grape and Wine Research, V6, P59, DOI 10.1111/j.1755-0238.2000.tb00163.x; PRICHARD T L, 1989, California Agriculture, V43, P23; Qian X, 2015, EUR J SOIL BIOL, V70, P23, DOI 10.1016/j.ejsobi.2015.06.005; Qin SH, 2014, AGR WATER MANAGE, V131, P87, DOI 10.1016/j.agwat.2013.09.015; Ramos ME, 2011, SOIL TILL RES, V112, P85, DOI 10.1016/j.still.2010.11.007; ROBERSON EB, 1991, SOIL SCI SOC AM J, V55, P734, DOI 10.2136/sssaj1991.03615995005500030016x; de Oliveira FER, 2016, REV BRAS CIENC SOLO, V40, DOI 10.1590/18069657rbcs20150105; Sanchez EE, 2007, PLANT SOIL, V292, P193, DOI 10.1007/s11104-007-9215-7; Smith DM, 1999, PLANT SOIL, V211, P191, DOI 10.1023/A:1004635414462; Szilagyi J, 2014, J HYDROL, V519, P455, DOI 10.1016/j.jhydrol.2014.07.040; TerAvest D, 2011, HORTSCIENCE, V46, P1687, DOI 10.21273/HORTSCI.46.12.1687; Walsh BD, 1996, CAN J SOIL SCI, V76, P203, DOI 10.4141/cjss96-028; [王改兰 WANG Gailan], 2006, [水土保持学报, Journal of Soil and Water Conservation], V20, P82; Wang H, 2015, AGR WATER MANAGE, V154, P20, DOI 10.1016/j.agwat.2015.02.010; Wu JS, 2014, SOIL RES, V52, P575, DOI 10.1071/SR14021; Yang Y., 2013, FOOD NUTR CHINA, V19, P23; Yao S, 2005, PLANT SOIL, V271, P377, DOI 10.1007/s11104-004-3610-0; Zhao ZP, 2014, INT J AGR BIOL ENG, V7, P45, DOI 10.3965/j.ijabe.20140702.006; Zribi W, 2015, SOIL TILL RES, V148, P40, DOI 10.1016/j.still.2014.12.003	49	26	28	9	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185705	10.1371/journal.pone.0185705	http://dx.doi.org/10.1371/journal.pone.0185705			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957428	gold, Green Published, Green Submitted			2022-12-26	WOS:000411985200109
J	Murakami, A; Matsuda, M; Harada, Y; Hirata, M				Murakami, Ayako; Matsuda, Miho; Harada, Yui; Hirata, Masato			Phospholipase C-related, but catalytically inactive protein (PRIP) up-regulates osteoclast differentiation via calcium-calcineurin-NFATc1 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROPHTHALMIA TRANSCRIPTION FACTOR; INS(1,4,5)P-3 BINDING-PROTEIN; ORTHODONTIC TOOTH MOVEMENT; NECROSIS-FACTOR RECEPTOR; GENE-EXPRESSION; EXPERIMENTAL-MODEL; GABA(A) RECEPTORS; NFATC1; CELLS; MICE	Phospholipase C-related, but catalytically inactive protein (PRIP) was previously identified as a novel inositol 1,4,5-trisphosphate-binding protein with a domain organization similar to that of phospholipase C-delta but lacking phospholipase activity. We recently showed that PRIP gene knock-out (KO) in mice increases bone formation and concomitantly decreases bone resorption, resulting in increased bone mineral density and trabecular bone volume. However, the role of PRIP in osteoclastogenesis has not yet been fully elucidated. Here, we investigated the effects of PRIP on bone remodeling by investigating dynamic tooth movement in mice fitted with orthodontic devices. Morphological analysis indicated that the extent of tooth movement was smaller in the PRIP-KO mice than in wild-type mice. Histological analysis revealed fewer osteoclasts on the bone-resorption side in maxillary bones of PRIP-KO mice, and osteoclast formation assays and flow cytometry indicated lower osteoclast differentiation in bone marrow cells isolated from these mice. The expression of genes implicated in bone resorption was lower in differentiated PRIP-KO cells, and genes involved in osteoclast differentiation, such as the transcription factor NFATc1, exhibited lower expression in immature PRIP-KO cells initiated by M-CSF. Moreover, calcineurin expression and activity were also lower in the PRIP-KO cells. The PRIP-KO cells also displayed fewer M-CSF-induced changes in intracellular Ca2+ and exhibited reduced nuclear localization of NFATc1. Up-regulation of intracellular Ca2+ restored osteoclastogenesis of the PRIP-KO cells. These results indicate that PRIP deficiency impairs osteoclast differentiation, particularly at the early stages, and that PRIP stimulates osteoclast differentiation through calcium-calcineurin-NFATc1 signaling via regulating intracellular Ca2+.	[Murakami, Ayako; Matsuda, Miho; Hirata, Masato] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 8128582, Japan; [Harada, Yui] Kyushu Univ, Grad Sch Pharmaceut Sci, R&D Lab Innovat Biotherapeut, Fukuoka 8128582, Japan; [Hirata, Masato] Fukuoka Dent Coll, Fukuoka 8140175, Japan	Kyushu University; Kyushu University; Fukuoka Dental College (FDC)	Matsuda, M (corresponding author), Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	natural@dent.kyushu-u.ac.jp			Japan Society for the Promotion of Science [24229009, 24592804]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-aid for Scientific Research (KAKENHI nos. 24229009 (to M. H.) and 24592804 (to M. M.)) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Andrade I, 2007, J DENT RES, V86, P1089, DOI 10.1177/154405910708601113; Andrade I, 2009, J DENT RES, V88, P1037, DOI 10.1177/0022034509346230; Armstrong AP, 2002, J BIOL CHEM, V277, P44347, DOI 10.1074/jbc.M202009200; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Bourette RP, 1997, EMBO J, V16, P5880, DOI 10.1093/emboj/16.19.5880; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Crotti T. N., 2008, J CELL; Taddei SRD, 2012, J BIOMECH, V45, P2729, DOI 10.1016/j.jbiomech.2012.09.006; Fujii M, 2010, J BIOL CHEM, V285, P4837, DOI 10.1074/jbc.M109.070045; Gao J, 2012, J BIOL CHEM, V287, P10565, DOI 10.1074/jbc.M111.294645; Harada K, 2005, J CELL PHYSIOL, V202, P422, DOI 10.1002/jcp.20136; Helfrich MH, 2003, MICROSC RES TECHNIQ, V61, P514, DOI 10.1002/jemt.10375; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Inaba T, 1996, MOL CELL BIOL, V16, P2264; Inoue M, 1998, MOL ENDOCRINOL, V12, P1955, DOI 10.1210/me.12.12.1955; Kanematsu T, 2005, MOL CELLS, V20, P305; Kanematsu T, 1996, BIOCHEM J, V313, P319, DOI 10.1042/bj3130319; KANEMATSU T, 1992, J BIOL CHEM, V267, P6518; Kanematsu T, 2000, EUR J BIOCHEM, V267, P2731, DOI 10.1046/j.1432-1327.2000.01291.x; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kotani M, 2015, J CELL BIOCHEM, V116, P2814, DOI 10.1002/jcb.25228; Long Courtney L, 2012, Bonekey Rep, V1; Luchin A, 2001, J BIOL CHEM, V276, P36703, DOI 10.1074/jbc.M106418200; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Matsuda M, 2009, BIOL REPROD, V81, P681, DOI 10.1095/biolreprod.109.076760; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Matsumoto M, 2001, J BIOL CHEM, V276, P33086, DOI 10.1074/jbc.M104299200; Mizokami A, 2007, J NEUROSCI, V27, P1692, DOI 10.1523/JNEUROSCI.3155-06.2007; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Pavlin D, 2000, ORTHODONTICALLY STRE, V3, P55; Ren YJ, 2007, J PERIODONTOL, V78, P453, DOI 10.1902/jop.2007.060261; Schmidt S, 2011, J CELL BIOL, V192, P883, DOI 10.1083/jcb.201007141; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; SHINAR DM, 1993, J BONE MINER RES, V8, P403; So H, 2003, J BIOL CHEM, V278, P24209, DOI 10.1074/jbc.M302940200; Soysa Niroshani Surangika, 2012, J Med Dent Sci, V59, P65; STOREY E, 1973, AM J ORTHOD DENTOFAC, V63, P292, DOI 10.1016/0002-9416(73)90353-9; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Sugiyama Goro, 2013, Advances in Biological Regulation, V53, P331, DOI 10.1016/j.jbior.2013.07.001; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takenaka K, 2003, MOL CELL BIOL, V23, P7329, DOI 10.1128/MCB.23.20.7329-7338.2003; Takeuchi H, 2000, BIOCHEM J, V349, P357, DOI 10.1042/0264-6021:3490357; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; Toyoda H, 2015, PFLUG ARCH EUR J PHY, V467, P267, DOI 10.1007/s00424-014-1511-5; Tsutsumi K, 2011, J BIOL CHEM, V286, P31032, DOI 10.1074/jbc.M111.235903; Verna C, 2004, EUR J ORTHODONT, V26, P459, DOI 10.1093/ejo/26.5.459; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; YOSHIDA M, 1994, J BIOCHEM, V115, P973, DOI 10.1093/oxfordjournals.jbchem.a124447; Yoshimatsu M, 2006, J BONE MINER METAB, V24, P20, DOI 10.1007/s00774-005-0641-4; Yoshimura K, 2001, J BIOL CHEM, V276, P17908, DOI 10.1074/jbc.M009677200; Zhang Z, 2013, J BIOL CHEM, V288, P7769, DOI 10.1074/jbc.M112.419317; Zhu HJ, 1996, J CELL BIOCHEM, V61, P420; Zou W, 2013, MOL CELL BIOL, V33, P830, DOI 10.1128/MCB.00790-12	60	20	23	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7994	8006		10.1074/jbc.M117.784777	http://dx.doi.org/10.1074/jbc.M117.784777			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28341745	Green Published, hybrid			2022-12-26	WOS:000401154100025
